<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE MedlineCitationSet PUBLIC "-//NLM//DTD Medline Citation, 1st January, 2016//EN"
                                    "https://www.nlm.nih.gov/databases/dtd/nlmmedlinecitationset_160101.dtd">
<MedlineCitationSet>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">17942999</PMID>
<DateCreated>
<Year>2007</Year>
<Month>10</Month>
<Day>18</Day>
</DateCreated>
<DateCompleted>
<Year>2008</Year>
<Month>02</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0922-6028</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>25</Volume>
<Issue>3-4</Issue>
<PubDate>
<Year>2007</Year>
</PubDate>
</JournalIssue>
<Title>Restorative neurology and neuroscience</Title>
<ISOAbbreviation>Restor. Neurol. Neurosci.</ISOAbbreviation>
</Journal>
<ArticleTitle>Neuroplasticity in the processing of pitch dimensions: a multidimensional scaling analysis of the mismatch negativity.</ArticleTitle>
<Pagination>
<MedlinePgn>195-210</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">An auditory electrophysiological study was conducted to explore the influence of language experience on the saliency of dimensions underlying cortical pitch processing.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Mismatch negativity (MMN) responses to Mandarin tones were recorded in Chinese and English participants (n=10 per group) using a passive oddball paradigm. Stimuli consisted of three tones (T1: high level; T2: high rising; T3: low falling-rising). There were three oddball conditions (standard/deviant): T1/T2, T1/T3, T2/T3. In the T1/T2 and T1/T3 conditions, each tonal pair represented a contrast between a level and a contour tone; the T2/T3 condition, a contrast between two contour tones. Twenty dissimilarity matrices were created using the MMN mean amplitude measured from the Fz location for each condition per participant, and analyzed by an individual differences multidimensional scaling model.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Two pitch dimensions were revealed, interpretively labeled as 'height' and 'contour'. The latter was found to be more important for Chinese than English subjects. Using individual weights on the contour dimension, a discriminant function showed that 17 out of 20 participants were correctly classified into their respective language groups.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The MMN can serve as an index of pitch features that are differentially weighted depending on a listener's experience with lexical tones and their acoustic correlates within a particular tone space.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chandrasekaran</LastName>
<ForeName>Bharath</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Speech Language &amp; Hearing Sciences, Purdue University, West Lafayette, IN 47907-2038, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gandour</LastName>
<ForeName>Jackson T</ForeName>
<Initials>JT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Krishnan</LastName>
<ForeName>Ananthanarayan</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 DC008549</GrantID>
<Acronym>DC</Acronym>
<Agency>NIDCD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DC008549-01A1</GrantID>
<Acronym>DC</Acronym>
<Agency>NIDCD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Restor Neurol Neurosci</MedlineTA>
<NlmUniqueID>9005499</NlmUniqueID>
<ISSNLinking>0922-6028</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000161">Acoustic Stimulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003627">Data Interpretation, Statistical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004569">Electroencephalography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005072">Evoked Potentials, Auditory</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007802">Language</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009473">Neuronal Plasticity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010898">Pitch Perception</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS672708</OtherID>
<OtherID Source="NLM">PMC4380289</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">18621939</PMID>
<DateCreated>
<Year>2008</Year>
<Month>07</Month>
<Day>14</Day>
</DateCreated>
<DateCompleted>
<Year>2008</Year>
<Month>08</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0033-3182</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>49</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2008 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Psychosomatics</Title>
<ISOAbbreviation>Psychosomatics</ISOAbbreviation>
</Journal>
<ArticleTitle>Clusters of alcohol use disorders diagnostic criteria and predictors of alcohol use after liver transplantation for alcoholic liver disease.</ArticleTitle>
<Pagination>
<MedlinePgn>332-40</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1176/appi.psy.49.4.332</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Establishing the correct alcohol use disorder diagnosis is clinically relevant because several reports of post-transplant alcohol use suggest that a pre-transplant diagnosis of alcohol dependence (rather than abuse) predicts relapse to alcohol use. Numerous combinations of specific symptoms are possible to achieve diagnostic significance.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The authors hypothesized that there would be distinct clusters of liver transplant recipients who showed specific combinations of alcohol-related symptoms and that these clusters would be predictive of alcohol-abuse outcome after transplant.</AbstractText>
<AbstractText Label="METHOD" NlmCategory="METHODS">A group of 120 ALD liver transplant recipients received the Structured Clinical Interview for DSM-IV (SCID) module for alcohol abuse/dependence, and a cluster analysis was performed.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Within the clusters of those with alcohol dependence, cluster assignment did not predict those more likely to drink. However, those assigned to the alcohol abuse cluster were significantly less likely to drink than those with alcohol dependence.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Results therefore suggest that the prognosis regarding continued abstinence posttransplant is much more positive for individuals with a diagnosis of abuse than for those who meet criteria for alcohol dependence.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>DiMartini</LastName>
<ForeName>Andrea</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>The University of Pittsburgh Medical Center and Starzl Transplant Institute, Pittsburgh, PA 15213, USA. dimartiniaf@upmc.edu</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dew</LastName>
<ForeName>Mary Amanda</ForeName>
<Initials>MA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fitzgerald</LastName>
<ForeName>Mary Grace</ForeName>
<Initials>MG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fontes</LastName>
<ForeName>Paulo</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K23 AA000257</GrantID>
<Acronym>AA</Acronym>
<Agency>NIAAA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K23 AA0257</GrantID>
<Acronym>AA</Acronym>
<Agency>NIAAA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DK066266</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DK066266</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Psychosomatics</MedlineTA>
<NlmUniqueID>0376506</NlmUniqueID>
<ISSNLinking>0033-3182</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000437">Alcoholism</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016000">Cluster Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D039721">Diagnostic and Statistical Manual of Mental Disorders</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008108">Liver Diseases, Alcoholic</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016031">Liver Transplantation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011182">Postoperative Care</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011237">Predictive Value of Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011300">Preoperative Care</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011795">Surveys and Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS724093</OtherID>
<OtherID Source="NLM">PMC4631030</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">19602546</PMID>
<DateCreated>
<Year>2009</Year>
<Month>07</Month>
<Day>31</Day>
</DateCreated>
<DateCompleted>
<Year>2009</Year>
<Month>11</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1078-0432</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>15</Volume>
<Issue>15</Issue>
<PubDate>
<Year>2009</Year>
<Month>Aug</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>Clinical cancer research : an official journal of the American Association for Cancer Research</Title>
<ISOAbbreviation>Clin. Cancer Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Prediction of muscle-invasive bladder cancer using urinary proteomics.</ArticleTitle>
<Pagination>
<MedlinePgn>4935-43</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1158/1078-0432.CCR-09-0226</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Minimally invasive methods of predicting the risk of muscle-invasive urothelial bladder carcinoma may expedite appropriate therapy and reduce morbidity and cost.</AbstractText>
<AbstractText Label="EXPERIMENTAL DESIGN" NlmCategory="METHODS">Here, capillary electrophoresis coupled mass spectrometry was used to identify urinary polypeptide bladder cancer biomarkers in 127 patients. These markers were used to construct a panel discriminating muscle-invasive from noninvasive disease, which was refined in 297 additional samples from healthy volunteers, patients with malignant and nonmalignant genitourinary conditions. Sequencing of panel polypeptides was then done. Finally, the ability of the panel to predict muscle-invasive disease was evaluated prospectively in 130 bladder carcinoma patients. Four sequenced polypeptides formed a panel predictive of muscle-invasive disease.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Prospective evaluation of this panel revealed a sensitivity of 81% [95% confidence interval (CI), 69-90] and specificity of 57% (95% CI, 45-69) for muscle-invasive disease. Multivariate analysis revealed the panel (P &lt; 0.0001) and tumor grade (P = 0.0001), but not urine cytology, predict muscle invasion. A model including grade and panel polypeptide levels improved sensitivity [92% (95% CI, 82-97)] and specificity [68% (95% CI, 55-79)] for muscle-invasive disease. A model score of &gt;0.88 provided a negative predictive value of 77% and positive predictive value of 90% for muscle invasion.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Use of urinary peptides seems promising in estimating the probability a patient harbors muscle-invasive urothelial bladder cancer. These peptides may also shed novel insights into the biology of bladder tumor progression not obtainable by other methods. Clinical trials seem warranted to evaluate the effect of this approach on practice.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Schiffer</LastName>
<ForeName>Eric</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Mosaiques Diagnostics and Therapeutics, Hannover, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vlahou</LastName>
<ForeName>Antonia</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Petrolekas</LastName>
<ForeName>Andreas</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Stravodimos</LastName>
<ForeName>Konstantinos</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tauber</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Geschwend</LastName>
<ForeName>Jürgen E</ForeName>
<Initials>JE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Neuhaus</LastName>
<ForeName>Jochen</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Stolzenburg</LastName>
<ForeName>Jens-Uwe</ForeName>
<Initials>JU</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Conaway</LastName>
<ForeName>Mark R</ForeName>
<Initials>MR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mischak</LastName>
<ForeName>Harald</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Theodorescu</LastName>
<ForeName>Dan</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>CA104106</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 CA046934</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA075115</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA075115-12</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2009</Year>
<Month>07</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Clin Cancer Res</MedlineTA>
<NlmUniqueID>9502500</NlmUniqueID>
<ISSNLinking>1078-0432</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010455">Peptides</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014408">Biomarkers, Tumor</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019075">Electrophoresis, Capillary</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013058">Mass Spectrometry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015999">Multivariate Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009361">Neoplasm Invasiveness</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010455">Peptides</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000032">analysis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011379">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D040901">Proteomics</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001749">Urinary Bladder Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019459">Urothelium</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">19302341</PMID>
<DateCreated>
<Year>2009</Year>
<Month>08</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2009</Year>
<Month>10</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1365-2869</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>18</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2009</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Journal of sleep research</Title>
<ISOAbbreviation>J Sleep Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Women sleep objectively better than men and the sleep of young women is more resilient to external stressors: effects of age and menopause.</ArticleTitle>
<Pagination>
<MedlinePgn>221-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1365-2869.2008.00713.x</ELocationID>
<Abstract>
<AbstractText>The aims of this study were to: (i) assess gender differences of objective sleep patterns in a general population sample; (ii) evaluate the effects of menopause and hormone treatment (HT) on the sleep of the same cohort; and (iii) examine gender differences in sleep resilience towards external stressors. The participants were (i) 1324 subjects without sleep complaints, recruited from the general population of Central Pennsylvania that spent one night in the sleep laboratory and (ii) 66 young, healthy volunteers whose sleep was disturbed during night four by an external stressor, i.e. 24-h blood drawing (average of nights 2 and 3 versus night 4). Women compared with men in the general population sample had significantly higher percentage of sleep time, lower percentage of stage 1, and higher percentage of slow wave sleep. Also, menopause, in the absence of HT, was associated with prolonged sleep latency and decreased deep sleep. Finally, young, healthy women compared with men experienced less sleep disturbance because of blood draws as indicated by a significantly smaller change in per cent sleep time, and percentage of stage 1 sleep. These findings suggest that women without sleep complaints sleep objectively better across age than men and the sleep of young women is more resistant to external stressors. Also, gonadal hormones exert a beneficial effect on women's sleep. This gender dimorphism in sleep regulation may have been to protect women from the demands of infant and child care, and in part, might contribute to women's lower cardiovascular risks and greater longevity.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bixler</LastName>
<ForeName>Edward O</ForeName>
<Initials>EO</Initials>
<AffiliationInfo>
<Affiliation>Sleep Research and Treatment Center, Department of Psychiatry, Penn State College of Medicine, Hershey, PA 17033, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Papaliaga</LastName>
<ForeName>Maria N</ForeName>
<Initials>MN</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vgontzas</LastName>
<ForeName>Alexandros N</ForeName>
<Initials>AN</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lin</LastName>
<ForeName>Hung-Mo</ForeName>
<Initials>HM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pejovic</LastName>
<ForeName>Slobodanka</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Karataraki</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vela-Bueno</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chrousos</LastName>
<ForeName>George P</ForeName>
<Initials>GP</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01  HL040916</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01  HL051931</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL040916</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL40916</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL51931</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL64415</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2009</Year>
<Month>03</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Sleep Res</MedlineTA>
<NlmUniqueID>9214441</NlmUniqueID>
<ISSNLinking>0962-1105</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Sleep Res. 2000 Mar;9(1):35-42</RefSource>
<PMID Version="1">10733687</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):608-13</RefSource>
<PMID Version="1">11254512</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Endocrinol Metab. 2001 Apr;86(4):1489-95</RefSource>
<PMID Version="1">11297573</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychiatry Clin Neurosci. 2001 Jun;55(3):305-10</RefSource>
<PMID Version="1">11422885</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2001 Dec 15;24(8):886-94</RefSource>
<PMID Version="1">11766158</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Psychosom Res. 2002 Jul;53(1):589-92</RefSource>
<PMID Version="1">12127176</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Psychiatr Res. 2003 Jan-Feb;37(1):9-15</RefSource>
<PMID Version="1">12482465</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Menopause. 2003 Jan-Feb;10(1):19-28</RefSource>
<PMID Version="1">12544673</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Crit Care Med. 2003 May 1;167(9):1186-92</RefSource>
<PMID Version="1">12531779</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2003 May 8;348(19):1839-54</RefSource>
<PMID Version="1">12642637</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2003 Sep15;26(6):667-72</RefSource>
<PMID Version="1">14572118</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Intern Med. 2004 Feb 23;164(4):406-18</RefSource>
<PMID Version="1">14980992</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2004 Mar 15;27(2):293-8</RefSource>
<PMID Version="1">15124725</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Endocrinol Metab. 2004 May;89(5):2119-26</RefSource>
<PMID Version="1">15126529</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br Med J. 1977 Nov 19;2(6098):1317-9</RefSource>
<PMID Version="1">338104</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 1979 Nov 30;242(22):2405-4</RefSource>
<PMID Version="1">226735</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 1980;3(3-4):221-4</RefSource>
<PMID Version="1">7221330</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychosom Med. 1981 Oct;43(5):439-51</RefSource>
<PMID Version="1">7313035</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 1982;5(2):154-8</RefSource>
<PMID Version="1">7100745</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biol Psychiatry. 1984 Nov;19(11):1537-50</RefSource>
<PMID Version="1">6542805</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 1989 Apr;12(2):113-9</RefSource>
<PMID Version="1">2711087</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Consult Clin Psychol. 1990 Jun;58(3):345-51</RefSource>
<PMID Version="1">2365898</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 1991 Oct;14(5):392-8</RefSource>
<PMID Version="1">1759091</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Gen Psychiatry. 1992 Aug;49(8):651-68; discussion 669-70</RefSource>
<PMID Version="1">1386215</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMJ. 1993 Jun 12;306(6892):1604-7</RefSource>
<PMID Version="1">8329929</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 1996 May;19(4):304-11</RefSource>
<PMID Version="1">8776788</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Ther. 1997 Mar-Apr;19(2):304-11</RefSource>
<PMID Version="1">9152569</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Obstet Gynaecol. 1997 Aug;104(8):923-33</RefSource>
<PMID Version="1">9255084</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 1997 Jun;20(6):381-7</RefSource>
<PMID Version="1">9302720</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Crit Care Med. 1998 Jan;157(1):144-8</RefSource>
<PMID Version="1">9445292</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep Med. 2006 Jan;7(1):49-53</RefSource>
<PMID Version="1">16194623</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000375">Aging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001143">Arousal</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001800">Blood Specimen Collection</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015331">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015914">Estrogen Replacement Therapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007600">Judgment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008593">Menopause</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017286">Polysomnography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011930">Reaction Time</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012016">Reference Values</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012727">Sex Characteristics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012894">Sleep Stages</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS450205</OtherID>
<OtherID Source="NLM">PMC3594776</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">19368899</PMID>
<DateCreated>
<Year>2009</Year>
<Month>08</Month>
<Day>28</Day>
</DateCreated>
<DateCompleted>
<Year>2009</Year>
<Month>11</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-2402</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>66</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2009</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Biological psychiatry</Title>
<ISOAbbreviation>Biol. Psychiatry</ISOAbbreviation>
</Journal>
<ArticleTitle>Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?</ArticleTitle>
<Pagination>
<MedlinePgn>549-53</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopsych.2009.02.017</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Brain-derived neurotrophic factor (BDNF) plays a critical role in neurodevelopment and plasticity; decreased BDNF functioning may contribute to the pathogenesis of schizophrenia. However, BDNF levels are not static; in animal experiments, brain BDNF increases during spatial learning, and in clinical depression, successful antidepressant treatment raises serum BDNF. We asked: would neuroplasticity-based cognitive training in schizophrenia result in increased serum BDNF?</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Fifty-six schizophrenia outpatients and 16 matched healthy comparison subjects were assessed on baseline cognitive performance and serum BDNF. Schizophrenia subjects were randomly assigned to either 50 hours (10 weeks) of computerized auditory training or a computer game control condition, followed by reassessment of cognition and serum BDNF.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">At baseline, schizophrenia participants had significantly lower-than-normal serum BDNF. Schizophrenia subjects who engaged in computerized cognitive training designed to improve auditory processing showed significant cognitive gains and a significant increase in serum BDNF compared with subjects who played computer games. This increase was evident after 2 weeks of training, and after 10 weeks in the active condition, subjects "normalized" their mean serum BDNF levels, whereas the control group showed no change. In the active condition, change in BDNF was significantly associated with improved quality of life.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Serum BDNF levels are significantly increased in clinically stable, chronically ill schizophrenia subjects after neuroplasticity-based cognitive training, but not after computer games. Serum BDNF levels may serve as a peripheral biomarker for the effects of intensive cognitive training and may provide a useful tool for the evaluation of cognitive enhancement methods in schizophrenia.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vinogradov</LastName>
<ForeName>Sophia</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, School of Medicine, University of California-San Francisco, California 94121, USA. Sophia.vinogradov@ucsf.edu</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fisher</LastName>
<ForeName>Melissa</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Holland</LastName>
<ForeName>Christine</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shelly</LastName>
<ForeName>Wendy</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wolkowitz</LastName>
<ForeName>Owen</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mellon</LastName>
<ForeName>Synthia H</ForeName>
<Initials>SH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 MH068725</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 MH068725-01A1</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 MH083784</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1 RR024131</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2009</Year>
<Month>04</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Biol Psychiatry</MedlineTA>
<NlmUniqueID>0213264</NlmUniqueID>
<ISSNLinking>0006-3223</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019208">Brain-Derived Neurotrophic Factor</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000704">Analysis of Variance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019208">Brain-Derived Neurotrophic Factor</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016022">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003072">Cognition Disorders</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000534">rehabilitation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015928">Cognitive Therapy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004797">Enzyme-Linked Immunosorbent Assay</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009483">Neuropsychological Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011569">Psychiatric Status Rating Scales</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011788">Quality of Life</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012559">Schizophrenia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012565">Schizophrenic Psychology</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013813">Therapy, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">20501835</PMID>
<DateCreated>
<Year>2010</Year>
<Month>06</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2010</Year>
<Month>07</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1538-7445</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>70</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2010</Year>
<Month>Jun</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Cancer research</Title>
<ISOAbbreviation>Cancer Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Strain-specific susceptibility for pulmonary metastasis of sarcoma 180 cells in inbred mice.</ArticleTitle>
<Pagination>
<MedlinePgn>4859-67</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1158/0008-5472.CAN-09-4177</ELocationID>
<Abstract>
<AbstractText>Most cancer deaths are a result of metastasis. To extend our understanding of the factors that influence the process, we aimed to develop a mouse model of pulmonary metastasis that can be assayed in multiple inbred mouse strains for further use in identification of host genetic variants that influence metastasis. We used i.v. injection of Sarcoma 180 (S180) cells, which can be tracked and quantified by bioluminescence imaging. We observed growth of S180 cells solely in the lung and observed a wide range of pulmonary metastasis among inbred mouse strains. Interestingly, we noted that the BTBRT+tf/J strain exhibited complete clearance and provide evidence that the mechanism of resistance may involve immune factors, as strains subjected to whole-body irradiation are significantly more susceptible to tumor growth. One possible mechanism of resistance to pulmonary metastasis in BTBRT+tf/J mice may require T-cell function. Our experiments present a new mouse model for further characterization of the genetics and mechanisms of pulmonary metastasis.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vikis</LastName>
<ForeName>Haris G</ForeName>
<Initials>HG</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jackson</LastName>
<ForeName>Erin N</ForeName>
<Initials>EN</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Krupnick</LastName>
<ForeName>Alexander S</ForeName>
<Initials>AS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Franklin</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gelman</LastName>
<ForeName>Andrew E</ForeName>
<Initials>AE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Qiong</ForeName>
<Initials>Q</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Piwnica-Worms</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>You</LastName>
<ForeName>Ming</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K08 CA131097</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 CA91842</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 DK052574</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 DK52574</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P50 CA94056</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA078797</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA134433</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL094601</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01CA134433</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2010</Year>
<Month>05</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Cancer Res</MedlineTA>
<NlmUniqueID>2984705R</NlmUniqueID>
<ISSNLinking>0008-5472</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004195">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004198">Disease Susceptibility</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005434">Flow Cytometry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008175">Lung Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000556">secondary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008212">Lymphocyte Depletion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008805">Mice, Inbred A</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008806">Mice, Inbred AKR</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008811">Mice, Inbred DBA</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009368">Neoplasm Transplantation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012510">Sarcoma 180</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000556">secondary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013045">Species Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013601">T-Lymphocytes</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014916">Whole-Body Irradiation</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS744202</OtherID>
<OtherID Source="NLM">PMC4690845</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">20939768</PMID>
<DateCreated>
<Year>2010</Year>
<Month>10</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>2011</Year>
<Month>06</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1464-5203</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>27</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2010</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Molecular membrane biology</Title>
<ISOAbbreviation>Mol. Membr. Biol.</ISOAbbreviation>
</Journal>
<ArticleTitle>pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents.</ArticleTitle>
<Pagination>
<MedlinePgn>341-52</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3109/09687688.2010.509285</ELocationID>
<Abstract>
<AbstractText>Abstract Here we review a novel class of delivery vehicles based on pH-sensitive, moderately polar membrane peptides, which we call pH (Low) Insertion Peptides (pHLIPs), that target cells located in the acidic environment found in many diseased tissues, including tumours. Acidity targeting by pHLIPs is achieved as a result of helix formation and transmembrane insertion. In contrast to the earlier technologies based on cell-penetrating peptides, pHLIPs act as monomeric membrane-inserting peptides that translocate one terminus across a membrane into the cytoplasm, while the other terminus remains in the extracellular space, locating the peptide in the membrane lipid bilayer. Therefore pHLIP has a dual delivery capability: it can tether cargo molecules or nanoparticles to the surfaces of cells in diseased tissues and/or it can move a cell-impermeable cargo molecule across the membrane into the cytoplasm. The source of energy for moving polar molecules attached to pHLIP through the hydrophobic layer of a membrane bilayer is the membrane-associated folding of the polypeptide. A drop in pH leads to the protonation of negatively charged residues (Asp or Glu), which enhances peptide hydrophobicity, increasing the affinity of the peptide for the lipid bilayer and triggering peptide folding and subsequent membrane insertion. The process is accompanied by the release of energy that can be utilized to move cell-impermeable cargo across a membrane. That the mechanism is now understood, and that targeting of tumours in mice has been shown, suggest a number of future applications of the pHLIP technology in the diagnosis and treatment of disease.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Andreev</LastName>
<ForeName>Oleg A</ForeName>
<Initials>OA</Initials>
<AffiliationInfo>
<Affiliation>Physics Department, University of Rhode Island, Kingston, Rhode Island 02881, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Engelman</LastName>
<ForeName>Donald M</ForeName>
<Initials>DM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Reshetnyak</LastName>
<ForeName>Yana K</ForeName>
<Initials>YK</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>GM073857</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P01 GM022778</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA133890</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 GM073857</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01133890</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21 CA125280</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>RCA125280A</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2010</Year>
<Month>10</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Mol Membr Biol</MedlineTA>
<NlmUniqueID>9430797</NlmUniqueID>
<ISSNLinking>0968-7688</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D057846">Cell-Penetrating Peptides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008051">Lipid Bilayers</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000970">Antineoplastic Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057846">Cell-Penetrating Peptides</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016503">Drug Delivery Systems</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006863">Hydrogen-Ion Concentration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057927">Hydrophobic and Hydrophilic Interactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008051">Lipid Bilayers</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017510">Protein Folding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017433">Protein Structure, Secondary</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS744441</OtherID>
<OtherID Source="NLM">PMC4691209</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">21615262</PMID>
<DateCreated>
<Year>2011</Year>
<Month>05</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2011</Year>
<Month>07</Month>
<Day>12</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0334-1763</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>22</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2011</Year>
</PubDate>
</JournalIssue>
<Title>Reviews in the neurosciences</Title>
<ISOAbbreviation>Rev Neurosci</ISOAbbreviation>
</Journal>
<ArticleTitle>Zebrafish assessment of cognitive improvement and anxiolysis: filling the gap between in vitro and rodent models for drug development.</ArticleTitle>
<Pagination>
<MedlinePgn>75-84</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1515/RNS.2011.009</ELocationID>
<Abstract>
<AbstractText>Zebrafish can provide a valuable animal model to screen potential cognitive enhancing and anxiolytic drugs. They are economical and can provide a relatively quick indication of possible functional efficacy. In as much as they have a complex nervous system and elaborate behavioral repertoire, zebrafish can provide a good intermediate model between in vitro receptor and cell-based assays and classic mammalian models for drug screening. In addition, the variety of molecular tools available in zebrafish makes them outstanding models for helping to determine the neuromolecular mechanisms for psychoactive drugs. However, to use zebrafish as a translational model we must have validated, sensitive and efficient behavioral tests. In a series of studies, our lab has developed tests of cognitive function and stress response, which are sensitive to drug effects in a similar manner as rodent models and humans for cognitive enhancement and alleviating stress response. In particular, the three-chamber task for learning and memory was shown to be sensitive to the cognitive enhancing effects of nicotine and has been useful in helping to determine neural mechanisms crucial for nicotinic-induced cognitive enhancement. The novel tank diving test was shown to be a valid and efficient test of stress response. It is sensitive to the reduction in stress-related behaviors due to the amxiolytic drugs diazepam and buspirone but not chlordiazepoxide. Nicotine also causes stress alleviating effects which can be interpreted as anxiolytic effects. Zebrafish models of behavioral pharmacology can be useful to efficiently screen test compounds for drug development and can be useful in helping to determine the mechanisms crucial for new therapeutic treatments of neurobehavioral impairments.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Levin</LastName>
<ForeName>Edward D</ForeName>
<Initials>ED</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Box #104790, Durham, NC 27710, USA. edlevin@duke.edu</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>ES10356</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P42 ES010356</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Rev Neurosci</MedlineTA>
<NlmUniqueID>8711016</NlmUniqueID>
<ISSNLinking>0334-1763</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014151">Anti-Anxiety Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018722">Nicotinic Agonists</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018733">Nicotinic Antagonists</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>6EE945D3OK</RegistryNumber>
<NameOfSubstance UI="D008464">Mecamylamine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>6M3C89ZY6R</RegistryNumber>
<NameOfSubstance UI="D009538">Nicotine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>TK65WKS8HL</RegistryNumber>
<NameOfSubstance UI="D002065">Buspirone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014151">Anti-Anxiety Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001007">Anxiety</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001288">Attention</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002065">Buspirone</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004195">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004305">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015195">Drug Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004353">Drug Evaluation, Preclinical</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005106">Exploratory Behavior</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008464">Mecamylamine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009448">Neurochemistry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009538">Nicotine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018722">Nicotinic Agonists</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018733">Nicotinic Antagonists</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013028">Space Perception</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015027">Zebrafish</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">21900593</PMID>
<DateCreated>
<Year>2011</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2012</Year>
<Month>02</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1946-6242</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>3</Volume>
<Issue>99</Issue>
<PubDate>
<Year>2011</Year>
<Month>Sep</Month>
<Day>7</Day>
</PubDate>
</JournalIssue>
<Title>Science translational medicine</Title>
<ISOAbbreviation>Sci Transl Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab.</ArticleTitle>
<Pagination>
<MedlinePgn>99ra86</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/scitranslmed.3002442</ELocationID>
<Abstract>
<AbstractText>Cetuximab, an antibody directed against the epidermal growth factor receptor, is an effective clinical therapy for patients with colorectal, head and neck, and non-small cell lung cancer, particularly for those with KRAS and BRAF wild-type cancers. Treatment in all patients is limited eventually by the development of acquired resistance, but little is known about the underlying mechanism. Here, we show that activation of ERBB2 signaling in cell lines, either through ERBB2 amplification or through heregulin up-regulation, leads to persistent extracellular signal-regulated kinase 1/2 signaling and consequently to cetuximab resistance. Inhibition of ERBB2 or disruption of ERBB2/ERBB3 heterodimerization restores cetuximab sensitivity in vitro and in vivo. A subset of colorectal cancer patients who exhibit either de novo or acquired resistance to cetuximab-based therapy has ERBB2 amplification or high levels of circulating heregulin. Collectively, these findings identify two distinct resistance mechanisms, both of which promote aberrant ERBB2 signaling, that mediate cetuximab resistance. Moreover, these results suggest that ERBB2 inhibitors, in combination with cetuximab, represent a rational therapeutic strategy that should be assessed in patients with cetuximab-resistant cancers.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yonesaka</LastName>
<ForeName>Kimio</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zejnullahu</LastName>
<ForeName>Kreshnik</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Okamoto</LastName>
<ForeName>Isamu</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Satoh</LastName>
<ForeName>Taroh</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cappuzzo</LastName>
<ForeName>Federico</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Souglakos</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ercan</LastName>
<ForeName>Dalia</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rogers</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Roncalli</LastName>
<ForeName>Massimo</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Takeda</LastName>
<ForeName>Masayuki</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fujisaka</LastName>
<ForeName>Yasuhito</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Philips</LastName>
<ForeName>Juliet</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shimizu</LastName>
<ForeName>Toshio</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Maenishi</LastName>
<ForeName>Osamu</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cho</LastName>
<ForeName>Yonggon</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sun</LastName>
<ForeName>Jason</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Destro</LastName>
<ForeName>Annarita</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Taira</LastName>
<ForeName>Koichi</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Takeda</LastName>
<ForeName>Koji</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Okabe</LastName>
<ForeName>Takafumi</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Swanson</LastName>
<ForeName>Jeffrey</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Itoh</LastName>
<ForeName>Hiroyuki</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Takada</LastName>
<ForeName>Minoru</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lifshits</LastName>
<ForeName>Eugene</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Okuno</LastName>
<ForeName>Kiyotaka</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Engelman</LastName>
<ForeName>Jeffrey A</ForeName>
<Initials>JA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shivdasani</LastName>
<ForeName>Ramesh A</ForeName>
<Initials>RA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nishio</LastName>
<ForeName>Kazuto</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fukuoka</LastName>
<ForeName>Masahiro</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Varella-Garcia</LastName>
<ForeName>Marileila</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nakagawa</LastName>
<ForeName>Kazuhiko</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jänne</LastName>
<ForeName>Pasi A</ForeName>
<Initials>PA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 CA046934</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA114465</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA135257</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA136851</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA136851-04</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Transl Med</MedlineTA>
<NlmUniqueID>101505086</NlmUniqueID>
<ISSNLinking>1946-6234</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D061067">Antibodies, Monoclonal, Humanized</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D020890">Neuregulin-1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.10.1</RegistryNumber>
<NameOfSubstance UI="C508053">ERBB2 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.10.1</RegistryNumber>
<NameOfSubstance UI="D011958">Receptor, Epidermal Growth Factor</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.10.1</RegistryNumber>
<NameOfSubstance UI="D018719">Receptor, ErbB-2</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.24</RegistryNumber>
<NameOfSubstance UI="D019950">Mitogen-Activated Protein Kinase 1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.24</RegistryNumber>
<NameOfSubstance UI="D048052">Mitogen-Activated Protein Kinase 3</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>PQX0D8J21J</RegistryNumber>
<NameOfSubstance UI="D000068818">Cetuximab</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Oncol. 2000 Feb;18(4):904-14</RefSource>
<PMID Version="1">10673534</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Oncol. 2010 Aug;11(8):753-62</RefSource>
<PMID Version="1">20619739</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2001 Dec 3;20(23):6793-804</RefSource>
<PMID Version="1">11726515</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2004 Apr;5(4):317-28</RefSource>
<PMID Version="1">15093539</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Cancer Res. 1999 Apr;5(4):909-16</RefSource>
<PMID Version="1">10213228</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Oncol. 2005 Feb;16(2):234-9</RefSource>
<PMID Version="1">15668276</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2005 Feb 24;352(8):786-92</RefSource>
<PMID Version="1">15728811</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3788-93</RefSource>
<PMID Version="1">15731348</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Med. 2005 Mar;2(3):e73</RefSource>
<PMID Version="1">15737014</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2005 Jul 1;65(13):5561-70</RefSource>
<PMID Version="1">15994928</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Natl Cancer Inst. 2005 Aug 17;97(16):1185-94</RefSource>
<PMID Version="1">16106023</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2006 Oct;116(10):2695-706</RefSource>
<PMID Version="1">16906227</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2007 May 18;316(5827):1039-43</RefSource>
<PMID Version="1">17463250</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Sci. 2007 Aug;98(8):1275-80</RefSource>
<PMID Version="1">17498200</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2007 Jul 15;67(14):6825-43</RefSource>
<PMID Version="1">17638894</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Cancer Res. 2007 Aug 15;13(16):4909-19</RefSource>
<PMID Version="1">17699871</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2007 Nov 15;357(20):2040-8</RefSource>
<PMID Version="1">18003960</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2007 Dec 15;67(24):11924-32</RefSource>
<PMID Version="1">18089823</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Oncol. 2008 May 20;26(15):2442-9</RefSource>
<PMID Version="1">18458038</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2008 Jun 26;27(28):3944-56</RefSource>
<PMID Version="1">18297114</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12480-4</RefSource>
<PMID Version="1">18711136</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2008 Sep 11;359(11):1116-27</RefSource>
<PMID Version="1">18784101</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2008 Oct 23;359(17):1757-65</RefSource>
<PMID Version="1">18946061</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Cancer Res. 2008 Nov 1;14(21):6963-73</RefSource>
<PMID Version="1">18980991</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Oncol. 2008 Dec 10;26(35):5705-12</RefSource>
<PMID Version="1">19001320</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2009 Feb 5;360(6):563-72</RefSource>
<PMID Version="1">19196673</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Oncol. 2009 Feb 10;27(5):663-71</RefSource>
<PMID Version="1">19114683</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2009 Apr 2;360(14):1408-17</RefSource>
<PMID Version="1">19339720</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Oncol. 2009 Apr 20;27(12):2091-6</RefSource>
<PMID Version="1">19188670</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2009 May 2;373(9674):1525-31</RefSource>
<PMID Version="1">19410716</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Cancer. 2009 Jul;9(7):463-75</RefSource>
<PMID Version="1">19536107</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2009 Nov 6;16(5):401-12</RefSource>
<PMID Version="1">19878872</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Oncol. 2009 Nov 20;27(33):5552-8</RefSource>
<PMID Version="1">19858400</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2009 Dec 24;462(7276):1070-4</RefSource>
<PMID Version="1">20033049</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2010 Jan 19;17(1):77-88</RefSource>
<PMID Version="1">20129249</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2010 Mar 15;70(6):2485-94</RefSource>
<PMID Version="1">20215504</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2010 Jun 17;362(24):2260-70</RefSource>
<PMID Version="1">20525995</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2001 Sep 1;61(17):6500-10</RefSource>
<PMID Version="1">11522647</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Cancer Cell. 2011 Oct 18;20(4):423-5</RefSource>
<PMID Version="1">22014569</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Nat Rev Clin Oncol. 2011 Nov;8(11):629</RefSource>
<PMID Version="1">21946843</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000911">Antibodies, Monoclonal</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D061067">Antibodies, Monoclonal, Humanized</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000970">Antineoplastic Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D045744">Cell Line, Tumor</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000068818">Cetuximab</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D019008">Drug Resistance, Neoplasm</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019950">Mitogen-Activated Protein Kinase 1</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D048052">Mitogen-Activated Protein Kinase 3</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009368">Neoplasm Transplantation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020890">Neuregulin-1</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011958">Receptor, Epidermal Growth Factor</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018719">Receptor, ErbB-2</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015398">Signal Transduction</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014183">Transplantation, Heterologous</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS337522</OtherID>
<OtherID Source="NLM">PMC3268675</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">21933749</PMID>
<DateCreated>
<Year>2011</Year>
<Month>10</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted>
<Year>2011</Year>
<Month>11</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1474-5488</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>12</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2011</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>The Lancet. Oncology</Title>
<ISOAbbreviation>Lancet Oncol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.</ArticleTitle>
<Pagination>
<MedlinePgn>1004-12</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/S1470-2045(11)70232-7</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">ALK gene rearrangement defines a new molecular subtype of non-small-cell lung cancer (NSCLC). In a recent phase 1 clinical trial, the ALK tyrosine-kinase inhibitor (TKI) crizotinib showed marked antitumour activity in patients with advanced, ALK-positive NSCLC. To assess whether crizotinib affects overall survival in these patients, we did a retrospective study comparing survival outcomes in crizotinib-treated patients in the trial and crizotinib-naive controls screened during the same time period.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We examined overall survival in patients with advanced, ALK-positive NSCLC who enrolled in the phase 1 clinical trial of crizotinib, focusing on the cohort of 82 patients who had enrolled through Feb 10, 2010. For comparators, we identified 36 ALK-positive patients from trial sites who were not given crizotinib (ALK-positive controls), 67 patients without ALK rearrangement but positive for EGFR mutation, and 253 wild-type patients lacking either ALK rearrangement or EGFR mutation. To assess differences in overall survival, we assessed subsets of clinically comparable ALK-positive and ALK-negative patients.</AbstractText>
<AbstractText Label="FINDINGS" NlmCategory="RESULTS">Among 82 ALK-positive patients who were given crizotinib, median overall survival from initiation of crizotinib has not been reached (95% CI 17 months to not reached); 1-year overall survival was 74% (95% CI 63-82), and 2-year overall survival was 54% (40-66). Overall survival did not differ based on age, sex, smoking history, or ethnic origin. Survival in 30 ALK-positive patients who were given crizotinib in the second-line or third-line setting was significantly longer than in 23 ALK-positive controls given any second-line therapy (median overall survival not reached [95% CI 14 months to not reached] vs 6 months [4-17], 1-year overall survival 70% [95% CI 50-83] vs 44% [23-64], and 2-year overall survival 55% [33-72] vs 12% [2-30]; hazard ratio 0·36, 95% CI 0·17-0·75; p=0·004). Survival in 56 crizotinib-treated, ALK-positive patients was similar to that in 63 ALK-negative, EGFR-positive patients given EGFR TKI therapy (median overall survival not reached [95% CI 17 months to not reached] vs 24 months [15-34], 1-year overall survival 71% [95% CI 58-81] vs 74% [61-83], and 2-year overall survival 57% [40-71] vs 52% [38-65]; p=0·786), whereas survival in 36 crizotinib-naive, ALK-positive controls was similar to that in 253 wild-type controls (median overall survival 20 months [95% CI 13-26] vs 15 months [13-17]; p=0·244).</AbstractText>
<AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">In patients with advanced, ALK-positive NSCLC, crizotinib therapy is associated with improved survival compared with that of crizotinib-naive controls. ALK rearrangement is not a favourable prognostic factor in advanced NSCLC.</AbstractText>
<AbstractText Label="FUNDING" NlmCategory="BACKGROUND">Pfizer Inc, V Foundation for Cancer Research.</AbstractText>
<CopyrightInformation>Copyright © 2011 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shaw</LastName>
<ForeName>Alice T</ForeName>
<Initials>AT</Initials>
<AffiliationInfo>
<Affiliation>Massachusetts General Hospital Cancer Center, Boston, MA, USA. ashaw1@partners.org</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yeap</LastName>
<ForeName>Beow Y</ForeName>
<Initials>BY</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Solomon</LastName>
<ForeName>Benjamin J</ForeName>
<Initials>BJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Riely</LastName>
<ForeName>Gregory J</ForeName>
<Initials>GJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gainor</LastName>
<ForeName>Justin</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Engelman</LastName>
<ForeName>Jeffrey A</ForeName>
<Initials>JA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shapiro</LastName>
<ForeName>Geoffrey I</ForeName>
<Initials>GI</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Costa</LastName>
<ForeName>Daniel B</ForeName>
<Initials>DB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ou</LastName>
<ForeName>Sai-Hong I</ForeName>
<Initials>SH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Butaney</LastName>
<ForeName>Mohit</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Salgia</LastName>
<ForeName>Ravi</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Maki</LastName>
<ForeName>Robert G</ForeName>
<Initials>RG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Varella-Garcia</LastName>
<ForeName>Marileila</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Doebele</LastName>
<ForeName>Robert C</ForeName>
<Initials>RC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bang</LastName>
<ForeName>Yung-Jue</ForeName>
<Initials>YJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kulig</LastName>
<ForeName>Kimary</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Selaru</LastName>
<ForeName>Paulina</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tang</LastName>
<ForeName>Yiyun</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wilner</LastName>
<ForeName>Keith D</ForeName>
<Initials>KD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kwak</LastName>
<ForeName>Eunice L</ForeName>
<Initials>EL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Clark</LastName>
<ForeName>Jeffrey W</ForeName>
<Initials>JW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Iafrate</LastName>
<ForeName>A John</ForeName>
<Initials>AJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Camidge</LastName>
<ForeName>D Ross</ForeName>
<Initials>DR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList>
<AccessionNumber>NCT00585195</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 CA046934</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P50 CA090578</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P50 CA090578-09</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P50-CA090578</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2011</Year>
<Month>09</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Lancet Oncol</MedlineTA>
<NlmUniqueID>100957246</NlmUniqueID>
<ISSNLinking>1470-2045</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011720">Pyrazoles</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011725">Pyridines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>53AH36668S</RegistryNumber>
<NameOfSubstance UI="C551994">crizotinib</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.10.1</RegistryNumber>
<NameOfSubstance UI="D020794">Receptor Protein-Tyrosine Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.10.1</RegistryNumber>
<NameOfSubstance UI="C086119">anaplastic lymphoma kinase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Oncol. 2009 Sep 10;27(26):4247-53</RefSource>
<PMID Version="1">19667264</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Surg Oncol. 2010 Mar;17(3):889-97</RefSource>
<PMID Version="1">20183914</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Thorac Oncol. 2010 May;5(5):620-30</RefSource>
<PMID Version="1">20354456</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO Mol Med. 2010 May;2(5):146-58</RefSource>
<PMID Version="1">20432502</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Thorac Oncol. 2010 Jul;5(7):1011-7</RefSource>
<PMID Version="1">20502360</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cancer. 2010;9:188</RefSource>
<PMID Version="1">20624322</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2010 Oct 28;363(18):1693-703</RefSource>
<PMID Version="1">20979469</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2010 Oct 28;363(18):1727-33</RefSource>
<PMID Version="1">20979472</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Thorac Oncol. 2011 Apr;6(4):774-80</RefSource>
<PMID Version="1">21336183</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Oncol. 2011 Jul 20;29(21):2866-74</RefSource>
<PMID Version="1">21670455</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Thorac Oncol. 2011 Sep;6(9):1474-80</RefSource>
<PMID Version="1">21642865</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mod Pathol. 2001 Jun;14(6):569-76</RefSource>
<PMID Version="1">11406658</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Oncol. 2004 May 1;22(9):1589-97</RefSource>
<PMID Version="1">15117980</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1994 Mar 4;263(5151):1281-4</RefSource>
<PMID Version="1">8122112</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 1999 Jun 15;59(12):2776-80</RefSource>
<PMID Version="1">10383129</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lung Cancer. 2004 Aug;45 Suppl 2:S247-52</RefSource>
<PMID Version="1">15552806</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2005 Jul 14;353(2):123-32</RefSource>
<PMID Version="1">16014882</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2007 Aug 2;448(7153):561-6</RefSource>
<PMID Version="1">17625570</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2007 Dec 14;131(6):1190-203</RefSource>
<PMID Version="1">18083107</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2008 May 1;68(9):3389-95</RefSource>
<PMID Version="1">18451166</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Cancer Res. 2008 Jul 1;14(13):4275-83</RefSource>
<PMID Version="1">18594010</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2008 Oct 16;455(7215):967-70</RefSource>
<PMID Version="1">18923523</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2008 Oct 16;455(7215):971-4</RefSource>
<PMID Version="1">18923524</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2008 Oct 16;455(7215):975-8</RefSource>
<PMID Version="1">18923525</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Cancer Res. 2008 Oct 15;14(20):6618-24</RefSource>
<PMID Version="1">18927303</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mod Pathol. 2009 Apr;22(4):508-15</RefSource>
<PMID Version="1">19234440</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer. 2009 Apr 15;115(8):1723-33</RefSource>
<PMID Version="1">19170230</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Thorac Oncol. 2009 Sep;4(9):1083-93</RefSource>
<PMID Version="1">19652625</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2009 Sep 3;361(10):947-57</RefSource>
<PMID Version="1">19692680</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Lancet Oncol. 2011 Oct;12(11):983-4</RefSource>
<PMID Version="1">21933750</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000970">Antineoplastic Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D001315">Australia</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002289">Carcinoma, Non-Small-Cell Lung</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000201">enzymology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017321">Clinical Trials, Phase I as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015321">Gene Rearrangement</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053208">Kaplan-Meier Estimate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008175">Lung Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000201">enzymology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015337">Multicenter Studies as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018579">Patient Selection</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016016">Proportional Hazards Models</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D047428">Protein Kinase Inhibitors</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011720">Pyrazoles</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011725">Pyridines</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020794">Receptor Protein-Tyrosine Kinases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000037">antagonists &amp; inhibitors</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018570">Risk Assessment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015996">Survival Rate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS367391</OtherID>
<OtherID Source="NLM">PMC3328296</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">21784659</PMID>
<DateCreated>
<Year>2012</Year>
<Month>01</Month>
<Day>13</Day>
</DateCreated>
<DateCompleted>
<Year>2012</Year>
<Month>04</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1878-4321</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>22</Volume>
<Issue>1</Issue>
<PubDate>
<MedlineDate>2012 Jan-Feb</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Women's health issues : official publication of the Jacobs Institute of Women's Health</Title>
<ISOAbbreviation>Womens Health Issues</ISOAbbreviation>
</Journal>
<ArticleTitle>Sexual risk behaviors among African-American and Hispanic women in five counties in the Southeastern United States: 2008-2009.</ArticleTitle>
<Pagination>
<MedlinePgn>e9-18</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.whi.2011.06.002</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">We examined sexual risk behaviors and unrecognized HIV infection among heterosexually active African-American and Hispanic women.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Women not previously diagnosed with HIV infection were recruited in rural counties in North Carolina (African American) and Alabama (African American), and an urban county in southern Florida (Hispanic) using multiple methods. They completed a computer-administered questionnaire and were tested for HIV infection.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Between October 2008 and September 2009, 1,527 women (1,013 African American and 514 Hispanic) enrolled in the study. Median age was 35 years (range, 18-59), 33% were married or living as married, 50% had an annual household income of $12,000 or less, and 56% were employed full or part time. Two women (0.13%) tested positive for HIV. In the past 12 months, 19% had been diagnosed with a sexually transmitted infection (other than HIV), 87% engaged in unprotected vaginal intercourse (UVI), and 26% engaged in unprotected anal intercourse (UAI). In multivariate analysis, UAI was significantly (p &lt; .05) more likely among those who reported ever being pregnant, binge drinking in the past 30 days, ever exchanging sex for things needed or wanted, engaging in UVI, or being of Hispanic ethnicity. UAI was also more likely to occur with partners with whom women had a current or past relationship as opposed to casual partners.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A high percentage of our sample of heterosexually active women of color had recently engaged in sexual risk behaviors, particularly UAI. More research is needed to elucidate the interpersonal dynamics that may promote this high-risk behavior. Educational messages that explicitly address the risks of heterosexual anal intercourse need to be developed for heterosexually active women and their male partners.</AbstractText>
<CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>McLellan-Lemal</LastName>
<ForeName>Eleanor</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. egm4@cdc.gov</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>O'Daniels</LastName>
<ForeName>Christine M</ForeName>
<Initials>CM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Marks</LastName>
<ForeName>Gary</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Villar-Loubet</LastName>
<ForeName>Olga</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Doherty</LastName>
<ForeName>Irene A</ForeName>
<Initials>IA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Simpson</LastName>
<ForeName>Cathy</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Weiss</LastName>
<ForeName>Stephen</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hanna</LastName>
<ForeName>Barbara</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Adimora</LastName>
<ForeName>Adaora A</ForeName>
<Initials>AA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>White</LastName>
<ForeName>Becky L</ForeName>
<Initials>BL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wheeling</LastName>
<ForeName>John T</ForeName>
<Initials>JT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Borkowf</LastName>
<ForeName>Craig B</ForeName>
<Initials>CB</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K23 MH094250</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 AI050410</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>PS05-197</GrantID>
<Acronym>PS</Acronym>
<Agency>NCHHSTP CDC HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2011</Year>
<Month>07</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Womens Health Issues</MedlineTA>
<NlmUniqueID>9101000</NlmUniqueID>
<ISSNLinking>1049-3867</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001741">African Americans</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015658">HIV Infections</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000208">ethnology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000635">transmission</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020010">Heterosexuality</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006630">Hispanic Americans</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012309">Risk-Taking</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012725">Sexual Behavior</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000208">ethnology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012747">Sexual Partners</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012749">Sexually Transmitted Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000208">ethnology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000635">transmission</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D015144">Southeastern United States</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D047568">Unsafe Sex</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000208">ethnology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS724190</OtherID>
<OtherID Source="NLM">PMC4584390</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">22508830</PMID>
<DateCreated>
<Year>2012</Year>
<Month>06</Month>
<Day>18</Day>
</DateCreated>
<DateCompleted>
<Year>2012</Year>
<Month>08</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1527-7755</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>30</Volume>
<Issue>18</Issue>
<PubDate>
<Year>2012</Year>
<Month>Jun</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</Title>
<ISOAbbreviation>J. Clin. Oncol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Randomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapy.</ArticleTitle>
<Pagination>
<MedlinePgn>2248-55</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1200/JCO.2011.38.9411</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Histone deacetylase inhibitors (HDACis) have been shown to overcome resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) linked to epigenetic changes and epithelial-mesenchymal transition (EMT) state. This randomized phase II study evaluated the outcome of erlotinib with and without the isoform selective HDACi, entinostat.</AbstractText>
<AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Previously treated patients with stage IIIB/IV non-small-cell lung cancer, no prior EGFR-TKIs, and performance status ≤ 2 were randomly administered erlotinib 150 mg on days 1 through 28 plus entinostat 10 mg orally on days 1 and 15 every 28 days (EE) or erlotinib plus placebo (EP). The primary end point was 4-month progression-free survival (PFS) rate with additional end points including 6-month PFS rate, PFS, and overall survival (OS). Exploratory analyses included EMT- and EGFR-related biomarker analysis on archival tissue.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred thirty-two patients were enrolled (EE, 67; EP, 65). The 4-month PFS rate was comparable for both groups (EE, 18% v EP, 20%; P = .7). In the subset of patients with high E-cadherin levels, OS was longer in the EE group compared with the EP group (9.4 v 5.4 months; hazard ratio, 0.35; 95% CI, 0.13 to 0.92; P = .03) with a corresponding trend toward increased PFS. The adverse event (AE) profile was acceptable, with rash, fatigue, diarrhea, and nausea the most common AEs in both groups.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Erlotinib combined with entinostat did not improve the outcomes of patients in the overall study population when compared with erlotinib monotherapy. High E-cadherin expression levels at time of diagnosis indicate an increased sensitivity to HDACi/EGFR-TKI inhibition providing the basis for a biomarker-driven validation study.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Witta</LastName>
<ForeName>Samir E</ForeName>
<Initials>SE</Initials>
<AffiliationInfo>
<Affiliation>University of Colorado Cancer Center, 12801 E 17th Ave, Mail Stop 8117, Aurora, CO 80045, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jotte</LastName>
<ForeName>Robert M</ForeName>
<Initials>RM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Konduri</LastName>
<ForeName>Katrik</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Neubauer</LastName>
<ForeName>Marcus A</ForeName>
<Initials>MA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Spira</LastName>
<ForeName>Alexander I</ForeName>
<Initials>AI</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ruxer</LastName>
<ForeName>Robert L</ForeName>
<Initials>RL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Varella-Garcia</LastName>
<ForeName>Marileila</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bunn</LastName>
<ForeName>Paul A</ForeName>
<Initials>PA</Initials>
<Suffix>Jr</Suffix>
</Author>
<Author ValidYN="Y">
<LastName>Hirsch</LastName>
<ForeName>Fred R</ForeName>
<Initials>FR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 CA046934</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 CA157715</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D017427">Clinical Trial, Phase II</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2012</Year>
<Month>04</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Clin Oncol</MedlineTA>
<NlmUniqueID>8309333</NlmUniqueID>
<ISSNLinking>0732-183X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001549">Benzamides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015820">Cadherins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D056572">Histone Deacetylase Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011725">Pyridines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011799">Quinazolines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>1ZNY4FKK9H</RegistryNumber>
<NameOfSubstance UI="C118739">entinostat</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>DA87705X9K</RegistryNumber>
<NameOfSubstance UI="D000069347">Erlotinib Hydrochloride</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000971">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001549">Benzamides</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014408">Biomarkers, Tumor</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015820">Cadherins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002289">Carcinoma, Non-Small-Cell Lung</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000069347">Erlotinib Hydrochloride</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056572">Histone Deacetylase Inhibitors</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008175">Lung Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011725">Pyridines</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011799">Quinazolines</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">22892811</PMID>
<DateCreated>
<Year>2012</Year>
<Month>09</Month>
<Day>13</Day>
</DateCreated>
<DateCompleted>
<Year>2012</Year>
<Month>12</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1524-4563</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>60</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2012</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Hypertension</Title>
<ISOAbbreviation>Hypertension</ISOAbbreviation>
</Journal>
<ArticleTitle>Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort.</ArticleTitle>
<Pagination>
<MedlinePgn>929-35</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1161/HYPERTENSIONAHA.112.193268</ELocationID>
<Abstract>
<AbstractText>Insomnia with objective short sleep duration appears to be a biologically more severe phenotype of the disorder. No longitudinal study to date has examined the association of this type of insomnia with incident hypertension using polysomnography. From a random, general population sample of 1741 adults of the Penn State Cohort, 1395 were followed-up after 7.5 years, and 786 did not have hypertension at baseline. Hypertension was determined by a self-report of receiving treatment for high blood pressure. Chronic insomnia was defined as a complaint of insomnia lasting ≥1 year, whereas poor sleep was defined as moderate-to-severe sleep difficulties. All of the subjects underwent 8-hour polysomnography. Sleep-disordered breathing (SDB) was defined as an obstructive apnea/hypopnea index≥5. We used the median polysomnographic percentage of sleep time to define short sleep duration (ie, &lt;6 hours). We controlled for sex, race, age, caffeine, cigarettes and alcohol consumption, depression, sleep-disordered breathing, diabetes mellitus, obesity, and blood pressure in our analyses. Compared with normal sleepers who slept≥6 hours, the highest risk for incident hypertension was in chronic insomniacs with short sleep duration (odds ratio, 3.8 [95% CI, 1.6-9.0]). The risk for incident hypertension in poor sleepers with short sleep duration was significantly increased but became marginally significant after controlling for obesity (odds ratio, 1.6 [95% CI, 0.9-2.8]). Chronic insomnia with short sleep duration is associated with an increased risk for incident hypertension in a degree comparable to sleep-disordered breathing. Objective short sleep duration in insomnia may serve as a useful predictor of the biological severity of the disorder.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Fernandez-Mendoza</LastName>
<ForeName>Julio</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Sleep Research and Treatment Center, Pennylvania State University College of Medicine, Department of Psychiatry H073, 500 University Dr, Hershey, PA 17033, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vgontzas</LastName>
<ForeName>Alexandros N</ForeName>
<Initials>AN</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Liao</LastName>
<ForeName>Duanping</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shaffer</LastName>
<ForeName>Michele L</ForeName>
<Initials>ML</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vela-Bueno</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Basta</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bixler</LastName>
<ForeName>Edward O</ForeName>
<Initials>EO</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01  HL040916</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01  HL051931</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 40916</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 51931</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 64415</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL040916</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL064415</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2012</Year>
<Month>08</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Hypertension</MedlineTA>
<NlmUniqueID>7906255</NlmUniqueID>
<ISSNLinking>0194-911X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2012 May;35(5):689-97</RefSource>
<PMID Version="1">22547895</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep Med. 2012 Apr;13(4):346-53</RefSource>
<PMID Version="1">22425576</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 2000 Apr 12;283(14):1829-36</RefSource>
<PMID Version="1">10770144</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Intern Med. 2000 Aug 14-28;160(15):2289-95</RefSource>
<PMID Version="1">10927725</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):608-13</RefSource>
<PMID Version="1">11254512</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2001 Jun 15;24(4):425-30</RefSource>
<PMID Version="1">11403527</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychiatry Clin Neurosci. 2001 Jun;55(3):305-10</RefSource>
<PMID Version="1">11422885</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Endocrinol Metab. 2001 Aug;86(8):3787-94</RefSource>
<PMID Version="1">11502812</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Psychosom Res. 2002 Jul;53(1):589-92</RefSource>
<PMID Version="1">12127176</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Behav Immun. 2003 Oct;17(5):365-72</RefSource>
<PMID Version="1">12946658</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychopharmacology (Berl). 2003 Dec;170(4):423-8</RefSource>
<PMID Version="1">13680082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Occup Health. 2003 Nov;45(6):344-50</RefSource>
<PMID Version="1">14676413</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychophysiology. 1975 Jul;12(4):412-5</RefSource>
<PMID Version="1">169540</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 1995 Sep;18(7):581-8</RefSource>
<PMID Version="1">8552929</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Intern Med. 1997 Aug 11-25;157(15):1746-52</RefSource>
<PMID Version="1">9250236</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Crit Care Med. 1998 Jan;157(1):144-8</RefSource>
<PMID Version="1">9445292</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Psychosom Res. 1998 Jul;45(1):21-31</RefSource>
<PMID Version="1">9720852</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychosom Med. 1998 Sep-Oct;60(5):610-5</RefSource>
<PMID Version="1">9773766</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychophysiology. 1999 Mar;36(2):233-44</RefSource>
<PMID Version="1">10194970</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2006 Feb;29(2):232-9</RefSource>
<PMID Version="1">16494091</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2006 Sep;29(9):1155-73</RefSource>
<PMID Version="1">17040003</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Sleep Med. 2005 Oct 15;1(4):412-21</RefSource>
<PMID Version="1">17564412</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Sleep Med. 2007 Aug 15;3(5):489-94</RefSource>
<PMID Version="1">17803012</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2009 Jan;32(1):65-72</RefSource>
<PMID Version="1">19189780</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2009 Apr;32(4):491-7</RefSource>
<PMID Version="1">19413143</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2009 Jun;32(6):760-6</RefSource>
<PMID Version="1">19544752</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychoneuroendocrinology. 2009 Oct;34(9):1346-54</RefSource>
<PMID Version="1">19450933</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes Care. 2009 Nov;32(11):1980-5</RefSource>
<PMID Version="1">19641160</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Hypertens. 2010 Jan;23(1):62-9</RefSource>
<PMID Version="1">19893498</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep Med. 2010 Jan;11(1):56-64</RefSource>
<PMID Version="1">19962939</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2010 Apr;33(4):459-65</RefSource>
<PMID Version="1">20394314</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2010 Sep;33(9):1159-64</RefSource>
<PMID Version="1">20857861</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Sleep Res. 2011 Mar;20(1 Pt 2):137-45</RefSource>
<PMID Version="1">20626615</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circulation. 2012 Jan 3;125(1):e2-e220</RefSource>
<PMID Version="1">22179539</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Hypertension. 2013 Feb;61(2):e11</RefSource>
<PMID Version="1">23266546</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Hypertension. 2013 Feb;61(2):e12</RefSource>
<PMID Version="1">23444458</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006306">Health Surveys</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006973">Hypertension</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015994">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017286">Polysomnography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012306">Risk</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012890">Sleep</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012891">Sleep Apnea Syndromes</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007319">Sleep Initiation and Maintenance Disorders</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011795">Surveys and Questionnaires</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS402176</OtherID>
<OtherID Source="NLM">PMC3679545</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23419741</PMID>
<DateCreated>
<Year>2013</Year>
<Month>06</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>02</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-2955</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>17</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2013</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Sleep medicine reviews</Title>
<ISOAbbreviation>Sleep Med Rev</ISOAbbreviation>
</Journal>
<ArticleTitle>Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder.</ArticleTitle>
<Pagination>
<MedlinePgn>241-54</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.smrv.2012.09.005</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1087-0792(12)00104-9</ELocationID>
<Abstract>
<AbstractText>Until recently, the association of chronic insomnia with significant medical morbidity was not established and its diagnosis was based solely on subjective complaints. We present evidence that insomnia with objective short sleep duration is the most biologically severe phenotype of the disorder, as it is associated with cognitive-emotional and cortical arousal, activation of both limbs of the stress system, and a higher risk for hypertension, impaired heart rate variability, diabetes, neurocognitive impairment, and mortality. Also, it appears that objective short sleep duration is a biological marker of genetic predisposition to chronic insomnia. In contrast, insomnia with objective normal sleep duration is associated with cognitive-emotional and cortical arousal and sleep misperception but not with signs of activation of both limbs of the stress system or medical complications. Furthermore, the first phenotype is associated with unremitting course, whereas the latter is more likely to remit. We propose that short sleep duration in insomnia is a reliable marker of the biological severity and medical impact of the disorder. Objective measures of sleep obtained in the home environment of the patient would become part of the routine assessment of insomnia patients in a clinician's office setting. We speculate that insomnia with objective short sleep duration has primarily biological roots and may respond better to biological treatments, whereas insomnia with objective normal sleep duration has primarily psychological roots and may respond better to psychological interventions alone.</AbstractText>
<CopyrightInformation>Copyright © 2012 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vgontzas</LastName>
<ForeName>Alexandros N</ForeName>
<Initials>AN</Initials>
<AffiliationInfo>
<Affiliation>Sleep Research &amp; Treatment Center, Department of Psychiatry, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. avgontzas@psu.edu</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fernandez-Mendoza</LastName>
<ForeName>Julio</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Liao</LastName>
<ForeName>Duanping</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bixler</LastName>
<ForeName>Edward O</ForeName>
<Initials>EO</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01  HL040916</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01  HL051931</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 40916</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 51931</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 64415</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL040916</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL051931</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL064415</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>02</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Sleep Med Rev</MedlineTA>
<NlmUniqueID>9804678</NlmUniqueID>
<ISSNLinking>1087-0792</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 1997 Oct;20(10):865-70</RefSource>
<PMID Version="1">9415946</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Crit Care Med. 1998 Jan;157(1):144-8</RefSource>
<PMID Version="1">9445292</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Sleep Res. 1998 Jun;7(2):105-14</RefSource>
<PMID Version="1">9682182</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Psychosom Res. 1998 Jul;45(1):21-31</RefSource>
<PMID Version="1">9720852</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychosom Med. 1998 Sep-Oct;60(5):610-5</RefSource>
<PMID Version="1">9773766</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Med. 1999;50:387-400</RefSource>
<PMID Version="1">10073285</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Gen Psychiatry. 2011 Oct;68(10):992-1002</RefSource>
<PMID Version="1">21646568</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Psychophysiol. 2011 Sep;81(3):177-90</RefSource>
<PMID Version="1">21708192</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circulation. 2011 Nov 8;124(19):2073-81</RefSource>
<PMID Version="1">22025601</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2011 Dec;34(12):1647-52</RefSource>
<PMID Version="1">22131601</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep Med Rev. 2012 Feb;16(1):83-94</RefSource>
<PMID Version="1">21636297</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2012 Jan;35(1):61-8</RefSource>
<PMID Version="1">22215919</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Endocrinol (Oxf). 1999 Aug;51(2):205-15</RefSource>
<PMID Version="1">10468992</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 1999 Oct 23;354(9188):1435-9</RefSource>
<PMID Version="1">10543671</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2000 Mar 15;23(2):205-12</RefSource>
<PMID Version="1">10737337</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2000 Mar 15;23(2):237-41</RefSource>
<PMID Version="1">10737341</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychosom Med. 2000 Mar-Apr;62(2):220-6</RefSource>
<PMID Version="1">10772401</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychosom Med. 2000 Mar-Apr;62(2):227-30</RefSource>
<PMID Version="1">10772402</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychosom Med. 2000 Jul-Aug;62(4):474-82</RefSource>
<PMID Version="1">10949091</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Physiol Behav. 2000 Jul 1-15;70(1-2):127-34</RefSource>
<PMID Version="1">10978487</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neurobiol Exp (Wars). 2000;60(3):373</RefSource>
<PMID Version="1">11016080</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2001 Feb 1;24(1):110-7</RefSource>
<PMID Version="1">11204046</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):608-13</RefSource>
<PMID Version="1">11254512</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Endocrinol Metab. 2001 Apr;86(4):1489-95</RefSource>
<PMID Version="1">11297573</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 2001 Apr 11;285(14):1856-64</RefSource>
<PMID Version="1">11308399</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Endocrinol Metab. 2001 Aug;86(8):3787-94</RefSource>
<PMID Version="1">11502812</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Gen Psychiatry. 2002 Feb;59(2):131-6</RefSource>
<PMID Version="1">11825133</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosci Lett. 2002 May 17;324(2):159-63</RefSource>
<PMID Version="1">11988351</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Psychosom Res. 2002 Jul;53(1):589-92</RefSource>
<PMID Version="1">12127176</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2002 Sep 15;25(6):630-40</RefSource>
<PMID Version="1">12224842</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychosom Med. 2002 Sep-Oct;64(5):793-802</RefSource>
<PMID Version="1">12271110</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychiatry Res. 2002 Dec 15;113(1-2):17-27</RefSource>
<PMID Version="1">12467942</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Psychosom Res. 2003 Jan;54(1):39-49</RefSource>
<PMID Version="1">12505554</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep Med Rev. 2002 Apr;6(2):97-111</RefSource>
<PMID Version="1">12531146</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Behav Res Ther. 2003 Apr;41(4):427-45</RefSource>
<PMID Version="1">12643966</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2003 May 1;26(3):342-92</RefSource>
<PMID Version="1">12749557</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep Med Rev. 2003 Jun;7(3):203-14</RefSource>
<PMID Version="1">12927120</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Behav Immun. 2003 Oct;17(5):365-72</RefSource>
<PMID Version="1">12946658</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep Med Rev. 2003 Aug;7(4):297-310</RefSource>
<PMID Version="1">14505597</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2003 Sep15;26(6):754-60</RefSource>
<PMID Version="1">14572131</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychopharmacology (Berl). 2003 Dec;170(4):423-8</RefSource>
<PMID Version="1">13680082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Occup Health. 2003 Nov;45(6):344-50</RefSource>
<PMID Version="1">14676413</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes Care. 2004 Jan;27(1):282-3</RefSource>
<PMID Version="1">14694011</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Inj. 2004 Mar;18(3):257-72</RefSource>
<PMID Version="1">14726285</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Endocrinol Metab. 2004 May;89(5):2119-26</RefSource>
<PMID Version="1">15126529</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes Care. 2004 Oct;27(10):2464-9</RefSource>
<PMID Version="1">15451917</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Abnorm Psychol. 1967 Jun;72(3):255-64</RefSource>
<PMID Version="1">6045597</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychosom Med. 1971 Nov-Dec;33(6):499-508</RefSource>
<PMID Version="1">4402134</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Abnorm Psychol. 1982 Oct;91(5):380-9</RefSource>
<PMID Version="1">7142575</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Neurobiol. 1982;1(3):195-204</RefSource>
<PMID Version="1">7185792</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 1984;7(3):230-8</RefSource>
<PMID Version="1">6484427</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biol Psychiatry. 1985 Jul;20(7):741-50</RefSource>
<PMID Version="1">4005333</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Psychiatr Res. 1986;20(4):301-16</RefSource>
<PMID Version="1">3806425</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Psychiatry. 1988 Mar;145(3):346-9</RefSource>
<PMID Version="1">3344849</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 1988 Feb;11(1):54-60</RefSource>
<PMID Version="1">3363270</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Neurol. 1987 Sep;7(3):236-42</RefSource>
<PMID Version="1">3332458</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 1989 Jun;3(8):1972-7</RefSource>
<PMID Version="1">2785942</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Psychiatry. 1991 Apr;148(4):432-8</RefSource>
<PMID Version="1">2006686</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Behav Res Ther. 1992 May;30(3):283-92</RefSource>
<PMID Version="1">1586365</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Behav Res Ther. 1994 Jan;32(1):123-9</RefSource>
<PMID Version="1">8135710</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Neurosci. 1994 Jul;77(1-2):11-21</RefSource>
<PMID Version="1">7989156</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 1994 Dec;17(8):693-702</RefSource>
<PMID Version="1">7701180</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 1995 Jan;18(1):58-70</RefSource>
<PMID Version="1">7761745</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Neurosci. 1995 May;82(1-2):47-60</RefSource>
<PMID Version="1">7591515</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 1995 Sep;18(7):581-8</RefSource>
<PMID Version="1">8552929</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol. 1996 Aug;271(2 Pt 1):E261-70</RefSource>
<PMID Version="1">8770019</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biol Psychiatry. 1997 Jan 15;41(2):209-16</RefSource>
<PMID Version="1">9018392</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychosom Med. 1997 Sep-Oct;59(5):533-40</RefSource>
<PMID Version="1">9316187</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Sleep Res. 1997 Sep;6(3):179-88</RefSource>
<PMID Version="1">9358396</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychol Bull. 2012 Jan;138(1):77-101</RefSource>
<PMID Version="1">21967449</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep Med. 2012 Apr;13(4):346-53</RefSource>
<PMID Version="1">22425576</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2012 May;35(5):689-97</RefSource>
<PMID Version="1">22547895</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Psychiatry. 2012 Apr;73(4):478-85</RefSource>
<PMID Version="1">22152403</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2012 Jun;35(6):727-34</RefSource>
<PMID Version="1">22654183</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hypertension. 2012 Oct;60(4):929-35</RefSource>
<PMID Version="1">22892811</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 1999 Mar 17;281(11):991-9</RefSource>
<PMID Version="1">10086433</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychophysiology. 1999 Mar;36(2):233-44</RefSource>
<PMID Version="1">10194970</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Intern Med. 2004 Dec 7;141(11):846-50</RefSource>
<PMID Version="1">15583226</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Sleep Res. 2005 Mar;14(1):49-59</RefSource>
<PMID Version="1">15743334</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetologia. 2005 Feb;48(2):235-41</RefSource>
<PMID Version="1">15645205</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Med. 2004 Dec;1(3):e62</RefSource>
<PMID Version="1">15602591</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes Care. 2005 Nov;28(11):2762-7</RefSource>
<PMID Version="1">16249553</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2005 Dec;28(12):1500-1</RefSource>
<PMID Version="1">16408406</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2005 Dec;28(12):1588-96</RefSource>
<PMID Version="1">16408419</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep Med. 2006 Mar;7(2):123-30</RefSource>
<PMID Version="1">16459140</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 2006 Jul 1;164(1):5-16</RefSource>
<PMID Version="1">16740591</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep Med Rev. 2006 Aug;10(4):247-54</RefSource>
<PMID Version="1">16563817</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2006 Sep;29(9):1155-73</RefSource>
<PMID Version="1">17040003</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biol Psychiatry. 2006 Dec 15;60(12):1324-30</RefSource>
<PMID Version="1">16876140</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E253-61</RefSource>
<PMID Version="1">16940468</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pediatr. 2007 Apr;150(4):364-9</RefSource>
<PMID Version="1">17382111</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Sleep Med. 2006 Jul 15;2(3):316-22</RefSource>
<PMID Version="1">17561544</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Sleep Med. 2005 Oct 15;1(4):412-21</RefSource>
<PMID Version="1">17564412</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Behav Sleep Med. 2007;5(3):178-93</RefSource>
<PMID Version="1">17680730</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Sleep Med. 2007 Aug 15;3(5):489-94</RefSource>
<PMID Version="1">17803012</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2007 Sep;30(9):1205-11</RefSource>
<PMID Version="1">17910392</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Behav Sleep Med. 2007;5(4):279-96</RefSource>
<PMID Version="1">17937583</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Epidemiol. 2007 Dec;17(12):948-55</RefSource>
<PMID Version="1">17855122</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2007 Dec;30(12):1614-5</RefSource>
<PMID Version="1">18246971</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Behav Sleep Med. 2008;6(1):32-54</RefSource>
<PMID Version="1">18412036</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Obes (Lond). 2008 May;32(5):801-9</RefSource>
<PMID Version="1">18253159</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Sleep Res. 2008 Jun;17(2):180-90</RefSource>
<PMID Version="1">18482106</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2008 May;31(5):599-607</RefSource>
<PMID Version="1">18517030</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Psychosom Res. 2008 Jul;65(1):23-30</RefSource>
<PMID Version="1">18582608</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2008 Sep;31(9):1203</RefSource>
<PMID Version="1">18788643</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2008 Oct 1;28(40):10167-84</RefSource>
<PMID Version="1">18829974</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2008 Nov;31(11):1499-506</RefSource>
<PMID Version="1">19014069</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 2008 Dec 24;300(24):2859-66</RefSource>
<PMID Version="1">19109114</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Int Neuropsychol Soc. 2009 May;15(3):438-50</RefSource>
<PMID Version="1">19402930</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2009 Apr;32(4):441-2</RefSource>
<PMID Version="1">19413138</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2009 Apr;32(4):491-7</RefSource>
<PMID Version="1">19413143</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Intern Med. 2009 Jun 8;169(11):1055-61</RefSource>
<PMID Version="1">19506175</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2009 Jun;32(6):760-6</RefSource>
<PMID Version="1">19544752</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychoneuroendocrinology. 2009 Oct;34(9):1346-54</RefSource>
<PMID Version="1">19450933</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes Care. 2009 Nov;32(11):1980-5</RefSource>
<PMID Version="1">19641160</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep Med. 2009 Dec;10(10):1139-45</RefSource>
<PMID Version="1">19595628</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep Med Rev. 2010 Feb;14(1):19-31</RefSource>
<PMID Version="1">19481481</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep Med Rev. 2010 Feb;14(1):9-15</RefSource>
<PMID Version="1">19640748</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep Med. 2010 Jan;11(1):56-64</RefSource>
<PMID Version="1">19962939</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Sleep Med. 2010 Feb 15;6(1):21-9</RefSource>
<PMID Version="1">20191934</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2010 Apr;33(4):459-65</RefSource>
<PMID Version="1">20394314</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychosom Med. 2010 May;72(4):397-403</RefSource>
<PMID Version="1">20368477</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2010 May;33(5):593-8</RefSource>
<PMID Version="1">20469801</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2010 Jun;33(6):739-44</RefSource>
<PMID Version="1">20550013</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep. 2010 Sep;33(9):1159-64</RefSource>
<PMID Version="1">20857861</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sleep Med Rev. 2010 Dec;14(6):379-89</RefSource>
<PMID Version="1">20359916</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Best Pract Res Clin Endocrinol Metab. 2010 Oct;24(5):731-43</RefSource>
<PMID Version="1">21112022</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychosom Med. 2011 Jan;73(1):88-97</RefSource>
<PMID Version="1">20978224</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Sleep Res. 2011 Mar;20(1 Pt 2):137-45</RefSource>
<PMID Version="1">20626615</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Sleep Res. 2011 Mar;20(1 Pt 2):129-36</RefSource>
<PMID Version="1">20673291</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Sleep Res. 2011 Jun;20(2):318-25</RefSource>
<PMID Version="1">20673289</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes Care. 2011 May;34(5):1171-6</RefSource>
<PMID Version="1">21411507</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hypertension. 2011 Oct;58(4):596-603</RefSource>
<PMID Version="1">21876072</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Sleep Med Rev. 2013 Aug;17(4):239-40</RefSource>
<PMID Version="1">23694859</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006973">Hypertension</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010641">Phenotype</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017286">Polysomnography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012890">Sleep</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007319">Sleep Initiation and Maintenance Disorders</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS447263</OtherID>
<OtherID Source="NLM">PMC3672328</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23415808</PMID>
<DateCreated>
<Year>2013</Year>
<Month>06</Month>
<Day>14</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>01</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1938-0690</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>14</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2013</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Clinical lung cancer</Title>
<ISOAbbreviation>Clin Lung Cancer</ISOAbbreviation>
</Journal>
<ArticleTitle>Southwestern oncology group phase II trial (S0526) of pemetrexed in bronchioloalveolar carcinoma subtypes of advanced adenocarcinoma.</ArticleTitle>
<Pagination>
<MedlinePgn>351-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cllc.2012.12.004</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1525-7304(12)00271-9</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pemetrexed, a multitargeted antifolate drug, is an active agent in non-small-cell lung cancer (NSCLC), especially adenocarcinomas. Based on preclinical data supporting the relevance of alpha-folate receptors in adenocarcinoma of the bronchioloalveolar carcinoma (BAC) subtype, this trial was designed to assess pemetrexed in patients with this pathologic subtype of lung adenocarcinoma.</AbstractText>
<AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Patients with histologically confirmed stage IIIB (with malignant pleural effusion) or stage IV adenocarcinoma with BAC features or pure BAC were eligible. Treatment consisted of pemetrexed, 500 mg/m(2), administered intravenously every 21 days.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 27 patients enrolled, 24 were eligible and assessable for adverse events: Toxicity was primarily hematologic, consisting of leukopenia/neutropenia, thrombocytopenia, and anemia. The median follow-up among patients still alive (n = 8) was 35 months (range, 26-47 months). Among 17 patients with measurable disease, the response rate was 23% (all partial responses; 95% confidence interval [CI], 10%-56%). The median progression-free survival (PFS) and overall survival (OS) were 6 and 25 months, respectively.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Pemetrexed is active and well tolerated and, in patients with adenocarcinoma BAC subtypes, likely related to its underlying mechanism of action as a multitargeted antifolate drug.</AbstractText>
<CopyrightInformation>Copyright © 2013 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lau</LastName>
<ForeName>Derick H M</ForeName>
<Initials>DH</Initials>
<AffiliationInfo>
<Affiliation>University of California, Davis, Sacramento, CA, USA. derick.lau@ucdmc.ucdavis.edu</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moon</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Davies</LastName>
<ForeName>Angela M</ForeName>
<Initials>AM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sanborn</LastName>
<ForeName>Rachel E</ForeName>
<Initials>RE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hirsch</LastName>
<ForeName>Fred R</ForeName>
<Initials>FR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Franklin</LastName>
<ForeName>Wilbur A</ForeName>
<Initials>WA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ruzich</LastName>
<ForeName>Janet C</ForeName>
<Initials>JC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Redman</LastName>
<ForeName>Mary W</ForeName>
<Initials>MW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gandara</LastName>
<ForeName>David R</ForeName>
<Initials>DR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>CA11083</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA12644</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA20319</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA32102</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA35090</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA37981</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA38926</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA42777</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA45377</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA45560</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA46441</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA58882</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA63844</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA67663</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 CA046934</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 CA093373</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D017427">Clinical Trial, Phase II</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>02</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Clin Lung Cancer</MedlineTA>
<NlmUniqueID>100893225</NlmUniqueID>
<ISSNLinking>1525-7304</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000964">Antimetabolites, Antineoplastic</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005971">Glutamates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>04Q9AIZ7NO</RegistryNumber>
<NameOfSubstance UI="D000068437">Pemetrexed</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>5Z93L87A1R</RegistryNumber>
<NameOfSubstance UI="D006147">Guanine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000230">Adenocarcinoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002282">Adenocarcinoma, Bronchiolo-Alveolar</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000284">Administration, Oral</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000964">Antimetabolites, Antineoplastic</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005971">Glutamates</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006147">Guanine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000031">analogs &amp; derivatives</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008175">Lung Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009367">Neoplasm Staging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000068437">Pemetrexed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011379">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015996">Survival Rate</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS458014</OtherID>
<OtherID Source="NLM">PMC4567037</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24107461</PMID>
<DateCreated>
<Year>2014</Year>
<Month>01</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1743-1328</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>36</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Neurological research</Title>
<ISOAbbreviation>Neurol. Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>ADC mapping and T1-weighted signal changes on post-injury MRI predict seizure susceptibility after experimental traumatic brain injury.</ArticleTitle>
<Pagination>
<MedlinePgn>26-37</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1179/1743132813Y.0000000269</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Post-traumatic epilepsy (PTE) is a serious complication of traumatic brain injury (TBI). This study is designed to determine the feasibility of using multiparametric MRI endpoints to predict differences in seizure susceptibility after experimental TBI.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">MRI imaging and behavioral measurements were performed at multiple time points after lateral fluid percussion injury (FPI) in rats. Seizure susceptibility was determined by video-electroencephalogram (EEG) monitoring and off-line signal analysis after chemoconvulsant challenge.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Multiple MRI endpoints, including measures of injury-related brain swelling (normalized interhemispheric volume difference, NIVD) and T1-weighted signal change with contrast enhancement (a measure of blood-brain barrier disruption, BBBD), reliably distinguished between injured and sham-injured animals at 72 hours after injury. ADC (apparent diffusion coefficient) values (a measure of water diffusivity) in injured cortex at 72 hours and 1 week after injury, BBBD in injured cortex at 72 hours after injury and NIVD at 72 hours after injury were significantly correlated with EEG-based measures of seizure susceptibility to chemoconvulsant challenge at 3 months after injury.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The correlations between our MRI quantitative endpoints and EEG-based measures of seizure susceptibility to chemoconvulsant challenge in injured animals versus sham-injured animals support the feasibility of these MRI endpoints as potential biomarkers for post-traumatic epileptogenesis.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Frey</LastName>
<ForeName>Lauren</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lepkin</LastName>
<ForeName>Aaron</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schickedanz</LastName>
<ForeName>Alyssa</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Huber</LastName>
<ForeName>Kendra</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Brown</LastName>
<ForeName>Mark S</ForeName>
<Initials>MS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Serkova</LastName>
<ForeName>Natalie</ForeName>
<Initials>N</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>CA046934</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 CA046934</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL 1RR025780</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1 TR001082</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>12</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Neurol Res</MedlineTA>
<NlmUniqueID>7905298</NlmUniqueID>
<ISSNLinking>0161-6412</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003292">Convulsants</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>SIV03811UC</RegistryNumber>
<NameOfSubstance UI="D007608">Kainic Acid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001812">Blood-Brain Barrier</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001929">Brain Edema</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001930">Brain Injuries</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003292">Convulsants</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D038524">Diffusion Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004569">Electroencephalography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004834">Epilepsy, Post-Traumatic</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007608">Kainic Acid</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011379">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051381">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017207">Rats, Sprague-Dawley</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012640">Seizures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012720">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Epileptogenesis,</Keyword>
<Keyword MajorTopicYN="N">Fluid percussion injury,</Keyword>
<Keyword MajorTopicYN="N">Kainate,</Keyword>
<Keyword MajorTopicYN="N">MRI,</Keyword>
<Keyword MajorTopicYN="N">Post-traumatic epilepsy</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24430799</PMID>
<DateCreated>
<Year>2014</Year>
<Month>01</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>06</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1940-087X</ISSN>
<JournalIssue CitedMedium="Internet">
<Issue>82</Issue>
<PubDate>
<Year>2013</Year>
</PubDate>
</JournalIssue>
<Title>Journal of visualized experiments : JoVE</Title>
<ISOAbbreviation>J Vis Exp</ISOAbbreviation>
</Journal>
<ArticleTitle>Whole-cell MALDI-TOF mass spectrometry is an accurate and rapid method to analyze different modes of macrophage activation.</ArticleTitle>
<Pagination>
<MedlinePgn>50926</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3791/50926</ELocationID>
<Abstract>
<AbstractText>MALDI-TOF is an extensively used mass spectrometry technique in chemistry and biochemistry. It has been also applied in medicine to identify molecules and biomarkers. Recently, it has been used in microbiology for the routine identification of bacteria grown from clinical samples, without preparation or fractionation steps. We and others have applied this whole-cell MALDI-TOF mass spectrometry technique successfully to eukaryotic cells. Current applications range from cell type identification to quality control assessment of cell culture and diagnostic applications. Here, we describe its use to explore the various polarization phenotypes of macrophages in response to cytokines or heat-killed bacteria. It allowed the identification of macrophage-specific fingerprints that are representative of the diversity of proteomic responses of macrophages. This application illustrates the accuracy and simplicity of the method. The protocol we described here may be useful for studying the immune host response in pathological conditions or may be extended to wider diagnostic applications. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ouedraogo</LastName>
<ForeName>Richard</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Unité de Recherche sur les Maladies Infectieuses Tropicales et Emergentes (URMITE), CNRS UMR 7278, INSERM U1095, Aix Marseille Université</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Daumas</LastName>
<ForeName>Aurélie</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Capo</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mege</LastName>
<ForeName>Jean-Louis</ForeName>
<Initials>JL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Textoris</LastName>
<ForeName>Julien</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D059040">Video-Audio Media</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>12</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Vis Exp</MedlineTA>
<NlmUniqueID>101313252</NlmUniqueID>
<ISSNLinking>1940-087X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016764">Cell Polarity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008262">Macrophage Activation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008264">Macrophages</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019032">Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4107981</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23983104</PMID>
<DateCreated>
<Year>2014</Year>
<Month>02</Month>
<Day>12</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1096-9861</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>522</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2014</Year>
<Month>Apr</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of comparative neurology</Title>
<ISOAbbreviation>J. Comp. Neurol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Organization of sensory input to the nociceptive-specific cutaneous trunk muscle reflex in rat, an effective experimental system for examining nociception and plasticity.</ArticleTitle>
<Pagination>
<MedlinePgn>1048-71</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/cne.23461</ELocationID>
<Abstract>
<AbstractText>Detailed characterization of neural circuitries furthers our understanding of how nervous systems perform specific functions and allows the use of those systems to test hypotheses. We have characterized the sensory input to the cutaneous trunk muscle (CTM; also cutaneus trunci [rat] or cutaneus maximus [mouse]) reflex (CTMR), which manifests as a puckering of the dorsal thoracolumbar skin and is selectively driven by noxious stimuli. CTM electromyography and neurogram recordings in naïve rats revealed that CTMR responses were elicited by natural stimuli and electrical stimulation of all segments from C4 to L6, a much greater extent of segmental drive to the CTMR than previously described. Stimulation of some subcutaneous paraspinal tissue can also elicit this reflex. Using a selective neurotoxin, we also demonstrate differential drive of the CTMR by trkA-expressing and nonexpressing small-diameter afferents. These observations highlight aspects of the organization of the CTMR system that make it attractive for studies of nociception and anesthesiology and plasticity of primary afferents, motoneurons, and the propriospinal system. We use the CTMR system to demonstrate qualitatively and quantitatively that experimental pharmacological treatments can be compared with controls applied either to the contralateral side or to another segment, with the remaining segments providing controls for systemic or other treatment effects. These data indicate the potential for using the CTMR system as both an invasive and a noninvasive quantitative assessment tool providing improved statistical power and reduced animal use.</AbstractText>
<CopyrightInformation>Copyright © 2013 Wiley Periodicals, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Petruska</LastName>
<ForeName>Jeffrey C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>Department of Anatomical Sciences and Neurobiology, University of Louisville, Louisville, Kentucky, 40202; Department of Neurological Surgery, Kentucky Spinal Cord Injury Research Center, University of Louisville, Louisville, Kentucky, 40202.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barker</LastName>
<ForeName>Darrell F</ForeName>
<Initials>DF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Garraway</LastName>
<ForeName>Sandra M</ForeName>
<Initials>SM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Trainer</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fransen</LastName>
<ForeName>James W</ForeName>
<Initials>JW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Seidman</LastName>
<ForeName>Peggy A</ForeName>
<Initials>PA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Soto</LastName>
<ForeName>Roy G</ForeName>
<Initials>RG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mendell</LastName>
<ForeName>Lorne M</ForeName>
<Initials>LM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Johnson</LastName>
<ForeName>Richard D</ForeName>
<Initials>RD</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>NS016996</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>NS027511</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>NS080091</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P01  NS027511</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P01 NS027511</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 GM103507</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30GM103507</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 NS016996</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21 NS080091</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Comp Neurol</MedlineTA>
<NlmUniqueID>0406041</NlmUniqueID>
<ISSNLinking>0021-9967</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018712">Analgesics, Non-Narcotic</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017475">Receptors, Nerve Growth Factor</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>51110-01-1</RegistryNumber>
<NameOfSubstance UI="D013004">Somatostatin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>67VB76HONO</RegistryNumber>
<NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.2.-</RegistryNumber>
<NameOfSubstance UI="C489034">PGP9.5 protein, rat</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.2.15</RegistryNumber>
<NameOfSubstance UI="D043222">Ubiquitin Thiolesterase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>Y8335394RO</RegistryNumber>
<NameOfSubstance UI="D002045">Bupivacaine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Neurol. 1998 Mar;150(1):115-21</RefSource>
<PMID Version="1">9514823</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1998 Apr 15;18(8):3059-72</RefSource>
<PMID Version="1">9526023</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Biol. 1998 Jun 1;198(1):57-81</RefSource>
<PMID Version="1">9640332</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Neurosci. 1998 Nov;12(4-5):256-68</RefSource>
<PMID Version="1">9828090</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurophysiol. 1999 May;81(5):2398-405</RefSource>
<PMID Version="1">10322075</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pain. 1999 Apr;80(3):463-70</RefSource>
<PMID Version="1">10342408</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1999 Jun 15;19(12):5138-48</RefSource>
<PMID Version="1">10366647</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 1999 Jul 19;410(1):73-89</RefSource>
<PMID Version="1">10397396</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7714-8</RefSource>
<PMID Version="1">10393886</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1999 Aug 1;19(15):6497-505</RefSource>
<PMID Version="1">10414978</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2005 Jan 6;45(1):17-25</RefSource>
<PMID Version="1">15629699</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 2005 Mar 10;1037(1-2):148-56</RefSource>
<PMID Version="1">15777763</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2005 May 11;25(19):4868-78</RefSource>
<PMID Version="1">15888662</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Physiol. 2005 Jun 15;565(Pt 3):927-43</RefSource>
<PMID Version="1">15831536</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anesthesiology. 2005 Jul;103(1):113-25</RefSource>
<PMID Version="1">15983463</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2005 Sep 15;47(6):787-93</RefSource>
<PMID Version="1">16157274</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pain. 2005 Nov;6(11):747-56</RefSource>
<PMID Version="1">16275599</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2005 Dec 15;438(7070):1017-21</RefSource>
<PMID Version="1">16355225</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anesth Analg. 2006 Jan;102(1):283-7</RefSource>
<PMID Version="1">16368844</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anesthesiology. 2006 Feb;104(2):368-73, discussion 5A</RefSource>
<PMID Version="1">16436858</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurophysiol. 2006 Apr;95(4):2098-107</RefSource>
<PMID Version="1">16381809</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2006 Jul 5;26(27):7281-92</RefSource>
<PMID Version="1">16822986</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2006 Aug 16;26(33):8578-87</RefSource>
<PMID Version="1">16914684</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2006 Aug 16;26(33):8588-99</RefSource>
<PMID Version="1">16914685</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 2007 Jan 20;500(3):513-29</RefSource>
<PMID Version="1">17120289</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurophysiol. 2000 May;83(5):3076-83</RefSource>
<PMID Version="1">10805702</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Anaesthesiol Scand. 2000 Jul;44(6):648-55</RefSource>
<PMID Version="1">10903011</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurophysiol. 2000 Aug;84(2):798-805</RefSource>
<PMID Version="1">10938306</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurophysiol. 2000 Nov;84(5):2365-79</RefSource>
<PMID Version="1">11067979</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroreport. 2000 Nov 9;11(16):3589-92</RefSource>
<PMID Version="1">11095524</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Chem Neuroanat. 2000 Nov;20(2):141-62</RefSource>
<PMID Version="1">11118807</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci Res. 2001 Dec 15;66(6):1179-86</RefSource>
<PMID Version="1">11746451</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anesthesiology. 2002 Jan;96(1):109-16</RefSource>
<PMID Version="1">11753010</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Biol. 2002 Jan;205(Pt 1):1-12</RefSource>
<PMID Version="1">11818407</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurosci. 2001 Dec;14(11):1800-8</RefSource>
<PMID Version="1">11860475</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Reg Anesth Pain Med. 2002 Mar-Apr;27(2):173-9</RefSource>
<PMID Version="1">11915065</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Neurosci. 2002 Aug;3(8):655-66</RefSource>
<PMID Version="1">12154366</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 2002;115(1):15-30</RefSource>
<PMID Version="1">12401318</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Physiol. 2002 Nov 15;545(Pt 1):43-50</RefSource>
<PMID Version="1">12433948</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurophysiol. 2003 Jan;89(1):513-24</RefSource>
<PMID Version="1">12522198</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 2003 Jul 14;462(1):29-41</RefSource>
<PMID Version="1">12761822</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroreport. 2003 Jul 18;14(10):1301-4</RefSource>
<PMID Version="1">12876461</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Neurobiol. 2003 Aug;13(4):500-5</RefSource>
<PMID Version="1">12965300</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Neurosci. 2003;26:1-30</RefSource>
<PMID Version="1">12651967</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurosci. 2003 Nov;18(9):2467-76</RefSource>
<PMID Version="1">14622147</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anesthesiology. 2007 Aug;107(2):305-11</RefSource>
<PMID Version="1">17667576</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pain. 2007 Dec 15;133(1-3):161-73</RefSource>
<PMID Version="1">17467172</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Neurobiol. 2008 Mar;68(4):457-75</RefSource>
<PMID Version="1">18172890</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Anaesth. 2008 Jul;101(1):8-16</RefSource>
<PMID Version="1">18417503</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anesth Analg. 2008 Jul;107(1):96-101</RefSource>
<PMID Version="1">18635472</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anesthesiology. 2008 Sep;109(3):502-11</RefSource>
<PMID Version="1">18719449</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anesth Analg. 2008 Oct;107(4):1397-405</RefSource>
<PMID Version="1">18806059</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Physiol. 2009 Mar 1;587(Pt 5):1013-32</RefSource>
<PMID Version="1">19124536</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anesthesiology. 2009 Jul;111(1):127-37</RefSource>
<PMID Version="1">19512868</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Pharmacol Sin. 2009 Sep;30(9):1227-36</RefSource>
<PMID Version="1">19730427</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Neurol. 2010 May;223(1):60-71</RefSource>
<PMID Version="1">20080088</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Reg Anesth Pain Med. 2011 May-Jun;36(3):236-40</RefSource>
<PMID Version="1">21364497</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurosci. 2012 Jan;35(2):221-32</RefSource>
<PMID Version="1">22211901</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):2009-14</RefSource>
<PMID Version="1">22308471</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron Glia Biol. 2011 Feb;7(1):99-108</RefSource>
<PMID Version="1">22613083</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2013 Feb;16(2):183-92</RefSource>
<PMID Version="1">23292683</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Neurobiol. 2007 Jun;67(7):960-75</RefSource>
<PMID Version="1">17506495</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 2004 Aug 2;475(4):575-89</RefSource>
<PMID Version="1">15236238</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Electromyogr Clin Neurophysiol. 1979 Jan-Mar;19(1-2):157-64</RefSource>
<PMID Version="1">499050</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 1981 Apr 6;210(1-2):83-9</RefSource>
<PMID Version="1">7225825</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Anat (Basel). 1981;109(3):209-17</RefSource>
<PMID Version="1">7257720</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 1981;6(10):1923-34</RefSource>
<PMID Version="1">6170910</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1983 Feb;3(2):399-406</RefSource>
<PMID Version="1">6185658</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 1984 Mar 19;295(2):217-25</RefSource>
<PMID Version="1">6713184</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Vet Res. 1984 Sep;45(9):1689-98</RefSource>
<PMID Version="1">6497126</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Histochemistry. 1985;83(2):175-80</RefSource>
<PMID Version="1">2864326</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 1987 Jul 22;261(4):583-91</RefSource>
<PMID Version="1">3611425</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Physiol Hung. 1987;69(3-4):315-21</RefSource>
<PMID Version="1">3310521</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Exp Pathol. 1988 Feb;69(1):91-104</RefSource>
<PMID Version="1">2964855</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurophysiol. 1988 Aug;60(2):446-62</RefSource>
<PMID Version="1">3171637</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurophysiol. 1988 Aug;60(2):463-77</RefSource>
<PMID Version="1">3171638</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pain. 1989 May;37(2):229-43</RefSource>
<PMID Version="1">2664665</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anesthesiology. 1989 Jul;71(1):75-9</RefSource>
<PMID Version="1">2568769</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1989 Nov 3;246(4930):670-3</RefSource>
<PMID Version="1">2530630</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurophysiol. 1989 Dec;62(6):1260-9</RefSource>
<PMID Version="1">2600623</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurocytol. 1989 Oct;18(5):583-91</RefSource>
<PMID Version="1">2559166</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 1990 Jun 22;296(4):614-33</RefSource>
<PMID Version="1">2358554</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 1990 Jun 22;296(4):634-53</RefSource>
<PMID Version="1">2358555</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurotrauma. 1991 Summer;8(2):103-19</RefSource>
<PMID Version="1">1870134</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Sci. 1991 Jun;103(2):156-71</RefSource>
<PMID Version="1">1880533</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1992 Apr;12(4):1454-66</RefSource>
<PMID Version="1">1556603</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Neurobiol. 1992 Aug;2(4):479-83</RefSource>
<PMID Version="1">1525546</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1992 Oct;12(10):4011-22</RefSource>
<PMID Version="1">1403097</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pain. 1994 Oct;59(1):85-94</RefSource>
<PMID Version="1">7854807</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 1995 Jan 16;351(3):329-38</RefSource>
<PMID Version="1">7706545</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Med. 1995 Apr;27(2):235-9</RefSource>
<PMID Version="1">7632420</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 1995 Oct 23;361(3):404-16</RefSource>
<PMID Version="1">8550888</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 1996 Jan;70(1):179-89</RefSource>
<PMID Version="1">8848123</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pain. 1996 Sep;67(1):197-202</RefSource>
<PMID Version="1">8895248</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurophysiol. 1997 Jan;77(1):502-6</RefSource>
<PMID Version="1">9120591</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 1997 Mar 28;752(1-2):143-50</RefSource>
<PMID Version="1">9106450</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 1997 May 19;381(4):428-38</RefSource>
<PMID Version="1">9136800</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Somatosens Mot Res. 1997;14(1):17-26</RefSource>
<PMID Version="1">9241725</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pain. 1996 Nov;68(1):133-40</RefSource>
<PMID Version="1">9252008</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pain. 1996 Nov;68(1):141-50</RefSource>
<PMID Version="1">9252009</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Biol. 1997 Oct 1;190(1):94-116</RefSource>
<PMID Version="1">9331334</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1997 Nov 1;17(21):8476-90</RefSource>
<PMID Version="1">9334420</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 1997 Oct;19(4):849-61</RefSource>
<PMID Version="1">9354331</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropharmacology. 1997 Sep;36(9):1229-42</RefSource>
<PMID Version="1">9364478</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 1997 Nov 3;387(4):489-506</RefSource>
<PMID Version="1">9373009</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 1997 Dec 29;389(4):545-68</RefSource>
<PMID Version="1">9421138</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000344">Afferent Pathways</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018712">Analgesics, Non-Narcotic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002045">Bupivacaine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020927">Dexmedetomidine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005073">Evoked Potentials, Somatosensory</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018482">Muscle, Skeletal</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009431">Neural Conduction</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009473">Neuronal Plasticity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059225">Nociception</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010812">Physical Stimulation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051381">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017207">Rats, Sprague-Dawley</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017475">Receptors, Nerve Growth Factor</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012018">Reflex</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012867">Skin</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000294">innervation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013004">Somatostatin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013116">Spinal Cord</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D043222">Ubiquitin Thiolesterase</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS527671</OtherID>
<OtherID Source="NLM">PMC3945951</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">anesthesiology</Keyword>
<Keyword MajorTopicYN="N">animal models</Keyword>
<Keyword MajorTopicYN="N">pain</Keyword>
<Keyword MajorTopicYN="N">pharmacology</Keyword>
<Keyword MajorTopicYN="N">plasticity</Keyword>
<Keyword MajorTopicYN="N">sensory neurons</Keyword>
<Keyword MajorTopicYN="N">spinal cord</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24597993</PMID>
<DateCreated>
<Year>2014</Year>
<Month>03</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">2155-1200</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>33</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Journal of nutrition in gerontology and geriatrics</Title>
<ISOAbbreviation>J Nutr Gerontol Geriatr</ISOAbbreviation>
</Journal>
<ArticleTitle>Vitamin K and bone health in older adults.</ArticleTitle>
<Pagination>
<MedlinePgn>10-22</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1080/21551197.2014.875818</ELocationID>
<Abstract>
<AbstractText>Vitamin K is one of several nutrients that have been linked with bone health. In particular, there is an emerging literature regarding the questionable efficacy of vitamin K supplementation in reducing age-related bone loss. This review aims to summarize the role of vitamin K in bone health in older adults and discuss the clinical implications from a select few human studies. The evidence for vitamin K supplementation in older adults is mixed. Although the observational studies have shown linkages between vitamin K intake and lower risk of fractures in this population, the current evidence from randomized controlled trials is not strongly supportive of vitamin K supplementation in older adults for the intent of improving bone health. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shah</LastName>
<ForeName>Krupa</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>a Division of Geriatrics and Aging , University of Rochester School of Medicine and Dentistry , Rochester , New York , USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gleason</LastName>
<ForeName>Lauren</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Villareal</LastName>
<ForeName>Dennis T</ForeName>
<Initials>DT</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>1K23 AG043319-01A1</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AG025501</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AG031176</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Nutr Gerontol Geriatr</MedlineTA>
<NlmUniqueID>101558292</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>12001-79-5</RegistryNumber>
<NameOfSubstance UI="D014812">Vitamin K</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CitationSubset>N</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000375">Aging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001842">Bone and Bones</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004032">Diet</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019587">Dietary Supplements</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D019317">Evidence-Based Medicine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006293">Health Promotion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018673">Nutrition Policy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010024">Osteoporosis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014812">Vitamin K</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014813">Vitamin K Deficiency</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000178">diet therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">24708602</PMID>
<DateCreated>
<Year>2014</Year>
<Month>04</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>04</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1748-7188</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>9</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Algorithms for molecular biology : AMB</Title>
<ISOAbbreviation>Algorithms Mol Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>Predicting gene ontology annotations of orphan GWAS genes using protein-protein interactions.</ArticleTitle>
<Pagination>
<MedlinePgn>10</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/1748-7188-9-10</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The number of genome-wide association studies (GWAS) has increased rapidly in the past couple of years, resulting in the identification of genes associated with different diseases. The next step in translating these findings into biomedically useful information is to find out the mechanism of the action of these genes. However, GWAS studies often implicate genes whose functions are currently unknown; for example, MYEOV, ANKLE1, TMEM45B and ORAOV1 are found to be associated with breast cancer, but their molecular function is unknown.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">We carried out Bayesian inference of Gene Ontology (GO) term annotations of genes by employing the directed acyclic graph structure of GO and the network of protein-protein interactions (PPIs). The approach is designed based on the fact that two proteins that interact biophysically would be in physical proximity of each other, would possess complementary molecular function, and play role in related biological processes. Predicted GO terms were ranked according to their relative association scores and the approach was evaluated quantitatively by plotting the precision versus recall values and F-scores (the harmonic mean of precision and recall) versus varying thresholds. Precisions of ~58% and ~ 40% for localization and functions respectively of proteins were determined at a threshold of ~30 (top 30 GO terms in the ranked list). Comparison with function prediction based on semantic similarity among nodes in an ontology and incorporation of those similarities in a k-nearest neighbor classifier confirmed that our results compared favorably.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This approach was applied to predict the cellular component and molecular function GO terms of all human proteins that have interacting partners possessing at least one known GO annotation. The list of predictions is available at http://severus.dbmi.pitt.edu/engo/GOPRED.html. We present the algorithm, evaluations and the results of the computational predictions, especially for genes identified in GWAS studies to be associated with diseases, which are of translational interest.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kuppuswamy</LastName>
<ForeName>Usha</ForeName>
<Initials>U</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ananthasubramanian</LastName>
<ForeName>Seshan</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Yanli</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Balakrishnan</LastName>
<ForeName>Narayanaswamy</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ganapathiraju</LastName>
<ForeName>Madhavi K</ForeName>
<Initials>MK</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Informatics and Intelligent Systems Program, University of Pittsburgh, Pittsburgh, PA 15213, USA. madhavi@pitt.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 MH094564</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>04</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Algorithms Mol Biol</MedlineTA>
<NlmUniqueID>101265088</NlmUniqueID>
<ISSNLinking>1748-7188</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4124845</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23625632</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1098-2744</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>53</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Molecular carcinogenesis</Title>
<ISOAbbreviation>Mol. Carcinog.</ISOAbbreviation>
</Journal>
<ArticleTitle>Role of PTEN in basal cell derived lung carcinogenesis.</ArticleTitle>
<Pagination>
<MedlinePgn>841-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mc.22030</ELocationID>
<Abstract>
<AbstractText>Lung adenocarcinoma (AdC) and lung squamous cell carcinoma (SCC) are the most common non-small cell lung cancer (NSCLC) subtypes, however, most genetic mouse models of lung cancer produce predominantly, if not exclusively, AdC. Whether this is secondary to targeting mutations to the distal airway cells or to the use of activating Kras mutations that drive AdC formation is unknown. We previously showed that targeting Kras(G12D) activation and transforming growth factor β receptor type II (TGFβRII) deletion to airway basal cells via a keratin promoter induced formation of both lung AdC and SCC. In this study we assessed if targeting phosphatase and tensin homologue (PTEN) deletion to airway basal cells could initiate lung tumor formation or increase lung SCC formation. We found that PTEN deletion is capable of initiating both lung AdC and SCC formation when targeted to basal cells and although PTEN deletion is a weaker tumor initiator than Kras(G12D) with low tumor multiplicity and long latency, tumors initiated by PTEN deletion were larger and displayed more malignant conversion than Kras(G12D) initiated tumors. That PTEN deletion did not increase lung SCC formation compared to Kras(G12D) activation, suggests that the initiating genetic event does not dictate tumor histology when genetic alterations are targeted to a specific cell. These studies also confirm that basal cells of the conducting airway are capable of giving rise to multiple NSCLC tumor types.</AbstractText>
<CopyrightInformation>© 2013 Wiley Periodicals, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Malkoski</LastName>
<ForeName>Stephen P</ForeName>
<Initials>SP</Initials>
<AffiliationInfo>
<Affiliation>Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado; Department of Pathology, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cleaver</LastName>
<ForeName>Timothy G</ForeName>
<Initials>TG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Thompson</LastName>
<ForeName>Joshua J</ForeName>
<Initials>JJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sutton</LastName>
<ForeName>Whitney P</ForeName>
<Initials>WP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Haeger</LastName>
<ForeName>Sarah M</ForeName>
<Initials>SM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rodriguez</LastName>
<ForeName>Karen J</ForeName>
<Initials>KJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lu</LastName>
<ForeName>Shi-Long</ForeName>
<Initials>SL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Merrick</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Xiao-Jing</ForeName>
<Initials>XJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>DE015953</GrantID>
<Acronym>DE</Acronym>
<Agency>NIDCR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K08 CA131483</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K08 CA131483</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 CA046934</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30CA046934</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DE021788</GrantID>
<Acronym>DE</Acronym>
<Agency>NIDCR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>04</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Mol Carcinog</MedlineTA>
<NlmUniqueID>8811105</NlmUniqueID>
<ISSNLinking>0899-1987</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>EC 3.1.3.48</RegistryNumber>
<NameOfSubstance UI="C487757">Pten protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.3.67</RegistryNumber>
<NameOfSubstance UI="D051059">PTEN Phosphohydrolase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.6.5.2</RegistryNumber>
<NameOfSubstance UI="C495971">Kras2 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.6.5.2</RegistryNumber>
<NameOfSubstance UI="D016283">Proto-Oncogene Proteins p21(ras)</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2004 Apr 1;64(7):2307-16</RefSource>
<PMID Version="1">15059877</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2004 Aug 1;64(15):5054-8</RefSource>
<PMID Version="1">15289303</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anat Rec. 1989 Jul;224(3):374-8</RefSource>
<PMID Version="1">2476949</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 2005 Mar 15;19(6):643-64</RefSource>
<PMID Version="1">15769940</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2005 Mar 15;65(6):2296-302</RefSource>
<PMID Version="1">15781643</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2005 Jun 17;121(6):823-35</RefSource>
<PMID Version="1">15960971</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2005 Aug 4;436(7051):725-30</RefSource>
<PMID Version="1">16079851</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2005 Nov 15;65(22):10280-8</RefSource>
<PMID Version="1">16288016</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2006 Jul;116(7):1843-52</RefSource>
<PMID Version="1">16767220</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Crit Care Med. 2007 Mar 15;175(6):547-53</RefSource>
<PMID Version="1">17158280</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2007 Aug 16;448(7155):807-10</RefSource>
<PMID Version="1">17676035</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2007 Oct;117(10):2929-40</RefSource>
<PMID Version="1">17909629</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2008 Feb 15;68(4):1119-27</RefSource>
<PMID Version="1">18281487</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2008 Sep 1;68(17):6913-21</RefSource>
<PMID Version="1">18757405</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2008 Dec;14(12):1351-6</RefSource>
<PMID Version="1">19029981</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49</RefSource>
<PMID Version="1">19474385</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12771-5</RefSource>
<PMID Version="1">19625615</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Biol Sci. 2010;6(1):68-79</RefSource>
<PMID Version="1">20140084</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 2010 Jul;177(1):362-76</RefSource>
<PMID Version="1">20522644</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2010 Aug 15;70(16):6639-48</RefSource>
<PMID Version="1">20710044</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Oncol. 2010 Oct;4(5):397-403</RefSource>
<PMID Version="1">20594926</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Cycle. 2011 Aug 15;10(16):2806-15</RefSource>
<PMID Version="1">21822053</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2011 Oct 28;147(3):525-38</RefSource>
<PMID Version="1">22036562</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2011 Nov 1;71(21):6665-75</RefSource>
<PMID Version="1">21911454</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2011 Dec 1;71(23):7250-8</RefSource>
<PMID Version="1">22088965</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2012 Mar 20;21(3):448.e2</RefSource>
<PMID Version="1">22439939</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):4910-5</RefSource>
<PMID Version="1">22411819</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Cancer Res. 2012 Apr 15;18(8):2173-83</RefSource>
<PMID Version="1">22399565</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Mol Cell Biol. 2012 May;13(5):283-96</RefSource>
<PMID Version="1">22473468</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Cancer Res. 2012 Dec 15;18(24):6771-83</RefSource>
<PMID Version="1">23136191</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genesis. 2000 Feb;26(2):160-1</RefSource>
<PMID Version="1">10686618</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2001 Apr 26;410(6832):1111-6</RefSource>
<PMID Version="1">11323676</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2001 May 15;29(10):E47</RefSource>
<PMID Version="1">11353092</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genesis. 2002 Feb;32(2):148-9</RefSource>
<PMID Version="1">11857804</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2003 Sep;4(3):181-9</RefSource>
<PMID Version="1">14522252</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2003 Sep;4(3):209-21</RefSource>
<PMID Version="1">14522255</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 2004 Feb;164(2):577-88</RefSource>
<PMID Version="1">14742263</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002294">Carcinoma, Squamous Cell</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017353">Gene Deletion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008175">Lung Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008822">Mice, Transgenic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020125">Mutation, Missense</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018295">Neoplasms, Basal Cell</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051059">PTEN Phosphohydrolase</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000172">deficiency</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016283">Proto-Oncogene Proteins p21(ras)</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS547701</OtherID>
<OtherID Source="NLM">PMC3906215</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Kras</Keyword>
<Keyword MajorTopicYN="N">adenocarcinoma</Keyword>
<Keyword MajorTopicYN="N">non-small cell lung cancer</Keyword>
<Keyword MajorTopicYN="N">squamous cell carcinoma</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25179794</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1573-7284</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>29</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>European journal of epidemiology</Title>
<ISOAbbreviation>Eur. J. Epidemiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Recalibration of the SCORE risk chart for the Russian population.</ArticleTitle>
<Pagination>
<MedlinePgn>621-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s10654-014-9947-7</ELocationID>
<Abstract>
<AbstractText>Persisting high levels of cardiovascular mortality in Russia present a specific case among developed countries. Application of cardiovascular risk prediction models holds great potential for primary prevention in this country. Using a unique set of cohort follow-up data from Moscow and Saint Petersburg, this study aims to test and recalibrate the Systematic Coronary Risk Evaluation (SCORE) methods for predicting CVD mortality risks in the general population. The study is based on pooled epidemiological cohort data covering the period 1975-2001. The algorithms from the SCORE project were used for the calibration of the SCORE equation for the Moscow and St. Petersburg populations (SCORE-MoSP). Age-specific 10-year cumulative cardiovascular mortality rates were estimated according to the original SCORE-High and SCORE-Low equations and compared to the estimates based on the recalibrated SCORE-MoSP model and observed CVD mortality rates. Ten-year risk prediction charts for CVD mortality were derived and compared using conventional SCORE-High and recalibrated SCORE-MoSP methods. The original SCORE-High model tends to substantially under-estimate 10-year cardiovascular mortality risk for females. The SCORE-MoSP model provided better results which were closer to the observed rates. For males, both the SCORE-High and SCORE-MoSP provided similar estimates which tend to under-estimate CVD mortality risk at younger ages. These differences are also reflected in the risk prediction charts. Using non-calibrated scoring models for Russia may lead to substantial under-estimation of cardiovascular mortality risk in some groups of individuals. Although the SCORE-MoSP provide better results for females, more complex scoring methods involving a wider range of risk factors are needed. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jdanov</LastName>
<ForeName>Dmitri A</ForeName>
<Initials>DA</Initials>
<AffiliationInfo>
<Affiliation>Max Planck Institute for Demographic Research, KonradZuse Str. 1, 18057, Rostock, Germany, jdanov@demogr.mpg.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Deev</LastName>
<ForeName>Alexander D</ForeName>
<Initials>AD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jasilionis</LastName>
<ForeName>Domantas</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shalnova</LastName>
<ForeName>Svetlana A</ForeName>
<Initials>SA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shkolnikova</LastName>
<ForeName>Maria A</ForeName>
<Initials>MA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shkolnikov</LastName>
<ForeName>Vladimir M</ForeName>
<Initials>VM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 AG 026786</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AG026786</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>09</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Eur J Epidemiol</MedlineTA>
<NlmUniqueID>8508062</NlmUniqueID>
<ISSNLinking>0393-2990</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000367">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D002138">Calibration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002318">Cardiovascular Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000401">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D044465">European Continental Ancestry Group</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006305">Health Status Indicators</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008962">Models, Theoretical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011159">Population Surveillance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011237">Predictive Value of Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012107">Research Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018570">Risk Assessment</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D012426">Russia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25440500</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>03</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1879-1913</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>114</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Nov</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The American journal of cardiology</Title>
<ISOAbbreviation>Am. J. Cardiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Persistence of evidence-based medication use after discharge from academic versus nonacademic hospitals among patients with non-ST-segment elevation myocardial infarction.</ArticleTitle>
<Pagination>
<MedlinePgn>1479-84</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjcard.2014.08.010</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0002-9149(14)01704-4</ELocationID>
<Abstract>
<AbstractText>There is increasing emphasis on optimizing evidence-based medication (EBM) persistence as a means to improve longitudinal patient outcomes after acute myocardial infarction (MI); yet it is unknown whether differences in medication persistence exist between patients discharged from academic versus nonacademic hospitals. We linked Medicare pharmacy claims data with 3,184 patients with non-ST-segment elevation MI &gt;65 years of age who were treated in 2006 at 253 hospitals participating in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology and American Heart Association guidelines registry. Using multivariate regression, we compared persistent filling of β blockers, angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers, clopidogrel, and statins at 90 days and 1 year postdischarge between patients discharged from academic and nonacademic hospitals. Patients treated at academic hospitals were more frequently nonwhite (19% vs 8%, p &lt;0.001) and had a greater co-morbidity burden (Charlson score ≥4 in 36% vs 30%, p = 0.001) than patients treated at nonacademic hospitals. Composite persistence to all EBMs prescribed at discharge was low and not significantly different between academic and nonacademic hospitals at 90 days (46% vs 45%, adjusted incidence rate ratio = 0.99, 95% confidence interval 0.95 to 1.04) and at 1 year (39% vs 39%, adjusted incidence rate ratio = 1.02, 95% confidence interval 0.98 to 1.07). Rates of persistence to EBMs were similar between patients with MI &gt;65 years old treated at academic versus nonacademic hospitals; however, persistence rates are low both early and late postdischarge, highlighting a continued need for quality improvement efforts to optimize post-MI management.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rymer</LastName>
<ForeName>Jennifer</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Duke University Medical Center, Department of Medicine, Duke University, Durham, North Carolina. Electronic address: Jennifer.rymer@duke.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McCoy</LastName>
<ForeName>Lisa A</ForeName>
<Initials>LA</Initials>
<AffiliationInfo>
<Affiliation>Duke Clinical Research Institute, Durham, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thomas</LastName>
<ForeName>Laine</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Duke Clinical Research Institute, Durham, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peterson</LastName>
<ForeName>Eric D</ForeName>
<Initials>ED</Initials>
<AffiliationInfo>
<Affiliation>Duke University Medical Center, Department of Medicine, Duke University, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Tracy Y</ForeName>
<Initials>TY</Initials>
<AffiliationInfo>
<Affiliation>Duke University Medical Center, Department of Medicine, Duke University, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>KM1 CA156687</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>KM1CA156687</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Cardiol</MedlineTA>
<NlmUniqueID>0207277</NlmUniqueID>
<ISSNLinking>0002-9149</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002317">Cardiovascular Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002317">Cardiovascular Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D019983">Guideline Adherence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017052">Hospital Mortality</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000639">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D006769">Hospitals, General</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009203">Myocardial Infarction</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010351">Patient Discharge</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000639">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012042">Registries</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D018570">Risk Assessment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS744217</OtherID>
<OtherID Source="NLM">PMC4691245</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25214372</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>05</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-8384</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>55</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2014</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Comprehensive psychiatry</Title>
<ISOAbbreviation>Compr Psychiatry</ISOAbbreviation>
</Journal>
<ArticleTitle>Auditory tasks for assessment of sensory function and affective prosody in schizophrenia.</ArticleTitle>
<Pagination>
<MedlinePgn>1862-74</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.comppsych.2014.08.046</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0010-440X(14)00238-7</ELocationID>
<Abstract>
<AbstractText>Schizophrenia patients exhibit impairments in auditory-based social cognition, indicated by deficits in detection of prosody, such as affective prosody and basic pitch perception. However, little is known about the psychometric properties of behavioral tests used to assess these functions. The goal of this paper is to characterize the properties of prosody and pitch perception tasks and to investigate whether they can be shortened. The pitch perception test evaluated is a tone-matching task developed by Javitt and colleagues (J-TMT). The prosody test evaluated is the auditory emotion recognition task developed by Juslin and Laukka (JL-AER). The sample includes 124 schizophrenia patients (SZ) and 131 healthy controls (HC). Properties, including facility and discrimination, of each item were assessed. Effects of item characteristics (e.g., emotion) were also evaluated. Shortened versions of the tests are proposed based on facility, discrimination, and/or ability of item characteristics to discriminate between patients and controls. Test-retest reliability is high for patients and controls for both the original and short forms of the J-TMT and JL-AER. Thus, the original as well as short forms of the J-TMT and JL-AER are suggested for inclusion in clinical trials of social cognitive and perceptual treatments. The development of short forms further increases the utility of these auditory tasks in clinical trials and clinical practice. The large SZ vs. HC differences reported here also highlight the profound nature of auditory deficits and a need for remediation. </AbstractText>
<CopyrightInformation>Copyright © 2014. Published by Elsevier Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Petkova</LastName>
<ForeName>Eva</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Child and Adolescent Psychiatry, New York University Langone Medical Center, New York, NY 10016, USA; Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA. Electronic address: eva.petkova@nyumc.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lu</LastName>
<ForeName>Feihan</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Statistics, Columbia University, New York, NY 10027, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kantrowitz</LastName>
<ForeName>Joshua</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY 10027, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sanchez</LastName>
<ForeName>Jamie L</ForeName>
<Initials>JL</Initials>
<AffiliationInfo>
<Affiliation>Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lehrfeld</LastName>
<ForeName>Jonathan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Scaramello</LastName>
<ForeName>Nayla</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Silipo</LastName>
<ForeName>Gail</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>DiCostanza</LastName>
<ForeName>Joanna</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ross</LastName>
<ForeName>Marina</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Su</LastName>
<ForeName>Zhe</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Department of Child and Adolescent Psychiatry, New York University Langone Medical Center, New York, NY 10016, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Javitt</LastName>
<ForeName>Daniel C</ForeName>
<Initials>DC</Initials>
<AffiliationInfo>
<Affiliation>Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY 10027, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Butler</LastName>
<ForeName>Pamela D</ForeName>
<Initials>PD</Initials>
<AffiliationInfo>
<Affiliation>Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA; Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 MH084848</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 MH084848</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Compr Psychiatry</MedlineTA>
<NlmUniqueID>0372612</NlmUniqueID>
<ISSNLinking>0010-440X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009483">Neuropsychological Tests</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000592">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010898">Pitch Perception</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012559">Schizophrenia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012938">Social Perception</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013067">Speech Perception</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS741901</OtherID>
<OtherID Source="NLM">PMC4691012</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24791715</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>08</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-7544</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>283</Volume>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>Neuroscience</Title>
<ISOAbbreviation>Neuroscience</ISOAbbreviation>
</Journal>
<ArticleTitle>Adult cortical plasticity following injury: Recapitulation of critical period mechanisms?</ArticleTitle>
<Pagination>
<MedlinePgn>4-16</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuroscience.2014.04.029</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0306-4522(14)00331-5</ELocationID>
<Abstract>
<AbstractText>A primary goal of research on developmental critical periods (CPs) is the recapitulation of a juvenile-like state of malleability in the adult brain that might enable recovery from injury. These ambitions are often framed in terms of the simple reinstatement of enhanced plasticity in the growth-restricted milieu of an injured adult brain. Here, we provide an analysis of the similarities and differences between deprivation-induced and injury-induced cortical plasticity, to provide for a nuanced comparison of these remarkably similar processes. As a first step, we review the factors that drive ocular dominance plasticity in the primary visual cortex of the uninjured brain during the CP and in adults, to highlight processes that might confer adaptive advantage. In addition, we directly compare deprivation-induced cortical plasticity during the CP and plasticity following acute injury or ischemia in mature brain. We find that these two processes display a biphasic response profile following deprivation or injury: an initial decrease in GABAergic inhibition and synapse loss transitions into a period of neurite expansion and synaptic gain. This biphasic response profile emphasizes the transition from a period of cortical healing to one of reconnection and recovery of function. Yet while injury-induced plasticity in adult shares several salient characteristics with deprivation-induced plasticity during the CP, the degree to which the adult injured brain is able to functionally rewire, and the time required to do so, present major limitations for recovery. Attempts to recapitulate a measure of CP plasticity in an adult injury context will need to carefully dissect the circuit alterations and plasticity mechanisms involved while measuring functional behavioral output to assess their ultimate success. </AbstractText>
<CopyrightInformation>Copyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nahmani</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Biology and Center for Behavioral Genomics, Brandeis University, Waltham, MA 02454, United States. Electronic address: nahmani@brandeis.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Turrigiano</LastName>
<ForeName>G G</ForeName>
<Initials>GG</Initials>
<AffiliationInfo>
<Affiliation>Department of Biology and Center for Behavioral Genomics, Brandeis University, Waltham, MA 02454, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 EY014439</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Neuroscience</MedlineTA>
<NlmUniqueID>7605074</NlmUniqueID>
<ISSNLinking>0306-4522</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Physiol. 1978 Aug;281:267-83</RefSource>
<PMID Version="1">702379</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Physiol. 1978 Oct;283:223-62</RefSource>
<PMID Version="1">102764</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Neurosci. 2012 Feb;35(2):111-22</RefSource>
<PMID Version="1">22104561</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2012 Apr 26;74(2):374-83</RefSource>
<PMID Version="1">22542189</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Neurosci. 2012;35:309-30</RefSource>
<PMID Version="1">22462544</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2012 Jul 26;75(2):230-49</RefSource>
<PMID Version="1">22841309</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2013 Feb 27;33(9):4181-91</RefSource>
<PMID Version="1">23447625</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2013 May 15;33(20):8810-9</RefSource>
<PMID Version="1">23678123</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscientist. 2013 Aug;19(4):384-93</RefSource>
<PMID Version="1">23474602</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 2013 Sep 5;247:117-33</RefSource>
<PMID Version="1">23707979</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2013 Sep 26;501(7468):543-6</RefSource>
<PMID Version="1">23975100</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2013 Oct 2;80(1):51-63</RefSource>
<PMID Version="1">24094102</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stroke. 1995 Nov;26(11):2135-44</RefSource>
<PMID Version="1">7482662</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosci Lett. 1995 Jun 30;193(2):101-4</RefSource>
<PMID Version="1">7478151</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1996 May 15;16(10):3274-86</RefSource>
<PMID Version="1">8627365</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1996 Jun 21;272(5269):1791-4</RefSource>
<PMID Version="1">8650578</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cereb Blood Flow Metab. 1996 Sep;16(5):906-14</RefSource>
<PMID Version="1">8784234</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 1998 Jul;85(1):15-27</RefSource>
<PMID Version="1">9607699</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 1998 Jul;85(1):29-43</RefSource>
<PMID Version="1">9607700</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 1998 Aug;44(2):255-8</RefSource>
<PMID Version="1">9708549</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stroke. 1998 Sep;29(9):1972-80; discussion 1980-1</RefSource>
<PMID Version="1">9731626</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 1998 Dec;87(4):871-9</RefSource>
<PMID Version="1">9759975</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 1998 Sep;21(3):505-20</RefSource>
<PMID Version="1">9768838</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stroke. 1998 Nov;29(11):2381-93; discussion 2393-5</RefSource>
<PMID Version="1">9804653</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1998 Nov 20;282(5393):1504-8</RefSource>
<PMID Version="1">9822384</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1998 Dec 1;18(23):9896-909</RefSource>
<PMID Version="1">9822746</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurophysiol. 1999 Jan;81(1):121-8</RefSource>
<PMID Version="1">9914273</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1999 Jan 28;397(6717):347-50</RefSource>
<PMID Version="1">9950426</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cereb Cortex. 1999 Mar;9(2):101-9</RefSource>
<PMID Version="1">10220223</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2007 Nov;10(11):1377-86</RefSource>
<PMID Version="1">17965658</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2007 Oct 25;56(2):327-38</RefSource>
<PMID Version="1">17964249</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1999 Jun 1;19(11):4388-406</RefSource>
<PMID Version="1">10341241</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stroke. 2008 Apr;39(4):1286-91</RefSource>
<PMID Version="1">18323506</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2008 Mar;63(3):272-87</RefSource>
<PMID Version="1">18383072</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2008 Jun 12;58(5):673-80</RefSource>
<PMID Version="1">18549780</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Neurobiol. 2008 Feb;18(1):101-7</RefSource>
<PMID Version="1">18534841</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2008 Jun 25;28(26):6592-606</RefSource>
<PMID Version="1">18579732</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2008 Aug 8;134(3):508-20</RefSource>
<PMID Version="1">18692473</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropharmacology. 2008 Sep;55(3):310-8</RefSource>
<PMID Version="1">18308346</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Brain Res. 2006 Feb;169(1):106-16</RefSource>
<PMID Version="1">16273404</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Rehabil Med. 2006 Mar;38(2):113-7</RefSource>
<PMID Version="1">16546768</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2006 Apr 20;440(7087):1054-9</RefSource>
<PMID Version="1">16547515</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2006 May;9(5):650-9</RefSource>
<PMID Version="1">16582906</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Neurobiol. 2006 Jun;16(3):258-64</RefSource>
<PMID Version="1">16713245</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurobiol Dis. 2006 Aug;23(2):362-73</RefSource>
<PMID Version="1">16782355</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stroke. 2006 Aug;37(8):2134-9</RefSource>
<PMID Version="1">16809554</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Neurobiol. 2006 Aug;16(4):451-9</RefSource>
<PMID Version="1">16837188</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Neurosci. 2006;28(4-5):364-79</RefSource>
<PMID Version="1">16943660</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2006 Sep 7;443(7107):81-4</RefSource>
<PMID Version="1">16929304</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurosci. 2007 Feb;25(3):795-804</RefSource>
<PMID Version="1">17328775</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2007 Jun 21;54(6):961-72</RefSource>
<PMID Version="1">17582335</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurophysiol. 2011 Aug;106(2):775-87</RefSource>
<PMID Version="1">21613595</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosci Biobehav Rev. 2011 Nov;35(10):2105-13</RefSource>
<PMID Version="1">21329722</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 2000;95(3):625-37</RefSource>
<PMID Version="1">10670431</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2000 Nov 17;290(5495):1321-4</RefSource>
<PMID Version="1">11082053</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Neuropsychol. 2000;18(3):423-44</RefSource>
<PMID Version="1">11385833</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 2001;104(3):705-15</RefSource>
<PMID Version="1">11440803</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurobiol Dis. 2001 Oct;8(5):910-22</RefSource>
<PMID Version="1">11592858</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2002 Nov 8;298(5596):1248-51</RefSource>
<PMID Version="1">12424383</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurosci. 2003 Jan;17(1):167-73</RefSource>
<PMID Version="1">12534981</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscientist. 2003 Feb;9(1):64-75</RefSource>
<PMID Version="1">12580341</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2003 Jun 19;38(6):977-85</RefSource>
<PMID Version="1">12818182</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2003 Aug;6(8):854-62</RefSource>
<PMID Version="1">12886226</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2003 Jul 30;23(17):6695-702</RefSource>
<PMID Version="1">12890762</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Neurosci. 2004 Feb;5(2):97-107</RefSource>
<PMID Version="1">14735113</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2004 Feb 4;24(5):1245-54</RefSource>
<PMID Version="1">14762143</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stroke. 2004 Mar;35(3):758-63</RefSource>
<PMID Version="1">14963280</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2004 Mar 12;303(5664):1681-3</RefSource>
<PMID Version="1">15017002</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2004 Jul 7;24(27):6209-17</RefSource>
<PMID Version="1">15240813</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Physiol. 2004 Sep 15;559(Pt 3):875-82</RefSource>
<PMID Version="1">15284339</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2004 Oct 27;24(43):9598-611</RefSource>
<PMID Version="1">15509747</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1968 Oct 26;220(5165):379-81</RefSource>
<PMID Version="1">5684881</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Physiol. 1970 Feb;206(2):419-36</RefSource>
<PMID Version="1">5498493</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 1974 Oct 18;79(2):273-9</RefSource>
<PMID Version="1">4423575</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Philos Trans R Soc Lond B Biol Sci. 1977 Apr 26;278(961):377-409</RefSource>
<PMID Version="1">19791</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurophysiol. 1978 Jan;41(1):28-42</RefSource>
<PMID Version="1">621544</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2008;3(9):e3120</RefSource>
<PMID Version="1">18769674</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2008 Nov 6;60(3):477-82</RefSource>
<PMID Version="1">18995822</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Behav Neurosci. 2008 Dec;122(6):1274-83</RefSource>
<PMID Version="1">19045947</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Philos Trans R Soc Lond B Biol Sci. 2009 Feb 12;364(1515):357-67</RefSource>
<PMID Version="1">18977732</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2009 Jan 15;457(7227):313-7</RefSource>
<PMID Version="1">19005470</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2009 Feb 11;29(6):1719-34</RefSource>
<PMID Version="1">19211879</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2009 May 20;29(20):6479-89</RefSource>
<PMID Version="1">19458219</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2009 May 27;29(21):7040-52</RefSource>
<PMID Version="1">19474331</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Neurosci. 2009 Dec;10(12):861-72</RefSource>
<PMID Version="1">19888284</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2009 Nov 25;64(4):463-70</RefSource>
<PMID Version="1">19945389</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2010 Jan 28;65(2):246-56</RefSource>
<PMID Version="1">20152130</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2010 Mar 3;30(9):3304-9</RefSource>
<PMID Version="1">20203190</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2010 May;13(5):642-8</RefSource>
<PMID Version="1">20400960</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2010 May 27;66(4):493-500</RefSource>
<PMID Version="1">20510854</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cortex. 2010 Sep;46(8):1043-59</RefSource>
<PMID Version="1">20079891</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2010 Jul 21;30(29):9670-82</RefSource>
<PMID Version="1">20660250</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2010 Oct 20;30(42):14116-26</RefSource>
<PMID Version="1">20962232</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):19026-31</RefSource>
<PMID Version="1">20937865</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2010 Nov 3;30(44):14685-90</RefSource>
<PMID Version="1">21048125</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2010 Dec;13(12):1496-504</RefSource>
<PMID Version="1">21057507</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Physiol. 2010 Dec 1;588(Pt 23):4695-703</RefSource>
<PMID Version="1">20961999</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 2011 Feb 3;174:10-25</RefSource>
<PMID Version="1">21115101</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 1978 Dec 8;158(1):45-64</RefSource>
<PMID Version="1">21348351</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2011 May;14(5):587-94</RefSource>
<PMID Version="1">21478885</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neural Plast. 2011;2011:614329</RefSource>
<PMID Version="1">21766043</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prog Brain Res. 2011;192:273-95</RefSource>
<PMID Version="1">21763529</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2011 Jul 27;31(30):10767-75</RefSource>
<PMID Version="1">21795529</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2013 Oct 16;80(2):327-34</RefSource>
<PMID Version="1">24139037</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2013 Oct 16;80(2):335-42</RefSource>
<PMID Version="1">24139038</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>IEEE Trans Neural Syst Rehabil Eng. 2013 Nov;21(6):1006-15</RefSource>
<PMID Version="1">24122563</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):E4540-7</RefSource>
<PMID Version="1">24191045</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20771-6</RefSource>
<PMID Version="1">24302763</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscientist. 2014 Feb;20(1):15-28</RefSource>
<PMID Version="1">23757300</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2014 Jan 22;34(4):1083-93</RefSource>
<PMID Version="1">24453301</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2014 Jan 22;81(2):314-20</RefSource>
<PMID Version="1">24462096</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2014 Feb 12;34(7):2571-82</RefSource>
<PMID Version="1">24523547</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosci Biobehav Rev. 2011 Nov;35(10):2114-6</RefSource>
<PMID Version="1">21334375</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1999 Aug 15;19(16):6965-78</RefSource>
<PMID Version="1">10436053</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1999 Sep 17;98(6):739-55</RefSource>
<PMID Version="1">10499792</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurophysiol. 1963 Nov;26:1003-17</RefSource>
<PMID Version="1">14084161</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Learn Mem. 2004 Nov-Dec;11(6):738-47</RefSource>
<PMID Version="1">15537732</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prog Brain Res. 2005;147:115-24</RefSource>
<PMID Version="1">15581701</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2004 Dec 16;44(6):917-23</RefSource>
<PMID Version="1">15603735</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2004 Dec 16;44(6):1021-30</RefSource>
<PMID Version="1">15603744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2004 Dec 16;44(6):1031-41</RefSource>
<PMID Version="1">15603745</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2004 Dec;7(12):1353-9</RefSource>
<PMID Version="1">15543139</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2005 Jan 20;45(2):279-91</RefSource>
<PMID Version="1">15664179</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stroke. 2005 Feb;36(2):189-92</RefSource>
<PMID Version="1">15637315</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2005 Mar;8(3):380-8</RefSource>
<PMID Version="1">15723060</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurophysiol. 2005 Apr;93(4):2117-26</RefSource>
<PMID Version="1">15774713</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2005 Apr 21;46(2):181-9</RefSource>
<PMID Version="1">15848798</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Neurol. 2005 Jun;193(2):291-311</RefSource>
<PMID Version="1">15869933</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2005 Jun 1;25(22):5333-8</RefSource>
<PMID Version="1">15930381</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2005 Sep 30;309(5744):2222-6</RefSource>
<PMID Version="1">16195464</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 1979 Jan 26;161(1):156-61</RefSource>
<PMID Version="1">758966</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 1980 May 1;191(1):1-51</RefSource>
<PMID Version="1">6772696</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1984 Oct;4(10):2543-52</RefSource>
<PMID Version="1">6491722</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1986 Dec;6(12):3655-68</RefSource>
<PMID Version="1">3794795</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 1988 Apr;1(2):133-9</RefSource>
<PMID Version="1">3272163</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1991 Feb 22;251(4996):944-7</RefSource>
<PMID Version="1">2000496</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1991 Oct;11(10):3268-88</RefSource>
<PMID Version="1">1941084</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurophysiol. 1992 Jan;67(1):197-202</RefSource>
<PMID Version="1">1552319</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosci Lett. 1993 May 28;155(1):69-72</RefSource>
<PMID Version="1">8361665</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 1994 Jun;60(4):891-906</RefSource>
<PMID Version="1">7936210</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000367">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001930">Brain Injuries</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002540">Cerebral Cortex</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009473">Neuronal Plasticity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020127">Recovery of Function</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012683">Sensory Deprivation</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS591710</OtherID>
<OtherID Source="NLM">PMC4216647</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24997269</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>08</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-7544</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>283</Volume>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>Neuroscience</Title>
<ISOAbbreviation>Neuroscience</ISOAbbreviation>
</Journal>
<ArticleTitle>Cortical reorganization after spinal cord injury: always for good?</ArticleTitle>
<Pagination>
<MedlinePgn>78-94</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuroscience.2014.06.056</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0306-4522(14)00541-7</ELocationID>
<Abstract>
<AbstractText>Plasticity constitutes the basis of behavioral changes as a result of experience. It refers to neural network shaping and re-shaping at the global level and to synaptic contacts remodeling at the local level, either during learning or memory encoding, or as a result of acute or chronic pathological conditions. 'Plastic' brain reorganization after central nervous system lesions has a pivotal role in the recovery and rehabilitation of sensory and motor dysfunction, but can also be "maladaptive". Moreover, it is clear that brain reorganization is not a "static" phenomenon but rather a very dynamic process. Spinal cord injury immediately initiates a change in brain state and starts cortical reorganization. In the long term, the impact of injury - with or without accompanying therapy - on the brain is a complex balance between supraspinal reorganization and spinal recovery. The degree of cortical reorganization after spinal cord injury is highly variable, and can range from no reorganization (i.e. "silencing") to massive cortical remapping. This variability critically depends on the species, the age of the animal when the injury occurs, the time after the injury has occurred, and the behavioral activity and possible therapy regimes after the injury. We will briefly discuss these dependencies, trying to highlight their translational value. Overall, it is not only necessary to better understand how the brain can reorganize after injury with or without therapy, it is also necessary to clarify when and why brain reorganization can be either "good" or "bad" in terms of its clinical consequences. This information is critical in order to develop and optimize cost-effective therapies to maximize functional recovery while minimizing maladaptive states after spinal cord injury. </AbstractText>
<CopyrightInformation>Copyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Moxon</LastName>
<ForeName>K A</ForeName>
<Initials>KA</Initials>
<AffiliationInfo>
<Affiliation>School of Biomedical Engineering, Science and Health Systems, Drexel University, 3141 Chestnut Street, Philadelphia, PA 19104, USA. Electronic address: Karen.Moxon@drexel.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Oliviero</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Hospital Nacional de Parapléjicos, SESCAM, Finca la Peraleda s/n, 45071 Toledo, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aguilar</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Hospital Nacional de Parapléjicos, SESCAM, Finca la Peraleda s/n, 45071 Toledo, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Foffani</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Hospital Nacional de Parapléjicos, SESCAM, Finca la Peraleda s/n, 45071 Toledo, Spain. Electronic address: gfoffani@sescam.jccm.es.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 NS05741</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 NS057419</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Neuroscience</MedlineTA>
<NlmUniqueID>7605074</NlmUniqueID>
<ISSNLinking>0306-4522</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002540">Cerebral Cortex</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007858">Learning</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009473">Neuronal Plasticity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013119">Spinal Cord Injuries</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS611292</OtherID>
<OtherID Source="NLM">PMC4556279</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">brain plasticity</Keyword>
<Keyword MajorTopicYN="N">brain-derived neurotrophic factor</Keyword>
<Keyword MajorTopicYN="N">exercise</Keyword>
<Keyword MajorTopicYN="N">pain</Keyword>
<Keyword MajorTopicYN="N">serotonin</Keyword>
<Keyword MajorTopicYN="N">spinal transection</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25345997</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>07</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1024-2708</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>20</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Hong Kong medical journal = Xianggang yi xue za zhi / Hong Kong Academy of Medicine</Title>
<ISOAbbreviation>Hong Kong Med J</ISOAbbreviation>
</Journal>
<ArticleTitle>Subthalamic nucleus deep brain stimulation for Parkinson's disease: evidence for effectiveness and limitations from 12 years' experience.</ArticleTitle>
<Pagination>
<MedlinePgn>474-80</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.12809/hkmj144242</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To present the result and experience of subthalamic nucleus deep brain stimulation for Parkinson's disease.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Case series.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Prince of Wales Hospital, Hong Kong.</AbstractText>
<AbstractText Label="PATIENTS" NlmCategory="METHODS">A cohort of patients with Parkinson's disease received subthalamic nucleus deep brain stimulation from September 1998 to January 2010. Patient assessment data before and after the operation were collected prospectively.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Forty-one patients (21 male and 20 female) with Parkinson's disease underwent bilateral subthalamic nucleus deep brain stimulation and were followed up for a median interval of 12 months. For the whole group, the mean improvements of Unified Parkinson's Disease Rating Scale (UPDRS) parts II and III were 32.5% and 31.5%, respectively (P&lt;0.001). Throughout the years, a multidisciplinary team was gradually built. The deep brain stimulation protocol evolved and was substantiated by updated patient selection criteria and outcome assessment, integrated imaging and neurophysiological targeting, refinement of surgical technique as well as the accumulation of experience in deep brain stimulation programming. Most of the structural improvement occurred before mid-2005. Patients receiving the operation before June 2005 (19 cases) and after (22 cases) were compared; the improvements in UPDRS part III were 13.2% and 55.2%, respectively (P&lt;0.001). There were three operative complications (one lead migration, one cerebral haematoma, and one infection) in the group operated on before 2005. There was no operative mortality.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The functional state of Parkinson's disease patients with motor disabilities refractory to best medical treatment improved significantly after subthalamic nucleus deep brain stimulation. A dedicated multidisciplinary team building, refined protocol for patient selection and assessment, improvement of targeting methods, meticulous surgical technique, and experience in programming are the key factors contributing to the improved outcome.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<CollectiveName>Movement Disorder Group</CollectiveName>
</Author>
<Author ValidYN="Y">
<LastName>Chan</LastName>
<ForeName>Anne Y Y</ForeName>
<Initials>AY</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yeung</LastName>
<ForeName>Jonas H M</ForeName>
<Initials>JH</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurology, Department of Medicine, Alice Ho Miu Ling Nethersole Hospital, Hong Kong.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mok</LastName>
<ForeName>Vincent C T</ForeName>
<Initials>VC</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ip</LastName>
<ForeName>Vincent H L</ForeName>
<Initials>VH</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wong</LastName>
<ForeName>Adrian</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kuo</LastName>
<ForeName>S H</ForeName>
<Initials>SH</Initials>
<AffiliationInfo>
<Affiliation>Neurological Institutes of New York, Columbia University, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chan</LastName>
<ForeName>Danny T M</ForeName>
<Initials>DT</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurosurgery, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhu</LastName>
<ForeName>X L</ForeName>
<Initials>XL</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurosurgery, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wong</LastName>
<ForeName>Edith</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurosurgery, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lau</LastName>
<ForeName>Claire K Y</ForeName>
<Initials>CK</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurosurgery, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wong</LastName>
<ForeName>Rosanna K M</ForeName>
<Initials>RK</Initials>
<AffiliationInfo>
<Affiliation>Department of Occupational Therapy, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tang</LastName>
<ForeName>Venus</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurosurgery, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong; Department of Clinical Psychology, Prince of Wales Hospital, Hospital Authority, Hong Kong.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lau</LastName>
<ForeName>Christine</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Poon</LastName>
<ForeName>W S</ForeName>
<Initials>WS</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurosurgery, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K08 NS083738</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>10</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>China</Country>
<MedlineTA>Hong Kong Med J</MedlineTA>
<NlmUniqueID>9512509</NlmUniqueID>
<ISSNLinking>1024-2708</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Hong Kong Med J. 2014 Dec;20(6):472-3</RefSource>
<PMID Version="1">25488032</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015331">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D046690">Deep Brain Stimulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D006723">Hong Kong</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006761">Hospitals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020531">Subthalamic Nucleus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS742091</OtherID>
<OtherID Source="NLM">PMC4691215</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Deep brain stimulation</Keyword>
<Keyword MajorTopicYN="N">Parkinson disease</Keyword>
<Keyword MajorTopicYN="N">Subthalamic nucleus</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25466483</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>11</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2015</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Femtosecond laser-assisted cataract surgery versus standard phacoemulsification cataract surgery: outcomes and safety in more than 4000 cases at a single center.</ArticleTitle>
<Pagination>
<MedlinePgn>47-52</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.06.025</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(14)01401-1</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To compare the intraoperative complications and safety of femtosecond laser-assisted cataract surgery and conventional phacoemulsification cataract surgery.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Single center.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective consecutive comparative cohort case series.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Eyes had femtosecond laser-assisted cataract surgery (study group) or phacoemulsification (control group) by 1 of 5 surgeons. The technique comprised manual corneal incisions and capsulorhexis or laser-assisted anterior capsulotomy, lens fragmentation, corneal incisions, phacoemulsification, and intraocular lens implantation.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The study group comprised 1852 eyes and the control group, 2228 eyes. Patient demographics were similar between groups. There was a significant improvement in vacuum/docking attempts, surface recognition adjustments, treatment, and vacuum time during the laser procedure in the study group. Anterior capsule tears occurred in 1.84% of eyes in the study group and 0.22% of eyes in the control group (P &lt; .0001). There was no difference in the incidence of anterior capsule tears between the first half and second half of laser-assisted cases. Anterior capsulotomy tags occurred in 1.62% study group eyes. There was no significant difference in posterior capsule tears between the 2 groups (0.43% versus 0.18%). The incidence of significant intraoperative corneal haze and miosis was higher and the effective phacoemulsification time significantly lower in the study group (P &lt; .001).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Significant intraoperative complications likely to affect refractive outcomes and patient satisfaction were low overall. The 2 cataract surgery techniques appear to be equally safe. Although anterior capsule tears remain a concern, the safety of femtosecond-assisted cataract surgery in terms of posterior capsule complications was equal to that of phacoemulsification.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">No author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Abell</LastName>
<ForeName>Robin G</ForeName>
<Initials>RG</Initials>
<AffiliationInfo>
<Affiliation>From the Tasmanian Eye Institute (Abell, Darian-Smith, Kan, Allen, Ewe, Vote) and the Launceston Eye Institute (Vote), Tasmania, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Darian-Smith</LastName>
<ForeName>Erica</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>From the Tasmanian Eye Institute (Abell, Darian-Smith, Kan, Allen, Ewe, Vote) and the Launceston Eye Institute (Vote), Tasmania, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kan</LastName>
<ForeName>Jeffrey B</ForeName>
<Initials>JB</Initials>
<AffiliationInfo>
<Affiliation>From the Tasmanian Eye Institute (Abell, Darian-Smith, Kan, Allen, Ewe, Vote) and the Launceston Eye Institute (Vote), Tasmania, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Allen</LastName>
<ForeName>Penelope L</ForeName>
<Initials>PL</Initials>
<AffiliationInfo>
<Affiliation>From the Tasmanian Eye Institute (Abell, Darian-Smith, Kan, Allen, Ewe, Vote) and the Launceston Eye Institute (Vote), Tasmania, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ewe</LastName>
<ForeName>Shaun Y P</ForeName>
<Initials>SY</Initials>
<AffiliationInfo>
<Affiliation>From the Tasmanian Eye Institute (Abell, Darian-Smith, Kan, Allen, Ewe, Vote) and the Launceston Eye Institute (Vote), Tasmania, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vote</LastName>
<ForeName>Brendan J</ForeName>
<Initials>BJ</Initials>
<AffiliationInfo>
<Affiliation>From the Tasmanian Eye Institute (Abell, Darian-Smith, Kan, Allen, Ewe, Vote) and the Launceston Eye Institute (Vote), Tasmania, Australia. Electronic address: eye.vote@bigpond.net.au.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 May;41(5):1124</RefSource>
<PMID Version="1">26049854</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Apr;41(4):907-8</RefSource>
<PMID Version="1">25840329</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1792</RefSource>
<PMID Version="1">26432150</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Apr;41(4):906-7</RefSource>
<PMID Version="1">25840328</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1793-4</RefSource>
<PMID Version="1">26432151</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 May;41(5):1124-5</RefSource>
<PMID Version="1">26049853</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D002387">Cataract Extraction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D063171">Corneal Pachymetry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019781">Corneal Topography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007431">Intraoperative Complications</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D053685">Laser Therapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D019654">Lens Implantation, Intraocular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018918">Phacoemulsification</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019591">Pseudophakia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D041623">Tomography, Optical Coherence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014792">Visual Acuity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25258324</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Protein phosphatase 2A and Cdc7 kinase regulate the DNA unwinding element-binding protein in replication initiation.</ArticleTitle>
<Pagination>
<MedlinePgn>35987-6000</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.589119</ELocationID>
<Abstract>
<AbstractText>The DNA unwinding element (DUE)-binding protein (DUE-B) binds to replication origins coordinately with the minichromosome maintenance (MCM) helicase and the helicase activator Cdc45 in vivo, and loads Cdc45 onto chromatin in Xenopus egg extracts. Human DUE-B also retains the aminoacyl-tRNA proofreading function of its shorter orthologs in lower organisms. Here we report that phosphorylation of the DUE-B unstructured C-terminal domain unique to higher organisms regulates DUE-B intermolecular binding. Gel filtration analyses show that unphosphorylated DUE-B forms multiple high molecular weight (HMW) complexes. Several aminoacyl-tRNA synthetases and Mcm2-7 proteins were identified by mass spectrometry of the HMW complexes. Aminoacyl-tRNA synthetase binding is RNase A sensitive, whereas interaction with Mcm2-7 is nuclease resistant. Unphosphorylated DUE-B HMW complex formation is decreased by PP2A inhibition or direct DUE-B phosphorylation, and increased by inhibition of Cdc7. These results indicate that the state of DUE-B phosphorylation is maintained by the equilibrium between Cdc7-dependent phosphorylation and PP2A-dependent dephosphorylation, each previously shown to regulate replication initiation. Alanine mutation of the DUE-B C-terminal phosphorylation target sites increases MCM binding but blocks Cdc45 loading in vivo and inhibits cell division. In egg extracts alanine mutation of the DUE-B C-terminal phosphorylation sites blocks Cdc45 loading and inhibits DNA replication. The effects of DUE-B C-terminal phosphorylation reveal a novel S phase kinase regulatory mechanism for Cdc45 loading and MCM helicase activation. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gao</LastName>
<ForeName>Yanzhe</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry and Molecular Biology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio 45435.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yao</LastName>
<ForeName>Jianhong</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry and Molecular Biology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio 45435.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Poudel</LastName>
<ForeName>Sumeet</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry and Molecular Biology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio 45435.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Romer</LastName>
<ForeName>Eric</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry and Molecular Biology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio 45435.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abu-Niaaj</LastName>
<ForeName>Lubna</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry and Molecular Biology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio 45435.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Leffak</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry and Molecular Biology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio 45435 Michael.Leffak@wright.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>GM53819</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>09</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C113571">CDC45 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C500359">DTD1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.-</RegistryNumber>
<NameOfSubstance UI="C068619">CDC7 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D017346">Protein-Serine-Threonine Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.3.16</RegistryNumber>
<NameOfSubstance UI="D054648">Protein Phosphatase 2</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.6.4.12</RegistryNumber>
<NameOfSubstance UI="D064110">Minichromosome Maintenance Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2011 Jul 8;146(1):80-91</RefSource>
<PMID Version="1">21729781</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2011 Nov 4;44(3):437-50</RefSource>
<PMID Version="1">22055189</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2013 Mar 1;41(5):3162-72</RefSource>
<PMID Version="1">23376927</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2013 May 23;50(4):577-88</RefSource>
<PMID Version="1">23603117</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2013 Jul;41(13):6460-74</RefSource>
<PMID Version="1">23658226</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Top Curr Chem. 2014;344:119-44</RefSource>
<PMID Version="1">24072587</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2000 Dec 15;275(50):39773-8</RefSource>
<PMID Version="1">11005825</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2001 Apr 17;20(8):2097-107</RefSource>
<PMID Version="1">11296242</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 2002 May 15;364(Pt 1):41-7</RefSource>
<PMID Version="1">11988074</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2002 Oct 25;277(43):40520-7</RefSource>
<PMID Version="1">12185086</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Biochem. 2003 Mar;270(6):1089-101</RefSource>
<PMID Version="1">12631269</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2004 Aug 1;117(Pt 17):3725-34</RefSource>
<PMID Version="1">15286174</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 1988 Nov 15;256(1):283-90</RefSource>
<PMID Version="1">2851982</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 1989 Jul 3;250(2):596-600</RefSource>
<PMID Version="1">2546812</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1992 May 14;357(6374):128-34</RefSource>
<PMID Version="1">1579162</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3151-5</RefSource>
<PMID Version="1">9096361</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Enzymol. 1997;283:549-64</RefSource>
<PMID Version="1">9251047</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1998 Aug 14;281(5379):1005-9</RefSource>
<PMID Version="1">9703500</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14693-8</RefSource>
<PMID Version="1">9843951</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 1999 Oct 1;18(19):5334-46</RefSource>
<PMID Version="1">10508166</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2005 Apr 1;280(13):13071-83</RefSource>
<PMID Version="1">15653697</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2006 Mar;26(5):1997-2011</RefSource>
<PMID Version="1">16479016</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2006 Apr 14;281(15):10281-90</RefSource>
<PMID Version="1">16446360</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2006 Jul;26(14):5270-83</RefSource>
<PMID Version="1">16809765</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11521-6</RefSource>
<PMID Version="1">16864800</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2006 Oct 6;24(1):101-13</RefSource>
<PMID Version="1">17018296</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2006 Dec 22;281(51):39249-61</RefSource>
<PMID Version="1">17046832</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2007 Jan 18;445(7125):281-5</RefSource>
<PMID Version="1">17167417</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2007 Apr 6;282(14):10441-8</RefSource>
<PMID Version="1">17264083</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2007 Nov;27(21):7594-602</RefSource>
<PMID Version="1">17724082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2007 Nov;27(22):7828-38</RefSource>
<PMID Version="1">17846122</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Chem Biol. 2008 Jun;4(6):357-65</RefSource>
<PMID Version="1">18469809</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biochem. 2008 Jun 1;104(3):1075-86</RefSource>
<PMID Version="1">18286467</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEMS Microbiol Rev. 2008 Jul;32(4):705-21</RefSource>
<PMID Version="1">18522650</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Mol Biol. 2009;521:229-52</RefSource>
<PMID Version="1">19563110</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2010 Jan 7;463(7277):113-7</RefSource>
<PMID Version="1">20054399</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 2010 Jan 15;24(2):183-94</RefSource>
<PMID Version="1">20080954</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2010 Feb 5;140(3):349-59</RefSource>
<PMID Version="1">20116089</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2010 Mar;30(6):1495-507</RefSource>
<PMID Version="1">20065034</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 2010 Mar 15;24(6):602-12</RefSource>
<PMID Version="1">20231317</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Cell Biol. 2010 May;12(5):484-91</RefSource>
<PMID Version="1">20383140</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 2010 Jun 15;24(12):1208-19</RefSource>
<PMID Version="1">20551170</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2010 Nov 12;40(3):353-63</RefSource>
<PMID Version="1">21070963</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2010 Dec 23;468(7327):1074-9</RefSource>
<PMID Version="1">21179163</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2011 Apr 1;286(13):11855-64</RefSource>
<PMID Version="1">21282109</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2011 Jun 13;193(6):995-1007</RefSource>
<PMID Version="1">21646402</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018797">Cell Cycle Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004261">DNA Replication</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004268">DNA-Binding Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006367">HeLa Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D064110">Minichromosome Maintenance Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010766">Phosphorylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054648">Protein Phosphatase 2</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011499">Protein Processing, Post-Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017346">Protein-Serine-Threonine Kinases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014982">Xenopus laevis</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276866</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cdc7</Keyword>
<Keyword MajorTopicYN="N">Cell Cycle</Keyword>
<Keyword MajorTopicYN="N">Cell Division</Keyword>
<Keyword MajorTopicYN="N">DNA Replication</Keyword>
<Keyword MajorTopicYN="N">DNA Synthesis</Keyword>
<Keyword MajorTopicYN="N">DUE-B</Keyword>
<Keyword MajorTopicYN="N">MCM</Keyword>
<Keyword MajorTopicYN="N">Protein Phosphatase 2 (PP2A)</Keyword>
<Keyword MajorTopicYN="N">cdc45</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25294880</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Biochemical and biophysical characterization of an unexpected bacteriolytic activity of VanX, a member of the vancomycin-resistance vanA gene cluster.</ArticleTitle>
<Pagination>
<MedlinePgn>35686-94</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.590265</ELocationID>
<Abstract>
<AbstractText>VanX is a d-alanyl-d-alanine (d-Ala-d-Ala) dipeptidase encoded in the vancomycin-resistance vanA gene cluster. Here we report that strong bacteriolysis occurred when isolated VanX was expressed in Escherichia coli at temperatures lower than 30 °C, which was unexpected because the vanA operon confers vancomycin resistance by protecting the cell wall. Therefore, we monitored cell lysis by measuring sample turbidity with absorbance at 590 nm and VanX expression using SDS-PAGE. No cell lysis was observed when VanX was expressed, even in large quantities, in the cell inclusion bodies at 37 °C, suggesting that a natively folded VanX is required for lysis. In addition, VanX mutants with suppressed dipeptidase activity did not lyse E. coli cells, confirming that bacteriolysis originated from the dipeptidase activity of VanX. We also observed shape changes in E. coli cells undergoing VanX-mediated lysis with optical microscopy and classified these changes into three classes: bursting, deformation, and leaking fluid. Optical microscopic image analysis fully corroborated our interpretation of the turbidity changes in the samples. From a practical perspective, the finding that VanX expressed in isolation induces cell lysis suggests that inhibitors of VanA and VanH that act downstream from VanX could provide a new class of therapeutic chemicals against bacteria expressing the vancomycin-resistance gene cluster. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sohya</LastName>
<ForeName>Shihori</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biotechnology and Life Science, Graduate School of Engineering, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kamioka</LastName>
<ForeName>Tetsuya</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biotechnology and Life Science, Graduate School of Engineering, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fujita</LastName>
<ForeName>Chisako</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biotechnology and Life Science, Graduate School of Engineering, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maki</LastName>
<ForeName>Tei</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Research Center for Science and Technology, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei-shi, Tokyo, 184-8588 Japan, and JEOL Ltd., EM Business Unit, 3-1-2 Musashino, Akishima, Tokyo 196-8558, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ohta</LastName>
<ForeName>Yoshihiro</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biotechnology and Life Science, Graduate School of Engineering, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kuroda</LastName>
<ForeName>Yutaka</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biotechnology and Life Science, Graduate School of Engineering, and ykuroda@cc.tuat.ac.jp.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>10</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.16.4</RegistryNumber>
<NameOfSubstance UI="D046929">Serine-Type D-Ala-D-Ala Carboxypeptidase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.17.14</RegistryNumber>
<NameOfSubstance UI="C091956">VanX dipeptidase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Microbiol. 2005 Aug;8(4):480-7</RefSource>
<PMID Version="1">15979390</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 1977 Feb 8;16(3):423-31</RefSource>
<PMID Version="1">13816</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Biochem. 2006 Jul 1;354(1):104-10</RefSource>
<PMID Version="1">16701071</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19713-8</RefSource>
<PMID Version="1">17172454</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 2001 Jul;41(1):167-78</RefSource>
<PMID Version="1">11454209</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Microbiol. 2007 Dec;45(6):593-6</RefSource>
<PMID Version="1">18176547</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 1980 Apr;142(1):52-9</RefSource>
<PMID Version="1">6768717</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Biochem. 1981 Nov 15;118(1):173-84</RefSource>
<PMID Version="1">7039409</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antimicrob Agents Chemother. 1990 Feb;34(2):252-6</RefSource>
<PMID Version="1">2139314</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11028-32</RefSource>
<PMID Version="1">10500118</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biophys Biochem Cytol. 1958 May 25;4(3):323-6</RefSource>
<PMID Version="1">13549505</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1963 Aug;238:2698-707</RefSource>
<PMID Version="1">14063294</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15334-9</RefSource>
<PMID Version="1">18829434</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioorg Med Chem Lett. 2009 Mar 1;19(5):1376-9</RefSource>
<PMID Version="1">19196510</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proteins. 2009 Dec;77(4):962-70</RefSource>
<PMID Version="1">19830687</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21550-4</RefSource>
<PMID Version="1">19995962</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Biotechnol. 2010 Dec;28(12):596-604</RefSource>
<PMID Version="1">20970210</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2011 Sep 22;477(7365):457-61</RefSource>
<PMID Version="1">21881561</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Electron Microsc (Tokyo). 2011 Dec;60(6):401-7</RefSource>
<PMID Version="1">22146677</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2012 Oct 9;51(40):7974-82</RefSource>
<PMID Version="1">22963334</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Biochem. 2013 Aug 15;439(2):212-7</RefSource>
<PMID Version="1">23624113</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biosci Bioeng. 2005 Nov;100(5):556-61</RefSource>
<PMID Version="1">16384796</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001426">Bacterial Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000096">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001433">Bacteriolysis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004926">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000201">enzymology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000254">growth &amp; development</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000648">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005798">Genes, Bacterial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005810">Multigene Family</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017433">Protein Structure, Secondary</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D046929">Serine-Type D-Ala-D-Ala Carboxypeptidase</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000096">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020713">Vancomycin Resistance</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276839</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Antibiotic Resistance</Keyword>
<Keyword MajorTopicYN="N">Bacterial Pathogenesis</Keyword>
<Keyword MajorTopicYN="N">Cell Wall</Keyword>
<Keyword MajorTopicYN="N">Murein</Keyword>
<Keyword MajorTopicYN="N">Peptidase</Keyword>
<Keyword MajorTopicYN="N">Peptidoglycan</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25336659</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Wnt-5a ligand modulates mitochondrial fission-fusion in rat hippocampal neurons.</ArticleTitle>
<Pagination>
<MedlinePgn>36179-93</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.557009</ELocationID>
<Abstract>
<AbstractText>The Wnt signaling pathway plays an important role in developmental processes, including embryonic patterning, cell specification, and cell polarity. Wnt components participate in the development of the central nervous system, and growing evidence indicates that this pathway also regulates the function of the adult nervous system. In this study, we report that Wnt-5a, a noncanonical Wnt ligand, is a potent activator of mitochondrial dynamics and induces acute fission and fusion events in the mitochondria of rat hippocampal neurons. The effect of Wnt-5a was inhibited in the presence of sFRP, a Wnt scavenger. Similarly, the canonical Wnt-3a ligand had no effect on mitochondrial fission-fusion events, suggesting that this effect is specific for Wnt-5a alone. We also show that the Wnt-5a effects on mitochondrial dynamics occur with an increase in both intracellular and mitochondrial calcium (Ca(2+)), which was correlated with an increased phosphorylation of Drp1(Ser-616) and a decrease of Ser-637 phosphorylation, both indicators of mitochondrial dynamics. Electron microscope analysis of hippocampal tissues in the CA1 region showed an increase in the number of mitochondria present in the postsynaptic region, and this finding correlated with a change in mitochondrial morphology. We conclude that Wnt-5a/Ca(2+) signaling regulates the mitochondrial fission-fusion process in hippocampal neurons, a feature that might help to further understand the role of Wnt-related pathologies, including neurodegenerative diseases associated with mitochondrial dysfunction, and represents a potentially important link between impaired metabolic function and degenerative disorders. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Godoy</LastName>
<ForeName>Juan A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>From the Centro de Envejecimiento y Regeneración, Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, 8331150 Santiago, Chile.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arrázola</LastName>
<ForeName>Macarena S</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>From the Centro de Envejecimiento y Regeneración, Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, 8331150 Santiago, Chile.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ordenes</LastName>
<ForeName>Daniela</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>From the Centro de Envejecimiento y Regeneración, Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, 8331150 Santiago, Chile.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Silva-Alvarez</LastName>
<ForeName>Carmen</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the Centro de Envejecimiento y Regeneración, Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, 8331150 Santiago, Chile.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Braidy</LastName>
<ForeName>Nady</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>the Centre for Healthy Brain Ageing, School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, 2031 New South Wales, Australia, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Inestrosa</LastName>
<ForeName>Nibaldo C</ForeName>
<Initials>NC</Initials>
<AffiliationInfo>
<Affiliation>From the Centro de Envejecimiento y Regeneración, Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, 8331150 Santiago, Chile, the Centre for Healthy Brain Ageing, School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, 2031 New South Wales, Australia, and the Centro de Excelencia en Biomedicina de Magallanes, Universidad de Magallanes, 6200000 Punta Arenas, Chile ninestrosa@bio.puc.cl.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051153">Wnt Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C491837">Wnt5a protein, rat</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.6.5.5</RegistryNumber>
<NameOfSubstance UI="C486391">Dnm1l protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.6.5.5</RegistryNumber>
<NameOfSubstance UI="D034281">Dynamins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2009 Feb 26;61(4):541-55</RefSource>
<PMID Version="1">19249275</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2010 Aug 9;190(3):363-75</RefSource>
<PMID Version="1">20696706</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Calcium. 2009 Jul;46(1):18-29</RefSource>
<PMID Version="1">19409612</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Physiol Rev. 2009 Jul;89(3):799-845</RefSource>
<PMID Version="1">19584314</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Neurosci. 2010 Feb;11(2):77-86</RefSource>
<PMID Version="1">20010950</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Cell Biol. 2010 Feb;20(2):102-12</RefSource>
<PMID Version="1">20006503</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Neurobiol. 2010 Jun;41(2-3):87-96</RefSource>
<PMID Version="1">20101529</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2010 Jun 23;30(25):8411-20</RefSource>
<PMID Version="1">20573888</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 2010 Jul 15;24(14):1507-18</RefSource>
<PMID Version="1">20634317</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann N Y Acad Sci. 2010 Jul;1201:21-5</RefSource>
<PMID Version="1">20649534</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann N Y Acad Sci. 2010 Jul;1201:34-9</RefSource>
<PMID Version="1">20649536</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):316-21</RefSource>
<PMID Version="1">9419373</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2010 Aug 18;29(16):2715-23</RefSource>
<PMID Version="1">20717141</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Mol Life Sci. 2010 Oct;67(20):3435-47</RefSource>
<PMID Version="1">20577776</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):21164-9</RefSource>
<PMID Version="1">21084636</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antioxid Redox Signal. 2011 Feb 1;14(3):439-57</RefSource>
<PMID Version="1">20518704</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2011 Jan 15;22(2):256-65</RefSource>
<PMID Version="1">21119009</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Cell Physiol. 2011 Mar;300(3):C447-55</RefSource>
<PMID Version="1">21160028</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Neurobiol. 2011 Feb;21(1):151-9</RefSource>
<PMID Version="1">21239163</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosci Res. 2011 May;70(1):9-15</RefSource>
<PMID Version="1">21352858</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2011 Jun 29;31(26):9466-71</RefSource>
<PMID Version="1">21715611</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2011 Oct 21;334(6054):358-62</RefSource>
<PMID Version="1">21885730</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2011 Nov 11;147(4):893-906</RefSource>
<PMID Version="1">22078885</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Neurosci. 2012 Feb;13(2):77-93</RefSource>
<PMID Version="1">22218207</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Endocrinol Metab. 2012 Mar 15;302(6):E731-9</RefSource>
<PMID Version="1">22252943</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2012 May 1;125(Pt 9):2095-104</RefSource>
<PMID Version="1">22619228</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2012 Jun 13;31(12):2697-704</RefSource>
<PMID Version="1">22617419</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2012 Jun 13;31(12):2670-84</RefSource>
<PMID Version="1">22617420</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2012 Jul;122(7):2405-16</RefSource>
<PMID Version="1">22728933</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11717-22</RefSource>
<PMID Version="1">22753465</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Appl Physiol (1985). 2013 Jan 15;114(2):161-71</RefSource>
<PMID Version="1">23104694</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2013 Mar;24(5):659-67</RefSource>
<PMID Version="1">23283981</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2004 Nov 22;167(4):661-72</RefSource>
<PMID Version="1">15545319</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Physiol Rev. 2000 Jan;80(1):315-60</RefSource>
<PMID Version="1">10617771</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cold Spring Harb Perspect Biol. 2013 Mar;5(3):a015081</RefSource>
<PMID Version="1">23085770</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(5):e64019</RefSource>
<PMID Version="1">23675519</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ageing Res Rev. 2013 Jun;12(3):786-800</RefSource>
<PMID Version="1">23665425</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(10):e78892</RefSource>
<PMID Version="1">24205342</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Neurodegener. 2013;8:45</RefSource>
<PMID Version="1">24330821</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2014 Feb 7;444(2):189-94</RefSource>
<PMID Version="1">24440698</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Cell Biol. 2014 Feb;6(1):64-74</RefSource>
<PMID Version="1">24549157</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2004 Dec 17;119(6):873-87</RefSource>
<PMID Version="1">15607982</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Cell Res. 2005 Mar 10;304(1):91-104</RefSource>
<PMID Version="1">15707577</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2006 Apr 28;281(17):11910-6</RefSource>
<PMID Version="1">16501258</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Neurosci. 2006;29:363-86</RefSource>
<PMID Version="1">16776590</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2006 Jun 28;26(26):7035-45</RefSource>
<PMID Version="1">16807333</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2006 Aug 11;281(32):22429-33</RefSource>
<PMID Version="1">16793760</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO Rep. 2007 Oct;8(10):939-44</RefSource>
<PMID Version="1">17721437</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Mol Biol. 2007;372:467-83</RefSource>
<PMID Version="1">18314746</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2008 Aug 11;182(3):573-85</RefSource>
<PMID Version="1">18695047</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15803-8</RefSource>
<PMID Version="1">18838687</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Genet. 2008;42:517-40</RefSource>
<PMID Version="1">18710302</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2008 Dec 4;456(7222):605-10</RefSource>
<PMID Version="1">19052620</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2009 Jan 9;136(1):163-74</RefSource>
<PMID Version="1">19135897</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2000 Sep 18;150(6):1489-98</RefSource>
<PMID Version="1">10995452</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>IUBMB Life. 2000 Jun;49(6):549-52</RefSource>
<PMID Version="1">11032251</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2001 Aug;12(8):2245-56</RefSource>
<PMID Version="1">11514614</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Cell. 2001 Oct;1(4):515-25</RefSource>
<PMID Version="1">11703942</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2002 Jul 15;22(14):5840-7</RefSource>
<PMID Version="1">12122046</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Biol. 2003 Jun;206(Pt 12):1985-92</RefSource>
<PMID Version="1">12756280</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biophys J. 2004 Jun;86(6):3993-4003</RefSource>
<PMID Version="1">15189895</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2009 Jun 5;284(23):15857-66</RefSource>
<PMID Version="1">19332546</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056547">CA1 Region, Hippocampal</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000166">cytology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020013">Calcium Signaling</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D034281">Dynamins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053078">Membrane Potential, Mitochondrial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008928">Mitochondria</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000648">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D063154">Mitochondrial Dynamics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009474">Neurons</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000648">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011499">Protein Processing, Post-Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021381">Protein Transport</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017207">Rats, Sprague-Dawley</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051153">Wnt Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276881</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Calcium</Keyword>
<Keyword MajorTopicYN="N">Mitochondria</Keyword>
<Keyword MajorTopicYN="N">Neurobiology</Keyword>
<Keyword MajorTopicYN="N">Signal Transduction</Keyword>
<Keyword MajorTopicYN="N">Wnt Signaling</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25352600</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Real-time detection of hepatic gluconeogenic and glycogenolytic states using hyperpolarized [2-13C]dihydroxyacetone.</ArticleTitle>
<Pagination>
<MedlinePgn>35859-67</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.613265</ELocationID>
<Abstract>
<AbstractText>Glycogenolysis and gluconeogenesis are sensitive to nutritional state, and the net direction of flux is controlled by multiple enzymatic steps. This delicate balance in the liver is disrupted by a variety of pathological states including cancer and diabetes mellitus. Hyperpolarized carbon-13 magnetic resonance is a new metabolic imaging technique that can probe intermediary metabolism nondestructively. There are currently no methods to rapidly distinguish livers in a gluconeogenic from glycogenolytic state. Here we use the gluconeogenic precursor dihydroxyacetone (DHA) to deliver hyperpolarized carbon-13 to the perfused mouse liver. DHA enters gluconeogenesis at the level of the trioses. Perfusion conditions were designed to establish either a gluconeogenic or a glycogenolytic state. Unexpectedly, we found that [2-(13)C]DHA was metabolized within a few seconds to the common intermediates and end products of both glycolysis and gluconeogenesis under both conditions, including [2,5-(13)C]glucose, [2-(13)C]glycerol 3-phosphate, [2-(13)C]phosphoenolpyruvate (PEP), [2-(13)C]pyruvate, [2-(13)C]alanine, and [2-(13)C]lactate. [2-(13)C]Phosphoenolpyruvate, a key branch point in gluconeogenesis and glycolysis, was monitored in functioning tissue for the first time. Observation of [2-(13)C]PEP was not anticipated as the free energy difference between PEP and pyruvate is large. Pyruvate kinase is the only regulatory step of the common glycolytic-gluconeogenic pathway that appears to exert significant control over the kinetics of any metabolites of DHA. A ratio of glycolytic to gluconeogenic products distinguished the gluconeogenic from glycogenolytic state in these functioning livers. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Moreno</LastName>
<ForeName>Karlos X</ForeName>
<Initials>KX</Initials>
<AffiliationInfo>
<Affiliation>From the Advanced Imaging Research Center.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Satapati</LastName>
<ForeName>Santhosh</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Advanced Imaging Research Center.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>DeBerardinis</LastName>
<ForeName>Ralph J</ForeName>
<Initials>RJ</Initials>
<AffiliationInfo>
<Affiliation>Children's Medical Center Research Institute, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Burgess</LastName>
<ForeName>Shawn C</ForeName>
<Initials>SC</Initials>
<AffiliationInfo>
<Affiliation>From the Advanced Imaging Research Center, Departments of Pharmacology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Malloy</LastName>
<ForeName>Craig R</ForeName>
<Initials>CR</Initials>
<AffiliationInfo>
<Affiliation>From the Advanced Imaging Research Center, Radiology, University of Texas - Southwestern Medical Center, Dallas, Texas 75390 and the Veterans Affairs North Texas Healthcare System, Lancaster, Texas 75216.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Merritt</LastName>
<ForeName>Matthew E</ForeName>
<Initials>ME</Initials>
<AffiliationInfo>
<Affiliation>From the Advanced Imaging Research Center, Radiology, University of Texas - Southwestern Medical Center, Dallas, Texas 75390 and matthew.merritt@utsouthwestern.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P41 EB015908</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P41 EB015908</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA157996</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DK058398</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DK078184</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL034557</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21 EB016197</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21 EB016197</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R37 HL034557</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R37 HL34557</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>10</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002247">Carbon Isotopes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>O10DDW6JOO</RegistryNumber>
<NameOfSubstance UI="D004098">Dihydroxyacetone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Endocrinol Metab. 2001 Oct;281(4):E848-56</RefSource>
<PMID Version="1">11551863</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Biochem. 2002 Feb;269(3):792-7</RefSource>
<PMID Version="1">11846780</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Biochem. 2003 Jan 15;312(2):228-34</RefSource>
<PMID Version="1">12531210</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Biochem. 2003 Jul 15;318(2):321-4</RefSource>
<PMID Version="1">12814639</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10158-63</RefSource>
<PMID Version="1">12930897</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Biochem. 2004 Apr 15;327(2):149-55</RefSource>
<PMID Version="1">15051530</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 1966 Nov;101(2):284-92</RefSource>
<PMID Version="1">5966267</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Adv Enzymol Relat Areas Mol Biol. 1981;52:247-331</RefSource>
<PMID Version="1">6261536</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1991 Oct 25;254(5031):573-6</RefSource>
<PMID Version="1">1948033</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Physiol. 1992;54:885-909</RefSource>
<PMID Version="1">1562196</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 1995 Jan;95(1):172-8</RefSource>
<PMID Version="1">7814612</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1995 Jun 16;270(24):14452-66</RefSource>
<PMID Version="1">7782307</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol. 1996 Apr;270(4 Pt 1):E709-17</RefSource>
<PMID Version="1">8928779</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol. 1996 Jan;270(1 Pt 1):E186-91</RefSource>
<PMID Version="1">8772491</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson. 1997 May;126(1):58-65</RefSource>
<PMID Version="1">9177796</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 1997 Jul 21;412(1):131-7</RefSource>
<PMID Version="1">9257705</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2004 Nov 19;279(47):48941-9</RefSource>
<PMID Version="1">15347677</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Endocrinol Metab. 2005 Jul;289(1):E53-61</RefSource>
<PMID Version="1">15797985</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 2006 Mar 1;394(Pt 2):465-73</RefSource>
<PMID Version="1">16288601</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Syst Biol (Stevenage). 2006 Jul;153(4):192-200</RefSource>
<PMID Version="1">16986621</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2010 Nov;64(5):1323-31</RefSource>
<PMID Version="1">20574989</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2011 Mar;65(3):610-9</RefSource>
<PMID Version="1">20939089</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):19084-9</RefSource>
<PMID Version="1">22065779</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Lipid Res. 2012 Jun;53(6):1080-92</RefSource>
<PMID Version="1">22493093</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2013 Feb;57(2):515-24</RefSource>
<PMID Version="1">22911492</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>NMR Biomed. 2013 Dec;26(12):1831-43</RefSource>
<PMID Version="1">24115045</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2014 Jan;20(1):93-7</RefSource>
<PMID Version="1">24317119</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2014 Feb 28;289(9):6212-24</RefSource>
<PMID Version="1">24415759</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019540">Area Under Curve</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002247">Carbon Isotopes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004098">Dihydroxyacetone</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D005943">Gluconeogenesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D050261">Glycogenolysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008099">Liver</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019906">Nuclear Magnetic Resonance, Biomolecular</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276855</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Diabetes</Keyword>
<Keyword MajorTopicYN="N">Dihydroxyacetone</Keyword>
<Keyword MajorTopicYN="N">Gluconeogenesis</Keyword>
<Keyword MajorTopicYN="N">Glucose Metabolism</Keyword>
<Keyword MajorTopicYN="N">Glycogenolytic</Keyword>
<Keyword MajorTopicYN="N">Glycolysis</Keyword>
<Keyword MajorTopicYN="N">Hyperpolarization</Keyword>
<Keyword MajorTopicYN="N">Nuclear Magnetic Resonance (NMR)</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25355318</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>p32 is a novel target for viral protein ICP34.5 of herpes simplex virus type 1 and facilitates viral nuclear egress.</ArticleTitle>
<Pagination>
<MedlinePgn>35795-805</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.603845</ELocationID>
<Abstract>
<AbstractText>As a large double-stranded DNA virus, herpes simplex virus type 1 (HSV-1) assembles capsids in the nucleus where the viral particles exit by budding through the inner nuclear membrane. Although a number of viral and host proteins are involved, the machinery of viral egress is not well understood. In a search for host interacting proteins of ICP34.5, which is a virulence factor of HSV-1, we identified a cellular protein, p32 (gC1qR/HABP1), by mass spectrophotometer analysis. When expressed, ICP34.5 associated with p32 in mammalian cells. Upon HSV-1 infection, p32 was recruited to the inner nuclear membrane by ICP34.5, which paralleled the phosphorylation and rearrangement of nuclear lamina. Knockdown of p32 in HSV-1-infected cells significantly reduced the production of cell-free viruses, suggesting that p32 is a mediator of HSV-1 nuclear egress. These observations suggest that the interaction between HSV-1 ICP34.5 and p32 leads to the disintegration of nuclear lamina and facilitates the nuclear egress of HSV-1 particles. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Yu</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>From the Key laboratory of Microbial Functional Genomics of the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Yin</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>From the Key laboratory of Microbial Functional Genomics of the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Songfang</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Key laboratory of Microbial Functional Genomics of the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pan</LastName>
<ForeName>Shuang</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Key laboratory of Microbial Functional Genomics of the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhou</LastName>
<ForeName>Chaodong</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry, Institute for Drug Control, Tianjin 300070, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ma</LastName>
<ForeName>Yijie</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Immunology, College of Medicine, University of Illinois, Chicago, Illinois 60612, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ru</LastName>
<ForeName>Yongxin</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Electron Microscopy, Institute of Hematology and Blood Diseases Hospital, Peking Union College, Tianjin 300020, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dong</LastName>
<ForeName>Shuxu</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Electron Microscopy, Institute of Hematology and Blood Diseases Hospital, Peking Union College, Tianjin 300020, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>He</LastName>
<ForeName>Bin</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Immunology, College of Medicine, University of Illinois, Chicago, Illinois 60612, and tshuo@uic.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Cuizhu</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the Key laboratory of Microbial Functional Genomics of the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China, czz912@aliyun.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cao</LastName>
<ForeName>Youjia</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>From the Key laboratory of Microbial Functional Genomics of the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China, caoyj@nankai.edu.cn.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>AI092230</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>10</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C087299">C1QBP protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D024101">Mitochondrial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C066469">gamma 34.5 protein, Human herpesvirus 1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C063301">lamin B receptor</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Gen Virol. 1991 Mar;72 ( Pt 3):631-9</RefSource>
<PMID Version="1">1848598</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2002 Feb;76(4):1537-47</RefSource>
<PMID Version="1">11799148</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 1993 Jun;91(6):2837-43</RefSource>
<PMID Version="1">8390490</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 1994 Jun 13;346(2-3):225-8</RefSource>
<PMID Version="1">7516896</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gen Virol. 1994 Dec;75 ( Pt 12):3679-86</RefSource>
<PMID Version="1">7996163</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 1995 May;69(5):3007-16</RefSource>
<PMID Version="1">7707527</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2000 Nov;106(10):1239-49</RefSource>
<PMID Version="1">11086025</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2001 May 12;357(9267):1513-8</RefSource>
<PMID Version="1">11377626</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2001 Jun;114(Pt 11):2115-23</RefSource>
<PMID Version="1">11493647</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2001 Sep;75(18):8803-17</RefSource>
<PMID Version="1">11507225</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2001 Sep;75(18):8818-30</RefSource>
<PMID Version="1">11507226</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2014 May;88(9):4657-67</RefSource>
<PMID Version="1">24522907</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2002 Feb 15;277(7):5247-55</RefSource>
<PMID Version="1">11698413</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2002 Sep;76(17):8939-52</RefSource>
<PMID Version="1">12163613</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2002 Sep;76(18):9434-45</RefSource>
<PMID Version="1">12186925</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2004 Jan;78(1):399-412</RefSource>
<PMID Version="1">14671121</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2004 Jun;78(11):5564-75</RefSource>
<PMID Version="1">15140953</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2004 Jun;78(11):5591-600</RefSource>
<PMID Version="1">15140956</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Immunol. 2004 Jun;41(2-3):173-83</RefSource>
<PMID Version="1">15159063</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Death Differ. 2004 Jul;11(7):771-81</RefSource>
<PMID Version="1">15031724</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2004 Jul;78(14):7653-66</RefSource>
<PMID Version="1">15220440</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 1969 Jul;4(1):75-93</RefSource>
<PMID Version="1">5808113</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 1982 Sep;43(3):1102-12</RefSource>
<PMID Version="1">6292453</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 1988 Dec;107(6 Pt 1):2029-36</RefSource>
<PMID Version="1">3058715</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1990 May 18;61(4):561-77</RefSource>
<PMID Version="1">2188730</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1990 May 18;61(4):579-89</RefSource>
<PMID Version="1">2344612</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1990 May 18;61(4):591-602</RefSource>
<PMID Version="1">2188731</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1990 Nov 30;250(4985):1262-6</RefSource>
<PMID Version="1">2173860</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 1995 Sep;69(9):5401-13</RefSource>
<PMID Version="1">7636985</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1996 Apr 26;271(17):10066-72</RefSource>
<PMID Version="1">8626563</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10423-7</RefSource>
<PMID Version="1">8816816</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):843-8</RefSource>
<PMID Version="1">9023344</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Virology. 1997 Sep 15;236(1):18-29</RefSource>
<PMID Version="1">9299613</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 1998 Apr 1;160(7):3534-42</RefSource>
<PMID Version="1">9531316</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1998 Aug 14;273(33):20737-43</RefSource>
<PMID Version="1">9694816</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 1999 Feb 15;18(4):1014-24</RefSource>
<PMID Version="1">10022843</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2005 Jan;79(2):1071-83</RefSource>
<PMID Version="1">15613336</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2005 Sep 30;280(39):33357-67</RefSource>
<PMID Version="1">15975922</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2006 Jan;80(1):494-504</RefSource>
<PMID Version="1">16352573</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2006 Feb;80(3):1476-86</RefSource>
<PMID Version="1">16415024</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Virology. 2006 Apr 10;347(2):261-76</RefSource>
<PMID Version="1">16427676</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2007 May;81(9):4429-37</RefSource>
<PMID Version="1">17301149</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2007 Jun;81(12):6459-70</RefSource>
<PMID Version="1">17428859</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2007 Oct;81(19):10792-803</RefSource>
<PMID Version="1">17652388</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gen Virol. 2007 Oct;88(Pt 10):2642-50</RefSource>
<PMID Version="1">17872514</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2007 Oct;81(20):11468-78</RefSource>
<PMID Version="1">17686835</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Host Microbe. 2007 Mar 15;1(1):23-35</RefSource>
<PMID Version="1">18005679</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2009 Jan 9;284(2):1097-105</RefSource>
<PMID Version="1">19010780</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2009 Jan;5(1):e1000275</RefSource>
<PMID Version="1">19165338</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1530-5</RefSource>
<PMID Version="1">19164550</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gen Virol. 2009 Mar;90(Pt 3):579-90</RefSource>
<PMID Version="1">19218202</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2009 May;83(10):4984-94</RefSource>
<PMID Version="1">19279105</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2009 Dec;83(23):12301-13</RefSource>
<PMID Version="1">19793812</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2010 Feb;84(4):2110-21</RefSource>
<PMID Version="1">19955312</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2011 Jul 15;286(28):24785-92</RefSource>
<PMID Version="1">21622569</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2012 Apr;86(8):4262-70</RefSource>
<PMID Version="1">22318149</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2012 Oct;40(19):9717-37</RefSource>
<PMID Version="1">22904065</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 1991 Jun;10(6):1535-44</RefSource>
<PMID Version="1">1851086</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002352">Carrier Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002467">Cell Nucleus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000821">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002522">Cercopithecus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057809">HEK293 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006367">HeLa Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018259">Herpesvirus 1, Human</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054884">Host-Pathogen Interactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D024101">Mitochondrial Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D025941">Protein Interaction Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021381">Protein Transport</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018160">Receptors, Cytoplasmic and Nuclear</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014709">Vero Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014764">Viral Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057074">Virus Release</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276848</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">HSV</Keyword>
<Keyword MajorTopicYN="N">Herpesvirus</Keyword>
<Keyword MajorTopicYN="N">ICP34.5</Keyword>
<Keyword MajorTopicYN="N">Nuclear Lamina</Keyword>
<Keyword MajorTopicYN="N">Nuclear Membrane</Keyword>
<Keyword MajorTopicYN="N">Protein-Protein Interaction</Keyword>
<Keyword MajorTopicYN="N">Viral Egress</Keyword>
<Keyword MajorTopicYN="N">Viral Protein</Keyword>
<Keyword MajorTopicYN="N">p32 (gC1qR/HABP1)</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25359768</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Differential light-induced responses in sectorial inherited retinal degeneration.</ArticleTitle>
<Pagination>
<MedlinePgn>35918-28</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.609958</ELocationID>
<Abstract>
<AbstractText>Retinitis pigmentosa (RP) is a group of genetically and clinically heterogeneous inherited degenerative retinopathies caused by abnormalities of photoreceptors or retinal pigment epithelium in the retina leading to progressive sight loss. Rhodopsin is the prototypical G-protein-coupled receptor located in the vertebrate retina and is responsible for dim light vision. Here, novel M39R and N55K variants were identified as causing an intriguing sector phenotype of RP in affected patients, with selective degeneration in the inferior retina. To gain insights into the molecular aspects associated with this sector RP phenotype, whose molecular mechanism remains elusive, the mutations were constructed by site-directed mutagenesis, expressed in heterologous systems, and studied by biochemical, spectroscopic, and functional assays. M39R and N55K opsins had variable degrees of chromophore regeneration when compared with WT opsin but showed no gross structural misfolding or altered trafficking. M39R showed a faster rate for transducin activation than WT rhodopsin with a faster metarhodopsinII decay, whereas N55K presented a reduced activation rate and an altered photobleaching pattern. N55K also showed an altered retinal release from the opsin binding pocket upon light exposure, affecting its optimal functional response. Our data suggest that these sector RP mutations cause different protein phenotypes that may be related to their different clinical progression. Overall, these findings illuminate the molecular mechanisms of sector RP associated with rhodopsin mutations. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ramon</LastName>
<ForeName>Eva</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>From the Centre de Biotecnologia Molecular, Departament d'Enginyeria Química, Universitat Politècnica de Catalunya, Rambla de Sant Nebridi 22, 08222 Terrassa, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cordomí</LastName>
<ForeName>Arnau</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>the Laboratori de Medicina Computacional, Unitat de Bioestadística, Facultat de Medicina, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aguilà</LastName>
<ForeName>Mònica</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>the University College London Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, United Kingdom, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Srinivasan</LastName>
<ForeName>Sundaramoorthy</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Centre de Biotecnologia Molecular, Departament d'Enginyeria Química, Universitat Politècnica de Catalunya, Rambla de Sant Nebridi 22, 08222 Terrassa, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dong</LastName>
<ForeName>Xiaoyun</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>From the Centre de Biotecnologia Molecular, Departament d'Enginyeria Química, Universitat Politècnica de Catalunya, Rambla de Sant Nebridi 22, 08222 Terrassa, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moore</LastName>
<ForeName>Anthony T</ForeName>
<Initials>AT</Initials>
<AffiliationInfo>
<Affiliation>the University College London Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, United Kingdom, and the Moorfields Eye Hospital, London EC1V 2PD, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Webster</LastName>
<ForeName>Andrew R</ForeName>
<Initials>AR</Initials>
<AffiliationInfo>
<Affiliation>the University College London Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, United Kingdom, and the Moorfields Eye Hospital, London EC1V 2PD, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cheetham</LastName>
<ForeName>Michael E</ForeName>
<Initials>ME</Initials>
<AffiliationInfo>
<Affiliation>the University College London Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, United Kingdom, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Garriga</LastName>
<ForeName>Pere</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>From the Centre de Biotecnologia Molecular, Departament d'Enginyeria Química, Universitat Politècnica de Catalunya, Rambla de Sant Nebridi 22, 08222 Terrassa, Spain, pere.garriga@upc.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>9009-81-8</RegistryNumber>
<NameOfSubstance UI="D012243">Rhodopsin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Invest Ophthalmol Vis Sci. 1999 Nov;40(12):2770-2</RefSource>
<PMID Version="1">10549634</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Invest Ophthalmol Vis Sci. 2000 May;41(6):1546-53</RefSource>
<PMID Version="1">10798675</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Invest Ophthalmol Vis Sci. 2001 Jan;42(1):3-9</RefSource>
<PMID Version="1">11133841</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):5982-7</RefSource>
<PMID Version="1">11972040</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Biophys Biomol Struct. 2002;31:443-84</RefSource>
<PMID Version="1">11988478</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Biochim Pol. 2001;48(4):1203-7</RefSource>
<PMID Version="1">11995993</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Invest Ophthalmol Vis Sci. 2003 Feb;44(2):848-55</RefSource>
<PMID Version="1">12556421</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Med Hypotheses. 2003 May;60(5):644-9</RefSource>
<PMID Version="1">12710896</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2004 Sep 10;342(2):571-83</RefSource>
<PMID Version="1">15327956</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2004 Nov 5;343(5):1409-38</RefSource>
<PMID Version="1">15491621</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1968 Oct 11;162(3850):230-9</RefSource>
<PMID Version="1">4877437</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Pharmacol Toxicol. 2013;53:531-56</RefSource>
<PMID Version="1">23140243</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8840-4</RefSource>
<PMID Version="1">1924344</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Ophthalmol. 1992 Aug;76(8):465-9</RefSource>
<PMID Version="1">1390527</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Invest Ophthalmol Vis Sci. 1993 Apr;34(5):1659-76</RefSource>
<PMID Version="1">8473105</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10206-10</RefSource>
<PMID Version="1">7901852</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1993 Dec 15;268(35):26645-9</RefSource>
<PMID Version="1">8253795</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1995 Mar 10;270(10):5073-6</RefSource>
<PMID Version="1">7890614</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 1995 Dec;1(12):1254-5</RefSource>
<PMID Version="1">7489404</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Invest Ophthalmol Vis Sci. 1996 Apr;37(5):775-82</RefSource>
<PMID Version="1">8603862</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Genet. 1997 Feb;15(2):216-9</RefSource>
<PMID Version="1">9020854</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10571-6</RefSource>
<PMID Version="1">9380676</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Hum Genet. 1998 Mar;62(3):503-8</RefSource>
<PMID Version="1">9497269</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mutat. 1999;13(1):83</RefSource>
<PMID Version="1">10189219</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1999 Jun 25;97(7):877-87</RefSource>
<PMID Version="1">10399916</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5233-8</RefSource>
<PMID Version="1">15784735</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Mol Med. 2005 Apr;11(4):177-85</RefSource>
<PMID Version="1">15823756</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Optometry. 2005 May;76(5):309-17</RefSource>
<PMID Version="1">15884421</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Cell Biol. 2005 Nov;15(11):574-80</RefSource>
<PMID Version="1">16202603</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Biochem. 2006;75:743-67</RefSource>
<PMID Version="1">16756510</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Ophthalmol. 2006 Aug;90(8):1060-6</RefSource>
<PMID Version="1">16707518</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Genomics Hum Genet. 2006;7:103-24</RefSource>
<PMID Version="1">16722804</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chembiochem. 2007 Jan 2;8(1):19-24</RefSource>
<PMID Version="1">17173267</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2007 Nov 15;450(7168):383-7</RefSource>
<PMID Version="1">17952055</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2008 Jul 10;454(7201):183-7</RefSource>
<PMID Version="1">18563085</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Chem Soc. 2008 Aug 6;130(31):10141-9</RefSource>
<PMID Version="1">18620390</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mol Genet. 2008 Oct 1;17(19):3043-54</RefSource>
<PMID Version="1">18635576</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2008 Sep 25;455(7212):497-502</RefSource>
<PMID Version="1">18818650</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2009;4(2):e4382</RefSource>
<PMID Version="1">19194506</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Pharmacol Sci. 2009 May;30(5):249-59</RefSource>
<PMID Version="1">19375807</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2009 May 21;459(7245):356-63</RefSource>
<PMID Version="1">19458711</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Pharmacol Sci. 2009 Sep;30(9):494-502</RefSource>
<PMID Version="1">19732972</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res Bull. 2010 Jan 15;81(1):12-24</RefSource>
<PMID Version="1">19808079</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Signal. 2010 Mar;22(3):447-56</RefSource>
<PMID Version="1">19887106</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2010 Feb 5;395(5):1063-78</RefSource>
<PMID Version="1">19913029</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2010 Mar 12;285(11):8114-21</RefSource>
<PMID Version="1">20042594</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 2010 May 15;428(1):1-10</RefSource>
<PMID Version="1">20423327</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Struct Mol Biol. 2010 Jun;17(6):650-2</RefSource>
<PMID Version="1">20520658</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Ophthalmol. 2010 Aug;128(8):1036-45</RefSource>
<PMID Version="1">20697005</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2011 Mar 31;471(7340):656-60</RefSource>
<PMID Version="1">21389983</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2011 Mar 31;471(7340):651-5</RefSource>
<PMID Version="1">21389988</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS J. 2011 May;278(9):1493-505</RefSource>
<PMID Version="1">21352497</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2011 Nov 18;286(46):39993-40001</RefSource>
<PMID Version="1">21940625</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biophys J. 2011 Dec 7;101(11):2798-806</RefSource>
<PMID Version="1">22261069</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2013 Jan 25;288(4):2593-604</RefSource>
<PMID Version="1">23223579</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chembiochem. 2013 Mar 18;14(5):639-44</RefSource>
<PMID Version="1">23447332</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nutrients. 2013 Jul;5(7):2646-66</RefSource>
<PMID Version="1">23857173</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12468-73</RefSource>
<PMID Version="1">23836670</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2014 Oct 1;34(40):13336-48</RefSource>
<PMID Version="1">25274813</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1987 Dec;84(24):8874-8</RefSource>
<PMID Version="1">2962193</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019556">COS Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D045744">Cell Line, Tumor</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002522">Cercopithecus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007700">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020125">Mutation, Missense</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055550">Protein Stability</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021381">Protein Transport</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012174">Retinitis Pigmentosa</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012243">Rhodopsin</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276860</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">G-protein-coupled Receptor</Keyword>
<Keyword MajorTopicYN="N">Light Exposure</Keyword>
<Keyword MajorTopicYN="N">Protein Stability</Keyword>
<Keyword MajorTopicYN="N">Protein Structure</Keyword>
<Keyword MajorTopicYN="N">Retinal Degeneration</Keyword>
<Keyword MajorTopicYN="N">Rhodopsin</Keyword>
<Keyword MajorTopicYN="N">Signal Transduction</Keyword>
<Keyword MajorTopicYN="N">Transducin</Keyword>
<Keyword MajorTopicYN="N">Visual Pigments</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25359771</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Secretion of a truncated osteopetrosis-associated transmembrane protein 1 (OSTM1) mutant inhibits osteoclastogenesis through down-regulation of the B lymphocyte-induced maturation protein 1 (BLIMP1)-nuclear factor of activated T cells c1 (NFATc1) axis.</ArticleTitle>
<Pagination>
<MedlinePgn>35868-81</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.589614</ELocationID>
<Abstract>
<AbstractText>Genetic mutations in osteoclastogenic genes are closely associated with osteopetrotic bone diseases. Genetic defects in OSTM1 (osteopetrosis-associated transmembrane protein 1) cause autosomal recessive osteopetrosis in humans. In particular, OSTM1 mutations that exclude the transmembrane domain might lead to the production of a secreted form of truncated OSTM1. However, the precise role of the secreted form of truncated OSTM1 remains unknown. In this study, we analyzed the functional role of truncated OSTM1 in osteoclastogenesis. Here, we showed that a secreted form of truncated OSTM1 binds to the cell surface of osteoclast (OC) precursors and inhibits the formation of multinucleated OCs through the reduction of cell fusion and survival. Truncated OSTM1 significantly inhibited the expression of OC marker genes through the down-regulation of the BLIMP1 (B lymphocyte-induced maturation protein 1)-NFATc1 (nuclear factor of activated T cells c1) axis. Finally, we demonstrated that truncated OSTM1 reduces lipopolysaccharide-induced bone destruction in vivo. Thus, these findings suggest that autosomal recessive osteopetrosis patients with an OSTM1 gene mutation lacking the transmembrane domain produce a secreted form of truncated OSTM1 that inhibits osteoclastogenesis. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shin</LastName>
<ForeName>Bongjin</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Microbiology and Molecular Biology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yu</LastName>
<ForeName>Jungeun</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Microbiology and Molecular Biology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Park</LastName>
<ForeName>Eui-Soon</ForeName>
<Initials>ES</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Microbiology and Molecular Biology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Choi</LastName>
<ForeName>Seunga</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Microbiology and Molecular Biology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yu</LastName>
<ForeName>Jiyeon</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Microbiology and Molecular Biology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hwang</LastName>
<ForeName>Jung Me</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Microbiology and Molecular Biology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yun</LastName>
<ForeName>Hyeongseok</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Microbiology and Molecular Biology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chung</LastName>
<ForeName>Young-Ho</ForeName>
<Initials>YH</Initials>
<AffiliationInfo>
<Affiliation>the Division of Life Science, Korea Basic Science Institute, 169-148 Gwahak-ro, Yuseong-gu, Daejeon 305-806, Korea, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hong</LastName>
<ForeName>Kwan Soo</ForeName>
<Initials>KS</Initials>
<AffiliationInfo>
<Affiliation>the Division of Life Science, Korea Basic Science Institute, 169-148 Gwahak-ro, Yuseong-gu, Daejeon 305-806, Korea, and the Graduate School of Analytical Science and Technology (GRAST), Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 305-764, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Choi</LastName>
<ForeName>Jong-Soon</ForeName>
<Initials>JS</Initials>
<AffiliationInfo>
<Affiliation>the Division of Life Science, Korea Basic Science Institute, 169-148 Gwahak-ro, Yuseong-gu, Daejeon 305-806, Korea, and the Graduate School of Analytical Science and Technology (GRAST), Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 305-764, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Takami</LastName>
<ForeName>Masamichi</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>the Department of Biochemistry, School of Dentistry, Showa University, 1-5-8 Hatanodai, Shinagawaku 142-8555, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rho</LastName>
<ForeName>Jaerang</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Microbiology and Molecular Biology and the Graduate School of Analytical Science and Technology (GRAST), Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 305-764, Korea, jrrho@cnu.ac.kr.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D050778">NFATC Transcription Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C494005">Nfatc1 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C509143">OSTM1 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C513258">Prdm1 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mutat. 2004 May;23(5):471-6</RefSource>
<PMID Version="1">15108279</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cells. 2004 Feb 29;17(1):1-9</RefSource>
<PMID Version="1">15055519</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1975 Nov 21;190(4216):784-5</RefSource>
<PMID Version="1">1105786</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2006 Mar 9;440(7081):220-3</RefSource>
<PMID Version="1">16525474</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Immunol. 2006;24:33-63</RefSource>
<PMID Version="1">16551243</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bone Miner Res. 2006 Jul;21(7):1098-105</RefSource>
<PMID Version="1">16813530</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Immunol. 2007 Apr;7(4):292-304</RefSource>
<PMID Version="1">17380158</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2006 Dec;12(12):1403-9</RefSource>
<PMID Version="1">17128270</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2006 Dec;12(12):1410-6</RefSource>
<PMID Version="1">17128269</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bone. 2008 Jan;42(1):19-29</RefSource>
<PMID Version="1">17936098</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bone Miner Res. 2008 Feb;23(2):296-300</RefSource>
<PMID Version="1">17922613</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Signal. 2008 May;20(5):949-57</RefSource>
<PMID Version="1">18296023</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2008 May 2;369(2):320-6</RefSource>
<PMID Version="1">18269914</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2008 Nov 7;283(45):30522-30</RefSource>
<PMID Version="1">18790735</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Genet. 2009 Jan;124(6):561-77</RefSource>
<PMID Version="1">18987890</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2009 May 1;284(18):12512-23</RefSource>
<PMID Version="1">19258321</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2009 May 29;284(22):15308-16</RefSource>
<PMID Version="1">19336404</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Glycoconj J. 2009 Aug;26(6):623-33</RefSource>
<PMID Version="1">18781385</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2009 Sep;15(9):1066-71</RefSource>
<PMID Version="1">19718038</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunol Rev. 2009 Sep;231(1):241-56</RefSource>
<PMID Version="1">19754901</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3117-22</RefSource>
<PMID Version="1">20133620</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Med. 2010 Apr 12;207(4):751-62</RefSource>
<PMID Version="1">20368579</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sci Signal. 2011;4(169):ra25</RefSource>
<PMID Version="1">21505187</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Keio J Med. 2011;60(4):101-5</RefSource>
<PMID Version="1">22200633</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Endocrinol Metab. 2012 Nov;23(11):582-90</RefSource>
<PMID Version="1">22705116</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Immunol. 2012 Dec;32(6):1360-71</RefSource>
<PMID Version="1">22711011</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Metab. 2013 Feb 5;17(2):249-60</RefSource>
<PMID Version="1">23395171</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bone. 2013 Aug;55(2):292-7</RefSource>
<PMID Version="1">23685543</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bone. 2001 May;28(5):513-23</RefSource>
<PMID Version="1">11344051</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2001 Dec;21(24):8365-70</RefSource>
<PMID Version="1">11713273</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Med. 2002 Jan 21;195(2):201-9</RefSource>
<PMID Version="1">11805147</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Cell. 2002 Dec;3(6):889-901</RefSource>
<PMID Version="1">12479813</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2003 Apr;9(4):399-406</RefSource>
<PMID Version="1">12627228</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8270-5</RefSource>
<PMID Version="1">12826607</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bone Miner Res. 2004 Jul;19(7):1194-9</RefSource>
<PMID Version="1">15177004</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001862">Bone Resorption</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002454">Cell Differentiation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002459">Cell Fusion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002470">Cell Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015536">Down-Regulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015870">Gene Expression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008070">Lipopolysaccharides</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008565">Membrane Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000557">secretion</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050778">NFATC Transcription Factors</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010010">Osteoclasts</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010024">Osteoporosis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015398">Signal Transduction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014157">Transcription Factors</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276856</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">BLIMP1</Keyword>
<Keyword MajorTopicYN="N">Bone</Keyword>
<Keyword MajorTopicYN="N">Cell Differentiation</Keyword>
<Keyword MajorTopicYN="N">NFATc1</Keyword>
<Keyword MajorTopicYN="N">OSTM1</Keyword>
<Keyword MajorTopicYN="N">Osteoblast</Keyword>
<Keyword MajorTopicYN="N">Osteoclast</Keyword>
<Keyword MajorTopicYN="N">Osteoclastogenesis</Keyword>
<Keyword MajorTopicYN="N">Osteopetrosis</Keyword>
<Keyword MajorTopicYN="N">Osteoporosis</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25359777</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Structural basis for the De-N-acetylation of Poly-β-1,6-N-acetyl-D-glucosamine in Gram-positive bacteria.</ArticleTitle>
<Pagination>
<MedlinePgn>35907-17</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.611400</ELocationID>
<Abstract>
<AbstractText>Exopolysaccharides are required for the development and integrity of biofilms produced by a wide variety of bacteria. In staphylococci, partial de-N-acetylation of the exopolysaccharide poly-β-1,6-N-acetyl-d-glucosamine (PNAG) by the extracellular protein IcaB is required for biofilm formation. To understand the molecular basis for PNAG de-N-acetylation, the structure of IcaB from Ammonifex degensii (IcaBAd) has been determined to 1.7 Å resolution. The structure of IcaBAd reveals a (β/α)7 barrel common to the family four carbohydrate esterases (CE4s) with the canonical motifs circularly permuted. The metal dependence of IcaBAd is similar to most CE4s showing the maximum rates of de-N-acetylation with Ni(2+), Co(2+), and Zn(2+). From docking studies with β-1,6-GlcNAc oligomers and structural comparison to PgaB from Escherichia coli, the Gram-negative homologue of IcaB, we identify Arg-45, Tyr-67, and Trp-180 as key residues for PNAG binding during catalysis. The absence of these residues in PgaB provides a rationale for the requirement of a C-terminal domain for efficient deacetylation of PNAG in Gram-negative species. Mutational analysis of conserved active site residues suggests that IcaB uses an altered catalytic mechanism in comparison to other characterized CE4 members. Furthermore, we identified a conserved surface-exposed hydrophobic loop found only in Gram-positive homologues of IcaB. Our data suggest that this loop is required for membrane association and likely anchors IcaB to the membrane during polysaccharide biosynthesis. The work presented herein will help guide the design of IcaB inhibitors to combat biofilm formation by staphylococci. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Little</LastName>
<ForeName>Dustin J</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo>
<Affiliation>From the Program in Molecular Structure and Function, Research Institute, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada, Department of Biochemistry, University of Toronto, Toronto, Ontario M5S 1A8, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bamford</LastName>
<ForeName>Natalie C</ForeName>
<Initials>NC</Initials>
<AffiliationInfo>
<Affiliation>From the Program in Molecular Structure and Function, Research Institute, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada, Department of Biochemistry, University of Toronto, Toronto, Ontario M5S 1A8, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pokrovskaya</LastName>
<ForeName>Varvara</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, University of Toronto, Toronto, Ontario M5S 3H6, Canada, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Robinson</LastName>
<ForeName>Howard</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Photon Sciences Division, Brookhaven National Laboratory, Upton, New York 11973-5000.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nitz</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, University of Toronto, Toronto, Ontario M5S 3H6, Canada, and mnitz@chem.utoronto.ca.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Howell</LastName>
<ForeName>P Lynne</ForeName>
<Initials>PL</Initials>
<AffiliationInfo>
<Affiliation>From the Program in Molecular Structure and Function, Research Institute, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada, Department of Biochemistry, University of Toronto, Toronto, Ontario M5S 1A8, Canada, howell@sickkids.ca.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>PDB</DataBankName>
<AccessionNumberList>
<AccessionNumber>4WCJ</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P41 GM111244</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D047071">beta-Glucans</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C505465">poly-N-acetyl-1-6-glucosamine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.5.-</RegistryNumber>
<NameOfSubstance UI="D000581">Amidohydrolases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.5.1.-</RegistryNumber>
<NameOfSubstance UI="C022427">polysaccharide deacetylase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>J41CSQ7QDS</RegistryNumber>
<NameOfSubstance UI="D015032">Zinc</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 2009 Oct;191(19):5953-63</RefSource>
<PMID Version="1">19633088</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comput Chem. 2010 Jan 30;31(2):455-61</RefSource>
<PMID Version="1">19499576</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21</RefSource>
<PMID Version="1">20057044</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Biochem Biophys. 2005 Jan 1;433(1):71-84</RefSource>
<PMID Version="1">15581567</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2004 Dec 24;279(52):54881-6</RefSource>
<PMID Version="1">15501828</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Microbiol. 2005 Jan;13(1):20-6</RefSource>
<PMID Version="1">15639628</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Immun. 2005 May;73(5):3007-17</RefSource>
<PMID Version="1">15845508</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15429-34</RefSource>
<PMID Version="1">16221761</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 2006 Apr;62(Pt 4):439-50</RefSource>
<PMID Version="1">16552146</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Microb Pathog. 2007 Jul;43(1):1-9</RefSource>
<PMID Version="1">17412552</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Immun. 2007 Jul;75(7):3406-13</RefSource>
<PMID Version="1">17470540</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2007 Jul;35(Web Server issue):W522-5</RefSource>
<PMID Version="1">17488841</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 2007 Nov;189(22):8270-6</RefSource>
<PMID Version="1">17586629</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 2008 May;190(10):3670-80</RefSource>
<PMID Version="1">18359807</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Protoc. 2009;4(3):363-71</RefSource>
<PMID Version="1">19247286</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Carbohydr Res. 2009 Mar 31;344(5):570-5</RefSource>
<PMID Version="1">19185294</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Cell Biol. 2010 Jan;89(1):103-11</RefSource>
<PMID Version="1">19913940</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21</RefSource>
<PMID Version="1">20124702</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Struct Mol Biol. 2010 May;17(5):582-9</RefSource>
<PMID Version="1">20400947</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cold Spring Harb Perspect Biol. 2010 Jul;2(7):a000398</RefSource>
<PMID Version="1">20519345</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 2010 Sep;77(6):1439-55</RefSource>
<PMID Version="1">20633227</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42</RefSource>
<PMID Version="1">21460441</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Appl Environ Microbiol. 2011 Dec;77(23):8303-9</RefSource>
<PMID Version="1">21984237</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Jul 1;68(Pt 7):842-5</RefSource>
<PMID Version="1">22750880</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Sep 7;287(37):31126-37</RefSource>
<PMID Version="1">22810235</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 2013 Jan;69(Pt 1):44-51</RefSource>
<PMID Version="1">23275162</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2013 May 16;497(7449):388-91</RefSource>
<PMID Version="1">23657259</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):E2209-18</RefSource>
<PMID Version="1">23716675</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2013 Aug 13;52(32):5463-71</RefSource>
<PMID Version="1">23866051</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Elife. 2013;2:e01456</RefSource>
<PMID Version="1">24040512</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 2014 May 21;588(10):1869-72</RefSource>
<PMID Version="1">24735724</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Angew Chem Int Ed Engl. 2014 Jul 1;53(27):6882-7</RefSource>
<PMID Version="1">24810719</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):11013-8</RefSource>
<PMID Version="1">24994902</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Molecules. 2009;14(7):2535-54</RefSource>
<PMID Version="1">19633622</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Graph Model. 1999 Feb;17(1):57-61</RefSource>
<PMID Version="1">10660911</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2000 Sep 15;28(18):3442-4</RefSource>
<PMID Version="1">10982861</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Microbiology. 2001 Jan;147(Pt 1):3-9</RefSource>
<PMID Version="1">11160795</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Microbiol. 2001 May;9(5):222-7</RefSource>
<PMID Version="1">11336839</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Med Microbiol. 2001 Jul;50(7):582-7</RefSource>
<PMID Version="1">11444767</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10037-41</RefSource>
<PMID Version="1">11517324</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Infect Dis. 2002 Nov;2(11):677-85</RefSource>
<PMID Version="1">12409048</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2002 Nov 29;298(5599):1793-6</RefSource>
<PMID Version="1">12459591</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Carbohydr Res. 2003 Apr 22;338(9):903-22</RefSource>
<PMID Version="1">12681914</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8146-50</RefSource>
<PMID Version="1">12819349</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Microbiol. 2004 Feb;2(2):95-108</RefSource>
<PMID Version="1">15040259</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 2004 May;186(9):2724-34</RefSource>
<PMID Version="1">15090514</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W665-7</RefSource>
<PMID Version="1">15215472</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 2004 Jul 16;570(1-3):13-9</RefSource>
<PMID Version="1">15251431</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2004 Aug 15;190(4):783-92</RefSource>
<PMID Version="1">15272407</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1972 Nov 24;178(4063):871-2</RefSource>
<PMID Version="1">5085985</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1987 Mar;84(6):1512-5</RefSource>
<PMID Version="1">3470737</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 1996 Jan;178(1):175-83</RefSource>
<PMID Version="1">8550413</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 1996 Jun;20(5):1083-91</RefSource>
<PMID Version="1">8809760</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1998 Jul 17;273(29):18586-93</RefSource>
<PMID Version="1">9660830</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1999 May 28;284(5419):1523-7</RefSource>
<PMID Version="1">10348739</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32</RefSource>
<PMID Version="1">15572765</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000107">Acetylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000581">Amidohydrolases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001426">Bacterial Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020134">Catalytic Domain</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017124">Conserved Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018360">Crystallography, X-Ray</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016937">Gram-Positive Endospore-Forming Rods</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000201">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057927">Hydrophobic and Hydrophilic Interactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D062105">Molecular Docking Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017433">Protein Structure, Secondary</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015032">Zinc</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D047071">beta-Glucans</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276859</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Biofilm</Keyword>
<Keyword MajorTopicYN="N">Carbohydrate Esterase</Keyword>
<Keyword MajorTopicYN="N">Catalysis</Keyword>
<Keyword MajorTopicYN="N">Deacetylase</Keyword>
<Keyword MajorTopicYN="N">Exopolysaccharide Biosynthesis</Keyword>
<Keyword MajorTopicYN="N">Microbiology</Keyword>
<Keyword MajorTopicYN="N">PNAG</Keyword>
<Keyword MajorTopicYN="N">Polysaccharide</Keyword>
<Keyword MajorTopicYN="N">Protein Structure</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25361765</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Soluble epoxide hydrolase as an anti-inflammatory target of the thrombolytic stroke drug SMTP-7.</ArticleTitle>
<Pagination>
<MedlinePgn>35826-38</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.588087</ELocationID>
<Abstract>
<AbstractText>Although ischemic stroke is a major cause of death and disability worldwide, only a small fraction of patients benefit from the current thrombolytic therapy due to a risk of cerebral hemorrhage caused by inflammation. Thus, the development of a new strategy to combat inflammation during thrombolysis is an urgent demand. The small molecule thrombolytic SMTP-7 effectively treats ischemic stroke in several animal models with reducing cerebral hemorrhage. Here we revealed that SMTP-7 targeted soluble epoxide hydrolase (sEH) to suppress inflammation. SMTP-7 inhibited both of the two sEH enzyme activities: epoxide hydrolase (which inactivates anti-inflammatory epoxy-fatty acids) and lipid phosphate phosphatase. SMTP-7 suppressed epoxy-fatty acid hydrolysis in HepG2 cells in culture, implicating the sEH inhibition in the anti-inflammatory mechanism. The sEH inhibition by SMTP-7 was independent of its thrombolytic activity. The simultaneous targeting of thrombolysis and sEH by a single molecule is a promising strategy to revolutionize the current stroke therapy. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Matsumoto</LastName>
<ForeName>Naoki</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Applied Biological Science, Tokyo Noko University, 3-5-8 Saiwaicho, Fuchu, Tokyo 183-8509, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Suzuki</LastName>
<ForeName>Eriko</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Applied Biological Science, Tokyo Noko University, 3-5-8 Saiwaicho, Fuchu, Tokyo 183-8509, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ishikawa</LastName>
<ForeName>Makoto</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Pharmaceutical Research Laboratory, Nihon Pharmaceutical, 34 Shin-izumi, Narita, Chiba 286-0825, Japan, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shirafuji</LastName>
<ForeName>Takumi</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Pharmaceutical Research Laboratory, Nihon Pharmaceutical, 34 Shin-izumi, Narita, Chiba 286-0825, Japan, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hasumi</LastName>
<ForeName>Keiji</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Applied Biological Science, Tokyo Noko University, 3-5-8 Saiwaicho, Fuchu, Tokyo 183-8509, Japan, TMS Co., Ltd., 1-32-1-102 Fuchucho, Fuchu, Tokyo 183-0055, Japan hasumi@cc.tuat.ac.jp.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001578">Benzopyrans</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011760">Pyrrolidinones</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C409191">SMTP 7</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9001-91-6</RegistryNumber>
<NameOfSubstance UI="D010958">Plasminogen</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.3.2.-</RegistryNumber>
<NameOfSubstance UI="D004851">Epoxide Hydrolases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Antibiot (Tokyo). 2012 Jul;65(7):361-7</RefSource>
<PMID Version="1">22511228</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Pharmacol. 2002 May 1;63(9):1599-608</RefSource>
<PMID Version="1">12007563</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Antibiot (Tokyo). 2003 Oct;56(10):832-7</RefSource>
<PMID Version="1">14700276</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2004 Apr 27;43(16):4716-23</RefSource>
<PMID Version="1">15096040</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 1987 Dec 24;317(26):1625-9</RefSource>
<PMID Version="1">3317057</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neuroimmunol. 1990 Dec;30(2-3):145-51</RefSource>
<PMID Version="1">1699975</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lab Invest. 1993 Aug;69(2):238-49</RefSource>
<PMID Version="1">8350599</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Biochem Biophys. 1995 Jan 10;316(1):443-51</RefSource>
<PMID Version="1">7840649</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Biochem Biophys. 1996 Jun 1;330(1):87-96</RefSource>
<PMID Version="1">8651708</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Scand J Gastroenterol Suppl. 1997;223:99-104</RefSource>
<PMID Version="1">9200314</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Antibiot (Tokyo). 2000 Mar;53(3):241-7</RefSource>
<PMID Version="1">10819294</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dig Dis Sci. 2012 Oct;57(10):2580-91</RefSource>
<PMID Version="1">22588244</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Antibiot (Tokyo). 2012 Sep;65(9):483-5</RefSource>
<PMID Version="1">22714026</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Pharmacol Toxicol. 2013;53:37-58</RefSource>
<PMID Version="1">23020295</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2013 May 17;288(20):14189-99</RefSource>
<PMID Version="1">23576437</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prostaglandins Other Lipid Mediat. 2013 Jul-Aug;104-105:18-24</RefSource>
<PMID Version="1">22922090</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cardiovasc Pharmacol. 2013 Sep;62(3):285-97</RefSource>
<PMID Version="1">23676336</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cardiovasc Ther. 2011 Apr;29(2):99-111</RefSource>
<PMID Version="1">20433684</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cereb Blood Flow Metab. 2013 Oct;33(10):1650-6</RefSource>
<PMID Version="1">23899929</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cereb Blood Flow Metab. 2014 Feb;34(2):235-41</RefSource>
<PMID Version="1">24192639</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2014;9(4):e94092</RefSource>
<PMID Version="1">24718617</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood Coagul Fibrinolysis. 2014 Jun;25(4):316-21</RefSource>
<PMID Version="1">24784315</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(6):e39165</RefSource>
<PMID Version="1">22720061</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10637-42</RefSource>
<PMID Version="1">10485878</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prog Lipid Res. 2005 Jan;44(1):1-51</RefSource>
<PMID Version="1">15748653</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2005 Sep 13;44(36):12179-87</RefSource>
<PMID Version="1">16142916</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Protein Sci. 2006 Jan;15(1):58-64</RefSource>
<PMID Version="1">16322563</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Can J Neurol Sci. 2005 Nov;32(4):433-9</RefSource>
<PMID Version="1">16408572</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pharmacol Ther. 2006 Sep;111(3):584-95</RefSource>
<PMID Version="1">16380164</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Inflamm Bowel Dis. 2006 Oct;12(10):995-9</RefSource>
<PMID Version="1">17012970</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Cell Physiol. 2007 Mar;292(3):C996-1012</RefSource>
<PMID Version="1">16987999</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Antibiot (Tokyo). 2007 Jul;60(7):463-8</RefSource>
<PMID Version="1">17721006</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cereb Blood Flow Metab. 2007 Dec;27(12):1931-40</RefSource>
<PMID Version="1">17440491</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stroke. 2008 Mar;39(3):924-8</RefSource>
<PMID Version="1">18239184</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2008 May 10;371(9624):1612-23</RefSource>
<PMID Version="1">18468545</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pharmacol Exp Ther. 2008 Jul;326(1):330-7</RefSource>
<PMID Version="1">18445784</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stroke. 2008 Jul;39(7):2073-8</RefSource>
<PMID Version="1">18369166</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cardiovasc Pharmacol. 2008 Oct;52(4):314-23</RefSource>
<PMID Version="1">18791465</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H2128-34</RefSource>
<PMID Version="1">18835921</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18901-6</RefSource>
<PMID Version="1">19028872</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Neurosci. 2009 Jan;32(1):48-55</RefSource>
<PMID Version="1">18963068</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Neurol. 2009 Jun;22(3):294-301</RefSource>
<PMID Version="1">19434798</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 2009 Oct 6;163(2):646-61</RefSource>
<PMID Version="1">19540314</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prostaglandins Other Lipid Mediat. 2010 Apr;91(3-4):68-84</RefSource>
<PMID Version="1">19545642</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2010 May 15;375(9727):1695-703</RefSource>
<PMID Version="1">20472172</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pharmacol Exp Ther. 2010 Aug;334(2):430-8</RefSource>
<PMID Version="1">20439437</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2010;5(8):e11979</RefSource>
<PMID Version="1">20694143</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Naunyn Schmiedebergs Arch Pharmacol. 2010 Sep;382(3):245-53</RefSource>
<PMID Version="1">20680247</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pharmacol Sci. 2010;114(1):41-9</RefSource>
<PMID Version="1">20703011</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Antibiot (Tokyo). 2010 Oct;63(10):589-93</RefSource>
<PMID Version="1">20842143</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS J. 2010 Sep;277(18):3675-87</RefSource>
<PMID Version="1">20718867</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stroke. 2011 Apr;42(4):1097-104</RefSource>
<PMID Version="1">21350203</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2011 May 31;108(22):9038-43</RefSource>
<PMID Version="1">21571638</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Naunyn Schmiedebergs Arch Pharmacol. 2011 Jul;384(1):103-8</RefSource>
<PMID Version="1">21533990</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Neurol. 2011 Jul;7(7):400-9</RefSource>
<PMID Version="1">21670766</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosci Lett. 2011 Oct 3;503(2):110-4</RefSource>
<PMID Version="1">21871536</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Antibiot (Tokyo). 2012 Feb;65(2):91-3</RefSource>
<PMID Version="1">22108677</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Lipid Res. 2012 Mar;53(3):505-12</RefSource>
<PMID Version="1">22217705</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2012 Mar 23;419(4):796-800</RefSource>
<PMID Version="1">22387545</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2012 Jun 23;379(9834):2364-72</RefSource>
<PMID Version="1">22632907</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2012 Jun 23;379(9834):2352-63</RefSource>
<PMID Version="1">22632908</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Cell Physiol. 2012 Aug 1;303(3):C278-90</RefSource>
<PMID Version="1">22621785</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Free Radic Biol Med. 2003 Dec 15;35(12):1679-87</RefSource>
<PMID Version="1">14680690</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000893">Anti-Inflammatory Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001578">Benzopyrans</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003093">Colitis, Ulcerative</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000201">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003424">Crohn Disease</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000201">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004851">Epoxide Hydrolases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000037">antagonists &amp; inhibitors</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005343">Fibrinolytic Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020275">Guillain-Barre Syndrome</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000201">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056945">Hep G2 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007700">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010958">Plasminogen</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011760">Pyrrolidinones</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011917">Rats, Inbred Lew</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276851</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Enzyme Inhibitor</Keyword>
<Keyword MajorTopicYN="N">Enzyme Kinetics</Keyword>
<Keyword MajorTopicYN="N">Inflammation</Keyword>
<Keyword MajorTopicYN="N">Proteolysis</Keyword>
<Keyword MajorTopicYN="N">Stroke</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25361766</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Molecular characterization and phylogenetic analysis of two novel regio-specific flavonoid prenyltransferases from Morus alba and Cudrania tricuspidata.</ArticleTitle>
<Pagination>
<MedlinePgn>35815-25</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.608265</ELocationID>
<Abstract>
<AbstractText>Prenylated flavonoids are attractive specialized metabolites with a wide range of biological activities and are distributed in several plant families. The prenylation catalyzed by prenyltransferases represents a Friedel-Crafts alkylation of the flavonoid skeleton in the biosynthesis of natural prenylated flavonoids and contributes to the structural diversity and biological activities of these compounds. To date, all identified plant flavonoid prenyltransferases (FPTs) have been identified in Leguminosae. In the present study two new FPTs, Morus alba isoliquiritigenin 3'-dimethylallyltransferase (MaIDT) and Cudrania tricuspidata isoliquiritigenin 3'-dimethylallyltransferase (CtIDT), were identified from moraceous plants M. alba and C. tricuspidata, respectively. MaIDT and CtIDT shared low levels of homology with the leguminous FPTs. MaIDT and CtIDT are predicted to be membrane-bound proteins with predicted transit peptides, seven transmembrane regions, and conserved functional domains that are similar to other homogentisate prenyltransferases. Recombinant MaIDT and CtIDT were able to regioselectively introduce dimethylallyl diphosphate into the A ring of three flavonoids with different skeleton types (chalcones, isoflavones, and flavones). Phylogenetic analysis revealed that MaIDT and CtIDT are distantly related to their homologs in Leguminosae, which suggests that FPTs in Moraceae and Leguminosae might have evolved independently. MaIDT and CtIDT represent the first two non-Leguminosae FPTs to be identified in plants and could thus lead to the identification of additional evolutionarily varied FPTs in other non-Leguminosae plants and could elucidate the biosyntheses of prenylated flavonoids in various plants. Furthermore, MaIDT and CtIDT might be used for regiospecific prenylation of flavonoids to produce bioactive compounds for potential therapeutic applications due to their high efficiency and catalytic promiscuity. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Ruishan</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>From the State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Xian Nong Tan Street, Beijing 100050, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Ridao</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>From the State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Xian Nong Tan Street, Beijing 100050, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Jianhua</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Xian Nong Tan Street, Beijing 100050, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Xiao</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>From the State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Xian Nong Tan Street, Beijing 100050, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Xie</LastName>
<ForeName>Kebo</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>From the State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Xian Nong Tan Street, Beijing 100050, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Dawei</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>From the State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Xian Nong Tan Street, Beijing 100050, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yin</LastName>
<ForeName>Yunze</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>From the State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Xian Nong Tan Street, Beijing 100050, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tao</LastName>
<ForeName>Xiaoyu</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>From the State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Xian Nong Tan Street, Beijing 100050, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Xie</LastName>
<ForeName>Dan</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>From the State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Xian Nong Tan Street, Beijing 100050, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zou</LastName>
<ForeName>Jianhua</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Xian Nong Tan Street, Beijing 100050, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Lin</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>From the State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Xian Nong Tan Street, Beijing 100050, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dai</LastName>
<ForeName>Jungui</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Xian Nong Tan Street, Beijing 100050, China jgdai@imm.ac.cn.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005419">Flavonoids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010940">Plant Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.5.-</RegistryNumber>
<NameOfSubstance UI="D019883">Alkyl and Aryl Transferases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Planta Med. 2001 Jul;67(5):475-7</RefSource>
<PMID Version="1">11488468</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Physiol. 2014 Sep;166(1):80-90</RefSource>
<PMID Version="1">25077796</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Biochem Biophys. 2002 Sep 1;405(1):112-21</RefSource>
<PMID Version="1">12176064</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Cell. 2003 Feb;15(2):481-94</RefSource>
<PMID Version="1">12566586</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 2004 Jan 16;557(1-3):33-8</RefSource>
<PMID Version="1">14741337</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Prod Rep. 1994 Apr;11(2):205-18</RefSource>
<PMID Version="1">15209130</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioorg Med Chem. 2004 Aug 15;12(16):4387-92</RefSource>
<PMID Version="1">15265490</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Can J Microbiol. 1970 Apr;16(4):223-6</RefSource>
<PMID Version="1">5445342</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Biochem. 1976 May 7;72:248-54</RefSource>
<PMID Version="1">942051</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Enzymol. 1985;110:130-44</RefSource>
<PMID Version="1">2991702</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Phytochemistry. 2000 Aug;54(7):649-55</RefSource>
<PMID Version="1">10975499</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Plant Sci. 2000 Oct;5(10):439-45</RefSource>
<PMID Version="1">11044721</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fortschr Chem Org Naturst. 1988;53:87-201</RefSource>
<PMID Version="1">3069663</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chem Pharm Bull (Tokyo). 2004 Nov;52(11):1285-9</RefSource>
<PMID Version="1">15516747</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioorg Med Chem. 2005 Jan 17;13(2):433-41</RefSource>
<PMID Version="1">15598564</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Med Chem. 2005;12(6):717-39</RefSource>
<PMID Version="1">15790308</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2005 Jun 16;435(7044):983-7</RefSource>
<PMID Version="1">15959519</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Pharmacol Sci. 2005 Dec;26(12):606-8</RefSource>
<PMID Version="1">16229901</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioinformatics. 2007 Nov 1;23(21):2947-8</RefSource>
<PMID Version="1">17846036</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Physiol. 2008 Mar;146(3):1075-84</RefSource>
<PMID Version="1">18218974</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Appl Microbiol Biotechnol. 2008 Jul;79(6):951-61</RefSource>
<PMID Version="1">18481055</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Physiol. 2009 Feb;149(2):683-93</RefSource>
<PMID Version="1">19091879</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Chem Biol. 2009 Apr;13(2):171-9</RefSource>
<PMID Version="1">19299193</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Antibiot (Tokyo). 2009 Jul;62(7):385-92</RefSource>
<PMID Version="1">19557032</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Med Chem. 2009;16(26):3414-68</RefSource>
<PMID Version="1">19548871</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Jpn Acad Ser B Phys Biol Sci. 2009;85(9):391-408</RefSource>
<PMID Version="1">19907125</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Phytochemistry. 2009 Oct-Nov;70(15-16):1739-45</RefSource>
<PMID Version="1">19819506</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Plant Biol. 2011;62:549-66</RefSource>
<PMID Version="1">21275647</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Phylogenet Evol. 2011 Jul;60(1):21-8</RefSource>
<PMID Version="1">21540119</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2011 Jul 8;286(27):24125-34</RefSource>
<PMID Version="1">21576242</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Physiol. 2011 Dec;157(4):1677-95</RefSource>
<PMID Version="1">21994349</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioorg Med Chem. 2012 Jan 1;20(1):346-55</RefSource>
<PMID Version="1">22112540</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2012 Jan 6;417(1):393-8</RefSource>
<PMID Version="1">22166201</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Physiol. 2012 May;159(1):70-80</RefSource>
<PMID Version="1">22430842</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chembiochem. 2011 Oct 17;12(15):2280-3</RefSource>
<PMID Version="1">23106077</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Zhongguo Zhong Yao Za Zhi. 2012 Dec;37(24):3734-7</RefSource>
<PMID Version="1">23627169</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Zhongguo Zhong Yao Za Zhi. 2012 Dec;37(24):3738-42</RefSource>
<PMID Version="1">23627170</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Physiol. 2013 Jun;162(2):1073-91</RefSource>
<PMID Version="1">23613273</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Commun. 2013;4:2445</RefSource>
<PMID Version="1">24048436</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Evol. 2013 Dec;30(12):2725-9</RefSource>
<PMID Version="1">24132122</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant J. 2014 Feb;77(4):627-38</RefSource>
<PMID Version="1">24354545</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Database (Oxford). 2014;2014. pii: bau054. doi: 10.1093/database/bau054</RefSource>
<PMID Version="1">24923822</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chembiochem. 2014 Jul 21;15(11):1673-81</RefSource>
<PMID Version="1">25044857</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Phytochemistry. 2002 Jul;60(5):533-40</RefSource>
<PMID Version="1">12052520</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019883">Alkyl and Aryl Transferases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003001">Cloning, Molecular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017124">Conserved Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005419">Flavonoids</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D029586">Moraceae</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000201">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D031625">Morus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000201">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010802">Phylogeny</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010940">Plant Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013379">Substrate Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276850</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cudrania tricuspidata</Keyword>
<Keyword MajorTopicYN="N">Flavonoid</Keyword>
<Keyword MajorTopicYN="N">Flavonoid Prenyltransferase</Keyword>
<Keyword MajorTopicYN="N">Gene Expression</Keyword>
<Keyword MajorTopicYN="N">Molecular Evolution</Keyword>
<Keyword MajorTopicYN="N">Morus alba</Keyword>
<Keyword MajorTopicYN="N">Phylogenetics</Keyword>
<Keyword MajorTopicYN="N">Plant Biochemistry</Keyword>
<Keyword MajorTopicYN="N">Promiscuity</Keyword>
<Keyword MajorTopicYN="N">Regiospecificity</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25362663</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Glutaredoxin 2 (Grx2) gene deletion induces early onset of age-dependent cataracts in mice.</ArticleTitle>
<Pagination>
<MedlinePgn>36125-39</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.620047</ELocationID>
<Abstract>
<AbstractText>Glutaredoxin 2 (Grx2) is an isozyme of glutaredoxin1 (thioltransferase) present in the mitochondria and nucleus with disulfide reductase and peroxidase activities, and it controls thiol/disulfide balance in cells. In this study, we investigated whether Grx2 gene deletion could induce faster age-related cataract formation and elucidated the biochemical changes effected by Grx2 gene deletion that may contribute to lens opacity. Slit lamp was used to examine the lenses in Grx2 knock-out (KO) mice and age-matched wild-type (WT) mice ages 1 to 16 months. In the Grx2 null mice, the lens nuclear opacity began at 5 months, 3 months sooner than that of the control mice, and the progression of cataracts was also much faster than the age-matched controls. Lenses of KO mice contained lower levels of protein thiols and GSH with a significant accumulation of S-glutathionylated proteins. Actin, αA-crystallin, and βB2-crystallin were identified by Western blot and mass spectroscopy as the major S-glutathionylated proteins in the lenses of 16-month-old Grx2 KO mice. Compared with the WT control, the lens of Grx2 KO mice had only 50% of the activity in complex I and complex IV and less than 10% of the ATP pool. It was concluded that Grx2 gene deletion altered the function of lens structural proteins through S-glutathionylation and also caused severe disturbance in mitochondrial function. These combined alterations affected lens transparency. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Hongli</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>From the School of Veterinary Medicine and Biomedical Sciences, Redox Biology Center, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, the Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas 76107.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yu</LastName>
<ForeName>Yibo</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>From the School of Veterinary Medicine and Biomedical Sciences, Redox Biology Center, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, the Department of Ophthalmology, Eye Center of the 2nd Affiliated Hospital, Medical College of Zhejiang University, Hangzhou 310009, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>David</LastName>
<ForeName>Larry</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>the Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland, Oregon 97239.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ho</LastName>
<ForeName>Ye-Shih</ForeName>
<Initials>YS</Initials>
<AffiliationInfo>
<Affiliation>the Institute of Environment Health Sciences, Wayne State University, Detroit, Michigan 48201, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lou</LastName>
<ForeName>Marjorie F</ForeName>
<Initials>MF</Initials>
<AffiliationInfo>
<Affiliation>From the School of Veterinary Medicine and Biomedical Sciences, Redox Biology Center, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, the Department of Ophthalmology, University of Nebraska Medical Center, Omaha, Nebraska 698583 mlou1@unl.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 ES06639</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 EY10595</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005136">Eye Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C516009">Glrx2 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054477">Glutaredoxins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>48TCX9A1VT</RegistryNumber>
<NameOfSubstance UI="D003553">Cystine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>8L70Q75FXE</RegistryNumber>
<NameOfSubstance UI="D000255">Adenosine Triphosphate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.6.5.3</RegistryNumber>
<NameOfSubstance UI="D042967">Electron Transport Complex I</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.9.3.1</RegistryNumber>
<NameOfSubstance UI="D003576">Electron Transport Complex IV</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>GAN16C9B8O</RegistryNumber>
<NameOfSubstance UI="D005978">Glutathione</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 1995 Sep;9(12):1173-82</RefSource>
<PMID Version="1">7672510</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3913-8</RefSource>
<PMID Version="1">12655060</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Eye Res. 2000 Jun;70(6):745-53</RefSource>
<PMID Version="1">10843779</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Surv Ophthalmol. 2000 Sep-Oct;45(2):115-34</RefSource>
<PMID Version="1">11033038</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2000 Nov 9;408(6809):239-47</RefSource>
<PMID Version="1">11089981</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Ophthalmol. 2001 Mar;85(3):261-6</RefSource>
<PMID Version="1">11222327</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2001 Jan 26;104(2):173-6</RefSource>
<PMID Version="1">11207359</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2001 Jul 13;276(28):26269-75</RefSource>
<PMID Version="1">11297543</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2001 Aug 10;276(32):30374-80</RefSource>
<PMID Version="1">11397793</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Eye Res. 2002 Jan;74(1):113-22</RefSource>
<PMID Version="1">11878824</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2003;53 Suppl 3:S26-36; discussion S36-8</RefSource>
<PMID Version="1">12666096</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Eye Res. 2015 Jan;130:58-65</RefSource>
<PMID Version="1">25479045</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3263-71</RefSource>
<PMID Version="1">12882768</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prog Retin Eye Res. 2003 Sep;22(5):657-82</RefSource>
<PMID Version="1">12892645</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Invest Ophthalmol Vis Sci. 2004 Jan;45(1):230-7</RefSource>
<PMID Version="1">14691178</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Drug Discov. 2004 Mar;3(3):205-14</RefSource>
<PMID Version="1">15031734</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Eye Res. 1977 Aug;25(2):139-48</RefSource>
<PMID Version="1">913506</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1978 Jul;75(7):3244-8</RefSource>
<PMID Version="1">277922</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stroke. 1979 Jul-Aug;10(4):437-46</RefSource>
<PMID Version="1">505482</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 1980 Jul 15;190(1):125-30</RefSource>
<PMID Version="1">7447929</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Eye Res. 1983 Jan;36(1):15-23</RefSource>
<PMID Version="1">6825728</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 1983 Feb 7;152(1):114-8</RefSource>
<PMID Version="1">6840271</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Eye Res. 1986 Jun;42(6):607-16</RefSource>
<PMID Version="1">3720875</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Eye Res. 1988 Apr;46(4):517-30</RefSource>
<PMID Version="1">3133235</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Eye Res. 1988 Jul;47(1):17-25</RefSource>
<PMID Version="1">3409984</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Ophthalmol. 1989 Jul;107(7):991-7</RefSource>
<PMID Version="1">2751471</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1989 Aug 25;264(24):13963-6</RefSource>
<PMID Version="1">2668278</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Eye Res. 1989 Sep;8(9):883-90</RefSource>
<PMID Version="1">2791632</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 1990 Jan 16;29(2):464-70</RefSource>
<PMID Version="1">2302385</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1991 Jun 28;65(7):1153-63</RefSource>
<PMID Version="1">2065352</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Eye Res. 1992 Dec;55(6):889-96</RefSource>
<PMID Version="1">1486943</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8424-8</RefSource>
<PMID Version="1">8378314</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1997 Nov 14;272(46):29099-103</RefSource>
<PMID Version="1">9360985</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1999 Feb 19;274(8):4735-42</RefSource>
<PMID Version="1">9988710</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Eye Res. 1999 May;68(5):547-52</RefSource>
<PMID Version="1">10328968</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2004 Nov 12;279(46):47939-51</RefSource>
<PMID Version="1">15347644</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2005 Feb 18;327(3):774-9</RefSource>
<PMID Version="1">15649413</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):348-66</RefSource>
<PMID Version="1">15706083</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8168-73</RefSource>
<PMID Version="1">15917333</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Eye Res. 2005 Sep;81(3):276-85</RefSource>
<PMID Version="1">16129095</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Invest Ophthalmol Vis Sci. 2005 Oct;46(10):3783-9</RefSource>
<PMID Version="1">16186363</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 2006 Dec;20(14):2645-7</RefSource>
<PMID Version="1">17065220</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Chem. 2007 Apr;53(4):729-34</RefSource>
<PMID Version="1">17332151</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Pharmacol. 2007 Aug;7(4):381-91</RefSource>
<PMID Version="1">17662654</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Free Radic Biol Med. 2007 Nov 1;43(9):1299-312</RefSource>
<PMID Version="1">17893043</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antioxid Redox Signal. 2007 Nov;9(11):2027-33</RefSource>
<PMID Version="1">17845131</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antioxid Redox Signal. 2008 Nov;10(11):1941-88</RefSource>
<PMID Version="1">18774901</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4497-505</RefSource>
<PMID Version="1">18586881</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2010 Jun 15;21(12):1945-54</RefSource>
<PMID Version="1">20427569</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochim Biophys Acta. 2010 Oct;1797(10):1705-15</RefSource>
<PMID Version="1">20547138</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Free Radic Biol Med. 2011 Dec 1;51(11):2108-17</RefSource>
<PMID Version="1">21983434</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2013 Mar 22;288(12):8365-79</RefSource>
<PMID Version="1">23335511</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2013 Sep 13;288(37):26497-504</RefSource>
<PMID Version="1">23861399</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Eye Res. 1996 Oct;63(4):433-41</RefSource>
<PMID Version="1">8944550</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000255">Adenosine Triphosphate</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002386">Cataract</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003553">Cystine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D042967">Electron Transport Complex I</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003576">Electron Transport Complex IV</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005136">Eye Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017353">Gene Deletion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054477">Glutaredoxins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005978">Glutathione</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007903">Lens Capsule, Crystalline</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057507">Mice, 129 Strain</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018345">Mice, Knockout</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276876</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Age-related Cataract</Keyword>
<Keyword MajorTopicYN="N">Electron Transport System</Keyword>
<Keyword MajorTopicYN="N">Glutaredoxin 2</Keyword>
<Keyword MajorTopicYN="N">Oxidative Stress</Keyword>
<Keyword MajorTopicYN="N">α-Crystallin Protein</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25368323</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Functional analysis of insect molting fluid proteins on the protection and regulation of ecdysis.</ArticleTitle>
<Pagination>
<MedlinePgn>35891-906</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.599597</ELocationID>
<Abstract>
<AbstractText>Molting fluid accumulates between the old and new cuticles during periodical ecdysis in Ecdysozoa. Natural defects in insect ecdysis are frequently associated with melanization (an immunity response) occurring primarily in molting fluids, suggesting that molting fluid may impact immunity as well as affect ecdysis. To address this hypothesis, proteomic analysis of molting fluids from Bombyx mori during three different types of ecdysis was performed. Many proteins were newly identified, including immunity-related proteins, in each molting fluid. Molting fluids inhibited the growth of bacteria in vitro. The entomopathogenic fungi Beauveria bassiana, which can escape immune responses in feeding larvae, is quickly recognized by larvae during ecdysis, followed by melanization in molting fluid and old cuticle. Fungal conidia germination was delayed, and no hyphae were detected in the hemocoels of pharate instar insects. Molting fluids protect the delicate pharate instar insects with extremely thin cuticles against microorganisms. To explore the function of molting fluids in ecdysis regulation, based on protein similarity, 32 genes were selected for analysis in ecdysis regulation through RNAi in Tribolium castaneum, a model commonly used to study integument development because RNAi is difficult to achieve in B. mori. We identified 24 molting proteins that affected ecdysis after knockdown, with different physiological functions, including old cuticle protein recycling, molting fluid pressure balance, detoxification, and signal detection and transfer of molting fluids. We report that insects secrete molting fluid for protection and regulation of ecdysis, which indicates a way to develop new pesticides through interrupting insect ecdysis in the future. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Jie</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Key Laboratory of Insect Developmental and Evolutionary Biology, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200032, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lu</LastName>
<ForeName>Anrui</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Key Laboratory of Insect Developmental and Evolutionary Biology, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200032, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kong</LastName>
<ForeName>Lulu</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>the College of Agriculture and Biology, Shanghai Jiaotong University, 800 Dongchuan Road, Shanghai 200240, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Qiaoli</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>From the Key Laboratory of Insect Developmental and Evolutionary Biology, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200032, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ling</LastName>
<ForeName>Erjun</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>From the Key Laboratory of Insect Developmental and Evolutionary Biology, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200032, China and erjunling@sippe.ac.cn ejling@sibs.ac.cn.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004792">Enzyme Precursors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019476">Insect Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008543">Melanins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.10.3.-</RegistryNumber>
<NameOfSubstance UI="C038451">pro-phenoloxidase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.10.3.1</RegistryNumber>
<NameOfSubstance UI="D004156">Catechol Oxidase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Immunology. 1997 Aug;91(4):609-17</RefSource>
<PMID Version="1">9378502</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Biochem. 1976 May 7;72:248-54</RefSource>
<PMID Version="1">942051</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Insect Biochem Mol Biol. 1999 Jul;29(7):585-97</RefSource>
<PMID Version="1">10436935</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Genes Evol. 2004 Nov;214(11):575-8</RefSource>
<PMID Version="1">15365833</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2004 Dec 10;306(5703):1937-40</RefSource>
<PMID Version="1">15591204</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Agric Food Chem. 2005 Mar 9;53(5):1470-4</RefSource>
<PMID Version="1">15740026</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Insect Biochem Mol Biol. 2005 May;35(5):443-59</RefSource>
<PMID Version="1">15804578</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cytometry A. 2005 Sep;67(1):45-52</RefSource>
<PMID Version="1">16082711</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Plant Physiol. 2005 Aug;162(8):929-36</RefSource>
<PMID Version="1">16146319</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Biol. 2005 Oct;3(10):e312</RefSource>
<PMID Version="1">16122351</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Appl Microbiol Biotechnol. 2012 Feb;93(4):1351-75</RefSource>
<PMID Version="1">22218770</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Apr 20;287(17):14270-9</RefSource>
<PMID Version="1">22375003</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Jul 6;287(28):23995-4003</RefSource>
<PMID Version="1">22645126</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(8):e43769</RefSource>
<PMID Version="1">22937093</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Insect Biochem Mol Biol. 2012 Oct;42(10):766-75</RefSource>
<PMID Version="1">22841512</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gen Comp Endocrinol. 2012 Dec 1;179(3):477-84</RefSource>
<PMID Version="1">22728566</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Genet. 2013;9(1):e1003268</RefSource>
<PMID Version="1">23382702</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Insect Mol Biol. 2013 Jun;22(3):273-83</RefSource>
<PMID Version="1">23496335</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12518-25</RefSource>
<PMID Version="1">23852731</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2005 Nov 4;310(5749):847-50</RefSource>
<PMID Version="1">16272120</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Biol. 2005 Oct;3(10):e349</RefSource>
<PMID Version="1">16207077</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2014 May;10(5):e1004067</RefSource>
<PMID Version="1">24788090</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Insect Biochem Mol Biol. 2006 Apr;36(4):231-40</RefSource>
<PMID Version="1">16551537</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2006 Oct 1;177(7):4594-604</RefSource>
<PMID Version="1">16982897</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Biochem. 2006 Dec 1;359(1):1-17</RefSource>
<PMID Version="1">16942745</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Insect Biochem Mol Biol. 2007 Feb;37(2):135-46</RefSource>
<PMID Version="1">17244542</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Insect Biochem Mol Biol. 2007 Sep;37(9):952-9</RefSource>
<PMID Version="1">17681234</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Philos Trans R Soc Lond B Biol Sci. 2008 Apr 27;363(1496):1529-37</RefSource>
<PMID Version="1">18192181</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Insect Biochem Mol Biol. 2008 Apr;38(4):430-9</RefSource>
<PMID Version="1">18342248</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Insect Biochem Mol Biol. 2008 Apr;38(4):478-89</RefSource>
<PMID Version="1">18342252</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2008 May 6;105(18):6650-5</RefSource>
<PMID Version="1">18436642</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Drug Metab Rev. 2008;40(4):553-624</RefSource>
<PMID Version="1">18949601</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Insect Biochem Mol Biol. 2009 Mar;39(3):207-17</RefSource>
<PMID Version="1">19114104</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Insect Mol Biol. 2009 Apr;18(2):223-32</RefSource>
<PMID Version="1">19141111</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Insect Biochem Mol Biol. 2009 May-Jun;39(5-6):355-65</RefSource>
<PMID Version="1">19268706</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2009 Jun 26;284(26):17549-63</RefSource>
<PMID Version="1">19406744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Genomics. 2009;10:553</RefSource>
<PMID Version="1">19930670</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Appl Microbiol Biotechnol. 2010 Jan;85(4):901-7</RefSource>
<PMID Version="1">19862514</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biomol Screen. 2010 Feb;15(2):213-7</RefSource>
<PMID Version="1">20042532</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Comp Biochem Physiol B Biochem Mol Biol. 2011 Jan;158(1):90-8</RefSource>
<PMID Version="1">20959145</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Insect Physiol. 2011 Feb;57(2):231-45</RefSource>
<PMID Version="1">21078327</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2011 Jan 18;108(3):1064-9</RefSource>
<PMID Version="1">21199936</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17028-33</RefSource>
<PMID Version="1">21930896</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Invertebr Pathol. 2012 Jan;109(1):105-9</RefSource>
<PMID Version="1">22024554</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Insect Biochem Mol Biol. 2000 Feb;30(2):135-43</RefSource>
<PMID Version="1">10696589</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Entomol. 2002;47:467-500</RefSource>
<PMID Version="1">11729082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2002 Jun;109(11):1417-27</RefSource>
<PMID Version="1">12045255</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Renin Angiotensin Aldosterone Syst. 2003 Mar;4(1):11-6</RefSource>
<PMID Version="1">12692748</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Insect Biochem Mol Biol. 2004 Jan;34(1):89-100</RefSource>
<PMID Version="1">14976985</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunol Rev. 2004 Apr;198:97-105</RefSource>
<PMID Version="1">15199957</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Biochem Biophys. 1970 Jul;139(1):143-8</RefSource>
<PMID Version="1">4990513</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1999 Mar 12;274(11):7441-53</RefSource>
<PMID Version="1">10066809</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001412">Bacillus subtilis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000254">growth &amp; development</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001826">Body Fluids</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012831">Bombyx</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004156">Catechol Oxidase</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004789">Enzyme Activation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004792">Enzyme Precursors</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004926">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000254">growth &amp; development</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007113">Immunity, Innate</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019476">Insect Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007814">Larva</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008543">Melanins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D018978">Molting</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010858">Pigmentation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017382">Reactive Oxygen Species</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014231">Tribolium</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276858</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bacteria</Keyword>
<Keyword MajorTopicYN="N">Epidermis</Keyword>
<Keyword MajorTopicYN="N">Fungi</Keyword>
<Keyword MajorTopicYN="N">Gene Silencing</Keyword>
<Keyword MajorTopicYN="N">Innate Immunity</Keyword>
<Keyword MajorTopicYN="N">Insect</Keyword>
<Keyword MajorTopicYN="N">Proteomics</Keyword>
<Keyword MajorTopicYN="N">Shedding</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25368326</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Isoliquiritigenin induces apoptosis and inhibits xenograft tumor growth of human lung cancer cells by targeting both wild type and L858R/T790M mutant EGFR.</ArticleTitle>
<Pagination>
<MedlinePgn>35839-48</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.585513</ELocationID>
<Abstract>
<AbstractText>Non-small-cell lung cancer (NSCLC) is associated with diverse genetic alterations including mutation of epidermal growth factor receptor (EGFR). Isoliquiritigenin (ILQ), a chalcone derivative, possesses anticancer activities. In the present study, we investigated the effects of ILQ on the growth of tyrosine kinase inhibitor (TKI)-sensitive and -resistant NSCLC cells and elucidated its underlying mechanisms. Treatment with ILQ inhibited growth and induced apoptosis in both TKI-sensitive and -resistant NSCLC cells. ILQ-induced apoptosis was associated with the cleavage of caspase-3 and poly-(ADP-ribose)-polymerase, increased expression of Bim, and reduced expression of Bcl-2. In vitro kinase assay results revealed that ILQ inhibited the catalytic activity of both wild type and double mutant (L858R/T790M) EGFR. Treatment with ILQ inhibited the anchorage-independent growth of NIH3T3 cells stably transfected with either wild type or double-mutant EGFR with or without EGF stimulation. ILQ also reduced the phosphorylation of Akt and ERK1/2 in both TKI-sensitive and -resistant NSCLC cells, and attenuated the kinase activity of Akt1 and ERK2 in vitro. ILQ directly interacted with both wild type and double-mutant EGFR in an ATP-competitive manner. A docking model study showed that ILQ formed two hydrogen bonds (Glu-762 and Met-793) with wild type EGFR and three hydrogen bonds (Lys-745, Met-793, and Asp-855) with mutant EGFR. ILQ attenuated the xenograft tumor growth of H1975 cells, which was associated with decreased expression of Ki-67 and diminished phosphorylation of Akt and ERK1/2. Taken together, ILQ suppresses NSCLC cell growth by directly targeting wild type or mutant EGFR. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jung</LastName>
<ForeName>Sung Keun</ForeName>
<Initials>SK</Initials>
<AffiliationInfo>
<Affiliation>From The Hormel Institute, University of Minnesota, Minnesota 55912, Division of Metabolism and Functionality Research, Korea Food Research Institute, Seongnam, Gyeonggi-do, 463-746 Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Mee-Hyun</ForeName>
<Initials>MH</Initials>
<AffiliationInfo>
<Affiliation>From The Hormel Institute, University of Minnesota, Minnesota 55912, College of Pharmacy, The Catholic University of Korea, Bucheon, Gyeonggi-do, 420-743 South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lim</LastName>
<ForeName>Do Young</ForeName>
<Initials>do Y</Initials>
<AffiliationInfo>
<Affiliation>From The Hormel Institute, University of Minnesota, Minnesota 55912.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Jong Eun</ForeName>
<Initials>JE</Initials>
<AffiliationInfo>
<Affiliation>From The Hormel Institute, University of Minnesota, Minnesota 55912, Advanced Institutes of Convergence Technology, Seoul National University, Suwon, Gyeonggi-do, 443-270 South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Puja</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>From The Hormel Institute, University of Minnesota, Minnesota 55912.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Sung-Young</ForeName>
<Initials>SY</Initials>
<AffiliationInfo>
<Affiliation>From The Hormel Institute, University of Minnesota, Minnesota 55912.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jeong</LastName>
<ForeName>Chul-Ho</ForeName>
<Initials>CH</Initials>
<AffiliationInfo>
<Affiliation>From The Hormel Institute, University of Minnesota, Minnesota 55912, College of Pharmacy, Keimyung University, Daegu, 704-701 South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lim</LastName>
<ForeName>Tae-Gyu</ForeName>
<Initials>TG</Initials>
<AffiliationInfo>
<Affiliation>From The Hormel Institute, University of Minnesota, Minnesota 55912, WCU Biomodulation Major, Department of Agricultural Biotechnology and Center for Food and Bioconvergence, Seoul National University, Seoul, 151-921, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Hanyong</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>From The Hormel Institute, University of Minnesota, Minnesota 55912.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chi</LastName>
<ForeName>Young-In</ForeName>
<Initials>YI</Initials>
<AffiliationInfo>
<Affiliation>From The Hormel Institute, University of Minnesota, Minnesota 55912.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kundu</LastName>
<ForeName>Joydeb Kumar</ForeName>
<Initials>JK</Initials>
<AffiliationInfo>
<Affiliation>College of Pharmacy, Keimyung University, Daegu, 704-701 South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Nam Hyouck</ForeName>
<Initials>NH</Initials>
<AffiliationInfo>
<Affiliation>Division of Metabolism and Functionality Research, Korea Food Research Institute, Seongnam, Gyeonggi-do, 463-746 Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Charles C</ForeName>
<Initials>CC</Initials>
<AffiliationInfo>
<Affiliation>From The Hormel Institute, University of Minnesota, Minnesota 55912, Department of Food Science, Cornell University, Ithaca, New York 14850, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cho</LastName>
<ForeName>Yong-Yeon</ForeName>
<Initials>YY</Initials>
<AffiliationInfo>
<Affiliation>College of Pharmacy, The Catholic University of Korea, Bucheon, Gyeonggi-do, 420-743 South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bode</LastName>
<ForeName>Ann M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>From The Hormel Institute, University of Minnesota, Minnesota 55912.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Ki Won</ForeName>
<Initials>KW</Initials>
<AffiliationInfo>
<Affiliation>Advanced Institutes of Convergence Technology, Seoul National University, Suwon, Gyeonggi-do, 443-270 South Korea, WCU Biomodulation Major, Department of Agricultural Biotechnology and Center for Food and Bioconvergence, Seoul National University, Seoul, 151-921, Republic of Korea, Research Institute of Bio Food Industry, Institute of Green Bio Science and Technology, Seoul National University, Pyeongchang, 232-916, Republic of Korea kiwon@snu.ac.kr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dong</LastName>
<ForeName>Zigang</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>From The Hormel Institute, University of Minnesota, Minnesota 55912, zgdong@hi.umn.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>CA1669011</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA172457</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>ES016548</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R37 CA081064</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000972">Antineoplastic Agents, Phytogenic</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D047188">Chalcones</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>B9CTI9GB8F</RegistryNumber>
<NameOfSubstance UI="C040920">isoliquiritigenin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.10.1</RegistryNumber>
<NameOfSubstance UI="C512478">EGFR protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.10.1</RegistryNumber>
<NameOfSubstance UI="D011958">Receptor, Epidermal Growth Factor</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.24</RegistryNumber>
<NameOfSubstance UI="D048049">Extracellular Signal-Regulated MAP Kinases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(7):e68566</RefSource>
<PMID Version="1">23861918</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lung Cancer. 2013 May;80(2):120-30</RefSource>
<PMID Version="1">23384674</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Front Biosci (Landmark Ed). 2014;19:259-71</RefSource>
<PMID Version="1">24389182</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Transl Oncol. 2014 Apr;16(4):339-50</RefSource>
<PMID Version="1">24307395</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Biol Markers. 2014 Apr-Jun;29(2):e112-9</RefSource>
<PMID Version="1">24425324</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2000 Jan 1;28(1):235-42</RefSource>
<PMID Version="1">10592235</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Lett. 2002 Sep 8;183(1):23-30</RefSource>
<PMID Version="1">12049811</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2002 Nov 29;277(48):46265-72</RefSource>
<PMID Version="1">12196540</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Lett. 2004 Apr 15;207(1):27-35</RefSource>
<PMID Version="1">15050731</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Carcinogenesis. 2004 May;25(5):647-59</RefSource>
<PMID Version="1">14688022</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Exp Pharmacol Physiol. 2004 Jul;31(7):414-8</RefSource>
<PMID Version="1">15236626</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comput Chem. 2004 Oct;25(13):1605-12</RefSource>
<PMID Version="1">15264254</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioorg Med Chem. 1998 Mar;6(3):339-47</RefSource>
<PMID Version="1">9568287</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2005 Feb 24;352(8):786-92</RefSource>
<PMID Version="1">15728811</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Life Sci. 2005 Jun 3;77(3):279-92</RefSource>
<PMID Version="1">15878356</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Med. 2005 Mar;2(3):e73</RefSource>
<PMID Version="1">15737014</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2007 May 18;316(5827):1039-43</RefSource>
<PMID Version="1">17463250</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Agric Food Chem. 2007 Jun 13;55(12):4691-7</RefSource>
<PMID Version="1">17516657</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2007 Aug 1;67(15):7319-26</RefSource>
<PMID Version="1">17671201</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Pharmacol. 2008 Apr 14;584(1):175-84</RefSource>
<PMID Version="1">18295200</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mod Pathol. 2008 May;21 Suppl 2:S16-22</RefSource>
<PMID Version="1">18437168</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Nutr Biochem. 2009 Sep;20(9):663-76</RefSource>
<PMID Version="1">18824345</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2009 Aug;28 Suppl 1:S14-23</RefSource>
<PMID Version="1">19680292</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2009 Dec 24;462(7276):1070-4</RefSource>
<PMID Version="1">20033049</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2010 Jan 19;17(1):77-88</RefSource>
<PMID Version="1">20129249</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Prev Res (Phila). 2010 Feb;3(2):221-32</RefSource>
<PMID Version="1">20068129</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Exp Pharmacol Physiol. 2010 Aug;37(8):841-7</RefSource>
<PMID Version="1">20456427</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Mol Cell Biol. 2010 Dec;11(12):834-48</RefSource>
<PMID Version="1">21102609</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90</RefSource>
<PMID Version="1">21296855</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(2):e31906</RefSource>
<PMID Version="1">22363766</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Asian Nat Prod Res. 2012;14(8):789-98</RefSource>
<PMID Version="1">22694287</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Med (Berl). 2012 Nov;90(11):1311-9</RefSource>
<PMID Version="1">22648519</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Med Rep. 2013 Feb;7(2):531-6</RefSource>
<PMID Version="1">23229626</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Expert Opin Ther Targets. 2013 Apr;17(4):337-49</RefSource>
<PMID Version="1">23327692</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Toxicol Appl Pharmacol. 2013 Oct 1;272(1):37-48</RefSource>
<PMID Version="1">23747687</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000972">Antineoplastic Agents, Phytogenic</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017209">Apoptosis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D045744">Cell Line, Tumor</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049109">Cell Proliferation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D047188">Chalcones</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D048049">Extracellular Signal-Regulated MAP Kinases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057809">HEK293 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008175">Lung Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008819">Mice, Nude</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020125">Mutation, Missense</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D041681">NIH 3T3 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011499">Protein Processing, Post-Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051057">Proto-Oncogene Proteins c-akt</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011958">Receptor, Epidermal Growth Factor</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000037">antagonists &amp; inhibitors</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D047368">Tumor Burden</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D023041">Xenograft Model Antitumor Assays</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276852</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Apoptosis</Keyword>
<Keyword MajorTopicYN="N">Cell Growth</Keyword>
<Keyword MajorTopicYN="N">Epidermal Growth Factor Receptor (EGFR)</Keyword>
<Keyword MajorTopicYN="N">Lung Cancer</Keyword>
<Keyword MajorTopicYN="N">Tyrosine-Protein Kinase (Tyrosine Kinase)</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25371200</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>MicroRNA-200 (miR-200) cluster regulation by achaete scute-like 2 (Ascl2): impact on the epithelial-mesenchymal transition in colon cancer cells.</ArticleTitle>
<Pagination>
<MedlinePgn>36101-15</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.598383</ELocationID>
<Abstract>
<AbstractText>Ascl2, a basic helix-loop-helix transcription factor, is a downstream target of WNT signaling that controls the fate of intestinal cryptic stem cells and colon cancer progenitor cells. However, its involvement in colon cancer and downstream molecular events is largely undefined; in particular, the mechanism by which Ascl2 regulates the plasticity of epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) programs in colon cancer cells remains unknown. In this study, we systematically demonstrate that Ascl2 loss of function in colon cancer cells promotes MET by derepressing the expression of microRNA (miR)-200s (i.e. miR-200b, miR-200a, miR-429, miR-200c, and miR-141) and further activating their expression through a transcriptional mechanism that involves direct binding to the most proximal E-box (E-box2) in the miR-200b-a-429 promoter. Activation of miR-200s due to Ascl2 deficiency led to the inhibition of ZEB1/2 expression and the alteration of epithelial and mesenchymal features. Transfection of miR-200b, miR-200a, and miR-429 inhibitors into Ascl2-deficient colon cancer cells promoted the epithelial-mesenchymal transition in a reversible manner. Transfection of miR-200a or miR-429 inhibitors into Ascl2-deficient colon cancer cells increased cellular proliferation and migration. Ascl2 mRNA levels and the miR-200a, miR-200b, miR-200c, miR-141, or miR-429 levels in the colon cancerous samples were inversely correlated. These results provide the first evidence of a link between Ascl2 and miR-200s in the regulation of EMT-MET plasticity in colon cancer. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tian</LastName>
<ForeName>Yin</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Gastroenterology of People's Liberation Army, Southwest Hospital, Third Military Medical University, Chongqing 400038, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pan</LastName>
<ForeName>Qiong</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Gastroenterology of People's Liberation Army, Southwest Hospital, Third Military Medical University, Chongqing 400038, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shang</LastName>
<ForeName>Yangyang</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Gastroenterology of People's Liberation Army, Southwest Hospital, Third Military Medical University, Chongqing 400038, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhu</LastName>
<ForeName>Rong</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Gastroenterology of People's Liberation Army, Southwest Hospital, Third Military Medical University, Chongqing 400038, China and Department of Gastroenterology, Zunyi Medical University, Guizhou 563000, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ye</LastName>
<ForeName>Jun</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Gastroenterology of People's Liberation Army, Southwest Hospital, Third Military Medical University, Chongqing 400038, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Yun</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Gastroenterology of People's Liberation Army, Southwest Hospital, Third Military Medical University, Chongqing 400038, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhong</LastName>
<ForeName>Xiaoli</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Gastroenterology of People's Liberation Army, Southwest Hospital, Third Military Medical University, Chongqing 400038, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Shanshan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Gastroenterology of People's Liberation Army, Southwest Hospital, Third Military Medical University, Chongqing 400038, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>He</LastName>
<ForeName>Yonghong</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Gastroenterology of People's Liberation Army, Southwest Hospital, Third Military Medical University, Chongqing 400038, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Lei</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Gastroenterology of People's Liberation Army, Southwest Hospital, Third Military Medical University, Chongqing 400038, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhao</LastName>
<ForeName>Jingjing</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Gastroenterology of People's Liberation Army, Southwest Hospital, Third Military Medical University, Chongqing 400038, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Wensheng</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Gastroenterology of People's Liberation Army, Southwest Hospital, Third Military Medical University, Chongqing 400038, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peng</LastName>
<ForeName>Zhihong</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Gastroenterology of People's Liberation Army, Southwest Hospital, Third Military Medical University, Chongqing 400038, China and pengzhh@yahoo.com.cn.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Rongquan</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Gastroenterology of People's Liberation Army, Southwest Hospital, Third Military Medical University, Chongqing 400038, China and rongquanw@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C065501">ASCL2 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051792">Basic Helix-Loop-Helix Transcription Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018398">Homeodomain Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C533896">MIRN200 microRNA, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012097">Repressor Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C486307">ZEB1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C492363">ZEB2 protein, human</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2011 Aug 4;30(31):3440-53</RefSource>
<PMID Version="1">21460854</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2011 May 15;22(10):1686-98</RefSource>
<PMID Version="1">21411626</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Stem Cell. 2011 Nov 4;9(5):476-85</RefSource>
<PMID Version="1">22056143</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(2):e32170</RefSource>
<PMID Version="1">22384170</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2012 Jun 21;31(25):3051-9</RefSource>
<PMID Version="1">22020340</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gut. 2012 Oct;61(10):1435-8</RefSource>
<PMID Version="1">22138533</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Dec 7;287(50):42180-94</RefSource>
<PMID Version="1">23038259</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Cancer. 2013 Feb 15;132(4):745-54</RefSource>
<PMID Version="1">22753312</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2013 Feb 22;288(8):5407-16</RefSource>
<PMID Version="1">23316049</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gut. 2013 Jul;62(7):1012-23</RefSource>
<PMID Version="1">22637696</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Carcinogenesis. 2013 Jul;34(7):1431-41</RefSource>
<PMID Version="1">23436804</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gut. 2013 Sep;62(9):1315-26</RefSource>
<PMID Version="1">22735571</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2014 Jan 9;33(2):203-11</RefSource>
<PMID Version="1">23318438</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>In Vitro. 1976 Mar;12(3):180-91</RefSource>
<PMID Version="1">1262041</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2004 Jan 23;116(2):281-97</RefSource>
<PMID Version="1">14744438</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2014 Jul 10;33(28):3707-16</RefSource>
<PMID Version="1">23975430</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3596-600</RefSource>
<PMID Version="1">1314394</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1994 Sep 22;371(6495):333-6</RefSource>
<PMID Version="1">8090202</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Mol Cell Biol. 2006 Feb;7(2):131-42</RefSource>
<PMID Version="1">16493418</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2006 Jun 8;25(24):3445-57</RefSource>
<PMID Version="1">16568095</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Stem Cell. 2007 Oct 11;1(4):389-402</RefSource>
<PMID Version="1">18371377</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2008 May 30;283(22):14910-4</RefSource>
<PMID Version="1">18411277</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2008 Oct 1;68(19):7846-54</RefSource>
<PMID Version="1">18829540</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2009 Mar 6;136(5):903-12</RefSource>
<PMID Version="1">19269367</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Cancer. 2009 Apr;9(4):293-302</RefSource>
<PMID Version="1">19262572</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stem Cells. 2009 Jan;27(1):40-8</RefSource>
<PMID Version="1">18948646</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gut. 2010 Sep;59(9):1236-44</RefSource>
<PMID Version="1">20479215</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2010 Nov 12;285(46):35293-302</RefSource>
<PMID Version="1">20826792</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Cell Biol. 2011 Mar;13(3):317-23</RefSource>
<PMID Version="1">21336307</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2011 Mar;17(3):313-9</RefSource>
<PMID Version="1">21386835</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2011 Mar 15;71(6):2328-38</RefSource>
<PMID Version="1">21285251</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Med. 2011 May 9;208(5):875-83</RefSource>
<PMID Version="1">21518799</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gut. 2011 Nov;60(11):1606-7; author reply 1607</RefSource>
<PMID Version="1">21106550</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051792">Basic Helix-Loop-Helix Transcription Factors</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003110">Colonic Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D058750">Epithelial-Mesenchymal Transition</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015972">Gene Expression Regulation, Neoplastic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055785">Gene Knockdown Techniques</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019073">HT29 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018398">Homeodomain Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008207">Lymphatic Metastasis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D035683">MicroRNAs</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000096">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005810">Multigene Family</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011401">Promoter Regions, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012097">Repressor Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014157">Transcription Factors</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014158">Transcription, Genetic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276874</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Colon Cancer</Keyword>
<Keyword MajorTopicYN="N">Colorectal Cancer</Keyword>
<Keyword MajorTopicYN="N">Epithelial-Mesenchymal Transition (EMT)</Keyword>
<Keyword MajorTopicYN="N">MicroRNA (miRNA)</Keyword>
<Keyword MajorTopicYN="N">Transcription Regulation</Keyword>
<Keyword MajorTopicYN="N">Wnt Signaling</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25371206</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>The functional differences between pro-survival and pro-apoptotic B cell lymphoma 2 (Bcl-2) proteins depend on structural differences in their Bcl-2 homology 3 (BH3) domains.</ArticleTitle>
<Pagination>
<MedlinePgn>36001-17</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.610758</ELocationID>
<Abstract>
<AbstractText>Bcl-2 homology 3 (BH3) domains are short sequence motifs that mediate nearly all protein-protein interactions between B cell lymphoma 2 (Bcl-2) family proteins in the intrinsic apoptotic cell death pathway. These sequences are found on both pro-survival and pro-apoptotic members, although their primary function is believed to be associated with induction of cell death. Here, we identify critical features of the BH3 domains of pro-survival proteins that distinguish them functionally from their pro-apoptotic counterparts. Biochemical and x-ray crystallographic studies demonstrate that these differences reduce the capacity of most pro-survival proteins to form high affinity "BH3-in-groove" complexes that are critical for cell death induction. Switching these residues for the corresponding residues in Bcl-2 homologous antagonist/killer (Bak) increases the binding affinity of isolated BH3 domains for pro-survival proteins; however, their exchange in the context of the parental protein causes rapid proteasomal degradation due to protein destabilization. This is supported by further x-ray crystallographic studies that capture elements of this destabilization in one pro-survival protein, Bcl-w. In pro-apoptotic Bak, we demonstrate that the corresponding distinguishing residues are important for its cell-killing capacity and antagonism by pro-survival proteins. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Erinna F</ForeName>
<Initials>EF</Initials>
<AffiliationInfo>
<Affiliation>From the Walter and Eliza Hall Institute of Medical Research, 1G Royal Pde, Parkville, Victoria 3052, Australia and the Department of Medical Biology, University of Melbourne, Parkville, Victoria 3010, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dewson</LastName>
<ForeName>Grant</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>From the Walter and Eliza Hall Institute of Medical Research, 1G Royal Pde, Parkville, Victoria 3052, Australia and the Department of Medical Biology, University of Melbourne, Parkville, Victoria 3010, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Evangelista</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From the Walter and Eliza Hall Institute of Medical Research, 1G Royal Pde, Parkville, Victoria 3052, Australia and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pettikiriarachchi</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Walter and Eliza Hall Institute of Medical Research, 1G Royal Pde, Parkville, Victoria 3052, Australia and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gold</LastName>
<ForeName>Grace J</ForeName>
<Initials>GJ</Initials>
<AffiliationInfo>
<Affiliation>From the Walter and Eliza Hall Institute of Medical Research, 1G Royal Pde, Parkville, Victoria 3052, Australia and the Department of Medical Biology, University of Melbourne, Parkville, Victoria 3010, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhu</LastName>
<ForeName>Haoran</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>From the Walter and Eliza Hall Institute of Medical Research, 1G Royal Pde, Parkville, Victoria 3052, Australia and the Department of Medical Biology, University of Melbourne, Parkville, Victoria 3010, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Colman</LastName>
<ForeName>Peter M</ForeName>
<Initials>PM</Initials>
<AffiliationInfo>
<Affiliation>From the Walter and Eliza Hall Institute of Medical Research, 1G Royal Pde, Parkville, Victoria 3052, Australia and the Department of Medical Biology, University of Melbourne, Parkville, Victoria 3010, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fairlie</LastName>
<ForeName>W Douglas</ForeName>
<Initials>WD</Initials>
<AffiliationInfo>
<Affiliation>From the Walter and Eliza Hall Institute of Medical Research, 1G Royal Pde, Parkville, Victoria 3052, Australia and the Department of Medical Biology, University of Melbourne, Parkville, Victoria 3010, Australia fairlie@wehi.edu.au.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>PDB</DataBankName>
<AccessionNumberList>
<AccessionNumber>4CIM</AccessionNumber>
<AccessionNumber>4CIN</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051017">Apoptosis Regulatory Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C494811">BCL2L1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C491073">BCL2L2 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051020">bcl-X Protein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-43-6</RegistryNumber>
<NameOfSubstance UI="D045304">Cytochromes c</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32</RefSource>
<PMID Version="1">20124692</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2010 May 21;398(5):747-62</RefSource>
<PMID Version="1">20363230</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Chem Biol. 2010 Aug;6(8):595-601</RefSource>
<PMID Version="1">20562877</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2010 Sep 10;285(37):28924-37</RefSource>
<PMID Version="1">20605789</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Res. 2011 Apr;21(4):627-41</RefSource>
<PMID Version="1">21060336</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Structure. 2011 Oct 12;19(10):1467-76</RefSource>
<PMID Version="1">22000515</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2011 Nov 18;44(4):517-31</RefSource>
<PMID Version="1">22036586</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Death Differ. 2012 Apr;19(4):661-70</RefSource>
<PMID Version="1">22015607</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2012 Apr;15(4):574-80</RefSource>
<PMID Version="1">22366758</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2013 Jan 9;425(1):171-85</RefSource>
<PMID Version="1">23154169</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2013 Jan 31;152(3):519-31</RefSource>
<PMID Version="1">23374347</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>ACS Chem Biol. 2013 Apr 19;8(4):778-88</RefSource>
<PMID Version="1">23363053</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Apoptosis. 2013 Sep;18(9):1093-105</RefSource>
<PMID Version="1">23733106</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2013 Sep 6;288(36):26027-38</RefSource>
<PMID Version="1">23893415</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chembiochem. 2013 Sep 2;14(13):1564-72</RefSource>
<PMID Version="1">23929624</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>ACS Chem Biol. 2014 Sep 19;9(9):1962-8</RefSource>
<PMID Version="1">25052212</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2014 Sep 18;55(6):938-46</RefSource>
<PMID Version="1">25175025</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1997 Feb 14;275(5302):983-6</RefSource>
<PMID Version="1">9020082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2000 Jul 21;275(29):22136-46</RefSource>
<PMID Version="1">10766760</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2000 Aug 18;275(33):25255-61</RefSource>
<PMID Version="1">10837489</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2000 Nov 10;103(4):645-54</RefSource>
<PMID Version="1">11106734</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Protein Sci. 2000 Dec;9(12):2528-34</RefSource>
<PMID Version="1">11206074</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2000 Dec;6(6):1389-99</RefSource>
<PMID Version="1">11163212</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3012-7</RefSource>
<PMID Version="1">11248023</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2001 Apr 27;292(5517):727-30</RefSource>
<PMID Version="1">11326099</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Death Differ. 2001 Sep;8(9):933-42</RefSource>
<PMID Version="1">11526448</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 2001 Oct;57(Pt 10):1373-82</RefSource>
<PMID Version="1">11567148</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neoplasia. 2001 Sep-Oct;3(5):437-45</RefSource>
<PMID Version="1">11687955</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2002 Sep;2(3):183-92</RefSource>
<PMID Version="1">12242151</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1948-54</RefSource>
<PMID Version="1">12393927</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2003 Apr 1;22(7):1497-507</RefSource>
<PMID Version="1">12660157</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2003 Jun 6;278(23):21124-8</RefSource>
<PMID Version="1">12651847</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunity. 2003 Sep;19(3):341-52</RefSource>
<PMID Version="1">14499110</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 2004 Mar;60(Pt 3):432-8</RefSource>
<PMID Version="1">14993666</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13590-5</RefSource>
<PMID Version="1">15342906</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1993 Aug 27;74(4):597-608</RefSource>
<PMID Version="1">8358789</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11024-8</RefSource>
<PMID Version="1">7479929</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1996 Mar 15;271(11):6306-12</RefSource>
<PMID Version="1">8626425</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1996 May 23;381(6580):335-41</RefSource>
<PMID Version="1">8692274</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Biol. 1997 Dec 1;7(12):913-20</RefSource>
<PMID Version="1">9382837</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1997 Dec 12;278(5345):1966-8</RefSource>
<PMID Version="1">9395403</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Cell Biol. 1998 Aug;8(8):324-30</RefSource>
<PMID Version="1">9704409</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 1999 Oct;19(10):6673-81</RefSource>
<PMID Version="1">10490606</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32</RefSource>
<PMID Version="1">15572765</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2005 Feb 11;280(6):4738-44</RefSource>
<PMID Version="1">15550399</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2005 Feb 4;17(3):393-403</RefSource>
<PMID Version="1">15694340</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2005 Feb 18;17(4):525-35</RefSource>
<PMID Version="1">15721256</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 2005 Apr;61(Pt 4):458-64</RefSource>
<PMID Version="1">15805601</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 2005 Jun 1;19(11):1294-305</RefSource>
<PMID Version="1">15901672</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Death Differ. 2005 Jul;12(7):713-23</RefSource>
<PMID Version="1">15861188</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2005 Jul 1;121(7):1085-95</RefSource>
<PMID Version="1">15989957</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2005 Sep 23;122(6):927-39</RefSource>
<PMID Version="1">16179260</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2006 Feb 17;356(2):367-81</RefSource>
<PMID Version="1">16368107</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2006 May;9(5):351-65</RefSource>
<PMID Version="1">16697956</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2006 Dec 1;281(48):36999-7008</RefSource>
<PMID Version="1">16987815</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Cell Biol. 2006 Dec;8(12):1348-58</RefSource>
<PMID Version="1">17115033</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2006 Dec 8;24(5):677-88</RefSource>
<PMID Version="1">17157251</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2007 Feb 9;315(5813):856-9</RefSource>
<PMID Version="1">17289999</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2007 Mar 23;128(6):1173-86</RefSource>
<PMID Version="1">17382885</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6217-22</RefSource>
<PMID Version="1">17389404</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2007 Apr 27;282(17):13123-32</RefSource>
<PMID Version="1">17337444</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 2007 Aug 1;21(15):1937-48</RefSource>
<PMID Version="1">17671092</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Mol Cell Biol. 2008 Jan;9(1):47-59</RefSource>
<PMID Version="1">18097445</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2008 Jan 28;180(2):341-55</RefSource>
<PMID Version="1">18209102</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Structure. 2008 May;16(5):818-29</RefSource>
<PMID Version="1">18462686</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2008 May 9;30(3):369-80</RefSource>
<PMID Version="1">18471982</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Biol. 2008 Jun 10;6(6):e147</RefSource>
<PMID Version="1">18547146</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2008 Jul 25;380(5):958-71</RefSource>
<PMID Version="1">18589438</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Death Differ. 2008 Oct;15(10):1564-71</RefSource>
<PMID Version="1">18551131</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2008 Oct 23;455(7216):1076-81</RefSource>
<PMID Version="1">18948948</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2008 Dec 12;135(6):1074-84</RefSource>
<PMID Version="1">19062087</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Angew Chem Int Ed Engl. 2009;48(24):4318-22</RefSource>
<PMID Version="1">19229915</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2009 Aug 15;122(Pt 16):2801-8</RefSource>
<PMID Version="1">19795525</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2009 Nov 25;36(4):696-703</RefSource>
<PMID Version="1">19941828</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017209">Apoptosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051017">Apoptosis Regulatory Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002470">Cell Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018360">Crystallography, X-Ray</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D045304">Cytochromes c</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008958">Models, Molecular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054730">Protein Interaction Domains and Motifs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055550">Protein Stability</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051020">bcl-X Protein</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276867</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Apoptosis</Keyword>
<Keyword MajorTopicYN="N">B cell Lymphoma 2 (Bcl-2) Family</Keyword>
<Keyword MajorTopicYN="N">Cell Death</Keyword>
<Keyword MajorTopicYN="N">Peptides</Keyword>
<Keyword MajorTopicYN="N">Protein Structure</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25371213</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>The role of autophagy during group B Streptococcus infection of blood-brain barrier endothelium.</ArticleTitle>
<Pagination>
<MedlinePgn>35711-23</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.588657</ELocationID>
<Abstract>
<AbstractText>Bacterial meningitis occurs when bloodborne pathogens invade and penetrate the blood-brain barrier (BBB), provoking inflammation and disease. Group B Streptococcus (GBS), the leading cause of neonatal meningitis, can enter human brain microvascular endothelial cells (hBMECs), but the host response to intracellular GBS has not been characterized. Here we sought to determine whether antibacterial autophagy, which involves selective recognition of intracellular organisms and their targeting to autophagosomes for degradation, is activated in BBB endothelium during bacterial infection. GBS infection resulted in increased punctate distribution of GFP-microtubule-associated protein 1 light chain 3 (LC3) and increased levels of endogenous LC3-II and p62 turnover, two hallmark indicators of active autophagic flux. Infection with GBS mutants revealed that bacterial invasion and the GBS pore-forming β-hemolysin/cytolysin (β-h/c) trigger autophagic activation. Cell-free bacterial extracts containing β-h/c activity induced LC3-II conversion, identifying this toxin as a principal provocative factor for autophagy activation. These results were confirmed in vivo using a mouse model of GBS meningitis as infection with WT GBS induced autophagy in brain tissue more frequently than a β-h/c-deficient mutant. Elimination of autophagy using Atg5-deficient fibroblasts or siRNA-mediated impairment of autophagy in hBMECs led to increased recovery of intracellular GBS. However, electron microscopy revealed that GBS was rarely found within double membrane autophagic structures even though we observed GBS-LC3 co-localization. These results suggest that although autophagy may act as a BBB cellular defense mechanism in response to invading and toxin-producing bacteria, GBS may actively thwart the autophagic pathway. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cutting</LastName>
<ForeName>Andrew S</ForeName>
<Initials>AS</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Del Rosario</LastName>
<ForeName>Yvette</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mu</LastName>
<ForeName>Rong</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rodriguez</LastName>
<ForeName>Anthony</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Till</LastName>
<ForeName>Andreas</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Biological Sciences and San Diego Center for Systems Biology, University of California, San Diego, La Jolla, California 92093-0322, Stem Cell Pathologies Group, Life and Brain Center, University of Bonn, D-53127 Bonn, Germany, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Subramani</LastName>
<ForeName>Suresh</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Division of Biological Sciences and San Diego Center for Systems Biology, University of California, San Diego, La Jolla, California 92093-0322.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gottlieb</LastName>
<ForeName>Roberta A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>Donald P. Shiley BioScience Center, San Diego State University, San Diego, California 92182.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Doran</LastName>
<ForeName>Kelly S</ForeName>
<Initials>KS</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biology and Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, California 92093 kdoran@mail.sdsu.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>GM069373</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>GM085764</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 NS051247</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01-NS051247</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001427">Bacterial Toxins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008869">Microtubule-Associated Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C466626">light chain 3, human</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Med. 2013 Jun 3;210(6):1265-81</RefSource>
<PMID Version="1">23712433</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2013;9(6):e1003394</RefSource>
<PMID Version="1">23762025</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2013 Aug 1;126(Pt 15):3237-47</RefSource>
<PMID Version="1">23908376</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Immunol. 2013 Oct;13(10):722-37</RefSource>
<PMID Version="1">24064518</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Host Microbe. 2013 Dec 11;14(6):675-82</RefSource>
<PMID Version="1">24331465</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Microbiol. 2014 Feb;12(2):101-14</RefSource>
<PMID Version="1">24384599</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Immunol. 2014 Feb;26:69-75</RefSource>
<PMID Version="1">24556403</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Autophagy. 2014 Mar;10(3):526-8</RefSource>
<PMID Version="1">24413059</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14491-6</RefSource>
<PMID Version="1">15381763</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 2001 Jan;39(2):236-47</RefSource>
<PMID Version="1">11136446</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Microbiol. 2000 Oct;2(5):365-77</RefSource>
<PMID Version="1">11207592</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2001 Feb 19;152(4):657-68</RefSource>
<PMID Version="1">11266458</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2002 Jan 15;185(2):196-203</RefSource>
<PMID Version="1">11807693</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mol Genet. 2002 May 1;11(9):1107-17</RefSource>
<PMID Version="1">11978769</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2003 Sep;112(5):736-44</RefSource>
<PMID Version="1">12952922</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2004 Mar;15(3):1101-11</RefSource>
<PMID Version="1">14699058</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Microbiol. 1977 Aug;6(2):183-4</RefSource>
<PMID Version="1">408376</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 1981 Jan;145(1):479-88</RefSource>
<PMID Version="1">6257640</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fed Proc. 1985 Jul;44(10):2614-5</RefSource>
<PMID Version="1">2989011</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 1985 Aug;152(2):323-9</RefSource>
<PMID Version="1">2993435</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Physiol. 1986;48:241-50</RefSource>
<PMID Version="1">2871806</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 1990 Jul;4(7):1111-7</RefSource>
<PMID Version="1">2122174</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Immun. 1996 Sep;64(9):3818-26</RefSource>
<PMID Version="1">8751934</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>In Vitro Cell Dev Biol Anim. 1997 Apr;33(4):243-7</RefSource>
<PMID Version="1">9156338</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Immun. 1997 Dec;65(12):5074-81</RefSource>
<PMID Version="1">9393798</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1998 Feb 13;273(7):3963-6</RefSource>
<PMID Version="1">9461583</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Struct Funct. 1998 Feb;23(1):33-42</RefSource>
<PMID Version="1">9639028</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2004 Nov 5;306(5698):1037-40</RefSource>
<PMID Version="1">15528445</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2004 Dec 23;432(7020):1032-6</RefSource>
<PMID Version="1">15525940</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2005 Feb 4;307(5710):727-31</RefSource>
<PMID Version="1">15576571</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Immun. 2005 Jul;73(7):4404-9</RefSource>
<PMID Version="1">15972538</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Infect Dis. 2005 Sep 15;41(6):839-47</RefSource>
<PMID Version="1">16107984</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2005 Sep;115(9):2499-507</RefSource>
<PMID Version="1">16138192</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2006 Apr 21;281(16):11374-83</RefSource>
<PMID Version="1">16495224</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2006 Oct 6;281(40):29776-87</RefSource>
<PMID Version="1">16882669</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 2007 Feb;189(4):1464-7</RefSource>
<PMID Version="1">17041051</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1829-34</RefSource>
<PMID Version="1">17267617</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Microbes Infect. 2007 May;9(6):714-20</RefSource>
<PMID Version="1">17400016</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Autophagy. 2007 Sep-Oct;3(5):442-51</RefSource>
<PMID Version="1">17568179</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2007 Aug 17;282(33):24131-45</RefSource>
<PMID Version="1">17580304</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Immunol. 2007 Oct;7(10):767-77</RefSource>
<PMID Version="1">17767194</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2007 Dec 20;450(7173):1253-7</RefSource>
<PMID Version="1">18097414</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Mol Biol. 2008;445:77-88</RefSource>
<PMID Version="1">18425443</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2008 May 5;181(3):497-510</RefSource>
<PMID Version="1">18443221</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 2008 Jun;22(6):1715-24</RefSource>
<PMID Version="1">18198218</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Expert Rev Mol Med. 2008;10:e27</RefSource>
<PMID Version="1">18803886</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Enzymol. 2009;452:13-23</RefSource>
<PMID Version="1">19200873</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Enzymol. 2009;452:181-97</RefSource>
<PMID Version="1">19200883</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Basic Res Cardiol. 2009 Mar;104(2):157-67</RefSource>
<PMID Version="1">19242639</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6226-31</RefSource>
<PMID Version="1">19339495</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2009 May 15;199(10):1479-87</RefSource>
<PMID Version="1">19392623</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Host Microbe. 2009 Aug 20;6(2):137-49</RefSource>
<PMID Version="1">19683680</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Cell Biol. 2009 Oct;11(10):1233-40</RefSource>
<PMID Version="1">19749745</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Top Microbiol Immunol. 2009;335:189-215</RefSource>
<PMID Version="1">19802566</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Immunol. 2009 Nov;10(11):1215-21</RefSource>
<PMID Version="1">19820708</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2009 Nov 1;183(9):5909-16</RefSource>
<PMID Version="1">19812211</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 2009 Dec;191(23):7165-73</RefSource>
<PMID Version="1">19820089</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Autophagy. 2010 Jan;6(1):110-25</RefSource>
<PMID Version="1">20110774</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 2010 Apr 2;584(7):1379-85</RefSource>
<PMID Version="1">20083108</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Med (Berl). 2010 Jun;88(6):633-9</RefSource>
<PMID Version="1">20419283</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2010 Jul 16;285(29):22666-75</RefSource>
<PMID Version="1">20472552</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 2010 Jul;77(2):431-43</RefSource>
<PMID Version="1">20497331</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Med. 2010 Oct 25;207(11):2313-22</RefSource>
<PMID Version="1">20956545</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2011 Jan 20;469(7330):323-35</RefSource>
<PMID Version="1">21248839</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2011;6(3):e17852</RefSource>
<PMID Version="1">21412437</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Microbiol. 2011 Jun;13(6):814-35</RefSource>
<PMID Version="1">21447143</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Immun. 2011 Jul;79(7):2510-8</RefSource>
<PMID Version="1">21518787</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2011 Jun;7(6):e1002082</RefSource>
<PMID Version="1">21731486</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2011 Jul 8;333(6039):228-33</RefSource>
<PMID Version="1">21617041</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2011 Jul 29;286(30):26987-95</RefSource>
<PMID Version="1">21646350</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Microbiol. 2011 Sep;13(9):1319-27</RefSource>
<PMID Version="1">21740500</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Commun. 2011;2:462</RefSource>
<PMID Version="1">21897373</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Cell Dev Biol. 2011;27:107-32</RefSource>
<PMID Version="1">21801009</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2012 Feb 16;482(7385):414-8</RefSource>
<PMID Version="1">22246324</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci Res. 2012 Jun;90(6):1105-18</RefSource>
<PMID Version="1">22344941</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Host Microbe. 2012 Jun 14;11(6):563-75</RefSource>
<PMID Version="1">22704617</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2012;8(10):e1002947</RefSource>
<PMID Version="1">23055927</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Immun. 2013 Jan;81(1):271-7</RefSource>
<PMID Version="1">23115045</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Microbiol. 2013 Mar;15(3):395-402</RefSource>
<PMID Version="1">23121192</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(4):e60160</RefSource>
<PMID Version="1">23593170</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001343">Autophagy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001427">Bacterial Toxins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000096">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001812">Blood-Brain Barrier</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000382">microbiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D042783">Endothelial Cells</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000382">microbiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004730">Endothelium, Vascular</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000382">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054884">Host-Pathogen Interactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008586">Meningitis, Pneumococcal</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008822">Mice, Transgenic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008869">Microtubule-Associated Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021381">Protein Transport</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013292">Streptococcus agalactiae</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276841</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Autophagy</Keyword>
<Keyword MajorTopicYN="N">Bacterial Meningitis</Keyword>
<Keyword MajorTopicYN="N">Bacterial Toxin</Keyword>
<Keyword MajorTopicYN="N">Endothelium</Keyword>
<Keyword MajorTopicYN="N">Host Defense</Keyword>
<Keyword MajorTopicYN="N">Host-Pathogen Interaction</Keyword>
<Keyword MajorTopicYN="N">Infectious Disease</Keyword>
<Keyword MajorTopicYN="N">Molecular Cell Biology</Keyword>
<Keyword MajorTopicYN="N">Streptococcus</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25378387</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Chrysanthemyl diphosphate synthase operates in planta as a bifunctional enzyme with chrysanthemol synthase activity.</ArticleTitle>
<Pagination>
<MedlinePgn>36325-35</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.623348</ELocationID>
<Abstract>
<AbstractText>Chrysanthemyl diphosphate synthase (CDS) is the first pathway-specific enzyme in the biosynthesis of pyrethrins, the most widely used plant-derived pesticide. CDS catalyzes c1'-2-3 cyclopropanation reactions of two molecules of dimethylallyl diphosphate (DMAPP) to yield chrysanthemyl diphosphate (CPP). Three proteins are known to catalyze this cyclopropanation reaction of terpene precursors. Two of them, phytoene and squalene synthase, are bifunctional enzymes with both prenyltransferase and terpene synthase activity. CDS, the other member, has been reported to perform only the prenyltransferase step. Here we show that the NDXXD catalytic motif of CDS, under the lower substrate conditions prevalent in plants, also catalyzes the next step, converting CPP into chrysanthemol by hydrolyzing the diphosphate moiety. The enzymatic hydrolysis reaction followed conventional Michaelis-Menten kinetics, with a Km value for CPP of 196 μm. For the chrysanthemol synthase activity, DMAPP competed with CPP as substrate. The DMAPP concentration required for half-maximal activity to produce chrysanthemol was ∼100 μm, and significant substrate inhibition was observed at elevated DMAPP concentrations. The N-terminal peptide of CDS was identified as a plastid-targeting peptide. Transgenic tobacco plants overexpressing CDS emitted chrysanthemol at a rate of 0.12-0.16 μg h(-1) g(-1) fresh weight. We propose that CDS should be renamed a chrysanthemol synthase utilizing DMAPP as substrate. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Ting</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>From Business Unit PRI-Bioscience, Wageningen UR, P.O. Box 16, 6700 AA Wageningen, The Netherlands, the Laboratory of Entomology, Wageningen UR, P.O. Box 8031, 6700 EH Wageningen, The Netherlands, the Laboratory of Plant Physiology, Wageningen UR, P.O. Box 658, 6700 AR Wageningen, The Netherlands, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gao</LastName>
<ForeName>Liping</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>From Business Unit PRI-Bioscience, Wageningen UR, P.O. Box 16, 6700 AA Wageningen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hu</LastName>
<ForeName>Hao</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>the Key Laboratory for Biology of Horticultural Plants, Ministry of Education, College of Horticulture and Forestry Sciences, Huazhong Agricultural University, Wuhan 430070, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stoopen</LastName>
<ForeName>Geert</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>From Business Unit PRI-Bioscience, Wageningen UR, P.O. Box 16, 6700 AA Wageningen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Caiyun</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>the Key Laboratory for Biology of Horticultural Plants, Ministry of Education, College of Horticulture and Forestry Sciences, Huazhong Agricultural University, Wuhan 430070, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jongsma</LastName>
<ForeName>Maarten A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>From Business Unit PRI-Bioscience, Wageningen UR, P.O. Box 16, 6700 AA Wageningen, The Netherlands, maarten.jongsma@wur.nl.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010940">Plant Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013729">Terpenes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>5617-92-5</RegistryNumber>
<NameOfSubstance UI="C056121">chrysanthemol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.5.-</RegistryNumber>
<NameOfSubstance UI="D019883">Alkyl and Aryl Transferases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Cell. 2004 Apr;16(4):977-92</RefSource>
<PMID Version="1">15031409</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Physiol. 2004 Jan;134(1):510-9</RefSource>
<PMID Version="1">14718674</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Biochem Biophys. 1993 Jul;304(1):133-43</RefSource>
<PMID Version="1">8323279</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2328-32</RefSource>
<PMID Version="1">7892265</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):8041-5</RefSource>
<PMID Version="1">7644535</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1961 Jul 15;191:281-2</RefSource>
<PMID Version="1">13696670</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Cell. 2004 Nov;16(11):3110-31</RefSource>
<PMID Version="1">15522848</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Biochim Pol. 2005;52(1):45-55</RefSource>
<PMID Version="1">15827605</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Phytochemistry. 2005 Jul;66(13):1529-35</RefSource>
<PMID Version="1">15964038</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2005 Jul 12;102(28):9760-5</RefSource>
<PMID Version="1">15983375</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Plant Biol. 2006 Jun;9(3):297-304</RefSource>
<PMID Version="1">16600670</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chem Rev. 2006 Aug;106(8):3412-42</RefSource>
<PMID Version="1">16895335</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Biotechnol. 2006 Nov;24(11):1441-7</RefSource>
<PMID Version="1">17057703</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Phytochemistry. 2007 Jan;68(2):176-88</RefSource>
<PMID Version="1">17140613</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2007 Apr 6;316(5821):73-6</RefSource>
<PMID Version="1">17412950</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Protoc. 2007;2(4):778-91</RefSource>
<PMID Version="1">17446877</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Physiol. 2007 Jun;144(2):1066-78</RefSource>
<PMID Version="1">17468218</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Naturwissenschaften. 2009 Jun;96(6):731-5</RefSource>
<PMID Version="1">19277597</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9914-9</RefSource>
<PMID Version="1">19482937</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Cell. 2009 Dec;21(12):4002-17</RefSource>
<PMID Version="1">20028839</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Cell. 2010 Feb;22(2):454-67</RefSource>
<PMID Version="1">20139160</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant J. 2011 Apr;66(1):212-29</RefSource>
<PMID Version="1">21443633</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Cell Environ. 2011 Jun;34(6):1043-53</RefSource>
<PMID Version="1">21388420</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Metab Eng. 2011 Jul;13(4):414-25</RefSource>
<PMID Version="1">21296182</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant J. 2012 Jul;71(2):183-93</RefSource>
<PMID Version="1">22385412</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Prod Rep. 2012 Oct;29(10):1153-75</RefSource>
<PMID Version="1">22907771</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Cell. 2012 Oct;24(10):4252-65</RefSource>
<PMID Version="1">23104830</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Evol Biol. 2012;12:214</RefSource>
<PMID Version="1">23137178</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13062-7</RefSource>
<PMID Version="1">10557273</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2000 Feb 22;39(7):1748-60</RefSource>
<PMID Version="1">10677224</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4373-8</RefSource>
<PMID Version="1">11287653</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Biochem. 2001 May 15;292(2):272-9</RefSource>
<PMID Version="1">11355861</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Physiol. 2001 Dec;127(4):1466-75</RefSource>
<PMID Version="1">11743090</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Physiol. 2002 May;129(1):134-44</RefSource>
<PMID Version="1">12011345</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Physiol. 2002 Jul;129(3):1276-84</RefSource>
<PMID Version="1">12114581</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2003 Mar 25;42(11):3359-65</RefSource>
<PMID Version="1">12641468</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2003 Aug 22;278(34):32132-40</RefSource>
<PMID Version="1">12782626</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Biochem. 1976 May 7;72:248-54</RefSource>
<PMID Version="1">942051</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019883">Alkyl and Aryl Transferases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053898">Biosynthetic Pathways</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011723">Chrysanthemum cinerariifolium</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000201">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010940">Plant Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D030821">Plants, Genetically Modified</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013729">Terpenes</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014026">Tobacco</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276892</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Biosynthesis</Keyword>
<Keyword MajorTopicYN="N">Enzyme Kinetics</Keyword>
<Keyword MajorTopicYN="N">Mutagenesis</Keyword>
<Keyword MajorTopicYN="N">Plant Biochemistry</Keyword>
<Keyword MajorTopicYN="N">Terpenoid</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25378391</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Modulation of the mevalonate pathway by akt regulates macrophage survival and development of pulmonary fibrosis.</ArticleTitle>
<Pagination>
<MedlinePgn>36204-19</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.593285</ELocationID>
<Abstract>
<AbstractText>Protein kinase B (Akt) is a key effector of multiple cellular processes, including cell survival. Akt, a serine/threonine kinase, is known to increase cell survival by regulation of the intrinsic pathway for apoptosis. In this study, we found that Akt modulated the mevalonate pathway, which is also linked to cell survival, by increasing Rho GTPase activation. Akt modulated the pathway by phosphorylating mevalonate diphosphate decarboxylase (MDD) at Ser(96). This phosphorylation in macrophages increased activation of Rac1, which enhanced macrophage survival because mutation of MDD (MDDS96A) induced apoptosis. Akt-mediated activation in macrophages was specific for Rac1 because Akt did not increase activity of other Rho GTP-binding proteins. The relationship between Akt and Rac1 was biologically relevant because Akt(+/-) mice had significantly less active Rac1 in alveolar macrophages, and macrophages from Akt(+/-) mice had an increase in active caspase-9 and -3. More importantly, Akt(+/-) mice were significantly protected from the development of pulmonary fibrosis, suggesting that macrophage survival is associated with the fibrotic phenotype. These observations for the first time suggest that Akt plays a critical role in the development and progression of pulmonary fibrosis by enhancing macrophage survival via modulation of the mevalonate pathway. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Larson-Casey</LastName>
<ForeName>Jennifer L</ForeName>
<Initials>JL</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Radiation Oncology and Program in Free Radical and Radiation Biology.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Murthy</LastName>
<ForeName>Shubha</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>the Department of Internal Medicine, Carver College of Medicine, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ryan</LastName>
<ForeName>Alan J</ForeName>
<Initials>AJ</Initials>
<AffiliationInfo>
<Affiliation>the Department of Internal Medicine, Carver College of Medicine, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Carter</LastName>
<ForeName>A Brent</ForeName>
<Initials>AB</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Radiation Oncology and Program in Free Radical and Radiation Biology, the Department of Internal Medicine, Carver College of Medicine, and the Department of Human Toxicology, College of Public Health, University of Iowa, Iowa City, Iowa 52242 and the Iowa City Veterans Affairs Health Care System, Iowa City, Iowa 52242 brent-carter@uiowa.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>2R01ES015981-07</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 ES005605</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30CA086862</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32CA078586</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009479">Neuropeptides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C484602">Rac1 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C508961">Tgfb1 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D053773">Transforming Growth Factor beta1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>BBX060AN9V</RegistryNumber>
<NameOfSubstance UI="D006861">Hydrogen Peroxide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="C514862">Akt1 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.6.5.2</RegistryNumber>
<NameOfSubstance UI="D020830">rac1 GTP-Binding Protein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>S5UOB36OCZ</RegistryNumber>
<NameOfSubstance UI="D008798">Mevalonic Acid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2000 Jan 7;275(1):423-8</RefSource>
<PMID Version="1">10617634</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2000 Mar 31;275(13):9106-9</RefSource>
<PMID Version="1">10734042</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2000 Jun 16;275(24):17974-8</RefSource>
<PMID Version="1">10770919</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2000 Nov 17;275(46):36108-15</RefSource>
<PMID Version="1">10945990</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2001 Jun 1;292(5522):1728-31</RefSource>
<PMID Version="1">11387480</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2001 May;7(5):937-47</RefSource>
<PMID Version="1">11389841</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11598-603</RefSource>
<PMID Version="1">11504915</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Cell Biol. 2001 Nov;3(11):973-82</RefSource>
<PMID Version="1">11715018</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8301-5</RefSource>
<PMID Version="1">12048257</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Cell. 2002 Jun;2(6):831-7</RefSource>
<PMID Version="1">12062094</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2002 Oct 3;419(6906):498-511</RefSource>
<PMID Version="1">12368864</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2003 Feb 27;22(8):1124-34</RefSource>
<PMID Version="1">12606940</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Death Differ. 2003 May;10(5):508-15</RefSource>
<PMID Version="1">12728249</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2003 May 16;113(4):457-68</RefSource>
<PMID Version="1">12757707</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2003 Jul 15;171(2):717-25</RefSource>
<PMID Version="1">12847238</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2003 Dec 15;63(24):8922-9</RefSource>
<PMID Version="1">14695209</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2004 Jan 22;23(3):706-15</RefSource>
<PMID Version="1">14737105</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2004 Apr 12;23(16):2934-49</RefSource>
<PMID Version="1">15077155</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Protein Sci. 2004 Jul;13(7):1875-81</RefSource>
<PMID Version="1">15169949</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Med. 2004 Aug 16;200(4):541-7</RefSource>
<PMID Version="1">15314078</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 1990 Feb;85(2):456-61</RefSource>
<PMID Version="1">2105340</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1990 Feb 1;343(6257):425-30</RefSource>
<PMID Version="1">1967820</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1990 Jul 13;62(1):81-8</RefSource>
<PMID Version="1">2194674</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1992 Aug 7;70(3):401-10</RefSource>
<PMID Version="1">1643658</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Biol. 1995 Apr 1;5(4):393-403</RefSource>
<PMID Version="1">7627555</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1996 Nov 15;87(4):619-28</RefSource>
<PMID Version="1">8929531</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1997 May 2;89(3):457-67</RefSource>
<PMID Version="1">9150145</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 1997 May 15;57(10):1846-50</RefSource>
<PMID Version="1">9157972</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1997 Jun 20;276(5320):1848-50</RefSource>
<PMID Version="1">9188528</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 1997 Oct 1;159(7):3565-73</RefSource>
<PMID Version="1">9317156</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1997 Oct 17;91(2):231-41</RefSource>
<PMID Version="1">9346240</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 1998 May 27;279(20):1643-50</RefSource>
<PMID Version="1">9613915</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1998 Nov 13;282(5392):1318-21</RefSource>
<PMID Version="1">9812896</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10182-7</RefSource>
<PMID Version="1">10468583</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2005 Jan;115(1):56-65</RefSource>
<PMID Version="1">15630444</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 2005 Feb;166(2):367-75</RefSource>
<PMID Version="1">15681821</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2005 Jun;7(6):561-73</RefSource>
<PMID Version="1">15950905</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circulation. 2005 Jul 5;112(1):117-24</RefSource>
<PMID Version="1">15998696</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunity. 2005 Oct;23(4):361-74</RefSource>
<PMID Version="1">16226502</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioorg Med Chem. 2006 Jun 15;14(12):4130-6</RefSource>
<PMID Version="1">16517172</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2006 Sep 1;108(5):1635-42</RefSource>
<PMID Version="1">16690965</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Lung Cell Mol Physiol. 2007 Nov;293(5):L1143-55</RefSource>
<PMID Version="1">17704189</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Med. 2008 Jul 7;205(7):1659-72</RefSource>
<PMID Version="1">18541712</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7</RefSource>
<PMID Version="1">18669648</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2008 Sep 1;112(5):1767-75</RefSource>
<PMID Version="1">18579797</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2008 Nov 1;112(9):3563-73</RefSource>
<PMID Version="1">18684863</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Crit Care. 2008;12(4):R103</RefSource>
<PMID Version="1">18691424</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2008 Dec 9;14(6):427-9</RefSource>
<PMID Version="1">19061832</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2008 Dec 9;14(6):458-70</RefSource>
<PMID Version="1">19061837</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2009 Jan 8;113(2):488-97</RefSource>
<PMID Version="1">18805968</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2009 Apr;29(8):2254-63</RefSource>
<PMID Version="1">19204084</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Lung Cell Mol Physiol. 2009 Nov;297(5):L846-55</RefSource>
<PMID Version="1">19684199</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Leukoc Biol. 2010 Jan;87(1):59-67</RefSource>
<PMID Version="1">20052800</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 2010 Feb;176(2):679-86</RefSource>
<PMID Version="1">20042669</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Cell Mol Biol. 2010 Apr;42(4):432-41</RefSource>
<PMID Version="1">19520917</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2010 Aug 6;285(32):25062-73</RefSource>
<PMID Version="1">20529870</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Immunol. 2010 Oct;137(1):89-101</RefSource>
<PMID Version="1">20674506</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Top Microbiol Immunol. 2010;347:105-33</RefSource>
<PMID Version="1">20549472</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2011 Mar 25;286(12):10483-94</RefSource>
<PMID Version="1">21266580</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2011 Apr 14;30(15):1812-21</RefSource>
<PMID Version="1">21242979</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pharmacol Exp Ther. 2011 May;337(2):540-6</RefSource>
<PMID Version="1">21335425</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2011 Apr 29;286(17):15597-607</RefSource>
<PMID Version="1">21393238</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H2169-76</RefSource>
<PMID Version="1">21357506</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Jan 27;287(5):3301-12</RefSource>
<PMID Version="1">22157762</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1778-83</RefSource>
<PMID Version="1">22247288</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9517-22</RefSource>
<PMID Version="1">22647600</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2013 Jan 11;288(2):770-7</RefSource>
<PMID Version="1">23204521</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunity. 2013 Mar 21;38(3):555-69</RefSource>
<PMID Version="1">23477737</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pharmacoepidemiol Drug Saf. 2013 Apr;22(4):345-58</RefSource>
<PMID Version="1">23225700</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2013 Jul 12;288(28):20745-57</RefSource>
<PMID Version="1">23720777</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(9):e74924</RefSource>
<PMID Version="1">24040362</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Cell Mol Biol. 2014 Apr;50(4):825-37</RefSource>
<PMID Version="1">24325577</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 1999 Nov 1;59(21):5492-6</RefSource>
<PMID Version="1">10554025</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 1999 Nov 15;13(22):2905-27</RefSource>
<PMID Version="1">10579998</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2000 Jan;20(1):139-48</RefSource>
<PMID Version="1">10594016</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053898">Biosynthetic Pathways</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016764">Cell Polarity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002470">Cell Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004789">Enzyme Activation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006861">Hydrogen Peroxide</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016676">Macrophages, Alveolar</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008798">Mevalonic Acid</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057507">Mice, 129 Strain</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008822">Mice, Transgenic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008928">Mitochondria</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009479">Neuropeptides</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018384">Oxidative Stress</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010766">Phosphorylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011499">Protein Processing, Post-Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051057">Proto-Oncogene Proteins c-akt</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011658">Pulmonary Fibrosis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000201">enzymology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053773">Transforming Growth Factor beta1</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020830">rac1 GTP-Binding Protein</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276883</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Akt PKB</Keyword>
<Keyword MajorTopicYN="N">Apoptosis</Keyword>
<Keyword MajorTopicYN="N">Fibrosis</Keyword>
<Keyword MajorTopicYN="N">Macrophage</Keyword>
<Keyword MajorTopicYN="N">Oxidative Stress</Keyword>
<Keyword MajorTopicYN="N">Ras-related C3 Botulinum Toxin Substrate 1 (Rac1)</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25378393</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Tumor progression locus 2-dependent oxidative burst drives phosphorylation of extracellular signal-regulated kinase during TLR3 and 9 signaling.</ArticleTitle>
<Pagination>
<MedlinePgn>36089-100</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.587121</ELocationID>
<Abstract>
<AbstractText>Signal transduction via NFκB and MAP kinase cascades is a universal response initiated upon pathogen recognition by Toll-like receptors (TLRs). How activation of these divergent signaling pathways is integrated to dictate distinct immune responses to diverse pathogens is still incompletely understood. Herein, contrary to current perception, we demonstrate that a signaling pathway defined by the inhibitor of κB kinase β (IKKβ), MAP3 kinase tumor progression locus 2 (Tpl2/MAP3K8), and MAP kinase ERK is differentially activated by TLRs. TLRs 2, 4, and 7 directly activate this inflammatory axis, inducing immediate ERK phosphorylation and early TNFα secretion. In addition to TLR adaptor proteins, IKKβ-Tpl2-ERK activation by TLR4 is regulated by the TLR4 co-receptor CD14 and the tyrosine kinase Syk. Signals from TLRs 3 and 9 do not initiate early activation of IKKβ-Tpl2-ERK pathway but instead induce delayed, NADPH-oxidase-dependent ERK phosphorylation and TNFα secretion via autocrine reactive oxygen species signaling. Unexpectedly, Tpl2 is an essential regulator of ROS production during TLR signaling. Overall, our study reveals distinct mechanisms activating a common inflammatory signaling cascade and delineates differences in MyD88-dependent signaling between endosomal TLRs 7 and 9. These findings further confirm the importance of Tpl2 in innate host defense mechanisms and also enhance our understanding of how the immune system tailors pathogen-specific gene expression patterns. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kuriakose</LastName>
<ForeName>Teneema</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Infectious Diseases, The University of Georgia, College of Veterinary Medicine, Athens, Georgia 30602.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rada</LastName>
<ForeName>Balázs</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Infectious Diseases, The University of Georgia, College of Veterinary Medicine, Athens, Georgia 30602.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Watford</LastName>
<ForeName>Wendy T</ForeName>
<Initials>WT</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Infectious Diseases, The University of Georgia, College of Veterinary Medicine, Athens, Georgia 30602 watfordw@uga.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D033942">Adaptor Proteins, Vesicular Transport</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018950">Antigens, CD14</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C556062">IL10 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C507780">Myd88 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D053594">Myeloid Differentiation Factor 88</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C476286">TICAM-1 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C519703">TLR3 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C493487">Tlr4 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C495370">Tlr9 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051196">Toll-Like Receptor 3</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051197">Toll-Like Receptor 4</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051217">Toll-Like Receptor 9</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>130068-27-8</RegistryNumber>
<NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.10.1</RegistryNumber>
<NameOfSubstance UI="D011505">Protein-Tyrosine Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.10.1</RegistryNumber>
<NameOfSubstance UI="C071980">Syk kinase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.10</RegistryNumber>
<NameOfSubstance UI="D051550">I-kappa B Kinase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.24</RegistryNumber>
<NameOfSubstance UI="D048049">Extracellular Signal-Regulated MAP Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.25</RegistryNumber>
<NameOfSubstance UI="D020930">MAP Kinase Kinase Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.25</RegistryNumber>
<NameOfSubstance UI="C489843">Map3k8 protein, mouse</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2008 Jan 15;121(Pt 2):149-54</RefSource>
<PMID Version="1">18187448</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):258-63</RefSource>
<PMID Version="1">18172197</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Immunol. 2008 Dec;9(12):1407-14</RefSource>
<PMID Version="1">18931679</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Med. 2009 Aug 31;206(9):1863-71</RefSource>
<PMID Version="1">19667062</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2009 Dec 15;183(12):7984-93</RefSource>
<PMID Version="1">19933865</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Immunol. 2010 May;11(5):373-84</RefSource>
<PMID Version="1">20404851</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2010;6(6):e1000930</RefSource>
<PMID Version="1">20532218</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2010;6(8):e1001071</RefSource>
<PMID Version="1">20865117</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2010 Nov 19;285(47):36635-44</RefSource>
<PMID Version="1">20855885</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunity. 2011 Jul 22;35(1):69-81</RefSource>
<PMID Version="1">21683627</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2011 Nov 11;147(4):868-80</RefSource>
<PMID Version="1">22078883</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Med. 2012 Feb 13;209(2):379-93</RefSource>
<PMID Version="1">22312110</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Signal. 2012 May;24(5):981-90</RefSource>
<PMID Version="1">22286106</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2012 Sep;32(17):3438-51</RefSource>
<PMID Version="1">22733995</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2012 Nov;32(22):4684-90</RefSource>
<PMID Version="1">22988300</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2013 Jan 4;288(1):442-54</RefSource>
<PMID Version="1">23166319</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Elife. 2013;2:e00291</RefSource>
<PMID Version="1">23426999</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS J. 2013 May;280(9):1944-65</RefSource>
<PMID Version="1">23461806</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2013 Jun 15;190(12):6368-77</RefSource>
<PMID Version="1">23670194</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2013 Aug 15;191(4):1732-43</RefSource>
<PMID Version="1">23842752</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Leukoc Biol. 2013 Oct;94(4):751-7</RefSource>
<PMID Version="1">23898046</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2014 Jan 3;289(1):299-311</RefSource>
<PMID Version="1">24275658</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 1999 Dec 15;18(24):6973-82</RefSource>
<PMID Version="1">10601019</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2000 Oct 15;165(8):4272-80</RefSource>
<PMID Version="1">11035061</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2000 Dec 22;103(7):1071-83</RefSource>
<PMID Version="1">11163183</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2002 Jun 21;277(25):22131-9</RefSource>
<PMID Version="1">11940570</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2002 Sep 16;21(18):4831-40</RefSource>
<PMID Version="1">12234923</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2003 Mar;11(3):685-94</RefSource>
<PMID Version="1">12667451</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2003 Aug 14;424(6950):743-8</RefSource>
<PMID Version="1">12872135</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Immunol. 2004 Oct;5(10):987-95</RefSource>
<PMID Version="1">15454922</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2004 Nov;24(21):9658-67</RefSource>
<PMID Version="1">15485931</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1990 Sep 21;249(4975):1431-3</RefSource>
<PMID Version="1">1698311</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 1993 Jul;67(7):4283-9</RefSource>
<PMID Version="1">8510223</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1993 Oct 25;268(30):22723-32</RefSource>
<PMID Version="1">8226782</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1994 Jul;14(7):4385-92</RefSource>
<PMID Version="1">8027786</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 1998 May 15;160(10):4755-61</RefSource>
<PMID Version="1">9590221</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 1998 Nov 1;161(9):4493-7</RefSource>
<PMID Version="1">9794373</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2350-5</RefSource>
<PMID Version="1">15699325</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2005 May 27;280(21):20442-8</RefSource>
<PMID Version="1">15778223</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Immunol. 2005 Jun;6(6):587-92</RefSource>
<PMID Version="1">15864310</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Immunol. 2005 Jun;6(6):565-70</RefSource>
<PMID Version="1">15895089</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2005 Jun 24;280(25):23748-57</RefSource>
<PMID Version="1">15833743</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2006 Jan 20;281(3):1371-80</RefSource>
<PMID Version="1">16291755</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3274-9</RefSource>
<PMID Version="1">16484370</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunity. 2006 Sep;25(3):417-28</RefSource>
<PMID Version="1">16973389</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62</RefSource>
<PMID Version="1">17183360</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Immunol. 2007 Feb;19(1):24-32</RefSource>
<PMID Version="1">17275323</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunol Cell Biol. 2007 Aug-Sep;85(6):420-4</RefSource>
<PMID Version="1">17637696</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2007 Nov;27(21):7355-64</RefSource>
<PMID Version="1">17709378</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Mol Med. 2007 Nov;13(11):460-9</RefSource>
<PMID Version="1">18029230</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D033942">Adaptor Proteins, Vesicular Transport</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018950">Antigens, CD14</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019898">Autocrine Communication</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D048049">Extracellular Signal-Regulated MAP Kinases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051550">I-kappa B Kinase</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016753">Interleukin-10</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000557">secretion</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D047908">Intracellular Signaling Peptides and Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008070">Lipopolysaccharides</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020930">MAP Kinase Kinase Kinases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020935">MAP Kinase Signaling System</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008264">Macrophages</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000557">secretion</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018345">Mice, Knockout</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053594">Myeloid Differentiation Factor 88</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010766">Phosphorylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D011499">Protein Processing, Post-Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011505">Protein-Tyrosine Kinases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011518">Proto-Oncogene Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017382">Reactive Oxygen Species</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016897">Respiratory Burst</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051196">Toll-Like Receptor 3</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051197">Toll-Like Receptor 4</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051217">Toll-Like Receptor 9</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015533">Transcriptional Activation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014409">Tumor Necrosis Factor-alpha</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000557">secretion</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276873</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Extracellular-signal-regulated Kinase (ERK)</Keyword>
<Keyword MajorTopicYN="N">Mitogen-activated Protein Kinase (MAPK)</Keyword>
<Keyword MajorTopicYN="N">Reactive Oxygen Species (ROS)</Keyword>
<Keyword MajorTopicYN="N">Signal Transduction</Keyword>
<Keyword MajorTopicYN="N">Toll-like Receptor (TLR)</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25378396</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Klotho up-regulates renal calcium channel transient receptor potential vanilloid 5 (TRPV5) by intra- and extracellular N-glycosylation-dependent mechanisms.</ArticleTitle>
<Pagination>
<MedlinePgn>35849-57</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.616649</ELocationID>
<Abstract>
<AbstractText>The anti-aging protein Klotho is a type 1 membrane protein produced predominantly in the distal convoluted tubule. The ectodomain of Klotho is cleaved and secreted into the urine to regulate several ion channels and transporters. Secreted Klotho (sKL) up-regulates the TRPV5 calcium channel from the cell exterior by removing sialic acids from N-glycan of the channel and inhibiting its endocytosis. Because TRPV5 and Klotho coexpress in the distal convoluted tubule, we investigated whether Klotho regulates TRPV5 action from inside the cell. Whole-cell TRPV5-mediated channel activity was recorded in HEK cells coexpressing TRPV5 and sKL or membranous Klotho (mKL). Transfection of sKL, but not mKL, produced detectable Klotho protein in cell culture media. As for sKL, mKL increased TRPV5 current density. The role of sialidase activity of mKL acting inside is supported by findings that mutations of putative sialidase activity sites in sKL and mKL abrogated the regulation of TRPV5 but that the extracellular application of a sialidase inhibitor prevented the regulation of TRPV5 by sKL only. Mechanistically, coexpression with a dominant-negative dynamin II prevented the regulation of TRPV5 by sKL but not by mKL. In contrast, blocking forward trafficking by brefeldin A prevented the effect with mKL but not with sKL. Therefore, Klotho up-regulates TRPV5 from both the inside and outside of cells. The intracellular action of Klotho is likely due to enhanced forward trafficking of channel proteins, whereas the extracellular action is due to inhibition of endocytosis. Both effects involve putative Klotho sialidase activity. These effects of Klotho may play important roles regarding calcium reabsorption in the kidney. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wolf</LastName>
<ForeName>Matthias T F</ForeName>
<Initials>MT</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Pediatrics and matthias.wolf@utsouthwestern.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>An</LastName>
<ForeName>Sung-Wan</ForeName>
<Initials>SW</Initials>
<AffiliationInfo>
<Affiliation>Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nie</LastName>
<ForeName>Mingzhu</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Pediatrics and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bal</LastName>
<ForeName>Manjot S</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Pediatrics and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Chou-Long</ForeName>
<Initials>CL</Initials>
<AffiliationInfo>
<Affiliation>Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 chou-long.huang@utsouthwestern.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K08 DK095994</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K08-DK095994-02</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K12-HD000850</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01-DK85726</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D050916">TRPV Cation Channels</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C492239">TRPV5 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C416507">fibroblast growth factor 23</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>20350-15-6</RegistryNumber>
<NameOfSubstance UI="D020126">Brefeldin A</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>62031-54-3</RegistryNumber>
<NameOfSubstance UI="D005346">Fibroblast Growth Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.2.1.31</RegistryNumber>
<NameOfSubstance UI="D005966">Glucuronidase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.2.1.31</RegistryNumber>
<NameOfSubstance UI="C108871">klotho protein</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Chem Biol. 2000 Oct;4(5):573-80</RefSource>
<PMID Version="1">11006547</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Physiology (Bethesda). 2008 Feb;23:32-40</RefSource>
<PMID Version="1">18268363</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Nutr. 2001 Dec;131(12):3182-8</RefSource>
<PMID Version="1">11739863</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):856-61</RefSource>
<PMID Version="1">11792841</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochim Biophys Acta. 2002 Jul 19;1576(3):341-5</RefSource>
<PMID Version="1">12084582</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Soc Nephrol. 2003 Apr;14(4):1082-95</RefSource>
<PMID Version="1">12660344</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Hum Genet. 2003 May;72(5):1154-61</RefSource>
<PMID Version="1">12669274</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2003 Dec;112(12):1906-14</RefSource>
<PMID Version="1">14679186</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2004 Feb;113(4):561-8</RefSource>
<PMID Version="1">14966565</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bone Miner Res. 2004 Mar;19(3):429-35</RefSource>
<PMID Version="1">15040831</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 2004 May 7;565(1-3):143-7</RefSource>
<PMID Version="1">15135068</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 1992 Mar;116(5):1071-80</RefSource>
<PMID Version="1">1740466</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Res. 1995 Jan;76(1):148-53</RefSource>
<PMID Version="1">8001273</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1997 Nov 6;390(6655):45-51</RefSource>
<PMID Version="1">9363890</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 1998 Jan 26;242(3):626-30</RefSource>
<PMID Version="1">9464267</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 1998 Mar 6;424(1-2):6-10</RefSource>
<PMID Version="1">9537505</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2005 Sep 16;309(5742):1829-33</RefSource>
<PMID Version="1">16123266</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2005 Oct 21;310(5747):490-3</RefSource>
<PMID Version="1">16239475</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2006 Mar 10;281(10):6120-3</RefSource>
<PMID Version="1">16436388</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Soc Nephrol. 2006 May;17(5):1305-15</RefSource>
<PMID Version="1">16597685</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Nephrol Hypertens. 2006 Jul;15(4):437-41</RefSource>
<PMID Version="1">16775459</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2006 Dec 7;444(7120):770-4</RefSource>
<PMID Version="1">17086194</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Soc Nephrol. 2007 Jul;18(7):2116-24</RefSource>
<PMID Version="1">17554146</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Biochem Biophys. 2007;47(3):376-91</RefSource>
<PMID Version="1">17652782</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2007 Aug 10;317(5839):803-6</RefSource>
<PMID Version="1">17690294</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19796-801</RefSource>
<PMID Version="1">18056631</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2008 Feb 15;283(7):4077-86</RefSource>
<PMID Version="1">18077461</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Renal Physiol. 2008 May;294(5):F1212-21</RefSource>
<PMID Version="1">18305097</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9805-10</RefSource>
<PMID Version="1">18606998</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Endocrinol Metab. 2008 Sep;19(7):239-45</RefSource>
<PMID Version="1">18692401</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2008 Nov 27;27(56):7094-105</RefSource>
<PMID Version="1">18762812</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Renal Physiol. 2009 Mar;296(3):F459-69</RefSource>
<PMID Version="1">18971212</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Pharmacol. 2009 Jul;76(1):38-46</RefSource>
<PMID Version="1">19349416</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Traffic. 2009 Oct;10(10):1405-13</RefSource>
<PMID Version="1">19650851</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2010 Jan 7;29(1):26-33</RefSource>
<PMID Version="1">19802015</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Kidney Int. 2010 May;77(10):855-60</RefSource>
<PMID Version="1">20375979</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 2010 Sep;24(9):3438-50</RefSource>
<PMID Version="1">20466874</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2011 Mar 11;286(10):8655-65</RefSource>
<PMID Version="1">21209102</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Glycobiology. 2011 Jul;21(7):853-63</RefSource>
<PMID Version="1">21112967</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2011;6(10):e26560</RefSource>
<PMID Version="1">22028908</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2014 Feb 3;33(3):229-46</RefSource>
<PMID Version="1">24434184</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Renal Physiol. 2001 Dec;281(6):F1021-7</RefSource>
<PMID Version="1">11704552</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020126">Brefeldin A</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002462">Cell Membrane</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004705">Endocytosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005346">Fibroblast Growth Factors</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015870">Gene Expression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005966">Glucuronidase</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006031">Glycosylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057809">HEK293 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D011499">Protein Processing, Post-Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050916">TRPV Cation Channels</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015854">Up-Regulation</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276853</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Biotin</Keyword>
<Keyword MajorTopicYN="N">Calcium Channel</Keyword>
<Keyword MajorTopicYN="N">Electrophysiology</Keyword>
<Keyword MajorTopicYN="N">Glycosylation</Keyword>
<Keyword MajorTopicYN="N">Intracellular Trafficking</Keyword>
<Keyword MajorTopicYN="N">Klotho</Keyword>
<Keyword MajorTopicYN="N">Membrane Trafficking</Keyword>
<Keyword MajorTopicYN="N">N-glycosylation</Keyword>
<Keyword MajorTopicYN="N">Renal Physiology</Keyword>
<Keyword MajorTopicYN="N">TRPV5 Channel</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25378398</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Zymogen activation and subcellular activity of subtilisin kexin isozyme 1/site 1 protease.</ArticleTitle>
<Pagination>
<MedlinePgn>35743-56</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.588525</ELocationID>
<Abstract>
<AbstractText>The proprotein convertase subtilisin kexin isozyme 1 (SKI-1)/site 1 protease (S1P) plays crucial roles in cellular homeostatic functions and is hijacked by pathogenic viruses for the processing of their envelope glycoproteins. Zymogen activation of SKI-1/S1P involves sequential autocatalytic processing of its N-terminal prodomain at sites B'/B followed by the herein newly identified C'/C sites. We found that SKI-1/S1P autoprocessing results in intermediates whose catalytic domain remains associated with prodomain fragments of different lengths. In contrast to other zymogen proprotein convertases, all incompletely matured intermediates of SKI-1/S1P showed full catalytic activity toward cellular substrates, whereas optimal cleavage of viral glycoproteins depended on B'/B processing. Incompletely matured forms of SKI-1/S1P further process cellular and viral substrates in distinct subcellular compartments. Using a cell-based sensor for SKI-1/S1P activity, we found that 9 amino acid residues at the cleavage site (P1-P8) and P1' are necessary and sufficient to define the subcellular location of processing and to determine to what extent processing of a substrate depends on SKI-1/S1P maturation. In sum, our study reveals novel and unexpected features of SKI-1/S1P zymogen activation and subcellular specificity of activity toward cellular and pathogen-derived substrates. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>da Palma</LastName>
<ForeName>Joel Ramos</ForeName>
<Initials>JR</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Microbiology, University Hospital Center and University of Lausanne, 1011 Lausanne, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Burri</LastName>
<ForeName>Dominique Julien</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Microbiology, University Hospital Center and University of Lausanne, 1011 Lausanne, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Oppliger</LastName>
<ForeName>Joël</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Microbiology, University Hospital Center and University of Lausanne, 1011 Lausanne, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Salamina</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>the Department of Biology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cendron</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>the Department of Biology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Laureto</LastName>
<ForeName>Patrizia Polverino</ForeName>
<Initials>PP</Initials>
<AffiliationInfo>
<Affiliation>the Department of Pharmaceutical Sciences, Centro Ricerche Interdipartimentale Biotecnologie Innovative, University of Padua, 35121 Padua, Italy, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Seidah</LastName>
<ForeName>Nabil Georges</ForeName>
<Initials>NG</Initials>
<AffiliationInfo>
<Affiliation>the Laboratory of Biochemical Neuroendocrinology, Clinical Research Institute of Montreal, University of Montreal, Montreal, Quebec H2W 1R7, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kunz</LastName>
<ForeName>Stefan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Microbiology, University Hospital Center and University of Lausanne, 1011 Lausanne, Switzerland, Stefan.Kunz@chuv.ch.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pasquato</LastName>
<ForeName>Antonella</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Microbiology, University Hospital Center and University of Lausanne, 1011 Lausanne, Switzerland, Antonella.Pasquato@chuv.ch.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>93792</GrantID>
<Agency>Canadian Institutes of Health Research</Agency>
<Country>Canada</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004792">Enzyme Precursors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.-</RegistryNumber>
<NameOfSubstance UI="D043484">Proprotein Convertases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.21.-</RegistryNumber>
<NameOfSubstance UI="D012697">Serine Endopeptidases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.21.112</RegistryNumber>
<NameOfSubstance UI="C115575">membrane-bound transcription factor peptidase, site 1</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2006 Aug 18;281(33):23471-81</RefSource>
<PMID Version="1">16790437</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13129-34</RefSource>
<PMID Version="1">16141315</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Med (Berl). 2007 Jul;85(7):685-96</RefSource>
<PMID Version="1">17351764</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2007 Sep 14;282(37):27402-13</RefSource>
<PMID Version="1">17623657</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proteins. 2008 Apr;71(1):261-77</RefSource>
<PMID Version="1">17932912</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2008 Jun;82(12):6045-51</RefSource>
<PMID Version="1">18400865</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Metab Eng. 2008 May-Jul;10(3-4):187-200</RefSource>
<PMID Version="1">18555198</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pharmacol Exp Ther. 2008 Sep;326(3):801-8</RefSource>
<PMID Version="1">18577702</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2011 Jul 1;333(6038):87-90</RefSource>
<PMID Version="1">21719679</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Mol Biol. 2011;768:59-106</RefSource>
<PMID Version="1">21805238</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Glycobiology. 2011 Oct;21(10):1290-300</RefSource>
<PMID Version="1">21527438</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2012 May;86(9):4935-46</RefSource>
<PMID Version="1">22357276</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Drug Discov. 2012 May;11(5):367-83</RefSource>
<PMID Version="1">22679642</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Methods. 2012 Jul;9(7):676-82</RefSource>
<PMID Version="1">22743772</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2013 Jun;87(11):6406-14</RefSource>
<PMID Version="1">23536681</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Cell Biol. 2013 Dec;15(12):1473-85</RefSource>
<PMID Version="1">24185178</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2000 Jan 28;275(4):2349-58</RefSource>
<PMID Version="1">10644685</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2000 Dec;6(6):1355-64</RefSource>
<PMID Version="1">11163209</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2001 Apr 20;276(16):12660-6</RefSource>
<PMID Version="1">11152678</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12701-5</RefSource>
<PMID Version="1">11606739</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2002 Mar 29;277(13):11265-75</RefSource>
<PMID Version="1">11756446</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Genet Dev. 2002 Oct;12(5):512-8</RefSource>
<PMID Version="1">12200155</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Essays Biochem. 2002;38:79-94</RefSource>
<PMID Version="1">12463163</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2003 Mar;77(5):2866-72</RefSource>
<PMID Version="1">12584310</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2003 Aug;77(16):8640-9</RefSource>
<PMID Version="1">12885882</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Virology. 2003 Sep 15;314(1):168-78</RefSource>
<PMID Version="1">14517070</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2004 Apr 23;279(17):17338-47</RefSource>
<PMID Version="1">14970232</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Virology. 1988 May;164(1):30-8</RefSource>
<PMID Version="1">2452517</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 1991 Jun;5(6):1507-10</RefSource>
<PMID Version="1">1686294</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8235-9</RefSource>
<PMID Version="1">1325651</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 1997 Apr 1;16(7):1508-18</RefSource>
<PMID Version="1">9130696</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1997 May 2;89(3):331-40</RefSource>
<PMID Version="1">9150132</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1998 Mar 6;273(10):5785-93</RefSource>
<PMID Version="1">9488713</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1998 Oct 23;273(43):28261-9</RefSource>
<PMID Version="1">9774448</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 1998 Oct;2(4):505-14</RefSource>
<PMID Version="1">9809072</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1999 Aug 6;274(32):22795-804</RefSource>
<PMID Version="1">10428864</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochim Biophys Acta. 2005 May 20;1749(1):15-22</RefSource>
<PMID Version="1">15848132</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Structure. 2007 May;15(5):545-52</RefSource>
<PMID Version="1">17502100</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016466">CHO Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003412">Cricetulus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004789">Enzyme Activation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004792">Enzyme Precursors</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007113">Immunity, Innate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D043484">Proprotein Convertases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017510">Protein Folding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011499">Protein Processing, Post-Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017434">Protein Structure, Tertiary</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021381">Protein Transport</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059748">Proteolysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012697">Serine Endopeptidases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014759">Viral Envelope Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276844</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bioluminescence</Keyword>
<Keyword MajorTopicYN="N">Biosensor</Keyword>
<Keyword MajorTopicYN="N">Enzyme Mechanism</Keyword>
<Keyword MajorTopicYN="N">Enzyme Processing</Keyword>
<Keyword MajorTopicYN="N">Serine Protease</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25378400</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Aha1 can act as an autonomous chaperone to prevent aggregation of stressed proteins.</ArticleTitle>
<Pagination>
<MedlinePgn>36220-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.590141</ELocationID>
<Abstract>
<AbstractText>Aha1 (activator of Hsp90 ATPase) stimulates the ATPase activity of the molecular chaperone Hsp90 to accelerate the conformational cycle during which client proteins attain their final shape. Thereby, Aha1 promotes effective folding of Hsp90-dependent clients such as steroid receptors and many kinases involved in cellular signaling. In our current study, we find that Aha1 plays a novel, additional role beyond regulating the Hsp90 ATP hydrolysis rate. We propose a new concept suggesting that Aha1 acts as an autonomous chaperone and associates with stress-denatured proteins to prevent them from aggregation similar to the chaperonin GroEL. Our study reveals that an N-terminal sequence of 22 amino acids, present in human but absent from yeast Aha1, is critical for this capability. However, in lieu of fostering their refolding, Aha1 allows ubiquitination of bound clients by the E3 ubiquitin ligase CHIP. Accordingly, Aha1 may promote disposal of folding defective proteins by the cellular protein quality control. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tripathi</LastName>
<ForeName>Vishwadeepak</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Cardiovascular Physiology, Ruhr-University Bochum, 44801 Bochum, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Darnauer</LastName>
<ForeName>Stefanie</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Cardiovascular Physiology, Ruhr-University Bochum, 44801 Bochum, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hartwig</LastName>
<ForeName>Nadine R</ForeName>
<Initials>NR</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Cardiovascular Physiology, Ruhr-University Bochum, 44801 Bochum, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Obermann</LastName>
<ForeName>Wolfgang M J</ForeName>
<Initials>WM</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Cardiovascular Physiology, Ruhr-University Bochum, 44801 Bochum, Germany Wolfgang.Obermann@rub.de.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C515652">AHSA1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018841">HSP90 Heat-Shock Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018832">Molecular Chaperones</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.13.12.7</RegistryNumber>
<NameOfSubstance UI="D049409">Luciferases, Firefly</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.8.1.1</RegistryNumber>
<NameOfSubstance UI="D013884">Thiosulfate Sulfurtransferase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Cell Biol. 2001 Jan;3(1):93-6</RefSource>
<PMID Version="1">11146632</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2014;9(3):e89436</RefSource>
<PMID Version="1">24614167</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2002 Dec;10(6):1307-18</RefSource>
<PMID Version="1">12504007</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2003 May 9;278(19):17228-35</RefSource>
<PMID Version="1">12604615</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2003 Jul 15;22(14):3613-23</RefSource>
<PMID Version="1">12853476</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2004 Feb 11;23(3):511-9</RefSource>
<PMID Version="1">14739935</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1991 Jul 4;352(6330):36-42</RefSource>
<PMID Version="1">1676490</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 1992 Dec;11(13):4767-78</RefSource>
<PMID Version="1">1361170</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 1993 Mar 16;32(10):2717-24</RefSource>
<PMID Version="1">8383523</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 1993 Sep 27;331(1-2):25-30</RefSource>
<PMID Version="1">8104824</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1996 Aug 9;271(32):19617-24</RefSource>
<PMID Version="1">8702658</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 1996 Aug 23;261(3):328-33</RefSource>
<PMID Version="1">8780775</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 1997 Jan 15;16(2):211-20</RefSource>
<PMID Version="1">9029142</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 1998 Aug 17;17(16):4829-36</RefSource>
<PMID Version="1">9707442</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 1998 Nov 16;143(4):901-10</RefSource>
<PMID Version="1">9817749</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 2005 May 1;387(Pt 3):789-96</RefSource>
<PMID Version="1">15584899</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Biochem. 2006;75:271-94</RefSource>
<PMID Version="1">16756493</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2006 Nov;26(22):8385-95</RefSource>
<PMID Version="1">16982694</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2006 Nov 17;127(4):803-15</RefSource>
<PMID Version="1">17110338</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2007 Aug 3;282(31):22267-77</RefSource>
<PMID Version="1">17545168</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2008 Feb 15;68(4):1188-97</RefSource>
<PMID Version="1">18281495</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2008 Mar 1;121(Pt 5):717-23</RefSource>
<PMID Version="1">18270269</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 2008 Mar 15;410(3):439-53</RefSource>
<PMID Version="1">18290764</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2008 Jun 27;283(26):17757-65</RefSource>
<PMID Version="1">18400751</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2010 Feb 12;37(3):344-54</RefSource>
<PMID Version="1">20159554</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2010 Mar 15;21(6):871-84</RefSource>
<PMID Version="1">20089831</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Mol Cell Biol. 2010 Jul;11(7):515-28</RefSource>
<PMID Version="1">20531426</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2012 Aug 10;47(3):434-43</RefSource>
<PMID Version="1">22727666</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Struct Mol Biol. 2013 Mar;20(3):326-31</RefSource>
<PMID Version="1">23396352</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biomed J. 2013 May-Jun;36(3):106-17</RefSource>
<PMID Version="1">23806880</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(8):e71856</RefSource>
<PMID Version="1">23951259</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2014 Jan 23;53(2):317-29</RefSource>
<PMID Version="1">24462205</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2002 Jun 7;277(23):20151-9</RefSource>
<PMID Version="1">11916974</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057809">HEK293 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018841">HSP90 Heat-Shock Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049409">Luciferases, Firefly</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008253">Macaca mulatta</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018832">Molecular Chaperones</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D066263">Protein Aggregation, Pathological</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058849">Protein Refolding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059748">Proteolysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013884">Thiosulfate Sulfurtransferase</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054875">Ubiquitination</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276884</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">ATPase</Keyword>
<Keyword MajorTopicYN="N">Activator of Hsp90 ATPase (Aha1)</Keyword>
<Keyword MajorTopicYN="N">Heat Shock Protein 90 (Hsp90)</Keyword>
<Keyword MajorTopicYN="N">Molecular Chaperone</Keyword>
<Keyword MajorTopicYN="N">Protein Aggregation</Keyword>
<Keyword MajorTopicYN="N">Protein Folding</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25378401</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>NGX6a is degraded through a proteasome-dependent pathway without ubiquitination mediated by ezrin, a cytoskeleton-membrane linker.</ArticleTitle>
<Pagination>
<MedlinePgn>35731-42</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.584771</ELocationID>
<Abstract>
<AbstractText>Our previous study demonstrated that the NGX6b gene acts as a suppressor in the invasion and migration of nasopharyngeal carcinoma (NPC). Recently, we identified the novel isoform NGX6a, which is longer than NGX6b. In this study, we first found that NGX6a was degraded in NPC cells and that this degradation was mediated by ezrin, a linker between membrane proteins and the cytoskeleton. Specific siRNAs against ezrin increase the protein level of NGX6a in these cells. During degradation, NGX6a is not ubiquitinated but is degraded through a proteasome-dependent pathway. The distribution pattern of ezrin was negatively associated with NGX6a in an immunochemistry analysis of a nasopharyngeal carcinoma tissue microarray and fetus multiple organ tissues and Western blot analysis in nasopharyngeal and NPC cell lines, suggesting that ezrin and NGX6a are associated and are involved in the progression and invasion of NPC. By mapping the interacting binding sites, the seven-transmembrane domain of NGX6a was found to be the critical region for the degradation of NGX6a, and the amino terminus of ezrin is required for the induction of NGX6a degradation. The knockdown of ezrin or transfection of the NGX6a mutant CO, which has an EGF-like domain and a transmembrane 1 domain, resulted in no degradation, significantly reducing the ability of invasion and migration of NPC cells. This study provides a novel molecular mechanism for the low expression of NGX6a in NPC cells and an important molecular event in the process of invasion and metastasis of nasopharyngeal carcinoma cells. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Li</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>the Cancer Research Institute, Central South University, Changsha, Hunan 410078, China, the Department of Cardio-Thoracic Surgery, Second Xiangya Hospital of Central South University, 139 Renmin Middle Road, Changsha, Hunan 410012, China, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Xiaoling</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>the Cancer Research Institute, Central South University, Changsha, Hunan 410078, China, From the Hunan Provincial Tumor Hospital and the Affiliated Tumor Hospital of Xiangya School of Medicine, Central South University, 582 Xianjiahu Road, Changsha, Hunan 410013, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Xiang</LastName>
<ForeName>Bo</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>the Cancer Research Institute, Central South University, Changsha, Hunan 410078, China, From the Hunan Provincial Tumor Hospital and the Affiliated Tumor Hospital of Xiangya School of Medicine, Central South University, 582 Xianjiahu Road, Changsha, Hunan 410013, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhou</LastName>
<ForeName>Ming</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>the Cancer Research Institute, Central South University, Changsha, Hunan 410078, China, From the Hunan Provincial Tumor Hospital and the Affiliated Tumor Hospital of Xiangya School of Medicine, Central South University, 582 Xianjiahu Road, Changsha, Hunan 410013, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Xiayu</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>the Third Xiang-Ya Hospital, Central South University, Changsha, Hunan 410013, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Xiong</LastName>
<ForeName>Wei</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>the Cancer Research Institute, Central South University, Changsha, Hunan 410078, China, From the Hunan Provincial Tumor Hospital and the Affiliated Tumor Hospital of Xiangya School of Medicine, Central South University, 582 Xianjiahu Road, Changsha, Hunan 410013, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Niu</LastName>
<ForeName>Man</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>the Cancer Research Institute, Central South University, Changsha, Hunan 410078, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wei</LastName>
<ForeName>Pingpin</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>the Cancer Research Institute, Central South University, Changsha, Hunan 410078, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Zeyou</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>the Cancer Research Institute, Central South University, Changsha, Hunan 410078, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Heran</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>the Cancer Research Institute, Central South University, Changsha, Hunan 410078, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Pan</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>From the Hunan Provincial Tumor Hospital and the Affiliated Tumor Hospital of Xiangya School of Medicine, Central South University, 582 Xianjiahu Road, Changsha, Hunan 410013, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shen</LastName>
<ForeName>Shourong</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>the Third Xiang-Ya Hospital, Central South University, Changsha, Hunan 410013, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peng</LastName>
<ForeName>Shuping</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>the Cancer Research Institute, Central South University, Changsha, Hunan 410078, China, From the Hunan Provincial Tumor Hospital and the Affiliated Tumor Hospital of Xiangya School of Medicine, Central South University, 582 Xianjiahu Road, Changsha, Hunan 410013, China, shuping@csu.edu.cn.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Guiyuan</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>the Cancer Research Institute, Central South University, Changsha, Hunan 410078, China, From the Hunan Provincial Tumor Hospital and the Affiliated Tumor Hospital of Xiangya School of Medicine, Central South University, 582 Xianjiahu Road, Changsha, Hunan 410013, China, lgy@csu.edu.cn.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003598">Cytoskeletal Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D020033">Protein Isoforms</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C477325">TMEM8B protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D025521">Tumor Suppressor Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C047877">ezrin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.25.1</RegistryNumber>
<NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C538339">Nasopharyngeal carcinoma</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2004 Feb;10(2):182-6</RefSource>
<PMID Version="1">14704791</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2004 Feb;10(2):175-81</RefSource>
<PMID Version="1">14704789</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1995 May 12;270(19):11623-7</RefSource>
<PMID Version="1">7744802</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1996 Mar 22;271(12):7224-9</RefSource>
<PMID Version="1">8636161</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 1997 Dec;110 ( Pt 24):3011-8</RefSource>
<PMID Version="1">9365271</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 1998 Feb 23;140(4):885-95</RefSource>
<PMID Version="1">9472040</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Carcinogenesis. 2005 Feb;26(2):281-91</RefSource>
<PMID Version="1">15498789</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biochem. 2005 May 1;95(1):64-73</RefSource>
<PMID Version="1">15723283</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Breast Cancer Res. 2005;7(3):R365-73</RefSource>
<PMID Version="1">15987432</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ai Zheng. 2005 Sep;24(9):1064-70</RefSource>
<PMID Version="1">16159426</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Sci. 2007 Mar;98(3):341-9</RefSource>
<PMID Version="1">17270023</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncology. 2006;71(3-4):273-81</RefSource>
<PMID Version="1">17641538</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Biochim Biophys Sin (Shanghai). 2009 Jun;41(6):504-14</RefSource>
<PMID Version="1">19499154</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biochem. 2009 Oct;330(1-2):71-81</RefSource>
<PMID Version="1">19353243</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Histochem Cytochem. 2010 Jan;58(1):41-51</RefSource>
<PMID Version="1">19755717</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Biochim Biophys Sin (Shanghai). 2010 Jul;42(7):450-6</RefSource>
<PMID Version="1">20705583</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biochem. 2010 Dec;345(1-2):283-90</RefSource>
<PMID Version="1">20859756</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2011 Apr;22(7):954-63</RefSource>
<PMID Version="1">21289089</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 2012 Dec;181(6):2172-87</RefSource>
<PMID Version="1">23031255</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncol Rep. 2013 Oct;30(4):1899-905</RefSource>
<PMID Version="1">23900701</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Biochem Biophys. 2013;67(3):1507-11</RefSource>
<PMID Version="1">23712870</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Cancer. 2013;13:520</RefSource>
<PMID Version="1">24182314</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Cancer. 2014 Feb 4;110(3):695-705</RefSource>
<PMID Version="1">24346284</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2014 May 1;33(18):2363-74</RefSource>
<PMID Version="1">23752190</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Commun. 2014;5:4234</RefSource>
<PMID Version="1">24953629</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Cycle. 2014;13(14):2200-10</RefSource>
<PMID Version="1">24844324</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Cell Biol. 2000 Apr;12(2):229-34</RefSource>
<PMID Version="1">10712924</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2001 Jun 1;20(11):2723-41</RefSource>
<PMID Version="1">11387207</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Protein Chem. 2001 Apr;20(3):265-71</RefSource>
<PMID Version="1">11565907</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Lett. 2002 May 8;179(1):79-86</RefSource>
<PMID Version="1">11880185</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res Mol Brain Res. 2002 Sep 30;105(1-2):47-59</RefSource>
<PMID Version="1">12399107</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cancer Res Clin Oncol. 2002 Dec;128(12):683-90</RefSource>
<PMID Version="1">12474055</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>World J Gastroenterol. 2003 Aug;9(8):1729-33</RefSource>
<PMID Version="1">12918109</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Enzymol. 1986;134:24-37</RefSource>
<PMID Version="1">3821564</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D045744">Cell Line, Tumor</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003598">Cytoskeletal Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003599">Cytoskeleton</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008565">Membrane Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009303">Nasopharyngeal Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D046988">Proteasome Endopeptidase Complex</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054730">Protein Interaction Domains and Motifs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020033">Protein Isoforms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059748">Proteolysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D025521">Tumor Suppressor Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054875">Ubiquitination</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276843</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Biodegradation</Keyword>
<Keyword MajorTopicYN="N">Cancer</Keyword>
<Keyword MajorTopicYN="N">Degradation</Keyword>
<Keyword MajorTopicYN="N">Ezrin</Keyword>
<Keyword MajorTopicYN="N">Metastasis</Keyword>
<Keyword MajorTopicYN="N">NGX6a</Keyword>
<Keyword MajorTopicYN="N">Nasopharyngeal Carcinoma</Keyword>
<Keyword MajorTopicYN="N">Ubiquitylation (Ubiquitination)</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25378403</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Metabolic control of Ca2+/calmodulin-dependent protein kinase II (CaMKII)-mediated caspase-2 suppression by the B55β/protein phosphatase 2A (PP2A).</ArticleTitle>
<Pagination>
<MedlinePgn>35882-90</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.585844</ELocationID>
<Abstract>
<AbstractText>High levels of metabolic activity confer resistance to apoptosis. Caspase-2, an apoptotic initiator, can be suppressed by high levels of nutrient flux through the pentose phosphate pathway. This metabolic control is exerted via inhibitory phosphorylation of the caspase-2 prodomain by activated Ca(2+)/calmodulin-dependent protein kinase II (CaMKII). We show here that this activation of CaMKII depends, in part, on dephosphorylation of CaMKII at novel sites (Thr(393)/Ser(395)) and that this is mediated by metabolic activation of protein phosphatase 2A in complex with the B55β targeting subunit. This represents a novel locus of CaMKII control and also provides a mechanism contributing to metabolic control of apoptosis. These findings may have implications for metabolic control of the many CaMKII-controlled and protein phosphatase 2A-regulated physiological processes, because both enzymes appear to be responsive to alterations in glucose metabolized via the pentose phosphate pathway. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Bofu</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Pharmacology and Cancer Biology.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Chih-Sheng</ForeName>
<Initials>CS</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Pharmacology and Cancer Biology.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wojton</LastName>
<ForeName>Jeffrey</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Pharmacology and Cancer Biology.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Nai-Jia</ForeName>
<Initials>NJ</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Pharmacology and Cancer Biology.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Chen</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Pharmacology and Cancer Biology.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Soderblom</LastName>
<ForeName>Erik J</ForeName>
<Initials>EJ</Initials>
<AffiliationInfo>
<Affiliation>the Proteomics and Metabolomics Core Facility, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Liguo</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>the Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27705 liguo.zhang@duke.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kornbluth</LastName>
<ForeName>Sally</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Pharmacology and Cancer Biology, sally.kornbluth@duke.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 GM080333</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D029867">Xenopus Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>56-73-5</RegistryNumber>
<NameOfSubstance UI="D019298">Glucose-6-Phosphate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.17</RegistryNumber>
<NameOfSubstance UI="D054732">Calcium-Calmodulin-Dependent Protein Kinase Type 2</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.3.16</RegistryNumber>
<NameOfSubstance UI="D054648">Protein Phosphatase 2</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.22.-</RegistryNumber>
<NameOfSubstance UI="D053143">Caspase 2</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Cell Physiol. 2000 Mar;278(3):C537-45</RefSource>
<PMID Version="1">10712242</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2013 Nov 7;52(3):325-39</RefSource>
<PMID Version="1">24095281</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2002 Apr 19;277(16):13430-7</RefSource>
<PMID Version="1">11832478</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2002 Aug 16;277(33):29803-9</RefSource>
<PMID Version="1">12065594</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2002 Aug 23;297(5585):1352-4</RefSource>
<PMID Version="1">12193789</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1985 Dec;5(12):3414-22</RefSource>
<PMID Version="1">3001244</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1988 Dec 5;263(34):18145-51</RefSource>
<PMID Version="1">2848027</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1989 Mar 25;264(9):4800-4</RefSource>
<PMID Version="1">2538462</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1990 Jul 5;265(19):11204-12</RefSource>
<PMID Version="1">2162838</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 1991 Nov;11(11):5767-80</RefSource>
<PMID Version="1">1656238</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Cell Biol. 1991;35:449-68</RefSource>
<PMID Version="1">1664032</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1992 May 22;256(5060):1199-202</RefSource>
<PMID Version="1">1317063</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1992 Jul 10;257(5067):201-6</RefSource>
<PMID Version="1">1378648</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1992 Aug 25;267(24):17216-24</RefSource>
<PMID Version="1">1324926</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 1993 Apr 23;609(1-2):1-8</RefSource>
<PMID Version="1">8389645</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 1994 May;12(5):943-56</RefSource>
<PMID Version="1">8185953</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 1994 Nov 1;8(21):2527-39</RefSource>
<PMID Version="1">7958915</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurochem. 1998 Jan;70(1):96-104</RefSource>
<PMID Version="1">9422351</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1998 Nov 20;273(47):31555-64</RefSource>
<PMID Version="1">9813071</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Res. 2005 Sep 16;97(6):541-9</RefSource>
<PMID Version="1">16109919</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2005 Oct 7;123(1):89-103</RefSource>
<PMID Version="1">16213215</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Cell Biol. 2006 Jan;8(1):72-7</RefSource>
<PMID Version="1">16362053</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2006 May;17(5):2150-7</RefSource>
<PMID Version="1">16495337</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Cell Res. 2006 Jul 15;312(12):2347-57</RefSource>
<PMID Version="1">16701639</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2006 Nov 17;127(4):759-73</RefSource>
<PMID Version="1">17110335</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5336-41</RefSource>
<PMID Version="1">19279217</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Cell. 2009 Jun;16(6):856-66</RefSource>
<PMID Version="1">19531356</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2011 Sep 2;43(5):834-42</RefSource>
<PMID Version="1">21884983</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2013 Mar 29;288(13):8838-48</RefSource>
<PMID Version="1">23400775</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Death Differ. 2013 Sep;20(9):1174-82</RefSource>
<PMID Version="1">23645210</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2000 May 12;275(19):14354-9</RefSource>
<PMID Version="1">10799516</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054732">Calcium-Calmodulin-Dependent Protein Kinase Type 2</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053143">Caspase 2</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004789">Enzyme Activation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019298">Glucose-6-Phosphate</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057809">HEK293 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010766">Phosphorylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054648">Protein Phosphatase 2</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011499">Protein Processing, Post-Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D029867">Xenopus Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014982">Xenopus laevis</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276857</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII)</Keyword>
<Keyword MajorTopicYN="N">Caspase 2</Keyword>
<Keyword MajorTopicYN="N">Metabolism</Keyword>
<Keyword MajorTopicYN="N">Mutagenesis</Keyword>
<Keyword MajorTopicYN="N">Phosphatase</Keyword>
<Keyword MajorTopicYN="N">Phosphorylation</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25378405</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Sestrin2 protein positively regulates AKT enzyme signaling and survival in human squamous cell carcinoma and melanoma cells.</ArticleTitle>
<Pagination>
<MedlinePgn>35806-14</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.595397</ELocationID>
<Abstract>
<AbstractText>Skin cancer is the most common cancer in the United States and is mainly caused by environmental UV radiation. Reducing skin cancer incidence is becoming an urgent issue. The stress-inducible protein Sestrin2 (Sesn2) plays an important role in maintaining redox and metabolic homeostasis and their related pathologies. However, the role of Sesn2 in cancer remains unclear. Here we show that UVB radiation induces Sesn2 expression in normal human keratinocytes, mouse skin, normal human melanocytes, and melanoma cells. In addition, Sesn2 promotes AKT activation through a PTEN-dependent mechanism. Sesn2 deletion or knockdown sensitizes squamous cell carcinoma (SCC) cells to 5-fluorouracil-induced apoptosis and melanoma cells to UVB- and vemurafenib-induced apoptosis. In mice Sesn2 knockdown suppresses tumor growth from injected human SCC and melanoma cells. Last, as compared with normal skin, Sesn2 is up-regulated in both human skin SCC and melanoma. Our findings demonstrate that Sesn2 promotes AKT activation and survival in response to UVB stress and chemotherapeutics and suggest that Sesn2 is oncogenic in skin SCC and melanoma. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zhao</LastName>
<ForeName>Baozhong</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Section of Dermatology, University of Chicago, Chicago, Illinois 60637.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shah</LastName>
<ForeName>Palak</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Section of Dermatology, University of Chicago, Chicago, Illinois 60637.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Budanov</LastName>
<ForeName>Andrei V</ForeName>
<Initials>AV</Initials>
<AffiliationInfo>
<Affiliation>Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, Virginia 23298.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Qiang</LastName>
<ForeName>Lei</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Section of Dermatology, University of Chicago, Chicago, Illinois 60637.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ming</LastName>
<ForeName>Mei</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Section of Dermatology, University of Chicago, Chicago, Illinois 60637.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aplin</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, and Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sims</LastName>
<ForeName>Diane M</ForeName>
<Initials>DM</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Section of Dermatology, University of Chicago, Chicago, Illinois 60637.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>He</LastName>
<ForeName>Yu-Ying</ForeName>
<Initials>YY</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Section of Dermatology, University of Chicago, Chicago, Illinois 60637, yyhe@medicine.bsd.uchicago.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>CA172660</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>ES016936</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>GM067983</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 CA014599</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 CA014599</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA172660</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 ES016936</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1 TR000430</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1 TR000430</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C465398">SESN2 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2005 Dec;11(12):1306-13</RefSource>
<PMID Version="1">16286925</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Cancer. 1999 Mar;79(9-10):1468-74</RefSource>
<PMID Version="1">10188892</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2008 Aug 8;134(3):451-60</RefSource>
<PMID Version="1">18692468</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Lett. 2009 Jun 28;279(1):13-21</RefSource>
<PMID Version="1">19232461</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pathol. 2010 Mar;220(4):446-51</RefSource>
<PMID Version="1">19967722</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2010 Mar 5;327(5970):1223-8</RefSource>
<PMID Version="1">20203043</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Dermatol. 2010 Mar;146(3):283-7</RefSource>
<PMID Version="1">20231499</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2010 Apr 9;285(15):11369-77</RefSource>
<PMID Version="1">20154081</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2010;5(8):e12059</RefSource>
<PMID Version="1">20706594</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2010 Aug 15;70(16):6670-81</RefSource>
<PMID Version="1">20647317</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO Mol Med. 2010 Oct;2(10):388-400</RefSource>
<PMID Version="1">20878915</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22623-8</RefSource>
<PMID Version="1">21149730</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1433-8</RefSource>
<PMID Version="1">21205897</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Cancer. 2010 Dec 15;127(12):2790-803</RefSource>
<PMID Version="1">21351258</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2011 Jul 7;475(7354):106-9</RefSource>
<PMID Version="1">21734707</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2011 Aug 1;71(15):5287-95</RefSource>
<PMID Version="1">21771908</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Signal. 2011 Oct;23(10):1515-27</RefSource>
<PMID Version="1">21620960</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antioxid Redox Signal. 2011 Sep 15;15(6):1679-90</RefSource>
<PMID Version="1">20712410</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(2):e32035</RefSource>
<PMID Version="1">22363791</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 May 25;287(22):18788-95</RefSource>
<PMID Version="1">22500024</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 2012 Jun 1;26(11):1131-55</RefSource>
<PMID Version="1">22661227</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2012 Jun 8;149(6):1269-83</RefSource>
<PMID Version="1">22682249</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2012 Jul 5;31(27):3265-76</RefSource>
<PMID Version="1">22081070</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Metab. 2012 Sep 5;16(3):311-21</RefSource>
<PMID Version="1">22958918</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Metab. 2013 Jan 8;17(1):73-84</RefSource>
<PMID Version="1">23274085</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2013 Jan 18;288(3):1603-11</RefSource>
<PMID Version="1">23212914</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Gerontol. 2013 Mar;48(3):371-9</RefSource>
<PMID Version="1">23318476</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Death Differ. 2013 Apr;20(4):611-9</RefSource>
<PMID Version="1">23238567</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2013 May 23;32(21):2682-9</RefSource>
<PMID Version="1">22751115</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Mol Sci. 2013;14(6):12222-48</RefSource>
<PMID Version="1">23749111</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Cell. 2013 Jun 10;25(5):463-77</RefSource>
<PMID Version="1">23726973</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Metab. 2013 Dec 3;18(6):792-801</RefSource>
<PMID Version="1">24055102</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Invest Dermatol. 2014 Feb;134(2):553-6</RefSource>
<PMID Version="1">23938463</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2014 Feb 14;289(7):4083-94</RefSource>
<PMID Version="1">24366874</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Autophagy. 2014 Oct 1;10(10):1864-5</RefSource>
<PMID Version="1">25126736</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2002 Sep 5;21(39):6017-31</RefSource>
<PMID Version="1">12203114</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2004 Apr 23;304(5670):596-600</RefSource>
<PMID Version="1">15105503</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Carcinogenesis. 1993 May;14(5):833-9</RefSource>
<PMID Version="1">8504475</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Chromosomes Cancer. 1996 Aug;16(4):211-29</RefSource>
<PMID Version="1">8875235</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 1999 Jan 7;18(1):127-37</RefSource>
<PMID Version="1">9926927</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2006 Jan 13;124(1):207-19</RefSource>
<PMID Version="1">16413492</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000970">Antineoplastic Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017209">Apoptosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002294">Carcinoma, Squamous Cell</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002470">Cell Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006367">HeLa Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008546">Melanoma, Experimental</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008819">Mice, Nude</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009368">Neoplasm Transplantation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009687">Nuclear Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051057">Proto-Oncogene Proteins c-akt</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015398">Signal Transduction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012878">Skin Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D047368">Tumor Burden</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015854">Up-Regulation</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276849</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Akt PKB</Keyword>
<Keyword MajorTopicYN="N">Apoptosis</Keyword>
<Keyword MajorTopicYN="N">Cancer</Keyword>
<Keyword MajorTopicYN="N">Cancer Biology</Keyword>
<Keyword MajorTopicYN="N">Tumor</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25378408</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>The human antimicrobial peptide LL-37 binds directly to CsrS, a sensor histidine kinase of group A Streptococcus, to activate expression of virulence factors.</ArticleTitle>
<Pagination>
<MedlinePgn>36315-24</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.605394</ELocationID>
<Abstract>
<AbstractText>Group A Streptococcus (GAS) responds to subinhibitory concentrations of LL-37 by up-regulation of virulence factors through the CsrRS (CovRS) two-component system. The signaling mechanism, however, is unclear. To determine whether LL-37 signaling reflects specific binding to CsrS or rather a nonspecific response to LL-37-mediated membrane damage, we tested LL-37 fragments for CsrRS signaling and for GAS antimicrobial activity. We identified a 10-residue fragment (RI-10) of LL-37 as the minimal peptide that retains the ability to signal increased expression of GAS virulence factors, yet it has no detectable antimicrobial activity against GAS. Substitution of individual key amino acids in RI-10 reduced or abrogated signaling. These data do not support the hypothesis that CsrS detects LL-37-induced damage to the bacterial cell membrane but rather suggest that LL-37 signaling is mediated by a direct interaction with CsrS. To test whether LL-37 binds to CsrS, we used the purified CsrS extracellular domain to pull down LL-37 in vitro, a result that provides further evidence that LL-37 binds to CsrS. The dissociation of CsrS-mediated signaling from membrane damage by LL-37 fragments together with in vitro evidence for a direct LL-37-CsrS binding interaction constitute compelling evidence that signal transduction by LL-37 through CsrS reflects a direct ligand/receptor interaction. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Velarde</LastName>
<ForeName>Jorge J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>From the Division of Infectious Diseases, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ashbaugh</LastName>
<ForeName>Melissa</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From the Division of Infectious Diseases, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wessels</LastName>
<ForeName>Michael R</ForeName>
<Initials>MR</Initials>
<AffiliationInfo>
<Affiliation>From the Division of Infectious Diseases, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115 Michael.Wessels@childrens.harvard.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>AI29952</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K12 HD000850</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K12-HD000850</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054804">Cathelicidins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D037521">Virulence Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C106170">cathelicidin antimicrobial peptide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.-</RegistryNumber>
<NameOfSubstance UI="D011494">Protein Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.-</RegistryNumber>
<NameOfSubstance UI="C432144">CsrS protein, bacteria</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Leukoc Biol. 2005 Apr;77(4):451-9</RefSource>
<PMID Version="1">15569695</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 1998 Oct;30(1):209-19</RefSource>
<PMID Version="1">9786197</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Korean Med Sci. 2005 Aug;20(4):649-54</RefSource>
<PMID Version="1">16100459</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antimicrob Agents Chemother. 2005 Sep;49(9):3883-8</RefSource>
<PMID Version="1">16127066</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Chem Soc. 2006 May 3;128(17):5776-85</RefSource>
<PMID Version="1">16637646</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochim Biophys Acta. 2006 Sep;1758(9):1408-25</RefSource>
<PMID Version="1">16716248</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 2007 Apr;64(1):34-41</RefSource>
<PMID Version="1">17376070</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 2007 Aug;65(3):671-83</RefSource>
<PMID Version="1">17608796</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2008 May 20;47(20):5565-72</RefSource>
<PMID Version="1">18439024</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Immun. 2008 Aug;76(8):3399-404</RefSource>
<PMID Version="1">18490458</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16755-60</RefSource>
<PMID Version="1">18936485</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2008 Nov 21;283(47):32637-43</RefSource>
<PMID Version="1">18818205</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Immun. 2009 Aug;77(8):3141-9</RefSource>
<PMID Version="1">19451242</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antimicrob Agents Chemother. 2009 Sep;53(9):3705-14</RefSource>
<PMID Version="1">19581460</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Prod Rep. 2009 Dec;26(12):1572-84</RefSource>
<PMID Version="1">19936387</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2010 Apr;6(4):e1000832</RefSource>
<PMID Version="1">20368967</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Innate Immun. 2009;1(3):202-14</RefSource>
<PMID Version="1">20375578</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biomol NMR. 2010 Nov;48(3):147-55</RefSource>
<PMID Version="1">20844927</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Microbiol. 2011 Oct;9(10):724-36</RefSource>
<PMID Version="1">21921933</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2011 Oct;7(10):e1002361</RefSource>
<PMID Version="1">22046138</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Oral Biol. 2012 Jun;57(6):642-6</RefSource>
<PMID Version="1">22153317</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 2012 Aug;194(16):4355-65</RefSource>
<PMID Version="1">22685286</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>MBio. 2012;3(5). pii: e00394-12. doi: 10.1128/mBio.00394-12</RefSource>
<PMID Version="1">23093388</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Nov 30;287(49):40891-7</RefSource>
<PMID Version="1">23038245</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Immunol. 2012 Nov;280(1):22-35</RefSource>
<PMID Version="1">23246832</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(4):e61655</RefSource>
<PMID Version="1">23637876</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2013;9(6):e1003394</RefSource>
<PMID Version="1">23762025</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Peptides. 2013 Nov;49:131-7</RefSource>
<PMID Version="1">24071034</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Immun. 2000 Jun;68(6):3516-22</RefSource>
<PMID Version="1">10816506</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Biochem. 2000;69:183-215</RefSource>
<PMID Version="1">10966457</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2001 Apr 1;183(7):1043-54</RefSource>
<PMID Version="1">11237829</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2001 Nov 22;414(6862):454-7</RefSource>
<PMID Version="1">11719807</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Protein Eng. 2002 Mar;15(3):225-32</RefSource>
<PMID Version="1">11932493</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 2002 Oct;46(1):157-68</RefSource>
<PMID Version="1">12366839</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13855-60</RefSource>
<PMID Version="1">12370433</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4227-32</RefSource>
<PMID Version="1">12646707</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2003 May 9;278(19):16561-6</RefSource>
<PMID Version="1">12621031</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Immun. 2004 Feb;72(2):623-8</RefSource>
<PMID Version="1">14742501</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 1996 Nov 1;98(9):1954-8</RefSource>
<PMID Version="1">8903312</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Microbiol. 2005 Apr;8(2):122-6</RefSource>
<PMID Version="1">15802241</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000900">Anti-Bacterial Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001426">Bacterial Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054804">Cathelicidins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015964">Gene Expression Regulation, Bacterial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008826">Microbial Sensitivity Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011494">Protein Kinases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013297">Streptococcus pyogenes</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000201">enzymology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015533">Transcriptional Activation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015854">Up-Regulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D037521">Virulence Factors</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000096">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276891</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Antimicrobial Peptide (AMP)</Keyword>
<Keyword MajorTopicYN="N">Cell Surface Receptor</Keyword>
<Keyword MajorTopicYN="N">Histidine Kinase</Keyword>
<Keyword MajorTopicYN="N">Host-Pathogen Interaction</Keyword>
<Keyword MajorTopicYN="N">Streptococcus pyogenes (S. pyogenes)</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25378410</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Structural dynamics as a contributor to error-prone replication by an RNA-dependent RNA polymerase.</ArticleTitle>
<Pagination>
<MedlinePgn>36229-48</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.616193</ELocationID>
<Abstract>
<AbstractText>RNA viruses encoding high- or low-fidelity RNA-dependent RNA polymerases (RdRp) are attenuated. The ability to predict residues of the RdRp required for faithful incorporation of nucleotides represents an essential step in any pipeline intended to exploit perturbed fidelity as the basis for rational design of vaccine candidates. We used x-ray crystallography, molecular dynamics simulations, NMR spectroscopy, and pre-steady-state kinetics to compare a mutator (H273R) RdRp from poliovirus to the wild-type (WT) enzyme. We show that the nucleotide-binding site toggles between the nucleotide binding-occluded and nucleotide binding-competent states. The conformational dynamics between these states were enhanced by binding to primed template RNA. For the WT, the occluded conformation was favored; for H273R, the competent conformation was favored. The resonance for Met-187 in our NMR spectra reported on the ability of the enzyme to check the correctness of the bound nucleotide. Kinetic experiments were consistent with the conformational dynamics contributing to the established pre-incorporation conformational change and fidelity checkpoint. For H273R, residues comprising the active site spent more time in the catalytically competent conformation and were more positively correlated than the WT. We propose that by linking the equilibrium between the binding-occluded and binding-competent conformations of the nucleotide-binding pocket and other active-site dynamics to the correctness of the bound nucleotide, faithful nucleotide incorporation is achieved. These studies underscore the need to apply multiple biophysical and biochemical approaches to the elucidation of the physical basis for polymerase fidelity. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Moustafa</LastName>
<ForeName>Ibrahim M</ForeName>
<Initials>IM</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry and Molecular Biology.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Korboukh</LastName>
<ForeName>Victoria K</ForeName>
<Initials>VK</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry and Molecular Biology.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arnold</LastName>
<ForeName>Jamie J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry and Molecular Biology.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Smidansky</LastName>
<ForeName>Eric D</ForeName>
<Initials>ED</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry and Molecular Biology.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marcotte</LastName>
<ForeName>Laura L</ForeName>
<Initials>LL</Initials>
<AffiliationInfo>
<Affiliation>the Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gohara</LastName>
<ForeName>David W</ForeName>
<Initials>DW</Initials>
<AffiliationInfo>
<Affiliation>the Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Xiaorong</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>the Department of Chemistry.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sánchez-Farrán</LastName>
<ForeName>María Antonieta</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>the Department of Chemical Engineering, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Filman</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>the Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maranas</LastName>
<ForeName>Janna K</ForeName>
<Initials>JK</Initials>
<AffiliationInfo>
<Affiliation>the Department of Chemical Engineering, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Boehr</LastName>
<ForeName>David D</ForeName>
<Initials>DD</Initials>
<AffiliationInfo>
<Affiliation>the Department of Chemistry.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hogle</LastName>
<ForeName>James M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>the Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Colina</LastName>
<ForeName>Coray M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo>
<Affiliation>the Department of Materials Science and Engineering, The Pennsylvania State University, University Park, Pennsylvania 16802 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cameron</LastName>
<ForeName>Craig E</ForeName>
<Initials>CE</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry and Molecular Biology, cec9@psu.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>PDB</DataBankName>
<AccessionNumberList>
<AccessionNumber>4R0E</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 AI020566</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AI045818</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AI104878</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009711">Nucleotides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.7.48</RegistryNumber>
<NameOfSubstance UI="D012324">RNA Replicase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2014 Oct 24;289(43):29531-44</RefSource>
<PMID Version="1">25213864</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Comput Biol. 2012;8(12):e1002851</RefSource>
<PMID Version="1">23300428</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2000 Dec;6(12):1375-9</RefSource>
<PMID Version="1">11100123</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7289-94</RefSource>
<PMID Version="1">12754380</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2004 May 11;43(18):5126-37</RefSource>
<PMID Version="1">15122878</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2004 May 11;43(18):5138-48</RefSource>
<PMID Version="1">15122879</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2004 May 11;43(18):5149-58</RefSource>
<PMID Version="1">15122880</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comput Chem. 2004 Oct;25(13):1605-12</RefSource>
<PMID Version="1">15264254</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2004 Sep 1;23(17):3462-71</RefSource>
<PMID Version="1">15306852</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proteins. 1991;11(3):205-17</RefSource>
<PMID Version="1">1749773</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proteins. 1993 Dec;17(4):412-25</RefSource>
<PMID Version="1">8108382</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Protein Expr Purif. 1999 Oct;17(1):128-38</RefSource>
<PMID Version="1">10497078</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32</RefSource>
<PMID Version="1">15572765</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Virus Res. 2005 Feb;107(2):173-81</RefSource>
<PMID Version="1">15649563</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2005 Apr 5;44(13):5177-87</RefSource>
<PMID Version="1">15794655</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 2005 Apr;61(Pt 4):458-64</RefSource>
<PMID Version="1">15805601</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2005 Jul 8;280(27):25706-16</RefSource>
<PMID Version="1">15878882</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comput Chem. 2005 Dec;26(16):1668-88</RefSource>
<PMID Version="1">16200636</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Rev Med Virol. 2006 Jan-Feb;16(1):37-48</RefSource>
<PMID Version="1">16287208</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2006 Jan 19;439(7074):344-8</RefSource>
<PMID Version="1">16327776</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proteins. 2006 Nov 15;65(3):712-25</RefSource>
<PMID Version="1">16981200</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2007 Feb;81(4):2012-24</RefSource>
<PMID Version="1">17151116</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2007 Mar;81(6):2930-9</RefSource>
<PMID Version="1">17202214</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2007 Apr;81(7):3583-96</RefSource>
<PMID Version="1">17251299</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biophys J. 2007 Jun 1;92(11):3817-29</RefSource>
<PMID Version="1">17351000</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2007 Dec 6;450(7171):838-44</RefSource>
<PMID Version="1">18026086</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2007 Dec 6;450(7171):913-6</RefSource>
<PMID Version="1">18026087</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2008 Feb;14(2):154-61</RefSource>
<PMID Version="1">18246077</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2008 Dec;82(24):12346-55</RefSource>
<PMID Version="1">18829745</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Struct Mol Biol. 2009 Feb;16(2):212-8</RefSource>
<PMID Version="1">19151724</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Struct Biol. 2009 Dec;19(6):768-74</RefSource>
<PMID Version="1">19910183</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochim Biophys Acta. 2010 May;1804(5):1041-8</RefSource>
<PMID Version="1">20079883</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501</RefSource>
<PMID Version="1">20383002</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7734-9</RefSource>
<PMID Version="1">20385846</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2010 May;6(5):e1000896</RefSource>
<PMID Version="1">20463816</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2010 Nov 2;49(43):9361-71</RefSource>
<PMID Version="1">20860410</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22505-10</RefSource>
<PMID Version="1">21148772</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Struct Biol. 2011 Feb;21(1):62-7</RefSource>
<PMID Version="1">21109422</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67</RefSource>
<PMID Version="1">21460454</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2011 Jun 7;50(22):5016-32</RefSource>
<PMID Version="1">21548588</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2011 Jul 1;410(1):159-81</RefSource>
<PMID Version="1">21575642</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):E2294-303</RefSource>
<PMID Version="1">22853955</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Structure. 2012 Sep 5;20(9):1519-27</RefSource>
<PMID Version="1">22819218</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Sep 14;287(38):31618-22</RefSource>
<PMID Version="1">22854962</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2012 Dec;18(12):1820-6</RefSource>
<PMID Version="1">23142821</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Phys Chem B. 2012 Dec 20;116(50):14515-24</RefSource>
<PMID Version="1">23157550</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2013 Jul 10;425(13):2279-87</RefSource>
<PMID Version="1">23542342</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2013 Aug;9(8):e1003565</RefSource>
<PMID Version="1">23966862</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2013 Nov 8;288(45):32753-65</RefSource>
<PMID Version="1">24085299</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2013;9(12):e1003760</RefSource>
<PMID Version="1">24348241</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2014 Apr 3;426(7):1407-19</RefSource>
<PMID Version="1">24424421</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Angew Chem Int Ed Engl. 2014 Sep 15;53(38):9992-10005</RefSource>
<PMID Version="1">25066036</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020134">Catalytic Domain</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018360">Crystallography, X-Ray</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007700">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056004">Molecular Dynamics Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009154">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020125">Mutation, Missense</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009711">Nucleotides</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017955">Poliovirus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000201">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017433">Protein Structure, Secondary</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012324">RNA Replicase</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012367">RNA, Viral</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014764">Viral Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276885</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Lethal Mutagenesis</Keyword>
<Keyword MajorTopicYN="N">Plus-stranded RNA Virus</Keyword>
<Keyword MajorTopicYN="N">Poliovirus</Keyword>
<Keyword MajorTopicYN="N">Polymerase Fidelity</Keyword>
<Keyword MajorTopicYN="N">Population Genetics</Keyword>
<Keyword MajorTopicYN="N">RNA Polymerase</Keyword>
<Keyword MajorTopicYN="N">RNA Virus</Keyword>
<Keyword MajorTopicYN="N">Viral Replication</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25381250</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Adaptor protein GRB2 promotes Src tyrosine kinase activation and podosomal organization by protein-tyrosine phosphatase ϵ in osteoclasts.</ArticleTitle>
<Pagination>
<MedlinePgn>36048-58</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.603548</ELocationID>
<Abstract>
<AbstractText>The non-receptor isoform of protein-tyrosine phosphatase ϵ (cyt-PTPe) supports adhesion of bone-resorbing osteoclasts by activating Src downstream of integrins. Loss of cyt-PTPe reduces Src activity in osteoclasts, reduces resorption of mineralized matrix both in vivo and in cell culture, and induces mild osteopetrosis in young female PTPe KO mice. Activation of Src by cyt-PTPe is dependent upon this phosphatase undergoing phosphorylation at its C-terminal Tyr-638 by partially active Src. To understand how cyt-PTPe activates Src, we screened 73 Src homology 2 (SH2) domains for binding to Tyr(P)-638 of cyt-PTPe. The SH2 domain of GRB2 bound Tyr(P)-638 of cyt-PTPe most prominently, whereas the Src SH2 domain did not bind at all, suggesting that GRB2 may link PTPe with downstream molecules. Further studies indicated that GRB2 is required for activation of Src by cyt-PTPe in osteoclast-like cells (OCLs) in culture. Overexpression of GRB2 in OCLs increased activating phosphorylation of Src at Tyr-416 and of cyt-PTPe at Tyr-638; opposite results were obtained when GRB2 expression was reduced by shRNA or by gene inactivation. Phosphorylation of cyt-PTPe at Tyr-683 and its association with GRB2 are integrin-driven processes in OCLs, and cyt-PTPe undergoes autodephosphorylation at Tyr-683, thus limiting Src activation by integrins. Reduced GRB2 expression also reduced the ability of bone marrow precursors to differentiate into OCLs and reduced the fraction of OCLs in which podosomal adhesion structures assume organization typical of active, resorbing cells. We conclude that GRB2 physically links cyt-PTPe with Src and enables cyt-PTPe to activate Src downstream of activated integrins in OCLs. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Levy-Apter</LastName>
<ForeName>Einat</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Molecular Genetics, The Weizmann Institute of Science, Rehovot 76100, Israel.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Finkelshtein</LastName>
<ForeName>Eynat</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Molecular Genetics, The Weizmann Institute of Science, Rehovot 76100, Israel.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vemulapalli</LastName>
<ForeName>Vidyasiri</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Department of Epigenetics and Molecular Carcinogenesis, The University of Texas M. D. Anderson Cancer Center, Smithville, Texas 78957, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Shawn S-C</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry and the Siebens-Drake Medical Research Institute, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario N6A 5C1, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bedford</LastName>
<ForeName>Mark T</ForeName>
<Initials>MT</Initials>
<AffiliationInfo>
<Affiliation>Department of Epigenetics and Molecular Carcinogenesis, The University of Texas M. D. Anderson Cancer Center, Smithville, Texas 78957, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Elson</LastName>
<ForeName>Ari</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Molecular Genetics, The Weizmann Institute of Science, Rehovot 76100, Israel, ari.elson@weizmann.ac.il.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015815">Cell Adhesion Molecules</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051380">GRB2 Adaptor Protein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C495949">Grb2 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.10.2</RegistryNumber>
<NameOfSubstance UI="D019061">src-Family Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.3.48</RegistryNumber>
<NameOfSubstance UI="C098067">Ptpre protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.3.48</RegistryNumber>
<NameOfSubstance UI="D054630">Receptor-Like Protein Tyrosine Phosphatases, Class 4</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2000 Mar 1;19(5):964-78</RefSource>
<PMID Version="1">10698938</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Adh Migr. 2014;8(3):191-204</RefSource>
<PMID Version="1">24714644</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2001 Nov 1;20(21):6037-49</RefSource>
<PMID Version="1">11689444</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2002 Apr 15;157(2):265-75</RefSource>
<PMID Version="1">11940607</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 2002 Nov 1;367(Pt 3):697-702</RefSource>
<PMID Version="1">12137563</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2003 May 2;278(18):15579-86</RefSource>
<PMID Version="1">12598528</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2003 May 15;423(6937):337-42</RefSource>
<PMID Version="1">12748652</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13298-302</RefSource>
<PMID Version="1">14593208</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2004 Jan;15(1):234-44</RefSource>
<PMID Version="1">14528021</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biotechniques. 1988 Jul-Aug;6(7):632-8</RefSource>
<PMID Version="1">3273409</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1992 Mar 26;356(6367):340-4</RefSource>
<PMID Version="1">1372395</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1992 Aug 7;70(3):431-42</RefSource>
<PMID Version="1">1322798</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1994 Jul 22;269(29):18731-4</RefSource>
<PMID Version="1">7518443</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 1994 Jul 1;13(13):3020-32</RefSource>
<PMID Version="1">7518772</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1995 Nov 3;270(44):26116-22</RefSource>
<PMID Version="1">7592814</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 1996 Jun 17;15(12):3016-27</RefSource>
<PMID Version="1">8670803</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1996 Nov 8;271(45):28086-96</RefSource>
<PMID Version="1">8910422</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 1999 Sep 9;18(36):5024-31</RefSource>
<PMID Version="1">10490839</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Cell Biol. 2006 Apr;85(3-4):203-11</RefSource>
<PMID Version="1">16360241</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Rev Endocr Metab Disord. 2006 Jun;7(1-2):123-39</RefSource>
<PMID Version="1">16951988</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 2007 Feb;170(2):427-35</RefSource>
<PMID Version="1">17255310</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Protoc. 2006;1(1):241-5</RefSource>
<PMID Version="1">17406239</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2007 Sep 7;130(5):811-23</RefSource>
<PMID Version="1">17803905</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2007 Oct;27(20):7102-12</RefSource>
<PMID Version="1">17709387</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2007 Oct 25;26(49):7028-37</RefSource>
<PMID Version="1">17486066</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2008 Jan;19(1):394-404</RefSource>
<PMID Version="1">17978100</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Proteomics. 2008 Apr;7(4):768-84</RefSource>
<PMID Version="1">17956856</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2009 Oct;20(20):4324-34</RefSource>
<PMID Version="1">19692574</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Metab. 2011 May 4;13(5):562-72</RefSource>
<PMID Version="1">21531338</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann N Y Acad Sci. 2011 Dec;1240:14-7</RefSource>
<PMID Version="1">22172034</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2012 Jun 22;149(7):1514-24</RefSource>
<PMID Version="1">22726438</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2012 Sep;32(18):3776-89</RefSource>
<PMID Version="1">22801373</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(11):e50996</RefSource>
<PMID Version="1">23226445</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2014 Feb;34(3):348-61</RefSource>
<PMID Version="1">24248601</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2014 Jun;25(11):1808-18</RefSource>
<PMID Version="1">24694598</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2000 Aug 1;19(15):4036-45</RefSource>
<PMID Version="1">10921884</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002448">Cell Adhesion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015815">Cell Adhesion Molecules</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002454">Cell Differentiation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051380">GRB2 Adaptor Protein</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057809">HEK293 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057507">Mice, 129 Strain</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018345">Mice, Knockout</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010010">Osteoclasts</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000201">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010766">Phosphorylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054730">Protein Interaction Domains and Motifs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011499">Protein Processing, Post-Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054630">Receptor-Like Protein Tyrosine Phosphatases, Class 4</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019061">src-Family Kinases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276870</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cell Adhesion</Keyword>
<Keyword MajorTopicYN="N">Cell Signaling</Keyword>
<Keyword MajorTopicYN="N">Growth Factor Receptor-bound Protein 2 (GRB2)</Keyword>
<Keyword MajorTopicYN="N">Osteoclast</Keyword>
<Keyword MajorTopicYN="N">Podosome</Keyword>
<Keyword MajorTopicYN="N">Protein Phosphorylation</Keyword>
<Keyword MajorTopicYN="N">Src</Keyword>
<Keyword MajorTopicYN="N">Src Homology 2 Domain (SH2 Domain)</Keyword>
<Keyword MajorTopicYN="N">Tyrosine Protein Phosphatase (Tyrosine Phosphatase)</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25381252</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>The hepatitis C virus core protein inhibits adipose triglyceride lipase (ATGL)-mediated lipid mobilization and enhances the ATGL interaction with comparative gene identification 58 (CGI-58) and lipid droplets.</ArticleTitle>
<Pagination>
<MedlinePgn>35770-80</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.587816</ELocationID>
<Abstract>
<AbstractText>Liver steatosis is a common health problem associated with hepatitis C virus (HCV) and an important risk factor for the development of liver fibrosis and cancer. Steatosis is caused by triglycerides (TG) accumulating in lipid droplets (LDs), cellular organelles composed of neutral lipids surrounded by a monolayer of phospholipids. The HCV nucleocapsid core localizes to the surface of LDs and induces steatosis in cultured cells and mouse livers by decreasing intracellular TG degradation (lipolysis). Here we report that core at the surface of LDs interferes with the activity of adipose triglyceride lipase (ATGL), the key lipolytic enzyme in the first step of TG breakdown. Expressing core in livers or mouse embryonic fibroblasts of ATGL(-/-) mice no longer decreases TG degradation as observed in LDs from wild-type mice, supporting the model that core reduces lipolysis by engaging ATGL. Core must localize at LDs to inhibit lipolysis, as ex vivo TG hydrolysis is impaired in purified LDs coated with core but not when free core is added to LDs. Coimmunoprecipitation experiments revealed that core does not directly interact with the ATGL complex but, unexpectedly, increased the interaction between ATGL and its activator CGI-58 as well as the recruitment of both proteins to LDs. These data link the anti-lipolytic activity of the HCV core protein with altered ATGL binding to CGI-58 and the enhanced association of both proteins with LDs. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Camus</LastName>
<ForeName>Gregory</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>From the Gladstone Institute of Virology and Immunology, San Francisco, California 94158.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schweiger</LastName>
<ForeName>Martina</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From the Gladstone Institute of Virology and Immunology, San Francisco, California 94158, Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Herker</LastName>
<ForeName>Eva</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>From the Gladstone Institute of Virology and Immunology, San Francisco, California 94158, UCSF Liver Center, University of California, San Francisco, California 94158, Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology, 20251 Hamburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Harris</LastName>
<ForeName>Charles</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>UCSF Liver Center, University of California, San Francisco, California 94158, Gladstone Institute of Cardiovascular Disease, San Francisco, California 94158, Department of Medicine, University of California, San Francisco, California 94158, Division of Endocrinology Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, Missouri 63110.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kondratowicz</LastName>
<ForeName>Andrew S</ForeName>
<Initials>AS</Initials>
<AffiliationInfo>
<Affiliation>From the Gladstone Institute of Virology and Immunology, San Francisco, California 94158.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tsou</LastName>
<ForeName>Chia-Lin</ForeName>
<Initials>CL</Initials>
<AffiliationInfo>
<Affiliation>From the Gladstone Institute of Virology and Immunology, San Francisco, California 94158.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Farese</LastName>
<ForeName>Robert V</ForeName>
<Initials>RV</Initials>
<Suffix>Jr</Suffix>
<AffiliationInfo>
<Affiliation>UCSF Liver Center, University of California, San Francisco, California 94158, Gladstone Institute of Cardiovascular Disease, San Francisco, California 94158, Department of Medicine, University of California, San Francisco, California 94158, Department of Biochemistry and Biophysics, University of California, San Francisco, California 94158, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Herath</LastName>
<ForeName>Kithsiri</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Merck Research Laboratories, Merck and Co., Inc., Kenilworth, New Jersey 07065.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Previs</LastName>
<ForeName>Stephen F</ForeName>
<Initials>SF</Initials>
<AffiliationInfo>
<Affiliation>Merck Research Laboratories, Merck and Co., Inc., Kenilworth, New Jersey 07065.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Roddy</LastName>
<ForeName>Thomas P</ForeName>
<Initials>TP</Initials>
<AffiliationInfo>
<Affiliation>Merck Research Laboratories, Merck and Co., Inc., Kenilworth, New Jersey 07065.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pinto</LastName>
<ForeName>Shirly</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Merck Research Laboratories, Merck and Co., Inc., Kenilworth, New Jersey 07065.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zechner</LastName>
<ForeName>Rudolf</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ott</LastName>
<ForeName>Melanie</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From the Gladstone Institute of Virology and Immunology, San Francisco, California 94158, UCSF Liver Center, University of California, San Francisco, California 94158, Department of Medicine, University of California, San Francisco, California 94158, mott@gladstone.ucsf.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>AI069090</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>AI097552</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 DK026743</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 DK026743</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AI097552</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014280">Triglycerides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014758">Viral Core Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C069130">nucleocapsid protein, Hepatitis C virus</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.3.1.51</RegistryNumber>
<NameOfSubstance UI="D051103">1-Acylglycerol-3-Phosphate O-Acyltransferase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.3.1.51</RegistryNumber>
<NameOfSubstance UI="C492986">Abhd5 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.1.1</RegistryNumber>
<NameOfSubstance UI="C494445">desnutrin protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.1.3</RegistryNumber>
<NameOfSubstance UI="D008049">Lipase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2000 Dec 8;275(49):38486-93</RefSource>
<PMID Version="1">10948207</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2014 Apr 25;289(17):12029-39</RefSource>
<PMID Version="1">24627478</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 2002 Feb;16(2):185-94</RefSource>
<PMID Version="1">11818366</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2002 Apr;35(4):937-46</RefSource>
<PMID Version="1">11915042</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2002 Aug 1;21(15):3980-8</RefSource>
<PMID Version="1">12145199</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2004 Oct 1;279(40):42062-71</RefSource>
<PMID Version="1">15292255</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2004 Oct 29;279(44):45495-502</RefSource>
<PMID Version="1">15322075</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1990 Nov 5;265(31):18769-75</RefSource>
<PMID Version="1">2172232</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1991 Jun 15;266(17):11341-6</RefSource>
<PMID Version="1">2040638</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8537-41</RefSource>
<PMID Version="1">1528859</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dig Dis Sci. 2005 Jul;50(7):1361-71</RefSource>
<PMID Version="1">16047488</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Metab. 2005 May;1(5):323-30</RefSource>
<PMID Version="1">16054079</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO Rep. 2006 Jan;7(1):106-13</RefSource>
<PMID Version="1">16239926</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2006 May 5;312(5774):734-7</RefSource>
<PMID Version="1">16675698</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biochem. 2006 May;139(5):921-30</RefSource>
<PMID Version="1">16751600</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2006 Dec 8;281(49):38022-37</RefSource>
<PMID Version="1">17032652</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1661-6</RefSource>
<PMID Version="1">17234812</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2007 Apr 20;355(4):883-8</RefSource>
<PMID Version="1">17331464</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Cell Biol. 2007 Sep;9(9):1089-97</RefSource>
<PMID Version="1">17721513</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Lipid Res. 2007 Dec;48(12):2751-61</RefSource>
<PMID Version="1">17872589</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2008 Feb;118(2):683-94</RefSource>
<PMID Version="1">18188449</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2008 Jun 20;283(25):17211-20</RefSource>
<PMID Version="1">18445597</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Traffic. 2008 Aug;9(8):1268-82</RefSource>
<PMID Version="1">18489704</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Genet. 2008 Dec;40(12):1461-5</RefSource>
<PMID Version="1">18820647</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Biol. 2008 Nov 25;6(11):e292</RefSource>
<PMID Version="1">19067489</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2009 Mar 6;284(10):6101-8</RefSource>
<PMID Version="1">19114707</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2009 Jun 1;122(Pt 11):1834-41</RefSource>
<PMID Version="1">19461073</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2009 Dec 11;284(50):34538-44</RefSource>
<PMID Version="1">19850935</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Metab. 2010 Mar 3;11(3):194-205</RefSource>
<PMID Version="1">20197052</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Biochem. 2010 Sep 15;404(2):235-7</RefSource>
<PMID Version="1">20488158</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Mol Life Sci. 2010 Sep;67(18):3151-61</RefSource>
<PMID Version="1">20422251</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2010 Sep 3;399(4):518-24</RefSource>
<PMID Version="1">20678475</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2010 Nov;16(11):1295-8</RefSource>
<PMID Version="1">20935628</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prog Lipid Res. 2011 Jan;50(1):14-27</RefSource>
<PMID Version="1">21087632</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Physiol Rev. 2011 Jan;91(1):119-49</RefSource>
<PMID Version="1">21248164</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2011 Feb 18;286(7):5126-35</RefSource>
<PMID Version="1">21148142</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Lipid Res. 2011 Apr;52(4):657-67</RefSource>
<PMID Version="1">21317108</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2011 May 6;286(18):15707-15</RefSource>
<PMID Version="1">21393244</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2011 Jul;54(1):38-49</RefSource>
<PMID Version="1">21465511</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Electron Microsc (Tokyo). 2011;60 Suppl 1:S101-16</RefSource>
<PMID Version="1">21844583</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2011 Dec 9;286(49):42615-25</RefSource>
<PMID Version="1">21984835</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Biochem. 2012;81:687-714</RefSource>
<PMID Version="1">22524315</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Mar 30;287(14):11164-73</RefSource>
<PMID Version="1">22311986</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Lipid Res. 2012 Nov;53(11):2307-17</RefSource>
<PMID Version="1">22891293</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1345-50</RefSource>
<PMID Version="1">23297223</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Lipid Res. 2013 Apr;54(4):1092-102</RefSource>
<PMID Version="1">23345410</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2013 Apr 5;288(14):9915-23</RefSource>
<PMID Version="1">23420847</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Regul Integr Comp Physiol. 2013 Apr 15;304(8):R644-50</RefSource>
<PMID Version="1">23408028</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(5):e64950</RefSource>
<PMID Version="1">23741432</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2013 Jun;19(6):722-9</RefSource>
<PMID Version="1">23708292</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Lipid Res. 2013 Oct;54(10):2615-22</RefSource>
<PMID Version="1">23828778</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Viral Hepat. 2014 Jan;21(1):1-8</RefSource>
<PMID Version="1">24329852</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Enzymol. 2014;538:171-93</RefSource>
<PMID Version="1">24529439</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2001 Jun;33(6):1358-64</RefSource>
<PMID Version="1">11391523</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051103">1-Acylglycerol-3-Phosphate O-Acyltransferase</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019556">COS Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D045744">Cell Line, Tumor</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002522">Cercopithecus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057809">HEK293 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006868">Hydrolysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008049">Lipase</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D066292">Lipid Droplets</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000201">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050356">Lipid Metabolism</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018345">Mice, Knockout</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D041681">NIH 3T3 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014280">Triglycerides</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014758">Viral Core Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276846</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Adipose Triglyceride Lipase (ATGL)</Keyword>
<Keyword MajorTopicYN="N">Hepatitis C Virus (HCV)</Keyword>
<Keyword MajorTopicYN="N">Lipid Droplet</Keyword>
<Keyword MajorTopicYN="N">Lipolysis</Keyword>
<Keyword MajorTopicYN="N">Triglyceride</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25381260</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>A role for Saccharomyces cerevisiae Tpa1 protein in direct alkylation repair.</ArticleTitle>
<Pagination>
<MedlinePgn>35939-52</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.590216</ELocationID>
<Abstract>
<AbstractText>Alkylating agents induce cytotoxic DNA base adducts. In this work, we provide evidence to suggest, for the first time, that Saccharomyces cerevisiae Tpa1 protein is involved in DNA alkylation repair. Little is known about Tpa1 as a repair protein beyond the initial observation from a high-throughput analysis indicating that deletion of TPA1 causes methyl methane sulfonate sensitivity in S. cerevisiae. Using purified Tpa1, we demonstrate that Tpa1 repairs both single- and double-stranded methylated DNA. Tpa1 is a member of the Fe(II) and 2-oxoglutarate-dependent dioxygenase family, and we show that mutation of the amino acid residues involved in cofactor binding abolishes the Tpa1 DNA repair activity. Deletion of TPA1 along with the base excision repair pathway DNA glycosylase MAG1 renders the tpa1Δmag1Δ double mutant highly susceptible to methylation-induced toxicity. We further demonstrate that the trans-lesion synthesis DNA polymerase Polζ (REV3) plays a key role in tolerating DNA methyl-base lesions and that tpa1Δmag1revΔ3 triple mutant is extremely susceptible to methylation-induced toxicity. Our results indicate a synergism between the base excision repair pathway and direct alkylation repair by Tpa1 in S. cerevisiae. We conclude that Tpa1 is a hitherto unidentified DNA repair protein in yeast and that it plays a crucial role in reverting alkylated DNA base lesions and cytotoxicity. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shivange</LastName>
<ForeName>Gururaj</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biotechnology, Indian Institute of Technology Hyderabad, Ordnance Factory Estate, Yeddumailaram 502205, Hyderabad, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kodipelli</LastName>
<ForeName>Naveena</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biotechnology, Indian Institute of Technology Hyderabad, Ordnance Factory Estate, Yeddumailaram 502205, Hyderabad, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Monisha</LastName>
<ForeName>Mohan</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biotechnology, Indian Institute of Technology Hyderabad, Ordnance Factory Estate, Yeddumailaram 502205, Hyderabad, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Anindya</LastName>
<ForeName>Roy</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biotechnology, Indian Institute of Technology Hyderabad, Ordnance Factory Estate, Yeddumailaram 502205, Hyderabad, India anindya@iith.ac.in.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004271">DNA, Fungal</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D029701">Saccharomyces cerevisiae Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C548775">Tpa1 protein, S cerevisiae</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.2.2.-</RegistryNumber>
<NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.2.2.21</RegistryNumber>
<NameOfSubstance UI="C445668">MAG1 protein, S cerevisiae</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 2000 May 15;14(10):1196-208</RefSource>
<PMID Version="1">10817755</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mutat Res. 2000 Jun 30;451(1-2):169-85</RefSource>
<PMID Version="1">10915871</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 2000 Aug 15;14(16):2097-105</RefSource>
<PMID Version="1">10950872</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genome Biol. 2001;2(3):RESEARCH0007</RefSource>
<PMID Version="1">11276424</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2001 Apr 20;292(5516):464-8</RefSource>
<PMID Version="1">11292862</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2001 May 18;276(20):16593-6</RefSource>
<PMID Version="1">11283009</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2001 Aug 2;412(6846):553-7</RefSource>
<PMID Version="1">11484057</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2001 Aug 2;412(6846):557-61</RefSource>
<PMID Version="1">11484058</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2002 Apr;22(7):2159-69</RefSource>
<PMID Version="1">11884603</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10605-10</RefSource>
<PMID Version="1">12149442</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2002 Sep 12;419(6903):174-8</RefSource>
<PMID Version="1">12226667</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2002 Sep 12;419(6903):178-82</RefSource>
<PMID Version="1">12226668</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16934-9</RefSource>
<PMID Version="1">12482937</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16660-5</RefSource>
<PMID Version="1">12486230</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>DNA Repair (Amst). 2002 Aug 6;1(8):645-59</RefSource>
<PMID Version="1">12509287</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2003 Feb 20;421(6925):859-63</RefSource>
<PMID Version="1">12594517</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Mol Cell Biol. 2004 Feb;5(2):148-57</RefSource>
<PMID Version="1">15040447</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Genomics. 2003 Dec 10;4(1):48</RefSource>
<PMID Version="1">14667252</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Inorg Biochem. 2004 May;98(5):856-61</RefSource>
<PMID Version="1">15134932</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2004;32(11):3456-61</RefSource>
<PMID Version="1">15229293</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14051-6</RefSource>
<PMID Version="1">15381779</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2004 Oct 8;16(1):107-16</RefSource>
<PMID Version="1">15469826</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 1983 Mar;153(3):1301-7</RefSource>
<PMID Version="1">6337994</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1987 Jun 4-10;327(6121):389-94</RefSource>
<PMID Version="1">2953976</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1989 Feb 24;56(4):619-30</RefSource>
<PMID Version="1">2645056</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genetics. 1989 May;122(1):19-27</RefSource>
<PMID Version="1">2659436</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mutat Res. 1990 Jul;231(1):11-30</RefSource>
<PMID Version="1">2195323</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Gen Genet. 1991 Oct;229(2):319-23</RefSource>
<PMID Version="1">1921981</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 1995 Sep;177(17):5009-15</RefSource>
<PMID Version="1">7665478</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 1996 Sep;178(17):5249-56</RefSource>
<PMID Version="1">8752345</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Genet. 1996 Dec;30(6):461-8</RefSource>
<PMID Version="1">8939806</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1997 Sep 12;272(37):23031-6</RefSource>
<PMID Version="1">9287300</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13804-9</RefSource>
<PMID Version="1">9391108</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1999 May 20;399(6733):271-5</RefSource>
<PMID Version="1">10353251</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2004;32(21):6260-7</RefSource>
<PMID Version="1">15576352</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2005 Jan;7(1):77-85</RefSource>
<PMID Version="1">15652751</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W382-8</RefSource>
<PMID Version="1">15980494</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2005 Aug;8(2):143-53</RefSource>
<PMID Version="1">16098467</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2005 Nov 25;280(47):39448-59</RefSource>
<PMID Version="1">16174769</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2006 Jul;26(14):5237-48</RefSource>
<PMID Version="1">16809762</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2006 Dec;26(24):9555-63</RefSource>
<PMID Version="1">17030609</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>DNA Repair (Amst). 2007 Apr 1;6(4):429-42</RefSource>
<PMID Version="1">17112791</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 2007 Apr 14;145(4):1222-32</RefSource>
<PMID Version="1">17175108</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 2007 Jun 1;21(11):1409-21</RefSource>
<PMID Version="1">17545469</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Struct Mol Biol. 2007 Aug;14(8):689-95</RefSource>
<PMID Version="1">17589523</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2007 Oct;27(20):7198-205</RefSource>
<PMID Version="1">17698580</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2007 Nov 9;28(3):386-97</RefSource>
<PMID Version="1">17996703</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2007 Nov 30;318(5855):1469-72</RefSource>
<PMID Version="1">17991826</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2008 Apr;36(6):1836-46</RefSource>
<PMID Version="1">18267974</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2008 Sep 5;283(36):25046-56</RefSource>
<PMID Version="1">18603530</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2008 Nov;36(19):6187-98</RefSource>
<PMID Version="1">18824477</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biometals. 2009 Feb;22(1):191-6</RefSource>
<PMID Version="1">19096759</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2010 Jan;30(2):436-46</RefSource>
<PMID Version="1">19901073</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2010 Apr;38(6):2099-110</RefSource>
<PMID Version="1">20040577</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2010 Jun 11;38(5):637-48</RefSource>
<PMID Version="1">20541997</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2010 Oct 1;285(40):30767-78</RefSource>
<PMID Version="1">20630870</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 2011 Mar 15;434(3):391-8</RefSource>
<PMID Version="1">21166655</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>DNA Repair (Amst). 2012 May 1;11(5):453-62</RefSource>
<PMID Version="1">22365419</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Parasitol. 2012 May;131(1):92-100</RefSource>
<PMID Version="1">22465611</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 2012 Jun 15;26(12):1326-38</RefSource>
<PMID Version="1">22677546</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2012 Jul;122(7):2680-9</RefSource>
<PMID Version="1">22684101</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(10):e46688</RefSource>
<PMID Version="1">23056405</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):16882-7</RefSource>
<PMID Version="1">23027975</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cancer Res. 2012 Dec;10(12):1580-96</RefSource>
<PMID Version="1">23038810</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4019-24</RefSource>
<PMID Version="1">24550462</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Biochem. 2014 Nov 15;465:35-7</RefSource>
<PMID Version="1">25062850</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3094-9</RefSource>
<PMID Version="1">10725365</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000478">Alkylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002352">Carrier Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004249">DNA Damage</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D045647">DNA Glycosylases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019175">DNA Methylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004260">DNA Repair</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004271">DNA, Fungal</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012441">Saccharomyces cerevisiae</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D029701">Saccharomyces cerevisiae Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276862</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cancer</Keyword>
<Keyword MajorTopicYN="N">DNA Damage</Keyword>
<Keyword MajorTopicYN="N">DNA Repair</Keyword>
<Keyword MajorTopicYN="N">Escherichia coli</Keyword>
<Keyword MajorTopicYN="N">Saccharomyces cerevisiae</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25381442</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Insights into the specificity of lysine acetyltransferases.</ArticleTitle>
<Pagination>
<MedlinePgn>36249-62</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.613901</ELocationID>
<Abstract>
<AbstractText>Reversible lysine acetylation by protein acetyltransferases is a conserved regulatory mechanism that controls diverse cellular pathways. Gcn5-related N-acetyltransferases (GNATs), named after their founding member, are found in all domains of life. GNATs are known for their role as histone acetyltransferases, but non-histone bacterial protein acetytransferases have been identified. Only structures of GNAT complexes with short histone peptide substrates are available in databases. Given the biological importance of this modification and the abundance of lysine in polypeptides, how specificity is attained for larger protein substrates is central to understanding acetyl-lysine-regulated networks. Here we report the structure of a GNAT in complex with a globular protein substrate solved to 1.9 Å. GNAT binds the protein substrate with extensive surface interactions distinct from those reported for GNAT-peptide complexes. Our data reveal determinants needed for the recognition of a protein substrate and provide insight into the specificity of GNATs. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tucker</LastName>
<ForeName>Alex C</ForeName>
<Initials>AC</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Microbiology, University of Georgia, Athens, Georgia 30602 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Taylor</LastName>
<ForeName>Keenan C</ForeName>
<Initials>KC</Initials>
<AffiliationInfo>
<Affiliation>the Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rank</LastName>
<ForeName>Katherine C</ForeName>
<Initials>KC</Initials>
<AffiliationInfo>
<Affiliation>the Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rayment</LastName>
<ForeName>Ivan</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>the Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Escalante-Semerena</LastName>
<ForeName>Jorge C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Microbiology, University of Georgia, Athens, Georgia 30602 and jcescala@uga.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>PDB</DataBankName>
<AccessionNumberList>
<AccessionNumber>4NXY</AccessionNumber>
<AccessionNumber>4U5Y</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 GM062203</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 GM062203</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 GM083987</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32-GM07215</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.3.1.-</RegistryNumber>
<NameOfSubstance UI="D000123">Acetyltransferases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>K3Z4F929H6</RegistryNumber>
<NameOfSubstance UI="D008239">Lysine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2007 Feb 23;128(4):693-705</RefSource>
<PMID Version="1">17320507</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proteins. 2006 Nov 1;65(2):392-406</RefSource>
<PMID Version="1">16933295</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2007 Oct 12;282(41):30239-45</RefSource>
<PMID Version="1">17684016</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioinformatics. 2007 Nov 1;23(21):2947-8</RefSource>
<PMID Version="1">17846036</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plasmid. 2008 May;59(3):231-7</RefSource>
<PMID Version="1">18295882</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 2010 May;76(4):874-88</RefSource>
<PMID Version="1">20345662</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 2010 Dec;192(23):6200-8</RefSource>
<PMID Version="1">20889757</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 2010 Nov;78(4):916-31</RefSource>
<PMID Version="1">20815825</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Microbiol. 2011 Apr;14(2):200-4</RefSource>
<PMID Version="1">21239213</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2011 Jul 5;50(26):5883-92</RefSource>
<PMID Version="1">21627103</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2011 Oct 7;44(1):160-6</RefSource>
<PMID Version="1">21981926</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 May 4;287(19):15590-601</RefSource>
<PMID Version="1">22416131</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Nov 30;287(49):41392-404</RefSource>
<PMID Version="1">23076154</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 2013 Jan;87(1):152-67</RefSource>
<PMID Version="1">23199287</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS J. 2013 Nov;280(22):5570-81</RefSource>
<PMID Version="1">23742047</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proteins. 2013 Dec;81(12):2159-66</RefSource>
<PMID Version="1">23996272</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 2014 Apr;196(8):1496-504</RefSource>
<PMID Version="1">24488314</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2002 Jan 11;290(1):397-402</RefSource>
<PMID Version="1">11779182</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Structure. 2002 Feb;10(2):147-51</RefSource>
<PMID Version="1">11839300</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2002 May 23;417(6887):455-8</RefSource>
<PMID Version="1">12024216</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2002 Dec 20;298(5602):2390-2</RefSource>
<PMID Version="1">12493915</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2003 Mar 18;42(10):2866-73</RefSource>
<PMID Version="1">12627952</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2003 Aug;12(2):461-73</RefSource>
<PMID Version="1">14536085</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioinformatics. 2004 Jan 1;20(1):45-50</RefSource>
<PMID Version="1">14693807</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W96-9</RefSource>
<PMID Version="1">15215358</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2004 Jul 23;340(5):1005-12</RefSource>
<PMID Version="1">15236963</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Mol Life Sci. 2004 Aug;61(16):2020-30</RefSource>
<PMID Version="1">15316652</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 1968 Jul;96(1):215-20</RefSource>
<PMID Version="1">4874308</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1970 Aug 15;227(5259):680-5</RefSource>
<PMID Version="1">5432063</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 1993 Dec 20;234(4):946-50</RefSource>
<PMID Version="1">8263940</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1995 May 12;270(19):11181-9</RefSource>
<PMID Version="1">7538113</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 1995 Jul;177(14):4121-30</RefSource>
<PMID Version="1">7608087</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 1998 Jul 1;54(Pt 4):487-93</RefSource>
<PMID Version="1">9761844</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1999 Sep 2;401(6748):93-8</RefSource>
<PMID Version="1">10485713</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 1951 Sep;62(3):293-300</RefSource>
<PMID Version="1">14888646</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32</RefSource>
<PMID Version="1">15572765</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2196-201</RefSource>
<PMID Version="1">15572772</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Biochem Biophys. 2005 Jan 1;433(1):212-26</RefSource>
<PMID Version="1">15581578</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gene. 2005 Dec 19;363:15-23</RefSource>
<PMID Version="1">16289629</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Protein Expr Purif. 2007 Sep;55(1):53-68</RefSource>
<PMID Version="1">17543538</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000107">Acetylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000123">Acetyltransferases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001426">Bacterial Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020134">Catalytic Domain</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018360">Crystallography, X-Ray</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008239">Lysine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008958">Models, Molecular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054730">Protein Interaction Domains and Motifs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011499">Protein Processing, Post-Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012484">Salmonella paratyphi B</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000201">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D048170">Streptomyces lividans</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000201">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013379">Substrate Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276886</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Acetyl Coenzyme A (Acetyl-CoA)</Keyword>
<Keyword MajorTopicYN="N">Bacterial Metabolism</Keyword>
<Keyword MajorTopicYN="N">Enzyme Inactivation</Keyword>
<Keyword MajorTopicYN="N">Histone Acetylase</Keyword>
<Keyword MajorTopicYN="N">Post-translational Modification (PTM)</Keyword>
<Keyword MajorTopicYN="N">Substrate Specificity</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25381443</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Thrombin-dependent Incorporation of von Willebrand Factor into a Fibrin Network.</ArticleTitle>
<Pagination>
<MedlinePgn>35979-86</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.591677</ELocationID>
<Abstract>
<AbstractText>Attachment of platelets from the circulation onto a growing thrombus is a process involving multiple platelet receptors, endothelial matrix components, and coagulation factors. It has been indicated previously that during a transglutaminase reaction activated factor XIII (FXIIIa) covalently cross-links von Willebrand factor (VWF) to polymerizing fibrin. Bound VWF further recruits and activates platelets via interactions with the platelet receptor complex glycoprotein Ib (GPIb). In the present study we found proof for binding of VWF to a fibrin monomer layer during the process of fibrinogen-to-fibrin conversion in the presence of thrombin, arvin, or a snake venom from Crotalus atrox. Using a domain deletion mutant we demonstrated the involvement of the C domains of VWF in this binding. Substantial binding of VWF to fibrin monomers persisted in the presence of the FXIIIa inhibitor K9-DON, illustrating that cross-linking via factor XIII is not essential for this phenomenon and suggesting the identification of a second mechanism through which VWF multimers incorporate into a fibrin network. Under high shear conditions, platelets were shown to adhere to fibrin only if VWF had been incorporated. In conclusion, our experiments show that the C domains of VWF and the E domain of fibrin monomers are involved in the incorporation of VWF during the polymerization of fibrin and that this incorporation fosters binding and activation of platelets. Fibrin thus is not an inert end product but partakes in further thrombus growth. Our findings help to elucidate the mechanism of thrombus growth and platelet adhesion under conditions of arterial shear rate. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Miszta</LastName>
<ForeName>Adam</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, 6229 EV, Maastricht, The Netherlands, Synapse BV, 6229 EV, Maastricht, The Netherlands, adam.miszta@thrombin.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pelkmans</LastName>
<ForeName>Leonie</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, 6229 EV, Maastricht, The Netherlands, Synapse BV, 6229 EV, Maastricht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lindhout</LastName>
<ForeName>Theo</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, 6229 EV, Maastricht, The Netherlands, Synapse BV, 6229 EV, Maastricht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Krishnamoorthy</LastName>
<ForeName>Ganeshram</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, 6229 EV, Maastricht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Groot</LastName>
<ForeName>Philip G</ForeName>
<Initials>PG</Initials>
<AffiliationInfo>
<Affiliation>Clinical Chemistry and Hematology, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hemker</LastName>
<ForeName>Coenraad H</ForeName>
<Initials>CH</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, 6229 EV, Maastricht, The Netherlands, Synapse BV, 6229 EV, Maastricht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Heemskerk</LastName>
<ForeName>Johan W M</ForeName>
<Initials>JW</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, 6229 EV, Maastricht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kelchtermans</LastName>
<ForeName>Hilde</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, 6229 EV, Maastricht, The Netherlands, Synapse BV, 6229 EV, Maastricht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Laat</LastName>
<ForeName>Bas</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, 6229 EV, Maastricht, The Netherlands, Synapse BV, 6229 EV, Maastricht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014841">von Willebrand Factor</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9001-31-4</RegistryNumber>
<NameOfSubstance UI="D005337">Fibrin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.21.5</RegistryNumber>
<NameOfSubstance UI="D013917">Thrombin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Atherosclerosis. 2010 Nov;213(1):77-84</RefSource>
<PMID Version="1">20810110</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chem Phys Lipids. 2010 Feb;163(2):200-6</RefSource>
<PMID Version="1">19931234</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Adv Protein Chem Struct Biol. 2011;83:75-127</RefSource>
<PMID Version="1">21570666</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Platelets. 2012;23(3):229-42</RefSource>
<PMID Version="1">22502645</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2012 Jul 12;120(2):449-58</RefSource>
<PMID Version="1">22490677</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2013 Mar 7;121(10):1712-9</RefSource>
<PMID Version="1">23305734</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Thromb Haemost. 2013 May;11(5):993-5</RefSource>
<PMID Version="1">23413924</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2014 Mar 20;123(12):1785-93</RefSource>
<PMID Version="1">24394662</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2002 Aug 16;297(5584):1176-9</RefSource>
<PMID Version="1">12183630</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 2003 Apr;17(6):685-7</RefSource>
<PMID Version="1">12586747</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Thromb Haemost. 2004 Jan;2(1):170-6</RefSource>
<PMID Version="1">14717981</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2004 Mar 1;103(5):1741-6</RefSource>
<PMID Version="1">14604963</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 1972 Mar;51(3):685-99</RefSource>
<PMID Version="1">4622107</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Biochem. 1978 Jan;84(1):56-67</RefSource>
<PMID Version="1">626380</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1983 Feb 25;258(4):2426-31</RefSource>
<PMID Version="1">6822569</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 1983 Jul;72(1):1-12</RefSource>
<PMID Version="1">6223940</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 1984 Nov;74(5):1730-41</RefSource>
<PMID Version="1">6334102</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 1986 Jul;68(1):95-101</RefSource>
<PMID Version="1">2872929</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 1986 Oct;78(4):1112-9</RefSource>
<PMID Version="1">3489737</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Biochem. 1986 Aug 15;157(1):77-83</RefSource>
<PMID Version="1">3766969</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 1987 Jan;79(1):117-23</RefSource>
<PMID Version="1">3491837</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biophys J. 1986 Dec;50(6):1079-93</RefSource>
<PMID Version="1">3801570</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 1989 Aug;84(2):435-42</RefSource>
<PMID Version="1">2788172</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 1990 Apr 1;75(7):1460-5</RefSource>
<PMID Version="1">2107883</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 1992 Mar;89(3):842-50</RefSource>
<PMID Version="1">1541676</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 1995 Dec 1;86(11):4158-65</RefSource>
<PMID Version="1">7492773</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Thromb Haemost. 1995 Jul;74(1):302-8</RefSource>
<PMID Version="1">8578476</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 1996 Oct 15;88(8):2939-50</RefSource>
<PMID Version="1">8874190</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Biochem. 1998;67:395-424</RefSource>
<PMID Version="1">9759493</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 1999 Jan 15;93(2):564-70</RefSource>
<PMID Version="1">9885217</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1951 Feb 10;167(4241):233-4</RefSource>
<PMID Version="1">14806439</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Langmuir. 2004 Nov 9;20(23):10129-37</RefSource>
<PMID Version="1">15518504</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 2005 May;19(7):825-7</RefSource>
<PMID Version="1">15758040</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2006 Sep 15;108(6):1903-10</RefSource>
<PMID Version="1">16772609</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2007 May 8;104(19):7899-903</RefSource>
<PMID Version="1">17470810</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2007 Sep 4;46(35):10089-101</RefSource>
<PMID Version="1">17691819</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pept Sci. 2008 Apr;14(4):503-9</RefSource>
<PMID Version="1">17994618</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2011 Jan 13;117(2):651-60</RefSource>
<PMID Version="1">21037087</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001665">Binding Sites</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001792">Blood Platelets</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005337">Fibrin</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010974">Platelet Aggregation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054730">Protein Interaction Domains and Motifs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013917">Thrombin</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014841">von Willebrand Factor</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276865</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Arvin</Keyword>
<Keyword MajorTopicYN="N">Ellipsometry</Keyword>
<Keyword MajorTopicYN="N">Fibrin</Keyword>
<Keyword MajorTopicYN="N">Fibrinogen</Keyword>
<Keyword MajorTopicYN="N">Platelet</Keyword>
<Keyword MajorTopicYN="N">Platelet Glycoprotein Ib</Keyword>
<Keyword MajorTopicYN="N">Surface Plasmon Resonance (SPR)</Keyword>
<Keyword MajorTopicYN="N">von Willebrand Factor</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25384980</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Molecular clock regulates daily α1-2-fucosylation of the neural cell adhesion molecule (NCAM) within mouse secondary olfactory neurons.</ArticleTitle>
<Pagination>
<MedlinePgn>36158-65</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.571141</ELocationID>
<Abstract>
<AbstractText>The circadian clock regulates various behavioral and physiological rhythms in mammals. Circadian changes in olfactory functions such as neuronal firing in the olfactory bulb (OB) and olfactory sensitivity have recently been identified, although the underlying molecular mechanisms remain unknown. We analyzed the temporal profiles of glycan structures in the mouse OB using a high-density microarray that includes 96 lectins, because glycoconjugates play important roles in the nervous system such as neurite outgrowth and synaptogenesis. Sixteen lectin signals significantly fluctuated in the OB, and the intensity of all three that had high affinity for α1-2-fucose (α1-2Fuc) glycan in the microarray was higher during the nighttime. Histochemical analysis revealed that α1-2Fuc glycan is located in a diurnal manner in the lateral olfactory tract that comprises axon bundles of secondary olfactory neurons. The amount of α1-2Fuc glycan associated with the major target glycoprotein neural cell adhesion molecule (NCAM) varied in a diurnal fashion, although the mRNA and protein expression of Ncam1 did not. The mRNA and protein expression of Fut1, a α1-2-specific fucosyltransferase gene, was diurnal in the OB. Daily fluctuation of the α1-2Fuc glycan was obviously damped in homozygous Clock mutant mice with disrupted diurnal Fut1 expression, suggesting that the molecular clock governs rhythmic α1-2-fucosylation in secondary olfactory neurons. These findings suggest the possibility that the molecular clock is involved in the diurnal regulation of olfaction via α1-2-fucosylation in the olfactory system. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kondoh</LastName>
<ForeName>Daisuke</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>From the Biological Clock Research Group, Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba 305-8566, the Department of Basic Veterinary Medicine, Laboratory of Veterinary Anatomy, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-8555.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tateno</LastName>
<ForeName>Hiroaki</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>the Research Center for Stem Cell Engineering, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba 305-8568.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hirabayashi</LastName>
<ForeName>Jun</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>the Research Center for Stem Cell Engineering, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba 305-8568.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yasumoto</LastName>
<ForeName>Yuki</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>From the Biological Clock Research Group, Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba 305-8566, the Department of Applied Biological Science, Graduate School of Science and Technology, Tokyo University of Science, Noda 278-8510, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nakao</LastName>
<ForeName>Reiko</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>From the Biological Clock Research Group, Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba 305-8566.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Oishi</LastName>
<ForeName>Katsutaka</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>From the Biological Clock Research Group, Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba 305-8566, the Department of Applied Biological Science, Graduate School of Science and Technology, Tokyo University of Science, Noda 278-8510, and the Department of Medical Genome Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8562, Japan k-ooishi@aist.go.jp.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019002">Antigens, CD56</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C501063">Ncam1 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>3713-31-3</RegistryNumber>
<NameOfSubstance UI="D005643">Fucose</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.3.1.48</RegistryNumber>
<NameOfSubstance UI="D056926">CLOCK Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.3.1.48</RegistryNumber>
<NameOfSubstance UI="C538944">Clock protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.4.1.-</RegistryNumber>
<NameOfSubstance UI="D005647">Fucosyltransferases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.4.1.69</RegistryNumber>
<NameOfSubstance UI="C041995">galactoside 2-alpha-L-fucosyltransferase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Biochem. 1998 Nov 15;258(1):243-70</RefSource>
<PMID Version="1">9851715</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Anat (Basel). 1998;161(1-4):234-53</RefSource>
<PMID Version="1">9780362</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Chem Soc. 2005 Feb 9;127(5):1340-1</RefSource>
<PMID Version="1">15686343</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 2005;132(2):519-28</RefSource>
<PMID Version="1">15802202</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):21-6</RefSource>
<PMID Version="1">16373512</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2006 Nov 22;26(47):12219-25</RefSource>
<PMID Version="1">17122046</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2009 Aug 4;48(30):7261-70</RefSource>
<PMID Version="1">19527073</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Morphol. 2010 Oct;271(10):1197-203</RefSource>
<PMID Version="1">20597100</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2011 Jun 10;286(23):20345-53</RefSource>
<PMID Version="1">21471226</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Rhythms. 2011 Dec;26(6):552-60</RefSource>
<PMID Version="1">22215613</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hippocampus. 2012 Jun;22(6):1325-37</RefSource>
<PMID Version="1">21830249</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 2012 Oct 11;222:38-48</RefSource>
<PMID Version="1">22813997</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Metab. 2013 Feb 5;17(2):291-302</RefSource>
<PMID Version="1">23395175</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Metab. 2013 Feb 5;17(2):303-10</RefSource>
<PMID Version="1">23395176</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(3):e58457</RefSource>
<PMID Version="1">23505510</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Handb Exp Pharmacol. 2013;(217):3-27</RefSource>
<PMID Version="1">23604473</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chem Soc Rev. 2013 May 21;42(10):4443-58</RefSource>
<PMID Version="1">23443201</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 2013 Sep 5;247:234-41</RefSource>
<PMID Version="1">23727009</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2013 Sep 27;288(39):27812-24</RefSource>
<PMID Version="1">23960070</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lab Invest. 1987 Jul;57(1):5-20</RefSource>
<PMID Version="1">3298849</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Glycobiology. 2001 May;11(5):373-84</RefSource>
<PMID Version="1">11425798</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 2001;106(2):255-61</RefSource>
<PMID Version="1">11566498</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 2002 Feb 11;443(3):213-25</RefSource>
<PMID Version="1">11807832</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2002 May 3;109(3):307-20</RefSource>
<PMID Version="1">12015981</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2002 Aug 1;418(6897):534-9</RefSource>
<PMID Version="1">12152080</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2002 Oct 25;298(2):198-202</RefSource>
<PMID Version="1">12387815</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2003 Jan 15;23(2):652-8</RefSource>
<PMID Version="1">12533624</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 2003;117(1):203-11</RefSource>
<PMID Version="1">12605906</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Glycobiology. 2003 Jul;13(7):41R-53R</RefSource>
<PMID Version="1">12651883</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 2003 Jul 25;979(1-2):15-26</RefSource>
<PMID Version="1">12850566</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurosci. 2004 Feb;19(4):898-906</RefSource>
<PMID Version="1">15009137</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1984 Jul;4(7):1830-9</RefSource>
<PMID Version="1">6204022</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 1985 Mar;14(3):875-80</RefSource>
<PMID Version="1">4039423</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 1987 May 5;410(2):245-56</RefSource>
<PMID Version="1">3594237</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 1991 Feb 1;540(1-2):237-42</RefSource>
<PMID Version="1">2054616</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 1994 Apr 18;643(1-2):130-5</RefSource>
<PMID Version="1">7518325</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosci Lett. 1995 Aug 4;195(2):117-20</RefSource>
<PMID Version="1">7478264</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 1996 Jul 1;725(2):276-80</RefSource>
<PMID Version="1">8836537</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurobiol. 1997 Jun 20;32(7):643-58</RefSource>
<PMID Version="1">9183743</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurobiol Learn Mem. 1997 Nov;68(3):317-24</RefSource>
<PMID Version="1">9398591</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Gerontol. 1998 Nov-Dec;33(7-8):853-64</RefSource>
<PMID Version="1">9951628</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019002">Antigens, CD56</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056926">CLOCK Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002940">Circadian Rhythm</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005643">Fucose</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005647">Fucosyltransferases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015870">Gene Expression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005786">Gene Expression Regulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006031">Glycosylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008813">Mice, Inbred ICR</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008822">Mice, Transgenic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009832">Olfactory Nerve</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000166">cytology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018034">Olfactory Receptor Neurons</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011499">Protein Processing, Post-Translational</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276879</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Circadian Rhythm</Keyword>
<Keyword MajorTopicYN="N">Clock Gene</Keyword>
<Keyword MajorTopicYN="N">Glycosylation</Keyword>
<Keyword MajorTopicYN="N">Lectin</Keyword>
<Keyword MajorTopicYN="N">Olfaction</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25384981</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Activation of 3-phosphoinositide-dependent kinase 1 (PDK1) and serum- and glucocorticoid-induced protein kinase 1 (SGK1) by short-chain sphingolipid C4-ceramide rescues the trafficking defect of ΔF508-cystic fibrosis transmembrane conductance regulator (ΔF508-CFTR).</ArticleTitle>
<Pagination>
<MedlinePgn>35953-68</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.598649</ELocationID>
<Abstract>
<AbstractText>Cystic fibrosis (CF) is due to a folding defect in the CF transmembrane conductance regulator (CFTR) protein. The most common mutation, ΔF508, prevents CFTR from trafficking to the apical plasma membrane. Here we show that activation of the PDK1/SGK1 signaling pathway with C4-ceramide (C4-CER), a non-toxic small molecule, functionally corrects the trafficking defect in both cultured CF cells and primary epithelial cell explants from CF patients. The mechanism of C4-CER action involves a series of mutual autophosphorylation and phosphorylation events between PDK1 and SGK1. Detailed mechanistic studies indicate that C4-CER initially induces autophosphorylation of SGK1 at Ser(422). SGK1[Ser(P)(422)] and C4-CER coincidently bind PDK1 and permit PDK1 to autophosphorylate at Ser(241). Then PDK1[Ser(P)(241)] phosphorylates SGK1[Ser(P)(422)] at Thr(256) to generate fully activated SGK1[Ser(422), Thr(P)(256)]. SGK1[Ser(P)(422),Thr(P)(256)] phosphorylates and inactivates the E3 ubiquitin ligase Nedd4-2. ΔF508-CFTR is thus free to traffic to the plasma membrane. Importantly, C4-CER-mediated activation of both PDK1 and SGK1 is independent of the PI3K/Akt/mammalian target of rapamycin signaling pathway. Physiologically, C4-CER significantly increases maturation and stability of ΔF508-CFTR (t½ ∼10 h), enhances cAMP-activated chloride secretion, and suppresses hypersecretion of interleukin-8 (IL-8). We suggest that candidate drugs for CF directed against the PDK1/SGK1 signaling pathway, such as C4-CER, provide a novel therapeutic strategy for a life-limiting disorder that affects one child, on average, each day. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Caohuy</LastName>
<ForeName>Hung</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Anatomy, Physiology, and Genetics, School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 and hung.caohuy@usuhs.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Qingfeng</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Anatomy, Physiology, and Genetics, School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eudy</LastName>
<ForeName>Yvonne</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Anatomy, Physiology, and Genetics, School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ha</LastName>
<ForeName>Thien-An</ForeName>
<Initials>TA</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Anatomy, Physiology, and Genetics, School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Xu</LastName>
<ForeName>Andrew E</ForeName>
<Initials>AE</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Anatomy, Physiology, and Genetics, School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Glover</LastName>
<ForeName>Matthew</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>the Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15224.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Frizzell</LastName>
<ForeName>Raymond A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>the Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15224.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jozwik</LastName>
<ForeName>Catherine</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Anatomy, Physiology, and Genetics, School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pollard</LastName>
<ForeName>Harvey B</ForeName>
<Initials>HB</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Anatomy, Physiology, and Genetics, School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 and harvey.pollard@usuhs.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>N01-HV-28187</GrantID>
<Acronym>HV</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01-DK-35051</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C505032">CFTR protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002518">Ceramides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D056827">Endosomal Sorting Complexes Required for Transport</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017874">Immediate-Early Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016209">Interleukin-8</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000596772">N-butanoylsphingosine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>126880-72-6</RegistryNumber>
<NameOfSubstance UI="D019005">Cystic Fibrosis Transmembrane Conductance Regulator</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.-</RegistryNumber>
<NameOfSubstance UI="D019869">Phosphatidylinositol 3-Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D017346">Protein-Serine-Threonine Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="C080320">serum-glucocorticoid regulated kinase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.2</RegistryNumber>
<NameOfSubstance UI="C022507">pyruvate dehydrogenase (acetyl-transferring) kinase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 6.3.2.19</RegistryNumber>
<NameOfSubstance UI="C099897">Nedd4 ubiquitin protein ligases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 6.3.2.19</RegistryNumber>
<NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1990 Nov 16;63(4):827-34</RefSource>
<PMID Version="1">1699669</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2004 Oct 29;279(44):45753-8</RefSource>
<PMID Version="1">15328345</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol. 1992 Jul;263(1 Pt 1):L1-14</RefSource>
<PMID Version="1">1322048</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1993 Oct 15;268(29):21592-8</RefSource>
<PMID Version="1">7691813</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 1993 Dec 1;296 ( Pt 2):297-301</RefSource>
<PMID Version="1">8257416</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1993 Dec 25;268(36):27299-306</RefSource>
<PMID Version="1">8262970</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1994 Feb 18;269(7):5241-8</RefSource>
<PMID Version="1">8106507</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 1995 Jan 23;358(2):211-4</RefSource>
<PMID Version="1">7828738</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 1996 Jan 16;35(2):626-33</RefSource>
<PMID Version="1">8555236</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1996 May 24;271(21):12646-54</RefSource>
<PMID Version="1">8647877</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Crit Care Med. 1996 Nov;154(5):1229-56</RefSource>
<PMID Version="1">8912731</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 1997 Jul 15;325 ( Pt 2):435-40</RefSource>
<PMID Version="1">9230125</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Biol. 1999 Feb 25;9(4):186-97</RefSource>
<PMID Version="1">10074427</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 1999 Apr 15;339 ( Pt 2):319-28</RefSource>
<PMID Version="1">10191262</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Hum Genet. 1999 Jun;64(6):1499-504</RefSource>
<PMID Version="1">10330337</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 1999 Sep 1;342 ( Pt 2):287-92</RefSource>
<PMID Version="1">10455013</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 2004 Dec 15;384(Pt 3):477-88</RefSource>
<PMID Version="1">15461589</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Pharmacol. 2005 Aug;68(2):330-5</RefSource>
<PMID Version="1">15900018</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2006 Jun 23;281(25):17369-78</RefSource>
<PMID Version="1">16621797</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2006 Oct 1;119(Pt 19):3944-57</RefSource>
<PMID Version="1">16954148</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Res. 2007 Mar 16;100(5):686-92</RefSource>
<PMID Version="1">17293474</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Cell Mol Biol. 2007 May;36(5):615-24</RefSource>
<PMID Version="1">17197571</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2007 Jun 15;67(12):5840-50</RefSource>
<PMID Version="1">17575152</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Physiol Biochem. 2007;20(1-4):91-8</RefSource>
<PMID Version="1">17595519</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 2007 Sep;21(11):2939-48</RefSource>
<PMID Version="1">17442732</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Cell Mol Biol. 2008 Jan;38(1):47-56</RefSource>
<PMID Version="1">17656682</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2008 Apr;14(4):382-91</RefSource>
<PMID Version="1">18376404</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2008 Sep 5;283(36):24707-17</RefSource>
<PMID Version="1">18596045</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2008 Sep 15;68(18):7475-83</RefSource>
<PMID Version="1">18794135</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Biochem. 2009 Jan 1;384(1):166-9</RefSource>
<PMID Version="1">18831956</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 2008 Dec 15;416(3):375-85</RefSource>
<PMID Version="1">18925875</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Cell Mol Biol. 2009 Jul;41(1):100-6</RefSource>
<PMID Version="1">19059886</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2009 Sep 11;284(37):25241-53</RefSource>
<PMID Version="1">19617352</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Mol Cell Biol. 2010 Jan;11(1):9-22</RefSource>
<PMID Version="1">20027184</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Lung Cell Mol Physiol. 2010 Mar;298(3):L304-14</RefSource>
<PMID Version="1">20008117</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2010 Aug 3;49(30):6352-7</RefSource>
<PMID Version="1">20590134</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Lipid Res. 2009 Oct;50(10):1986-95</RefSource>
<PMID Version="1">19075030</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Adv Exp Med Biol. 2010;688:1-23</RefSource>
<PMID Version="1">20919643</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 2011 Jan 15;433(2):357-69</RefSource>
<PMID Version="1">21087210</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2011 Apr 1;286(13):11604-15</RefSource>
<PMID Version="1">21282106</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Endocr Metab Immune Disord Drug Targets. 2011 Mar;11(1):8-22</RefSource>
<PMID Version="1">21348822</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Mol Biol. 2011;741:13-21</RefSource>
<PMID Version="1">21594775</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18843-8</RefSource>
<PMID Version="1">21976485</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Crit Rev Oncog. 2012;17(1):69-95</RefSource>
<PMID Version="1">22471665</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Med. 2012;18:685-96</RefSource>
<PMID Version="1">22396015</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(3):e60118</RefSource>
<PMID Version="1">23555901</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Physiol Biochem. 2013;31(6):785-94</RefSource>
<PMID Version="1">23735862</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2000 Jun 15;19(12):2924-34</RefSource>
<PMID Version="1">10856237</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2001 Mar 16;276(11):8297-305</RefSource>
<PMID Version="1">11096096</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2001 Aug 15;20(16):4380-90</RefSource>
<PMID Version="1">11500365</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2001 Oct 2;40(39):11851-9</RefSource>
<PMID Version="1">11570885</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2001 Dec 3;20(23):6783-92</RefSource>
<PMID Version="1">11726514</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochim Biophys Acta. 2002 Aug 8;1583(3):305-10</RefSource>
<PMID Version="1">12176398</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2004 Mar 19;279(12):11320-6</RefSource>
<PMID Version="1">14676210</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2004 May 18;101(20):7693-8</RefSource>
<PMID Version="1">15136726</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2004 Jun;15(6):2684-96</RefSource>
<PMID Version="1">15075371</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5562-6</RefSource>
<PMID Version="1">1376923</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002460">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002462">Cell Membrane</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002518">Ceramides</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003550">Cystic Fibrosis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019005">Cystic Fibrosis Transmembrane Conductance Regulator</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004353">Drug Evaluation, Preclinical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056827">Endosomal Sorting Complexes Required for Transport</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004789">Enzyme Activation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017874">Immediate-Early Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016209">Interleukin-8</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000557">secretion</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019869">Phosphatidylinositol 3-Kinases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010766">Phosphorylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011499">Protein Processing, Post-Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055550">Protein Stability</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021381">Protein Transport</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017346">Protein-Serine-Threonine Kinases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017384">Sequence Deletion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015398">Signal Transduction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013329">Structure-Activity Relationship</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D044767">Ubiquitin-Protein Ligases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276863</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Ceramide</Keyword>
<Keyword MajorTopicYN="N">Cystic Fibrosis</Keyword>
<Keyword MajorTopicYN="N">Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)</Keyword>
<Keyword MajorTopicYN="N">Inflammation</Keyword>
<Keyword MajorTopicYN="N">Membrane Trafficking</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25384983</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Carbon monoxide (CO) is a novel inhibitor of connexin hemichannels.</ArticleTitle>
<Pagination>
<MedlinePgn>36150-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.602243</ELocationID>
<Abstract>
<AbstractText>Hemichannels (HCs) are hexamers of connexins that can form gap-junction channels at points of cell contacts or "free HCs" at non-contacting regions. HCs are involved in paracrine and autocrine cell signaling, and under pathological conditions may induce and/or accelerate cell death. Therefore, studies of HC regulation are of great significance. Nitric oxide affects the activity of Cx43 and Cx46 HCs, whereas carbon monoxide (CO), another gaseous transmitter, modulates the activity of several ion channels, but its effect on HCs has not been explored. We studied the effect of CO donors (CORMs) on Cx46 HCs expressed in Xenopus laevis oocytes using two-electrode voltage clamp and on Cx43 and Cx46 expressed in HeLa cells using a dye-uptake technique. CORM-2 inhibited Cx46 HC currents in a concentration-dependent manner. The C-terminal domain and intracellular Cys were not necessary for the inhibition. The effect of CORM-2 was not prevented by guanylyl-cyclase, protein kinase G, or thioredoxin inhibitors, and was not due to endocytosis of HCs. However, the effect of CORM-2 was reversed by reducing agents that act extracellularly. Additionally, CO inhibited dye uptake of HeLa cells expressing Cx43 or Cx46, and MCF-7 cells, which endogenously express Cx43 and Cx46. Because CORM-2 carbonylates Cx46 in vitro and induces conformational changes, a direct effect of that CO on Cx46 is possible. The inhibition of HCs could help to understand some of the biological actions of CO in physiological and pathological conditions. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>León-Paravic</LastName>
<ForeName>Carmen G</ForeName>
<Initials>CG</Initials>
<AffiliationInfo>
<Affiliation>From the Centro de Fisiología Celular e Integrativa, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, Chile 7690000 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Figueroa</LastName>
<ForeName>Vania A</ForeName>
<Initials>VA</Initials>
<AffiliationInfo>
<Affiliation>From the Centro de Fisiología Celular e Integrativa, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, Chile 7690000 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guzmán</LastName>
<ForeName>Diego J</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo>
<Affiliation>From the Centro de Fisiología Celular e Integrativa, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, Chile 7690000 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Valderrama</LastName>
<ForeName>Carlos F</ForeName>
<Initials>CF</Initials>
<AffiliationInfo>
<Affiliation>From the Centro de Fisiología Celular e Integrativa, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, Chile 7690000 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vallejos</LastName>
<ForeName>Antonio A</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>From the Centro de Fisiología Celular e Integrativa, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, Chile 7690000 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fiori</LastName>
<ForeName>Mariana C</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>the Department of Cell Physiology and Molecular Biophysics, and Center for Membrane Protein Research, Texas Tech University Health Sciences Center, Lubbock, Texas 79430.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Altenberg</LastName>
<ForeName>Guillermo A</ForeName>
<Initials>GA</Initials>
<AffiliationInfo>
<Affiliation>the Department of Cell Physiology and Molecular Biophysics, and Center for Membrane Protein Research, Texas Tech University Health Sciences Center, Lubbock, Texas 79430.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Reuss</LastName>
<ForeName>Luis</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>the Department of Cell Physiology and Molecular Biophysics, and Center for Membrane Protein Research, Texas Tech University Health Sciences Center, Lubbock, Texas 79430.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Retamal</LastName>
<ForeName>Mauricio A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>From the Centro de Fisiología Celular e Integrativa, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, Chile 7690000 and the Department of Cell Physiology and Molecular Biophysics, and Center for Membrane Protein Research, Texas Tech University Health Sciences Center, Lubbock, Texas 79430 mretamal@udd.cl.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>3R01GM079629-03S1</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01GM79629 AND</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018031">Connexin 43</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017630">Connexins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009942">Organometallic Compounds</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019163">Reducing Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C082917">connexin 46</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C447082">tricarbonyldichlororuthenium (II) dimer</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7U1EE4V452</RegistryNumber>
<NameOfSubstance UI="D002248">Carbon Monoxide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>GAN16C9B8O</RegistryNumber>
<NameOfSubstance UI="D005978">Glutathione</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>IUBMB Life. 2012 May;64(5):378-86</RefSource>
<PMID Version="1">22431507</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Adv Exp Med Biol. 2012;740:777-94</RefSource>
<PMID Version="1">22453969</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Biochem Biophys. 2012 Aug 1;524(1):2-15</RefSource>
<PMID Version="1">22430362</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Membr Biol. 2012 Jun;245(5-6):319-32</RefSource>
<PMID Version="1">22739962</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 2012 Sep;26(9):3649-57</RefSource>
<PMID Version="1">22665389</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Membr Biol. 2012 Aug;245(8):453-63</RefSource>
<PMID Version="1">22825713</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 2012 Dec 3;1487:25-38</RefSource>
<PMID Version="1">22796289</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochim Biophys Acta. 2013 Jan;1828(1):35-50</RefSource>
<PMID Version="1">22796188</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Nov 23;287(48):40826-34</RefSource>
<PMID Version="1">23048025</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Free Radic Biol Med. 2013 Dec;65:1126-33</RefSource>
<PMID Version="1">24044890</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropharmacology. 2013 Dec;75:583-93</RefSource>
<PMID Version="1">23499662</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Redox Biol. 2014;2:430-5</RefSource>
<PMID Version="1">24624332</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Res. 2002 Feb 8;90(2):E17-24</RefSource>
<PMID Version="1">11834719</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci Methods. 2002 Nov 15;121(1):81-92</RefSource>
<PMID Version="1">12393164</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1982 May 25;257(10):5738-44</RefSource>
<PMID Version="1">7068616</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 1997 Jun;11(7):526-34</RefSource>
<PMID Version="1">9212076</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Eye Res. 1997 Sep;65(3):435-43</RefSource>
<PMID Version="1">9299180</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10925-30</RefSource>
<PMID Version="1">9380736</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2005 May;57(5):749-54</RefSource>
<PMID Version="1">15852376</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4475-80</RefSource>
<PMID Version="1">16537412</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hypertension. 2007 Oct;50(4):643-51</RefSource>
<PMID Version="1">17724275</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Res. 2008 Feb 15;102(3):310-8</RefSource>
<PMID Version="1">18079412</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Res. 2008 Feb 15;102(3):273-4</RefSource>
<PMID Version="1">18276922</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Pharmacol. 2008 Aug 20;590(1-3):99-104</RefSource>
<PMID Version="1">18582862</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Cell Physiol. 2009 Jun;296(6):C1356-63</RefSource>
<PMID Version="1">19357237</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Pharmacol. 2009 Oct;158(3):862-71</RefSource>
<PMID Version="1">19694727</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Cell Mol Biol. 2009 Dec;41(6):639-50</RefSource>
<PMID Version="1">19251942</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Cell Physiol. 2010 Jan;298(1):C132-9</RefSource>
<PMID Version="1">19889966</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antioxid Redox Signal. 2010 Mar;12(3):393-404</RefSource>
<PMID Version="1">19686045</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antioxid Redox Signal. 2010 Jul 15;13(2):157-92</RefSource>
<PMID Version="1">19939208</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Cancer. 2010 Aug 15;127(4):839-48</RefSource>
<PMID Version="1">20013805</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gen Physiol. 2010 Jul;136(1):47-62</RefSource>
<PMID Version="1">20584891</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Cell Res. 2010 Sep 10;316(15):2377-89</RefSource>
<PMID Version="1">20595004</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Drug Discov. 2010 Sep;9(9):728-43</RefSource>
<PMID Version="1">20811383</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Eye Res. 2011 Apr;92(4):251-9</RefSource>
<PMID Version="1">21320488</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pflugers Arch. 2011 Jun;461(6):665-75</RefSource>
<PMID Version="1">21301863</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Physiol. 2011 Jul 1;589(Pt 13):3055-62</RefSource>
<PMID Version="1">21521759</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Physiol. 2011 Sep;96(9):836-9</RefSource>
<PMID Version="1">21551266</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antioxid Redox Signal. 2012 Jan 15;16(2):153-63</RefSource>
<PMID Version="1">21864022</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2011 Dec;22(24):4776-86</RefSource>
<PMID Version="1">22031297</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(2):e32531</RefSource>
<PMID Version="1">22393412</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 May 4;287(19):15786-97</RefSource>
<PMID Version="1">22418432</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002248">Carbon Monoxide</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018031">Connexin 43</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000037">antagonists &amp; inhibitors</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017630">Connexins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000037">antagonists &amp; inhibitors</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005978">Glutathione</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006367">HeLa Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D061986">MCF-7 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008564">Membrane Potentials</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009942">Organometallic Compounds</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050050">Protein Carbonylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019163">Reducing Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014982">Xenopus laevis</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276878</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Carbon Monoxide</Keyword>
<Keyword MajorTopicYN="N">Carbonylation</Keyword>
<Keyword MajorTopicYN="N">Connexin</Keyword>
<Keyword MajorTopicYN="N">Hemichannels</Keyword>
<Keyword MajorTopicYN="N">Ion Channel</Keyword>
<Keyword MajorTopicYN="N">Post-translational Modification (PTM)</Keyword>
<Keyword MajorTopicYN="N">Redox Signaling</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25384984</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Amino acid residues 489-503 of dihydropyridine receptor (DHPR) β1a subunit are critical for structural communication between the skeletal muscle DHPR complex and type 1 ryanodine receptor.</ArticleTitle>
<Pagination>
<MedlinePgn>36116-24</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.615526</ELocationID>
<Abstract>
<AbstractText>The β1a subunit is a cytoplasmic component of the dihydropyridine receptor (DHPR) complex that plays an essential role in skeletal muscle excitation-contraction (EC) coupling. Here we investigate the role of the C-terminal end of this auxiliary subunit in the functional and structural communication between the DHPR and the Ca(2+) release channel (RyR1). Progressive truncation of the β1a C terminus showed that deletion of amino acid residues Gln(489) to Trp(503) resulted in a loss of depolarization-induced Ca(2+) release, a severe reduction of L-type Ca(2+) currents, and a lack of tetrad formation as evaluated by freeze-fracture analysis. However, deletion of this domain did not affect expression/targeting or density (Qmax) of the DHPR-α1S subunit to the plasma membrane. Within this motif, triple alanine substitution of residues Leu(496), Leu(500), and Trp(503), which are thought to mediate direct β1a-RyR1 interactions, weakened EC coupling but did not replicate the truncated phenotype. Therefore, these data demonstrate that an amino acid segment encompassing sequence (489)QVQVLTSLRRNLSFW(503) of β1a contains critical determinant(s) for the physical link of DHPR and RyR1, further confirming a direct correspondence between DHPR positioning and DHPR/RyR functional interactions. In addition, our data strongly suggest that the motif Leu(496)-Leu(500)-Trp(503) within the β1a C-terminal tail plays a nonessential role in the bidirectional DHPR/RyR1 signaling that supports skeletal-type EC coupling. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Eltit</LastName>
<ForeName>Jose M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>the Department of Physiology and Biophysics, School of Medicine, Virginia Commonwealth University, Richmond, Virgina 23298, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Franzini-Armstrong</LastName>
<ForeName>Clara</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>the Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Perez</LastName>
<ForeName>Claudio F</ForeName>
<Initials>CF</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Anesthesiology Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, cperez@zeus.bwh.harvard.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>2P01AR052354</GrantID>
<Acronym>AR</Acronym>
<Agency>NIAMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL48093</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R03 AR066359</GrantID>
<Acronym>AR</Acronym>
<Agency>NIAMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R03AR066359</GrantID>
<Acronym>AR</Acronym>
<Agency>NIAMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C492923">Cacnb1 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D020746">Calcium Channels, L-Type</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D021122">Protein Subunits</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019837">Ryanodine Receptor Calcium Release Channel</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7046-51</RefSource>
<PMID Version="1">21482776</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biophys J. 2011 Feb 16;100(4):922-30</RefSource>
<PMID Version="1">21320436</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7488-93</RefSource>
<PMID Version="1">23589859</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Channels (Austin). 2012 Jan-Feb;6(1):26-40</RefSource>
<PMID Version="1">22522946</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biophys J. 2014 Feb 4;106(3):535-47</RefSource>
<PMID Version="1">24507594</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biophys J. 1999 Dec;77(6):2953-67</RefSource>
<PMID Version="1">10585919</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2001 May 25;276(21):17732-8</RefSource>
<PMID Version="1">11278546</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6935-40</RefSource>
<PMID Version="1">11371610</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biophys J. 2003 Jan;84(1):220-37</RefSource>
<PMID Version="1">12524277</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2004 Jun 10;429(6992):671-5</RefSource>
<PMID Version="1">15141227</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2004 Jun 10;429(6992):675-80</RefSource>
<PMID Version="1">15170217</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biophys J. 2004 Aug;87(2):929-42</RefSource>
<PMID Version="1">15298900</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2004 Sep 3;342(1):145-53</RefSource>
<PMID Version="1">15313613</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1986 Mar 13-19;320(6058):168-70</RefSource>
<PMID Version="1">2419767</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1988 Nov 10;336(6195):134-9</RefSource>
<PMID Version="1">2903448</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1989 Jan 25;264(3):1345-8</RefSource>
<PMID Version="1">2536362</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Biol. 1989 Jun;133(2):456-67</RefSource>
<PMID Version="1">2731637</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1990 Aug 9;346(6284):569-72</RefSource>
<PMID Version="1">2165571</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gen Physiol. 1994 Jan;103(1):107-23</RefSource>
<PMID Version="1">8169594</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gen Physiol. 1994 Jan;103(1):125-47</RefSource>
<PMID Version="1">8169595</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biophys J. 1994 Aug;67(2):793-803</RefSource>
<PMID Version="1">7948692</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3381-5</RefSource>
<PMID Version="1">7724570</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1996 Mar 7;380(6569):72-5</RefSource>
<PMID Version="1">8598910</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13961-6</RefSource>
<PMID Version="1">8943043</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):1019-22</RefSource>
<PMID Version="1">9023375</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 1997 May 19;137(4):859-70</RefSource>
<PMID Version="1">9151688</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biophys J. 1997 Aug;73(2):807-18</RefSource>
<PMID Version="1">9251797</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 1998 Feb 23;140(4):831-42</RefSource>
<PMID Version="1">9472035</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1998 Sep 25;273(39):24983-6</RefSource>
<PMID Version="1">9737952</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1999 Jul 30;274(31):21913-9</RefSource>
<PMID Version="1">10419512</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2004 Dec;15(12):5408-19</RefSource>
<PMID Version="1">15385628</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biol Res. 2004;37(4):565-75</RefSource>
<PMID Version="1">15709683</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Calcium. 2005 Jul;38(1):35-44</RefSource>
<PMID Version="1">15955561</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Muscle Res Cell Motil. 2005;26(1):1-6</RefSource>
<PMID Version="1">16088377</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17219-24</RefSource>
<PMID Version="1">16286639</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19225-30</RefSource>
<PMID Version="1">16357209</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19760-5</RefSource>
<PMID Version="1">17172444</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2008 Feb 15;111(4):2280-9</RefSource>
<PMID Version="1">18042799</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biophys J. 2008 Apr 15;94(8):3023-34</RefSource>
<PMID Version="1">18192372</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2009 Jan 9;284(2):1242-51</RefSource>
<PMID Version="1">19008220</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Cell Res. 2010 Jul 15;316(12):1966-76</RefSource>
<PMID Version="1">20381487</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gen Physiol. 2010 Jun;135(6):629-40</RefSource>
<PMID Version="1">20479108</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Calcium. 2010 Jun;47(6):500-6</RefSource>
<PMID Version="1">20451250</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 2012 Dec;26(12):5049-59</RefSource>
<PMID Version="1">22962299</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020816">Amino Acid Motifs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020746">Calcium Channels, L-Type</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056966">Excitation Contraction Coupling</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057927">Hydrophobic and Hydrophilic Interactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008564">Membrane Potentials</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021122">Protein Subunits</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021381">Protein Transport</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019837">Ryanodine Receptor Calcium Release Channel</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276875</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Ca2+ Current</Keyword>
<Keyword MajorTopicYN="N">Ca2+ Release</Keyword>
<Keyword MajorTopicYN="N">Calcium Intracellular Release</Keyword>
<Keyword MajorTopicYN="N">Charge Movement</Keyword>
<Keyword MajorTopicYN="N">Patch Clamp</Keyword>
<Keyword MajorTopicYN="N">Retrograde Signaling</Keyword>
<Keyword MajorTopicYN="N">Ryanodine Receptor</Keyword>
<Keyword MajorTopicYN="N">Signal Transduction</Keyword>
<Keyword MajorTopicYN="N">Skeletal Muscle</Keyword>
<Keyword MajorTopicYN="N">Tetrad Array</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25389287</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Knockout of nuclear high molecular weight FGF2 isoforms in mice modulates bone and phosphate homeostasis.</ArticleTitle>
<Pagination>
<MedlinePgn>36303-14</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.619569</ELocationID>
<Abstract>
<AbstractText>We previously reported that targeted overexpression of the fibroblast growth factor 2 (FGF2) high molecular weight (HMW) isoforms in osteoblastic lineage cells in mice resulted in phenotypic changes, including dwarfism, rickets, osteomalacia, hypophosphatemia, increased serum parathyroid hormone, and increased levels of the phosphatonin FGF23 in serum and bone. This study examined the effects of genetically knocking out the FGF2HMW isoforms (HMWKO) on bone and phosphate homeostasis. HMWKO mice were not dwarfed and had significantly increased bone mineral density and bone mineral content in femurs and lumbar vertebrae when compared with the wild-type (WT) littermates. Micro-computed tomography analysis of femurs revealed increased trabecular bone volume, thickness, number, and connective tissue density with decreased trabecular spacing compared with WT. In addition, there was significantly decreased cortical porosity and increased cortical thickness and sub-periosteal area in femurs of HMWKO. Histomorphometric analysis demonstrated increased osteoblast activity and diminished osteoclast activity in the HMWKO. In vitro bone marrow stromal cell cultures showed there was a significant increase in alkaline phosphatase-positive colony number at 1 week in HMWKO. At 3 weeks of culture, the mineralized area was also significantly increased. There was increased expression of osteoblast differentiation marker genes and reduced expression of genes associated with impaired mineralization, including a significant reduction in Fgf23 and Sost mRNA. Normal serum phosphate and parathyroid hormone were observed in HMWKO mice. This study demonstrates a significant negative impact of HMWFGF2 on biological functions in bone and phosphate homeostasis in mice. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Homer-Bouthiette</LastName>
<ForeName>Collin</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Institute for Systems Genomics, University of Connecticut Health Center, Farmington, Connecticut 06030 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Doetschman</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>the B105 Institute and Department Cellular and Molecular Medicine, University of Arizona, Tucson, Arizona 85724-5217.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Xiao</LastName>
<ForeName>Liping</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Institute for Systems Genomics, University of Connecticut Health Center, Farmington, Connecticut 06030 and xiao@uchc.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hurley</LastName>
<ForeName>Marja M</ForeName>
<Initials>MM</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Institute for Systems Genomics, University of Connecticut Health Center, Farmington, Connecticut 06030 and hurley@nso1.uchc.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>DK098566-01-A1</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DK098566</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010710">Phosphates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D020033">Protein Isoforms</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>103107-01-3</RegistryNumber>
<NameOfSubstance UI="D016222">Fibroblast Growth Factor 2</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.3.1</RegistryNumber>
<NameOfSubstance UI="D000469">Alkaline Phosphatase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2011 Nov;121(11):4393-408</RefSource>
<PMID Version="1">21985788</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 2011 Aug;25(8):2551-62</RefSource>
<PMID Version="1">21507898</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Endocrinol. 2012 May;8(5):276-86</RefSource>
<PMID Version="1">22249518</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bone Miner Res. 2013 Jan;28(1):35-45</RefSource>
<PMID Version="1">22836867</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Orthop Res. 2011 Mar;29(3):414-8</RefSource>
<PMID Version="1">20939046</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Osteoporos Rep. 2011 Jun;9(2):103-8</RefSource>
<PMID Version="1">21404002</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 2000 Feb 18;468(1):6-10</RefSource>
<PMID Version="1">10683430</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Biochem Cell Biol. 2000 Mar;32(3):263-7</RefSource>
<PMID Version="1">10716624</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2000 Apr;105(8):1085-93</RefSource>
<PMID Version="1">10772653</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2000 Nov;106(9):1095-103</RefSource>
<PMID Version="1">11067862</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2002 Feb 8;277(6):4388-94</RefSource>
<PMID Version="1">11741887</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2001 May 1;29(9):e45</RefSource>
<PMID Version="1">11328886</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Osteoporos Int. 2003;14 Suppl 3:S13-8</RefSource>
<PMID Version="1">12730800</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biol Cell. 2003 May-Jun;95(3-4):169-78</RefSource>
<PMID Version="1">12867081</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Mater. 2003 Aug;2(8):552-8</RefSource>
<PMID Version="1">12872163</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biochem. 2003 Nov 1;90(4):662-91</RefSource>
<PMID Version="1">14587025</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Endocrinology. 2004 Jul;145(7):3087-94</RefSource>
<PMID Version="1">14988389</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cardiovasc Res. 2004 Aug 15;63(3):458-66</RefSource>
<PMID Version="1">15276471</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bone Miner Res. 1987 Dec;2(6):595-610</RefSource>
<PMID Version="1">3455637</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1989 Mar;86(6):1836-40</RefSource>
<PMID Version="1">2538817</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Orthop Relat Res. 1990 Aug;(257):231-48</RefSource>
<PMID Version="1">2199121</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 1995 Dec;6(12):1861-73</RefSource>
<PMID Version="1">8590811</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 1997 Mar 15;99(6):1200-9</RefSource>
<PMID Version="1">9077527</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1997 Nov 6;390(6655):45-51</RefSource>
<PMID Version="1">9363890</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 1999 Jan;19(1):505-14</RefSource>
<PMID Version="1">9858574</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bone Miner Res. 1999 May;14(5):776-83</RefSource>
<PMID Version="1">10320526</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biochem. 2005 May 1;95(1):83-94</RefSource>
<PMID Version="1">15723277</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cytokine Growth Factor Rev. 2005 Apr;16(2):221-32</RefSource>
<PMID Version="1">15863037</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2006 Mar 10;281(10):6120-3</RefSource>
<PMID Version="1">16436388</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioessays. 2006 May;28(5):504-14</RefSource>
<PMID Version="1">16615083</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Genet. 2006 Nov;38(11):1248-50</RefSource>
<PMID Version="1">17033625</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2006 Dec 7;444(7120):770-4</RefSource>
<PMID Version="1">17086194</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bone Miner Res. 2008 Jun;23(6):939-48</RefSource>
<PMID Version="1">18282132</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2009 Jan 30;284(5):3170-82</RefSource>
<PMID Version="1">19056741</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Dyn. 2009 Feb;238(2):351-7</RefSource>
<PMID Version="1">19105223</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Pharmacol. 2009 Oct;76(4):679-91</RefSource>
<PMID Version="1">19570949</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2010 Jan 22;285(4):2834-46</RefSource>
<PMID Version="1">19933269</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Cell Cardiol. 2010 Jun;48(6):1245-54</RefSource>
<PMID Version="1">20116383</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bone. 2010 Aug;47(2):360-70</RefSource>
<PMID Version="1">20510392</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 2010 Aug 1;429(3):583-92</RefSource>
<PMID Version="1">20507281</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bone Miner Res. 2011 Jul;26(7):1425-36</RefSource>
<PMID Version="1">21312267</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bone. 2011 Sep;49(3):343-8</RefSource>
<PMID Version="1">21645651</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Crit Rev Eukaryot Gene Expr. 2012;22(1):61-86</RefSource>
<PMID Version="1">22339660</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000469">Alkaline Phosphatase</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015519">Bone Density</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001854">Bone Marrow Cells</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000201">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001842">Bone and Bones</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016222">Fibroblast Growth Factor 2</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D006706">Homeostasis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057507">Mice, 129 Strain</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018345">Mice, Knockout</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008970">Molecular Weight</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010006">Osteoblasts</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010710">Phosphates</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020033">Protein Isoforms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276890</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bone</Keyword>
<Keyword MajorTopicYN="N">Fibroblast Growth Factor (FGF)</Keyword>
<Keyword MajorTopicYN="N">RNA</Keyword>
<Keyword MajorTopicYN="N">Transcription Regulation</Keyword>
<Keyword MajorTopicYN="N">Wnt Signaling</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25389292</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Peroxisome proliferator-activated receptor-α-mediated transcription of miR-199a2 attenuates endothelin-1 expression via hypoxia-inducible factor-1α.</ArticleTitle>
<Pagination>
<MedlinePgn>36031-47</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.600775</ELocationID>
<Abstract>
<AbstractText>Endothelin-1, a potent vasoconstrictor, plays an important role in pulmonary hypertension (PH) in sickle cell disease (SCD). Our previous studies show that higher levels of placenta growth factor (PlGF), secreted by erythroid precursor cells, correlate with increased plasma levels of endothelin-1 (ET-1) and other functional markers of PH in SCD. PlGF-mediated ET-1 expression occurs via activation of hypoxia-inducible factor-1α (HIF-1α). However, relatively less is understood regarding how PlGF-mediated expression of HIF-1α and its downstream effector ET-1 are post-transcriptionally regulated. Herein, we show that PlGF treatment of endothelial cells resulted in reduced levels of miR-199a2, which targeted the 3'-UTR of HIF-1α mRNA and concomitantly led to augmented ET-1 expression. Plasma levels of miR-199a2 in SCD subjects were significantly lower with reciprocally high levels of plasma ET-1, unlike unaffected controls. This observation provided a molecular link between miR-199a2 and high levels of ET-1 in SCD. Furthermore, we show that miR-199a2 located in the DNM3os transcription unit was co-transcriptionally regulated by peroxisome proliferator-activated receptor α (PPARα). Binding of the latter to PPARα cis-elements in the promoter of DNM3os was demonstrated by promoter mutational analysis and ChIP. Additionally, we show that fenofibrate, a PPARα agonist, increased the expression of miR-199a2 and DNM3os; the former was responsible for reduced expression of HIF-1α and ET-1. In vivo studies of fenofibrate-fed Berkeley sickle mice resulted in increased levels of miR-199a2 and reduced levels of ET-1 in lung tissues. Our studies provide a potential therapeutic approach whereby fenofibrate-induced miR-199a2 expression can ameliorate PH by reduction of ET-1 levels. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Chen</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Biochemistry and Molecular Biology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mpollo</LastName>
<ForeName>Marthe-Sandrine Eiymo Mwa</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>the Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gonsalves</LastName>
<ForeName>Caryn S</ForeName>
<Initials>CS</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Biochemistry and Molecular Biology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tahara</LastName>
<ForeName>Stanley M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Molecular Microbiology and Immunology, Keck School of Medicine of University of Southern California, Los Angeles, California 90089 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Malik</LastName>
<ForeName>Punam</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>the Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229 Punam.Malik@cchmc.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kalra</LastName>
<ForeName>Vijay K</ForeName>
<Initials>VK</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Biochemistry and Molecular Biology and vkalra@usc.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30-DK048522</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01-HL111372</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D020413">3' Untranslated Regions</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019332">Endothelin-1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C497442">HIF1A protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051795">Hypoxia-Inducible Factor 1, alpha Subunit</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D047493">PPAR alpha</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C531408">mirn199 microRNA, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.6.5.5</RegistryNumber>
<NameOfSubstance UI="D034286">Dynamin III</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2010 Aug 5;116(5):687-92</RefSource>
<PMID Version="1">20395414</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2010 Jul 8;116(1):109-12</RefSource>
<PMID Version="1">20335221</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pharmacol Res. 2011 Jun;63(6):504-11</RefSource>
<PMID Version="1">21419223</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Respir Res. 2011;12:98</RefSource>
<PMID Version="1">21794125</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2012 Feb 3;148(3):399-408</RefSource>
<PMID Version="1">22304911</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Crit Care Med. 2012 Jun 1;185(11):1154-65</RefSource>
<PMID Version="1">22447965</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Oct 12;287(42):35161-9</RefSource>
<PMID Version="1">22932900</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes. 2013 Jan;62(1):261-72</RefSource>
<PMID Version="1">23043158</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):621-8</RefSource>
<PMID Version="1">23329136</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Haematologica. 2013 Mar;98(3):464-72</RefSource>
<PMID Version="1">22983573</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1861-71</RefSource>
<PMID Version="1">23702660</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Free Radic Biol Med. 2013 Sep;64:20-30</RefSource>
<PMID Version="1">23712003</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Metab. 2013 Sep 3;18(3):341-54</RefSource>
<PMID Version="1">24011070</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biochem. 2013 Dec;384(1-2):173-80</RefSource>
<PMID Version="1">24022342</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2014 Feb 7;289(6):3352-64</RefSource>
<PMID Version="1">24347168</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Crit Care Med. 2014 Mar 15;189(6):727-40</RefSource>
<PMID Version="1">24628312</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circulation. 2014 Apr 22;129(16):1650-8</RefSource>
<PMID Version="1">24515990</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>RNA Biol. 2014;11(4):281-94</RefSource>
<PMID Version="1">24643020</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2015 Feb;35(3):514-28</RefSource>
<PMID Version="1">25403488</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Pharmacol Toxicol. 2001;41:851-76</RefSource>
<PMID Version="1">11264479</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2001 Apr 20;276(16):12645-53</RefSource>
<PMID Version="1">11278891</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2003 May 15;170(10):5281-94</RefSource>
<PMID Version="1">12734378</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2003 Aug 15;102(4):1506-14</RefSource>
<PMID Version="1">12714517</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2004 Feb 26;350(9):886-95</RefSource>
<PMID Version="1">14985486</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 1991 Sep;88(3):1054-7</RefSource>
<PMID Version="1">1885767</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1997 Oct 31;278(5339):876-8</RefSource>
<PMID Version="1">9346488</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 1998 Apr 28;245(3):894-9</RefSource>
<PMID Version="1">9588211</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 1998 Oct 1;92(7):2594-6</RefSource>
<PMID Version="1">9746804</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Res. 1999 Sep 3;85(5):394-402</RefSource>
<PMID Version="1">10473669</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genomics. 2005 Jun;85(6):782-9</RefSource>
<PMID Version="1">15885504</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2006 Nov 15;177(10):7211-24</RefSource>
<PMID Version="1">17082639</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):145-56</RefSource>
<PMID Version="1">17237841</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2007 Apr 1;109(7):3088-98</RefSource>
<PMID Version="1">17158223</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2008 Jan 1;111(1):402-10</RefSource>
<PMID Version="1">17848621</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Haematologica. 2008 Jan;93(1):20-6</RefSource>
<PMID Version="1">18166781</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Hematol. 2008 Jan;83(1):4-5</RefSource>
<PMID Version="1">17924550</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2008 Aug 1;112(3):856-65</RefSource>
<PMID Version="1">18411415</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Dyn. 2008 Dec;237(12):3738-48</RefSource>
<PMID Version="1">18985749</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2009 Jan;37(1):123-8</RefSource>
<PMID Version="1">19029138</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2009 Jan 29;113(5):1129-38</RefSource>
<PMID Version="1">18945963</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Biochem. 2009 Mar 15;386(2):251-5</RefSource>
<PMID Version="1">19150324</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Res. 2009 Apr 10;104(7):879-86</RefSource>
<PMID Version="1">19265035</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Haematol. 2009 Dec;147(5):737-43</RefSource>
<PMID Version="1">19775299</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2010 Apr 1;184(7):3878-88</RefSource>
<PMID Version="1">20194722</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arterioscler Thromb Vasc Biol. 2010 May;30(5):894-9</RefSource>
<PMID Version="1">20393155</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2010 May 28;285(22):16713-22</RefSource>
<PMID Version="1">20351105</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hypertension. 2010 Jul;56(1):121-8</RefSource>
<PMID Version="1">20516397</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 2011 Mar 15;434(3):473-82</RefSource>
<PMID Version="1">21175428</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020413">3' Untranslated Regions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001483">Base Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001665">Binding Sites</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D034286">Dynamin III</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019332">Endothelin-1</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051795">Hypoxia-Inducible Factor 1, alpha Subunit</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D035683">MicroRNAs</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000096">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D047493">PPAR alpha</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D034622">RNA Interference</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D014158">Transcription, Genetic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276869</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Endothelin-1</Keyword>
<Keyword MajorTopicYN="N">Hypoxia-inducible Factor (HIF)</Keyword>
<Keyword MajorTopicYN="N">MicroRNA (miRNA)</Keyword>
<Keyword MajorTopicYN="N">Peroxisome Proliferator-activated Receptor (PPAR)</Keyword>
<Keyword MajorTopicYN="N">Pulmonary Hypertension</Keyword>
<Keyword MajorTopicYN="N">Sickle Cell Disease</Keyword>
<Keyword MajorTopicYN="N">Transcription</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25389294</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Structural and biochemical insights into the activation mechanisms of germinal center kinase OSR1.</ArticleTitle>
<Pagination>
<MedlinePgn>35969-78</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.592097</ELocationID>
<Abstract>
<AbstractText>The oxidative stress-responsive 1 (OSR1) kinase belongs to the mammalian STE20-like kinase family. OSR1 is activated by with no lysine [K] (WNKs) kinases, and then it phosphorylates cation-coupled Cl-cotransporters, regulating ion homeostasis and cell volume in mammalian cells. However, the specific mechanisms of OSR1 activation remains poorly defined, largely due to its extremely low basal activity. Here, we dissect in detail the regulatory mechanisms of OSR1 activation from the aspects of autoinhibition, upstream kinase WNK, and the newly identified master regulator mouse protein-25 (MO25). Based on our structural and biochemical studies, we propose a "double lock" model, accounting for the tight autoinhibition of OSR1, an effect that has to be removed by WNK before MO25 further activates OSR1. Particularly, the conserved C-terminal (CCT) domain and αAL helix act together to strongly suppress OSR1 basal activity. WNKs bind to the CCT and trigger its conformational rearrangement to release the kinase domain of OSR1, allowing for MO25 binding and full activation. Finally, the regulatory mechanisms of OSR1 activation were further corroborated by cellular studies of OSR1-regulated cell volume control through WNK-OSR1 signaling pathway. Collectively, these results provide insights into the OSR1 kinase activation to facilitate further functional study. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Chuanchuan</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the National Center for Protein Science Shanghai, State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Feng</LastName>
<ForeName>Miao</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From the National Center for Protein Science Shanghai, State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shi</LastName>
<ForeName>Zhubing</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>From the National Center for Protein Science Shanghai, State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China and School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hao</LastName>
<ForeName>Qian</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>From the National Center for Protein Science Shanghai, State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Song</LastName>
<ForeName>Xiaomin</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>From the National Center for Protein Science Shanghai, State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Wenjia</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>From the National Center for Protein Science Shanghai, State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhao</LastName>
<ForeName>Yun</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>From the National Center for Protein Science Shanghai, State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jiao</LastName>
<ForeName>Shi</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the National Center for Protein Science Shanghai, State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China and jiaoshi@sibcb.ac.cn.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhou</LastName>
<ForeName>Zhaocai</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>From the National Center for Protein Science Shanghai, State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China and zczhou@sibcb.ac.cn.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002135">Calcium-Binding Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C540569">Mo25 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="C588052">OSR1 kinase, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D017346">Protein-Serine-Threonine Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="C498743">WNK1 protein, human</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2002 Dec 27;277(52):50812-9</RefSource>
<PMID Version="1">12386165</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Cell Biol. 2001 May;11(5):220-30</RefSource>
<PMID Version="1">11316611</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioinformatics. 2004 Jan 1;20(1):45-50</RefSource>
<PMID Version="1">14693807</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Struct Mol Biol. 2004 Feb;11(2):193-200</RefSource>
<PMID Version="1">14730349</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2004 Mar 10;23(5):1112-22</RefSource>
<PMID Version="1">14988727</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2004 Mar 19;279(12):11129-36</RefSource>
<PMID Version="1">14707132</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Structure. 2004 Jul;12(7):1303-11</RefSource>
<PMID Version="1">15242606</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1993 Jun 17;363(6430):595-602</RefSource>
<PMID Version="1">8510751</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Struct Mol Biol. 2004 Dec;11(12):1192-7</RefSource>
<PMID Version="1">15543157</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pharmacol Exp Ther. 2005 Apr;313(1):46-55</RefSource>
<PMID Version="1">15608081</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 2005 Oct 1;391(Pt 1):17-24</RefSource>
<PMID Version="1">16083423</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2005 Dec 30;280(52):42685-93</RefSource>
<PMID Version="1">16263722</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2006 Jan;26(2):689-98</RefSource>
<PMID Version="1">16382158</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2006 Feb 10;340(2):535-43</RefSource>
<PMID Version="1">16389068</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Physiol (Oxf). 2006 May-Jun;187(1-2):103-13</RefSource>
<PMID Version="1">16734747</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 2006 Jul 1;397(1):223-31</RefSource>
<PMID Version="1">16669787</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO Rep. 2007 Sep;8(9):839-45</RefSource>
<PMID Version="1">17721439</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 2008 Jan 15;409(2):321-31</RefSource>
<PMID Version="1">18092945</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Signal. 2008 Jul;20(7):1237-47</RefSource>
<PMID Version="1">18255267</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proteins. 2008 Dec;73(4):1082-7</RefSource>
<PMID Version="1">18831043</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Protein Sci. 2009 Feb;18(2):304-13</RefSource>
<PMID Version="1">19177573</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Biol. 2009 Jun 9;7(6):e1000126</RefSource>
<PMID Version="1">19513107</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pflugers Arch. 2009 Sep;458(5):953-67</RefSource>
<PMID Version="1">19399514</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2009 Dec 18;326(5960):1707-11</RefSource>
<PMID Version="1">19892943</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2010;5(8):e11905</RefSource>
<PMID Version="1">20730082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2011 Mar 1;124(Pt 5):789-800</RefSource>
<PMID Version="1">21321328</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2011 May 4;30(9):1730-41</RefSource>
<PMID Version="1">21423148</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2011 Aug 12;333(6044):843-50</RefSource>
<PMID Version="1">21737702</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Physiol Biochem. 2011;28(6):1219-30</RefSource>
<PMID Version="1">22179010</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2012 Jan 11;32(2):593-8</RefSource>
<PMID Version="1">22238094</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Physiol Rev. 2012 Oct;92(4):1577-617</RefSource>
<PMID Version="1">23073627</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Nov 2;287(45):37673-90</RefSource>
<PMID Version="1">22977235</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Mol Immunol. 2012 Nov;9(6):439-45</RefSource>
<PMID Version="1">22960604</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Cell Physiol. 2012 Dec 1;303(11):C1198-205</RefSource>
<PMID Version="1">23034389</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2013 Feb 15;431(3):604-9</RefSource>
<PMID Version="1">23296203</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Structure. 2013 Mar 5;21(3):449-61</RefSource>
<PMID Version="1">23434407</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):18826-31</RefSource>
<PMID Version="1">24191005</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2014 Feb 10;25(2):166-80</RefSource>
<PMID Version="1">24525233</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Struct Biol. 2014 May;186(2):224-33</RefSource>
<PMID Version="1">24746913</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2014 Jun 20;289(25):17680-8</RefSource>
<PMID Version="1">24811174</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hypertension. 2012 Oct;60(4):981-90</RefSource>
<PMID Version="1">22949526</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2000 Dec;28(3):793-806</RefSource>
<PMID Version="1">11163267</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2003 Jun 16;22(12):3062-72</RefSource>
<PMID Version="1">12805220</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002135">Calcium-Binding Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020134">Catalytic Domain</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D048429">Cell Size</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004789">Enzyme Activation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057809">HEK293 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006706">Homeostasis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D047908">Intracellular Signaling Peptides and Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055503">Protein Multimerization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017346">Protein-Serine-Threonine Kinases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276864</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Enzyme Mechanism</Keyword>
<Keyword MajorTopicYN="N">Homeostasis</Keyword>
<Keyword MajorTopicYN="N">OSR1</Keyword>
<Keyword MajorTopicYN="N">Protein Kinase</Keyword>
<Keyword MajorTopicYN="N">Protein Structure</Keyword>
<Keyword MajorTopicYN="N">Protein-Protein Interaction</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25391656</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>MicroRNA-200 is induced by thioredoxin-interacting protein and regulates Zeb1 protein signaling and beta cell apoptosis.</ArticleTitle>
<Pagination>
<MedlinePgn>36275-83</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.592360</ELocationID>
<Abstract>
<AbstractText>Small noncoding microRNAs have emerged as important regulators of cellular processes, but their role in pancreatic beta cells has only started to be elucidated. Loss of pancreatic beta cells is a key factor in the pathogenesis of diabetes, and we have demonstrated that beta cell expression of thioredoxin-interacting protein (TXNIP) is increased in diabetes and causes beta cell apoptosis, whereas TXNIP deficiency is protective against diabetes. Recently, we found that TXNIP also impairs beta cell function by inducing microRNA (miR)-204. Interestingly, using INS-1 beta cells and primary islets, we have now discovered that expression of another microRNA, miR-200, is induced by TXNIP and by diabetes. Furthermore, we found that miR-200 targeted and decreased Zeb1 (zinc finger E-box-binding homeobox 1) and promoted beta cell apoptosis as measured by cleaved caspase-3 levels, Bax/Bcl2 ratio, and TUNEL. In addition, Zeb1 knockdown mimicked the miR-200 effects on beta cell apoptosis, suggesting that Zeb1 plays an important role in mediating miR-200 effects. Moreover, miR-200 increased beta cell expression of the epithelial marker E-cadherin, consistent with inhibition of epithelial-mesenchymal transition, a process thought to be involved in beta cell expansion. Thus, we have identified a novel TXNIP/miR-200/Zeb1/E-cadherin signaling pathway that, for the first time, links miR-200 to beta cell apoptosis and diabetes and also beta cell TXNIP to epithelial-mesenchymal transition. In addition, our results shed new light on the regulation and function of miR-200 in beta cells and show that TXNIP-induced microRNAs control various processes of beta cell biology. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Filios</LastName>
<ForeName>Stephen R</ForeName>
<Initials>SR</Initials>
<AffiliationInfo>
<Affiliation>From the Comprehensive Diabetes Center and Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294-2182.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Xu</LastName>
<ForeName>Guanlan</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>From the Comprehensive Diabetes Center and Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294-2182.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Junqin</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Comprehensive Diabetes Center and Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294-2182.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hong</LastName>
<ForeName>Kyunghee</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>From the Comprehensive Diabetes Center and Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294-2182.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jing</LastName>
<ForeName>Gu</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>From the Comprehensive Diabetes Center and Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294-2182.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shalev</LastName>
<ForeName>Anath</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Comprehensive Diabetes Center and Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294-2182 shalev@uab.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 DK-078752</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DK078752</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064200">Cdh1 Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018398">Homeodomain Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C555600">MIRN200 microRNA, rat</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C493796">TXNIP protein, rat</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C101171">Tcf8 protein, rat</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2010 Jul 22;29(29):4237-44</RefSource>
<PMID Version="1">20498632</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2010 Jun 25;38(6):908-15</RefSource>
<PMID Version="1">20620960</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO Rep. 2010 Sep;11(9):670-7</RefSource>
<PMID Version="1">20706219</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2010 Sep 10;39(5):761-72</RefSource>
<PMID Version="1">20832727</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Cycle. 2010 Oct 15;9(20):4077-9</RefSource>
<PMID Version="1">20948307</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Cancer. 2011 Mar 15;128(6):1327-34</RefSource>
<PMID Version="1">20473948</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Death Differ. 2011 Oct;18(10):1628-39</RefSource>
<PMID Version="1">21527937</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2011;6(9):e25566</RefSource>
<PMID Version="1">21984932</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2011;6(11):e27840</RefSource>
<PMID Version="1">22132151</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2011 Dec 15;71(24):7670-82</RefSource>
<PMID Version="1">21987723</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2013 May 15;126(Pt 10):2256-66</RefSource>
<PMID Version="1">23525011</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2013 Sep;19(9):1141-6</RefSource>
<PMID Version="1">23975026</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Lett. 2013 Oct 28;340(1):72-81</RefSource>
<PMID Version="1">23851184</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(12):e83991</RefSource>
<PMID Version="1">24391862</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2001 Dec 13;414(6865):792-8</RefSource>
<PMID Version="1">11742411</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Endocrinology. 2002 Feb;143(2):339-42</RefSource>
<PMID Version="1">11796484</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Endocrinology. 2002 Sep;143(9):3695-8</RefSource>
<PMID Version="1">12193586</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2004 Sep;114(6):828-36</RefSource>
<PMID Version="1">15372107</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Anat (Basel). 1995;154(1):8-20</RefSource>
<PMID Version="1">8714286</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2004 Nov 11;432(7014):226-30</RefSource>
<PMID Version="1">15538371</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2004 Dec 24;306(5705):2261-4</RefSource>
<PMID Version="1">15564314</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Endocrinology. 2005 May;146(5):2397-405</RefSource>
<PMID Version="1">15705778</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2005;33(8):2697-706</RefSource>
<PMID Version="1">15891114</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes. 2007 Mar;56(3):699-702</RefSource>
<PMID Version="1">17327438</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes. 2008 Apr;57(4):938-44</RefSource>
<PMID Version="1">18171713</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 2008 Apr 1;22(7):894-907</RefSource>
<PMID Version="1">18381893</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Cell Biol. 2008 May;10(5):593-601</RefSource>
<PMID Version="1">18376396</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2008 May 30;283(22):14910-4</RefSource>
<PMID Version="1">18411277</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO Rep. 2008 Jun;9(6):582-9</RefSource>
<PMID Version="1">18483486</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Cell. 2008 Jun;14(6):818-29</RefSource>
<PMID Version="1">18539112</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 2008 Oct;22(10):3581-94</RefSource>
<PMID Version="1">18552236</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2008 Oct 1;68(19):7846-54</RefSource>
<PMID Version="1">18829540</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5813-8</RefSource>
<PMID Version="1">19289822</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2009;4(7):e6417</RefSource>
<PMID Version="1">19641613</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Cancer Res. 2009 Aug 15;15(16):5060-72</RefSource>
<PMID Version="1">19671845</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes. 2010 Feb;59(2):440-7</RefSource>
<PMID Version="1">19875615</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2010 Feb 5;285(6):3997-4005</RefSource>
<PMID Version="1">19959470</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Breast Cancer Res. 2010;12(2):201</RefSource>
<PMID Version="1">20346098</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2010 Jul 29;29(30):4297-306</RefSource>
<PMID Version="1">20514023</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017209">Apoptosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001483">Base Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001665">Binding Sites</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002352">Carrier Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D064200">Cdh1 Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002460">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003920">Diabetes Mellitus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018398">Homeodomain Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050417">Insulin-Secreting Cells</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008809">Mice, Inbred C3H</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008822">Mice, Transgenic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D035683">MicroRNAs</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000096">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051381">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015398">Signal Transduction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014157">Transcription Factors</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015533">Transcriptional Activation</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276888</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Apoptosis</Keyword>
<Keyword MajorTopicYN="N">Beta Cell (β-Cell)</Keyword>
<Keyword MajorTopicYN="N">Diabetes</Keyword>
<Keyword MajorTopicYN="N">Epithelial-Mesenchymal Transition (EMT)</Keyword>
<Keyword MajorTopicYN="N">MicroRNA (miRNA)</Keyword>
<Keyword MajorTopicYN="N">TXNIP</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25391657</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>A splice variant of the human ion channel TRPM2 modulates neuroblastoma tumor growth through hypoxia-inducible factor (HIF)-1/2α.</ArticleTitle>
<Pagination>
<MedlinePgn>36284-302</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.620922</ELocationID>
<Abstract>
<AbstractText>The calcium-permeable ion channel TRPM2 is highly expressed in a number of cancers. In neuroblastoma, full-length TRPM2 (TRPM2-L) protected cells from moderate oxidative stress through increased levels of forkhead box transcription factor 3a (FOXO3a) and superoxide dismutase 2. Cells expressing the dominant negative short isoform (TRPM2-S) had reduced FOXO3a and superoxide dismutase 2 levels, reduced calcium influx in response to oxidative stress, and enhanced reactive oxygen species, leading to decreased cell viability. Here, in xenografts generated with SH-SY5Y neuroblastoma cells stably expressing TRPM2 isoforms, growth of tumors expressing TRPM2-S was significantly reduced compared with tumors expressing TRPM2-L. Expression of hypoxia-inducible factor (HIF)-1/2α was significantly reduced in TRPM2-S-expressing tumor cells as was expression of target proteins regulated by HIF-1/2α including those involved in glycolysis (lactate dehydrogenase A and enolase 2), oxidant stress (FOXO3a), angiogenesis (VEGF), mitophagy and mitochondrial function (BNIP3 and NDUFA4L2), and mitochondrial electron transport chain activity (cytochrome oxidase 4.1/4.2 in complex IV). The reduction in HIF-1/2α was mediated through both significantly reduced HIF-1/2α mRNA levels and increased levels of von Hippel-Lindau E3 ligase in TRPM2-S-expressing cells. Inhibition of TRPM2-L by pretreatment with clotrimazole or expression of TRPM2-S significantly increased sensitivity of cells to doxorubicin. Reduced survival of TRPM2-S-expressing cells after doxorubicin treatment was rescued by gain of HIF-1 or -2α function. These data suggest that TRPM2 activity is important for tumor growth and for cell viability and survival following doxorubicin treatment and that interference with TRPM2-L function may be a novel approach to reduce tumor growth through modulation of HIF-1/2α, mitochondrial function, and mitophagy. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Shu-jen</ForeName>
<Initials>SJ</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Pediatrics.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hoffman</LastName>
<ForeName>Nicholas E</ForeName>
<Initials>NE</Initials>
<AffiliationInfo>
<Affiliation>the Center for Translational Medicine and Departments of Biochemistry and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shanmughapriya</LastName>
<ForeName>Santhanam</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>the Center for Translational Medicine and Departments of Biochemistry and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bao</LastName>
<ForeName>Lei</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Pediatrics.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Keefer</LastName>
<ForeName>Kerry</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Pediatrics.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Conrad</LastName>
<ForeName>Kathleen</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Pediatrics.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Merali</LastName>
<ForeName>Salim</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Departments of Biochemistry and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Takahashi</LastName>
<ForeName>Yoshinori</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Pediatrics, Pharmacology.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abraham</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Research Resources, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hirschler-Laszkiewicz</LastName>
<ForeName>Iwona</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Pediatrics.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>JuFang</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>the Center for Translational Medicine and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Xue-Qian</ForeName>
<Initials>XQ</Initials>
<AffiliationInfo>
<Affiliation>the Center for Translational Medicine and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Song</LastName>
<ForeName>Jianliang</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>the Center for Translational Medicine and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barrero</LastName>
<ForeName>Carlos</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Departments of Biochemistry and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shi</LastName>
<ForeName>Yuguang</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Cellular and Molecular Physiology, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kawasawa</LastName>
<ForeName>Yuka Imamura</ForeName>
<Initials>YI</Initials>
<AffiliationInfo>
<Affiliation>Pharmacology, Biochemistry and Molecular Biology, Institute for Personalized Medicine, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bayerl</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Pathology.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sun</LastName>
<ForeName>Tianyu</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Pediatrics.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barbour</LastName>
<ForeName>Mustafa</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Pediatrics.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Hong-Gang</ForeName>
<Initials>HG</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Pediatrics, Pharmacology.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Madesh</LastName>
<ForeName>Muniswamy</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>the Center for Translational Medicine and Departments of Biochemistry and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cheung</LastName>
<ForeName>Joseph Y</ForeName>
<Initials>JY</Initials>
<AffiliationInfo>
<Affiliation>the Center for Translational Medicine and Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Miller</LastName>
<ForeName>Barbara A</ForeName>
<Initials>BA</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Pediatrics, Biochemistry and Molecular Biology, bmiller3@psu.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 DK076685</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01-DK46778</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01-HL58672</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01-HL74854</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01-HL86699</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000903">Antibiotics, Antineoplastic</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051792">Basic Helix-Loop-Helix Transcription Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C497442">HIF1A protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051795">Hypoxia-Inducible Factor 1, alpha Subunit</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D020033">Protein Isoforms</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D050053">TRPM Cation Channels</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C121934">TRPM2 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C105713">endothelial PAS domain-containing protein 1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>80168379AG</RegistryNumber>
<NameOfSubstance UI="D004317">Doxorubicin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2006 Nov;10(5):413-23</RefSource>
<PMID Version="1">17097563</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2006 Dec 29;281(52):40429-39</RefSource>
<PMID Version="1">17079231</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2007 Jan 26;25(2):193-205</RefSource>
<PMID Version="1">17244528</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2007 Apr 6;129(1):111-22</RefSource>
<PMID Version="1">17418790</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Mol Life Sci. 2007 Aug;64(16):2170-80</RefSource>
<PMID Version="1">17514355</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2007 Dec 21;282(51):37064-73</RefSource>
<PMID Version="1">17965024</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2008 Feb 22;366(4):1054-60</RefSource>
<PMID Version="1">18155155</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Res. 2008 Feb 15;102(3):347-55</RefSource>
<PMID Version="1">18048770</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2008 Apr 18;283(16):10892-903</RefSource>
<PMID Version="1">18281291</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2008 Jul;14(7):738-47</RefSource>
<PMID Version="1">18542050</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2008 Sep 5;283(36):24571-83</RefSource>
<PMID Version="1">18599483</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Res. 2008 Nov;18(11):1128-40</RefSource>
<PMID Version="1">18957938</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):18029-34</RefSource>
<PMID Version="1">19004782</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Cancer Biol. 2009 Feb;19(1):12-6</RefSource>
<PMID Version="1">19114105</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2009 May;29(10):2570-81</RefSource>
<PMID Version="1">19273585</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7239-44</RefSource>
<PMID Version="1">19372375</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Drug Discov. 2009 Jul;8(7):579-91</RefSource>
<PMID Version="1">19478820</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gen Physiol. 2009 Dec;134(6):471-88</RefSource>
<PMID Version="1">19917732</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Cancer Res. 2009 Dec 1;15(23):7130-6</RefSource>
<PMID Version="1">19903792</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurotoxicology. 2010 Mar;31(2):204-14</RefSource>
<PMID Version="1">20064552</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):6064-9</RefSource>
<PMID Version="1">20231460</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Physiol. 2010 Apr 15;588(Pt 8):1227-40</RefSource>
<PMID Version="1">20194125</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2010 Jul 23;142(2):270-83</RefSource>
<PMID Version="1">20655468</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2010 Sep 24;285(39):30091-102</RefSource>
<PMID Version="1">20650899</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Cardiol. 2010 Oct;7(10):564-75</RefSource>
<PMID Version="1">20842180</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Microsc Microanal. 2010 Dec;16(6):710-24</RefSource>
<PMID Version="1">20946701</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Adv Exp Med Biol. 2011;704:531-44</RefSource>
<PMID Version="1">21290315</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Heart Circ Physiol. 2011 Mar;300(3):H859-68</RefSource>
<PMID Version="1">21193587</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pediatr Cardiol. 2011 Mar;32(3):267-74</RefSource>
<PMID Version="1">21210091</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Physiol. 2011 Apr 1;589(Pt 7):1515-25</RefSource>
<PMID Version="1">21135052</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Calcium. 2011 Sep;50(3):242-50</RefSource>
<PMID Version="1">21571367</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Metab. 2011 Dec 7;14(6):768-79</RefSource>
<PMID Version="1">22100406</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Cell Physiol. 2012 Jan 1;302(1):C195-202</RefSource>
<PMID Version="1">21940668</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Immunol. 2012 Jan;13(1):29-34</RefSource>
<PMID Version="1">22101731</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Apr 6;287(15):12455-68</RefSource>
<PMID Version="1">22362782</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(7):e40879</RefSource>
<PMID Version="1">22911714</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Mol Cell Biol. 2012 Sep;13(9):566-78</RefSource>
<PMID Version="1">22850819</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proteomics. 2012 Sep;12(18):2792-6</RefSource>
<PMID Version="1">22833312</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Cancer. 2012 Oct;12(10):685-98</RefSource>
<PMID Version="1">23001348</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2012 Oct 26;151(3):630-44</RefSource>
<PMID Version="1">23101630</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Cell Biol. 2012 Dec;14(12):1336-43</RefSource>
<PMID Version="1">23178883</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):E458-67</RefSource>
<PMID Version="1">23341591</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neoplasia. 2013 Mar;15(3):328-34</RefSource>
<PMID Version="1">23479510</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Cell Physiol. 2013 Mar;304(6):C548-60</RefSource>
<PMID Version="1">23302782</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Heart Circ Physiol. 2013 Apr 1;304(7):H1010-22</RefSource>
<PMID Version="1">23376831</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11011-6</RefSource>
<PMID Version="1">23776229</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(7):e68376</RefSource>
<PMID Version="1">23874603</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Cell Biol. 2013 Aug;25(4):443-8</RefSource>
<PMID Version="1">23478213</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Crit Care Med. 2013 Sep 15;188(6):673-83</RefSource>
<PMID Version="1">23924319</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2014 Mar 14;289(11):7615-29</RefSource>
<PMID Version="1">24492610</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Handb Exp Pharmacol. 2014;222:403-26</RefSource>
<PMID Version="1">24756715</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Physiol. 2010 May 15;588(Pt 10):1661-2</RefSource>
<PMID Version="1">20472899</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mol Genet. 2000 Jan 22;9(2):203-16</RefSource>
<PMID Version="1">10607831</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2001 May 1;61(9):3760-9</RefSource>
<PMID Version="1">11325849</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2001 May 31;411(6837):595-9</RefSource>
<PMID Version="1">11385575</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2001 Aug 17;293(5533):1327-30</RefSource>
<PMID Version="1">11509734</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2002 Jan;9(1):163-73</RefSource>
<PMID Version="1">11804595</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2002 May 28;99(11):7461-6</RefSource>
<PMID Version="1">12032305</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2002 Jun 28;277(26):23150-6</RefSource>
<PMID Version="1">11960981</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2002 Sep 19;419(6904):316-21</RefSource>
<PMID Version="1">12239572</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2002 Dec 13;277(50):48303-10</RefSource>
<PMID Version="1">12377790</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2003 Mar 28;278(13):11002-6</RefSource>
<PMID Version="1">12529379</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2003 May 2;278(18):16222-9</RefSource>
<PMID Version="1">12594222</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2003 Dec 26;115(7):863-77</RefSource>
<PMID Version="1">14697204</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropharmacology. 2004 Sep;47(3):450-60</RefSource>
<PMID Version="1">15275834</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Pharmacol. 2004 Sep;143(1):186-92</RefSource>
<PMID Version="1">15302683</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol Methods. 1991 Sep 13;142(2):257-65</RefSource>
<PMID Version="1">1919029</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1996 May 24;271(21):12610-6</RefSource>
<PMID Version="1">8647872</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 1997 Jan 1;89(1):92-100</RefSource>
<PMID Version="1">8978281</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 1998 Apr 1;58(7):1515-20</RefSource>
<PMID Version="1">9537257</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genomics. 1998 Nov 15;54(1):124-31</RefSource>
<PMID Version="1">9806837</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1999 Jul 16;274(29):20465-72</RefSource>
<PMID Version="1">10400674</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Naunyn Schmiedebergs Arch Pharmacol. 2004 Oct;370(4):227-37</RefSource>
<PMID Version="1">15549272</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2004 Dec 15;104(13):3993-4001</RefSource>
<PMID Version="1">15328163</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2005 Feb 11;280(6):4321-8</RefSource>
<PMID Version="1">15569687</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2005 Mar 25;328(4):1232-43</RefSource>
<PMID Version="1">15708008</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2005 Feb 18;280(7):6138-48</RefSource>
<PMID Version="1">15561722</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2005 Apr 1;18(1):61-9</RefSource>
<PMID Version="1">15808509</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurochem. 2005 Nov;95(3):715-23</RefSource>
<PMID Version="1">16104849</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2006 Feb 3;281(5):2489-96</RefSource>
<PMID Version="1">16316998</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Physiol. 2006;68:619-47</RefSource>
<PMID Version="1">16460286</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 2006 Mar;20(3):466-75</RefSource>
<PMID Version="1">16507764</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2006 Apr 7;281(14):9076-85</RefSource>
<PMID Version="1">16461353</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gen Physiol. 2006 May;127(5):525-37</RefSource>
<PMID Version="1">16636202</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2006 Sep;10(3):175-6</RefSource>
<PMID Version="1">16959608</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000311">Adrenal Glands</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000903">Antibiotics, Antineoplastic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001343">Autophagy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051792">Basic Helix-Loop-Helix Transcription Factors</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D045744">Cell Line, Tumor</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049109">Cell Proliferation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002470">Cell Survival</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015536">Down-Regulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004317">Doxorubicin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015972">Gene Expression Regulation, Neoplastic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051795">Hypoxia-Inducible Factor 1, alpha Subunit</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053078">Membrane Potential, Mitochondrial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008564">Membrane Potentials</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008819">Mice, Nude</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009368">Neoplasm Transplantation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009447">Neuroblastoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020033">Protein Isoforms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021381">Protein Transport</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050053">TRPM Cation Channels</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D047368">Tumor Burden</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276889</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Hypoxia-inducible Factor (HIF)</Keyword>
<Keyword MajorTopicYN="N">Mitochondria</Keyword>
<Keyword MajorTopicYN="N">Mitophagy</Keyword>
<Keyword MajorTopicYN="N">Neuroblastoma</Keyword>
<Keyword MajorTopicYN="N">Oxidative Stress</Keyword>
<Keyword MajorTopicYN="N">TRP</Keyword>
<Keyword MajorTopicYN="N">TRPM</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25395623</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Unfolded protein response-regulated Drosophila Fic (dFic) protein reversibly AMPylates BiP chaperone during endoplasmic reticulum homeostasis.</ArticleTitle>
<Pagination>
<MedlinePgn>36059-69</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.612515</ELocationID>
<Abstract>
<AbstractText>Drosophila Fic (dFic) mediates AMPylation, a covalent attachment of adenosine monophosphate (AMP) from ATP to hydroxyl side chains of protein substrates. Here, we identified the endoplasmic reticulum (ER) chaperone BiP as a substrate for dFic and mapped the modification site to Thr-366 within the ATPase domain. The level of AMPylated BiP in Drosophila S2 cells is high during homeostasis, whereas the level of AMPylated BiP decreases upon the accumulation of misfolded proteins in the ER. Both dFic and BiP are transcriptionally activated upon ER stress, supporting the role of dFic in the unfolded protein response pathway. The inactive conformation of BiP is the preferred substrate for dFic, thus endorsing a model whereby AMPylation regulates the function of BiP as a chaperone, allowing acute activation of BiP by deAMPylation during an ER stress response. These findings not only present the first substrate of eukaryotic AMPylator but also provide a target for regulating the unfolded protein response, an emerging avenue for cancer therapy. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ham</LastName>
<ForeName>Hyeilin</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Molecular Biology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Woolery</LastName>
<ForeName>Andrew R</ForeName>
<Initials>AR</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Molecular Biology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tracy</LastName>
<ForeName>Charles</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Neuroscience, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stenesen</LastName>
<ForeName>Drew</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Neuroscience, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Krämer</LastName>
<ForeName>Helmut</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Neuroscience, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Orth</LastName>
<ForeName>Kim</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Molecular Biology and kim.orth@utsouthwestern.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>5T32GM008203</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 EY021922</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 EY021922</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01-AI056404</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D029721">Drosophila Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D050883">HSC70 Heat-Shock Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C570457">Hsc70-3 protein, Drosophila</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>415SHH325A</RegistryNumber>
<NameOfSubstance UI="D000249">Adenosine Monophosphate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.7.-</RegistryNumber>
<NameOfSubstance UI="C574946">Fic protein, Drosophila</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.7.-</RegistryNumber>
<NameOfSubstance UI="D009713">Nucleotidyltransferases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Cold Spring Harb Perspect Biol. 2013 Mar;5(3):a013169</RefSource>
<PMID Version="1">23388626</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2012 Dec 7;151(6):1296-307</RefSource>
<PMID Version="1">23217711</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anticancer Res. 2013 Nov;33(11):4683-94</RefSource>
<PMID Version="1">24222102</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Chem Biol. 2013 Dec;9(12):811-7</RefSource>
<PMID Version="1">24141193</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Biochem Sci. 2014 Mar;39(3):121-9</RefSource>
<PMID Version="1">24507752</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2014 Mar 14;289(11):7788-98</RefSource>
<PMID Version="1">24448800</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2014 Mar 17;204(6):869-79</RefSource>
<PMID Version="1">24637321</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Cell Biol. 2014 Sep;24(9):506-14</RefSource>
<PMID Version="1">24946960</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2014 Nov 21;289(47):32977-88</RefSource>
<PMID Version="1">25301945</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 1998 Apr 1;12(7):982-95</RefSource>
<PMID Version="1">9531536</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Cell Dev Biol. 1999 Oct;10(5):465-72</RefSource>
<PMID Version="1">10597629</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2000 Jun 30;275(26):19620-7</RefSource>
<PMID Version="1">10777498</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2002 May 3;277(18):15947-56</RefSource>
<PMID Version="1">11836248</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2002 Dec 6;277(49):47557-63</RefSource>
<PMID Version="1">12356756</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1967 Aug;58(2):642-9</RefSource>
<PMID Version="1">4860756</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1967 Oct;58(4):1703-10</RefSource>
<PMID Version="1">4867671</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1983 Aug;80(15):4664-8</RefSource>
<PMID Version="1">6576354</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1986 Jul 18;46(2):291-300</RefSource>
<PMID Version="1">3087629</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 1990 Dec 10;276(1-2):29-33</RefSource>
<PMID Version="1">2265706</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioessays. 1990 Nov;12(11):527-31</RefSource>
<PMID Version="1">2085319</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Biochem Biophys. 1991 Sep;289(2):256-61</RefSource>
<PMID Version="1">1910317</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 1992 Apr;11(4):1563-71</RefSource>
<PMID Version="1">1373378</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 1992 Aug;6(8):1402-13</RefSource>
<PMID Version="1">1644286</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1993 Jun 15;268(17):12691-8</RefSource>
<PMID Version="1">8509403</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Experientia. 1994 Nov 30;50(11-12):1012-20</RefSource>
<PMID Version="1">7988659</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biochem. 1994 Sep;138(1-2):141-8</RefSource>
<PMID Version="1">7898457</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1996 Sep 20;273(5282):1725-8</RefSource>
<PMID Version="1">8781238</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Structure. 1997 Mar 15;5(3):403-14</RefSource>
<PMID Version="1">9083109</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 1997 Jun 30;137(7):1483-93</RefSource>
<PMID Version="1">9199165</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Stress Chaperones. 1997 Dec;2(4):252-62</RefSource>
<PMID Version="1">9495282</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 1998 Jan;1(2):171-82</RefSource>
<PMID Version="1">9659914</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 1998 Dec;9(12):3533-45</RefSource>
<PMID Version="1">9843586</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Mol Med. 2006 Feb;6(1):45-54</RefSource>
<PMID Version="1">16472112</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2006 May 5;125(3):443-51</RefSource>
<PMID Version="1">16678092</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2006 Jun 7;25(11):2519-28</RefSource>
<PMID Version="1">16688212</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Mol Life Sci. 2006 Nov;63(22):2560-70</RefSource>
<PMID Version="1">16952052</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Mol Biol. 2007;362:415-22</RefSource>
<PMID Version="1">17417030</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2007 Apr 13;26(1):27-39</RefSource>
<PMID Version="1">17434124</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cancer Res. 2008 Aug;6(8):1268-75</RefSource>
<PMID Version="1">18708359</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2008 Nov 5;27(21):2862-72</RefSource>
<PMID Version="1">18923430</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Mol Cell Biol. 2008 Dec;9(12):944-57</RefSource>
<PMID Version="1">19002207</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2009 Jan 9;323(5911):269-72</RefSource>
<PMID Version="1">19039103</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2009 Apr 10;34(1):93-103</RefSource>
<PMID Version="1">19362538</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2009;4(6):e5818</RefSource>
<PMID Version="1">19503829</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antioxid Redox Signal. 2009 Sep;11(9):2307-16</RefSource>
<PMID Version="1">19309259</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biochem. 2009 Dec;146(6):743-50</RefSource>
<PMID Version="1">19861400</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2010 Apr 16;285(16):12445-53</RefSource>
<PMID Version="1">20177057</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2010 Aug 20;329(5994):946-9</RefSource>
<PMID Version="1">20651120</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biotechnol. 2011 Feb 10;151(3):251-4</RefSource>
<PMID Version="1">21185336</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Cell Biol. 2011 Apr;23(2):150-6</RefSource>
<PMID Version="1">20970977</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Formos Med Assoc. 2011 Jul;110(7):428-37</RefSource>
<PMID Version="1">21742246</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2011 Jul 28;475(7357):506-9</RefSource>
<PMID Version="1">21734656</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2011 Sep 1;477(7362):103-6</RefSource>
<PMID Version="1">21822290</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2012 Feb 2;482(7383):107-10</RefSource>
<PMID Version="1">22266942</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2012 May 3;485(7396):114-8</RefSource>
<PMID Version="1">22504181</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2012 Aug 6;198(3):371-85</RefSource>
<PMID Version="1">22869598</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2012 Jun;15(6):871-5</RefSource>
<PMID Version="1">22544313</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cold Spring Harb Perspect Biol. 2013 Sep;5(9). pii: a013185. doi: 10.1101/cshperspect.a013185</RefSource>
<PMID Version="1">23232094</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000249">Adenosine Monophosphate</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020134">Catalytic Domain</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002460">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D029721">Drosophila Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004331">Drosophila melanogaster</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000201">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004721">Endoplasmic Reticulum</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059865">Endoplasmic Reticulum Stress</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050883">HSC70 Heat-Shock Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006706">Homeostasis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009713">Nucleotidyltransferases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011499">Protein Processing, Post-Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014158">Transcription, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D056811">Unfolded Protein Response</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015854">Up-Regulation</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276871</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">AMP</Keyword>
<Keyword MajorTopicYN="N">AMPylation</Keyword>
<Keyword MajorTopicYN="N">Adenosine</Keyword>
<Keyword MajorTopicYN="N">BiP</Keyword>
<Keyword MajorTopicYN="N">Chaperone</Keyword>
<Keyword MajorTopicYN="N">Drosophila</Keyword>
<Keyword MajorTopicYN="N">ER Stress</Keyword>
<Keyword MajorTopicYN="N">Unfolded Protein Response (UPR)</Keyword>
<Keyword MajorTopicYN="N">grp78</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25395624</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Development and characterization of pepducins as Gs-biased allosteric agonists.</ArticleTitle>
<Pagination>
<MedlinePgn>35668-84</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.618819</ELocationID>
<Abstract>
<AbstractText>The β2-adrenergic receptor (β2AR) is a prototypical G protein-coupled receptor that mediates many hormonal responses, including cardiovascular and pulmonary function. β-Agonists used to combat hypercontractility in airway smooth muscle stimulate β2AR-dependent cAMP production that ultimately promotes airway relaxation. Chronic stimulation of the β2AR by long acting β-agonists used in the treatment of asthma can promote attenuated responsiveness to agonists and an increased frequency of fatal asthmatic attacks. β2AR desensitization to β-agonists is primarily mediated by G protein-coupled receptor kinases and β-arrestins that attenuate receptor-Gs coupling and promote β2AR internalization and degradation. A biased agonist that can selectively stimulate Gs signaling without promoting receptor interaction with G protein-coupled receptor kinases and β-arrestins should serve as an advantageous asthma therapeutic. To identify such molecules, we screened ∼50 lipidated peptides derived from the intracellular loops of the β2AR, known as pepducins. This screen revealed two classes of Gs-biased pepducins, receptor-independent and receptor-dependent, as well as several β-arrestin-biased pepducins. The receptor-independent Gs-biased pepducins operate by directly stimulating G protein activation. In contrast, receptor-dependent Gs-biased pepducins appear to stabilize a Gs-biased conformation of the β2AR that couples to Gs but does not undergo G protein-coupled receptor kinase-mediated phosphorylation or β-arrestin-mediated internalization. Functional studies in primary human airway smooth muscle cells demonstrate that Gs-biased pepducins are not subject to conventional desensitization and thus may be good candidates for the development of next generation asthma therapeutics. Our study reports the first Gs-biased activator of the β2AR and provides valuable tools for the study of β2AR function. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Carr</LastName>
<ForeName>Richard</ForeName>
<Initials>R</Initials>
<Suffix>3rd</Suffix>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Du</LastName>
<ForeName>Yang</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>the Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California 94305.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Quoyer</LastName>
<ForeName>Julie</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>the Department of Biochemistry and Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Quebec H3C 3J7, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Panettieri</LastName>
<ForeName>Reynold A</ForeName>
<Initials>RA</Initials>
<Suffix>Jr</Suffix>
<AffiliationInfo>
<Affiliation>the Department of Medicine, Pulmonary, Allergy and Critical Care Division, Airways Biology Initiative, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Janz</LastName>
<ForeName>Jay M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Anchor Therapeutics, Cambridge, Massachusetts 02139.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bouvier</LastName>
<ForeName>Michel</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>the Department of Biochemistry and Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Quebec H3C 3J7, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kobilka</LastName>
<ForeName>Brian K</ForeName>
<Initials>BK</Initials>
<AffiliationInfo>
<Affiliation>the Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California 94305.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Benovic</LastName>
<ForeName>Jeffrey L</ForeName>
<Initials>JL</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, jeffrey.benovic@jefferson.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>CIHR-11215</GrantID>
<Agency>Canadian Institutes of Health Research</Agency>
<Country>Canada</Country>
</Grant>
<Grant>
<GrantID>P01 HL114471</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P01 HL114471</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 CA056036</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 ES013508</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 ES013508</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 GM044944</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 GM044944</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 GM083118</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 NS028471</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R37 GM047417</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R37 GM047417</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 GM100836</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 GM100836</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000318">Adrenergic beta-Agonists</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019151">Peptide Library</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018343">Receptors, Adrenergic, beta-2</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>E0399OZS9N</RegistryNumber>
<NameOfSubstance UI="D000242">Cyclic AMP</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.6.5.1</RegistryNumber>
<NameOfSubstance UI="D019205">GTP-Binding Protein alpha Subunits, Gs</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Pediatrics. 2011 Nov;128(5):e1147-54</RefSource>
<PMID Version="1">22025595</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2011 Sep 29;477(7366):549-55</RefSource>
<PMID Version="1">21772288</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2012 Mar 2;335(6072):1106-10</RefSource>
<PMID Version="1">22267580</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Apr 13;287(16):12787-96</RefSource>
<PMID Version="1">22374997</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Structure. 2012 Aug 8;20(8):1391-402</RefSource>
<PMID Version="1">22748765</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2013 Jan 31;152(3):532-42</RefSource>
<PMID Version="1">23374348</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Struct Biol. 2013 Jun;182(3):209-18</RefSource>
<PMID Version="1">23523730</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(8):e71980</RefSource>
<PMID Version="1">23977191</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2013 Dec 24;110(52):E5088-97</RefSource>
<PMID Version="1">24309376</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Pharmacol. 2014 Mar;85(3):472-81</RefSource>
<PMID Version="1">24319111</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Pharmacol. 2014 Mar;85(3):492-509</RefSource>
<PMID Version="1">24366668</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Endocrinol. 2014 Mar;28(3):281-94</RefSource>
<PMID Version="1">24433041</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Cell Biol. 2014 Apr;27:63-71</RefSource>
<PMID Version="1">24680432</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Can J Cardiol. 2014 May;30(5 Suppl):S9-S15</RefSource>
<PMID Version="1">24684855</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):643-8</RefSource>
<PMID Version="1">11805322</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2002 Oct;8(10):1161-5</RefSource>
<PMID Version="1">12357249</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2003 Aug;112(4):566-74</RefSource>
<PMID Version="1">12925697</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2003 Sep 15;102(6):2099-107</RefSource>
<PMID Version="1">12763936</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11406-11</RefSource>
<PMID Version="1">13679574</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Pharmacol. 2004 Jan;65(1):196-206</RefSource>
<PMID Version="1">14722251</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol. 1989 Feb;256(2 Pt 1):C329-35</RefSource>
<PMID Version="1">2645779</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1990 Jun 22;248(4962):1547-50</RefSource>
<PMID Version="1">2163110</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 1991 Feb 25;279(2):277-80</RefSource>
<PMID Version="1">1848192</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cardiovasc Res. 1992 May;26(5):518-25</RefSource>
<PMID Version="1">1359930</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1993 Mar 5;268(7):4625-36</RefSource>
<PMID Version="1">8095262</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cardiology. 1993;82 Suppl 3:24-8</RefSource>
<PMID Version="1">8106160</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Pharmacol. 1994 Mar;45(3):390-4</RefSource>
<PMID Version="1">7908404</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Pharmacol. 1994 Mar;45(3):490-9</RefSource>
<PMID Version="1">7908406</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Pharmacol. 1997 May;51(5):711-20</RefSource>
<PMID Version="1">9145909</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1998 Jan 2;273(1):322-8</RefSource>
<PMID Version="1">9417083</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Pharmacol. 1998 Feb;123(4):701-11</RefSource>
<PMID Version="1">9517390</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Cell Mol Biol. 1998 Aug;19(2):338-48</RefSource>
<PMID Version="1">9698608</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Methods. 2005 Mar;2(3):177-84</RefSource>
<PMID Version="1">15782186</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2005 Jun;11(6):661-5</RefSource>
<PMID Version="1">15880119</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biomol Screen. 2005 Aug;10(5):463-75</RefSource>
<PMID Version="1">16093556</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chest. 2006 Jan;129(1):15-26</RefSource>
<PMID Version="1">16424409</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2006 Mar 17;281(11):7684-92</RefSource>
<PMID Version="1">16407241</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Chem Biol. 2006 Aug;2(8):417-22</RefSource>
<PMID Version="1">16799554</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Struct Mol Biol. 2006 Sep;13(9):778-86</RefSource>
<PMID Version="1">16906158</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Signal. 2006 Dec;18(12):2105-20</RefSource>
<PMID Version="1">16828259</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Physiol (Oxf). 2007 May;190(1):9-19</RefSource>
<PMID Version="1">17428228</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Med Chem. 2007 Sep 6;50(18):4534-8</RefSource>
<PMID Version="1">17685505</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16657-62</RefSource>
<PMID Version="1">17925438</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2007 Nov 15;450(7168):383-7</RefSource>
<PMID Version="1">17952055</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2007 Nov 23;318(5854):1266-73</RefSource>
<PMID Version="1">17962519</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2007 Nov 23;318(5854):1258-65</RefSource>
<PMID Version="1">17962520</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Headache. 2008 Jan;48(1):118-25</RefSource>
<PMID Version="1">18184294</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2008 Feb 29;283(9):5669-76</RefSource>
<PMID Version="1">18086673</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 2008 Jul;22(7):2134-41</RefSource>
<PMID Version="1">18337459</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9501-6</RefSource>
<PMID Version="1">19470481</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2010;5(4):e10235</RefSource>
<PMID Version="1">20422032</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Cell Mol Biol. 2010 Sep;43(3):269-75</RefSource>
<PMID Version="1">19805483</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 2010 Sep 24;584(18):4102-8</RefSource>
<PMID Version="1">20804753</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22255-9</RefSource>
<PMID Version="1">21139054</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2011 Jan 13;469(7329):175-80</RefSource>
<PMID Version="1">21228869</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Pharmacol. 2011 May;163(1):4-17</RefSource>
<PMID Version="1">21232045</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Pharmacol Sci. 2011 Apr;32(4):227-34</RefSource>
<PMID Version="1">21429598</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sci Signal. 2011 Aug 9;4(185):ra51</RefSource>
<PMID Version="1">21868357</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18684-9</RefSource>
<PMID Version="1">22031696</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000318">Adrenergic beta-Agonists</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000494">Allosteric Regulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000242">Cyclic AMP</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000096">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019205">GTP-Binding Protein alpha Subunits, Gs</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057809">HEK293 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010446">Peptide Fragments</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019151">Peptide Library</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010766">Phosphorylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011499">Protein Processing, Post-Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017434">Protein Structure, Tertiary</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021381">Protein Transport</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018343">Receptors, Adrenergic, beta-2</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015290">Second Messenger Systems</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276837</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Adrenergic Receptor</Keyword>
<Keyword MajorTopicYN="N">Asthma</Keyword>
<Keyword MajorTopicYN="N">Biased Agonist</Keyword>
<Keyword MajorTopicYN="N">Drug Discovery</Keyword>
<Keyword MajorTopicYN="N">Functional Selectivity</Keyword>
<Keyword MajorTopicYN="N">G Protein-coupled Receptor (GPCR)</Keyword>
<Keyword MajorTopicYN="N">Pepducin</Keyword>
<Keyword MajorTopicYN="N">Peptides</Keyword>
<Keyword MajorTopicYN="N">Signal Transduction</Keyword>
<Keyword MajorTopicYN="N">β2-Adrenergic Receptor</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25398878</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Characterization of the Vibrio vulnificus 1-Cys peroxiredoxin Prx3 and regulation of its expression by the Fe-S cluster regulator IscR in response to oxidative stress and iron starvation.</ArticleTitle>
<Pagination>
<MedlinePgn>36263-74</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.611020</ELocationID>
<Abstract>
<AbstractText>Peroxiredoxins (Prxs) are ubiquitous antioxidant enzymes that reduce toxic peroxides. A new Vibrio vulnificus Prx, named Prx3, was identified and characterized in this study. Biochemical and mutational analyses revealed that Prx3 reduces H2O2, utilizing glutaredoxin 3 (Grx3) and glutathione (GSH) as reductants, and requires only N-terminal peroxidatic cysteine for its catalysis. These results, combined with the monomeric size of Prx3 observed under non-reducing conditions, suggested that Prx3 is a Grx3/GSH-dependent 1-Cys Prx and oxidized without forming intermolecular disulfide bonds. The prx3 mutation impaired growth in the medium containing peroxides and reduced virulence in mice, indicating that Prx3 is essential for survival under oxidative stress and pathogenesis of V. vulnificus. The Fe-S cluster regulator IscR activates prx3 by direct binding to a specific binding sequence centered at -44 from the transcription start site. The binding sequence was homologous to the Type 2 IscR-binding sequence, most likely recognized by the Fe-S clusterless apo-IscR in Escherichia coli. The iscR3CA mutant, chromosomally encoding the apo-locked IscR, exhibited 3-fold higher levels of activation of prx3 than the wild type and accumulated more IscR3CA protein in cells. The IscR-dependent activation of prx3 by aerobic growth and iron starvation was also associated with the increase in cellular levels of IscR protein. Taken together, the results suggested that IscR senses iron starvation as well as reactive oxygen species and shifts to the apo-form, which leads to the increase of cellular IscR and in turn prx3 expression, contributing to the survival and virulence of V. vulnificus during pathogenesis. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lim</LastName>
<ForeName>Jong Gyu</ForeName>
<Initials>JG</Initials>
<AffiliationInfo>
<Affiliation>From the National Research Laboratory of Molecular Microbiology and Toxicology, Department of Agricultural Biotechnology, Center for Food Safety and Toxicology, Seoul National University, Seoul 151-921, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bang</LastName>
<ForeName>Ye-Ji</ForeName>
<Initials>YJ</Initials>
<AffiliationInfo>
<Affiliation>From the National Research Laboratory of Molecular Microbiology and Toxicology, Department of Agricultural Biotechnology, Center for Food Safety and Toxicology, Seoul National University, Seoul 151-921, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Choi</LastName>
<ForeName>Sang Ho</ForeName>
<Initials>SH</Initials>
<AffiliationInfo>
<Affiliation>From the National Research Laboratory of Molecular Microbiology and Toxicology, Department of Agricultural Biotechnology, Center for Food Safety and Toxicology, Seoul National University, Seoul 151-921, South Korea choish@snu.ac.kr.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>E1UOL152H7</RegistryNumber>
<NameOfSubstance UI="D007501">Iron</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.11.1.15</RegistryNumber>
<NameOfSubstance UI="D061105">Peroxiredoxin III</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):14895-900</RefSource>
<PMID Version="1">11742080</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2002 Apr 19;277(16):13609-14</RefSource>
<PMID Version="1">11832487</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2003 May 9;278(19):16658-66</RefSource>
<PMID Version="1">12606554</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Microbiol. 2004 Jan;2(1):57-65</RefSource>
<PMID Version="1">15035009</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 2004 May;52(3):861-72</RefSource>
<PMID Version="1">15101990</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Microbiol. 2004 Oct;2(10):820-32</RefSource>
<PMID Version="1">15378046</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 1981 Apr 5;147(2):217-26</RefSource>
<PMID Version="1">6270337</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 1996 Mar;178(5):1310-9</RefSource>
<PMID Version="1">8631707</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Microbiol Rev. 1997 Jan;10(1):1-18</RefSource>
<PMID Version="1">8993856</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Protein Expr Purif. 1999 Feb;15(1):34-9</RefSource>
<PMID Version="1">10024467</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Microbiol. 1999 Apr;2(2):188-94</RefSource>
<PMID Version="1">10322176</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1999 Oct 22;274(43):30451-8</RefSource>
<PMID Version="1">10521424</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2005 Mar 4;346(4):1021-34</RefSource>
<PMID Version="1">15701514</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 2006 Feb;59(4):1073-82</RefSource>
<PMID Version="1">16430685</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 2006 May;60(4):1058-75</RefSource>
<PMID Version="1">16677314</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 2006 Jul;61(1):206-18</RefSource>
<PMID Version="1">16824106</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2006 Oct 20;281(42):31736-42</RefSource>
<PMID Version="1">16916801</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Subcell Biochem. 2007;44:27-40</RefSource>
<PMID Version="1">18084888</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Subcell Biochem. 2007;44:61-81</RefSource>
<PMID Version="1">18084890</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Subcell Biochem. 2007;44:143-93</RefSource>
<PMID Version="1">18084893</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Biochem. 2008;77:755-76</RefSource>
<PMID Version="1">18173371</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 2009 Feb;191(4):1248-57</RefSource>
<PMID Version="1">19074392</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2009 Mar 20;387(1):28-41</RefSource>
<PMID Version="1">19361432</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS J. 2009 May;276(9):2469-77</RefSource>
<PMID Version="1">19476488</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2009 Oct 13;48(40):9416-26</RefSource>
<PMID Version="1">19737009</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Microbiol. 2009 Oct;47(5):624-32</RefSource>
<PMID Version="1">19851736</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2010 Jan 1;201(1):97-105</RefSource>
<PMID Version="1">19919301</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2010 Feb 16;49(6):1319-30</RefSource>
<PMID Version="1">20078128</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Microbiol. 2010 Jun;8(6):436-46</RefSource>
<PMID Version="1">20467446</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antioxid Redox Signal. 2010 Aug 1;13(3):249-58</RefSource>
<PMID Version="1">20059400</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2010;6(8):e1000949</RefSource>
<PMID Version="1">20711357</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antioxid Redox Signal. 2011 Mar 15;14(6):1049-63</RefSource>
<PMID Version="1">20626317</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Protoc Toxicol. 2011 Aug;Chapter 7:Unit7.9</RefSource>
<PMID Version="1">21818754</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Microbiology. 2012 Aug;158(Pt 8):2017-25</RefSource>
<PMID Version="1">22679105</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Biochem Biophys. 2012 Sep 15;525(2):161-9</RefSource>
<PMID Version="1">22381957</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 2012 Oct;194(20):5495-503</RefSource>
<PMID Version="1">22797754</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Dec 14;287(51):42516-24</RefSource>
<PMID Version="1">23095744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 2013 Feb;87(3):478-92</RefSource>
<PMID Version="1">23075318</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Struct Mol Biol. 2013 Jun;20(6):740-7</RefSource>
<PMID Version="1">23644595</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochim Biophys Acta. 2013 Aug;1830(8):4073-90</RefSource>
<PMID Version="1">23624334</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Microbiol. 2013 Jul;11(7):443-54</RefSource>
<PMID Version="1">23712352</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Immun. 2014 Feb;82(2):569-78</RefSource>
<PMID Version="1">24478072</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Microbiol. 2014 May;52(5):413-21</RefSource>
<PMID Version="1">24535746</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2014 Jun;10(6):e1004194</RefSource>
<PMID Version="1">24945271</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Microbiol. 2014 Sep;93(5):992-1009</RefSource>
<PMID Version="1">25041181</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2000 Jan 28;275(4):2924-30</RefSource>
<PMID Version="1">10644761</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2000 Jul 7;275(27):20346-54</RefSource>
<PMID Version="1">10751410</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8841-8</RefSource>
<PMID Version="1">10922044</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 2001 Aug;183(15):4562-70</RefSource>
<PMID Version="1">11443091</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Physiol. 2001 Nov;127(3):1299-309</RefSource>
<PMID Version="1">11706208</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001426">Bacterial Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001483">Base Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001665">Binding Sites</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015964">Gene Expression Regulation, Bacterial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007501">Iron</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008813">Mice, Inbred ICR</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050296">Microbial Viability</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018384">Oxidative Stress</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D061105">Peroxiredoxin III</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011401">Promoter Regions, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014158">Transcription, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014735">Vibrio Infections</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000382">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D041261">Vibrio vulnificus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000201">enzymology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000472">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014774">Virulence</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276887</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bacterial Pathogenesis</Keyword>
<Keyword MajorTopicYN="N">Gene Regulation</Keyword>
<Keyword MajorTopicYN="N">Iron Starvation</Keyword>
<Keyword MajorTopicYN="N">IscR</Keyword>
<Keyword MajorTopicYN="N">Oxidative Stress</Keyword>
<Keyword MajorTopicYN="N">Peroxiredoxin</Keyword>
<Keyword MajorTopicYN="N">Reactive Oxygen Species (ROS)</Keyword>
<Keyword MajorTopicYN="N">Vibrio vulnificus</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25406310</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Whirlin and PDZ domain-containing 7 (PDZD7) proteins are both required to form the quaternary protein complex associated with Usher syndrome type 2.</ArticleTitle>
<Pagination>
<MedlinePgn>36070-88</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.610535</ELocationID>
<Abstract>
<AbstractText>Usher syndrome (USH) is the leading genetic cause of combined hearing and vision loss. Among the three USH clinical types, type 2 (USH2) occurs most commonly. USH2A, GPR98, and WHRN are three known causative genes of USH2, whereas PDZD7 is a modifier gene found in USH2 patients. The proteins encoded by these four USH genes have been proposed to form a multiprotein complex, the USH2 complex, due to interactions found among some of these proteins in vitro, their colocalization in vivo, and mutual dependence of some of these proteins for their normal in vivo localizations. However, evidence showing the formation of the USH2 complex is missing, and details on how this complex is formed remain elusive. Here, we systematically investigated interactions among the intracellular regions of the four USH proteins using colocalization, yeast two-hybrid, and pull-down assays. We show that multiple domains of the four USH proteins interact among one another. Importantly, both WHRN and PDZD7 are required for the complex formation with USH2A and GPR98. In this USH2 quaternary complex, WHRN prefers to bind to USH2A, whereas PDZD7 prefers to bind to GPR98. Interaction between WHRN and PDZD7 is the bridge between USH2A and GPR98. Additionally, the USH2 quaternary complex has a variable stoichiometry. These findings suggest that a non-obligate, short term, and dynamic USH2 quaternary protein complex may exist in vivo. Our work provides valuable insight into the physiological role of the USH2 complex in vivo and informs possible reconstruction of the USH2 complex for future therapy. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Qian</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zou</LastName>
<ForeName>Junhuang</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shen</LastName>
<ForeName>Zuolian</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Weiping</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Jun</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, the Department of Neurobiology and Anatomy, and the Department of Otolaryngology Head and Neck Surgery, University of Utah, Salt Lake City, Utah 84132 jun.yang@hsc.utah.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>EY014800</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>EY020853</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 EY020853</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016326">Extracellular Matrix Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C485949">Mass1 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000594656">PDZD7 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D043562">Receptors, G-Protein-Coupled</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C491810">Ush2a protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C477218">Whrn protein, mouse</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Genet. 2010 May;6(5):e1000955</RefSource>
<PMID Version="1">20502675</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2009 Apr 3;137(1):159-71</RefSource>
<PMID Version="1">19345194</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Struct Biol. 2011 Feb;21(1):50-61</RefSource>
<PMID Version="1">21071205</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Invest Ophthalmol Vis Sci. 2011 Apr;52(5):2343-51</RefSource>
<PMID Version="1">21212183</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mol Genet. 2012 Feb 1;21(3):692-710</RefSource>
<PMID Version="1">22048959</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(2):e30573</RefSource>
<PMID Version="1">22363448</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2012 Mar 15;483(7389):336-40</RefSource>
<PMID Version="1">22398450</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 2012 Aug 14;586(17):2638-47</RefSource>
<PMID Version="1">22576124</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Sep 28;287(40):33460-71</RefSource>
<PMID Version="1">22879593</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2012 Oct 3;32(40):13841-59</RefSource>
<PMID Version="1">23035094</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2012 Oct 10;32(41):14288-93</RefSource>
<PMID Version="1">23055499</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Pharmacol. 2012 Nov;82(5):777-83</RefSource>
<PMID Version="1">22821233</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biol Chem. 2013 Aug;394(8):937-50</RefSource>
<PMID Version="1">23518449</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mol Genet. 2014 May 1;23(9):2374-90</RefSource>
<PMID Version="1">24334608</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2000 Nov 28;39(47):14638-46</RefSource>
<PMID Version="1">11087420</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Neurosci. 2001;24:1-29</RefSource>
<PMID Version="1">11283303</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2001 Aug 30;31(4):537-44</RefSource>
<PMID Version="1">11545713</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2002 Nov;52(5):654-7</RefSource>
<PMID Version="1">12402266</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Ophthalmol. 2002 Nov;120(11):1566-71</RefSource>
<PMID Version="1">12427073</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2003 Mar 7;278(10):8501-7</RefSource>
<PMID Version="1">12493751</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Genet. 2003 Aug;34(4):421-8</RefSource>
<PMID Version="1">12833159</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2003 Nov 28;278(48):48099-104</RefSource>
<PMID Version="1">12954649</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Hum Genet. 2004 Feb;74(2):357-66</RefSource>
<PMID Version="1">14740321</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Neurosci. 2004 Jun;26(2):322-9</RefSource>
<PMID Version="1">15207856</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1998 Jun 12;280(5370):1753-7</RefSource>
<PMID Version="1">9624053</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurochem. 2005 Jan;92(1):191-202</RefSource>
<PMID Version="1">15606908</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mol Genet. 2005 Feb 1;14(3):401-10</RefSource>
<PMID Version="1">15590698</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mol Genet. 2005 Feb 1;14(3):391-400</RefSource>
<PMID Version="1">15590699</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Cell Biol. 2005 Feb;7(2):148-56</RefSource>
<PMID Version="1">15654330</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genomics. 2005 May;85(5):582-90</RefSource>
<PMID Version="1">15820310</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mol Genet. 2005 Dec 15;14(24):3933-43</RefSource>
<PMID Version="1">16301216</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mol Genet. 2005 Dec 15;14(24):3921-32</RefSource>
<PMID Version="1">16301217</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mol Genet. 2006 Mar 1;15(5):751-65</RefSource>
<PMID Version="1">16434480</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2006 Jun 14;26(24):6543-53</RefSource>
<PMID Version="1">16775142</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2006 Nov 18;368(9549):1795-809</RefSource>
<PMID Version="1">17113430</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Cells. 2007 Feb;12(2):235-50</RefSource>
<PMID Version="1">17295842</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Genet. 2007 Apr;121(2):203-11</RefSource>
<PMID Version="1">17171570</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4413-8</RefSource>
<PMID Version="1">17360538</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2007 Apr 18;26(8):2192-205</RefSource>
<PMID Version="1">17396155</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2007 Jun 13;27(24):6478-88</RefSource>
<PMID Version="1">17567809</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2007 Jul 20;317(5836):364-9</RefSource>
<PMID Version="1">17641200</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2007 Dec 28;282(52):37710-6</RefSource>
<PMID Version="1">17928286</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Biol. 2008 Sep 30;6(9):e239</RefSource>
<PMID Version="1">18828675</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mol Genet. 2009 Feb 15;18(4):655-66</RefSource>
<PMID Version="1">19028668</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2010 Jun;120(6):1812-23</RefSource>
<PMID Version="1">20440071</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019556">COS Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002352">Carrier Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002522">Cercopithecus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016326">Extracellular Matrix Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057809">HEK293 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008565">Membrane Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054731">PDZ Domains</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055503">Protein Multimerization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020836">Protein Structure, Quaternary</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D043562">Receptors, G-Protein-Coupled</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020798">Two-Hybrid System Techniques</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D052245">Usher Syndromes</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276872</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">GPR98</Keyword>
<Keyword MajorTopicYN="N">Hair Cell</Keyword>
<Keyword MajorTopicYN="N">PDZ Domain</Keyword>
<Keyword MajorTopicYN="N">PDZD7</Keyword>
<Keyword MajorTopicYN="N">Photoreceptor</Keyword>
<Keyword MajorTopicYN="N">Protein Complex</Keyword>
<Keyword MajorTopicYN="N">Protein-Protein Interaction</Keyword>
<Keyword MajorTopicYN="N">USH2A</Keyword>
<Keyword MajorTopicYN="N">Usher Syndrome</Keyword>
<Keyword MajorTopicYN="N">WHRN</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25411247</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Human NAT10 is an ATP-dependent RNA acetyltransferase responsible for N4-acetylcytidine formation in 18 S ribosomal RNA (rRNA).</ArticleTitle>
<Pagination>
<MedlinePgn>35724-30</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.C114.602698</ELocationID>
<Abstract>
<AbstractText>Human N-acetyltransferase 10 (NAT10) is known to be a lysine acetyltransferase that targets microtubules and histones and plays an important role in cell division. NAT10 is highly expressed in malignant tumors, and is also a promising target for therapies against laminopathies and premature aging. Here we report that NAT10 is an ATP-dependent RNA acetyltransferase responsible for formation of N(4)-acetylcytidine (ac(4)C) at position 1842 in the terminal helix of mammalian 18 S rRNA. RNAi-mediated knockdown of NAT10 resulted in growth retardation of human cells, and this was accompanied by high-level accumulation of the 30 S precursor of 18 S rRNA, suggesting that ac(4)C1842 formation catalyzed by NAT10 is involved in rRNA processing and ribosome biogenesis. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ito</LastName>
<ForeName>Satoshi</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Horikawa</LastName>
<ForeName>Sayuri</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Suzuki</LastName>
<ForeName>Tateki</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>the Graduate School of Life Science and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kawauchi</LastName>
<ForeName>Hiroki</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>the Graduate School of Life Science and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tanaka</LastName>
<ForeName>Yoshikazu</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>the Graduate School of Life Science and Faculty of Advanced Life Science, Hokkaido University, Sapporo 060-0810, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Suzuki</LastName>
<ForeName>Takeo</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Suzuki</LastName>
<ForeName>Tsutomu</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656 and ts@chembio.t.u-tokyo.ac.jp.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012337">RNA, Ribosomal, 18S</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.3.1.88</RegistryNumber>
<NameOfSubstance UI="D063213">N-Terminal Acetyltransferase E</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.3.1.88</RegistryNumber>
<NameOfSubstance UI="C522989">NAT10 protein, human</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Enzymol. 2007;425:211-29</RefSource>
<PMID Version="1">17673085</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2007 Sep 14;282(37):27447-58</RefSource>
<PMID Version="1">17631499</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2003 Nov 14;311(2):506-13</RefSource>
<PMID Version="1">14592445</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1978 Feb 25;253(4):1101-5</RefSource>
<PMID Version="1">624721</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1988 Feb;85(4):1033-7</RefSource>
<PMID Version="1">3277187</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2007;35(4):e27</RefSource>
<PMID Version="1">17259216</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2007;35(5):1452-64</RefSource>
<PMID Version="1">17284456</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2008 Jan;36(Database issue):D178-83</RefSource>
<PMID Version="1">17947322</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2008 Aug 20;27(16):2194-203</RefSource>
<PMID Version="1">18668122</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2009 May 6;28(9):1362-73</RefSource>
<PMID Version="1">19322199</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Cell Res. 2009 Jun 10;315(10):1653-67</RefSource>
<PMID Version="1">19303003</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Chem Biol. 2010 Dec;6(12):863-5</RefSource>
<PMID Version="1">21079590</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2011 Mar 4;286(9):7139-48</RefSource>
<PMID Version="1">21177859</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochimie. 2012 Jul;94(7):1521-32</RefSource>
<PMID Version="1">22342225</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2013 Jan;41(Database issue):D262-7</RefSource>
<PMID Version="1">23118484</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Chem Biol. 2013 Feb;9(2):105-11</RefSource>
<PMID Version="1">23242255</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO Mol Med. 2013 Jul;5(7):983-98</RefSource>
<PMID Version="1">23666744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2013 Aug 23;341(6148):849-50</RefSource>
<PMID Version="1">23970686</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochim Biophys Acta. 2014 Jun;1842(6):758-64</RefSource>
<PMID Version="1">24240090</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2014 May 2;344(6183):527-32</RefSource>
<PMID Version="1">24786082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Cancer Res. 2014 Sep 1;20(17):4717-29</RefSource>
<PMID Version="1">24982245</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2014 Sep 19;289(38):26201-12</RefSource>
<PMID Version="1">25086048</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000107">Acetylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001483">Base Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057809">HEK293 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006367">HeLa Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D063213">N-Terminal Acetyltransferase E</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009690">Nucleic Acid Conformation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012323">RNA Processing, Post-Transcriptional</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012337">RNA, Ribosomal, 18S</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276842</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Acetyl Coenzyme A (Acetyl-CoA)</Keyword>
<Keyword MajorTopicYN="N">Acetyltransferase</Keyword>
<Keyword MajorTopicYN="N">RNA Modification</Keyword>
<Keyword MajorTopicYN="N">Ribosomal RNA Processing (rRNA Processing)</Keyword>
<Keyword MajorTopicYN="N">Ribosome Assembly</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25542932</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>289</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Asymmetrical macromolecular complex formation of lysophosphatidic acid receptor 2 (LPA2) mediates gradient sensing in fibroblasts.</ArticleTitle>
<Pagination>
<MedlinePgn>35757-69</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.595512</ELocationID>
<Abstract>
<AbstractText>Chemotactic migration of fibroblasts toward growth factors relies on their capacity to sense minute extracellular gradients and respond to spatially confined receptor-mediated signals. Currently, mechanisms underlying the gradient sensing of fibroblasts remain poorly understood. Using single-particle tracking methodology, we determined that a lysophosphatidic acid (LPA) gradient induces a spatiotemporally restricted decrease in the mobility of LPA receptor 2 (LPA2) on chemotactic fibroblasts. The onset of decreased LPA2 mobility correlates to the spatial recruitment and coupling to LPA2-interacting proteins that anchor the complex to the cytoskeleton. These localized PDZ motif-mediated macromolecular complexes of LPA2 trigger a Ca(2+) puff gradient that governs gradient sensing and directional migration in response to LPA. Disruption of the PDZ motif-mediated assembly of the macromolecular complex of LPA2 disorganizes the gradient of Ca(2+) puffs, disrupts gradient sensing, and reduces the directional migration of fibroblasts toward LPA. Our findings illustrate that the asymmetric macromolecular complex formation of chemoattractant receptors mediates gradient sensing and provides a new mechanistic basis for models to describe gradient sensing of fibroblasts. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ren</LastName>
<ForeName>Aixia</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee 38163.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moon</LastName>
<ForeName>Changsuk</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee 38163, the Division of Pulmonary Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Weiqiang</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee 38163, the Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee 38103.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sinha</LastName>
<ForeName>Chandrima</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee 38163.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yarlagadda</LastName>
<ForeName>Sunitha</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee 38163, the Division of Pulmonary Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arora</LastName>
<ForeName>Kavisha</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee 38163, the Division of Pulmonary Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Xusheng</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>the Department of Structural Biology and Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yue</LastName>
<ForeName>Junming</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee 38163.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Parthasarathi</LastName>
<ForeName>Kaushik</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee 38163.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Heil-Chapdelaine</LastName>
<ForeName>Rick</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Olympus America Inc., Center Valley, Pennsylvania 18034.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tigyi</LastName>
<ForeName>Gabor</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee 38163.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Naren</LastName>
<ForeName>Anjaparavanda P</ForeName>
<Initials>AP</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee 38163, the Division of Pulmonary Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, anaren@cchmc.org.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>CA092160</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>DK080834</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>DK093045</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008246">Lysophospholipids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D049368">Receptors, Lysophosphatidic Acid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>22002-87-5</RegistryNumber>
<NameOfSubstance UI="C032881">lysophosphatidic acid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.4.11</RegistryNumber>
<NameOfSubstance UI="D054799">Phospholipase C beta</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2000 Feb 11;287(5455):1034-6</RefSource>
<PMID Version="1">10669414</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2004 Dec 16;44(6):909-16</RefSource>
<PMID Version="1">15603734</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Renal Physiol. 2001 Mar;280(3):F389-95</RefSource>
<PMID Version="1">11181400</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2001 Jan 15;20(1-2):65-76</RefSource>
<PMID Version="1">11226156</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2001 Oct 26;294(5543):864-7</RefSource>
<PMID Version="1">11679673</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2001 Dec 28;276(52):49213-20</RefSource>
<PMID Version="1">11604399</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2002 May 31;109(5):611-23</RefSource>
<PMID Version="1">12062104</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2002 Oct;22(19):6921-9</RefSource>
<PMID Version="1">12215548</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2002 Sep 27;277(39):36005-8</RefSource>
<PMID Version="1">12130648</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Cell. 2002 Oct;3(4):469-78</RefSource>
<PMID Version="1">12408799</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2003 Mar;23(6):1922-34</RefSource>
<PMID Version="1">12612067</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2003 Jun 6;278(23):20445-8</RefSource>
<PMID Version="1">12672811</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2003 May 19;22(20):3113-22</RefSource>
<PMID Version="1">12789288</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2003 Dec 5;302(5651):1704-9</RefSource>
<PMID Version="1">14657486</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO Rep. 2004 Jan;5(1):35-40</RefSource>
<PMID Version="1">14710184</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2004 Jun;24(11):5069-79</RefSource>
<PMID Version="1">15143197</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):8951-6</RefSource>
<PMID Version="1">15184679</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biochem. 2004 Aug 1;92(5):937-48</RefSource>
<PMID Version="1">15258917</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2004 Aug 30;166(5):697-708</RefSource>
<PMID Version="1">15337778</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Mol Cell Biol. 2004 Aug;5(8):626-34</RefSource>
<PMID Version="1">15366706</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Cell Biol. 2004 Oct;6(10):977-83</RefSource>
<PMID Version="1">15448700</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1982 Feb;28(2):225-32</RefSource>
<PMID Version="1">6277507</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1991 Nov 1;254(5032):703-6</RefSource>
<PMID Version="1">1948048</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Membr Biol. 1995 Mar;144(1):49-58</RefSource>
<PMID Version="1">7595941</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Biophys Biomol Struct. 1997;26:373-99</RefSource>
<PMID Version="1">9241424</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 1997 Oct 20;139(2):365-74</RefSource>
<PMID Version="1">9334341</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1998 Oct 2;95(1):81-91</RefSource>
<PMID Version="1">9778249</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1999 Apr 30;284(5415):765-70</RefSource>
<PMID Version="1">10221901</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1999 Jul 22;400(6742):382-6</RefSource>
<PMID Version="1">10432119</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1999 Sep 16;401(6750):286-90</RefSource>
<PMID Version="1">10499588</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11346-51</RefSource>
<PMID Version="1">10500179</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2005 Feb;16(2):676-88</RefSource>
<PMID Version="1">15563608</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Cell Physiol. 2005 Apr;288(4):C942-9</RefSource>
<PMID Version="1">15590898</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2005 Apr 14;434(7035):894-8</RefSource>
<PMID Version="1">15758952</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2005 Jun;8(6):730-5</RefSource>
<PMID Version="1">15880110</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2006 Apr;17(4):1503-13</RefSource>
<PMID Version="1">16421252</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2006 Aug 15;119(Pt 16):3261-4</RefSource>
<PMID Version="1">16899816</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Cell. 2006 Nov;11(5):613-27</RefSource>
<PMID Version="1">17084355</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Cell Biol. 2007 Jan;9(1):86-91</RefSource>
<PMID Version="1">17173040</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2007 Apr;18(4):1220-32</RefSource>
<PMID Version="1">17229887</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Cell. 2007 Apr;12(4):603-14</RefSource>
<PMID Version="1">17419997</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Cell Physiol. 2007 May;292(5):C1927-33</RefSource>
<PMID Version="1">17496233</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2007 Aug 1;120(Pt 15):2517-31</RefSource>
<PMID Version="1">17623773</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int Rev Cytol. 2007;263:1-62</RefSource>
<PMID Version="1">17725964</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16176-81</RefSource>
<PMID Version="1">17911247</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plant Cell Physiol. 2007 Nov;48(11):1601-11</RefSource>
<PMID Version="1">17925310</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2008 Jan;14(1):45-54</RefSource>
<PMID Version="1">18066075</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2008 May 15;121(Pt 10):1750-7</RefSource>
<PMID Version="1">18469015</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochim Biophys Acta. 2008 Sep;1781(9):558-62</RefSource>
<PMID Version="1">18501721</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2009 Feb 12;457(7231):901-5</RefSource>
<PMID Version="1">19118385</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Oncol. 2008 Jun;2(1):54-69</RefSource>
<PMID Version="1">19081821</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2009 May 22;284(21):14558-71</RefSource>
<PMID Version="1">19293149</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Mol Biol. 2009;571:371-83</RefSource>
<PMID Version="1">19763980</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2009 Sep 23;29(38):11912-23</RefSource>
<PMID Version="1">19776277</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Pharmacol Toxicol. 2010;50:157-86</RefSource>
<PMID Version="1">20055701</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Can J Physiol Pharmacol. 2010 Feb;88(2):105-10</RefSource>
<PMID Version="1">20237584</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2010 Aug 18;29(16):2675-6</RefSource>
<PMID Version="1">20717137</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sci Signal. 2010;3(141):ra71</RefSource>
<PMID Version="1">20876874</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cells. 2010 Dec;30(6):563-7</RefSource>
<PMID Version="1">21103944</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gastroenterology. 2011 Mar;140(3):924-34</RefSource>
<PMID Version="1">21134377</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2013 Feb 8;288(6):3786-94</RefSource>
<PMID Version="1">23264633</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2013 May;33(10):2016-28</RefSource>
<PMID Version="1">23478264</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2000 Feb 11;287(5455):1037-40</RefSource>
<PMID Version="1">10669415</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020013">Calcium Signaling</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002633">Chemotaxis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005347">Fibroblasts</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008246">Lysophospholipids</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021962">Membrane Microdomains</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D041681">NIH 3T3 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054799">Phospholipase C beta</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055503">Protein Multimerization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021381">Protein Transport</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049368">Receptors, Lysophosphatidic Acid</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4276845</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Calcium Intracellular Release</Keyword>
<Keyword MajorTopicYN="N">Cell Migration</Keyword>
<Keyword MajorTopicYN="N">Cell Surface Receptor</Keyword>
<Keyword MajorTopicYN="N">Fibroblast</Keyword>
<Keyword MajorTopicYN="N">G Protein-coupled Receptor (GPCR)</Keyword>
<Keyword MajorTopicYN="N">PDZ Domain</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25020153</PMID>
<DateCreated>
<Year>2014</Year>
<Month>12</Month>
<Day>30</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>03</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1930-7810</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>34</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2015</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Health psychology : official journal of the Division of Health Psychology, American Psychological Association</Title>
<ISOAbbreviation>Health Psychol</ISOAbbreviation>
</Journal>
<ArticleTitle>Message framing for health: moderation by perceived susceptibility and motivational orientation in a diverse sample of Americans.</ArticleTitle>
<Pagination>
<MedlinePgn>20-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1037/hea0000101</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The present study examined how gain- and loss-framed informational videos about oral health influence self-reported flossing behavior over a 6-month period, as well as the roles of perceived susceptibility to oral health problems and approach/avoidance motivational orientation in moderating these effects.</AbstractText>
<AbstractText Label="METHOD" NlmCategory="METHODS">An age and ethnically diverse sample of 855 American adults were randomized to receive no health message, or either a gain-framed or loss-framed video presented on the Internet. Self-reported flossing was assessed longitudinally at 2 and 6 months.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the entire sample, susceptibility interacted with frame to predict flossing. Participants who watched a video where the frame (gain/loss) matched perceived susceptibility (low/high) had significantly greater likelihood of flossing at recommended levels at the 6-month follow-up, compared with those who viewed a mismatched video or no video at all. However, young adults (18-24) showed stronger moderation by motivational orientation than by perceived susceptibility, in line with previous work largely conducted with young adult samples.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Brief informational interventions can influence long-term health behavior, particularly when the gain- or loss-frame of the information matches the recipient's beliefs about their health outcome risks.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Updegraff</LastName>
<ForeName>John A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychology, Kent State University.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brick</LastName>
<ForeName>Cameron</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychological and Brain Sciences, University of California, Santa Barbara.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Emanuel</LastName>
<ForeName>Amber S</ForeName>
<Initials>AS</Initials>
<AffiliationInfo>
<Affiliation>Department of Community Dentistry and Behavioral Science, University of Florida.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mintzer</LastName>
<ForeName>Roy E</ForeName>
<Initials>RE</Initials>
<AffiliationInfo>
<Affiliation>Herman Ostrow School of Dentistry, University of Southern California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sherman</LastName>
<ForeName>David K</ForeName>
<Initials>DK</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychological and Brain Sciences, University of California, Santa Barbara.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R21 DE019704</GrantID>
<Acronym>DE</Acronym>
<Agency>NIDCR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21 DE019704</GrantID>
<Acronym>DE</Acronym>
<Agency>NIDCR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Health Psychol</MedlineTA>
<NlmUniqueID>8211523</NlmUniqueID>
<ISSNLinking>0278-6133</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001294">Attitude to Health</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003742">Dental Devices, Home Care</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000656">utilization</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D009042">Motivation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009909">Oral Health</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000193">education</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D010565">Persuasive Communication</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018570">Risk Assessment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057566">Self Report</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014741">Video Recording</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25541750</PMID>
<DateCreated>
<Year>2015</Year>
<Month>01</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>09</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1554-8937</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>10</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2015</Year>
<Month>Jan</Month>
<Day>16</Day>
</PubDate>
</JournalIssue>
<Title>ACS chemical biology</Title>
<ISOAbbreviation>ACS Chem. Biol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Mass spectrometry-based detection and assignment of protein posttranslational modifications.</ArticleTitle>
<Pagination>
<MedlinePgn>63-71</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1021/cb500904b</ELocationID>
<Abstract>
<AbstractText>Recent advances in mass spectrometry (MS)-based proteomics allow the identification and quantitation of thousands of posttranslational modification (PTM) sites in a single experiment. This follows from the development of more effective class enrichment strategies, new high performance instrumentation and bioinformatic algorithms with rigorous scoring strategies. More widespread use of these combined capabilities have led to a vast expansion in our knowledge of the complexity of biological processes mediated by PTMs. The classes most actively pursued include phosphorylation, ubiquitination, O-GlcNAcylation, methylation, and acetylation. Very recently succinylation, SUMOylation, and citrullination have emerged. Among the some 260 000 PTM sites that have been identified in the human proteome thus far, only a few have been assigned to key regulatory and/or other biological roles. Here, we provide an update of MS-based PTM analyses, with a focus on current enrichment strategies coupled with revolutionary advances in high performance MS. Furthermore, we discuss examples of the discovery of recently described biological roles of PTMs and address the challenges of defining site-specific functions. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Doll</LastName>
<ForeName>Sophia</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutical Chemistry, University of California , San Francisco, California 94158-2517, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Burlingame</LastName>
<ForeName>Alma L</ForeName>
<Initials>AL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>8P41GM103481</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P41 GM103481</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>ACS Chem Biol</MedlineTA>
<NlmUniqueID>101282906</NlmUniqueID>
<ISSNLinking>1554-8929</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>EC 3.6.5.2</RegistryNumber>
<NameOfSubstance UI="D018631">ras Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12658-63</RefSource>
<PMID Version="1">19541641</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2009 Aug 14;325(5942):834-40</RefSource>
<PMID Version="1">19608861</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Soc Mass Spectrom. 2009 Sep;20(9):1652-9</RefSource>
<PMID Version="1">19523847</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Proteomics. 2009 Oct;8(10):2266-84</RefSource>
<PMID Version="1">19654425</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sci Signal. 2010;3(104):ra3</RefSource>
<PMID Version="1">20068231</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Soc Mass Spectrom. 2010 Mar;21(3):455-9</RefSource>
<PMID Version="1">20060315</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Proteomics. 2010 May;9(5):804-10</RefSource>
<PMID Version="1">19955076</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Proteomics. 2010 May;9(5):824-37</RefSource>
<PMID Version="1">20133344</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Soc Mass Spectrom. 2010 Jun;21(6):940-8</RefSource>
<PMID Version="1">20223681</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Anal Chem (Palo Alto Calif). 2010;3:365-85</RefSource>
<PMID Version="1">20636047</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2010 Sep 3;142(5):682-5</RefSource>
<PMID Version="1">20813257</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2010 Nov 5;285(45):34460-8</RefSource>
<PMID Version="1">20805223</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Biotechnol. 2005 Jan;23(1):94-101</RefSource>
<PMID Version="1">15592455</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Proteomics. 2005 Mar;4(3):310-27</RefSource>
<PMID Version="1">15665377</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Proteome Res. 2010 Dec 3;9(12):6786-94</RefSource>
<PMID Version="1">20873877</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Signal. 2011 Feb;23(2):458-67</RefSource>
<PMID Version="1">21044682</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Proteomics. 2011 Feb;10(2):M000031-MCP201</RefSource>
<PMID Version="1">20360033</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Oncol (Dordr). 2011 Apr;34(2):141-53</RefSource>
<PMID Version="1">21394647</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Proteome Res. 2011 May 6;10(5):2377-88</RefSource>
<PMID Version="1">21413819</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Struct Mol Biol. 2007 Nov;14(11):1017-24</RefSource>
<PMID Version="1">17984964</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2011 Jun 10;332(6035):1317-22</RefSource>
<PMID Version="1">21659604</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Biochem. 2011;80:825-58</RefSource>
<PMID Version="1">21391816</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2011 Jul 22;286(29):25451-8</RefSource>
<PMID Version="1">21632550</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Proteomics. 2011 Oct;10(10):M110.006452</RefSource>
<PMID Version="1">21715320</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Chem. 2011 Oct 15;83(20):7698-703</RefSource>
<PMID Version="1">21888424</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2011 Oct 21;44(2):325-40</RefSource>
<PMID Version="1">21906983</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Proteomics. 2011 Dec;10(12):M111.009910</RefSource>
<PMID Version="1">21917720</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Mass Spectrom (Chichester, Eng). 2011;17(5):497-506</RefSource>
<PMID Version="1">22173536</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mass Spectrom Rev. 2012 Jan-Feb;31(1):134-78</RefSource>
<PMID Version="1">21755525</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Cardiovasc Genet. 2011 Dec;4(6):711</RefSource>
<PMID Version="1">22187450</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Mol Cell Biol. 2012 Jan;13(1):39-51</RefSource>
<PMID Version="1">22189424</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Bioanal Chem. 2012 Jan;402(2):711-20</RefSource>
<PMID Version="1">22002561</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Angew Chem Int Ed Engl. 2012 Mar 26;51(13):3216-9</RefSource>
<PMID Version="1">22351305</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2012 May 25;46(4):542-8</RefSource>
<PMID Version="1">22633491</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Mol Cell Biol. 2012 Jul;13(7):448-62</RefSource>
<PMID Version="1">22722607</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12432-7</RefSource>
<PMID Version="1">22802652</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Proteomics. 2012 Aug;11(8):215-29</RefSource>
<PMID Version="1">22645316</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):16888-93</RefSource>
<PMID Version="1">23027940</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proteomics. 2012 Oct;12(19-20):2937-48</RefSource>
<PMID Version="1">22888084</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Proteomics. 2013 Feb;12(2):302-11</RefSource>
<PMID Version="1">23152538</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Metab. 2013 Feb 5;17(2):291-302</RefSource>
<PMID Version="1">23395175</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Proteomics. 2013 Mar;12(3):825-31</RefSource>
<PMID Version="1">23266961</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proteomics. 2013 Mar;13(6):982-91</RefSource>
<PMID Version="1">23335398</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proteomics. 2013 Mar;13(6):910-31</RefSource>
<PMID Version="1">23404676</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2013 Apr 26;288(17):12142-51</RefSource>
<PMID Version="1">23482559</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Methods. 2013 Jul;10(7):634-7</RefSource>
<PMID Version="1">23749302</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2013 Jul 11;499(7457):166-71</RefSource>
<PMID Version="1">23846654</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2013 Jul 11;51(1):5-19</RefSource>
<PMID Version="1">23747011</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Commun Signal. 2013;11:52</RefSource>
<PMID Version="1">23902637</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2013 Sep 26;51(6):707-22</RefSource>
<PMID Version="1">24011590</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Methods. 2013 Oct;10(10):957-63</RefSource>
<PMID Version="1">24076990</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Proteomics. 2013 Dec;12(12):3489-97</RefSource>
<PMID Version="1">23824911</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Syst Biol. 2013;9:714</RefSource>
<PMID Version="1">24366814</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Proteomics. 2014 Jan;13(1):339-47</RefSource>
<PMID Version="1">24143002</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Proteomics. 2014 Feb;13(2):537-50</RefSource>
<PMID Version="1">24263382</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proteomics. 2014 Mar;14(4-5):513-24</RefSource>
<PMID Version="1">24339426</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2014 Mar 6;507(7490):104-8</RefSource>
<PMID Version="1">24463520</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Wiley Interdiscip Rev Dev Biol. 2014 Jan-Feb;3(1):83-112</RefSource>
<PMID Version="1">24902836</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sci Rep. 2014;4:5396</RefSource>
<PMID Version="1">24953798</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Enzymol. 2014;544:327-58</RefSource>
<PMID Version="1">24974296</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Proteome Res. 2014 Jul 3;13(7):3410-9</RefSource>
<PMID Version="1">24869485</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Proteome Res. 2014 Jul 3;13(7):3200-11</RefSource>
<PMID Version="1">24926564</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Epigenetics. 2014 Sep;9(9):1207-11</RefSource>
<PMID Version="1">25147920</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2014 Oct 9;426(20):3350-62</RefSource>
<PMID Version="1">24805349</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Struct Mol Biol. 2014 Oct;21(10):927-36</RefSource>
<PMID Version="1">25218447</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2015 May 7;34(19):2527-37</RefSource>
<PMID Version="1">24954506</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Chem. 2000 Feb 1;72(3):563-73</RefSource>
<PMID Version="1">10695143</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Soc Mass Spectrom. 2001 Oct;12(10):1106-13</RefSource>
<PMID Version="1">11605972</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cancer Res. 2003 Dec;1(14):1001-8</RefSource>
<PMID Version="1">14707283</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Chem Biol. 2004 Feb;8(1):33-41</RefSource>
<PMID Version="1">15036154</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Proteomics. 2004 May;3(5):456-65</RefSource>
<PMID Version="1">14762214</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Proteomics. 2004 Jun;3(6):608-14</RefSource>
<PMID Version="1">15034119</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9528-33</RefSource>
<PMID Version="1">15210983</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Chem. 2004 Jul 15;76(14):3935-43</RefSource>
<PMID Version="1">15253627</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Proteomics. 2004 Sep;3(9):872-86</RefSource>
<PMID Version="1">15199121</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2004 Oct 21;431(7011):931-45</RefSource>
<PMID Version="1">15496913</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Enzymol. 1995;250:630-40</RefSource>
<PMID Version="1">7651182</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mass Spectrom Rev. 1998 Jan-Feb;17(1):1-35</RefSource>
<PMID Version="1">9768511</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mass Spectrom Rev. 2005 Jul-Aug;24(4):508-48</RefSource>
<PMID Version="1">15389847</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Soc Mass Spectrom. 2005 Aug;16(8):1384-98</RefSource>
<PMID Version="1">15979330</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2005 Dec 22;438(7071):1116-22</RefSource>
<PMID Version="1">16222246</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Proteome Res. 2006 Feb;5(2):248-53</RefSource>
<PMID Version="1">16457589</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2006 May 26;312(5777):1211-4</RefSource>
<PMID Version="1">16728640</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2006 Nov 3;127(3):635-48</RefSource>
<PMID Version="1">17081983</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Methods. 2007 Oct;4(10):798-806</RefSource>
<PMID Version="1">17901869</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Mol Cell Biol. 2007 Dec;8(12):983-94</RefSource>
<PMID Version="1">18037899</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2007 Dec 14;28(5):730-8</RefSource>
<PMID Version="1">18082598</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Proteomics. 2008 Apr;7(4):661-71</RefSource>
<PMID Version="1">18039691</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Proteome Res. 2008 Aug;7(8):3127-36</RefSource>
<PMID Version="1">18613715</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Biochem Sci. 2008 Aug;33(8):351-2</RefSource>
<PMID Version="1">18603430</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Proteome Res. 2008 Oct;7(10):4225-36</RefSource>
<PMID Version="1">18700791</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioorg Med Chem Lett. 2008 Nov 15;18(22):6000-3</RefSource>
<PMID Version="1">18762420</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Genet. 2009 Jan;10(1):57-63</RefSource>
<PMID Version="1">19015660</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>DNA Repair (Amst). 2009 Apr 5;8(4):483-90</RefSource>
<PMID Version="1">19217357</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Rapid Commun Mass Spectrom. 2009 May;23(10):1508-14</RefSource>
<PMID Version="1">19370712</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013058">Mass Spectrometry</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D011499">Protein Processing, Post-Translational</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021381">Protein Transport</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D040901">Proteomics</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020239">Receptor Cross-Talk</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018631">ras Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000037">antagonists &amp; inhibitors</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4301092</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25541747</PMID>
<DateCreated>
<Year>2015</Year>
<Month>01</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>09</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1520-510X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>54</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2015</Year>
<Month>Jan</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Inorganic chemistry</Title>
<ISOAbbreviation>Inorg Chem</ISOAbbreviation>
</Journal>
<ArticleTitle>Calorimetric investigation of copper binding in the N-terminal region of the prion protein at low copper loading: evidence for an entropically favorable first binding event.</ArticleTitle>
<Pagination>
<MedlinePgn>441-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1021/ic502014x</ELocationID>
<Abstract>
<AbstractText>Although the Cu(2+)-binding sites of the prion protein have been well studied when the protein is fully saturated by Cu(2+), the Cu(2+)-loading mechanism is just beginning to come into view. Because the Cu(2+)-binding modes at low and intermediate Cu(2+) occupancy necessarily represent the highest-affinity binding modes, these are very likely populated under physiological conditions, and it is thus essential to characterize them in order to understand better the biological function of copper-prion interactions. Besides binding-affinity data, almost no other thermodynamic parameters (e.g., ΔH and ΔS) have been measured, thus leaving undetermined the enthalpic and entropic factors that govern the free energy of Cu(2+) binding to the prion protein. In this study, isothermal titration calorimetry (ITC) was used to quantify the thermodynamic parameters (K, ΔG, ΔH, and TΔS) of Cu(2+) binding to a peptide, PrP(23-28, 57-98), that encompasses the majority of the residues implicated in Cu(2+) binding by full-length PrP. Use of the buffer N-(2-acetomido)-aminoethanesulfonic acid (ACES), which is also a well-characterized Cu(2+) chelator, allowed for the isolation of the two highest affinity binding events. Circular dichroism spectroscopy was used to characterize the different binding modes as a function of added Cu(2+). The Kd values determined by ITC, 7 and 380 nM, are well in line with those reported by others. The first binding event benefits significantly from a positive entropy, whereas the second binding event is enthalpically driven. The thermodynamic values associated with Cu(2+) binding by the Aβ peptide, which is implicated in Alzheimer's disease, bear striking parallels to those found here for the prion protein. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gogineni</LastName>
<ForeName>Devi Praneetha</ForeName>
<Initials>DP</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, East Carolina University , East 5th Street, Greenville, North Carolina 27858, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Spuches</LastName>
<ForeName>Anne M</ForeName>
<Initials>AM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Burns</LastName>
<ForeName>Colin S</ForeName>
<Initials>CS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>1R15NS061332-01</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>12</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Inorg Chem</MedlineTA>
<NlmUniqueID>0366543</NlmUniqueID>
<ISSNLinking>0020-1669</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011328">Prions</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>4QD397987E</RegistryNumber>
<NameOfSubstance UI="D006639">Histidine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>789U1901C5</RegistryNumber>
<NameOfSubstance UI="D003300">Copper</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2005 Dec 30;280(52):42750-8</RefSource>
<PMID Version="1">16258172</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Chem Soc. 2005 Sep 14;127(36):12647-56</RefSource>
<PMID Version="1">16144413</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2006 Oct 31;45(43):13083-92</RefSource>
<PMID Version="1">17059225</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 2006 Dec 15;400(3):501-10</RefSource>
<PMID Version="1">16925523</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 2007 Apr 3;581(7):1430-4</RefSource>
<PMID Version="1">17359979</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2007 May 18;368(5):1448-57</RefSource>
<PMID Version="1">17397862</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 2007 Jun 15;404(3):393-402</RefSource>
<PMID Version="1">17331076</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2008 Jan 25;283(4):1870-81</RefSource>
<PMID Version="1">18042548</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Biochem. 2008 Jun 15;377(2):223-33</RefSource>
<PMID Version="1">18381199</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2008 Sep 2;47(35):9258-68</RefSource>
<PMID Version="1">18690704</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dalton Trans. 2009 Feb 21;(7):1080-94</RefSource>
<PMID Version="1">19322475</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2009 Mar 31;48(12):2610-9</RefSource>
<PMID Version="1">19196019</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Phys Chem B. 2010 Sep 2;114(34):11261-71</RefSource>
<PMID Version="1">20690669</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Inorg Chem. 2010 Nov;15(8):1183-91</RefSource>
<PMID Version="1">20725755</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Inorg Chem. 2011 Mar 7;50(5):1956-72</RefSource>
<PMID Version="1">21261254</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2011 Jul 29;411(2):312-6</RefSource>
<PMID Version="1">21726530</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2011 Dec 20;50(50):10781-91</RefSource>
<PMID Version="1">22039779</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Inorg Chem. 2012 Apr;17(4):531-41</RefSource>
<PMID Version="1">22270944</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Inorg Biochem. 2013 Dec;129:58-61</RefSource>
<PMID Version="1">24077022</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2000 Nov 14;39(45):13760-71</RefSource>
<PMID Version="1">11076515</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Protein Sci. 2000 Feb;9(2):332-43</RefSource>
<PMID Version="1">10716185</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chemistry. 2007;13(7):1991-2001</RefSource>
<PMID Version="1">17152102</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2001 May 18;276(20):16711-9</RefSource>
<PMID Version="1">11278306</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8531-5</RefSource>
<PMID Version="1">11438695</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2002 Mar 26;41(12):3991-4001</RefSource>
<PMID Version="1">11900542</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2003 Feb 28;278(9):6795-802</RefSource>
<PMID Version="1">12454014</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2003 Jun 10;42(22):6794-803</RefSource>
<PMID Version="1">12779334</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci Methods. 2003 Sep 30;128(1-2):159-72</RefSource>
<PMID Version="1">12948559</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2004 Jul 30;279(31):32018-27</RefSource>
<PMID Version="1">15145944</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Biochem. 1980 Apr;103(2):214-21</RefSource>
<PMID Version="1">6247932</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1987 Oct 23;51(2):229-40</RefSource>
<PMID Version="1">2444340</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1988 Jan 15;263(2):799-805</RefSource>
<PMID Version="1">3335527</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Synapse. 1988;2(4):412-5</RefSource>
<PMID Version="1">3187909</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1993 Jul 25;268(21):15922-8</RefSource>
<PMID Version="1">8101844</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1997 Dec 18-25;390(6661):684-7</RefSource>
<PMID Version="1">9414160</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1998 Dec 11;273(50):33107-10</RefSource>
<PMID Version="1">9837873</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2042-7</RefSource>
<PMID Version="1">10051591</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 1999 Jun 25;289(5):1163-78</RefSource>
<PMID Version="1">10373359</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem J. 2006 Nov 1;399(3):435-44</RefSource>
<PMID Version="1">16824036</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D002151">Calorimetry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003300">Copper</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D019277">Entropy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006639">Histidine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011328">Prions</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4303328</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25636559</PMID>
<DateCreated>
<Year>2015</Year>
<Month>01</Month>
<Day>31</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>147</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2015</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Correction of a skeletal Class II malocclusion with severe crowding by a specially designed rapid maxillary expander.</ArticleTitle>
<Pagination>
<MedlinePgn>242-51</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2013.12.032</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(14)00926-3</ELocationID>
<Abstract>
<AbstractText>To correct an Angle Class II malocclusion or to create spaces in the maxillary arch by nonextraction treatment, distal movement of the maxillary molars is required. Various modalities for distalizing the buccal segment have been reported. Conventional extraoral appliances can be used to obtain maximum anchorage. However, many patients reject headgear wear because of social and esthetic concerns, and the success of this treatment depends on patient compliance. Intraoral appliances, such as repelling magnets, nickel-titanium coils, pendulum appliance, Jones jig appliance, distal jet appliance, and modified Nance appliance, have been introduced to distalize the molars with little or no patient cooperation. However, intraoral appliances can result in anchorage loss of the anterior teeth and distal tipping of the maxillary molars. In this case report, we introduce a diversified rapid maxillary expansion appliance that was custom designed and fabricated for the treatment of a growing girl with a skeletal Class II malocclusion and severe crowding from a totally lingually positioned lateral incisor. The appliance concomitantly expanded the maxilla transversely and retracted the buccal segment sagittally, distalizing the maxillary molars to reach a Class I relationship and creating the spaces to displace the malpositioned lateral incisor. The uniqueness of this special diversified rapid maxillary expansion appliance was highlighted by a series of reconstructions and modifications at different stages of the treatment to reinforce the anchorage. </AbstractText>
<CopyrightInformation>Copyright © 2015 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Honghong</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Postgraduate student, Department of Orthodontics, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, Shanghai, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Feng</LastName>
<ForeName>Jing</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Assistant professor, Department of Orthodontics, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, Shanghai, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lu</LastName>
<ForeName>Peijun</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Postgraduate student, Department of Orthodontics, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, Shanghai, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shen</LastName>
<ForeName>Gang</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Chair, Department of Orthodontics, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, Shanghai, China. Electronic address: orthoshengang@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Am J Orthod Dentofacial Orthop. 2015 Oct;148(4):529</RefSource>
<PMID Version="1">26432305</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002508">Cephalometry</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007180">Incisor</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008312">Malocclusion, Angle Class II</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008963">Molar</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D052280">Orthodontic Anchorage Procedures</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000295">instrumentation</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D016382">Orthodontic Appliance Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057887">Overbite</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010155">Palatal Expansion Technique</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010347">Patient Care Planning</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014079">Tooth Eruption, Ectopic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014087">Tooth Movement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000295">instrumentation</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25541905</PMID>
<DateCreated>
<Year>2015</Year>
<Month>02</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1520-4995</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>54</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Feb</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>Biochemistry</Title>
<ISOAbbreviation>Biochemistry</ISOAbbreviation>
</Journal>
<ArticleTitle>Peptide amyloid surface display.</ArticleTitle>
<Pagination>
<MedlinePgn>987-93</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1021/bi5011442</ELocationID>
<Abstract>
<AbstractText>Homomeric self-assembly of peptides into amyloid fibers is a feature of many diseases. A central role has been suggested for the lateral fiber surface affecting gains of toxic function. To investigate this, a protein scaffold that presents a discrete, parallel β-sheet surface for amyloid subdomains up to eight residues in length has been designed. Scaffolds that present the fiber surface of islet amyloid polypeptide (IAPP) were prepared. The designs show sequence-specific surface effects apparent in that they gain the capacity to attenuate rates of IAPP self-assembly in solution and affect IAPP-induced toxicity in insulin-secreting cells. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rubio</LastName>
<ForeName>Marisa A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Biophysics and Biochemistry, Yale University , 260 Whitney Avenue, New Haven, Connecticut 06520-8114, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schlamadinger</LastName>
<ForeName>Diana E</ForeName>
<Initials>DE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>White</LastName>
<ForeName>Ellen M</ForeName>
<Initials>EM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Miranker</LastName>
<ForeName>Andrew D</ForeName>
<Initials>AD</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 GM102815</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 GM102815</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 GM007223</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32GM007223</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>01</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Biochemistry</MedlineTA>
<NlmUniqueID>0370623</NlmUniqueID>
<ISSNLinking>0006-2960</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D058228">Islet Amyloid Polypeptide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010455">Peptides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012710">Serum Albumin, Bovine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Feb 17;287(8):5235-41</RefSource>
<PMID Version="1">22187437</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 2012 Mar;26(3):1228-38</RefSource>
<PMID Version="1">22183778</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2012 Mar 16;148(6):1188-203</RefSource>
<PMID Version="1">22424229</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>ACS Chem Neurosci. 2010 Jan 20;1(1):13-8</RefSource>
<PMID Version="1">22778803</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2012 Aug 10;421(2-3):282-95</RefSource>
<PMID Version="1">22206987</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9758-63</RefSource>
<PMID Version="1">23703910</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Alzheimers Dis. 2014;38(4):753-65</RefSource>
<PMID Version="1">24072068</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biophys J. 2014 Dec 2;107(11):2559-66</RefSource>
<PMID Version="1">25468335</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2000 Jan 28;295(4):1055-71</RefSource>
<PMID Version="1">10656810</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chem Biol. 2000 Nov;7(11):855-71</RefSource>
<PMID Version="1">11094339</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2001 Sep 7;276(36):34156-61</RefSource>
<PMID Version="1">11445568</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2002 Jan 31;415(6871):553-7</RefSource>
<PMID Version="1">11823865</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Neurosci. 2003 Jan;4(1):49-60</RefSource>
<PMID Version="1">12511861</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Structure. 1997 Jun 15;5(6):789-98</RefSource>
<PMID Version="1">9261070</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Struct Biol. 1998 Apr;5(4):284-8</RefSource>
<PMID Version="1">9546219</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bacteriol. 1999 May;181(9):2739-44</RefSource>
<PMID Version="1">10217762</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Biol. 2006 Jan;4(1):e6</RefSource>
<PMID Version="1">16300414</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Biochem. 2006;75:333-66</RefSource>
<PMID Version="1">16756495</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12341-6</RefSource>
<PMID Version="1">17640888</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes. 2007 Aug;56(8):2016-27</RefSource>
<PMID Version="1">17475933</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Protein Sci. 2007 Nov;16(11):2334-44</RefSource>
<PMID Version="1">17962399</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2007 Nov 27;46(47):13505-22</RefSource>
<PMID Version="1">17979302</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2007 Dec 14;131(6):1059-71</RefSource>
<PMID Version="1">18083097</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Chem Soc. 2008 Nov 12;130(45):14990-5001</RefSource>
<PMID Version="1">18937465</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Org Lett. 2009 Jul 16;11(14):3000-3</RefSource>
<PMID Version="1">19534505</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2009 Oct 16;393(1):214-26</RefSource>
<PMID Version="1">19524594</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biophys J. 2009 Nov 4;97(9):2585-94</RefSource>
<PMID Version="1">19883602</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Small. 2010 Sep 6;6(17):1873-9</RefSource>
<PMID Version="1">20661999</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Chem Biol. 2011 May;7(5):285-95</RefSource>
<PMID Version="1">21445056</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Org Chem. 2011 May 6;76(9):3166-73</RefSource>
<PMID Version="1">21452877</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002417">Cattle</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D045744">Cell Line, Tumor</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058228">Islet Amyloid Polypeptide</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000037">antagonists &amp; inhibitors</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010455">Peptides</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000037">antagonists &amp; inhibitors</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017433">Protein Structure, Secondary</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051381">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012710">Serum Albumin, Bovine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013499">Surface Properties</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4318585</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25658195</PMID>
<DateCreated>
<Year>2015</Year>
<Month>03</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1520-4995</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>54</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Mar</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>Biochemistry</Title>
<ISOAbbreviation>Biochemistry</ISOAbbreviation>
</Journal>
<ArticleTitle>Investigation of signal transduction routes within the sensor/transducer protein BlaR1 of Staphylococcus aureus.</ArticleTitle>
<Pagination>
<MedlinePgn>1600-10</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1021/bi501463k</ELocationID>
<Abstract>
<AbstractText>The transmembrane antibiotic sensor/signal transducer protein BlaR1 is part of a cohort of proteins that confer β-lactam antibiotic resistance in methicillin-resistant Staphylococcus aureus (MRSA) [Fisher, J. F., Meroueh, S. O., and Mobashery, S. (2005) Chem. Rev. 105, 395-424; Llarrull, L. I., Fisher, J. F., and Mobashery, S. (2009) Antimicrob. Agents Chemother. 53, 4051-4063; Llarrull, L. I., Toth, M., Champion, M. M., and Mobashery, S. (2011) J. Biol. Chem. 286, 38148-38158]. Specifically, BlaR1 regulates the inducible expression of β-lactamases that hydrolytically destroy β-lactam antibiotics. The resistance phenotype starts with β-lactam antibiotic acylation of the BlaR1 extracellular domain (BlaRS). The acylation activates the cytoplasmic protease domain through an obscure signal transduction mechanism. Here, we compare protein dynamics of apo versus antibiotic-acylated BlaRS using nuclear magnetic resonance. Our analyses reveal inter-residue interactions that relay acylation-induced perturbations within the antibiotic-binding site to the transmembrane helix regions near the membrane surface. These are the first insights into the process of signal transduction by BlaR1.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Staude</LastName>
<ForeName>Michael W</ForeName>
<Initials>MW</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry and Biochemistry, University of Notre Dame , Notre Dame, Indiana 46556, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Frederick</LastName>
<ForeName>Thomas E</ForeName>
<Initials>TE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Natarajan</LastName>
<ForeName>Sivanandam V</ForeName>
<Initials>SV</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wilson</LastName>
<ForeName>Brian D</ForeName>
<Initials>BD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tanner</LastName>
<ForeName>Carol E</ForeName>
<Initials>CE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ruggiero</LastName>
<ForeName>Steven T</ForeName>
<Initials>ST</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mobashery</LastName>
<ForeName>Shahriar</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Peng</LastName>
<ForeName>Jeffrey W</ForeName>
<Initials>JW</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>AI104987</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>GM085109</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AI104987</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32GM075762</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>02</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Biochemistry</MedlineTA>
<NlmUniqueID>0370623</NlmUniqueID>
<ISSNLinking>0006-2960</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.24.-</RegistryNumber>
<NameOfSubstance UI="C569108">BlaR1 protein, Staphylococcus aureus</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.24.-</RegistryNumber>
<NameOfSubstance UI="D008666">Metalloendopeptidases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000215">Acylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001426">Bacterial Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008666">Metalloendopeptidases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055624">Methicillin-Resistant Staphylococcus aureus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019906">Nuclear Magnetic Resonance, Biomolecular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017434">Protein Structure, Tertiary</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015398">Signal Transduction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D018440">beta-Lactam Resistance</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS745339 [Available on 03/03/16]</OtherID>
<OtherID Source="NLM">PMC4691190 [Available on 03/03/16]</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">25741385</PMID>
<DateCreated>
<Year>2015</Year>
<Month>03</Month>
<Day>05</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>03</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1758-2946</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Journal of cheminformatics</Title>
<ISOAbbreviation>J Cheminform</ISOAbbreviation>
</Journal>
<ArticleTitle>Systems biology approaches for advancing the discovery of effective drug combinations.</ArticleTitle>
<Pagination>
<MedlinePgn>7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13321-015-0055-9</ELocationID>
<Abstract>
<AbstractText>Complex diseases like cancer are regulated by large, interconnected networks with many pathways affecting cell proliferation, invasion, and drug resistance. However, current cancer therapy predominantly relies on the reductionist approach of one gene-one disease. Combinations of drugs may overcome drug resistance by limiting mutations and induction of escape pathways, but given the enormous number of possible drug combinations, strategies to reduce the search space and prioritize experiments are needed. In this review, we focus on the use of computational modeling, bioinformatics and high-throughput experimental methods for discovery of drug combinations. We highlight cutting-edge systems approaches, including large-scale modeling of cell signaling networks, network motif analysis, statistical association-based models, identifying correlations in gene signatures, functional genomics, and high-throughput combination screens. We also present a list of publicly available data and resources to aid in discovery of drug combinations. Integration of these systems approaches will enable faster discovery and translation of clinically relevant drug combinations. Graphical abstractSpectrum of Systems Biology Approaches for Drug Combinations. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ryall</LastName>
<ForeName>Karen A</ForeName>
<Initials>KA</Initials>
<AffiliationInfo>
<Affiliation>Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, Department of Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, 12801 E.17th Ave., L18-8116, Aurora, CO 80045 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tan</LastName>
<ForeName>Aik Choon</ForeName>
<Initials>AC</Initials>
<AffiliationInfo>
<Affiliation>Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, Department of Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, 12801 E.17th Ave., L18-8116, Aurora, CO 80045 USA ; Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO USA ; Department of Computer Science and Engineering, Korea University, Seoul, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 CA046934</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>02</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Cheminform</MedlineTA>
<NlmUniqueID>101516718</NlmUniqueID>
<ISSNLinking>1758-2946</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4348553</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cancer</Keyword>
<Keyword MajorTopicYN="N">Computational modeling</Keyword>
<Keyword MajorTopicYN="N">Drug combinations</Keyword>
<Keyword MajorTopicYN="N">Drug discovery</Keyword>
<Keyword MajorTopicYN="N">Systems biology</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25766232</PMID>
<DateCreated>
<Year>2015</Year>
<Month>03</Month>
<Day>13</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>03</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1095-9203</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>347</Volume>
<Issue>6227</Issue>
<PubDate>
<Year>2015</Year>
<Month>Mar</Month>
<Day>13</Day>
</PubDate>
</JournalIssue>
<Title>Science (New York, N.Y.)</Title>
<ISOAbbreviation>Science</ISOAbbreviation>
</Journal>
<ArticleTitle>Reduced vaccination and the risk of measles and other childhood infections post-Ebola.</ArticleTitle>
<Pagination>
<MedlinePgn>1240-2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.aaa3438</ELocationID>
<Abstract>
<AbstractText>The Ebola epidemic in West Africa has caused substantial morbidity and mortality. The outbreak has also disrupted health care services, including childhood vaccinations, creating a second public health crisis. We project that after 6 to 18 months of disruptions, a large connected cluster of children unvaccinated for measles will accumulate across Guinea, Liberia, and Sierra Leone. This pool of susceptibility increases the expected size of a regional measles outbreak from 127,000 to 227,000 cases after 18 months, resulting in 2000 to 16,000 additional deaths (comparable to the numbers of Ebola deaths reported thus far). There is a clear path to avoiding outbreaks of childhood vaccine-preventable diseases once the threat of Ebola begins to recede: an aggressive regional vaccination campaign aimed at age groups left unprotected because of health care disruptions. </AbstractText>
<CopyrightInformation>Copyright © 2015, American Association for the Advancement of Science.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Takahashi</LastName>
<ForeName>Saki</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Metcalf</LastName>
<ForeName>C Jessica E</ForeName>
<Initials>CJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544, USA. Woodrow Wilson School, Princeton University, Princeton, NJ 08544, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ferrari</LastName>
<ForeName>Matthew J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Centre for Infectious Disease Dynamics, Pennsylvania State University, State College, PA 16801, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moss</LastName>
<ForeName>William J</ForeName>
<Initials>WJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Truelove</LastName>
<ForeName>Shaun A</ForeName>
<Initials>SA</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tatem</LastName>
<ForeName>Andrew J</ForeName>
<Initials>AJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Geography and Environment, University of Southampton, Southampton SO17 1BJ, UK. Fogarty International Center, National Institutes of Health, Bethesda, MD 20892, USA. Flowminder Foundation, 17177 Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Grenfell</LastName>
<ForeName>Bryan T</ForeName>
<Initials>BT</Initials>
<AffiliationInfo>
<Affiliation>Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544, USA. Fogarty International Center, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lessler</LastName>
<ForeName>Justin</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. justin@jhu.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 AI102939</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AI102939</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U19AI089674</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Science</MedlineTA>
<NlmUniqueID>0404511</NlmUniqueID>
<ISSNLinking>0036-8075</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008458">Measles Vaccine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Science. 2015 Mar 13;347(6227):1189</RefSource>
<PMID Version="1">25766214</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004196">Disease Outbreaks</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004198">Disease Susceptibility</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D016701">Guinea</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019142">Hemorrhagic Fever, Ebola</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017589">Immunization Programs</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D007988">Liberia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008457">Measles</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008458">Measles Vaccine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D012807">Sierra Leone</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014611">Vaccination</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25596075</PMID>
<DateCreated>
<Year>2015</Year>
<Month>04</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1549-9642</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>11</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Nanomedicine : nanotechnology, biology, and medicine</Title>
<ISOAbbreviation>Nanomedicine</ISOAbbreviation>
</Journal>
<ArticleTitle>Magnetic field-guided cell delivery with nanoparticle-loaded human corneal endothelial cells.</ArticleTitle>
<Pagination>
<MedlinePgn>499-509</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nano.2014.12.002</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1549-9634(15)00007-6</ELocationID>
<Abstract>
<AbstractText>To improve the delivery and integration of cell therapy using magnetic cell guidance for replacement of corneal endothelium, here we assess magnetic nanoparticles' (MNPs') effects on human corneal endothelial cells (HCECs) in vitro. Biocompatible, 50 nm superparamagnetic nanoparticles endocytosed by cultured HCECs induced no short- or long-term change in viability or identity. Assessment of guidance of the magnetic HCECs in the presence of different magnet shapes and field strengths showed a 2.4-fold increase in delivered cell density compared to gravity alone. After cell delivery, HCECs formed a functional monolayer, with no difference in tight junction formation between MNP-loaded and control HCECs. These data suggest that nanoparticle-mediated magnetic cell delivery may increase the efficiency of cell delivery without compromising HCEC survival, identity or function. Future studies may assess the safety and efficacy of this therapeutic modality in vivo. From the clinical editor: The authors show in this article that magnetic force facilitates the delivery of human corneal endothelial cells loaded by superparamagnetic nanoparticles to cornea, without changing their morphology, identity or functional properties. This novel idea can potentially have vast impact in the treatment of corneal endothelial dystrophies by providing self-endothelial cells after ex-vivo expansion.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Moysidis</LastName>
<ForeName>Stavros N</ForeName>
<Initials>SN</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alvarez-Delfin</LastName>
<ForeName>Karen</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peschansky</LastName>
<ForeName>Veronica J</ForeName>
<Initials>VJ</Initials>
<AffiliationInfo>
<Affiliation>MD/PhD Program in Neuroscience University of Miami Miller School of Medicine, Miami, FL, USA; Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Salero</LastName>
<ForeName>Enrique</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Weisman</LastName>
<ForeName>Alejandra D</ForeName>
<Initials>AD</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bartakova</LastName>
<ForeName>Alena</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Shiley Eye Center, University of California San Diego, La Jolla, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Raffa</LastName>
<ForeName>Gabriella A</ForeName>
<Initials>GA</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Merkhofer</LastName>
<ForeName>Richard M</ForeName>
<Initials>RM</Initials>
<Suffix>Jr</Suffix>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kador</LastName>
<ForeName>Karl E</ForeName>
<Initials>KE</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA; Shiley Eye Center, University of California San Diego, La Jolla, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kunzevitzky</LastName>
<ForeName>Noelia J</ForeName>
<Initials>NJ</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA; Shiley Eye Center, University of California San Diego, La Jolla, CA, USA; Emmetrope Ophthalmics LLC, Key Biscayne, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Goldberg</LastName>
<ForeName>Jeffrey L</ForeName>
<Initials>JL</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA; Shiley Eye Center, University of California San Diego, La Jolla, CA, USA. Electronic address: jlgoldberg@ucsd.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 EY022589</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30-EY014801</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30-EY022589</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>01</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Nanomedicine</MedlineTA>
<NlmUniqueID>101233142</NlmUniqueID>
<ISSNLinking>1549-9634</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003315">Cornea</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000166">cytology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D042783">Endothelial Cells</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000166">cytology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000637">transplantation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D060526">Magnetic Fields</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053758">Nanoparticles</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cell therapy</Keyword>
<Keyword MajorTopicYN="N">Corneal edema</Keyword>
<Keyword MajorTopicYN="N">Human corneal endothelial cells</Keyword>
<Keyword MajorTopicYN="N">Magnetic nanoparticles</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25596077</PMID>
<DateCreated>
<Year>2015</Year>
<Month>04</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1549-9642</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>11</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Nanomedicine : nanotechnology, biology, and medicine</Title>
<ISOAbbreviation>Nanomedicine</ISOAbbreviation>
</Journal>
<ArticleTitle>Promoting filopodial elongation in neurons by membrane-bound magnetic nanoparticles.</ArticleTitle>
<Pagination>
<MedlinePgn>559-67</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nano.2014.11.011</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1549-9634(15)00005-2</ELocationID>
<Abstract>
<AbstractText>Filopodia are 5-10 μm long processes that elongate by actin polymerization, and promote axon growth and guidance by exerting mechanical tension and by molecular signaling. Although axons elongate in response to mechanical tension, the structural and functional effects of tension specifically applied to growth cone filopodia are unknown. Here we developed a strategy to apply tension specifically to retinal ganglion cell (RGC) growth cone filopodia through surface-functionalized, membrane-targeted superparamagnetic iron oxide nanoparticles (SPIONs). When magnetic fields were applied to surface-bound SPIONs, RGC filopodia elongated directionally, contained polymerized actin filaments, and generated retrograde forces, behaving as bona fide filopodia. Data presented here support the premise that mechanical tension induces filopodia growth but counter the hypothesis that filopodial tension directly promotes growth cone advance. Future applications of these approaches may be used to induce sustained forces on multiple filopodia or other subcellular microstructures to study axon growth or cell migration. From the clinical editor: Mechanical tension to the tip of filopodia is known to promote axonal growth. In this article, the authors used superparamagnetic iron oxide nanoparticles (SPIONs) targeted specifically to membrane molecules, then applied external magnetic field to elicit filopodial elongation, which provided a tool to study the role of mechanical forces in filopodia dynamics and function.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pita-Thomas</LastName>
<ForeName>Wolfgang</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA; Department of Anatomy and Neurobiology, Washington University, St. Louis, MO, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Steketee</LastName>
<ForeName>Michael B</ForeName>
<Initials>MB</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA; Department of Ophthalmology and McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moysidis</LastName>
<ForeName>Stavros N</ForeName>
<Initials>SN</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thakor</LastName>
<ForeName>Kinjal</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hampton</LastName>
<ForeName>Blake</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Goldberg</LastName>
<ForeName>Jeffrey L</ForeName>
<Initials>JL</Initials>
<AffiliationInfo>
<Affiliation>Bascom Palmer Eye Institute and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA; Department of Ophthalmology, Shiley Eye Center, UC San Diego, San Diego, CA, USA. Electronic address: JLGoldberg@ucsd.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>EY017971</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 EY014801</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 EY022589</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 EY022589</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21 EY017971</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32NS007044</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>01</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Nanomedicine</MedlineTA>
<NlmUniqueID>101233142</NlmUniqueID>
<ISSNLinking>1549-9634</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D058185">Magnetite Nanoparticles</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020439">Growth Cones</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D060526">Magnetic Fields</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058185">Magnetite Nanoparticles</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011554">Pseudopodia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051381">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017207">Rats, Sprague-Dawley</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012165">Retinal Ganglion Cells</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000166">cytology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Axon growth</Keyword>
<Keyword MajorTopicYN="N">Filopodia</Keyword>
<Keyword MajorTopicYN="N">Mechanical tension</Keyword>
<Keyword MajorTopicYN="N">Nanoparticles</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25840296</PMID>
<DateCreated>
<Year>2015</Year>
<Month>04</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>10</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Clinical study of pain sensation during phacoemulsification with and without cryoanalgesia.</ArticleTitle>
<Pagination>
<MedlinePgn>719-23</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.06.040</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00213-8</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To compare the analgesic efficacy of 2 types of anesthetic techniques-topical and topical associated with cryoanalgesia-during cataract surgery.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Department of Ophthalmology, University of São Paulo, Ribeirão Preto, Brazil.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective randomized study.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Patients with symmetrical bilateral cataract had phacoemulsification with the use of an intraocular irrigation solution at room temperature in 1 eye and a cold (4°C) solution in the contralateral eye (Group 2). The pain related to the procedure was assessed using a visual analog scale ranging from 0 to 100, with 0 representing no pain and 100 the worst pain. In addition, endothelial cell loss, the change in corneal thickness, and visual acuity were evaluated 30 days ± 2 (SD) after each surgery. The surgery duration, total irrigation volume, phacoemulsification time, and ultrasound power used were analyzed.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The study enrolled 25 patients (50 eyes). There was no statistically significant difference in the mean pain score between Group 1 (26.0 ± 3.7) and Group 2 (21.3 ± 3.6) (P = .2016, paired t test). No significant difference was found in the mean corneal endothelial cell loss (Group 1: 10.0% ± 0.4%; Group 2: 9.9% ± 0.3%; P = .7576), corneal thickness increase (Group 1: 1.5 ± 1.0 μm; Group 2: 1.4 ± 0.9 μm; P = .9340), or visual acuity gain (Group 1: 0.54 ± 0.06 logMAR; Group 2: 0.55 ± 0.09 logMAR; P = .8208).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">There is no difference in the intensity of pain during phacoemulsification with the use of topical anesthesia or topical anesthesia associated with cryoanalgesia.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">No author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Coelho</LastName>
<ForeName>Roberto Pinto</ForeName>
<Initials>RP</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology, Otorrinolaringology and Head and Neck Surgery, Medical School of Ribeirão Preto, University of São Paulo-Ribeirão Preto, São Paulo, Brazil. Electronic address: robertopintocoelho1@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Biaggi</LastName>
<ForeName>Ricardo Helio</ForeName>
<Initials>RH</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology, Otorrinolaringology and Head and Neck Surgery, Medical School of Ribeirão Preto, University of São Paulo-Ribeirão Preto, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jorge</LastName>
<ForeName>Rodrigo</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology, Otorrinolaringology and Head and Neck Surgery, Medical School of Ribeirão Preto, University of São Paulo-Ribeirão Preto, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rodrigues</LastName>
<ForeName>Maria de Lourdes Veronese</ForeName>
<Initials>Mde L</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology, Otorrinolaringology and Head and Neck Surgery, Medical School of Ribeirão Preto, University of São Paulo-Ribeirão Preto, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Messias</LastName>
<ForeName>André</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology, Otorrinolaringology and Head and Neck Surgery, Medical School of Ribeirão Preto, University of São Paulo-Ribeirão Preto, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000779">Anesthetics, Local</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Jul;41(7):1548-9</RefSource>
<PMID Version="1">26287906</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Jul;41(7):1548</RefSource>
<PMID Version="1">26287905</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1795-6</RefSource>
<PMID Version="1">26432153</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1796-7</RefSource>
<PMID Version="1">26432155</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000698">Analgesia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000772">Anesthesia, Local</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000779">Anesthetics, Local</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002386">Cataract</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055954">Corneal Endothelial Cell Loss</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017679">Cryotherapy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058447">Eye Pain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D019654">Lens Implantation, Intraocular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D010147">Pain Measurement</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018918">Phacoemulsification</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014792">Visual Acuity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25840302</PMID>
<DateCreated>
<Year>2015</Year>
<Month>04</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>10</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Influence of corneal asphericity on the refractive outcome of intraocular lens implantation in cataract surgery.</ArticleTitle>
<Pagination>
<MedlinePgn>785-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.07.035</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00143-1</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate the possible influence of anterior corneal surface asphericity on the refractive outcomes in eyes having intraocular lens (IOL) implantation after cataract surgery.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Fondazione G.B. Bietti IRCCS, Rome, Italy.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective comparative case series.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Intraocular lens power was calculated using the Haigis, Hoffer Q, Holladay 1, and SRK/T formulas. Asphericity (Q-value) was measured at 8.0 mm with a Placido-disk corneal topographer (Keratron), a rotating Scheimpflug camera (Pentacam), and a rotating Scheimpflug camera combined with Placido-disk corneal topography (Sirius). The relationship between the error in refraction prediction (ie, difference between expected refraction and refraction measured 1 month after surgery) and the Q-value was assessed by linear regression.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The same IOL model (Acrysof SA60AT) was implanted in 115 eyes of 115 consecutive patients. Regression analysis showed a statistically significant relationship between the error in refraction prediction and the Q-value with all formulas and all devices. In all cases, a more negative Q-value (prolate cornea) was associated with a myopic outcome, whereas a more positive Q-value (oblate cornea) was associated with a hyperopic outcome. The highest coefficient of determination was detected between the Hoffer Q formula and the Placido-disk corneal topographer (R(2) = 0.2630), for which the error in refraction prediction (y) was related to the Q-value (x) according to the formula y = -0.2641 + 1.4589 × x.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Corneal asphericity influences the refractive outcomes of IOL implantation and should be taken into consideration when using third-generation IOL power formulas.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">Dr. Hoffer receives book royalties from Slack, Inc., Thorofare, New Jersey, and formula royalties from all manufacturers using the Hoffer Q formula. No other author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Savini</LastName>
<ForeName>Giacomo</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>From the Fondazione G.B. Bietti IRCCS (Savini), Rome, Studio Oculistico d'Azeglio (Barboni), Bologna, and the Scientific Institute San Raffaele (Barboni), Milan, Italy; the Stein Eye Institute (Hoffer), University of California, and St. Mary's Eye Center (Hoffer), Santa Monica, California, USA. Electronic address: giacomo.savini@alice.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hoffer</LastName>
<ForeName>Kenneth J</ForeName>
<Initials>KJ</Initials>
<AffiliationInfo>
<Affiliation>From the Fondazione G.B. Bietti IRCCS (Savini), Rome, Studio Oculistico d'Azeglio (Barboni), Bologna, and the Scientific Institute San Raffaele (Barboni), Milan, Italy; the Stein Eye Institute (Hoffer), University of California, and St. Mary's Eye Center (Hoffer), Santa Monica, California, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barboni</LastName>
<ForeName>Piero</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>From the Fondazione G.B. Bietti IRCCS (Savini), Rome, Studio Oculistico d'Azeglio (Barboni), Bologna, and the Scientific Institute San Raffaele (Barboni), Milan, Italy; the Stein Eye Institute (Hoffer), University of California, and St. Mary's Eye Center (Hoffer), Santa Monica, California, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Jul;41(7):1553-4</RefSource>
<PMID Version="1">26287912</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1797-8</RefSource>
<PMID Version="1">26432156</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1798</RefSource>
<PMID Version="1">26432157</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Jul;41(7):1554-5</RefSource>
<PMID Version="1">26287913</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058452">Axial Length, Eye</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001699">Biometry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003315">Cornea</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019781">Corneal Topography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D019654">Lens Implantation, Intraocular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007910">Lenses, Intraocular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D055095">Optics and Photonics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D018918">Phacoemulsification</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012029">Refraction, Ocular</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012030">Refractive Errors</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">25838000</PMID>
<DateCreated>
<Year>2015</Year>
<Month>04</Month>
<Day>13</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6327</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>46</Volume>
<PubDate>
<Year>2015</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Addictive behaviors</Title>
<ISOAbbreviation>Addict Behav</ISOAbbreviation>
</Journal>
<ArticleTitle>Low self-esteem and positive beliefs about smoking: a destructive combination for male college students.</ArticleTitle>
<Pagination>
<MedlinePgn>94-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.addbeh.2015.03.007</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0306-4603(15)00104-5</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Men exhibit higher rates of smoking relative to women (CDC, 2014). Given the associated health and socio-economic consequences, it would be valuable to explore the psychological factors underlying this variance. We contend that positive beliefs about smoking influence this difference, and that self-esteem moderates these beliefs.</AbstractText>
<AbstractText Label="METHOD" NlmCategory="METHODS">As part of a multi-institutional collaborative study funded by the American Legacy Foundation, 445 participants who reported being either steady or occasional smokers completed a series of questionnaires assessing their beliefs and behaviors involving smoking as well as several dispositional variables. Moderated mediation was used to test for conditional indirect effects.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The total, indirect, and direct effects of gender were significant for individuals with lower, but not higher self-esteem. Males with lower self-esteem exhibited more positive beliefs and smoking behavior than females with lower self-esteem. No differences between males and females with higher self-esteem were observed.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The gender gap in smoking behavior appears to occur primarily among individuals with lower self-esteem. It is a particularly detrimental risk factor for males, as it is related to higher positive views about smoking and increased tobacco consumption. These results highlight the importance of developing multifaceted gender specific belief-based preventative interventions to address smoking related behaviors.</AbstractText>
<CopyrightInformation>Copyright © 2015. Published by Elsevier Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hale</LastName>
<ForeName>Willie J</ForeName>
<Initials>WJ</Initials>
<AffiliationInfo>
<Affiliation>University of Texas at San Antonio, United States. Electronic address: wjhale@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Perrotte</LastName>
<ForeName>Jessica K</ForeName>
<Initials>JK</Initials>
<AffiliationInfo>
<Affiliation>University of Texas at San Antonio, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baumann</LastName>
<ForeName>Michael R</ForeName>
<Initials>MR</Initials>
<AffiliationInfo>
<Affiliation>University of Texas at San Antonio, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Garza</LastName>
<ForeName>Raymond T</ForeName>
<Initials>RT</Initials>
<AffiliationInfo>
<Affiliation>University of Texas at San Antonio, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R25 GM060655</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>03</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Addict Behav</MedlineTA>
<NlmUniqueID>7603486</NlmUniqueID>
<ISSNLinking>0306-4603</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">NIHMS697330 [Available on 07/01/16]</OtherID>
<OtherID Source="NLM">PMC4691237 [Available on 07/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Gender</Keyword>
<Keyword MajorTopicYN="N">Moderated mediation</Keyword>
<Keyword MajorTopicYN="N">Positive beliefs</Keyword>
<Keyword MajorTopicYN="N">Self-esteem</Keyword>
<Keyword MajorTopicYN="N">Smoking</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">25864598</PMID>
<DateCreated>
<Year>2015</Year>
<Month>04</Month>
<Day>13</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1521-0391</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>24</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2015</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions</Title>
<ISOAbbreviation>Am J Addict</ISOAbbreviation>
</Journal>
<ArticleTitle>Typologies of positive psychotic symptoms in methamphetamine dependence.</ArticleTitle>
<Pagination>
<MedlinePgn>94-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/ajad.12160</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">Understanding methamphetamine associated psychotic (MAP) symptom typologies could aid in identifying individuals at risk of progressing to schizophrenia and guide early intervention.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Latent class analysis (LCA) of psychotic symptoms collected from 40 (n = 40) methamphetamine dependent individuals with a history of psychotic symptoms but no history of a primary psychotic disorder.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Three typologies were identified. In one, persecutory delusions dominated (Type 1), in another persecutory delusions were accompanied by hallucinations (Type 2), and in the third a high frequency of all the assessed hallucinatory and delusional symptoms was observed (Type 3).</AbstractText>
<AbstractText Label="DISCUSSION AND CONCLUSION" NlmCategory="CONCLUSIONS">MAP is a heterogeneous syndrome with positive symptom typologies.</AbstractText>
<AbstractText Label="SCIENTIFIC SIGNIFICANCE" NlmCategory="CONCLUSIONS">This study represents the first attempt at identifying typologies of MAP and highlights the potential utility of LCA in future large-scale studies.</AbstractText>
<CopyrightInformation>© American Academy of Addiction Psychiatry.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bousman</LastName>
<ForeName>Chad A</ForeName>
<Initials>CA</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, University of Melbourne, Parkville, VIC, Australia; Department of General Practice, University of Melbourne, Parkville, VIC, Australia; Centre for Human Psychopharmacology, Swinburne University of Technology, Hawthorne, VIC, Australia; Florey Institute for Neuroscience and Mental Health, Parkville, VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McKetin</LastName>
<ForeName>Rebecca</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Burns</LastName>
<ForeName>Richard</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Woods</LastName>
<ForeName>Steven Paul</ForeName>
<Initials>SP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Morgan</LastName>
<ForeName>Erin E</ForeName>
<Initials>EE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Atkinson</LastName>
<ForeName>J Hampton</ForeName>
<Initials>JH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Everall</LastName>
<ForeName>Ian P</ForeName>
<Initials>IP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Grant</LastName>
<ForeName>Igor</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<CollectiveName>Translational Methamphetamine AIDS Research Center (TMARC) Group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P50DA026306</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 DA031098</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32DA031098</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Am J Addict</MedlineTA>
<NlmUniqueID>9208821</NlmUniqueID>
<ISSNLinking>1055-0496</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Addiction. 2006 Oct;101(10):1473-8</RefSource>
<PMID Version="1">16968349</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychiatry Res. 2014 Jan 30;215(1):208-16</RefSource>
<PMID Version="1">24290100</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cogn Behav Neurol. 2008 Jun;21(2):98-103</RefSource>
<PMID Version="1">18541986</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Early Interv Psychiatry. 2012 Nov;6(4):368-79</RefSource>
<PMID Version="1">22776068</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Psychiatry. 2013 Jan;74(1):e94-9</RefSource>
<PMID Version="1">23419236</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Compr Psychiatry. 1995 Nov-Dec;36(6):428-34</RefSource>
<PMID Version="1">8565447</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Addict. 2008 Mar-Apr;17(2):83-98</RefSource>
<PMID Version="1">18393050</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Addict. 2000 Winter;9(1):28-37</RefSource>
<PMID Version="1">10914291</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Neuropsychopharmacol. 2003 Dec;6(4):347-52</RefSource>
<PMID Version="1">14604449</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychol Med. 2003 Nov;33(8):1407-14</RefSource>
<PMID Version="1">14672249</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA Psychiatry. 2013 Mar;70(3):319-24</RefSource>
<PMID Version="1">23303471</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">NIHMS625459 [Available on 03/01/16]</OtherID>
<OtherID Source="NLM">PMC4369467 [Available on 03/01/16]</OtherID>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Grant</LastName>
<ForeName>Igor</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ellis</LastName>
<ForeName>Ronald J</ForeName>
<Initials>RJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Letendre</LastName>
<ForeName>Scott L</ForeName>
<Initials>SL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Achim</LastName>
<ForeName>Cristian L</ForeName>
<Initials>CL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Woods</LastName>
<ForeName>Steven Paul</ForeName>
<Initials>SP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Carr</LastName>
<ForeName>Aaron M</ForeName>
<Initials>AM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Letendre</LastName>
<ForeName>Scott L</ForeName>
<Initials>SL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ellis</LastName>
<ForeName>Ronald J</ForeName>
<Initials>RJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Schrier</LastName>
<ForeName>Rachel</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Heaton</LastName>
<ForeName>Robert K</ForeName>
<Initials>RK</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Atkinson</LastName>
<ForeName>J  Hampton</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cherner</LastName>
<ForeName>Mariana</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Marcotte</LastName>
<ForeName>Thomas D</ForeName>
<Initials>TD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Morgan</LastName>
<ForeName>Erin E</ForeName>
<Initials>EE</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Brown</LastName>
<ForeName>Gregory</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jernigan</LastName>
<ForeName>Terry</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dale</LastName>
<ForeName>Anders</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Scadeng</LastName>
<ForeName>Miriam</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fennema-Notestine</LastName>
<ForeName>Christine</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Archibald</LastName>
<ForeName>Sarah L</ForeName>
<Initials>SL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Achim</LastName>
<ForeName>Cristian L</ForeName>
<Initials>CL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Masliah</LastName>
<ForeName>Eliezer</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lipton</LastName>
<ForeName>Stuart</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Soontornniyomkij</LastName>
<ForeName>Virawudh</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gamst</LastName>
<ForeName>Anthony C</ForeName>
<Initials>AC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cushman</LastName>
<ForeName>Clint</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Abramson</LastName>
<ForeName>Ian</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vaida</LastName>
<ForeName>Florin</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Deutsch</LastName>
<ForeName>Reena</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Umlauf</LastName>
<ForeName>Anya</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Atkinson</LastName>
<ForeName>J  Hampton</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Marquie-Beck</LastName>
<ForeName>Jennifer</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Minassian</LastName>
<ForeName>Arpi</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Perry</LastName>
<ForeName>William</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Geyer</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Henry</LastName>
<ForeName>Brook</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Grethe</LastName>
<ForeName>Amanda B</ForeName>
<Initials>AB</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Paulus</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ellis</LastName>
<ForeName>Ronald J</ForeName>
<Initials>RJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Morris</LastName>
<ForeName>Sheldon</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>David M</ForeName>
<Initials>DM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Grant</LastName>
<ForeName>Igor</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Semenova</LastName>
<ForeName>Svetlana</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Markou</LastName>
<ForeName>Athina</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kesby</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kaul</LastName>
<ForeName>Marcus</ForeName>
<Initials>M</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25919099</PMID>
<DateCreated>
<Year>2015</Year>
<Month>04</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>07</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>147</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2015</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Postsurgical volumetric airway changes in 2-jaw orthognathic surgery patients.</ArticleTitle>
<Pagination>
<MedlinePgn>536-46</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2014.12.023</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00037-2</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Findings from early cephalometric studies on airway changes after 2-jaw orthognathic surgery have been challenged because the previous anteroposterior interpretation of airway changes can now be evaluated in 3 dimensions. The aims of this study were to use cone-beam computed tomography to quantify the nasopharynx, oropharynx, and total airway volume changes associated with skeletal movements of the maxilla and mandible in a sample of patients undergoing 2-jaw orthognathic surgery for correction of skeletal malocclusion.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Skeletal movements and airway volumes of 71 postpubertal patients (31 male, 40 female; mean age, 18.8 years) were measured. They were divided into 2 groups based on ANB angle, overjet, and occlusion (Class II: ANB, &gt;2°; overjet, &gt;1 mm; total, 35 subjects; and Class III: ANB, &lt;1°; overjet, &lt;1 mm; total, 36 subjects). Presurgical and postsurgical measurements were collected for horizontal, vertical, and transverse movements of the maxilla and the mandible, along with changes in the nasopharynx, oropharynx, and total airways. Associations between the directional movements of skeletal structures and the regional changes in airway volume were quantified. Changes in the most constricted area were also noted.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Horizontal movements of D-point were significantly associated with increases in both total airway (403.6 ± 138.6 mm(3); P &lt;0.01) and oropharynx (383.9 ± 127.9 mm(3); P &lt;0.01) volumes. Vertical movements of the posterior nasal spine were significantly associated with decreases in total airway volume (-459.2 ± 219.9 mm(3); P = 0.04) and oropharynx volume (-639.7 ± 195.3 mm(3); P &lt;0.01), increases in nasopharynx (187.2 ± 47.1 mm(3); P &lt;0.01) volume, and decreases in the most constricted area (-10.63 ± 3.69 mm(2); P &lt;0.01). In the Class III patients only, the vertical movement of D-point was significantly associated with decreases in both total airway (-724.0 ± 284.4 mm(3); P = 0.02) and oropharynx (-648.2 ± 270.4 mm(3); P = 0.02) volumes. A similar negative association was observed for the most constricted area for the vertical movement of D-point (-15.45 ± 4.91 mm(2); P &lt;0.01).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Optimal control of airway volume is through management of the mandible in the horizontal direction and the vertical movement of the posterior maxilla for all patients. The surgeon and the orthodontist should optimally plan these movements to control gains or losses in airway volume as a result of orthognathic surgery.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hart</LastName>
<ForeName>P Sheamus</ForeName>
<Initials>PS</Initials>
<AffiliationInfo>
<Affiliation>Private practice, Woodridge, Va.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McIntyre</LastName>
<ForeName>Brian P</ForeName>
<Initials>BP</Initials>
<AffiliationInfo>
<Affiliation>Private practice, Omaha, Neb.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kadioglu</LastName>
<ForeName>Onur</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Assistant professor and program director, Department of Orthodontics, University of Oklahoma, Oklahoma City, Okla. Electronic address: onur-kadioglu@ouhsc.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Currier</LastName>
<ForeName>G Fräns</ForeName>
<Initials>GF</Initials>
<AffiliationInfo>
<Affiliation>Professor and chair, Department of Orthodontics, University of Oklahoma, Oklahoma City, Okla.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sullivan</LastName>
<ForeName>Steven M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Professor and chair, Department of Oral and Maxillofacial Surgery, University of Oklahoma, Oklahoma City, Okla.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Ji</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Biostatistician, Department of Biostatistics and Epidemiology, University of Oklahoma, Oklahoma City, Okla.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shay</LastName>
<ForeName>Christina</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Assistant professor, Department of Biostatistics and Epidemiology, University of Oklahoma, Oklahoma City, Okla.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Am J Orthod Dentofacial Orthop. 2015 Oct;148(4):528-9</RefSource>
<PMID Version="1">26432303</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Am J Orthod Dentofacial Orthop. 2015 Oct;148(4):528</RefSource>
<PMID Version="1">26432302</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059925">Anatomic Landmarks</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002508">Cephalometry</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054893">Cone-Beam Computed Tomography</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021621">Imaging, Three-Dimensional</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008312">Malocclusion, Angle Class II</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008313">Malocclusion, Angle Class III</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008334">Mandible</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008437">Maxilla</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009295">Nasal Bone</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009305">Nasopharynx</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009929">Organ Size</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009960">Oropharynx</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056948">Orthognathic Surgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057887">Overbite</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010614">Pharynx</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014716">Vertical Dimension</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24842892</PMID>
<DateCreated>
<Year>2015</Year>
<Month>05</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>07</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1535-5667</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>55</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</Title>
<ISOAbbreviation>J. Nucl. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease.</ArticleTitle>
<Pagination>
<MedlinePgn>1106-11</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2967/jnumed.113.130161</ELocationID>
<Abstract>
<AbstractText Label="UNLABELLED">Studies in animals and postmortem human brain tissue support a role for P-glycoprotein in clearance of cerebral β-amyloid across the blood-brain barrier (BBB). We tested the hypothesis that BBB P-glycoprotein activity is diminished in Alzheimer disease (AD) by accounting for an AD-related reduction in regional cerebral blood flow (rCBF).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We compared P-glycoprotein activity in mild-AD patients (n = 9) and cognitively normal, age-matched controls (n = 9) using PET with a labeled P-glycoprotein substrate, (11)C-verapamil, and (15)O-water to measure rCBF. BBB P-glycoprotein activity was expressed as the (11)C-verapamil radioactivity extraction ratio ((11)C-verapamil brain distributional clearance, K1/rCBF).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared with controls, BBB P-glycoprotein activity was significantly lower in the parietotemporal, frontal, and posterior cingulate cortices and hippocampus of mild AD subjects.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">BBB P-glycoprotein activity in brain regions affected by AD is reduced and is independent of rCBF. This study improves on prior work by eliminating the confounding effect that reduced rCBF has on assessment of BBB P-glycoprotein activity and suggests that impaired P-glycoprotein activity may contribute to cerebral β-amyloid accumulation in AD. P-glycoprotein induction or activation to increase cerebral β-amyloid clearance could constitute a novel preventive or therapeutic strategy for AD.</AbstractText>
<CopyrightInformation>© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Deo</LastName>
<ForeName>Anand K</ForeName>
<Initials>AK</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics, University of Washington, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Borson</LastName>
<ForeName>Soo</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Link</LastName>
<ForeName>Jeanne M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Washington, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Domino</LastName>
<ForeName>Karen</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, University of Washington, Seattle, Washington; and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eary</LastName>
<ForeName>Janet F</ForeName>
<Initials>JF</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Washington, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ke</LastName>
<ForeName>Ban</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics, University of Washington, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Richards</LastName>
<ForeName>Todd L</ForeName>
<Initials>TL</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Washington, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mankoff</LastName>
<ForeName>David A</ForeName>
<Initials>DA</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Washington, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Minoshima</LastName>
<ForeName>Satoshi</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Washington, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>O'Sullivan</LastName>
<ForeName>Finbarr</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Washington, Seattle, Washington Department of Statistics, University College Cork, Cork, Ireland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eyal</LastName>
<ForeName>Sara</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics, University of Washington, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hsiao</LastName>
<ForeName>Peng</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics, University of Washington, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maravilla</LastName>
<ForeName>Ken</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Washington, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Unadkat</LastName>
<ForeName>Jashvant D</ForeName>
<Initials>JD</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics, University of Washington, Seattle, Washington jash@u.washington.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>AG 031485</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R33 AG031485</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>TL1 RR 025016</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Nucl Med</MedlineTA>
<NlmUniqueID>0217410</NlmUniqueID>
<ISSNLinking>0161-5505</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002250">Carbon Radioisotopes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010104">Oxygen Radioisotopes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D020168">P-Glycoprotein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>059QF0KO0R</RegistryNumber>
<NameOfSubstance UI="D014867">Water</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>CJ0O37KU29</RegistryNumber>
<NameOfSubstance UI="D014700">Verapamil</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000544">Alzheimer Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000531">radionuclide imaging</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016229">Amyloid beta-Peptides</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001812">Blood-Brain Barrier</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000531">radionuclide imaging</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002250">Carbon Radioisotopes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016022">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002560">Cerebrovascular Circulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010104">Oxygen Radioisotopes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020168">P-Glycoprotein</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014700">Verapamil</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014867">Water</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS744705</OtherID>
<OtherID Source="NLM">PMC4691246</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Alzheimer’s disease</Keyword>
<Keyword MajorTopicYN="N">P-glycoprotein activity</Keyword>
<Keyword MajorTopicYN="N">PET imaging</Keyword>
<Keyword MajorTopicYN="N">blood–brain barrier</Keyword>
<Keyword MajorTopicYN="N">relative extraction ratio</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26012633</PMID>
<DateCreated>
<Year>2015</Year>
<Month>05</Month>
<Day>27</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1937-9145</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>8</Volume>
<Issue>378</Issue>
<PubDate>
<Year>2015</Year>
<Month>May</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>Science signaling</Title>
<ISOAbbreviation>Sci Signal</ISOAbbreviation>
</Journal>
<ArticleTitle>A large-scale screen reveals genes that mediate electrotaxis in Dictyostelium discoideum.</ArticleTitle>
<Pagination>
<MedlinePgn>ra50</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/scisignal.aab0562</ELocationID>
<Abstract>
<AbstractText>Directional cell migration in an electric field, a phenomenon called galvanotaxis or electrotaxis, occurs in many types of cells, and may play an important role in wound healing and development. Small extracellular electric fields can guide the migration of amoeboid cells, and we established a large-scale screening approach to search for mutants with electrotaxis phenotypes from a collection of 563 Dictyostelium discoideum strains with morphological defects. We identified 28 strains that were defective in electrotaxis and 10 strains with a slightly higher directional response. Using plasmid rescue followed by gene disruption, we identified some of the mutated genes, including some previously implicated in chemotaxis. Among these, we studied PiaA, which encodes a critical component of TORC2, a kinase protein complex that transduces changes in motility by activating the kinase PKB (also known as Akt). Furthermore, we found that electrotaxis was decreased in mutants lacking gefA, rasC, rip3, lst8, or pkbR1, genes that encode other components of the TORC2-PKB pathway. Thus, we have developed a high-throughput screening technique that will be a useful tool to elucidate the molecular mechanisms of electrotaxis.</AbstractText>
<CopyrightInformation>Copyright © 2015, American Association for the Advancement of Science.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gao</LastName>
<ForeName>Runchi</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>School of Life Sciences, Yunnan Normal University, Kunming, Yunnan 650500, China. Departments of Dermatology and Ophthalmology, Institute for Regenerative Cures, School of Medicine, University of California at Davis, Davis, CA 95817, USA. Department of Cell Biology and Anatomy, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhao</LastName>
<ForeName>Siwei</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Engineering, University of California at Davis, Davis, CA 95616, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jiang</LastName>
<ForeName>Xupin</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University, Chongqing 400042, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sun</LastName>
<ForeName>Yaohui</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Departments of Dermatology and Ophthalmology, Institute for Regenerative Cures, School of Medicine, University of California at Davis, Davis, CA 95817, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhao</LastName>
<ForeName>Sanjun</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>School of Life Sciences, Yunnan Normal University, Kunming, Yunnan 650500, China. Departments of Dermatology and Ophthalmology, Institute for Regenerative Cures, School of Medicine, University of California at Davis, Davis, CA 95817, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gao</LastName>
<ForeName>Jing</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>School of Life Sciences, Yunnan Normal University, Kunming, Yunnan 650500, China. Departments of Dermatology and Ophthalmology, Institute for Regenerative Cures, School of Medicine, University of California at Davis, Davis, CA 95817, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Borleis</LastName>
<ForeName>Jane</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Cell Biology and Anatomy, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Willard</LastName>
<ForeName>Stacey</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Cell Biology and Anatomy, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tang</LastName>
<ForeName>Ming</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Cell Biology and Anatomy, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cai</LastName>
<ForeName>Huaqing</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Cell Biology and Anatomy, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kamimura</LastName>
<ForeName>Yoichiro</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Cell Biology and Anatomy, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Yuesheng</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University, Chongqing 400042, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jiang</LastName>
<ForeName>Jianxin</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University, Chongqing 400042, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Zunxi</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>School of Life Sciences, Yunnan Normal University, Kunming, Yunnan 650500, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mogilner</LastName>
<ForeName>Alex</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Courant Institute and Department of Biology, New York University, 251 Mercer Street, New York, NY 10012, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pan</LastName>
<ForeName>Tingrui</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Engineering, University of California at Davis, Davis, CA 95616, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Devreotes</LastName>
<ForeName>Peter N</ForeName>
<Initials>PN</Initials>
<AffiliationInfo>
<Affiliation>Department of Cell Biology and Anatomy, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhao</LastName>
<ForeName>Min</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Departments of Dermatology and Ophthalmology, Institute for Regenerative Cures, School of Medicine, University of California at Davis, Davis, CA 95817, USA. minzhao@ucdavis.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>1R01EY019101</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>EB015737</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>GM64346</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 GM028007</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 GM034933</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 GM068952</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>WT082887MA</GrantID>
<Agency>Wellcome Trust</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Signal</MedlineTA>
<NlmUniqueID>101465400</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Cell. 2010 Dec 14;19(6):845-57</RefSource>
<PMID Version="1">21145500</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2011 Feb 15;22(4):437-47</RefSource>
<PMID Version="1">21169559</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Mol Biol. 2011;769:287-309</RefSource>
<PMID Version="1">21748684</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2011 Sep 19;194(6):815-24</RefSource>
<PMID Version="1">21930774</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Wound Repair Regen. 2011 Sep-Oct;19(5):645-55</RefSource>
<PMID Version="1">22092802</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(3):e59447</RefSource>
<PMID Version="1">23555674</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Biol. 2013 Apr 8;23(7):569-74</RefSource>
<PMID Version="1">23541726</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Biol. 2013 Apr 8;23(7):560-8</RefSource>
<PMID Version="1">23541731</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2013 May 1;126(Pt 9):1942-51</RefSource>
<PMID Version="1">23447677</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2013 Oct 15;126(Pt 20):4602-13</RefSource>
<PMID Version="1">23943873</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Biomed Eng. 2014 Jul 11;16:397-430</RefSource>
<PMID Version="1">25014787</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Cell Dev Biol. 2014;30:317-36</RefSource>
<PMID Version="1">25062359</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Biol. 2014 Dec;12(12):e1002029</RefSource>
<PMID Version="1">25548923</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biomed Mater Res. 2000 Sep 5;51(3):343-51</RefSource>
<PMID Version="1">10880075</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2001 Jul;114(Pt 14):2697-705</RefSource>
<PMID Version="1">11683396</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2002 Jun 10;157(6):921-7</RefSource>
<PMID Version="1">12045182</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Langmuir. 2001 Sep 4;17(18):5440-7</RefSource>
<PMID Version="1">12448421</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1234-9</RefSource>
<PMID Version="1">15130919</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 1974 Nov;63(2 Pt 1):614-28</RefSource>
<PMID Version="1">4421919</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gen Physiol. 1977 Jun;69(6):743-63</RefSource>
<PMID Version="1">19555</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Physiol. 1981 May;314:121-35</RefSource>
<PMID Version="1">7310685</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol. 1982 Mar;242(3):R358-66</RefSource>
<PMID Version="1">7065232</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8803-7</RefSource>
<PMID Version="1">1326764</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Motil Cytoskeleton. 1993;24(1):54-66</RefSource>
<PMID Version="1">8319267</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurobiol. 1994 Dec;25(12):1509-16</RefSource>
<PMID Version="1">7861115</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 1996 Jun;109 ( Pt 6):1405-14</RefSource>
<PMID Version="1">8799828</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 1996 Jan;109 ( Pt 1):199-207</RefSource>
<PMID Version="1">8834804</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Invest Ophthalmol Vis Sci. 1996 Dec;37(13):2548-58</RefSource>
<PMID Version="1">8977469</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 1997 Dec 1;11(23):3218-31</RefSource>
<PMID Version="1">9389653</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biotechnology (N Y). 1995 Jun;13(6):565-76</RefSource>
<PMID Version="1">9634795</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 1999 Apr;10(4):1259-76</RefSource>
<PMID Version="1">10198071</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gen Physiol. 1951 Sep;35(1):1-16</RefSource>
<PMID Version="1">14873916</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2005 Mar 15;118(Pt 6):1117-28</RefSource>
<PMID Version="1">15728257</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2005 Oct;16(10):4572-83</RefSource>
<PMID Version="1">16079174</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2006 Jul 27;442(7101):457-60</RefSource>
<PMID Version="1">16871217</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Theor Biol. 2006 Sep 21;242(2):314-28</RefSource>
<PMID Version="1">16620869</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Mol Biol. 2006;346:201-9</RefSource>
<PMID Version="1">16957292</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2006 Nov;17(11):4925-35</RefSource>
<PMID Version="1">16914518</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biosystems. 2007 Apr;88(3):261-72</RefSource>
<PMID Version="1">17184899</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Protoc. 2007;2(3):661-9</RefSource>
<PMID Version="1">17406628</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Protoc. 2007;2(6):1479-89</RefSource>
<PMID Version="1">17545984</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Wound Repair Regen. 2008 May-Jun;16(3):432-41</RefSource>
<PMID Version="1">18471262</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Chem Biol. 2008 Nov;4(11):691-9</RefSource>
<PMID Version="1">18849971</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6667-72</RefSource>
<PMID Version="1">19346484</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Biophys. 2010;39:265-89</RefSource>
<PMID Version="1">20192768</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Cell. 2010 May 18;18(5):737-49</RefSource>
<PMID Version="1">20493808</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2010 Jul 26;190(2):233-45</RefSource>
<PMID Version="1">20660630</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">NIHMS686384</OtherID>
<OtherID Source="NLM">PMC4470479</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25901762</PMID>
<DateCreated>
<Year>2015</Year>
<Month>05</Month>
<Day>28</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>09</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1520-4804</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>58</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>May</Month>
<Day>28</Day>
</PubDate>
</JournalIssue>
<Title>Journal of medicinal chemistry</Title>
<ISOAbbreviation>J. Med. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Discovery, synthesis, and molecular pharmacology of selective positive allosteric modulators of the δ-opioid receptor.</ArticleTitle>
<Pagination>
<MedlinePgn>4220-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.jmedchem.5b00007</ELocationID>
<Abstract>
<AbstractText>Allosteric modulators of G protein-coupled receptors (GPCRs) have a number of potential advantages compared to agonists or antagonists that bind to the orthosteric site of the receptor. These include the potential for receptor selectivity, maintenance of the temporal and spatial fidelity of signaling in vivo, the ceiling effect of the allosteric cooperativity which may prevent overdose issues, and engendering bias by differentially modulating distinct signaling pathways. Here we describe the discovery, synthesis, and molecular pharmacology of δ-opioid receptor-selective positive allosteric modulators (δ PAMs). These δ PAMs increase the affinity and/or efficacy of the orthosteric agonists leu-enkephalin, SNC80 and TAN67, as measured by receptor binding, G protein activation, β-arrestin recruitment, adenylyl cyclase inhibition, and extracellular signal-regulated kinases (ERK) activation. As such, these compounds are useful pharmacological tools to probe the molecular pharmacology of the δ receptor and to explore the therapeutic potential of δ PAMs in diseases such as chronic pain and depression. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Burford</LastName>
<ForeName>Neil T</ForeName>
<Initials>NT</Initials>
<AffiliationInfo>
<Affiliation>†Research and Development/Discovery, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Livingston</LastName>
<ForeName>Kathryn E</ForeName>
<Initials>KE</Initials>
<AffiliationInfo>
<Affiliation>‡Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan 48109, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Canals</LastName>
<ForeName>Meritxell</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ryan</LastName>
<ForeName>Molly R</ForeName>
<Initials>MR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Budenholzer</LastName>
<ForeName>Lauren M L</ForeName>
<Initials>LM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Han</LastName>
<ForeName>Ying</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>†Research and Development/Discovery, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shang</LastName>
<ForeName>Yi</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>⊥Department of Structural and Chemical Biology Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York 10029-6574, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Herbst</LastName>
<ForeName>John J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>†Research and Development/Discovery, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>O'Connell</LastName>
<ForeName>Jonathan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>#FORMA Therapeutics, Arsenal Street, Suite 100, Watertown, Massachusetts 02472, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Banks</LastName>
<ForeName>Martyn</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>†Research and Development/Discovery, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Litao</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>†Research and Development/Discovery, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Filizola</LastName>
<ForeName>Marta</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>⊥Department of Structural and Chemical Biology Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York 10029-6574, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bassoni</LastName>
<ForeName>Daniel L</ForeName>
<Initials>DL</Initials>
<AffiliationInfo>
<Affiliation>∞DiscoveRx Corporation, 42501 Albrae Street, Suite 100, Fremont, California 94538, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wehrman</LastName>
<ForeName>Tom S</ForeName>
<Initials>TS</Initials>
<AffiliationInfo>
<Affiliation>×Primity Bio, 3350 Scott Boulevard, Ste 6101, Santa Clara, California 95054, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Christopoulos</LastName>
<ForeName>Arthur</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Traynor</LastName>
<ForeName>John R</ForeName>
<Initials>JR</Initials>
<AffiliationInfo>
<Affiliation>‡Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan 48109, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gerritz</LastName>
<ForeName>Samuel W</ForeName>
<Initials>SW</Initials>
<AffiliationInfo>
<Affiliation>†Research and Development/Discovery, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alt</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>†Research and Development/Discovery, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>DA026434</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>DA034049</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>DA035316</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K02 DA026434</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DA034049</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Med Chem</MedlineTA>
<NlmUniqueID>9716531</NlmUniqueID>
<ISSNLinking>0022-2623</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019390">Arrestins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001549">Benzamides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010879">Piperazines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011804">Quinolines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017465">Receptors, Opioid, delta</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C094142">TAN 67</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C074198">beta-arrestin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>156727-74-1</RegistryNumber>
<NameOfSubstance UI="C088464">4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>58822-25-6</RegistryNumber>
<NameOfSubstance UI="D004743">Enkephalin, Leucine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.24</RegistryNumber>
<NameOfSubstance UI="D048049">Extracellular Signal-Regulated MAP Kinases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019390">Arrestins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001549">Benzamides</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001667">Binding, Competitive</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016466">CHO Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002462">Cell Membrane</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D060326">Chemistry Techniques, Synthetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003412">Cricetulus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055808">Drug Discovery</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004353">Drug Evaluation, Preclinical</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004743">Enkephalin, Leucine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004789">Enzyme Activation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D048049">Extracellular Signal-Regulated MAP Kinases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015394">Molecular Structure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058990">Molecular Targeted Therapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010879">Piperazines</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011804">Quinolines</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017465">Receptors, Opioid, delta</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013329">Structure-Activity Relationship</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25936681</PMID>
<DateCreated>
<Year>2015</Year>
<Month>06</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2015</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Prediction of refractive outcomes with toric intraocular lens implantation.</ArticleTitle>
<Pagination>
<MedlinePgn>936-44</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.08.036</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00422-8</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate and compare the accuracy of different methods to measure and predict postoperative astigmatism with toric intraocular lens (IOL) implantation.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Ein-Tal Ophthalmology Center, Tel-Aviv, Israel.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective case series.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Postoperative corneal astigmatism was measured with 3 devices (IOLMaster 500; optical low-coherence reflectometry [OLCR]-based Lenstar LS 900; Atlas topographer) and compared with the manifest astigmatic refractive outcome in patients with toric IOLs. The error in the predicted residual astigmatism was calculated by vector analysis according to the measurement and calculation method used to predict the required toric IOL cylinder power.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The centroid errors in predicted residual astigmatism were against the rule with the Alcon and Holladay toric calculators (0.53 to 0.56 diopter [D]), were lower with the Baylor nomogram (0.21 to 0.26 D), and were lowest for the Barrett toric calculator (0.01 to 0.16 D) (P &lt;.001). The Barrett toric calculator had the lowest median absolute error in predicted residual astigmatism (0.35 to 0.54 D, all devices) compared with the Alcon and Holladay toric calculators with or without the Baylor nomogram (P &lt;.021). The Barrett toric calculator and the OLCR device achieved the most accurate results; 75.0% and 97.1% of eyes were within ±0.50 D and ±0.75 D of the predicted residual astigmatism, respectively.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Prediction of astigmatic outcomes with toric IOLs can be improved with appropriate measuring devices and methods to establish the required toric IOL power.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Abulafia</LastName>
<ForeName>Adi</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Ein-Tal Eye Center (Abulafia, Ofir, Kleinmann, Levy, Marcovich, Michaeli, Assia), Tel Aviv Medical Center (Michaeli), and Tel-Aviv University (Abulafia, Ofir, Michaeli, Assia), Tel Aviv, the Meir Medical Center (Ofir, Assia), Kfar-Saba, and the Kaplan Medical Center (Kleinmann, Marcovich), Rehovot, Israel; the Sir Charles Gairdner Hospital (Abulafia, Barrett), Nedlands, Australia; Cullen Eye Institute (Koch, Wang), Baylor College of Medicine, Houston, Texas, USA. Electronic address: adi.abulafia@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barrett</LastName>
<ForeName>Graham D</ForeName>
<Initials>GD</Initials>
<AffiliationInfo>
<Affiliation>From the Ein-Tal Eye Center (Abulafia, Ofir, Kleinmann, Levy, Marcovich, Michaeli, Assia), Tel Aviv Medical Center (Michaeli), and Tel-Aviv University (Abulafia, Ofir, Michaeli, Assia), Tel Aviv, the Meir Medical Center (Ofir, Assia), Kfar-Saba, and the Kaplan Medical Center (Kleinmann, Marcovich), Rehovot, Israel; the Sir Charles Gairdner Hospital (Abulafia, Barrett), Nedlands, Australia; Cullen Eye Institute (Koch, Wang), Baylor College of Medicine, Houston, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kleinmann</LastName>
<ForeName>Guy</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>From the Ein-Tal Eye Center (Abulafia, Ofir, Kleinmann, Levy, Marcovich, Michaeli, Assia), Tel Aviv Medical Center (Michaeli), and Tel-Aviv University (Abulafia, Ofir, Michaeli, Assia), Tel Aviv, the Meir Medical Center (Ofir, Assia), Kfar-Saba, and the Kaplan Medical Center (Kleinmann, Marcovich), Rehovot, Israel; the Sir Charles Gairdner Hospital (Abulafia, Barrett), Nedlands, Australia; Cullen Eye Institute (Koch, Wang), Baylor College of Medicine, Houston, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ofir</LastName>
<ForeName>Shay</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Ein-Tal Eye Center (Abulafia, Ofir, Kleinmann, Levy, Marcovich, Michaeli, Assia), Tel Aviv Medical Center (Michaeli), and Tel-Aviv University (Abulafia, Ofir, Michaeli, Assia), Tel Aviv, the Meir Medical Center (Ofir, Assia), Kfar-Saba, and the Kaplan Medical Center (Kleinmann, Marcovich), Rehovot, Israel; the Sir Charles Gairdner Hospital (Abulafia, Barrett), Nedlands, Australia; Cullen Eye Institute (Koch, Wang), Baylor College of Medicine, Houston, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Levy</LastName>
<ForeName>Adi</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Ein-Tal Eye Center (Abulafia, Ofir, Kleinmann, Levy, Marcovich, Michaeli, Assia), Tel Aviv Medical Center (Michaeli), and Tel-Aviv University (Abulafia, Ofir, Michaeli, Assia), Tel Aviv, the Meir Medical Center (Ofir, Assia), Kfar-Saba, and the Kaplan Medical Center (Kleinmann, Marcovich), Rehovot, Israel; the Sir Charles Gairdner Hospital (Abulafia, Barrett), Nedlands, Australia; Cullen Eye Institute (Koch, Wang), Baylor College of Medicine, Houston, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marcovich</LastName>
<ForeName>Arie L</ForeName>
<Initials>AL</Initials>
<AffiliationInfo>
<Affiliation>From the Ein-Tal Eye Center (Abulafia, Ofir, Kleinmann, Levy, Marcovich, Michaeli, Assia), Tel Aviv Medical Center (Michaeli), and Tel-Aviv University (Abulafia, Ofir, Michaeli, Assia), Tel Aviv, the Meir Medical Center (Ofir, Assia), Kfar-Saba, and the Kaplan Medical Center (Kleinmann, Marcovich), Rehovot, Israel; the Sir Charles Gairdner Hospital (Abulafia, Barrett), Nedlands, Australia; Cullen Eye Institute (Koch, Wang), Baylor College of Medicine, Houston, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Michaeli</LastName>
<ForeName>Adi</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Ein-Tal Eye Center (Abulafia, Ofir, Kleinmann, Levy, Marcovich, Michaeli, Assia), Tel Aviv Medical Center (Michaeli), and Tel-Aviv University (Abulafia, Ofir, Michaeli, Assia), Tel Aviv, the Meir Medical Center (Ofir, Assia), Kfar-Saba, and the Kaplan Medical Center (Kleinmann, Marcovich), Rehovot, Israel; the Sir Charles Gairdner Hospital (Abulafia, Barrett), Nedlands, Australia; Cullen Eye Institute (Koch, Wang), Baylor College of Medicine, Houston, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Koch</LastName>
<ForeName>Douglas D</ForeName>
<Initials>DD</Initials>
<AffiliationInfo>
<Affiliation>From the Ein-Tal Eye Center (Abulafia, Ofir, Kleinmann, Levy, Marcovich, Michaeli, Assia), Tel Aviv Medical Center (Michaeli), and Tel-Aviv University (Abulafia, Ofir, Michaeli, Assia), Tel Aviv, the Meir Medical Center (Ofir, Assia), Kfar-Saba, and the Kaplan Medical Center (Kleinmann, Marcovich), Rehovot, Israel; the Sir Charles Gairdner Hospital (Abulafia, Barrett), Nedlands, Australia; Cullen Eye Institute (Koch, Wang), Baylor College of Medicine, Houston, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Li</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>From the Ein-Tal Eye Center (Abulafia, Ofir, Kleinmann, Levy, Marcovich, Michaeli, Assia), Tel Aviv Medical Center (Michaeli), and Tel-Aviv University (Abulafia, Ofir, Michaeli, Assia), Tel Aviv, the Meir Medical Center (Ofir, Assia), Kfar-Saba, and the Kaplan Medical Center (Kleinmann, Marcovich), Rehovot, Israel; the Sir Charles Gairdner Hospital (Abulafia, Barrett), Nedlands, Australia; Cullen Eye Institute (Koch, Wang), Baylor College of Medicine, Houston, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Assia</LastName>
<ForeName>Ehud I</ForeName>
<Initials>EI</Initials>
<AffiliationInfo>
<Affiliation>From the Ein-Tal Eye Center (Abulafia, Ofir, Kleinmann, Levy, Marcovich, Michaeli, Assia), Tel Aviv Medical Center (Michaeli), and Tel-Aviv University (Abulafia, Ofir, Michaeli, Assia), Tel Aviv, the Meir Medical Center (Ofir, Assia), Kfar-Saba, and the Kaplan Medical Center (Kleinmann, Marcovich), Rehovot, Israel; the Sir Charles Gairdner Hospital (Abulafia, Barrett), Nedlands, Australia; Cullen Eye Institute (Koch, Wang), Baylor College of Medicine, Houston, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>04</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1794-5</RefSource>
<PMID Version="1">26432152</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1795</RefSource>
<PMID Version="1">26432154</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001251">Astigmatism</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001699">Biometry</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000295">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003315">Cornea</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003941">Diagnostic Techniques, Ophthalmological</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000295">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D019654">Lens Implantation, Intraocular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D007910">Lenses, Intraocular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018918">Phacoemulsification</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D011183">Postoperative Complications</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011474">Prosthesis Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012029">Refraction, Ocular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014792">Visual Acuity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26059205</PMID>
<DateCreated>
<Year>2015</Year>
<Month>06</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>06</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">2110-5820</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Annals of intensive care</Title>
<ISOAbbreviation>Ann Intensive Care</ISOAbbreviation>
</Journal>
<ArticleTitle>Efficiency of a mechanical device in controlling tracheal cuff pressure in intubated critically ill patients: a randomized controlled study.</ArticleTitle>
<Pagination>
<MedlinePgn>54</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13613-015-0054-z</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cuff pressure (P cuff) control is mandatory to avoid leakage of oral secretions passing the tracheal tube and tracheal ischemia. The aim of the present trial was to determine the efficacy of a mechanical device (PressureEasy®) in the continuous control of P cuff in patients intubated with polyvinyl chloride (PVC)-cuffed tracheal tubes, compared with routine care using a manometer.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">This is a prospective, randomized, controlled, cross-over study. All patients requiring intubation with a predicted duration of mechanical ventilation ≥48 h were eligible. Eighteen patients randomly received continuous control of P cuff with PressureEasy® device for 24 h, followed by discontinuous control (every 4 h) with a manual manometer for 24 h, or vice versa. P cuff and airway pressure were continuously recorded. P cuff target was 25 cmH2O during the two periods.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The percentage of time spent with P cuff 20-30 cmH2O (median (IQR) 34 % (17-57) versus 50 % (35-64), p = 0.184) and the percentage of time spent with P cuff &lt;20 cmH2O (23 % (5-63) versus 43 % (16-60), p = 0.5) were similar during continuous control of P cuff and routine care, respectively. However, the percentage of time spent with P cuff &gt;30 cmH2O was significantly higher during continuous control compared with routine care of tracheal cuff (26 % (14-39) versus 7 % (1-18), p = 0.002). No significant difference was found in P cuff (25 (18-28) versus 21 (18-26), p = 0.17), mean airway pressure (14 (10-17) versus 14 (11-16), p = 0.679), or coefficient of variation of P cuff (19 % (11-26) versus 20 % (11-25), p = 0.679) during continuous control compared with routine care of tracheal cuff, respectively.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PressureEasy® did not demonstrate a better control of P cuff between 20 and 30 cmH2O, compared with routine care using a manometer. Moreover, the device use resulted in significantly higher time spent with overinflation of tracheal cuff, which might increase the risk for tracheal ischemic lesions.</AbstractText>
<AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">Clinicaltrial.gov: NCT02109003.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nseir</LastName>
<ForeName>Saad</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Critical Care Center, Hospital de Sabadell, Universidad Autonoma de Barcelona, CIBER enfermedades respiratorias, Corporació Sanitaria Parc Tauli, Parc Tauli 1, 08208, Sabadell, Spain, s-nseir@chru-lille.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rodriguez</LastName>
<ForeName>Andrey</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Saludes</LastName>
<ForeName>Paula</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>De Jonckheere</LastName>
<ForeName>Julien</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Valles</LastName>
<ForeName>Jordi</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Artigas</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Martin-Loeches</LastName>
<ForeName>Ignacio</ForeName>
<Initials>I</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Ann Intensive Care</MedlineTA>
<NlmUniqueID>101562873</NlmUniqueID>
<ISSNLinking>2110-5820</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4461648</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">26102394</PMID>
<DateCreated>
<Year>2015</Year>
<Month>06</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>08</Month>
<Day>31</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1546-3141</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>205</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2015</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>AJR. American journal of roentgenology</Title>
<ISOAbbreviation>AJR Am J Roentgenol</ISOAbbreviation>
</Journal>
<ArticleTitle>Transcranial MRI-Guided Focused Ultrasound: A Review of the Technologic and Neurologic Applications.</ArticleTitle>
<Pagination>
<MedlinePgn>150-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2214/AJR.14.13632</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This article reviews the physical principles of MRI-guided focused ultra-sound and discusses current and potential applications of this exciting technology.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">MRI-guided focused ultrasound is a new minimally invasive method of targeted tissue thermal ablation that may be of use to treat central neuropathic pain, essential tremor, Parkinson tremor, and brain tumors. The system has also been used to temporarily disrupt the blood-brain barrier to allow targeted drug delivery to brain tumors.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ghanouni</LastName>
<ForeName>Pejman</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>1 Division of Body MRI, Department of Radiology, Stanford University, Stanford, CA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pauly</LastName>
<ForeName>Kim Butts</ForeName>
<Initials>KB</Initials>
<AffiliationInfo>
<Affiliation>2 Departments of Radiology and Electrical Engineering and Bioengineering, Stanford University, Stanford, CA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Elias</LastName>
<ForeName>W Jeff</ForeName>
<Initials>WJ</Initials>
<AffiliationInfo>
<Affiliation>3 Department of Neurosurgery, University of Virginia, Charlottesville, VA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Henderson</LastName>
<ForeName>Jaimie</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>4 Department of Neurosurgery and Neurology and Neurological Sciences, Stanford University, Stanford, CA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sheehan</LastName>
<ForeName>Jason</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>3 Department of Neurosurgery, University of Virginia, Charlottesville, VA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Monteith</LastName>
<ForeName>Stephen</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>5 Department of Neurosurgery, Swedish Medical Center, Seattle, WA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wintermark</LastName>
<ForeName>Max</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>6 Present address: Division of Neuroradiology, Department of Radiology, Stanford University, 300 Pasteur Dr, Rm S047, Stanford, CA 94305-5105.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P01 CA159992</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>AJR Am J Roentgenol</MedlineTA>
<NlmUniqueID>7708173</NlmUniqueID>
<ISSNLinking>0361-803X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001927">Brain Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057086">High-Intensity Focused Ultrasound Ablation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053783">Magnetic Resonance Imaging, Interventional</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS726468</OtherID>
<OtherID Source="NLM">PMC4687492</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">MRI-guided focused ultrasound</Keyword>
<Keyword MajorTopicYN="N">brain</Keyword>
<Keyword MajorTopicYN="N">brain tumors</Keyword>
<Keyword MajorTopicYN="N">movement disorders</Keyword>
<Keyword MajorTopicYN="N">neuropathic pain</Keyword>
<Keyword MajorTopicYN="N">stroke</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26066846</PMID>
<DateCreated>
<Year>2015</Year>
<Month>06</Month>
<Day>25</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1364-548X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>51</Volume>
<Issue>55</Issue>
<PubDate>
<Year>2015</Year>
<Month>Jul</Month>
<Day>14</Day>
</PubDate>
</JournalIssue>
<Title>Chemical communications (Cambridge, England)</Title>
<ISOAbbreviation>Chem. Commun. (Camb.)</ISOAbbreviation>
</Journal>
<ArticleTitle>Design and synthesis of active heparan sulfate-based probes.</ArticleTitle>
<Pagination>
<MedlinePgn>11019-21</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1039/c5cc02008e</ELocationID>
<Abstract>
<AbstractText>A chemoenzymatic approach for synthesizing heparan sulfate oligosaccharides with a reactive diazoacetyl saccharide residue is reported. The resultant oligosaccharides were demonstrated to serve as specific inhibitors for heparan sulfate sulfotransferases, offering a new set of tools to probe the structural selectivity for heparan sulfate-binding proteins. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zhou</LastName>
<ForeName>Wen</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Rm 1044, Genetic Medicine Building, Chapel Hill, NC 27599, USA. jian_liu@unc.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hsieh</LastName>
<ForeName>Po-Hung</ForeName>
<Initials>PH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Xu</LastName>
<ForeName>Yongmei</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>O'Leary</LastName>
<ForeName>Timothy R</ForeName>
<Initials>TR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Xuefei</ForeName>
<Initials>X</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Jian</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>GM072667</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>GM102137</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HL094463</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HL120598</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 GM102137</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Chem Commun (Camb)</MedlineTA>
<NlmUniqueID>9610838</NlmUniqueID>
<ISSNLinking>1359-7345</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Struct Biol. 2012 Oct;22(5):550-7</RefSource>
<PMID Version="1">22840348</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5265-70</RefSource>
<PMID Version="1">22431632</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Cell. 2014 Jun 23;29(6):662-73</RefSource>
<PMID Version="1">24960693</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2006 Jul 31;174(3):323-7</RefSource>
<PMID Version="1">16880267</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chem Rev. 2002 Dec;102(12):4639-750</RefSource>
<PMID Version="1">12475205</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Med Res Rev. 2002 Jan;22(1):1-25</RefSource>
<PMID Version="1">11746174</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Prod Rep. 2014 Dec;31(12):1676-85</RefSource>
<PMID Version="1">25197032</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2007 Apr 26;446(7139):1030-7</RefSource>
<PMID Version="1">17460664</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Biochem. 2014;83:129-57</RefSource>
<PMID Version="1">24606135</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2014 May 9;289(19):13407-18</RefSource>
<PMID Version="1">24652287</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">NIHMS700123 [Available on 01/14/16]</OtherID>
<OtherID Source="NLM">PMC4502442 [Available on 01/14/16]</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">26022416</PMID>
<DateCreated>
<Year>2015</Year>
<Month>06</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>07</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1095-9203</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>348</Volume>
<Issue>6242</Issue>
<PubDate>
<Year>2015</Year>
<Month>Jun</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>Science (New York, N.Y.)</Title>
<ISOAbbreviation>Science</ISOAbbreviation>
</Journal>
<ArticleTitle>GENE SILENCING. Epigenetic silencing by the HUSH complex mediates position-effect variegation in human cells.</ArticleTitle>
<Pagination>
<MedlinePgn>1481-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.aaa7227</ELocationID>
<Abstract>
<AbstractText>Forward genetic screens in Drosophila melanogaster for modifiers of position-effect variegation have revealed the basis of much of our understanding of heterochromatin. We took an analogous approach to identify genes required for epigenetic repression in human cells. A nonlethal forward genetic screen in near-haploid KBM7 cells identified the HUSH (human silencing hub) complex, comprising three poorly characterized proteins, TASOR, MPP8, and periphilin; this complex is absent from Drosophila but is conserved from fish to humans. Loss of HUSH components resulted in decreased H3K9me3 both at endogenous genomic loci and at retroviruses integrated into heterochromatin. Our results suggest that the HUSH complex is recruited to genomic loci rich in H3K9me3, where subsequent recruitment of the methyltransferase SETDB1 is required for further H3K9me3 deposition to maintain transcriptional silencing. </AbstractText>
<CopyrightInformation>Copyright © 2015, American Association for the Advancement of Science.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tchasovnikarova</LastName>
<ForeName>Iva A</ForeName>
<Initials>IA</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge CB2 0XY, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Timms</LastName>
<ForeName>Richard T</ForeName>
<Initials>RT</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge CB2 0XY, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Matheson</LastName>
<ForeName>Nicholas J</ForeName>
<Initials>NJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge CB2 0XY, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wals</LastName>
<ForeName>Kim</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge CB2 0XY, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Antrobus</LastName>
<ForeName>Robin</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge CB2 0XY, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Göttgens</LastName>
<ForeName>Berthold</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Haematology, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge CB2 0XY, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dougan</LastName>
<ForeName>Gordon</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge CB10 1SA, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dawson</LastName>
<ForeName>Mark A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lehner</LastName>
<ForeName>Paul J</ForeName>
<Initials>PJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge CB2 0XY, UK. pjl30@cam.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>GEO</DataBankName>
<AccessionNumberList>
<AccessionNumber>GSE60056</AccessionNumber>
<AccessionNumber>GSE63116</AccessionNumber>
</AccessionNumberList>
</DataBank>
<DataBank>
<DataBankName>SRA</DataBankName>
<AccessionNumberList>
<AccessionNumber>PRJNA257239</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>100140</GrantID>
<Agency>Wellcome Trust</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>101835</GrantID>
<Agency>Wellcome Trust</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>101835/Z/13/Z</GrantID>
<Agency>Wellcome Trust</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Science</MedlineTA>
<NlmUniqueID>0404511</NlmUniqueID>
<ISSNLinking>0036-8075</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000951">Antigens, Neoplasm</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006570">Heterochromatin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006657">Histones</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C547278">MPP8 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D046912">Multiprotein Complexes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C478775">PPHLN1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000599477">TASOR protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C485192">green fluorescent protein, Aequorea victoria</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>147336-22-9</RegistryNumber>
<NameOfSubstance UI="D049452">Green Fluorescent Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.1.1.-</RegistryNumber>
<NameOfSubstance UI="D011496">Protein Methyltransferases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.1.1.-</RegistryNumber>
<NameOfSubstance UI="C454062">SETDB1 protein, human</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1989 Aug;86(15):5974-8</RefSource>
<PMID Version="1">2762307</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1990 Dec;87(24):9923-7</RefSource>
<PMID Version="1">2124708</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 1986 Nov;6(11):3862-72</RefSource>
<PMID Version="1">3099166</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2000 Aug 10;406(6796):593-9</RefSource>
<PMID Version="1">10949293</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2001 Mar 1;410(6824):120-4</RefSource>
<PMID Version="1">11242054</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2001 Apr 2;20(7):1726-38</RefSource>
<PMID Version="1">11285236</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 2002 Apr 15;16(8):919-32</RefSource>
<PMID Version="1">11959841</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Gene Ther. 2002 May 1;13(7):803-13</RefSource>
<PMID Version="1">11975847</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Cell Dev Biol. 2003 Feb;14(1):67-75</RefSource>
<PMID Version="1">12524009</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2003 Apr 15;22(8):1868-77</RefSource>
<PMID Version="1">12682019</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2004 Nov 12;324(2):554-61</RefSource>
<PMID Version="1">15474462</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genome Res. 2014 Nov;24(11):1842-53</RefSource>
<PMID Version="1">25301795</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mamm Genome. 2014 Aug;25(7-8):293-303</RefSource>
<PMID Version="1">24781204</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2013;9(11):e1003772</RefSource>
<PMID Version="1">24278019</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Protoc. 2013 Nov;8(11):2281-308</RefSource>
<PMID Version="1">24157548</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cold Spring Harb Perspect Biol. 2013 Aug;5(8):a017780</RefSource>
<PMID Version="1">23906716</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(6):e39651</RefSource>
<PMID Version="1">22745803</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Methods. 2012 Apr;9(4):357-9</RefSource>
<PMID Version="1">22388286</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2011;6(10):e25104</RefSource>
<PMID Version="1">22022377</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Biotechnol. 2011 Jun;29(6):542-6</RefSource>
<PMID Version="1">21623355</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2011 May 20;408(5):807-14</RefSource>
<PMID Version="1">21419134</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2010;5(12):e15082</RefSource>
<PMID Version="1">21170338</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2010 Nov 3;29(21):3673-87</RefSource>
<PMID Version="1">20871592</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Stem Cell. 2010 Oct 8;7(4):532-44</RefSource>
<PMID Version="1">20887958</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genesis. 2009 Oct;47(10):697-707</RefSource>
<PMID Version="1">19621438</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2009 Oct 8;461(7265):819-22</RefSource>
<PMID Version="1">19783980</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2007 Dec 28;364(4):930-6</RefSource>
<PMID Version="1">17963697</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Genet. 2007 Jun;3(6):e89</RefSource>
<PMID Version="1">17542650</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Science. 2015 Jun 26;348(6242):1433-4</RefSource>
<PMID Version="1">26113708</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000951">Antigens, Neoplasm</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D055012">Chromosomal Position Effects</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017124">Conserved Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004331">Drosophila melanogaster</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019143">Evolution, Molecular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D020868">Gene Silencing</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017930">Genes, Reporter</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056426">Genetic Loci</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049452">Green Fluorescent Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006367">HeLa Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006570">Heterochromatin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006657">Histones</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D047468">Immunoprecipitation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D046912">Multiprotein Complexes</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009687">Nuclear Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010750">Phosphoproteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011496">Protein Methyltransferases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">EMS63497</OtherID>
<OtherID Source="NLM">PMC4487827</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">26044300</PMID>
<DateCreated>
<Year>2015</Year>
<Month>06</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>07</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1095-9203</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>348</Volume>
<Issue>6242</Issue>
<PubDate>
<Year>2015</Year>
<Month>Jun</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>Science (New York, N.Y.)</Title>
<ISOAbbreviation>Science</ISOAbbreviation>
</Journal>
<ArticleTitle>GENE REGULATION. Discrete functions of nuclear receptor Rev-erbα couple metabolism to the clock.</ArticleTitle>
<Pagination>
<MedlinePgn>1488-92</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.aab3021</ELocationID>
<Abstract>
<AbstractText>Circadian and metabolic physiology are intricately intertwined, as illustrated by Rev-erbα, a transcription factor (TF) that functions both as a core repressive component of the cell-autonomous clock and as a regulator of metabolic genes. Here, we show that Rev-erbα modulates the clock and metabolism by different genomic mechanisms. Clock control requires Rev-erbα to bind directly to the genome at its cognate sites, where it competes with activating ROR TFs. By contrast, Rev-erbα regulates metabolic genes primarily by recruiting the HDAC3 co-repressor to sites to which it is tethered by cell type-specific transcription factors. Thus, direct competition between Rev-erbα and ROR TFs provides a universal mechanism for self-sustained control of the molecular clock across all tissues, whereas Rev-erbα uses lineage-determining factors to convey a tissue-specific epigenomic rhythm that regulates metabolism tailored to the specific need of that tissue. </AbstractText>
<CopyrightInformation>Copyright © 2015, American Association for the Advancement of Science.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Yuxiang</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Department of Genetics, and the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fang</LastName>
<ForeName>Bin</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Department of Genetics, and the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Emmett</LastName>
<ForeName>Matthew J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Department of Genetics, and the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Damle</LastName>
<ForeName>Manashree</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Department of Genetics, and the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sun</LastName>
<ForeName>Zheng</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Department of Genetics, and the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Department of Molecular and Cellular Biology, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Feng</LastName>
<ForeName>Dan</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Department of Genetics, and the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Armour</LastName>
<ForeName>Sean M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Department of Genetics, and the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Remsberg</LastName>
<ForeName>Jarrett R</ForeName>
<Initials>JR</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Department of Genetics, and the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jager</LastName>
<ForeName>Jennifer</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Department of Genetics, and the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Soccio</LastName>
<ForeName>Raymond E</ForeName>
<Initials>RE</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Department of Genetics, and the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Steger</LastName>
<ForeName>David J</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Department of Genetics, and the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lazar</LastName>
<ForeName>Mitchell A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Department of Genetics, and the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. lazar@mail.med.upenn.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>GEO</DataBankName>
<AccessionNumberList>
<AccessionNumber>GSE67973</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>F30 DK104513</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>F32 DK102284</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K08 DK094968</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 DK050306</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 DK19525</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R00 DK099443</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R00 DK099443</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DK045586</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DK098542</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DK45586</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 GM0008275</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 GM008275</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Science</MedlineTA>
<NlmUniqueID>0404511</NlmUniqueID>
<ISSNLinking>0036-8075</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051559">Hepatocyte Nuclear Factor 6</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C498262">Nr1d1 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D056953">Nuclear Receptor Subfamily 1, Group D, Member 1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D057094">Nuclear Receptor Subfamily 1, Group F, Member 1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C496606">Onecut1 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.3.1.48</RegistryNumber>
<NameOfSubstance UI="D056926">CLOCK Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.5.1.98</RegistryNumber>
<NameOfSubstance UI="D006655">Histone Deacetylases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.5.1.98</RegistryNumber>
<NameOfSubstance UI="C438596">histone deacetylase 3</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Struct Mol Biol. 2007 Dec;14(12):1207-13</RefSource>
<PMID Version="1">18037887</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Genet. 2008 Oct;9(10):764-75</RefSource>
<PMID Version="1">18802415</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 1995 Sep;15(9):4791-802</RefSource>
<PMID Version="1">7651396</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Endocrinol. 1994 Sep;8(9):1253-61</RefSource>
<PMID Version="1">7838158</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 1994 Mar 1;8(5):538-53</RefSource>
<PMID Version="1">7926749</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2002 Jul 26;110(2):251-60</RefSource>
<PMID Version="1">12150932</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Endocrinol. 2005 Jun;19(6):1452-9</RefSource>
<PMID Version="1">15761026</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2007 Dec 14;318(5857):1786-9</RefSource>
<PMID Version="1">18006707</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2015 Mar 26;161(1):84-92</RefSource>
<PMID Version="1">25815987</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Endocrinol Metab. 2014 Nov;25(11):586-92</RefSource>
<PMID Version="1">25066191</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2014 Nov 20;159(5):1140-52</RefSource>
<PMID Version="1">25416951</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2014 Nov 10;42(20):e156</RefSource>
<PMID Version="1">25249628</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Rep. 2014 Feb 27;6(4):633-45</RefSource>
<PMID Version="1">24529706</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2013 Nov 21;503(7476):410-3</RefSource>
<PMID Version="1">24162845</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Neurobiol. 2013 Oct;23(5):724-31</RefSource>
<PMID Version="1">23731779</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2013 Aug;19(8):1039-46</RefSource>
<PMID Version="1">23852339</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2013 Jun 27;498(7455):511-5</RefSource>
<PMID Version="1">23728303</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Endocrinol Metab. 2012 Dec;23(12):619-27</RefSource>
<PMID Version="1">22789990</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genome Res. 2012 Nov;22(11):2163-75</RefSource>
<PMID Version="1">22780989</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2012 Sep 1;40(17):8519-35</RefSource>
<PMID Version="1">22753030</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2012 Jul 27;47(2):158-67</RefSource>
<PMID Version="1">22841001</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2012 May 3;485(7396):123-7</RefSource>
<PMID Version="1">22460952</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 2012 Apr 1;26(7):657-67</RefSource>
<PMID Version="1">22474260</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2011 Dec 9;147(6):1408-19</RefSource>
<PMID Version="1">22153082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Endocrinol. 2011 Apr;25(4):564-74</RefSource>
<PMID Version="1">21330404</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2011 Mar 11;331(6022):1315-9</RefSource>
<PMID Version="1">21393543</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2010 Dec 3;330(6009):1349-54</RefSource>
<PMID Version="1">21127246</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Immunol. 2010 May;10(5):365-76</RefSource>
<PMID Version="1">20414208</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Cell Metab. 2015 Aug 4;22(2):197-8</RefSource>
<PMID Version="1">26244927</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056926">CLOCK Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057906">Circadian Clocks</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002940">Circadian Rhythm</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D005786">Gene Expression Regulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051559">Hepatocyte Nuclear Factor 6</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006655">Histone Deacetylases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050356">Lipid Metabolism</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008099">Liver</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008660">Metabolism</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018345">Mice, Knockout</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056953">Nuclear Receptor Subfamily 1, Group D, Member 1</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057094">Nuclear Receptor Subfamily 1, Group F, Member 1</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009928">Organ Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014018">Tissue Distribution</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS730140</OtherID>
<OtherID Source="NLM">PMC4613749</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">25947342</PMID>
<DateCreated>
<Year>2015</Year>
<Month>07</Month>
<Day>01</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1476-3524</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>28</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Neurotoxicity research</Title>
<ISOAbbreviation>Neurotox Res</ISOAbbreviation>
</Journal>
<ArticleTitle>NMDAR-Mediated Hippocampal Neuronal Death is Exacerbated by Activities of ASIC1a.</ArticleTitle>
<Pagination>
<MedlinePgn>122-37</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12640-015-9530-3</ELocationID>
<Abstract>
<AbstractText>NMDARs and ASIC1a both exist in central synapses and mediate important physiological and pathological conditions, but the functional relationship between them is unclear. Here we report several novel findings that may shed light on the functional relationship between these two ion channels in the excitatory postsynaptic membrane of mouse hippocampus. Firstly, NMDAR activation induced by either NMDA or OGD led to increased [Ca(2+)](i)and greater apoptotic and necrotic cell deaths in cultured hippocampal neurons; these cell deaths were prevented by application of NMDAR antagonists. Secondly, ASIC1a activation induced by pH 6.0 extracellular solution (ECS) showed similar increases in apoptotic and necrotic cell deaths; these cell deaths were prevented by ASIC1a antagonists, and also by NMDAR antagonists. Since increased [Ca(2+)](i)leads to increased cell deaths and since NMDAR exhibits much greater calcium permeability than ASIC1a, these data suggest that ASIC1a-induced neuronal death is mediated through activation of NMDARs. Thirdly, treatment of hippocampal cultures with both NMDA and acidic ECS induced greater degrees of cell deaths than either NMDA or acidic ECS treatment alone. These results suggest that ASIC1a activation up-regulates NMDAR function. Additional data supporting the functional relationship between ASIC1a and NMDAR are found in our electrophysiology experiments in hippocampal slices, where stimulation of ASIC1a induced a marked increase in NMDAR EPSC amplitude, and inhibition of ASIC1a resulted in a decrease in NMDAR EPSC amplitude. In summary, we present evidence that ASIC1a activity facilitates NMDAR function and exacerbates NMDAR-mediated neuronal death in pathological conditions. These findings are invaluable to the search for novel therapeutic targets in the treatment of brain ischemia.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gao</LastName>
<ForeName>Su</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Physiology, Binzhou Medical University, Yantai Campus, 346 Guanhai Road, Laishan District, Yantai, 264003, Shandong, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yu</LastName>
<ForeName>Yang</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ma</LastName>
<ForeName>Zhi-Yuan</ForeName>
<Initials>ZY</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sun</LastName>
<ForeName>Hui</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Yong-Li</ForeName>
<Initials>YL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Xing-Tao</ForeName>
<Initials>XT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Chaoyun</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fan</LastName>
<ForeName>Wei-Ming</ForeName>
<Initials>WM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zheng</LastName>
<ForeName>Qing-Yin</ForeName>
<Initials>QY</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ma</LastName>
<ForeName>Chun-Lei</ForeName>
<Initials>CL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 DC009246</GrantID>
<Acronym>DC</Acronym>
<Agency>NIDCD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Neurotox Res</MedlineTA>
<NlmUniqueID>100929017</NlmUniqueID>
<ISSNLinking>1029-8428</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">25359600</PMID>
<DateCreated>
<Year>2015</Year>
<Month>07</Month>
<Day>25</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1469-7602</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>42</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of child language</Title>
<ISOAbbreviation>J Child Lang</ISOAbbreviation>
</Journal>
<ArticleTitle>Dense neighborhoods and mechanisms of learning: evidence from children with phonological delay.</ArticleTitle>
<Pagination>
<MedlinePgn>1036-72</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1017/S0305000914000701</ELocationID>
<Abstract>
<AbstractText>There is a noted advantage of dense neighborhoods in language acquisition, but the learning mechanism that drives the effect is not well understood. Two hypotheses--long-term auditory word priming and phonological working memory--have been advanced in the literature as viable accounts. These were evaluated in two treatment studies enrolling twelve children with phonological delay. Study 1 exposed children to dense neighbors versus non-neighbors before training sound production in evaluation of the priming hypothesis. Study 2 exposed children to the same stimuli after training sound production as a test of the phonological working memory hypothesis. Results showed that neighbors led to greater phonological generalization than non-neighbors, but only when presented prior to training production. There was little generalization and no differential effect of exposure to neighbors or non-neighbors after training production. Priming was thus supported as a possible mechanism of learning behind the dense neighborhood advantage in phonological acquisition.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gierut</LastName>
<ForeName>Judith A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>Indiana University,USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Morrisette</LastName>
<ForeName>Michele L</ForeName>
<Initials>ML</Initials>
<AffiliationInfo>
<Affiliation>Indiana University,USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 DC001694</GrantID>
<Acronym>DC</Acronym>
<Agency>NIDCD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Child Lang</MedlineTA>
<NlmUniqueID>0425743</NlmUniqueID>
<ISSNLinking>0305-0009</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">25998582</PMID>
<DateCreated>
<Year>2015</Year>
<Month>08</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1474-547X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>386</Volume>
<Issue>9991</Issue>
<PubDate>
<Year>2015</Year>
<Month>Jul</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>Lancet (London, England)</Title>
<ISOAbbreviation>Lancet</ISOAbbreviation>
</Journal>
<ArticleTitle>Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial.</ArticleTitle>
<Pagination>
<MedlinePgn>341-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(15)60933-3</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0140-6736(15)60933-3</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Meta-analyses of previous randomised controlled trials concluded that the smooth muscle relaxant drugs tamsulosin and nifedipine assisted stone passage for people managed expectantly for ureteric colic, but emphasised the need for high-quality trials with wide inclusion criteria. We aimed to fulfil this need by testing effectiveness of these drugs in a standard clinical care setting.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">For this multicentre, randomised, placebo-controlled trial, we recruited adults (aged 18-65 years) undergoing expectant management for a single ureteric stone identified by CT at 24 UK hospitals. Participants were randomly assigned by a remote randomisation system to tamsulosin 400 μg, nifedipine 30 mg, or placebo taken daily for up to 4 weeks, using an algorithm with centre, stone size (≤5 mm or &gt;5 mm), and stone location (upper, mid, or lower ureter) as minimisation covariates. Participants, clinicians, and trial personnel were masked to treatment assignment. The primary outcome was the proportion of participants who did not need further intervention for stone clearance within 4 weeks of randomisation, analysed in a modified intention-to-treat population defined as all eligible patients for whom we had primary outcome data. This trial is registered with the European Clinical Trials Database, EudraCT number 2010-019469-26, and as an International Standard Randomised Controlled Trial, number 69423238.</AbstractText>
<AbstractText Label="FINDINGS" NlmCategory="RESULTS">Between Jan 11, 2011, and Dec 20, 2013, we randomly assigned 1167 participants, 1136 (97%) of whom were included in the primary analysis (17 were excluded because of ineligibility and 14 participants were lost to follow-up). 303 (80%) of 379 participants in the placebo group did not need further intervention by 4 weeks, compared with 307 (81%) of 378 in the tamsulosin group (adjusted risk difference 1·3% [95% CI -5·7 to 8·3]; p=0·73) and 304 (80%) of 379 in the nifedipine group (0·5% [-5·6 to 6·5]; p=0·88). No difference was noted between active treatment and placebo (p=0·78), or between tamsulosin and nifedipine (p=0·77). Serious adverse events were reported in three participants in the nifedipine group (one had right loin pain, diarrhoea, and vomiting; one had malaise, headache, and chest pain; and one had severe chest pain, difficulty breathing, and left arm pain) and in one participant in the placebo group (headache, dizziness, lightheadedness, and chronic abdominal pain).</AbstractText>
<AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Tamsulosin 400 μg and nifedipine 30 mg are not effective at decreasing the need for further treatment to achieve stone clearance in 4 weeks for patients with expectantly managed ureteric colic.</AbstractText>
<AbstractText Label="FUNDING" NlmCategory="BACKGROUND">UK National Institute for Health Research Health Technology Assessment Programme.</AbstractText>
<CopyrightInformation>Copyright © 2015 Pickard et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pickard</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Starr</LastName>
<ForeName>Kathryn</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Centre for Healthcare Randomised Trials, Health Services Research Unit, University of Aberdeen, Aberdeen, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>MacLennan</LastName>
<ForeName>Graeme</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Centre for Healthcare Randomised Trials, Health Services Research Unit, University of Aberdeen, Aberdeen, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lam</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Academic Urology Unit, University of Aberdeen, Aberdeen, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thomas</LastName>
<ForeName>Ruth</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Centre for Healthcare Randomised Trials, Health Services Research Unit, University of Aberdeen, Aberdeen, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Burr</LastName>
<ForeName>Jennifer</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>School of Medicine, University of St Andrews, St Andrews, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McPherson</LastName>
<ForeName>Gladys</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Centre for Healthcare Randomised Trials, Health Services Research Unit, University of Aberdeen, Aberdeen, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McDonald</LastName>
<ForeName>Alison</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Centre for Healthcare Randomised Trials, Health Services Research Unit, University of Aberdeen, Aberdeen, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Anson</LastName>
<ForeName>Kenneth</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>St Georges Healthcare NHS Trust, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>N'Dow</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Academic Urology Unit, University of Aberdeen, Aberdeen, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Burgess</LastName>
<ForeName>Neil</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Clark</LastName>
<ForeName>Terry</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Stone Patient Advisory Group, Section of Endourology, British Association of Urological Surgeons, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kilonzo</LastName>
<ForeName>Mary</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Health Economics Research Unit, University of Aberdeen, Aberdeen, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gillies</LastName>
<ForeName>Katie</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Centre for Healthcare Randomised Trials, Health Services Research Unit, University of Aberdeen, Aberdeen, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shearer</LastName>
<ForeName>Kirsty</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Centre for Healthcare Randomised Trials, Health Services Research Unit, University of Aberdeen, Aberdeen, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Boachie</LastName>
<ForeName>Charles</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Centre for Healthcare Randomised Trials, Health Services Research Unit, University of Aberdeen, Aberdeen, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cameron</LastName>
<ForeName>Sarah</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Centre for Healthcare Randomised Trials, Health Services Research Unit, University of Aberdeen, Aberdeen, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Norrie</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Centre for Healthcare Randomised Trials, Health Services Research Unit, University of Aberdeen, Aberdeen, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McClinton</LastName>
<ForeName>Samuel</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Academic Urology Unit, University of Aberdeen, Aberdeen, UK; Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, UK. Electronic address: smcclinton@nhs.net.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>EudraCT</DataBankName>
<AccessionNumberList>
<AccessionNumber>2010-019469-26</AccessionNumber>
</AccessionNumberList>
</DataBank>
<DataBank>
<DataBankName>ISRCTN</DataBankName>
<AccessionNumberList>
<AccessionNumber>ISRCTN69423238</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Lancet</MedlineTA>
<NlmUniqueID>2985213R</NlmUniqueID>
<ISSNLinking>0140-6736</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Nat Rev Urol. 2015 Jul;12(7):357</RefSource>
<PMID Version="1">26032542</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Evid Based Med. 2015 Oct;20(5):171</RefSource>
<PMID Version="1">26239305</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Urology. 2015 Oct;86(4):649-50</RefSource>
<PMID Version="1">26431759</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Lancet. 2015 Jul 25;386(9991):315-6</RefSource>
<PMID Version="1">25998581</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25974212</PMID>
<DateCreated>
<Year>2015</Year>
<Month>08</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>10</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1365-2141</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>170</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>British journal of haematology</Title>
<ISOAbbreviation>Br. J. Haematol.</ISOAbbreviation>
</Journal>
<ArticleTitle>A phase II trial of RCHOP followed by radioimmunotherapy for early stage (stages I/II) diffuse large B-cell non-Hodgkin lymphoma: ECOG3402.</ArticleTitle>
<Pagination>
<MedlinePgn>679-86</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/bjh.13493</ELocationID>
<Abstract>
<AbstractText>Patients with early stage diffuse large B-cell lymphoma (DLBCL) receive RCHOP (rituximab cyclophosphamide, doxorubicin, vincristine, prednisone) alone or with involved field radiotherapy (IFRT). Anti-CD20 radioimmunotherapy (RIT) delivers radiation to microscopic sites outside of known disease. This phase II study aimed to achieve a functional complete response (CR) rate of ≥75% to RCHOP and (90) Yttrium-ibritumomab tiuxetan RIT. Patients with stages I/II DLBCL received 4-6 cycles of RCHOP followed by RIT [14·8 MBq/kg (0·4 mCi/kg)]; patients with positron emission tomographypositive sites of disease after RCHOP/RIT received 30 Gy IFRT. Of the 62 patients enrolled; 53 were eligible. 42% (22/53) had stage I/IE; 58% (31/53) stage II/IIE. After RCHOP, 79% (42/53) were in CR/unconfirmed CR. Forty-eight patients proceeded to RIT. One partial responder after RIT received IFRT and achieved a CR. The best response after RCHOP + RIT in all 53 patients was a functional CR rate of 89% (47/53; 95% confidence interval: 77-96%). With a median follow-up of 5·9 years, 7 (13%) patients have progressed and 4 (8%) have died (2 with DLBCL). At 5 years, 78% of patients remain in remission and 94% are alive. Chemoimmunotherapy and RIT is an active regimen for early stage DLBCL patients. Eighty-nine percent of patients achieved functional CR without the requirement of IFRT. This regimen is worthy of further study for early stage DLBCL in a phase III trial. </AbstractText>
<CopyrightInformation>© 2015 John Wiley &amp; Sons Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Witzig</LastName>
<ForeName>Thomas E</ForeName>
<Initials>TE</Initials>
<AffiliationInfo>
<Affiliation>Mayo Clinic, Rochester, MN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hong</LastName>
<ForeName>Fangxin</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Dana Farber Cancer Institute, Boston, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Micallef</LastName>
<ForeName>Ivana N</ForeName>
<Initials>IN</Initials>
<AffiliationInfo>
<Affiliation>Mayo Clinic, Rochester, MN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gascoyne</LastName>
<ForeName>Randy D</ForeName>
<Initials>RD</Initials>
<AffiliationInfo>
<Affiliation>British Columbia Cancer Agency, Centre for Lymphoid Cancer, Vancouver, BC, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dogan</LastName>
<ForeName>Ahmet</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Mayo Clinic, Rochester, MN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wagner</LastName>
<ForeName>Henry</ForeName>
<Initials>H</Initials>
<Suffix>Jr</Suffix>
<AffiliationInfo>
<Affiliation>Penn State Cancer Institute, Hershey, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kahl</LastName>
<ForeName>Brad S</ForeName>
<Initials>BS</Initials>
<AffiliationInfo>
<Affiliation>University of Wisconsin, Madison, WI, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Advani</LastName>
<ForeName>Ranjana H</ForeName>
<Initials>RH</Initials>
<AffiliationInfo>
<Affiliation>Stanford University, Stanford, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Horning</LastName>
<ForeName>Sandra J</ForeName>
<Initials>SJ</Initials>
<AffiliationInfo>
<Affiliation>Stanford University, Stanford, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>CA13650</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA21076</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA21115</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA23318</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA66636</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U10 CA013650</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U10 CA021076</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U10 CA021115</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U10 CA023318</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U10 CA066636</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D017427">Clinical Trial, Phase II</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Br J Haematol</MedlineTA>
<NlmUniqueID>0372544</NlmUniqueID>
<ISSNLinking>0007-1048</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D058846">Antibodies, Monoclonal, Murine-Derived</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C571759">R-CHOP protocol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C422802">ibritumomab tiuxetan</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>5J49Q6B70F</RegistryNumber>
<NameOfSubstance UI="D014750">Vincristine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>80168379AG</RegistryNumber>
<NameOfSubstance UI="D004317">Doxorubicin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>8N3DW7272P</RegistryNumber>
<NameOfSubstance UI="D003520">Cyclophosphamide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>VB0R961HZT</RegistryNumber>
<NameOfSubstance UI="D011241">Prednisone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000911">Antibodies, Monoclonal</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058846">Antibodies, Monoclonal, Murine-Derived</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000971">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003520">Cyclophosphamide</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018572">Disease-Free Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004317">Doxorubicin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007167">Immunotherapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016403">Lymphoma, Large B-Cell, Diffuse</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009367">Neoplasm Staging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011241">Prednisone</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015996">Survival Rate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014750">Vincristine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS743866 [Available on 09/01/16]</OtherID>
<OtherID Source="NLM">PMC4691189 [Available on 09/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">R-CHOP</Keyword>
<Keyword MajorTopicYN="N">large cell lymphoma</Keyword>
<Keyword MajorTopicYN="N">radioimmunotherapy</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26260607</PMID>
<DateCreated>
<Year>2015</Year>
<Month>08</Month>
<Day>11</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1940-6029</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>1335</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Methods in molecular biology (Clifton, N.J.)</Title>
<ISOAbbreviation>Methods Mol. Biol.</ISOAbbreviation>
</Journal>
<ArticleTitle>The Dynamic Process of Drug-GPCR Binding at Either Orthosteric or Allosteric Sites Evaluated by Metadynamics.</ArticleTitle>
<Pagination>
<MedlinePgn>277-94</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/978-1-4939-2914-6_18</ELocationID>
<Abstract>
<AbstractText>Major advances in G Protein-Coupled Receptor (GPCR) structural biology over the past few years have yielded a significant number of high-resolution crystal structures for several different receptor subtypes. This dramatic increase in GPCR structural information has underscored the use of automated docking algorithms for the discovery of novel ligands that can eventually be developed into improved therapeutics. However, these algorithms are often unable to discriminate between different, yet energetically similar, poses because of their relatively simple scoring functions. Here, we describe a metadynamics-based approach to study the dynamic process of ligand binding to/unbinding from GPCRs with a higher level of accuracy and yet satisfying efficiency. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Schneider</LastName>
<ForeName>Sebastian</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, P.O. Box 1677, New York, NY, 10029-6574, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Provasi</LastName>
<ForeName>Davide</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Filizola</LastName>
<ForeName>Marta</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>DA026434</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>DA034049</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K02 DA026434</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DA034049</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Methods Mol Biol</MedlineTA>
<NlmUniqueID>9214969</NlmUniqueID>
<ISSNLinking>1064-3745</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26162689</PMID>
<DateCreated>
<Year>2015</Year>
<Month>09</Month>
<Day>04</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1538-8514</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>14</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Molecular cancer therapeutics</Title>
<ISOAbbreviation>Mol. Cancer Ther.</ISOAbbreviation>
</Journal>
<ArticleTitle>Small Molecule Inhibition of MERTK Is Efficacious in Non-Small Cell Lung Cancer Models Independent of Driver Oncogene Status.</ArticleTitle>
<Pagination>
<MedlinePgn>2014-22</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1158/1535-7163.MCT-15-0116</ELocationID>
<Abstract>
<AbstractText>Treatment of non-small cell lung cancer (NSCLC) has been transformed by targeted therapies directed against molecular aberrations specifically activated within an individual patient's tumor. However, such therapies are currently only available against a small number of such aberrations, and new targets and therapeutics are needed. Our laboratory has previously identified the MERTK receptor tyrosine kinase (RTK) as a potential drug target in multiple cancer types, including NSCLC. We have recently developed UNC2025--the first-in-class small molecule inhibitor targeting MERTK with pharmacokinetic properties sufficient for clinical translation. Here, we utilize this compound to further validate the important emerging biologic functions of MERTK in lung cancer pathogenesis, to establish that MERTK can be effectively targeted by a clinically translatable agent, and to demonstrate that inhibition of MERTK is a valid treatment strategy in a wide variety of NSCLC lines independent of their driver oncogene status, including in lines with an EGFR mutation, a KRAS/NRAS mutation, an RTK fusion, or another or unknown driver oncogene. Biochemically, we report the selectivity of UNC2025 for MERTK, and its inhibition of oncogenic downstream signaling. Functionally, we demonstrate that UNC2025 induces apoptosis of MERTK-dependent NSCLC cell lines, while decreasing colony formation in vitro and tumor xenograft growth in vivo in murine models. These findings provide further evidence for the importance of MERTK in NSCLC, and demonstrate that MERTK inhibition by UNC2025 is a feasible, clinically relevant treatment strategy in a wide variety of NSCLC subtypes, which warrants further investigation in clinical trials.</AbstractText>
<CopyrightInformation>©2015 American Association for Cancer Research.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cummings</LastName>
<ForeName>Christopher T</ForeName>
<Initials>CT</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, Section of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado Anschutz Medical Campus, Aurora, Colorado.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Weihe</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Center for Integrative Chemical Biology and Drug Discovery and Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Davies</LastName>
<ForeName>Kurtis D</ForeName>
<Initials>KD</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, Section of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado Anschutz Medical Campus, Aurora, Colorado.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kirkpatrick</LastName>
<ForeName>Gregory D</ForeName>
<Initials>GD</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, Section of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado Anschutz Medical Campus, Aurora, Colorado.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Dehui</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Center for Integrative Chemical Biology and Drug Discovery and Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>DeRyckere</LastName>
<ForeName>Deborah</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, Section of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado Anschutz Medical Campus, Aurora, Colorado.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Xiaodong</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Center for Integrative Chemical Biology and Drug Discovery and Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Frye</LastName>
<ForeName>Stephen V</ForeName>
<Initials>SV</Initials>
<AffiliationInfo>
<Affiliation>Center for Integrative Chemical Biology and Drug Discovery and Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Department of Medicine, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Earp</LastName>
<ForeName>H Shelton</ForeName>
<Initials>HS</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina. Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Graham</LastName>
<ForeName>Douglas K</ForeName>
<Initials>DK</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, Section of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado Anschutz Medical Campus, Aurora, Colorado. doug.graham@ucdenver.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 CA046934</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P50 CA058187</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P50CA058187</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA137078</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01CA137078</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Mol Cancer Ther</MedlineTA>
<NlmUniqueID>101132535</NlmUniqueID>
<ISSNLinking>1535-7163</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26214389</PMID>
<DateCreated>
<Year>2015</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1097-0134</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>83</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Proteins</Title>
<ISOAbbreviation>Proteins</ISOAbbreviation>
</Journal>
<ArticleTitle>Selective refinement and selection of near-native models in protein structure prediction.</ArticleTitle>
<Pagination>
<MedlinePgn>1823-35</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/prot.24866</ELocationID>
<Abstract>
<AbstractText>In recent years in silico protein structure prediction reached a level where fully automated servers can generate large pools of near-native structures. However, the identification and further refinement of the best structures from the pool of models remain problematic. To address these issues, we have developed (i) a target-specific selective refinement (SR) protocol; and (ii) molecular dynamics (MD) simulation based ranking (SMDR) method. In SR the all-atom refinement of structures is accomplished via the Rosetta Relax protocol, subject to specific constraints determined by the size and complexity of the target. The best-refined models are selected with SMDR by testing their relative stability against gradual heating through all-atom MD simulations. Through extensive testing we have found that Mufold-MD, our fully automated protein structure prediction server updated with the SR and SMDR modules consistently outperformed its previous versions.</AbstractText>
<CopyrightInformation>© 2015 Wiley Periodicals, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Jiong</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Physics and Astronomy, University of Missouri, Columbia, Missouri, 65211.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barz</LastName>
<ForeName>Bogdan</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Physics and Astronomy, University of Missouri, Columbia, Missouri, 65211.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Jingfen</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Computer Science, Christopher S. Bond Life Sciences Center, University of Missouri, Columbia, Missouri, 65211.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Xu</LastName>
<ForeName>Dong</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Computer Science, Christopher S. Bond Life Sciences Center, University of Missouri, Columbia, Missouri, 65211.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kosztin</LastName>
<ForeName>Ioan</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Department of Physics and Astronomy, University of Missouri, Columbia, Missouri, 65211.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 GM100701</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 GM100701</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Proteins</MedlineTA>
<NlmUniqueID>8700181</NlmUniqueID>
<ISSNLinking>0887-3585</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">CASP</Keyword>
<Keyword MajorTopicYN="N">MDR ranking</Keyword>
<Keyword MajorTopicYN="N">model refinement</Keyword>
<Keyword MajorTopicYN="N">protein structure prediction</Keyword>
<Keyword MajorTopicYN="N">protein structure quality assessment</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">25990557</PMID>
<DateCreated>
<Year>2015</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1367-4811</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>31</Volume>
<Issue>18</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Bioinformatics (Oxford, England)</Title>
<ISOAbbreviation>Bioinformatics</ISOAbbreviation>
</Journal>
<ArticleTitle>DSigDB: drug signatures database for gene set analysis.</ArticleTitle>
<Pagination>
<MedlinePgn>3069-71</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/bioinformatics/btv313</ELocationID>
<Abstract>
<AbstractText Label="UNLABELLED">We report the creation of Drug Signatures Database (DSigDB), a new gene set resource that relates drugs/compounds and their target genes, for gene set enrichment analysis (GSEA). DSigDB currently holds 22 527 gene sets, consists of 17 389 unique compounds covering 19 531 genes. We also developed an online DSigDB resource that allows users to search, view and download drugs/compounds and gene sets. DSigDB gene sets provide seamless integration to GSEA software for linking gene expressions with drugs/compounds for drug repurposing and translational research.</AbstractText>
<AbstractText Label="AVAILABILITY AND IMPLEMENTATION" NlmCategory="METHODS">DSigDB is freely available for non-commercial use at http://tanlab.ucdenver.edu/DSigDB.</AbstractText>
<AbstractText Label="SUPPLEMENTARY INFORMATION" NlmCategory="BACKGROUND">Supplementary data are available at Bioinformatics online.</AbstractText>
<AbstractText Label="CONTACT" NlmCategory="BACKGROUND">aikchoon.tan@ucdenver.edu.</AbstractText>
<CopyrightInformation>© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yoo</LastName>
<ForeName>Minjae</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA and Department of Computer Science and Engineering, Korea University, Seoul 136-713, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shin</LastName>
<ForeName>Jimin</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA and Department of Computer Science and Engineering, Korea University, Seoul 136-713, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Jihye</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA and Department of Computer Science and Engineering, Korea University, Seoul 136-713, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ryall</LastName>
<ForeName>Karen A</ForeName>
<Initials>KA</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA and Department of Computer Science and Engineering, Korea University, Seoul 136-713, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Kyubum</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA and Department of Computer Science and Engineering, Korea University, Seoul 136-713, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Sunwon</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA and Department of Computer Science and Engineering, Korea University, Seoul 136-713, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jeon</LastName>
<ForeName>Minji</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA and Department of Computer Science and Engineering, Korea University, Seoul 136-713, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kang</LastName>
<ForeName>Jaewoo</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA and Department of Computer Science and Engineering, Korea University, Seoul 136-713, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tan</LastName>
<ForeName>Aik Choon</ForeName>
<Initials>AC</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA and Department of Computer Science and Engineering, Korea University, Seoul 136-713, South Korea Department of Medicine, Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA and Department of Computer Science and Engineering, Korea University, Seoul 136-713, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 CA046934</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30CA046934</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P50CA058187</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Bioinformatics</MedlineTA>
<NlmUniqueID>9808944</NlmUniqueID>
<ISSNLinking>1367-4803</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Genet. 2003 Jul;34(3):267-73</RefSource>
<PMID Version="1">12808457</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50</RefSource>
<PMID Version="1">16199517</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cancer Res. 2006 Aug;4(8):521-8</RefSource>
<PMID Version="1">16877703</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2006 Sep 29;313(5795):1929-35</RefSource>
<PMID Version="1">17008526</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2010 Jan;38(Database issue):D716-25</RefSource>
<PMID Version="1">19934259</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioinformatics. 2011 Jun 15;27(12):1739-40</RefSource>
<PMID Version="1">21546393</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Med Inform Decis Mak. 2012;12 Suppl 1:S7</RefSource>
<PMID Version="1">22595092</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2013 Jan;41(Database issue):D955-61</RefSource>
<PMID Version="1">23180760</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Database (Oxford). 2013;2013:bat080</RefSource>
<PMID Version="1">24288140</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2014 Jan;42(Database issue):D1118-23</RefSource>
<PMID Version="1">24265219</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">PMC4668778 [Available on 09/15/16]</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26205039</PMID>
<DateCreated>
<Year>2015</Year>
<Month>09</Month>
<Day>16</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1521-3773</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>54</Volume>
<Issue>36</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>Angewandte Chemie (International ed. in English)</Title>
<ISOAbbreviation>Angew. Chem. Int. Ed. Engl.</ISOAbbreviation>
</Journal>
<ArticleTitle>Total Syntheses and Biological Evaluation of Both Enantiomers of Several Hydroxylated Dimeric Nuphar Alkaloids.</ArticleTitle>
<Pagination>
<MedlinePgn>10604-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/anie.201503934</ELocationID>
<Abstract>
<AbstractText>Herein, we describe the first total syntheses of five members of the dimeric nuphar alkaloids: (+)-6,6'-dihydroxythiobinupharidine (+)-1 a, (+)-6-hydroxythiobinupharidine (+)-1 b, (-)-6,6'-dihydroxythionuphlutine (-)-2 a, (-)-6,6'-dihydroxyneothiobinupharidine (-)-3 a, and (+)-6,6'-dihydroxyneothionuphlutine (+)-4 a. The latter two have not been found in nature. We have also made each of their enantiomers (-)-1 a-b, (+)-2 a, (+)-3 a, and (-)-4 a. The key step in these syntheses was the dimerization of an α-aminonitrile (a hydrolytically stable surrogate for its corresponding hemiaminal) with chiral Lewis acid complexes. We have also reassigned the literature structures of (+)-1 a-1 b—for those instances in which the NMR spectra were obtained in CD3OD—to their corresponding CD3O-adducts. Our efforts provide for the first time apoptosis data for (-)-3 a, (+)-4 a, and all five non-natural enantiomers prepared. The data indicate high apoptotic activity regardless of the enantiomer or relative stereochemical configuration at C7 and C7'.</AbstractText>
<CopyrightInformation>© 2015 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Korotkov</LastName>
<ForeName>Alexander</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, Dartmouth College, Hanover, New Hampshire 03755 (United States).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Hui</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, Dartmouth College, Hanover, New Hampshire 03755 (United States).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chapman</LastName>
<ForeName>Charles W</ForeName>
<Initials>CW</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology and Toxicology, Geisel School of Medicine, Lebanon, New Hampshire 03756 (United States).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Xue</LastName>
<ForeName>Haoran</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, Dartmouth College, Hanover, New Hampshire 03755 (United States).</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Natural Products LINCHPIN Laboratory, Texas A&amp;M University, College Station, Texas, 77840 (United States).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>MacMillan</LastName>
<ForeName>John B</ForeName>
<Initials>JB</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry, UT Southwestern Medical Center, Dallas, Texas, 75390 (United States). john.macmillan@utsouthwestern.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eastman</LastName>
<ForeName>Alan</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology and Toxicology, Geisel School of Medicine, Lebanon, New Hampshire 03756 (United States). alan.r.eastman@dartmouth.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Jimmy</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, Dartmouth College, Hanover, New Hampshire 03755 (United States). jimmy.wu@dartmouth.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 CA149833</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA149833</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Angew Chem Int Ed Engl</MedlineTA>
<NlmUniqueID>0370543</NlmUniqueID>
<ISSNLinking>1433-7851</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">apoptosis</Keyword>
<Keyword MajorTopicYN="N">cancer</Keyword>
<Keyword MajorTopicYN="N">caspases</Keyword>
<Keyword MajorTopicYN="N">nuphar alkaloids</Keyword>
<Keyword MajorTopicYN="N">total synthesis</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26407462</PMID>
<DateCreated>
<Year>2015</Year>
<Month>09</Month>
<Day>26</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1120-9763</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>39</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Epidemiologia e prevenzione</Title>
<ISOAbbreviation>Epidemiol Prev</ISOAbbreviation>
</Journal>
<ArticleTitle>[Vaccines are drugs].</ArticleTitle>
<Pagination>
<MedlinePgn>145-6</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Traversa</LastName>
<ForeName>Giuseppe</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Reparto di farmacoepidemiologia, Istituto superiore di sanità, Roma. giuseppe.traversa@iss.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Raschetti</LastName>
<ForeName>Roberto</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<VernacularTitle>I vaccini sono farmaci.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Epidemiol Prev</MedlineTA>
<NlmUniqueID>8902507</NlmUniqueID>
<ISSNLinking>1120-9763</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26407463</PMID>
<DateCreated>
<Year>2015</Year>
<Month>09</Month>
<Day>26</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1120-9763</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>39</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Epidemiologia e prevenzione</Title>
<ISOAbbreviation>Epidemiol Prev</ISOAbbreviation>
</Journal>
<ArticleTitle>[Mandatory medical certificates for physical activity: prevention or medicalisation?].</ArticleTitle>
<Pagination>
<MedlinePgn>147-8</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>D'Argenio</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>già vicedirettore della Direzione generale della prevenzione, Ministero della salute, Roma. dargeniopaolo@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<VernacularTitle>Certificati medici obbligatori per praticare l'attività sportiva: prevenzione o medicalizzazione?</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Epidemiol Prev</MedlineTA>
<NlmUniqueID>8902507</NlmUniqueID>
<ISSNLinking>1120-9763</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26407464</PMID>
<DateCreated>
<Year>2015</Year>
<Month>09</Month>
<Day>26</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1120-9763</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>39</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Epidemiologia e prevenzione</Title>
<ISOAbbreviation>Epidemiol Prev</ISOAbbreviation>
</Journal>
<ArticleTitle>[Screening mammography: a clear statement by the IARC Handbook].</ArticleTitle>
<Pagination>
<MedlinePgn>149-50</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sardanelli</LastName>
<ForeName>Francesco</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Dipartimento di scienze biomediche per la salute, Università degli Studi di Milano. francesco.sardanelli@unimi.it.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<VernacularTitle>Screening mammografico: un punto fermo dallo IARC Handbook.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Epidemiol Prev</MedlineTA>
<NlmUniqueID>8902507</NlmUniqueID>
<ISSNLinking>1120-9763</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26407465</PMID>
<DateCreated>
<Year>2015</Year>
<Month>09</Month>
<Day>26</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1120-9763</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>39</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Epidemiologia e prevenzione</Title>
<ISOAbbreviation>Epidemiol Prev</ISOAbbreviation>
</Journal>
<ArticleTitle>[Breast screening: efficacy, adverse effects, and communication].</ArticleTitle>
<Pagination>
<MedlinePgn>151-3</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Segnan</LastName>
<ForeName>Nereo</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Centro di riferimento per l'epidemiologia e la prevenzione oncologica in Piemonte (CPO), AOU Città della salute e della scienza di Torino. nereo.segnan@cpo.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Paci</LastName>
<ForeName>Eugenio</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Epidemiologo, Firenze.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
<VernacularTitle>Mammografia di screening: efficacia, effetti avversi e comunicazione.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Epidemiol Prev</MedlineTA>
<NlmUniqueID>8902507</NlmUniqueID>
<ISSNLinking>1120-9763</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26407466</PMID>
<DateCreated>
<Year>2015</Year>
<Month>09</Month>
<Day>26</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1120-9763</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>39</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Epidemiologia e prevenzione</Title>
<ISOAbbreviation>Epidemiol Prev</ISOAbbreviation>
</Journal>
<ArticleTitle>[Epidemiology and prevention at the times of the Italian National Prevention Plan 2014-2018].</ArticleTitle>
<Pagination>
<MedlinePgn>154-6</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Faggiano</LastName>
<ForeName>Fabrizio</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Presidente AIE.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pirastu</LastName>
<ForeName>Roberta</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Segreteria AIE.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Allara</LastName>
<ForeName>Elias</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Segreteria AIE.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Falcone</LastName>
<ForeName>Manuele</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Segreteria AIE.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ferrante</LastName>
<ForeName>Gianluigi</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Segreteria AIE.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pacelli</LastName>
<ForeName>Barbara</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Segreteria AIE.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schifano</LastName>
<ForeName>Patrizia</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Segreteria AIE.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Senore</LastName>
<ForeName>Carlo</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Segreteria AIE.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Serinelli</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Segreteria AIE.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
<VernacularTitle>L'epidemiologia e la prevenzione ai tempi del Piano nazionale di prevenzione 2014-2018.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Epidemiol Prev</MedlineTA>
<NlmUniqueID>8902507</NlmUniqueID>
<ISSNLinking>1120-9763</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26407467</PMID>
<DateCreated>
<Year>2015</Year>
<Month>09</Month>
<Day>26</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1120-9763</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>39</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Epidemiologia e prevenzione</Title>
<ISOAbbreviation>Epidemiol Prev</ISOAbbreviation>
</Journal>
<ArticleTitle>[Pathology registries, everything flows…].</ArticleTitle>
<Pagination>
<MedlinePgn>156-7</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Paci</LastName>
<ForeName>Eugenio</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Epidemiologo, Firenze. paci.eugenio@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
<VernacularTitle>Registri di patologia, tutto scorre….</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Epidemiol Prev</MedlineTA>
<NlmUniqueID>8902507</NlmUniqueID>
<ISSNLinking>1120-9763</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26407468</PMID>
<DateCreated>
<Year>2015</Year>
<Month>09</Month>
<Day>26</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1120-9763</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>39</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Epidemiologia e prevenzione</Title>
<ISOAbbreviation>Epidemiol Prev</ISOAbbreviation>
</Journal>
<ArticleTitle>[Oncogenesis: only somatic mutations?].</ArticleTitle>
<Pagination>
<MedlinePgn>158-9</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Oddone</LastName>
<ForeName>Enrico</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Dipartimento di sanità pubblica, medicina sperimentale e forense, Università degli Studi di Pavia. enrico.oddone@unipv.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Modonesi</LastName>
<ForeName>Carlo</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Dipartimento di bioscienze, Sezione museo di storia naturale, Università degli Studi di Parma.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Giuliani</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Dipartimento di ambiente e connessa prevenzione primaria, Istituto superiore di sanità, Roma.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
<VernacularTitle>Oncogenesi: solo mutazioni somatiche?</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Epidemiol Prev</MedlineTA>
<NlmUniqueID>8902507</NlmUniqueID>
<ISSNLinking>1120-9763</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26407469</PMID>
<DateCreated>
<Year>2015</Year>
<Month>09</Month>
<Day>26</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1120-9763</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>39</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Epidemiologia e prevenzione</Title>
<ISOAbbreviation>Epidemiol Prev</ISOAbbreviation>
</Journal>
<ArticleTitle>[Foundation of the science and society alliance in France. Towards a conscious and recognised collaboration between actors of research and civil society].</ArticleTitle>
<Pagination>
<MedlinePgn>160-5</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>In the last two decades, the debate on the meaning of science in relation to societies that create it, nourish it, and benefit from it, focused on civil society's ability to produce knowledge. This yielded first the concept of participatory science and later the wider concept of participatory research. Throughout Europe, numerous collective experimentations have generated countless interactions, and new interfaces between the world of research and civil society are constantly being created. But in spite of the proliferation of these experiences, a paradox slows down their acknowledgment and legitimation. On the one hand, these interactions often go unseen and unrecognized by the institutions, public policies, and even at times their very creators. On the other hand, scientists, are still overwhelmingly wary of civil society and, perceiving only its intellectual deficit and lack of comprehension, they fail to consider the study and development of these interactions as being of primary importance. The Sciences and Society Alliance, which was recently founded in France, provides a platform where these collaborative experiences can be collected, studied, supported, communicated, and institutionally acknowledged. The launch of this process,which is soon to be European in scope, answers the need to bring science into the democratic path tread by the societies that create it. In its ability to compose diversity, this process is an example of deep democracy. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Fellini</LastName>
<ForeName>Nadia</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Controvento società cooperativa sociale ONLUS. n.fellini@coopcontrovento.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Faroult</LastName>
<ForeName>Elie</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>ex-funzionario Commissione europea.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
<VernacularTitle>Genesi dell'allenaza scienza società in Francia. Verso una collaborazione consapevole e riconosciuta tra attori della ricerca e della società civile.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Epidemiol Prev</MedlineTA>
<NlmUniqueID>8902507</NlmUniqueID>
<ISSNLinking>1120-9763</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26407470</PMID>
<DateCreated>
<Year>2015</Year>
<Month>09</Month>
<Day>26</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1120-9763</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>39</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Epidemiologia e prevenzione</Title>
<ISOAbbreviation>Epidemiol Prev</ISOAbbreviation>
</Journal>
<ArticleTitle>[Débat public: the French way towards participatory decision-making].</ArticleTitle>
<Pagination>
<MedlinePgn>166</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sturloni</LastName>
<ForeName>Giancarlo</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>International school for advanced studies (SISSA), Trieste. giancarlo.sturloni@sissa.it.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
<VernacularTitle>Débat public: la via francese ai processi decisionali partecipativi.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Epidemiol Prev</MedlineTA>
<NlmUniqueID>8902507</NlmUniqueID>
<ISSNLinking>1120-9763</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26407471</PMID>
<DateCreated>
<Year>2015</Year>
<Month>09</Month>
<Day>26</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1120-9763</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>39</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Epidemiologia e prevenzione</Title>
<ISOAbbreviation>Epidemiol Prev</ISOAbbreviation>
</Journal>
<ArticleTitle>[Correction: Adverse events and preventable consequences: retrospective study in five large Italian hospitals].</ArticleTitle>
<Pagination>
<MedlinePgn>210</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>[This corrects the Table 4 of the article: pmid: 22828228]. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tartaglia</LastName>
<ForeName>Riccardo</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Centro gestione rischio clinico e sicurezza del paziente, Regione Toscana. riccardo.tartaglia@regione.toscana.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Albolino</LastName>
<ForeName>Sara</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bellandi</LastName>
<ForeName>Tommaso</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bianchini</LastName>
<ForeName>Elisa</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Biggeri</LastName>
<ForeName>Annibale</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fabbro</LastName>
<ForeName>Giancarlo</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bevilacqua</LastName>
<ForeName>Luciana</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dell'Erba</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Privitera</LastName>
<ForeName>Gaetano</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sommella</LastName>
<ForeName>Lorenzo</ForeName>
<Initials>L</Initials>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016425">Published Erratum</PublicationType>
</PublicationTypeList>
<VernacularTitle>Correzione: Eventi avversi e conseguenze prevenibili: studio retrospettivo in cinque grandi ospedali italiani.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Epidemiol Prev</MedlineTA>
<NlmUniqueID>8902507</NlmUniqueID>
<ISSNLinking>1120-9763</ISSNLinking>
</MedlineJournalInfo>
<CommentsCorrectionsList>
<CommentsCorrections RefType="ErratumFor">
<RefSource>Epidemiol Prev. 2012 May-Aug;36(3-4):151-61</RefSource>
<PMID Version="1">22828228</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26347990</PMID>
<DateCreated>
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1549-960X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>55</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
<Day>28</Day>
</PubDate>
</JournalIssue>
<Title>Journal of chemical information and modeling</Title>
<ISOAbbreviation>J Chem Inf Model</ISOAbbreviation>
</Journal>
<ArticleTitle>Ligand-Based Discovery of a New Scaffold for Allosteric Modulation of the μ-Opioid Receptor.</ArticleTitle>
<Pagination>
<MedlinePgn>1836-43</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.jcim.5b00388</ELocationID>
<Abstract>
<AbstractText>With the hope of discovering effective analgesics with fewer side effects, attention has recently shifted to allosteric modulators of the opioid receptors. In the past two years, the first chemotypes of positive or silent allosteric modulators (PAMs or SAMs, respectively) of μ- and δ-opioid receptor types have been reported in the literature. During a structure-guided lead optimization campaign with μ-PAMs BMS-986121 and BMS-986122 as starting compounds, we discovered a new chemotype that was confirmed to display μ-PAM or μ-SAM activity depending on the specific substitutions as assessed by endomorphin-1-stimulated β-arrestin2 recruitment assays in Chinese Hamster Ovary (CHO)-μ PathHunter cells. The most active μ-PAM of this series was analyzed further in competition binding and G-protein activation assays to understand its effects on ligand binding and to investigate the nature of its probe dependence. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bisignano</LastName>
<ForeName>Paola</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai , New York, New York 10029, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Burford</LastName>
<ForeName>Neil T</ForeName>
<Initials>NT</Initials>
<AffiliationInfo>
<Affiliation>Discovery, Bristol-Myers Squibb Company , Wallingford, Connecticut 06492, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shang</LastName>
<ForeName>Yi</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai , New York, New York 10029, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marlow</LastName>
<ForeName>Brennica</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai , New York, New York 10029, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Livingston</LastName>
<ForeName>Kathryn E</ForeName>
<Initials>KE</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology, University of Michigan Medical School , Ann Arbor, Michigan 48109, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fenton</LastName>
<ForeName>Abigail M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology, University of Michigan Medical School , Ann Arbor, Michigan 48109, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rockwell</LastName>
<ForeName>Kristin</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Discovery, Bristol-Myers Squibb Company , Wallingford, Connecticut 06492, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Budenholzer</LastName>
<ForeName>Lauren</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Biophysics and Biochemistry, Yale University , New Haven, Connecticut 06520, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Traynor</LastName>
<ForeName>John R</ForeName>
<Initials>JR</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology, University of Michigan Medical School , Ann Arbor, Michigan 48109, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gerritz</LastName>
<ForeName>Samuel W</ForeName>
<Initials>SW</Initials>
<AffiliationInfo>
<Affiliation>Discovery, Bristol-Myers Squibb Company , Wallingford, Connecticut 06492, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alt</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Discovery, Bristol-Myers Squibb Company , Wallingford, Connecticut 06492, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Filizola</LastName>
<ForeName>Marta</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai , New York, New York 10029, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>DA026434</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>DA034049</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>DA035316</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K02 DA026434</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DA034049</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Chem Inf Model</MedlineTA>
<NlmUniqueID>101230060</NlmUniqueID>
<ISSNLinking>1549-9596</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26423191</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>01</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">2352-3018</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>2</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>The lancet. HIV</Title>
<ISOAbbreviation>Lancet HIV</ISOAbbreviation>
</Journal>
<ArticleTitle>The need for standardisation of the HIV continuum of care.</ArticleTitle>
<Pagination>
<MedlinePgn>e225-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/S2352-3018(15)00086-7</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S2352-3018(15)00086-7</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lourenço</LastName>
<ForeName>Lillian</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hull</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nosyk</LastName>
<ForeName>Bohdan</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada; Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Montaner</LastName>
<ForeName>Julio S G</ForeName>
<Initials>JS</Initials>
<AffiliationInfo>
<Affiliation>British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada; Faculty of Medicine, University of British Columbia, Vancouver, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lima</LastName>
<ForeName>Viviane D</ForeName>
<Initials>VD</Initials>
<AffiliationInfo>
<Affiliation>British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada; Faculty of Medicine, University of British Columbia, Vancouver, Canada. Electronic address: vlima@cfenet.ubc.ca.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>MOP-125948</GrantID>
<Agency>Canadian Institutes of Health Research</Agency>
<Country>Canada</Country>
</Grant>
<Grant>
<GrantID>R01 DA036307</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01DA036307</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R03DA033851-01</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Lancet HIV</MedlineTA>
<NlmUniqueID>101645355</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CitationSubset>X</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26056739</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Human African trypanosomiasis prevention, treatment and control costs: a systematic review.</ArticleTitle>
<Pagination>
<MedlinePgn>4-13</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.06.003</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30026-7</ELocationID>
<Abstract>
<AbstractText>The control and eventual elimination of human African trypanosomiasis (HAT) requires the expansion of current control and surveillance activities. A systematic review of the published literature on the costs of HAT prevention, treatment, and control, in addition to the economic burden, was conducted. All studies that contained primary or secondary data on costs of prevention, treatment and control were considered, resulting in the inclusion of 42 papers. The geographically focal nature of the disease and a lack of standardization in the cost data limit the usefulness of the available information for making generalizations across diverse settings. More recent information on the costs of treatment and control interventions for HAT is needed to provide accurate information for analyses and planning. The cost information contained herein can be used to inform rational decision making in control and elimination programs, and to assess potential synergies with existing vector-borne disease control programs, but programs would benefit significantly from new cost data collection.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Keating</LastName>
<ForeName>Joseph</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Center for Applied Malaria Research and Evaluation, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, USA; Department of Tropical Medicine, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2309, New Orleans, LA 70112, USA. Electronic address: jkeating@tulane.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yukich</LastName>
<ForeName>Joshua O</ForeName>
<Initials>JO</Initials>
<AffiliationInfo>
<Affiliation>Center for Applied Malaria Research and Evaluation, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, USA; Department of Tropical Medicine, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2309, New Orleans, LA 70112, USA. Electronic address: jyukich@tulane.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sutherland</LastName>
<ForeName>C Simone</ForeName>
<Initials>CS</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiologyand Public Health, Swiss Tropicaland Public Health Institute, Socinstrasse 57, 4002 Basel, Switzerland; University of Basel, Switzerland. Electronic address: simone.sutherland@unibas.ch.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Woods</LastName>
<ForeName>Geordie</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Sightsavers, 35 Perrymount Road, Haywards Heath, West Sussex, RH16 3BW, UK. Electronic address: gwoods@sightsavers.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tediosi</LastName>
<ForeName>Fabrizio</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiologyand Public Health, Swiss Tropicaland Public Health Institute, Socinstrasse 57, 4002 Basel, Switzerland; University of Basel, Switzerland; Centre for Research on Health and Social Care Management (CERGAS), UniversitàBocconi, Milan, Italy. Electronic address: fabrizio.tediosi@unibas.ch.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Control</Keyword>
<Keyword MajorTopicYN="N">Cost</Keyword>
<Keyword MajorTopicYN="N">Prevention</Keyword>
<Keyword MajorTopicYN="N">Sleeping sickness</Keyword>
<Keyword MajorTopicYN="N">Treatment</Keyword>
<Keyword MajorTopicYN="N">Trypanosomiasis</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26086952</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Natural infection of Algerian hedgehog, Atelerix algirus (Lereboullet 1842) with Leishmania parasites in Tunisia.</ArticleTitle>
<Pagination>
<MedlinePgn>42-51</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.06.009</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30030-9</ELocationID>
<Abstract>
<AbstractText>In Tunisia, Leishmania parasites are responsible of visceral leishmaniasis, caused by Leishmania infantum species while three cutaneous disease forms are documented: chronic cutaneous leishmaniasis due to Leishmania killicki, sporadic cutaneous form (SCL) caused by L. infantum and the predominant zoonotic cutaneous leishmanaisis (ZCL) due to Leishmania major. ZCL reservoirs are rodents of the Psammomys and Meriones genera, while for SCL the dog is supposed to be a reservoir. Ctenodactylus gundii is involved in the transmission of L. killicki. However, other mammals could constitute potential reservoir hosts in Tunisia and other North African countries. In order to explore the role of hedgehogs as potential reservoirs of leishmaniasis, specimens (N=6) were captured during July-November period in 2011-2013 in an SCL endemic area in El Kef region, North-Western Tunisia. Using morphological characteristics, all specimens were described and measured. Biopsies from liver, heart, kidney and spleen of each animal were used to extract genomic DNA, which was further used in PCR assays to assess the presence of Leishmania parasites. Different PCRs targeting kinetoplast minicircles, ITS1, mini-exon genes and a repetitive Leishmania- specific sequence, were applied. To further identify Leishmania species involved, RFLP analysis of amplified fragments was performed with appropriate restriction enzymes. Using morphological characters, animals were identified as North African hedgehogs, also called Algerian hedgehogs, that belong to the Erinaceidae family, genus Atelerix Pomel 1848, and species algirus (Lereboullet, 1842). PCR results showed in total that all specimens were Leishmania infected, with different organs incriminated, mainly liver and spleen. Results were confirmed by direct sequencing of amplified fragments. Species identification showed that all specimens were infected with L. major, three of which were additionally co-infected with L. infantum. The present study demonstrates, for the first time in Tunisia, natural infection of hedgehog animals (Atelerix algirus) by the Leishmania parasites species L. major and L. infantum. L. major is also detected for the first time in wild animals captured in the North Western part of the country; likewise for the co-infection of these animals by the 2 Leishmania species. This mammal could play a potential reservoir role in epidemiology of SCL or ZCL and could contribute to emergence or extension of ZCL in the studied region.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chemkhi</LastName>
<ForeName>Jomaa</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Laboratoire d'Epidémiologie Moléculaire et Pathologie Expérimentale Appliquée aux Maladies Infectieuses (LR11IPT04), Institut Pasteur de Tunis, Université Tunis el Manar, Tunis, Tunisia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Souguir</LastName>
<ForeName>Hejer</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Laboratoire d'Epidémiologie Moléculaire et Pathologie Expérimentale Appliquée aux Maladies Infectieuses (LR11IPT04), Institut Pasteur de Tunis, Université Tunis el Manar, Tunis, Tunisia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ali</LastName>
<ForeName>Insaf Bel Hadj</ForeName>
<Initials>IB</Initials>
<AffiliationInfo>
<Affiliation>Laboratoire d'Epidémiologie Moléculaire et Pathologie Expérimentale Appliquée aux Maladies Infectieuses (LR11IPT04), Institut Pasteur de Tunis, Université Tunis el Manar, Tunis, Tunisia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Driss</LastName>
<ForeName>Mehdi</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Laboratoire d'Epidémiologie Moléculaire et Pathologie Expérimentale Appliquée aux Maladies Infectieuses (LR11IPT04), Institut Pasteur de Tunis, Université Tunis el Manar, Tunis, Tunisia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guizani</LastName>
<ForeName>Ikram</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Laboratoire d'Epidémiologie Moléculaire et Pathologie Expérimentale Appliquée aux Maladies Infectieuses (LR11IPT04), Institut Pasteur de Tunis, Université Tunis el Manar, Tunis, Tunisia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guerbouj</LastName>
<ForeName>Souheila</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Laboratoire d'Epidémiologie Moléculaire et Pathologie Expérimentale Appliquée aux Maladies Infectieuses (LR11IPT04), Institut Pasteur de Tunis, Université Tunis el Manar, Tunis, Tunisia. Electronic address: souheila.guerbouj@pasteur.rns.tn.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Hedgehog</Keyword>
<Keyword MajorTopicYN="N">Leishmania</Keyword>
<Keyword MajorTopicYN="N">PCR–RFLP</Keyword>
<Keyword MajorTopicYN="N">Reservoir host</Keyword>
<Keyword MajorTopicYN="N">Tunisia</Keyword>
<Keyword MajorTopicYN="N">natural infection</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26095044</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Trends in malaria case management following changes in the treatment policy to artemisinin combination therapy at the Mbakong Health Centre, Cameroon 2006-2012: a retrospective study.</ArticleTitle>
<Pagination>
<MedlinePgn>100-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.06.014</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30036-X</ELocationID>
<Abstract>
<AbstractText>National malaria treatment policies are devised to guide health professionals and to facilitate diagnosis and case management. Following the recommendations of the WHO, Cameroon changed its malaria treatment policy from monotherapy to artemisinin-based combination therapy (ACT) as the first-line treatment for uncomplicated malaria. We report an investigation into trends of case management following this change in policy. Data was collected retrospectively, through consultation and perusal of laboratory and prescription registers of the Mbakong Health Centre. Analysis of data was done using SPSS and SAS Statistics. Data presented herein demonstrate that from 2006 to 2012, a total of 2484 (58.7%) of the total prescriptions included an anti-malarial, 1989 (47.0%) included an antibiotic and 1935(45.7%) included an antipyretic. The anti-malarials prescribed were Anti-malaria combination therapy (ACT) - 1216 (47.6%), quinine 1044 (40.8%) or SP 296 (11.6%). Of the 1216 patients prescribed an ACT, 441(36.3%) had a positive malaria parasite confirmation, 746 (61.3%) were negative for plasmodium. Overall, 29 patients (2.4%) were treated either with an ACT without any test performed. Quinine intake was recorded in 566 (54.2%) patients positive for plasmodium. ACT prescription increased from 23% in 2007 to between 44 and 45% in 2008-2009. During this period there was a corresponding drop in the prescription of quinine from 38% in 2007 to 13% in 2009 (r=-0.43, p&gt;0.05). Sulphadoxine-Pyrimethamine (SP) was restrictively prescribed to women of childbearing age (97.0%) after 2008. Antibiotics prescription dropped from 53.7% to 39.3% from 2010 to 2012. The odds of being prescribed an antibiotic was significantly higher in patients with a malaria negative result compared to malaria positive patients (OR=6.12, CI 4.74-7.91, p&lt;0.00001). Overall, there is an over treatment of malaria, thus departing from the WHO guidelines of appropriate treatment. Although there is an overall increase in the prescription of ACT, less prescription of quinine and a noticeable restrain from prescription of SP to febrile cases, the old practice was still rampant. There is need for healthcare workers to adhere to guidelines in order to enhance the rational use of drugs to achieve appropriate treatment of uncomplicated malaria according to WHO guidelines.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ndong</LastName>
<ForeName>Ignatius C</ForeName>
<Initials>IC</Initials>
<AffiliationInfo>
<Affiliation>DST/NWU, Preclinical Drug Development Platform, North-West University, Potchefstroom Campus, South Africa; Department of Biochemistry, Catholic University of Cameroon, Bamenda, Cameroon; Laboratory of Public Health Research Biotechnologies, University of Yaoundé I, Cameroon. Electronic address: ndongicheng@yahoo.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Reenen</LastName>
<ForeName>Mari van</ForeName>
<Initials>Mv</Initials>
<AffiliationInfo>
<Affiliation>Statistical Consultation Services, North-West University, Potchefstroom Campus, South Africa. Electronic address: 12791733@nwu.ac.za.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Boakye</LastName>
<ForeName>Daniel A</ForeName>
<Initials>DA</Initials>
<AffiliationInfo>
<Affiliation>Noguchi Memorial Institute of Medical Research, University of Ghana Legon, Ghana. Electronic address: dboakye@noguchi.mimcom.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mbacham</LastName>
<ForeName>Wilfred F</ForeName>
<Initials>WF</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry, Catholic University of Cameroon, Bamenda, Cameroon; Laboratory of Public Health Research Biotechnologies, University of Yaoundé I, Cameroon. Electronic address: wfmbacham@yahoo.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Grobler</LastName>
<ForeName>Anne F</ForeName>
<Initials>AF</Initials>
<AffiliationInfo>
<Affiliation>DST/NWU, Preclinical Drug Development Platform, North-West University, Potchefstroom Campus, South Africa. Electronic address: anne.grobler@nwu.ac.za.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Artemisinin-based combination therapy</Keyword>
<Keyword MajorTopicYN="N">Cameroon</Keyword>
<Keyword MajorTopicYN="N">Case management</Keyword>
<Keyword MajorTopicYN="N">Malaria</Keyword>
<Keyword MajorTopicYN="N">Mbakong</Keyword>
<Keyword MajorTopicYN="N">Policy</Keyword>
<Keyword MajorTopicYN="N">Quinine</Keyword>
<Keyword MajorTopicYN="N">Sulfadoxine-pyrimethamine</Keyword>
<Keyword MajorTopicYN="N">Trends</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26099681</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Comparative pathogenicity of Trypanosoma brucei rhodesiense strains in Swiss white mice and Mastomys natalensis rats.</ArticleTitle>
<Pagination>
<MedlinePgn>23-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.06.010</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30034-6</ELocationID>
<Abstract>
<AbstractText>We evaluated Mastomys natelensis rat as an animal model for Rhodesian sleeping sickness. Parasitaemia, clinical and pathological characteristics induced by T. b. rhodesiense isolates, KETRI 3439, 3622 and 3637 were compared in Mastomys rats and Swiss white mice. Each isolate was intra-peritonially injected in mice and rat groups (n=12) at 1×10(4) trypanosomes/0.2mL. Pre-patent period (PP) range for KETRI 3439 and KETRI 3622-groups was 3-6 days for mice and 4-5 days for rats while for KETRI 3637-infected mice and rats was 5-9 and 4-12 days, respectively. Pairwise comparison between PP of mice and rats separately infected with either isolate showed no significant difference (p&gt;0.05). The PP's of KETRI 3637-infected mice were significantly (p&gt;0.01) longer than those infected with KETRI 3439 or KETRI 3622, a trend also observed in rats. The second parasitaemic wave was more prominent in mice. Clinical signs included body weakness, dyspnoea, peri-orbital oedema and extreme emaciation which were more common in rats. Survival time for KETRI 3439 and 3622-infected groups was significantly (p&lt;0.05) longer in mice than rats but similar in KETRI 3637-infected groups. Inflammatory lesions were more severe in rats than mice. All mice and KETRI 3622-infected rats had splenomegaly, organ congestion with rats additionally showing prominent lymphadenopathy. KETRI 3439-infected rats showed hemorrhagic pneumonia, enteritis with moderate splenomegaly and lymphadenopathy. KETRI 3637-infected rats had the most severe lesions characterized by prominent splenomegaly, lymphadenopathy, hepatomegaly, enlarged adrenal glands, organ congestion, generalized oedemas, gastroenteritis, pneumonia and brain congestion. KETRI 3637-infected Mastomys is a suitable model for studying pathophysiology of HAT.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Muchiri</LastName>
<ForeName>Margaret Wanjiku</ForeName>
<Initials>MW</Initials>
<AffiliationInfo>
<Affiliation>Kenya Agricultural and Livestock Research Organization (KALRO), Biotechnology Research Institute (BioRI), P. O. Box 362, Kikuyu, Kenya; Jomo Kenyatta University of Agriculture and Technology, P.O. Box 62000-00200, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ndung'u</LastName>
<ForeName>Kariuki</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Kenya Agricultural and Livestock Research Organization (KALRO), Biotechnology Research Institute (BioRI), P. O. Box 362, Kikuyu, Kenya. Electronic address: kariukindungu36@yahoo.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kibugu</LastName>
<ForeName>James Karuku</ForeName>
<Initials>JK</Initials>
<AffiliationInfo>
<Affiliation>Kenya Agricultural and Livestock Research Organization (KALRO), Biotechnology Research Institute (BioRI), P. O. Box 362, Kikuyu, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thuita</LastName>
<ForeName>John Kibuthu</ForeName>
<Initials>JK</Initials>
<AffiliationInfo>
<Affiliation>Kenya Agricultural and Livestock Research Organization (KALRO), Biotechnology Research Institute (BioRI), P. O. Box 362, Kikuyu, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gitonga</LastName>
<ForeName>Purity Kaari</ForeName>
<Initials>PK</Initials>
<AffiliationInfo>
<Affiliation>Kenya Agricultural and Livestock Research Organization (KALRO), Biotechnology Research Institute (BioRI), P. O. Box 362, Kikuyu, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ngae</LastName>
<ForeName>Geoffrey Njuguna</ForeName>
<Initials>GN</Initials>
<AffiliationInfo>
<Affiliation>Kenya Food Crop Research Institute, P. O. Box 30148, Nairobi, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mdachi</LastName>
<ForeName>Raymond Ellie</ForeName>
<Initials>RE</Initials>
<AffiliationInfo>
<Affiliation>Kenya Agricultural and Livestock Research Organization (KALRO), Biotechnology Research Institute (BioRI), P. O. Box 362, Kikuyu, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kagira</LastName>
<ForeName>John Maina</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Jomo Kenyatta University of Agriculture and Technology, P.O. Box 62000-00200, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Mastomys rats</Keyword>
<Keyword MajorTopicYN="N">Mice</Keyword>
<Keyword MajorTopicYN="N">Rhodesian HAT rat model</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26099682</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Rotation of the external genitalia in male Phlebotomine sand flies (Diptera, Psychodidae) in laboratory conditions and in captured specimens in Algarve, Portugal.</ArticleTitle>
<Pagination>
<MedlinePgn>1-3</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.06.016</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30038-3</ELocationID>
<Abstract>
<AbstractText>Protozoal parasites are the causative agents of many insect-borne infectious diseases worldwide with impact on human and animal health. Leishmaniasis is caused by Leishmania spp. and transmitted by female Phlebotomine sand flies. In Portugal, two species of Phlebotomus (Larroussius), namely Phlebotomus perniciosus and Phlebotomus ariasi are the proven vectors of Leishmania infantum. Phlebotomine females and males rest and breed in the same sites; and these locations can be predicted according to the male external genitalia maturation. Therefore, this study aimed to determine the timing of complete rotation of the male external genitalia in laboratory conditions and to characterize the external genitalia rotation in field captured males to predict the male and female sand fly breeding and resting sites. This knowledge can be applied in the design and implementation of integrated sand fly control strategies targeting these sites.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ferrolho</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>UEI Parasitologia Médica, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa (IHMT-UNL), Rua da Junqueira 100, 1349-008 Lisboa, Portugal; Global Health and Tropical Medicine, IHMT-UNL, Portugal. Electronic address: joana.ferrolho@ihmt.unl.pt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maia</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>UEI Parasitologia Médica, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa (IHMT-UNL), Rua da Junqueira 100, 1349-008 Lisboa, Portugal; Global Health and Tropical Medicine, IHMT-UNL, Portugal.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gomes</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>UEI Parasitologia Médica, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa (IHMT-UNL), Rua da Junqueira 100, 1349-008 Lisboa, Portugal.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alves-Pires</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>UEI Parasitologia Médica, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa (IHMT-UNL), Rua da Junqueira 100, 1349-008 Lisboa, Portugal.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cristóvão</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>UEI Parasitologia Médica, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa (IHMT-UNL), Rua da Junqueira 100, 1349-008 Lisboa, Portugal.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Campino</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>UEI Parasitologia Médica, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa (IHMT-UNL), Rua da Junqueira 100, 1349-008 Lisboa, Portugal; Global Health and Tropical Medicine, IHMT-UNL, Portugal.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Afonso</LastName>
<ForeName>M O</ForeName>
<Initials>MO</Initials>
<AffiliationInfo>
<Affiliation>UEI Parasitologia Médica, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa (IHMT-UNL), Rua da Junqueira 100, 1349-008 Lisboa, Portugal; Global Health and Tropical Medicine, IHMT-UNL, Portugal.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Breeding sites</Keyword>
<Keyword MajorTopicYN="N">Male external genitalia rotation</Keyword>
<Keyword MajorTopicYN="N">Phlebotomine sand flies</Keyword>
<Keyword MajorTopicYN="N">Phlebotomus spp</Keyword>
<Keyword MajorTopicYN="N">Portugal</Keyword>
<Keyword MajorTopicYN="N">Sergentomyia minuta</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26113175</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Characteristics of commercial and traditional village poultry farming in Mali with a focus on practices influencing the risk of transmission of avian influenza and Newcastle disease.</ArticleTitle>
<Pagination>
<MedlinePgn>14-22</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.06.015</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30037-1</ELocationID>
<Abstract>
<AbstractText>We aimed at characterizing commercial and traditional village poultry farming in Mali, with a focus on practices influencing the risk of transmission of avian influenza and Newcastle disease. Surveys were conducted in 2009-2011 in a study area covering approximately 98% of the Malian poultry population. Among the 282 commercial farms investigated, of which 64 had not been known by the government authorities, 83% were located within a 50km radius from the capitals of the country and regions and 54% had low biosecurity standard. Among the 152 randomly selected village household flocks investigated, characteristics were overall similar to those in other African countries but some differences were notable including a large flock size (median 44 poultry), a low presence of ducks and geese (11% and 1.1% of flocks, respectively), vaccination against Newcastle disease being common (49% of flocks), a low proportion of households selling sick and dead birds (0.7% and 0%, respectively) and limited cohabitation between poultry and humans at night. Our recommendations to limit the risk of disease transmission include (1) for commercial farms, to introduce compulsory farm registration and accreditation, to increase technical proficiency and access to credit for farms with low biosecurity, and to support poultry producer associations; (2) for village poultry, to promote better quarantine and management of sick and dead birds. Such detailed knowledge of country-specific characteristics of poultry production systems is essential to be able to develop more efficient disease risk management policies.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Molia</LastName>
<ForeName>Sophie</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>CIRAD, Centre Régional de Santé Animale, Sotuba, Route de Koulikoro, BP1813 Bamako, Mali; CIRAD, UPR AGIRs, Campus International Baillarguet, F-34398 Montpellier, France. Electronic address: sophie.molia@cirad.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Traoré</LastName>
<ForeName>Idrissa</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Laboratoire Central Vétérinaire, Km 8, Route de Koulikoro, BP 2295 Bamako, Mali. Electronic address: iditraorefr@yahoo.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kamissoko</LastName>
<ForeName>Badian</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Laboratoire Central Vétérinaire, Km 8, Route de Koulikoro, BP 2295 Bamako, Mali. Electronic address: kbadian2001@yahoo.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Diakité</LastName>
<ForeName>Adama</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Laboratoire Central Vétérinaire, Km 8, Route de Koulikoro, BP 2295 Bamako, Mali. Electronic address: mladama2002@yahoo.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sidibé</LastName>
<ForeName>Maimouna Sanogo</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>Direction Nationale des Services Vétérinaires, 03 BP 220 Bamako 3, Mali. Electronic address: maisanogo@yahoo.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sissoko</LastName>
<ForeName>Kadiatou Diarra</ForeName>
<Initials>KD</Initials>
<AffiliationInfo>
<Affiliation>Direction Nationale des Services Vétérinaires, 03 BP 220 Bamako 3, Mali. Electronic address: kadiston1@yahoo.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pfeiffer</LastName>
<ForeName>Dirk Udo</ForeName>
<Initials>DU</Initials>
<AffiliationInfo>
<Affiliation>VEEPH Group, Royal Veterinary College, Royal College St., London NW1 0TU, United Kingdom. Electronic address: pfeiffer@rvc.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Avian influenza</Keyword>
<Keyword MajorTopicYN="N">Commercial poultry</Keyword>
<Keyword MajorTopicYN="N">Mali</Keyword>
<Keyword MajorTopicYN="N">Newcastle disease</Keyword>
<Keyword MajorTopicYN="N">Production systems</Keyword>
<Keyword MajorTopicYN="N">Village poultry</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26116785</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Vaccine potential of recombinant pro- and mature cathepsinL1 against fasciolosis gigantica in mice.</ArticleTitle>
<Pagination>
<MedlinePgn>71-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.06.020</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30042-5</ELocationID>
<Abstract>
<AbstractText>In Fasciola gigantica cathepsin L1 (CatL1) is a family of predominant proteases that is expressed in caecal epithelial cells and secreted into the excretory-secretory products (ES). CatL1 isotypes are expressed in both early and late stages of the life cycle and the parasites use them for migration and digestion. Therefore, CatL1 is a plausible target for vaccination against this parasite. Recombinant pro-F.gigantica CatL1 (rproFgCatL1) and recombinant mature F.gigantica CatL1 (rmatFgCatL1) were expressed in Escherichia coli BL21. The vaccination was performed in Imprinting Control Region (ICR) mice (n=10) by subcutaneous injection with 50μg of rproFgCatL1 and rmatFgCatL1 combined with Freund's adjuvant. Two weeks after the second boost, mice were infected with 15 metacercariae by the oral route. The level of protection of rproFgCatL1 and rmatFgCatL1 vaccines was estimated to be 39.1, 41.7% and 44.9, 47.2% when compared with non vaccinated-infected and adjuvant-infected controls, respectively. Antibodies in the immune sera of vaccinated mice were shown by immuno-blotting to react with the native FgCatL1 in the extract of newly excysted juveniles (NEJ), 4-week-old juveniles and the ES products of 4 week-old juveniles. By determining the levels of IgG1 and IgG2a in the immune sera, which are indicative of Th2 and Th1 immune response, respectively, it was found that both Th1 and Th2 responses were significantly increased in rproFgCatL1- and rmatFgCatL1-immunized groups compared with the control groups, with higher levels of Th2 (IgG1) than Th1 (IgG2a). The levels of serum aspartate aminotransferase (AST) and alanine transaminase (ALT) in rmatFgCatL1-immunized group showed a significant decrease when compared to rproFgCatL1-immunized group, indicating that rmatFgCatL1-vaccinated mice had reduced liver parenchyma damage. The pathological lesions of liver in vaccinated groups were significantly decreased when compared with control groups. This study indicates that rFgCatL1 has a potential as a vaccine candidate against F. gigantica in mice, and this potential will be tested in ruminants.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kueakhai</LastName>
<ForeName>Pornanan</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Faculty of Allied Health Sciences, Burapha University, Long-Hard Bangsaen Road, Mueang District, Chonburi 20131, Thailand. Electronic address: pornanan@buu.ac.th.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Changklungmoa</LastName>
<ForeName>Narin</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Faculty of Allied Health Sciences, Burapha University, Long-Hard Bangsaen Road, Mueang District, Chonburi 20131, Thailand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chaichanasak</LastName>
<ForeName>Pannigan</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Faculty of Veterinary Medicine, Mahanakorn University of Technology, Cheum-Sampan Road, Nong Chok, Bangkok 10530, Thailand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jaikua</LastName>
<ForeName>Wipaphorn</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathobiology, Faculty of Science, Mahidol University, Rama 6 Road, Ratchathewi, Bangkok 10400, Thailand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Itagaki</LastName>
<ForeName>Tadashi</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Veterinary Parasitology, Faculty of Agriculture, Iwate University, Ueda 3-18-8, Morioka 020-8550, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sobhon</LastName>
<ForeName>Prasert</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Anatomy, Faculty of Science, Mahidol University, Rama 6 Road, Ratchathewi, Bangkok 10400, Thailand.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cathepsin L1</Keyword>
<Keyword MajorTopicYN="N">Fasciola gigantica</Keyword>
<Keyword MajorTopicYN="N">Mice</Keyword>
<Keyword MajorTopicYN="N">Protection</Keyword>
<Keyword MajorTopicYN="N">Vaccine</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26119042</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Formulation of attractive toxic sugar bait (ATSB) with safe EPA-exempt substance significantly diminishes the Anopheles sergentii population in a desert oasis.</ArticleTitle>
<Pagination>
<MedlinePgn>29-34</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.06.018</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30040-1</ELocationID>
<Abstract>
<AbstractText>Attractive toxic sugar bait (ATSB) is a highly effective method which targets mosquitoes based on their sugar foraging behavior, by presenting baits of attractive compounds in combination with sugar and oral toxin to local mosquito populations. Environmental concerns and insecticide selection-pressure have prompted investigations of novel, ecologically-harmless substances which can be used as insecticides. This study examined the efficacy of microencapsulated garlic-oil as the oral toxin component of ATSB for controlling Anopheles sergentii populations inhabiting desert-surrounded wetlands in Israel. ATSB solution containing 0.4% encapsulated garlic oil was applied to local vegetation around a streamlet located in the lower Jordan Valley. To determine the propensity of bait ingestion, and assess the potential ecological impact of the method, mosquito and non-target specimens were collected and tested for the presence of natural plant- or attractive sugar bait (ASB)-derived sugars. Over the experimental period, biting-pressure values in the ATSB treatment site decreased by 97.5%, while at the control site, treated with non-toxic ASB, no significant changes were observed. Approximately 70% of the mosquitoes collected before both treatments, as well as those captured following the application of ASB at the control site, were found to have ingested sugar prior to capture. Non-target insects were minimally affected by the treatment when ATSB was applied to foliage of non-flowering plants. Of the non-Diptera species, only 0.7% of the sampled non-target insects were found to have ingested ASB-solution which was applied to green vegetation, compared with 8.5% which have foraged on ASB-derived sugars applied to flowering plants. Conversely, a high proportion of the non-target species belonging to the order Diptera, especially non-biting midges, were found to have ingested foliage-applied ASB, with more than 36% of the specimens collected determined to have foraged on bait-derived sugars. These results prove that food-grade, EPA-exempt microencapsulated garlic oil is a highly effective insecticide which can be utilized for mosquito population control. The relatively short half-life of this active ingredient makes it a suitable for use in areas where repeated application is possible, limiting the accumulation of deleterious compounds and ensuring minimal environmental impact when applied in accordance with label recommendations.</AbstractText>
<CopyrightInformation>Copyright © 2015. Published by Elsevier B.V.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Revay</LastName>
<ForeName>Edita E</ForeName>
<Initials>EE</Initials>
<AffiliationInfo>
<Affiliation>Department of Anatomy and Cell Biology, Bruce Rappaport Faculty of Medicine, Technion, Haifa 34995, Israel.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schlein</LastName>
<ForeName>Yosef</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Molecular Genetics, IMRIC, Kuvin Centre for the Study of Infectious and Tropical Diseases, Faculty of Medicine, Hebrew University, Jerusalem 91120, Israel.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tsabari</LastName>
<ForeName>Onie</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, 33136 FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kravchenko</LastName>
<ForeName>Vasiliy</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Department of Zoology, Tel Aviv University, Ramat Aviv, 69978, Israel.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Qualls</LastName>
<ForeName>Whitney</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, 33136 FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>De-Xue</LastName>
<ForeName>Rui</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Anastasia Mosquito Control District, 500 Old Beach Road, St. Augustine, FL 32080, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Beier</LastName>
<ForeName>John C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, 33136 FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Traore</LastName>
<ForeName>Sekou F</ForeName>
<Initials>SF</Initials>
<AffiliationInfo>
<Affiliation>Malaria Research and Training Center, Faculty of Medicine, Pharmacy and Odontostomatology, University of Bamako, BP 1805 Bamako, Mali.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Doumbia</LastName>
<ForeName>Seydou</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Malaria Research and Training Center, Faculty of Medicine, Pharmacy and Odontostomatology, University of Bamako, BP 1805 Bamako, Mali.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hausmann</LastName>
<ForeName>Axel</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Entomology, SNSB - Zoologische Staatssammlung München, Münchhausenstraße 21, D-81247 München, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Müller</LastName>
<ForeName>Günter C</ForeName>
<Initials>GC</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Molecular Genetics, IMRIC, Kuvin Centre for the Study of Infectious and Tropical Diseases, Faculty of Medicine, Hebrew University, Jerusalem 91120, Israel. Electronic address: guntercmuller@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01AI100968</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">ATSB</Keyword>
<Keyword MajorTopicYN="N">Anopheles sergentii</Keyword>
<Keyword MajorTopicYN="N">Culicidae</Keyword>
<Keyword MajorTopicYN="N">Non-targets</Keyword>
<Keyword MajorTopicYN="N">Sugar-feeding</Keyword>
<Keyword MajorTopicYN="N">Vector-control</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26119043</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Leptin augments protective immune responses in murine macrophages and enhances potential of miltefosine against experimental visceral leishmaniasis.</ArticleTitle>
<Pagination>
<MedlinePgn>35-41</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.06.024</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30045-0</ELocationID>
<Abstract>
<AbstractText>Adverse side effects and drug resistance issues are the two most important drawbacks which influence the widespread use of existing antileishmanial drugs. Use of immune stimulating agent with standard antileishmanial might be helpful to minimize the toxic effect of drug, shorten the dose regimen and delay the emergence of resistance. In the present study, we explored the in vitro immunomodulatory potential of an immunomodulator, leptin with lower concentration of standard drug, miltefosine. The level of Th1/Th2 cytokines, production of nitric oxide and reactive oxygen species and phagocytic activity was assessed by ELISA, Griess reaction and flow cytometric analysis, respectively. Leptin at a concentration of 15μg/mL showed heightened level of Th1 cytokines and nitric oxide generation from murine macrophages (J-774A.1 cells). Leptin (15μg/mL) also reduces the effective concentration of miltefosine by 2-folds from 7.5μM to 3.7μM. When given in conjunction with lower concentration of miltefosine (4μM), leptin (15μg/mL) significantly (***p&lt;0.001) elevated the level of IL-12 (7.7 fold), TNF-α (8.1 fold) and nitric oxide (6.6 fold) along with markedly (***p&lt;0.001) suppressed level of IL-10 and TGF-β when compared with untreated infected macrophages. Leptin plus miltefosine also induces the phagocytic ability (**p&lt;0.01) of macrophages in comparison to leptin alone and miltefosine alone treated groups. These finding illustrate that leptin activates host macrophages to generate protective immune response for the successful elimination of Leishmania parasite at lower concentration of miltefosine and has potential for further exploration in experimental animal model of visceral leishmaniasis (VL).</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shivahare</LastName>
<ForeName>Rahul</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, King George's Medical University, Lucknow 226 003, India. Electronic address: rahul_biotech08@yahoo.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ali</LastName>
<ForeName>Wahid</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, King George's Medical University, Lucknow 226 003, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vishwakarma</LastName>
<ForeName>Preeti</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Division of Parasitology, CSIR-Central Drug Research Institute, Lucknow 226 031, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Natu</LastName>
<ForeName>S M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, King George's Medical University, Lucknow 226 003, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Puri</LastName>
<ForeName>Sunil K</ForeName>
<Initials>SK</Initials>
<AffiliationInfo>
<Affiliation>Division of Parasitology, CSIR-Central Drug Research Institute, Lucknow 226 031, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gupta</LastName>
<ForeName>Suman</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Division of Parasitology, CSIR-Central Drug Research Institute, Lucknow 226 031, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Combination therapy</Keyword>
<Keyword MajorTopicYN="N">Immune response</Keyword>
<Keyword MajorTopicYN="N">J-774.A1 cells</Keyword>
<Keyword MajorTopicYN="N">Leishmania donovani</Keyword>
<Keyword MajorTopicYN="N">Leptin</Keyword>
<Keyword MajorTopicYN="N">Miltefosine</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26123192</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Echinococcus granulosus infection dynamics in livestock of Greece.</ArticleTitle>
<Pagination>
<MedlinePgn>64-70</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.06.021</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30043-7</ELocationID>
<Abstract>
<AbstractText>An epidemiological and molecular survey on the occurrence of Echinococcus hydatid cysts in livestock was conducted in Greece. In total 898 sheep, 483 goats, 38 buffaloes, 273 wild boars and 15 deer were examined and 30.2% (6.45% cyst fertility), 7.86% (3.2% cyst fertility), 42% (7.9% cyst fertility), 1.1% (0% cyst fertility), 0% of them were found infected, respectively. Infection rate in different geographical regions varied between 26.1 and 53.8% (cyst fertility 2.04 and 34.6%) in sheep, 7.33 and 13.3% (cyst fertility 0 and 3.2%) in goats. Genotyping, based on cox1 and nad1 analyses, demonstrated the predominance of E. granulosus s.s. (G1 genotype). The presence of one single genotype-complex within a relatively large spectrum of intermediate host species in Greece indicates the presence of a dominant transmission dog-sheep cycle involving additional host species which may act as disease reservoir for human infections.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chaligiannis</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Veterinary Research Institute, Hellenic Agricultural Organisation-Demeter, Thessaloniki, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maillard</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Institute of Parasitology, Vetsuisse Faculty and Faculty of Medicine, University of Bern, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Boubaker</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Institute of Parasitology, Vetsuisse Faculty and Faculty of Medicine, University of Bern, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Spiliotis</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute of Parasitology, Vetsuisse Faculty and Faculty of Medicine, University of Bern, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Saratsis</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Veterinary Research Institute, Hellenic Agricultural Organisation-Demeter, Thessaloniki, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gottstein</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Institute of Parasitology, Vetsuisse Faculty and Faculty of Medicine, University of Bern, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sotiraki</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Veterinary Research Institute, Hellenic Agricultural Organisation-Demeter, Thessaloniki, Greece. Electronic address: smaro_sotiraki@yahoo.gr.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cystic echinococcosis</Keyword>
<Keyword MajorTopicYN="N">Echinococcus granulosus</Keyword>
<Keyword MajorTopicYN="N">Livestock</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26126785</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Identification through DNA barcoding of Tabanidae (Diptera) vectors of surra disease in India.</ArticleTitle>
<Pagination>
<MedlinePgn>52-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.06.023</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30046-2</ELocationID>
<Abstract>
<AbstractText>Horse flies and deer flies are common names applied to members of the family Tabanidae (Diptera). Tabanid flies are pestiferous and of veterinary and medical importance, with about 244 species in India. They are major vectors of Trypanosoma evansi that causes trypanosomiasis (surra disease). Lack of stable morphological characters, and scarcity of taxonomic expertise, is major impediments for accurate species identification of these important pest and disease vectors. Molecular data, especially DNA barcode data, has been widely used in the identification of Diptera of economic importance. We evaluated the utility of DNA barcode data to discriminate the vectors of surra disease (trypanosomiasis) from India. We used barcode gap and reciprocal monophyly (neighbor-joining and Bayesian tree) criteria to analyze barcode data. A total of 46 specimens belonging to 7 species under four genera in two subfamilies were used for this study. DNA barcode data was not available previously for these species. Analysis revealed that all morphologically identifiable species can be discriminated using DNA barcoding data. Further, our study clearly demonstrated the presence of cryptic species in Chrysops dispar. Moreover, we revealed that closely related species without stable taxonomic distinguishing characters in the "Tabanus striatus species complex" can be discriminated using DNA barcode data.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Banerjee</LastName>
<ForeName>Dhriti</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Diptera Section, Zoological Survey of India, Kolkata, West Bengal, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>Vikas</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Centre for DNA Taxonomy, Molecular Systematics Division, Zoological Survey of India, Kolkata, West Bengal, India. Electronic address: vikaszsi77@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maity</LastName>
<ForeName>Aniruddha</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Diptera Section, Zoological Survey of India, Kolkata, West Bengal, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ghosh</LastName>
<ForeName>Biswatosh</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Centre for DNA Taxonomy, Molecular Systematics Division, Zoological Survey of India, Kolkata, West Bengal, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tyagi</LastName>
<ForeName>Kaomud</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Centre for DNA Taxonomy, Molecular Systematics Division, Zoological Survey of India, Kolkata, West Bengal, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singha</LastName>
<ForeName>Devkant</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Centre for DNA Taxonomy, Molecular Systematics Division, Zoological Survey of India, Kolkata, West Bengal, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kundu</LastName>
<ForeName>Shantanu</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Centre for DNA Taxonomy, Molecular Systematics Division, Zoological Survey of India, Kolkata, West Bengal, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Laskar</LastName>
<ForeName>Boni Amin</ForeName>
<Initials>BA</Initials>
<AffiliationInfo>
<Affiliation>Centre for DNA Taxonomy, Molecular Systematics Division, Zoological Survey of India, Kolkata, West Bengal, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Naskar</LastName>
<ForeName>Atanu</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Diptera Section, Zoological Survey of India, Kolkata, West Bengal, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rath</LastName>
<ForeName>Shibananda</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Cytotaxonomy Research Laboratory, Molecular Systematics Division, Zoological Survey of India, Kolkata, West Bengal, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">DNA barcoding</Keyword>
<Keyword MajorTopicYN="N">Discrimination</Keyword>
<Keyword MajorTopicYN="N">Tabanid</Keyword>
<Keyword MajorTopicYN="N">Trypanosomiasis</Keyword>
<Keyword MajorTopicYN="N">Vectors</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26149541</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>10</Month>
<Day>05</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Correlation of serum and dried blood spot results for quantitation of Schistosoma circulating anodic antigen: a proof of principle.</ArticleTitle>
<Pagination>
<MedlinePgn>59-63</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.06.026</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30047-4</ELocationID>
<Abstract>
<AbstractText>Circulating anodic antigen (CAA) testing is a powerful, increasingly-used tool for diagnosis of active schistosome infection. We sought to determine the feasibility and reliability of measuring CAA in blood spots collected on Whatman 903 protein saver cards, which are the predominant filter papers used worldwide for dried blood spot (DBS) research and clinical care. CAA was eluted from blood spots collected from 19 individuals onto Whatman 903 cards in Mwanza, Tanzania, and the assay was optimized to achieve CAA ratios comparable to those obtained from the spots' corresponding serum samples. The optimized assay was then used to determine the correlation of serum samples (n=16) with DBS from cards that had been stored for 8 years at ambient temperature. Using a DBS volume equivalent to approximately four times the quantity of serum, CAA testing in DBS had a sensitivity of 76% and a specificity of 79% compared to CAA testing in serum. CAA testing was reliable in samples eluted from Whatman 903 cards that had been stored for 8 years at ambient temperature. The overall kappa coefficient was 0.53 (standard error 0.17, p&lt;0.001). We conclude that CAA can be reliably and accurately measured in DBS collected onto the filter paper that is most commonly used for clinical care and research, and that can be stored from prolonged periods of time. This finding opens new avenues for future work among more than 700million individuals living in areas worldwide in which schistosomes are endemic.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Downs</LastName>
<ForeName>Jennifer A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>Center for Global Health, Weill Cornell Medical College, 402 E. 67th Street, Second Floor, New York, NY, USA; Department of Medicine, Bugando Medical Centre, Box 1370, Mwanza, Tanzania. Electronic address: jna2002@med.cornell.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Corstjens</LastName>
<ForeName>Paul L A M</ForeName>
<Initials>PL</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Cell Biology, Leiden University Medical Center, Postzone S1-P, Postbus 9600, 2300 RC Leiden, The Netherlands. Electronic address: p.corstjens@lumc.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mngara</LastName>
<ForeName>Julius</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>National Institute for Medical Research-Mwanza Research Centre, Box 1462, Mwanza, Tanzania. Electronic address: juliusmngara@yahoo.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lutonja</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>National Institute for Medical Research-Mwanza Research Centre, Box 1462, Mwanza, Tanzania. Electronic address: peter.lutonja@mitu.or.tz.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Isingo</LastName>
<ForeName>Raphael</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>National Institute for Medical Research-Mwanza Research Centre, Box 1462, Mwanza, Tanzania. Electronic address: rrisingo@yahoo.co.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Urassa</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>National Institute for Medical Research-Mwanza Research Centre, Box 1462, Mwanza, Tanzania. Electronic address: urassamark@yahoo.co.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kornelis</LastName>
<ForeName>Dieuwke</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: d.kornelis@lumc.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van Dam</LastName>
<ForeName>Govert J</ForeName>
<Initials>GJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: G.J.van_Dam@lumc.nl.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K23 AI110238</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K23 AI110238</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Trop Med Hyg. 1986 May;35(3):549-58</RefSource>
<PMID Version="1">3518506</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trans R Soc Trop Med Hyg. 1989 May-Jun;83(3):368-72</RefSource>
<PMID Version="1">2515625</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Microbiol. 2008 Jan;46(1):171-6</RefSource>
<PMID Version="1">17942645</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Microbiol. 2007 Feb;45(2):517-21</RefSource>
<PMID Version="1">17166967</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trans R Soc Trop Med Hyg. 1997 Jul-Aug;91(4):412-5</RefSource>
<PMID Version="1">9373636</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Parasitol. 1996 Aug;82(4):557-64</RefSource>
<PMID Version="1">8691363</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1994 Dec 16;269(50):31510-7</RefSource>
<PMID Version="1">7989318</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Infect Dis. 1994 Mar;18(3):408-13</RefSource>
<PMID Version="1">8011824</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMJ. 1992 Feb 29;304(6826):555-6</RefSource>
<PMID Version="1">1559065</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Trop Med Hyg. 1991 Mar;44(3):323-8</RefSource>
<PMID Version="1">1903605</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Trop Med Hyg. 2008 Jan;78(1):114-6</RefSource>
<PMID Version="1">18187793</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2011;5(1):e938</RefSource>
<PMID Version="1">21245910</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Virol. 2012 Oct;55(2):101-6</RefSource>
<PMID Version="1">22776163</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Malar J. 2012;11:266</RefSource>
<PMID Version="1">22873569</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trans R Soc Trop Med Hyg. 2001 Jan-Feb;95(1):33-5</RefSource>
<PMID Version="1">11280060</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Trop. 2000 Oct 23;77(1):69-80</RefSource>
<PMID Version="1">10996122</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Malar J. 2008;7:195</RefSource>
<PMID Version="1">18826573</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Trop. 2015 Jan;141(Pt B):190-7</RefSource>
<PMID Version="1">25128703</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parasitology. 2014 Dec;141(14):1841-55</RefSource>
<PMID Version="1">24932595</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Parasitol. 2013 Oct;135(2):274-82</RefSource>
<PMID Version="1">23850995</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Microbiol. 2013 Jan;51(1):55-60</RefSource>
<PMID Version="1">23077127</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Trop Med Hyg. 2012 Nov;87(5):868-73</RefSource>
<PMID Version="1">23033399</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">NIHMS707195 [Available on 10/01/16]</OtherID>
<OtherID Source="NLM">PMC4592803 [Available on 10/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Circulating anodic antigen</Keyword>
<Keyword MajorTopicYN="N">Diagnostics</Keyword>
<Keyword MajorTopicYN="N">Dried blood spot</Keyword>
<Keyword MajorTopicYN="N">Schistosomiasis</Keyword>
<Keyword MajorTopicYN="N">Serum</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26169761</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Transmission of Enterobius vermicularis eggs through hands of school children in rural South Africa.</ArticleTitle>
<Pagination>
<MedlinePgn>94-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.07.001</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30049-8</ELocationID>
<Abstract>
<AbstractText>Enterobius vermicularis is a helminth that is difficult to control, is found globally, especially in crowded conditions, and can be transmitted from person to person by contaminated hands. A newly developed method for the quantification of helminth eggs on hands was tested among schoolchildren in a rural South African region to look at the role hands play in helminth infection, and to determine the risk factors for hand contamination. The study found 16.6% of participants' hands positive for helminth eggs, with E. vermicularis most commonly identified. Egg concentrations on hands ranged from 0 to 57 eggs/2 hands. Gender, toilet type used at home, and not reporting to wash hands with soap before eating were all associated with the presence of eggs on hands. The study highlights the need to improve sanitation facilities, and promote handwashing with soap in schools to prevent transmission of E. vermicularis.</AbstractText>
<CopyrightInformation>Crown Copyright © 2015. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cranston</LastName>
<ForeName>Imogen</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Environmental Health Group, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK. Electronic address: mollycranston@hotmail.co.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Potgieter</LastName>
<ForeName>Natasha</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology, University of Venda, Thohoyandou, Limpopo Province, 0950, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mathebula</LastName>
<ForeName>Sammy</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology, University of Venda, Thohoyandou, Limpopo Province, 0950, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ensink</LastName>
<ForeName>Jeroen H J</ForeName>
<Initials>JH</Initials>
<AffiliationInfo>
<Affiliation>Environmental Health Group, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Enterobius vermicularis</Keyword>
<Keyword MajorTopicYN="N">Hands</Keyword>
<Keyword MajorTopicYN="N">Hygiene</Keyword>
<Keyword MajorTopicYN="N">South Africa</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26184560</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Comparative proteomic analysis of surface proteins of Trichinella spiralis muscle larvae and intestinal infective larvae.</ArticleTitle>
<Pagination>
<MedlinePgn>79-86</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.07.002</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30050-4</ELocationID>
<Abstract>
<AbstractText>The critical step for Trichinella spiralis infection is that muscle larvae (ML) are activated to intestinal infective larvae (IIL) and invade intestinal epithelium to further develop. The IIL is its first invasive stage, surface proteins are directly exposed to host environment and are crucial for larval invasion and development. In this study, shotgun LC-MS/MS was used to analyze surface protein profiles of ML and IIL. Totally, 41 proteins common to both larvae, and 85 ML biased and 113 IIL biased proteins. Some proteins (e.g., putative scavenger receptor cysteine-rich domain protein and putative onchocystatin) were involved in host-parasite interactions. Gene ontology analysis revealed that proteins involved in generation of precursor metabolites and energy; and nucleobase, nucleoside, nucleotide and nucleic acid metabolic process were enriched in IIL at level 4. Some IIL biased proteins might play important role in larval invasion and development. qPCR results confirmed the high expression of some genes in IIL. Our study provides new insights into larval invasion, host-Trichinella interaction and for screening vaccine candidate antigens. </AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Ruo Dan</ForeName>
<Initials>RD</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, Medical College, Zhengzhou University, Zhengzhou 450052, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cui</LastName>
<ForeName>Jing</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, Medical College, Zhengzhou University, Zhengzhou 450052, China. Electronic address: cuij@zzu.edu.cn.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Xiao Lin</ForeName>
<Initials>XL</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, Medical College, Zhengzhou University, Zhengzhou 450052, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jiang</LastName>
<ForeName>Peng</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, Medical College, Zhengzhou University, Zhengzhou 450052, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sun</LastName>
<ForeName>Ge Ge</ForeName>
<Initials>GG</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, Medical College, Zhengzhou University, Zhengzhou 450052, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Xi</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, Medical College, Zhengzhou University, Zhengzhou 450052, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Long</LastName>
<ForeName>Shao Rong</ForeName>
<Initials>SR</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, Medical College, Zhengzhou University, Zhengzhou 450052, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Li</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, Medical College, Zhengzhou University, Zhengzhou 450052, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Zhong Quan</ForeName>
<Initials>ZQ</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, Medical College, Zhengzhou University, Zhengzhou 450052, China. Electronic address: wangzq@zzu.edu.cn.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Intestinal infective larvae</Keyword>
<Keyword MajorTopicYN="N">Muscle larvae</Keyword>
<Keyword MajorTopicYN="N">Surface proteins</Keyword>
<Keyword MajorTopicYN="N">Trichinella spiralis</Keyword>
<Keyword MajorTopicYN="N">proteome</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26187357</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Redescription of Spirura guianensis (Nematoda: Spiruridae) from a rare South American Gracile Opossum.</ArticleTitle>
<Pagination>
<MedlinePgn>87-93</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.07.003</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30051-6</ELocationID>
<Abstract>
<AbstractText>Spirura genus Blanchard, 1849 comprise of nematode parasites that infect primate and marsupial species. Although several taxonomical studies have shown that the infection by this species occurs primarily in the esophagus of primates, evidence for the occurrence of these parasites in other hosts (marsupials, rodents and bats) has become the subject of investigation by several groups. In this work, we describe the presence of Spirura guianensis Ortlepp, 1924 in the marsupial Gracilinanus agilis (Marsupialia: Didelphidae) found in the Pantanal of Mato Grosso do Sul state of Brazil. Structural characteristics of this nematode were identified using light microscopy (bright field and fluorescence stereomicroscopy) and scanning electron microscopy (SEM) approaches. Details of the surface topography such as cephalic projections, ventral boss, details of the caudal papillae and cuticular ornamentations were shown, providing taxonomic characteristics that may help in the establishment of diagnostic protocols. In addition, the presence of this species in a new host and new geographical area of Brazil provide grounds for a revision on the distribution of S. guianensis in South America.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Torres</LastName>
<ForeName>E J Lopes</ForeName>
<Initials>EJ</Initials>
<AffiliationInfo>
<Affiliation>Laboratório de Helmintologia Romero Lascasas Porto, Faculdade de Ciências Médicas, Departamento de Microbiologia, Imunologia e Parasitologia, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil; Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho e Instituto Nacional de Ciência e Tecnologia em Biologia Estrutural e Bioimagem, Universidade Federal do Rio de Janeiro, Brazil. Electronic address: ejtorres@biof.ufrj.br.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maldonado</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<Suffix>Jr</Suffix>
<AffiliationInfo>
<Affiliation>Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Laboratório de Biologia e Parasitologia de Mamíferos Silvestres Reservatórios, Rio de Janeiro, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Anjos</LastName>
<ForeName>D H da Silva</ForeName>
<Initials>DH</Initials>
<AffiliationInfo>
<Affiliation>Laboratório de Biologia de Helmintos Otto Wucherer, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Souza</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho e Instituto Nacional de Ciência e Tecnologia em Biologia Estrutural e Bioimagem, Universidade Federal do Rio de Janeiro, Brazil; Divisão de Biologia Estrutural, Diretoria de Metrologia Aplicada a Ciências da Vida, Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO), Xerém, Brazil; Laboratório de Biologia de Helmintos Otto Wucherer, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Miranda</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho e Instituto Nacional de Ciência e Tecnologia em Biologia Estrutural e Bioimagem, Universidade Federal do Rio de Janeiro, Brazil; Divisão de Biologia Estrutural, Diretoria de Metrologia Aplicada a Ciências da Vida, Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO), Xerém, Brazil. Electronic address: kmiranda@biof.ufrj.br.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">3D modeling</Keyword>
<Keyword MajorTopicYN="N">Esophageal nematode</Keyword>
<Keyword MajorTopicYN="N">Marsupial</Keyword>
<Keyword MajorTopicYN="N">Parasite–host adaptation</Keyword>
<Keyword MajorTopicYN="N">Taxonomy</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26193424</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>11</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Incidence of Trypanosoma cruzi infection in triatomines collected at Indio Mountains Research Station.</ArticleTitle>
<Pagination>
<MedlinePgn>97-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.07.004</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30054-1</ELocationID>
<Abstract>
<AbstractText>Chagas disease, caused by the parasite Trypanosoma cruzi, is an emerging infectious disease in the United States. In our study, 24 out of 39 triatomines, from the specie Triatoma rubida, were infected with T. cruzi. Additionally, only the genotype TcI was characterized among the parasite specimens. Improved knowledge of local epidemiology is needed to prevent transmission of Chagas disease.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Buhaya</LastName>
<ForeName>Munir H</ForeName>
<Initials>MH</Initials>
<AffiliationInfo>
<Affiliation>Department of Biological Sciences, The University of Texas at El Paso, 500 West University Drive, El Paso, TX 79968, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Galvan</LastName>
<ForeName>Steven</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Biological Sciences, The University of Texas at El Paso, 500 West University Drive, El Paso, TX 79968, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maldonado</LastName>
<ForeName>Rosa A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>Department of Biological Sciences, The University of Texas at El Paso, 500 West University Drive, El Paso, TX 79968, USA. Electronic address: ramaldonado@utep.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>5G12MD007592</GrantID>
<Acronym>MD</Acronym>
<Agency>NIMHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>G12 MD007592</GrantID>
<Acronym>MD</Acronym>
<Agency>NIMHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R25 GM069621</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R25GM069621-11</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>S06 GM008012</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biochem Parasitol. 1990 Sep-Oct;42(2):175-87</RefSource>
<PMID Version="1">2270100</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Trop Med Hyg. 1999 Mar;60(3):377-86</RefSource>
<PMID Version="1">10466963</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Med Assoc. 1955 Oct 15;159(7):676-7</RefSource>
<PMID Version="1">13263111</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>MMWR Morb Mortal Wkly Rep. 2007 Feb 23;56(7):141-3</RefSource>
<PMID Version="1">17318113</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Emerg Infect Dis. 2007 Apr;13(4):605-7</RefSource>
<PMID Version="1">17553277</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Emerg Infect Dis. 2008 Jul;14(7):1123-5</RefSource>
<PMID Version="1">18598637</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vector Borne Zoonotic Dis. 2009 Feb;9(1):41-50</RefSource>
<PMID Version="1">18800865</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Genet Evol. 2012 Mar;12(2):240-53</RefSource>
<PMID Version="1">22226704</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2012;6(7):e1777</RefSource>
<PMID Version="1">22860154</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Microbiol Rev. 2011 Oct;24(4):655-81</RefSource>
<PMID Version="1">21976603</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2000 Jan;181(1):395-9</RefSource>
<PMID Version="1">10608796</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Microbiol. 1989 Jul;27(7):1477-82</RefSource>
<PMID Version="1">2504769</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Emerg Infect Dis. 2010 Mar;16(3):400-5</RefSource>
<PMID Version="1">20202413</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">NIHMS711243 [Available on 10/01/16]</OtherID>
<OtherID Source="NLM">PMC4659426 [Available on 10/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Chagas disease</Keyword>
<Keyword MajorTopicYN="N">Indio Mountains Reseach Station</Keyword>
<Keyword MajorTopicYN="N">Triatoma rubida</Keyword>
<Keyword MajorTopicYN="N">Triatomine</Keyword>
<Keyword MajorTopicYN="N">Trypanosoma cruzi</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26200784</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Homologous prime-boost strategy with TgPI-1 improves the immune response and protects highly susceptible mice against chronic Toxoplasma gondii infection.</ArticleTitle>
<Pagination>
<MedlinePgn>159-65</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.07.013</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30060-7</ELocationID>
<Abstract>
<AbstractText>Subunit-based vaccines are safer than live or attenuated pathogen vaccines, although they are generally weak immunogens. Thus, proper combination of immunization strategies and adjuvants are needed to increase their efficacy. We have previously protected C3H/HeN mice from Toxoplasma gondii infection by immunization with the serine protease inhibitor-1 (TgPI-1) in combination with alum. In this work, we explore an original vaccination protocol that combines administration of recombinant TgPI-1 by intradermal and intranasal routes in order to enhance protection in the highly susceptible C57BL/6 strain. Mice primed intradermally with rTgPI-1 plus alum and boosted intranasally with rTgPI-1 plus CpG-ODN elicited a strong specific Th1/Th2 humoral response, along with a mucosal immune response characterized by specific-IgA in intestinal lavages. A positive cellular response of mesentheric lymph node cells and Th1/Th2 cytokine secretion in the ileon were also detected. When immunized mice were challenged with the cystogenic Me49 T. gondii strain, they displayed up to 62% reduction in brain parasite burden. Moreover, adoptive transfer of mesenteric lymph node cells from vaccinated to naïve mice induced significant protection against infection. These results demonstrate that this strategy that combines the administration of TgPI-1 by two different routes, intradermal priming and intranasal boost, improves protective immunity against T. gondii chronic infection in highly susceptible mice.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sánchez</LastName>
<ForeName>Vanesa R</ForeName>
<Initials>VR</Initials>
<AffiliationInfo>
<Affiliation>Laboratorio de Inmunología, Vacunas y Alergia, Centro de Salud y Medio Ambiente (CESyMA), Escuela de Ciencia y Tecnología (ECyT), Universidad Nacional de San Martín, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fenoy</LastName>
<ForeName>Ignacio M</ForeName>
<Initials>IM</Initials>
<AffiliationInfo>
<Affiliation>Laboratorio de Inmunología, Vacunas y Alergia, Centro de Salud y Medio Ambiente (CESyMA), Escuela de Ciencia y Tecnología (ECyT), Universidad Nacional de San Martín, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Picchio</LastName>
<ForeName>Mariano S</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>Laboratorio de Inmunología, Vacunas y Alergia, Centro de Salud y Medio Ambiente (CESyMA), Escuela de Ciencia y Tecnología (ECyT), Universidad Nacional de San Martín, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Soto</LastName>
<ForeName>Ariadna S</ForeName>
<Initials>AS</Initials>
<AffiliationInfo>
<Affiliation>Laboratorio de Inmunología, Vacunas y Alergia, Centro de Salud y Medio Ambiente (CESyMA), Escuela de Ciencia y Tecnología (ECyT), Universidad Nacional de San Martín, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arcon</LastName>
<ForeName>Nadia</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Laboratorio de Inmunología, Vacunas y Alergia, Centro de Salud y Medio Ambiente (CESyMA), Escuela de Ciencia y Tecnología (ECyT), Universidad Nacional de San Martín, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Goldman</LastName>
<ForeName>Alejandra</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Laboratorio de Inmunología, Vacunas y Alergia, Centro de Salud y Medio Ambiente (CESyMA), Escuela de Ciencia y Tecnología (ECyT), Universidad Nacional de San Martín, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Martin</LastName>
<ForeName>Valentina</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Laboratorio de Inmunología, Vacunas y Alergia, Centro de Salud y Medio Ambiente (CESyMA), Escuela de Ciencia y Tecnología (ECyT), Universidad Nacional de San Martín, Argentina. Electronic address: vmartin@unsam.edu.ar.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Mucosal immunity</Keyword>
<Keyword MajorTopicYN="N">Prime-boost strategy</Keyword>
<Keyword MajorTopicYN="N">Serin protease inhibitor-1</Keyword>
<Keyword MajorTopicYN="N">Subunit vaccine</Keyword>
<Keyword MajorTopicYN="N">Toxoplasma gondii</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26200786</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Dermatophytosis in patients with human immunodeficiency virus infection: clinical aspects and etiologic agents.</ArticleTitle>
<Pagination>
<MedlinePgn>111-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.07.012</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30061-9</ELocationID>
<Abstract>
<AbstractText>Dermatophytosis in individuals with human immunodeficiency virus infection seems to manifest with atypical, multiple, or extensive lesions more frequently. In addition, there are reports of presentations with little inflammation, called anergics. Less common etiologic agents have been isolated in these individuals, such as Microsporum species. To describe clinical aspects and etiologic agents of dermatophytosis in individuals with human immunodeficiency virus (HIV) infection. Patients with clinical diagnosis of dermatophytosis underwent scarification for mycological diagnosis through direct microscopic examination and fungal isolation in culture on Sabouraud dextrose agar. Sixty individuals had a clinical hypothesis of dermatophytosis. In 20 (33.3%) of the 60 patients, dermatophytosis was confirmed through a mycological study. Tinea corporis, diagnosed in 14 patients, was the most frequent clinical form, followed by tinea unguium in 7, tinea cruris in 5, and tinea pedis in 1 patient. Most of the lesions of tinea corporis were anergic. Five patients with tinea unguium had involvement of multiple nails, with onychodystrophy as the predominant subtype. Multiple cutaneous lesions occurred in 3 patients and extensive cutaneous lesions in 4. Regarding the agent, Trichophyton rubrum was the most commonly isolated. The high occurrence of anergic skin lesions and involvement of multiple nails, especially as onychodystrophy, corroborates the hypothesis that atypical, disseminated, and more severe presentations are common in individuals with HIV infection. However, no Microsporum species was isolated even in atypical, extensive, or disseminated cases, in disagreement with previous reports. Therefore, the approach of squamous lesions in HIV-positive patients must include a mycological study, in view of the possibility of anergic dermatophytosis, to promote the introduction of a suitable therapeutic agent.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Costa</LastName>
<ForeName>J E F</ForeName>
<Initials>JE</Initials>
<AffiliationInfo>
<Affiliation>Department of Tropical Medicine, Center for Health Sciences, Federal University of Pernambuco, Brazil. Electronic address: joanne_ferraz@yahoo.com.br.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Neves</LastName>
<ForeName>R P</ForeName>
<Initials>RP</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Medical Mycology, Department of Mycology, Centre of Biological Sciences, Federal University of Pernambuco, Brazil. Electronic address: rejadel@yahoo.com.br.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Delgado</LastName>
<ForeName>M M</ForeName>
<Initials>MM</Initials>
<AffiliationInfo>
<Affiliation>Correia Picanço Hospital, Brazil. Electronic address: mariliaderma@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lima-Neto</LastName>
<ForeName>R G</ForeName>
<Initials>RG</Initials>
<AffiliationInfo>
<Affiliation>Department of Tropical Medicine, Center for Health Sciences, Federal University of Pernambuco, Brazil. Electronic address: goncalves_reginaldo@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Morais</LastName>
<ForeName>V M S</ForeName>
<Initials>VM</Initials>
<AffiliationInfo>
<Affiliation>Department of Tropical Medicine, Center for Health Sciences, Federal University of Pernambuco, Brazil; Virology Division, Laboratory of Immunopathology Keizo Asami, Federal University of Pernambuco, Brazil. Electronic address: vivi.martha@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Coêlho</LastName>
<ForeName>M R C D</ForeName>
<Initials>MR</Initials>
<AffiliationInfo>
<Affiliation>Division of Virology, Laboratory of Immunopathology Keizo Asami (LIKA), Department of Physiology and Pharmacology, Center of Biological Sciences, Federal University of Pernambuco, Brazil. Electronic address: rcoelholika@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">AIDS</Keyword>
<Keyword MajorTopicYN="N">Dermatophytosis</Keyword>
<Keyword MajorTopicYN="N">HIV</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26200789</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Evaluating the sterilizing effect of pyriproxyfen treated mosquito nets against Anopheles gambiae at different blood-feeding intervals.</ArticleTitle>
<Pagination>
<MedlinePgn>131-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.07.011</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30062-0</ELocationID>
<Abstract>
<AbstractText>Pyrethroid resistant malaria vectors are widespread throughout sub-Saharan Africa and new insecticides with different modes of action are urgently needed. Pyriproxyfen is a juvenile hormone mimic that reduces fecundity and fertility of adult Anopheles mosquitoes when used as a contact insecticide. A long-lasting insecticidal net incorporating pyriproxyfen is under development. As wild, host-seeking females may succeed in blood-feeding at different intervals after initial contact with mosquito nets the aim of this study was to determine the effect that age and gonotrophic status (nulliparous or parous) and the interval between initial pyriproxyfen exposure and blood-feeding has in terms of subsequent reduced fecundity and fertility. Anopheles gambiae s.s. were exposed to pyriproxyfen LLIN for three minutes in WHO cone bioassays. Four regimens were tested with different blood-feeding intervals A-1 hour (nulliparous), B-1 hour (parous), C-24h (nulliparous), or D-120h (nulliparous) after pyriproxyfen exposure. Mosquito oviposition rate, fecundity and fertility of eggs were recorded for several days. All four treatment regimens produced levels of mortality similar to unexposed females. The overall reduction in reproductive rate of 99.9% for regimen A relative to the untreated net was primarily due to oviposition inhibition in exposed females (97%). Pyriproxyfen was equally effective against older parous mosquitoes and when blood-feeding was 24h after exposure. Regimen D produced a reduction in reproductive rate of 60.1% but this was of lesser magnitude than other regimens and was the only regimen that failed to reduce fertility of laid eggs, indicating the effects of pyriproxyfen exposure on reproduction are to some extent reversible as mosquitoes age. In an area of moderate to high mosquito net coverage a host-seeking mosquito is likely to contact a treated mosquito net before: (a) penetrating a holed net and blood-feeding shortly after exposure or, (b) be frustrated by intact nets before succeeding in blood-feeding on an unprotected individual the following night. Mosquito nets are an appropriate delivery system for pyriproxyfen, based on the large reductions in reproductive rate when blood-feeding between 1h and 24h after exposure. Combining with a pyrethroid should be an effective approach if susceptible mosquitoes are killed and resistant mosquitoes sterilized.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jaffer</LastName>
<ForeName>Aneesa</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK. Electronic address: aneesajaffer@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Protopopoff</LastName>
<ForeName>Natacha</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK; Department of Entomology and Parasitology, Kilimanjaro Christian Medical University College, Moshi, Kilimanjaro, Tanzania; Pan-African Malaria Vector Research Consortium, (PAMVERC), Moshi, Tanzania. Electronic address: nprotopopoff@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mosha</LastName>
<ForeName>Franklin W</ForeName>
<Initials>FW</Initials>
<AffiliationInfo>
<Affiliation>Department of Entomology and Parasitology, Kilimanjaro Christian Medical University College, Moshi, Kilimanjaro, Tanzania; Pan-African Malaria Vector Research Consortium, (PAMVERC), Moshi, Tanzania. Electronic address: fwmosha@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Malone</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Innovative Vector Control Consortium (IVCC), Liverpool School of Tropical Medicine, Liverpool, UK. Electronic address: david.malone@ivcc.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rowland</LastName>
<ForeName>Mark W</ForeName>
<Initials>MW</Initials>
<AffiliationInfo>
<Affiliation>Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK; Pan-African Malaria Vector Research Consortium, (PAMVERC), Moshi, Tanzania. Electronic address: mark.rowland@lshtm.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Oxborough</LastName>
<ForeName>Richard M</ForeName>
<Initials>RM</Initials>
<AffiliationInfo>
<Affiliation>Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK; Department of Entomology and Parasitology, Kilimanjaro Christian Medical University College, Moshi, Kilimanjaro, Tanzania; Pan-African Malaria Vector Research Consortium, (PAMVERC), Moshi, Tanzania. Electronic address: oxandbull@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Fecundity</Keyword>
<Keyword MajorTopicYN="N">Fertility</Keyword>
<Keyword MajorTopicYN="N">Juvenile hormone mimic</Keyword>
<Keyword MajorTopicYN="N">LLIN</Keyword>
<Keyword MajorTopicYN="N">Oviposition</Keyword>
<Keyword MajorTopicYN="N">Pyriproxyfen</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26209103</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Early biting of the Anopheles gambiae s.s. and its challenges to vector control using insecticide treated nets in western Kenya highlands.</ArticleTitle>
<Pagination>
<MedlinePgn>136-42</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.07.008</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30057-7</ELocationID>
<Abstract>
<AbstractText>Long term use of insecticides in malaria vector control has been shown to alter the behavior of vectors. Such behavioral shifts have the potential of undermining the effectiveness of insecticide-based control interventions. The effects of insecticide treated nets (ITNs) use on the composition, biting/feeding and sporozoite rates of Anopheles gambiae s.l. mosquitoes in Musilongo village, Vihiga County of western Kenya highlands were investigated. Adult mosquitoes were collected in selected sleeping spaces inside six randomly selected houses using miniature Centre for Disease Control and Prevention (CDC) light traps. Mosquito sampling in each house was conducted twice every week for 16 consecutive months (May 2010-August 2012). At each sampling a single trap was set in the selected space inside each house such that it collected mosquitoes alternatively from 18:00 to 21:00h and 21:00 to 06:00h every week. All collected mosquitoes were morphologically identified. Female Anopheles mosquitoes were classified according to their physiological status as unfed, fed, partially gravid and gravid, sorted and counted. Members of the A. gambiae complex were identified using a Polymerase chain reaction (PCR) method. Enzyme-linked-immunosorbent assay (ELISA) was used to determine blood meal sources and Plasmodium infection rates in A. gambiae s.l. mosquitoes. Blood meal tests were conducted on DNA extracted from gut contents of blood fed A. gambiae s.l. The head and thorax section of dried samples of A. gambiae s.l. were used in testing for the presence of Plasmodium falciparum (Pf) sporozoites. Overall, 735 adult female Anopheles comprising 708 [96.3%] A. gambiae s.l. and 27 [3.7%] Anopheles funestus mosquitoes were collected. A. gambiae s.l. population collected comprised, 615 [86.9%] unfed and 38 [5.4%] fed adult mosquitoes. The rest were either partially or fully gravid. The proportion of A. gambiae s.l. biting indoors within 18:00-21:00h was 15.8% (103/653) at a rate of 3.2bites per person per hour compared to 84.2% biting from 21:00-06:00h at a rate of 3.8 bites/per/h. An estimated 97.7% A. gambiae ss and 2.3% A. arabiensis constituted the indoor biting A. gambiae s.l. The population of An. gambiae s.l. biting from 18:00 to 21:00h had a Plasmodium faciparum (pf) sporozoite rate of 3.8% compared to 3.5% observed in populations biting within 21:00-06:00h. Human blood constituted 89% of An. gambiae s.l. blood meal sources. The risk of malaria transmission from 21:00 to 06:00h was approximately 5 fold the risk within 18:00-21:00h. Majority of the infective female A. gambiae s.l. adults were biting deep into the night than in the early hours of the night. Humans remain the preferred source of blood meal for A. gambiae s.s. the dominant malaria vector in the highlands. ITNs remain a fundamental control intervention against malaria transmission since female blood seekers were more during bed time than pre-bed time. Advocacy on enhanced net availability, integrity and usage in Kenyan highlands can reduce Pf transmission. Additional complementary interventions are required to control the biting and parasite transmission encountered before bed-time.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wamae</LastName>
<ForeName>P M</ForeName>
<Initials>PM</Initials>
<AffiliationInfo>
<Affiliation>Climate and Human Health Research Unit, Centre for Global Health Research, Kenya Medical Research Institute (KEMRI), P.O Box 1578-40100, Kisumu, Kenya. Electronic address: wamaepm@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Githeko</LastName>
<ForeName>A K</ForeName>
<Initials>AK</Initials>
<AffiliationInfo>
<Affiliation>Climate and Human Health Research Unit, Centre for Global Health Research, Kenya Medical Research Institute (KEMRI), P.O Box 1578-40100, Kisumu, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Otieno</LastName>
<ForeName>G O</ForeName>
<Initials>GO</Initials>
<AffiliationInfo>
<Affiliation>Climate and Human Health Research Unit, Centre for Global Health Research, Kenya Medical Research Institute (KEMRI), P.O Box 1578-40100, Kisumu, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kabiru</LastName>
<ForeName>E W</ForeName>
<Initials>EW</Initials>
<AffiliationInfo>
<Affiliation>Department of Community Health, School of Public Health Kenyatta University, P.O Box 43844-00100, Nairobi, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Duombia</LastName>
<ForeName>S O</ForeName>
<Initials>SO</Initials>
<AffiliationInfo>
<Affiliation>Malaria Research and Training Centre, Faculty of Medicine University of Mali Bamako P.O Box 1805, Bamako, Mali.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Anopheles gambiae</Keyword>
<Keyword MajorTopicYN="N">ITN</Keyword>
<Keyword MajorTopicYN="N">Mosquito biting time</Keyword>
<Keyword MajorTopicYN="N">Sporozoites</Keyword>
<Keyword MajorTopicYN="N">Vector control</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26209104</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>A new species of Simulium (Chirostilbia) (Diptera: Simuliidae) from Mantiqueira mountain range, southeastern Brazil.</ArticleTitle>
<Pagination>
<MedlinePgn>143-58</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.07.006</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30055-3</ELocationID>
<Abstract>
<AbstractText>Simulium (Chirostilbia) vitribasi n. sp. from the Mantiqueira mountain range, in São Paulo and Minas Gerais states, southeastern Brazil, is described and illustrated based on male, female, pupal and larval morphologies. The pupae of the new species is similar to the one of Simulium pertinax Kollar, one of the most voracious black fly species in the South and Southeast regions of Brazil and a target of control programs in these regions. But the pupa of the new species has a large basal fenestra in the gills that distinguishes it from all other S. (Chirostilibia) species. The other life stages of the new species also have morphological characters that distinguish it from the other species in the subgenus: male has scutum black, with patches of thick, golden hairs; female has scutum similar to that of the male, without banding or other markers, abdominal tergites I and II whitish and sternite VIII dark, heavily sclerotized; anal lobe almost as wide as long, with thin, long hairs on its outer margin; larva body cuticle has wide scale-like setae, with lobulated distal margins. Females were not observed biting humans during the fieldwork.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hamada</LastName>
<ForeName>Neusa</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Biodiversidade, Instituto Nacional de Pesquisas da Amazônia, 69067-375 Manaus, AM, Brazil. Electronic address: nhamada@inpa.gov.br.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nascimento</LastName>
<ForeName>Jeane Marcelle Cavalcante</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Biodiversidade, Instituto Nacional de Pesquisas da Amazônia, 69067-375 Manaus, AM, Brazil. Electronic address: jeanemarcelle@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pepinelli</LastName>
<ForeName>Mateus</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Ecology and Evolutionary Biology, University of Toronto, Canada. Electronic address: mateuspepi@yahoo.com.br.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Aquatic insects</Keyword>
<Keyword MajorTopicYN="N">Atlantic Forest</Keyword>
<Keyword MajorTopicYN="N">Black fly</Keyword>
<Keyword MajorTopicYN="N">Paraná River drainage</Keyword>
<Keyword MajorTopicYN="N">Taxonomy</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26209105</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Epidemiological characteristics of a new focus of cutaneous leishmaniasis caused by Leishmania tropica in Settat, Morocco.</ArticleTitle>
<Pagination>
<MedlinePgn>116-21</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.07.020</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30068-1</ELocationID>
<Abstract>
<AbstractText>A new emerging focus of human cutaneous leishmaniasis (HCL) caused by Leishmania tropica was identified within the province of Settat. This study was performed in order to analyze the reasons of the extension of CL in this area, and to describe the clinico-epidemiological characteristic of this emerging focus during 2007-2012. A total of 553 suspected cases of CL were diagnosed in laboratory of Settat, controlled and confirmed in reference national laboratory of leishmaniasis in Rabat. Leishmania parasite is found in 356 cases. Most of them (33.89%) were recorded in localities of Ouled Ghalem (110 cases) and Laamarcha (102 cases) of El Borouj sector. The lesions were typically small, dry and mostly located on the face and extremities. Majority of infection (25%) was recorded among children under 11 years old, and female (72%). Strains of L. tropica were identified by PCR ITS1 from positive slides and zymodeme MON-102 was typed using isoenzyme technique on starch gel electrophoresis.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Fatima</LastName>
<ForeName>Amarir</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>National Reference Laboratory of Leishmaniasis, National Institute of Hygiene, Rabat, Morocco. Electronic address: Fatima.inhr@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Faiza</LastName>
<ForeName>Sebti</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>National Reference Laboratory of Leishmaniasis, National Institute of Hygiene, Rabat, Morocco.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hajiba</LastName>
<ForeName>Fellah</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>National Reference Laboratory of Leishmaniasis, National Institute of Hygiene, Rabat, Morocco.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Francine</LastName>
<ForeName>Pratlong</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Université Montpellier 1 (UFR Médecine), Centre National de référence des leishmanioses, UMR "MIVEGEC" (CNRS 5290, IRD 224, UM1, UM2), Département de Parasitologie-Mycologie (Professeur Patrick Bastien), CHRU de Montpellier, 39, Avenue Charles Flahault, 34295 Montpellier Cedex 5, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dedet</LastName>
<ForeName>Jean-Pierre</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>Université Montpellier 1 (UFR Médecine), Centre National de référence des leishmanioses, UMR "MIVEGEC" (CNRS 5290, IRD 224, UM1, UM2), Département de Parasitologie-Mycologie (Professeur Patrick Bastien), CHRU de Montpellier, 39, Avenue Charles Flahault, 34295 Montpellier Cedex 5, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bouchra</LastName>
<ForeName>El Mansouri</ForeName>
<Initials>el M</Initials>
<AffiliationInfo>
<Affiliation>National Reference Laboratory of Leishmaniasis, National Institute of Hygiene, Rabat, Morocco.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Asmae</LastName>
<ForeName>Hmamouch</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>FST, University of Sidi Med Ben Abdellah, Fés, Morocco.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bouchra</LastName>
<ForeName>Delouane</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>National Reference Laboratory of Leishmaniasis, National Institute of Hygiene, Rabat, Morocco.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Khalid</LastName>
<ForeName>Habbari</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>FST, University of sultan Moulay Slimane, Beni Mellal, Morocco.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abderrahim</LastName>
<ForeName>Sadak</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Faculty of Science, Rabat Agdal, Morocco.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ibrahim</LastName>
<ForeName>Abassi</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, University El Quds, Palestine.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mohamed</LastName>
<ForeName>Rhajaoui</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>National Reference Laboratory of Leishmaniasis, National Institute of Hygiene, Rabat, Morocco.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cutaneous leishmaniasis</Keyword>
<Keyword MajorTopicYN="N">Leishmania tropica MON 102</Keyword>
<Keyword MajorTopicYN="N">Morocco</Keyword>
<Keyword MajorTopicYN="N">Settat</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26209106</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Multiple dengue virus types harbored by individual mosquitoes.</ArticleTitle>
<Pagination>
<MedlinePgn>107-10</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.07.007</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30056-5</ELocationID>
<Abstract>
<AbstractText>The existing knowledge on pathogenesis and aetiology of DHF establishes that Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS) are caused by two subsequent infections of two different serotypes of dengue affecting a common human population with a time gap. Present studies have been undertaken on 212 laboratory reared infected individual mosquitoes from larvae collected from 31 dengue endemic towns of Rajasthan, India. Type specific DEN viruses were detected from individual mosquitoes employing RT-PCR. In 78.7% of 212 infected individual mosquitoes studied, vertically transmitted multiple DENV types were observed. We report for the first time that single mosquitoes contain multiple dengue virus types.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Angel</LastName>
<ForeName>Bennet</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Virology &amp; Molecular Biology, Desert Medicine Research Centre, Indian Council of Medical Research, Jodhpur, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Angel</LastName>
<ForeName>Annette</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Virology &amp; Molecular Biology, Desert Medicine Research Centre, Indian Council of Medical Research, Jodhpur, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Joshi</LastName>
<ForeName>Vinod</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Virology &amp; Molecular Biology, Desert Medicine Research Centre, Indian Council of Medical Research, Jodhpur, India. Electronic address: vinodjoshidmrc@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">DHF</Keyword>
<Keyword MajorTopicYN="N">Etiology</Keyword>
<Keyword MajorTopicYN="N">Multiple dengue types</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26209107</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>First detection of Leishmania spp. DNA in Brazilian bats captured strictly in urban areas.</ArticleTitle>
<Pagination>
<MedlinePgn>176-81</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.07.010</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30059-0</ELocationID>
<Abstract>
<AbstractText>Leishmania spp. is a protozoan that maintains its life cycle in domestic and wild animals and it may include bats, a population that has increased in urban environments. This study aimed to investigate the presence of Leishmania spp. in bats captured strictly in urban areas that are endemic for visceral leishmaniasis. The spleen and skin samples of 488 bats from 21 endemic cities in northwestern São Paulo State, Brazil, were tested for the presence of Leishmania kDNA using real-time PCR. Differentiation from Trypanosoma spp. was achieved by amplifying a DNA fragment of the ribosomal RNA gene. The presence of Leishmania spp. kDNA was verified in 23.9% of bats and Trypanosoma spp. DNA was identified in 3.9%. Leishmania species differentiation revealed the presence of Leishmania amazonensis in 78.3% of the bats; L. infantum in 17.4%, and 1 sample (4.3%) showed a mix pattern of L. infantum and L. amazonensis. We also detected, for the first time, L. infantum and L. amazonensis DNA in Desmodus rotundus, the hematophagous bat. The presence of Leishmania spp. DNA in bats strictly from urban areas endemic for visceral leishmaniasis in the State of São Paulo, Brazil indicates that these wild and abundant animals are capable of harboring Leishmania spp. in this new scenario. Due to their longevity, high dispersion capacity and adaptability to synanthropic environments, they may play a role in the maintenance of the life cycle of Leishmania parasites.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>de Oliveira</LastName>
<ForeName>Fernanda Müller</ForeName>
<Initials>FM</Initials>
<AffiliationInfo>
<Affiliation>UNESP, Univ Estadual Paulista, Faculty of Veterinary Medicine, Rua Clóvis Pestana, 793, Jd. D. Amélia, Araçatuba, São Paulo CEP 16050-680, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Costa</LastName>
<ForeName>Luis Henrique Camargo</ForeName>
<Initials>LH</Initials>
<AffiliationInfo>
<Affiliation>UNESP, Univ Estadual Paulista, Faculty of Veterinary Medicine, Rua Clóvis Pestana, 793, Jd. D. Amélia, Araçatuba, São Paulo CEP 16050-680, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Barros</LastName>
<ForeName>Thainá Landim</ForeName>
<Initials>TL</Initials>
<AffiliationInfo>
<Affiliation>UNESP, Univ Estadual Paulista, Faculty of Veterinary Medicine, Rua Clóvis Pestana, 793, Jd. D. Amélia, Araçatuba, São Paulo CEP 16050-680, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ito</LastName>
<ForeName>Pier Kenji Rauschkolb Katsuda</ForeName>
<Initials>PK</Initials>
<AffiliationInfo>
<Affiliation>UNESP, Univ Estadual Paulista, Faculty of Veterinary Medicine, Rua Clóvis Pestana, 793, Jd. D. Amélia, Araçatuba, São Paulo CEP 16050-680, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Colombo</LastName>
<ForeName>Fábio Antonio</ForeName>
<Initials>FA</Initials>
<AffiliationInfo>
<Affiliation>UNIFAL, University Federal of Alfenas, Rua Gabriel Monteiro da Silva,700, Centro, Alfenas, Minas Gerais CEP 37130-000, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Carvalho</LastName>
<ForeName>Cristiano</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>UNESP, Univ Estadual Paulista, Faculty of Veterinary Medicine, Rua Clóvis Pestana, 793, Jd. D. Amélia, Araçatuba, São Paulo CEP 16050-680, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pedro</LastName>
<ForeName>Wagner André</ForeName>
<Initials>WA</Initials>
<AffiliationInfo>
<Affiliation>UNESP, Univ Estadual Paulista, Faculty of Veterinary Medicine, Rua Clóvis Pestana, 793, Jd. D. Amélia, Araçatuba, São Paulo CEP 16050-680, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Queiroz</LastName>
<ForeName>Luzia Helena</ForeName>
<Initials>LH</Initials>
<AffiliationInfo>
<Affiliation>UNESP, Univ Estadual Paulista, Faculty of Veterinary Medicine, Rua Clóvis Pestana, 793, Jd. D. Amélia, Araçatuba, São Paulo CEP 16050-680, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nunes</LastName>
<ForeName>Cáris Maroni</ForeName>
<Initials>CM</Initials>
<AffiliationInfo>
<Affiliation>UNESP, Univ Estadual Paulista, Faculty of Veterinary Medicine, Rua Clóvis Pestana, 793, Jd. D. Amélia, Araçatuba, São Paulo CEP 16050-680, Brazil. Electronic address: caris@fmva.unesp.br.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bats</Keyword>
<Keyword MajorTopicYN="N">Leishmaniasis</Keyword>
<Keyword MajorTopicYN="N">Reservoir</Keyword>
<Keyword MajorTopicYN="N">Trypanosoma</Keyword>
<Keyword MajorTopicYN="N">qPCR</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26215128</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Effectiveness of hyperbaric oxygen for experimental treatment of schistosomiasis mansoni using praziquantel-free and encapsulated into liposomes: assay in adult worms and oviposition.</ArticleTitle>
<Pagination>
<MedlinePgn>182-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.07.022</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30070-X</ELocationID>
<Abstract>
<AbstractText>The treatment of schistosomiasis depends on a single drug: praziquantel (PZQ). However, this treatment presents limitations such as low and/or erratic bioavailability that can contribute to cases of tolerance. Improvements to the available drug are urgently needed and studies with a controlled system of drug release, like liposomes, have been gaining prominence. The present study evaluated the activity and synergy between liposomal-praziquantel (lip.PZQ) and hyperbaric oxygen therapy (HBO). Mice received doses of 60 or 100mg/kg PZQ or lip.PZQ, 50 days post-infection, and after the treatment, were exposed to HBO (3 atmosphere absolute - ATA) for 1h. The viability of adult worms and oviposition were analyzed, by necropsy and Kato-Katz examination performed after 15 days of treatment. A concentration of 100mg/kg of lip.PZQ+HBO was more effective (48.0% reduction of worms, 83.3% reduction of eggs/gram of feces) and 100% of the mice had altered of oograms (indicating interruption of oviposition) compared to other treatments and to the Control group (infected and untreated). It is known that PZQ requires participation of the host immune system to complete its antischistosomal activity and that HBO is able to stimulate the immune system. The drug became more available in the body when incorporated into liposomes and, used with HBO, the HBO worked as an adjuvant. This explains the decreases of oviposition and worms recovered form hepatic portal system.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Frezza</LastName>
<ForeName>Tarsila Ferraz</ForeName>
<Initials>TF</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Biologia Animal, Laboratório de Helmintologia, Instituto de Biologia, UNICAMP, Campinas, SP, Brazil; Instituto Federal de Educação Ciência e Tecnologia de São Paulo, Licenciatura em Ciências Biológicas, IFSP, Avaré, SP, Brazil. Electronic address: taferraz@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Souza</LastName>
<ForeName>Ana Luiza Ribeiro</ForeName>
<Initials>AL</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Fármacos e Medicamentos, Faculdade de Ciências Farmacêuticas, UNESP, Araraquara, SP, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Prado</LastName>
<ForeName>César Corat Ribeiro</ForeName>
<Initials>CC</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Biologia Animal, Laboratório de Helmintologia, Instituto de Biologia, UNICAMP, Campinas, SP, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Oliveira</LastName>
<ForeName>Claudineide Nascimento Fernandes</ForeName>
<Initials>CN</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Biologia Animal, Laboratório de Helmintologia, Instituto de Biologia, UNICAMP, Campinas, SP, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gremião</LastName>
<ForeName>Maria Palmira Daflon</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Fármacos e Medicamentos, Faculdade de Ciências Farmacêuticas, UNESP, Araraquara, SP, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Giorgio</LastName>
<ForeName>Selma</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Biologia Animal, Laboratório de Helmintologia, Instituto de Biologia, UNICAMP, Campinas, SP, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dolder</LastName>
<ForeName>Mary Anne Heidi</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Biologia Estrutural e Funcional, Instituto de Biologia, UNICAMP, Campinas, SP, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Joazeiro</LastName>
<ForeName>Paulo Pinto</ForeName>
<Initials>PP</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Bioquímica e Biologia Tecidual, Instituto de Biologia, UNICAMP, Campinas, SP, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Allegretti</LastName>
<ForeName>Silmara Marques</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Biologia Animal, Laboratório de Helmintologia, Instituto de Biologia, UNICAMP, Campinas, SP, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Hiperbaric-oxigen</Keyword>
<Keyword MajorTopicYN="N">In vivo assay</Keyword>
<Keyword MajorTopicYN="N">Liposomal-praziquantel</Keyword>
<Keyword MajorTopicYN="N">Praziquantel</Keyword>
<Keyword MajorTopicYN="N">Schistosoma mansoni</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26215129</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>DDT and pyrethroid resistance status and laboratory evaluation of bio-efficacy of long lasting insecticide treated nets against Culex quinquefasciatus and Culex decens in Ghana.</ArticleTitle>
<Pagination>
<MedlinePgn>122-30</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.07.009</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30058-9</ELocationID>
<Abstract>
<AbstractText>Nuisance from Culex mosquitoes in Ghana has a serious negative impact on the standard of living in many urban communities. In addition, a perceived lack of efficacy of long lasting insecticide treated nets (LLINs) against nuisance mosquitoes contributes to their discontinued use. This again compromises malaria control, even if Anopheles species themselves would still be susceptible to the insecticides used. Control strategies involve pyrethroid insecticides but information on Culex mosquito susceptibility to these insecticides is limited. A nationwide survey was conducted to address this problem. In adults, susceptibility to permethrin, deltamethrin and DDT as well as enzyme activity and kdr mutation were determined. Cone and tunnel bioassay were also carried out to determine the efficacy of LLINs against the mosquitoes. Culex quinquefasciatus and Culex decens were identified in the study area. Higher deltamethrin and DDT resistance and relatively low permethrin resistance were observed in both species. High enzyme activities and kdr mutations were observed in C. quinquefasciatus but not in C. decens. However, reduced efficacy of LLINs was observed in both mosquito species. This adds up to the evidence of the spread of pyrethroid resistance in mosquitoes and its negative impact on control strategies.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kudom</LastName>
<ForeName>Andreas A</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>Center for International Health, Department of Infectious Diseases and Tropical Medicine, Ludwig-Maximilians-Universität Munich, Germany; Department of Entomology and Wildlife, School of Biological Sciences, University of Cape Coast, Ghana. Electronic address: akudom@ucc.edu.gh.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mensah</LastName>
<ForeName>Ben A</ForeName>
<Initials>BA</Initials>
<AffiliationInfo>
<Affiliation>Department of Entomology and Wildlife, School of Biological Sciences, University of Cape Coast, Ghana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Froeschl</LastName>
<ForeName>Guenter</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Center for International Health, Department of Infectious Diseases and Tropical Medicine, Ludwig-Maximilians-Universität Munich, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rinder</LastName>
<ForeName>Heinz</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Center for International Health, Department of Infectious Diseases and Tropical Medicine, Ludwig-Maximilians-Universität Munich, Germany; Bavarian Health and Food Safety Authority (LGL), Oberschleissheim, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Boakye</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Noguchi Memorial Institute for Medical Research, University of Ghana, Ghana.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Culex</Keyword>
<Keyword MajorTopicYN="N">Malaria</Keyword>
<Keyword MajorTopicYN="N">Pyrethroid</Keyword>
<Keyword MajorTopicYN="N">Resistance</Keyword>
<Keyword MajorTopicYN="N">Urban</Keyword>
<Keyword MajorTopicYN="N">kdr mutation</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26215130</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Real-time PCR for detection of Strongyloides stercoralis in human stool samples from Côte d'Ivoire: diagnostic accuracy, inter-laboratory comparison and patterns of hookworm co-infection.</ArticleTitle>
<Pagination>
<MedlinePgn>210-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.07.019</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30067-X</ELocationID>
<Abstract>
<AbstractText>Human infections with the helminth species Strongyloides stercoralis encompass a wide clinical spectrum, ranging from asymptomatic carriage to life-threatening disease. The diagnosis of S. stercoralis is cumbersome and the sensitivity of conventional stool microscopy is low. New molecular tools have been developed to increase sensitivity. We compared the diagnostic accuracy of real-time PCR with microscopy for the detection of S. stercoralis and hookworm in human stool samples, and investigated the inter-laboratory agreement of S. stercoralis-specific real-time PCR in two European laboratories. Stool specimens from 256 randomly selected individuals in rural Côte d'Ivoire were examined using three microscopic techniques (i.e. Kato-Katz, Koga agar plate (KAP) and Baermann (BM)). Additionally, ethanol-fixed stool aliquots were subjected to molecular diagnosis. The prevalence of S. stercoralis and hookworm infection was 21.9% and 52.0%, respectively, whilst co-infections were detected in 35 (13.7%) participants. The diagnostic agreement between real-time PCR and microscopy was excellent when both KAP and BM tested positive for S. stercoralis, but was considerably lower when only one microscopic technique was positive. The sensitivity of KAP, BM and real-time PCR for detection of S. stercoralis as compared to a combination of all diagnostic techniques was 21.4%, 37.5% and 76.8%, respectively. The inter-laboratory agreement of S. stercoralis-specific PCR was substantial (κ=0.63, p&lt;0.001). We conclude that a combination of real-time PCR and stool microscopy shows high accuracy for S. stercoralis diagnosis. Besides high sensitivity, PCR may also enhance specificity by reducing microscopic misdiagnosis of morphologically similar helminth larvae (i.e. hookworm and S. stercoralis) in settings where both helminth species co-exist.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Becker</LastName>
<ForeName>Sören L</ForeName>
<Initials>SL</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, P.O. Box, CH-4003 Basel, Switzerland; Institute of Medical Microbiology and Hygiene, Saarland University, Kirrberger Straße, Building 43, D-66421 Homburg/Saar, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Piraisoody</LastName>
<ForeName>Nivetha</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Institute of Medical Microbiology and Hygiene, Saarland University, Kirrberger Straße, Building 43, D-66421 Homburg/Saar, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kramme</LastName>
<ForeName>Stefanie</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>University of Basel, P.O. Box, CH-4003 Basel, Switzerland; Department of Medical Services and Diagnostics, Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marti</LastName>
<ForeName>Hanspeter</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>University of Basel, P.O. Box, CH-4003 Basel, Switzerland; Department of Medical Services and Diagnostics, Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Silué</LastName>
<ForeName>Kigbafori D</ForeName>
<Initials>KD</Initials>
<AffiliationInfo>
<Affiliation>Unité de Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, 02 BP 770, Abidjan 02, Côte d'Ivoire; Département Environnement et Santé, Centre Suisse de Recherches Scientifiques en Côte d'Ivoire, 01 BP 1303, Abidjan 01, Côte d'Ivoire.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Panning</LastName>
<ForeName>Marcus</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute of Virology, University Medical Center Freiburg, Hermann-Herder-Straße 11, D-79104 Freiburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nickel</LastName>
<ForeName>Beatrice</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>University of Basel, P.O. Box, CH-4003 Basel, Switzerland; Department of Medical Services and Diagnostics, Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kern</LastName>
<ForeName>Winfried V</ForeName>
<Initials>WV</Initials>
<AffiliationInfo>
<Affiliation>Division of Infectious Diseases, Department of Internal Medicine, University Medical Center Freiburg, Hugstetter Straße 55, D-79106 Freiburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Herrmann</LastName>
<ForeName>Mathias</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute of Medical Microbiology and Hygiene, Saarland University, Kirrberger Straße, Building 43, D-66421 Homburg/Saar, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hatz</LastName>
<ForeName>Christoph F</ForeName>
<Initials>CF</Initials>
<AffiliationInfo>
<Affiliation>University of Basel, P.O. Box, CH-4003 Basel, Switzerland; Department of Medical Services and Diagnostics, Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, P.O. Box, CH-8001 Zurich, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>N'Goran</LastName>
<ForeName>Eliézer K</ForeName>
<Initials>EK</Initials>
<AffiliationInfo>
<Affiliation>Unité de Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, 02 BP 770, Abidjan 02, Côte d'Ivoire; Département Environnement et Santé, Centre Suisse de Recherches Scientifiques en Côte d'Ivoire, 01 BP 1303, Abidjan 01, Côte d'Ivoire.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Utzinger</LastName>
<ForeName>Jürg</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, P.O. Box, CH-4003 Basel, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>von Müller</LastName>
<ForeName>Lutz</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Institute of Medical Microbiology and Hygiene, Saarland University, Kirrberger Straße, Building 43, D-66421 Homburg/Saar, Germany. Electronic address: lutz.mueller@christophorus-kliniken.de.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Baermann technique</Keyword>
<Keyword MajorTopicYN="N">Diagnostic accuracy</Keyword>
<Keyword MajorTopicYN="N">Hookworm</Keyword>
<Keyword MajorTopicYN="N">Koga agar plate culture</Keyword>
<Keyword MajorTopicYN="N">Real-time PCR</Keyword>
<Keyword MajorTopicYN="N">Strongyloides stercoralis</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26232655</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Little known chewing lice (Phthiraptera) infesting crab plover Dromas ardeola Paykull, 1805 (Charadriiformes: Dromadidae) from the Red Sea.</ArticleTitle>
<Pagination>
<MedlinePgn>171-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.07.025</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30073-5</ELocationID>
<Abstract>
<AbstractText>Scanty information is available for many species of chewing lice of marine birds. Through this work we investigated one of most characteristic marine bird for chewing lice. Seven individuals of crab plovers Dromas ardeola Paykull, 1805 were trapped using standard mist nets on Humr Island in Farasan Archipelago, Saudi Arabia. Two species of chewing lice were found to infest these birds: Actornithophilus ardeolae Timmermann, 1954 of suborder Amblycera and Quadraceps brunneus (Nitzsch in Giebel, 1866) of suborder Ischnocera. Diagnostic characters, data of specimens examined, high definition photos and host distribution map are provided through this paper.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Alahmed</LastName>
<ForeName>Azzam</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Research Chair of Insect Vector Borne Diseases, Department of Plant Protection, College of Food and Agriculture Science, King Saud University, Riyadh, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shobrak</LastName>
<ForeName>Mohammed</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Departments of Biology, Science College, Ta'if University, Ta'if, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kheir</LastName>
<ForeName>Salah</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Research Chair of Insect Vector Borne Diseases, Department of Plant Protection, College of Food and Agriculture Science, King Saud University, Riyadh, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nasser</LastName>
<ForeName>Mohamed</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Research Chair of Insect Vector Borne Diseases, Department of Plant Protection, College of Food and Agriculture Science, King Saud University, Riyadh, Saudi Arabia. Electronic address: mgnasser@ksu.edu.sa.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Actornithophilus ardeolae</Keyword>
<Keyword MajorTopicYN="N">Chewing lice</Keyword>
<Keyword MajorTopicYN="N">Crab plover</Keyword>
<Keyword MajorTopicYN="N">Quadraceps brunneus</Keyword>
<Keyword MajorTopicYN="N">Saudi Arabia</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26232657</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Natural infection of bats with Leishmania in Ethiopia.</ArticleTitle>
<Pagination>
<MedlinePgn>166-70</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.07.024</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30072-3</ELocationID>
<Abstract>
<AbstractText>The leishmaniases, a group of diseases with a worldwide-distribution, are caused by different species of Leishmania parasites. Both cutaneous and visceral leishmaniasis remain important public health problems in Ethiopia. Epidemiological cycles of these protozoans involve various sand fly (Diptera: Psychodidae) vectors and mammalian hosts, including humans. In recent years, Leishmania infections in bats have been reported in the New World countries endemic to leishmaniasis. The aim of this study was to survey natural Leishmania infection in bats collected from various regions of Ethiopia. Total DNA was isolated from spleens of 163 bats belonging to 23 species and 18 genera. Leishmania infection was detected by real-time (RT) PCR targeting a kinetoplast (k) DNA and internal transcribed spacer one (ITS1) gene of the parasite. Detection was confirmed by sequencing of the PCR products. Leishmania kDNA was detected in eight (4.9%) bats; four of them had been captured in the Aba-Roba and Awash-Methara regions that are endemic for leishmaniasis, while the other four specimens originated from non-endemic localities of Metu, Bedele and Masha. Leishmania isolates from two bats were confirmed by ITS1 PCR to be Leishmania tropica and Leishmania major, isolated from two individual bats, Cardioderma cor and Nycteris hispida, respectively. These results represent the first confirmed observation of natural infection of bats with the Old World Leishmania. Hence, bats should be considered putative hosts of Leishmania spp. affecting humans with a significant role in the transmission.</AbstractText>
<CopyrightInformation>Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kassahun</LastName>
<ForeName>Aysheshm</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, Faculty of Science, Charles University in Prague, Vinicna 7, 128 44 Prague 2, Czech Republic. Electronic address: ayshek2000@yahoo.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sadlova</LastName>
<ForeName>Jovana</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, Faculty of Science, Charles University in Prague, Vinicna 7, 128 44 Prague 2, Czech Republic. Electronic address: jovanas@seznam.cz.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Benda</LastName>
<ForeName>Petr</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Zoology, National Museum (Natural History), Vaclavske nam. 68, 115 79 Prague 1, Czech Republic; Department of Zoology, Faculty of Science, Charles University in Prague, Vinicna 7, 128 44 Prague 2, Czech Republic. Electronic address: petr_benda@nm.cz.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kostalova</LastName>
<ForeName>Tatiana</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, Faculty of Science, Charles University in Prague, Vinicna 7, 128 44 Prague 2, Czech Republic. Electronic address: tatianakostalova@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Warburg</LastName>
<ForeName>Alon</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Molecular Genetics, The Institute for Medical Research Israel-Canada, The Kuvin Centre for the Study of Infectious and Tropical Diseases, Hadassah Medical School, The Hebrew University of Jerusalem, Jerusalem 91120, Israel. Electronic address: alonw@ekmd.huji.ac.il.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hailu</LastName>
<ForeName>Asrat</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology, Immunology &amp; Parasitology, Faculty of Medicine, Addis Ababa University, P.O. Box 9086, Addis Ababa, Ethiopia. Electronic address: hailu_a2004@yahoo.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baneth</LastName>
<ForeName>Gad</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>School of Veterinary Medicine, Hebrew University, P.O. Box 12, Rehovot 76100, Israel. Electronic address: gad.baneth@mail.huji.ac.il.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Volf</LastName>
<ForeName>Petr</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, Faculty of Science, Charles University in Prague, Vinicna 7, 128 44 Prague 2, Czech Republic. Electronic address: volf@cesnet.cz.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Votypka</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, Faculty of Science, Charles University in Prague, Vinicna 7, 128 44 Prague 2, Czech Republic. Electronic address: jan.votypka@natur.cuni.cz.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bats</Keyword>
<Keyword MajorTopicYN="N">ITS1</Keyword>
<Keyword MajorTopicYN="N">Natural infection</Keyword>
<Keyword MajorTopicYN="N">kDNA</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26238982</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Detection of parasite-specific IgG and IgA in paired serum and saliva samples for diagnosis of human strongyloidiasis in northern Paraná state, Brazil.</ArticleTitle>
<Pagination>
<MedlinePgn>190-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.07.026</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30074-7</ELocationID>
<Abstract>
<AbstractText>Human strongyloidiasis is an infection caused by the helminth Strongyloides stercoralis that can be fatal, especially in immunosuppressed patients. The aim of this study is to evaluate parasite-specific IgG and IgA levels using S. venezuelensis third-stage (L3) infective larvae alkaline extract as a heterologous antigen by ELISA in paired serum and saliva samples with improved sensitivity and specificity. Individuals from northern Paraná state, Brazil were divided into three groups: 30 patients copropositive for S. stercoralis (Group I); 30 clinically healthy individuals (Group II); and 30 patients copropositive for other parasites (Group III). The area under ROC curve (AUC), an overall index of diagnostic accuracy, and Kappa index were calculated. Data were analyzed using analysis of variance (ANOVA) followed by a Kruskal-Wallis test. Probability (p) values of &lt;0.05 were regarded as significant. In Group I, IgG was detected in 96.7% serum and in 6.7% saliva samples. IgG was not detected in Group II. In Group III, cross-reactivity was observed for serum IgG in 26.7% and in 6.7% for saliva samples. In Group I, IgA was detected in 76.7% serum and 56.7% saliva samples. In Group II, 3.3% were positive for IgA in serum, whereas IgA was not detected in any saliva samples. Group III showed 6.7% serum and 26.7% saliva-positive samples. The sensitivity values for detection of IgG and IgA in serum samples were 96.7% and 76.7%, respectively. In saliva samples, the sensitivity values for detection of IgG and IgA were 6.7% and 56.7%, respectively. The specificity value was 100% for the detection of IgG in serum and for detection of IgG and IgA in saliva, and 96.7% for detection of IgA in serum samples. The proper choice of immunological diagnosis to supplement parasitological methods is essential to estimate the true prevalence of the parasite, and will permit analysis of population immune response profiles, particularly in northern Paraná state, where there are no previous reports.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bosqui</LastName>
<ForeName>Larissa R</ForeName>
<Initials>LR</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Ciências Patológicas, Laboratório de Parasitologia, Universidade Estadual de Londrina, PR, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gonçalves</LastName>
<ForeName>Ana Lúcia R</ForeName>
<Initials>AL</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Imunologia, Microbiologia e Parasitologia, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia, MG, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gonçalves-Pires</LastName>
<ForeName>Maria do Rosário F</ForeName>
<Initials>Mdo R</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Imunologia, Microbiologia e Parasitologia, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia, MG, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Custodio</LastName>
<ForeName>Luiz Antonio</ForeName>
<Initials>LA</Initials>
<AffiliationInfo>
<Affiliation>Ambulatório de Especialidades do Hospital Universitário de Londrina, PR, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Menezes</LastName>
<ForeName>Maria Cláudia N D</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Ciências Patológicas, Laboratório de Parasitologia, Universidade Estadual de Londrina, PR, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Murad</LastName>
<ForeName>Valter A</ForeName>
<Initials>VA</Initials>
<AffiliationInfo>
<Affiliation>Ambulatório de Especialidades do Hospital Universitário de Londrina, PR, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Paula</LastName>
<ForeName>Fabiana M</ForeName>
<Initials>FM</Initials>
<AffiliationInfo>
<Affiliation>Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, SP, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pavanelli</LastName>
<ForeName>Wander R</ForeName>
<Initials>WR</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Ciências Patológicas, Laboratório de Parasitologia, Universidade Estadual de Londrina, PR, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Conchon-Costa</LastName>
<ForeName>Ivete</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Ciências Patológicas, Laboratório de Parasitologia, Universidade Estadual de Londrina, PR, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Costa-Cruz</LastName>
<ForeName>Julia Maria</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Imunologia, Microbiologia e Parasitologia, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia, MG, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Costa</LastName>
<ForeName>Idessania N</ForeName>
<Initials>IN</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Ciências Patológicas, Laboratório de Parasitologia, Universidade Estadual de Londrina, PR, Brazil. Electronic address: idessania@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>31</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Brazil</Keyword>
<Keyword MajorTopicYN="N">Immunodiagnostic</Keyword>
<Keyword MajorTopicYN="N">Paraná state</Keyword>
<Keyword MajorTopicYN="N">Saliva</Keyword>
<Keyword MajorTopicYN="N">Strongyloidiasis</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26259816</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Effects of fish cues on mosquito larvae development.</ArticleTitle>
<Pagination>
<MedlinePgn>196-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.08.001</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30078-4</ELocationID>
<Abstract>
<AbstractText>We investigated the effects of predator-released kairomones on life history traits of larval Culex pipiens (Linnaeus). We compared the development time and survival of sibling larvae, reared in either water conditioned by the presence of Gambusia affinis (Baird and Girard) or fishless control-water. Our results indicate that larvae developing in fish-conditioned water (FCW) pupated faster than larvae in fishless-control water. The effect of FCW on larval survival was evident only in females. Surprisingly, FCW increased female survival. In both development-time and survival, boiling the water eliminated the FCW effect, supporting our hypothesis that fish conditioning is based on kairomones. Accelerated metamorphosis in response to predator released kairomones, evident in our results, is a rarely described phenomenon. Intuitively, when exposed to predator associated signals, aquatic larvae should metamorphose earlier to escape the higher risk of predation. However, theoretical models predict this outcome only under specific conditions. Indeed, longer - rather than shorter - time to metamorphosis is usually observed in response to predation risk. We argue that the response of larval mosquitoes to predation risk is context-dependent. Shortening larval development time may not be an exceptional response, but rather represents a part of a response spectrum that depends on the level of predation risk and resource abundance.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Silberbush</LastName>
<ForeName>Alon</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Center for Biological Control, Department of Life Sciences, Ben-Gurion University of the Negev, Israel. Electronic address: alonsil@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abramsky</LastName>
<ForeName>Zvika</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Center for Biological Control, Department of Life Sciences, Ben-Gurion University of the Negev, Israel.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tsurim</LastName>
<ForeName>Ido</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Center for Biological Control, Department of Life Sciences, Ben-Gurion University of the Negev, Israel; Department of Life Sciences, Achva Academic College, Israel.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Culex pipiens</Keyword>
<Keyword MajorTopicYN="N">Life history</Keyword>
<Keyword MajorTopicYN="N">Phenotypic plasticity</Keyword>
<Keyword MajorTopicYN="N">Predator cues</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26259817</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Diversity and abundance of mosquitoes (Diptera:Culicidae) in an urban park: larval habitats and temporal variation.</ArticleTitle>
<Pagination>
<MedlinePgn>200-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.08.002</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30079-6</ELocationID>
<Abstract>
<AbstractText>Urban parks are areas designated for human recreation but also serve as shelter and refuge for populations of several species of native fauna, both migratory and introduced. In Brazil, the effect of annual climate variations on Aedes aegypti and dengue epidemics in large cities like São Paulo is well known, but little is known about how such variations can affect the diversity of mosquito vectors in urban parks and the risk of disease transmission by these vectors. This study investigates the influence of larval habitats and seasonal factors on the diversity and abundance of Culicidae fauna in Anhanguera Park, one of the largest remaining green areas in the city of São Paulo. Species composition and richness and larval habitats were identified. Seasonality (cold-dry and hot-rainy periods) and year were considered as explanatory variables and the models selection approach was developed to investigate the relationship of these variables with mosquito diversity and abundance. A total of 11,036 specimens from 57 taxa distributed in 13 genera were collected. Culex nigripalpus, Cx. quinquefasciatus and Aedes albopictus were the most abundant species. Bamboo internodes and artificial breeding sites showed higher abundance, while ponds and puddles showed greater richness. Significant relationships were observed between abundance and seasonality, with a notable increase in the mosquitos abundance in the warm-rainy periods. The Shannon and Berger-Parker indices were related with interaction between seasonality and year, however separately these predictors showed no relationship with ones. The increased abundance of mosquitoes in warm-rainy months and the fact that some of the species are epidemiologically important increase not only the risk of pathogen transmission to people who frequent urban parks but also the nuisance represented by insect bites. The findings of this study highlight the importance of knowledge of culicid ecology in green areas in urban environments.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Medeiros-Sousa</LastName>
<ForeName>Antônio R</ForeName>
<Initials>AR</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Epidemiologia, Faculdade de Saúde Pública, Universidade de São Paulo, Av. Dr. Arnaldo 715, CEP 01246-904 SP, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ceretti-Júnior</LastName>
<ForeName>Walter</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Epidemiologia, Faculdade de Saúde Pública, Universidade de São Paulo, Av. Dr. Arnaldo 715, CEP 01246-904 SP, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Carvalho</LastName>
<ForeName>Gabriela C</ForeName>
<Initials>GC</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Epidemiologia, Faculdade de Saúde Pública, Universidade de São Paulo, Av. Dr. Arnaldo 715, CEP 01246-904 SP, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nardi</LastName>
<ForeName>Marcello S</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Parques e Áreas Verdes, Prefeitura de São Paulo, São Paulo, 04030-090, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Araujo</LastName>
<ForeName>Alessandra B</ForeName>
<Initials>AB</Initials>
<AffiliationInfo>
<Affiliation>Centro de Controle de Zoonoses, Prefeitura de São Paulo, São Paulo, 02031-020, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vendrami</LastName>
<ForeName>Daniel P</ForeName>
<Initials>DP</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Medicina Tropical de São Paulo, Universidade de São Paulo, São Paulo, 05403-000, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marrelli</LastName>
<ForeName>Mauro T</ForeName>
<Initials>MT</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Epidemiologia, Faculdade de Saúde Pública, Universidade de São Paulo, Av. Dr. Arnaldo 715, CEP 01246-904 SP, Brazil; Instituto de Medicina Tropical de São Paulo, Universidade de São Paulo, São Paulo, 05403-000, Brazil. Electronic address: mmarelli@usp.br.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Culicidae</Keyword>
<Keyword MajorTopicYN="N">Mosquito abundance</Keyword>
<Keyword MajorTopicYN="N">Mosquito diversity</Keyword>
<Keyword MajorTopicYN="N">Urban park</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26277067</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-6254</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Acta tropica</Title>
<ISOAbbreviation>Acta Trop.</ISOAbbreviation>
</Journal>
<ArticleTitle>Genetic and clinical characterization of canine leishmaniasis caused by Leishmania (Leishmania) infantum in northeastern Argentina.</ArticleTitle>
<Pagination>
<MedlinePgn>218-23</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2015.08.007</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0001-706X(15)30084-X</ELocationID>
<Abstract>
<AbstractText>Leishmaniases comprise zoonotic diseases caused by protozoan flagellates of the Leishmania genus. They are endemic to South America, and the visceral form has been recently reported in Argentina. Dogs can play different roles in the Leishmania transmission cycles, depending mainly on the species of parasite involved. Here we focused on the clinical characterization of canine leishmaniasis (CanL) in Northeast Argentina and on the molecular typing of its etiological agent. The nested polymerase chain reaction and sequence analysis of the Leishmania cytochrome b (cyt b) gene was performed on DNA templates purified from lymph nodes, bone marrow or spleen aspirates obtained from 48 dogs previously diagnosed by the observation of Leishmania amastigotes on smears from these aspirates. Their clinical and epidemiological data were also recorded. Systemic abnormalities were observed in 46 subjects (95.8%), most frequently lymphadenopathy, and emaciation (89.6 and 75%). Furthermore, 87% also presented tegumentary abnormalities, such as alopecia (54.2%) or secondary skin lesions (47.9%), among others. Twenty three dogs were positive for cyt b amplification. The sequence analysis showed the presence of two genotypes, LiA1 and LiA2, assigned to Leishmania (Leishmania) infantum, with 99.9 and 100% homology with the reference strain MHOM/TN/80/IPT1 respectively. LiA1 was identified in 18 cases (78.3%) and LiA2 in five (21.7%). Two cyt b variants of L. (L.) infantum were incriminated as the causative agents of CanL cases from three cities: Posadas, Garupá, and Ituzaingó. All three cities are located in the northeastern area of the country, where these parasites seem to be spreading in urban areas.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Barroso</LastName>
<ForeName>Paola A</ForeName>
<Initials>PA</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Patología Experimental, Facultad de Ciencias de la Salud, Universidad Nacional de Salta (UNSa) / Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Bolivia 5150, A4408FVY Salta, Argentina; Instituto de Investigaciones en Enfermedades Tropicales, Sede Regional Orán, UNSa, Alvarado 751, A4530ANQ San Ramón de la Nueva Orán, Argentina. Electronic address: paobarar@yahoo.com.ar.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nevot</LastName>
<ForeName>M Cecilia</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>Veterinaria del Oeste, Lavalle 257, N3300ONN Posadas, Argentina. Electronic address: cecilianevot@yahoo.com.ar.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hoyos</LastName>
<ForeName>Carlos L</ForeName>
<Initials>CL</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Investigaciones en Enfermedades Tropicales, Sede Regional Orán, UNSa, Alvarado 751, A4530ANQ San Ramón de la Nueva Orán, Argentina. Electronic address: carloslhoyos@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Locatelli</LastName>
<ForeName>Fabricio M</ForeName>
<Initials>FM</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, Kochi Medical School, Kochi University, Kohasu, Oko, Nankoku, 783-8505 Kochi, Japan. Electronic address: fm.locatelli@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lauthier</LastName>
<ForeName>Juan J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Patología Experimental, Facultad de Ciencias de la Salud, Universidad Nacional de Salta (UNSa) / Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Bolivia 5150, A4408FVY Salta, Argentina. Electronic address: juanjoselauthier@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ruybal</LastName>
<ForeName>Paula</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Investigaciones en Microbiología y Parasitología Médica, Facultad de Medicina, Universidad de Buenos Aires / CONICET, Paraguay 2155, C1121ABG Buenos Aires, Argentina. Electronic address: pruybal@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cardozo</LastName>
<ForeName>Rubén M</ForeName>
<Initials>RM</Initials>
<AffiliationInfo>
<Affiliation>Coordinación de Gestión Epidemiológica, Ministerio de Salud Pública, Centro Cívico Grand Bourg, 4400 Salta, Argentina. Electronic address: cardozo_rm@yahoo.com.ar.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Russo</LastName>
<ForeName>Pablo D</ForeName>
<Initials>PD</Initials>
<AffiliationInfo>
<Affiliation>Veterinaria del Oeste, Lavalle 257, N3300ONN Posadas, Argentina. Electronic address: veterinariorusso@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vassiliades</LastName>
<ForeName>Carola N</ForeName>
<Initials>CN</Initials>
<AffiliationInfo>
<Affiliation>Veterinaria del Oeste, Lavalle 257, N3300ONN Posadas, Argentina. Electronic address: laboratoriomisiones@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mora</LastName>
<ForeName>María C</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Patología Experimental, Facultad de Ciencias de la Salud, Universidad Nacional de Salta (UNSa) / Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Bolivia 5150, A4408FVY Salta, Argentina. Electronic address: mariaceliamora@yahoo.com.ar.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Estévez</LastName>
<ForeName>J Octavio</ForeName>
<Initials>JO</Initials>
<AffiliationInfo>
<Affiliation>Veterinaria del Oeste, Lavalle 257, N3300ONN Posadas, Argentina. Electronic address: octavioes2003@yahoo.com.ar.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hashiguchi</LastName>
<ForeName>Yoshihisa</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, Kochi Medical School, Kochi University, Kohasu, Oko, Nankoku, 783-8505 Kochi, Japan; Centro de Biomedicina, Universidad Central del Ecuador y Proyecto Prometeo, SNESCYT, Sodiro N14-121 e Iquique, Quito, Ecuador. Electronic address: hasiguti@kochi-u.ac.jp.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Korenaga</LastName>
<ForeName>Masataka</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Parasitology, Kochi Medical School, Kochi University, Kohasu, Oko, Nankoku, 783-8505 Kochi, Japan. Electronic address: korenaga@kochi-u.ac.jp.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Basombrío</LastName>
<ForeName>Miguel A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Patología Experimental, Facultad de Ciencias de la Salud, Universidad Nacional de Salta (UNSa) / Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Bolivia 5150, A4408FVY Salta, Argentina. Electronic address: basombri@unsa.edu.ar.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marco</LastName>
<ForeName>Jorge D</ForeName>
<Initials>JD</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Patología Experimental, Facultad de Ciencias de la Salud, Universidad Nacional de Salta (UNSa) / Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Bolivia 5150, A4408FVY Salta, Argentina; Cátedra de Microbiología, Facultad de Ciencias Exactas, UNSa, Bolivia 5150, A4408FVY Salta, Argentina. Electronic address: diegomarcoar@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Acta Trop</MedlineTA>
<NlmUniqueID>0370374</NlmUniqueID>
<ISSNLinking>0001-706X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Argentina</Keyword>
<Keyword MajorTopicYN="N">Canine</Keyword>
<Keyword MajorTopicYN="N">Cytochrome b</Keyword>
<Keyword MajorTopicYN="N">Dog</Keyword>
<Keyword MajorTopicYN="N">Leishmania infantum</Keyword>
<Keyword MajorTopicYN="N">Typing</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432299</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Dr Edgar R. R. Parker: his time and now.</ArticleTitle>
<Pagination>
<MedlinePgn>521-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.08.003</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00945-2</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Behrents</LastName>
<ForeName>Rolf G</ForeName>
<Initials>RG</Initials>
<AffiliationInfo>
<Affiliation>St Louis, Mo.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432300</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>The cleft child.</ArticleTitle>
<Pagination>
<MedlinePgn>525</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.07.010</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00834-3</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sotiropoulos</LastName>
<ForeName>Gus G</ForeName>
<Initials>GG</Initials>
<AffiliationInfo>
<Affiliation>Formerly, professor of orthodontics, retired, Center for Advanced Dental Education, Saint Louis University, St Louis, Mo.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432301</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Matched, equal, equipoise.</ArticleTitle>
<Pagination>
<MedlinePgn>526-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.07.016</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00853-7</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tuncay</LastName>
<ForeName>Orhan C</ForeName>
<Initials>OC</Initials>
<AffiliationInfo>
<Affiliation>Professor, Department of Orthodontics, Temple University, Philadelphia, Pa.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432302</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Postsurgical volumetric airway changes in 2-jaw orthognathic surgery patients.</ArticleTitle>
<Pagination>
<MedlinePgn>528</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.07.017</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00854-9</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Antosz</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Calgary, Alberta, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Am J Orthod Dentofacial Orthop. 2015 Oct;148(4):528-9</RefSource>
<PMID Version="1">26432303</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn">
<RefSource>Am J Orthod Dentofacial Orthop. 2015 May;147(5):536-46</RefSource>
<PMID Version="1">25919099</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432303</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Authors' response.</ArticleTitle>
<Pagination>
<MedlinePgn>528-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.07.018</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00855-0</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kadioglu</LastName>
<ForeName>Onur</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Oklahoma City, Okla.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hart</LastName>
<ForeName>P Sheamus</ForeName>
<Initials>PS</Initials>
<AffiliationInfo>
<Affiliation>Woodridge, Va.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McIntyre</LastName>
<ForeName>Brian P</ForeName>
<Initials>BP</Initials>
<AffiliationInfo>
<Affiliation>Omaha, Neb.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Currier</LastName>
<ForeName>G Fräns</ForeName>
<Initials>GF</Initials>
<AffiliationInfo>
<Affiliation>Oklahoma City, Okla.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sullivan</LastName>
<ForeName>Steven M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Oklahoma City, Okla.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Ji</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Oklahoma City, Okla.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shay</LastName>
<ForeName>Christina</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Oklahoma City, Okla.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>Am J Orthod Dentofacial Orthop. 2015 May;147(5):536-46</RefSource>
<PMID Version="1">25919099</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn">
<RefSource>Am J Orthod Dentofacial Orthop. 2015 Oct;148(4):528</RefSource>
<PMID Version="1">26432302</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432304</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>The 101st man of influence.</ArticleTitle>
<Pagination>
<MedlinePgn>529-30</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.07.020</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00876-8</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yan</LastName>
<ForeName>Bo-Xi</ForeName>
<Initials>BX</Initials>
<AffiliationInfo>
<Affiliation>Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432305</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Diversified rapid maxillary expander or utility maxillary expander?</ArticleTitle>
<Pagination>
<MedlinePgn>529</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.07.019</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00875-6</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Babacan</LastName>
<ForeName>Hasan</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Denizli, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>Am J Orthod Dentofacial Orthop. 2015 Feb;147(2):242-51</RefSource>
<PMID Version="1">25636559</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432307</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Without undue influence.</ArticleTitle>
<Pagination>
<MedlinePgn>534</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.07.026</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00891-4</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Greco</LastName>
<ForeName>Peter M</ForeName>
<Initials>PM</Initials>
<AffiliationInfo>
<Affiliation>Philadelphia, Pa.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432308</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>T.M. "Tom" Graber: a passion for orthodontics.</ArticleTitle>
<Pagination>
<MedlinePgn>535-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.07.023</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00883-5</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Graber</LastName>
<ForeName>Lee W</ForeName>
<Initials>LW</Initials>
<AffiliationInfo>
<Affiliation>Secretary General, World Federation of Orthodontists &amp; Past President, American Association of Orthodontists, Vernon Hills, Ill.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432309</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Viken Sassouni: scientist, teacher, and mentor.</ArticleTitle>
<Pagination>
<MedlinePgn>540-2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.07.011</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00835-5</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Araújo</LastName>
<ForeName>Eustáquio</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Professor, Center for Advanced Dental Education, Saint Louis University, St Louis, Mo. Electronic address: araujoea@slu.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432310</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Overview of orthodontic care for children with cleft lip and palate, 1915-2015.</ArticleTitle>
<Pagination>
<MedlinePgn>543-56</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.07.021</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00881-1</ELocationID>
<Abstract>
<AbstractText>The purpose of this article is to review and discuss the advances in the management of children born with cleft lip and palate (CLP) as it has evolved over the past 100 years. This overview is based on articles published in the American Journal of Orthodontics, which frequently changed its name, over the past century. Additionally, other journals will be cited as craniofacial anomalies became recognized during the 20th century and the biologic basis became refined, with the new discipline of genetics replacing the term hereditary and its connotations of eugenics. The Human Genome Project, completed in 2003, has now provided an understanding of syndromic and nonsyndromic CLP that has led to advances in the diagnosis and treatment of CLP in the 21st century. These evolving concepts will be discussed in an overview of the types of procedures published from 1915 to 2015 and the major transition in the mid-20th century from multiple uncoordinated interventions from various specialists to a coordinated team approach in which the orthodontist has a specific role in the timing and sequencing of interdisciplinary treatment goals. Major technologic advancements in treatment modalities and the contemporary approach to the health-related quality of life of the patient and the caregiver have resulted in their participation in treatment options and decisions. The requirement of informed consent reflects the legal doctrine that now emphasizes the ethical imperative of greater respect for patient autonomy in the decision-making process. The orthodontist no longer makes decisions alone, but rather with the team and the patient or the caregiver.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vig</LastName>
<ForeName>Katherine W L</ForeName>
<Initials>KW</Initials>
<AffiliationInfo>
<Affiliation>Faculty, Advanced Graduate Education Program in Orthodontics, Department of Developmental Biology, Harvard School of Dental Medicine, Boston, Mass. Electronic address: Katherine_Vig@hsdm.harvard.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mercado</LastName>
<ForeName>Ana M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Clinical assistant professor, Department of Orthodontics, College of Dentistry, Ohio State University, Columbus, Ohio.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432311</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Etiology of maxillary canine impaction: a review.</ArticleTitle>
<Pagination>
<MedlinePgn>557-67</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.06.013</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00842-2</ELocationID>
<Abstract>
<AbstractText>This article is a review that enumerates the causes of impaction of the maxillary permanent canines, including hard tissue obstructions, soft tissue lesions, and anomalies of neighboring teeth, and discusses the much-argued relationship between environmental and genetic factors. These phenomena have been shown in many investigations to accompany the diagnosis of canine impaction and have been presented as unrelated anomalous features, each of which is etiologically construed as genetic, including the aberrant canine itself. While in general the influence of genetics pervades the wider picture, a guidance theory proposes an alternative etiologic line of reasoning and interpretation of these studies, in which the same genetically determined anomalous features provide an abnormal milieu in which the canine is reared and from which it is guided in its misdirected and often abortive path of eruption.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Becker</LastName>
<ForeName>Adrian</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Clinical associate professor emeritus, Department of Orthodontics, Hebrew University-Hadassah School of Dental Medicine, Jerusalem, Israel. Electronic address: adrian.becker@mail.huji.ac.il.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chaushu</LastName>
<ForeName>Stella</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Full professor and chair, Department of Orthodontics, Hebrew University-Hadassah School of Dental Medicine, Jerusalem, Israel.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432312</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Oral health-related quality of life changes in standard, cleft, and surgery patients after orthodontic treatment.</ArticleTitle>
<Pagination>
<MedlinePgn>568-75</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.03.028</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00543-0</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The purpose of this study was to investigate the effect of orthodontic treatment on oral health-related quality of life (OHRQoL) in groups of standard patients with severe malocclusions; cleft lip, cleft palate, or cleft lip and palate patients; and orthognathic surgery patients.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The study sample consisted of 83 consecutive patients undergoing treatment at the orthodontic unit of Christchurch Hospital, Christchurch, New Zealand, divided into 3 groups: 30 adolescents with severe malocclusions; 24 adolescents with cleft lip, cleft palate, or cleft lip and palate; and 29 adults with severe skeletal discrepancies requiring both orthognathic surgery and orthodontic treatment. Each patient completed the Short Form of the Oral Health Impact Profile (OHIP-14) questionnaire before and after orthodontic treatment.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The baseline OHIP-14 subscale scores among the 3 study groups were significantly different, with the surgery patients having nearly twice the OHIP-14 scores of the other 2 groups for nearly half of the items (P &lt;0.05). The surgery patients experienced the greatest reduction in OHIP-14 scores (ie, improvement in OHRQoL), with the largest effect sizes reported for the psychological discomfort (+2.73) and disability (+2.65) domains. The group with clefts experienced the smallest changes in OHIP-14 scores across all 7 domains (-0.03 to +0.63). After adjusting for age and sex, the surgical patients had a significantly greater reduction in pretreatment OHIP-14 scores than did the standard and the cleft patients (P &lt;0.01).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The effect of orthodontic treatment on OHRQoL varies for different patient groups even after adjusting for age and sex. The greatest improvement in OHRQoL occurred in adults with a need for orthognathic surgery, whereas the least improvement seemed to occur in adolescents with cleft lip, cleft palate, or cleft lip and palate.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Antoun</LastName>
<ForeName>Joseph S</ForeName>
<Initials>JS</Initials>
<AffiliationInfo>
<Affiliation>Senior lecturer, Discipline of Orthodontics, Department of Oral Sciences, Sir John Walsh Research Institute, Faculty of Dentistry, University of Otago, Dunedin, New Zealand. Electronic address: joseph.antoun@otago.ac.nz.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fowler</LastName>
<ForeName>Peter V</ForeName>
<Initials>PV</Initials>
<AffiliationInfo>
<Affiliation>Consultant, Orthodontic Department, Christchurch Hospital, Christchurch, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jack</LastName>
<ForeName>Hannah C</ForeName>
<Initials>HC</Initials>
<AffiliationInfo>
<Affiliation>Professional practice fellow, Discipline of Orthodontics, Department of Oral Sciences, Sir John Walsh Research Institute, Faculty of Dentistry, University of Otago, Dunedin, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Farella</LastName>
<ForeName>Mauro</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Professor and chair, Discipline of Orthodontics, Department of Oral Sciences, Sir John Walsh Research Institute, Faculty of Dentistry, University of Otago, Dunedin, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432313</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Growth-related changes of skeletal and upper-airway features in bilateral cleft lip and palate patients.</ArticleTitle>
<Pagination>
<MedlinePgn>576-86</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.02.031</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00654-X</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The craniofacial morphology of subjects with cleft lip and palate differs from that of subjects without clefts. Subjects with bilateral cleft lip and palate tend to have maxillary retrognathism, a smaller mandible with an obtuse gonial angle, greater anterior upper and lower facial heights, and retroclined maxillary incisors. The purposes of this research were to compare the skeletal and upper-airway features of subjects with bilateral cleft lip and palate with the same features in control subjects without clefts and to determine the growth-related changes at different growth stages.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The sample comprised 212 subjects divided into 2 groups: 68 with bilateral cleft lip and palate, and 144 controls without clefts; each group was further divided into 4 subgroups according to growth stage using the cervical vertebral maturation stage method. The subgroups were defined as early childhood (stage 1), prepubertal (stage 2), pubertal (stage 3), and postpubertal (stage 4). The cephalometric variables were evaluated with 2-way analysis of variance and the Bonferroni test.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Maxillary position showed no significant differences between the male groups. The maxilla was more prognathic at stage 2 and became more retrognathic at stages 3 and 4 in the females. The mandible was more retrusive in the bilateral cleft lip and palate subjects at stage 1 in males and at stages 3 and 4 in females. ANB was larger at stages 1 and 2, and it became similar to the controls at stages 3 and 4 in male and female bilateral cleft lip and palate subjects. Vertical growth was seen in the bilateral cleft lip and palate subjects regardless of sex, and no change was observed with age. Posterior airway space was narrower in all stages (except for stage 1 in females). Middle airway space was wider after stage 1 in the male and female bilateral cleft lip and palate subjects. Inferior airway space was narrower in the male bilateral cleft lip and palate patients at the early childhood and pubertal stages.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Age- and sex-dependent differences in skeletal morphology and upper-airway widths of the bilateral cleft lip and palate subjects were identified when compared with the control subjects without clefts.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Akarsu-Guven</LastName>
<ForeName>Bengisu</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Assistant professor, Department of Orthodontics, Faculty of Dentistry, Hacettepe University, Research and Application Center for the Treatment of Cleft Lip and Palate and Craniomaxillofacial Deformities, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Karakaya</LastName>
<ForeName>Jale</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Research assistant, Department of Biostatistics, Faculty of Medicine, Hacettepe University, Research and Application Center for the Treatment of Cleft Lip and Palate and Craniomaxillofacial Deformities, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ozgur</LastName>
<ForeName>Figen</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Professor, Department of Plastic, Reconstructive and Esthetic Surgery, Faculty of Medicine, Hacettepe University, Research and Application Center for the Treatment of Cleft Lip and Palate and Craniomaxillofacial Deformities, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aksu</LastName>
<ForeName>Muge</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Associate professor, Department of Orthodontics, Faculty of Dentistry, Hacettepe University, Research and Application Center for the Treatment of Cleft Lip and Palate and Craniomaxillofacial Deformities, Ankara, Turkey. Electronic address: muge.aksu@hacettepe.edu.tr.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432314</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Evaluation of root and alveolar bone development of unilateral osseous impacted immature maxillary central incisors after the closed-eruption technique.</ArticleTitle>
<Pagination>
<MedlinePgn>587-98</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.04.035</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00771-4</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">In this study, we evaluated root and alveolar bone development in unilateral osseous impacted immature maxillary central incisors by cone-beam computed tomography before and after closed-eruption treatment, in comparison with naturally erupted contralateral immature maxillary central incisors.</AbstractText>
<AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">The study included 30 patients, 20 boys and 10 girls, with a mean age of 8.44 ± 1.20 years (range, 6.5-11.2 years). After treatment, the root lengths of both the impacted maxillary central incisors (10.66 ± 2.10 mm) and the contralateral maxillary central incisors (11.04 ± 1.76 mm) were significantly greater than their pretreatment values (6.67 ± 1.94 and 9.02 ± 2.13 mm, respectively). The root canal widths of the incisors decreased significantly after treatment. From the posttreatment cone-beam computed tomography images, the ratio of exposed root length to total root length and the thickness of the alveolar bone at 1 mm under the alveolar crest and at the apex were calculated to evaluate alveolar bone development. Impacted immature maxillary central incisors differed significantly from contralateral immature maxillary central incisors in labial exposed root length, labial ratio to total root length, and lingual alveolar crest. Clinical crown height was higher (statistically but not clinically) for the impacted incisors (9.87 mm) than for the contralateral incisors (9.37 mm).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Impacted immature incisors grew to the same stage as did erupted contralateral incisors after closed-eruption treatment. Both incisor types had some alveolar bone loss, and thin alveolar bone surrounded the roots.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shi</LastName>
<ForeName>Xiangru</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Postgraduate student, Department of Preventive Dentistry, Peking University School and Hospital of Stomatology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Xie</LastName>
<ForeName>Xiaoyan</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Resident, Department of Oral and Maxillofacial Radiology, Peking University School and Hospital of Stomatology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Quan</LastName>
<ForeName>Junkang</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Resident, Department of Preventive Dentistry, Peking University School and Hospital of Stomatology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Xiaozhe</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Resident, Department of Preventive Dentistry, Peking University School and Hospital of Stomatology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sun</LastName>
<ForeName>Xiangyu</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Resident, Department of Preventive Dentistry, Peking University School and Hospital of Stomatology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Chenying</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Resident, Department of Preventive Dentistry, Peking University School and Hospital of Stomatology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zheng</LastName>
<ForeName>Shuguo</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Professor, Department of Preventive Dentistry, Peking University School and Hospital of Stomatology, Beijing, China. Electronic address: zhengsg86@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432315</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Comparison of transverse changes during maxillary expansion with 4-point bone-borne and tooth-borne maxillary expanders.</ArticleTitle>
<Pagination>
<MedlinePgn>599-607</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.04.040</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00777-5</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The purposes of this study were to evaluate and compare the dentoskeletal changes concurrent with 4-point bone-borne and tooth-borne rapid maxillary expanders in growing children.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The study was conducted with 20 growing girls (ages, 12 ± 0.6 years) with posterior crossbite. They were divided into 2 equal groups; patients in one group were treated with a tooth-borne maxillary hyrax expander (TBME), and those in the other group received a bone-borne maxillary hyrax expander (BBME) anchored directly to the palatal bone. Changes were assessed using cone-beam computed tomography. Images were taken before and immediately after expansion.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Superimpositions of the 3-dimensional palatal images showed significant increases in skeletal widths at the canine, first premolar, and first molar areas in both groups. The TBME group had greater nasal width expansion. Regarding the transverse dentolinear measurements, significant increases were seen in both groups, whereas the TBME group showed a greater increase than the BBME group. Significant increases in the dentoangular measurements were seen in the TBME group only and were significantly greater than in the BBME group at the first premolars.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There were significant increases in facial and maxillary widths for the BBME group and in nasal width for the TBME group. Both expanders produced basal bone expansion at the level of the hard palate. The TBMEs produced more dental expansion, buccal rolling, and a greater increase in nasal width than did the BBMEs.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mosleh</LastName>
<ForeName>Mennatallah Ihab</ForeName>
<Initials>MI</Initials>
<AffiliationInfo>
<Affiliation>Research assistant, Orthodontics and Pediatric Dentistry, National Research Centre, Cairo, Egypt. Electronic address: menna_mosleh@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kaddah</LastName>
<ForeName>Mohamed Amgad</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Chairman and professor, Department of Orthodontics, Faculty of Oral and Dental Medicine, Cairo University, Cairo, Egypt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abd ElSayed</LastName>
<ForeName>Fatma Abdou</ForeName>
<Initials>FA</Initials>
<AffiliationInfo>
<Affiliation>Professor, Department of Orthodontics, Faculty of Oral and Dental Medicine, Cairo University, Cairo, Egypt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>ElSayed</LastName>
<ForeName>Hend Salah</ForeName>
<Initials>HS</Initials>
<AffiliationInfo>
<Affiliation>Researcher, Orthodontics and Pediatric Dentistry, National Research Centre, Cairo, Egypt.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432316</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of low-level laser therapy on orthodontic tooth movement into bone-grafted alveolar defects.</ArticleTitle>
<Pagination>
<MedlinePgn>608-17</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.04.034</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00770-2</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The objective of this study was to investigate the effect of low-level laser therapy (LLLT) on the rate of orthodontic tooth movement (OTM) into bone-grafted alveolar defects based on different healing states.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Ten male beagles were randomly allocated to 3 groups: group C, OTM alone as a control; group G, OTM into the grafted defects; group GL, OTM into the grafted defects with LLLT. The maxillary second premolars were protracted into the defects for 6 weeks, immediately (G-0 and GL-0) and at 2 weeks (G-2 and GL-2) after surgery. The defects were irradiated with a diode laser (dose, 4.5 J/cm(2)) every other day for 2 weeks. The rates of OTM and alveolar bone apposition, and maturational states of the defects were analyzed by histomorphometry, microcomputed tomography, and histology.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The total amounts of OTM and new bone apposition rates were decreased by LLLT, with increased bone mineral density and trabecular maturation in the defects. Group GL-2 had the slowest movement with root resorption in relation to less woven bone in the hypermatured defect.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">LLLT significantly decreased the rate of OTM into the bone-grafted surgical defects by accelerating defect healing and maturation, particularly when the start of postoperative OTM was delayed.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Kyung-A</ForeName>
<Initials>KA</Initials>
<AffiliationInfo>
<Affiliation>Clinical fellow, Department of Orthodontics, Dental Hospital, Kyung Hee University, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Choi</LastName>
<ForeName>Eun-Kyung</ForeName>
<Initials>EK</Initials>
<AffiliationInfo>
<Affiliation>Postgraduate student, Department of Orthodontics, School of Dentistry, Kyung Hee University, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ohe</LastName>
<ForeName>Joo-Young</ForeName>
<Initials>JY</Initials>
<AffiliationInfo>
<Affiliation>Assistant professor, Department of Oral and Maxillofacial Surgery, School of Dentistry, Kyung Hee University, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ahn</LastName>
<ForeName>Hyo-Won</ForeName>
<Initials>HW</Initials>
<AffiliationInfo>
<Affiliation>Assistant professor, Department of Orthodontics, School of Dentistry, Kyung Hee University, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Su-Jung</ForeName>
<Initials>SJ</Initials>
<AffiliationInfo>
<Affiliation>Associate professor, Department of Orthodontics, School of Dentistry, Kyung Hee University, Seoul, Korea. Electronic address: ksj113@khu.ac.kr.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432317</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of physical activity level on orthodontic pain perception and analgesic consumption in adolescents.</ArticleTitle>
<Pagination>
<MedlinePgn>618-27</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.04.037</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00773-8</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The objective of this study was to assess the effect of baseline physical activity level on orthodontic pain perception and analgesic consumption after orthodontic separator placement in adolescents.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">One hundred fifty participants (mean age, 14.5 years; SD, 1.7 years; 73 girls, 77 boys) were included in this longitudinal study. The physical activity questionnaire was used to assess their baseline physical activity levels. Once participants completed the questionnaire, orthodontic separators were placed at the mesial and distal contact points of the maxillary and mandibular first molars. A 100-mm visual analog scale was used for pain assessment. Analgesic consumption was recorded as a binary response (yes/no). Both outcomes were assessed at 1 baseline time point and 7 follow-up time points (bedtime on days 1 to 7). A multilevel mixed-effect model analysis approach was used to analyze the longitudinal data.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 150 participants in the study, data from 137 were included in the analysis (mean age, 14.4 years; SD, 1.7 years; 65 girls, 72 boys). Compared with the low-activity group (84 participants; 61.3%), the high-activity group (53 participants; 38.7%) experienced significantly less pain (mean estimate, -8.958; P = 0.0114; 95% confidence interval, -15.868 to -2.049) and consumed fewer analgesics (odds ratio, 0.443; P &lt;0.0318; 95% confidence interval, 0.199 to 0.786) during the study period.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Physical activity has a significant influence on orthodontic pain perception and analgesic consumption in adolescents undergoing orthodontic treatment. Further research is needed on this topic to elucidate the association between physical activity and orthodontic pain.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sandhu</LastName>
<ForeName>Satpal S</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>Professor, Department of Orthodontics and Dentofacial Orthopedics, Genesis Institute of Dental Sciences and Research, Ferozepur, Punjab, India. Electronic address: drsatpalsandhu@yahoo.co.in.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sandhu</LastName>
<ForeName>Jasleen</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Private practice, Jalandhar, Punjab, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432318</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Compliance by state-subsidized and self-pay orthodontic patients.</ArticleTitle>
<Pagination>
<MedlinePgn>628-32</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.05.018</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00769-6</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Medicaid is a needs-based program in the United States that subsidizes medical and dental care for minors. The purpose of this study was to test for compliance differences between self-pay and Medicaid-supported patients.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Medicaid patient records (n = 88) were perused retrospectively for characteristics that distract from an orthodontist's workflow (missed appointments, broken brackets, treatment duration, and so on) and compared with a sample (n = 145) of self-pay patients from the same teaching clinic. Differences in treatment difficulty were adjusted by subject selection and statistically (analysis of covariance).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Medicaid patients were younger (mean age, 14.1 vs 14.9 years) and significantly more likely to be dismissed from treatment (19% vs 4%), generally for noncompliance. Broken brackets and missed appointments were more common in the Medicaid sample. There was no difference in the number of appointments in those completing treatment, but treatment duration was significantly longer for the Medicaid patients who completed treatment (29 vs 25 months). Commute distance and estimated driving time were significantly shorter for the Medicaid-assisted group.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Greater difficulty in managing Medicaid patients may partly explain why they are underserved. Prospective studies are needed to clarify the causes of the differences.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wilson</LastName>
<ForeName>Joshua J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>Postgraduate student, Department of Orthodontics, Health Science Center, University of Tennessee, Memphis, Tenn.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Harris</LastName>
<ForeName>Edward F</ForeName>
<Initials>EF</Initials>
<AffiliationInfo>
<Affiliation>Professor, Department of Orthodontics, Health Science Center, University of Tennessee, Memphis, Tenn. Electronic address: eharris@uthsc.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432319</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Mandibular changes secondary to serial extractions compared with late premolar extractions and controls.</ArticleTitle>
<Pagination>
<MedlinePgn>633-40</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.04.036</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00772-6</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Variations in treatment times for serial extraction and late premolar extraction patients may be due to differences in the time needed to flatten the occlusal curves. In this study, we compared tooth tipping and occlusal curves in patients treated by serial extractions or late premolar extractions with untreated controls.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Mandibular dental casts and cephalometric radiographs were collected from 90 subjects (30 Class I control subjects, 30 patients with serial extractions, and 30 with late premolar extractions) at 3 time points: T0, baseline for the controls and serial extraction patients; T1, after natural drift and preorthodontics for the controls and the serial extraction patients, and pretreatment for the late premolar extraction patients; and T2, after comprehensive orthodontic treatment for the serial extraction and the late premolar extraction groups. The long axes of the central incisor, canine, and first molar to the palatal plane were measured on digitized headfilms to determine the direction and the amount of tipping between the time points. Three occlusal curves were measured by sphere fitting cusp-tip landmarks on digitized mandibular casts.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">From T0 to T1, incisors and canines in the patients with serial extractions tipped distally. Molars at T1 in the patients with serial extractions were tipped forward more than in the late premolar extraction patients and the controls. From T1 to T2, canines and molars in the patients with serial extractions were uprighted.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Serial extractions produce steeper occlusal curves and distal tipping of the incisors and canines after drift (T1). Posttreatment (T2) occlusal curves in the patients with serial extractions are steeper than in the late premolar extraction patients and controls (except for the curve of Spee). After the serial extractions, orthodontic treatment included incisor and canine proclination, with molar uprighting and occlusal curve flattening.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Feldman</LastName>
<ForeName>Esther</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Formerly, graduate student, Department of Orthodontics, Faculty of Dentistry, University of British Columbia, Vancouver, British Columbia, Canada; private practice, Los Angeles, Calif. Electronic address: estherfeldman@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kennedy</LastName>
<ForeName>David B</ForeName>
<Initials>DB</Initials>
<AffiliationInfo>
<Affiliation>Clinical professor, Department of Orthodontics, Faculty of Dentistry, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aleksejuniene</LastName>
<ForeName>Jolanta</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Assistant professor, Department of Orthodontics, Faculty of Dentistry, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hannam</LastName>
<ForeName>Alan G</ForeName>
<Initials>AG</Initials>
<AffiliationInfo>
<Affiliation>Professor emeritus, Department of Orthodontics, Faculty of Dentistry, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yen</LastName>
<ForeName>Edwin H</ForeName>
<Initials>EH</Initials>
<AffiliationInfo>
<Affiliation>Program director and dean emeritus, Department of Orthodontics, Faculty of Dentistry, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432320</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of maxillary protraction with alternating rapid palatal expansion and constriction vs expansion alone in maxillary retrusive patients: a single-center, randomized controlled trial.</ArticleTitle>
<Pagination>
<MedlinePgn>641-51</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.04.038</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00774-X</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The objective of this randomized controlled trial was to investigate the effects of facemask protraction combined with alternating rapid palatal expansion and constriction (RPE/C) vs rapid palatal expansion (RPE) alone in the early treatment of maxillary retrusive patients.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Patients with a midface deficiency were recruited and randomly allocated into either the control group (RPE) or the intervention group (RPE/C). Eligibility criteria included the following: age 7 to 13 years old, Class III malocclusion, anterior crossbite, ANB less than 0°, Wits appraisal less than -2 mm, A-Np less than 0 mm, and no cleft of lip or palate. The primary outcome was the degree of maxillary forward movement after treatment. The secondary outcomes were the changes of the other cephalometric variables after treatment and the treatment time. Simple randomization was carried out using a random number table at the beginning of the study. Envelopes containing the grouping information were used to ensure allocation concealment from the researchers. Blinding was applicable for cephalometric analysis only. Hyrax palatal expanders and facemask maxillary protraction were used in all patients. Patients in the RPE group were treated with rapid palatal expansion for 1 week. Patients in the RPE/C group were treated with RPE/C for 7 weeks. The expansion or constriction rate was 1 mm per day. Cephalometric analysis with traditional cephalometric measurements and an x-y coordinate system were used to compare the pretreatment and posttreatment cephalometric radiographs. Independent t tests were used to compare the data between the 2 groups.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 44 patients were randomized to either the RPE group or the RPE/C group in a 1:1 ratio. One subject in the RPE group was lost to follow-up during the treatment. Per-protocol analysis was used. All the other 43 patients reached the treatment completion criteria and were analyzed (RPE group: n = 21; RPE/C group: n = 22). The average protraction time was 10.84 months in the RPE group, which was significantly longer than that in the RPE/C group (9.06 months) (effect size [ES], 1.78 [95% CI, 0.15, 3.42; P = 0.033]). Maxillary forward movement increased by 3.04 mm in the RPE/C group, which was significantly greater than that in the RPE group (2.11 mm) (ES, -0.93 [95% CI, -1.65, -0.20; P = 0.013]). The counterclockwise rotation of the palatal plane was 1.73° in the RPE/C group, which was significantly greater than that in the RPE group (0.83°) (ES, 0.90 [95% CI, 0.08, 1.73; P = 0.033]). The degree of mandibular downward and backward rotation was significantly smaller in the RPE/C group (P &lt;0.05). No serious harm was observed during treatment and research.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Facemask maxillary protraction with RPE/C might positively affect the forward movement of the maxilla compared with facemask protraction with RPE alone in the early treatment of maxillary retrusive patients. Although the differences between the groups were statistically significant for forward movement of the maxilla and rotation of the palatal and mandibular planes, these may not be clinically relevant, since the differences were less than 1 mm and 1°, respectively.</AbstractText>
<AbstractText Label="REGISTRATION" NlmCategory="BACKGROUND">This trial was not registered.</AbstractText>
<AbstractText Label="PROTOCOL" NlmCategory="METHODS">The protocol was not published before trial commencement.</AbstractText>
<AbstractText Label="FUNDING" NlmCategory="BACKGROUND">This research was supported by Peking University Research Fund. No conflict of interest is declared.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Weitao</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Assistant professor, Department of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhou</LastName>
<ForeName>Yanheng</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Professor and chair, Department of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, China. Electronic address: yanhengzhou@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Xuedong</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Assistant professor, Department of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Dawei</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Assistant professor, Department of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhou</LastName>
<ForeName>Shaonan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Resident, Department of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432321</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Factors associated with patient and parent satisfaction after orthodontic treatment: a systematic review.</ArticleTitle>
<Pagination>
<MedlinePgn>652-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.04.039</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00775-1</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Our objective was to identify factors associated with orthodontic treatment satisfaction of patients and their caregivers, when applicable.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">MEDLINE via Ovid, PubMed, EBM Reviews and EMBASE via OVIDSP, LILACS, Web of Science, and Google Scholar were searched electronically. Reference lists of included articles were also screened for potential relevant studies missed during the electronic searches. Studies evaluating the satisfaction levels of patients or caregivers after orthodontic treatment were considered. Methodologic quality of the included studies was assessed using a modified Newcastle-Ottawa scale.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighteen studies satisfied the inclusion criteria, representing 2891 patients and 464 parents. The risk of bias was moderate in 13 and low in 4 of the included articles. The studies used different questionnaires and timings to assess postorthodontic treatment satisfaction. Based on the available limited evidence, satisfaction was associated with perceived esthetic outcomes, psychological benefits, and quality of care. The latter was specifically linked to dentist-staff-patient interactions. Dissatisfaction was associated with treatment duration, pain levels and discomfort, and the use of retention appliances. When both assessments were available, the patient's and the parent's satisfaction levels were strongly correlated.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Based on the limited available evidence with moderate risk of bias, we identified factors that appear to be more commonly associated with a high or low level of satisfaction. Consideration of these factors could be important for practitioners attempting to set realistic expectations of their patients and caregivers regarding orthodontic treatment outcomes.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pachêco-Pereira</LastName>
<ForeName>Camila</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Clinical assistant professor, School of Dentistry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada. Electronic address: cppereir@ualberta.ca.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pereira</LastName>
<ForeName>José Roberto</ForeName>
<Initials>JR</Initials>
<AffiliationInfo>
<Affiliation>Private practice, Edmonton, Alberta, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dick</LastName>
<ForeName>Bruce D</ForeName>
<Initials>BD</Initials>
<AffiliationInfo>
<Affiliation>Associate professor, Departments of Anesthesiology and Pain Medicine, Psychiatry and Pediatrics, University of Alberta, Edmonton, Alberta, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Perez</LastName>
<ForeName>Arnaldo</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Doctoral candidate, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Flores-Mir</LastName>
<ForeName>Carlos</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Professor and division head of orthodontics, School of Dentistry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432322</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Treatment of a mandibular functional shift in an adolescent boy with temporomandibular disorder and crossbites.</ArticleTitle>
<Pagination>
<MedlinePgn>660-73</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2014.10.037</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00838-0</ELocationID>
<Abstract>
<AbstractText>A mandibular functional shift usually poses a challenge for orthodontists, especially when it is accompanied by a temporomandibular disorder (TMD). Accurate diagnosis and complete elimination of the etiologic factors are the keys to an esthetic and stable outcome. This article describes the treatment of a teenager with a mandibular functional shift, TMD symptoms, and facial asymmetry resulting from an asymmetric maxillary arch form and multiple crossbites as occlusal interferences. The treatment alternatives and effective orthodontic techniques are described. To optimize the treatment results and prevent the recurrence of the TMD after treatment, the displaced mandible was repositioned by full-time wearing of a splint for 10 months. Adhesive bite-blocks were used to maintain the newly acquired mandibular position during fixed appliance treatment. A series of nickel-titanium and stainless steel rectangular archwires was placed in the maxillary arch to reshape it for 8 months after alignment. Finally, the displaced mandible was steadily seated into its physiologic position with fine occlusion. The TMD symptoms disappeared and never relapsed after treatment. At 2 years 3 months of retention, there was good stability. The combined splint and fixed appliance approach resolved an intractable clinical problem and avoided using additional appliances. An esthetic, functional, and stable outcome was achieved that satisfied both the patient and his parents.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Qi</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>Resident doctor, Department of Stomatology, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mai</LastName>
<ForeName>Zhi-Hui</ForeName>
<Initials>ZH</Initials>
<AffiliationInfo>
<Affiliation>Attending doctor, Department of Stomatology, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lu</LastName>
<ForeName>Hong-Fei</ForeName>
<Initials>HF</Initials>
<AffiliationInfo>
<Affiliation>Associate professor, Department of Stomatology, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Lin</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Attending doctor, Department of Stomatology, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Zheng</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Resident doctor, Department of Stomatology, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ai</LastName>
<ForeName>Hong</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Professor, Department of Stomatology, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Electronic address: shermancq@163.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432323</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Sagittal correction of adolescent patients with modified palatal anchorage plate appliances.</ArticleTitle>
<Pagination>
<MedlinePgn>674-84</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.06.012</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00836-7</ELocationID>
<Abstract>
<AbstractText>The palate has been reported to be a suitable skeletal anchorage site in adolescents and adults. This article introduces new treatment modalities for correction of sagittal discrepancies by molar protraction and distalization with a modified palatal anchorage plate appliance. The effectiveness and versatility of this method are demonstrated in 2 adolescent patients.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kook</LastName>
<ForeName>Yoon-Ah</ForeName>
<Initials>YA</Initials>
<AffiliationInfo>
<Affiliation>Professor, Department of Orthodontics, Seoul St. Mary's Hospital, Catholic University of Korea, Seoul, Korea. Electronic address: kook190036@yahoo.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Park</LastName>
<ForeName>Jae Hyun</ForeName>
<Initials>JH</Initials>
<AffiliationInfo>
<Affiliation>Professor and chair, Postgraduate Orthodontic Program, Arizona School of Dentistry &amp; Oral Health, A. T. Still University, Mesa; adjunct professor, Graduate School of Dentistry, Kyung Hee University, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>YoonJi</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Associate professor, Department of Orthodontics, Seoul St. Mary's Hospital, Catholic University of Korea, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ahn</LastName>
<ForeName>Chee Soo</ForeName>
<Initials>CS</Initials>
<AffiliationInfo>
<Affiliation>Formerly, resident, Department of Orthodontics, Seoul St. Mary's Hospital, Catholic University of Korea, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bayome</LastName>
<ForeName>Mohamed</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Research assistant professor, Graduate School, Catholic University of Korea, Seoul, Korea; visiting professor, Department of Postgraduate Studies, Universidad Autonóma del Paraguay, Asunción, Paraguay.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432324</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Impact on perceived root resorption based on the amount of incisal inclination as determined from conventional panoramic radiography.</ArticleTitle>
<Pagination>
<MedlinePgn>685-91</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.05.019</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00776-3</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Our objective was to measure the impact on perceived root resorption based on the amount of anteroposterior incisal inclination as determined in vitro from conventional panoramic radiography.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A rapid prototyping model was created to mimic different maxillary and mandibular incisal anteroposterior inclinations. Two titanium beads were placed on the incisors at the apical and incisal edges. Panoramic radiographs were obtained, with the incisors changing relative inclination by 10° increments. The length was measured from the midpoint of the bead on the incisal edge to the midpoint of the bead on the apical edge. By using a length of wire of known size, this value was compared in all images to correct for image magnification.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Changes to mandibular incisor anteroposterior inclinations, as either a theoretical proclination or retroclination, resulted in an increase of "apparent" root resorption on a panoramic radiograph. When the maxillary incisors were significantly and severely retroclined, they appeared larger than expected. When the maxillary incisors were mildly retroclined, the length was roughly similar to the theoretical model. When the maxillary incisors were mildly proclined, they appeared shorter than expected.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The foreshortening or forelengthening of incisor root lengths because of incisor inclination vs root resorption cannot be reliably evaluated from panoramic images. The proposed theoretical model helps to understand the direction of the changes produced by the magnification factor. More severe scenarios where either the maxillary or the mandibular teeth are outside the focal trough have not been fully evaluated. The clinical impact of these changes is likely to be questionable.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tieu</LastName>
<ForeName>Long Dao</ForeName>
<Initials>LD</Initials>
<AffiliationInfo>
<Affiliation>Private practice, Calgary, Alberta, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Normando</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Professor, Faculty of Dentistry, Universidade Federal do Pará, Belém, Pará, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Toogood</LastName>
<ForeName>Roger</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Professor, Faculty of Mechanical Engineering, University of Alberta, Edmonton, Alberta, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Flores-Mir</LastName>
<ForeName>Carlos</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Professor and division head of orthodontics, School of Dentistry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada. Electronic address: carlosflores@ualberta.ca.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432325</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Litigation and Legislation. Heeding the advice of others.</ArticleTitle>
<Pagination>
<MedlinePgn>692-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.07.013</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00839-2</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jerrold</LastName>
<ForeName>Laurance</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Program director, Orthodontics and Dentofacial Orthopedics, NYU-Lutheran, Department of Dental Medicine, Brooklyn, NY.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432326</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1097-6752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>148</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title>
<ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation>
</Journal>
<ArticleTitle>Nonparametric methods.</ArticleTitle>
<Pagination>
<MedlinePgn>695</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2015.07.014</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0889-5406(15)00840-9</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pandis</LastName>
<ForeName>Nikolaos</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Private practice, Corfu, Greece; visiting assistant professor, Department of Orthodontics and Dentofacial Orthopedics, School of Dental Medicine/Medical Faculty, University of Bern, Bern, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA>
<NlmUniqueID>8610224</NlmUniqueID>
<ISSNLinking>0889-5406</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26143364</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Differential expression of vascular endothelial growth factor angiogenic factors in different endometrial compartments in women who have an elevated progesterone level before oocyte retrieval, during in vitro fertilization-embryo transfer treatment.</ArticleTitle>
<Pagination>
<MedlinePgn>1030-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.021</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00448-3</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the relationship between endometrial expressions of angiogenic factors around the time of embryo implantation and P level before oocyte retrieval during IVF-ET treatment.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective study.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">University Assisted Reproductive Unit.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">Forty patients were recruited, 20 women with an elevated P level, and 20 women with a normal P level, into cancelled embryo transfer (ET) cycles.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">Endometrial biopsy samples were obtained from women who had an elevated or normal P level 7 days after human chorionic gonadotropin administration. The protein expression levels of VEGF-A, VEGF-C, and PLGF were examined using immunohistochemistry.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">A semiquantitative analysis was performed using histochemical-score analysis of staining intensity in the luminal epithelium, glandular epithelium, and stroma, separately.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">Luminal epithelial expression of vascular endothelial growth factor (VEGF)-A, VEGF-C, and PLGF did not significantly differ in women with elevated or normal P levels before oocyte retrieval. Glandular epithelial expression of VEGF-A, VEGF-C, and PLGF was higher in women with elevated P levels, compared with those with normal P levels. A significantly higher stromal expression of VEGF-A and PLGF was found in women with elevated P levels.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">A high P level before oocyte retrieval was associated with expression of VEGF angiogenic factors in glandular epithelium and stromal compartment around the time of embryo implantation. Our findings suggest that the lower implantation rates observed in this group of women may relate to decreased endometrial receptivity arising from altered expression of angiogenic factors.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Xiaoyan</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Shatin, Hong Kong, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jin</LastName>
<ForeName>Xiaoying</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynaecology, Center for Reproductive Medicine, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Liu</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynaecology, Center for Reproductive Medicine, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Man</LastName>
<ForeName>Chi Wai</ForeName>
<Initials>CW</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Shatin, Hong Kong, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Jin</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Shatin, Hong Kong, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Chi Chiu</ForeName>
<Initials>CC</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Shatin, Hong Kong, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Songying</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynaecology, Center for Reproductive Medicine, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, People's Republic of China. Electronic address: zhangsongying@126.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Tin Chiu</ForeName>
<Initials>TC</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Shatin, Hong Kong, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Implantation</Keyword>
<Keyword MajorTopicYN="N">angiogenesis</Keyword>
<Keyword MajorTopicYN="N">endometrium</Keyword>
<Keyword MajorTopicYN="N">progesterone</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26171996</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Ectopic pregnancy rate increases with the number of retrieved oocytes in autologous in vitro fertilization with non-tubal infertility but not donor/recipient cycles: an analysis of 109,140 clinical pregnancies from the Society for Assisted Reproductive Technology registry.</ArticleTitle>
<Pagination>
<MedlinePgn>873-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.025</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00452-5</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study the impact of controlled ovarian stimulation on ectopic pregnancy (EP) rate as a function of the number of oocytes retrieved, using donor IVF cycles as a control.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective cohort study using a large national database.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Not applicable.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">Data from 109,140 cycles from the 2008-2010 SART registry, including 91,504 autologous cycles and 17,636 donor cycles in patients with non-tubal infertility.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">Varying amounts of oocytes retrieved in autologous and donor IVF.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Ectopic pregnancy rates.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">In autologous cycles, the EP rate significantly increased as oocyte yield increased. This association was not found in oocyte recipients.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">In autologous IVF cycles, increasing oocyte yield is correlated with a significantly increased EP rate. This association is not found in oocyte recipients, indicating that the increased EP rate may be due to the supraphysiologic hormone levels achieved with controlled ovarian hyperstimulation.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Acharya</LastName>
<ForeName>Kelly S</ForeName>
<Initials>KS</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Endocrinology and Infertility, Duke University, Durham, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Acharya</LastName>
<ForeName>Chaitanya R</ForeName>
<Initials>CR</Initials>
<AffiliationInfo>
<Affiliation>Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Provost</LastName>
<ForeName>Meredith P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Endocrinology and Infertility, Duke University, Durham, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yeh</LastName>
<ForeName>Jason S</ForeName>
<Initials>JS</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Endocrinology and Infertility, Duke University, Durham, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Steward</LastName>
<ForeName>Ryan G</ForeName>
<Initials>RG</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Endocrinology and Infertility, Duke University, Durham, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eaton</LastName>
<ForeName>Jennifer L</ForeName>
<Initials>JL</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Endocrinology and Infertility, Duke University, Durham, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Muasher</LastName>
<ForeName>Suheil J</ForeName>
<Initials>SJ</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Endocrinology and Infertility, Duke University, Durham, North Carolina. Electronic address: muashersj@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Ectopic pregnancy</Keyword>
<Keyword MajorTopicYN="N">IVF</Keyword>
<Keyword MajorTopicYN="N">autologous</Keyword>
<Keyword MajorTopicYN="N">donor</Keyword>
<Keyword MajorTopicYN="N">in vitro fertilization</Keyword>
<Keyword MajorTopicYN="N">oocytes</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26171998</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Ongoing pregnancy rates in intrauterine insemination are affected by late follicular-phase progesterone levels.</ArticleTitle>
<Pagination>
<MedlinePgn>879-83</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.026</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00453-7</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine the relationship between serum P levels on the day of hCG administration and ongoing pregnancy rates.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective study.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">University-affiliated private IVF.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">A total of 2,458 couples undergoing IUI.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">Ovarian stimulation with human recombinant FSH.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Ongoing pregnancy and miscarriage rates.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">Progesterone concentrations were significantly higher given that the E2 concentration increased. Ongoing pregnancy rates were significantly decreased in women with P levels higher than 1.1 ng/mL; similar results were obtained in relation to miscarriage rates.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">Significant differences in ongoing pregnancy rates when P levels were elevated on the day of hCG administration may help clinicians to counsel patients about the reduced success rates with IUI and manage the timing of insemination to optimize implantation.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Requena</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Reproductive Medicine, Instituto Valenciano de Infertilidad Madrid, Madrid, Spain. Electronic address: antonio.requena@ivi.es.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cruz</LastName>
<ForeName>María</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Reproductive Medicine, Instituto Valenciano de Infertilidad Madrid, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pacheco</LastName>
<ForeName>Alberto</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Reproductive Medicine, Instituto Valenciano de Infertilidad Madrid, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>García-Velasco</LastName>
<ForeName>Juan Antonio</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>Department of Reproductive Medicine, Instituto Valenciano de Infertilidad Madrid, Madrid, Spain; Departments of Nursing, Gynecology and Obstetrics, Pediatrics, and Psychiatry, Faculty of Health Sciences, Rey Juan Carlos University, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Progesterone levels</Keyword>
<Keyword MajorTopicYN="N">intrauterine insemination</Keyword>
<Keyword MajorTopicYN="N">ongoing pregnancy</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26183313</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Two new automated, compared with two enzyme-linked immunosorbent, antimüllerian hormone assays.</ArticleTitle>
<Pagination>
<MedlinePgn>1016-1021.e6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.024</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00451-3</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare new automated antimüllerian hormone (AMH) assay performance characteristics from the new automated Elecsys AMH (Roche; Elecsys) and Access AMH (Beckman Coulter; Access) assays with the existing AMH Gen II ELISA (enzyme-linked immunosorbent assay; Gen II; Beckman Coulter) and AMH ELISA (Ansh Labs) assays.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective assay evaluation.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">University-affiliated clinical chemistry laboratory.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">Patients referred for serum AMH measurement (n = 83) before start of in vitro fertilization cycle between September 2014 and October 2014.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">None.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Serum AMH concentration.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">Intra-assay coefficients of variation were low; Ansh ≤ 9.0%; Gen II ≤ 5.8%; Access ≤ 10.7%; and Elecsys ≤ 2.8%. The Passing-Bablok regression equations (pmol/L) were y (Access) = 0.128 + (0.781 × Gen II); and y (Access) = 0.302 + (0.742 x Ansh). For y (Elecys) = 0.087 + (0.729 x Gen II) and y (Elecys) = 0.253 + (0.688 x Ansh Labs). For y (Elecys) = 0.943 - (0.037 × Access). For all the assays, AMH exhibited a moderate positive correlation with AFC (r = 0.62-0.64); number of cumulus oocyte complexes (r = 0.60-0.64); and metaphase II oocytes (r = 0.48-0.50). Accuracy of pregnancy prediction, as determined by area under the receiver operating characteristic curve, was uniformly low for all assays (0.62-0.63).</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">The novel automated assays exhibit strong concordance in calibration, but derived values are substantially lower than those obtained from pre-existing assays, with assay-specific interpretation required for routine clinical use. These results highlight the need for an international standard of measurement of AMH.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nelson</LastName>
<ForeName>Scott M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>School of Medicine, University of Glasgow, Glasgow, United Kingdom. Electronic address: scott.nelson@glasgow.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pastuszek</LastName>
<ForeName>Ewa</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>NVICTA Fertility and Reproductive Center, Gdansk, Poland; Department of Nursing, Medical University, Gdansk, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kloss</LastName>
<ForeName>Grzegorz</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>NVICTA Fertility and Reproductive Center, Gdansk, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Malinowska</LastName>
<ForeName>Iwona</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>NVICTA Fertility and Reproductive Center, Gdansk, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liss</LastName>
<ForeName>Joanna</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>NVICTA Fertility and Reproductive Center, Gdansk, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lukaszuk</LastName>
<ForeName>Aron</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>NVICTA Fertility and Reproductive Center, Gdansk, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Plociennik</LastName>
<ForeName>Lukasz</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>NVICTA Fertility and Reproductive Center, Gdansk, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lukaszuk</LastName>
<ForeName>Krzysztof</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>NVICTA Fertility and Reproductive Center, Gdansk, Poland; Department of Nursing, Medical University, Gdansk, Poland; INVICTA Fertility and Reproductive Center, Warsaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Antimüllerian hormone</Keyword>
<Keyword MajorTopicYN="N">antral follicle count</Keyword>
<Keyword MajorTopicYN="N">assay</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26183314</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Use of suboptimal sperm increases the risk of aneuploidy of the sex chromosomes in preimplantation blastocyst embryos.</ArticleTitle>
<Pagination>
<MedlinePgn>866-72</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.033</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00460-4</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare autosomal and sex chromosome aneuploidy rates of embryos derived from sperm with abnormal and normal parameters.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective cohort study.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Assisted reproduction center.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">Three thousand eight hundred thirty-five embryos generated from 629 couples undergoing IVF.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">None.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Incidence of aneuploidy in the trophectoderm of blastocyst embryos derived from standard IVF embryos and intracytoplasmic (ICSI) males with normal and oligozoospermic semen samples, in couples with donor eggs (mean maternal age, 25.0 years) and their own eggs (mean maternal age, 35.4 years).</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">The rate of sex chromosome aneuploidy was significantly (around threefold) higher in the oligozoospermic group compared with in both control groups (standard vs. ICSI insemination). This applied whether donor (young) or own (older) eggs were used. Significant differences were seen in the oligozoospermic samples for autosomes 1, 2, 11 (own eggs), and 18 (donor eggs) compared with both control groups; however, no significant difference was seen between each of the treatment groups for the overall rate of autosomal aneuploidy. No significant differences were seen between the two control groups (normozoospermic males, standard vs. ICSI insemination) in either of the egg group types for any chromosome pairs.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">Severe male factor infertility is associated with a significant increase in the occurrence of sex chromosome abnormalities in blastocyst embryos compared with in embryos derived from normal semen samples. Aneuploidy rates in embryos derived from sperm with normal parameters were not significantly different whether ICSI or standard insemination was used to achieve fertilization. These results highlight severe male factor infertility as a possible referral category for preimplantation comprehensive chromosomal screening.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Coates</LastName>
<ForeName>Alison</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Oregon Reproductive Medicine, Portland, Oregon; School of Biosciences, University of Kent, Canterbury, Kent, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hesla</LastName>
<ForeName>John S</ForeName>
<Initials>JS</Initials>
<AffiliationInfo>
<Affiliation>Oregon Reproductive Medicine, Portland, Oregon.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hurliman</LastName>
<ForeName>Amanda</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Oregon Reproductive Medicine, Portland, Oregon.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Coate</LastName>
<ForeName>Breanne</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Oregon Reproductive Medicine, Portland, Oregon.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Holmes</LastName>
<ForeName>Elizabeth</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Oregon Reproductive Medicine, Portland, Oregon.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Matthews</LastName>
<ForeName>Rebecca</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Oregon Reproductive Medicine, Portland, Oregon.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mounts</LastName>
<ForeName>Emily L</ForeName>
<Initials>EL</Initials>
<AffiliationInfo>
<Affiliation>Oregon Reproductive Medicine, Portland, Oregon.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Turner</LastName>
<ForeName>Kara J</ForeName>
<Initials>KJ</Initials>
<AffiliationInfo>
<Affiliation>School of Biosciences, University of Kent, Canterbury, Kent, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thornhill</LastName>
<ForeName>Alan R</ForeName>
<Initials>AR</Initials>
<AffiliationInfo>
<Affiliation>School of Biosciences, University of Kent, Canterbury, Kent, United Kingdom; Illumina, Cambridge, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Griffin</LastName>
<ForeName>Darren K</ForeName>
<Initials>DK</Initials>
<AffiliationInfo>
<Affiliation>School of Biosciences, University of Kent, Canterbury, Kent, United Kingdom. Electronic address: d.k.griffin@kent.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">ICSI</Keyword>
<Keyword MajorTopicYN="N">Sex chromosome</Keyword>
<Keyword MajorTopicYN="N">aneuploidy</Keyword>
<Keyword MajorTopicYN="N">autosome</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26187300</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Intercycle variability of the ovarian response in patients undergoing repeated stimulation with corifollitropin alfa in a gonadotropin-releasing hormone antagonist protocol.</ArticleTitle>
<Pagination>
<MedlinePgn>884-890.e2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.027</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00454-9</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine whether individual subject variation in ovarian response between repeated cycles with the same ovarian stimulation protocol can be predicted.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective data analysis.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Multicenter, open-label, uncontrolled clinical trial.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">Women aged 18-39 from a phase 3, open-label, uncontrolled trial with complete data across all cycles (n = 176).</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">Up to three cycles of a single injection of 150 μg corifollitropin alfa for 7 days, then daily recombinant FSH/hMG until three follicles reached ≥17 mm. Gonadotropin-releasing hormone antagonist from stimulation day 5 until day of hCG administration.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Numbers of follicles ≥11 mm on day of hCG in cycles 1-3, transition in ovarian response type between cycles from low (0-&lt;6), normal (6-&lt;18), and high (≥18), and serum FSH concentrations and antral follicle count (AFC) at each cycle start.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">The mean (SD) numbers of follicles ≥11 mm on day of hCG were 13.4 (6.2), 13.3 (5.4), and 13.8 (6.4) in cycles 1, 2 and 3, respectively. Between cycles 1 and 2, 11.9% switched from normal to low or high response, and 12.5% switched from low or high to normal response; 75.6% remained in the same category. Between cycles 2 and 3, 15.9% switched from normal to low or high response, and 10.2% switched from low or high to normal response; 73.9% remained in the same category. These shifts are symmetrical in nature, in that the percentage of subjects who shift from normal to low or high response is comparable to the percentage of subjects who shift from low or high to normal response. Baseline FSH and AFC did not significantly predict transition in ovarian response.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">The variability in ovarian responses between repeated cycles using the same protocol was not explained by baseline FSH and AFC.</AbstractText>
<AbstractText Label="CLINICAL TRIAL REGISTRATION NUMBER" NlmCategory="BACKGROUND">NCT00696878 Protocol P05714.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rombauts</LastName>
<ForeName>Luk</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia; Monash IVF, Clayton, Victoria, Australia. Electronic address: lrombauts@monashivf.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lambalk</LastName>
<ForeName>Cornelis B</ForeName>
<Initials>CB</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics/Gynecology, VU University Medical Center, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schultze-Mosgau</LastName>
<ForeName>Askan</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Reproductive Medicine and Gynecologic Endocrinology, University Clinic of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van Kuijk</LastName>
<ForeName>Jacqueline</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>MSD Oss N.V., Oss, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Verweij</LastName>
<ForeName>Pierre</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>MSD Oss N.V., Oss, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gates</LastName>
<ForeName>Davis</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Merck &amp; Co., Inc., Kenilworth, New Jersey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gordon</LastName>
<ForeName>Keith</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Merck &amp; Co., Inc., Kenilworth, New Jersey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Griesinger</LastName>
<ForeName>Georg</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Reproductive Medicine and Gynecologic Endocrinology, University Clinic of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList>
<AccessionNumber>NCT00696878</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Corifollitropin alfa</Keyword>
<Keyword MajorTopicYN="N">GnRH antagonist</Keyword>
<Keyword MajorTopicYN="N">controlled ovarian stimulation</Keyword>
<Keyword MajorTopicYN="N">ovarian response</Keyword>
<Keyword MajorTopicYN="N">repeated ovarian stimulation</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26196233</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Antimüllerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization.</ArticleTitle>
<Pagination>
<MedlinePgn>891-898.e2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.030</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00457-4</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the accuracy of antimüllerian hormone (AMH) in predicting cumulative live birth rate (CLBR) within 1 year after treatment initiation in GnRH antagonist treatment cycles for in vitro fertilization (IVF).</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Observational (retrospective) substudy as part of an ongoing prospective cohort study.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">University medical center.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">A total of 487 patients scheduled for IVF/intracytoplasmic sperm injection (ICSI).</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">Patients starting their first IVF/ICSI cycle with 150 or 225 IU recombinant FSH and GnRH antagonist cotreatment were included. Serum samples collected before the first IVF treatment were used to determine AMH. Treatment data after treatment initiation for a maximum of 1 year were recorded.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Prediction of CLBR with the use of AMH.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">The model for predicting CLBR within 1 year included age at first treatment, AMH, type of infertility, and previous assisted reproductive technology treatment leading to live birth. The accuracy in discriminating between women who did or did not achieve a live birth was only 59%. AMH had intermediate added value in the prediction of CLBR as demonstrated by the net reclassification improvement (total 29.8). A nomogram based on age and AMH was developed by which a subgroup of patients could be identified with the poorest pregnancy prospects.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">The predictive accuracy of AMH for 1-year CLBR in GnRH antagonist treatment cycles was limited and did not yield much additional value on top of age. Withholding treatment based on predictors such as age and AMH, or a combination, remains problematic.</AbstractText>
<AbstractText Label="CLINICAL TRIAL REGISTRATION NUMBER" NlmCategory="BACKGROUND">www.clinicaltrials.gov, NCT02309073.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hamdine</LastName>
<ForeName>Ouijdane</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Department of Reproductive Medicine and Gynecology, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: o.hamdine@umcutrecht.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eijkemans</LastName>
<ForeName>Marinus J C</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Reproductive Medicine and Gynecology, University Medical Center Utrecht, Utrecht, the Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lentjes</LastName>
<ForeName>Eef G W</ForeName>
<Initials>EG</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Torrance</LastName>
<ForeName>Helen L</ForeName>
<Initials>HL</Initials>
<AffiliationInfo>
<Affiliation>Department of Reproductive Medicine and Gynecology, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Macklon</LastName>
<ForeName>Nick S</ForeName>
<Initials>NS</Initials>
<AffiliationInfo>
<Affiliation>Department of Reproductive Medicine and Gynecology, University Medical Center Utrecht, Utrecht, the Netherlands; Academic Unit of Human Development and Health, Princess Anne Hospital, University of Southampton, Southampton, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fauser</LastName>
<ForeName>Bart C J M</ForeName>
<Initials>BC</Initials>
<AffiliationInfo>
<Affiliation>Department of Reproductive Medicine and Gynecology, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Broekmans</LastName>
<ForeName>Frank J</ForeName>
<Initials>FJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Reproductive Medicine and Gynecology, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList>
<AccessionNumber>NCT02309073</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">AMH</Keyword>
<Keyword MajorTopicYN="N">GnRH antagonist</Keyword>
<Keyword MajorTopicYN="N">IVF</Keyword>
<Keyword MajorTopicYN="N">live birth</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26196234</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>New strategy for diagnosing embryo implantation potential by combining proteomics and time-lapse technologies.</ArticleTitle>
<Pagination>
<MedlinePgn>908-14</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.032</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00459-8</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To develop a diagnostic tool for embryo implantation potential with the use of proteomic fingerprinting combined with time-lapse morphokinetic analysis.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective cohort study.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">University-affiliated private in vitro fertilization center.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">Seventeen infertile patients undergoing intracytoplasmic sperm injection (ICSI) from our ovum donation program.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">No patient intervention. We examined morphokinetic data and proteomic data from the spent media of 16 embryos that implanted and 12 embryos that did not implant.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">We analyzed seven proteins in the embryo spent media-SCF, TNFR1, PIGF-1, IFN-α2, IL-6, CXCL13, and GM-CSF-with the use of a bead-based multiplexing technology and combined this data with the exact timing (in hours) of cell cycle duration (cc2), blastomere synchrony (s2), and 5-blastomere cleavage (t5) with the use of an incubator equipped with time-lapse videography.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">Logistic regression analysis with the use of the forward-step likelihood selection method revealed that the presence/absence of interleukin (IL) 6 and the duration of cc2 were the most relevant embryo features for embryo selection. We combined these two parameters to obtain a hierarchic model that established four categories (A/B/C/D), based on the presence of IL-6 and a cc2 range of 5-12 hours. A direct relationship was observed between the morphologic categories and implantation rates: Those with the presence of IL-6 and 5-12 h cc2 had significantly higher implantation rates.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">The strategy we report here combines time-lapse and proteome analysis to improve embryo selection while minimizing handling and monitoring by the embryologist. Our results describe the utility of a combined biochemical/morphokinetic approach to select embryos for transfer according to their implantation potential. Clinical validation with larger sample sizes is mandatory to confirm the effectiveness of this initial study.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dominguez</LastName>
<ForeName>Francisco</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Fundacion Instituto Valenciano de Infertilidad (FIVI), Instituto Universitario IVI (IUIVI), Valencia, Spain; INCLIVA Biomedical Research Institute, Valencia, Spain INCLIVA, Valencia, Spain. Electronic address: francisco.dominguez@ivi.es.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Meseguer</LastName>
<ForeName>Marcos</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>INCLIVA Biomedical Research Institute, Valencia, Spain INCLIVA, Valencia, Spain; IVI Valencia, Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aparicio-Ruiz</LastName>
<ForeName>Belen</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>IVI Valencia, Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Piqueras</LastName>
<ForeName>Paloma</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>IVI Valencia, Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Quiñonero</LastName>
<ForeName>Alicia</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Fundacion Instituto Valenciano de Infertilidad (FIVI), Instituto Universitario IVI (IUIVI), Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Simón</LastName>
<ForeName>Carlos</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Fundacion Instituto Valenciano de Infertilidad (FIVI), Instituto Universitario IVI (IUIVI), Valencia, Spain; INCLIVA Biomedical Research Institute, Valencia, Spain INCLIVA, Valencia, Spain; IVI Valencia, Valencia, Spain; Department of Obstetrics and Gynecology, Stanford University, Stanford, California.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Embryo kinetics</Keyword>
<Keyword MajorTopicYN="N">IL-6</Keyword>
<Keyword MajorTopicYN="N">blastocyst</Keyword>
<Keyword MajorTopicYN="N">implantation potential</Keyword>
<Keyword MajorTopicYN="N">proteomics</Keyword>
<Keyword MajorTopicYN="N">time lapse</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26206343</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Circulating miR-200-family micro-RNAs have altered plasma levels in patients with endometriosis and vary with blood collection time.</ArticleTitle>
<Pagination>
<MedlinePgn>938-946.e2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.029</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00456-2</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine whether circulating micro-RNA (miR) 200a, miR-200b, and miR-141 have altered levels in patients with endometriosis compared with control individuals.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Experimental laboratory study.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">University.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">Patients with endometriosis (n = 61), laparoscopically confirmed endometriosis-free women (n = 35), and self-reported healthy women (n = 30) were included in the study.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">None.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Plasma miRNA levels in endometriosis patients and control subjects.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">We found that the levels of studied miRNAs varied with blood collection time, being lower in the morning than in the evening. When blood collection time was taken into account, the results revealed significantly lower levels of miR-200a and miR-141 in the evening plasma samples of women with endometriosis compared with surgically confirmed disease-free patients. However, the evening-sample levels of all three miRNAs were significantly lower in patients with stage I-II endometriosis than in endometriosis-free control subjects. In cases of stage III-IV endometriosis, only miR-200a levels were significantly lower compared with patients without endometriosis. Circulating miR-200a showed the best discriminative power to differentiate women with endometriosis from patients with similar complaints but without the disease.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">Our findings suggest that miR-200a and miR-141 have a potential as novel noninvasive biomarkers for endometriosis. In addition, we found that the plasma miR-200a, miR-200b and miR-141 levels vary with blood sampling time, so it is important to take the sample collection time into account when studying miRNAs as biomarkers.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rekker</LastName>
<ForeName>Kadri</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, University of Tartu, Tartu, Estonia; Competence Center on Health Technologies, Tartu, Estonia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Saare</LastName>
<ForeName>Merli</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, University of Tartu, Tartu, Estonia; Competence Center on Health Technologies, Tartu, Estonia; Institute of Bio- and Translational Medicine, University of Tartu, Tartu, Estonia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Roost</LastName>
<ForeName>Anne Mari</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Competence Center on Health Technologies, Tartu, Estonia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kaart</LastName>
<ForeName>Tanel</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Estonian University of Life Sciences, Institute of Veterinary Medicine and Animal Sciences, Tartu, Estonia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sõritsa</LastName>
<ForeName>Deniss</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Competence Center on Health Technologies, Tartu, Estonia; Tartu University Hospital's Women's Clinic, Tartu, Estonia; Elite Clinic, Tartu, Estonia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Karro</LastName>
<ForeName>Helle</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, University of Tartu, Tartu, Estonia; Tartu University Hospital's Women's Clinic, Tartu, Estonia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sõritsa</LastName>
<ForeName>Andrei</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Elite Clinic, Tartu, Estonia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Simón</LastName>
<ForeName>Carlos</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Fundación Instituto Valenciano de Infertilidad, Instituto Universitario IVI, University of Valencia, Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Salumets</LastName>
<ForeName>Andres</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, University of Tartu, Tartu, Estonia; Competence Center on Health Technologies, Tartu, Estonia; Institute of Bio- and Translational Medicine, University of Tartu, Tartu, Estonia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peters</LastName>
<ForeName>Maire</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, University of Tartu, Tartu, Estonia; Competence Center on Health Technologies, Tartu, Estonia. Electronic address: maire.peters@ut.ee.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">biomarker</Keyword>
<Keyword MajorTopicYN="N">circadian rhythm</Keyword>
<Keyword MajorTopicYN="N">endometriosis</Keyword>
<Keyword MajorTopicYN="N">miR-200 family</Keyword>
<Keyword MajorTopicYN="N">miRNA</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26206344</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>10</Month>
<Day>05</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Men's meat intake and treatment outcomes among couples undergoing assisted reproduction.</ArticleTitle>
<Pagination>
<MedlinePgn>972-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.037</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00464-1</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study the relationship between men's meat intake and clinical outcomes in couples undergoing infertility treatment with the use of assisted reproductive technology (ART).</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective cohort study.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Fertility center.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">A total of 141 men whose female partners underwent 246 ART cycles from 2007 to 2014.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">None. Total and specific types of meat intake were estimated from dietary questionnaires.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Fertilization, implantation, clinical pregnancy, and live-birth rates per initiated cycle. Mixed-effects models account for multiple IVF cycles per woman.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">There was a positive association between poultry intake and fertilization rate, with a 13% higher fertilization rate among men in the highest quartile of poultry intake compared with those in the lowest quartile (78% vs. 65%). Processed meat intake was inversely related to fertilization rate in conventional IVF cycles but not in IVF cycles using intracytoplasmic sperm injection. The adjusted fertilization rates for men in increasing quartiles of processed meat intake were 82%, 67%, 70%, and 54% in conventional IVF cycles. Men's total meat intake, including intake of specific types of meat, was not associated with implantation, clinical pregnancy, or live-birth rates.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">Poultry intake was positively associated with fertilization rates, whereas processed meat intake was negatively associated with fertilization rates among couples undergoing conventional IVF. This, however, did not translate into associations with clinical pregnancy or live-birth rates.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Xia</LastName>
<ForeName>Wei</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Family Planning Research, Tongji Medical College, Huazhong University of Science and Technology, Hubei, People's Republic of China; Reproductive Medicine Center, Tongji Medical College, Huazhong University of Science and Technology, Hubei, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chiu</LastName>
<ForeName>Yu-Han</ForeName>
<Initials>YH</Initials>
<AffiliationInfo>
<Affiliation>Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Williams</LastName>
<ForeName>Paige L</ForeName>
<Initials>PL</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gaskins</LastName>
<ForeName>Audrey J</ForeName>
<Initials>AJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Toth</LastName>
<ForeName>Thomas L</ForeName>
<Initials>TL</Initials>
<AffiliationInfo>
<Affiliation>Vincent Obstetrics and Gynecology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tanrikut</LastName>
<ForeName>Cigdem</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Urology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hauser</LastName>
<ForeName>Russ</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Vincent Obstetrics and Gynecology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chavarro</LastName>
<ForeName>Jorge E</ForeName>
<Initials>JE</Initials>
<AffiliationInfo>
<Affiliation>Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: jchavarr@hsph.harvard.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>L50 HD056672</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 DK046200</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 ES000002</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30DK46200</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30ES000002</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 ES009718</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 ES022955</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01ES009718</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01ES022955</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 DK007703</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32DK007703</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Reprod. 1991 Jul;6(6):811-6</RefSource>
<PMID Version="1">1757519</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 1992 May 15;135(10):1114-26; discussion 1127-36</RefSource>
<PMID Version="1">1632423</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Diet Assoc. 1993 Jul;93(7):790-6</RefSource>
<PMID Version="1">8320406</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Reprod. 2007 Jun;22(6):1497-502</RefSource>
<PMID Version="1">17392290</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Androl. 2008 Sep;31(5):499-507</RefSource>
<PMID Version="1">17651398</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Reprod. 2008 Nov;23(11):2584-90</RefSource>
<PMID Version="1">18650557</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2009 Mar;91(3):812-8</RefSource>
<PMID Version="1">18314116</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 2010 Apr 15;171(8):883-91</RefSource>
<PMID Version="1">20338976</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2010 May 1;93(7):2222-31</RefSource>
<PMID Version="1">19261274</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Jul;35(7):738-42</RefSource>
<PMID Version="1">20693717</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Public Health Nutr. 2011 Apr;14(4):575-83</RefSource>
<PMID Version="1">21070685</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2012 Jan;97(1):53-9</RefSource>
<PMID Version="1">22078783</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Reprod. 2012 May;27(5):1466-74</RefSource>
<PMID Version="1">22416013</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Reprod. 2012 Aug;27(8):2526-31</RefSource>
<PMID Version="1">22593431</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Reprod. 2012 Sep;27(9):2807-14</RefSource>
<PMID Version="1">22752607</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Reprod. 2012 Oct;27(10):2899-907</RefSource>
<PMID Version="1">22888168</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Reprod. 2012 Nov;27(11):3328-36</RefSource>
<PMID Version="1">22940769</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2012 Nov;98(5):1193-9.e1</RefSource>
<PMID Version="1">22884013</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Clin Nutr. 2013 Feb;97(2):411-8</RefSource>
<PMID Version="1">23269819</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2013 Apr;99(5):1324-1331.e1</RefSource>
<PMID Version="1">23290741</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2014 Feb;101(2):453-62</RefSource>
<PMID Version="1">24239161</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Epidemiology. 2014 May;25(3):323-30</RefSource>
<PMID Version="1">24681577</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Nutr. 2014 Jul;144(7):1091-8</RefSource>
<PMID Version="1">24850626</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">NIHMS707481 [Available on 10/01/16]</OtherID>
<OtherID Source="NLM">PMC4592805 [Available on 10/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cohort studies</Keyword>
<Keyword MajorTopicYN="N">assisted reproductive technology</Keyword>
<Keyword MajorTopicYN="N">infertility</Keyword>
<Keyword MajorTopicYN="N">meat intake</Keyword>
<Keyword MajorTopicYN="N">men</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26207958</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Pregnancy outcomes in women with chronic endometritis and recurrent pregnancy loss.</ArticleTitle>
<Pagination>
<MedlinePgn>927-31</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.044</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00473-2</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the prevalence of chronic endometritis (CE) in women with recurrent pregnancy loss (RPL) and compare pregnancy outcomes in women with and without CE.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Case-control observational study.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Academic fertility practice.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">Women with two or more pregnancy losses.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">Hematoxylin and eosin (H &amp; E) staining was performed on all endometrial biopsies and plasma cells were identified by morphology. Immunohistochemical (IHC) staining for CD138 was later applied to all tissue samples. Charts were reviewed to evaluate the outcome of the next clinical intrauterine pregnancy.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Miscarriage rate and live birth rate.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">A total of 107 women met inclusion criteria. The use of CD138 IHC staining resulted in a significantly higher prevalence of CE compared with the use of H &amp; E staining and morphological assessment alone (56% [60/107] vs. 13% [14/107]). The 51 women with untreated CE were compared with the 45 women without CE by CD138 staining. Among those women with a subsequent pregnancy, the live birth rate in the next clinical intrauterine pregnancy after endometrial evaluation was 67.6% (23/34) in women with untreated CE and 87.1% (27/31) in women without CE. Age, body mass index (BMI), results of RPL evaluation, and number of prior losses were not significantly different between the two groups.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">CD138 IHC staining of endometrial biopsies in women with RPL provides increased sensitivity when screening for CE compared with H &amp; E staining and morphological assessment alone. Untreated CE may contribute to poor pregnancy outcomes and deserves further investigation in a larger cohort.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>McQueen</LastName>
<ForeName>Dana B</ForeName>
<Initials>DB</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, The University of Chicago, Chicago, Illinois.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Perfetto</LastName>
<ForeName>Candice O</ForeName>
<Initials>CO</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Stanford University, Palo Alto, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hazard</LastName>
<ForeName>Florette K</ForeName>
<Initials>FK</Initials>
<AffiliationInfo>
<Affiliation>Departments of Pathology and Pediatrics, Stanford University School of Medicine, Stanford, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lathi</LastName>
<ForeName>Ruth B</ForeName>
<Initials>RB</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Stanford University, Palo Alto, California. Electronic address: rlathi@stanford.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Chronic endometritis</Keyword>
<Keyword MajorTopicYN="N">miscarriage</Keyword>
<Keyword MajorTopicYN="N">pregnancy loss</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26207960</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Live delivery outcome after tubal sterilization reversal: a population-based study.</ArticleTitle>
<Pagination>
<MedlinePgn>921-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.042</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00471-9</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine the cumulative incidence of live delivery in women who underwent reversal of tubal sterilization.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Population-based retrospective cohort study.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Hospitals in Western Australia.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">All women aged 20-44 years, with a history of hospital admission for tubal sterilization, who subsequently underwent reversal of sterilization during the period 1985 to 2009 in Western Australia (n = 1,898).</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">Data regarding reversal of sterilization and prior tubal sterilization were extracted from routinely collected administrative hospital separation records, until commencement of IVF treatment.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">First live-delivery rates.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">There were 969 first live deliveries observed during the study period. The overall cumulative live-delivery rate was 20% (95% confidence interval [CI] 18-23) within the first year after reversal, 40% (95% CI 38-42) at 2 years, 51% (95% CI 48-53) at 5 years, and 52% (95% CI 50-55) at 10 years. The 5-year cumulative live-delivery rate was significantly lower in women who were aged 40-44 years (26%) compared with younger women (aged 20-29, 30-34, and 35-39 years) (50%, 56%, and 51%, respectively).</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">Women undergoing reversal of sterilization before they reach age 40 years have at least a 50% chance of delivering a live baby within the next 5 years. Up to that age, there is no significant difference in live deliveries. The live-delivery rate halves after the age of 40 years.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Malacova</LastName>
<ForeName>Eva</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Centre for Health Services Research, School of Population Health, The University of Western Australia, Crawley, Western Australia, Australia; School of Paediatrics and Child Health, The University of Western Australia, Crawley, Western Australia, Australia. Electronic address: eva.malacova@uwa.edu.au.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kemp-Casey</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Centre for Health Services Research, School of Population Health, The University of Western Australia, Crawley, Western Australia, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bremner</LastName>
<ForeName>Alexandra</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Centre for Health Services Research, School of Population Health, The University of Western Australia, Crawley, Western Australia, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hart</LastName>
<ForeName>Roger</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>School of Women's and Infants Health, The University of Western Australia, Crawley, Western Australia, Australia; Fertility Specialists of Western Australia, Claremont, Western Australia, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stewart</LastName>
<ForeName>Louise Maree</ForeName>
<Initials>LM</Initials>
<AffiliationInfo>
<Affiliation>Centre for Population Health Research, Faculty of Health Sciences, Curtin University, Bentley, Western Australia, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Preen</LastName>
<ForeName>David Brian</ForeName>
<Initials>DB</Initials>
<AffiliationInfo>
<Affiliation>Centre for Health Services Research, School of Population Health, The University of Western Australia, Crawley, Western Australia, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cohort studies</Keyword>
<Keyword MajorTopicYN="N">life tables</Keyword>
<Keyword MajorTopicYN="N">live birth</Keyword>
<Keyword MajorTopicYN="N">sterilization reversal</Keyword>
<Keyword MajorTopicYN="N">tubal sterilization</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26207961</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>The time to prevent mendelian genetic diseases from donated or own gametes has come.</ArticleTitle>
<Pagination>
<MedlinePgn>833-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.047</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00504-X</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Garrido</LastName>
<ForeName>Nicolás</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Andrology Laboratory and Semen Bank, Instituto Universitario IVI Valencia, Universidad de Valencia, Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bosch</LastName>
<ForeName>Ernesto</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Andrology Laboratory and Semen Bank, Instituto Universitario IVI Valencia, Universidad de Valencia, Valencia, Spain; Reproductive Medicine, Instituto Universitario IVI Valencia, Universidad de Valencia, Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alamá</LastName>
<ForeName>Pilar</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Andrology Laboratory and Semen Bank, Instituto Universitario IVI Valencia, Universidad de Valencia, Valencia, Spain; Reproductive Medicine, Instituto Universitario IVI Valencia, Universidad de Valencia, Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ruiz</LastName>
<ForeName>Amparo</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Andrology Laboratory and Semen Bank, Instituto Universitario IVI Valencia, Universidad de Valencia, Valencia, Spain; Reproductive Medicine, Instituto Universitario IVI Valencia, Universidad de Valencia, Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26207962</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Single human sperm cryopreservation method using hollow-core agarose capsules.</ArticleTitle>
<Pagination>
<MedlinePgn>1004-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.043</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00472-0</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To develop an efficient cryopreservation method using a single sperm.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Experimental study.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Laboratory of a private institute.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">A fertile donor.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">We produced hollow-core capsules with agarose walls. A single human sperm was injected into each capsule as per the conventional intracytoplasmic sperm injection (ICSI) method. The capsules that contained the spermatozoa were cryopreserved on polycarbonate or nylon mesh sheets using nitrogen vapor. Before their use, the capsules were thawed and recovered. The motile spermatozoa in the capsules were counted.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">The recovery rates of the agarose capsules and the spermatozoa in these capsules after thawing and the mortality and survival rates of the spermatozoa.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">The recovery rates of the capsules were 91.5% (75/82) using polycarbonate sheets (PS) and 98.3% (59/60) using mesh sheets (MS) after thawing. The recovered capsules were not at all damaged. The recovery rates of the spermatozoa were 91.5% (75/82) using PS and 96.7% (58/60) using MS. Sperm motility rates were 85.3% (64/75) and 82.8% (48/58), whereas the survival rates of the immotile spermatozoa by the hypoosmotic swelling test were 81.8% (9/11) and 50.0% (5/10); furthermore, the total survival rates of the spermatozoa were 97.3% (73/75) and 91.4% (53/58) using PS and MS, respectively. There was no significant difference between the results obtained using PS and MS.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">A cryopreservation method for a single sperm using an agarose capsule has been developed. The method is expected to be useful in ICSI treatment in patients with few spermatozoa.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Araki</LastName>
<ForeName>Yasuyuki</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>The Institute for Assisted Reproductive Medical Technology, Fujimi, Maebashi, Gunma, Japan. Electronic address: yasuyuki@armt.net.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yao</LastName>
<ForeName>Tatsuma</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Fuso Pharmaceutical Industries, Ltd., Research and Development Center, Joto, Osaka, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Asayama</LastName>
<ForeName>Yuta</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Fuso Pharmaceutical Industries, Ltd., Research and Development Center, Joto, Osaka, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Matsuhisa</LastName>
<ForeName>Akio</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Fuso Pharmaceutical Industries, Ltd., Research and Development Center, Joto, Osaka, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Araki</LastName>
<ForeName>Yasuhisa</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>The Institute for Assisted Reproductive Medical Technology, Fujimi, Maebashi, Gunma, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Agarose capsule</Keyword>
<Keyword MajorTopicYN="N">a single human sperm</Keyword>
<Keyword MajorTopicYN="N">cryopreservation</Keyword>
<Keyword MajorTopicYN="N">nylon mesh sheets</Keyword>
<Keyword MajorTopicYN="N">polycarbonate sheets</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26209829</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Follicular fluid and mural granulosa cells microRNA profiles vary in in vitro fertilization patients depending on their age and oocyte maturation stage.</ArticleTitle>
<Pagination>
<MedlinePgn>1037-1046.e1</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.07.001</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00466-5</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine whether there is any difference in the follicular fluid (FF) microRNA (miRNA) profiles from in vitro fertilization (IVF) patients according to their age and oocyte maturation stage.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Observational prospective study.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">IVF clinic/hospital facilities.</AbstractText>
<AbstractText Label="PATIENTS(S)" NlmCategory="METHODS">We included 30 women with primary infertility undergoing intracytoplasmic sperm injection treatment and excluded patients with polycystic ovarian syndrome, endometriosis, severe male factor, and low ovarian reserve.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">After the collection of FF and granulosa cells from each patient, the samples were processed for total RNA extraction. RNA was pooled into different groups (three samples per pool) for microarray analysis to evaluate the expression of a total of 866 human miRNAs. Individual samples were analyzed to validate the pooled microarray results using real-time polymerase chain reaction.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Evaluation of the expression of a total of 866 human miRNAs in FF and granulosa cells.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">We identified only one differentially expressed miRNA, hsa-miR-424, which is present in higher proportions in FF from patients with advanced age. When we compared the FF from metaphase II (MII) versus GV (germinal vesicle) oocytes, we found 13 differentially expressed miRNAs (two up- and 11 downregulated). When we compared FF from MII versus MI, we found seven differentially expressed miRNAs in MII (three up- and four downregulated).</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">We have described the FF miRNA profiles according to IVF patients' age and the maturation stage of their oocytes. This descriptive study may aid our understanding of the physiology and regulation of oocyte maturation and could identify some potential miRNA biomarkers for this process.</AbstractText>
<AbstractText Label="CLINICAL TRIAL REGISTRATION NUMBER" NlmCategory="BACKGROUND">Not applicable.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Moreno</LastName>
<ForeName>Juan Manuel</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Fundación Instituto Valenciano de Infertilidad, Instituto Universitario IVI, Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Núñez</LastName>
<ForeName>María José</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Reproductive Medicine Research Group, Instituto de Investigación Sanitaria La Fe, La Fe University Hospital, Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Quiñonero</LastName>
<ForeName>Alicia</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Fundación Instituto Valenciano de Infertilidad, Instituto Universitario IVI, Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Martínez</LastName>
<ForeName>Sebastian</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Fundación Instituto Valenciano de Infertilidad, Instituto Universitario IVI, Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de la Orden</LastName>
<ForeName>Marina</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Reproductive Medicine Research Group, Instituto de Investigación Sanitaria La Fe, La Fe University Hospital, Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Simón</LastName>
<ForeName>Carlos</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Fundación Instituto Valenciano de Infertilidad, Instituto Universitario IVI, Valencia, Spain; INCLIVA Biomedical Research Institute, Valencia, Spain; Department of Obstetrics and Gynecology, Stanford University, Stanford, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pellicer</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Fundación Instituto Valenciano de Infertilidad, Instituto Universitario IVI, Valencia, Spain; Reproductive Medicine Research Group, Instituto de Investigación Sanitaria La Fe, La Fe University Hospital, Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Díaz-García</LastName>
<ForeName>César</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Reproductive Medicine Research Group, Instituto de Investigación Sanitaria La Fe, La Fe University Hospital, Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Domínguez</LastName>
<ForeName>Francisco</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Fundación Instituto Valenciano de Infertilidad, Instituto Universitario IVI, Valencia, Spain; INCLIVA Biomedical Research Institute, Valencia, Spain. Electronic address: francisco.dominguez@ivi.es.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Follicular fluid</Keyword>
<Keyword MajorTopicYN="N">biomarker</Keyword>
<Keyword MajorTopicYN="N">granulosa cells</Keyword>
<Keyword MajorTopicYN="N">miRNA</Keyword>
<Keyword MajorTopicYN="N">oocytes</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26209830</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Profiling signaling proteins in human spermatozoa: biomarker identification for sperm quality evaluation.</ArticleTitle>
<Pagination>
<MedlinePgn>845-856.e8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.039</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00468-9</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine the correlation between semen basic parameters and the expression and activity of signaling proteins.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">In vitro studies with human spermatozoa.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Academic research institute.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">Thirty-seven men provided semen samples for routine analysis.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">None.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Basic semen parameters tracked included sperm DNA fragmentation (SDF), the expression levels of 75 protein kinases, and the phosphorylation/cleavage patterns of 18 signaling proteins in human spermatozoa.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">The results indicated that the phosphorylated levels of several proteins (Bad, GSK-3β, HSP27, JNK/SAPK, mTOR, p38 MAPK, and p53), as well as cleavage of PARP (at D214) and Caspase-3 (at D175), were significantly correlated with motility parameters. Additionally, the percentage of morphologically normal spermatozoa demonstrated a significant positive correlation with the phosphorylated levels of p70 S6 kinase and, in turn, head defects and the teratozoospermia index (TZI) showed a significant negative correlation with the phosphorylated levels of Stat3. There was a significant positive correlation between SDF and the teratozoospermia index, as well as the presence of head defects. In contrast, SDF negatively correlated with the percentage of morphologically normal spermatozoa and the phosphorylation of Akt and p70 S6 kinase. Subjects with varicocele demonstrated a significant negative correlation between head morphological defects and the phosphorylated levels of Akt, GSK3β, p38 MAPK, and Stat1. Additionally, 34 protein kinases were identified as expressed in their total protein levels in normozoospermic samples.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">This study contributed toward establishing a biomarker "fingerprint" to assess sperm quality on the basis of molecular parameters.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Silva</LastName>
<ForeName>Joana Vieira</ForeName>
<Initials>JV</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Signal Transduction, Institute for Research in Biomedicine, Health Sciences Program, University of Aveiro, Campus Universitário de Santiago, Aveiro, Portugal.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Freitas</LastName>
<ForeName>Maria João</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Signal Transduction, Institute for Research in Biomedicine, Health Sciences Program, University of Aveiro, Campus Universitário de Santiago, Aveiro, Portugal.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Correia</LastName>
<ForeName>Bárbara Regadas</ForeName>
<Initials>BR</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Signal Transduction, Institute for Research in Biomedicine, Health Sciences Program, University of Aveiro, Campus Universitário de Santiago, Aveiro, Portugal.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Korrodi-Gregório</LastName>
<ForeName>Luís</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Signal Transduction, Institute for Research in Biomedicine, Health Sciences Program, University of Aveiro, Campus Universitário de Santiago, Aveiro, Portugal.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Patrício</LastName>
<ForeName>António</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Hospital Infante D. Pedro E.P.E., Aveiro, Portugal.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pelech</LastName>
<ForeName>Steven</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Kinexus Bioinformatics Corporation, Vancouver, British Columbia, Canada; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fardilha</LastName>
<ForeName>Margarida</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Signal Transduction, Institute for Research in Biomedicine, Health Sciences Program, University of Aveiro, Campus Universitário de Santiago, Aveiro, Portugal. Electronic address: mfardilha@ua.pt.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Human spermatozoa</Keyword>
<Keyword MajorTopicYN="N">conventional semen parameters</Keyword>
<Keyword MajorTopicYN="N">molecular markers</Keyword>
<Keyword MajorTopicYN="N">signaling pathways</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26209831</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Heritability of endometriosis.</ArticleTitle>
<Pagination>
<MedlinePgn>947-52</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.035</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00462-8</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To estimate the relative contribution of genetic influences and prevalence on endometriosis.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Analysis of self-reported data from a nationwide population-based twin registry.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Not applicable.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">A total of 28,370 women, female monozygotic (MZ) or dizygotic (DZ) twins, who participated in either of two surveys (1998-2002 or 2005-2006).</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">None.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Self-reported endometriosis, validated by medical records.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">A history of endometriosis was reported by 1,228 female twins. The probandwise concordance was 0.21 for MZ and 0.10 for DZ twins. Higher within-pair (tetrachoric) correlation was observed among MZ (0.47) compared with DZ (0.20) twins. The best-fitting model revealed a contribution of 47% by additive genetic factors and the remaining 53% attributed to unique environmental effects.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">Our findings suggest both genetic and unique (nonshared) environmental influences on the complex etiology of endometriosis and support the hypothesis that genes have a strong influence on phenotypic manifestations of endometriosis.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Saha</LastName>
<ForeName>Rama</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden. Electronic address: rama.saha@ki.se.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pettersson</LastName>
<ForeName>Hans Järnbert</ForeName>
<Initials>HJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Svedberg</LastName>
<ForeName>Pia</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Division of Insurance Medicine, Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Olovsson</LastName>
<ForeName>Matts</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bergqvist</LastName>
<ForeName>Agneta</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Karolinska Institutet, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marions</LastName>
<ForeName>Lena</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tornvall</LastName>
<ForeName>Per</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kuja-Halkola</LastName>
<ForeName>Ralf</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>CA085739</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>DK066134</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Concordance</Keyword>
<Keyword MajorTopicYN="N">endometriosis</Keyword>
<Keyword MajorTopicYN="N">heritability</Keyword>
<Keyword MajorTopicYN="N">twins</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26211882</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Perinatal outcomes after fresh versus vitrified-warmed blastocyst transfer: retrospective analysis.</ArticleTitle>
<Pagination>
<MedlinePgn>899-907.e3</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.031</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00458-6</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the possible effect of controlled ovarian stimulation on the perinatal outcomes of assisted reproductive technology pregnancies, by comparing the outcomes from fresh ET with frozen ET (FET) with blastocysts of similar quality.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective observational study.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Private fertility center.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">Seven hundred eighty-four fresh transfers and 382 vitrified-warmed double blastocyst transfers.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">None.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Miscarriage, perinatal mortality, preterm delivery, live birth, live-birth weights, and gestational age of live births.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">FET resulted in higher implantation rates (51.5% vs. 40.6%), higher live-birth rates per transfer (56.8% vs. 44.3%), and lower ectopic pregnancy rates (0.32% vs. 1.80%). FET pregnancies also had higher day 14 βhCG levels per implantation (148.2 vs. 176.2 IU/L) and higher infant birth weights (singletons Δ109.4 g, twins Δ124 g). Female infants benefitted the most in terms of birth weight. Miscarriage, premature delivery, perinatal morbidity, and live birth per pregnancy were all nonsignificantly different between fresh ET and FET.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">Clinically significant differences between the peri-implantation and perinatal outcomes of fresh ET and FET suggest better endometrial receptivity and placentation in FET cycles.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ozgur</LastName>
<ForeName>Kemal</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Antalya IVF, Özel Antalya Tüp Bebek Merkezi, Antalya, Turkey. Electronic address: kemalozg@yahoo.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Berkkanoglu</LastName>
<ForeName>Murat</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Antalya IVF, Özel Antalya Tüp Bebek Merkezi, Antalya, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bulut</LastName>
<ForeName>Hasan</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Antalya IVF, Özel Antalya Tüp Bebek Merkezi, Antalya, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Humaidan</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>The Fertility Clinic, Skive Regional Hospital and Faculty of Health, Aarhus University, Aarhus, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Coetzee</LastName>
<ForeName>Kevin</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Antalya IVF, Özel Antalya Tüp Bebek Merkezi, Antalya, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">COS</Keyword>
<Keyword MajorTopicYN="N">HRT-FET</Keyword>
<Keyword MajorTopicYN="N">blastocysts</Keyword>
<Keyword MajorTopicYN="N">fresh ET</Keyword>
<Keyword MajorTopicYN="N">perinatal outcomes</Keyword>
<Keyword MajorTopicYN="N">pregnancy</Keyword>
<Keyword MajorTopicYN="N">vitrification</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26211883</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Early-life factors and endometriosis risk.</ArticleTitle>
<Pagination>
<MedlinePgn>964-971.e5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.040</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00469-0</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study early-life factors in relation to endometriosis risk in adulthood.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Population-based case-control study.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Integrated healthcare system.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">Cases (n = 310) were women diagnosed for the first time with endometriosis between the years 1996 and 2001, and controls (n = 727) were women without a diagnosis of endometriosis randomly selected from the healthcare system population.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">None.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) for the associations between intrauterine diethylstilbestrol (DES) exposure, maternal smoking, mother's age at delivery, firstborn status, birth weight, fetal number, prematurity, and regular soy formula feeding during infancy and endometriosis were estimated using unconditional logistic regression, adjusting for frequency matching and confounding variables. Information on early-life factors was ascertained retrospectively by in-person interview, with information on maternal DES use and regular soy formula feeding directly gathered from the participant's mother or other family member.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">We observed that women who were regularly fed soy formula as infants had more than twice the risk of endometriosis compared with unexposed women (aOR 2.4, 95% CI 1.2-4.9). Our data also suggested increased endometriosis risk with prematurity (aOR 1.7, 95% CI 0.9-3.1) and maternal use of DES (OR 2.0, 95% CI 0.8-4.9, adjusting only for frequency matching variables), although these confidence intervals included the null.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">Our results support the hypothesis that disruption of development during fetal and infant periods may increase the risk of endometriosis in adulthood.</AbstractText>
<CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Upson</LastName>
<ForeName>Kristen</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina. Electronic address: kristen.upson@nih.gov.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sathyanarayana</LastName>
<ForeName>Sheela</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, School of Medicine, University of Washington, Seattle, Washington; Department of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, Washington; Seattle Children's Research Institute, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Scholes</LastName>
<ForeName>Delia</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington; Group Health Research Institute, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Holt</LastName>
<ForeName>Victoria L</ForeName>
<Initials>VL</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>1F31NR013092-01</GrantID>
<Acronym>NR</Acronym>
<Agency>NINR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HD033792</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01HD033792-05</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 HD052462-05</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Population-based case–control study</Keyword>
<Keyword MajorTopicYN="N">early-life</Keyword>
<Keyword MajorTopicYN="N">endometriosis</Keyword>
<Keyword MajorTopicYN="N">soy formula</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26211884</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Presence of human papillomavirus in semen of healthy men is firmly associated with HPV infections of the penile epithelium.</ArticleTitle>
<Pagination>
<MedlinePgn>838-844.e8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.028</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00455-0</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study the source of human papillomavirus (HPV) in semen.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Observational study (CCMO-NL3248800010).</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Academic hospital-based laboratory.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">Healthy male volunteers (n = 213).</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">One penile scrape and three semen samples were obtained per participant for HPV-DNA testing by both GP5+/6+ polymerase chain reaction (PCR) and SPF10-PCR to detect moderate/high and low viral loads, respectively; flat penile lesions (FPL) were detected by penoscopy.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">HPV-DNA presence in semen and penile scrapes, and the presence of FPL.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">HPV-DNA at moderate/high viral loads (i.e., GP5+/6+ PCR-positive) was detected in ≥1 semen sample(s) in 27% of participants. Most men with moderate/high viral loads in the penile scrape also had moderate/high viral loads in semen (85%). Men with a HPV-negative penile scrape were very unlikely to have moderate/high viral loads in semen (3%). The presence of HPV in semen was associated with the presence of HPV in the penile scrape also on a genotype-specific level. Having FPL was a risk factor for HPV presence in semen.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">HPV-DNA presence in semen of healthy men is common and associated with HPV infections of the penile epithelium. HPV-DNA presence in semen may result from desquamation of HPV-infected penile cells.</AbstractText>
<CopyrightInformation>Copyright © 2015. Published by Elsevier Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Luttmer</LastName>
<ForeName>Roosmarijn</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dijkstra</LastName>
<ForeName>Maaike G</ForeName>
<Initials>MG</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynaecology, VU University Medical Center, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Snijders</LastName>
<ForeName>Peter J F</ForeName>
<Initials>PJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jordanova</LastName>
<ForeName>Ekaterina S</ForeName>
<Initials>ES</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynaecology, VU University Medical Center, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>King</LastName>
<ForeName>Audrey J</ForeName>
<Initials>AJ</Initials>
<AffiliationInfo>
<Affiliation>Department of the National Immunisation Programme and Virology, Centre for Infectious Disease Research, Diagnostics and Screening, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pronk</LastName>
<ForeName>Divera T M</ForeName>
<Initials>DT</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Foresta</LastName>
<ForeName>Carlo</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Section of Clinical Pathology and Unit for Human Reproduction Pathology, Department of Medicine, University of Padova, Padova, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Garolla</LastName>
<ForeName>Andrea</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Section of Clinical Pathology and Unit for Human Reproduction Pathology, Department of Medicine, University of Padova, Padova, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hompes</LastName>
<ForeName>Peter G A</ForeName>
<Initials>PG</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynaecology, VU University Medical Center, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Berkhof</LastName>
<ForeName>Johannes</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology &amp; Biostatistics, VU University Medical Center, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bleeker</LastName>
<ForeName>Maaike C G</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Doorbar</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, University of Cambridge, Cambridge, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Heideman</LastName>
<ForeName>Daniëlle A M</ForeName>
<Initials>DA</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Meijer</LastName>
<ForeName>Chris J L M</ForeName>
<Initials>CJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands. Electronic address: cjlm.meijer@vumc.nl.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Flat penile lesion</Keyword>
<Keyword MajorTopicYN="N">human papillomavirus</Keyword>
<Keyword MajorTopicYN="N">semen</Keyword>
<Keyword MajorTopicYN="N">transmission</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26211885</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Split thickness skin graft for cervicovaginal reconstruction in congenital atresia of cervix.</ArticleTitle>
<Pagination>
<MedlinePgn>e9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.07.002</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00467-7</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To introduce a new technique that combines laparoscopic and vaginal cervicovaginal reconstruction using split thickness skin graft in patients with congenital atresia of the cervix.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Video article introducing a new surgical technique.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">University hospital.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">A 16-year-old patient with congenital cervical atresia, vaginal dysgenesis, and ovarian endometrial cyst.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">An original technique of combined laparoscopic and vaginal cervicovaginal reconstruction using split thickness skin graft for cervicovaginal reconstruction.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">A midline incision at the vaginal introitus was made, and a 9-cm canal was made between the bladder and the rectum using sharp and blunt dissection along the anatomic vaginal route, with the aid of laparoscopy to ensure correct orientation. A 14 × 12 cm split thickness skin graft was harvested from the right lateral thigh. By laparoscopy, the level of the lowest pole of the uterine cavity was exposed and the cervix was incised by shape dissection. The proximal segment of the harvested skin to the lower uterine segment was secured, and the distal segment was sutured with the upper margin of vulva vaginally. Surgical technique reports in anonymous patients are exempted from ethical approval by the Institutional Review Board. The patient gave consent to use the video in the article.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">The procedure was successfully completed. Since February 2013, our experiences of combined laparoscopic and vaginal cervicovaginal reconstruction using split thickness skin graft in 10 patients with congenital atresia of cervix were positive, with successful results and without complications or cervical, or vaginal stenosis.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">Our technique is feasible and safe for congenital atresia of cervix, with successful results and without complications or cervical or vaginal stenosis.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Xuyin</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Han</LastName>
<ForeName>Tiantian</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ding</LastName>
<ForeName>Jingxin</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hua</LastName>
<ForeName>Keqin</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, People's Republic of China. Electronic address: huakeqinjiaoshou@163.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Split thickness skin graft</Keyword>
<Keyword MajorTopicYN="N">cervicovaginal reconstruction</Keyword>
<Keyword MajorTopicYN="N">congenital atresia of cervix</Keyword>
<Keyword MajorTopicYN="N">laparoscopy</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26215756</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Shifting anaerobic to aerobic metabolism stimulates apoptosis through modulation of redox balance: potential intervention in the pathogenesis of postoperative adhesions.</ArticleTitle>
<Pagination>
<MedlinePgn>1022-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.041</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00470-7</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare the effect of shifting anaerobic to aerobic metabolism on key regulators of oxidative stress, including extracellular superoxide dismutase (SOD3), inducible nitric oxide synthase (iNOS), and its product, nitric oxide (NO), as well as mitochondrial potential (Δψm) and apoptosis in fibroblasts established from normal peritoneum and adhesion tissues.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective, experimental study.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">University medical center.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">Fibroblasts established from normal peritoneum and adhesion tissues from the same patients.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">Treatment with dichloroacetate (0, 20, 40, and 80 μg/mL, 24 hours).</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">The expression of SOD3, iNOS, and NO levels were measured utilizing real-time reverse transcription-polymerase chain reaction and Greiss assay. The Δψm was evaluated by the JC-1 Mitochondrial Membrane Potential Assay. Apoptosis was determined by caspase-3 activity and TUNEL assays. Data were analyzed using SPSS 19.0. Mixed model repeated-measures analysis of variance was used with a Bonferroni correction. Significant interactions were analyzed with independent sample t tests.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">Dichloroacetate increased apoptosis, SOD3 messenger RNA, iNOS messenger RNA, and NO levels in fibroblasts from peritoneum and adhesions. There was enhanced Δψm adhesion as compared with normal peritoneal fibroblasts. Creating oxidative stress by exposure by hypoxia markedly increased Δψm in fibroblasts from normal peritoneum to levels observed in adhesions; dichloroacetate protected against the effects of hypoxia.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">Anaerobic metabolism and oxidative stress are associated with the development of the adhesion phenotype, which manifests decreased apoptosis. Dichloroacetate induces adhesion fibroblasts to undergo apoptosis via modulation of redox homeostasis. These findings may provide targets for therapeutic treatment for reduction of profibrotic disorders, including postoperative adhesions.</AbstractText>
<CopyrightInformation>Copyright © 2015. Published by Elsevier Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Fletcher</LastName>
<ForeName>Nicole M</ForeName>
<Initials>NM</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, The C. S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, Michigan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Awonuga</LastName>
<ForeName>Awoniyi O</ForeName>
<Initials>AO</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, The C. S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, Michigan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Neubauer</LastName>
<ForeName>Bailey R</ForeName>
<Initials>BR</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, The C. S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, Michigan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abusamaan</LastName>
<ForeName>Mohammed S</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, The C. S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, Michigan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Saed</LastName>
<ForeName>Mohammed G</ForeName>
<Initials>MG</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, The C. S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, Michigan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Diamond</LastName>
<ForeName>Michael P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Georgia Regents University, Augusta, Georgia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Saed</LastName>
<ForeName>Ghassan M</ForeName>
<Initials>GM</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, The C. S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, Michigan. Electronic address: gsaed@med.wayne.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Fertil Steril. 2015 Oct;104(4):836-7</RefSource>
<PMID Version="1">26297645</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Dichloroacetate</Keyword>
<Keyword MajorTopicYN="N">apoptosis</Keyword>
<Keyword MajorTopicYN="N">oxidative stress</Keyword>
<Keyword MajorTopicYN="N">postoperative adhesions</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26215757</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of paternal age on reproductive outcomes in oocyte donation model: a systematic review.</ArticleTitle>
<Pagination>
<MedlinePgn>857-865.e1</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.036</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00463-X</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To perform a meta-analysis of the literature examining the influence of paternal age on oocyte donation outcomes.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review of the literature with no language or time restrictions.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Not applicable.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">None.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">None.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Pregnancy and live-birth rates.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">By independent screening of titles and abstracts, two investigators selected original studies examining the influence of paternal age on oocyte donation outcomes. Twelve articles were included, encompassing a total of 12,538 oocyte-donation cases. No statistically significant correlation was found by most studies between advanced paternal age and the rate of fertilization, cleavage embryo development, implantation, pregnancy, miscarriage, or live birth. A statistically significant decrease in blastocyst embryo formation was suggested in two articles. Except for volume and possibly motility, other sperm characteristics such as concentration and morphology did not alter with age. However, the overall quality of the evidence was rated as very low according to Grading of Recommendations Assessment, Development, and Evaluation criteria.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">The available evidence suggests that advancing paternal age is not associated with adverse oocyte donation outcomes, including pregnancy and live-birth rates. However, the suboptimal quality of the available evidence necessitates high-quality, well-adjusted prospective trials that are also aimed at evaluating additional outcomes such as congenital anomalies and various specific long-term disorders.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sagi-Dain</LastName>
<ForeName>Lena</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Carmel Medical Center, Haifa, Israel; Genetics Institute, HaEmek Medical Center, Afula, Israel. Electronic address: lena2303@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sagi</LastName>
<ForeName>Shlomi</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Bnai Zion Medical Center, Haifa, Israel.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dirnfeld</LastName>
<ForeName>Martha</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Carmel Medical Center, Haifa, Israel.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Live birth</Keyword>
<Keyword MajorTopicYN="N">oocyte donation</Keyword>
<Keyword MajorTopicYN="N">paternal age</Keyword>
<Keyword MajorTopicYN="N">pregnancy rates</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26231464</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Uterus transplantation trial: Psychological evaluation of recipients and partners during the post-transplantation year.</ArticleTitle>
<Pagination>
<MedlinePgn>1010-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.038</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00465-3</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To explore the psychology and well-being of the nine patients undergoing uterus transplantation (UTx) as part of the first clinical trial, during the first 12 months of which seven patients experienced graft survival with occasional mild rejection episodes and two patients experienced graft failure, with hysterectomy.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective observational study.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">University hospital.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">Nine female uterine recipients and their partners.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">Psychological evaluations by questionnaires focusing on quality of life, mood, relationship, and fertility quality of life were conducted at inclusion and at 3, 6, and 12 months after UTx.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Scores of four different questionnaires regarding mood, quality of life, fertility quality of life, and relationship.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">In all questionnaire domains, the recipients and their partners showed a similar pattern at baseline, and the UTx group, including both recipients and partners, scored similarly or better when compared with relevant norm groups. Among the recipients there was a reversible decline in score of physical activity and increased bodily pain at 3 months past surgery.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">The results show that participants of this first UTx trial were psychologically stable both at baseline and during the first year, despite rejection episodes and possible worries about viability of graft.</AbstractText>
<AbstractText Label="CLINICAL TRIAL REGISTRATION NUMBER" NlmCategory="BACKGROUND">ClinicalTrials.govNCT01844362.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Järvholm</LastName>
<ForeName>Stina</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden; Department of Psychology, University of Gothenburg, Göteborg, Sweden. Electronic address: stina.jarvholm@vgregion.se.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Johannesson</LastName>
<ForeName>Liza</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Clarke</LastName>
<ForeName>Alex</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Plastic and Reconstructive Surgery, Royal Free London, National Health Service Foundation Trust, London, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brännström</LastName>
<ForeName>Mats</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList>
<AccessionNumber>NCT01844362</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Infertility</Keyword>
<Keyword MajorTopicYN="N">psychology</Keyword>
<Keyword MajorTopicYN="N">transplantation</Keyword>
<Keyword MajorTopicYN="N">uterus</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26232746</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>10</Month>
<Day>05</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Effects of fertility drugs on cancers other than breast and gynecologic malignancies.</ArticleTitle>
<Pagination>
<MedlinePgn>980-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.045</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00474-4</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine the relationship of ovulation-stimulating drugs to risk of cancers other than breast and gynecologic malignancies.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective cohort study, with additional follow-up since initial report.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Reproductive endocrinology practices.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">Among a cohort of 12,193 women evaluated for infertility between 1965 and 1988, a total of 9,892 women (81.1% of the eligible population) were followed through 2010, via passive and active (questionnaire) approaches.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">None.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Hazard ratios (HRs) and 95% confidence intervals (CIs) for various fertility treatment parameters for select cancers.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">During 30.0 median years of follow-up (285,332 person-years), 91 colorectal cancers, 84 lung cancers, 55 thyroid cancers, and 70 melanomas were diagnosed among study subjects. Clomiphene citrate (CC), used by 38.1% of patients, was not associated with colorectal or lung cancer risks, but was related significantly to melanoma (HR = 1.95; 95% CI: 1.18-3.22), and non-significantly to thyroid cancer risks (HR = 1.57; 95% CI: 0.89-2.75). The highest melanoma risks were seen among those with the lowest drug exposure levels, but thyroid cancer risk was greatest among the heavily exposed patients (HR = 1.96; 95% CI: 0.92-4.17 for those receiving &gt;2,250 mg). Clomiphene citrate-associated risks for thyroid cancer were somewhat higher among nulligravid, compared with gravid, women, but did not differ according to distinct causes of infertility. Gonadotropins, used by only 9.7% of subjects, were not related to risk of any of the assessed cancers.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">Our results provide support for continued monitoring of both melanoma and thyroid cancer risk among patients receiving fertility drugs.</AbstractText>
<CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Brinton</LastName>
<ForeName>Louise A</ForeName>
<Initials>LA</Initials>
<AffiliationInfo>
<Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland. Electronic address: brintonl@mail.nih.gov.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moghissi</LastName>
<ForeName>Kamran S</ForeName>
<Initials>KS</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Wayne State University, Detroit, Michigan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Scoccia</LastName>
<ForeName>Bert</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, University of Illinois, Chicago, Illinois.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lamb</LastName>
<ForeName>Emmet J</ForeName>
<Initials>EJ</Initials>
<AffiliationInfo>
<Affiliation>Stanford University, Stanford, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Trabert</LastName>
<ForeName>Britton</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Niwa</LastName>
<ForeName>Shelley</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Westat, Inc., Rockville, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ruggieri</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>IMS, Inc., Rockville, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Westhoff</LastName>
<ForeName>Carolyn L</ForeName>
<Initials>CL</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Columbia University, New York, New York.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>Z01 CP010126-12</GrantID>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Oncol. 2009 Feb;20(2):358-64</RefSource>
<PMID Version="1">18725391</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Cancer. 2009 Jun 2;100(11):1824-31</RefSource>
<PMID Version="1">19436296</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Invest Dermatol. 2009 Jul;129(7):1666-74</RefSource>
<PMID Version="1">19131946</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Gastroenterol. 2010 Aug;105(8):1843-50</RefSource>
<PMID Version="1">20354510</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2010 Oct;94(5):1787-92</RefSource>
<PMID Version="1">19939368</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Cancer. 2010 Nov 23;103(11):1755-9</RefSource>
<PMID Version="1">21045829</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Cancer. 2011 Mar 15;128(6):1404-13</RefSource>
<PMID Version="1">20473922</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 2011 May 15;173(10):1192-202</RefSource>
<PMID Version="1">21415032</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):900-11</RefSource>
<PMID Version="1">21467241</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Natl Cancer Inst. 2011 Oct 5;103(19):1469-75</RefSource>
<PMID Version="1">21878677</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Obstet Gynecol. 2011 Dec;54(4):537-45</RefSource>
<PMID Version="1">22031244</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Cancer. 2011 Nov;47(17):2607-17</RefSource>
<PMID Version="1">21620689</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Reprod. 2012 Apr;27(4):1149-55</RefSource>
<PMID Version="1">22343550</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Reprod Med. 2012 Apr;30(2):131-45</RefSource>
<PMID Version="1">22549713</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Cancer. 2013 Jun 1;132(11):2630-9</RefSource>
<PMID Version="1">23129166</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Reprod. 2013 Oct;28(10):2813-21</RefSource>
<PMID Version="1">23943795</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Melanoma Res. 2013 Dec;23(6):489-95</RefSource>
<PMID Version="1">24048222</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2013 Dec;100(6):1660-6</RefSource>
<PMID Version="1">24011610</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Epidemiol Biomarkers Prev. 2014 Apr;23(4):584-93</RefSource>
<PMID Version="1">24700523</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA Dermatol. 2014 Apr;150(4):434-44</RefSource>
<PMID Version="1">24522401</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Tumour Biol. 2014 Sep;35(9):8415-24</RefSource>
<PMID Version="1">24969557</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Cancer. 2015 Mar 1;136(5):1218-27</RefSource>
<PMID Version="1">25041790</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Reprod. 2015 May;30(5):1216-28</RefSource>
<PMID Version="1">25743782</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Natl Cancer Inst. 2011 May 18;103(10):826-34</RefSource>
<PMID Version="1">21447807</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2011 Sep;96(3):780-5</RefSource>
<PMID Version="1">21742326</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Cancer. 1999 Nov;81(5):918-23</RefSource>
<PMID Version="1">10555769</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Melanoma Res. 2001 Oct;11(5):535-41</RefSource>
<PMID Version="1">11595893</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2004 Aug;82(2):405-14</RefSource>
<PMID Version="1">15302291</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Natl Cancer Inst. 1987 Jul;79(1):1-12</RefSource>
<PMID Version="1">3474436</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Causes Control. 1990 Nov;1(3):223-34</RefSource>
<PMID Version="1">2102295</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Melanoma Res. 1992 May;2(1):71-4</RefSource>
<PMID Version="1">1643427</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Melanoma Res. 1995 Apr;5(2):123-7</RefSource>
<PMID Version="1">7620340</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 1995 Oct 14;346(8981):995-1000</RefSource>
<PMID Version="1">7475593</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 1998 Jun 1;147(11):1038-42</RefSource>
<PMID Version="1">9620047</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Causes Control. 1999 Apr;10(2):157-66</RefSource>
<PMID Version="1">10231164</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Obstet Gynecol. 1999 Jun;180(6 Pt 1):1499-503</RefSource>
<PMID Version="1">10368497</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Epidemiol. 2005 Aug;15(7):545-50</RefSource>
<PMID Version="1">16029848</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):668-74</RefSource>
<PMID Version="1">16150258</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Causes Control. 2006 Feb;17(1):11-9</RefSource>
<PMID Version="1">16411048</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 2007 Mar 1;165(5):505-13</RefSource>
<PMID Version="1">17158470</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 2007 Apr 1;165(7):794-801</RefSource>
<PMID Version="1">17215381</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Cancer. 2007 May 15;120(10):2214-20</RefSource>
<PMID Version="1">17278095</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 2007 Jun 1;165(11):1265-70</RefSource>
<PMID Version="1">17327217</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Causes Control. 2007 Sep;18(7):723-33</RefSource>
<PMID Version="1">17549595</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2007 Aug 1;67(15):7534-9</RefSource>
<PMID Version="1">17671225</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Cancer. 2008 Feb 1;122(3):643-6</RefSource>
<PMID Version="1">17847020</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Reprod. 2008 Feb;23(2):451-6</RefSource>
<PMID Version="1">18065402</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Dermatol. 2008 Apr;35(4):215-21</RefSource>
<PMID Version="1">18419678</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Causes Control. 2008 Jun;19(5):437-42</RefSource>
<PMID Version="1">18197460</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Causes Control. 2008 Sep;19(7):759-65</RefSource>
<PMID Version="1">18340541</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 2009 Feb 1;169(3):365-75</RefSource>
<PMID Version="1">19037008</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">NIHMS706393 [Available on 10/01/16]</OtherID>
<OtherID Source="NLM">PMC4592810 [Available on 10/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cancer</Keyword>
<Keyword MajorTopicYN="N">clomiphene citrate</Keyword>
<Keyword MajorTopicYN="N">gonadotropins</Keyword>
<Keyword MajorTopicYN="N">infertility</Keyword>
<Keyword MajorTopicYN="N">risk</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26239024</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>10</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Aberrant expression and localization of deoxyribonucleic acid methyltransferase 3B in endometriotic stromal cells.</ArticleTitle>
<Pagination>
<MedlinePgn>953-963.e2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.06.046</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)00475-6</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To define the expression and function of DNA methyltransferases (DNMTs) in response to decidualizing stimuli in endometriotic cells compared with healthy endometrial stroma.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Basic science.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">University research center.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">Premenopausal women with or without endometriosis.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">Primary cultures of stromal cells from healthy endometrium (E-IUM) or endometriomas (E-OSIS) were subjected to in vitro decidualization (IVD) using 1 μM medroxyprogesterone acetate, 35 nM 17β-estradiol, and 0.05 mM 8-Br-cAMP.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Expression of DNMT1, DNMT3A, and DNMT3B in E-IUM and E-OSIS were assessed by quantitative real-time polymerase chain reaction and immunoblotting. Recruitment of DNMT3B to the promoters of steroidogenic factor 1 (SF-1) and estrogen receptor α (ESR1) was examined by chromatin immunoprecipitation.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">IVD treatment reduced DNMT3B messenger RNA (74%) and protein levels (81%) only in E-IUM; DNMT1 and DNMT3A were unchanged in both cell types. Significantly more DNMT3B bound to the SF-1 promoter in E-IUM compared with E-OSIS, and IVD treatment reduced binding in E-IUM to levels similar to those in E-OSIS. Enrichment of DNMT3B across 3 ESR1 promoters was reduced in E-IUM after IVD, although the more-distal promoter showed increased DNMT3B enrichment in E-OSIS after IVD.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">The inability to downregulate DNMT3B expression in E-OSIS may contribute to an aberrant epigenetic fingerprint that misdirects gene expression in endometriosis and contributes to its altered response to steroid hormones.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dyson</LastName>
<ForeName>Matthew T</ForeName>
<Initials>MT</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Biology Research, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: m-dyson@northwestern.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kakinuma</LastName>
<ForeName>Toshiyuki</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Biology Research, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pavone</LastName>
<ForeName>Mary Ellen</ForeName>
<Initials>ME</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Biology Research, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Monsivais</LastName>
<ForeName>Diana</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Biology Research, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Navarro</LastName>
<ForeName>Antonia</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Biology Research, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Malpani</LastName>
<ForeName>Saurabh S</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Biology Research, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ono</LastName>
<ForeName>Masanori</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Biology Research, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bulun</LastName>
<ForeName>Serdar E</ForeName>
<Initials>SE</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Biology Research, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R37 HD038691</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R37-HD038691</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54 HD040093</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54-HD40093</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Genet. 2013 Mar;14(3):204-20</RefSource>
<PMID Version="1">23400093</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biol Reprod. 2013 Feb;88(2):44</RefSource>
<PMID Version="1">23284138</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Hum Reprod. 2013 May;19(5):302-12</RefSource>
<PMID Version="1">23233487</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 1999 Dec;19(12):8211-8</RefSource>
<PMID Version="1">10567546</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2001 Oct 1;61(19):7025-9</RefSource>
<PMID Version="1">11585728</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods. 2001 Dec;25(4):402-8</RefSource>
<PMID Version="1">11846609</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Reprod Med. 2003 May;21(2):125-34</RefSource>
<PMID Version="1">12917782</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Obstet Gynecol. 1984 Aug;64(2):151-4</RefSource>
<PMID Version="1">6234483</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Endocrinol Metab. 1994 Mar;78(3):642-9</RefSource>
<PMID Version="1">8126136</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 1994 May 15;54(10):2552-5</RefSource>
<PMID Version="1">8168078</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Endocrinol Metab. 1997 Feb;82(2):600-6</RefSource>
<PMID Version="1">9024261</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 1998 Feb 15;26(4):1038-45</RefSource>
<PMID Version="1">9461465</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 1999 Jun 1;27(11):2291-8</RefSource>
<PMID Version="1">10325416</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2004 Nov 13-19;364(9447):1789-99</RefSource>
<PMID Version="1">15541453</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2005 Jul;84(1):33-4; discussion 38-9</RefSource>
<PMID Version="1">16009151</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Obstet Gynecol. 2005 Aug;193(2):371-80</RefSource>
<PMID Version="1">16098858</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Genet. 2005 Aug;6(8):597-610</RefSource>
<PMID Version="1">16136652</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2006 Feb 16;439(7078):871-4</RefSource>
<PMID Version="1">16357870</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2006 May 12;281(19):13604-11</RefSource>
<PMID Version="1">16537533</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Top Microbiol Immunol. 2006;310:179-98</RefSource>
<PMID Version="1">16909911</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2007 Jan;87(1):24-32</RefSource>
<PMID Version="1">17081533</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Protoc. 2006;1(2):729-48</RefSource>
<PMID Version="1">17406303</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Hum Reprod. 2007 May;13(5):323-32</RefSource>
<PMID Version="1">17350963</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Endocrinol Metab. 2007 Aug;92(8):3261-7</RefSource>
<PMID Version="1">17519303</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biol Reprod. 2007 Oct;77(4):681-7</RefSource>
<PMID Version="1">17625110</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Reprod Med. 2007 Nov;25(6):445-53</RefSource>
<PMID Version="1">17960529</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Epigenetics. 2006 Apr-Jun;1(2):106-11</RefSource>
<PMID Version="1">17965625</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2008 May;89(5 Suppl):1390-6</RefSource>
<PMID Version="1">17662285</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Obstet Gynecol Reprod Biol. 2008 Jun;138(2):127-34</RefSource>
<PMID Version="1">18336988</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Cancer. 2008 Jul 15;123(2):296-302</RefSource>
<PMID Version="1">18404674</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2009 Jan 15;360(3):268-79</RefSource>
<PMID Version="1">19144942</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Endocrinol Metab. 2009 Feb;94(2):615-22</RefSource>
<PMID Version="1">19001520</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Reprod Sci. 2009 Feb;16(2):152-61</RefSource>
<PMID Version="1">19208783</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Reprod. 2009 May;24(5):1126-32</RefSource>
<PMID Version="1">19202141</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Genet. 2009 May;10(5):295-304</RefSource>
<PMID Version="1">19308066</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Cancer Res. 2009 Jun 15;15(12):3927-37</RefSource>
<PMID Version="1">19509173</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Reprod Med. 2010 Jan;28(1):17-26</RefSource>
<PMID Version="1">20104425</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Bioinformatics. 2010;11:27</RefSource>
<PMID Version="1">20070912</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Hum Reprod. 2010 May;16(5):297-310</RefSource>
<PMID Version="1">20139117</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2010;5(4):e10338</RefSource>
<PMID Version="1">20454457</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Endocrinol. 2010 Sep;24(9):1872-85</RefSource>
<PMID Version="1">20685852</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2011 Jan;39(Database issue):D876-82</RefSource>
<PMID Version="1">20959295</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2011 Mar 15;95(4):1522-5.e1</RefSource>
<PMID Version="1">20970125</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2011 Mar 15;95(4):1421-7</RefSource>
<PMID Version="1">21316665</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Endocrinology. 2011 May;152(5):2100-12</RefSource>
<PMID Version="1">21343250</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Obstet Gynaecol Res. 2011 Jul;37(7):683-95</RefSource>
<PMID Version="1">21651673</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Reprod. 2011 Aug;26(8):2157-64</RefSource>
<PMID Version="1">21659316</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Reprod Sci. 2011 Nov;18(11):1080-4</RefSource>
<PMID Version="1">21926385</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Endocrinol. 2012 Jan 2;348(1):67-77</RefSource>
<PMID Version="1">21802491</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioessays. 2012 Jan;34(1):26-35</RefSource>
<PMID Version="1">22057551</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Physiol. 2012 Apr;227(4):1653-6</RefSource>
<PMID Version="1">21678420</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(3):e33284</RefSource>
<PMID Version="1">22428009</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2012 Apr;97(4):997-1003</RefSource>
<PMID Version="1">22306710</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Steroid Biochem Mol Biol. 2012 May;130(1-2):96-104</RefSource>
<PMID Version="1">22342840</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 2012 May;180(5):1781-6</RefSource>
<PMID Version="1">22401780</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gene Expr Patterns. 2012 May-Jun;12(5-6):196-203</RefSource>
<PMID Version="1">22476030</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Endocrinol. 2012 Jul 25;358(2):185-96</RefSource>
<PMID Version="1">22067514</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Genet. 2012 Jul;13(7):484-92</RefSource>
<PMID Version="1">22641018</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2012 Jul;18(7):1016-8</RefSource>
<PMID Version="1">22772552</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Hum Reprod. 2012 Sep;18(9):451-8</RefSource>
<PMID Version="1">22570358</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2012 Sep;98(3):511-9</RefSource>
<PMID Version="1">22819144</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Med Res. 2012;17:12</RefSource>
<PMID Version="1">22608095</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Endocrinology. 2012 Dec;153(12):6078-90</RefSource>
<PMID Version="1">23033272</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Obstet Gynecol Reprod Biol. 2013 Jan;166(1):81-5</RefSource>
<PMID Version="1">23018098</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Obstet Gynecol. 2013 Jun;25(3):193-200</RefSource>
<PMID Version="1">23562953</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2014;9(1):e83612</RefSource>
<PMID Version="1">24465385</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Reprod Sci. 2014 Mar;21(3):395-400</RefSource>
<PMID Version="1">23899549</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Genet. 2014 Mar;10(3):e1004158</RefSource>
<PMID Version="1">24603652</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Pharm Des. 2014;20(11):1786-95</RefSource>
<PMID Version="1">23888948</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Reprod Sci. 2014 Oct;21(10):1237-43</RefSource>
<PMID Version="1">24784717</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2006 Mar;85(3):564-72</RefSource>
<PMID Version="1">16500320</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Reprod Med. 2012 Jan;30(1):39-45</RefSource>
<PMID Version="1">22271293</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Reprod Biol Endocrinol. 2012;10:1</RefSource>
<PMID Version="1">22233680</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">NIHMS720805 [Available on 10/01/16]</OtherID>
<OtherID Source="NLM">PMC4603532 [Available on 10/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">DNA methyltransferase</Keyword>
<Keyword MajorTopicYN="N">Endometriosis</Keyword>
<Keyword MajorTopicYN="N">decidualization</Keyword>
<Keyword MajorTopicYN="N">estrogen receptor</Keyword>
<Keyword MajorTopicYN="N">steroidogenic factor-1</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26253817</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>10</Month>
<Day>05</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Urinary concentrations of benzophenone-type ultraviolet light filters and semen quality.</ArticleTitle>
<Pagination>
<MedlinePgn>989-96</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.07.1129</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)01640-4</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess benzophenone-type ultraviolet (UV) filter concentrations, chemicals used in sunscreen and personal care products, and semen endpoints.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Cohort.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Not applicable.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">A total of 413 men provided semen and urine samples, 2005-2009. Five UV filters were quantified (ng/mL) in urine using liquid chromatography-triple quadrupole mass spectrometry: BP-1 (2,4-dihydroxybenzophenone), BP-2 (2,2',4,4'-tetrahydroxybenzophenone), BP-3 (2-hydroxy-4-methoxybenzophenone), BP-8 (2,2'-dihydroxy-4-methoxybenzophenone), and 4-OH-BP (4-hydroxybenzophenone). Using linear regression, β-coefficients (β) and 95% confidence intervals (CIs) for each chemical dichotomized at the 75th percentile and Box-Cox transformed semen endpoint were estimated, after adjusting for age, body mass index, cotinine, season, and site.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">None.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Thirty-five semen endpoints.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">BP-2 was associated with diminished sperm concentration (β = -0.74; 95% CI -1.41, -0.08), straight (β = -4.57; 95% CI -8.95, -0.18) and linear movement (β = -3.15; 95% CI -6.01, -0.30), more immature sperm (β = 0.38; 95% CI 0.15, 0.62), and a decreased percentage of other tail abnormalities (β = -0.16; 95% CI -0.31, -0.01). BP-8 was associated with decreased hypo-osmotic swelling (β = -2.57; 95% CI -4.86, -0.29) and higher acrosome area (β = 1.14; 95% CI 0.01, 2.26). No associations were observed for BP-1, BP-3, or 4OH-BP.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">The findings suggest that specific UV filters may be associated with some aspects of semen endpoints, but await future corroboration.</AbstractText>
<CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Louis</LastName>
<ForeName>Germaine M Buck</ForeName>
<Initials>GM</Initials>
<AffiliationInfo>
<Affiliation>Office of the Director, Division of Intramural Population Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Rockville, Maryland. Electronic address: louisg@mail.nsih.gov.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Zhen</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Biostatistics and Bioinformatics Branch, Division of Intramural Population Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Rockville, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Sungduk</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Biostatistics and Bioinformatics Branch, Division of Intramural Population Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Rockville, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sapra</LastName>
<ForeName>Katherine J</ForeName>
<Initials>KJ</Initials>
<AffiliationInfo>
<Affiliation>Office of the Director, Division of Intramural Population Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Rockville, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bae</LastName>
<ForeName>Jisuk</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Office of the Director, Division of Intramural Population Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Rockville, Maryland; Department of Preventive Medicine, Catholic University of Daegu School of Medicine, Daegu, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kannan</LastName>
<ForeName>Kurunthachalam</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Wadsworth Center, New York State Department of Health, Albany, New York; Department of Environmental Health Sciences, School of Public Health, The University at Albany-SUNY, Albany, New York.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>HHSN27500001</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>N01-HD-3-3355</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>N01-HD-3-3356</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>N0HHD-3-3358</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>Z01 HD008770-04</GrantID>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>Z01 HD008770-05</GrantID>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>ZIA HD008770-06</GrantID>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>ZIA HD008770-07</GrantID>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>ZIA HD008770-08</GrantID>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>ZIA HD008770-09</GrantID>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>ZIA HD008770-10</GrantID>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>ZIA HD008770-11</GrantID>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Clin Pharmacol. 1999 Oct;48(4):635-7</RefSource>
<PMID Version="1">10583038</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Androl. 2002 Jan-Feb;23(1):25-43</RefSource>
<PMID Version="1">11780920</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Androl. 2002 Sep-Oct;23(5):629-34</RefSource>
<PMID Version="1">12185096</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 2003 Feb 15;157(4):355-63</RefSource>
<PMID Version="1">12578806</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Toxicol Sci. 2003 Jul;74(1):43-50</RefSource>
<PMID Version="1">12730620</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Epidemiology. 2003 May;14(3):269-77</RefSource>
<PMID Version="1">12859026</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Invest Dermatol. 2004 Jul;123(1):57-61</RefSource>
<PMID Version="1">15191542</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Toxicol Lett. 1994 Aug;73(2):113-22</RefSource>
<PMID Version="1">8048080</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Chem. 1997 Dec;43(12):2281-91</RefSource>
<PMID Version="1">9439445</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Toxicol Sci. 2005 Feb;83(2):264-72</RefSource>
<PMID Version="1">15537743</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Toxicol Appl Pharmacol. 2005 Feb 15;203(1):9-17</RefSource>
<PMID Version="1">15694459</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Toxicol In Vitro. 2005 Jun;19(4):457-69</RefSource>
<PMID Version="1">15826804</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 2006 Feb 15;163(4):374-83</RefSource>
<PMID Version="1">16394206</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Environ Health Perspect. 2007 Aug;115(8):1169-76</RefSource>
<PMID Version="1">17687443</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Urol. 2007 Oct;178(4 Pt 2):1637-42</RefSource>
<PMID Version="1">17707034</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Toxicol Appl Pharmacol. 2007 Dec 15;225(3):255-66</RefSource>
<PMID Version="1">17889917</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2008 Feb;89(2):395-7</RefSource>
<PMID Version="1">17482174</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2008 Jun;89(6):1718-22</RefSource>
<PMID Version="1">17658521</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Environ Health Perspect. 2008 Jul;116(7):893-7</RefSource>
<PMID Version="1">18629311</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2009 Jul;92(1):170-3</RefSource>
<PMID Version="1">18692792</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anal Bioanal Chem. 2010 Sep;398(2):831-43</RefSource>
<PMID Version="1">20625888</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Natl Med J India. 2010 May-Jun;23(3):134-6</RefSource>
<PMID Version="1">20949713</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Paediatr Perinat Epidemiol. 2011 Sep;25(5):413-24</RefSource>
<PMID Version="1">21819423</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Steroid Biochem Mol Biol. 2011 Oct;127(1-2):118-27</RefSource>
<PMID Version="1">21073950</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Andrologia. 2011 Dec;43(6):373-7</RefSource>
<PMID Version="1">21919930</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Environ Health Perspect. 2012 Apr;120(4):535-40</RefSource>
<PMID Version="1">22189045</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Environ Sci Technol. 2012 Apr 17;46(8):4624-32</RefSource>
<PMID Version="1">22417702</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Toxicol Appl Pharmacol. 2012 Sep 1;263(2):184-94</RefSource>
<PMID Version="1">22721600</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Mol Biol. 2013;927:27-37</RefSource>
<PMID Version="1">22992901</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Environ Health Perspect. 2012 Oct;120(10):1397-403</RefSource>
<PMID Version="1">22832070</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Environ Sci Technol. 2013 Apr 2;47(7):3439-47</RefSource>
<PMID Version="1">23469879</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Environ Health Perspect. 2013 Apr;121(4):453-8</RefSource>
<PMID Version="1">23360585</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sci Total Environ. 2013 Sep 1;461-462:49-55</RefSource>
<PMID Version="1">23712115</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Environ Res. 2013 Oct;126:164-70</RefSource>
<PMID Version="1">23932849</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Environ Sci Technol. 2013;47(21):12532-8</RefSource>
<PMID Version="1">24073792</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2014 Jan;101(1):215-221.e5</RefSource>
<PMID Version="1">24182411</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fertil Steril. 2014 Feb;101(2):453-62</RefSource>
<PMID Version="1">24239161</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Environ Int. 2014 Sep;70:143-57</RefSource>
<PMID Version="1">24934855</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 2014 Dec 15;180(12):1168-75</RefSource>
<PMID Version="1">25395025</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Toxicol Lett. 2014 Dec 1;231(2):261-9</RefSource>
<PMID Version="1">24956590</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Environ Health Perspect. 2015 Jan;123(1):57-63</RefSource>
<PMID Version="1">25127343</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Zhonghua Nan Ke Xue. 2014 Nov;20(11):995-8</RefSource>
<PMID Version="1">25577834</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Reprod Toxicol. 2015 Jan;51:7-13</RefSource>
<PMID Version="1">25462789</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chemosphere. 2015 Sep;135:427-35</RefSource>
<PMID Version="1">25441930</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">NIHMS709818 [Available on 10/01/16]</OtherID>
<OtherID Source="NLM">PMC4592813 [Available on 10/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Benzophenones</Keyword>
<Keyword MajorTopicYN="N">fecundity</Keyword>
<Keyword MajorTopicYN="N">semen</Keyword>
<Keyword MajorTopicYN="N">sperm</Keyword>
<Keyword MajorTopicYN="N">sunscreens</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26253819</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Risk of preterm birth after blastocyst embryo transfer: a large population study using contemporary registry data from Australia and New Zealand.</ArticleTitle>
<Pagination>
<MedlinePgn>997-1003</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.07.1130</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)01641-6</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate whether there is an increased risk of preterm birth with blastocyst transfer compared with cleavage-stage embryo transfer (ET) after assisted reproductive technology (ART).</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">A retrospective, population-based study.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Not applicable.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">A total of 50,788 infants conceived after ART treatment performed from 2009 to 2012.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">None.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">The rates of preterm birth, low birth weight (LBW), and small for gestational age (SGA) for 43,952 singleton and 3,418 twin deliveries after transfers of blastocyst or cleavage-stage embryos.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">Among singletons, there was no significant difference in the odds of preterm birth between blastocyst and cleavage-stage ET (9.1% compared with 9.3%, respectively, adjusted odds ratio 1.00, 95% confidence interval 0.94-1.08). Among twins, the crude rates of preterm birth were similar after blastocyst and cleavage-stage ETs (61.5% and 64.4%, respectively). However, after adjusting for potential confounders, blastocyst transfer was associated with a lower odds of preterm birth among twins (adjusted odds ratio 0.80, 95% confidence interval 0.70-0.93). There was no difference in risks of LBW and SGA between blastocyst and cleavage-stage ETs for both singletons and twins after adjusting for potential confounders.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">In contrast with the findings from a number of other studies, blastocyst culture in Australian and New Zealand is not associated with an increased risk of preterm, LBW, and SGA for singletons. Further studies are needed to assess longer-term outcomes of children born after ART treatment and possible biological or treatment factors related to adverse outcomes.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chambers</LastName>
<ForeName>Georgina M</ForeName>
<Initials>GM</Initials>
<AffiliationInfo>
<Affiliation>National Perinatal Epidemiology and Statistics Unit, Center for Big Data Research in Health, School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia. Electronic address: g.chambers@unsw.edu.au.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chughtai</LastName>
<ForeName>Abrar A</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>National Perinatal Epidemiology and Statistics Unit, Center for Big Data Research in Health, School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Farquhar</LastName>
<ForeName>Cynthia M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Yueping A</ForeName>
<Initials>YA</Initials>
<AffiliationInfo>
<Affiliation>Faculty of Health, University of Technology, Sydney, Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Assisted reproductive technology</Keyword>
<Keyword MajorTopicYN="N">blastocyst</Keyword>
<Keyword MajorTopicYN="N">low birth weight</Keyword>
<Keyword MajorTopicYN="N">preterm</Keyword>
<Keyword MajorTopicYN="N">singletons</Keyword>
<Keyword MajorTopicYN="N">twins</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26255087</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization.</ArticleTitle>
<Pagination>
<MedlinePgn>915-920.e1</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.07.1131</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)01642-8</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine whether there is any difference between the outcomes of two standard treatment protocols for frozen embryo replacement (FER): natural and down-regulated hormone replacement treatment (HRT).</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Open, single-center, randomized, controlled pilot trial.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Private fertility clinic.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">Women (n = 159) planning an FER cycle at the Oxford Fertility Unit, aged &lt;40 years at the time their embryos were frozen; with at least one blastocyst or two cleavage-stage embryos in storage; regular ovulatory cycles; and at most two previous FER cycles.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">Eligible participants were recruited and randomized between March 2010 and July 2012 into one of two standard FER treatment groups: natural (n = 80) menstrual (Natural) or GnRH agonist/HRT (n = 79) cycles.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Live birth rate after replacement of frozen-thawed embryos, clinical pregnancy rate, implantation rate, and cycle cancellations.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">A total of 159 women were randomized (80 Natural; 79 HRT), and 145 had ET and completed the study (72 Natural; 73 HRT). Pregnancy outcomes were not significantly different between the two groups. The live birth rates were 26.3% (Natural) and 31.7% (HRT) per randomized patient. Per ET/protocol the live birth rates were 29.2% and 34.2%. The implantation rates were 24.3% and 26.0%, and there were three twin births in the Natural and five in the HRT arms.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">The findings of this pilot study support the suggestion that for women with ovulatory cycles undergoing FER, the outcomes are similar between natural and HRT protocols.</AbstractText>
<AbstractText Label="CLINICAL TRIAL REGISTRATION NUMBER" NlmCategory="BACKGROUND">NCT00843570. Registered at www.clinicaltrials.gov.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mounce</LastName>
<ForeName>Ginny</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Nuffield Department of Obstetrics and Gynaecology, Institute of Reproductive Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McVeigh</LastName>
<ForeName>Enda</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Nuffield Department of Obstetrics and Gynaecology, Institute of Reproductive Sciences, University of Oxford, Oxford, United Kingdom; Oxford Fertility Unit, Institute of Reproductive Sciences, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Turner</LastName>
<ForeName>Karen</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Nuffield Department of Obstetrics and Gynaecology, Institute of Reproductive Sciences, University of Oxford, Oxford, United Kingdom; Oxford Fertility Unit, Institute of Reproductive Sciences, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Child</LastName>
<ForeName>Tim J</ForeName>
<Initials>TJ</Initials>
<AffiliationInfo>
<Affiliation>Nuffield Department of Obstetrics and Gynaecology, Institute of Reproductive Sciences, University of Oxford, Oxford, United Kingdom; Oxford Fertility Unit, Institute of Reproductive Sciences, Oxford, United Kingdom. Electronic address: tim.child@obs-gyn.ox.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList>
<AccessionNumber>NCT00843570</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">IVF</Keyword>
<Keyword MajorTopicYN="N">In vitro fertilization</Keyword>
<Keyword MajorTopicYN="N">frozen embryo replacement</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26260201</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Successful treatment algorithm for evaluation of early pregnancy after in vitro fertilization.</ArticleTitle>
<Pagination>
<MedlinePgn>932-937.e1</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.07.1133</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)01644-1</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate a prospectively implemented clinical algorithm for early identification of ectopic pregnancy (EP) and heterotopic pregnancy (HP) after assisted reproductive technology (ART).</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Analysis of prospectively collected data.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Academic medical center.</AbstractText>
<AbstractText Label="PATIENT(S)" NlmCategory="METHODS">All ART-conceived pregnancies between January 1995 and June 2013.</AbstractText>
<AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">Early pregnancy monitoring via clinical algorithm with all pregnancies screened using human chorionic gonadotropin (hCG) levels and reported symptoms, with subsequent early ultrasound evaluation if hCG levels were abnormal or if the patient reported pain or vaginal bleeding.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Algorithmic efficiency for diagnosis of EP and HP and their subsequent clinical outcomes using a binary forward stepwise logistic regression model built to determine predictors of early pregnancy failure.</AbstractText>
<AbstractText Label="RESULT(S)" NlmCategory="RESULTS">Of the 3,904 pregnancies included, the incidence of EP and HP was 0.77% and 0.46%, respectively. The algorithm selected 96.7% and 83.3% of pregnancies diagnosed with EP and HP, respectively, for early ultrasound evaluation, leading to earlier treatment and resolution. Logistic regression revealed that first hCG, second hCG, hCG slope, age, pain, and vaginal bleeding were all independent predictors of early pregnancy failure after ART.</AbstractText>
<AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">Our clinical algorithm for early pregnancy evaluation after ART is effective for identification and prompt intervention of EP and HP without significant over- or misdiagnosis, and avoids the potential catastrophic morbidity associated with delayed diagnosis.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cookingham</LastName>
<ForeName>Lisa Marii</ForeName>
<Initials>LM</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Iowa College of Medicine, Iowa City, Iowa. Electronic address: lisa-cookingham@uiowa.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Goossen</LastName>
<ForeName>Rachel P</ForeName>
<Initials>RP</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Iowa College of Medicine, Iowa City, Iowa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sparks</LastName>
<ForeName>Amy E T</ForeName>
<Initials>AE</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Iowa College of Medicine, Iowa City, Iowa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Van Voorhis</LastName>
<ForeName>Bradley J</ForeName>
<Initials>BJ</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Iowa College of Medicine, Iowa City, Iowa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Duran</LastName>
<ForeName>Eyup Hakan</ForeName>
<Initials>EH</Initials>
<AffiliationInfo>
<Affiliation>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Iowa College of Medicine, Iowa City, Iowa.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">ART</Keyword>
<Keyword MajorTopicYN="N">IVF</Keyword>
<Keyword MajorTopicYN="N">algorithm</Keyword>
<Keyword MajorTopicYN="N">ectopic</Keyword>
<Keyword MajorTopicYN="N">heterotopic</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26297645</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Exploring adhesion formation and prevention.</ArticleTitle>
<Pagination>
<MedlinePgn>836-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.07.1153</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)01665-9</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hurst</LastName>
<ForeName>Bradley S</ForeName>
<Initials>BS</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Carolinas Medical Center, Charlotte, North Carolina.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>Fertil Steril. 2015 Oct;104(4):1022-9</RefSource>
<PMID Version="1">26215756</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26327237</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Peritoneal fluid in the pouch of Douglas: strategically located and affecting reproductive events.</ArticleTitle>
<Pagination>
<MedlinePgn>831-2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.08.010</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)01847-6</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Younis</LastName>
<ForeName>Johnny S</ForeName>
<Initials>JS</Initials>
<AffiliationInfo>
<Affiliation>Reproductive Medicine, Department of Obstetrics and Gynecology, Poriya Medical Center, Tiberias, Faculty of Medicine in Galilee, Bar-Ilan University, Ramat Gan, Israel.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Laufer</LastName>
<ForeName>Neri</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Reproductive Medicine, Department of Obstetrics and Gynecology, Poriya Medical Center, Tiberias, Faculty of Medicine in Galilee, Bar-Ilan University, Ramat Gan, Israel; Reproductive Medicine, Department of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, Ein-Kerem, Jerusalem, Israel.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26335131</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Endometriosis and ovarian cancer: potential benefits and harms of screening and risk-reducing surgery.</ArticleTitle>
<Pagination>
<MedlinePgn>813-30</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.08.006</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)01760-4</ELocationID>
<Abstract>
<AbstractText>Although endometriosis is well recognized as a benign gynecologic condition, its association with ovarian cancer (OVCA) has frequently been reported. Review articles on this topic are voluminous, yet there seems to be no consensus as to whether endometriosis is truly a precursor of OVCA and whether any screening or risk-reducing surgery should be instituted, on the basis of our current knowledge. In this review, published data are compiled and critically appraised. Through this critical appraisal, it seems clear that the strongest evidence seems to come from prevalence data. This type of data also suggests a reduced risk of certain histotypes (mainly type II) of OVCA in women with endometriosis. This may explain the rather moderate increase in risk as shown in epidemiologic studies. Even with this moderate increase in OVCA risk, caution should be exercised because of apparent bias in favor of publication of positive results, extensive heterogeneities among prevalence estimates, and inverse relationship between estimates and sizes of the studies. Many molecular studies are conflicting, and earlier studies showing molecular aberrations involved in genomic instability and mutation that enable malignant transformation are not replicated in later studies. Given the low incidence of OVCA and the rather moderate increase in risk of mostly type I tumors, screening seems to be ill-advised, and risk-reducing surgery such as salpingectomy with or without oophorectomy does not seem to yield any substantial benefit to women with endometriosis.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Guo</LastName>
<ForeName>Sun-Wei</ForeName>
<Initials>SW</Initials>
<AffiliationInfo>
<Affiliation>Shanghai Obstetrics and Gynecology Hospital, Fudan University, Shanghai, People's Republic of China; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Fudan University, Shanghai, People's Republic of China; Department of Biochemistry and Molecular Biology, Shanghai College of Medicine, Fudan University, Shanghai, People's Republic of China. Electronic address: hoxa10@outlook.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>31</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Association</Keyword>
<Keyword MajorTopicYN="N">endometriosis</Keyword>
<Keyword MajorTopicYN="N">epidemiology</Keyword>
<Keyword MajorTopicYN="N">molecular</Keyword>
<Keyword MajorTopicYN="N">ovarian cancer</Keyword>
<Keyword MajorTopicYN="N">screening</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26342244</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Treatment of infertility associated with deep endometriosis: definition of therapeutic balances.</ArticleTitle>
<Pagination>
<MedlinePgn>764-70</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.08.003</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)01757-4</ELocationID>
<Abstract>
<AbstractText>Deep endometriosis is a demanding condition that is associated with infertility. However, evidence supporting a direct link between deep endometriosis and infertility is weak. In fact, infertility in affected patients is more likely to be explained by the strong association between deep endometriosis and adhesions, superficial endometriotic implants, ovarian endometriomas, and adenomyosis. The purported beneficial effects of surgery on infertility are mainly based on the 40%-42% pregnancy rate (PR) after surgery observed in published case series. However, this level of evidence is questionable and overestimates the benefits of the intervention. Even if comparative studies are lacking, IVF may be a valid alternative. The procedure may be less effective in affected women compared with other indications and it is not without additional deep endometriosis-related risks. Some case reports suggest that lesions might progress during IVF causing ureteral or intestinal complications or can decidualize during pregnancy causing intestinal perforation, pneumothorax, and pelvic vessels rupture. Finally, in the decision-making process, physicians should also consider that women with a history of deep endometriosis may face an increased risk of pregnancy complications. In conclusion, clear recommendation for the management of infertile women with deep endometriosis cannot be extrapolated from the literature. The therapeutic decision should be based on a comprehensive evaluation that includes clinical history, instrumental findings, pain symptoms, risks of pregnancy complications, and the woman's wishes.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Somigliana</LastName>
<ForeName>Edgardo</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Garcia-Velasco</LastName>
<ForeName>Juan Antonio</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>IVI-Madrid and Rey Juan Carlos University, Madrid, Spain. Electronic address: juan.garcia.velasco@ivi.es.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Deep endometriosis</Keyword>
<Keyword MajorTopicYN="N">IVF</Keyword>
<Keyword MajorTopicYN="N">pregnancy</Keyword>
<Keyword MajorTopicYN="N">surgery</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26348274</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Beyond infertility: obstetrical and postpartum complications associated with endometriosis and adenomyosis.</ArticleTitle>
<Pagination>
<MedlinePgn>802-12</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.08.030</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)01876-2</ELocationID>
<Abstract>
<AbstractText>The risk of pregnancy and neonatal complications in women with endometriosis and adenomyosis is debatable. A literature review looking at rates, presentation, and management of spontaneous hemoperitoneum, enlargement, abscess, and rupture of an endometrioma, uterine rupture, and bowel perforation in pregnant women with endometriosis was conducted. Moreover, studies addressing differences in early pregnancy (miscarriage), late pregnancy (gestational diabetes mellitus, preeclampsia, prematurity, placenta previa, placental abruption, cesarean section, hemorrhages) and neonatal outcomes (weight at birth) between endometriosis and adenomyosis patients versus control subjects were reviewed. The overall prevalence of endometriosis-related spontaneous hemoperitoneum in pregnancy is estimated to be ∼0.4%. Only four cases of endometrioma rupture in pregnancy have been reported. Although during pregnancy there is no way to anticipate the onset of complications from preexisting endometriosis, it is important, when a specific abdominal pain occurs, to suspect rare but potentially life-threating events. Population-based studies suggest a possible association of endometriosis with preterm birth and placenta previa. Limits of the published studies are noted and discussed.</AbstractText>
<CopyrightInformation>Copyright © 2015. Published by Elsevier Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vigano</LastName>
<ForeName>Paola</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Reproductive Sciences Laboratory, Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milan, Italy. Electronic address: vigano.paola@hsr.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Corti</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Reproductive Sciences Laboratory, Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Berlanda</LastName>
<ForeName>Nicola</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics, Gynecology, and Neonatology, Fondazione Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Endometriosis</Keyword>
<Keyword MajorTopicYN="N">adenomyosis</Keyword>
<Keyword MajorTopicYN="N">complication</Keyword>
<Keyword MajorTopicYN="N">placenta previa</Keyword>
<Keyword MajorTopicYN="N">pregnancy</Keyword>
<Keyword MajorTopicYN="N">preterm birth</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26354093</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis.</ArticleTitle>
<Pagination>
<MedlinePgn>793-801</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.08.026</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)01872-5</ELocationID>
<Abstract>
<AbstractText>Although surgical excision of endometriosis both improves pain and enhances fertility, recurrence can further exacerbate pain and reduce fertility, which in turn impacts the quality of life and increases personal as well as social costs. Therefore, it is crucial to prevent the recurrence of symptoms and lesions after conservative surgery. This article reviews evidence regarding the prevention of postoperative recurrence of endometriosis reported since the 1990s. Over the past 5 years, many new studies have been conducted and have demonstrated that long-term postoperative medication markedly reduces the recurrence. Most of these studies used oral contraceptives (OC), with either the cyclic or continuous regimen, while some used oral or intrauterine progestin. Continuous OC is more efficacious than cyclic OC, especially for dysmenorrhea. The levonorgestrel-releasing intrauterine system is also shown to prevent recurrence of dysmenorrhea and possibly endometriosis lesions. Dienogest, a new progestin, is shown to reduce the recurrence of endometrioma. Similar to the case of ovarian endometriosis, long-term postoperative medication after conservative surgery for deep infiltrating or extragenital endometriosis seems important, although data are limited. Regardless of the lesion and the medication type, patients who discontinued medication experienced a higher incidence of recurrence, indicating that the protective effect of these medications seems to vanish rapidly after the discontinuation. On the basis of these facts, together with the pathogenesis of recurrence (retrograde menstruation and ovulation), regular and prolonged medication until the patient wishes to conceive is highly recommended to prevent the postoperative recurrence of endometriosis.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Koga</LastName>
<ForeName>Kaori</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, University of Tokyo, Tokyo, Japan. Electronic address: kawotan-tky@umin.ac.jp.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Takamura</LastName>
<ForeName>Masashi</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, University of Tokyo, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fujii</LastName>
<ForeName>Tomoyuki</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, University of Tokyo, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Osuga</LastName>
<ForeName>Yutaka</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, University of Tokyo, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Endometriosis</Keyword>
<Keyword MajorTopicYN="N">oral contraceptives</Keyword>
<Keyword MajorTopicYN="N">prevention</Keyword>
<Keyword MajorTopicYN="N">progestin</Keyword>
<Keyword MajorTopicYN="N">recurrence</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26363383</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Introduction: Management of endometriosis: moving toward a problem-oriented and patient-centered approach.</ArticleTitle>
<Pagination>
<MedlinePgn>761-3</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.09.004</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)01890-7</ELocationID>
<Abstract>
<AbstractText>Endometriosis is a protean disease, and its manifestations, associated clinical problems, and possible treatments are numerous. Deep endometriosis that infiltrates multiple pelvic organs should be considered the most severe endometriotic form that poses the most difficult therapeutic uncertainties in both infertility and pelvic pain symptoms limiting quality of life. The available evidence demonstrates that endometriosis is not only a gynecologic disorder but, contrary to previous belief, its impact extends into pregnancy, delivery, and the post-partum period. The old clinical tenet that pregnancy is a cure for endometriosis may be revealed as fallacious. Safe and effective modalities to reduce the risk of the recurrence of symptoms and lesions after conservative surgery for endometriosis are now available. These treatment options should be offered post-operatively to women not immediately seeking conception. Endometriosis is associated with a moderate increase in ovarian cancer risk. However, as there are no definitive demonstrations that endometriosis constitutes per se a pre-neoplastic condition, it seems currently unwise to set-up a screening program to detect undiagnosed endometriosis in asymptomatic women. Endometriosis is not a cancer; therefore a paradigm shift from treatment of lesions to treatment of symptoms is warranted. Management should be shaped on the main clinical problem, taking into consideration a woman's preferences and priorities. Quantitative information should be provided to describe the potential benefits, potential harms, and costs of each treatment alternative. Counseling should be complete and transparent, and the duty of the caring gynecologist is to inform the woman on the pros and cons of each option and support her in the shared decision-making process. The physician should be able to explain in detail all the available treatments, and not only those that the physician prefers or is able to offer.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vercellini</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Sciences and Community Health, Università degli Studi di Milano and Fondazione Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: paolo.vercellini@unimi.it.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Deep endometriosis</Keyword>
<Keyword MajorTopicYN="N">infertility</Keyword>
<Keyword MajorTopicYN="N">ovarian cancer</Keyword>
<Keyword MajorTopicYN="N">pelvic pain</Keyword>
<Keyword MajorTopicYN="N">recurrence</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26363387</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-5653</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Fertility and sterility</Title>
<ISOAbbreviation>Fertil. Steril.</ISOAbbreviation>
</Journal>
<ArticleTitle>Treatment of pain associated with deep endometriosis: alternatives and evidence.</ArticleTitle>
<Pagination>
<MedlinePgn>771-92</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fertnstert.2015.08.031</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0015-0282(15)01877-4</ELocationID>
<Abstract>
<AbstractText>Pain is the most evident clinical manifestation of deep infiltrating endometriosis (DIE). Several hormonal and immunologic mechanisms are markedly altered in DIE compared with superficial peritoneal and ovarian endometriosis, and may explain its most aggressive behavior and the presence of severe pain symptoms. Hormonal therapies, such as combined hormonal contraceptives and progestogens, should be regarded as first-line treatment, as they are efficacious, safe, and well tolerated. Gonadotropin-releasing hormone agonists may be used in patients with symptoms persisting after the administration of first-line therapies. Scanty literature is available for danazol treatment in patients with DIE and, however, it has become less popular due to the high rates of androgenic adverse events (AEs). The partial relief of pain that often is achieved with available therapies and its recurrence after the suspension of the treatment have brought to the development of new therapies (such as aromatase inhibitors, oral GnRH antagonists) that are currently under investigation. Surgical excision of DIE should be considered in patients with pain symptoms persisting after first-line hormonal therapies. The benefits of surgery in terms of pain improvement should be always balanced with the risk of intraoperative complications and for this reason surgical cases should be referred to tertiary centers for the treatment of DIE. A multidisciplinary approach is mandatory in patients with DIE involving the bowel and/or the urinary tract.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ferrero</LastName>
<ForeName>Simone</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Unit of Obstetrics and Gynecology, San Martino Hospital and National Institute for Cancer Research, University of Genoa, Genoa, Italy; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy. Electronic address: simone.ferrero@unige.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alessandri</LastName>
<ForeName>Franco</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Unit of Obstetrics and Gynecology, San Martino Hospital and National Institute for Cancer Research, University of Genoa, Genoa, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Racca</LastName>
<ForeName>Annalisa</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Unit of Obstetrics and Gynecology, San Martino Hospital and National Institute for Cancer Research, University of Genoa, Genoa, Italy; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Leone Roberti Maggiore</LastName>
<ForeName>Umberto</ForeName>
<Initials>U</Initials>
<AffiliationInfo>
<Affiliation>Unit of Obstetrics and Gynecology, San Martino Hospital and National Institute for Cancer Research, University of Genoa, Genoa, Italy; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Fertil Steril</MedlineTA>
<NlmUniqueID>0372772</NlmUniqueID>
<ISSNLinking>0015-0282</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Deep endometriosis</Keyword>
<Keyword MajorTopicYN="N">endometriosis</Keyword>
<Keyword MajorTopicYN="N">medical treatment</Keyword>
<Keyword MajorTopicYN="N">pain</Keyword>
<Keyword MajorTopicYN="N">surgery</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432109</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Surgical diversity and evolution in cataract and refractive surgery.</ArticleTitle>
<Pagination>
<MedlinePgn>1557-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.08.012</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)01003-2</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dupps</LastName>
<ForeName>William J</ForeName>
<Initials>WJ</Initials>
<Suffix>Jr</Suffix>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016421">Editorial</PublicationType>
<PublicationType UI="D054711">Introductory Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432110</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>New add-on intraocular lens for patients with age-related macular degeneration.</ArticleTitle>
<Pagination>
<MedlinePgn>1559-63</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.07.018</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00848-2</ELocationID>
<Abstract>
<AbstractText Label="UNLABELLED">We present a new option for visual rehabilitation of patients with advanced macular degeneration and evaluate the outcomes in the first 8 patients who had implantation of the ciliary sulcus-fixated macular add-on intraocular lens (IOL) (Scharioth Macula Lens) at our institute. The surgical technique for implantation of the add-on IOL is described. Near vision improved in 7 eyes and was stable in 1 eye. The corrected near visual acuity improved by 4.4 lines with the macular add-on IOL at 15 cm versus with glasses at 40 cm; it improved by 2.1 lines with the macular add-on IOL at 15 cm versus with glasses at 15 cm. Distance vision was stable in all eyes. No intraoperative or postoperative complication occurred. The macular add-on IOL has the potential of improving near vision and reading ability in patients with advanced age-related macular degeneration.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">Dr. Scharioth is a consultant to Alcon Laboratories, Inc., and Medicontur Ltd. He is the inventor of the Scharioth Macula Lens and receives royalties.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Scharioth</LastName>
<ForeName>Gabor B</ForeName>
<Initials>GB</Initials>
<AffiliationInfo>
<Affiliation>From Aurelios Augenzentrum, Recklinghausen, Germany, and the Department of Ophthalmology, University of Szeged, Szeged, Hungary. Electronic address: gabor.scharioth@augenzentrum.org.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432111</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Suture-guided capsular tension ring insertion to reduce risk for iatrogenic zonular damage.</ArticleTitle>
<Pagination>
<MedlinePgn>1564-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.08.004</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00955-4</ELocationID>
<Abstract>
<AbstractText Label="UNLABELLED">The capsular tension ring (CTR) is a useful device for managing a zonular dialysis. However, insertion of the CTR has potential complications. The CTR can damage zonular fibers during deployment into the capsular bag. Also, the angle and point of initial contact of the CTR with the capsular bag relative to the orientation of the dialysis must be considered to avoid damage to the zonular fibers. Adequate fill of the capsular bag with an ophthalmic viscosurgical device is important to minimize the risk for capsule entanglement with the leading eyelet of the CTR. A simple technique is described to prevent these complications. The technique can be used with both standard and modified CTRs.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">Dr. Page is a consultant to Bausch &amp; Lomb, Inc. and Abbott Medical Optics, Inc. He has no financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Page</LastName>
<ForeName>Timothy P</ForeName>
<Initials>TP</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, USA. Electronic address: tpagemd@yahoo.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432112</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Range of refractive independence and mechanism of action of a corneal shape-changing hydrogel inlay: results and theory.</ArticleTitle>
<Pagination>
<MedlinePgn>1568-79</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.08.007</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00996-7</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To demonstrate the independence of visual performance over a range of preoperative refraction and age in presbyopes implanted with a corneal shape-changing inlay (Raindrop Near Vision Inlay).</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Two multispecialty clinics, Monterrey and Tijuana, Mexico.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective case series.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The nondominant eyes of patients were implanted with the hydrogel corneal inlay beneath a femtosecond flap, centered on the pupil. Clinical outcomes included uncorrected near, intermediate, and distance visual acuity (UNVA, UIVA, and UDVA) and patient-assessed task performance in good light and dim light. Statistical analyses assessed the dependencies on preoperative age (45 to 60 years) and preoperative manifest refraction spherical equivalent (MRSE) (-0.5 to +1.5 diopters [D]). Using the inlay effect derived from wavefront measurements, an eye model was created through which letter charts were simulated.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The study evaluated eyes of 188 patients. Postoperative UNVA, UIVA, and task performance at these distances in good light was independent of age and preoperative MRSE (P &gt; .05). Postoperative UDVA was weakly dependent on preoperative MRSE, but distance task performance in good light was not (P &gt; .05). In the treated eye, the mean postoperative UNVA was 20/25, UIVA was 20/25, and UDVA was 20/32. The clinical outcomes are explained by consideration of zones within the pupil generating good near, intermediate, and distance image quality. This was confirmed by visual acuity simulations.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The continuous center-near power profile induced by the corneal shape-changing inlay provides good visual acuity and performance from distance through near over a 2.0 D range of preoperative refraction and presbyopic age.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">Drs. Steinert, Schwiegerling, Barragán-Garza, and Chayet are consultants to Revision Optics, Inc. Drs. Lang and Holliday and Mr. Roy are employees of Revision Optics, Inc. Drs. Steinert, Schwiegerling, Barragán-Garza, and Chayet have no financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Steinert</LastName>
<ForeName>Roger F</ForeName>
<Initials>RF</Initials>
<AffiliationInfo>
<Affiliation>From the Gavin Herbert Eye Institute (Steinert), University of California, Irvine, Revision Optics, Inc. (Lang, Holliday, Roy), Lake Forest, California, the College of Optical Sciences/Ophthalmology (Schwiegerling), University of Arizona, Tucson, Arizona, USA; Laser Ocular Hidalgo (Barragán), Monterrey, and the Codet Aris Vision Institute (Chayet), Tijuana, Mexico. Electronic address: steinert@uci.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schwiegerling</LastName>
<ForeName>Jim</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Gavin Herbert Eye Institute (Steinert), University of California, Irvine, Revision Optics, Inc. (Lang, Holliday, Roy), Lake Forest, California, the College of Optical Sciences/Ophthalmology (Schwiegerling), University of Arizona, Tucson, Arizona, USA; Laser Ocular Hidalgo (Barragán), Monterrey, and the Codet Aris Vision Institute (Chayet), Tijuana, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lang</LastName>
<ForeName>Alan</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Gavin Herbert Eye Institute (Steinert), University of California, Irvine, Revision Optics, Inc. (Lang, Holliday, Roy), Lake Forest, California, the College of Optical Sciences/Ophthalmology (Schwiegerling), University of Arizona, Tucson, Arizona, USA; Laser Ocular Hidalgo (Barragán), Monterrey, and the Codet Aris Vision Institute (Chayet), Tijuana, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Roy</LastName>
<ForeName>Adam</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Gavin Herbert Eye Institute (Steinert), University of California, Irvine, Revision Optics, Inc. (Lang, Holliday, Roy), Lake Forest, California, the College of Optical Sciences/Ophthalmology (Schwiegerling), University of Arizona, Tucson, Arizona, USA; Laser Ocular Hidalgo (Barragán), Monterrey, and the Codet Aris Vision Institute (Chayet), Tijuana, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Holliday</LastName>
<ForeName>Keith</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>From the Gavin Herbert Eye Institute (Steinert), University of California, Irvine, Revision Optics, Inc. (Lang, Holliday, Roy), Lake Forest, California, the College of Optical Sciences/Ophthalmology (Schwiegerling), University of Arizona, Tucson, Arizona, USA; Laser Ocular Hidalgo (Barragán), Monterrey, and the Codet Aris Vision Institute (Chayet), Tijuana, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barragán Garza</LastName>
<ForeName>Enrique</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>From the Gavin Herbert Eye Institute (Steinert), University of California, Irvine, Revision Optics, Inc. (Lang, Holliday, Roy), Lake Forest, California, the College of Optical Sciences/Ophthalmology (Schwiegerling), University of Arizona, Tucson, Arizona, USA; Laser Ocular Hidalgo (Barragán), Monterrey, and the Codet Aris Vision Institute (Chayet), Tijuana, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chayet</LastName>
<ForeName>Arturo S</ForeName>
<Initials>AS</Initials>
<AffiliationInfo>
<Affiliation>From the Gavin Herbert Eye Institute (Steinert), University of California, Irvine, Revision Optics, Inc. (Lang, Holliday, Roy), Lake Forest, California, the College of Optical Sciences/Ophthalmology (Schwiegerling), University of Arizona, Tucson, Arizona, USA; Laser Ocular Hidalgo (Barragán), Monterrey, and the Codet Aris Vision Institute (Chayet), Tijuana, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432113</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Corneal sensitivity after small-incision lenticule extraction and laser in situ keratomileusis.</ArticleTitle>
<Pagination>
<MedlinePgn>1580-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.12.055</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00846-9</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To longitudinally evaluate corneal sensitivity after small-incision lenticule extraction and compare the results with those in previous studies.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">London Vision Clinic, London, United Kingdom.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective case series.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Consecutive myopic eyes treated with small-incision lenticule extraction using the Visumax femtosecond laser were studied. Corneal sensitivity was measured centrally and at 4 paracentral locations using a Cochet-Bonnet esthesiometer preoperatively and 1 day, 1 week, and 1, 3, 6, and 12 months postoperatively. Results were compared with averaged results from previous laser in situ keratomileusis (LASIK) and small-incision lenticule extraction studies.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean spherical equivalent was -6.85 diopters (D) ± 2.57 (SD). The mean age was 36 ± 11 years. After small-incision lenticule extraction, the preoperative mean central corneal sensitivity dropped from 54 mm preoperatively to 33 mm 1 day postoperatively, rising to 40 mm, 45 mm, 48 mm, 54 mm, and 55 mm over 12 months; it reached baseline at 6 months (P &gt; .05). For 21 LASIK studies, the mean central corneal sensitivity dropped from 56 mm preoperatively to 6 mm at 1 day, rising to 14 mm, 23 mm, 34 mm, 45 mm, and 51 mm over 12 months. For 8 small-incision lenticule extraction studies, central corneal sensitivity dropped from 57 mm preoperatively to 39 mm at 1 week, then rose to 39 mm, 42 mm, 49 mm, 52 mm, and 54 mm over 12 months; it was higher than after LASIK at 1 week and 1, 3, and 6 months (P &lt; .05).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Recovery of central corneal sensitivity to baseline was reached by 6 months after small-incision lenticule extraction and was higher than after LASIK for the first 6 months after surgery.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">Dr. Reinstein is a consultant to Carl Zeiss Meditec AG, has a proprietary interest in the Artemis technology (Arcscan, Inc.), and is an author of patents related to very high-frequency digital ultrasound administered by the Center for Technology Licensing at Cornell University, Ithaca, New York, USA. No other author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Reinstein</LastName>
<ForeName>Dan Z</ForeName>
<Initials>DZ</Initials>
<AffiliationInfo>
<Affiliation>From the London Vision Clinic (Reinstein, Archer, Gobbe), London, United Kingdom; the Department of Ophthalmology (Reinstein), Columbia University Medical Center, New York, New York, USA; Centre Hospitalier National d'Ophtalmologie (Reinstein), Paris, France; Laser SRL Refractive Laser Center (Bartoli), Torino, Italy. Electronic address: dzr@londonvisionclinic.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Archer</LastName>
<ForeName>Timothy J</ForeName>
<Initials>TJ</Initials>
<AffiliationInfo>
<Affiliation>From the London Vision Clinic (Reinstein, Archer, Gobbe), London, United Kingdom; the Department of Ophthalmology (Reinstein), Columbia University Medical Center, New York, New York, USA; Centre Hospitalier National d'Ophtalmologie (Reinstein), Paris, France; Laser SRL Refractive Laser Center (Bartoli), Torino, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gobbe</LastName>
<ForeName>Marine</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From the London Vision Clinic (Reinstein, Archer, Gobbe), London, United Kingdom; the Department of Ophthalmology (Reinstein), Columbia University Medical Center, New York, New York, USA; Centre Hospitalier National d'Ophtalmologie (Reinstein), Paris, France; Laser SRL Refractive Laser Center (Bartoli), Torino, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bartoli</LastName>
<ForeName>Elena</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>From the London Vision Clinic (Reinstein, Archer, Gobbe), London, United Kingdom; the Department of Ophthalmology (Reinstein), Columbia University Medical Center, New York, New York, USA; Centre Hospitalier National d'Ophtalmologie (Reinstein), Paris, France; Laser SRL Refractive Laser Center (Bartoli), Torino, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432114</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Safety and efficacy of wavefront-guided myopic laser in situ keratomileusis using a new wavefront sensor technology: first 100 cases.</ArticleTitle>
<Pagination>
<MedlinePgn>1588-93</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.11.053</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00953-0</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate the safety and efficacy of wavefront-guided laser in situ keratomileusis (LASIK) for the correction of low to high myopia and myopic astigmatism using data derived from a new-generation Hartmann-Shack aberrometer.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Refractive Surgery Unit, Bordeaux Hospital University, France.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective case series.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective study analyzed the initial group of eyes treated with wavefront-guided LASIK for myopia and myopic astigmatism using the Visx S4IR excimer laser and wavefront data derived from a new Hartmann-Shack aberrometer (iDesign Advanced Wavescan aberrometer). Refractive (refraction and refractive accuracy) and visual outcomes (uncorrected [UDVA] and corrected [CDVA] distance visual acuities) were recorded 3 months postoperatively.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The study included 100 eyes of 50 consecutively treated patients. The mean decimal UDVA improved from 0.1 ± 0.1 (SD) preoperatively to 1.1 ± 0.15 postoperatively (P &lt; .01). A monocular UDVA of 20/16, 20/20, and 20/25 were achieved in 76.6%, 94.4%, and 96.6% of eyes, respectively. The postoperative manifest spherical equivalent was within ±0.5 diopter in all eyes. No eye lost 2 or more lines of CDVA, and 29.2% of the eyes gained 1 or more lines of CDVA.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Wavefront-guided LASIK performed using data derived from the new Hartmann-Shack aberrometer was safe, effective, and predictable for treating myopia and myopic astigmatism.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">No author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Smadja</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>From the Ophthalmology Department, Tel Aviv Sourasky Medical Center (Smadja), and the Institute of Nanotechnology and Advanced Materials (Smadja), Bar-Ilan University, Tel Aviv, Israel; the National Reference Center for Keratoconus (Smadja, Tellouck, De Castro, Lecomte, Touboul), Bordeaux Hospital University, Bordeaux, France; Department of Ophthalmology (Santhiago), Federal University of Rio De Janeiro, Rio, Brazil, Department Of Ophthalmology (Mello), Federal University Of Paraná, Curitiba, Brazil. Electronic address: davidsmadj@hotmail.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Santhiago</LastName>
<ForeName>Marcony R</ForeName>
<Initials>MR</Initials>
<AffiliationInfo>
<Affiliation>From the Ophthalmology Department, Tel Aviv Sourasky Medical Center (Smadja), and the Institute of Nanotechnology and Advanced Materials (Smadja), Bar-Ilan University, Tel Aviv, Israel; the National Reference Center for Keratoconus (Smadja, Tellouck, De Castro, Lecomte, Touboul), Bordeaux Hospital University, Bordeaux, France; Department of Ophthalmology (Santhiago), Federal University of Rio De Janeiro, Rio, Brazil, Department Of Ophthalmology (Mello), Federal University Of Paraná, Curitiba, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tellouck</LastName>
<ForeName>Joy</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Ophthalmology Department, Tel Aviv Sourasky Medical Center (Smadja), and the Institute of Nanotechnology and Advanced Materials (Smadja), Bar-Ilan University, Tel Aviv, Israel; the National Reference Center for Keratoconus (Smadja, Tellouck, De Castro, Lecomte, Touboul), Bordeaux Hospital University, Bordeaux, France; Department of Ophthalmology (Santhiago), Federal University of Rio De Janeiro, Rio, Brazil, Department Of Ophthalmology (Mello), Federal University Of Paraná, Curitiba, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>De Castro</LastName>
<ForeName>Tania</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>From the Ophthalmology Department, Tel Aviv Sourasky Medical Center (Smadja), and the Institute of Nanotechnology and Advanced Materials (Smadja), Bar-Ilan University, Tel Aviv, Israel; the National Reference Center for Keratoconus (Smadja, Tellouck, De Castro, Lecomte, Touboul), Bordeaux Hospital University, Bordeaux, France; Department of Ophthalmology (Santhiago), Federal University of Rio De Janeiro, Rio, Brazil, Department Of Ophthalmology (Mello), Federal University Of Paraná, Curitiba, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lecomte</LastName>
<ForeName>Fanny</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>From the Ophthalmology Department, Tel Aviv Sourasky Medical Center (Smadja), and the Institute of Nanotechnology and Advanced Materials (Smadja), Bar-Ilan University, Tel Aviv, Israel; the National Reference Center for Keratoconus (Smadja, Tellouck, De Castro, Lecomte, Touboul), Bordeaux Hospital University, Bordeaux, France; Department of Ophthalmology (Santhiago), Federal University of Rio De Janeiro, Rio, Brazil, Department Of Ophthalmology (Mello), Federal University Of Paraná, Curitiba, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mello</LastName>
<ForeName>Glauco R</ForeName>
<Initials>GR</Initials>
<AffiliationInfo>
<Affiliation>From the Ophthalmology Department, Tel Aviv Sourasky Medical Center (Smadja), and the Institute of Nanotechnology and Advanced Materials (Smadja), Bar-Ilan University, Tel Aviv, Israel; the National Reference Center for Keratoconus (Smadja, Tellouck, De Castro, Lecomte, Touboul), Bordeaux Hospital University, Bordeaux, France; Department of Ophthalmology (Santhiago), Federal University of Rio De Janeiro, Rio, Brazil, Department Of Ophthalmology (Mello), Federal University Of Paraná, Curitiba, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Touboul</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>From the Ophthalmology Department, Tel Aviv Sourasky Medical Center (Smadja), and the Institute of Nanotechnology and Advanced Materials (Smadja), Bar-Ilan University, Tel Aviv, Israel; the National Reference Center for Keratoconus (Smadja, Tellouck, De Castro, Lecomte, Touboul), Bordeaux Hospital University, Bordeaux, France; Department of Ophthalmology (Santhiago), Federal University of Rio De Janeiro, Rio, Brazil, Department Of Ophthalmology (Mello), Federal University Of Paraná, Curitiba, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432115</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Femtosecond-assisted laser in situ keratomileusis for consecutive hyperopia after radial keratotomy.</ArticleTitle>
<Pagination>
<MedlinePgn>1594-601</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.08.014</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)01023-8</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate femtosecond-assisted laser in situ keratomileusis (LASIK) for the treatment of hyperopic shift after radial keratotomy (RK).</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Private practice, Siena, Italy.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective case series.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Eyes with a spherical equivalent (SE) of +1.0 diopters (D) to +4.0 D after RK with 6 or 8 incisions had LASIK. The flap (nominal thickness 130 μm) was created with a femtosecond laser (LDV Z2); the refractive ablation was performed with an excimer laser (217P). The flap was dissected in a centrifugal fashion along previous RK cuts.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighteen eyes of 10 patients were treated. Preoperatively, the mean defocus equivalent was 3.13 diopters (D) ± 0.71 (SD); the corrected distance visual acuity (CDVA) was 0.09 ± 0.06 logMAR. At 9 months, the mean defocus equivalent was 0.51 ± 0.47 D (P &lt; .05), with 13 eyes (72%) having 0.50 D or less of defocus equivalent and 16 eyes (89%) having 1.0 D or less of defocus equivalent. The mean CDVA was 0.04 ± 0.06 logMAR (P &lt; .05). No lines of logMAR CDVA were lost. The mean uncorrected distance visual acuity was 0.11 ± 0.10 logMAR. The safety index was 1.11; the efficacy index was 0.97. No retreatments were performed. Flap complications were limited to an RK incision opening larger than 2 mm in 3 eyes and 1 case of a small, self-limiting epithelial ingrowth.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Laser in situ keratomileusis with a low-energy femtosecond laser was a safe and effective approach to treat post-RK hyperopia, causing no relevant inflammation.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">Neither author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Leccisotti</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Siena Eye Laser (Leccisotti, Fields), Poggibonsi, Siena, Italy; the School of Biomedical Sciences (Leccisotti), University of Ulster, Coleraine, United Kingdom. Electronic address: leccisotti@libero.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fields</LastName>
<ForeName>Stefania V</ForeName>
<Initials>SV</Initials>
<AffiliationInfo>
<Affiliation>From the Siena Eye Laser (Leccisotti, Fields), Poggibonsi, Siena, Italy; the School of Biomedical Sciences (Leccisotti), University of Ulster, Coleraine, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432116</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Hyperopic laser in situ keratomileusis: comparison of femtosecond laser and mechanical microkeratome flap creation.</ArticleTitle>
<Pagination>
<MedlinePgn>1602-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.11.049</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00839-1</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate and compare the refractive predictability and stability of laser in situ keratomileusis (LASIK) flap creation performed with a femtosecond laser and with a mechanical microkeratome to correct mild to moderate hyperopia.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">American University of Beirut Medical Center, Beirut, Lebanon.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective case series.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Patients who had hyperopic LASIK treatment using the Amaris excimer laser were included. Eyes in which the LDV femtosecond laser was used for flap creation were compared with eyes in which the Moria M2 microkeratome was used.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The microkeratome group comprised 53 eyes and the femtosecond laser group, 72 eyes. Baseline characteristics were similar between groups (P &gt; .05). The mean spherical equivalent (SE) deviation from target 1 week postoperatively was -0.08 diopter (D) ± 0.58 (SD) in the femtosecond laser group and -0.06 ± 0.87 D in the microkeratome group (P = .92). Thereafter, the mean SE deviation from target increased gradually and by 6 months postoperatively was +0.30 ± 0.50 D and +0.70 ± 0.71 D, respectively (P = .001). The correlation between the achieved and the attempted SE refraction was better in the femtosecond laser group (R(2) = 0.806) than the microkeratome group (R(2) = 0.671).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Using the same nomogram, the short-term refractive outcomes of hyperopic LASIK with flap creation performed with the femtosecond laser were comparable to those for the microkeratome; however, the femtosecond group showed significantly better stability over the 6-month follow-up and better predictability, as reflected by a lower standard deviation and stronger Pearson correlation.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">Dr. Arba Mosquera is an employee of Schwind eye-tech-solutions GmbH and Co. KG. No other author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Antonios</LastName>
<ForeName>Rafic</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Antonios, Awwad), American University of Beirut, Beirut, Lebanon; the Department of Research and Development (Arba Mosquera), Schwind eye-tech-solutions GmbH and Co. KG, Kleinostheim, Germany; the Recognized Research Group in Optical Diagnostic Techniques (Arba Mosquera), University of Valladolid, Valladolid, and the Department of Ophthalmology and Sciences of Vision (Arba Mosquera), University of Oviedo, Oviedo, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arba Mosquera</LastName>
<ForeName>Samuel</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Antonios, Awwad), American University of Beirut, Beirut, Lebanon; the Department of Research and Development (Arba Mosquera), Schwind eye-tech-solutions GmbH and Co. KG, Kleinostheim, Germany; the Recognized Research Group in Optical Diagnostic Techniques (Arba Mosquera), University of Valladolid, Valladolid, and the Department of Ophthalmology and Sciences of Vision (Arba Mosquera), University of Oviedo, Oviedo, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Awwad</LastName>
<ForeName>Shady T</ForeName>
<Initials>ST</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Antonios, Awwad), American University of Beirut, Beirut, Lebanon; the Department of Research and Development (Arba Mosquera), Schwind eye-tech-solutions GmbH and Co. KG, Kleinostheim, Germany; the Recognized Research Group in Optical Diagnostic Techniques (Arba Mosquera), University of Valladolid, Valladolid, and the Department of Ophthalmology and Sciences of Vision (Arba Mosquera), University of Oviedo, Oviedo, Spain. Electronic address: shady.awwad@aub.edu.lb.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432117</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>New posterior chamber phakic intraocular lens for high myopia: three-year results.</ArticleTitle>
<Pagination>
<MedlinePgn>1610-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.11.052</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00844-5</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To present the 3-year results regarding the safety and efficacy of the Epi.Lens N, a new posterior chamber phakic intraocular lens (PC pIOL).</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Eye Center, University Hospital Freiburg, Freiburg, Germany.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective clinical study.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A PC pIOL was implanted in highly myopic eyes of consecutive patients. Standardized follow-up examinations including uncorrected (UDVA) and corrected (CDVA) distance visual acuities and refractions were performed 1, 3, and 6 months and 1, 2, and 3 years postoperatively.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The patient cohort consisted of 30 eyes of 16 patients. The study eyes had a mean manifest refraction spherical equivalent of -10.1 diopters (D) ± 3.4 (SD), which decreased to -0.3 ± 0.8 D postoperatively. After 3 years, all eyes achieved (47%) or exceeded (53%) their preoperative CDVA, thus improving the mean CDVA from 20/21 (0.94) preoperatively to 20/18 (1.14) postoperatively. The mean postoperative UDVA (20/20 [0.98]) resembled the preoperative CDVA (20/21 [0.94]). When analyzing all eyes with good visual potential (preoperative CDVA 20/20 or better; n = 18), 94% achieved a postoperative UDVA of 20/20 or better. One small-diameter PC pIOL contacted the crystalline lens, which led to slight anterior subcapsular lens opacification. Despite this, the patient achieved a CDVA of 20/20.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The 3-year results of this pilot study of a new PC pIOL showed good efficacy and safety.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">No author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gasser</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>From the Eye Center, University Hospital Freiburg, Freiburg, Germany. Electronic address: laura.gasser@uniklinik-freiburg.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Biermann</LastName>
<ForeName>Julia</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Eye Center, University Hospital Freiburg, Freiburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Reinhard</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>From the Eye Center, University Hospital Freiburg, Freiburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432118</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Posterior chamber phakic intraocular lens sizing based on iris pigment layer measurements by anterior segment optical coherence tomography.</ArticleTitle>
<Pagination>
<MedlinePgn>1616-22</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.12.051</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00823-8</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To use anterior segment optical coherence tomography (AS-OCT) to evaluate the clinical effectiveness of Implantable Collamer Lens posterior chamber phakic intraocular lens (PC pIOL) sizing based on measurement of the distance from the iris pigment end to the iris pigment end.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">S. Fyodorov Eye Microsurgery Federal State Institution, Moscow, Russia.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Evaluation of diagnostic test or technology.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Stage 1 was a prospective study. The sulcus-to-sulcus (STS) distance was measured using ultrasound biomicroscopy (UBM) (Vumax 2), and the distance from iris pigment end to iris pigment end was assessed using a proposed AS-OCT algorithm. Part 2 used retrospective data from patients after implantation of a PC pIOL with the size selected according to AS-OCT (Visante) measurements of the distance from iris pigment end to iris pigment end. The PC pIOL vault was measured by AS-OCT, and adverse events were assessed.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Stage 1 comprised 32 eyes of 32 myopic patients (mean age 28.4 years ± 6.3 [SD]; mean spherical equivalent [SE] -13.11 ± 4.28 diopters [D]). Stage 2 comprised 29 eyes of 16 patients (mean age 27.7 ± 4.7 years; mean SE -16.55 ± 3.65 D). The mean STS distance (12.35 ± 0.47 mm) was similar to the mean distance from iris pigment end to iris pigment end distance (examiner 1: 12.36 ± 0.51 mm; examiner 2: 12.37 ± 0.53 mm). The PC pIOL sized using the new AS-OCT algorithm had a mean vault of 0.53 ± 0.18 mm and did not produce adverse events during the 12-month follow-up. In 16 of 29 eyes, the PC pIOL vault was within an optimum interval (0.35 to 0.70 mm).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The new measurement algorithm can be effectively used for PC pIOL sizing.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">No author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Malyugin</LastName>
<ForeName>Boris E</ForeName>
<Initials>BE</Initials>
<AffiliationInfo>
<Affiliation>From the Cataract &amp; Implant Surgery Department (Malyugin, Pokrovskiy) and Clinical &amp; Functional Diagnostics Department (Shpak), S. Fyodorov Eye Microsurgery Federal State Institution, Moscow, Russia. Electronic address: boris.malyugin@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shpak</LastName>
<ForeName>Alexander A</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>From the Cataract &amp; Implant Surgery Department (Malyugin, Pokrovskiy) and Clinical &amp; Functional Diagnostics Department (Shpak), S. Fyodorov Eye Microsurgery Federal State Institution, Moscow, Russia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pokrovskiy</LastName>
<ForeName>Dmitry F</ForeName>
<Initials>DF</Initials>
<AffiliationInfo>
<Affiliation>From the Cataract &amp; Implant Surgery Department (Malyugin, Pokrovskiy) and Clinical &amp; Functional Diagnostics Department (Shpak), S. Fyodorov Eye Microsurgery Federal State Institution, Moscow, Russia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432119</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Implantation of a diffractive trifocal intraocular lens: one-year follow-up.</ArticleTitle>
<Pagination>
<MedlinePgn>1623-30</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.11.050</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00840-8</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate the visual, refractive, contrast-sensitivity, and aberrometric outcomes during a 1-year follow-up after implantation of a trifocal intraocular lens (IOL).</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Premium Clinic, Teplice, Czech Republic.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective case series.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">This study included eyes of patients having cataract surgery with implantation of the trifocal IOL model AT Lisa tri 839MP. Distance, intermediate (66 and 80 cm), and near (33 and 40 cm) vision; contrast sensitivity; aberrometric outcomes; and the defocus curve were evaluated during a 12-month follow-up. The level of posterior capsule opacification (PCO) was also evaluated.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In 120 eyes (60 patients), 1 month postoperatively, an improvement was observed in all visual parameters (P ≤ .03) except corrected near and intermediate visual acuities (both P ≥ .05). From 1 month to 12 months postoperatively, small but statistically significant changes were observed in uncorrected and corrected distance and near visual acuities (all P ≤ .03) and in uncorrected intermediate visual acuity (P = .01). In the defocus curve, no significant differences were found between visual acuities corresponding to defocus levels of -1.0 diopter (D) and -2.0 D (P = .22). The level of ocular spherical aberration decreased statistically significantly at 6 months (P &lt; .001). Ocular and internal higher-order aberrations increased minimally but significantly from 6 to 12 months postoperatively (P &lt; .001). The mean 12-month PCO score was 0.32 ± 0.44 (SD). Four eyes (3.3%) required neodymium:YAG capsulotomy.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The trifocal IOL provided complete and stable visual restoration after cataract surgery during a 12-month follow-up, with good levels of visual quality.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">No author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mojzis</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>From the Premium Clinic (Mojzis, Piñero), Teplice, and the Eye Department of Regional Hospital (Mojzis, Majerova, Hrckova), Havlickuv Brod, Czech Republic; the Department of Optics, Pharmacology and Anatomy (Piñero), University of Alicante, Alicante, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Majerova</LastName>
<ForeName>Katarina</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>From the Premium Clinic (Mojzis, Piñero), Teplice, and the Eye Department of Regional Hospital (Mojzis, Majerova, Hrckova), Havlickuv Brod, Czech Republic; the Department of Optics, Pharmacology and Anatomy (Piñero), University of Alicante, Alicante, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hrckova</LastName>
<ForeName>Lucia</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>From the Premium Clinic (Mojzis, Piñero), Teplice, and the Eye Department of Regional Hospital (Mojzis, Majerova, Hrckova), Havlickuv Brod, Czech Republic; the Department of Optics, Pharmacology and Anatomy (Piñero), University of Alicante, Alicante, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Piñero</LastName>
<ForeName>David P</ForeName>
<Initials>DP</Initials>
<AffiliationInfo>
<Affiliation>From the Premium Clinic (Mojzis, Piñero), Teplice, and the Eye Department of Regional Hospital (Mojzis, Majerova, Hrckova), Havlickuv Brod, Czech Republic; the Department of Optics, Pharmacology and Anatomy (Piñero), University of Alicante, Alicante, Spain. Electronic address: david.pinyero@ua.es.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432120</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Comparison of a trifocal intraocular lens with a +3.0 D bifocal IOL: results of a prospective randomized clinical trial.</ArticleTitle>
<Pagination>
<MedlinePgn>1631-40</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.08.011</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)01002-0</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To compare visual outcomes in patients with cataract surgery and bilateral implantation of a trifocal or bifocal intraocular lens (IOL).</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">University Eye Clinic Maastricht, the Netherlands.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective randomized clinical trial.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Eyes with cataract and less than 1.0 diopter (D) of corneal astigmatism were randomized to receive bilateral implantation of Finevision Micro F trifocal IOLs or Acrysof IQ Restor +3.0 bifocal IOLs. Outcome measures were monocular and binocular uncorrected distance (UDVA), uncorrected intermediate (UIVA), and uncorrected near (UNVA) visual acuities; refractive outcomes; binocular defocus curve; contrast sensitivity; reading speed; patient satisfaction; and spectacle independence.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Six months postoperatively, the mean binocular UDVA, UIVA, and UNVA in 56 eyes of 28 patients were 0.01 logMAR ± 0.11 (SD), 0.32 ± 0.15 logMAR, and 0.15 ± 0.13 logMAR in the trifocal group (n = 15) and 0.00 ± 0.09 logMAR, 0.28 ± 0.08 logMAR, and 0.12 ± 0.08 logMAR in the bifocal group (n = 13), respectively. The trifocal group showed a more continuous defocus curve and better results at -1.0 D of defocus (P &lt; .01). The mean mesopic contrast sensitivity was higher in the bifocal group (P = .02). Complete spectacle independence was reported by 80% of trifocal patients and 50% of bifocal patients. There were no significant differences in refractive outcomes, reading speed, or patient satisfaction.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study showed noninferiority of visual outcomes with the trifocal IOL compared with the bifocal IOL, although the defocus curve was better at an intermediate distance with the trifocal IOL.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">Dr. Bauer received study grants from Alcon Laboratories, Inc., Carl Zeiss Meditec AG, and Physiol S.A. and a lecture fee from Alcon Surgical, Inc. Dr. Nuijts is a consultant to Alcon Surgical, Inc., Théa Pharma GmbH, and ASICO LLC; he has received study grants from Acufocus, Inc., Alcon Surgical, Inc., Carl Zeiss Meditec AG, Ophtec BV, and Physiol S.A. No other author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jonker</LastName>
<ForeName>Soraya M R</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>From the University Eye Clinic Maastricht, Maastricht University Medical Center, Maastricht, the Netherlands. Electronic address: soraya.jonker@mumc.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bauer</LastName>
<ForeName>Noël J C</ForeName>
<Initials>NJ</Initials>
<AffiliationInfo>
<Affiliation>From the University Eye Clinic Maastricht, Maastricht University Medical Center, Maastricht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Makhotkina</LastName>
<ForeName>Natalia Y</ForeName>
<Initials>NY</Initials>
<AffiliationInfo>
<Affiliation>From the University Eye Clinic Maastricht, Maastricht University Medical Center, Maastricht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Berendschot</LastName>
<ForeName>Tos T J M</ForeName>
<Initials>TT</Initials>
<AffiliationInfo>
<Affiliation>From the University Eye Clinic Maastricht, Maastricht University Medical Center, Maastricht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van den Biggelaar</LastName>
<ForeName>Frank J H M</ForeName>
<Initials>FJ</Initials>
<AffiliationInfo>
<Affiliation>From the University Eye Clinic Maastricht, Maastricht University Medical Center, Maastricht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nuijts</LastName>
<ForeName>Rudy M M A</ForeName>
<Initials>RM</Initials>
<AffiliationInfo>
<Affiliation>From the University Eye Clinic Maastricht, Maastricht University Medical Center, Maastricht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432121</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Correction of low levels of astigmatism.</ArticleTitle>
<Pagination>
<MedlinePgn>1641-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.12.060</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00995-5</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To reevaluate the analysis of the correction of astigmatism.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Academia, industry, and private practice.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Evaluation of diagnostic test or technology.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Astigmatic refractive surgery outcomes are based on vector methods, including the correction index (also known as the correction ratio), which is the ratio of the surgically induced astigmatism to the target induced astigmatism (TIA). Mean correction indices substantially greater than 1 have been reported for astigmatic corrections less than 1.00 diopter (D) and as representing systematic overcorrection. We hypothesize that this reflects a limitation of the correction index rather than systematic flaws in treatments. The theoretical mathematic behavior of the correction index was analyzed, accounting for variability in astigmatism measurement. Then, the impact of cylinder measurement variability on the mean correction index was modeled. A Monte Carlo simulation was performed and calculated 10 000 values of correction index for various values of TIA. Finally, correction indices from published and unpublished studies of refractive lasers were compared with the simulations.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean correction index is always greater than 1 for the case of a perfect refractive correction; however, for astigmatic corrections less than 1.00 D, the mean correction index increases sharply because the measurement variability is similar in magnitude to TIA. Almost all previous studies show the predicted increase in the correction index for low astigmatic corrections.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The correction index is a useful vector-based metric for the evaluation of refractive procedures, but mean values greater than 1 should be anticipated for lower astigmatic treatments and do not necessarily represent systematic overcorrection.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">Dr. Bullimore is a consultant to Alcon Surgical, Inc., Carl Zeiss Meditec AG, Digital Vision Systems, Essilor, Innovega, Inc., and Paragon Vision Sciences, Inc. Dr. Spooner is a consultant to Alcon Surgical, Inc., Carl Zeiss Meditec AG, Digital Vision Systems, Thru-Focus Optics LLC, and i2eyediagnostics, Ltd. Dr. Dishler is a consultant to Carl Zeiss Meditec AG and Revision Optics, Inc. Dr. Sluyterman is an employee of Carl Zeiss Meditec AG.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bullimore</LastName>
<ForeName>Mark A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>From the College of Optometry (Bullimore), University of Houston, Houston, Texas, Gain Consulting Services (Spooner), San Francisco, California, and the Dishler Laser Institute (Dishler), Greenwood Village, Colorado, USA; Carl Zeiss Meditec AG (Sluyterman), Jena, Germany. Electronic address: bullers2020@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Spooner</LastName>
<ForeName>Greg</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>From the College of Optometry (Bullimore), University of Houston, Houston, Texas, Gain Consulting Services (Spooner), San Francisco, California, and the Dishler Laser Institute (Dishler), Greenwood Village, Colorado, USA; Carl Zeiss Meditec AG (Sluyterman), Jena, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sluyterman</LastName>
<ForeName>Georg</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>From the College of Optometry (Bullimore), University of Houston, Houston, Texas, Gain Consulting Services (Spooner), San Francisco, California, and the Dishler Laser Institute (Dishler), Greenwood Village, Colorado, USA; Carl Zeiss Meditec AG (Sluyterman), Jena, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dishler</LastName>
<ForeName>Jon G</ForeName>
<Initials>JG</Initials>
<AffiliationInfo>
<Affiliation>From the College of Optometry (Bullimore), University of Houston, Houston, Texas, Gain Consulting Services (Spooner), San Francisco, California, and the Dishler Laser Institute (Dishler), Greenwood Village, Colorado, USA; Carl Zeiss Meditec AG (Sluyterman), Jena, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432122</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Comparison of SRK/T and Haigis formulas for predicting corneal astigmatism correction with toric intraocular lenses.</ArticleTitle>
<Pagination>
<MedlinePgn>1650-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.12.053</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00843-3</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To compare the accuracy of the SRK/T and Haigis formulas for predicting corneal astigmatism correction with a toric intraocular lens (IOL).</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Department of Ophthalmology, Korea University College of Medicine, Seoul, South Korea.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective cross-sectional study.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Eyes with an Acrysof toric IOL were enrolled in the study. The corneal plane effective cylinder power of toric IOLs (target induced astigmatism vector [TIA]) predicted by the SRK/T and Haigis formulas were compared with the cylindrical correction achieved postoperatively (surgically induced astigmatism vector [SIA]). The magnitude of error was defined as the difference between the magnitudes of the SIA and TIA. The median absolute magnitudes of error predicted by the SRK/T and Haigis formulas were compared. The median absolute errors predicted by the 2 formulas were also compared.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean postoperative SIA was 1.80 diopters (D) ± 0.55 (SD). The magnitude of error predicted by the SRK/T and Haigis formulas was 0.31 ± 0.40 D and 0.23 ± 0.40 D, respectively. The median absolute magnitude of error predicted by the Haigis formula was statistically significantly smaller than that predicted by the SRK/T formula (P &lt; .001). The median absolute error predicted by the Haigis formula (0.35 D) was also statistically significantly smaller than that predicted by the SRK/T formula (0.43 D) (P = .003).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The Haigis formula was more accurate than the SRK/T formula not only in predicting the refractive outcome but also in predicting corneal astigmatism correction by toric IOLs.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">No author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Eom</LastName>
<ForeName>Youngsub</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology, Korea University College of Medicine, Seoul, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Song</LastName>
<ForeName>Jong Suk</ForeName>
<Initials>JS</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology, Korea University College of Medicine, Seoul, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Yong Yeon</ForeName>
<Initials>YY</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology, Korea University College of Medicine, Seoul, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Hyo Myung</ForeName>
<Initials>HM</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology, Korea University College of Medicine, Seoul, South Korea. Electronic address: hyomkim@kumc.or.kr.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432123</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Comparison of corneal power, astigmatism, and wavefront aberration measurements obtained by a point-source color light-emitting diode-based topographer, a Placido-disk topographer, and a combined Placido and dual Scheimpflug device.</ArticleTitle>
<Pagination>
<MedlinePgn>1658-71</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.11.051</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00842-1</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate and compare the performance of a point-source color light-emitting diode (LED)-based topographer (color-LED) in measuring anterior corneal power and aberrations with that of a Placido-disk topographer and a combined Placido and dual Scheimpflug device.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Cullen Eye Institute, Baylor College of Medicine, Houston, Texas USA.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective observational case series.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Normal eyes and post-refractive-surgery eyes were consecutively measured using color-LED, Placido, and dual-Scheimpflug devices. The main outcome measures were anterior corneal power, astigmatism, and higher-order aberrations (HOAs) (6.0 mm pupil), which were compared using the t test.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">There were no statistically significant differences in corneal power measurements in normal and post-refractive surgery eyes and in astigmatism magnitude in post-refractive surgery eyes between the color-LED device and Placido or dual Scheimpflug devices (all P &gt; .05). In normal eyes, there were no statistically significant differences in 3rd-order coma and 4th-order spherical aberration between the color-LED and Placido devices and in HOA root mean square, 3rd-order coma, 3rd-order trefoil, 4th-order spherical aberration, and 4th-order secondary astigmatism between the color-LED and dual Scheimpflug devices (all P &gt; .05). In post-refractive surgery eyes, the color-LED device agreed with the Placido and dual-Scheimpflug devices regarding 3rd-order coma and 4th-order spherical aberration (all P &gt; .05).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In normal and post-refractive surgery eyes, all 3 devices were comparable with respect to corneal power. The agreement in corneal aberrations varied.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">Drs. Wang, Koch, and Weikert are consultants to Ziemer Ophthalmic Systems AG. Dr. Koch is a consultant to Abbott Medical Optics, Inc., Alcon Surgical, Inc., and i-Optics Corp.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ventura</LastName>
<ForeName>Bruna V</ForeName>
<Initials>BV</Initials>
<AffiliationInfo>
<Affiliation>From the Cullen Eye Institute (Ventura, Wang, Ali, Koch, Weikert), Department of Ophthalmology, Baylor College of Medicine, Houston, Texas, USA; Altino Ventura Foundation (Ventura), Recife, and the Department of Ophthalmology (Ventura), Federal University of São Paulo, São Paulo, Brazil. Electronic address: brunaventuramd@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Li</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>From the Cullen Eye Institute (Ventura, Wang, Ali, Koch, Weikert), Department of Ophthalmology, Baylor College of Medicine, Houston, Texas, USA; Altino Ventura Foundation (Ventura), Recife, and the Department of Ophthalmology (Ventura), Federal University of São Paulo, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ali</LastName>
<ForeName>Shazia F</ForeName>
<Initials>SF</Initials>
<AffiliationInfo>
<Affiliation>From the Cullen Eye Institute (Ventura, Wang, Ali, Koch, Weikert), Department of Ophthalmology, Baylor College of Medicine, Houston, Texas, USA; Altino Ventura Foundation (Ventura), Recife, and the Department of Ophthalmology (Ventura), Federal University of São Paulo, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Koch</LastName>
<ForeName>Douglas D</ForeName>
<Initials>DD</Initials>
<AffiliationInfo>
<Affiliation>From the Cullen Eye Institute (Ventura, Wang, Ali, Koch, Weikert), Department of Ophthalmology, Baylor College of Medicine, Houston, Texas, USA; Altino Ventura Foundation (Ventura), Recife, and the Department of Ophthalmology (Ventura), Federal University of São Paulo, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Weikert</LastName>
<ForeName>Mitchell P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>From the Cullen Eye Institute (Ventura, Wang, Ali, Koch, Weikert), Department of Ophthalmology, Baylor College of Medicine, Houston, Texas, USA; Altino Ventura Foundation (Ventura), Recife, and the Department of Ophthalmology (Ventura), Federal University of São Paulo, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432124</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of tear osmolarity on repeatability of keratometry for cataract surgery planning.</ArticleTitle>
<Pagination>
<MedlinePgn>1672-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.01.016</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00835-4</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate the effects of tear osmolarity on the repeatability of keratometry (K) measurements in patients presenting for cataract surgery.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Three clinical practices.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Observational prospective nonrandomized study.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Subjects were prospectively recruited based on tear osmolarity (Tearlab Osmolarity System); that is, osmolarity more than 316 mOsm/L in at least 1 eye (hyperosmolar) and osmolarity less than 308 mOsm/L in both eyes (normal). The baseline K value was measured, and a second measurement was taken on the same instrument (IOLMaster) within 3 weeks of the first. Variability in average K, calculated corneal astigmatism using vector analysis, and intraocular lens (IOL) sphere power calculations were compared between groups.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The hyperosmolar group (50 subjects) had a statistically significantly higher variability in the average K reading (P = .05) than the normal group (25 subjects) and a statistically significantly higher percentage of eyes with a 1.0 diopter (D) or greater difference in the measured corneal astigmatism (P = .02). A statistically significantly higher percentage of eyes in the hyperosmolar group had an IOL power difference of more than 0.5 D (P = .02). No statistically significant differences were present when the subjects were grouped by self-reported dry eye.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Significantly more variability in average K and anterior corneal astigmatism was observed in the hyperosmolar group, with significant resultant differences in IOL power calculations. Variability was not significantly different when subjects were grouped by self-reported dry eye. Measurement of tear osmolarity at the time of cataract surgery planning can effectively identify patients with a higher likelihood of high unexpected refractive error resulting from inaccurate keratometry.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">Drs. Epitropoulos, Matossian, Berdy, and Malhotra received compensation from Tearlab for participating in the study. No author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Epitropoulos</LastName>
<ForeName>Alice T</ForeName>
<Initials>AT</Initials>
<AffiliationInfo>
<Affiliation>From the Eye Center of Columbus (Epitropoulos), Columbus, Ohio, Matossian Eye Associates (Matossian), Pennington, New Jersey, Ophthalmology Associates (Berdy, Malhotra), Saint Louis, Missouri, and Science in Vision (Potvin), Akron, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Matossian</LastName>
<ForeName>Cynthia</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the Eye Center of Columbus (Epitropoulos), Columbus, Ohio, Matossian Eye Associates (Matossian), Pennington, New Jersey, Ophthalmology Associates (Berdy, Malhotra), Saint Louis, Missouri, and Science in Vision (Potvin), Akron, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Berdy</LastName>
<ForeName>Gregg J</ForeName>
<Initials>GJ</Initials>
<AffiliationInfo>
<Affiliation>From the Eye Center of Columbus (Epitropoulos), Columbus, Ohio, Matossian Eye Associates (Matossian), Pennington, New Jersey, Ophthalmology Associates (Berdy, Malhotra), Saint Louis, Missouri, and Science in Vision (Potvin), Akron, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Malhotra</LastName>
<ForeName>Ranjan P</ForeName>
<Initials>RP</Initials>
<AffiliationInfo>
<Affiliation>From the Eye Center of Columbus (Epitropoulos), Columbus, Ohio, Matossian Eye Associates (Matossian), Pennington, New Jersey, Ophthalmology Associates (Berdy, Malhotra), Saint Louis, Missouri, and Science in Vision (Potvin), Akron, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Potvin</LastName>
<ForeName>Richard</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>From the Eye Center of Columbus (Epitropoulos), Columbus, Ohio, Matossian Eye Associates (Matossian), Pennington, New Jersey, Ophthalmology Associates (Berdy, Malhotra), Saint Louis, Missouri, and Science in Vision (Potvin), Akron, New York, USA. Electronic address: rick@scienceinvision.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432125</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Comparability of anterior chamber depth measurements with partial coherence interferometry and optical low-coherence reflectometry in pseudophakic eyes.</ArticleTitle>
<Pagination>
<MedlinePgn>1678-84</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.08.013</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)01004-4</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To assess whether anterior chamber depth (ACD) measurements in pseudophakic eyes obtained with partial coherence interferometry (PCI) and optical low-coherence reflectometry (OLCR) devices can be used interchangeably.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Vienna Institute for Research in Ocular Surgery, A Karl Landsteiner Institute, Hanusch Hospital, Vienna, Austria.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective case series.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The ACD measurements in 1 eye of each pseudophakic patient were performed with the PCI-based ACMaster device and the OLCR-based Lenstar LS900 device at least 1 day postoperatively.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The study comprised 65 eyes of 65 patients with a mean age of 71.7 years ± 9.0 (SD) (range 39 to 91 years). In 15 eyes, no valid ACD readings could be obtained with the OLCR device. No obvious reason for these measurement failures was identified; however, tear-film alterations shortly after surgery were suspected. No significant difference in the mean ACD in the remaining 50 eyes was found between PCI measurements (5019 ± 660 μm; range 4008 to 6181 μm) and OLCR measurements (5015 ± 663 μm; range 4017 to 6163 μm) (P = .06). Three (6%) of 50 measurements were not within the 95% limits of agreement in the Bland-Altman analysis.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Pseudophakic ACD measurements with the PCI and OLCR devices can be used interchangeably. The OLCR device proved to be more user-friendly and faster; however, in a substantial number of eyes, no usable values were obtainable.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">No author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Luft</LastName>
<ForeName>Nikolaus</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>From the Vienna Institute for Research in Ocular Surgery (Luft, Hirnschall, Farrokhi, Findl), A Karl Landsteiner Institute, Hanusch Hospital, Vienna, Austria; Moorfields Eye Hospital NHS Foundation Trust (Findl), London, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hirnschall</LastName>
<ForeName>Nino</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>From the Vienna Institute for Research in Ocular Surgery (Luft, Hirnschall, Farrokhi, Findl), A Karl Landsteiner Institute, Hanusch Hospital, Vienna, Austria; Moorfields Eye Hospital NHS Foundation Trust (Findl), London, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Farrokhi</LastName>
<ForeName>Sanaz</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Vienna Institute for Research in Ocular Surgery (Luft, Hirnschall, Farrokhi, Findl), A Karl Landsteiner Institute, Hanusch Hospital, Vienna, Austria; Moorfields Eye Hospital NHS Foundation Trust (Findl), London, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Findl</LastName>
<ForeName>Oliver</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>From the Vienna Institute for Research in Ocular Surgery (Luft, Hirnschall, Farrokhi, Findl), A Karl Landsteiner Institute, Hanusch Hospital, Vienna, Austria; Moorfields Eye Hospital NHS Foundation Trust (Findl), London, United Kingdom. Electronic address: oliver@findl.at.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432126</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Pediatric bag-in-the-lens intraocular lens implantation: long-term follow-up.</ArticleTitle>
<Pagination>
<MedlinePgn>1685-92</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.12.057</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00940-2</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate long-term follow-up results of pediatric cataract surgery using the bag-in-the-lens (BIL) intraocular lens (IOL) implantation technique.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Antwerp University Hospital, Edegem, Antwerp, Belgium.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective case series.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">All pediatric cataract surgeries with BIL IOL implantation performed at the Antwerp University Hospital were evaluated. Only cases that completed a follow-up of 5 years at the hospital's Department of Ophthalmology were included in this study.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Forty-six eyes of 31 children had a complete follow-up of 5 years or more after BIL IOL implantation. Sixteen cases were unilateral and 15 were bilateral. Patient age at time of surgery ranged from 2 months to 14 years. The mean refraction at the end of follow-up was -1.99 diopters (D) ± 3.70 (SD). In bilateral cases, a corrected distance visual acuity (CDVA) of better than 0.5 was attained in 86.7% and a CDVA of 1.0 was achieved in 56.7%. In unilateral cases, 31.2% achieved a CDVA of better than 0.5 but none obtained a CDVA of 1.0. A clear visual axis was maintained in 91.3% of cases during follow-up. Visual axis reopacification was detected in 4 eyes of 3 cases, all due to inadequate BIL IOL positioning. None of these eyes needed more than 1 intervention to maintain visual axis clarity. Other than 1 case of glaucoma, no severe complications were detected.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Long-term follow-up results show that BIL IOL implantation is a safe, well-tolerated approach for treating pediatric cataract with a very low rate of visual axis reopacification and a low rate of secondary interventions for other postoperative complications.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">Dr. Tassignon has intellectual property rights to the bag-in-the-lens intraocular lens (U.S. patent 6 027 531; EU patent 009406794.PCT/120268), which is licensed to Morcher GmbH, Stuttgart, Germany. No other author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Van Looveren</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Van Looveren, Ní Dhubhghaill, Godts, Bakker, De Veuster, Mathysen, Tassignon), Antwerp University Hospital, Edegem, and the Faculty of Medicine and Health Sciences (Van Looveren, De Veuster, Mathysen, Tassignon), University of Antwerp, Antwerp, Belgium. Electronic address: jan.van.looveren@uza.be.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ní Dhubhghaill</LastName>
<ForeName>Sorcha</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Van Looveren, Ní Dhubhghaill, Godts, Bakker, De Veuster, Mathysen, Tassignon), Antwerp University Hospital, Edegem, and the Faculty of Medicine and Health Sciences (Van Looveren, De Veuster, Mathysen, Tassignon), University of Antwerp, Antwerp, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Godts</LastName>
<ForeName>Daisy</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Van Looveren, Ní Dhubhghaill, Godts, Bakker, De Veuster, Mathysen, Tassignon), Antwerp University Hospital, Edegem, and the Faculty of Medicine and Health Sciences (Van Looveren, De Veuster, Mathysen, Tassignon), University of Antwerp, Antwerp, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bakker</LastName>
<ForeName>Ellen</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Van Looveren, Ní Dhubhghaill, Godts, Bakker, De Veuster, Mathysen, Tassignon), Antwerp University Hospital, Edegem, and the Faculty of Medicine and Health Sciences (Van Looveren, De Veuster, Mathysen, Tassignon), University of Antwerp, Antwerp, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>De Veuster</LastName>
<ForeName>Ilse</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Van Looveren, Ní Dhubhghaill, Godts, Bakker, De Veuster, Mathysen, Tassignon), Antwerp University Hospital, Edegem, and the Faculty of Medicine and Health Sciences (Van Looveren, De Veuster, Mathysen, Tassignon), University of Antwerp, Antwerp, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mathysen</LastName>
<ForeName>Danny G P</ForeName>
<Initials>DG</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Van Looveren, Ní Dhubhghaill, Godts, Bakker, De Veuster, Mathysen, Tassignon), Antwerp University Hospital, Edegem, and the Faculty of Medicine and Health Sciences (Van Looveren, De Veuster, Mathysen, Tassignon), University of Antwerp, Antwerp, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tassignon</LastName>
<ForeName>Marie-José</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Van Looveren, Ní Dhubhghaill, Godts, Bakker, De Veuster, Mathysen, Tassignon), Antwerp University Hospital, Edegem, and the Faculty of Medicine and Health Sciences (Van Looveren, De Veuster, Mathysen, Tassignon), University of Antwerp, Antwerp, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432127</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Traumatic cataracts secondary to combat ocular trauma.</ArticleTitle>
<Pagination>
<MedlinePgn>1693-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.12.059</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00994-3</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To describe the characteristics, visual outcomes, and predictive value of the Ocular Trauma Score (OTS) in eyes with traumatic cataract from combat ocular trauma.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Walter Reed Army Medical Center, Washington, DC, USA.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective case series.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Records of service members with traumatic cataract from combat ocular trauma over a 7-year period were reviewed. Visual acuity at initial presentation and visual acuity at the final follow-up were compared in addition to outcomes in closed versus open globes, by final lens status, and in eyes receiving primary versus secondary intraocular lenses (IOLs). Visual outcomes were predicted using the OTS and compared to the achieved corrected distance visual acuity (CDVA).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 181 eyes of 167 patients were included in the final analysis. Twenty-six percent of all eye injuries sustained traumatic cataract. The mean final visual outcome was 0.86 logMAR ± 1.01 (SD) with 44 no light perception (NLP) eyes and 26 light perception (LP) eyes compared with an initial visual acuity of 2.41 ± 0.88 logMAR with 27 no NLP eyes and 64 LP eyes (P ≤ .001, 2-tailed Student t test). Final CDVAs in eyes receiving primary IOLs were 0.72 ± 0.84 logMAR with 1 NLP and 1 LP eye versus 0.51 ± 0.78 logMAR with 2 LP eyes in eyes receiving a secondary IOL (P = .37, Student t test).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Traumatic cataracts are frequently associated with ocular trauma. The OTS is a reliable means of predicting visual outcome. There was no difference in eyes receiving primary IOLs versus secondary IOLs.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">No author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>Michael P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>From the Ophthalmology Service (Smith, Colyer, Stutzman), Department of Surgery, Walter Reed National Military Medical Center, Bethesda, and the Retina Group of Washington (Weichel), Greenbelt, Maryland, USA. Electronic address: smithpmichael@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Colyer</LastName>
<ForeName>Marcus H</ForeName>
<Initials>MH</Initials>
<AffiliationInfo>
<Affiliation>From the Ophthalmology Service (Smith, Colyer, Stutzman), Department of Surgery, Walter Reed National Military Medical Center, Bethesda, and the Retina Group of Washington (Weichel), Greenbelt, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Weichel</LastName>
<ForeName>Eric D</ForeName>
<Initials>ED</Initials>
<AffiliationInfo>
<Affiliation>From the Ophthalmology Service (Smith, Colyer, Stutzman), Department of Surgery, Walter Reed National Military Medical Center, Bethesda, and the Retina Group of Washington (Weichel), Greenbelt, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stutzman</LastName>
<ForeName>Richard D</ForeName>
<Initials>RD</Initials>
<AffiliationInfo>
<Affiliation>From the Ophthalmology Service (Smith, Colyer, Stutzman), Department of Surgery, Walter Reed National Military Medical Center, Bethesda, and the Retina Group of Washington (Weichel), Greenbelt, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432128</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery.</ArticleTitle>
<Pagination>
<MedlinePgn>1699-704</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.12.056</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00849-4</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate the efficacy and safety of using sodium hyaluronate 0.1% and carboxymethylcellulose 0.5% artificial tears for ocular discomfort and tear-film stability in eyes after cataract surgery.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Twenty ophthalmic centers in Italy.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective randomized case series.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">This study enrolled patients scheduled for unilateral cataract surgery. After surgery, patients received artificial tears and a topical steroid-antibiotic (study group) or topical steroid-antibiotic alone (control group) and were assessed postoperatively at 1 and 5 weeks. Outcome measures were tear breakup time (TBUT), ocular surface disease index (OSDI), frequency of dry-eye symptoms evaluated using a visual analog scale (VAS), and corneal fluorescein staining.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The study comprised 282 patients. At 5 weeks, the mean TBUT was statistically significantly higher in the study group than in the control group (P = .0003). The mean OSDI score statistically significantly improved in both groups from 1 to 5 weeks (P &lt; .0001 for both groups); however, there was no statistically significant difference between the groups at these timepoints. The artificial tears statistically significantly improved VAS-assessed dry-eye symptoms in the study group compared with the control group at 5 weeks (P &lt; .001). The mean corneal fluorescein staining was significantly reduced in the study group compared with the control group at 5 weeks (P = .002 versus P = .05, respectively). No treatment-related adverse events were reported.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Sodium hyaluronate 0.1% and carboxymethylcellulose 0.5% ophthalmic solution was effective and well tolerated in reducing dry-eye disease symptoms and improving the clinical outcome after cataract surgery.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">No author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mencucci</LastName>
<ForeName>Rita</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Surgery and Translational Medicine, Eye Clinic, University of Florence, Florence, Italy. Electronic address: rita.mencucci@unifi.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Boccalini</LastName>
<ForeName>Carlotta</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Surgery and Translational Medicine, Eye Clinic, University of Florence, Florence, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Caputo</LastName>
<ForeName>Roberto</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Surgery and Translational Medicine, Eye Clinic, University of Florence, Florence, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Favuzza</LastName>
<ForeName>Eleonora</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Surgery and Translational Medicine, Eye Clinic, University of Florence, Florence, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432129</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Association between serum 25-hydroxyvitamin D levels and age-related cataracts.</ArticleTitle>
<Pagination>
<MedlinePgn>1705-15</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.12.052</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00841-X</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To investigate associations between serum 25-hydroxyvitamin D levels and age-related cataracts.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Department of Ophthalmology, College of Medicine, Catholic University of Korea, South Korea.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Observational cross-sectional study.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Participants aged 40 years or older in the fourth (2008 to 2009) and fifth (2010 to 2012) Korea National Health and Nutrition Examination Survey (KNHANES) had evaluation of their serum 25-hydroxyvitamin D levels and ophthalmic slitlamp examinations to identify cataract. An age-related cataract was defined as the presence of a cortical, nuclear, anterior subcapsular, posterior subcapsular, or mixed cataract or a history of cataract surgery.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The study evaluated eyes of 18 804 patients. The mean levels of serum 25-hydroxyvitamin D were 20.0 ng/mL in men and 17.5 ng/mL in women. In men, but not in women, the odds ratio (OR) for age-related cataracts decreased statistically significantly when the serum 25-hydroxyvitamin D levels were in the highest quintile than when they were in the lowest quintile (OR, 0.76; 95% confidence interval, 0.59-0.99) after adjusting for potentially confounding factors including age, sex, smoking status, diabetes, hypertension, and sunlight exposure. However, trend analysis did not show a significant declining trend in the cataract risk associated with higher serum 25-hydroxyvitamin D quintiles (P = .084). In women, serum 25-hydroxyvitamin D levels were not associated with age-related cataracts.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The age-related cataract risk decreased in men with higher serum 25-hydroxyvitamin D levels than in those with lower serum 25-hydroxyvitamin D levels after adjusting for potential confounding factors. In light of previous research indicating an antioxidative effect of vitamin D, the connection between vitamin D and age-related cataract warrants further study.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">Neither author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jee</LastName>
<ForeName>Donghyun</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology and Visual Science (Jee), St. Vincent's Hospital, College of Medicine, Catholic University of Korea, Suwon, Gyenggido, and the Department of Ophthalmology and Visual Science (Kim), Bucheon St. Mary's Hospital, College of Medicine, Catholic University of Korea, Bucheon, Gyeonggido, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Eun Chul</ForeName>
<Initials>EC</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology and Visual Science (Jee), St. Vincent's Hospital, College of Medicine, Catholic University of Korea, Suwon, Gyenggido, and the Department of Ophthalmology and Visual Science (Kim), Bucheon St. Mary's Hospital, College of Medicine, Catholic University of Korea, Bucheon, Gyeonggido, South Korea. Electronic address: eunchol@hanmail.net.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432130</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Efficacy and safety of combined cataract surgery with 2 trabecular microbypass stents versus ab interno trabeculotomy.</ArticleTitle>
<Pagination>
<MedlinePgn>1716-24</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.12.061</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)01000-7</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To compare the outcomes of combined cataract surgery with trabecular microbypass stents and ab interno trabeculotomy in patients with open-angle glaucoma.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">University of Toronto, Toronto, Ontario, and University of Montreal, Montreal, Quebec, Canada, and Glaucoma Associates of Texas, Dallas, Texas, USA.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective case series.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Patients with primary open-angle, pseudoexfoliative, or pigmentary dispersion glaucoma were included. Primary outcome measures were intraocular pressure (IOP), postoperative medications, success (IOP ≤18 mm Hg, no glaucoma medications or reoperations), and postoperative adverse events.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The average patient age was 76.5 years ± 12 [SD]. Forty-nine eyes had phacoemulsification and 2 had stent implantations; 52 eyes had phacoemulsification and trabeculotomy surgery with a 12-month postoperative follow-up. The analysis of variance indicated a significant reduction in mean IOP from baseline to 12 months for stent (19.6 ± 5.3 mm Hg to 14.3 ± 3.1 mm Hg; P &lt; .001) and trabeculotomy (20.6 ± 6.8 mm Hg to 17.3 ± 6.5 mm Hg; P &lt; .001) and lower mean IOP at 12 months in the stent group (P = .01). The median number of glaucoma medications decreased from baseline to 12 months in both groups and was lower in the stent group at 3, 6, and 12 months. Thirty-nine percent (19 eyes) in the stent group and 14% (7 eyes) in the trabeculotomy group achieved success at 12 months (P = .006). The incidence of hyphema was lower in the stent group (P = .008).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Both types of surgery achieved a significant reduction in IOP and medication use at 12 months, with the stent group achieving higher success and a reduced incidence of postoperative hyphema.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">Dr. Ahmed is a consultant to and investigator for Glaukos Corp., Ivantis, Inc., Transcend Medical, Inc., and Aquesys, Inc., and has received speaker honoraria from Neomedix, Inc. Dr. Saheb has received travel funding from Glaukos Corp., Ivantis, Inc., and Transcend Medical, Inc., and a research grant from Ivantis, Inc. Dr. Harasymowycz has received a research grant from Ivantis, Inc. Dr. Fellman is a consultant to Endo Optiks, Inc., and has received honoraria from Optous and research funds from Ivantis, Inc., Glaukos Corp., and Transcend Medical, Inc. No other author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Khan</LastName>
<ForeName>Michelle</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From the University of Toronto (Khan), Toronto, Ontario, McGill University Health Centre (Saheb), University of Montreal (Harasymowycz), Montreal, Quebec, and Credit Valley EyeCare (Ahmed), Mississauga, Ontario, Canada; the Glaucoma Center of Texas (Neelakantan) and Glaucoma Associates of Texas (Fellman, Vest), Dallas, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Saheb</LastName>
<ForeName>Hady</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>From the University of Toronto (Khan), Toronto, Ontario, McGill University Health Centre (Saheb), University of Montreal (Harasymowycz), Montreal, Quebec, and Credit Valley EyeCare (Ahmed), Mississauga, Ontario, Canada; the Glaucoma Center of Texas (Neelakantan) and Glaucoma Associates of Texas (Fellman, Vest), Dallas, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Neelakantan</LastName>
<ForeName>Arvind</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the University of Toronto (Khan), Toronto, Ontario, McGill University Health Centre (Saheb), University of Montreal (Harasymowycz), Montreal, Quebec, and Credit Valley EyeCare (Ahmed), Mississauga, Ontario, Canada; the Glaucoma Center of Texas (Neelakantan) and Glaucoma Associates of Texas (Fellman, Vest), Dallas, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fellman</LastName>
<ForeName>Ronald</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>From the University of Toronto (Khan), Toronto, Ontario, McGill University Health Centre (Saheb), University of Montreal (Harasymowycz), Montreal, Quebec, and Credit Valley EyeCare (Ahmed), Mississauga, Ontario, Canada; the Glaucoma Center of Texas (Neelakantan) and Glaucoma Associates of Texas (Fellman, Vest), Dallas, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vest</LastName>
<ForeName>Zachary</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>From the University of Toronto (Khan), Toronto, Ontario, McGill University Health Centre (Saheb), University of Montreal (Harasymowycz), Montreal, Quebec, and Credit Valley EyeCare (Ahmed), Mississauga, Ontario, Canada; the Glaucoma Center of Texas (Neelakantan) and Glaucoma Associates of Texas (Fellman, Vest), Dallas, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Harasymowycz</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>From the University of Toronto (Khan), Toronto, Ontario, McGill University Health Centre (Saheb), University of Montreal (Harasymowycz), Montreal, Quebec, and Credit Valley EyeCare (Ahmed), Mississauga, Ontario, Canada; the Glaucoma Center of Texas (Neelakantan) and Glaucoma Associates of Texas (Fellman, Vest), Dallas, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ahmed</LastName>
<ForeName>Iqbal Ike K</ForeName>
<Initials>II</Initials>
<AffiliationInfo>
<Affiliation>From the University of Toronto (Khan), Toronto, Ontario, McGill University Health Centre (Saheb), University of Montreal (Harasymowycz), Montreal, Quebec, and Credit Valley EyeCare (Ahmed), Mississauga, Ontario, Canada; the Glaucoma Center of Texas (Neelakantan) and Glaucoma Associates of Texas (Fellman, Vest), Dallas, Texas, USA. Electronic address: ike.ahmed@utoronto.ca.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432131</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Changes in intraocular pressure after cataract surgery: analysis of the Swedish National Cataract Register Data.</ArticleTitle>
<Pagination>
<MedlinePgn>1725-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.12.054</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00845-7</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To analyze changes in intraocular pressure (IOP) after cataract surgery based on data from the Swedish National Cataract Register (NCR).</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Ophthalmic surgery units in Sweden.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective database study.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Data for 2012 through 2014 were obtained prospectively from the NCR. The outcome register of the NCR has collected data on IOP before and a mean of 37.7 days ± 29.1 (SD) after cataract surgery since 2012.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The analyses were based on 20 437 cataract extractions reported during 1 month each year to the outcome registry of the NCR. Cataract surgery was found to reduce IOP by a mean of 1.46 mm Hg, which was statistically significant (P &lt; .001). A larger IOP reduction was seen in cases with a higher preoperative IOP (r = 0.557, P &lt; .001). Older patients and shorter eyes had a greater IOP reduction after surgery (P &lt; .001 and P = .001, respectively). Women had a greater IOP reduction than men (P = .04) When high IOP was given as an indication for surgery, the IOP reduction after cataract surgery was 5.50 mm Hg compared with a reduction of 1.40 mm Hg in patients for whom this indication was not given (P &lt; .001). Patients with glaucoma or pseudoexfoliation (PXF) had a more pronounced IOP reduction than patients without these diagnoses (P &lt; .001).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Cataract surgery had an IOP-lowering effect, in particular in older patients, women, short eyes, eyes with high preoperative IOP, and eyes with glaucoma or PXF.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">No author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zetterström</LastName>
<ForeName>Charlotta</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Clinical Neuroscience (Zetterström, Kugelberg, Montan), Division of Ophthalmology and Vision, Karolinska Institutet, and EyeNet Sweden (Zetterström, Lundström), Blekinge Hospital, Karolinska; St. Erik Eye Hospital (Kugelberg, Montan), Stockholm; the Department of Clinical Sciences/Ophthalmology (Behndig), Umeå University Hospital, Umeå; and the Department of Clinical Sciences (Lundström) Ophthalmology, Faculty of Medicine, Lund University, Lund, Sweden. Electronic address: charlotta.zetterstrom@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Behndig</LastName>
<ForeName>Anders</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Clinical Neuroscience (Zetterström, Kugelberg, Montan), Division of Ophthalmology and Vision, Karolinska Institutet, and EyeNet Sweden (Zetterström, Lundström), Blekinge Hospital, Karolinska; St. Erik Eye Hospital (Kugelberg, Montan), Stockholm; the Department of Clinical Sciences/Ophthalmology (Behndig), Umeå University Hospital, Umeå; and the Department of Clinical Sciences (Lundström) Ophthalmology, Faculty of Medicine, Lund University, Lund, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kugelberg</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Clinical Neuroscience (Zetterström, Kugelberg, Montan), Division of Ophthalmology and Vision, Karolinska Institutet, and EyeNet Sweden (Zetterström, Lundström), Blekinge Hospital, Karolinska; St. Erik Eye Hospital (Kugelberg, Montan), Stockholm; the Department of Clinical Sciences/Ophthalmology (Behndig), Umeå University Hospital, Umeå; and the Department of Clinical Sciences (Lundström) Ophthalmology, Faculty of Medicine, Lund University, Lund, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Montan</LastName>
<ForeName>Per</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Clinical Neuroscience (Zetterström, Kugelberg, Montan), Division of Ophthalmology and Vision, Karolinska Institutet, and EyeNet Sweden (Zetterström, Lundström), Blekinge Hospital, Karolinska; St. Erik Eye Hospital (Kugelberg, Montan), Stockholm; the Department of Clinical Sciences/Ophthalmology (Behndig), Umeå University Hospital, Umeå; and the Department of Clinical Sciences (Lundström) Ophthalmology, Faculty of Medicine, Lund University, Lund, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lundström</LastName>
<ForeName>Mats</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Clinical Neuroscience (Zetterström, Kugelberg, Montan), Division of Ophthalmology and Vision, Karolinska Institutet, and EyeNet Sweden (Zetterström, Lundström), Blekinge Hospital, Karolinska; St. Erik Eye Hospital (Kugelberg, Montan), Stockholm; the Department of Clinical Sciences/Ophthalmology (Behndig), Umeå University Hospital, Umeå; and the Department of Clinical Sciences (Lundström) Ophthalmology, Faculty of Medicine, Lund University, Lund, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432132</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Mechanical epithelial removal followed by corneal collagen crosslinking in progressive keratoconus: short-term complications.</ArticleTitle>
<Pagination>
<MedlinePgn>1730-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2014.12.058</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00951-7</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To compare the complications occurring within the first 3 months of corneal collagen crosslinking (CXL) performed with mechanical or transepithelial phototherapeutic keratectomy (PTK) epithelial removal in keratoconus patients.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Yildirim Beyazit University Ataturk Training and Research Hospital, Ankara, Turkey.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Nonrandomized retrospective clinical study.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Eyes of consecutive progressive keratoconus patients who had PTK or mechanical epithelial removal followed by CXL were included. All patients were examined regularly until epithelial healing. Detailed ophthalmologic examinations were performed preoperatively and 1 and 3 months postoperatively.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The study comprised 499 eyes (302 patients) that had transepithelial PTK (Group 1, 153 eyes) or mechanical epithelial removal (Group 2, 256 eyes) followed by CXL. Delayed epithelial healing occurred in 15.0% of eyes in Group 1 and 3.5% of eyes in Group 2 (P = .001). Epithelial hypertrophy occurred in 24.8% of eyes and 3.5% of eyes, respectively (P = .001). Salzmann-like epithelial nodules (2.6%), epithelial herpetic keratitis (1.9%), anterior uveitis (1.9%), and elevated intraocular pressure (1.9%) occurred in Group 1 only and infective keratitis (0.8%) in Group 2 only. Marked stromal edema and peripheral sterile infiltrates occurred at similar rates in both groups (P = .567 and P = .479, respectively). Grade 1+ corneal haze was significantly high in Group 2. Grade 2+ and 3+ haze was significantly high in Group 1 (P = .001).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Ocular surface healing disorders were the most common early complications of CXL. Short-term complications were higher with the transepithelial PTK epithelial removal technique than with mechanical epithelial removal.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">No author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cagil</LastName>
<ForeName>Nurullah</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology, Yildirim Beyazit University, Ankara Ataturk Training and Research Hospital, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sarac</LastName>
<ForeName>Ozge</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology, Yildirim Beyazit University, Ankara Ataturk Training and Research Hospital, Ankara, Turkey. Electronic address: drozgesarac@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cakmak</LastName>
<ForeName>Hasan Basri</ForeName>
<Initials>HB</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology, Yildirim Beyazit University, Ankara Ataturk Training and Research Hospital, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Can</LastName>
<ForeName>Gamze</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology, Yildirim Beyazit University, Ankara Ataturk Training and Research Hospital, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Can</LastName>
<ForeName>Erol</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology, Yildirim Beyazit University, Ankara Ataturk Training and Research Hospital, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432133</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Evaluation of stability and capsular bag opacification with a foldable intraocular lens coupled with a protective membrane in the rabbit model.</ArticleTitle>
<Pagination>
<MedlinePgn>1738-44</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.03.017</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00993-1</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate the stability and capsular bag opacification of a smooth or a patterned silicone protective membrane implanted in the bag with secondary placement of an intraocular lens (IOL).</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Experimental study.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Twelve New Zealand rabbits had bilateral implantation of a protective membrane and an IOL or an IOL alone. Three groups of 8 eyes each received the IOL and the smooth protective membrane, the IOL and the patterned membrane, or the IOL alone. Slitlamp examination was performed weekly for 4 weeks. The rabbits were then humanely killed and their globes enucleated. Capsular bag opacification was scored based on the Miyake-Apple view, and the eyes underwent histopathology.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">At 4 weeks, the mean central posterior capsule opacification (PCO) score was 0.28 ± 0.32 (SD) in all eyes with a protective membrane and 2.08 ± 1.28 in eyes with the IOL alone (P &lt; .00001, Student t test). Peripheral PCO and Soemmerring ring formation were also significantly less in eyes with the protective membrane. Histopathologically, the posterior capsules were relatively clear in most IOLs with the protective membrane. The smooth and patterned protective membranes showed a significant difference in overall capsular bag opacification formation compared with the IOLs without the membrane.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The circular geometry of the protective membrane led to expansion of the capsular bag and appeared to prevent capsular bag opacification. Further studies are warranted to assess whether the pattern on the device's posterior surface further enhances this effect.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">No author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kramer</LastName>
<ForeName>Gregory D</ForeName>
<Initials>GD</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Werner</LastName>
<ForeName>Liliana</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA. Electronic address: liliana.werner@hsc.utah.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>MacLean</LastName>
<ForeName>Kyle</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Farukhi</LastName>
<ForeName>Aabid</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gardiner</LastName>
<ForeName>Gareth L</ForeName>
<Initials>GL</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mamalis</LastName>
<ForeName>Nick</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>1R43EY022541-01A1</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432134</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Resistance force for intraocular lens insertion through lens cartridges and syringe-type injectors.</ArticleTitle>
<Pagination>
<MedlinePgn>1745-51</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.03.018</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)01001-9</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To measure and compare the resistance force for intraocular lens (IOL) insertion using 5 syringe-type injector systems.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Tokyo Medical University and laboratory in Kowa Co., Tokyo, Japan.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Experimental study.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Intraocular lenses were inserted into the lens capsular bag of porcine eyes after phacoemulsification using 5 implantation systems (Groups A, B, C, D, and E). For each system, the resistance force for IOL insertion to the lens capsular bag of porcine eyes was measured using an automated force gauge system. For control, the resistance force for IOL delivery into a plastic dish was measured. Changes in the resistance force and its curve and maximum value were evaluated. The mean total area under the curve (AUC) was compared. Data were statistically analyzed.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">For all groups, the mean resistance forces were 17.2, 6.3, 4.2, 20.7, and 2.3 newtons (N), respectively, in porcine eyes, and 14.4, 5.8, 4.5, 12.6, and 2.2 N in controls. The mean sizes of the total AUC were 43 371, 8465, 6771, 30 306, and 2334 pixels in porcine eyes and 40 940, 7080, 6876, 20 710, and 2215 pixels in controls; the correlation coefficients between the resistance forces and the sizes of the total area were 0.576, 0.113, 0.346, 0.726, and 0.933 in porcine eyes and 0.707, 0.557, 0.914, 0.951, and 0.893 in controls.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Resistance force and its curve were clarified in 5 IOL implantation systems. Appropriate IOL and injector selection may be achieved after clarifying resistance force and its waveform during IOL insertion.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">Neither author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015. Published by Elsevier Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Usui</LastName>
<ForeName>Masahiko</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From Tokyo Medical University (Usui) and the Eye Institute (Tanaka), Ebisu Clinic Ganka, Tokyo, Japan. Electronic address: gakucho@tokyo-med.ac.jp.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tanaka</LastName>
<ForeName>Takao</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>From Tokyo Medical University (Usui) and the Eye Institute (Tanaka), Ebisu Clinic Ganka, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432135</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Effects of torsional movements in refractive procedures.</ArticleTitle>
<Pagination>
<MedlinePgn>1752-66</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.07.017</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00847-0</ELocationID>
<Abstract>
<AbstractText Label="UNLABELLED">Using PubMed and our internal database, we extensively reviewed the literature on the history of measurement of torsional movements of the eye from 1963 to the present, focusing specifically on the implications of torsional measurement and compensation in corneal refractive and ocular surgery. Mean cyclotorsional movements observed in refractive surgery procedures have been reported to be around 3 degrees, which can be well controlled by the currently used technology. Torsional movements affect aberrations with a vectorial component (astigmatic procedures) more adversely. Currently available eye-registration technology provides an accuracy of ±1.5 degrees. The vectorial components of residual aberrations can be minimized by intentionally underplanning the refractive treatments. The gaps in our knowledge limit the precision in current surgical procedures due to imperfect cyclotorsion compensation. This review summarizes about the explored aspects of torsional movements in surgical applications and raises questions about the unexplored implications.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">Dr. Arba Mosquera and Mr. Verma are employees of Schwind eye-tech-solutions GmbH and Co. KG.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Arba Mosquera</LastName>
<ForeName>Samuel</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Research and Development Department, Schwind eye-tech-solutions GmbH and Co. KG, Kleinostheim, Germany. Electronic address: samuel.arba.mosquera@eye-tech.net.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Verma</LastName>
<ForeName>Shwetabh</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Research and Development Department, Schwind eye-tech-solutions GmbH and Co. KG, Kleinostheim, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432136</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Femtosecond laser-assisted primary posterior capsulotomy for toric intraocular lens fixation and stabilization.</ArticleTitle>
<Pagination>
<MedlinePgn>1767-71</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.07.002</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00779-8</ELocationID>
<Abstract>
<AbstractText Label="UNLABELLED">We describe 2 cases in which a spontaneously rotated toric intraocular lens (IOL) was fixated and stabilized using the femtosecond laser to create a primary posterior capsulotomy for posterior optic capture. We also review the literature on previous techniques that have been used to prevent or stabilize recurrent toric IOL rotation. The design of toric IOLs must be evaluated further to determine the risk for rotation in myopic eyes.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">Dr. Scott is a consultant to Abbott Medical Optics, Inc. Neither author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Scott</LastName>
<ForeName>Wendell J</ForeName>
<Initials>WJ</Initials>
<AffiliationInfo>
<Affiliation>From the Mercy Clinic Eye Specialists, Springfield, Missouri, USA. Electronic address: wendell.scott@mercy.net.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Owsiak</LastName>
<ForeName>Rachel R</ForeName>
<Initials>RR</Initials>
<AffiliationInfo>
<Affiliation>From the Mercy Clinic Eye Specialists, Springfield, Missouri, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432137</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Early-onset methicillin-resistant Staphylococcus aureus keratitis and late-onset infectious keratitis in astigmatic keratotomy incision following femtosecond laser-assisted cataract surgery.</ArticleTitle>
<Pagination>
<MedlinePgn>1772-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.06.017</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00774-9</ELocationID>
<Abstract>
<AbstractText Label="UNLABELLED">A 79-year-old woman had uneventful femtosecond laser-assisted cataract surgery including paired laser astigmatic keratotomies (AKs) in the right eye. Three weeks postoperatively, a corneal infiltrate developed in the superotemporal AK incision. Cultures grew methicillin-resistant Staphylococcus aureus. The infection was treated with topical fortified vancomycin and tobramycin; full resolution required several months of therapy. Five months after cataract surgery, the patient presented with a second stromal infiltrate, also in the superotemporal AK incision. Despite negative cultures, the infiltrate resolved quickly on a short course of broad-spectrum fortified antibiotics. At 6 months, the corrected distance visual acuity was 20/30. This case demonstrates that infectious keratitis can occur following uneventful femtosecond laser-assisted AK performed concurrently with cataract surgery. We reviewed the literature on infectious keratitis following refractive keratotomy and femtosecond laser-assisted procedures. Several recommendations to prevent these infections are proposed.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">No author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chou</LastName>
<ForeName>Timothy Y</ForeName>
<Initials>TY</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Chou, Abazari, Barash, Kaplowitz), Stony Brook University, Stony Brook, and the Long Island Eye Surgical Care PC (Shah), Brentwood, New York, USA. Electronic address: timothy.chou@stonybrookmedicine.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abazari</LastName>
<ForeName>Azin</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Chou, Abazari, Barash, Kaplowitz), Stony Brook University, Stony Brook, and the Long Island Eye Surgical Care PC (Shah), Brentwood, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barash</LastName>
<ForeName>Alexander</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Chou, Abazari, Barash, Kaplowitz), Stony Brook University, Stony Brook, and the Long Island Eye Surgical Care PC (Shah), Brentwood, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shah</LastName>
<ForeName>Shetal</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Chou, Abazari, Barash, Kaplowitz), Stony Brook University, Stony Brook, and the Long Island Eye Surgical Care PC (Shah), Brentwood, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kaplowitz</LastName>
<ForeName>Kevin</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Chou, Abazari, Barash, Kaplowitz), Stony Brook University, Stony Brook, and the Long Island Eye Surgical Care PC (Shah), Brentwood, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432138</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Massilia timonae as cause of chronic endophthalmitis following cataract surgery.</ArticleTitle>
<Pagination>
<MedlinePgn>1778-80</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.07.016</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00837-8</ELocationID>
<Abstract>
<AbstractText Label="UNLABELLED">This is the first report of chronic postoperative endophthalmitis caused by Massilia timonae. The gram-negative bacillus was isolated from a patient who developed chronic endophthalmitis after cataract extraction. The microorganism was cultured on brain-heart infusion broth and identified using the 16S rRNA sequence analysis. Biochemically, the organism was positive for catalase and oxidase and negative for arginine dihydrolase. It was pansensitive to β-lactams, fluoroquinolones, aminoglycosides, and trimethoprim-sulfamethoxazole but resistant to aztreonam. Massilia timonae is a new bacterium implicated in postoperative chronic endophthalmitis. Eubacterial polymerase chain reaction was useful in identifying M timonae because phenotyping testing and conventional algorithms could not identify it.</AbstractText>
<AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">No author has a financial or proprietary interest in any material or method mentioned.</AbstractText>
<CopyrightInformation>Copyright © 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chiquet</LastName>
<ForeName>Christophe</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Chiquet, Aptel) and the Department of Microbiology (Boisset), Centre Hospitalier Universitaire de Grenoble, Grenoble Université Alpes, Grenoble, and the Department of Microbiology (Pechinot) and Department of Ophthalmology (Creuzot-Garcher, Bron), Centre Hospitalier Universitaire de Dijon, Dijon University, Dijon, France. Electronic address: cchiquet@chu-grenoble.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Boisset</LastName>
<ForeName>Sandrine</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Chiquet, Aptel) and the Department of Microbiology (Boisset), Centre Hospitalier Universitaire de Grenoble, Grenoble Université Alpes, Grenoble, and the Department of Microbiology (Pechinot) and Department of Ophthalmology (Creuzot-Garcher, Bron), Centre Hospitalier Universitaire de Dijon, Dijon University, Dijon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pechinot</LastName>
<ForeName>Andre</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Chiquet, Aptel) and the Department of Microbiology (Boisset), Centre Hospitalier Universitaire de Grenoble, Grenoble Université Alpes, Grenoble, and the Department of Microbiology (Pechinot) and Department of Ophthalmology (Creuzot-Garcher, Bron), Centre Hospitalier Universitaire de Dijon, Dijon University, Dijon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Creuzot-Garcher</LastName>
<ForeName>Catherine</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Chiquet, Aptel) and the Department of Microbiology (Boisset), Centre Hospitalier Universitaire de Grenoble, Grenoble Université Alpes, Grenoble, and the Department of Microbiology (Pechinot) and Department of Ophthalmology (Creuzot-Garcher, Bron), Centre Hospitalier Universitaire de Dijon, Dijon University, Dijon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aptel</LastName>
<ForeName>Florent</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Chiquet, Aptel) and the Department of Microbiology (Boisset), Centre Hospitalier Universitaire de Grenoble, Grenoble Université Alpes, Grenoble, and the Department of Microbiology (Pechinot) and Department of Ophthalmology (Creuzot-Garcher, Bron), Centre Hospitalier Universitaire de Dijon, Dijon University, Dijon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bron</LastName>
<ForeName>Alain M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Ophthalmology (Chiquet, Aptel) and the Department of Microbiology (Boisset), Centre Hospitalier Universitaire de Grenoble, Grenoble Université Alpes, Grenoble, and the Department of Microbiology (Pechinot) and Department of Ophthalmology (Creuzot-Garcher, Bron), Centre Hospitalier Universitaire de Dijon, Dijon University, Dijon, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432139</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Bibliometric analysis of literature on cataract research in PubMed (2001-2013).</ArticleTitle>
<Pagination>
<MedlinePgn>1781-3</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.07.019</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00939-6</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wen</LastName>
<ForeName>Peng-Fei</ForeName>
<Initials>PF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dong</LastName>
<ForeName>Ze-Ying</ForeName>
<Initials>ZY</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Bao-Zhu</ForeName>
<Initials>BZ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jia</LastName>
<ForeName>Yu-Qin</ForeName>
<Initials>YQ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432140</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Association between age and incidence of posterior capsule rupture during cataract surgery: cross-sectional study.</ArticleTitle>
<Pagination>
<MedlinePgn>1783-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.07.003</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00781-6</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tsinopoulos</LastName>
<ForeName>Ioannis T</ForeName>
<Initials>IT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Karras</LastName>
<ForeName>Georgios I</ForeName>
<Initials>GI</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Haidich</LastName>
<ForeName>Anna-Bettina</ForeName>
<Initials>AB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tsaousis</LastName>
<ForeName>Konstantinos T</ForeName>
<Initials>KT</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432141</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Structural changes of the anterior chamber following cataract surgery during infancy.</ArticleTitle>
<Pagination>
<MedlinePgn>1784-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.07.001</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00777-4</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nguyen</LastName>
<ForeName>Matthew</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shainberg</LastName>
<ForeName>Marla</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Beck</LastName>
<ForeName>Allen D</ForeName>
<Initials>AD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lambert</LastName>
<ForeName>Scott R</ForeName>
<Initials>SR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432142</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Peaked Pupil One Day After Cataract Surgery: August consultation #1.</ArticleTitle>
<Pagination>
<MedlinePgn>1787; discussion 1791</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.07.021</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00942-6</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Masket</LastName>
<ForeName>Samuel</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1790-1; discussion 1791</RefSource>
<PMID Version="1">26432149</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1789-90; discussion 1791</RefSource>
<PMID Version="1">26432147</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1788; discussion 1791</RefSource>
<PMID Version="1">26432145</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1788; discussion 1791</RefSource>
<PMID Version="1">26432144</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1790; discussion 1791</RefSource>
<PMID Version="1">26432148</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1787-8; discussion 1791</RefSource>
<PMID Version="1">26432143</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1789; discussion 1791</RefSource>
<PMID Version="1">26432146</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432143</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>August consultation #2.</ArticleTitle>
<Pagination>
<MedlinePgn>1787-8; discussion 1791</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.07.022</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00943-8</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Crema</LastName>
<ForeName>Armando</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Rio de Janeiro, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1787; discussion 1791</RefSource>
<PMID Version="1">26432142</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432144</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>August consultation #3.</ArticleTitle>
<Pagination>
<MedlinePgn>1788; discussion 1791</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.07.023</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00944-X</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hannush</LastName>
<ForeName>Sadeer B</ForeName>
<Initials>SB</Initials>
<AffiliationInfo>
<Affiliation>Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1787; discussion 1791</RefSource>
<PMID Version="1">26432142</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432145</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>August consultation #4.</ArticleTitle>
<Pagination>
<MedlinePgn>1788; discussion 1791</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.07.024</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00945-1</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hoffman</LastName>
<ForeName>Richard S</ForeName>
<Initials>RS</Initials>
<AffiliationInfo>
<Affiliation>Eugene, Oregon, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1787; discussion 1791</RefSource>
<PMID Version="1">26432142</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432146</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>August consultation #5.</ArticleTitle>
<Pagination>
<MedlinePgn>1789; discussion 1791</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.07.025</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00946-3</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jackson</LastName>
<ForeName>Mitchell A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Lake Villa, Illinois, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1787; discussion 1791</RefSource>
<PMID Version="1">26432142</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432147</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>August consultation #6.</ArticleTitle>
<Pagination>
<MedlinePgn>1789-90; discussion 1791</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.07.026</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00947-5</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jacob</LastName>
<ForeName>Soosan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Chennai, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1787; discussion 1791</RefSource>
<PMID Version="1">26432142</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432148</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>August consultation #7.</ArticleTitle>
<Pagination>
<MedlinePgn>1790; discussion 1791</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.07.027</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00948-7</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Snyder</LastName>
<ForeName>Michael E</ForeName>
<Initials>ME</Initials>
<AffiliationInfo>
<Affiliation>Cincinnati, Ohio, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1787; discussion 1791</RefSource>
<PMID Version="1">26432142</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432149</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>August consultation #8.</ArticleTitle>
<Pagination>
<MedlinePgn>1790-1; discussion 1791</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.07.028</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00949-9</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Weikert</LastName>
<ForeName>Mitchell P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Houston, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1787; discussion 1791</RefSource>
<PMID Version="1">26432142</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432150</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Potential confounding factors in a comparison of femtosecond laser-assisted cataract surgery versus standard phacoemulsification.</ArticleTitle>
<Pagination>
<MedlinePgn>1792</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.06.026</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00964-5</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Talamo</LastName>
<ForeName>Jonathan H</ForeName>
<Initials>JH</Initials>
<AffiliationInfo>
<Affiliation>Waltham, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dick</LastName>
<ForeName>H Burkhard</ForeName>
<Initials>HB</Initials>
<AffiliationInfo>
<Affiliation>Bochum, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schultz</LastName>
<ForeName>Tim</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Bochum, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Scott</LastName>
<ForeName>Wendell J</ForeName>
<Initials>WJ</Initials>
<AffiliationInfo>
<Affiliation>Springfield, Missouri, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1793-4</RefSource>
<PMID Version="1">26432151</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cataract Refract Surg. 2015 Jan;41(1):47-52</RefSource>
<PMID Version="1">25466483</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432151</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Reply.</ArticleTitle>
<Pagination>
<MedlinePgn>1793-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.06.025</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00963-3</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vote</LastName>
<ForeName>Brendan J</ForeName>
<Initials>BJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Oakley</LastName>
<ForeName>Carmen L</ForeName>
<Initials>CL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Allen</LastName>
<ForeName>Penelope L</ForeName>
<Initials>PL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Abell</LastName>
<ForeName>Robin G</ForeName>
<Initials>RG</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cataract Refract Surg. 2015 Jan;41(1):47-52</RefSource>
<PMID Version="1">25466483</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1792</RefSource>
<PMID Version="1">26432150</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432152</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Other comparators for outcomes in treatment of astigmatism with toric intraocular lenses.</ArticleTitle>
<Pagination>
<MedlinePgn>1794-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.06.023</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00961-X</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Goggin</LastName>
<ForeName>Michael J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Adelaide, South Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1795</RefSource>
<PMID Version="1">26432154</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cataract Refract Surg. 2015 May;41(5):936-44</RefSource>
<PMID Version="1">25936681</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432153</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Pain during phacoemulsification with and without cryoanalgesia.</ArticleTitle>
<Pagination>
<MedlinePgn>1795-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.07.030</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00959-1</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lim</LastName>
<ForeName>Louis W</ForeName>
<Initials>LW</Initials>
<AffiliationInfo>
<Affiliation>Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tan</LastName>
<ForeName>Colin S H</ForeName>
<Initials>CS</Initials>
<AffiliationInfo>
<Affiliation>Singapore.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1796-7</RefSource>
<PMID Version="1">26432155</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cataract Refract Surg. 2015 Apr;41(4):719-23</RefSource>
<PMID Version="1">25840296</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432154</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Reply.</ArticleTitle>
<Pagination>
<MedlinePgn>1795</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.06.024</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00962-1</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Abulafia</LastName>
<ForeName>Adi</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Barrett</LastName>
<ForeName>Graham D</ForeName>
<Initials>GD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Koch</LastName>
<ForeName>Douglas D</ForeName>
<Initials>DD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Li</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Assia</LastName>
<ForeName>Ehud I</ForeName>
<Initials>EI</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1794-5</RefSource>
<PMID Version="1">26432152</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cataract Refract Surg. 2015 May;41(5):936-44</RefSource>
<PMID Version="1">25936681</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432155</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Reply.</ArticleTitle>
<Pagination>
<MedlinePgn>1796-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.07.031</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00960-8</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Coelho</LastName>
<ForeName>Roberto Pinto</ForeName>
<Initials>RP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Biaggi</LastName>
<ForeName>Ricardo Helio</ForeName>
<Initials>RH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jorge</LastName>
<ForeName>Rodrigo</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rodrigues</LastName>
<ForeName>Maria de Lourdes Veronese</ForeName>
<Initials>Mde L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Messias</LastName>
<ForeName>André Marcio Vieira</ForeName>
<Initials>AM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1795-6</RefSource>
<PMID Version="1">26432153</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cataract Refract Surg. 2015 Apr;41(4):719-23</RefSource>
<PMID Version="1">25840296</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432156</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Influence of corneal asphericity on refractive outcomes after cataract surgery.</ArticleTitle>
<Pagination>
<MedlinePgn>1797-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.05.021</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00819-6</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Arba Mosquera</LastName>
<ForeName>Samuel</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Kleinostheim, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1798</RefSource>
<PMID Version="1">26432157</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cataract Refract Surg. 2015 Apr;41(4):785-9</RefSource>
<PMID Version="1">25840302</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26432157</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-4502</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Reply.</ArticleTitle>
<Pagination>
<MedlinePgn>1798</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.07.029</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)00958-X</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Savini</LastName>
<ForeName>Giacomo</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hoffer</LastName>
<ForeName>Kenneth J</ForeName>
<Initials>KJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Barboni</LastName>
<ForeName>Piero</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cataract Refract Surg. 2015 Apr;41(4):785-9</RefSource>
<PMID Version="1">25840302</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cataract Refract Surg. 2015 Aug;41(8):1797-8</RefSource>
<PMID Version="1">26432156</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26311886</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1098-5514</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>89</Volume>
<Issue>21</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Bst2/Tetherin Is Induced in Neurons by Type I Interferon and Viral Infection but Is Dispensable for Protection against Neurotropic Viral Challenge.</ArticleTitle>
<Pagination>
<MedlinePgn>11011-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.01745-15</ELocationID>
<Abstract>
<AbstractText Label="UNLABELLED">In permissive mouse central nervous system (CNS) neurons, measles virus (MV) spreads in the absence of hallmark viral budding or neuronal death, with transmission occurring efficiently and exclusively via the synapse. MV infection also initiates a robust type I interferon (IFN) response, resulting in the synthesis of a large number of genes, including bone marrow stromal antigen 2 (Bst2)/tetherin/CD317. Bst2 restricts the release of some enveloped viruses, but to date, its role in viral infection of neurons has not been assessed. Consequently, we investigated how Bst2 was induced and what role it played in MV neuronal infection. The magnitude of induction of neuronal Bst2 RNA and protein following IFN exposure and viral infection was notably higher than in similarly treated mouse embryo fibroblasts (MEFs). Bst2 synthesis was both IFN and Stat1 dependent. Although Bst2 prevented MV release from nonneuronal cells, its deletion had no effect on viral pathogenesis in MV-challenged mice. Our findings underscore how cell-type-specific differences impact viral infection and pathogenesis.</AbstractText>
<AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Viral infections of the central nervous system can lead to debilitating disease and death. Moreover, it is becoming increasingly clear that nonrenewable cells, including most central nervous system neurons, combat neurotropic viral infections in fundamentally different ways than other rapidly dividing and renewable cell populations. Here we identify type I interferon signaling as a key inducer of a known antiviral protein (Bst2) in neurons. Unexpectedly, the gene is dispensable for clearance of neurotropic viral infection despite its well-defined contribution to limiting the spread of enveloped viruses in proliferating cells. A deeper appreciation of the importance of cell type heterogeneity in antiviral immunity will aid in the identification of unique therapeutic targets for life-threatening viral infections.</AbstractText>
<CopyrightInformation>Copyright © 2015, American Society for Microbiology. All Rights Reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Holmgren</LastName>
<ForeName>Alicia M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA Program in Blood Cell Development and Function, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Miller</LastName>
<ForeName>Katelyn D</ForeName>
<Initials>KD</Initials>
<AffiliationInfo>
<Affiliation>Program in Blood Cell Development and Function, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA Program in Cell and Molecular Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cavanaugh</LastName>
<ForeName>Sarah E</ForeName>
<Initials>SE</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA Program in Blood Cell Development and Function, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rall</LastName>
<ForeName>Glenn F</ForeName>
<Initials>GF</Initials>
<AffiliationInfo>
<Affiliation>Program in Blood Cell Development and Function, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA glenn.rall@fccc.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>T32 NS007180</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2013 Dec 13;425(24):4956-64</RefSource>
<PMID Version="1">24075872</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2013;9(7):e1003487</RefSource>
<PMID Version="1">23853598</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Virology. 2015 Jan 15;475:96-109</RefSource>
<PMID Version="1">25462350</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neuroimmunol. 2015 Feb 15;279:11-9</RefSource>
<PMID Version="1">25669994</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Med. 2000 May 1;191(9):1459-66</RefSource>
<PMID Version="1">10790421</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2000 Feb;74(4):1908-18</RefSource>
<PMID Version="1">10644364</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Immunol. 2015 Jun;34:91-8</RefSource>
<PMID Version="1">25771184</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gen Virol. 2000 Oct;81(Pt 10):2341-64</RefSource>
<PMID Version="1">10993923</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2002 May;76(9):4497-506</RefSource>
<PMID Version="1">11932415</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2002 Dec 1;186 Suppl 2:S215-9</RefSource>
<PMID Version="1">12424700</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 1993 Oct;67(10):6025-32</RefSource>
<PMID Version="1">8371352</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1993 Oct 22;75(2):295-305</RefSource>
<PMID Version="1">8402913</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 1994 Sep 15;84(6):1922-30</RefSource>
<PMID Version="1">8080996</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4659-63</RefSource>
<PMID Version="1">9114047</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 1999 Mar;73(3):1795-801</RefSource>
<PMID Version="1">9971756</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Virology. 2006 Mar 30;347(1):234-45</RefSource>
<PMID Version="1">16529787</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2006 May 16;103(20):7835-40</RefSource>
<PMID Version="1">16682623</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2006 Sep 1;177(5):3260-5</RefSource>
<PMID Version="1">16920966</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Virology. 2007 May 25;362(1):235-44</RefSource>
<PMID Version="1">17434199</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neuroimmunol. 2007 Dec;192(1-2):145-56</RefSource>
<PMID Version="1">18006082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2008 Jan 24;451(7177):425-30</RefSource>
<PMID Version="1">18200009</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Host Microbe. 2008 Apr 17;3(4):245-52</RefSource>
<PMID Version="1">18342597</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2886-91</RefSource>
<PMID Version="1">19179289</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2009 Mar 9;184(5):721-36</RefSource>
<PMID Version="1">19273615</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2009 Apr;83(8):3429-35</RefSource>
<PMID Version="1">19176616</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2009 Jun 5;284(23):15927-41</RefSource>
<PMID Version="1">19359243</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2009 Oct 30;139(3):499-511</RefSource>
<PMID Version="1">19879838</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2010 Feb;6(2):e1000749</RefSource>
<PMID Version="1">20140192</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2010 Mar;6(3):e1000701</RefSource>
<PMID Version="1">20221443</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunol Res. 2010 Jul;47(1-3):123-33</RefSource>
<PMID Version="1">20087684</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Microbiol. 2010 Sep;18(9):388-96</RefSource>
<PMID Version="1">20688520</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):17872-9</RefSource>
<PMID Version="1">20923878</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2010 Dec;84(24):12646-57</RefSource>
<PMID Version="1">20943977</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Microbiol. 2011 Jul;9(7):519-31</RefSource>
<PMID Version="1">21677686</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2011 Nov;7(11):e1002332</RefSource>
<PMID Version="1">22072961</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>DNA Cell Biol. 2011 Dec;30(12):965-74</RefSource>
<PMID Version="1">21919738</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurovirol. 2011 Dec;17(6):528-34</RefSource>
<PMID Version="1">22161682</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2012 Feb 15;188(4):1915-23</RefSource>
<PMID Version="1">22246627</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2012 Mar 15;188(6):2488-92</RefSource>
<PMID Version="1">22327075</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Virol. 2011 Sep;1(3):216-21</RefSource>
<PMID Version="1">21927638</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neuroimmunol. 2012 Oct 15;251(1-2):33-8</RefSource>
<PMID Version="1">22769061</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2012 Oct 1;189(7):3462-71</RefSource>
<PMID Version="1">22922816</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2012 Sep;8(9):e1002931</RefSource>
<PMID Version="1">23028328</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Viruses. 2013 Mar;5(3):834-57</RefSource>
<PMID Version="1">23503326</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2013 Apr;19(4):458-64</RefSource>
<PMID Version="1">23455712</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Elife. 2014;3:e02362</RefSource>
<PMID Version="1">24843023</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">PMC4621123 [Available on 05/01/16]</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26431759</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1527-9995</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>86</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Urology</Title>
<ISOAbbreviation>Urology</ISOAbbreviation>
</Journal>
<ArticleTitle>Medical Expulsive Therapy for Ureteric Colic: New Hard Evidence: Commentary on: Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial.</ArticleTitle>
<Pagination>
<MedlinePgn>649-50</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.urology.2015.06.030</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0090-4295(15)00626-3</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Van Asseldonk</LastName>
<ForeName>Brandon</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Elterman</LastName>
<ForeName>Dean S</ForeName>
<Initials>DS</Initials>
<AffiliationInfo>
<Affiliation>Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Urology</MedlineTA>
<NlmUniqueID>0366151</NlmUniqueID>
<ISSNLinking>0090-4295</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>Lancet. 2015 Jul 25;386(9991):341-9</RefSource>
<PMID Version="1">25998582</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25995305</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0020-7314</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>45</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>International journal of health services : planning, administration, evaluation</Title>
<ISOAbbreviation>Int J Health Serv</ISOAbbreviation>
</Journal>
<ArticleTitle>Education Improves Public Health and Promotes Health Equity.</ArticleTitle>
<Pagination>
<MedlinePgn>657-78</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1177/0020731415585986</ELocationID>
<Abstract>
<AbstractText>This article describes a framework and empirical evidence to support the argument that educational programs and policies are crucial public health interventions. Concepts of education and health are developed and linked, and we review a wide range of empirical studies to clarify pathways of linkage and explore implications. Basic educational expertise and skills, including fundamental knowledge, reasoning ability, emotional self-regulation, and interactional abilities, are critical components of health. Moreover, education is a fundamental social determinant of health - an upstream cause of health. Programs that close gaps in educational outcomes between low-income or racial and ethnic minority populations and higher-income or majority populations are needed to promote health equity. Public health policy makers, health practitioners and educators, and departments of health and education can collaborate to implement educational programs and policies for which systematic evidence indicates clear public health benefits. </AbstractText>
<CopyrightInformation>© The Author(s) 2015.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hahn</LastName>
<ForeName>Robert A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>Centers for Disease Control and Prevention, Atlanta, GA, USA rah1@cdc.gov.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Truman</LastName>
<ForeName>Benedict I</ForeName>
<Initials>BI</Initials>
<AffiliationInfo>
<Affiliation>Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>CC999999</GrantID>
<Agency>Intramural CDC HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Int J Health Serv</MedlineTA>
<NlmUniqueID>1305035</NlmUniqueID>
<ISSNLinking>0020-7314</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004522">Educational Status</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015438">Health Behavior</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000069576">Health Equity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D006304">Health Status</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009017">Morbidity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D011634">Public Health</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D064890">Social Determinants of Health</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012959">Socioeconomic Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">HHSPA746316</OtherID>
<OtherID Source="NLM">PMC4691207</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">disparities</Keyword>
<Keyword MajorTopicYN="N">equity</Keyword>
<Keyword MajorTopicYN="N">health in all policies</Keyword>
<Keyword MajorTopicYN="N">social determinant</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26460342</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>20</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1759-5037</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>11</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Nature reviews. Endocrinology</Title>
<ISOAbbreviation>Nat Rev Endocrinol</ISOAbbreviation>
</Journal>
<ArticleTitle>Decade in review-reproductive endocrinology: Understanding reproductive endocrine disorders.</ArticleTitle>
<Pagination>
<MedlinePgn>640-1</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/nrendo.2015.179</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kaiser</LastName>
<ForeName>Ursula B</ForeName>
<Initials>UB</Initials>
<AffiliationInfo>
<Affiliation>Brigham and Women's Hospital, 221 Longwood Avenue, Boston, MA 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 HD019938</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HD082314</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54 HD028138</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>10</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Nat Rev Endocrinol</MedlineTA>
<NlmUniqueID>101500078</NlmUniqueID>
<ISSNLinking>1759-5029</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26382853</PMID>
<DateCreated>
<Year>2015</Year>
<Month>10</Month>
<Day>23</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1095-9203</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>350</Volume>
<Issue>6259</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
<Day>23</Day>
</PubDate>
</JournalIssue>
<Title>Science (New York, N.Y.)</Title>
<ISOAbbreviation>Science</ISOAbbreviation>
</Journal>
<ArticleTitle>The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression.</ArticleTitle>
<Pagination>
<MedlinePgn>455-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.aac7442</ELocationID>
<Abstract>
<AbstractText>Autoantibodies target the RNA binding protein Ro60 in systemic lupus erythematosus (SLE) and Sjögren's syndrome. However, it is unclear whether Ro60 and its associated RNAs contribute to disease pathogenesis. We catalogued the Ro60-associated RNAs in human cell lines and found that among other RNAs, Ro60 bound an RNA motif derived from endogenous Alu retroelements. Alu transcripts were induced by type I interferon and stimulated proinflammatory cytokine secretion by human peripheral blood cells. Ro60 deletion resulted in enhanced expression of Alu RNAs and interferon-regulated genes. Anti-Ro60-positive SLE immune complexes contained Alu RNAs, and Alu transcripts were up-regulated in SLE whole blood samples relative to controls. These findings establish a link among the lupus autoantigen Ro60, Alu retroelements, and type I interferon. </AbstractText>
<CopyrightInformation>Copyright © 2015, American Association for the Advancement of Science.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hung</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Genentech, South San Francisco, CA 94080, USA. behrens.tim@gene.com hungt2@gene.com geneyeo@ucsd.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pratt</LastName>
<ForeName>G A</ForeName>
<Initials>GA</Initials>
<AffiliationInfo>
<Affiliation>Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, Stem Cell Program, University of California at San Diego, Sanford Consortium for Regenerative Medicine, 2880 Torrey Pines Scenic Drive, La Jolla, CA 92037, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sundararaman</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, Stem Cell Program, University of California at San Diego, Sanford Consortium for Regenerative Medicine, 2880 Torrey Pines Scenic Drive, La Jolla, CA 92037, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Townsend</LastName>
<ForeName>M J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Genentech, South San Francisco, CA 94080, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chaivorapol</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Genentech, South San Francisco, CA 94080, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bhangale</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Genentech, South San Francisco, CA 94080, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Graham</LastName>
<ForeName>R R</ForeName>
<Initials>RR</Initials>
<AffiliationInfo>
<Affiliation>Genentech, South San Francisco, CA 94080, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ortmann</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Genentech, South San Francisco, CA 94080, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Criswell</LastName>
<ForeName>L A</ForeName>
<Initials>LA</Initials>
<AffiliationInfo>
<Affiliation>Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center, University of California, San Francisco, CA 94143, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yeo</LastName>
<ForeName>G W</ForeName>
<Initials>GW</Initials>
<AffiliationInfo>
<Affiliation>Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, Stem Cell Program, University of California at San Diego, Sanford Consortium for Regenerative Medicine, 2880 Torrey Pines Scenic Drive, La Jolla, CA 92037, USA. Department of Physiology, National University of Singapore, Singapore. Genome Institute of Singapore and Molecular Engineering Laboratory, Agency for Science, Technology and Research, Singapore. behrens.tim@gene.com hungt2@gene.com geneyeo@ucsd.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Behrens</LastName>
<ForeName>T W</ForeName>
<Initials>TW</Initials>
<AffiliationInfo>
<Affiliation>Genentech, South San Francisco, CA 94080, USA. behrens.tim@gene.com hungt2@gene.com geneyeo@ucsd.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>HG004659</GrantID>
<Acronym>HG</Acronym>
<Agency>NHGRI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HG007005</GrantID>
<Acronym>HG</Acronym>
<Agency>NHGRI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>NS075449</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 GM084317</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HG004659</GrantID>
<Acronym>HG</Acronym>
<Agency>NHGRI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 NS075449</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Science</MedlineTA>
<NlmUniqueID>0404511</NlmUniqueID>
<ISSNLinking>0036-8075</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26522283</PMID>
<DateCreated>
<Year>2015</Year>
<Month>11</Month>
<Day>02</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1120-9763</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>39</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Epidemiologia e prevenzione</Title>
<ISOAbbreviation>Epidemiol Prev</ISOAbbreviation>
</Journal>
<ArticleTitle>[Vaccines: building on scientific excellence and dispelling false myths].</ArticleTitle>
<Pagination>
<MedlinePgn>198-201</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The EU and Italian institutions have recently reiterated their commitment to harmonize and implement vaccination policies as a fundamental strategy for public health. Nonetheless, vaccines are losing public confidence. False myths related to vaccine adverse reactions and commercial interests, combined with the recent judgements of the Court and the "Fluad® episode", are fuelling vaccine hesitancy. In such a context, a lively debate is ongoing in Italian scientific community. Aim of this contribution is to recall the available solid scientific evidence demonstrating that vaccines are among the most effective prevention tools ever invented and recall the economic data that support the cost-effectiveness of the immunisation. As every other medicine, vaccines are registered after large and solid clinical trials have been conducted. Immunization schedules are proposed by experts in the field of clinical medicine, epidemiology and public health on the basis of the available scientific evidence, and then implemented by policy makers also taking into consideration resources allocation and financial sustainability. The false myth that vaccines are offered because of economic interests is to be dispelled;moreover, researchers, policy makers, scientific societies and the healthcare community at large should renew commitment to invest in health education and communication on vaccines, always disclosing potential conflicts of interests. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Signorelli</LastName>
<ForeName>Carlo</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Dipartimento di scienze biomediche, biotecnologiche e traslazionali, Università di Parma. carlo.signorelli@unipr.it.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Presidente Società italiana di igiene, medicina preventiva e sanità pubblica (SItI).</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>La vera eccellenza dei vaccini e i falsi miti da sfatare.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Epidemiol Prev</MedlineTA>
<NlmUniqueID>8902507</NlmUniqueID>
<ISSNLinking>1120-9763</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26524568</PMID>
<DateCreated>
<Year>2015</Year>
<Month>11</Month>
<Day>03</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1664-2155</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>83</Volume>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Nestlé Nutrition Institute workshop series</Title>
<ISOAbbreviation>Nestle Nutr Inst Workshop Ser</ISOAbbreviation>
</Journal>
<ArticleTitle>Physical Exercise as Therapy for Frailty.</ArticleTitle>
<Pagination>
<MedlinePgn>83-92</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1159/000382065</ELocationID>
<Abstract>
<AbstractText>Longitudinal studies demonstrate that regular physical exercise extends longevity and reduces the risk of physical disability. Decline in physical activity with aging is associated with a decrease in exercise capacity that predisposes to frailty. The frailty syndrome includes a lowered activity level, poor exercise tolerance, and loss of lean body and muscle mass. Poor exercise tolerance is related to aerobic endurance. Aerobic endurance training can significantly improve peak oxygen consumption by ∼10-15%. Resistance training is the best way to increase muscle strength and mass. Although the increase in muscle mass in response to resistance training may be attenuated in frail older adults, resistance training can significantly improve muscle strength, particularly in institutionalized patients, by ∼110%. Because both aerobic and resistance training target specific components of frailty, studies combining aerobic and resistance training provide the most promising evidence with respect to successfully treating frailty. At the molecular level, exercise reduces frailty by decreasing muscle inflammation, increasing anabolism, and increasing muscle protein synthesis. More studies are needed to determine which exercises are best suited, most effective, and safe for this population. Based on the available studies, an individualized multicomponent exercise program that includes aerobic activity, strength exercises, and flexibility is recommended to treat frailty. </AbstractText>
<CopyrightInformation>© 2015 Michael E. DeBakey VA Medical Center (US Government) Published by S. Karger AG, Basel.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Aguirre</LastName>
<ForeName>Lina E</ForeName>
<Initials>LE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Villareal</LastName>
<ForeName>Dennis T</ForeName>
<Initials>DT</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 AG025501</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AG031176</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Nestle Nutr Inst Workshop Ser</MedlineTA>
<NlmUniqueID>101577268</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26411977</PMID>
<DateCreated>
<Year>2015</Year>
<Month>11</Month>
<Day>09</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1573-7241</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>29</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy</Title>
<ISOAbbreviation>Cardiovasc Drugs Ther</ISOAbbreviation>
</Journal>
<ArticleTitle>Electrocardiographic Predictors of Torsadogenic Risk During Dofetilide or Sotalol Initiation: Utility of a Novel T Wave Analysis Program.</ArticleTitle>
<Pagination>
<MedlinePgn>433-41</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s10557-015-6619-0</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Initiation of class III anti-arrhythmic medications requires telemetric monitoring for ventricular arrhythmias and QT prolongation to reduce the risk of torsades de pointes (TdP). Heart rate-corrected QT interval (QTc) is an indicator of risk, however it is imperfect, and subtle abnormalities of repolarization have been linked with arrhythmogenesis.</AbstractText>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Identification of electrocardiographic predictors of torsadogenic risk through the application of a novel T wave analysis tool.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Among all patients admitted to Mayo Clinic for initiation of dofetilide or sotalol, we identified 13 cases who developed drug-induced TdP and 26 age and sex matched controls that did not develop TdP. The immediate pre-TdP ECG of those with TdP was compared to the last ECG performed prior to hospital discharge in controls using a novel T wave program that quantified subtle changes in T wave morphology.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The QTc and 12 T wave parameters successfully distinguished TdP cases from controls. The top performing parameters were the QTc in lead V3 (mean case vs control 480 vs 420 msec, p &lt; 0.001, r = 0.72) and T wave right slope in lead I (mean case vs control -840.29 vs -1668.71 mV/s, p = 0.002, r = 0.45). The addition of T wave right slope to QTc improved prediction accuracy from 79 to 88 %.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our data demonstrate that, in addition to QTc, the T wave right slope is correlated strongly with TdP risk. This suggests that a computer-based repolarization measurement tool that integrates additional data beyond the QTc may identify patients with the greatest torsadogenic potential.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sugrue</LastName>
<ForeName>Alan</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-9921-6968</Identifier>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kremen</LastName>
<ForeName>Vaclav</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Czech Institute of Informatics, Robotics, and Cybernetics, Czech Technical University in Prague, Prague, Czech Republic.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Qiang</LastName>
<ForeName>Bo</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sheldon</LastName>
<ForeName>Seth H</ForeName>
<Initials>SH</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, University of Michigan, Ann Arbor, MI, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>DeSimone</LastName>
<ForeName>Christopher V</ForeName>
<Initials>CV</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sapir</LastName>
<ForeName>Yehu</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Ben Gurion University of the Negev, Beersheba, Israel.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Striemer</LastName>
<ForeName>Bryan L</ForeName>
<Initials>BL</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brady</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Asirvatham</LastName>
<ForeName>Samuel J</ForeName>
<Initials>SJ</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Division of Pediatric Cardiology, Department of Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ackerman</LastName>
<ForeName>Michael J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Division of Pediatric Cardiology, Department of Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular Pharmacology &amp; Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Friedman</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Noseworthy</LastName>
<ForeName>Peter A</ForeName>
<Initials>PA</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, USA. noseworthy.peter@mayo.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>T32 HL007111</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Cardiovasc Drugs Ther</MedlineTA>
<NlmUniqueID>8712220</NlmUniqueID>
<ISSNLinking>0920-3206</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Class III antiarrhythmics</Keyword>
<Keyword MajorTopicYN="N">Electrocardiography</Keyword>
<Keyword MajorTopicYN="N">Risk stratification</Keyword>
<Keyword MajorTopicYN="N">T wave analysis</Keyword>
<Keyword MajorTopicYN="N">Torsade de pointes</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26439693</PMID>
<DateCreated>
<Year>2015</Year>
<Month>11</Month>
<Day>10</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1949-2553</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>6</Volume>
<Issue>33</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
<Day>27</Day>
</PubDate>
</JournalIssue>
<Title>Oncotarget</Title>
<ISOAbbreviation>Oncotarget</ISOAbbreviation>
</Journal>
<ArticleTitle>Antitumor activity of a potent MEK inhibitor, TAK-733, against colorectal cancer cell lines and patient derived xenografts.</ArticleTitle>
<Pagination>
<MedlinePgn>34561-72</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.5949</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">CRC is a significant cause of cancer mortality, and new therapies are needed for patients with advanced disease. TAK-733 is a highly potent and selective investigational novel MEK allosteric site inhibitor.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">In a preclinical study of TAK-733, a panel of CRC cell lines were exposed to varying concentrations of the agent for 72 hours followed by a sulforhodamine B assay. Twenty patient-derived colorectal cancer xenografts were then treated with TAK-733 in vivo. Tumor growth inhibition index (TGII) was assessed to evaluate the sensitivity of the CRC explants to TAK-733 while linear regression was utilized to investigate the predictive effects of genotype on the TGII of explants.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty-four CRC cell lines were exposed to TAK-733, while 42 cell lines were deemed sensitive across a broad range of mutations. Eighty-two percent of the cell lines within the sensitive subset were BRAF or KRAS/NRAS mutant, whereas 80% of the cell lines within the sensitive subset were PIK3CA WT. Twenty patient-derived human tumor CRC explants were then treated with TAK-733. In total, 15 primary human tumor explants were found to be sensitive to TAK-733 (TGII ≤ 20%), including 9 primary human tumor explants that exhibited tumor regression (TGII &gt; 100%). Explants with a BRAF/KRAS/NRAS mutant and PIK3CA wild-type genotype demonstrated increased sensitivity to TAK-733 with a median TGII of -6%. MEK-response gene signatures also correlated with responsiveness to TAK-733 in KRAS-mutant CRC.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The MEK inhibitor TAK-733 demonstrated robust antitumor activity against CRC cell lines and patient-derived tumor explants. While the preclinical activity observed in this study was considerable, single-agent efficacy in the clinic has been limited in CRC, supporting the use of these models in an iterative manner to elucidate resistance mechanisms that can guide rational combination strategies.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lieu</LastName>
<ForeName>Christopher H</ForeName>
<Initials>CH</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Klauck</LastName>
<ForeName>Peter J</ForeName>
<Initials>PJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Henthorn</LastName>
<ForeName>Patrick K</ForeName>
<Initials>PK</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tentler</LastName>
<ForeName>John J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tan</LastName>
<ForeName>Aik-Choon</ForeName>
<Initials>AC</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Spreafico</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Selby</LastName>
<ForeName>Heather M</ForeName>
<Initials>HM</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Britt</LastName>
<ForeName>Blair C</ForeName>
<Initials>BC</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bagby</LastName>
<ForeName>Stacey M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arcaroli</LastName>
<ForeName>John J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Messersmith</LastName>
<ForeName>Wells A</ForeName>
<Initials>WA</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pitts</LastName>
<ForeName>Todd M</ForeName>
<Initials>TM</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eckhardt</LastName>
<ForeName>S Gail</ForeName>
<Initials>SG</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 CA046934</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Oncotarget</MedlineTA>
<NlmUniqueID>101532965</NlmUniqueID>
<ISSNLinking>1949-2553</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">MEK</Keyword>
<Keyword MajorTopicYN="N">TAK-733</Keyword>
<Keyword MajorTopicYN="N">colorectal cancer</Keyword>
<Keyword MajorTopicYN="N">patient derived xenografts</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26564759</PMID>
<DateCreated>
<Year>2015</Year>
<Month>11</Month>
<Day>13</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">2375-6314</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>86</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Aerospace medicine and human performance</Title>
<ISOAbbreviation>Aerosp Med Hum Perform</ISOAbbreviation>
</Journal>
<ArticleTitle>Development and Validation of the Cognition Test Battery for Spaceflight.</ArticleTitle>
<Pagination>
<MedlinePgn>942-52</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3357/AMHP.4343.2015</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sustained high-level cognitive performance is of paramount importance for the success of space missions, which involve environmental, physiological, and psychological stressors that may affect brain functions. Despite subjective symptom reports of cognitive fluctuations in spaceflight, the nature of neurobehavioral functioning in space has not been clarified.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We developed a computerized cognitive test battery (Cognition) that has sensitivity to multiple cognitive domains and was specifically designed for the high-performing astronaut population. Cognition consists of 15 unique forms of 10 neuropsychological tests that cover a range of cognitive domains, including emotion processing, spatial orientation, and risk decision making. Cognition is based on tests known to engage specific brain regions as evidenced by functional neuroimaging. Here we describe the first normative and acute total sleep deprivation data on the Cognition test battery as well as several efforts underway to establish the validity, sensitivity, feasibility, and acceptability of Cognition.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Practice effects and test-retest variability differed substantially between the 10 Cognition tests, illustrating the importance of normative data that both reflect practice effects and differences in stimulus set difficulty in the population of interest. After one night without sleep, medium to large effect sizes were observed for 3 of the 10 tests addressing vigilant attention (Cohen's d = 1.00), cognitive throughput (d = 0.68), and abstract reasoning (d = 0.65).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In addition to providing neuroimaging-based novel information on the effects of spaceflight on a range of cognitive functions, Cognition will facilitate comparing the effects of ground-based analogues to spaceflight, increase consistency across projects, and thus enable meta-analyses.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Basner</LastName>
<ForeName>Mathias</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Division of Sleep and Chronobiology, Department of Psychiatry, and the Behavior Laboratory, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Savitt</LastName>
<ForeName>Adam</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Moore</LastName>
<ForeName>Tyler M</ForeName>
<Initials>TM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Port</LastName>
<ForeName>Allison M</ForeName>
<Initials>AM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>McGuire</LastName>
<ForeName>Sarah</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ecker</LastName>
<ForeName>Adrian J</ForeName>
<Initials>AJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nasrini</LastName>
<ForeName>Jad</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mollicone</LastName>
<ForeName>Daniel J</ForeName>
<Initials>DJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mott</LastName>
<ForeName>Christopher M</ForeName>
<Initials>CM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>McCann</LastName>
<ForeName>Thom</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dinges</LastName>
<ForeName>David F</ForeName>
<Initials>DF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gur</LastName>
<ForeName>Ruben C</ForeName>
<Initials>RC</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 NR004281</GrantID>
<Acronym>NR</Acronym>
<Agency>NINR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01NR00428</GrantID>
<Acronym>NR</Acronym>
<Agency>NINR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Aerosp Med Hum Perform</MedlineTA>
<NlmUniqueID>101654770</NlmUniqueID>
<ISSNLinking>2375-6314</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CitationSubset>S</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26083773</PMID>
<DateCreated>
<Year>2015</Year>
<Month>11</Month>
<Day>17</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1530-0315</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>47</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Medicine and science in sports and exercise</Title>
<ISOAbbreviation>Med Sci Sports Exerc</ISOAbbreviation>
</Journal>
<ArticleTitle>Physical Activity, Physical Fitness, and Leukocyte Telomere Length: The Cardiovascular Health Study.</ArticleTitle>
<Pagination>
<MedlinePgn>2525-34</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1249/MSS.0000000000000720</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The influence of physical activity (PA) and physical fitness (PF) at older ages on changes in telomere length (TL)-repetitive DNA sequences that may mark biologic aging-is not well-established. Few prior studies (mainly cross-sectional) have been conducted in older adults, and few studies have evaluated PF.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We investigated cross-sectional and prospective associations of PA and PF with leukocyte TL among 582 older adults (mean ± SD age, 73 ± 5 yr at baseline) in the Cardiovascular Health Study, with serial TL measures and PA and PF assessed multiple times. Cross-sectional associations were assessed using multivariable repeated-measures regression, in which cumulatively averaged PA and PF measures were related to TL. Longitudinal analyses assessed cumulatively averaged PA and PF against later changes in TL, and changes in cumulatively averaged PA and PF against changes in TL.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Cross-sectionally, greater walking distance and chair test performance, but not other PA and PF measures, were each associated with longer TL (P trend = 0.007 and 0.04, respectively). In longitudinal analyses, no significant associations of baseline PA and PF with change in TL were observed. In contrast, changes in leisure-time activity and chair test performance were each inversely associated with changes in TL.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Cross-sectional analyses suggest that greater PA and PF are associated with longer TL. Prospective analyses show that changes in PA and PF are associated with differences in changes in TL. Even later in life, changes in certain PA and PF measures are associated with changes in TL, suggesting that leisure-time activity and fitness could reduce leukocyte telomere attrition among older adults.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Soares-Miranda</LastName>
<ForeName>Luisa</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>1Research Center in Physical Activity Health and Leisure, Faculty of Sport, University of Porto, Porto, PORTUGAL; 2MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UNITED KINGDOM; 3New York Academy of Medicine, New York, NY; 4Department of Epidemiology, University of Washington, Seattle, WA; 5Department of Pathology, University of Vermont College of Medicine, Burlington, VT; and 6Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Imamura</LastName>
<ForeName>Fumiaki</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Siscovick</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jenny</LastName>
<ForeName>Nancy Swords</ForeName>
<Initials>NS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fitzpatrick</LastName>
<ForeName>Annette L</ForeName>
<Initials>AL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mozaffarian</LastName>
<ForeName>Dariush</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>HHSN268200800007C</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HHSN268201200036C</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>MC_UU_12015/5</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>N01HC55222</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>N01HC85079</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>N01HC85080</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>N01HC85081</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>N01HC85082</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>N01HC85083</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>N01HC85086</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AG023629</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 HL080295</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Med Sci Sports Exerc</MedlineTA>
<NlmUniqueID>8005433</NlmUniqueID>
<ISSNLinking>0195-9131</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2009 May 26;106(21):8665-70</RefSource>
<PMID Version="1">19433800</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Med Sci Sports Exerc. 2009 Jul;41(7):1510-30</RefSource>
<PMID Version="1">19516148</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Geriatr Med. 2009 Nov;25(4):677-702, viii-ix</RefSource>
<PMID Version="1">19944267</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 2010 Jan 20;303(3):250-7</RefSource>
<PMID Version="1">20085953</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mech Ageing Dev. 2010 Feb;131(2):165-7</RefSource>
<PMID Version="1">20064545</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Aging (Albany NY). 2009 Jan;1(1):81-8</RefSource>
<PMID Version="1">20195384</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2010 Mar 18;29(11):1561-5</RefSource>
<PMID Version="1">20237481</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Clin Nutr. 2010 May;91(5):1273-80</RefSource>
<PMID Version="1">20219960</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2010;5(5):e10837</RefSource>
<PMID Version="1">20520771</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Aging Cell. 2010 Aug;9(4):607-15</RefSource>
<PMID Version="1">20560902</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pediatr. 2011 Feb;158(2):215-20</RefSource>
<PMID Version="1">20855079</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Epidemiol. 1995 Jul;5(4):270-7</RefSource>
<PMID Version="1">8520708</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Clin Nutr Metab Care. 2011 Jan;14(1):28-34</RefSource>
<PMID Version="1">21102320</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2011 Feb 17;470(7334):342-3</RefSource>
<PMID Version="1">21307852</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gerontol A Biol Sci Med Sci. 2011 Apr;66(4):421-9</RefSource>
<PMID Version="1">21289018</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2011;6(6):e21485</RefSource>
<PMID Version="1">21720548</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 2012 Mar 1;175(5):414-22</RefSource>
<PMID Version="1">22302075</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gerontol A Biol Sci Med Sci. 2012 Apr;67(4):409-16</RefSource>
<PMID Version="1">21934123</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mech Ageing Dev. 2012 May;133(5):275-81</RefSource>
<PMID Version="1">22449406</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oxid Med Cell Longev. 2012;2012:756132</RefSource>
<PMID Version="1">22701757</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Menopause. 2012 Oct;19(10):1109-15</RefSource>
<PMID Version="1">22668817</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Gerontol. 2013 Jan;48(1):81-4</RefSource>
<PMID Version="1">22386580</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2013 Jun 6;153(6):1194-217</RefSource>
<PMID Version="1">23746838</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2013 Jul;41(13):e131</RefSource>
<PMID Version="1">23671336</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sci Rep. 2013;3:2401</RefSource>
<PMID Version="1">23929129</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Sports Med. 2014 Oct;48(19):1407-9</RefSource>
<PMID Version="1">25185586</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Rejuvenation Res. 2015 Feb;18(1):57-89</RefSource>
<PMID Version="1">25431878</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Mol Med. 2015 Apr;21(4):203-5</RefSource>
<PMID Version="1">25725977</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Vasc Res. 2000 Jan-Feb;37(1):8-15; discussion 68-70</RefSource>
<PMID Version="1">10720881</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Atherosclerosis. 2000 Oct;152(2):391-8</RefSource>
<PMID Version="1">10998467</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Anat. 2000 Nov;197 Pt 4:539-41</RefSource>
<PMID Version="1">11197526</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2001 Feb 13;56(3):368-75</RefSource>
<PMID Version="1">11171903</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hypertension. 2001 Feb;37(2 Pt 2):381-5</RefSource>
<PMID Version="1">11230304</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Chronic Dis. 1978;31(12):741-55</RefSource>
<PMID Version="1">748370</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Epidemiol. 1991 Feb;1(3):263-76</RefSource>
<PMID Version="1">1669507</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Epidemiol. 1993 Jul;3(4):358-66</RefSource>
<PMID Version="1">8275211</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 1997 Jun 1;145(11):977-86</RefSource>
<PMID Version="1">9169906</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sci Aging Knowledge Environ. 2004 Dec 22;2004(51):pe43</RefSource>
<PMID Version="1">15618136</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes Care. 2006 Feb;29(2):283-9</RefSource>
<PMID Version="1">16443874</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 2007 Jan 1;165(1):14-21</RefSource>
<PMID Version="1">17043079</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Med Sci Sports Exerc. 2007 Oct;39(10):1714-9</RefSource>
<PMID Version="1">17909397</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Intern Med. 2008 Jan 28;168(2):154-8</RefSource>
<PMID Version="1">18227361</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mech Ageing Dev. 2008 May;129(5):254-60</RefSource>
<PMID Version="1">18295822</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circulation. 2008 Aug 19;118(8):800-7</RefSource>
<PMID Version="1">18678768</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Med Sci Sports Exerc. 2008 Oct;40(10):1764-71</RefSource>
<PMID Version="1">18799986</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Intern Med. 2008 Oct 27;168(19):2163-4</RefSource>
<PMID Version="1">18955647</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Oncol. 2008 Nov;9(11):1048-57</RefSource>
<PMID Version="1">18799354</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Genet. 2009 Feb;5(2):e1000375</RefSource>
<PMID Version="1">19214207</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">EMS63842 [Available on 06/01/16]</OtherID>
<OtherID Source="NLM">PMC4648672 [Available on 06/01/16]</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26423942</PMID>
<DateCreated>
<Year>2015</Year>
<Month>11</Month>
<Day>20</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1098-5514</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>89</Volume>
<Issue>24</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>MDA5 Is Critical to Host Defense during Infection with Murine Coronavirus.</ArticleTitle>
<Pagination>
<MedlinePgn>12330-40</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.01470-15</ELocationID>
<Abstract>
<AbstractText Label="UNLABELLED">Infection with the murine coronavirus mouse hepatitis virus (MHV) activates the pattern recognition receptors melanoma differentiation-associated gene 5 (MDA5) and Toll-like receptor 7 (TLR7) to induce transcription of type I interferon. Type I interferon is crucial for control of viral replication and spread in the natural host, but the specific contributions of MDA5 signaling to this pathway as well as to pathogenesis and subsequent immune responses are largely unknown. In this study, we use MHV infection of the liver as a model to demonstrate that MDA5 signaling is critically important for controlling MHV-induced pathology and regulation of the immune response. Mice deficient in MDA5 expression (MDA5(-/-) mice) experienced more severe disease following MHV infection, with reduced survival, increased spread of virus to additional sites of infection, and more extensive liver damage than did wild-type mice. Although type I interferon transcription decreased in MDA5(-/-) mice, the interferon-stimulated gene response remained intact. Cytokine production by innate and adaptive immune cells was largely intact in MDA5(-/-) mice, but perforin induction by natural killer cells and levels of interferon gamma, interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-α) in serum were elevated. These data suggest that MDA5 signaling reduces the severity of MHV-induced disease, at least in part by reducing the intensity of the proinflammatory cytokine response.</AbstractText>
<AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Multicellular organisms employ a wide range of sensors to detect viruses and other pathogens. One such sensor, MDA5, detects viral RNA and triggers induction of type I interferons, chemical messengers that induce inflammation and help regulate the immune responses. In this study, we sought to determine the role of MDA5 during infection with mouse hepatitis virus, a murine coronavirus used to model viral hepatitis as well as other human diseases. We found that mice lacking the MDA5 sensor were more susceptible to infection than were mice with MDA5 and experienced decreased survival. Viral replication in the liver was similar in mice with and without MDA5, but liver damage was increased in MDA5(-/-) mice, suggesting that the immune response is causing the damage. Production of several proinflammatory cytokines was elevated in MDA5(-/-) mice, suggesting that MDA5 may be responsible for keeping pathological inflammatory responses in check.</AbstractText>
<CopyrightInformation>Copyright © 2015, American Society for Microbiology. All Rights Reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zalinger</LastName>
<ForeName>Zachary B</ForeName>
<Initials>ZB</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Elliott</LastName>
<ForeName>Ruth</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rose</LastName>
<ForeName>Kristine M</ForeName>
<Initials>KM</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Weiss</LastName>
<ForeName>Susan R</ForeName>
<Initials>SR</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-8155-4528</Identifier>
<AffiliationInfo>
<Affiliation>Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA weisssr@upenn.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 AI060021</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 NS007180</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2001 Mar;75(5):2452-7</RefSource>
<PMID Version="1">11160748</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunity. 2001 Apr;14(4):461-70</RefSource>
<PMID Version="1">11336691</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2002 Feb 1;168(3):1204-11</RefSource>
<PMID Version="1">11801656</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):637-42</RefSource>
<PMID Version="1">11805321</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Virology. 1995 Apr 1;208(1):173-9</RefSource>
<PMID Version="1">11831697</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2003 Apr;77(8):4972-8</RefSource>
<PMID Version="1">12663803</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2003 May 29;423(6939):506-11</RefSource>
<PMID Version="1">12724780</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2004 Mar 4;23(9):1789-800</RefSource>
<PMID Version="1">14676839</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 1984 May;34(5):597-603</RefSource>
<PMID Version="1">6324031</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lab Anim Sci. 1986 Apr;36(2):130-5</RefSource>
<PMID Version="1">3009966</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 1989 Feb 1;142(3):954-8</RefSource>
<PMID Version="1">2783605</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Immunol. 1992 Apr;4(2):121-7</RefSource>
<PMID Version="1">1617166</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Virology. 1994 Apr;200(1):1-10</RefSource>
<PMID Version="1">8128613</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 1995 Dec;69(12):8127-31</RefSource>
<PMID Version="1">7494335</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Med. 1997 Oct 6;186(7):989-97</RefSource>
<PMID Version="1">9314549</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 1998 Aug;153(2):417-28</RefSource>
<PMID Version="1">9708802</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Biochem. 1998;67:227-64</RefSource>
<PMID Version="1">9759489</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 1999 Apr;103(8):1201-9</RefSource>
<PMID Version="1">10207172</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 1999 Jun 15;162(12):7358-68</RefSource>
<PMID Version="1">10358187</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 1999 Sep;73(9):7752-60</RefSource>
<PMID Version="1">10438865</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2005 Mar;79(6):3370-81</RefSource>
<PMID Version="1">15731231</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2005 Apr 15;174(8):4465-9</RefSource>
<PMID Version="1">15814665</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Med. 2005 Sep 5;202(5):637-50</RefSource>
<PMID Version="1">16129706</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Microbiol. 2006 Feb;4(2):121-32</RefSource>
<PMID Version="1">16415928</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2006 Feb 9;439(7077):682-7</RefSource>
<PMID Version="1">16382236</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2006 May 4;441(7089):101-5</RefSource>
<PMID Version="1">16625202</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Microbes Infect. 2006 Jul;8(8):2013-20</RefSource>
<PMID Version="1">16797201</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2007 Feb 1;109(3):1131-7</RefSource>
<PMID Version="1">16985170</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2008 Jan;82(1):300-10</RefSource>
<PMID Version="1">17928334</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2008 Jan;82(1):335-45</RefSource>
<PMID Version="1">17942531</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2658-63</RefSource>
<PMID Version="1">18268348</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2008 Jun 1;180(11):7506-15</RefSource>
<PMID Version="1">18490751</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2008 Jun 1;180(11):7553-7</RefSource>
<PMID Version="1">18490756</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2008 Jul;4(7):e1000108</RefSource>
<PMID Version="1">18636103</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2008 Oct;82(20):9829-38</RefSource>
<PMID Version="1">18667505</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Autoimmun Rev. 2008 Dec;8(2):107-11</RefSource>
<PMID Version="1">18700171</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2741-6</RefSource>
<PMID Version="1">19202065</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunol Rev. 2009 May;229(1):12-26</RefSource>
<PMID Version="1">19426212</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Immunol. 2009 Sep;9(9):645-55</RefSource>
<PMID Version="1">19696766</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Immunol. 2010 Jun;22(3):397-401</RefSource>
<PMID Version="1">20427170</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2010 Nov;84(21):11030-44</RefSource>
<PMID Version="1">20739537</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Adv Virus Res. 2011;81:85-164</RefSource>
<PMID Version="1">22094080</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2012 Feb;86(3):1531-43</RefSource>
<PMID Version="1">22090123</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2013;9(7):e1003504</RefSource>
<PMID Version="1">23874205</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunity. 2013 Jul 25;39(1):123-35</RefSource>
<PMID Version="1">23871209</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2013 Nov;87(21):11401-15</RefSource>
<PMID Version="1">23966390</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">PMC4665247 [Available on 06/15/16]</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26619116</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>09</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">2235-3186</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>131</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Nephron</Title>
<ISOAbbreviation>Nephron</ISOAbbreviation>
</Journal>
<ArticleTitle>The Role of Energy Regulation in the Tubular Epithelial Cell Response to Sepsis.</ArticleTitle>
<Pagination>
<MedlinePgn>255-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1159/000437278</ELocationID>
<Abstract>
<AbstractText>Sepsis is considered today a major public health problem. Despite that mortality has been consistently associated with organ compromise, the mechanisms by which sepsis causes multiple organ dysfunction are not well understood, and hence, therapy remains reactive and non-specific. Recent studies have challenged previous paradigms by demonstrating that acute kidney injury can occur in the setting of a normal or an even increased renal blood flow, and that it is characterized by tubular injury and not by necrosis or apoptosis. This finding suggests that mechanisms other than hypoperfusion may be at play, and that adaptive responses of the tubular epithelial cell may be key to understanding the origin of organ dysfunction in the setting of sepsis. In this review, we discuss evidence suggesting that the activation of energy regulatory processes and mitochondrial quality control processes may not only be drivers of this response, but also be factors that may alter the course of organ dysfunction during sepsis in clinically relevant ways. </AbstractText>
<CopyrightInformation>© 2015 S. Karger AG, Basel.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gómez</LastName>
<ForeName>Hernando</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Center for Critical Care Nephrology, The CRISMA Center, Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pa., USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jin</LastName>
<ForeName>Kui</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kellum</LastName>
<ForeName>John A</ForeName>
<Initials>JA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K12 HL109068</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Nephron</MedlineTA>
<NlmUniqueID>0331777</NlmUniqueID>
<ISSNLinking>1660-8151</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">NIHMS744163 [Available on 12/01/16]</OtherID>
<OtherID Source="NLM">PMC4691208 [Available on 12/01/16]</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26668916</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>14</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1120-9763</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>39</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Epidemiologia e prevenzione</Title>
<ISOAbbreviation>Epidemiol Prev</ISOAbbreviation>
</Journal>
<ArticleTitle>[Trends in occurrence, treatment, and outcomes of acute myocardial infarction in Tuscany Region (Central Italy), 1997-2010].</ArticleTitle>
<Pagination>
<MedlinePgn>167-75</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">to describe trends in attack rate, treatment, and outcomes of acute myocardial infarction (AMI) in Tuscany Region (Central Italy).</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">population-based epidemiological study using the Tuscany Acute Myocardial Infarction Registry.</AbstractText>
<AbstractText Label="SETTING AND PARTICIPANTS" NlmCategory="METHODS">cases have been identified by record linkage between the hospital discharge database and the mortality registry, and divided into hospitalised AMI (1997-2012) and out-of-hospital coronary deaths (1997-2010). Details on hospitalised cases based on the presence/absence of ST-segment elevation (STEMI / NSTEMI) can be detected for the period 2001-2012.</AbstractText>
<AbstractText Label="MAIN OUTCOMEMEASURES" NlmCategory="UNASSIGNED">distribution by calendar time, gender, and type of event of absolute frequencies, age-standardised attack rates (per 100,000; standard Tuscany population, 2001) and percentages (standard: total hospitalised cases in 2011) of invasive cardiac procedures and 28-day case fatality in hospitalised cases.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">a reduction in both out-of-hospital coronary deaths and STEMI hospitalisations (attack rates, respectively, - 2.3% and -3.9% in males, -3.3% and -4.1% in females) and an increase in NSTEMI hospitalisations (+13.1% in males and +13.3% in females) were shown. The use of invasive cardiac procedures (PCI, coronary angiography) in hospitalised cases shows a considerable increase over time both in STEMI and in NSTEMI. The proportion, however, always remains lower in the whole period after the age of 70 and in women. The short term prognosis in hospitalised AMI cases shows an improvement over time, which, however, disappears when stratified by type of AMI. This trend is mainly related to the different weight that STEMI and NSTEMI have on incidence over time (increase in attack rates for NSTEMI and reduction for STEMI, with worst prognosis).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">results confirm the important changes in epidemiology, clinical presentation, and treatment of acute coronary disease in Tuscany, previously identified in the international literature. Differences in coronary reperfusion treatment of hospitalised cases still persist by age and gender. Additional efforts are needed to ensure equity in access to the best treatment for AMI.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Barchielli</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Profili</LastName>
<ForeName>Francesco</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Balzi</LastName>
<ForeName>Daniela</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Francesconi</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zuppiroli</LastName>
<ForeName>Alfredo</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cipriani</LastName>
<ForeName>Francesco</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Trend temporali di occorrenza, trattamento ed esiti dell’infarto miocardico acuto in Toscana, 1997-2010.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Epidemiol Prev</MedlineTA>
<NlmUniqueID>8902507</NlmUniqueID>
<ISSNLinking>1120-9763</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26668917</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>14</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1120-9763</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>39</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Epidemiologia e prevenzione</Title>
<ISOAbbreviation>Epidemiol Prev</ISOAbbreviation>
</Journal>
<ArticleTitle>[Childhood cancer incidence in Apulia Region (Southern Italy), 2003-2008].</ArticleTitle>
<Pagination>
<MedlinePgn>176-82</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">to investigate, for the first time, the incidence rates of malignant childhood cancers (children aged 0-14 years) in Apulia Region (Southern Italy) in the period 2003-2008.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">to compute incidence rates of childhood cancers from Apulia Region Cancer Registry database compared with the corresponding results published in 2012 by the Italian cancer registries network (AIRTUM),where data from the Apulia population were not included, because not available.</AbstractText>
<AbstractText Label="SETTING AND PARTICIPANTS" NlmCategory="METHODS">we selected all incident cases of malignant tumours (behaviour: /3 of ICD-O-3 classification) in children aged 0-14 registered in the Apulia cancer registry. Local health unit (LHU) of Lecce (section of the Apulia cancer registry) collected data from 2003 to 2006; LHU of Taranto, BT, and Brindisi collected data from 2006 to 2008.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">we computed crude, age specific, and directly standardised rates (DSR), with 95% confidence intervals, of all malignant tumours, all categories and 5 subgroups of the ICCC-3 classification; standardised incidence ratios (SIR) for all childhood malignant tumours using the rates of the AIRTUM Pool 2003-2008 as reference .</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">incident cases were 183. DSR (x106) of all childhood malignant tumours are: Apulia Region 169.7 (95%CI 145.9- 196.4); Brindisi 160.4 (95%CI 106.2-232.9); BT 177.7 (95%CI 122.7-248.7); Lecce 144.3 (95%CI 111.1-184.2); Taranto 216.2 (95%CI 163.0-281.4). SIR estimates are: Apulia Region 102.9 (95%CI 88.5-119.0); Brindisi 100.2 (95%CI 66.6-144.9); BT 105.4 (95%CI 73.0-147.2); Lecce 85.5 (95%CI 66.0-109.0); Taranto 134.6 (95%CI 101.7-174.8). Main incidence measures for all ICCC-3 categories and five subgroups of childhood cancers in Apulia are also reported.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">in Apulia Region, we estimated a DSR for all childhood malignant tumours very close to that of the AIRTUM Pool. DSRs for each ICCC-3 category look comparable with the data from the national survey too. When data of each LHU were analysed, the SIR estimate makes it evident an excess of all malignant childhood cancers in the LHU of Taranto. Other results of particular cancers and specific age groups also provide suggestions for further investigations.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cannone</LastName>
<ForeName>Grazia Antonella</ForeName>
<Initials>GA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lo Monaco</LastName>
<ForeName>Maria Giovanna Burgio</ForeName>
<Initials>MG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Carone</LastName>
<ForeName>Simona</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Melcarne</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tanzarella</LastName>
<ForeName>Margherita</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bisceglia</LastName>
<ForeName>Lucia</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ardizzone</LastName>
<ForeName>Antonino</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Minerba</LastName>
<ForeName>Sante</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Quarta</LastName>
<ForeName>Fabrizio</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Coviello</LastName>
<ForeName>Vincenzo</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<CollectiveName>Gruppo di lavoro Registro tumori Puglia</CollectiveName>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Incidenza dei tumori maligni infantili in Puglia, 2003-2008.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Epidemiol Prev</MedlineTA>
<NlmUniqueID>8902507</NlmUniqueID>
<ISSNLinking>1120-9763</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26668918</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>14</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1120-9763</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>39</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Epidemiologia e prevenzione</Title>
<ISOAbbreviation>Epidemiol Prev</ISOAbbreviation>
</Journal>
<ArticleTitle>[Confirmation of an excess of cancer mortality in a cohort of workers of a chromium thin-layer plating].</ArticleTitle>
<Pagination>
<MedlinePgn>183-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">to extend up to year 2013 the follow-up for mortality of a cohort of workers in a chromium and nickel plating plant, where an excess of lung cancers was already identified.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">10 years after the first study about cancer mortality in a cohort of workers involved in the chromium thin-layer plating, published in 2006, we updated the evaluation of themortality of a cohort ofworkers employed in the same chromiumthin-layer plating factory with at least 6 months of work between 1968 and 1994.The mortality rates are compared with those of the Italian and Veneto Region (Northern Italy) populations.The dose-response relationship between work duration and lung cancer is assessed by adjusted Poisson regression.</AbstractText>
<AbstractText Label="SETTING AND PARTICIPANTS" NlmCategory="METHODS">127 unskilled or skilled workers involved in the production process.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">in the updated follow-up, 35 deaths occurred among the subjects under study: 19 for cancer (of which 11 for lung cancer and 3 for pancreatic cancer). A marked excess ofmortality due to lung cancer is observed. In addition, the newfollowup shows a significant excess of pancreatic cancer mortality. Lung cancer mortality is positively associated with work duration and the risk increases by 13%(95%CI 1-26) for each additional year of work.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">the extension of followup confirms that this cohort expresses an increased mortality from cancer deaths, due to a marked excess of lung and pancreatic cancers. The effect of smoking has only a secondary effect in the cancer onset expressed by this cohort. The risk of lung cancer increased with work duration and thus with occupational exposure to chromium and nickel.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Girardi</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bressan</LastName>
<ForeName>Vittoria</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mabilia</LastName>
<ForeName>Tommy</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Merler</LastName>
<ForeName>Enzo</ForeName>
<Initials>E</Initials>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Conferma di un eccesso di mortalità per tumori in una coorte di addetti a cromatura a strato sottile.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Epidemiol Prev</MedlineTA>
<NlmUniqueID>8902507</NlmUniqueID>
<ISSNLinking>1120-9763</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26668919</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>14</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1120-9763</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>39</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Epidemiologia e prevenzione</Title>
<ISOAbbreviation>Epidemiol Prev</ISOAbbreviation>
</Journal>
<ArticleTitle>[Reducing non-communicable diseases and health care costs: building a prevention alliance].</ArticleTitle>
<Pagination>
<MedlinePgn>202-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>In Italy, as well as in most European Countries, the loss of almost 70% of the years of life is attributable to cerebro-cardiovascular diseases and cancers. Whereas the Italian population is expected to grow older, with a significant increase in the burden of chronic non-communicable diseases, the reduction in incidence of chronic diseases and the compression of morbidity are priorities. This is the reason why in Italy the implementation of the National Plan for Prevention and related regional plans becomes necessary, as it can promote the co-operation of multidisciplinary skills in several areas: political, health, economic, legal, sociological. In Piedmont (Northern Italy), it seems useful the creation of a regional Laboratory of prevention,which provides support for the development and implementation of the regional prevention plan, through actions and programmes based on cost-effectiveness analyses. The use of resources in prevention should not be exclusively interpreted as a cost, but as an investment, which, in some cases, can become an avoided cost. Using prevention policies makes it possible to gain years of healthy life and to potentially reduce the cost of healthcare system. The creation of the Laboratory of prevention is a multidisciplinary context, so it is an opportunity to involve the stakeholders in order to achieve the regional health objectives.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Piccinelli</LastName>
<ForeName>Cristiano</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pagano</LastName>
<ForeName>Eva</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Segnan</LastName>
<ForeName>Nereo</ForeName>
<Initials>N</Initials>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Un laboratorio di prevenzione quale strumento per ridurre le malattie croniche non trasmissibili e la spesa sanitaria.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Epidemiol Prev</MedlineTA>
<NlmUniqueID>8902507</NlmUniqueID>
<ISSNLinking>1120-9763</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26668920</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>14</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1120-9763</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>39</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Epidemiologia e prevenzione</Title>
<ISOAbbreviation>Epidemiol Prev</ISOAbbreviation>
</Journal>
<ArticleTitle>[Economic difficulties keep on influencing early diagnosis of colorectal cancer].</ArticleTitle>
<Pagination>
<MedlinePgn>210</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Carrozzi</LastName>
<ForeName>Giuliano</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sampaolo</LastName>
<ForeName>Letizia</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bolognesi</LastName>
<ForeName>Lara</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bertozzi</LastName>
<ForeName>Nicoletta</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sardonini</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ferrante</LastName>
<ForeName>Gianluigi</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Quarchioni</LastName>
<ForeName>Elisa</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Masocco</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<CollectiveName>Gruppo Tecnico PASSI</CollectiveName>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Le difficoltà economiche continuano a influenzare la diagnosi precoce dei tumori del colon retto.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Epidemiol Prev</MedlineTA>
<NlmUniqueID>8902507</NlmUniqueID>
<ISSNLinking>1120-9763</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26668921</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>14</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1120-9763</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>39</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Epidemiologia e prevenzione</Title>
<ISOAbbreviation>Epidemiol Prev</ISOAbbreviation>
</Journal>
<ArticleTitle>[Léonard Defrance and occupational health in 18th century art].</ArticleTitle>
<Pagination>
<MedlinePgn>211</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Carnevale</LastName>
<ForeName>Franco</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Léonard Defrance e la salute dei lavoratori nell'arte settecentesca.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Epidemiol Prev</MedlineTA>
<NlmUniqueID>8902507</NlmUniqueID>
<ISSNLinking>1120-9763</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26668922</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>14</Day>
</DateCreated>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1120-9763</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>39</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Epidemiologia e prevenzione</Title>
<ISOAbbreviation>Epidemiol Prev</ISOAbbreviation>
</Journal>
<ArticleTitle>[Analysis of psychological distress between the paediatric population immigrant and resident in a Local Health Unit of Milan Province (Northern Italy)].</ArticleTitle>
<Pagination>
<MedlinePgn>188-97</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">to figure out if there are differences in access to psychiatric services between Italian and immigrant paediatric populations.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">we analysed the data of the year 2012 from the Banca dati del disagio psichico, a database on psychological distress created by the Epidemiological Unit of the Local Health Unit Milan 1 (Lombardy, Northern Italy). The database is based on a data warehouse system that integrates health and social data, and gives the opportunity to calculate the prevalence rates of the main clusters of psychiatric diseases according to ICD-10 categories.</AbstractText>
<AbstractText Label="SETTING AND PARTICIPANTS" NlmCategory="METHODS">the sample includes 162,197 residents younger than 18 years (minors), divided into 4 subgroups depending on the place of birth (Italy or abroad) and citizenship (Italian or foreign).</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">we calculated the standardised treated prevalence of the 11 clusters of mental diseases in the 4 subgroups and evaluated the Standardised Prevalence Ratio (SPR) and their confidence intervals using as reference the Italian paediatric population with Italian citizenship.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">in 2012, 7.2%minors were diagnosed a mental illness or accessed mental health services or were prescribed psychotropic medicines. We found the lowest SPRs of psychiatric illnesses in immigrants (0.91 born in Italy; 0.74 born abroad) and the higher in Italians born in foreign Countries (1.34). In particular, migrant minors born in Italy have lower SPR of developmental disorders (0.84) and behaviour and emotional disorders (0.68), but higher SPR of mental retardation (1.52) and anxiety disorders (1.36). Migrant minors born abroad have lower SPR of developmental disorders (0.52), but higher rates of mental retardation (1.30). Italians born in foreign Countries show a SPR for personality disorders and mental retardation of 4.86 and 2.02, respectively.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">immigrant minors have a lower prevalence of psychiatric diseases than Italian minors; however, Italians born in foreign Countries show a higher prevalence of psychiatric disorders.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gattoni</LastName>
<ForeName>Maria Elena</ForeName>
<Initials>ME</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Andreoni</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fonte</LastName>
<ForeName>Luigi</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Russo</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Analisi del disagio psichico nella popolazione pediatrica immigrata e residente in una ASL della Provincia di Milano.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Epidemiol Prev</MedlineTA>
<NlmUniqueID>8902507</NlmUniqueID>
<ISSNLinking>1120-9763</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26668772</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>15</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">2165-8242</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>74</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Hawai'i journal of medicine &amp; public health : a journal of Asia Pacific Medicine &amp; Public Health</Title>
<ISOAbbreviation>Hawaii J Med Public Health</ISOAbbreviation>
</Journal>
<ArticleTitle>Sociocultural Factors that Affect Chewing Behaviors among Betel Nut Chewers and Ex-Chewers on Guam.</ArticleTitle>
<Pagination>
<MedlinePgn>406-11</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Areca nut (betel nut) is chewed by an estimated 10% of the world's population which is equivalent to about 600 million people. It is classified as a Group 1 carcinogen by the World Health Organization (WHO) and has been linked to various types of oral cancer. Chewing areca predominates in South and South East Asia, East Africa, and the Western Pacific and has important social and cultural implications. The purpose of the pilot study was twofold: (1) to examine sociocultural factors that affect why people on Guam chew betel nut, their chewing behaviors, perceptions of risks, probability of changing behaviors, and methods that could be used to reduce use or quit; and (2) to pilot two surveys (one for chewers and one for ex-chewers) to be used in a larger study in the future. A mixed methods design was employed that included surveys pertaining to their status (chewer or ex-chewer) and in-depth interviews. A total of 30 adults participated in this pilot study: adult betel nut chewers (n = 15) and ex-chewers (n = 15). Chewing betel nut is a learned behavior, embedded within the culture, and is viewed as an important cultural identifier. Socially, chewing is viewed as positive. Chewers stated that they were not as aware of health issues; however, ex-chewers stated health reasons for quitting. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Murphy</LastName>
<ForeName>Kelle L</ForeName>
<Initials>KL</Initials>
<AffiliationInfo>
<Affiliation>Department of Kinesiology and Rehabilitation Science, University of Hawai'i at Manoa, Honolulu, HI (KLM).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Herzog</LastName>
<ForeName>Thaddeus A</ForeName>
<Initials>TA</Initials>
<AffiliationInfo>
<Affiliation>Department of Kinesiology and Rehabilitation Science, University of Hawai'i at Manoa, Honolulu, HI (KLM).</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>U54 CA143727</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Hawaii J Med Public Health</MedlineTA>
<NlmUniqueID>101579076</NlmUniqueID>
<ISSNLinking>2165-8242</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Addict Biol. 2002 Jan;7(1):77-83</RefSource>
<PMID Version="1">11900626</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Addict Biol. 2002 Jan;7(1):85-97</RefSource>
<PMID Version="1">11900627</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Addict Biol. 2002 Jan;7(1):103-10</RefSource>
<PMID Version="1">11900629</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Addict Biol. 2002 Jan;7(1):111-4</RefSource>
<PMID Version="1">11900630</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Addict Biol. 2002 Jan;7(1):127-32</RefSource>
<PMID Version="1">11900632</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Addict Biol. 2002 Jan;7(1):133-8</RefSource>
<PMID Version="1">11900633</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Addict Biol. 2002 Jan;7(1):139-46</RefSource>
<PMID Version="1">11900634</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Addict Biol. 2002 Jan;7(1):147-54</RefSource>
<PMID Version="1">11900635</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Paediatr Child Health. 2002 Oct;38(5):507-10</RefSource>
<PMID Version="1">12354270</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychol Rev. 1977 Mar;84(2):191-215</RefSource>
<PMID Version="1">847061</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Res Q Exerc Sport. 1993 Dec;64(4):453-68</RefSource>
<PMID Version="1">8278672</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>IARC Monogr Eval Carcinog Risks Hum. 2004;85:1-334</RefSource>
<PMID Version="1">15635762</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bull World Health Organ. 2005 Sep;83(9):656-60</RefSource>
<PMID Version="1">16211156</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pac Health Dialog. 2005 Mar;12(1):153-4</RefSource>
<PMID Version="1">18181481</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Clin Nutr. 2008 May;87(5):1204-11</RefSource>
<PMID Version="1">18469240</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Rural Remote Health. 2009 Apr-Jun;9(2):1118</RefSource>
<PMID Version="1">19445556</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Drug Alcohol Depend. 2012 Feb 1;121(1-2):18-22</RefSource>
<PMID Version="1">21955360</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hawaii J Med Public Health. 2012 Jan;71(1):23-6</RefSource>
<PMID Version="1">22413101</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int Nurs Rev. 2014 Mar;61(1):148-55</RefSource>
<PMID Version="1">24512263</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Drug Alcohol Depend. 2014 May 1;138:154-60</RefSource>
<PMID Version="1">24629627</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Oral Health. 2014;14:62</RefSource>
<PMID Version="1">24889863</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Oral Health. 2014;14:151</RefSource>
<PMID Version="1">25495475</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hawaii J Med Public Health. 2014 Dec;73(12):400-3</RefSource>
<PMID Version="1">25628974</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26657567</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>15</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">2045-2322</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Scientific reports</Title>
<ISOAbbreviation>Sci Rep</ISOAbbreviation>
</Journal>
<ArticleTitle>PTEN stabilizes TOP2A and regulates the DNA decatenation.</ArticleTitle>
<Pagination>
<MedlinePgn>17873</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/srep17873</ELocationID>
<Abstract>
<AbstractText>PTEN is a powerful tumor suppressor that antagonizes the cytoplasmic PI3K-AKT pathway and suppresses cellular proliferation. PTEN also plays a role in the maintenance of genomic stability in the nucleus. Here we report that PTEN facilitates DNA decatenation and controls a decatenation checkpoint. Catenations of DNA formed during replication are decatenated by DNA topoisomerase II (TOP2), and this process is actively monitored by a decatenation checkpoint in G2 phase. We found that PTEN deficient cells form ultra-fine bridges (UFBs) during anaphase and these bridges are generated as a result of insufficient decatenation. We show that PTEN is physically associated with a decatenation enzyme TOP2A and that PTEN influences its stability through OTUD3 deubiquitinase. In the presence of PTEN, ubiquitination of TOP2A is inhibited by OTUD3. Deletion or deficiency of PTEN leads to down regulation of TOP2A, dysfunction of the decatenation checkpoint and incomplete DNA decatenation in G2 and M phases. We propose that PTEN controls DNA decatenation to maintain genomic stability and integrity. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kang</LastName>
<ForeName>Xi</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Institute of Systems Biomedicine, Beijing Key Laboratory of Tumor Systems Biology, Department of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Weill Medical College of Cornell University, New York, NY 10065, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Song</LastName>
<ForeName>Chang</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Institute of Systems Biomedicine, Beijing Key Laboratory of Tumor Systems Biology, Department of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Du</LastName>
<ForeName>Xiao</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Institute of Systems Biomedicine, Beijing Key Laboratory of Tumor Systems Biology, Department of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Cong</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Institute of Systems Biomedicine, Beijing Key Laboratory of Tumor Systems Biology, Department of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Yu</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Institute of Systems Biomedicine, Beijing Key Laboratory of Tumor Systems Biology, Department of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liang</LastName>
<ForeName>Ling</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Institute of Systems Biomedicine, Beijing Key Laboratory of Tumor Systems Biology, Department of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>He</LastName>
<ForeName>Jinxue</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Weill Medical College of Cornell University, New York, NY 10065, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lamb</LastName>
<ForeName>Kristy</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Weill Medical College of Cornell University, New York, NY 10065, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shen</LastName>
<ForeName>Wen H</ForeName>
<Initials>WH</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Weill Medical College of Cornell University, New York, NY 10065, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yin</LastName>
<ForeName>Yuxin</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Institute of Systems Biomedicine, Beijing Key Laboratory of Tumor Systems Biology, Department of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Weill Medical College of Cornell University, New York, NY 10065, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Peking-Tsinghua Center for Life Sciences, Beijing, 100191, China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 GM100478</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Sci Rep</MedlineTA>
<NlmUniqueID>101563288</NlmUniqueID>
<ISSNLinking>2045-2322</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Biol. 1998 Oct 22;8(21):1169-78</RefSource>
<PMID Version="1">9799734</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1998 Oct 2;95(1):29-39</RefSource>
<PMID Version="1">9778245</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1563-8</RefSource>
<PMID Version="1">9990064</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1999 May 25;96(11):6199-204</RefSource>
<PMID Version="1">10339565</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2005 Feb;7(2):193-204</RefSource>
<PMID Version="1">15710331</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Struct Mol Biol. 2005 Jul;12(7):589-93</RefSource>
<PMID Version="1">15965487</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2005 Aug 4;436(7051):725-30</RefSource>
<PMID Version="1">16079851</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Cycle. 2005 Jul;4(7):927-9</RefSource>
<PMID Version="1">15970699</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2005 Nov 4;280(44):37041-7</RefSource>
<PMID Version="1">16100112</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2005 Dec;8(6):479-84</RefSource>
<PMID Version="1">16338661</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2006 May 25;441(7092):475-82</RefSource>
<PMID Version="1">16598206</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2007 Jan;27(2):662-77</RefSource>
<PMID Version="1">17060456</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2007 Jan 12;128(1):101-14</RefSource>
<PMID Version="1">17218258</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2007 Jan 12;128(1):157-70</RefSource>
<PMID Version="1">17218262</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Cancer. 2007 Jan 29;96(2):201-5</RefSource>
<PMID Version="1">17211475</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2007 Jul 25;26(14):3397-409</RefSource>
<PMID Version="1">17599064</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2007 Nov 15;120(Pt 22):3952-64</RefSource>
<PMID Version="1">17956945</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antioxid Redox Signal. 2008 May;10(5):939-49</RefSource>
<PMID Version="1">18162055</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Leuk Lymphoma. 2007 Nov;48(11):2221-32</RefSource>
<PMID Version="1">17926183</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Cell Biol. 2009 Feb;11(2):204-10</RefSource>
<PMID Version="1">19098900</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Cancer. 2009 May;9(5):327-37</RefSource>
<PMID Version="1">19377505</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Cell Biol. 2009 Jun;11(6):753-60</RefSource>
<PMID Version="1">19465922</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2010 Mar 1;123(Pt 5):806-13</RefSource>
<PMID Version="1">20144989</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2010 Aug 26;29(34):4787-99</RefSource>
<PMID Version="1">20562910</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2011 Jan 21;144(2):187-99</RefSource>
<PMID Version="1">21241890</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2011 Mar 4;144(5):646-74</RefSource>
<PMID Version="1">21376230</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2011 Aug 17;30(16):3309-21</RefSource>
<PMID Version="1">21743438</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell. 2011 Oct 7;44(1):97-107</RefSource>
<PMID Version="1">21981921</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Cell Dev Biol. 2011 Oct;22(8):906-12</RefSource>
<PMID Version="1">21782962</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2012 Dec 7;424(3-4):109-24</RefSource>
<PMID Version="1">22841979</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2012 Dec 10;199(6):871-81</RefSource>
<PMID Version="1">23229895</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cancer. 2013;12:21</RefSource>
<PMID Version="1">23514585</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Res. 2013 Apr;23(4):465-72</RefSource>
<PMID Version="1">23528705</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2013 May 9;153(4):910-8</RefSource>
<PMID Version="1">23643243</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2013 Dec 13;288(50):36020-8</RefSource>
<PMID Version="1">24169697</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Rep. 2014 Mar 13;6(5):844-54</RefSource>
<PMID Version="1">24561254</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2014 Apr;42(7):4414-26</RefSource>
<PMID Version="1">24476913</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Metab. 2014 May 6;19(5):836-48</RefSource>
<PMID Version="1">24768297</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Rep. 2014 Sep 25;8(6):2003-14</RefSource>
<PMID Version="1">25199838</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 2015 Jul 30;34(31):4019-31</RefSource>
<PMID Version="1">25328138</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1994 Dec 1;372(6505):467-70</RefSource>
<PMID Version="1">7984241</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1999 Oct 29;99(3):323-34</RefSource>
<PMID Version="1">10555148</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2000 Jul 1;60(13):3605-11</RefSource>
<PMID Version="1">10910075</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 2000 Oct;157(4):1097-103</RefSource>
<PMID Version="1">11021813</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 2000 Nov;20(22):8602-12</RefSource>
<PMID Version="1">11046155</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12044-9</RefSource>
<PMID Version="1">11593014</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Cancer. 2002 May 1;99(1):63-7</RefSource>
<PMID Version="1">11948493</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer. 2002 Apr 15;94(8):2239-47</RefSource>
<PMID Version="1">12001123</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 2002 Aug;161(2):439-47</RefSource>
<PMID Version="1">12163369</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mutat. 2003 Sep;22(3):183-98</RefSource>
<PMID Version="1">12938083</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Cell. 2003 Sep;4(3):209-21</RefSource>
<PMID Version="1">14522255</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Cancer. 1998 Nov;78(10):1296-300</RefSource>
<PMID Version="1">9823969</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2004 Jul 15;64(14):4826-32</RefSource>
<PMID Version="1">15256452</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Natl Cancer Inst. 2003 Dec 17;95(24):1859-68</RefSource>
<PMID Version="1">14679155</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chromosome Res. 1996 Sep;4(6):457-66</RefSource>
<PMID Version="1">8889245</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 1996 Nov 15;24(22):4464-70</RefSource>
<PMID Version="1">8948636</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 1997 Jan;17(1):389-97</RefSource>
<PMID Version="1">8972219</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Genet. 1997 Apr;15(4):356-62</RefSource>
<PMID Version="1">9090379</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 1997 Nov 15;57(22):4997-5000</RefSource>
<PMID Version="1">9371490</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncogene. 1998 Apr 2;16(13):1743-8</RefSource>
<PMID Version="1">9582022</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1998 May 29;273(22):13375-8</RefSource>
<PMID Version="1">9593664</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Genet. 1998 Aug;19(4):348-55</RefSource>
<PMID Version="1">9697695</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26621724</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>16</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1091-6490</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>112</Volume>
<Issue>50</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
<ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>
</Journal>
<ArticleTitle>Omega-3 and -6 fatty acids allocate somatic and germline lipids to ensure fitness during nutrient and oxidative stress in Caenorhabditis elegans.</ArticleTitle>
<Pagination>
<MedlinePgn>15378-83</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1514012112</ELocationID>
<Abstract>
<AbstractText>Animals in nature are continually challenged by periods of feast and famine as resources inevitably fluctuate, and must allocate somatic reserves for reproduction to abate evolutionary pressures. We identify an age-dependent lipid homeostasis pathway in Caenorhabditis elegans that regulates the mobilization of lipids from the soma to the germline, which supports fecundity but at the cost of survival in nutrient-poor and oxidative stress environments. This trade-off is responsive to the levels of dietary carbohydrates and organismal oleic acid and is coupled to activation of the cytoprotective transcription factor SKN-1 in both laboratory-derived and natural isolates of C. elegans. The homeostatic balance of lipid stores between the somatic and germ cells is mediated by arachidonic acid (omega-6) and eicosapentaenoic acid (omega-3) precursors of eicosanoid signaling molecules. Our results describe a mechanism for resource reallocation within intact animals that influences reproductive fitness at the cost of somatic resilience. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lynn</LastName>
<ForeName>Dana A</ForeName>
<Initials>DA</Initials>
<AffiliationInfo>
<Affiliation>Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089; Dornsife College of Letters, Arts, and Sciences, Department of Molecular and Computational Biology, University of Southern California, Los Angeles, CA 90089;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dalton</LastName>
<ForeName>Hans M</ForeName>
<Initials>HM</Initials>
<AffiliationInfo>
<Affiliation>Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089; Dornsife College of Letters, Arts, and Sciences, Department of Molecular and Computational Biology, University of Southern California, Los Angeles, CA 90089;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sowa</LastName>
<ForeName>Jessica N</ForeName>
<Initials>JN</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular and Human Genetics, Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Meng C</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular and Human Genetics, Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Soukas</LastName>
<ForeName>Alexander A</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>Center for Human Genetic Research and Diabetes Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Curran</LastName>
<ForeName>Sean P</ForeName>
<Initials>SP</Initials>
<AffiliationInfo>
<Affiliation>Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089; Dornsife College of Letters, Arts, and Sciences, Department of Molecular and Computational Biology, University of Southern California, Los Angeles, CA 90089; spcurran@usc.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 GM109028</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
<NlmUniqueID>7505876</NlmUniqueID>
<ISSNLinking>0027-8424</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">PMC4687584</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">germline</Keyword>
<Keyword MajorTopicYN="N">lipids</Keyword>
<Keyword MajorTopicYN="N">soma</Keyword>
<Keyword MajorTopicYN="N">survival</Keyword>
<Keyword MajorTopicYN="N">trade-off</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26694915</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">2197-425X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>3</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Intensive care medicine experimental</Title>
<ISOAbbreviation>Intensive Care Med Exp</ISOAbbreviation>
</Journal>
<ArticleTitle>The effects of airway pressure release ventilation on respiratory mechanics in extrapulmonary lung injury.</ArticleTitle>
<Pagination>
<MedlinePgn>35</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40635-015-0071-0</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lung injury is often studied without consideration for pathologic changes in the chest wall. In order to reduce the incidence of lung injury using preemptive mechanical ventilation, it is important to recognize the influence of altered chest wall mechanics on disease pathogenesis. In this study, we hypothesize that airway pressure release ventilation (APRV) may be able to reduce the chest wall elastance associated with an extrapulmonary lung injury model as compared with low tidal volume (LVt) ventilation.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Female Yorkshire pigs were anesthetized and instrumented. Fecal peritonitis was established, and the superior mesenteric artery was clamped for 30 min to induce an ischemia/reperfusion injury. Immediately following injury, pigs were randomized into (1) LVt (n = 3), positive end-expiratory pressure (PEEP) 5 cmH2O, V t 6 cc kg(-1), FiO2 21 %, and guided by the ARDSnet protocol or (2) APRV (n = 3), P High 16-22 cmH2O, P Low 0 cmH2O, T High 4.5 s, T Low set to terminate the peak expiratory flow at 75 %, and FiO2 21 %. Pigs were monitored continuously for 48 h. Lung samples and bronchoalveolar lavage fluid were collected at necropsy.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">LVt resulted in mild acute respiratory distress syndrome (ARDS) (PaO2/FiO2 = 226.2 ± 17.1 mmHg) whereas APRV prevented ARDS (PaO2/FiO2 = 465.7 ± 66.5 mmHg; p &lt; 0.05). LVt had a reduced surfactant protein A concentration and increased histologic injury as compared with APRV. The plateau pressure in APRV (34.3 ± 0.9 cmH2O) was significantly greater than LVt (22.2 ± 2.0 cmH2O; p &lt; 0.05) yet transpulmonary pressure between groups was similar (p &gt; 0.05). This was because the pleural pressure was significantly lower in LVt (7.6 ± 0.5 cmH2O) as compared with APRV (17.4 ± 3.5 cmH2O; p &lt; 0.05). Finally, the elastance of the lung, chest wall, and respiratory system were all significantly greater in LVt as compared with APRV (all p &lt; 0.05).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">APRV preserved surfactant and lung architecture and maintenance of oxygenation. Despite the greater plateau pressure and tidal volumes in the APRV group, the transpulmonary pressure was similar to that of LVt. Thus, the majority of the plateau pressure in the APRV group was distributed as pleural pressure in this extrapulmonary lung injury model. APRV maintained a normal lung elastance and an open, homogeneously ventilated lung without increasing lung stress.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kollisch-Singule</LastName>
<ForeName>Michaela</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY, 13210, USA. KolliscM@upstate.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Emr</LastName>
<ForeName>Bryanna</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY, 13210, USA. EmrB@upstate.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jain</LastName>
<ForeName>Sumeet V</ForeName>
<Initials>SV</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY, 13210, USA. JainSu@upstate.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Andrews</LastName>
<ForeName>Penny</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Trauma Critical Care Medicine, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD, USA. plandrews@intensivecareonline.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Satalin</LastName>
<ForeName>Joshua</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY, 13210, USA. satalinj@upstate.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Jiao</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY, 13210, USA. catherine015@163.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Porcellio</LastName>
<ForeName>Elizabeth</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY, 13210, USA. PorcellE@upstate.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kenyon</LastName>
<ForeName>Van</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY, 13210, USA. KenyonV@upstate.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Guirong</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY, 13210, USA. WangG@upstate.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marx</LastName>
<ForeName>William</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY, 13210, USA. MarxW@upstate.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gatto</LastName>
<ForeName>Louis A</ForeName>
<Initials>LA</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY, 13210, USA. Louis.Gatto@cortland.edu.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Biological Sciences, SUNY Cortland, Cortland, NY, USA. Louis.Gatto@cortland.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nieman</LastName>
<ForeName>Gary F</ForeName>
<Initials>GF</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY, 13210, USA. NiemanG@upstate.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Habashi</LastName>
<ForeName>Nader M</ForeName>
<Initials>NM</Initials>
<AffiliationInfo>
<Affiliation>Department of Trauma Critical Care Medicine, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD, USA. nmh@xmxmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Intensive Care Med Exp</MedlineTA>
<NlmUniqueID>101645149</NlmUniqueID>
<ISSNLinking>2197-425X</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688284</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Airway pressure release ventilation (APRV)</Keyword>
<Keyword MajorTopicYN="N">Chest wall elastance</Keyword>
<Keyword MajorTopicYN="N">Low tidal volume ventilation</Keyword>
<Keyword MajorTopicYN="N">Lung injury</Keyword>
<Keyword MajorTopicYN="N">Transpulmonary pressure</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702294</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1748-7188</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>10</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Algorithms for molecular biology : AMB</Title>
<ISOAbbreviation>Algorithms Mol Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>HIA: a genome mapper using hybrid index-based sequence alignment.</ArticleTitle>
<Pagination>
<MedlinePgn>30</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13015-015-0062-4</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A number of alignment tools have been developed to align sequencing reads to the human reference genome. The scale of information from next-generation sequencing (NGS) experiments, however, is increasing rapidly. Recent studies based on NGS technology have routinely produced exome or whole-genome sequences from several hundreds or thousands of samples. To accommodate the increasing need of analyzing very large NGS data sets, it is necessary to develop faster, more sensitive and accurate mapping tools.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">HIA uses two indices, a hash table index and a suffix array index. The hash table performs direct lookup of a q-gram, and the suffix array performs very fast lookup of variable-length strings by exploiting binary search. We observed that combining hash table and suffix array (hybrid index) is much faster than the suffix array method for finding a substring in the reference sequence. Here, we defined the matching region (MR) is a longest common substring between a reference and a read. And, we also defined the candidate alignment regions (CARs) as a list of MRs that is close to each other. The hybrid index is used to find candidate alignment regions (CARs) between a reference and a read. We found that aligning only the unmatched regions in the CAR is much faster than aligning the whole CAR. In benchmark analysis, HIA outperformed in mapping speed compared with the other aligners, without significant loss of mapping accuracy.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our experiments show that the hybrid of hash table and suffix array is useful in terms of speed for mapping NGS sequencing reads to the human reference genome sequence. In conclusion, our tool is appropriate for aligning massive data sets generated by NGS sequencing.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Choi</LastName>
<ForeName>Jongpill</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Division of Bio-Medical Informatics, Center for Genome Science, Korea National Institute of Health, Osong, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Park</LastName>
<ForeName>Kiejung</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Biomedical Research Institute, College of Medicine, Hanyang University, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cho</LastName>
<ForeName>Seong Beom</ForeName>
<Initials>SB</Initials>
<AffiliationInfo>
<Affiliation>Division of Bio-Medical Informatics, Center for Genome Science, Korea National Institute of Health, Osong, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chung</LastName>
<ForeName>Myungguen</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Division of Bio-Medical Informatics, Center for Genome Science, Korea National Institute of Health, Osong, Korea.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Algorithms Mol Biol</MedlineTA>
<NlmUniqueID>101265088</NlmUniqueID>
<ISSNLinking>1748-7188</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688996</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Hash table index</Keyword>
<Keyword MajorTopicYN="N">Hybrid index</Keyword>
<Keyword MajorTopicYN="N">Mapper</Keyword>
<Keyword MajorTopicYN="N">NGS</Keyword>
<Keyword MajorTopicYN="N">Sequence alignment</Keyword>
<Keyword MajorTopicYN="N">Suffix array index</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702332</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1942-2962</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>8</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>American health &amp; drug benefits</Title>
<ISOAbbreviation>Am Health Drug Benefits</ISOAbbreviation>
</Journal>
<ArticleTitle>My Kind of Town.</ArticleTitle>
<Pagination>
<MedlinePgn>409-10</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nash</LastName>
<ForeName>David B</ForeName>
<Initials>DB</Initials>
<AffiliationInfo>
<Affiliation>Editor-in-Chief, American Health &amp; Drug Benefits ; Founding Dean, Jefferson College of Population Health, Philadelphia, PA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am Health Drug Benefits</MedlineTA>
<NlmUniqueID>101479877</NlmUniqueID>
<ISSNLinking>1942-2962</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4684631</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702333</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1942-2962</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>8</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>American health &amp; drug benefits</Title>
<ISOAbbreviation>Am Health Drug Benefits</ISOAbbreviation>
</Journal>
<ArticleTitle>Characteristics of Academic Detailing: Results of a Literature Review.</ArticleTitle>
<Pagination>
<MedlinePgn>414-22</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Academic detailing is an evidence-based strategy to improve patient care. Efforts to understand the intervention and to use it strategically require an understanding of its important characteristics. A recent systematic review and a subsequent reporting framework call for more accurate and complete reporting of continuing medical education interventions.</AbstractText>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Building on a previously published systematic review of 69 studies, we sought to determine how an expanded set of 106 academic detailing studies, including many recently published articles, fared with respect to reporting of important data about this intervention.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a search of MEDLINE, the Cumulative Index to Nursing and Allied Health Literature (clinical) database, and Scopus, from which we identified 38 additional randomized controlled trials published from August 2007 through March 2013. Including the original 69 studies, we abstracted 106 available English-language studies and quantitatively analyzed information about 4 important characteristics of academic detailing: content of visits, clinicians being visited, communication process underlying visits, and outreach workers making visits.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">We found considerable variation (36.5%-100%) in the extent of reporting intervention characteristics, especially about the communication process underlying visits and the outreach workers making visits. The best overall documentation of intervention characteristics of any single study was 68%. Results also demonstrate wide variation in the approach to academic detailing.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study demonstrates the need for a standardized approach to collecting and reporting data about academic detailing interventions. Our findings also highlight opportunities for using academic detailing more effectively in research and quality-improvement efforts.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Van Hoof</LastName>
<ForeName>Thomas J</ForeName>
<Initials>TJ</Initials>
<AffiliationInfo>
<Affiliation>Associate Professor, University of Connecticut School of Nursing, Storrs, CT, and Associate Professor, Department of Community Medicine and Health Care, University of Connecticut School of Medicine, Farmington, CT.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Harrison</LastName>
<ForeName>Lisa G</ForeName>
<Initials>LG</Initials>
<AffiliationInfo>
<Affiliation>PhD candidate, University of Connecticut School of Nursing, Storrs, CT.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Miller</LastName>
<ForeName>Nicole E</ForeName>
<Initials>NE</Initials>
<AffiliationInfo>
<Affiliation>Nurse, Hartford Healthcare, Hartford, CT.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pappas</LastName>
<ForeName>Maryanne S</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>Nurse Practitioner, Division of Neuroscience, Hartford Hospital, Hartford, CT, and a PhD candidate, University of Connecticut School of Nursing, Storrs, CT.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fischer</LastName>
<ForeName>Michael A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Director, National Resource Center for Academic Detailing, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Associate Professor, Harvard Medical School, Boston, MA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am Health Drug Benefits</MedlineTA>
<NlmUniqueID>101479877</NlmUniqueID>
<ISSNLinking>1942-2962</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4684632</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">academic detailing</Keyword>
<Keyword MajorTopicYN="N">continuing education</Keyword>
<Keyword MajorTopicYN="N">continuing medical education</Keyword>
<Keyword MajorTopicYN="N">educational outreach</Keyword>
<Keyword MajorTopicYN="N">health professions education</Keyword>
<Keyword MajorTopicYN="N">narrative review</Keyword>
<Keyword MajorTopicYN="N">quality improvement</Keyword>
<Keyword MajorTopicYN="N">systematic review</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702334</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1942-2962</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>8</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>American health &amp; drug benefits</Title>
<ISOAbbreviation>Am Health Drug Benefits</ISOAbbreviation>
</Journal>
<ArticleTitle>Reviewing the Unmet Needs of Patients with Multiple Sclerosis.</ArticleTitle>
<Pagination>
<MedlinePgn>426-31</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Significant innovations in the treatment of patients with multiple sclerosis (MS) have primarily addressed the frequency of flare-ups in relapsing-remitting MS (RRMS). Many advances have been made in this area, and the medical community may be on the verge of a serious discussion of what constitutes a truly effective MS treatment. Certainly, it is important to further delay MS flare-ups and more effectively treat RRMS symptoms. However, great strides in reducing or preventing MS-related disability and providing neuroprotection have been elusive. Many unmet needs are still voiced by patients with MS, clinicians, and caregivers. Current information on the need for progress in various areas is reviewed in this article, including psychosocial care, treatments for progressive MS, biomarker identification, functional outcome measures, individualization of treatment, reducing side effects of medications, and improving medication adherence. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mehr</LastName>
<ForeName>Stanton R</ForeName>
<Initials>SR</Initials>
<AffiliationInfo>
<Affiliation>President, SM Health Communications, Newtown, PA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zimmerman</LastName>
<ForeName>Marj P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>President, RxDirections, Bucyrus, KS.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am Health Drug Benefits</MedlineTA>
<NlmUniqueID>101479877</NlmUniqueID>
<ISSNLinking>1942-2962</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4684633</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">adherence</Keyword>
<Keyword MajorTopicYN="N">biomarkers</Keyword>
<Keyword MajorTopicYN="N">disability</Keyword>
<Keyword MajorTopicYN="N">multiple sclerosis</Keyword>
<Keyword MajorTopicYN="N">neuroprotection</Keyword>
<Keyword MajorTopicYN="N">outcomes</Keyword>
<Keyword MajorTopicYN="N">primary progressive multiple sclerosis</Keyword>
<Keyword MajorTopicYN="N">relapsing-remitting multiple sclerosis</Keyword>
<Keyword MajorTopicYN="N">secondary progressive multiple sclerosis</Keyword>
<Keyword MajorTopicYN="N">unmet needs</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702335</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1942-2962</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>8</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>American health &amp; drug benefits</Title>
<ISOAbbreviation>Am Health Drug Benefits</ISOAbbreviation>
</Journal>
<ArticleTitle>How Do PCSK9 Inhibitors Stack Up to Statins for Low-Density Lipoprotein Cholesterol Control?</ArticleTitle>
<Pagination>
<MedlinePgn>436-42</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Despite advances in the approach toward treating hypercholesterolemia and widespread access to statin medications, not all people are able to reach target low-density lipoprotein cholesterol (LDL-C) levels to reduce their cardiovascular risk. Some of the reasons include the inability to tolerate statin therapy, LDL-C levels that remain high even in the presence of statin therapy, and a familial disorder that is characterized by extremely high levels of LDL-C. A new therapeutic class, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, represents a novel and promising approach to reducing LDL-C levels using a mechanism at the LDL receptor level. The recent approval of the first 2 PCSK9 inhibitors and the anticipated approval of the third agent in this class within approximately 1 year may provide clinicians powerful new weapons to lower LDL-C levels in patients who are not satisfactorily managed with statins. However, the results of long-term studies of the ability of these new medications to influence cardiovascular outcomes will not be known for several years. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zimmerman</LastName>
<ForeName>Marj P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>President, RxDirections LLC, Bucyrus, KS.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am Health Drug Benefits</MedlineTA>
<NlmUniqueID>101479877</NlmUniqueID>
<ISSNLinking>1942-2962</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4684634</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">PCSK9 inhibitors</Keyword>
<Keyword MajorTopicYN="N">alirocumab</Keyword>
<Keyword MajorTopicYN="N">bococizumab</Keyword>
<Keyword MajorTopicYN="N">evolocumab</Keyword>
<Keyword MajorTopicYN="N">familial hypercholesterolemia</Keyword>
<Keyword MajorTopicYN="N">low-density lipoprotein cholesterol</Keyword>
<Keyword MajorTopicYN="N">statin adverse effects</Keyword>
<Keyword MajorTopicYN="N">statin treatment</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702336</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1942-2962</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>8</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>American health &amp; drug benefits</Title>
<ISOAbbreviation>Am Health Drug Benefits</ISOAbbreviation>
</Journal>
<ArticleTitle>The Latest Innovations in the Drug Pipeline for Multiple Sclerosis.</ArticleTitle>
<Pagination>
<MedlinePgn>448-53</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Several new medications are being investigated in late-phase studies for the treatment of patients with relapsing or progressive multiple sclerosis (MS). These agents represent a variety of mechanisms of action and provide not only lower relapse rates but also improvement in disabilities. The majority of investigational trials involve selective sphingosine-1-phosphate receptor 1 immunomodulators, such as laquinimod, ozanimod, ponesimod, and siponimod, in an effort to build on the success of fingolimod. Ocrelizumab is a CD20-positive B-cell-targeting monoclonal antibody with a promising new mechanism of action. Ofatumumab is also a CD20 inhibitor. Daclizumab, an interleukin-2 inhibitor, has evidence of good efficacy but is associated with unfavorable side effects. Masitinib is a mast-cell inhibitor that also has shown efficacy in Alzheimer's disease and amyotrophic lateral sclerosis. Phase 3 trials for some of these agents will conclude in the next 12 months, and their manufacturers are expected to apply for US Food and Drug Administration approval soon thereafter. This review article summarizes data for newly approved and late-phase investigational agents for the treatment of patients with MS. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Radick</LastName>
<ForeName>Lea</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>medical writer based in Chicago, IL.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mehr</LastName>
<ForeName>Stanton R</ForeName>
<Initials>SR</Initials>
<AffiliationInfo>
<Affiliation>President, SM Health Communications, Newtown, PA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am Health Drug Benefits</MedlineTA>
<NlmUniqueID>101479877</NlmUniqueID>
<ISSNLinking>1942-2962</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4684635</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26700004</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">0717-6287</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>48</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Biological research</Title>
<ISOAbbreviation>Biol. Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Human amnion mesenchymal cells inhibit lipopolysaccharide-induced TNF-α and IL-1β production in THP-1 cells.</ArticleTitle>
<Pagination>
<MedlinePgn>69</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40659-015-0062-3</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Human amnion mesenchymal cells (hAMCs), isolated from the amniotic membrane of human placenta, are a unique population of mesenchymal stem cells. Recent studies demonstrated that hAMCs could inhibit the activities and functions of several immune cells. However, their effect on inflammatory macrophages is largely unknown. This study investigated the effect of hAMCs on expression of inflammatory cytokines and mitogen-activated protein kinases (MAPKs)/NF-κB pathway in human THP-1 macrophages induced by lipopolysaccharide (LPS).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The levels of TNF-α and IL-1β secreted by LPS- stimulated THP-1 cells were increased significantly compared with those in the control group. After co-culture with different numbers of hAMCs, the levels of TNF-α and IL-1β in LPS-stimulated THP-1 cells were significantly reduced compared with the LPS group. The mRNA expression of TNF-α and IL-1β were also markedly inhibited. Moreover, treating LPS-stimulated THP-1 cells with hAMCs supernatants could also suppress TNF-α and IL-1β production in THP-1 cells. Important signaling pathways involved in the production of TNF-α and IL-1β were affected by hAMCs co-culture: hAMCs remarkably suppressed NF-κB activation and down-regulated the phosphorylation of ERK and JNK in LPS- stimulated THP-1 cells.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Human amnion mesenchymal cells inhibited the production of TNF-α and IL-1β secreted by LPS-stimulated THP-1 cells, partly through the suppression of NF-κB activation and ERK and JNK phosphorylation.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shu</LastName>
<ForeName>Jun</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Institute of Clinical Medical Science, China-Japan Friendship Hospital, 100029, Beijing, China. junyshu@126.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>He</LastName>
<ForeName>Xiaojuan</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, 100700, Beijing, China. hxj19@126.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Lan</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Institute of Clinical Medical Science, China-Japan Friendship Hospital, 100029, Beijing, China. milan_z0210@sina.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Hong</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Institute of Clinical Medical Science, China-Japan Friendship Hospital, 100029, Beijing, China. jiefu_001@sina.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Ping</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Institute of Clinical Medical Science, China-Japan Friendship Hospital, 100029, Beijing, China. zryywangping@126.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Xiaojie</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Institute of Clinical Medical Science, China-Japan Friendship Hospital, 100029, Beijing, China. huangxiaojie2008@sina.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Biol Res</MedlineTA>
<NlmUniqueID>9308271</NlmUniqueID>
<ISSNLinking>0716-9760</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">PMC4690291</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702300</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1754-6834</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>8</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Biotechnology for biofuels</Title>
<ISOAbbreviation>Biotechnol Biofuels</ISOAbbreviation>
</Journal>
<ArticleTitle>Periodic-peristole agitation for process enhancement of butanol fermentation.</ArticleTitle>
<Pagination>
<MedlinePgn>225</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13068-015-0409-6</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Mass transfer plays an important role in determining the efficiency of the biofuel conversion. However, adverse effect of shear stress from traditional agitation inhibits the cell growth and production of biofuels. How to enhance the mass transfer with less adverse effect is considered as one of the important bioengineering issues.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In this study, a novel agitation type, named periodic-peristole was applied to butanol fermentation with Clostridium acetobutylicum ATCC 824. Meanwhile, the enhancement mechanism was studied. Initially, the fermentation performance of periodic-peristole agitation was compared with the traditional Rushton impeller and stationary cultivation. Result showed that the biomass, butanol and total solvent in periodic-peristole group (PPG) was enhanced to 1.92-, 2.06-, and 2.4-fold of those in the traditional Rushton impeller group (TIG), as well as 1.64-, 1.19- and 1.41-fold of those in the stationary group (SG). Subsequently, to get in-depth insight into enhancement mechanism, hydromechanics analysis and metabolic flux analysis (MFA) were carried out. The periodic-peristole agitation exhibits significant difference on velocity distribution, shear force, and mixing efficiency from the traditional Rushton impeller agitation. And the shear force in PPG is only 74 % of that in TIG. According to MFA result, fructose 6-phosphate, pyruvate, acetyl-CoA, oxaloacetate and α-ketoglutarate were determined the key nodes of cells in response to hydrodynamic mechanical stress. Based on such key information, rational enhancement strategies were proposed and butanol production was further improved.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The agitation associated with three issues which resulted in significant changes in cell metabolic behaviors: first, a rebalanced redox status; second, the energy (ATP) acquirement and consumption; third, the tolerance mechanism of the cell for survival of solvent. Periodic-peristole agitation provides an answer to address a long-standing problem of biofuel engineering. Key information derived from current study deepens the understanding of agitation, which can guide the designment of new bioreactors and development of enhancement strategies for biofuel refinery.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Xia</LastName>
<ForeName>Meng-Lei</ForeName>
<Initials>ML</Initials>
<AffiliationInfo>
<Affiliation>State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, No. 1 Beiertiao, Zhongguancun, Haidian District, Beijing, 100190 China ; University of Chinese Academy of Sciences, No. 80 Zhongguancun East Road, Haidian District, Beijing, 100039 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Lan</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, No. 1 Beiertiao, Zhongguancun, Haidian District, Beijing, 100190 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Zhi-Xia</ForeName>
<Initials>ZX</Initials>
<AffiliationInfo>
<Affiliation>College of Mathematics and System Science, Xinjiang University, No. 14 Shengli Road, Urumchi, 830046 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Hong-Zhang</ForeName>
<Initials>HZ</Initials>
<AffiliationInfo>
<Affiliation>State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, No. 1 Beiertiao, Zhongguancun, Haidian District, Beijing, 100190 China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Biotechnol Biofuels</MedlineTA>
<NlmUniqueID>101316935</NlmUniqueID>
<ISSNLinking>1754-6834</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4689062</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Butanol</Keyword>
<Keyword MajorTopicYN="N">Enhancement mechanism of agitation</Keyword>
<Keyword MajorTopicYN="N">Hydrodynamic analysis</Keyword>
<Keyword MajorTopicYN="N">Metabolic flux analysis</Keyword>
<Keyword MajorTopicYN="N">Periodic-peristoleagitation</Keyword>
<Keyword MajorTopicYN="N">Rational enhancement strategy</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702360</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2054-3581</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>2</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Canadian journal of kidney health and disease</Title>
<ISOAbbreviation>Can J Kidney Health Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>Fluid volume expansion and depletion in hemodialysis patients lack association with clinical parameters.</ArticleTitle>
<Pagination>
<MedlinePgn>54</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40697-015-0090-5</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Achievement of normal volume status is crucial in hemodialysis (HD), since both volume expansion and volume contraction have been associated with adverse outcome and events.</AbstractText>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The objectives of this study are to assess the prevalence of fluid volume expansion and depletion and to identify the best clinical parameter or set of parameters that can predict fluid volume expansion in HD patients.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">This study is cross-sectional.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">This study was conducted in three hemodialysis units.</AbstractText>
<AbstractText Label="PATIENTS" NlmCategory="METHODS">In this study, there are 194 HD patients.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Volume status was assessed by multifrequency bio-impedance spectroscopy (The Body Composition Monitor, Fresenius) prior to the mid-week HD session.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of all patients, 48 % (n = 94) were volume-expanded and 9 % of patients were volume-depleted (n = 17). Interdialytic weight gain was not different between hypovolemic, normovolemic, and hypervolemic patients. Fifty percent of the volume-expanded patients were hypertensive. Paradoxical hypertension was very common (31 % of all patients); its incidence was not different between patient groups. Intradialytic hypotension was relatively common and was more frequent among hypovolemic patients. Multivariate regression analysis identified only four predictors for volume expansion (edema, lower BMI, higher SBP, and smoking). None of these parameters displayed both a good sensitivity and specificity.</AbstractText>
<AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">The volume assessment was performed once.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The study indicates that volume expansion is highly prevalent in HD population and could not be identified using clinical parameters alone. No clinical parameters were identified that could reliably predict volume status. This study shows that bio-impedance can assist to determine volume status. Volume status, in turn, is not related to intradialytic weight gain and is unable to explain the high incidence of paradoxical hypertension.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kalainy</LastName>
<ForeName>Sylvia</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Nephrology, University of Alberta, 11-107 CSB, Edmonton, AB T6G 2G3 Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Reid</LastName>
<ForeName>Ryan</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Nephrology, University of Alberta, 11-107 CSB, Edmonton, AB T6G 2G3 Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jindal</LastName>
<ForeName>Kailash</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Nephrology, University of Alberta, 11-107 CSB, Edmonton, AB T6G 2G3 Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pannu</LastName>
<ForeName>Neesh</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Nephrology, University of Alberta, 11-107 CSB, Edmonton, AB T6G 2G3 Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Braam</LastName>
<ForeName>Branko</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Nephrology, University of Alberta, 11-107 CSB, Edmonton, AB T6G 2G3 Canada ; Department Physiology, University of Alberta, Edmonton, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Can J Kidney Health Dis</MedlineTA>
<NlmUniqueID>101640242</NlmUniqueID>
<ISSNLinking>2054-3581</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4689039</OtherID>
<OtherAbstract Language="fre" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bio-impedance</Keyword>
<Keyword MajorTopicYN="N">Extracellular fluid volume</Keyword>
<Keyword MajorTopicYN="N">Hemodialysis</Keyword>
<Keyword MajorTopicYN="N">Hypertension</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702357</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2049-3002</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>3</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Cancer &amp; metabolism</Title>
<ISOAbbreviation>Cancer Metab</ISOAbbreviation>
</Journal>
<ArticleTitle>Mathematical models of cancer metabolism.</ArticleTitle>
<Pagination>
<MedlinePgn>14</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40170-015-0140-6</ELocationID>
<Abstract>
<AbstractText>Metabolism is essential for life, and its alteration is implicated in multiple human diseases. The transformation from a normal to a cancerous cell requires metabolic changes to fuel the high metabolic demands of cancer cells, including but not limited to cell proliferation and cell migration. In recent years, there have been a number of new discoveries connecting known aberrations in oncogenic and tumour suppressor pathways with metabolic alterations required to sustain cell proliferation and migration. However, an understanding of the selective advantage of these metabolic alterations is still lacking. Here, we review the literature on mathematical models of metabolism, with an emphasis on their contribution to the identification of the selective advantage of metabolic phenotypes that seem otherwise wasteful or accidental. We will show how the molecular hallmarks of cancer can be related to cell proliferation and tissue remodelling, the two major physiological requirements for the development of a multicellular structure. We will cover different areas such as genome-wide gene expression analysis, flux balance models, kinetic models, reaction diffusion models and models of the tumour microenvironment. We will also highlight current challenges and how their resolution will help to achieve a better understanding of cancer metabolism and the metabolic vulnerabilities of cancers. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Markert</LastName>
<ForeName>Elke Katrin</ForeName>
<Initials>EK</Initials>
<AffiliationInfo>
<Affiliation>Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, G61 1BD UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vazquez</LastName>
<ForeName>Alexei</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Cancer Metab</MedlineTA>
<NlmUniqueID>101607582</NlmUniqueID>
<ISSNLinking>2049-3002</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688954</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702297</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1753-2000</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>9</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Child and adolescent psychiatry and mental health</Title>
<ISOAbbreviation>Child Adolesc Psychiatry Ment Health</ISOAbbreviation>
</Journal>
<ArticleTitle>What do we know about the risks for young people moving into, through and out of inpatient mental health care? Findings from an evidence synthesis.</ArticleTitle>
<Pagination>
<MedlinePgn>55</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13034-015-0087-y</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Young people with complex or severe mental health needs sometimes require care and treatment in inpatient settings. There are risks for young people in this care context, and this study addressed the question: 'What is known about the identification, assessment and management of risk in young people (aged 11-18) with complex mental health needs entering, using and exiting inpatient child and adolescent mental health services in the UK?'</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">In phase 1 a scoping search of two electronic databases (MEDLINE and PsychINFO) was undertaken. Items included were themed and presented to members of a stakeholder advisory group, who were asked to help prioritise the focus for phase 2. In phase 2, 17 electronic databases (EconLit; ASSIA; BNI; Cochrane Library; CINAHL; ERIC; EMBASE; HMIC; MEDLINE; PsycINFO; Scopus; Social Care Online; Social Services Abstracts; Sociological Abstracts; OpenGrey; TRiP; and Web of Science) were searched. Websites were explored and a call for evidence was circulated to locate items related to the risks to young people in mental health hospitals relating to 'dislocation' and 'contagion'. All types of evidence including research, policies and service and practice responses relating to outcomes, views and experiences, costs and cost-effectiveness were considered. Materials identified were narratively synthesised.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In phase 1, 4539 citations were found and 124 items included. Most were concerned with clinical risks. In phase 2, 15,662 citations were found, and 40 addressing the risks of 'dislocation' and 'contagion' were included supplemented by 20 policy and guidance documents. The quality of studies varied. Materials were synthesised using the categories: Dislocation: Normal Life; Dislocation: Identity; Dislocation: Friends; Dislocation: Stigma; Dislocation: Education; Dislocation: Families; and Contagion. No studies included an economic analysis. Although we found evidence of consideration of risk to young people in these areas we found little evidence to improve practice and services.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The importance to stakeholders of the risks of 'dislocation' and 'contagion' contrasted with the limited quantity and quality of evidence to inform policy, services and practice. The risks of dislocation and contagion are important, but new research is needed to inform how staff might identify, assess and manage them.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Edwards</LastName>
<ForeName>Deborah</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>School of Healthcare Sciences, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Evans</LastName>
<ForeName>Nicola</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>School of Healthcare Sciences, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gillen</LastName>
<ForeName>Elizabeth</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Information Services, Cardiff University, Cardiff, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Longo</LastName>
<ForeName>Mirella</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>College of Human and Health Sciences, Swansea University, Swansea, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pryjmachuk</LastName>
<ForeName>Steven</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>School of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Trainor</LastName>
<ForeName>Gemma</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Greater Manchester West Mental Health NHS Foundation Trust, Manchester, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hannigan</LastName>
<ForeName>Ben</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>School of Healthcare Sciences, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Child Adolesc Psychiatry Ment Health</MedlineTA>
<NlmUniqueID>101297974</NlmUniqueID>
<ISSNLinking>1753-2000</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4689041</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Child and adolescent mental health services</Keyword>
<Keyword MajorTopicYN="N">Contagion</Keyword>
<Keyword MajorTopicYN="N">Education</Keyword>
<Keyword MajorTopicYN="N">Families</Keyword>
<Keyword MajorTopicYN="N">Friends</Keyword>
<Keyword MajorTopicYN="N">Identity</Keyword>
<Keyword MajorTopicYN="N">Inpatient</Keyword>
<Keyword MajorTopicYN="N">Normal life</Keyword>
<Keyword MajorTopicYN="N">Risk</Keyword>
<Keyword MajorTopicYN="N">Stigma</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702296</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1753-2000</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>9</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Child and adolescent psychiatry and mental health</Title>
<ISOAbbreviation>Child Adolesc Psychiatry Ment Health</ISOAbbreviation>
</Journal>
<ArticleTitle>Health managers' views on the status of national and decentralized health systems for child and adolescent mental health in Uganda: a qualitative study.</ArticleTitle>
<Pagination>
<MedlinePgn>54</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13034-015-0086-z</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Robust health systems are required for the promotion of child and adolescent mental health (CAMH). In low and middle income countries such as Uganda neuropsychiatric illness in childhood and adolescence represent 15-30 % of all loss in disability-adjusted life years. In spite of this burden, service systems in these countries are weak. The objective of our assessment was to explore strengths and weaknesses of CAMH systems at national and district level in Uganda from a management perspective.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Seven key informant interviews were conducted during July to October 2014 in Kampala and Mbale district, Eastern Uganda representing the national and district level, respectively. The key informants selected were all public officials responsible for supervision of CAMH services at the two levels. The interview guide included the following CAMH domains based on the WHO Assessment Instrument for Mental Health Systems (WHO-AIMS): policy and legislation, financing, service delivery, health workforce, medicines and health information management. Inductive thematic analysis was applied in which the text in data transcripts was reduced to thematic codes. Patterns were then identified in the relations among the codes.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven themes emerged from the six domains of enquiry in the WHO-AIMS. A CAMH policy has been drafted to complement the national mental health policy, however district managers did not know about it. All managers at the district level cited inadequate national mental health policies. The existing laws were considered sufficient for the promotion of CAMH, however CAMH financing and services were noted by all as inadequate. CAMH services were noted to be absent at lower health centers and lacked integration with other health sector services. Insufficient CAMH workforce was widely reported, and was noted to affect medicines availability. Lastly, unlike national level managers, lower level managers considered the health management information system as being insufficient for service planning.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Managers at national and district level agree that most components of the CAMH system in Uganda are weak; but perceptions about CAMH policy and health information systems were divergent.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Akol</LastName>
<ForeName>Angela</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Faculty of Medicine and Dentistry, Center for International Health, University of Bergen, Bergen, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Engebretsen</LastName>
<ForeName>Ingunn Marie Stadskleiv</ForeName>
<Initials>IM</Initials>
<AffiliationInfo>
<Affiliation>Faculty of Medicine and Dentistry, Center for International Health, University of Bergen, Bergen, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Skylstad</LastName>
<ForeName>Vilde</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Faculty of Medicine and Dentistry, Center for International Health, University of Bergen, Bergen, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nalugya</LastName>
<ForeName>Joyce</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Mulago National Referral Hospital Kampala, Kampala, Uganda.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ndeezi</LastName>
<ForeName>Grace</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics and Child Health, Makerere University College of Health Sciences Kampala, Kampala, Uganda.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tumwine</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Mulago National Referral Hospital Kampala, Kampala, Uganda.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Child Adolesc Psychiatry Ment Health</MedlineTA>
<NlmUniqueID>101297974</NlmUniqueID>
<ISSNLinking>1753-2000</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688939</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Africa</Keyword>
<Keyword MajorTopicYN="N">Child Adolescent Mental Health</Keyword>
<Keyword MajorTopicYN="N">Health systems (decentralized)</Keyword>
<Keyword MajorTopicYN="N">Qualitative research</Keyword>
<Keyword MajorTopicYN="N">Sub-Saharan country</Keyword>
<Keyword MajorTopicYN="N">Uganda</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702353</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2045-7022</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Clinical and translational allergy</Title>
<ISOAbbreviation>Clin Transl Allergy</ISOAbbreviation>
</Journal>
<ArticleTitle>Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose.</ArticleTitle>
<Pagination>
<MedlinePgn>44</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13601-015-0088-1</ELocationID>
<Abstract>
<AbstractText>Sublingual immunotherapy (SLIT) is an effective and well-tolerated method of treating allergic respiratory diseases associated with seasonal and perennial allergens. In contrast to the subcutaneous route, SLIT requires a much greater amount of antigen to achieve a clinical effect. Many studies have shown that SLIT involves a dose-response relationship, and therefore it is important to use a proven clinically effective dose from the onset of treatment, because low doses are ineffective and very high doses may increase the risk of side effects. A well-defined standardization of allergen content is also crucial to ensure consistent quality, potency and appropriate immunomodulatory action of the SLIT product. Several methods of measuring antigenicity are used by manufacturers of SLIT products, including the index of reactivity (IR), standardized quality tablet unit, and bioequivalent allergy unit. A large body of evidence has established the 300 IR dose of SLIT as offering optimal efficacy and tolerability for allergic rhinitis due to grass and birch pollen and HDM, and HDM-induced moderate, persistent allergic asthma. The 300 IR dose also offers consistency of dosing across a variety of different allergens, and is associated with higher rates of adherence and patient satisfaction. Studies in patients with grass pollen allergies showed that the 300 IR dose has a rapid onset of action, is effective in both adults and children in the short term and, when administered pre-coseasonally in the long term, and maintains the clinical benefit, even after cessation of treatment. In patients with HDM-associated AR and/or asthma, the 300 IR dose also demonstrated significant improvements in symptoms and quality of life, and significantly decreased use of symptomatic medication. The 300 IR dose is well tolerated, with adverse events generally being of mild or moderate severity, declining in frequency and severity over time and in the subsequent courses. We discuss herein the most important factors that affect the selection of the optimal dose of SLIT with natural allergens, and review the rationale and evidence supporting the use of the 300 IR dose. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Demoly</LastName>
<ForeName>Pascal</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Allergy Division, Pulmonology Department, Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, Montpellier, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Passalacqua</LastName>
<ForeName>Gianni</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Allergy and Respiratory Diseases, IRCCS San Martino-IST, University of Genoa, Genoa, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Calderon</LastName>
<ForeName>Moises A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Section of Allergy and Clinical Immunology, Imperial College London-NHLI, Royal Brompton Hospital, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yalaoui</LastName>
<ForeName>Tarik</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Global Medical Affairs Department, Stallergenes, Antony, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Clin Transl Allergy</MedlineTA>
<NlmUniqueID>101576043</NlmUniqueID>
<ISSNLinking>2045-7022</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4689001</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">300 index of reactivity</Keyword>
<Keyword MajorTopicYN="N">Adherence</Keyword>
<Keyword MajorTopicYN="N">Allergen-specific immunotherapy</Keyword>
<Keyword MajorTopicYN="N">Dose-ranging</Keyword>
<Keyword MajorTopicYN="N">Grass pollen allergy</Keyword>
<Keyword MajorTopicYN="N">House dust mite allergy</Keyword>
<Keyword MajorTopicYN="N">Sublingual immunotherapy</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702339</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2001-0370</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>14</Volume>
<PubDate>
<Year>2016</Year>
</PubDate>
</JournalIssue>
<Title>Computational and structural biotechnology journal</Title>
<ISOAbbreviation>Comput Struct Biotechnol J</ISOAbbreviation>
</Journal>
<ArticleTitle>Blood transcriptomics and metabolomics for personalized medicine.</ArticleTitle>
<Pagination>
<MedlinePgn>1-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.csbj.2015.10.005</ELocationID>
<Abstract>
<AbstractText>Molecular analysis of blood samples is pivotal to clinical diagnosis and has been intensively investigated since the rise of systems biology. Recent developments have opened new opportunities to utilize transcriptomics and metabolomics for personalized and precision medicine. Efforts from human immunology have infused into this area exquisite characterizations of subpopulations of blood cells. It is now possible to infer from blood transcriptomics, with fine accuracy, the contribution of immune activation and of cell subpopulations. In parallel, high-resolution mass spectrometry has brought revolutionary analytical capability, detecting &gt; 10,000 metabolites, together with environmental exposure, dietary intake, microbial activity, and pharmaceutical drugs. Thus, the re-examination of blood chemicals by metabolomics is in order. Transcriptomics and metabolomics can be integrated to provide a more comprehensive understanding of the human biological states. We will review these new data and methods and discuss how they can contribute to personalized medicine. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Shuzhao</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Emory University School of Medicine, 615 Michael Street, Atlanta, GA 30322, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Todor</LastName>
<ForeName>Andrei</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Emory University School of Medicine, 615 Michael Street, Atlanta, GA 30322, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Luo</LastName>
<ForeName>Ruiyan</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Division of Epidemiology and Biostatistics, School of Public Health, Georgia State University, One Park Place, Atlanta, GA 30303, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>10</Month>
<Day>31</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Sweden</Country>
<MedlineTA>Comput Struct Biotechnol J</MedlineTA>
<NlmUniqueID>101585369</NlmUniqueID>
<ISSNLinking>2001-0370</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669660</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Blood systems biology</Keyword>
<Keyword MajorTopicYN="N">Data integration</Keyword>
<Keyword MajorTopicYN="N">Metabolomics</Keyword>
<Keyword MajorTopicYN="N">Personalized medicine</Keyword>
<Keyword MajorTopicYN="N">Transcriptomics</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702340</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2001-0370</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>14</Volume>
<PubDate>
<Year>2016</Year>
</PubDate>
</JournalIssue>
<Title>Computational and structural biotechnology journal</Title>
<ISOAbbreviation>Comput Struct Biotechnol J</ISOAbbreviation>
</Journal>
<ArticleTitle>A Review on Genomics APIs.</ArticleTitle>
<Pagination>
<MedlinePgn>8-15</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.csbj.2015.10.004</ELocationID>
<Abstract>
<AbstractText>The constant improvement and falling prices of whole human genome Next Generation Sequencing (NGS) has resulted in rapid adoption of genomic information at both clinics and research institutions. Considered together, the complexity of genomics data, due to its large volume and diversity along with the need for genomic data sharing, has resulted in the creation of Application Programming Interface (API) for secure, modular, interoperable access to genomic data from different applications, platforms, and even organizations. The Genomics APIs are a set of special protocols that assist software developers in dealing with multiple genomic data sources for building seamless, interoperable applications leading to the advancement of both genomic and clinical research. These APIs help define a standard for retrieval of genomic data from multiple sources as well as to better package genomic information for integration with Electronic Health Records. This review covers three currently available Genomics APIs: a) Google Genomics, b) SMART Genomics, and c) 23andMe. The functionalities, reference implementations (if available) and authentication protocols of each API are reviewed. A comparative analysis of the different features across the three APIs is provided in the Discussion section. Though Genomics APIs are still under active development and have yet to reach widespread adoption, they hold the promise to make building of complicated genomics applications easier with downstream constructive effects on healthcare. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Swaminathan</LastName>
<ForeName>Rajeswari</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Research Information Solutions and Innovation, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Yungui</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Research Information Solutions and Innovation, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moosavinasab</LastName>
<ForeName>Soheil</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Research Information Solutions and Innovation, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Buckley</LastName>
<ForeName>Ronald</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Research Information Solutions and Innovation, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bartlett</LastName>
<ForeName>Christopher W</ForeName>
<Initials>CW</Initials>
<AffiliationInfo>
<Affiliation>The Battelle Center for Mathematical Medicine, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lin</LastName>
<ForeName>Simon M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Research Information Solutions and Innovation, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>10</Month>
<Day>31</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Sweden</Country>
<MedlineTA>Comput Struct Biotechnol J</MedlineTA>
<NlmUniqueID>101585369</NlmUniqueID>
<ISSNLinking>2001-0370</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669666</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Application Programming Interface (API)</Keyword>
<Keyword MajorTopicYN="N">Clinical</Keyword>
<Keyword MajorTopicYN="N">Data sharing</Keyword>
<Keyword MajorTopicYN="N">Genomics</Keyword>
<Keyword MajorTopicYN="N">Sequencing</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702295</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1752-1505</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>9</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Conflict and health</Title>
<ISOAbbreviation>Confl Health</ISOAbbreviation>
</Journal>
<ArticleTitle>Soap is not enough: handwashing practices and knowledge in refugee camps, Maban County, South Sudan.</ArticleTitle>
<Pagination>
<MedlinePgn>39</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13031-015-0065-2</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Refugees are at high risk for communicable diseases due to overcrowding and poor water, sanitation, and hygiene conditions. Handwashing with soap removes pathogens from hands and reduces disease risk. A hepatitis E outbreak in the refugee camps of Maban County, South Sudan in 2012 prompted increased hygiene promotion and improved provision of soap, handwashing stations, and latrines. We conducted a study 1 year after the outbreak to assess the knowledge, attitudes, and practices of the refugees in Maban County.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a cross sectional survey of female heads of households in three refugee camps in Maban County. We performed structured observations on a subset of households to directly observe their handwashing practices at times of possible pathogen transmission.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 600 households interviewed, nearly all had soap available and 91 % reported water was available "always" or "sometimes". Exposure to handwashing promotion was reported by 85 % of the respondents. Rinsing hands with water alone was more commonly observed than handwashing with soap at critical handwashing times including "before eating" (80 % rinsing vs. 7 % washing with soap) and "before preparing/cooking food" (72.3 % vs 23 %). After toilet use, 46 % were observed to wash hands with soap and an additional 38 % rinsed with water alone.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Despite intensive messaging regarding handwashing with soap and access to soap and water, rinsing hands with water alone rather than washing hands with soap remains more common among the refugees in Maban County. This practice puts them at continued risk for communicable disease transmission. Qualitative research into local beliefs and more effective messaging may help future programs tailor handwashing interventions.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Phillips</LastName>
<ForeName>Raina M</ForeName>
<Initials>RM</Initials>
<AffiliationInfo>
<Affiliation>Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vujcic</LastName>
<ForeName>Jelena</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>University of Buffalo, Buffalo, NY USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Boscoe</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Oxfam International, Juba, South Sudan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Handzel</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aninyasi</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Oxfam International, Juba, South Sudan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cookson</LastName>
<ForeName>Susan T</ForeName>
<Initials>ST</Initials>
<AffiliationInfo>
<Affiliation>Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Blanton</LastName>
<ForeName>Curtis</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>S Blum</LastName>
<ForeName>Lauren</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Dakar, Senegal.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ram</LastName>
<ForeName>Pavani K</ForeName>
<Initials>PK</Initials>
<AffiliationInfo>
<Affiliation>University of Buffalo, Buffalo, NY USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Confl Health</MedlineTA>
<NlmUniqueID>101286573</NlmUniqueID>
<ISSNLinking>1752-1505</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4689052</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Emergencies</Keyword>
<Keyword MajorTopicYN="N">Handwashing</Keyword>
<Keyword MajorTopicYN="N">Hygiene</Keyword>
<Keyword MajorTopicYN="N">Refugees</Keyword>
<Keyword MajorTopicYN="N">Sanitation</Keyword>
<Keyword MajorTopicYN="N">Soap</Keyword>
<Keyword MajorTopicYN="N">South Sudan</Keyword>
<Keyword MajorTopicYN="N">Structured observation</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702413</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2352-3409</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Data in brief</Title>
<ISOAbbreviation>Data Brief</ISOAbbreviation>
</Journal>
<ArticleTitle>The proteomic dataset for bone marrow derived human mesenchymal stromal cells: Effect of in vitro passaging.</ArticleTitle>
<Pagination>
<MedlinePgn>864-70</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dib.2015.10.020</ELocationID>
<Abstract>
<AbstractText>Bone-marrow derived mesenchymal stromal cells (BMSCs) have been in clinical trials for therapy. One major bottleneck in the advancement of BMSC-based products is the challenge associated with cell isolation, characterization, and ensuring cell fitness over the course of in vitro cell propagation steps. The data in this report is part of publications that explored the proteomic changes following in vitro passaging of BMSCs [4] and the molecular heterogeneity in cultures obtained from different human donors [5], [6].The methodological details involving cell manufacturing, proteome harvesting, protein identification and quantification as well as the bioinformatic analyses were described to ensure reproducibility of the results. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mindaye</LastName>
<ForeName>Samuel T</ForeName>
<Initials>ST</Initials>
<AffiliationInfo>
<Affiliation>Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lo Surdo</LastName>
<ForeName>Jessica</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Cellular and Tissue Therapies Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bauer</LastName>
<ForeName>Steven R</ForeName>
<Initials>SR</Initials>
<AffiliationInfo>
<Affiliation>Cellular and Tissue Therapies Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alterman</LastName>
<ForeName>Michail A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Data Brief</MedlineTA>
<NlmUniqueID>101654995</NlmUniqueID>
<ISSNLinking>2352-3409</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669433</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702419</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2352-3409</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Data in brief</Title>
<ISOAbbreviation>Data Brief</ISOAbbreviation>
</Journal>
<ArticleTitle>Data set for diffusion coefficients of alloying elements in dilute Mg alloys from first-principles.</ArticleTitle>
<Pagination>
<MedlinePgn>900-12</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dib.2015.10.024</ELocationID>
<Abstract>
<AbstractText>Diffusion coefficients of alloying elements in Mg are critical for the development of new Mg alloys for lightweight applications. Here we present the data set of the temperature-dependent dilute tracer diffusion coefficients for 47 substitutional alloying elements in hexagonal closed packed (hcp) Mg calculated from first-principles calculations based on density functional theory (DFT) by combining transition state theory and an 8-frequency model. Benchmark for the DFT calculations and systematic comparison with experimental diffusion data are also presented. The data set refers to "Diffusion coefficients of alloying elements in dilute Mg alloys: A comprehensive first-principles study" by Zhou et al. [1]. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zhou</LastName>
<ForeName>Bi-Cheng</ForeName>
<Initials>BC</Initials>
<AffiliationInfo>
<Affiliation>Department of Materials Science and Engineering, The Pennsylvania State University, University Park, PA 16802, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shang</LastName>
<ForeName>Shun-Li</ForeName>
<Initials>SL</Initials>
<AffiliationInfo>
<Affiliation>Department of Materials Science and Engineering, The Pennsylvania State University, University Park, PA 16802, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Yi</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Materials Science and Engineering, The Pennsylvania State University, University Park, PA 16802, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Zi-Kui</ForeName>
<Initials>ZK</Initials>
<AffiliationInfo>
<Affiliation>Department of Materials Science and Engineering, The Pennsylvania State University, University Park, PA 16802, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Data Brief</MedlineTA>
<NlmUniqueID>101654995</NlmUniqueID>
<ISSNLinking>2352-3409</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669471</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702412</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2352-3409</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Data in brief</Title>
<ISOAbbreviation>Data Brief</ISOAbbreviation>
</Journal>
<ArticleTitle>Local overexpression of Su(H)-MAPK variants affects Notch target gene expression and adult phenotypes in Drosophila.</ArticleTitle>
<Pagination>
<MedlinePgn>852-63</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dib.2015.11.004</ELocationID>
<Abstract>
<AbstractText>In Drosophila, Notch and EGFR signalling pathways are closely intertwined. Their relationship is mostly antagonistic, and may in part be based on the phosphorylation of the Notch signal transducer Suppressor of Hairless [Su(H)] by MAPK. Su(H) is a transcription factor that together with several cofactors regulates the expression of Notch target genes. Here we address the consequences of a local induction of three Su(H) variants on Notch target gene expression. To this end, wild-type Su(H), a phospho-deficient Su(H) (MAPK-) (ko) and a phospho-mimetic Su(H) (MAPK-ac) isoform were overexpressed in the central domain of the wing anlagen. The expression of the Notch target genes cut, wingless, E(spl)m8-HLH and vestigial, was monitored. For the latter two, reporter genes were used (E(spl)m8-lacZ, vg (BE) -lacZ). In general, Su(H) (MAPK-) (ko) induced a stronger response than wild-type Su(H), whereas the response to Su(H) (MAPK-ac) was very weak. Notch target genes cut, wingless and vg (BE) -lacZ were ectopically activated, whereas E(spl)m8-lacZ was repressed by overexpression of Su(H) proteins. In addition, in epistasis experiments an activated form of the EGF-receptor (DER (act) ) or the MAPK (rl (SEM) ) and individual Su(H) variants were co-overexpressed locally, to compare the resultant phenotypes in adult flies (thorax, wings and eyes) as well as to assay the response of the Notch target gene cut in cell clones. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Auer</LastName>
<ForeName>Jasmin S</ForeName>
<Initials>JS</Initials>
<AffiliationInfo>
<Affiliation>Universität Hohenheim, Insitut für Genetik (240A), Garbenstr. 30, 70599 Stuttgart, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nagel</LastName>
<ForeName>Anja C</ForeName>
<Initials>AC</Initials>
<AffiliationInfo>
<Affiliation>Universität Hohenheim, Insitut für Genetik (240A), Garbenstr. 30, 70599 Stuttgart, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schulz</LastName>
<ForeName>Adriana</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Universität Hohenheim, Insitut für Genetik (240A), Garbenstr. 30, 70599 Stuttgart, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wahl</LastName>
<ForeName>Vanessa</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Universität Hohenheim, Insitut für Genetik (240A), Garbenstr. 30, 70599 Stuttgart, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Preiss</LastName>
<ForeName>Anette</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Universität Hohenheim, Insitut für Genetik (240A), Garbenstr. 30, 70599 Stuttgart, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Data Brief</MedlineTA>
<NlmUniqueID>101654995</NlmUniqueID>
<ISSNLinking>2352-3409</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669530</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Drosophila</Keyword>
<Keyword MajorTopicYN="N">EGFR signalling</Keyword>
<Keyword MajorTopicYN="N">MAPK</Keyword>
<Keyword MajorTopicYN="N">Notch signalling</Keyword>
<Keyword MajorTopicYN="N">Su(H)</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702415</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2352-3409</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Data in brief</Title>
<ISOAbbreviation>Data Brief</ISOAbbreviation>
</Journal>
<ArticleTitle>Elastic properties of fly ash-stabilized mixes.</ArticleTitle>
<Pagination>
<MedlinePgn>879-83</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dib.2015.11.005</ELocationID>
<Abstract>
<AbstractText>Stabilized mixes are used in the construction of bearing layers in asphalt and concrete pavement structures. Two nondestructive methods: resonant frequency method and ultrasonic pulse velocity method, were used for estimation of elastic properties of fly ash-stabilized mixes. Stabilized mixes were designed containing sand from the river Drava and binder composed of different share of cement and fly ash. The aim of the research was to analyze the relationship between the dynamic modulus of elasticity determined by different nondestructive methods. Data showed that average value of elasticity modulus obtained by the ultrasound velocity method is lower than the values of elasticity modulus obtained by resonant frequency method. For further analysis and enhanced discussion of elastic properties of fly ash stabilized mixes, see Dimter et al. [1]. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dimter</LastName>
<ForeName>Sanja</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>University of Osijek, Faculty of Civil Engineering, Drinska 16a, 31000 Osijek, Croatia, Europe.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rukavina</LastName>
<ForeName>Tatjana</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>University of Zagreb, Faculty of Civil Engineering, Department of Transportation, Kačićeva 26, 10000 Zagreb, Croatia, Europe.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Minažek</LastName>
<ForeName>Krunoslav</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>University of Osijek, Faculty of Civil Engineering, Drinska 16a, 31000 Osijek, Croatia, Europe.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Data Brief</MedlineTA>
<NlmUniqueID>101654995</NlmUniqueID>
<ISSNLinking>2352-3409</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669529</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702421</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2352-3409</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Data in brief</Title>
<ISOAbbreviation>Data Brief</ISOAbbreviation>
</Journal>
<ArticleTitle>Supplementary data of "Impacts of mesic and xeric urban vegetation on outdoor thermal comfort and microclimate in Phoenix, AZ".</ArticleTitle>
<Pagination>
<MedlinePgn>918-20</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dib.2015.11.006</ELocationID>
<Abstract>
<AbstractText>An advanced Markov-Chain Monte Carlo approach called Subset Simulation is described in Au and Beck (2001) [1] was used to quantify parameter uncertainty and model sensitivity of the urban land-atmospheric framework, viz. the coupled urban canopy model-single column model (UCM-SCM). The results show that the atmospheric dynamics are sensitive to land surface conditions. The most sensitive parameters are dimensional parameters, i.e. roof width, aspect ratio, roughness length of heat and momentum, since these parameters control the magnitude of sensible heat flux. The relative insensitive parameters are hydrological parameters since the lawns or green roofs in urban areas are regularly irrigated so that the water availability for evaporation is never constrained. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Song</LastName>
<ForeName>Jiyun</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>School of Sustainable Engineering and the Built Environment, Arizona State University, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Zhi-Hua</ForeName>
<Initials>ZH</Initials>
<AffiliationInfo>
<Affiliation>School of Sustainable Engineering and the Built Environment, Arizona State University, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Data Brief</MedlineTA>
<NlmUniqueID>101654995</NlmUniqueID>
<ISSNLinking>2352-3409</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669528</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702422</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2352-3409</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Data in brief</Title>
<ISOAbbreviation>Data Brief</ISOAbbreviation>
</Journal>
<ArticleTitle>Presence of an HO-1 expression threshold in renal glomeruli.</ArticleTitle>
<Pagination>
<MedlinePgn>921-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dib.2015.11.001</ELocationID>
<Abstract>
<AbstractText>This article reports data describing HO-1 expression patterns of heme oxygenase (HO)-1 in isolated rat glomeruli and in cultured glomerular epithelial cells (GEC) in response to its natural substrate heme. Qualitative and quantitative data are presented to support presence of a HO-1 expression threshold in glomeruli but not in GEC. Interpretation of our data and further insight into HO-1 expression pattern in glomeruli may be found in 'HO-1 expression control in the rat glomerulus' [1]. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Detsika</LastName>
<ForeName>Maria G</ForeName>
<Initials>MG</Initials>
<AffiliationInfo>
<Affiliation>1st Department of Critical Care Medicine &amp; Pulmonary Services, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Atsaves</LastName>
<ForeName>Vassileios</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>1st Department of Critical Care Medicine &amp; Pulmonary Services, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Papalois</LastName>
<ForeName>Apostolos</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Research and Experimental center of ELPEN Pharmaceuticals, Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lianos</LastName>
<ForeName>Elias A</ForeName>
<Initials>EA</Initials>
<AffiliationInfo>
<Affiliation>1st Department of Critical Care Medicine &amp; Pulmonary Services, National and Kapodistrian University of Athens School of Medicine, Athens, Greece ; Division of Nephrology, Department of Medicine, Robert Wood Johnson Medical School, Rutgers Biomedical and Health Sciences, New Brunswick, NJ, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Data Brief</MedlineTA>
<NlmUniqueID>101654995</NlmUniqueID>
<ISSNLinking>2352-3409</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669487</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Glomeruli</Keyword>
<Keyword MajorTopicYN="N">Heme oxygenase</Keyword>
<Keyword MajorTopicYN="N">Kidney</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702424</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2352-3409</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Data in brief</Title>
<ISOAbbreviation>Data Brief</ISOAbbreviation>
</Journal>
<ArticleTitle>Trajectories of cortical surface area and cortical volume maturation in normal brain development.</ArticleTitle>
<Pagination>
<MedlinePgn>929-38</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dib.2015.10.044</ELocationID>
<Abstract>
<AbstractText>This is a report of developmental trajectories of cortical surface area and cortical volume in the NIH MRI Study of Normal Brain Development. The quality-controlled sample included 384 individual typically-developing subjects with repeated scanning (1-3 per subject, total scans n=753) from 4.9 to 22.3 years of age. The best-fit model (cubic, quadratic, or first-order linear) was identified at each vertex using mixed-effects models, with statistical correction for multiple comparisons using random field theory. Analyses were performed with and without controlling for total brain volume. These data are provided for reference and comparison with other databases. Further discussion and interpretation on cortical developmental trajectories can be found in the associated Ducharme et al.׳s article "Trajectories of cortical thickness maturation in normal brain development - the importance of quality control procedures" (Ducharme et al., 2015) [1]. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ducharme</LastName>
<ForeName>Simon</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Montreal Neurological Institute, McConnell Brain Imaging Centre, McGill University, 3801 University Street, Montreal, QC, Canada H3A 2B4 ; McGill University Health Centre, Department of Psychiatry, McGill University, 1025 Pine Avenue West, Montreal, QC, Canada H3A 1A1.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Albaugh</LastName>
<ForeName>Matthew D</ForeName>
<Initials>MD</Initials>
<AffiliationInfo>
<Affiliation>Vermont Centre for Children, Youth and Families, Fletcher Allen Pediatric Psychiatry, University of Vermont, 1 South Prospect Street, Arnold, Level 3, Burlington, VT, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nguyen</LastName>
<ForeName>Tuong-Vi</ForeName>
<Initials>TV</Initials>
<AffiliationInfo>
<Affiliation>McGill University Health Centre, Department of Psychiatry, McGill University, 1025 Pine Avenue West, Montreal, QC, Canada H3A 1A1 ; McGill University Health Centre, Department of Obstetrics and Gynecology, McGill University, 1025 Pine Avenue West, Montreal, QC, Canada H3A 1A1.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hudziak</LastName>
<ForeName>James J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>Vermont Centre for Children, Youth and Families, Fletcher Allen Pediatric Psychiatry, University of Vermont, 1 South Prospect Street, Arnold, Level 3, Burlington, VT, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mateos-Pérez</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Montreal Neurological Institute, McConnell Brain Imaging Centre, McGill University, 3801 University Street, Montreal, QC, Canada H3A 2B4.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Labbe</LastName>
<ForeName>Aurelie</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Douglas Mental Health University Institute, Department of Psychiatry, McGill University, 6875 Lasalle Boulevard, Verdun, QC, Canada H4H 1R3 ; Douglas Mental Health University Institute, Department of Epidemiology, Biostatistics and Occupational Health, McGill University, 6875 Lasalle Boulevard, Verdun, QC, Canada H4H 1R3.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Evans</LastName>
<ForeName>Alan C</ForeName>
<Initials>AC</Initials>
<AffiliationInfo>
<Affiliation>Montreal Neurological Institute, McConnell Brain Imaging Centre, McGill University, 3801 University Street, Montreal, QC, Canada H3A 2B4.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Karama</LastName>
<ForeName>Sherif</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Montreal Neurological Institute, McConnell Brain Imaging Centre, McGill University, 3801 University Street, Montreal, QC, Canada H3A 2B4 ; Douglas Mental Health University Institute, Department of Psychiatry, McGill University, 6875 Lasalle Boulevard, Verdun, QC, Canada H4H 1R3.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>Brain Development Cooperative Group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Data Brief</MedlineTA>
<NlmUniqueID>101654995</NlmUniqueID>
<ISSNLinking>2352-3409</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669480</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Brain development</Keyword>
<Keyword MajorTopicYN="N">Cortical surface area</Keyword>
<Keyword MajorTopicYN="N">Cortical thickness</Keyword>
<Keyword MajorTopicYN="N">Cortical volume</Keyword>
<Keyword MajorTopicYN="N">Magnetic resonance</Keyword>
<Keyword MajorTopicYN="N">imaging</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702425</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2352-3409</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Data in brief</Title>
<ISOAbbreviation>Data Brief</ISOAbbreviation>
</Journal>
<ArticleTitle>Effects of methacholine infusion on desflurane pharmacokinetics in piglets.</ArticleTitle>
<Pagination>
<MedlinePgn>939-47</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dib.2015.11.002</ELocationID>
<Abstract>
<AbstractText>The data of a corresponding animal experiment demonstrates that nebulized methacholine (MCh) induced severe bronchoconstriction and significant inhomogeneous ventilation and pulmonary perfusion (V̇A/Q̇) distribution in pigs, which is similar to findings in human asthma. The inhalation of MCh induced bronchoconstriction and delayed both uptake and elimination of desflurane (Kretzschmar et al., 2015) [1]. The objective of the present data is to determine V̇A/Q̇ matching by Multiple Inert Gas Elimination Technique (MIGET) in piglets before and during methacholine- (MCh-) induced bronchoconstriction, induced by MCh infusion, and to assess the blood concentration profiles for desflurane (DES) by Micropore Membrane Inlet Mass Spectrometry (MMIMS). Healthy piglets (n=4) under general anesthesia were instrumented with arterial, central venous, and pulmonary artery lines. The airway was secured via median tracheostomy with an endotracheal tube, and animals were mechanically ventilated with intermittent positive pressure ventilation (IPPV) with a FiO2 of 0.4, tidal volume (V T)=10 ml/kg and PEEP of 5cmH2O using an open system. The determination of V.A/Q. was done by MIGET: before desflurane application and at plateau in both healthy state and during MCh infusion. Arterial blood was sampled at 0, 1, 2, 5, 10, 20, and 30 min during wash-in and washout, respectively. Bronchoconstriction was established by MCH infusion aiming at doubling the peak airway pressure, after which wash-in and washout of the anesthetic gas was repeated. Anesthesia gas concentrations were measured by MMIMS. Data were analyzed by ANOVA, paired t-test, and by nonparametric Friedman׳s test and Wilcoxon׳s matched pairs test. We measured airway pressures, pulmonary resistance, and mean paO2 as well as hemodynamic variables in all pigs before desflurane application and at plateau in both healthy state and during methacholine administration by infusion. By MIGET, fractional alveolar ventilation and pulmonary perfusion in relation to the V.A/Q. compartments, data of logSDQ̇ and logSDV̇ (the second moments describing global dispersion, i.e. heterogeneity of distribution) were estimated prior to and after MCh infusion. The uptake and elimination of desflurane was determined by MMIMS. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kozian</LastName>
<ForeName>Alf</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology and Intensive Care Medicine, Otto-von-Guericke-University Magdeburg, Germany ; Department of Surgical Sciences, Hedenstierna Laboratory, Uppsala University, Uppsala, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kretzschmar</LastName>
<ForeName>Moritz</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology and Intensive Care Medicine, Otto-von-Guericke-University Magdeburg, Germany ; Department of Surgical Sciences, Hedenstierna Laboratory, Uppsala University, Uppsala, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baumgardner</LastName>
<ForeName>James E</ForeName>
<Initials>JE</Initials>
<AffiliationInfo>
<Affiliation>Oscillogy ® LLC, Folsom, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schreiber</LastName>
<ForeName>Jens</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Pneumology, Otto-von-Guericke-University Magdeburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hedenstierna</LastName>
<ForeName>Göran</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Sciences, Clinical Physiology, Uppsala University, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Larsson</LastName>
<ForeName>Anders</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgical Sciences, Anesthesia and Intensive Care, Uppsala University, Uppsala, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hachenberg</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology and Intensive Care Medicine, Otto-von-Guericke-University Magdeburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schilling</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology and Intensive Care Medicine, Otto-von-Guericke-University Magdeburg, Germany ; Department of Surgical Sciences, Hedenstierna Laboratory, Uppsala University, Uppsala, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Data Brief</MedlineTA>
<NlmUniqueID>101654995</NlmUniqueID>
<ISSNLinking>2352-3409</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669490</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Alveolar ventilation</Keyword>
<Keyword MajorTopicYN="N">Animal model</Keyword>
<Keyword MajorTopicYN="N">Arterial blood gas concentration</Keyword>
<Keyword MajorTopicYN="N">Bronchoconstriction</Keyword>
<Keyword MajorTopicYN="N">Desflurane</Keyword>
<Keyword MajorTopicYN="N">Methacholine</Keyword>
<Keyword MajorTopicYN="N">Ventilation-/perfusion-mismatch</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702418</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2352-3409</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Data in brief</Title>
<ISOAbbreviation>Data Brief</ISOAbbreviation>
</Journal>
<ArticleTitle>Preferential binding of 4-hydroxynonenal to lysine residues in specific parasite proteins in plakortin-treated Plasmodium falciparum-parasitized red blood cells.</ArticleTitle>
<Pagination>
<MedlinePgn>893-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dib.2015.11.003</ELocationID>
<Abstract>
<AbstractText>The data show the frequencies by which the amino acid residues lysine, histidine and cysteine of six proteins of the malaria parasite Plasmodium falciparum are post-translationally modified by the lipoperoxydation endproduct 4-hydroxynonenal after challenging the parasitized red blood cell with plakortin. Plakortin is an antimalarial endoperoxide whose molecular anti-parasitic effect is described in Skorokhod et al. (2015) [1]. Plakortin did not elicit hemoglobin leakage from host red blood cells and did not oxidize reduced glutathione. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Schwarzer</LastName>
<ForeName>Evelin</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Oncology, University of Torino, Via Santena 5bis, 10126 Torino, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gallo</LastName>
<ForeName>Valentina</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Department of Oncology, University of Torino, Via Santena 5bis, 10126 Torino, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Valente</LastName>
<ForeName>Elena</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Oncology, University of Torino, Via Santena 5bis, 10126 Torino, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ulliers</LastName>
<ForeName>Daniela</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Oncology, University of Torino, Via Santena 5bis, 10126 Torino, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Taglialatela-Scafati</LastName>
<ForeName>Orazio</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacy, University of Napoli "Federico II", Via D. Montesano 49, 80131 Napoli, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arese</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Oncology, University of Torino, Via Santena 5bis, 10126 Torino, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Skorokhod</LastName>
<ForeName>Oleksii A</ForeName>
<Initials>OA</Initials>
<AffiliationInfo>
<Affiliation>Department of Oncology, University of Torino, Via Santena 5bis, 10126 Torino, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Data Brief</MedlineTA>
<NlmUniqueID>101654995</NlmUniqueID>
<ISSNLinking>2352-3409</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669491</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">4-hydroxynonenal</Keyword>
<Keyword MajorTopicYN="N">Plasmodium falciparum</Keyword>
<Keyword MajorTopicYN="N">antimalarial drug</Keyword>
<Keyword MajorTopicYN="N">endoperoxide</Keyword>
<Keyword MajorTopicYN="N">plakortin</Keyword>
<Keyword MajorTopicYN="N">post-translational modifications</Keyword>
<Keyword MajorTopicYN="N">red blood cell</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702420</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2352-3409</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Data in brief</Title>
<ISOAbbreviation>Data Brief</ISOAbbreviation>
</Journal>
<ArticleTitle>Asymmetric real-time PCR and multiplex melting curve analysis with TaqMan probes for detecting PIK3CA mutations.</ArticleTitle>
<Pagination>
<MedlinePgn>913-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dib.2015.10.046</ELocationID>
<Abstract>
<AbstractText>The data in this article are related to the research article entitled "Optimization of melting analysis with TaqMan probes for detection of KRAS, NRAS, and BRAF mutations" Botezatu et al. [1]. Somatic mutations in the PIK3CA gene ("hot spots" in exons 9 and 20) are found in many human cancers, and their presence can determine prognosis and a treatment strategy. An effective method of mutation scanning PIK3CA in clinical laboratories is DNA Melting Analysis (DMA) (Vorkas et al., 2010; Simi et al., 2008) [2], [3]. It was demonstrated recently that the TaqMan probes which have been long used in Real Time PCR may also be utilized in DMA (Huang et al., 2011) [4]. After optimization of this method Botezatu et al. [1], it was used for multiplex scanning PIK3CA hotspot mutations in formalin-fixed paraffin-embedded (FFPE) samples from patients with colorectal and lung cancer. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Botezatu</LastName>
<ForeName>Irina V</ForeName>
<Initials>IV</Initials>
<AffiliationInfo>
<Affiliation>N.N. Blokhin Russian Cancer Research Center, Kashirskoe Shosse 24, 115478 Moscow, Russia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nechaeva</LastName>
<ForeName>Irina O</ForeName>
<Initials>IO</Initials>
<AffiliationInfo>
<Affiliation>N.N. Blokhin Russian Cancer Research Center, Kashirskoe Shosse 24, 115478 Moscow, Russia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stroganova</LastName>
<ForeName>Аnna М</ForeName>
<Initials>АМ</Initials>
<AffiliationInfo>
<Affiliation>N.N. Blokhin Russian Cancer Research Center, Kashirskoe Shosse 24, 115478 Moscow, Russia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Senderovich</LastName>
<ForeName>Anastasia I</ForeName>
<Initials>AI</Initials>
<AffiliationInfo>
<Affiliation>N.N. Blokhin Russian Cancer Research Center, Kashirskoe Shosse 24, 115478 Moscow, Russia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kondratova</LastName>
<ForeName>Valentina N</ForeName>
<Initials>VN</Initials>
<AffiliationInfo>
<Affiliation>N.N. Blokhin Russian Cancer Research Center, Kashirskoe Shosse 24, 115478 Moscow, Russia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shelepov</LastName>
<ForeName>Valery P</ForeName>
<Initials>VP</Initials>
<AffiliationInfo>
<Affiliation>N.N. Blokhin Russian Cancer Research Center, Kashirskoe Shosse 24, 115478 Moscow, Russia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lichtenstein</LastName>
<ForeName>Anatoly V</ForeName>
<Initials>AV</Initials>
<AffiliationInfo>
<Affiliation>N.N. Blokhin Russian Cancer Research Center, Kashirskoe Shosse 24, 115478 Moscow, Russia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Data Brief</MedlineTA>
<NlmUniqueID>101654995</NlmUniqueID>
<ISSNLinking>2352-3409</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669479</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">DNA melting analysis</Keyword>
<Keyword MajorTopicYN="N">Multiplex analysis</Keyword>
<Keyword MajorTopicYN="N">Mutation scanning</Keyword>
<Keyword MajorTopicYN="N">PIK3CA</Keyword>
<Keyword MajorTopicYN="N">TaqMan probes</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702427</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2352-3409</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Data in brief</Title>
<ISOAbbreviation>Data Brief</ISOAbbreviation>
</Journal>
<ArticleTitle>Transcriptional profiles of valvular interstitial cells cultured on tissue culture polystyrene, on 2D hydrogels, or within 3D hydrogels.</ArticleTitle>
<Pagination>
<MedlinePgn>959-62</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dib.2015.11.017</ELocationID>
<Abstract>
<AbstractText>Valvular interstitial cells (VICs) actively maintain and repair heart valve tissue; however, persistent activation of VICs to a myofibroblast phenotype can lead to aortic stenosis (Chen and Simmons, 2011) [1]. To better understand and quantify how microenvironmental cues influence VIC phenotype, we compared expression profiles of VICs cultured on/in poly(ethylene glycol) (PEG) gels to those cultured on tissue culture polystyrene (TCPS), as well as fresh isolates. Here, we present both the raw and processed microarray data from these culture conditions. Interpretation of this data can be found in a research article entitled "Microarray analyses to quantify advantages of 2D and 3D hydrogel culture systems in maintaining the native valvular interstitial cell phenotype" (Mabry et al., 2015) [2]. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mabry</LastName>
<ForeName>Kelly M</ForeName>
<Initials>KM</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemical and Biological Engineering, University of Colorado at Boulder, Boulder, CO 80309, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Payne</LastName>
<ForeName>Samuel Z</ForeName>
<Initials>SZ</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemical and Biological Engineering, University of Colorado at Boulder, Boulder, CO 80309, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Anseth</LastName>
<ForeName>Kristi S</ForeName>
<Initials>KS</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemical and Biological Engineering, University of Colorado at Boulder, Boulder, CO 80309, USA ; Howard Hughes Medical Institute and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Data Brief</MedlineTA>
<NlmUniqueID>101654995</NlmUniqueID>
<ISSNLinking>2352-3409</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669531</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702428</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2352-3409</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Data in brief</Title>
<ISOAbbreviation>Data Brief</ISOAbbreviation>
</Journal>
<ArticleTitle>Corynebacterium pseudotuberculosis RNA-seq data from abiotic stresses.</ArticleTitle>
<Pagination>
<MedlinePgn>963-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dib.2015.11.010</ELocationID>
<Abstract>
<AbstractText>Corynebacterium pseudotuberculosis causes significant loss to goat and sheep farmers because it is the causal agent of the infectious disease caseous lymphadenitis, which may lead to outcomes ranging from skin injury to animal death (Ruiz et al., 2011) [1]. This bacterium was grown under osmotic (2 M), acid (pH) and heat (50 °C) stress and under control (Normal-BHI brain heart infusion) conditions, which simulate the conditions faced by the bacteria during the infectious process. Subsequently, cDNA of each condition was sequenced by the SOLiD3 Plus platform using the RNA-Seq technique [2], [3], [4]. The data produced was processed to evaluate the differential gene expression, which is helpful to understand the adaptation mechanisms during the infection in the host. The sequencing data of all conditions are available in the European Bioinformatics Institute (EBI) repository under accession number E-MTAB-2017. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>de Sá</LastName>
<ForeName>Pablo H C G</ForeName>
<Initials>PH</Initials>
<AffiliationInfo>
<Affiliation>Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Veras</LastName>
<ForeName>Adonney A O</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Carneiro</LastName>
<ForeName>Adriana R</ForeName>
<Initials>AR</Initials>
<AffiliationInfo>
<Affiliation>Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barúna</LastName>
<ForeName>Rafael A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guimarães</LastName>
<ForeName>Luís C</ForeName>
<Initials>LC</Initials>
<AffiliationInfo>
<Affiliation>Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pinheiro</LastName>
<ForeName>Kenny C</ForeName>
<Initials>KC</Initials>
<AffiliationInfo>
<Affiliation>Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pinto</LastName>
<ForeName>Anne C</ForeName>
<Initials>AC</Initials>
<AffiliationInfo>
<Affiliation>Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Soares</LastName>
<ForeName>Siomar C</ForeName>
<Initials>SC</Initials>
<AffiliationInfo>
<Affiliation>Institute of Biological and Natural Sciences, Federal University of Triângulo Mineiro, Uberaba, Minas Gerais, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schneider</LastName>
<ForeName>Maria P C</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Azevedo</LastName>
<ForeName>Vasco</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Silva</LastName>
<ForeName>Artur</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ramos</LastName>
<ForeName>Rommel T J</ForeName>
<Initials>RT</Initials>
<AffiliationInfo>
<Affiliation>Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Data Brief</MedlineTA>
<NlmUniqueID>101654995</NlmUniqueID>
<ISSNLinking>2352-3409</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669661</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Corynebaterium pseudotuberculosis</Keyword>
<Keyword MajorTopicYN="N">Infection stresses</Keyword>
<Keyword MajorTopicYN="N">RNA-seq</Keyword>
<Keyword MajorTopicYN="N">SOLiD</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702426</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2352-3409</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Data in brief</Title>
<ISOAbbreviation>Data Brief</ISOAbbreviation>
</Journal>
<ArticleTitle>Effects of whole life exposure to Bisphenol A or 17α-ethinyl estradiol in uterus of nulligravida CD1 mice.</ArticleTitle>
<Pagination>
<MedlinePgn>948-53</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dib.2015.10.034</ELocationID>
<Abstract>
<AbstractText>Bisphenol A (BPA) is an endocrine disrupting chemical (EDC) with known estrogenic activity. Exposure to BPA in adult mice was shown previously to increase uterine pathology with associated alterations in the immune response and fibrosis. Reported here are uterine histopathology findings from CD1 mice exposed to BPA or 17α-ethinyl estradiol at multiple doses from conception through postnatal day 90. Along with uterine pathology, impacts of exposure on collagen accumulation and F4/80 positive macrophage numbers, as an indicator of immune response in the endometrium and myometrium, are presented. These companion data are from offspring (F1) of the dams analyzed for effects of adult exposures published in the Reproductive Toxicology manuscript titled "Strain-Specific Induction of Endometrial Periglandular Fibrosis in Mice Exposed during Adulthood to the Endocrine Disrupting Chemical Bisphenol A" (doi: 10.1016/j.reprotox.2015.08.001). </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kendziorski</LastName>
<ForeName>Jessica A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology and Cell Biophysics, University of Cincinnati, Cincinnati, OH 45267, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Belcher</LastName>
<ForeName>Scott M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology and Cell Biophysics, University of Cincinnati, Cincinnati, OH 45267, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Data Brief</MedlineTA>
<NlmUniqueID>101654995</NlmUniqueID>
<ISSNLinking>2352-3409</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669472</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">BPA</Keyword>
<Keyword MajorTopicYN="N">Collagen</Keyword>
<Keyword MajorTopicYN="N">EDC</Keyword>
<Keyword MajorTopicYN="N">Estrogen</Keyword>
<Keyword MajorTopicYN="N">Fibrosis</Keyword>
<Keyword MajorTopicYN="N">Immune</Keyword>
<Keyword MajorTopicYN="N">Macrophage</Keyword>
<Keyword MajorTopicYN="N">endocrine disruption</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702417</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2352-3409</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Data in brief</Title>
<ISOAbbreviation>Data Brief</ISOAbbreviation>
</Journal>
<ArticleTitle>Demographic data for urinary Acute Kidney Injury (AKI) marker [IGFBP7]·[TIMP2] reference range determinations.</ArticleTitle>
<Pagination>
<MedlinePgn>888-92</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dib.2015.10.036</ELocationID>
<Abstract>
<AbstractText>This data in brief describes characteristics of chronic stable comorbid patients who were included in reference range studies of [IGFBP7]·[TIMP-2] "Reference Intervals of Urinary Acute Kidney Injury (AKI) Markers [IGFBP7]·[TIMP2] in Apparently Healthy Subjects and Chronic Comorbid Subjects without AKI" [1]. In order to determine the specificity of [IGFBP7]·[TIMP-2] for identifying patients at risk of developing AKI we studied a cohort with nine broad classification of disease who did not have AKI. Details regarding the population that was targeted for inclusion in the study are also described. Finally, we present data on the inclusion criteria for the healthy subjects used in this investigation to determine the reference range. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chindarkar</LastName>
<ForeName>Nandkishor S</ForeName>
<Initials>NS</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Center for Advanced Laboratory Medicine, University of California, San Diego Health Systems, San Diego, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chawla</LastName>
<ForeName>Lakhmir S</ForeName>
<Initials>LS</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology and Critical Care Medicine, George Washington, University Medical Center, Washington, DC, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Straseski</LastName>
<ForeName>Joely A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology and ARUP Laboratories, University of Utah School of Medicine, Salt Lake City, UT, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jortani</LastName>
<ForeName>Saeed A</ForeName>
<Initials>SA</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, University of Louisville, Louisville, KY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Uettwiller-Geiger</LastName>
<ForeName>Denise</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>John T. Mather Memorial Hospital, Port Jefferson, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Orr</LastName>
<ForeName>Robert R</ForeName>
<Initials>RR</Initials>
<AffiliationInfo>
<Affiliation>Phoenix Medical Group, Peoria, AZ, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kellum</LastName>
<ForeName>John A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>Center for Critical Care Nephrology Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fitzgerald</LastName>
<ForeName>Robert L</ForeName>
<Initials>RL</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Center for Advanced Laboratory Medicine, University of California, San Diego Health Systems, San Diego, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Data Brief</MedlineTA>
<NlmUniqueID>101654995</NlmUniqueID>
<ISSNLinking>2352-3409</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669474</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Acute kidney injury, Biomarkers, IGFBP7</Keyword>
<Keyword MajorTopicYN="N">Insulin-like growth factor-binding protein 7</Keyword>
<Keyword MajorTopicYN="N">Reference ranges</Keyword>
<Keyword MajorTopicYN="N">TIMP2</Keyword>
<Keyword MajorTopicYN="N">Tissue inhibitor of metalloproteinases-2</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702416</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2352-3409</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Data in brief</Title>
<ISOAbbreviation>Data Brief</ISOAbbreviation>
</Journal>
<ArticleTitle>Nemopilema nomurai Jellyfish venom treatment leads to alterations in rat cardiomyocytes proteome.</ArticleTitle>
<Pagination>
<MedlinePgn>884-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dib.2015.10.041</ELocationID>
<Abstract>
<AbstractText>This data article restrains data associated to the Choudhary et al. [1]. Nemopilema nomurai Jellyfish venom (NnV) can lead to cardiac toxicity. Here we analyzed the effect of NnV on rat cardiomyocytes cell line H9c2 at the proteome level using two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS). This analysis resulted in 34 proteins with differential expression. Here we provide the dataset for the proteins with amplified or reduced level as compare to control. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Choudhary</LastName>
<ForeName>Indu</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>College of Veterinary Medicine, Gyeongsang National University, Jinju 660-701, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Hyunkyoung</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>College of Veterinary Medicine, Gyeongsang National University, Jinju 660-701, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pyo</LastName>
<ForeName>Min-Jung</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>College of Veterinary Medicine, Gyeongsang National University, Jinju 660-701, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Heo</LastName>
<ForeName>Yunwi</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>College of Veterinary Medicine, Gyeongsang National University, Jinju 660-701, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bae</LastName>
<ForeName>Seong Kyeong</ForeName>
<Initials>SK</Initials>
<AffiliationInfo>
<Affiliation>College of Veterinary Medicine, Gyeongsang National University, Jinju 660-701, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kwon</LastName>
<ForeName>Young Chul</ForeName>
<Initials>YC</Initials>
<AffiliationInfo>
<Affiliation>College of Veterinary Medicine, Gyeongsang National University, Jinju 660-701, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yoon</LastName>
<ForeName>Won Duk</ForeName>
<Initials>WD</Initials>
<AffiliationInfo>
<Affiliation>Headquarters for Marine Environment, National Fisheries Research &amp; Development Institute, Shiran-ri, Gijang-eup, Gijang-gun, Busan 619-705, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kang</LastName>
<ForeName>Changkeun</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>College of Veterinary Medicine, Gyeongsang National University, Jinju 660-701, Republic of Korea ; Institutes of Agriculture and Life Science, Gyeongsang National University, Jinju, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Euikyung</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>College of Veterinary Medicine, Gyeongsang National University, Jinju 660-701, Republic of Korea ; Institute of Animal Medicine, Gyeongsang National University, Jinju 660-701, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Data Brief</MedlineTA>
<NlmUniqueID>101654995</NlmUniqueID>
<ISSNLinking>2352-3409</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669470</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702423</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2352-3409</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Data in brief</Title>
<ISOAbbreviation>Data Brief</ISOAbbreviation>
</Journal>
<ArticleTitle>Dispersion relation data for methylammonium lead triiodide perovskite deposited on a (100) silicon wafer using a two-step vapour-phase reaction process.</ArticleTitle>
<Pagination>
<MedlinePgn>926-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dib.2015.10.026</ELocationID>
<Abstract>
<AbstractText>Ellipsometry was used to measure the amplitude ratio and phase difference of light undergoing a phase shift as it interacts with a thin film of organic-inorganic hybrid perovskite CH3NH3PbI3 (MAPI) deposited onto a (100) silicon wafer. The refractive index and extinction coefficient was extracted from a multi-oscillator model fit to the ellipsometry data, as a function of wavelength, from 300 to 1500 nm. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Phillips</LastName>
<ForeName>Laurie J</ForeName>
<Initials>LJ</Initials>
<AffiliationInfo>
<Affiliation>Stephenson Institute for Renewable Energy, University of Liverpool, Liverpool L69 7ZF, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rashed</LastName>
<ForeName>Atef M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Stephenson Institute for Renewable Energy, University of Liverpool, Liverpool L69 7ZF, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Treharne</LastName>
<ForeName>Robert E</ForeName>
<Initials>RE</Initials>
<AffiliationInfo>
<Affiliation>Stephenson Institute for Renewable Energy, University of Liverpool, Liverpool L69 7ZF, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kay</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Stephenson Institute for Renewable Energy, University of Liverpool, Liverpool L69 7ZF, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yates</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Stephenson Institute for Renewable Energy, University of Liverpool, Liverpool L69 7ZF, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mitrovic</LastName>
<ForeName>Ivona Z</ForeName>
<Initials>IZ</Initials>
<AffiliationInfo>
<Affiliation>Department of Electrical Engineering and Electronics, University of Liverpool, Brownlow Hill, Liverpool L69 3GJ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Weerakkody</LastName>
<ForeName>Ayendra</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Electrical Engineering and Electronics, University of Liverpool, Brownlow Hill, Liverpool L69 3GJ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hall</LastName>
<ForeName>Steve</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Electrical Engineering and Electronics, University of Liverpool, Brownlow Hill, Liverpool L69 3GJ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Durose</LastName>
<ForeName>Ken</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Stephenson Institute for Renewable Energy, University of Liverpool, Liverpool L69 7ZF, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Data Brief</MedlineTA>
<NlmUniqueID>101654995</NlmUniqueID>
<ISSNLinking>2352-3409</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669473</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702414</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2352-3409</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Data in brief</Title>
<ISOAbbreviation>Data Brief</ISOAbbreviation>
</Journal>
<ArticleTitle>Profile of Inflammation-associated genes during Hepatic Differentiation of Human Pluripotent Stem Cells.</ArticleTitle>
<Pagination>
<MedlinePgn>871-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dib.2015.10.023</ELocationID>
<Abstract>
<AbstractText>Expression of genes associated with inflammation was analyzed during differentiation of human pluripotent stem cells (PSCs) to hepatic cells. Messenger RNA transcript profiles of differentiated endoderm (day 5), hepatoblast (day 15) and hepatocyte-like cells (day 21) were obtained by RNA sequencing analysis. When compared to endoderm cells an immature cell type, the hepatic cells (days 15 and 21) had significantly higher expression of acute phase protein genes including complement factors, coagulation factors, serum amyloid A and serpins. Furthermore, hepatic phase of cells expressed proinflammatory cytokines IL18 and IL32 as well as cytokine receptors IL18R1, IL1R1, IL1RAP, IL2RG, IL6R, IL6ST and IL10RB. These cells also produced CCL14, CCL15, and CXCL- 1, 2, 3, 16 and 17 chemokines. Endoderm cells had higher levels of chemokine receptors, CXCR4 and CXCR7, than that of hepatic cells. Sirtuin family of genes involved in aging, inflammation and metabolism were differentially regulated in endoderm and hepatic phase cells. Ligands and receptors of the tumor necrosis factor (TNF) family as well as downstream signaling factors TRAF2, TRAF4, FADD, NFKB1 and NFKBIB were differentially expressed during hepatic differentiation. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ignatius Irudayam</LastName>
<ForeName>Joseph</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Contreras</LastName>
<ForeName>Deisy</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Spurka</LastName>
<ForeName>Lindsay</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Cedars-Sinai Genomics Core, Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ren</LastName>
<ForeName>Songyang</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kanagavel</LastName>
<ForeName>Vidhya</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ramaiah</LastName>
<ForeName>Arunachalam</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Centre for Infectious Disease Research, Indian Institute of Science, Bangalore, Karnataka 560012, India ; Hindustan Genomics Institute, SVA Medical Center, Kadayam, Tamil Nadu 627415, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Annamalai</LastName>
<ForeName>Alagappan</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>French</LastName>
<ForeName>Samuel W</ForeName>
<Initials>SW</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology and Laboratory Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Klein</LastName>
<ForeName>Andrew S</ForeName>
<Initials>AS</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA ; Department of Surgery, University of California at Los Angeles, Los Angeles, CA 90095, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Funari</LastName>
<ForeName>Vincent</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Cedars-Sinai Genomics Core, Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arumugaswami</LastName>
<ForeName>Vaithilingaraja</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA ; Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA ; Department of Surgery, University of California at Los Angeles, Los Angeles, CA 90095, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Data Brief</MedlineTA>
<NlmUniqueID>101654995</NlmUniqueID>
<ISSNLinking>2352-3409</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669432</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">SIRT1</Keyword>
<Keyword MajorTopicYN="N">cytokines</Keyword>
<Keyword MajorTopicYN="N">differential gene expression</Keyword>
<Keyword MajorTopicYN="N">differentiation</Keyword>
<Keyword MajorTopicYN="N">endoderm</Keyword>
<Keyword MajorTopicYN="N">hepatic cells</Keyword>
<Keyword MajorTopicYN="N">hepatoblast</Keyword>
<Keyword MajorTopicYN="N">hepatocytes</Keyword>
<Keyword MajorTopicYN="N">inflammation</Keyword>
<Keyword MajorTopicYN="N">pluripotent stem cells</Keyword>
<Keyword MajorTopicYN="N">sirtuin</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702293</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1742-7622</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Emerging themes in epidemiology</Title>
<ISOAbbreviation>Emerg Themes Epidemiol</ISOAbbreviation>
</Journal>
<ArticleTitle>County-level hurricane exposure and birth rates: application of difference-in-differences analysis for confounding control.</ArticleTitle>
<Pagination>
<MedlinePgn>19</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s12982-015-0042-7</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Epidemiological analyses of aggregated data are often used to evaluate theoretical health effects of natural disasters. Such analyses are susceptible to confounding by unmeasured differences between the exposed and unexposed populations. To demonstrate the difference-in-difference method our population included all recorded Florida live births that reached 20 weeks gestation and conceived after the first hurricane of 2004 or in 2003 (when no hurricanes made landfall). Hurricane exposure was categorized using ≥74 mile per hour hurricane wind speed as well as a 60 km spatial buffer based on weather data from the National Oceanic and Atmospheric Administration. The effect of exposure was quantified as live birth rate differences and 95 % confidence intervals [RD (95 % CI)]. To illustrate sensitivity of the results, the difference-in-differences estimates were compared to general linear models adjusted for census-level covariates. This analysis demonstrates difference-in-differences as a method to control for time-invariant confounders investigating hurricane exposure on live birth rates.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Difference-in-differences analysis yielded consistently null associations across exposure metrics and hurricanes for the post hurricane rate difference between exposed and unexposed areas (e.g., Hurricane Ivan for 60 km spatial buffer [-0.02 births/1000 individuals (-0.51, 0.47)]. In contrast, general linear models suggested a positive association between hurricane exposure and birth rate [Hurricane Ivan for 60 km spatial buffer (2.80 births/1000 individuals (1.94, 3.67)] but not all models.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Ecological studies of associations between environmental exposures and health are susceptible to confounding due to unmeasured population attributes. Here we demonstrate an accessible method of control for time-invariant confounders for future research.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Grabich</LastName>
<ForeName>Shannon C</ForeName>
<Initials>SC</Initials>
<Identifier Source="ORCID">0000-0003-3474-6874</Identifier>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 135 Dauer Drive 2101 McGavran-Greenberg Hall, CB #7435, Chapel Hill, NC 27599 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Robinson</LastName>
<ForeName>Whitney R</ForeName>
<Initials>WR</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 135 Dauer Drive 2101 McGavran-Greenberg Hall, CB #7435, Chapel Hill, NC 27599 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Engel</LastName>
<ForeName>Stephanie M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 135 Dauer Drive 2101 McGavran-Greenberg Hall, CB #7435, Chapel Hill, NC 27599 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Konrad</LastName>
<ForeName>Charles E</ForeName>
<Initials>CE</Initials>
<AffiliationInfo>
<Affiliation>Department of Geography, University of North Carolina at Chapel Hill, Chapel Hill, NC USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Richardson</LastName>
<ForeName>David B</ForeName>
<Initials>DB</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 135 Dauer Drive 2101 McGavran-Greenberg Hall, CB #7435, Chapel Hill, NC 27599 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Horney</LastName>
<ForeName>Jennifer A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology and Biostatistics, School of Rural Public Health, Texas A&amp;M Health Science Center, College Station, TX USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Emerg Themes Epidemiol</MedlineTA>
<NlmUniqueID>101232986</NlmUniqueID>
<ISSNLinking>1742-7622</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688997</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Birth rates</Keyword>
<Keyword MajorTopicYN="N">Difference-in-difference</Keyword>
<Keyword MajorTopicYN="N">Disaster</Keyword>
<Keyword MajorTopicYN="N">Fixed-effect regression</Keyword>
<Keyword MajorTopicYN="N">General linear models</Keyword>
<Keyword MajorTopicYN="N">Hurricane</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702352</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2041-9139</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>6</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>EvoDevo</Title>
<ISOAbbreviation>Evodevo</ISOAbbreviation>
</Journal>
<ArticleTitle>Posterior eyespots in larval chitons have a molecular identity similar to anterior cerebral eyes in other bilaterians.</ArticleTitle>
<Pagination>
<MedlinePgn>40</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13227-015-0036-0</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Development of cerebral eyes is generally based on fine-tuned networks and closely intertwined with the formation of brain and head. Consistently and best studied in insects and vertebrates, many signaling pathways relaying the activity of eye developmental factors to positional information in the head region are characterized. Though known from several organisms, photoreceptors developing outside the head region are much less studied and the course of their development, relation to cerebral eyes and evolutionary origin is in most cases unknown. To explore how position influences development of otherwise similar photoreceptors, we analyzed the molecular characteristics of photoreceptors we discovered at the very anterior, the posttrochal mid-body and posterior body region of larval Leptochiton asellus, a representative of the chiton subgroup of mollusks.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Irrespective of their position, all found photoreceptors exhibit a molecular signature highly similar to cerebral eye photoreceptors of related animals. All photoreceptors employ the same subtype of visual pigments (r-opsin), and the same key elements for phototransduction such as GNAq, trpC and arrestin and intracellular r-opsin transport such as rip11 and myosinV as described from other protostome cerebral eyes. Several transcription factors commonly involved in cerebral eye and brain development such as six1/2, eya, dachshund, lhx2/9 and prox are also expressed by all found photoreceptor cells, only pax6 being restricted to the anterior most cells. Coexpression of pax6 and MITF in photoreceptor-associated shielding pigment cells present at the mid-body position matches the common situation in cerebral eye retinal pigment epithelium specification and differentiation. Notably, all photoreceptors, even the posterior ones, further express clear anterior markers such as foxq2, irx, otx, and six3/6 (only the latter absent in the most posterior photoreceptors), which play important roles in the early patterning of the anterior neurogenic area throughout the animal kingdom.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our data suggest that anterior eyes with brain-associated development can indeed be subject to heterotopic replication to developmentally distinct and even posterior body regions. Retention of the transcriptional activity of a broad set of eye developmental factors and common anterior markers suggests a mode of eye development induction, which is largely independent of body regionalization.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vöcking</LastName>
<ForeName>Oliver</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Sars International Centre for Marine Molecular Biology, University of Bergen, Thormøhlensgate 55, 5008 Bergen, Norway ; Department of Biology, University of Bergen, Thormøhlensgate 55, 5008 Bergen, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kourtesis</LastName>
<ForeName>Ioannis</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Sars International Centre for Marine Molecular Biology, University of Bergen, Thormøhlensgate 55, 5008 Bergen, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hausen</LastName>
<ForeName>Harald</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Sars International Centre for Marine Molecular Biology, University of Bergen, Thormøhlensgate 55, 5008 Bergen, Norway.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Evodevo</MedlineTA>
<NlmUniqueID>101525836</NlmUniqueID>
<ISSNLinking>2041-9139</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4689004</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Development</Keyword>
<Keyword MajorTopicYN="N">Evolution</Keyword>
<Keyword MajorTopicYN="N">Eyes</Keyword>
<Keyword MajorTopicYN="N">Mollusks</Keyword>
<Keyword MajorTopicYN="N">Replication</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702395</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2211-5463</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>5</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>FEBS open bio</Title>
<ISOAbbreviation>FEBS Open Bio</ISOAbbreviation>
</Journal>
<ArticleTitle>Quantifying NAD(P)H production in the upper Entner-Doudoroff pathway from Pseudomonas putida KT2440.</ArticleTitle>
<Pagination>
<MedlinePgn>908-15</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fob.2015.11.002</ELocationID>
<Abstract>
<AbstractText>Despite the lack of biochemical information, all available in silico metabolic models of Pseudomonas putida KT2440 consider NADP as the only cofactor accepted by the glucose-6-phosphate dehydrogenases. Because the Entner-Doudoroff pathway is the main glycolytic route in this bacterium, determining how much NADH and NADPH are produced in the reaction catalyzed by these enzymes is very important for the correct interpretation of metabolic flux distributions. To determine the actual cofactor preference of the glucose-6-phosphate dehydrogenase encoded by the zwf-1 gene (PputG6PDH-1), the major isoform during growth on glucose, we purified this protein and studied its kinetic properties. Based on simple kinetic principles, we estimated the in vivo relative production of NADH and NADPH during the oxidation of glucose-6-phosphate (G6P). Contrary to the general assumption, our calculations showed that the reaction catalyzed by PputG6PDH-1 yields around 1/3 mol of NADPH and 2/3 mol of NADH per mol of oxidized G6P. Additionally, we obtained data suggesting that the reaction catalyzed by the 6-phosphogluconate dehydrogenase is active during growth on glucose, and it also produces NADH. These results indicate that the stoichiometric matrix of in silico models of P. putida KT2440 must be corrected and highlight the importance of considering the physiological concentrations of the involved metabolites to estimate the actual proportion of NADH and NADPH produced by a dehydrogenase. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Olavarria</LastName>
<ForeName>Karel</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Departmento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marone</LastName>
<ForeName>Marina Pupke</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Departmento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>da Costa Oliveira</LastName>
<ForeName>Henrique</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Departmento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Roncallo</LastName>
<ForeName>Juan Camilo</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>Departmento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>da Costa Vasconcelos</LastName>
<ForeName>Fernanda Nogales</ForeName>
<Initials>FN</Initials>
<AffiliationInfo>
<Affiliation>Departmento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>da Silva</LastName>
<ForeName>Luiziana Ferreira</ForeName>
<Initials>LF</Initials>
<AffiliationInfo>
<Affiliation>Departmento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gomez</LastName>
<ForeName>José Gregório Cabrera</ForeName>
<Initials>JG</Initials>
<AffiliationInfo>
<Affiliation>Departmento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>FEBS Open Bio</MedlineTA>
<NlmUniqueID>101580716</NlmUniqueID>
<ISSNLinking>2211-5463</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669411</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">EDP, Entner–Doudoroff pathway</Keyword>
<Keyword MajorTopicYN="N">Entner–Doudoroff pathway</Keyword>
<Keyword MajorTopicYN="N">G6P, glucose-6-phosphate</Keyword>
<Keyword MajorTopicYN="N">G6PDH, glucose-6-phosphate dehydrogenase</Keyword>
<Keyword MajorTopicYN="N">GND, 6-phospho-gluconate dehydrogenase</Keyword>
<Keyword MajorTopicYN="N">Glucose-6-phosphate dehydrogenase</Keyword>
<Keyword MajorTopicYN="N">NAD(H)</Keyword>
<Keyword MajorTopicYN="N">NADP(H)</Keyword>
<Keyword MajorTopicYN="N">PputG6PDH-1, glucose-6-phosphate dehydrogenase encoded by the gene zwf-1 from Pseudomonas putida KT2440</Keyword>
<Keyword MajorTopicYN="N">Pseudomonas putida</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26699342</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">2213-0772</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>3</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Healthcare (Amsterdam, Netherlands)</Title>
<ISOAbbreviation>Healthc (Amst)</ISOAbbreviation>
</Journal>
<ArticleTitle>Lessons learned from implementing the HIV infant tracking system (HITSystem): A web-based intervention to improve early infant diagnosis in Kenya.</ArticleTitle>
<Pagination>
<MedlinePgn>190-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hjdsi.2015.07.004</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S2213-0764(15)00058-5</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Guided by the RE-AIM model, we describe preliminary data and lessons learned from multiple serial implementations of an eHealth intervention to improve early infant diagnosis (EID) of HIV in Kenya.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We describe the reach, effectiveness, adoption, implementation and maintenance of the HITSystem, an eHealth intervention that links key stakeholders to improve retention and outcomes in EID. Our target community includes mother-infant pairs utilizing EID services and government health care providers and lab personnel. We also explore our own role as program and research personnel supporting the dissemination and scale up of the HITSystem in Kenya.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Key findings illustrate the importance of continual adaptation of the HITSystem interface to accommodate varied stakeholders' workflows in different settings. Surprisingly, technology capacity and internet connectivity posed minimal short-term challenges. Early and sustained ownership of the HITSystem among stakeholders proved critical to reach, effectiveness and successful adoption, implementation and maintenance.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Preliminary data support the ability of the HITSystem to improve EID outcomes in Kenya. Strong and sustained collaborations with stakeholders improve the quality and reach of eHealth public health interventions.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Finocchario-Kessler</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>University of Kansas Medical Center, Department of Family Medicine, Kansas City, KS, USA. Electronic address: Skessler2@kumc.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Odera</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Global Health Innovations, Nairobi, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Okoth</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Global Health Innovations, Nairobi, Kenya; Kenya Medical Research Institute, Nairobi, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bawcom</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>University of Kansas Medical Center, Department of Family Medicine, Kansas City, KS, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gautney</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Global Health Innovations, Kansas City, MO, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Khamadi</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Kenya Medical Research Institute, Nairobi, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Clark</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>University of Kansas, Department of Global Studies, Lawrence, KS, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Goggin</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Children's Mercy Hospital, Health Services and Outcomes Research, Kansas City, MO, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 HD076673</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Healthc (Amst)</MedlineTA>
<NlmUniqueID>101622189</NlmUniqueID>
<ISSNLinking>2213-0764</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">NIHMS712917 [Available on 12/01/16]</OtherID>
<OtherID Source="NLM">PMC4690847 [Available on 12/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Early infant diagnosis (EID)</Keyword>
<Keyword MajorTopicYN="N">HIV infant tracking system (HITSystem)</Keyword>
<Keyword MajorTopicYN="N">Implementation</Keyword>
<Keyword MajorTopicYN="N">Kenya</Keyword>
<Keyword MajorTopicYN="N">Lessons learned</Keyword>
<Keyword MajorTopicYN="N">Technology</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702167</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Insanity Defense: Past, Present, and Future.</ArticleTitle>
<Pagination>
<MedlinePgn>381-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168559</ELocationID>
<Abstract>
<AbstractText>Insanity defense is primarily used in criminal prosecutions. It is based on the assumption that at the time of the crime, the defendant was suffering from severe mental illness and therefore, was incapable of appreciating the nature of the crime and differentiating right from wrong behavior, hence making them not legally accountable for crime. Insanity defense is a legal concept, not a clinical one (medical one). This means that just suffering from a mental disorder is not sufficient to prove insanity. The defendant has the burden of proving the defense of insanity by a "preponderance of the evidence" which is similar to a civil case. It is hard to determine legal insanity, and even harder to successfully defend it in court. This article focuses on the recent Supreme Court decision on insanity defense and standards employed in Indian court. Researchers present a model for evaluating a defendant's mental status examination and briefly discuss the legal standards and procedures for the assessment of insanity defense evaluations. There is an urgent need to initiate formal graduation course, setup Forensic Psychiatric Training and Clinical Services Providing Centers across the country to increase the manpower resources and to provide fair and speedy trail. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Math</LastName>
<ForeName>Suresh Bada</ForeName>
<Initials>SB</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, National Institute of Mental Health and Neurosciences (Institute of National Importance), Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>Channaveerachari Naveen</ForeName>
<Initials>CN</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, National Institute of Mental Health and Neurosciences (Institute of National Importance), Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moirangthem</LastName>
<ForeName>Sydney</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, National Institute of Mental Health and Neurosciences (Institute of National Importance), Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676201</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Criminal responsibility</Keyword>
<Keyword MajorTopicYN="N">Indian Penal Code Section-84</Keyword>
<Keyword MajorTopicYN="N">insanity defense</Keyword>
<Keyword MajorTopicYN="N">legal insanity</Keyword>
<Keyword MajorTopicYN="N">medical insanity</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702168</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Impact of Modafinil Add-on with Atypical Anti-psychotics on Excessive Daytime Drowsiness.</ArticleTitle>
<Pagination>
<MedlinePgn>388-92</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168561</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Atypical antipsychotic drugs are known to cause many side effects which include daytime drowsiness. So many add on drugs are tried to reduce the same.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">72 patients who were on atypical antipsychotic drugs were randomly assigned to either Modafinil or placebo and were followed for a period of 12 weeks. Daytime drowsiness, was taken at baseline, week 3, and at week 12 by using VAS, EDD scales.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The results were analyzed and showed that the Modafinil add on therapy significantly reduced the daytime Drowsiness.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Modafinil could be a potential candidate in selected group of patients to decrease some of the unwanted adverse events like daytime drowsiness produced by atypical antipsychotics.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Prasuna</LastName>
<ForeName>P Lakshmi</ForeName>
<Initials>PL</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Sri Venkateswara Medical College, Tirupati, Andhra Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sudhakar</LastName>
<ForeName>T P</ForeName>
<Initials>TP</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Sri Venkateswara Medical College, Tirupati, Andhra Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676202</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Adverse events</Keyword>
<Keyword MajorTopicYN="N">Atypical antipsychotic drugs</Keyword>
<Keyword MajorTopicYN="N">Daytime drowsiness</Keyword>
<Keyword MajorTopicYN="N">Modafinil</Keyword>
<Keyword MajorTopicYN="N">Visual Analogue Scale</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702169</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Do Personality Traits Such as Impulsivity and Hostility-Aggressiveness Predict Severity of Intent in Attempted Suicide? Findings From a Record Based Study in South India.</ArticleTitle>
<Pagination>
<MedlinePgn>393-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168563</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Little is known about the association of personality traits with intent in attempted suicide.</AbstractText>
<AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Our objectives were to assess the levels of selected personality factors among suicide attempters and to examine their association with suicide intent.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">A chart review of 156 consecutive suicide attempters was carried out. All participants were administered the Beck Suicide Intent Scale, Barratt Impulsivity Scale-11, Buss-Perry Aggression Questionnaire, and Past Feelings and Acts of Violence Scale to assess suicide intent, trait impulsivity, hostility-aggression, and violence, respectively. Pearson's product moment correlation was the used as the test of association. Stepwise linear regression was used to identify predictors of suicide intent.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Suicide intent was significantly correlated with verbal aggression (Pearson r = 0.90, P = 0.030), hostility (Pearson r = 0.316, P &lt; 0.001), and nonplanning impulsivity (r = -0.174, P = 0.049). High hostility and low motor impulsivity emerged as significant predictors of suicide intent.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Personality traits such as hostility and to an extent, impulsivity are accurate predictors of intentionality in attempted suicide. Clinicians should focus on these personality attributes during a routine evaluation of suicide attempters. They can also be considered as potential targets for suicide prevention programs.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Menon</LastName>
<ForeName>Vikas</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sarkar</LastName>
<ForeName>Siddharth</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Sree Balaji Medical College and Hospital, Chennai, Tamil Nadu, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kattimani</LastName>
<ForeName>Shivanand</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mathan</LastName>
<ForeName>Kaliaperumal</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676203</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Aggression</Keyword>
<Keyword MajorTopicYN="N">attempted suicide</Keyword>
<Keyword MajorTopicYN="N">hostility</Keyword>
<Keyword MajorTopicYN="N">impulsivity</Keyword>
<Keyword MajorTopicYN="N">personality</Keyword>
<Keyword MajorTopicYN="N">suicide intent</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702170</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Symptoms at Onset in First Episode Schizophrenia: Caregivers Perspectives.</ArticleTitle>
<Pagination>
<MedlinePgn>399-402</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168564</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Early recognition of symptoms is important in the management of psychosis. Caregivers understanding and attribution of symptoms plays a major role in treatment selection.</AbstractText>
<AbstractText Label="AIM" NlmCategory="OBJECTIVE">The aim was to identify the various symptoms cluster recognized by caregivers at illness onset in first episode schizophrenia.</AbstractText>
<AbstractText Label="SUBJECTS AND METHODS" NlmCategory="METHODS">In a cross-sectional study 40 key caregivers of patients with first episode of Schizophrenia (International Classification of Diseases-10) attending the outpatient services of Schizophrenia Research Foundation were recruited. Caregivers were assessed using a questionnaire adapted from the Psychiatric and Personal History Schedule.</AbstractText>
<AbstractText Label="STATISTICAL ANALYSIS" NlmCategory="METHODS">Principal component (PCP) analysis.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Caregivers were predominantly women. Parents (58%), siblings (18%), spouse (12%), and children (12%) formed the sample. The caregiver easily recognized depressive symptoms. An analysis was done to analyze symptom data rated on the caregiver questionnaire indicated a four-factor solution. PCP analysis produced a clear depressive, anxious, irritable, and vegetative factor (Eigenvalue &gt;0.05). Caregivers (40%) attributed present lifestyle as causality. The first contact of help in almost half of the sample (45%) was to a psychiatric facility.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Caregiver's perception about mental illness and ability to identify the four factors has important treatment implications. Studying patterns of help seeking may be a useful strategy in early intervention programs.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tharoor</LastName>
<ForeName>Hema</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Consultant Psychiatrist, Schizophrenia Research Foundation, Chennai, Tamil Nadu, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ganesh</LastName>
<ForeName>Aarthi</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Consultant Psychiatrist, Schizophrenia Research Foundation, Chennai, Tamil Nadu, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676204</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Caregivers</Keyword>
<Keyword MajorTopicYN="N">first episode</Keyword>
<Keyword MajorTopicYN="N">prodrome</Keyword>
<Keyword MajorTopicYN="N">schizophrenia</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702171</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Symptom Dimensions in Obsessive-Compulsive Disorder and Obsessive Beliefs.</ArticleTitle>
<Pagination>
<MedlinePgn>403-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168579</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Obsessive-compulsive disorder (OCD) is a heterogeneous condition with a few major symptom dimensions. These symptom dimensions are thought to have unique clinical and neurobiological correlates. There seems to be a specific relation between OCD symptom dimensions and obsessive beliefs, but the findings are not consistent across studies. There is also a paucity of literature from culturally diverse settings. One of the reasons for the varied findings could be due to the method employed in measuring OCD symptoms.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">In this study, we examined the relation between symptom dimensions and obsessive beliefs using the Dimensional Yale-Brown Obsessive-Compulsive Scale and the Obsessive Beliefs Questionnaire respectively in 75 patients with Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition OCD.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Perfectionism predicted both aggressive and symmetry dimensions whereas responsibility beliefs predicted sexual and religious dimensions.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The findings suggest that certain obsessive beliefs predicted certain OCD symptom dimensions, but results are not entirely consistent with the published literature suggesting the possibility of cross-cultural variations. That the symptom dimensions have unique belief domains support the argument that symptom dimensions could be targeted to reduce the heterogeneity in etiological and treatment studies of OCD. Therapeutic interventions may have to aim at modifying unique belief domains underlying certain symptom dimensions rather than having generic cognitive-behavioral strategies.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cordeiro</LastName>
<ForeName>Trinette</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Psychology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sharma</LastName>
<ForeName>Mahendra P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Psychology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thennarasu</LastName>
<ForeName>Kandavel</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Biostatistics, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Reddy</LastName>
<ForeName>Y C Janardhan</ForeName>
<Initials>YC</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676205</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Obsessive beliefs</Keyword>
<Keyword MajorTopicYN="N">obsessive-compulsive disorder</Keyword>
<Keyword MajorTopicYN="N">symptom dimensions</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702172</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Handprints of the Mind: Decoding Personality Traits and Handwritings.</ArticleTitle>
<Pagination>
<MedlinePgn>409-12</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168580</ELocationID>
<Abstract>
<AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Handwriting analysis is a unique, specialized and emerging scientific process that has been carried out and applied for centuries now. However, its reliability and effectiveness as a method of assessing personality and behavior is not established and is still a debatable issue. The present paper aimed to examine the possibility of a correlation between clinical diagnosis and graphological analysis and to explore the key links between the underlying personality traits and its manifestations in handwriting among children.</AbstractText>
<AbstractText Label="AIM" NlmCategory="OBJECTIVE">The aim was to study the possibility of a correlation between clinical diagnosis and graphological analysis.</AbstractText>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To explore the key links between the underlying personality traits and its manifestations in handwriting among children. To study the possibility of using Graphotherapy as a remedial tool in aid of teaching/learning techniques and behavior modifications.</AbstractText>
<AbstractText Label="HYPOTHESIS" NlmCategory="OBJECTIVE">There are no significant and concrete differences between the psychodiagnostic assessment of personality through Children's Personality Questionnaire (CPQ) and handwriting analysis.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">N = 60, age group = 8-12 years.</AbstractText>
<AbstractText Label="TOOLS" NlmCategory="METHODS">CPQ - a 16 personality factor scale and a semi-structured proforma. Simple random sampling technique was used.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The P values for the study sample were found to be greater than 0.05 at 5% level of significance to all the 14 dimensions of personality hence going in line with the null hypothesis that states "there are no significant and concrete differences between the psychodiagnostic assessment of Personality through CPQ and handwriting analysis." Graphologists were thoroughly trained to interpret on the same 14 dimensions of personality as that of CPQ, most samples were analyzed to have a lying loop, a trait, which might also be attributed to the difference found in Trait-H, further asserting the subjective limitations of most psychological tests.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gowda</LastName>
<ForeName>Mahesh Ramanina</ForeName>
<Initials>MR</Initials>
<AffiliationInfo>
<Affiliation>Consultant Psychiatrist, Spandana Health Care, Bangalore, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Harish</LastName>
<ForeName>Nikitha</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Psychiatric Rehabilitator, Spandana Health Care, Bangalore, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aslam</LastName>
<ForeName>Arun</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Grapho-Analyst, Spandana Health Care, Bangalore, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Padmanabiah</LastName>
<ForeName>Mangala</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Grapho-Analyst, Spandana Health Care, Bangalore, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Magaji</LastName>
<ForeName>Radhika</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Psychologist, Spandana Health Care, Bangalore, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676206</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Children's Personality Questionnaire</Keyword>
<Keyword MajorTopicYN="N">clinical diagnosis</Keyword>
<Keyword MajorTopicYN="N">handwriting analysis</Keyword>
<Keyword MajorTopicYN="N">psychodiagnostic assessment of personality</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702173</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Catatonia in Children Following Systemic Illness.</ArticleTitle>
<Pagination>
<MedlinePgn>413-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168582</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The term catatonia was first introduced in 1874 and several etiologies, both organic and psychiatric have been attributed to the clinical phenotype of catatonia. The interesting feature is their response to lorazepam irrespective of their etiology.</AbstractText>
<AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Four patients admitted with verbal and motor unresponsiveness following febrile illness were evaluated for infective and metabolic causes. Those who qualified for catatonia as per Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition criteria and Bush-Francis Catatonia Screening Instrument screening tool and rating scale were evaluated in detail and reported.</AbstractText>
<AbstractText Label="OBSERVATIONS" NlmCategory="METHODS">Catatonia occurs in clusters, females are more affected than males. Electroencephalogram can be abnormal based on the precipitating symptom. Minor changes in serum total iron and transferrin saturation and nonspecific elevation of viral antibody titers are seen in some patients. Lorazepam challenge always gives the diagnosis.</AbstractText>
<AbstractText Label="RESULT" NlmCategory="RESULTS">All patients where females and had preceeding systemic or CNS infection. Three out of the Four patients where independent at the end of one month.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Catatonia should be considered as a differential diagnosis in all children with verbal and motor unresponsiveness, which have no other explanation. Early initiation of treatment is very rewarding at least during short term follow-up.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chandra</LastName>
<ForeName>Sadanandavalli Retnaswami</ForeName>
<Initials>SR</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Issac</LastName>
<ForeName>Thomas Gregor</ForeName>
<Initials>TG</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Neurosciences, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shivaram</LastName>
<ForeName>Sumanth</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676207</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Lorazepam challenge</Keyword>
<Keyword MajorTopicYN="N">organic background</Keyword>
<Keyword MajorTopicYN="N">pediatric catatonia</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702174</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of Transcranial Direct Current Stimulation on Prefrontal Inhibition in Schizophrenia Patients with Persistent Auditory Hallucinations: A Study on Antisaccade Task Performance.</ArticleTitle>
<Pagination>
<MedlinePgn>419-22</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168584</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Deficient prefrontal cortex inhibitory control is of particular interest with regard to the pathogenesis of auditory hallucinations (AHs) in schizophrenia. Antisaccade task performance is a sensitive index of prefrontal inhibitory function and has been consistently found to be abnormal in schizophrenia.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">This study investigated the effect of transcranial direct current stimulation (tDCS) on antisaccade performance in 13 schizophrenia patients.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The tDCS resulted in significant reduction in antisaccade error percentage (t = 3.4; P = 0.005), final eye position gain (t = 2.3; P = 0.042), and AHs severity (t = 4.1; P = 0.003).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results raise the possibility that improvement in antisaccade performance and severity of AH may be mechanistically related.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Subramaniam</LastName>
<ForeName>Aditi</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, The Schizophrenia Clinic, Translational Psychiatry Laboratory, Neurobiology Research Centre, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Agarwal</LastName>
<ForeName>Sri Mahavir</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, The Schizophrenia Clinic, Translational Psychiatry Laboratory, Neurobiology Research Centre, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kalmady</LastName>
<ForeName>Sunil</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, The Schizophrenia Clinic, Translational Psychiatry Laboratory, Neurobiology Research Centre, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shivakumar</LastName>
<ForeName>Venkataram</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, The Schizophrenia Clinic, Translational Psychiatry Laboratory, Neurobiology Research Centre, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chhabra</LastName>
<ForeName>Harleen</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, The Schizophrenia Clinic, Translational Psychiatry Laboratory, Neurobiology Research Centre, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bose</LastName>
<ForeName>Anushree</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, The Schizophrenia Clinic, Translational Psychiatry Laboratory, Neurobiology Research Centre, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Damodharan</LastName>
<ForeName>Dinakaran</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, The Schizophrenia Clinic, Translational Psychiatry Laboratory, Neurobiology Research Centre, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Narayanaswamy</LastName>
<ForeName>Janardhanan C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, The Schizophrenia Clinic, Translational Psychiatry Laboratory, Neurobiology Research Centre, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hutton</LastName>
<ForeName>Sam B</ForeName>
<Initials>SB</Initials>
<AffiliationInfo>
<Affiliation>University of Sussex, Brighton, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Venkatasubramanian</LastName>
<ForeName>Ganesan</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, The Schizophrenia Clinic, Translational Psychiatry Laboratory, Neurobiology Research Centre, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676208</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Antisaccade</Keyword>
<Keyword MajorTopicYN="N">hallucinations</Keyword>
<Keyword MajorTopicYN="N">schizophrenia</Keyword>
<Keyword MajorTopicYN="N">transcranial direct current stimulation</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702175</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Factors Affecting Well-being and Socio-occupational Functioning in Schizophrenia Patients Following an Acute Exacerbation: A Hospital Based Observational Study.</ArticleTitle>
<Pagination>
<MedlinePgn>423-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168585</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Improving functioning levels are an important goal of treatment in schizophrenia. Most studies have described long-term course and outcome in schizophrenia. However, understanding factors influencing functioning in the immediate recovery period following an acute exacerbation may be of important clinical relevance.</AbstractText>
<AbstractText Label="AIM" NlmCategory="OBJECTIVE">The aim of this study is to assess the factors that influence well-being and socio-occupational functioning following an acute exacerbation in schizophrenia patients.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The study included 40 patients during the period from June 2013 to June 2014. The possible effect of gender, duration of illness, duration of untreated psychosis, premorbid adjustment, cognitive impairment, facial affect perception and treatment compliance on well-being, and socio-occupational functioning was examined.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">About 45% of the individuals experienced below average well-being. On logistic regression analysis poor compliance with medication and poorer cognitive functioning significantly differentiated the patient group with below average well-being from those with an above average well-being. Male gender, poor premorbid adjustment, poor compliance to treatment, poor cognitive functioning, and greater duration of untreated psychosis were found to be associated with a poorer socio-occupational functioning.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Clinical interventions focusing on improving cognitive impairment and compliance to treatment could play a role in improving well-being, and socio-occupational functioning in schizophrenia patients following an acute exacerbation.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gopalakrishnan</LastName>
<ForeName>Roopa</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Kasturba Medical College, Manipal University, Manipal, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Behere</LastName>
<ForeName>Rishikesh V</ForeName>
<Initials>RV</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Kasturba Medical College, Manipal University, Manipal, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sharma</LastName>
<ForeName>P S V N</ForeName>
<Initials>PS</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Kasturba Medical College, Manipal University, Manipal, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676209</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Schizophrenia</Keyword>
<Keyword MajorTopicYN="N">socio-occupational functioning</Keyword>
<Keyword MajorTopicYN="N">well-being</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702176</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Predictors of Effect of Atypical Antipsychotics on Speech.</ArticleTitle>
<Pagination>
<MedlinePgn>429-33</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168586</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Most of the studies have looked into the effect of typical antipsychotics on speech secondary to tardive dyskinesia.</AbstractText>
<AbstractText Label="AIMS" NlmCategory="OBJECTIVE">This study was aimed to explore the factors predicting the effect of atypical antipsychotic medications on the production of speech.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">One hundred and forty patients on stable regimen of three or more months on risperidone (92), olanzapine (28), aripiprazole (14), and clozapine (6) were recruited for the study. Speech was assessed by maximum phonation duration task, s/z ratio, diadochokinetic task, acoustic analysis and Frenchay Dysarthria Assessment (FDA). Extrapyramidal symptoms (EPS) were assessed by Simpson Angus scale.</AbstractText>
<AbstractText Label="STATISTICAL ANALYSIS" NlmCategory="METHODS">Spearman correlation analysis was carried out to find the association between speech parameters and continuous variables. Effect of EPS, duration and dose of antipsychotic treatment on speech parameters was compared using Mann-Whitney test.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The risperidone group differ from other antipsychotics groups significantly in s/z ratio (0.07), FDA-total (0.23) and FDA-reflex (0.25). People who took antipsychotic for more than 2 years had lower score of FDA-palate (P = 0.042), and FDA-respiratory (P = 0.04) and higher values in noise-harmonic ratio (P = 0.011) and maximum /fundamental frequency (MFF) for males (P = 0.02). Effect of EPS was seen on MFF for males (spearman correlation coefficient = 0.34) and on almost all sections of FDA (spearman correlation coefficients = -0.2 to -0.33).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Both duration of use and propensity of atypical antipsychotics to cause EPS can influence the speech performance of the patients. This information can be useful, particularly in people with the requirement of high quality speech.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sinha</LastName>
<ForeName>Preeti</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vandana</LastName>
<ForeName>Valiya Parambath</ForeName>
<Initials>VP</Initials>
<AffiliationInfo>
<Affiliation>National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lewis</LastName>
<ForeName>Nikita V</ForeName>
<Initials>NV</Initials>
<AffiliationInfo>
<Affiliation>National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jayaram</LastName>
<ForeName>Mannaralukrishnaiah</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Enderby</LastName>
<ForeName>Pamela</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>University of Sheffield, Sheffield, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676210</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Atypical antipsychotics</Keyword>
<Keyword MajorTopicYN="N">dysarthria</Keyword>
<Keyword MajorTopicYN="N">extrapyramidal symptoms</Keyword>
<Keyword MajorTopicYN="N">maximum fundamental frequency</Keyword>
<Keyword MajorTopicYN="N">noise-harmonic ratio</Keyword>
<Keyword MajorTopicYN="N">s/z ratio</Keyword>
<Keyword MajorTopicYN="N">speech</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702177</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>A Cross-sectional Study of Prevalence and Implications of Depression and Anxiety in Psoriasis.</ArticleTitle>
<Pagination>
<MedlinePgn>434-40</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168587</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Physical and mental comorbidity is common and has significant implications for overall health outcomes. Psoriasis, a psychocutaneous disorder, is a classic example of mental-physical comorbidity.</AbstractText>
<AbstractText Label="AIMS" NlmCategory="OBJECTIVE">In view of the impact of socio-cultural influences on mind-body interactions and the paucity of Indian research pertaining to psychiatric morbidity in psoriatic patients, this study was undertaken to measure the prevalence of anxiety and depression in patients with psoriasis, and to correlate these with severity of psoriasis and quality of life.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">This cross-sectional study was conducted on 90 consecutive patients of psoriasis, over a period of 12 months, in a tertiary care centre. The Psoriasis Area and Severity Index was used to assess severity of psoriasis. PHQ-9, GAD-7 and the Perceived Stress Scale were used to screen for depression, anxiety and perceived stress respectively. The WHOQOL-BREF was used to determine the quality of life.</AbstractText>
<AbstractText Label="STATISTICS ANALYSIS" NlmCategory="METHODS">All analysis was performed using Microsoft Excel software and Statistical Package for Social Sciences.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 71 (78.9%) subjects had depression and 69 (76.7%) had anxiety. Fifty one patients had significant stress. A significant positive correlation was established between psoriasis variables (severity and duration of psoriasis) and psychological variables (depression, anxiety and stress). Severity of psoriasis had a significant negative correlation with social relationships and environmental domains of WHOQOL. Quality of life was significantly worse in patients with psoriasis with comorbid anxiety/depression.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Patients with psoriasis have a clinically significant prevalence of depression, anxiety and perceived stress. This study highlights the complex relationship between psoriasis, psychiatric comorbidity and quality of life and the need to simultaneously consider dermatological and psychological factors.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lakshmy</LastName>
<ForeName>Sreelatha</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Mahatma Gandhi Medical College and Research Institute, Puducherry, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Balasundaram</LastName>
<ForeName>Sivaprakash</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Mahatma Gandhi Medical College and Research Institute, Puducherry, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sarkar</LastName>
<ForeName>Sukanto</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Mahatma Gandhi Medical College and Research Institute, Puducherry, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Audhya</LastName>
<ForeName>Moutusi</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Dermatology, Mahatma Gandhi Medical College and Research Institute, Puducherry, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Subramaniam</LastName>
<ForeName>Eswaran</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Mahatma Gandhi Medical College and Research Institute, Puducherry, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676211</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Anxiety</Keyword>
<Keyword MajorTopicYN="N">depression</Keyword>
<Keyword MajorTopicYN="N">psoriasis</Keyword>
<Keyword MajorTopicYN="N">psychodermatology</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702178</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Organic Mood Disorder Following Left Anterior Temporal Lobectomy with Amygdalohippocampectomy.</ArticleTitle>
<Pagination>
<MedlinePgn>441-2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168590</ELocationID>
<Abstract>
<AbstractText>One third of patients with antiepileptic-resistant temporal lobe epilepsy (TLE) will have to undergo surgery for a better seizure control. Anterior temporal lobectomy (ATL) is done for mesial temporal sclerosis that is the most common histopathological lesion associated with TLE. Psychiatric manifestations following ATL are not uncommon with depressive symptoms more common with left ATL and manic symptoms following right ATL. Mr. A is a 42-year-old left cerebral dominant (Confirmed by WADA test) male with no past history of psychiatric illness who had undergone anterior temporal lobectomy with amygdalohippocampectomy. He started having manic episodes post operatively which subsided with antipsychotics. He had multiple such episodes over the next 13 years with minimal inter episodic symptoms. This is a rare instance of manic symptoms following left-sided ATL that emphasizes the need for better understanding of the cerebral laterality of affective symptoms. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Haridas</LastName>
<ForeName>Nishanth J</ForeName>
<Initials>NJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Government Medical College, Kozhikode, Kerala, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kalayil</LastName>
<ForeName>Rajeesh V</ForeName>
<Initials>RV</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Government Medical College, Kozhikode, Kerala, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tharayil</LastName>
<ForeName>Harish M</ForeName>
<Initials>HM</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Government Medical College, Kozhikode, Kerala, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rappai</LastName>
<ForeName>Mary P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Comprehensive Center For Sleep Disorders, Sri Chitra Tirunal Institute of Medical Sciences and Technology, Thiruvananthapuram, Kerala, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676212</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Anterior temporal lobectomy</Keyword>
<Keyword MajorTopicYN="N">mania</Keyword>
<Keyword MajorTopicYN="N">mood disorder</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702179</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Comorbid Functional Shoulder Pain and Zolpidem Dependence Treated with Pramipexole.</ArticleTitle>
<Pagination>
<MedlinePgn>443-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168591</ELocationID>
<Abstract>
<AbstractText>Pramipexole is a dopamine agonist with higher affinity for D3 receptors. Treatment with pramipexole in clinical conditions such as restless legs syndrome, fibromyalgia, and parkinsonism has been found to significantly improve measures of pain and sleep along with the other symptoms. There is no research data available that explores the usefulness of pramipexole in somatoform/functional pain syndromes. We report a case of a 65-year-old male with bilateral functional shoulder pain associated with insomnia and zolpidem dependence effectively treated with pramipexole. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kandre</LastName>
<ForeName>Dhiraj</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Smt. N.H.L. Municipal Medical College and Sheth V.S. General Hospital, Ahmedabad, Gujarat, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Banwari</LastName>
<ForeName>Girish</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Smt. N.H.L. Municipal Medical College and Sheth V.S. General Hospital, Ahmedabad, Gujarat, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sharma</LastName>
<ForeName>Prateek</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Smt. N.H.L. Municipal Medical College and Sheth V.S. General Hospital, Ahmedabad, Gujarat, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676213</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Functional pain</Keyword>
<Keyword MajorTopicYN="N">insomnia</Keyword>
<Keyword MajorTopicYN="N">pramipexole</Keyword>
<Keyword MajorTopicYN="N">zolpidem dependence</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702180</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Low-dose Amisulpride for Debilitating Clozapine-induced Sialorrhea: Case Series and Review of Literature.</ArticleTitle>
<Pagination>
<MedlinePgn>446-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168592</ELocationID>
<Abstract>
<AbstractText>Clozapine-induced sialorrhea (CIS) affects about one-third of patients treated with clozapine, at times can be stigmatizing, socially embarrassing, disabling, affect quality-of-life, cause poor compliance and can be potentially life-threatening adverse effect. Prompt and effective treatment of CIS may assist treatment tolerability, adherence, and better outcomes in patients with treatment nonresponsive schizophrenia. The beneficial effect of amisulpride augmentation of clozapine therapy for such patients may be enhanced by its anti-salivatory effect on CIS. Current series of five subjects who developed CIS that responded poorly to anticholinergic drugs found drastic improvement in daytime and nocturnal CIS with very low-dose (50-100 mg/day) of amisulpride. Low-dose amisulpride augmentation may also provide strong ameliorating effect on CIS. Nevertheless, a long-term, large-scale study with a broader dose range is warranted to evaluate the stability of this effect across time. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kulkarni</LastName>
<ForeName>Ranganath R</ForeName>
<Initials>RR</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, SDM College of Medical Sciences and Hospital, Dharwad, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676214</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">adverse effect</Keyword>
<Keyword MajorTopicYN="N">amisulpride</Keyword>
<Keyword MajorTopicYN="N">clozapine</Keyword>
<Keyword MajorTopicYN="N">hypersalivation</Keyword>
<Keyword MajorTopicYN="N">sialorrhea</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702181</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Carbamazepine in Treatment of Visual Hallucinations: A Case of Chronic Hallucinatory Psychosis.</ArticleTitle>
<Pagination>
<MedlinePgn>449-51</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168594</ELocationID>
<Abstract>
<AbstractText>Visual hallucinations are commonly present in various neurological and psychiatric conditions such as schizophrenia and other hallucinatory psychosis. Current conceptualization of hallucinations assume pattern completion model of thalamus to be responsible for the origin of this type of the perceptual abnormality and proposes that central inhibition of such circuits may treat hallucinations. We present a case of chronic hallucinatory psychosis with significantly distressing visual hallucinations, resistant to antipsychotics, which successfully responded to carbamazepine. This case illustrates the novel use of an antiepileptic in the treatment of resistant visual hallucinations. Targeted therapy of this kind can be considered in the future, although more evidence is required in this field. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mitra</LastName>
<ForeName>Sayantanava</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Central Institute of Psychiatry, Ranchi, Jharkhand, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Khanra</LastName>
<ForeName>Sourav</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Central Institute of Psychiatry, Ranchi, Jharkhand, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mondal</LastName>
<ForeName>Supriya Kumar</ForeName>
<Initials>SK</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Murshidabad Medical College, Murshidabad, West Bengal, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kavoor</LastName>
<ForeName>Anjana Rao</ForeName>
<Initials>AR</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Central Institute of Psychiatry, Ranchi, Jharkhand, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Das</LastName>
<ForeName>Basudeb</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Central Institute of Psychiatry, Ranchi, Jharkhand, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676215</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Antiepileptic</Keyword>
<Keyword MajorTopicYN="N">carbamazepine</Keyword>
<Keyword MajorTopicYN="N">resistant hallucinations</Keyword>
<Keyword MajorTopicYN="N">visual hallucinations</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702182</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Pachygyria Presented as Mania.</ArticleTitle>
<Pagination>
<MedlinePgn>452-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168595</ELocationID>
<Abstract>
<AbstractText>Psychiatric manifestation of pachygyria, a neuronal migration disorder is rare in literature; rarer if it is bipolar disorder specifically. Here, we report a case of mania and seizure who subsequently diagnosed as pachygyria. Proper literature about pathophysiology is discussed and recently discovered putative genetic role in bipolar disorder explained. This case also emphasis the importance of detailed history taking and imaging investigation even in a pure psychiatric presentation. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chatterjee</LastName>
<ForeName>Seshadri Sekhar</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>Depratment of Psychiatry, Medical College, Kolkata, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Talapatra</LastName>
<ForeName>Devlina</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Depratment of Psychiatry, Medical College, Kolkata, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Acharya</LastName>
<ForeName>Rudra</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Depratment of Psychiatry, Medical College, Kolkata, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sarkhel</LastName>
<ForeName>Sujit</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Institute of Psychiatry, IPGMER, Kolkata, West Bengal, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676216</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bipolar disorder</Keyword>
<Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword>
<Keyword MajorTopicYN="N">pachygyria</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702183</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Systemic Lupus Erythematous Presenting as Catatonia and its Response to Electroconvulie Therapy.</ArticleTitle>
<Pagination>
<MedlinePgn>456-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168597</ELocationID>
<Abstract>
<AbstractText>Neuropsychiatric systemic lupus erythematous (SLE) encompasses various psychiatric and neurological manifestations that develop in SLE patients, secondary to involvement of central nervous system. Neuropsychiatric SLE, presenting as catatonia is very uncommon, and treatment of this condition is not well defined. Previously the role of benzodiazepines, immunosuppression, plasma exchange, and electroconvulsive therapy (ECT) has been described in its management. Here we describe a case of neuropsychiatric lupus presenting as catatonia that did not respond to benzodiazepines or immunosuppression. The symptoms of catatonia showed improvement with ECT. Furthermore, we have discussed the pathology of the disorder and the role of ECT in the treatment of cases of catatonia associated with SLE, who do not respond to benzodiazepines. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hussain</LastName>
<ForeName>Arshad</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mir</LastName>
<ForeName>Tajamul H</ForeName>
<Initials>TH</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Government Medical College, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dar</LastName>
<ForeName>Mansoor Ahmad</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Naqashbandi</LastName>
<ForeName>Javid Iqbal</ForeName>
<Initials>JI</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesia, Government Medical College, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hussain</LastName>
<ForeName>Tajamul</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bashir</LastName>
<ForeName>Anam</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shah</LastName>
<ForeName>Majid Shafi</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mushtaq</LastName>
<ForeName>Raheel</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Saleem</LastName>
<ForeName>Basharat</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesia, Government Medical College, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676217</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Benzodiazepines</Keyword>
<Keyword MajorTopicYN="N">catatonia</Keyword>
<Keyword MajorTopicYN="N">electroconvulsive therapy</Keyword>
<Keyword MajorTopicYN="N">systemic lupus erythematous</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702184</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>An Unusual Startling.</ArticleTitle>
<Pagination>
<MedlinePgn>460-1</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168599</ELocationID>
<Abstract>
<AbstractText>Hyperekplexia is a rare movement disorder, which is mostly of genetic origin; though acquired cases are rarely reported. This disorder is characterized by excessive startling response to external stimuli; this can be disenabling, affecting quality-of-life. Furthermore, it can easily be mistaken for an epileptic disorder. Therefore, the case of a 10-year-old boy who presented with excessive startling shortly after been treated for cerebral malaria is reported; the patient responded to carbamazepine and was discharged home afterward. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Aliyu</LastName>
<ForeName>Ibrahim</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Department of Paediatrics, Aminu Kano Teaching Hospital, Bayero University, Kano, Nigeria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ibrahim</LastName>
<ForeName>Zainab</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Department of Nursing, Aminu Kano Teaching Hospital, Kano, Nigeria.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676218</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Acquired</Keyword>
<Keyword MajorTopicYN="N">hyperekplexia</Keyword>
<Keyword MajorTopicYN="N">startle syndrome</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702185</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Pituitary Macroadenoma Presenting with Multiple Psychiatric Complications.</ArticleTitle>
<Pagination>
<MedlinePgn>462-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168600</ELocationID>
<Abstract>
<AbstractText>We report a case of pituitary macroadenoma with multiple physical and psychiatric complications, which posed a significant diagnostic dilemma and management challenge for the treating teams of neurosurgery, endocrinology and psychiatry. A pragmatic approach comprising of interdisciplinary collaboration resulted in satisfactory management of the case. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sood</LastName>
<ForeName>Mamta</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Patra</LastName>
<ForeName>Bichitra Nanda</ForeName>
<Initials>BN</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Agrawal</LastName>
<ForeName>Alok</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Khandelwal</LastName>
<ForeName>Sudhir K</ForeName>
<Initials>SK</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676219</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Depression</Keyword>
<Keyword MajorTopicYN="N">opioid</Keyword>
<Keyword MajorTopicYN="N">pituitary macroadenoma</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702186</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Electroconvulsive Therapy in a Child Suffering from Acute and Transient Psychotic Disorder with Catatonic Features.</ArticleTitle>
<Pagination>
<MedlinePgn>465-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168603</ELocationID>
<Abstract>
<AbstractText>Electroconvulsive therapy (ECT) is a recognized and effective treatment in adults for several psychiatric disorders. However, the lack of knowledge and experience with the use of ECT among child and adolescent psychiatrists is an obstacle to its appropriate use. Treatment using ECT in children of prepubertal age has been less reported. We present a case of 10-year-old child with a diagnosis of acute and transient psychotic disorder with catatonic features, where we have used ECT successfully. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mohapatra</LastName>
<ForeName>Satyakam</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Mental Health Institute, S.C.B. Medical College, Cuttack, Odisha, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rath</LastName>
<ForeName>Neelmadhav</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Mental Health Institute, S.C.B. Medical College, Cuttack, Odisha, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676220</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Catatonia</Keyword>
<Keyword MajorTopicYN="N">child</Keyword>
<Keyword MajorTopicYN="N">electroconvulsive therapy</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702187</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Obsessive Compulsive Disorder Presenting as Neurological Emergency.</ArticleTitle>
<Pagination>
<MedlinePgn>467-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168611</ELocationID>
<Abstract>
<AbstractText>Chronic epilepsy is leading to behavioral changes including obsessive-compulsive symptoms has been well-studied and shown to be about 22%, but the converse has not been reported. Here, we present a case discussion of a 45-year-old female, who presented with recurrent seizures with hyponatremia, which latter was ascribed to her undiagnosed obsessive compulsive disorder (OCD). This patient later did well on anti-obsessional treatment without any antiepileptic. This embarks the need for detailed psychiatric evaluation for patients in emergency care settings and gives a rare presentation of OCD. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dar</LastName>
<ForeName>Mansoor Ahmad</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wani</LastName>
<ForeName>Rayees Ahmad</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rather</LastName>
<ForeName>Yasir Hassan</ForeName>
<Initials>YH</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kawoos</LastName>
<ForeName>Yuman</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hussain</LastName>
<ForeName>Arshad</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Margoob</LastName>
<ForeName>Mushtaq Ahmad</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dar</LastName>
<ForeName>Mohammad Maqbool</ForeName>
<Initials>MM</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Malla</LastName>
<ForeName>Altaf Ahmad</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676221</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Hyponatremia</Keyword>
<Keyword MajorTopicYN="N">obsessive compulsive disorder</Keyword>
<Keyword MajorTopicYN="N">seizure</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702188</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Disorders Related to Use of Psychoactive Substances in DSM-5: Changes and Challenges.</ArticleTitle>
<Pagination>
<MedlinePgn>470-2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168613</ELocationID>
<Abstract>
<AbstractText>In the most recent edition of Diagnostic and Statistical Manual (DSM) that is DSM-5 many modifications have been made in substance use disorder section. These include changes in terminology; sections and categories; diagnostic criteria; threshold for diagnosis; severity; and specifier. Additionally, there have been certain additions and omissions from the earlier version. Critical evaluation of the changes made to the section on disorders related to use of psychoactive substances in India context has not been published so far. The current paper presents a critique of the changes made to the substance use disorder section in DSM-5. The rationale for these changes put forth by DSM-5 work group on substance related disorders have been discussed. Additionally, attempt has been made to highlight the possible future challenges consequent to the current nosological revision for substance use disorder category. Overall DSM-5 seems to be promising in fulfilling its goal of DSM-ICD harmonisation and movement towards an internationally compatible and practical diagnostic system for mental health disorders. It has increased the scope of addiction by inclusion of behavioural addiction. It has also tried to balance the categorical and dimensional approach to diagnosis. However, the real test of this newer edition of one of the most commonly used nosological systems will be during clinical care and research. This will help address the debatable issues regarding the changes that DSM-5 brings with it. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bhad</LastName>
<ForeName>Roshan</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lal</LastName>
<ForeName>Rakesh</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Balhara</LastName>
<ForeName>Yatan Pal Singh</ForeName>
<Initials>YP</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676222</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Abuse</Keyword>
<Keyword MajorTopicYN="N">DSM 5</Keyword>
<Keyword MajorTopicYN="N">addiction</Keyword>
<Keyword MajorTopicYN="N">dependence</Keyword>
<Keyword MajorTopicYN="N">substance use disorders</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702189</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Pramipexole in the Treatment of Refractory Depression in a Patient with Rapid Cycling Bipolar Disorder.</ArticleTitle>
<Pagination>
<MedlinePgn>473-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168614</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hegde</LastName>
<ForeName>Aditya</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Aditi</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ravi</LastName>
<ForeName>Malvika</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Narayanaswamy</LastName>
<ForeName>Janardhanan C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Math</LastName>
<ForeName>Suresh Bada</ForeName>
<Initials>SB</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676223</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702190</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Mirtazapine Induced Akathisia: Understanding a Complex Mechanism.</ArticleTitle>
<Pagination>
<MedlinePgn>474-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168615</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Raveendranathan</LastName>
<ForeName>Dhanya</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, B. R. Ambedkar Medical College, Bangalore, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Swaminath</LastName>
<ForeName>Gopal Rao</ForeName>
<Initials>GR</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, B. R. Ambedkar Medical College, Bangalore, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676224</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702191</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Helicobacter Pylori-Related Vitamin B12 Deficiency: A Potential Contributor in Neuropsychiatric Disorders.</ArticleTitle>
<Pagination>
<MedlinePgn>475-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168616</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kountouras</LastName>
<ForeName>Jannis</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Polyzos</LastName>
<ForeName>Stergios A</ForeName>
<Initials>SA</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Grigoriadis</LastName>
<ForeName>Nikolaos</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Deretzi</LastName>
<ForeName>Georgia</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676225</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702192</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0253-7176</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of psychological medicine</Title>
<ISOAbbreviation>Indian J Psychol Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Sleep-Walking with Zolpidem: Need for Continued Postmarketing Surveillance.</ArticleTitle>
<Pagination>
<MedlinePgn>476-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0253-7176.168617</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sharma</LastName>
<ForeName>Ajitha</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology, Pondicherry Institute of Medical Sciences, Puducherry, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rama</LastName>
<ForeName>Prakash S</ForeName>
<Initials>PS</Initials>
<AffiliationInfo>
<Affiliation>Department of Emergency Medicine Services, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Psychol Med</MedlineTA>
<NlmUniqueID>7910727</NlmUniqueID>
<ISSNLinking>0253-7176</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676226</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702229</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Is Indian Cancer Unique?</ArticleTitle>
<Pagination>
<MedlinePgn>255-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1398-1</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chintamani</LastName>
<AffiliationInfo>
<Affiliation>Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688265 [Available on 08/01/16]</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702230</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Simulation Training-a Necessity for Future Surgeons.</ArticleTitle>
<Pagination>
<MedlinePgn>258-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1396-3</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mittal</LastName>
<ForeName>Vijay K</ForeName>
<Initials>VK</Initials>
<AffiliationInfo>
<Affiliation>Program Director, General Surgery and Surgical Director, Simulation Center, Providence Hospital and Medical Centers, Clinical Professor Surgery, Wayne State University School of Medicine, 16001 W. Nine Mile Rd., Southfield, MI 48075 USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688276 [Available on 08/01/16]</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702231</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Is Radical Bowel Cancer Resection Under Local Anaesthesia and Sedation Feasible?</ArticleTitle>
<Pagination>
<MedlinePgn>260-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1281-0</ELocationID>
<Abstract>
<AbstractText>Some patients with bowel cancer have significant comorbidities, making them unfit for major surgery under general anaesthesia. However, treatment without surgery offers no possibility of cure, and furthermore, symptom control may be poor. We investigated the possibility of performing these resections under local anaesthesia in patients with a slim body habitus in a cohort of patients rejected for general anaesthesia. Eight patients (4 M, 4 F) aged 77-89 were included in this study. All had significant comorbidities and were deemed unfit for general anaesthesia by the consultant anaesthetist in charge of pre assessing high-risk patients. All patients had undergone a thorough assessment, which included P-POSSUM scoring. The recruited patients underwent a careful and fully informed consenting process, leading to standard cancer resections. These resections occurred between 2005 and 2012, under combined local anaesthesia and sedation. The operations undertaken were four right hemicolectomies (for caecal cancer), two Hartmann's procedures (for sigmoid cancer), one Hartmann's procedure with en bloc small bowel resection (for sigmoid cancer invading small bowel) and one transverse colectomy (for mid transverse colon cancer). Seven patients survived radical surgery without complications, although one died from an unrelated cause 8 months after surgery. One of these surviving patients subsequently underwent CABG and further bowel surgery under GA 2 years later for a metachronous sigmoid cancer. There was one postoperative death due to cardiogenic shock on the third postoperative day. Radical cancer resections under local anaesthesia are feasible in suitably selected high-risk patients with acceptable mortality and comparable medium- to long-term results. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sebastian</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Queen Elizabeth the Queen Mother Hospital, Margate, Kent UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sran</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Queen Elizabeth the Queen Mother Hospital, Margate, Kent UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marzouk</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Queen Elizabeth the Queen Mother Hospital, Margate, Kent UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688268 [Available on 08/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bowel cancer</Keyword>
<Keyword MajorTopicYN="N">Local anaesthesia</Keyword>
<Keyword MajorTopicYN="N">Resection</Keyword>
<Keyword MajorTopicYN="N">Sedation</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702232</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>No Evidence Supporting the Routine Use of Digital Rectal Examinations in Trauma Patients.</ArticleTitle>
<Pagination>
<MedlinePgn>265-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1283-y</ELocationID>
<Abstract>
<AbstractText>Digital rectal exams (DRE) are routinely used on trauma patients during the secondary survey as recommended by current Advanced Trauma Life Support (ATLS) protocols. However, recent literature has called the blanket use of the DRE on each trauma patient into question. The purpose of this study was to evaluate the efficacy of the DRE as a diagnostic tool in the setting of urethral, spinal cord, small bowel, colon, and rectal injuries and determine if it can be eliminated from routine use in the trauma setting. Trauma patients with small bowel, colon, rectal, urethral, and spinal cord injuries, age of 18 years or older, and a noted DRE were included. Exclusion criteria included an age less than 18, patients who received paralytics, a Glasgow Coma Scale (GCS) of 3, and a history of paraplegia or quadriplegia. One-hundred eleven patient records were retrospectively reviewed. Ninety-two male (82.9 %) and 19 (17.1 %) females with a GCS of 13.7 were evaluated. Sixty-two (55.9 %) injuries were penetrating with 49 (44.1) being blunt. The DRE missed 100 % of urethral, 91.7 % of spinal cord, 93.1 % of small bowel, 100 % of colon, and 66.7 % of rectal injuries. For injuries confirmed with radiologic modalities, the DRE missed 93.3 %. For injuries confirmed on exploratory laparotomy, the DRE missed 94.9 %. The DRE has poor sensitivity for the diagnosis of urethral, spinal cord, small bowel, and large bowel injury. The DRE was found to be the most sensitive in the setting of rectal injuries. The DRE offers no benefit or predictive value when compared to other imaging modalities. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Docimo</LastName>
<ForeName>Salvatore</ForeName>
<Initials>S</Initials>
<Suffix>Jr</Suffix>
<AffiliationInfo>
<Affiliation>Department of Surgery, NYU Lutheran Medical Center, 150 55th Street, Brooklyn, NY 11220 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Diggs</LastName>
<ForeName>Laurence</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>NYU Lutheran Medical Center, 150 55th Street, Brooklyn, NY 11220 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Crankshaw</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>NYU Lutheran Medical Center, 150 55th Street, Brooklyn, NY 11220 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Young</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>NYU Lutheran Medical Center, 150 55th Street, Brooklyn, NY 11220 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vinces</LastName>
<ForeName>Fausto</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, St. Barnabas Hospital, 4422 Third Avenue, Bronx, NY 10457 USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688269 [Available on 08/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Digital rectal exam in trauma</Keyword>
<Keyword MajorTopicYN="N">Rectal exam and bowel injury</Keyword>
<Keyword MajorTopicYN="N">Rectal exam and spinal cord injury</Keyword>
<Keyword MajorTopicYN="N">Rectal exam and urethral injury</Keyword>
<Keyword MajorTopicYN="N">Trauma diagnostics</Keyword>
<Keyword MajorTopicYN="N">Trauma protocol</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702233</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Single-Port Microthoracoscopic Sympathicotomy for the Treatment of Primary Palmar Hyperhidrosis: an Analysis of 56 Consecutive Cases.</ArticleTitle>
<Pagination>
<MedlinePgn>270-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1288-6</ELocationID>
<Abstract>
<AbstractText>The objective of this study is to investigate the feasibility and safety of single-port microthoracoscopic thoracic sympathicotomy for the treatment of palmar hyperhidrosis. Between January 2008 and March 2013, 56 patients (36 male, 20 female; mean age 25.6 years, age range 16-39 years) underwent single-port microthoracoscopic thoracic sympathicotomy for palmar hyperhidrosis. Nineteen patients (33.9 %) had moderate palmar hyperhidrosis that could thoroughly wet a handkerchief, and 37 (66.1 %) had severe palmar hyperhidrosis with sweat dripping from the palm. Eight patients (14.3 %) had a positive family history, 34 (60.7 %) had plantar hyperhidrosis, 22 (39.3 %) had axillary hyperhidrosis, and 20 (35.7 %) had both plantar and axillary hyperhidrosis. In addition, 21 patients (37.5 %) had palmar pompholyx, five (8.9 %) had keratolysis exfoliativa, 10 (17.9 %) had chilblains, and nine (16.1 %) had palmar rhagades. A single 10-mm skin incision was made in the third intercostal space at the anterior axillary line, posterior to the pectoralis muscle. A 5-mm microthoracoscope and a 3-mm microelectrocautery hook were inserted through a single port into the thoracic cavity. The third and fourth ribs were identified, and the sympathetic chain was cut using the microelectrocautery hook. The bypassing nerve fibers, such as the Kuntz nerve fiber bundle, were ablated for 2-3 cm along the surface of the rib. The palmar temperature was recorded before and after sympathicotomy. All 56 procedures were completed using single-port microthoracoscopy. No postoperative complications such as hemorrhage, wound infection, hemopneumothorax, bradycardia, or Horner's syndrome were observed. Bilateral procedures were completed in 20-56 min (mean 30 min). The palmar temperature increased by 2.2 ± 0.3 °C after surgery. The postoperative hospital stay was 1-4 days (mean 2.5 days). Mild compensatory sweating of the back and thigh occurred in five patients (8.9 %) at 2-3 days after surgery and disappeared at 7-15 days. The patients were followed up for 28.5 months (range 1-62 months). Hyperhidrosis resolved in both hands after surgery, and the previously wet, cold hands became dry and warm. The efficacy rate was 100 %. Plantar hyperhidrosis was also significantly reduced in 33 of the 34 patients with this condition (remission rate 97.1 %), and axillary hyperhidrosis was significantly reduced in 19 of 22 patients (remission rate 86.4 %). Eighteen of the 20 patients (90.0 %) with both plantar and axillary hyperhidrosis experienced significant alleviation of their symptoms. Single-port microthoracoscopic thoracic sympathicotomy is a safe, convenient, and effective method of treating palmar hyperhidrosis. This procedure can accurately locate the sympathetic chain with a small incision, minimal invasiveness, and good cosmetic results. The procedure is suitable for extensive clinical use. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shi</LastName>
<ForeName>Hongcan</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiothoracic Surgery, Clinical College, Yangzhou University, 11 Huaihai Road, Yangzhou, 225001 Jiangsu Province People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shu</LastName>
<ForeName>Yusheng</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiothoracic Surgery, Clinical College, Yangzhou University, 11 Huaihai Road, Yangzhou, 225001 Jiangsu Province People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shi</LastName>
<ForeName>Weiping</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiothoracic Surgery, Clinical College, Yangzhou University, 11 Huaihai Road, Yangzhou, 225001 Jiangsu Province People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lu</LastName>
<ForeName>Shichun</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiothoracic Surgery, Clinical College, Yangzhou University, 11 Huaihai Road, Yangzhou, 225001 Jiangsu Province People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sun</LastName>
<ForeName>Chao</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiothoracic Surgery, Clinical College, Yangzhou University, 11 Huaihai Road, Yangzhou, 225001 Jiangsu Province People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688259 [Available on 08/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Compensatory sweating</Keyword>
<Keyword MajorTopicYN="N">Primary palmar hyperhidrosis</Keyword>
<Keyword MajorTopicYN="N">Single-port surgery</Keyword>
<Keyword MajorTopicYN="N">Thoracic sympathicotomy</Keyword>
<Keyword MajorTopicYN="N">Video thoracoscope</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702234</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>The Feasibility of Hepatic Resections Using a Bipolar Radiofrequency Device (Habib®).</ArticleTitle>
<Pagination>
<MedlinePgn>276-82</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1295-7</ELocationID>
<Abstract>
<AbstractText>The bipolar radiofrequency device (Habib®) has been recently introduced in order to reduce intraoperative bleeding for a safe hepatic resection as an alternative to the conventional tools. However, indications, perioperative findings, and outcome of the device for hepatic resections remain and deserve to be analyzed. The current study aims to analyze the feasibility of the bipolar radiofrequency device (Habib®) for hepatic resections. Information of the patients that underwent hepatic resection using with the Habib® device between 2007 and 2011 was abstracted. Patient, disease, and operation-related findings and perioperative data were investigated. A total of 71 cases (38 [53.5 %] males, mean age was 56.8 ± 11.9) were analyzed. Metastatic disease (n = 55; 77.5 %) was the leading indication followed by primary liver and biliary malignancies (n = 7; 9.9 %), hemangioma (n = 5; 7 %), hydatid disease (n = 3; 2.8 %), and hepatic gunshot trauma (n = 1; 1.4 %). Metastasectomy was the most commonly performed procedure (n = 31; 56.3 %), but in 24 (77.4 %) cases, it was performed in addition to extended resections. Other procedures in the study patients include segmentectomy in 17, bisegmentectomy in 19, trisegmentectomy in 17, right or left hepatectomy in 8, and extended right/left hepatectomy in 3. The mean (±SD) operation time was 241.7 ± 78.2 min. The median amount of bleeding was 300 cc (range 25-2500), and 23 (32.4 %) cases required perioperative transfusion. The median hospitalization period was 5 days (range 1-47). Lengthened drainage (n = 9, 12.7 %) and intraabdominal abscess (n = 8, 11.23 %) were the most common problems. Hepatic resections using the Habib® device seem to be feasible in cases with primary and metastatic hepatic lesions and benign liver masses and even those with hepatic trauma. It may lessen the amount of intraoperative hemorrhage, although lengthened drainage and intraabdominal abscess were the major postoperative problems in these cases. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Civil</LastName>
<ForeName>Osman</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Department of General Surgery, Kartal Education and Research Hospital, Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kement</LastName>
<ForeName>Metin</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of General Surgery, Kartal Education and Research Hospital, Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Okkabaz</LastName>
<ForeName>Nuri</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of General Surgery, Kartal Education and Research Hospital, Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Haksal</LastName>
<ForeName>Mustafa</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of General Surgery, Kartal Education and Research Hospital, Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gezen</LastName>
<ForeName>Cem</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of General Surgery, Kartal Education and Research Hospital, Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Oncel</LastName>
<ForeName>Mustafa</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of General Surgery, Kartal Education and Research Hospital, Istanbul, Turkey ; Department of General Surgery, Medipol University Hospital, Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688258 [Available on 08/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Blood loss</Keyword>
<Keyword MajorTopicYN="N">Habib</Keyword>
<Keyword MajorTopicYN="N">Hepatectomy</Keyword>
<Keyword MajorTopicYN="N">Liver surgery</Keyword>
<Keyword MajorTopicYN="N">Radiofrequency device</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702235</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Serum Total Cholesterol Levels Would Predict Nosocomial Infections After Gastrointestinal Surgery.</ArticleTitle>
<Pagination>
<MedlinePgn>283-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1296-6</ELocationID>
<Abstract>
<AbstractText>It has been suggested that total cholesterol levels and the use of statin medications are associated with the incidence of complications after gastrointestinal surgery. The aim of this study was to determine if preoperative total cholesterol levels are associated with a higher risk of postoperative infections and mortality. A total of 2211 patients undergoing general surgical procedures between December 2006 and November 2008 at Iizuka Hospital and between January 2010 and March 2012 at Jichi Medical University Hospital were reviewed. Multiple logistic regression models were used to evaluate serum total cholesterol and other variables as predictors of postoperative nosocomial infections. Serum total cholesterol concentrations lower than 160 mg/dl were associated with an increased incidence of superficial and deep incisional surgical site infections. Serum total cholesterol levels showed a reverse J-shaped relationship with the development of organ space surgical site infection and pneumonia. There was no discernible effect of serum cholesterol levels on the postoperative mortality observed in this cohort of patients. Decreased serum albumin was one of the strongest risk factors for the development of nosocomial infection after surgery. Postoperative pneumonia was not observed in patients taking statin medications whose cholesterol levels were &lt;200 mg/dl. Serum total cholesterol may be a valid predictor of surgical outcome. Preoperative statin use may affect the development of postoperative pneumonia in patients with total cholesterol levels below 200 mg/dl. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Morimoto</LastName>
<ForeName>Mitsuaki</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Gastrointestinal Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498 Japan ; Department of Public Health, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nakamura</LastName>
<ForeName>Yoshikazu</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yasuda</LastName>
<ForeName>Yoshikazu</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Gastrointestinal Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lefor</LastName>
<ForeName>Alan T</ForeName>
<Initials>AT</Initials>
<AffiliationInfo>
<Affiliation>Department of Gastrointestinal Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nagaie</LastName>
<ForeName>Takashi</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, Iizuka Hospital, 3-83 Yoshio-machi, Iizuka, Fukuoka 820-8505 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sata</LastName>
<ForeName>Naohiro</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Gastrointestinal Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hosoya</LastName>
<ForeName>Yoshinori</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Gastrointestinal Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Horie</LastName>
<ForeName>Hisanaga</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Gastrointestinal Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Koinuma</LastName>
<ForeName>Koji</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Gastrointestinal Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498 Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688261 [Available on 08/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Pneumonia</Keyword>
<Keyword MajorTopicYN="N">Statins</Keyword>
<Keyword MajorTopicYN="N">Surgical site infections</Keyword>
<Keyword MajorTopicYN="N">Total cholesterol</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702236</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Effects of an Educational Module in Rationalizing Surgical Prophylaxis.</ArticleTitle>
<Pagination>
<MedlinePgn>290-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1297-5</ELocationID>
<Abstract>
<AbstractText>Assessment of current antibiotic prescribing patterns is an important step towards appropriate use of antimicrobial agents. This study was planned to know the surgical prophylaxis practices and the influence of educational intervention. In this educational interventional study, only clean and clean-contaminated surgeries were included. Preinterventional study was done by collecting data regarding the use of surgical prophylaxis in the Department of Surgery. After analyzing the preinterventional data, educational intervention was done. A pretest questionnaire was given to all the surgeons to assess knowledge and practice of surgical prophylaxis in our institute. The questionnaire was designed to collect information regarding the use of prophylactic antibiotic, its duration, time of administration, and prevention of surgical site infections (SSI). In our study, third-generation cephalosporin was used in maximum cases in preinterventional analysis and prophylaxis was continued for 3-5 days. Surgeon's decision in selecting a prophylactic agent was based on information taken from departmental colleagues or drug companies. Two or more doses of antibiotic were used even when duration of surgery did not exceed more than two and half hours. Definite improvement was seen after the education where single antibiotic was used as prophylactic drug and the first dose of antibiotic was administered 30 to 60 min before incision. This shows that educational intervention makes a change in antibiotic prescribing habit. Hence, there is an urgent need for adoption of specific guidelines to ensure standardization of surgical antibiotic prophylaxis practices in hospitals. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nagdeo</LastName>
<ForeName>Neena</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology, NKP Salve Institute of Medical Sciences, Wana Dongri, Hingna, Nagpur 440019 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sonarkar</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, NKP Salve Institute of Medical Sciences, Nagpur, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thombare</LastName>
<ForeName>V R</ForeName>
<Initials>VR</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology, NKP Salve Institute of Medical Sciences, Wana Dongri, Hingna, Nagpur 440019 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Akhtar</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, NKP Salve Institute of Medical Sciences, Nagpur, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dasgupta</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>NKP Salve Institute of Medical Sciences, Nagpur, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688270 [Available on 08/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cephalosporins</Keyword>
<Keyword MajorTopicYN="N">Educational intervention</Keyword>
<Keyword MajorTopicYN="N">Prophylactic antibiotic</Keyword>
<Keyword MajorTopicYN="N">Surgical prophylaxis</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702237</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Trauma Registry Development for Jos University Teaching Hospital: Report of the First Year Experience.</ArticleTitle>
<Pagination>
<MedlinePgn>297-300</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1298-4</ELocationID>
<Abstract>
<AbstractText>Adequate intervention in trauma management and prevention requires a well-documented database for objective study of the disease characteristics, hence the need for a trauma registry. The aim and objective of this study is to document in a database all patients admitted in our hospital following trauma. This study was conducted at the Jos University Teaching Hospital, Jos, Plateau State, Nigeria. Beginning 1 January 2012, data was collected on a trauma data sheet and transferred to a 3-page, 80-point questionnaire on Epi info3.5.2 software and stored in a standalone desktop computer. Four hundred fifty-nine patients were registered. Road traffic collisions were the most common causes of trauma, 312 (70.0 %), followed by gunshots, 58 (12.6 %). Mechanism of injury was blunt in 307 patients (66.9 %) and penetrating in 152 patients (33.1 %). Only 9 patients (2.0 %) were brought in by ambulance; majority came by public transportation, 401 (87.4 %). Eighty four patients (18.3 %) suffered various complications; 342 (74.5 %) were discharged home in satisfactory condition, and there were 32 hospital mortalities (7.0 %). Challenges encountered include difficulty in data collection, lack of computer software and internet access, no dedicated registry staff and no funding to engage, train and retain data gathering and management personnel. Our results provide data in support of the known epidemiology of trauma in our environment. Challenges encountered can be overcome using local assets and resources. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ozoilo</LastName>
<ForeName>Kenneth N</ForeName>
<Initials>KN</Initials>
<Identifier Source="ORCID">0000-0002-3689-5876</Identifier>
<AffiliationInfo>
<Affiliation>Surgery Department, Jos University Teaching Hospital, Jos, Nigeria ; Accident and Emergency Unit, Trauma division, Surgery Department, Jos University Teaching Hospital, Jos, Plateau State Nigeria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ali</LastName>
<ForeName>Mariam</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynaecology, Jos University Teaching Hospital, Jos, Nigeria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peter</LastName>
<ForeName>Solomon</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Surgery Department, Jos University Teaching Hospital, Jos, Nigeria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chirdan</LastName>
<ForeName>Lohfa</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Surgery Department, Jos University Teaching Hospital, Jos, Nigeria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mock</LastName>
<ForeName>Charles</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Harborview Injury Prevention and Research Center, Harborview Medical Centre, Seattle, WA USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688274 [Available on 08/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Injury</Keyword>
<Keyword MajorTopicYN="N">Registry</Keyword>
<Keyword MajorTopicYN="N">Trauma</Keyword>
<Keyword MajorTopicYN="N">Trauma record keeping</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702238</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Single-Incision Laparoscopic Right Hemi-Colectomy: a Systematic Review.</ArticleTitle>
<Pagination>
<MedlinePgn>301-12</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1282-z</ELocationID>
<Abstract>
<AbstractText>As surgeons became more adept with laparoscopic colon surgery, other less invasive procedures, such as single-incision laparoscopic right hemi-colectomy (SIL-RH), have been applied. The objective of this study was to evaluate the safety of SIL-RH as well as its intraoperative and postoperative outcomes for right-sided colon diseases. A detailed search in PubMed for citations that included SIL-RH from 2000 to 2014 revealed 21 studies fulfilling the criteria of the present review. A total of 684 patients were analyzed. Of the patients, 50.2 % were men. Mean patient age was 64.8 years. Of the patients, 36.1 % had already undergone an abdominal operation before the performance of SIL-RH, while 69 % of the patients underwent SIL-RH for colon cancer. Relatively low rates of overall morbidity (15 %) and mortality (0.75 %) were reported in the included studies. Mean length of postoperative hospital stay (LOS) was 5.5 days. Bowel motility return had a mean value of 2.8 days. Mean number of harvested lymph nodes (LN) was 19.2 LN. All resection margins were tumor-free. SIL-RH was a safe alternative to multiport laparoscopic right hemi-colectomy (ML-RH) in terms of morbidity and mortality, postoperative gastrointestinal function recovery, LOS, as well as oncological radicalness. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Apostolou</LastName>
<ForeName>K G</ForeName>
<Initials>KG</Initials>
<AffiliationInfo>
<Affiliation>1st Department of Surgery, General Hospital of Athens Laiko, Athens School of Medicine, University of Athens, Agiou Thoma 17, 11527 Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Orfanos</LastName>
<ForeName>S V</ForeName>
<Initials>SV</Initials>
<AffiliationInfo>
<Affiliation>1st Department of Surgery, General Hospital of Athens Laiko, Athens School of Medicine, University of Athens, Agiou Thoma 17, 11527 Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Papalois</LastName>
<ForeName>A E</ForeName>
<Initials>AE</Initials>
<AffiliationInfo>
<Affiliation>1st Department of Propaedeutic Surgery, Athens Medical School, Hippocration Hospital of Athens, Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Felekouras</LastName>
<ForeName>E S</ForeName>
<Initials>ES</Initials>
<AffiliationInfo>
<Affiliation>1st Department of Surgery, General Hospital of Athens Laiko, Athens School of Medicine, University of Athens, Agiou Thoma 17, 11527 Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zografos</LastName>
<ForeName>G C</ForeName>
<Initials>GC</Initials>
<AffiliationInfo>
<Affiliation>1st Department of Propaedeutic Surgery, Athens Medical School, Hippocration Hospital of Athens, Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liakakos</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>1st Department of Surgery, General Hospital of Athens Laiko, Athens School of Medicine, University of Athens, Agiou Thoma 17, 11527 Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688263 [Available on 08/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Laparoscopic</Keyword>
<Keyword MajorTopicYN="N">Oncological</Keyword>
<Keyword MajorTopicYN="N">Right hemi-colectomy</Keyword>
<Keyword MajorTopicYN="N">Single incision</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702239</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Current Concepts in the Management of Congenital Diaphragmatic Hernia in Infants.</ArticleTitle>
<Pagination>
<MedlinePgn>313-21</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1286-8</ELocationID>
<Abstract>
<AbstractText>The therapeutic approach to congenital diaphragmatic hernia (CDH) has shifted from one of immediate repair to management of pulmonary hypertension, physiologic stabilization, and delayed surgical repair. Lung hypoplasia, remodeled pulmonary vasculature, and ventricular dysfunction all contribute to the high morbidity and mortality associated with CDH. In addition, genetic syndromes associated with CDH can increase the incidence of serious anomalies and hence impact survival. Prenatal and postnatal management of infants with CDH is challenging in the best of circumstances and need multidisciplinary teams for optimal outcomes. However, advances using ultrasound and fetal MRI can predict prognosis and survival and plan for postnatal management. Survival rates for patients with CDH have increased for the past decade with better management at resuscitation; implementation of gentle ventilation strategies; and medical management of pulmonary hypertension, physiologic stabilization, and extracorporeal membrane oxygenation. However, follow-up of these infants for long-term morbidities is essential for optimal outcomes after discharge. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>Vasanth H S</ForeName>
<Initials>VH</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, University at Buffalo, State University of New York, Buffalo, NY USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688266 [Available on 08/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">CDH</Keyword>
<Keyword MajorTopicYN="N">ECMO</Keyword>
<Keyword MajorTopicYN="N">Lung hypoplasia</Keyword>
<Keyword MajorTopicYN="N">Neonate</Keyword>
<Keyword MajorTopicYN="N">Pulmonary hypertension</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702240</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Postoperative Mesh Infection-Still a Concern in Laparoscopic Era.</ArticleTitle>
<Pagination>
<MedlinePgn>322-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1304-x</ELocationID>
<Abstract>
<AbstractText>Introduction of synthetic mesh was a landmark breakthrough in the management of hernia repair and has significantly reduced recurrence rates. But in addition to the benefits, some more problems have come in picture major being 'mesh infection'. Prolene mesh has shown promise when used in abdominal and inguinal hernia repair, especially when used in planned surgeries. This material, derived from monofilament polypropelene, is found to be biologically inert in almost every person. Being a foreign material, a slightest breach in asepsis can lead to favourable environment for bacterial proliferation and form a 'biofilm'. This phenomenon especially after laparoscopic surgeries gives rise to chronic discharging sinus at the port site, abscess formation around mesh and even sepsis. It appears that laparoscopic hernia repair is a promising method but having chances of mesh infection owing to difficult approach and lack of uniformity in sterilization of laparoscopic instruments. Slightest breach in sterility or protocols might lead to such a large ventral wall sinus, increasing morbidity and cost of treatment. Treatment of infected mesh is possible by local debridement, irrigation, mesh removal and systemic antibiotics culminating in increased morbidity over duration of disease, but still it would be worth emphasizing-'Prevention is better than cure'. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Narkhede</LastName>
<ForeName>Rajvilas</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of General Surgery, B J Medical College, Ahmedabad, India ; Shemba, Nandura, Buldana, Maharashtra 443103 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shah</LastName>
<ForeName>N M</ForeName>
<Initials>NM</Initials>
<AffiliationInfo>
<Affiliation>Department of General Surgery, B J Medical College, Ahmedabad, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dalal</LastName>
<ForeName>P R</ForeName>
<Initials>PR</Initials>
<AffiliationInfo>
<Affiliation>Department of General Surgery, B J Medical College, Ahmedabad, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mangukia</LastName>
<ForeName>Chirantan</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of General Surgery, B J Medical College, Ahmedabad, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dholaria</LastName>
<ForeName>Shreyas</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of General Surgery, B J Medical College, Ahmedabad, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688277 [Available on 08/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Atypical mycobacteria</Keyword>
<Keyword MajorTopicYN="N">Complication of meshplasty</Keyword>
<Keyword MajorTopicYN="N">Mesh infection</Keyword>
<Keyword MajorTopicYN="N">Mesh rejection</Keyword>
<Keyword MajorTopicYN="N">TEP</Keyword>
<Keyword MajorTopicYN="N">Ventral wall sinus</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702241</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>A Rare Case of Calcified Enterolith Presenting As Subacute Intestinal Obstruction.</ArticleTitle>
<Pagination>
<MedlinePgn>327-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1289-5</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yadav</LastName>
<ForeName>Govind</ForeName>
<Initials>G</Initials>
<Identifier Source="ORCID">0000-0002-6231-4780</Identifier>
<AffiliationInfo>
<Affiliation>Department of General Surgery, RD Gardi Medical College, Ujjain, MP India ; 408 Sector-40, Gurgaon, Haryana 122001 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Husain</LastName>
<ForeName>Sabir</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of General Surgery, RD Gardi Medical College, Ujjain, MP India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shukla</LastName>
<ForeName>Ram</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of General Surgery, RD Gardi Medical College, Ujjain, MP India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Patidar</LastName>
<ForeName>Rakesh</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of General Surgery, RD Gardi Medical College, Ujjain, MP India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Luthra</LastName>
<ForeName>Rohtash</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of General Surgery, RD Gardi Medical College, Ujjain, MP India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688267 [Available on 08/01/16]</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702242</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Medullary Thyroid Carcinoma Metastasis to the Breast and Axillary Lymph Nodes.</ArticleTitle>
<Pagination>
<MedlinePgn>329-31</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1302-z</ELocationID>
<Abstract>
<AbstractText>Breast metastases of medullary thyroid carcinoma (MTC) are extremely rare, and only a few cases have been reported in the literature so far. Here, we report a case of metastatic MTC to the breast and axillary lymph nodes (LN). The case illustrates that (1) metastatic MTC of the breast could be clinically and pathologically misdiagnosed as primary breast cancer, such as invasive lobular carcinoma with axillary LN involvement; (2) unlike other metastatic breast cancer patients, who have very poor prognoses, our patient survived for more than 5 years after the breast and axillary surgery; and (3) metastasis of MTC to the breast is accompanied by axillary LN metastasis, which requires thorough axillary LN dissection, as in most primary breast cancers. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jung</LastName>
<ForeName>Seung Pil</ForeName>
<Initials>SP</Initials>
<AffiliationInfo>
<Affiliation>Division of Breast and Endocrine Surgery, Department of Surgery, Korea University College of Medicine, Seoul, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Hye Yoon</ForeName>
<Initials>HY</Initials>
<AffiliationInfo>
<Affiliation>Division of Breast and Endocrine Surgery, Department of Surgery, Korea University College of Medicine, Seoul, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bae</LastName>
<ForeName>Jeoung Won</ForeName>
<Initials>JW</Initials>
<AffiliationInfo>
<Affiliation>Division of Breast and Endocrine Surgery, Department of Surgery, Korea University College of Medicine, Seoul, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Hoon Yub</ForeName>
<Initials>HY</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, Korea University Thyroid Center, Korea University College of Medicine, Seoul, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688272 [Available on 08/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Breast neoplasm</Keyword>
<Keyword MajorTopicYN="N">Carcinoma</Keyword>
<Keyword MajorTopicYN="N">Medullary</Keyword>
<Keyword MajorTopicYN="N">Neoplasm metastasis</Keyword>
<Keyword MajorTopicYN="N">Thyroid</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702243</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Ectopic Pancreas in the Duodenojejunal Flexure-Computed Tomographic and Endoscopic Ultrasonographic Images.</ArticleTitle>
<Pagination>
<MedlinePgn>332-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1284-x</ELocationID>
<Abstract>
<AbstractText>Ectopic pancreas is a rare entity where the pancreatic tissue has no anatomic and vascular contact with the main body of the pancreas and has its own duct system and vascular supply. A detailed clinical report with contrast-enhanced computed tomography (CT) and endoscopic ultrasonography (EUS) imaging findings of a 40-year-old male came with vague symptoms. CT showed a well-defined homogeneously enhancing mass lesion in the duodenojejunal (DJ) flexure. EUS revealed a well-defined hypoechoic mass lesion in the submucosal layer of the DJ flexure. Surgical resection of the mass was performed, and histopathological examination of specimen confirmed the pancreatic tissues. Here, we have described the CT and EUS imaging features which can help to differentiate the ectopic pancreas from the gastrointestinal submucosal tumours. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rawat</LastName>
<ForeName>Kishan Singh</ForeName>
<Initials>KS</Initials>
<Identifier Source="ORCID">0000-0003-1739-1418</Identifier>
<AffiliationInfo>
<Affiliation>Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, 110060 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Buxi</LastName>
<ForeName>T B S</ForeName>
<Initials>TB</Initials>
<AffiliationInfo>
<Affiliation>Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, 110060 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yadav</LastName>
<ForeName>Anurag</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, 110060 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ghuman</LastName>
<ForeName>Samarjit Singh</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, 110060 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bhalla</LastName>
<ForeName>Sunita</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, 110060 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dhawan</LastName>
<ForeName>Shashi</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, 110060 India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688262 [Available on 08/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Computed tomography</Keyword>
<Keyword MajorTopicYN="N">Duodenojejunal flexure</Keyword>
<Keyword MajorTopicYN="N">Ectopic pancreas</Keyword>
<Keyword MajorTopicYN="N">Endoscopic ultrasonography</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702244</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Epigastric Hernia.</ArticleTitle>
<Pagination>
<MedlinePgn>335</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1285-9</ELocationID>
<Abstract>
<AbstractText>Epigastric hernia is a common condition, mostly asymptomatic although sometimes their unusual clinical presentation still represents a diagnostic dilemma for clinician. The theory of extra tension in the epigastric region by the diaphragm is the most likely theory of epigastric hernia formation. A detailed history and clinical examination in our thin, elderly male patient who presented with abdominal pain and constipation of 5 days of evolution was crucial in establishing a diagnosis. Noninvasive radiologic modalities such as ultrasonographic studies in the case of our patient can reliably confirm the diagnosis of epigastric hernia. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Suarez Acosta</LastName>
<ForeName>Carlos Enrique</ForeName>
<Initials>CE</Initials>
<AffiliationInfo>
<Affiliation>University Hospital Clinico San Carlos, Complutense University from Madrid, C/Profesor Martin Lagos s/n, PC 28040 Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Romero Fernandez</LastName>
<ForeName>Esperanza</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>University Hospital Clinico San Carlos, Complutense University from Madrid, C/Profesor Martin Lagos s/n, PC 28040 Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Calvo Manuel</LastName>
<ForeName>Elpidio</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>University Hospital Clinico San Carlos, Complutense University from Madrid, C/Profesor Martin Lagos s/n, PC 28040 Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688273 [Available on 08/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Carlos Enrique</Keyword>
<Keyword MajorTopicYN="N">Epigastric</Keyword>
<Keyword MajorTopicYN="N">Hernia</Keyword>
<Keyword MajorTopicYN="N">Suárez Acosta</Keyword>
<Keyword MajorTopicYN="N">Ultrasonography</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702245</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Sternal Resection and Reconstruction for Malignant Phylloides Tumor.</ArticleTitle>
<Pagination>
<MedlinePgn>336-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1287-7</ELocationID>
<Abstract>
<AbstractText>Malignant phylloides tumor is a locally aggressive breast neoplasm constituting less than 1 % of all breast cancers. It has a tendency for local recurrence and management is multidisciplinary. We hereby report a case of total sternal resection and reconstruction using Biopore HDPE prosthesis for Malignant Phylloides tumor. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Selvakumar</LastName>
<ForeName>Veda Padma Priya</ForeName>
<Initials>VP</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgical Oncology, Rajiv Gandhi Cancer Institute &amp; Research Centre, Sector V, Rohini, Delhi, 110085 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Poonia</LastName>
<ForeName>Dharmaram</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgical Oncology, Rajiv Gandhi Cancer Institute &amp; Research Centre, Sector V, Rohini, Delhi, 110085 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Agrawal</LastName>
<ForeName>Juhi</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of plastic and Reconstructive Surgery, Rajiv Gandhi Cancer Institute &amp; Research Centre, Sector V, Rohini, Delhi, 110085 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Goel</LastName>
<ForeName>Ashish</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgical Oncology, Rajiv Gandhi Cancer Institute &amp; Research Centre, Sector V, Rohini, Delhi, 110085 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mehta</LastName>
<ForeName>Sandeep</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of plastic and Reconstructive Surgery, Rajiv Gandhi Cancer Institute &amp; Research Centre, Sector V, Rohini, Delhi, 110085 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>Kapil</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgical Oncology, Rajiv Gandhi Cancer Institute &amp; Research Centre, Sector V, Rohini, Delhi, 110085 India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688275 [Available on 08/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Major chest wall reconstruction</Keyword>
<Keyword MajorTopicYN="N">Malignant phylloides tumor</Keyword>
<Keyword MajorTopicYN="N">Total sternal resection</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702246</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Robotic Left Hepatectomy: a Case Report (First Reported Case of Robotic Hepatectomy in India).</ArticleTitle>
<Pagination>
<MedlinePgn>338-40</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1307-7</ELocationID>
<Abstract>
<AbstractText>Robotic surgical platform is being increasingly used by liver surgeons for performing minimal invasive liver surgery, with results comparable to open surgery and added benefits of laparoscopic approach. The authors describe a case of robotic left hepatectomy done for recurrent pyogenic cholangitis. This is the first reported case of robotic hepatectomy done in India. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Goja</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Medanta Institute of Liver Diseases and Transplantation, Medanta-The Medicity, Gurgaon, Haryana India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>M K</ForeName>
<Initials>MK</Initials>
<AffiliationInfo>
<Affiliation>Medanta Institute of Liver Diseases and Transplantation, Medanta-The Medicity, Gurgaon, Haryana India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vohra</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Medanta Institute of Liver Diseases and Transplantation, Medanta-The Medicity, Gurgaon, Haryana India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Soin</LastName>
<ForeName>A S</ForeName>
<Initials>AS</Initials>
<AffiliationInfo>
<Affiliation>Medanta Institute of Liver Diseases and Transplantation, Medanta-The Medicity, Gurgaon, Haryana India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688264 [Available on 08/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Liver</Keyword>
<Keyword MajorTopicYN="N">Recurrent pyogenic cholangitis</Keyword>
<Keyword MajorTopicYN="N">Resection</Keyword>
<Keyword MajorTopicYN="N">Robotic</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702247</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Surgical Management of Nontoxic Multinodular Goiter: Is the Jury Still Out?</ArticleTitle>
<Pagination>
<MedlinePgn>341-2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1310-z</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mohanty</LastName>
<ForeName>Debajyoti</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of General Surgery, All India Institute of Medical Sciences, Raipur, Chhattisgarh 492099 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dalal</LastName>
<ForeName>Ashwani Kumar</ForeName>
<Initials>AK</Initials>
<AffiliationInfo>
<Affiliation>Department of General Surgery, All India Institute of Medical Sciences, Raipur, Chhattisgarh 492099 India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688260 [Available on 08/01/16]</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702248</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0972-2068</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>77</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of surgery</Title>
<ISOAbbreviation>Indian J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>The Cost-Effectiveness of Glove Reprocessing.</ArticleTitle>
<Pagination>
<MedlinePgn>343</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12262-015-1315-7</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Coskun</LastName>
<ForeName>Ali Kagan</ForeName>
<Initials>AK</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, Gulhane School of Medicine, Tevfik Saglam St Etlik, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Harlak</LastName>
<ForeName>Ali</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, Gulhane School of Medicine, Tevfik Saglam St Etlik, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Indian J Surg</MedlineTA>
<NlmUniqueID>0373026</NlmUniqueID>
<ISSNLinking>0973-9793</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688271 [Available on 08/01/16]</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26700703</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1879-355X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>94</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>International journal of radiation oncology, biology, physics</Title>
<ISOAbbreviation>Int. J. Radiat. Oncol. Biol. Phys.</ISOAbbreviation>
</Journal>
<ArticleTitle>Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233.</ArticleTitle>
<Pagination>
<MedlinePgn>67-74</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijrobp.2015.09.030</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0360-3016(15)26529-7</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To investigate the differences in outcomes among patients with muscle-invasive bladder cancer on NRG Oncology Radiation Therapy Oncology Group protocols 9906 and 0233 who achieved complete response and near-complete response after induction chemoradiation and then completed bladder-preserving therapy with chemoradiation therapy (chemo-RT) to full dose (60-64 Gy).</AbstractText>
<AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">A pooled analysis was performed on 119 eligible patients with muscle-invasive bladder cancer enrolled on NRG Oncology Radiation Therapy Oncology Group trials 9906 and 0233, who were classified as having a complete (T0) or near-complete (Ta or Tis) response after induction chemo-RT and completed consolidation with a total RT dose of at least 60 Gy. Bladder recurrence, salvage cystectomy rates, and disease-specific survival were estimated by the cumulative incidence method and bladder-intact and overall survivals by the Kaplan-Meier method.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 119 eligible patients, 101 (85%) achieved T0, and 18 (15%) achieved Ta or Tis after induction chemo-RT and proceeded to consolidation. After a median follow-up of 5.9 years, 36 of 101 T0 patients (36%) versus 5 of 18 Ta or Tis patients (28%) experienced bladder recurrence (P=.52). Thirteen patients among complete responders eventually required late salvage cystectomy for tumor recurrence, compared with 1 patient among near-complete responders (P=.63). Disease-specific, bladder-intact, and overall survivals were not significantly different between T0 and Ta/Tis cases.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The bladder recurrence and salvage cystectomy rates of the complete and the near-complete responders were similar. Therefore it is reasonable to recommend that patients with Ta or Tis after induction chemo-RT continue with bladder-sparing therapy with consolidation chemo-RT to full dose (60-64 Gy).</AbstractText>
<CopyrightInformation>Copyright © 2016 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mitin</LastName>
<ForeName>Timur</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Oregon Health &amp; Science University, Portland, Oregon. Electronic address: mitin@ohsu.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>George</LastName>
<ForeName>Asha</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zietman</LastName>
<ForeName>Anthony L</ForeName>
<Initials>AL</Initials>
<AffiliationInfo>
<Affiliation>Massachusetts General Hospital, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Heney</LastName>
<ForeName>Niall M</ForeName>
<Initials>NM</Initials>
<AffiliationInfo>
<Affiliation>Massachusetts General Hospital, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kaufman</LastName>
<ForeName>Donald S</ForeName>
<Initials>DS</Initials>
<AffiliationInfo>
<Affiliation>Massachusetts General Hospital, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Uzzo</LastName>
<ForeName>Robert G</ForeName>
<Initials>RG</Initials>
<AffiliationInfo>
<Affiliation>Fox Chase Cancer Center, Philadelphia, Pennsylvania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dreicer</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>University of Virginia, Charlottesville, Virginia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wallace</LastName>
<ForeName>H James</ForeName>
<Initials>HJ</Initials>
<Suffix>3rd</Suffix>
<AffiliationInfo>
<Affiliation>University of Vermont College of Medicine, Burlington, Vermont.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Souhami</LastName>
<ForeName>Luis</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>McGill University Health Centre, Montreal, Québec, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dobelbower</LastName>
<ForeName>M Chris</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>University of Alabama at Birmingham, Birmingham, Alabama.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sandler</LastName>
<ForeName>Howard M</ForeName>
<Initials>HM</Initials>
<AffiliationInfo>
<Affiliation>Cedars-Sinai Medical Center, Los Angeles, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shipley</LastName>
<ForeName>William U</ForeName>
<Initials>WU</Initials>
<AffiliationInfo>
<Affiliation>Massachusetts General Hospital, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>U10 CA021661</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U10 CA037422</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U10 CA180822</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U10 CA180868</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Int J Radiat Oncol Biol Phys</MedlineTA>
<NlmUniqueID>7603616</NlmUniqueID>
<ISSNLinking>0360-3016</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">NIHMS737289 [Available on 01/01/17]</OtherID>
<OtherID Source="NLM">PMC4690848 [Available on 01/01/17]</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702196</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>An introduction to peer review.</ArticleTitle>
<Pagination>
<MedlinePgn>437-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169047</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yaddanapudi</LastName>
<ForeName>Lakshmi Narayana</ForeName>
<Initials>LN</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Intensive Care, PGIMER, Chandigarh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yaddanapudi</LastName>
<ForeName>Sandhya</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Intensive Care, PGIMER, Chandigarh, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676228</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702197</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Small is the new big: An overview of newer supraglottic airways for children.</ArticleTitle>
<Pagination>
<MedlinePgn>440-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169048</ELocationID>
<Abstract>
<AbstractText>Almost all supraglottic airways (SGAs) are now available in pediatric sizes. The availability of these smaller sizes, especially in the last five years has brought a marked change in the whole approach to airway management in children. SGAs are now used for laparoscopic surgeries, head and neck surgeries, remote anesthesia; and for ventilation during resuscitation. A large number of reports have described the use of SGAs in difficult airway situations, either as a primary or a rescue airway. Despite this expanded usage, there remains little evidence to support its usage in prolonged surgeries and in the intensive care unit. This article presents an overview of the current options available, suitability of one over the other and reviews the published data relating to each device. In this review, the author also addresses some of the general concerns regarding the use of SGAs and explores newer roles of their use in children. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Goyal</LastName>
<ForeName>Rakhee</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesia and Critical Care, Armed Forces Medical College, Pune, Maharashtra, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676229</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">2nd generation device</Keyword>
<Keyword MajorTopicYN="N">Air Q</Keyword>
<Keyword MajorTopicYN="N">Ambu Aura</Keyword>
<Keyword MajorTopicYN="N">i-gel</Keyword>
<Keyword MajorTopicYN="N">laryngeal mask airway</Keyword>
<Keyword MajorTopicYN="N">laryngeal tube suction</Keyword>
<Keyword MajorTopicYN="N">pediatric</Keyword>
<Keyword MajorTopicYN="N">pediatric airway management</Keyword>
<Keyword MajorTopicYN="N">supraglottic airways</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702198</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Topical anesthesia.</ArticleTitle>
<Pagination>
<MedlinePgn>450-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169049</ELocationID>
<Abstract>
<AbstractText>Topical anesthetics are being widely used in numerous medical and surgical sub-specialties such as anesthesia, ophthalmology, otorhinolaryngology, dentistry, urology, and aesthetic surgery. They cause superficial loss of pain sensation after direct application. Their delivery and effectiveness can be enhanced by using free bases; by increasing the drug concentration, lowering the melting point; by using physical and chemical permeation enhancers and lipid delivery vesicles. Various topical anesthetic agents available for use are eutectic mixture of local anesthetics, ELA-max, lidocaine, epinephrine, tetracaine, bupivanor, 4% tetracaine, benzocaine, proparacaine, Betacaine-LA, topicaine, lidoderm, S-caine patch™ and local anesthetic peel. While using them, careful attention must be paid to their pharmacology, area and duration of application, age and weight of the patients and possible side-effects. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>Mritunjay</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology and Intensive Care, Govind Ballabh Pant Hospital, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chawla</LastName>
<ForeName>Rajiv</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology and Intensive Care, Govind Ballabh Pant Hospital, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Goyal</LastName>
<ForeName>Manish</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology and Intensive Care, Govind Ballabh Pant Hospital, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676230</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Eutectic mixture of local anesthetics</Keyword>
<Keyword MajorTopicYN="N">Topical anesthesia</Keyword>
<Keyword MajorTopicYN="N">iontophoresis</Keyword>
<Keyword MajorTopicYN="N">local anesthetic</Keyword>
<Keyword MajorTopicYN="N">skin permeation enhancer</Keyword>
<Keyword MajorTopicYN="N">sonophoresis</Keyword>
<Keyword MajorTopicYN="N">uses and side-effects of topical anesthetics</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702199</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Ropivacaine: Is it a good choice for spinal anesthesia?</ArticleTitle>
<Pagination>
<MedlinePgn>457-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169050</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mohta</LastName>
<ForeName>Medha</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology and Critical Care, University College of Medical Sciences and GTB Hospital, Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676231</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702200</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Endotracheal tube leak: What should we do?</ArticleTitle>
<Pagination>
<MedlinePgn>459</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169051</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gupta</LastName>
<ForeName>Nishkarsh</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Dr. BRAIRCH, AIIMS, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676232</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702201</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Systematic review of use of β-blockers in sepsis.</ArticleTitle>
<Pagination>
<MedlinePgn>460-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169063</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">We proposed a review of present literature and systematic analysis of present literature to summarize the evidence on the use of β-blockers on the outcome of a patient with severe sepsis and septic shock.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Medline, EMBASE, Cochrane Library were searched from 1946 to December 2013. The bibliography of all relevant articles was hand searched. Full-text search of the grey literature was done through the medical institution database. The database search identified a total of 1241 possible studies. The citation list was hand searched by both the authors. A total of 9 studies were identified.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Most studies found a benefit from β-blocker administration in sepsis. This included improved heart rate (HR) control, decreased mortality and improvement in acid-base parameters. Chronic β-blocker usage in sepsis was also associated with improved mortality. The administration of β-blockers during sepsis was associated with better control of HR. The methodological quality of all the included studies, however, was poor.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">There is insufficient evidence to justify the routine use of β-blockers in sepsis. A large adequately powered multi-centered randomized controlled clinical trial is required to address the question on the efficacy of β-blocker usage in sepsis. This trial should also consider a number of important questions including the choice of β-blocker used, optimal dosing, timing of intervention, duration of intervention and discontinuation of the drug. Until such time based on the available evidence, there is no place for the use of β-blockers in sepsis in current clinical practice.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chacko</LastName>
<ForeName>Cyril Jacob</ForeName>
<Initials>CJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesia and Intensive Care Medicine, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gopal</LastName>
<ForeName>Shameer</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesia and Intensive Care Medicine, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676233</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">cardiac index</Keyword>
<Keyword MajorTopicYN="N">heart rate control</Keyword>
<Keyword MajorTopicYN="N">mortality</Keyword>
<Keyword MajorTopicYN="N">sepsis</Keyword>
<Keyword MajorTopicYN="N">systematic review</Keyword>
<Keyword MajorTopicYN="N">β-blockers</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702202</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Hyperbaric spinal ropivacaine in lower limb and hip surgery: A comparison with hyperbaric bupivacaine.</ArticleTitle>
<Pagination>
<MedlinePgn>466-70</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169064</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Bupivacaine is more cardiotoxic than ropivacaine. Ropivacaine provides effective spinal anesthesia for lower limb and hip surgeries. This prospective study was designed to compare the efficacy and safety of intrathecal hyperbaric ropivacaine with hyperbaric bupivacaine for patients undergoing limb and hip surgeries.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Two hundred patients aged 40-75 years, with American Society of Anesthesiologists I and II of either gender were randomly divided into Group R (Ropivacaine) and Group B (Bupivacaine) to receive an intrathecal injection of 3 ml of hyperbaric ropivacaine 0.5% or 3 ml of hyperbaric bupivacaine 0.5%, respectively. Onset and duration of sensory blockade were determined using the pinprick method by a three-point scale at T-10 dermatome. Onset and duration of motor block were assessed by modified Bromage scale. Duration of postoperative analgesia, hemodynamic changes, central nervous system and cardiovascular system toxicity or any adverse effects were observed.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean onset of sensory block (6 ± 1.3 min vs. 3 ± 1.1 min; P &lt; 0.001) and motor block (13 ± 1.6 min vs. 9 ± 1.3 min; P &lt; 0.05) was significantly slower in ropivacaine group as compared to bupivacaine group. The total duration of sensory block was significantly shorter in the ropivacaine group (160 ± 12.9 min) than in the bupivacaine group (260 ± 16.1 min; P &lt; 0.05). The mean duration of motor block was also shorter in the ropivacaine group compared to bupivacaine group (126 ± 9.2 min vs. 174 ± 12.6 min; P &lt; 0.05). Quality of anesthesia was comparable in two groups (P = 0.04).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We conclude that hyperbaric bupivacaine used intrathecally has a faster onset of sensory block and prolonged duration of analgesia compared to hyperbaric ropivacaine.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dar</LastName>
<ForeName>Feroz Ahmad</ForeName>
<Initials>FA</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Sher-e-Kashmir Institute of Medical Sciences, Medical College Hospital, Bemina, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mushtaq</LastName>
<ForeName>Mohsin Bin</ForeName>
<Initials>MB</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Sher-e-Kashmir Institute of Medical Sciences, Medical College Hospital, Bemina, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Khan</LastName>
<ForeName>Umar Mushtaq</ForeName>
<Initials>UM</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Sher-e-Kashmir Institute of Medical Sciences, Medical College Hospital, Bemina, Srinagar, Jammu and Kashmir, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676234</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bupivacaine</Keyword>
<Keyword MajorTopicYN="N">hyperbaric</Keyword>
<Keyword MajorTopicYN="N">ropivacaine</Keyword>
<Keyword MajorTopicYN="N">spinal anesthesia</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702203</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Ropivacaine 0.025% mixed with fentanyl 3.0 μg/ml and epinephrine 0.5 μg/ml is effective for epidural patient-controlled analgesia after cesarean section.</ArticleTitle>
<Pagination>
<MedlinePgn>471-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169065</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">We aimed to determine the ropivacaine concentration that provided adequate analgesia with early ambulation and minimal urinary retention or other side-effects when used with fentanyl and epinephrine for patient-controlled epidural analgesia (PCEA) after elective cesarean section.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Forty-eight patients were randomized to four groups in a double-blinded fashion. All groups received an initial 10 ml/h of epidural study solution for 24 h. The solution contained: 0.2, 0.1, 0.05, or 0.025% ropivacaine for Groups I-IV, respectively, with fentanyl 3.0 μg/ml and epinephrine 0.5 μg/ml. Patients could administer additional PCEA doses of 4 ml of their study solution with a lock-out time of 10 min. Overall satisfaction, side-effects, motor block, neurologic function, and pain using Visual Analog Scale were assessed.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients in all groups showed no difference in sedation, pruritus, nausea, vomiting, and uterine cramps. Pain scores at rest were lower for Group IV than Groups I-III (P &lt; 0.001). Twelve, five, one, and zero patients could not ambulate in Groups I-IV, respectively. Nine, nine, two, and zero (III &lt;I and II, P = 0.02; IV P = 0.001) patients reported urinary retention in Groups I-IV, respectively. Overall satisfaction scores were high for all groups. Neonatal behavior score was similar and high in all groups.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">0.025% ropivacaine PCEA combined with fentanyl and epinephrine provided effective pain relief after cesarean section with early ambulation and without sensory loss, urinary retention, or increase of side-effects.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cohen</LastName>
<ForeName>Shaul</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Rutgers, The State University of New Jersey - Robert Wood Johnson Medical School, New Brunswick, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chhokra</LastName>
<ForeName>Renu</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Rutgers, The State University of New Jersey - Robert Wood Johnson Medical School, New Brunswick, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stein</LastName>
<ForeName>Mark H</ForeName>
<Initials>MH</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Rutgers, The State University of New Jersey - Robert Wood Johnson Medical School, New Brunswick, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Denny</LastName>
<ForeName>John T</ForeName>
<Initials>JT</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Rutgers, The State University of New Jersey - Robert Wood Johnson Medical School, New Brunswick, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shah</LastName>
<ForeName>Shruti</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Rutgers, The State University of New Jersey - Robert Wood Johnson Medical School, New Brunswick, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mohiuddin</LastName>
<ForeName>Adil</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Rutgers, The State University of New Jersey - Robert Wood Johnson Medical School, New Brunswick, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Naftalovich</LastName>
<ForeName>Rotem</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Rutgers, The State University of New Jersey - Robert Wood Johnson Medical School, New Brunswick, USA ; Department of Anesthesiology, Saint Barnabas Medical Center, Livingston, New Jersey, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhao</LastName>
<ForeName>Rong</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Rutgers, The State University of New Jersey - Robert Wood Johnson Medical School, New Brunswick, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pashkova</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Rutgers, The State University of New Jersey - Robert Wood Johnson Medical School, New Brunswick, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rolleri</LastName>
<ForeName>Noah</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Rutgers, The State University of New Jersey - Robert Wood Johnson Medical School, New Brunswick, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Patel</LastName>
<ForeName>Arpan G</ForeName>
<Initials>AG</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Rutgers, The State University of New Jersey - Robert Wood Johnson Medical School, New Brunswick, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hunter-Fratzola</LastName>
<ForeName>Christine W</ForeName>
<Initials>CW</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Rutgers, The State University of New Jersey - Robert Wood Johnson Medical School, New Brunswick, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676235</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cesarean section</Keyword>
<Keyword MajorTopicYN="N">epidural</Keyword>
<Keyword MajorTopicYN="N">fentanyl</Keyword>
<Keyword MajorTopicYN="N">patient-controlled</Keyword>
<Keyword MajorTopicYN="N">ropivacaine</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702204</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Continuous spinal analgesia with levobupivacaine for postoperative pain management: Comparison of 0.125% versus 0.0625% in elective total knee and hip replacement: A double-blind randomized study.</ArticleTitle>
<Pagination>
<MedlinePgn>478-84</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169066</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Continuous spinal anesthesia (CSA) has not been widely used for postoperative analgesia, mainly to avoid complications from the subarachnoid injection. Recently, the introduction of low caliber CSA catheters (Spinocath(®)), has allowed to decrease anesthetics doses and volumes with good analgesia and reduced complications. The aim of this present study was to compare two concentrations of levobupivacaine administered through CSA for postoperative pain management after major orthopedic surgery. Secondary outcomes were adverse events associated with CSA.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Thirty-two patients were randomized to receive sufentanil 1 mcg/h plus levobupivacaine 0.125%-1 ml/h (Group A0.125) or 0.0625%-2 ml/h (Group B0.0625) for postoperative analgesia through CSA catheter, connected to the elastomeric pump over 48 h. The quality of analgesia was assessed based on pain intensity by Visual Analogic Scale (VAS). Sensory and motor function, hemodynamic, and respiratory parameters were recorded for 96 h after surgery, after which the catheter was removed. In addition, joint mobility was assessed, and any side effects were noted.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">VAS score was ≤30 mm in 25 patients. Three patients in Group A0.125 and 4 in Group B0.0625 (NS), received a rescue dose of levobupivacaine. Median VAS in Group A0.125 was lower than in Group B0.0625 on T1 h (8 ± 11 vs 16 ± 11; P &lt; 0.05), and on T4 h (11 ± 8 vs 18 ± 1; P &lt; 0.05). All patients remained hemodynamically stable. There were no significant differences between groups for postoperative joints mobility.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Levobupivacaine at a dose of 1.25 mg/h administered by CSA provides good quality analgesia independent of concentration and solution volume in patients undergoing total knee and hip replacement.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>D'Ambrosio</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Intensive Care, University of Foggia, Foggia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Spadaro</LastName>
<ForeName>Savino</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Morphology, Surgery and Experimental Medicine, Section Anesthesia and Intensive Care, University of Ferrara, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Natale</LastName>
<ForeName>Chiara</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Intensive Care, University of Foggia, Foggia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cotoia</LastName>
<ForeName>Antonella</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Intensive Care, University of Foggia, Foggia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dambrosio</LastName>
<ForeName>Michele</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Intensive Care, University of Foggia, Foggia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cinnella</LastName>
<ForeName>Gilda</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Intensive Care, University of Foggia, Foggia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676236</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Continuous spinal analgesia</Keyword>
<Keyword MajorTopicYN="N">levobupivacaine</Keyword>
<Keyword MajorTopicYN="N">orthopedic surgery</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702205</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of clonidine and/or fentanyl in combination with intrathecal bupivacaine for lower limb surgery.</ArticleTitle>
<Pagination>
<MedlinePgn>485-90</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169069</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Various adjuncts to local anesthetics have been used with the purpose of improving the quality of subarachnoid block. This randomized double-blind study was conducted to evaluate the efficacy of adding clonidine to bupivacaine and bupivacaine-fentanyl combination.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">A total of 100 patients scheduled for surgery under spinal anesthesia were randomly allocated into four groups (n = 25 each) to receive intrathecal bupivacaine 7.5 mg plus normal saline 0.5 ml (group BS), intrathecal bupivacaine 7.5 mg, and fentanyl 25 μg (group BF), intrathecal bupivacaine 7.5 mg and clonidine 75 μg (group BC), intrathecal bupivacaine 7.5 mg, clonidine 37.5 μg, and fentanyl 12.5 μg (group BCF). The time of onset and duration of sensory block, highest dermatome level of sensory block, time of onset of motor block, time to complete motor block recovery and duration of spinal anesthesia, intraoperative and postoperative hemodynamics and side effects if any were recorded. VAS, total number of patients who were administered supplemental analgesic in each group and the total amount of supplemental analgesic administered in the next 24 h was quantified and documented in all the groups.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The time of onset of sensory block (min) in groups BS, BC, BCF, and BF was 10.80 ± 2.26, 10.20 ± 1.00, 10.00 ± 0.00, and 13.80 ± 2.61 respectively, thus onset of sensory block was significantly earlier in groups BC and BCF. Similarly, onset of motor block was also quicker in groups BC and BCF. Time of requirement of supplemental analgesia was 135.20 ± 12.70 min, 199.2 ± 21.92 min, 209.80 ± 26.32 min, and 208.00 ± 26.58 min in groups BS, BF, BC, and BCF respectively. Intraoperative and postoperative changes in heart rate, mean arterial blood pressure, oxygen saturation, and respiratory rate were comparable. Sedation scores were significantly higher in group BC. Pruritus was only observed in groups BF and BCF. Mean nausea vomiting scores were comparable in all groups.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We conclude that the addition of clonidine in doses of 75 μg and 37.5 μg to low-dose bupivacaine and bupivacaine-fentanyl prolongs the sensory and motor block while increasing the duration of postoperative analgesia without significant side-effects.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Ravanjit</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kundra</LastName>
<ForeName>Sandeep</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gupta</LastName>
<ForeName>Shikha</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Grewal</LastName>
<ForeName>Anju</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tewari</LastName>
<ForeName>Anurag</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676237</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Intrathecal clonidine</Keyword>
<Keyword MajorTopicYN="N">spinal adjuvants</Keyword>
<Keyword MajorTopicYN="N">subarachnoid fentanyl</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702206</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Comparison of different routes of administration of clonidine for analgesia following anterior cruciate ligament repair.</ArticleTitle>
<Pagination>
<MedlinePgn>491-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169070</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">A high percentage of patients undergoing arthroscopic repairs on day care basis complain of inadequate postoperative pain relief. Clonidine was evaluated for the best route as an adjuvant in regional anesthesia in anterior cruciate ligament (ACL) repair to prolong analgesia.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">A prospective randomized double-blinded study was planned in a tertiary care hospital in North India in which 85 American Society of Anesthesiologists I and II patients undergoing ACL repair were enrolled. All groups received 0.5% hyperbaric bupivacaine intrathecally as in control group C. Group IT received intrathecal 1 μg/kg of clonidine along with hyperbaric bupivacaine, group IA received 0.25% bupivacaine and 1 μg/kg clonidine intra-articularly, and group NB received 0.25% bupivacaine and 1 μg/kg clonidine in femoro-sciatic nerve block (FSNB). Postoperative pain free interval and block characteristics were the primary outcomes studied.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Pain-free duration was 546.90 (±93.66) min in group NB (P &lt; 0.001) in comparison to 234.90 (±20.99), 367.80 (±47.40) and 172.20 (±54.82) min in groups IA, IT and C, respectively. Sensory block and motor blockade in NB were 474.90 (±43.80) and 267.40 (±34.59) min, respectively, and were significantly prolonged (P &gt; 0.001) in comparison to other groups. The mean rescue analgesic requirement and cumulative frequency of rescue analgesia were least in group NB, followed by groups IT, IA and C.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Clonidine is safe and effective adjuvant with bupivacaine in prolonging analgesia through various routes employed for post knee surgery pain. The maximum prolongation of analgesia is achieved through FSNB with a risk of prolonging postanesthesia care unit stay.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sahni</LastName>
<ForeName>Neeru</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Panda</LastName>
<ForeName>Nidhi B</ForeName>
<Initials>NB</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jain</LastName>
<ForeName>Kajal</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Batra</LastName>
<ForeName>Yatinder Kumar</ForeName>
<Initials>YK</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dhillon</LastName>
<ForeName>Mandeep Singh</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopedics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jagannath</LastName>
<ForeName>Pushpa</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676238</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Anterior cruciate ligament</Keyword>
<Keyword MajorTopicYN="N">clonidine</Keyword>
<Keyword MajorTopicYN="N">postoperative pain</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702207</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of buprenorphine as an adjunct with plain local anesthetic solution in supraclavicular brachial plexus block on quality and duration of postoperative analgesia.</ArticleTitle>
<Pagination>
<MedlinePgn>496-500</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169072</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Supraclavicular brachial plexus block is ideal for upper limb surgical procedures. Buprenorphine, an agonist antagonist opioid has been used as an adjunct to prolong analgesia. We aimed to evaluate the quality and duration of postoperative analgesia by addition of buprenorphine to local anesthetic solution.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">A prospective, randomized, double-blind control study was conducted on 50 healthy patients of ASA Grade I/II of age group 20-70 years scheduled for orthopedic and reconstructive surgery of upper limb under supraclavicular brachial plexus block. Patients were allocated into two groups, 25 in each group viz.: Group B (buprenorphine group) received 20 ml 0.5% bupivacaine + 15 ml 2% lignocaine with adrenaline (1:200,000) + 4 ml normal saline + 1500 units hyaluronidase + 3 μg/kg buprenorphine diluted to 1 ml normal saline. Group C (control group) received 20 ml 0.5% bupivacaine + 15 ml 2% lignocaine with adrenaline (1:200,000) + 4 ml normal saline + 1500 units hyaluronidase + 1 ml normal saline. The parameters observed were onset and duration of sensory and motor block, quality and duration of analgesia and side-effects.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean duration of postoperative analgesia was significantly longer in Group B (16.04 ± 3.19 h) than in Group C (6.20 ± 0.74 h). There was no difference between two groups on mean onset of sensory block. The mean duration motor block was significantly longer in Group B (4.93 ± 0.94 h) than in Group C (2.25 ± 0.62 h) [P &lt; 0.05]. The mean duration of sensory block was also significantly longer in Group B (5.71 ± 0.94 h) than in Group C (4.94 ± 0.70 h) with P &lt; 0.05.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Addition of 3 μg/kg buprenorphine to 0.5% bupivacaine for supraclavicular brachial plexus block prolonged duration of postoperative analgesia and sensory blockade without an increase in side effects.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Patil</LastName>
<ForeName>Surekha</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Padmashree Dr. D. Y. Patil Medical College and Hospital, Navi Mumbai, Maharashtra, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Debata</LastName>
<ForeName>Debasis</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Padmashree Dr. D. Y. Patil Medical College and Hospital, Navi Mumbai, Maharashtra, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Doshi</LastName>
<ForeName>Chaula</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Padmashree Dr. D. Y. Patil Medical College and Hospital, Navi Mumbai, Maharashtra, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vyas</LastName>
<ForeName>Varsha</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Padmashree Dr. D. Y. Patil Medical College and Hospital, Navi Mumbai, Maharashtra, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sinha</LastName>
<ForeName>Sapna</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Padmashree Dr. D. Y. Patil Medical College and Hospital, Navi Mumbai, Maharashtra, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676239</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bupivacaine</Keyword>
<Keyword MajorTopicYN="N">buprenorphine</Keyword>
<Keyword MajorTopicYN="N">local anesthetics</Keyword>
<Keyword MajorTopicYN="N">postoperative analgesia</Keyword>
<Keyword MajorTopicYN="N">supraclavicular brachial plexus block</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702208</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Incident reporting by acute pain service at a tertiary care university hospital.</ArticleTitle>
<Pagination>
<MedlinePgn>501-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169074</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Provision of effective and safe postoperative pain management is the principal responsibility of acute pain services (APSs). Continuous quality assurance is essential for high-quality patient care. We initiated anonymous reporting of critical incidents by APS to ensure continuous quality improvement and here present prospectively collected data on the reported incidents. Our objective was to analyze the frequency and nature of incidents and to see if any harm was caused to patients.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Data were collected from January 1, 2012 to September 30, 2013. An incident related to pain management was defined as An incident that occurs in a patient receiving pain management supervised by APS, and causes or has the potential to cause harm or affects patient safety. A form was filled including incident type, personnel involved, any harm caused, and steps taken to rectify it. Frequencies and percentages were computed for categorical variables.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 2042 patients were seen and 442 (21.64%) incidents reported during the study period, including documentation errors (136/31%), noncompliance with protocols (113/25.56%), wrong combination of drugs (56/12.66%), premature discontinuation (74/16.72%), prolonged delays in change of syringes (27/6.10%), loss to follow-up (19/4.29%), administration of contraindicated drugs (9/2.03%), catheter pull-outs (6/1.35%), and faulty equipment (2/0.45%). Steps were taken to rectify the errors accordingly. No harm was caused to any patient.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Reporting of untoward incidents and their regular analysis by APS is recommended to ensure high-quality patient care and to provide guidance in making teaching strategies and guidelines to improve patient safety.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ahmed</LastName>
<ForeName>Aliya</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Aga Khan University, Karachi, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yasir</LastName>
<ForeName>Muhammad</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Aga Khan University, Karachi, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676240</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Pain management</Keyword>
<Keyword MajorTopicYN="N">patient safety</Keyword>
<Keyword MajorTopicYN="N">postoperative pain</Keyword>
<Keyword MajorTopicYN="N">quality improvement</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702209</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Different mechanical properties in Seldinger guide wires.</ArticleTitle>
<Pagination>
<MedlinePgn>505-10</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169076</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Most central venous catheters are placed using Seldinger guide wires. EN ISO 11070 is the guideline for testing guide wire flexing performance and tensile strength, and we can safely assume that guide wires in use meet these requirements. Unfortunately, EN ISO 11070 guidelines do not reflect the clinical requirements and we continue to see mechanical failures and their associated complications.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">This in vitro study was performed in an accredited laboratory. With regard to flexing, we: (1) Established the minimum flexing performance needed to meet clinical requirements, (2) developed flexing performance tests which mimic clinical requirement, and (3) evaluated the mechanical properties of various guide wires relative to these requirements. With regard to tensile strength, we used the testing method prescribed in ISO 11070, but did not end the test at 5 Newton (N). We continued until the guide wire was damaged, or we reached maximum tractive force. We then did a wire-to-wire comparison. We examined two basic wire constructions, monofil and core and coil.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Tensile strength: All wires tested, except one, met EN ISO 11070 requirements for 5 N tensile strength. The mean of the wire types tested ranged from 15.06 N to 257.76 N. Flexing performance: None of the wires kinked. The monofil had no evidence of bending. Two core/coil wires displayed minor bending (angle 1.5°). All other wires displayed bending angles between 22.5° and 43.0°.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We recommend that: (1) Clinicians use guide wires with high-end mechanical properties, (2) EN ISO 11070 incorporate our flexing test into their testing method, raise the flexing requirement to kink-proof, (3) and raise the tensile strength requirement to a minimum of 30 N, and (3) all manufacturers and suppliers be required to display mechanical properties of all guide wire, and guide wire kits sold.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Schummer</LastName>
<ForeName>Wolfram</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Intensive Care and Emergency Medicine, SRH Clinic Suhl, Suhl, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676241</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Central venous cannulation</Keyword>
<Keyword MajorTopicYN="N">complications</Keyword>
<Keyword MajorTopicYN="N">flexing/bending/kinking characteristics</Keyword>
<Keyword MajorTopicYN="N">guide wire</Keyword>
<Keyword MajorTopicYN="N">mechanical properties</Keyword>
<Keyword MajorTopicYN="N">tensile strength</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702210</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Pretreatment with nitrous oxide enhances induction of anesthesia with sevoflurane: A randomized controlled trial.</ArticleTitle>
<Pagination>
<MedlinePgn>511-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169079</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Inhalation anesthesia with sevoflurane may be enhanced by several drugs or techniques. The aim of the present study was to investigate the effect of nitrous oxide (N2O) pretreatment on the speed of anesthesia induction with sevoflurane.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Eighty patients scheduled for hysteroscopy under general anesthesia were randomly assigned to inhale for 10 min before induction 50% N2O in oxygen or air via a facemask. Anesthesia was induced with 7-8% sevoflurane in oxygen via a facemask. Bispectral index (BIS), end-tidal carbon dioxide (EtCO2) tidal volume, respiratory rate, oxygen saturation (SpO2), and heart rate were recorded every minute during the 10 min pretreatment periods and every 30 s during the first 300 s of induction with sevoflurane. During induction of anesthesia inspired and end-tidal sevoflurane concentrations were also recorded.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">During the 10 min of inspired 50% N2O or air BIS, EtCO2, tidal volume, respiratory rate and heart rate values did not differ between the two groups except for the SpO2, which was higher in the N2O group (P &lt; 0.001). During induction of anesthesia the N2O group exhibited lower BIS values (P = 0.001), being significant at 60-150 s (P &lt; 0.001, P &lt; 0.001, P = 0.002, P = 0.014) as well as at 270 s (P = 0.004). EtCO2 and tidal volume were consistently lower in the N2O group (P = 0.001, P = 0.041 respectively) and respiratory rate was higher (P = 0.007).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results show that pretreatment of the patients with 50% N2O for 10 min enhances the speed of induction with sevoflurane as assessed by the BIS monitoring.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Fassoulaki</LastName>
<ForeName>Argyro</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Medical School, Aretaieio Hospital, University of Athens, Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Staikou</LastName>
<ForeName>Chryssoula</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Medical School, Aretaieio Hospital, University of Athens, Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676242</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bispectral index</Keyword>
<Keyword MajorTopicYN="N">inhalation induction</Keyword>
<Keyword MajorTopicYN="N">nitrous oxide</Keyword>
<Keyword MajorTopicYN="N">sevoflurane</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702211</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Comparison of ventilatory efficacy and airway dynamics between ProSeal laryngeal mask airway and endotracheal tube in adult patients during general anesthesia.</ArticleTitle>
<Pagination>
<MedlinePgn>517-21</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169081</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Studies have demonstrated minimal hemodynamic variation and postoperative complications with ProSeal laryngeal mask airway (PLMA) compared to endotracheal tube (ETT). Hence, a study was conducted to compare the ventilatory parameters and airway dynamics required to maintain normocarbia and stable hemodynamics with PLMA and ETT.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">A prospective, randomized, single blinded study was conducted on 60 patients aged 20-40 years of American society of anesthesiologists class I and II, divided into Group PLMA and Group ETT. Standard anesthesia protocol was instituted. Group PLMA received PLMA sizes as per manufacturer's recommendations and group ETT received appropriate sized cuffed ETT. Patients were initially ventilated at 14 bpm, I:E ratio 1:2, tidal volume (Vt) 6 ml/kg and later adjusted to maintain end tidal carbon dioxide (EtCO2) between 35 and 40 mmHg. Peak airway pressure (Ppeak), compliance (Compl.), Vt, airway resistance (Raw), hemodynamic parameters, oxygen saturation (SpO2) and EtCO2 were recorded throughout surgery. Postoperative complications if any, were noted.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Demographic parameters, Raw, EtCO2, SpO2 were comparable between groups. Ppeak was lower and Vt needed to maintain EtCO2 of 35-40 mmHg was lesser in Group PLMA. Compl was low for 5 min after insertion of PLMA. Heart rate was significantly reduced at 1 min post insertion; blood pressures were significantly lower upto 2 min after insertion and post removal in group PLMA. Incidence of cough was significantly lower in group PLMA.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">ProSeal laryngeal mask airway maintains adequate ventilation at lower Vts and minimal peak pressures, has lesser hemodynamic variations and lower incidence of postoperative cough compared to ETT.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kannan</LastName>
<ForeName>Sudheesh</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Harsoor</LastName>
<ForeName>S S</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sowmiya</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nethra</LastName>
<ForeName>S S</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>DevikaRani</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sathesha</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676243</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Airway dynamics</Keyword>
<Keyword MajorTopicYN="N">ProSeal laryngeal mask airway</Keyword>
<Keyword MajorTopicYN="N">endotracheal tube</Keyword>
<Keyword MajorTopicYN="N">peak airway pressure</Keyword>
<Keyword MajorTopicYN="N">positive pressure ventilation</Keyword>
<Keyword MajorTopicYN="N">ventilatory parameters</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702212</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Can low dose of propofol effectively suppress fentanyl-induced cough during induction of anaesthesia? A double blind randomized controlled trial.</ArticleTitle>
<Pagination>
<MedlinePgn>522-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169082</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Fentanyl-induced cough (FIC) is often seen after intravenous (IV) administration of fentanyl during the induction of general anesthesia. The aim of this study was to evaluate the effectiveness of low dose of propofol in suppressing of FIC during induction of anesthesia.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">In a prospective double-blind randomized controlled trial, a total of 240 patients, American Society of Anesthesiologists physical status Class I and II, scheduled for elective surgery were randomly assigned into two equally sized groups (n = 120). Patients in Group A received low dose of propofol (10 mg) and patients in Group B received the same volume of normal saline (control group). Two minutes later, all patients were given fentanyl (2 μg/kg) over 2 s through the peripheral IV line in the forearm. The vital sign profiles and frequency and intensity of cough were recorded within 2 min after fentanyl bolus by a nurse blinded to study design. Data were analyzed using independent t-test, paired t-test and Chi-square test.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidences of FIC were 9.2% and 40.8% in Group A (propofol) and Group B (placebo) respectively (P = 0.04). Furthermore, there was a significant difference in the intensity of cough between Groups A and B (P &lt; 0.0001). The hemodynamic value (systolic blood pressure, diastolic blood pressure, heart rate, mean arterial pressure and saturation of oxygen) were similar, and there was no significant difference between two groups in the baseline value or after propofol or placebo injection.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Firouzian</LastName>
<ForeName>Abolfazl</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Emadi</LastName>
<ForeName>Seyed Abdollah</ForeName>
<Initials>SA</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baradari</LastName>
<ForeName>Afshin Gholipour</ForeName>
<Initials>AG</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mousavi</LastName>
<ForeName>Robabeh</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>General Practitioner, Mazandaran University of Medical Sciences, Sari, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kiasari</LastName>
<ForeName>Alieh Zamani</ForeName>
<Initials>AZ</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676244</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cough</Keyword>
<Keyword MajorTopicYN="N">fentanyl</Keyword>
<Keyword MajorTopicYN="N">general anesthesia</Keyword>
<Keyword MajorTopicYN="N">propofol</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702213</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Prevention of hypotension associated with the induction dose of propofol: A randomized controlled trial comparing equipotent doses of phenylephrine and ephedrine.</ArticleTitle>
<Pagination>
<MedlinePgn>526-30</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169083</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Propofol, the most commonly used intravenous (IV) anesthetic agent is associated with hypotension on induction of anesthesia. Different methods have been used to prevent hypotension but with variable results. The objective of this study was to evaluate efficacy of equipotent doses of phenylpehrine and ephedrine in preventing the hypotensive response to the induction dose of propofol.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">One hundred thirty five adult patients were randomised to one of the study groups: propofol-saline (PS), propofol-phenylephrine (PP) or propofol-ephedrine (PE) by adding study drugs to propofol. Anesthesia was induced with a mixture of propofol and the study drug. Patients were manually mask-ventilated for 5 min using 40% oxygen in nitrous oxide and isoflurane at 1%. A baseline mean arterial pressure (MAP) was recorded prior to induction of anesthesia. Systolic, diastolic and mean blood pressure and heart rate were recorded every minute for up to 5 min after induction. Hypotension was defined as a 20% decrease from the baseline MAP.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">There were no significant demographic differences between the groups. Overall incidence of hypotension in this study was 38.5% (52/135). Rate of hypotension was significantly higher in group PS than group PP (60% vs. 24.4% P = 0.001) and group PE (60% vs. 31.1% P = 0.005). In contrast, a significant difference in rate of hypotension was not observed between groups PP and group PE.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In equipotent doses, phenylephrine is as good as ephedrine in preventing the hypotensive response to an induction dose of propofol.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Farhan</LastName>
<ForeName>Muhammad</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, The Aga Khan University Hospital, Karachi, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hoda</LastName>
<ForeName>Muhammad Qamarul</ForeName>
<Initials>MQ</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, The Aga Khan University Hospital, Karachi, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ullah</LastName>
<ForeName>Hameed</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, The Aga Khan University Hospital, Karachi, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676245</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Ephedrine</Keyword>
<Keyword MajorTopicYN="N">hypotension</Keyword>
<Keyword MajorTopicYN="N">induction</Keyword>
<Keyword MajorTopicYN="N">phenylephrine</Keyword>
<Keyword MajorTopicYN="N">propofol</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702214</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>The analgesic efficacy of continuous transversus abdominis plane block in renal transplant recipients.</ArticleTitle>
<Pagination>
<MedlinePgn>531-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169084</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Transversus abdominis plane (TAP) block is suitable for operations where parietal pain is a major cause of pain. Renal transplant recipients are ideally suited to gain maximum benefit from TAP block as the incision classically involves the lower abdomen. This study was conducted to evaluate the analgesic efficacy of continuous TAP block in transplant recipients.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">In a prospective double-blind study, 40 chronic renal failure patients undergoing open renal transplant were randomly divided into two groups. At the end of surgery during closure, a multiorifice epidural catheter was placed in TAP plane. Study group (Group S) received Inj bupivacaine bolus 1 mg/kg (0.25%) followed by infusion 0.25 mg/kg (0.125%) through the catheter, whereas control group (Group C) received normal saline through the catheter. Inj pentazocine (0.3 mg/kg) was given as rescue analgesic at visual analogue score (VAS) &gt; 3 in any group at rest or on movement. The analgesic efficacy was judged by VAS, time of first rescue analgesic, and total analgesic consumption in 24 h.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients in Group S had significant lower VAS scores, longer time to first rescue analgesic (270 ± 347.96 vs. 42.85 ± 32.27 min) and lower pentazocine consumption (9.75 ± 13.95 vs. 56.42 ± 12.46 mg) in 24 h. There was significant sedation in Group C.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The TAP catheter technique for postoperative pain control after renal transplant has proved to be effective in relieving the postoperative pain after renal transplant with less pentazocine requirement and less sedation.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Parikh</LastName>
<ForeName>Beena Kandarp</ForeName>
<Initials>BK</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Critical Care, Institute of Kidney Diseases and Research Centre, Civil Hospital Campus, Ahmedabad, Gujarat, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Waghmare</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Critical Care, Institute of Kidney Diseases and Research Centre, Civil Hospital Campus, Ahmedabad, Gujarat, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shah</LastName>
<ForeName>Veena R</ForeName>
<Initials>VR</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Critical Care, Institute of Kidney Diseases and Research Centre, Civil Hospital Campus, Ahmedabad, Gujarat, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Modi</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Urology and Transplantation, Institute of Kidney Diseases and Research Centre, Civil Hospital Campus, Ahmedabad, Gujarat, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rizvi</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Urology and Transplantation, Institute of Kidney Diseases and Research Centre, Civil Hospital Campus, Ahmedabad, Gujarat, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Khemchandani</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Urology and Transplantation, Institute of Kidney Diseases and Research Centre, Civil Hospital Campus, Ahmedabad, Gujarat, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Butala</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Critical Care, Institute of Kidney Diseases and Research Centre, Civil Hospital Campus, Ahmedabad, Gujarat, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Parikh</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Critical Care, Institute of Kidney Diseases and Research Centre, Civil Hospital Campus, Ahmedabad, Gujarat, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676246</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Drugs-Bupivacaine and pentazocine</Keyword>
<Keyword MajorTopicYN="N">renal transplant</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702215</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Incidence of cesarean section and analysis of risk factors for failed conversion of labor epidural to surgical anesthesia: A prospective, observational study in a tertiary care center.</ArticleTitle>
<Pagination>
<MedlinePgn>535-41</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169085</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">This study aimed to analyze the effect of labor epidural (LE) on the incidence of cesarean section (CS) and assess the risk factors involved in failed conversion of LE to surgical anesthesia for CS.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">A prospective observational study of 18 months from January 2012 to June 2013 was conducted on all patients who had delivered in the labor room suit of our hospital. The data collected for all 4694 patients included their demographics, parity and mode of delivery. In addition a predesigned proforma, with additional information was used for 629 parturient with LE.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">During the study period, total numbers of deliveries performed in our hospital were 4694, with an epidural rate of 13.4% (629/4694). No significant difference (P = 0.06) was observed in the rate of CS among women with or without LE (28 % [n = 176/629] vs. 31.7 % [n = 1289/4065]), however, a statistically significant difference (P &lt; 0.01) was observed in the rate of assisted delivery in patients receiving LE as compared to those delivering without it (8.7% [n = 55/629] vs. n = 3.7% [154/4065]). For 176 patients requiring CS, LE utilization for surgical anesthesia was 52.8% (93/176) and factors identified for not utilizing LE in 47% (83/176) were; failure to achieve surgical anesthesia in 6.8% (12/176), emergency CS in 28.4% (50/176), patient preference in 6.8% (12/176) and inadequate labor pain relief with LE in 5.1% (9/176) patients. Non-obstetric anesthesiologists were involved in 59% (49/83) of cases where LE was not used for CS.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">LE had no effect on the rate of CS; however it significantly increased (P &lt; 0.01) the rate of assisted delivery. Factors like inadequate LE, emergency situations and non-obstetric anesthesiologists can all be responsible for failed conversion of LE to surgical anesthesia for CS.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ismail</LastName>
<ForeName>Samina</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesia, Aga Khan University Hospital, Karachi 74800, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chugtai</LastName>
<ForeName>Shakaib</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesia, Aga Khan University Hospital, Karachi 74800, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hussain</LastName>
<ForeName>Alia</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesia, Aga Khan University Hospital, Karachi 74800, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676247</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cesarean section</Keyword>
<Keyword MajorTopicYN="N">epidural analgesia</Keyword>
<Keyword MajorTopicYN="N">general anesthesia</Keyword>
<Keyword MajorTopicYN="N">labor epidural</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702216</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Comparison between intrathecal isobaric ropivacaine-fentanyl and bupivacaine-fentanyl in elective infraumbilical orthopedic surgery: A randomized controlled study.</ArticleTitle>
<Pagination>
<MedlinePgn>542-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169086</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">We aimed to evaluate and compare the block characteristics and duration of analgesia of intrathecal isobaric ropivacaine-fentanyl and bupivacaine-fentanyl combination in adult patients undergoing lower limb orthopedic surgery.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Seventy-four American Society of Anesthesiologists' I and II adult patients undergoing lower limb orthopedic surgery under subarachnoid block were randomized to receive either 3 ml 0.5% isobaric ropivacaine and 25 mcg fentanyl (Group R) or 3 ml 0.5% isobaric bupivacaine and 25 mcg fentanyl (Group B). The hemodynamic profiles, maximum upper level of sensory block height, time to reach peak block height, two dermatome regression time, and duration of motor block were recorded.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">There was no statistically significant difference regarding the hemodynamic parameters between the groups. The median (range) peak sensory block height was T7 (T4-T9) in Group R and T7 (T4-T10) in Group B. Time to reach peak block height (13.2 ± 2.3 min in Group R vs. 13.7 ± 2.2 min in Group B; P = 0.385) was similar between the groups. Two dermatome regression time in sensory block (median 120 min vs. 85 min; P &lt; 0.001) and duration of motor block (median 245 min vs. 150 min; P &lt; 0.001) was significantly higher in Group B. The duration of analgesia (median 360 min vs. 245 min; P &lt; 0.001) was significantly higher in the bupivacaine group.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Intrathecal isobaric bupivacaine-fentanyl combination produces a significantly longer duration of analgesia, sensory block and motor block than isobaric ropivacaine-fentanyl combination. As ropivacaine has a shorter duration of sensory and motor block, it may be preferred in day care surgery.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Layek</LastName>
<ForeName>Amitava</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Institute of Post Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital, Kolkata, West Bengal, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maitra</LastName>
<ForeName>Souvik</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Institute of Post Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital, Kolkata, West Bengal, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gozi</LastName>
<ForeName>Nitish K</ForeName>
<Initials>NK</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Institute of Post Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital, Kolkata, West Bengal, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bhattacharjee</LastName>
<ForeName>Sulagna</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Institute of Post Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital, Kolkata, West Bengal, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pal</LastName>
<ForeName>Sugata</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Institute of Post Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital, Kolkata, West Bengal, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sen</LastName>
<ForeName>Suvadeep</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Institute of Post Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital, Kolkata, West Bengal, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hazra</LastName>
<ForeName>Avijit</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology, Institute of Post Graduate Medical Education and Research, Kolkata, West Bengal, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676248</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bupivacaine</Keyword>
<Keyword MajorTopicYN="N">intrathecal bupivacaine</Keyword>
<Keyword MajorTopicYN="N">orthopedic surgery</Keyword>
<Keyword MajorTopicYN="N">ropivacaine</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702217</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Basics, common errors and essentials of statistical tools and techniques in anesthesiology research.</ArticleTitle>
<Pagination>
<MedlinePgn>547-53</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169087</ELocationID>
<Abstract>
<AbstractText>The statistical portion is a vital component of any research study. The research methodology and the application of statistical tools and techniques have evolved over the years and have significantly helped the research activities throughout the globe. The results and inferences are not accurately possible without proper validation with various statistical tools and tests. The evidencebased anesthesia research and practice has to incorporate statistical tools in the methodology right from the planning stage of the study itself. Though the medical fraternity is well acquainted with the significance of statistics in research, there is a lack of in-depth knowledge about the various statistical concepts and principles among majority of the researchers. The clinical impact and consequences can be serious as the incorrect analysis, conclusions, and false results may construct an artificial platform on which future research activities are replicated. The present tutorial is an attempt to make anesthesiologists aware of the various aspects of statistical methods used in evidence-based research and also to highlight the common areas where maximum number of statistical errors are committed so as to adopt better statistical practices. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bajwa</LastName>
<ForeName>Sukhminder Jit Singh</ForeName>
<Initials>SJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology and Intensive Care, Gian Sagar Medical College and Hospital, Banur, Patiala, Punjab, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676249</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Confidence interval</Keyword>
<Keyword MajorTopicYN="N">research studies</Keyword>
<Keyword MajorTopicYN="N">statistics</Keyword>
<Keyword MajorTopicYN="N">study design</Keyword>
<Keyword MajorTopicYN="N">type-I error</Keyword>
<Keyword MajorTopicYN="N">type-II error</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702218</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Acute pain services in India: A glimpse of the current scenario.</ArticleTitle>
<Pagination>
<MedlinePgn>554-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169088</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Acute postoperative pain is still a neglected and unresolved issue in day to day practice. Acute pain services were conceived three decades ago to form a dedicated team to monitor pain assessment and treatment as per laid down pain protocols and guidelines. The concept of acute pain service (APS) is slowly evolving in India.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">This nationwide questionnaire survey was conducted to identify the status of postoperative pain, the prevalent treatment practices, and the prevalence of acute pain services in India. An electronic communication was sent to 4000 Indian Society of Anesthesiologists life members.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">We received only 146 responses mainly from faculties/consultants from few corporate hospitals or medical colleges. About 68 APSs were functioning, however, 20 APS do not have any training programs and 34 have no written protocols. Anesthesiologists were involved in postoperative pain management only when epidural analgesia was employed.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This survey found that majority of anesthesiologists agree to establish an APS, however administrative issues seem to be a major barrier.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jain</LastName>
<ForeName>Parmanand N</ForeName>
<Initials>PN</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Tata Memorial Hospital, Mumbai, Maharashtra, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bakshi</LastName>
<ForeName>Sumitra G</ForeName>
<Initials>SG</Initials>
<AffiliationInfo>
<Affiliation>Department of Critical Care and Pain, Tata Memorial Hospital, Mumbai, Maharashtra, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thota</LastName>
<ForeName>Raghu S</ForeName>
<Initials>RS</Initials>
<AffiliationInfo>
<Affiliation>Department of Critical Care and Pain, Tata Memorial Hospital, Mumbai, Maharashtra, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676250</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Acute pain service</Keyword>
<Keyword MajorTopicYN="N">pain in India</Keyword>
<Keyword MajorTopicYN="N">post-operative pain</Keyword>
<Keyword MajorTopicYN="N">questionnaire survey</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702219</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Anesthetic management of parturient with thoracic kyphoscoliosis, malaria and acute respiratory distress syndrome for urgent cesarean section.</ArticleTitle>
<Pagination>
<MedlinePgn>558-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169090</ELocationID>
<Abstract>
<AbstractText>The management of cesarean section in kyphoscoliotic patient is challenging. The respiratory changes and increased metabolic demands due to pregnancy may compromise the limited respiratory reserves in such patients. Presence of other comorbidities like malaria and respiratory tract infection will further compromise the effective oxygenation. We report a case of kyphoscoliosis along with malaria and acute respiratory distress syndrome for urgent cesarean section. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pandey</LastName>
<ForeName>Ravindra Kr</ForeName>
<Initials>RK</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology and Intensive Care, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Batra</LastName>
<ForeName>Meenu M</ForeName>
<Initials>MM</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology and Intensive Care, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Darlong</LastName>
<ForeName>Vanlal</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology and Intensive Care, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Garg</LastName>
<ForeName>Rakesh</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology and Intensive Care, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Punj</LastName>
<ForeName>Jyotsna</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology and Intensive Care, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>Sri</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology and Intensive Care, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676251</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cesarean section</Keyword>
<Keyword MajorTopicYN="N">kyphoscoliosis</Keyword>
<Keyword MajorTopicYN="N">malaria</Keyword>
<Keyword MajorTopicYN="N">respiratory tract infection</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702220</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Fluoroscopically-guided epidural blood patch for spontaneous intracranial hypotension.</ArticleTitle>
<Pagination>
<MedlinePgn>560-1</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169091</ELocationID>
<Abstract>
<AbstractText>We present three patients with spontaneous intracranial hypotension who failed conservative treatment and were treated with image-guided epidural blood patch close to the cerebrospinal fluid (CSF) leak site. Each patient achieved significant long-term improvement of clinical symptoms and CSF leak related image findings. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shah</LastName>
<ForeName>Manish</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Penn State Hershey Medical Center, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Giampetro</LastName>
<ForeName>David M</ForeName>
<Initials>DM</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Penn State Hershey Medical Center, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kalapos</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Penn State Hershey Medical Center, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Caldwell</LastName>
<ForeName>Julia C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Penn State Hershey Medical Center, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676252</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cerebrospinal spinal fluid leak</Keyword>
<Keyword MajorTopicYN="N">connective tissue</Keyword>
<Keyword MajorTopicYN="N">epidural blood patch</Keyword>
<Keyword MajorTopicYN="N">fluoroscopy</Keyword>
<Keyword MajorTopicYN="N">headache</Keyword>
<Keyword MajorTopicYN="N">intracranial hypotension</Keyword>
<Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword>
<Keyword MajorTopicYN="N">myelography</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702221</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>All that appears well is not well: A novel method to detect an unusual manufacturing defect of the endotracheal tube.</ArticleTitle>
<Pagination>
<MedlinePgn>562</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169092</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sachdeva</LastName>
<ForeName>Ritu</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesia, ESIC Model Hospital, Baddi, Himachal Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bhatia</LastName>
<ForeName>Nidhi</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesia and Intensive Care, PGIMER, Chandigarh, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676253</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702222</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Difficult airway after late postoperative bleeding in a case of total thyroidectomy, tracheal resection and reconstruction.</ArticleTitle>
<Pagination>
<MedlinePgn>563-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169096</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kapoor</LastName>
<ForeName>Mukul Chandra</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Saket City Hospital, Saket, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Garg</LastName>
<ForeName>Shaloo</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Saket City Hospital, Saket, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jaiswal</LastName>
<ForeName>Binita</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Saket City Hospital, Saket, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Choudhri</LastName>
<ForeName>Sharan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Oncosurgery, Saket City Hospital, Saket, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Saxena</LastName>
<ForeName>Prashant</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Pulmonology, Saket City Hospital, Saket, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676254</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702223</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Unrecognized epiglottic cyst: Cause of difficult mask ventilation.</ArticleTitle>
<Pagination>
<MedlinePgn>566-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169097</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jayaram</LastName>
<ForeName>Kavitha</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology and Critical Care, Nizam's Institute of Medical Sciences, Punjagutta, Hyderabad, Telangana, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gurajala</LastName>
<ForeName>Indira</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology and Critical Care, Nizam's Institute of Medical Sciences, Punjagutta, Hyderabad, Telangana, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Diddi</LastName>
<ForeName>Srikanth</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology and Critical Care, Nizam's Institute of Medical Sciences, Punjagutta, Hyderabad, Telangana, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ramachandran</LastName>
<ForeName>Gopinath</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology and Critical Care, Nizam's Institute of Medical Sciences, Punjagutta, Hyderabad, Telangana, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676255</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702224</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>High arch palate: A bane for ProSeal laryngeal mask airway but a boon for I-gel.</ArticleTitle>
<Pagination>
<MedlinePgn>568</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169098</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bala</LastName>
<ForeName>Renu</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Neuroanaesthesiology, Neurosciences Centre, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hazarika</LastName>
<ForeName>Amarjyoti</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Neuroanaesthesiology, Neurosciences Centre, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pandia</LastName>
<ForeName>Mihir Prakash</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Department of Neuroanaesthesiology, Neurosciences Centre, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>Niraj</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Neuroanaesthesiology, Neurosciences Centre, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676256</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702225</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Unusual airway foreign body: Vigilance is the price of safety.</ArticleTitle>
<Pagination>
<MedlinePgn>568-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169099</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Barde</LastName>
<ForeName>Sushma</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Critical Care, Medanta - The Medicity, Gurgaon, Haryana, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Roy</LastName>
<ForeName>Preety Mittal</ForeName>
<Initials>PM</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Critical Care, Medanta - The Medicity, Gurgaon, Haryana, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Khanna</LastName>
<ForeName>Sangeeta</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Critical Care, Medanta - The Medicity, Gurgaon, Haryana, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mehta</LastName>
<ForeName>Yatin</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Critical Care, Medanta - The Medicity, Gurgaon, Haryana, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676257</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702226</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Ultrasound: An ode to perioperative complicated malaria.</ArticleTitle>
<Pagination>
<MedlinePgn>570-2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169100</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Samanta</LastName>
<ForeName>Sukhen</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesia and Critical Care (Trauma Centre), JPNA Trauma Centre, AIIMS, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Samanta</LastName>
<ForeName>Sujay</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Critical Care Medicine, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jain</LastName>
<ForeName>Kajal</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sinha</LastName>
<ForeName>Bireswar</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Community Medicine, Lady Hardinge Medical College, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Haldar</LastName>
<ForeName>Rudrashish</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesia, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676258</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702227</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>A child with Jervell and Lange-Nielsen syndrome for permanent pacemaker implantation and sympathectomy: Anesthesia management and considerations.</ArticleTitle>
<Pagination>
<MedlinePgn>573-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169101</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nair</LastName>
<ForeName>Abhijit S</ForeName>
<Initials>AS</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Care Hospital, Axon Anesthesia Associates, Hyderabad, Andhra Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nirale</LastName>
<ForeName>Anand M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Care Hospital, Axon Anesthesia Associates, Hyderabad, Andhra Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gopal</LastName>
<ForeName>Thota Venkata Sanjeev</ForeName>
<Initials>TV</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Care Hospital, Axon Anesthesia Associates, Hyderabad, Andhra Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sriprakash</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Care Hospital, Axon Anesthesia Associates, Hyderabad, Andhra Pradesh, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676259</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702228</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0970-9185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2015 Oct-Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of anaesthesiology, clinical pharmacology</Title>
<ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Mirror therapy: An adjunct to conventional pharmacotherapy in phantom limb pain.</ArticleTitle>
<Pagination>
<MedlinePgn>575-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.169102</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Datta</LastName>
<ForeName>Rashmi</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology and Critical Care, Base Hospital, Delhi Cantonment, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dhar</LastName>
<ForeName>Mridul</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology and Critical Care, Base Hospital, Delhi Cantonment, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA>
<NlmUniqueID>9516972</NlmUniqueID>
<ISSNLinking>0970-9185</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4676260</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702355</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Print">1674-9782</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>6</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Journal of animal science and biotechnology</Title>
<ISOAbbreviation>J Anim Sci Biotechnol</ISOAbbreviation>
</Journal>
<ArticleTitle>Molecular cloning and expression patterns of the cholesterol side chain cleavage enzyme (CYP11A1) gene during the reproductive cycle in goose (Anas cygnoides).</ArticleTitle>
<Pagination>
<MedlinePgn>54</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40104-015-0053-9</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">CYP11A1, a gene belonging to the family 11 of cytochrome P450, encodes a crucial steroidogenic enzyme that catalyzes the initial step in the production of all classes of steroids. Many studies show that CYP11A1 plays a role in ovary function. However, the role of CYP11A1 in goose reproductive cycle remains largely unknown.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In this study, full-length CYP11A1 cDNA of Zhedong goose was obtained using reverse transcription polymerase chain reaction (RT-PCR) and rapid amplification of cDNA ends (RACE). The cDNA consisted of a 96-base pair (bp) 5'untranslated region (UTR), a 179-bp 3'UTR and a 1509-bp open reading frame. The open reading frame encodes a putative 503 amino acid protein that shares high homology with CYP11A1 of other birds. The amino acid sequence possesses conserved domains of the P450 superfamily, which include the steroid-binding domain and the heme-binding region. Real-time quantitative polymerase chain reaction (qPCR) analysis revealed CYP11A1 mRNA was expressed ubiquitously in every Zhedong goose tissue analyzed, including the heart, liver, glandular stomach, lung, spleen, kidney, intestinum tenue, intestinum crassum, cerebrum, cerebellum, muscle, oviduct, pituitary, hypothalamus and ovary.. The relatively low levels of CYP11A1 mRNA were detected in pituitary, ovary and oviduct tissues at ovulation when compared with levels at oviposition. Interestingly, higher expression was observed in ovary and oviduct tissues during brooding. Lastly, higher mRNA expression of Yangzhou geese was detected during the ovulation period than that of Zhedong geese.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings reveal the sequence characterization and expression patterns of the CYP11A1 gene during the goose reproductive cycle, which may provides correlative evidence that CYP11A1 expression is important in reproduction activity.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Xu</LastName>
<ForeName>Qi</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, 225009 PR China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Song</LastName>
<ForeName>Yadong</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, 225009 PR China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Yang</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, 225009 PR China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Ran</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, 225009 PR China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Yang</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, 225009 PR China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Yang</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, 225009 PR China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Zhengyang</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, 225009 PR China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhao</LastName>
<ForeName>Wenming</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, 225009 PR China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chang</LastName>
<ForeName>Guobin</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, 225009 PR China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Guohong</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Key Laboratory of Animal Genetics and Breeding and Molecular Design of Jiangsu Province, Yangzhou University, Yangzhou, 225009 PR China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Anim Sci Biotechnol</MedlineTA>
<NlmUniqueID>101581293</NlmUniqueID>
<ISSNLinking>1674-9782</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688999</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">CYP11A1</Keyword>
<Keyword MajorTopicYN="N">Gene expression</Keyword>
<Keyword MajorTopicYN="N">Goose</Keyword>
<Keyword MajorTopicYN="N">Reproduction</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702356</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Print">1674-9782</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>6</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Journal of animal science and biotechnology</Title>
<ISOAbbreviation>J Anim Sci Biotechnol</ISOAbbreviation>
</Journal>
<ArticleTitle>Effects of SNPs and alternative splicing within HGF gene on its expression patterns in Qinchuan cattle.</ArticleTitle>
<Pagination>
<MedlinePgn>55</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40104-015-0059-3</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Identification of genetic variants, including SNPs (Single Nucleotide Polymorphisms), CNVs (Copy Number Variations) and alternative splicing, within functional genes has received increasing attention in animal science research. HGF (Hepatocyte Growth Factor) is a very important growth factor that works as a mitogen or a morphogen during tissue growth, development and regeneration. However, to date, the functions of genetic variants within the bovine HGF gene, particularly their effects on mRNA expression, have not been determined well.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The present study aimed to perform association analysis between genetic variants and mRNA expression for the bovine HGF gene in Qinchuan cattle using various strategies, including PCR-RFLP (Restriction Fragment Length Polymorphism), qPCR (Quantitative Real-time quantitative PCR), TA cloning, DNA sequencing and bioinformatics analysis. A total of five SNPs were identified and only SV1 locus significantly affected HGF mRNA expression in fetal skeletal muscle (P &lt; 0.05). Heterozygous genotype individuals showed significantly higher HGF expression (P &lt; 0.05), which was significantly greater in the "CTCCAGGGTT" combined genotype than that in the "CCCCGGGGTT" combined genotype (P &lt; 0.05). In addition, two alternative splicing variations, HGF-W and HGF-M, were identified, which resulted from alternative 3' splice sites of exon 5, and HGF-W showed higher mRNA levels than HGF-M in all tissues.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In summary, genetic variations within the HGF gene affected mRNA expression. These findings provide new insight into the molecular characteristics and functions of bovine HGF.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cai</LastName>
<ForeName>Hanfang</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>College of Animal Science and Technology, Shaanxi Key Laboratory of Molecular Biology for Agriculture, Northwest A&amp;F University, Yangling, Shaanxi 712100 People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhou</LastName>
<ForeName>Yang</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>College of Animal Science and Technology, Shaanxi Key Laboratory of Molecular Biology for Agriculture, Northwest A&amp;F University, Yangling, Shaanxi 712100 People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jia</LastName>
<ForeName>Wenchao</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>College of Animal Science and Technology, Shaanxi Key Laboratory of Molecular Biology for Agriculture, Northwest A&amp;F University, Yangling, Shaanxi 712100 People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Bowen</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>College of Animal Science and Technology, Shaanxi Key Laboratory of Molecular Biology for Agriculture, Northwest A&amp;F University, Yangling, Shaanxi 712100 People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lan</LastName>
<ForeName>Xianyong</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>College of Animal Science and Technology, Shaanxi Key Laboratory of Molecular Biology for Agriculture, Northwest A&amp;F University, Yangling, Shaanxi 712100 People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lei</LastName>
<ForeName>Chuzhao</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>College of Animal Science and Technology, Shaanxi Key Laboratory of Molecular Biology for Agriculture, Northwest A&amp;F University, Yangling, Shaanxi 712100 People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fang</LastName>
<ForeName>Xintang</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Institute of Cellular and Molecular Biology, Xuzhou Normal University, Xuzhou, Jiangsu 221116 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Hong</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>College of Animal Science and Technology, Shaanxi Key Laboratory of Molecular Biology for Agriculture, Northwest A&amp;F University, Yangling, Shaanxi 712100 People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Anim Sci Biotechnol</MedlineTA>
<NlmUniqueID>101581293</NlmUniqueID>
<ISSNLinking>1674-9782</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688982</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Alternative splicing</Keyword>
<Keyword MajorTopicYN="N">Expression</Keyword>
<Keyword MajorTopicYN="N">HGF</Keyword>
<Keyword MajorTopicYN="N">Qinchuan cattle</Keyword>
<Keyword MajorTopicYN="N">SNPs</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702311</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1880-4276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of arrhythmia</Title>
<ISOAbbreviation>J Arrhythm</ISOAbbreviation>
</Journal>
<ArticleTitle>The impact of yoga on atrial fibrillation: A review of The Yoga My Heart Study.</ArticleTitle>
<Pagination>
<MedlinePgn>337-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joa.2015.05.001</ELocationID>
<Abstract>
<AbstractText>Atrial fibrillation is a common arrhythmia affecting thousands of individuals worldwide. It is a conduction disorder that causes the heart to beat irregularly and rapidly. There are a few medical approaches to manage this costly health care burden: antiarrhythmics to maintain normal sinus rhythm, beta blockers to achieve rate control while allowing atrial fibrillation to persist, and electro-physiologic intervention for rate and rhythm control. These treatments can be costly and are not without side effects. Yoga, an intervention that is available to people worldwide, has shown some promise in combating this widespread heart disorder. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Deutsch</LastName>
<ForeName>Steven Brent</ForeName>
<Initials>SB</Initials>
<AffiliationInfo>
<Affiliation>University of South Florida Morsani College of Medicine, 1 Tampa General Circle, Tampa, FL 33606, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Krivitsky</LastName>
<ForeName>Eric Lawrence</ForeName>
<Initials>EL</Initials>
<AffiliationInfo>
<Affiliation>University of South Florida Morsani College of Medicine, 1 Tampa General Circle, Tampa, FL 33606, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>J Arrhythm</MedlineTA>
<NlmUniqueID>101263026</NlmUniqueID>
<ISSNLinking>1880-4276</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4672029</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Arrhythmia</Keyword>
<Keyword MajorTopicYN="N">Atrial fibrillation</Keyword>
<Keyword MajorTopicYN="N">Exercise</Keyword>
<Keyword MajorTopicYN="N">Health care cost reduction</Keyword>
<Keyword MajorTopicYN="N">Medication alternative</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702312</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1880-4276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of arrhythmia</Title>
<ISOAbbreviation>J Arrhythm</ISOAbbreviation>
</Journal>
<ArticleTitle>Persistence of non-vitamin K antagonist oral anticoagulant use in Japanese patients with atrial fibrillation: A single-center observational study.</ArticleTitle>
<Pagination>
<MedlinePgn>339-44</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joa.2015.04.004</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Non-vitamin K antagonist oral anticoagulants (NOACs) show a favorable balance between efficacy and safety compared with warfarin for patients with non-valvular atrial fibrillation (NVAF). In "real-world" practice, however, NOAC adherence and persistence among patients are not clear. The aim of this study is to evaluate NOAC and warfarin persistence in Japanese patients with NVAF who newly started these drugs.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively studied 401 patients with NVAF who had newly started NOACs during the first 18 months after our hospital adopted their use (197 dabigatran, 107 rivaroxaban, 102 apixaban) and 200 patients with NVAF who had newly started warfarin during the same period. The endpoint was drug discontinuation for each drug.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">During the follow-up period (up to a maximum of 24 months), 113 (28%) patients who had newly started NOACs and 33 (17%) patients who had newly started warfarin discontinued the drug. The persistence rates of patients prescribed NOACs was lower than that of patients prescribed warfarin at 3, 6, and 12 months (85% versus 93%, 79% versus 88%, and 70% versus 82%, respectively). One-tenth of patients who had newly started NOACs discontinued the drug by their own decision. Drug adverse events, worsening renal dysfunction, and patient desire were the major causes of NOAC discontinuation.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The rate of persistence of prescribed NOACs was significantly lower than that of warfarin in Japanese patients with NVAF.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shiga</LastName>
<ForeName>Tsuyoshi</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Naganuma</LastName>
<ForeName>Miyoko</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Intelligent Clinical Research and Innovation Center, Tokyo Women's Medical University Hospital, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nagao</LastName>
<ForeName>Takehiko</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maruyama</LastName>
<ForeName>Kenji</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Suzuki</LastName>
<ForeName>Atsushi</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Murasaki</LastName>
<ForeName>Kagari</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hagiwara</LastName>
<ForeName>Nobuhisa</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>J Arrhythm</MedlineTA>
<NlmUniqueID>101263026</NlmUniqueID>
<ISSNLinking>1880-4276</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4672038</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Adherence</Keyword>
<Keyword MajorTopicYN="N">Atrial fibrillation</Keyword>
<Keyword MajorTopicYN="N">Japanese</Keyword>
<Keyword MajorTopicYN="N">Non-vitamin K antagonist oral anticoagulants</Keyword>
<Keyword MajorTopicYN="N">Warfarin</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702313</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1880-4276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of arrhythmia</Title>
<ISOAbbreviation>J Arrhythm</ISOAbbreviation>
</Journal>
<ArticleTitle>Ability of magnetocardiography to detect regional dominant frequencies of atrial fibrillation.</ArticleTitle>
<Pagination>
<MedlinePgn>345-51</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joa.2015.05.003</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lead V1 on electrocardiography (ECG) can detect the dominant frequency (DF) of atrial fibrillation (AF) in the right atrium (RA). Paroxysmal AF is characterized by a frequency gradient from the left atrium (LA) to the right atrium (RA). We examined the ability of magnetocardiography (MCG) to detect regional DFs in both the atria.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Study subjects comprised 18 consecutive patients referred for catheter ablation of persistent AF. An MCG system with 64 magnetic sensors was used to perform MCG in the frontal, lateral, and back planes prior to the ablation procedure in each patient. DFMCG and organization index (OIMCG) were calculated using fast Fourier transformation. Intracardiac electrograms (ICEs) in both the atria and the coronary sinus (CS) were mapped at 17 sites. Regional DFsICE were also determined.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Mean LA DFICE was higher than mean RA DFICE (6.40±0.66 versus 6.16±0.80 Hz, P=0.03). DFMCG in the channel having the highest OIMCG was 6.61±0.88 Hz in the frontal plane, 6.52±0.64 Hz in the lateral plane, and 6.42±0.62 Hz in the back plane (P=0.3). In each plane, DFMCG correlated with DFICE at the RA appendage (R=0.95, P&lt;0.0001), the LA appendage (R=0.91, P&lt;0.0001), and the CS (R=0.93, P&lt;0.0001). DFECG in V5 modestly correlated with DFICE at the LA appendage (R=0.82, P&lt;0.0001).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">MCG could more precisely detect the DFs in the LA and the CS than ECG. However, the usefulness of pre-procedural detection of the AF frequency gradient for ablation therapy needs to be evaluated in future prospective studies.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yoshida</LastName>
<ForeName>Kentaro</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Medicine, University of Tsukuba, Tsukuba, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ogata</LastName>
<ForeName>Kuniomi</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Advanced Research Laboratory, Hitachi Ltd., Kokubunji, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Inaba</LastName>
<ForeName>Takeshi</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Medicine, University of Tsukuba, Tsukuba, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nakazawa</LastName>
<ForeName>Yoko</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Medicine, University of Tsukuba, Tsukuba, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ito</LastName>
<ForeName>Yoko</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Medicine, University of Tsukuba, Tsukuba, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yamaguchi</LastName>
<ForeName>Iwao</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Ibaraki Health Service Association, Mito, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kandori</LastName>
<ForeName>Akihiko</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Advanced Research Laboratory, Hitachi Ltd., Kokubunji, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aonuma</LastName>
<ForeName>Kazutaka</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Medicine, University of Tsukuba, Tsukuba, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>J Arrhythm</MedlineTA>
<NlmUniqueID>101263026</NlmUniqueID>
<ISSNLinking>1880-4276</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4672036</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Atrial fibrillation</Keyword>
<Keyword MajorTopicYN="N">Dominant frequency</Keyword>
<Keyword MajorTopicYN="N">Magnetocardiography</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702314</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1880-4276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of arrhythmia</Title>
<ISOAbbreviation>J Arrhythm</ISOAbbreviation>
</Journal>
<ArticleTitle>Effects of a high-fat diet on the electrical properties of porcine atria.</ArticleTitle>
<Pagination>
<MedlinePgn>352-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joa.2015.05.004</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Because obesity is an important risk factor for atrial fibrillation (AF), we conducted an animal study to examine the effect of a high-fat diet (HFD) on atrial properties and AF inducibility.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Ten 8-week-old pigs (weight, 18-23 kg) were divided into two groups. For 18 weeks, five pigs were fed a HFD (HFD group) and five were fed a normal diet (control group). Maps of atrial activation and voltages during sinus rhythm were created for all pigs using the EnSite NavX system. Effective refractory period (ERP) and AF inducibility were also determined. When AF was induced, complex fractionated atrial electrogram (CFAE) mapping was performed. At 18 weeks, hearts were removed for comparing the results of histological analysis between the two groups. Body weight, lipid levels, hemodynamics, cardiac structures, and electrophysiological properties were also compared.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Total cholesterol levels were significantly higher (347 [191-434] vs. 81 [67-88] mg/dL, P=0.0088), and left atrium pressure was higher (34.5 [25.6-39.5] vs. 24.5 [21.3-27.8] mmHg, P=0.0833) in the HFD group than in the control group, although body weight only increased marginally (89 [78-101] vs. 70 [66-91] kg, P=0.3472). ERPs of the pulmonary vein (PV) were shorter (P&lt;0.05) and AF lasted longer in the HFD group than in the control group (80 [45-1350] vs. 22 [3-30] s, P=0.0212). Neither CFAE site distribution nor histopathological characteristics differed between the two groups.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The shorter ERPs for the PV observed in response to the HFD increased vulnerability to AF, and these electrophysiological characteristics may underlie obesity-related AF.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Okumura</LastName>
<ForeName>Yasuo</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Ohyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Watanabe</LastName>
<ForeName>Ichiro</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Ohyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nagashima</LastName>
<ForeName>Koichi</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Ohyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sonoda</LastName>
<ForeName>Kazumasa</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Ohyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sasaki</LastName>
<ForeName>Naoko</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Ohyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kogawa</LastName>
<ForeName>Rikitake</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Ohyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Takahashi</LastName>
<ForeName>Keiko</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Ohyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Iso</LastName>
<ForeName>Kazuki</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Ohyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ohkubo</LastName>
<ForeName>Kimie</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Ohyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nakai</LastName>
<ForeName>Toshiko</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Ohyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Takahashi</LastName>
<ForeName>Rie</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Advanced Cardiovascular Imaging, Nihon University School of Medicine, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Taniguchi</LastName>
<ForeName>Yoshiki</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Institute of Medical Science, Medical Research Support Center, Section of Laboratory for Animal Experiments, Nihon University School of Medicine, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mitsumata</LastName>
<ForeName>Masako</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Nihon University School of Medicine, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nikaido</LastName>
<ForeName>Mizuki</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Nihon Kohden Corporation Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hirayama</LastName>
<ForeName>Atsushi</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Ohyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>J Arrhythm</MedlineTA>
<NlmUniqueID>101263026</NlmUniqueID>
<ISSNLinking>1880-4276</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4672030</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Atrial fibrillation</Keyword>
<Keyword MajorTopicYN="N">Electrical properties</Keyword>
<Keyword MajorTopicYN="N">High-fat diet</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702315</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1880-4276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of arrhythmia</Title>
<ISOAbbreviation>J Arrhythm</ISOAbbreviation>
</Journal>
<ArticleTitle>Efficacy of ablation at the anteroseptal line for the treatment of perimitral flutter.</ArticleTitle>
<Pagination>
<MedlinePgn>359-63</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joa.2015.06.001</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Left atrial flutter following atrial fibrillation (AF) ablation is increasingly common and difficult to treat. We evaluated the safety and efficacy of ablation of the anteroseptal line connecting the right superior pulmonary vein (RSPV) to the anteroseptal mitral annulus (MA) for the treatment of perimitral flutter (PMF).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We systematically studied patients who were previously treated with AF ablation and who presented to the electrophysiology laboratory with atrial tachyarrhythmias between January 2000 and July 2010. The diagnosis of PMF was confirmed by activation mapping and/or entrainment. After re-isolation of any recovered pulmonary vein, a linear radiofrequency (RF) ablation was performed on the line that connected the RSPV to the anteroseptal MA. In this analysis, we included only patients who were treated with an anteroseptal line for their PMF.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Ablation was performed at the anteroseptal line in 27 PMF patients (63±13 years; 9 women) who had undergone prior ablation for paroxysmal (n=3) or persistent (n=24) AF, using electroanatomic activation mapping (70% CARTO, 30% NavX). The anteroseptal ablation line was effective in 22/27 (81.5%) patients in the acute-care setting. Termination of AF to sinus rhythm occurred in 15/22 (68.2%) patients, and 7/22 (31.8%) patients׳ AF converted to another right or left atrial flutter. At the 6-month follow-up, 20% of patients demonstrated recurrent left atrial tachyarrhythmia. Only one patient required repeat ablation, and the remaining patients׳ condition was controlled with antiarrhythmic medications. No major procedural complications or heart block occurred.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Ablation at the left atrial anteroseptal line is safe and efficacious for the treatment of PMF. Unlike ablation at the traditional mitral isthmus line, ablation at the left atrial anteroseptal line does not require ablation in the coronary sinus.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Abi-Saleh</LastName>
<ForeName>Bernard</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine (Cardiology Division/Cardiac Electrophysiology Section), American University of Beirut Medical Center, P.O. Box 11-0236, Beirut, Lebanon.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Skouri</LastName>
<ForeName>Hadi</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine (Cardiology Division/Cardiac Electrophysiology Section), American University of Beirut Medical Center, P.O. Box 11-0236, Beirut, Lebanon.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cantillon</LastName>
<ForeName>Daniel J</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo>
<Affiliation>Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Section of Cardiac Electrophysiology and Pacing, Cleveland Clinic, Cleveland, OH, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fowler</LastName>
<ForeName>Jeffery</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Section of Cardiac Electrophysiology and Pacing, Cleveland Clinic, Cleveland, OH, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wazni</LastName>
<ForeName>Oussama</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Section of Cardiac Electrophysiology and Pacing, Cleveland Clinic, Cleveland, OH, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tchou</LastName>
<ForeName>Patrick</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Section of Cardiac Electrophysiology and Pacing, Cleveland Clinic, Cleveland, OH, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Saliba</LastName>
<ForeName>Walid</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Section of Cardiac Electrophysiology and Pacing, Cleveland Clinic, Cleveland, OH, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>J Arrhythm</MedlineTA>
<NlmUniqueID>101263026</NlmUniqueID>
<ISSNLinking>1880-4276</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4672076</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">AAD, Antiarrhythmic drug</Keyword>
<Keyword MajorTopicYN="N">AF, Atrial fibrillation</Keyword>
<Keyword MajorTopicYN="N">Ablation</Keyword>
<Keyword MajorTopicYN="N">Atrial fibrillation</Keyword>
<Keyword MajorTopicYN="N">CS, Coronary sinus</Keyword>
<Keyword MajorTopicYN="N">CTI, Cavotricuspid isthmus</Keyword>
<Keyword MajorTopicYN="N">ICE, Intracardiac echocardiography</Keyword>
<Keyword MajorTopicYN="N">LA, Left atrium</Keyword>
<Keyword MajorTopicYN="N">LAA, Left atrial appendage</Keyword>
<Keyword MajorTopicYN="N">Left atrial anteroseptal line</Keyword>
<Keyword MajorTopicYN="N">MA, Mitral annulus</Keyword>
<Keyword MajorTopicYN="N">PMF, Perimitral flutter</Keyword>
<Keyword MajorTopicYN="N">PVI, Pulmonary vein isolation</Keyword>
<Keyword MajorTopicYN="N">Perimitral flutter</Keyword>
<Keyword MajorTopicYN="N">RF, Radiofrequency</Keyword>
<Keyword MajorTopicYN="N">RSVP, Right superior pulmonary vein</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702316</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1880-4276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of arrhythmia</Title>
<ISOAbbreviation>J Arrhythm</ISOAbbreviation>
</Journal>
<ArticleTitle>Evaluation of periesophageal nerve injury after pulmonary vein isolation using the (13)C-acetate breath test.</ArticleTitle>
<Pagination>
<MedlinePgn>364-70</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joa.2015.06.004</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pulmonary vein isolation (PVI) has become an important option for treating patients with atrial fibrillation (AF). Periesophageal nerve (PEN) injury after PVI causes pyloric spasms and gastric hypomotility. This study aimed to clarify the impact of PVI on gastric motility and assess the prevalence of gastric hypomotility after PVI.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Thirty consecutive patients with AF underwent PVI under luminal esophageal temperature (LET) monitoring. The (13)C-acetate breath test was conducted before and after the procedure for all patients (PVI group). Gastric emptying was evaluated using the time to peak concentration of (13)CO2 (T max). This test was also conducted in another 20 patients who underwent catheter ablation procedures other than PVI (control group).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The number of patients with abnormal T max (≥75 min) increased from seven (23%) to 13 (43%) and from three (15%) to five (25%) after the procedure in the PVI group and control group, respectively. The mean T max was longer after PVI than before PVI (64±14 min vs. 57±15 min, p=0.006), whereas there was no significant difference before and after the procedure in the control group. However, no significant difference in ΔT max was observed between the two groups (p=0.27). No patients suffered from symptomatic gastric hypomotility.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Asymptomatic gastric hypomotility occurred more often after PVI. However, the average impact of PVI on gastric motility was minimal.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kanaeda</LastName>
<ForeName>Tomonori</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ueda</LastName>
<ForeName>Marehiko</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arai</LastName>
<ForeName>Makoto</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ishimura</LastName>
<ForeName>Masayuki</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kajiyama</LastName>
<ForeName>Takatsugu</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hashiguchi</LastName>
<ForeName>Naotaka</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nakano</LastName>
<ForeName>Masahiro</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kondo</LastName>
<ForeName>Yusuke</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hiranuma</LastName>
<ForeName>Yasunori</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Oyamada</LastName>
<ForeName>Arata</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yokosuka</LastName>
<ForeName>Osamu</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kobayashi</LastName>
<ForeName>Yoshio</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>J Arrhythm</MedlineTA>
<NlmUniqueID>101263026</NlmUniqueID>
<ISSNLinking>1880-4276</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4672080</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">13C-acetate breath test</Keyword>
<Keyword MajorTopicYN="N">Atrial fibrillation</Keyword>
<Keyword MajorTopicYN="N">Gastric emptying</Keyword>
<Keyword MajorTopicYN="N">Periesophageal nerve</Keyword>
<Keyword MajorTopicYN="N">Pulmonary vein isolation</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702317</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1880-4276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of arrhythmia</Title>
<ISOAbbreviation>J Arrhythm</ISOAbbreviation>
</Journal>
<ArticleTitle>Hemodynamic effects of Purkinje potential pacing in the left ventricular endocardium in patients with advanced heart failure.</ArticleTitle>
<Pagination>
<MedlinePgn>371-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joa.2015.06.005</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Various difficulties can occur in patients who undergo cardiac resynchronization therapy for drug-refractory heart failure with respect to placement of the left ventricular (LV) lead, because of anatomical features, pacing thresholds, twitching, or pacing lead anchoring, possibly requiring other pacing sites. The goal of this study was to determine whether Purkinje potential (PP) pacing could provide better hemodynamics in patients with left bundle branch block and heart failure than biventricular (BiV) pacing.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Eleven patients with New York Heart Association functional class II or III heart failure despite optimal medical therapy were selected for this study. All patients underwent left- and right-sided cardiac catheterization for measurement of LV functional parameters in the control state during BiV and PP pacing.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Maximum dP/dt increased during BiV and PP pacing when compared with control measurements. This study compared parameters measured during BiV pacing with PP pacing and non-paced beats as the control state in each patient (717±171 mmHg/s vs. 917±191 mmHg/s, p&lt;0.05; and 921±199 mmHg/s, p&lt;0.005); however, the difference between PP pacing and BiV pacing was not significant. There was no difference in heart rate, electrocardiographic wave complex duration, minimum dP/dt, left ventricular end-diastolic pressure, left ventricular end-systolic pressure, pulmonary capillary wedge pressure, or cardiac index when comparing BiV pacing and PP pacing to control measurements.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The hemodynamic outcome of PP pacing was comparable to that of BiV pacing in patients with advanced heart failure.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hamaoka</LastName>
<ForeName>Mamoru</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, Cardiovascular Division, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya Hyogo 663-8501, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mine</LastName>
<ForeName>Takanao</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, Cardiovascular Division, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya Hyogo 663-8501, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kodani</LastName>
<ForeName>Takeshi</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, Cardiovascular Division, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya Hyogo 663-8501, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kishima</LastName>
<ForeName>Hideyuki</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, Cardiovascular Division, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya Hyogo 663-8501, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mitsuno</LastName>
<ForeName>Masataka</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya Hyogo 663-8501, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Masuyama</LastName>
<ForeName>Tohru</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, Cardiovascular Division, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya Hyogo 663-8501, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>J Arrhythm</MedlineTA>
<NlmUniqueID>101263026</NlmUniqueID>
<ISSNLinking>1880-4276</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4672074</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cardiac resynchronization therapy</Keyword>
<Keyword MajorTopicYN="N">Congestive heart failure</Keyword>
<Keyword MajorTopicYN="N">Purkinje fiber</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702318</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1880-4276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of arrhythmia</Title>
<ISOAbbreviation>J Arrhythm</ISOAbbreviation>
</Journal>
<ArticleTitle>Biphasic P wave in inferior leads and the development of atrial fibrillation.</ArticleTitle>
<Pagination>
<MedlinePgn>376-80</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joa.2015.06.008</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Anisotropic and slow conduction in the atrium underlie the development of atrial fibrillation (AF). This study aimed to investigate the P wave characteristics associated with the development of AF in patients with a biphasic P wave in the inferior leads.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Digital analysis of retrospectively recorded 12-lead electrocardiograms was performed to select patients with a biphasic P wave (positive/negative) in lead II from a database of 114,334 patients. Characteristics of the P wave in the inferior leads associated with incidence of AF were determined. Receiver operating characteristic curves dichotomized P wave variables were measured in each lead.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 141 patients (77 men; mean age, 64±19 years) were enrolled in this study. Twenty-nine (20.6%) patients developed AF (AF group) vs. 112 (79.6%) who did not (non-AF group) during a follow-up period of 50±62 months. The amplitude of the initial P wave portion in lead II was significantly larger in the AF group when compared with the non-AF group (77.3±77.0 µV vs. 51.0±30.1 µV, p=0.003), while the amplitude of the terminal P wave portion in lead III was significantly decreased in the AF group when compared with the non-AF group (-70.6±41.3 µV vs. -89.1±38.1 µV, p=0.024). The duration of the initial P wave portion in lead III was significantly longer in the AF group when compared with the non-AF group (52.7±34.6 ms vs. 35.8±30.4 ms, p=0.011). Multivariate Cox proportional-hazards analysis confirmed that the increased duration of the initial P wave portion in lead III (≥71 ms) was independently associated with AF development (hazard ratio 2.90, 95% confidence interval 1.16-7.11, p=0.02).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The analyses of the biphasic P wave in the inferior leads suggest that the development of AF could be attributed to increased atrial slow conduction.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hayashi</LastName>
<ForeName>Hideki</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Horie</LastName>
<ForeName>Minoru</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>J Arrhythm</MedlineTA>
<NlmUniqueID>101263026</NlmUniqueID>
<ISSNLinking>1880-4276</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4672077</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Atrial fibrillation</Keyword>
<Keyword MajorTopicYN="N">Biphasic P wave</Keyword>
<Keyword MajorTopicYN="N">Conduction</Keyword>
<Keyword MajorTopicYN="N">Electrocardiography</Keyword>
<Keyword MajorTopicYN="N">Prognosis</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702319</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1880-4276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of arrhythmia</Title>
<ISOAbbreviation>J Arrhythm</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of adenosine triphosphate on left atrial electrogram interval and dominant frequency in human atrial fibrillation.</ArticleTitle>
<Pagination>
<MedlinePgn>381-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joa.2015.07.001</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Complex fractionated atrial electrograms (CFAEs) and high dominant frequency (DF) are targets for atrial fibrillation (AF) ablation. Although adenosine triphosphate (ATP) is known to promote AF by shortening the atrial refractory period, its role in the pathogenesis of CFAEs and DF during AF is not fully understood.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We recorded electrical activity from a 64-electrode basket catheter placed in the left atrium (LA) of patients with paroxysmal AF (PAF, n=18) or persistent AF (PerAF, n=19) before ablation. Atrial electrogram fractionation intervals (FIs) and DFs were measured from bipolar electrograms of each adjacent electrode pair. Offline mean atrial FIs and DFs were obtained before bolus injection of 30 mg ATP. Peak effect was defined as an R-R interval &gt;3 s.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">With ATP, the mean FI decreased (from 110.4±29.1 ms to 90.5±24.7 ms, P&lt;0.0001) and DF increased (from 6.4±0.6 Hz to 7.1±0.8 Hz, P&lt;0.0001) in all patients. There was no difference in the FI decrease between the two groups (-20.3±20.5 ms vs. -19.6±14.5 ms, P=0.6032), but the increase in DF was significantly greater in PAF patients (1.1±0.8 Hz vs. 0.3±0.6 Hz, P=0.0051).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">ATP shortens atrial FIs and increases DFs in both PAF and PerAF patients. The significant increase in DF in PAF patients suggests that pathophysiologic characteristics related to the frequency of atrial fractionation change as atrial remodeling progresses.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kogawa</LastName>
<ForeName>Rikitake</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Okumura</LastName>
<ForeName>Yasuo</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Watanabe</LastName>
<ForeName>Ichiro</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kofune</LastName>
<ForeName>Masayoshi</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nagashima</LastName>
<ForeName>Koichi</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mano</LastName>
<ForeName>Hiroaki</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sonoda</LastName>
<ForeName>Kazumasa</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sasaki</LastName>
<ForeName>Naoko</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Iso</LastName>
<ForeName>Kazuki</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Takahashi</LastName>
<ForeName>Keiko</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ohkubo</LastName>
<ForeName>Kimie</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nakai</LastName>
<ForeName>Toshiko</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hirayama</LastName>
<ForeName>Atsushi</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>J Arrhythm</MedlineTA>
<NlmUniqueID>101263026</NlmUniqueID>
<ISSNLinking>1880-4276</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4672075</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Atrial fibrillation</Keyword>
<Keyword MajorTopicYN="N">Basket catheter</Keyword>
<Keyword MajorTopicYN="N">Complex fractionated atrial electrogram</Keyword>
<Keyword MajorTopicYN="N">Dominant frequency</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702320</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1880-4276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of arrhythmia</Title>
<ISOAbbreviation>J Arrhythm</ISOAbbreviation>
</Journal>
<ArticleTitle>A case of extensive encircling pulmonary vein isolation in a patient with severe scoliosis.</ArticleTitle>
<Pagination>
<MedlinePgn>388-90</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joa.2015.04.005</ELocationID>
<Abstract>
<AbstractText>The patient was a 62-year-old man with atrial fibrillation and severe scoliosis. Scoliosis may impair cardiorespiratory function. Enhanced computed tomography (CT) was helpful for the Brockenbrough method. Three-dimensional (3D) mapping also demonstrated clockwise rotation of the heart. We successfully isolated extensive encircling pulmonary vein in this patient using enhanced CT and 3D mapping. The CT venous images revealed appropriate localization of the vein and heart. CT and 3D mapping may ensure a more stable and safer procedure. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kamihara</LastName>
<ForeName>Takahiro</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Toyota Kosei Hospital, 500-1, Ibobara, Josui-cho, Toyota-city, Aichi 4700396, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kaneko</LastName>
<ForeName>Shinji</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Toyota Kosei Hospital, 500-1, Ibobara, Josui-cho, Toyota-city, Aichi 4700396, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fujita</LastName>
<ForeName>Masaya</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Toyota Kosei Hospital, 500-1, Ibobara, Josui-cho, Toyota-city, Aichi 4700396, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yamaguchi</LastName>
<ForeName>Kazutoshi</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Toyota Kosei Hospital, 500-1, Ibobara, Josui-cho, Toyota-city, Aichi 4700396, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Narita</LastName>
<ForeName>Shingo</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Toyota Kosei Hospital, 500-1, Ibobara, Josui-cho, Toyota-city, Aichi 4700396, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Haga</LastName>
<ForeName>Tomoaki</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Toyota Kosei Hospital, 500-1, Ibobara, Josui-cho, Toyota-city, Aichi 4700396, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hayashi</LastName>
<ForeName>Daisuke</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Toyota Kosei Hospital, 500-1, Ibobara, Josui-cho, Toyota-city, Aichi 4700396, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ohashi</LastName>
<ForeName>Taiki</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Toyota Kosei Hospital, 500-1, Ibobara, Josui-cho, Toyota-city, Aichi 4700396, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kubota</LastName>
<ForeName>Ryuji</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Toyota Kosei Hospital, 500-1, Ibobara, Josui-cho, Toyota-city, Aichi 4700396, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shinoda</LastName>
<ForeName>Masanori</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Toyota Kosei Hospital, 500-1, Ibobara, Josui-cho, Toyota-city, Aichi 4700396, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>J Arrhythm</MedlineTA>
<NlmUniqueID>101263026</NlmUniqueID>
<ISSNLinking>1880-4276</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4672034</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Ablation</Keyword>
<Keyword MajorTopicYN="N">Atrial fibrillation</Keyword>
<Keyword MajorTopicYN="N">Scoliosis</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702321</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1880-4276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of arrhythmia</Title>
<ISOAbbreviation>J Arrhythm</ISOAbbreviation>
</Journal>
<ArticleTitle>Recurrent syncope in two patients with a sigmoid-shaped interventricular septum and no left ventricular hypertrophy.</ArticleTitle>
<Pagination>
<MedlinePgn>391-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joa.2015.04.006</ELocationID>
<Abstract>
<AbstractText>Sigmoid-shaped interventricular septum (SIS) is not uncommon in elderly patients and is considered a normal part of the aging process. However, several patients have been reported to have clinical symptoms due to the narrowing of the left ventricular outflow tract (LVOT). Two patients with SIS presented with recurrent episodes of syncope after drinking or taking sublingual nitroglycerin (NG). In both patients, a head-up tilt test involving provocation with alcohol, NG, or isoproterenol induced the vasovagal reflex along with an increase in the pressure gradient between the apex and LVOT. The patients experienced no further episodes of syncope after initiating bisoprolol treatment. In patients with SIS, induction of the vasovagal reflex via an increase in left ventricular (LV) pressure due to LVOT obstruction concomitant with increased LV construction is a potentially important cause of syncope, which may be effectively prevented by beta-blockers. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yamaguchi</LastName>
<ForeName>Yoshiaki</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mizumaki</LastName>
<ForeName>Koichi</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Clinical Research and Ethics Center, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Iwamoto</LastName>
<ForeName>Jotaro</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nishida</LastName>
<ForeName>Kunihiro</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sakamoto</LastName>
<ForeName>Tamotsu</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nakatani</LastName>
<ForeName>Yosuke</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kataoka</LastName>
<ForeName>Naoya</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Inoue</LastName>
<ForeName>Hiroshi</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>J Arrhythm</MedlineTA>
<NlmUniqueID>101263026</NlmUniqueID>
<ISSNLinking>1880-4276</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4672037</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Left ventricular outflow tract obstruction</Keyword>
<Keyword MajorTopicYN="N">Sigmoid septum</Keyword>
<Keyword MajorTopicYN="N">Vasovagal reflex</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702322</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1880-4276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of arrhythmia</Title>
<ISOAbbreviation>J Arrhythm</ISOAbbreviation>
</Journal>
<ArticleTitle>A case of inappropriate implantable cardioverter defibrillator therapy induced by T-wave oversensing due to hyperkalemia.</ArticleTitle>
<Pagination>
<MedlinePgn>395-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joa.2015.04.007</ELocationID>
<Abstract>
<AbstractText>There have been reports of hyperkalemia-induced T-wave oversensing in patients with implantable cardioverter defibrillators (ICDs). However, a comparison of T-wave amplitudes and morphologies between the surface 12-lead electrocardiogram (ECG) and ICD electrogram has not been reported. We present the case of a 70-year-old man who received inappropriate ICD shocks due to hyperkalemia-induced T-wave oversensing. The T-wave amplitudes on both the ICD electrogram and 12-lead ECG corresponded and normalized after normalization of the potassium level. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Aoki</LastName>
<ForeName>Kosuke</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Himeji Cardiovascular Center, 520 kou saishou, Himeji, Hyogo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Okajima</LastName>
<ForeName>Katsunori</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Himeji Cardiovascular Center, 520 kou saishou, Himeji, Hyogo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kiuchi</LastName>
<ForeName>Kunihiko</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Himeji Cardiovascular Center, 520 kou saishou, Himeji, Hyogo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yokoi</LastName>
<ForeName>Kiminobu</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Himeji Cardiovascular Center, 520 kou saishou, Himeji, Hyogo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Teranishi</LastName>
<ForeName>Jin</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Himeji Cardiovascular Center, 520 kou saishou, Himeji, Hyogo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shimane</LastName>
<ForeName>Akira</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Himeji Cardiovascular Center, 520 kou saishou, Himeji, Hyogo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>J Arrhythm</MedlineTA>
<NlmUniqueID>101263026</NlmUniqueID>
<ISSNLinking>1880-4276</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4672032</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Hyperkalemia</Keyword>
<Keyword MajorTopicYN="N">Implantable cardioverter defibrillator</Keyword>
<Keyword MajorTopicYN="N">Inappropriate ICD therapy</Keyword>
<Keyword MajorTopicYN="N">T-wave oversensing</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702323</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1880-4276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of arrhythmia</Title>
<ISOAbbreviation>J Arrhythm</ISOAbbreviation>
</Journal>
<ArticleTitle>Aortic perforation due to cardiac resynchronisation therapy defibrillator lead placement: Case report and medicolegal considerations.</ArticleTitle>
<Pagination>
<MedlinePgn>398-400</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joa.2015.05.002</ELocationID>
<Abstract>
<AbstractText>A 45-year-old woman with dilated cardiomyopathy was admitted for the upgrade of a previously implanted pacemaker. Echocardiography showed intraventricular dyssynchrony and a low ejection fraction (0.35). Treatment with a cardiac resynchronization therapy defibrillator (CRT-D) was selected and the device was implanted. CRT-D interrogation revealed proper function. Following procedure termination, the patient went into cardiac arrest and died despite resuscitation attempts. An autopsy revealed that the medial aspect of the right atrium was pierced by an active lead and that the aorta had a deep lesion, 2 mm in length, on its lateral aspect. We explain the probable pathogenesis of this patient׳s death. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Grande</LastName>
<ForeName>Antonino M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Divisione Cardiochirurgia IRCCS Policlinico San Matteo Pavia, Viale C. Golgi, 19, 27100 Pavia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fiore</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Divisione Cardiochirurgia IRCCS Policlinico San Matteo Pavia, Viale C. Golgi, 19, 27100 Pavia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Merlano</LastName>
<ForeName>Maurizio</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Istituto Medicina Legale Università degli Studi Pavia, Via C. Forlanini, 12, 27100 Pavia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Buzzi</LastName>
<ForeName>Fabio</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Istituto Medicina Legale Università degli Studi Pavia, Via C. Forlanini, 12, 27100 Pavia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mazzola</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Divisione Cardiochirurgia IRCCS Policlinico San Matteo Pavia, Viale C. Golgi, 19, 27100 Pavia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>J Arrhythm</MedlineTA>
<NlmUniqueID>101263026</NlmUniqueID>
<ISSNLinking>1880-4276</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4672031</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Active lead</Keyword>
<Keyword MajorTopicYN="N">Aortic perforation</Keyword>
<Keyword MajorTopicYN="N">Cardiac resynchronization therapy defibrillator</Keyword>
<Keyword MajorTopicYN="N">Implantable cardioverter defibrillator</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702324</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1880-4276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of arrhythmia</Title>
<ISOAbbreviation>J Arrhythm</ISOAbbreviation>
</Journal>
<ArticleTitle>A case of premature ventricular contractions, ventricular tachycardia, and arrhythmic storm induced by right ventricular pacing during cardiac resynchronization therapy: Electrophysiological mechanism and catheter ablation.</ArticleTitle>
<Pagination>
<MedlinePgn>401-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joa.2015.06.002</ELocationID>
<Abstract>
<AbstractText>A 77-year-old man with ischemic cardiomyopathy and a cardiac resynchronization therapy-defibrillator (CRT-D) device came to our attention due to incessant ventricular tachycardia and multiple implantable cardioverter defibrillator (ICD) shocks. An electrocardiogram showed non-sustained monomorphic ventricular tachycardias (NSVTs) constantly occurring after each biventricular stimulation. During an electrophysiological study, NSVTs reproducibly recurred only after right ventricular (RV) pacing; LV pacing did not induce any NSVTs. The activation map was consistent with a localized reentry at the interventricular septum, and a double exit; at the LV exit site, a single radiofrequency energy application immediately interrupted the occurrence of the NSVTs. Current evidence supports LV pacing to be pro-arrhythmogenic in few CRT patients. This unusual case shows that RV pacing during CRT could produce frequent ventricular arrhythmias and arrhythmic storm. Catheter ablation can be considered an effective therapeutic option, especially when CRT maintenance is highly advisable. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pedretti</LastName>
<ForeName>Stefano</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Electrophysiology Unit, Cardio-thoracic Department, Niguarda Ca׳ Granda Hospital, Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vargiu</LastName>
<ForeName>Sara</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Electrophysiology Unit, Cardio-thoracic Department, Niguarda Ca׳ Granda Hospital, Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Paolucci</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Electrophysiology Unit, Cardio-thoracic Department, Niguarda Ca׳ Granda Hospital, Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lunati</LastName>
<ForeName>Maurizio</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Electrophysiology Unit, Cardio-thoracic Department, Niguarda Ca׳ Granda Hospital, Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>J Arrhythm</MedlineTA>
<NlmUniqueID>101263026</NlmUniqueID>
<ISSNLinking>1880-4276</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4672078</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Arrhythmia mechanism</Keyword>
<Keyword MajorTopicYN="N">Cardiac mapping</Keyword>
<Keyword MajorTopicYN="N">Cardiac resynchronization therapy</Keyword>
<Keyword MajorTopicYN="N">Catheter ablation</Keyword>
<Keyword MajorTopicYN="N">Ventricular arrhythmia</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702325</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1880-4276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of arrhythmia</Title>
<ISOAbbreviation>J Arrhythm</ISOAbbreviation>
</Journal>
<ArticleTitle>Identifying the true origin of sustained monomorphic ventricular tachycardia associated with dilated-phase hypertrophic cardiomyopathy: A case of successful catheter ablation.</ArticleTitle>
<Pagination>
<MedlinePgn>406-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joa.2015.06.003</ELocationID>
<Abstract>
<AbstractText>This case report describes sustained monomorphic ventricular tachycardia (VT) caused by a large epicardial scar, related to dilated-phase hypertrophic cardiomyopathy mimicking VT originating from the apical septum. VT resolved with epicardial catheter ablation. The exit of the VT circuit suggested that a 12-lead electrocardiogram can be remote with respect to the critical isthmus in this case. In patients with structural heart disease, it is difficult to identify the VT reentrant circuit by surface electrocardiography, which shows only the exit site. VT originating in the epicardium should be considered, even if the suspected origin is another ventricular site. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kawakami</LastName>
<ForeName>Hiroshi</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nagai</LastName>
<ForeName>Takayuki</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fujii</LastName>
<ForeName>Akira</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Uetani</LastName>
<ForeName>Teruyoshi</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nishimura</LastName>
<ForeName>Kazuhisa</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Inoue</LastName>
<ForeName>Katsuji</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Suzuki</LastName>
<ForeName>Jun</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Satomi</LastName>
<ForeName>Kazuhiro</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Okura</LastName>
<ForeName>Takafumi</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Higaki</LastName>
<ForeName>Jitsuo</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ogimoto</LastName>
<ForeName>Akiyoshi</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Department of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>J Arrhythm</MedlineTA>
<NlmUniqueID>101263026</NlmUniqueID>
<ISSNLinking>1880-4276</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4672081</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bipolar ablation</Keyword>
<Keyword MajorTopicYN="N">Dilated-phase hypertrophic cardiomyopathy</Keyword>
<Keyword MajorTopicYN="N">Epicardial ablation</Keyword>
<Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702326</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1880-4276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of arrhythmia</Title>
<ISOAbbreviation>J Arrhythm</ISOAbbreviation>
</Journal>
<ArticleTitle>Kaya et al. Is it a typical crosstalk: Need for re-implantation?</ArticleTitle>
<Pagination>
<MedlinePgn>410</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joa.2015.04.009</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Akbarzadeh</LastName>
<ForeName>Mohammad Ali</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran ; Cardiology Department, Shahid Modarres Hospital, Tehran, Iran.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>J Arrhythm</MedlineTA>
<NlmUniqueID>101263026</NlmUniqueID>
<ISSNLinking>1880-4276</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4672035</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702327</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1880-4276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of arrhythmia</Title>
<ISOAbbreviation>J Arrhythm</ISOAbbreviation>
</Journal>
<ArticleTitle>Shortness of breath in a patient with complete heart block and permanent pacemaker: A case of effective pacemaker reprogramming.</ArticleTitle>
<Pagination>
<MedlinePgn>411-3</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joa.2015.04.010</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Arora</LastName>
<ForeName>Sandeep</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Cardiac Electrophysiology Department, Excela Health Westmoreland Hospital, 532 W, Pittsburgh Street, Greensburg, PA 15601, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>J Arrhythm</MedlineTA>
<NlmUniqueID>101263026</NlmUniqueID>
<ISSNLinking>1880-4276</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4672072</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Complete heart block</Keyword>
<Keyword MajorTopicYN="N">Noncompetitive atrial pacing</Keyword>
<Keyword MajorTopicYN="N">Repetitive non-reentrant ventriculo-atrial synchrony</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702298</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1754-1611</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>9</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Journal of biological engineering</Title>
<ISOAbbreviation>J Biol Eng</ISOAbbreviation>
</Journal>
<ArticleTitle>A novel approach for metabolic pathway optimization: Oligo-linker mediated assembly (OLMA) method.</ArticleTitle>
<Pagination>
<MedlinePgn>23</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13036-015-0021-0</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Imbalances in gene expression of a metabolic pathway can result in less-yield of the desired products. Several targets were intensively investigated to balance the gene expression, such as promoter, ribosome binding site (RBS), the order of genes, as well as the species of the enzymes. However, the capability of simultaneous manipulation of multiple targets still needs to be explored.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">We reported a new DNA assembling method to vary all the above types of regulatory targets simultaneously, named oligo-linker mediated assembly (OLMA) method, which can incorporate up to 8 targets in a single assembly step. Two experimental cases were used to demonstrate the capability of the method: (1) assembly of multiple pieces of lacZ expression cassette; (2) optimization of four enzymes in lycopene biosynthetic pathway. Our results indicated that the OLMA method not only exploited larger combinatorial space, but also reduced the inefficient mutants.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The unique feature of oligo-linker mediated assembly (OLMA) method is inclusion of a set of chemically synthetic double-stranded DNA oligo library, which can be designed as promoters and RBSs, or designed with different overhang to bridge the genes in different orders. The inclusion of the oligos resulted in a PCR-free and zipcode-free DNA assembly reaction for OLMA.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Shasha</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Chinese Academy of Sciences Key Laboratory of Microbial Physiological, and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101 China ; University of Chinese Academy of Sciences, Beijing, 100049 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhao</LastName>
<ForeName>Xuejin</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Chinese Academy of Sciences Key Laboratory of Microbial Physiological, and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tao</LastName>
<ForeName>Yong</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Chinese Academy of Sciences Key Laboratory of Microbial Physiological, and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lou</LastName>
<ForeName>Chunbo</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Chinese Academy of Sciences Key Laboratory of Microbial Physiological, and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101 China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Biol Eng</MedlineTA>
<NlmUniqueID>101306640</NlmUniqueID>
<ISSNLinking>1754-1611</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688952</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Gene order</Keyword>
<Keyword MajorTopicYN="N">Lycopene</Keyword>
<Keyword MajorTopicYN="N">Oligo-linker mediated DNA assembly</Keyword>
<Keyword MajorTopicYN="N">Pathway optimization</Keyword>
<Keyword MajorTopicYN="N">RBS</Keyword>
<Keyword MajorTopicYN="N">Species of enzymes</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702299</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1754-1611</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>9</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Journal of biological engineering</Title>
<ISOAbbreviation>J Biol Eng</ISOAbbreviation>
</Journal>
<ArticleTitle>Heterologous expression of the isopimaric acid pathway in Nicotiana benthamiana and the effect of N-terminal modifications of the involved cytochrome P450 enzyme.</ArticleTitle>
<Pagination>
<MedlinePgn>24</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13036-015-0022-z</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Plant terpenoids are known for their diversity, stereochemical complexity, and their commercial interest as pharmaceuticals, food additives, and cosmetics. Developing biotechnology approaches for the production of these compounds in heterologous hosts can increase their market availability, reduce their cost, and provide sustainable production platforms. In this context, we aimed at producing the antimicrobial diterpenoid isopimaric acid from Sitka spruce. Isopimaric acid is synthesized using geranylgeranyl diphosphate as a precursor molecule that is cyclized by a diterpene synthase in the chloroplast and subsequently oxidized by a cytochrome P450, CYP720B4.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">We transiently expressed the isopimaric acid pathway in Nicotiana benthamiana leaves and enhanced its productivity by the expression of two rate-limiting steps in the pathway (providing the general precursor of diterpenes). This co-expression resulted in 3-fold increase in the accumulation of both isopimaradiene and isopimaric acid detected using GC-MS and LC-MS methodology. We also showed that modifying or deleting the transmembrane helix of CYP720B4 does not alter the enzyme activity and led to successful accumulation of isopimaric acid in the infiltrated leaves. Furthermore, we demonstrated that a modified membrane anchor is a prerequisite for a functional CYP720B4 enzyme when the chloroplast targeting peptide is added. We report the accumulation of 45-55 μg/g plant dry weight of isopimaric acid four days after the infiltration with the modified enzymes.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">It is possible to localize a diterpenoid pathway from spruce fully within the chloroplast of N. benthamiana and a few modifications of the N-terminal sequences of the CYP720B4 can facilitate the expression of plant P450s in the plastids. The coupling of terpene biosynthesis closer to photosynthesis paves the way for light-driven biosynthesis of valuable terpenoids.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gnanasekaran</LastName>
<ForeName>Thiyagarajan</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Plant and Environmental Sciences, Copenhagen Plant Science Centre, UNIK Center for Synthetic Biology, Villum Research Center "Plant Plasticity", University of Copenhagen, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vavitsas</LastName>
<ForeName>Konstantinos</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Plant and Environmental Sciences, Copenhagen Plant Science Centre, UNIK Center for Synthetic Biology, Villum Research Center "Plant Plasticity", University of Copenhagen, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Andersen-Ranberg</LastName>
<ForeName>Johan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Plant and Environmental Sciences, Copenhagen Plant Science Centre, UNIK Center for Synthetic Biology, Villum Research Center "Plant Plasticity", University of Copenhagen, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Copenhagen, Denmark ; Present address: Plant and Microbial Biology, University of California, 371 Koshland Hall, Berkeley, CA 94720 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nielsen</LastName>
<ForeName>Agnieszka Zygadlo</ForeName>
<Initials>AZ</Initials>
<AffiliationInfo>
<Affiliation>Department of Plant and Environmental Sciences, Copenhagen Plant Science Centre, UNIK Center for Synthetic Biology, Villum Research Center "Plant Plasticity", University of Copenhagen, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Olsen</LastName>
<ForeName>Carl Erik</ForeName>
<Initials>CE</Initials>
<AffiliationInfo>
<Affiliation>Department of Plant and Environmental Sciences, Copenhagen Plant Science Centre, UNIK Center for Synthetic Biology, Villum Research Center "Plant Plasticity", University of Copenhagen, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hamberger</LastName>
<ForeName>Björn</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Plant and Environmental Sciences, Copenhagen Plant Science Centre, UNIK Center for Synthetic Biology, Villum Research Center "Plant Plasticity", University of Copenhagen, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jensen</LastName>
<ForeName>Poul Erik</ForeName>
<Initials>PE</Initials>
<AffiliationInfo>
<Affiliation>Department of Plant and Environmental Sciences, Copenhagen Plant Science Centre, UNIK Center for Synthetic Biology, Villum Research Center "Plant Plasticity", University of Copenhagen, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Biol Eng</MedlineTA>
<NlmUniqueID>101306640</NlmUniqueID>
<ISSNLinking>1754-1611</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688937</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Chloroplasts</Keyword>
<Keyword MajorTopicYN="N">Cytochrome P450</Keyword>
<Keyword MajorTopicYN="N">Diterpenoids</Keyword>
<Keyword MajorTopicYN="N">Isopimaric acid</Keyword>
<Keyword MajorTopicYN="N">Protein engineering</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702402</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Print">1790-045X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>22</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of biological research (Thessalonikē, Greece)</Title>
<ISOAbbreviation>J Biol Res (Thessalon)</ISOAbbreviation>
</Journal>
<ArticleTitle>Identification and functional analysis of the BIM interactome; new clues on its possible involvement in Epstein-Barr Virus-associated diseases.</ArticleTitle>
<Pagination>
<MedlinePgn>14</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40709-015-0037-0</ELocationID>
<Abstract>
<AbstractText>Epigenetic deregulation is a common feature in the pathogenesis of Epstein-Barr Virus (EBV)-related lymphomas and carcinomas. Previous studies have demonstrated a strong association between EBV latency in B-cells and epigenetic silencing of the tumor suppressor gene BIM. This study aimed to the construction and functional analysis of the BIM interactome in order to identify novel host genes that may be targeted by EBV. Fifty-nine unique interactors were found to compose the BIM gene network. Ontological analysis at the pathway level highlighted infectious diseases along with neuropathologies. These results underline the possible interplay between the BIM interactome and EBV-associated disorders. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rouka</LastName>
<ForeName>Erasmia</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Transfusion Medicine, University Hospital of Larisa, Viopolis, 41110 Larisa, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kyriakou</LastName>
<ForeName>Despoina</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Transfusion Medicine, University Hospital of Larisa, Viopolis, 41110 Larisa, Greece.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Greece</Country>
<MedlineTA>J Biol Res (Thessalon)</MedlineTA>
<NlmUniqueID>101248115</NlmUniqueID>
<ISSNLinking>1790-045X</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688984</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">BIM interactome</Keyword>
<Keyword MajorTopicYN="N">EBV</Keyword>
<Keyword MajorTopicYN="N">Functional analysis</Keyword>
<Keyword MajorTopicYN="N">Infectious agents</Keyword>
<Keyword MajorTopicYN="N">Neurodegenerative disorders</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702341</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">2008-5117</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Journal of cardiovascular and thoracic research</Title>
<ISOAbbreviation>J Cardiovasc Thorac Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Haemodynamic Responses to Tracheal Intubation Using Propofol, Etomidate and Etomidate-Propofol Combination in Anaesthesia Induction.</ArticleTitle>
<Pagination>
<MedlinePgn>134-40</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.15171/jcvtr.2015.30</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The aim of this study was to measure the haemodynamic responses to a etomidate-propofol combination used for anaesthesia induction and to compare the haemodynamic responses with the separate use of each drug.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The patients were randomly divided into three groups as group P (n = 30, propofol 2.5 mg kg(-1)), group E (n = 30, etomidate 0.3 mg kg(-1)) and group PE (n = 30, propofol 1.25 mg kg(-1) + etomidate 0.15 mg kg(-1)). For each patient, the times of measurement of the heart rate (HR) and mean arterial pressure values were defined as baseline, after the induction, before the intubation, immediately after the intubation and 1, 2, 3, 4, 5 and 10 minutes after the intubation.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In all 3 groups, a significant decrease in MAP values were seen at T2 and T3 compared to the baseline values, and this decrease was greater in group P compared to that in group E and PE (P &lt; 0.001, P &lt; 0.01). A significant increase was seen in all 3 groups in the mean arterial pressure (MAP) value at T4 after the intubation. When the groups were compared with each other, this increase was greater in group E than in the other two groups (with group P, P &lt; 0.001; with group PE, P &lt; 0.01).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Etomidate-propofol combination may be a valuable alternative when extremes of hypotensive and hypertensive responses due to propofol and etomidate are best to be avoided.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yağan</LastName>
<ForeName>Özgür</ForeName>
<Initials>Ö</Initials>
<AffiliationInfo>
<Affiliation>Ordu University, School of Medicine, Department of Anesthesiology, Ordu, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Taş</LastName>
<ForeName>Nilay</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Ordu University, School of Medicine, Department of Anesthesiology, Ordu, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Küçük</LastName>
<ForeName>Ahmet</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Harran University, School of Medicine, Department of Anesthesiology, Sanlıurfa, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hancı</LastName>
<ForeName>Volkan</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Dokuz Eylül University, School of Medicine, Department of Anesthesiology, Izmir, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yurtlu</LastName>
<ForeName>Bülent Serhan</ForeName>
<Initials>BS</Initials>
<AffiliationInfo>
<Affiliation>Dokuz Eylül University, School of Medicine, Department of Anesthesiology, Izmir, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Iran</Country>
<MedlineTA>J Cardiovasc Thorac Res</MedlineTA>
<NlmUniqueID>101528712</NlmUniqueID>
<ISSNLinking>2008-5117</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4685278</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Endotracheal Intubation</Keyword>
<Keyword MajorTopicYN="N">Etomidate</Keyword>
<Keyword MajorTopicYN="N">Hemodynamic</Keyword>
<Keyword MajorTopicYN="N">Propofol</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702342</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">2008-5117</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Journal of cardiovascular and thoracic research</Title>
<ISOAbbreviation>J Cardiovasc Thorac Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Ibuprofen - a Safe Analgesic During Cardiac Surgery Recovery? A Randomized Controlled Trial.</ArticleTitle>
<Pagination>
<MedlinePgn>141-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.15171/jcvtr.2015.31</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Postoperative pain-management with non-steroid anti-inflammatory drugs has been controversial, due to related side-effects. We investigated whether there was a significant difference between an oxycodone-based pain-management regimen versus a slow-release ibuprofen based regimen, in a short term post-cardiac surgery setting. Particular attention was given to the rate of myocardial infarction, sternal healing, gastro-intestinal complications, renal failure and all-cause mortality.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">This was a single-centre, open label parallel design randomised controlled study. Patients, who were undergoing cardiac surgery for the first time, were randomly allocated either to a regimen of slow-release oxycodone (10 mg twice daily) or slow-release ibuprofen (800 mg twice daily) combined with lansoprazole. Data relating to blood-tests, angiographies, surgical details and administered medicine were obtained from patient records. The follow-up period was 1 to 37 months (median 25 months).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred eighty-two patients were included in the trial and available for intention to treat analysis. There were no significant difference between the groups (P&gt;0.05) in the rates of sternal healing, postoperative myocardial infarction or gastrointestinal bleeding. The preoperative levels of creatinine were found to increase by 100% in nine patients (9.6%) in the ibuprofen group, resulting in an acute renal injury (in accordance with the RIFLE-criteria). Eight of these patients returned to normal renal function within 14 days. The levels of creatinine in patients in the oxycodone group were not found to increase to the same magnitude.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results of this study suggest that patients treated postoperatively, following cardiac surgery, are at no greater risk of harm if short term slow release ibuprofen combined with lansoprazole treatment is used when compared to an oxycodone based regimen. Renal function should, however, be closely monitored and in the event of any decrease in renal function ibuprofen must be discontinued.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Qazi</LastName>
<ForeName>Saddiq Mohammad</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiothoracic Surgery, Aalborg University Hospital, Hobrovej 18-22 9000 Aalborg, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sindby</LastName>
<ForeName>Eske Jesper</ForeName>
<Initials>EJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiothoracic Surgery, Aalborg University Hospital, Hobrovej 18-22 9000 Aalborg, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nørgaard</LastName>
<ForeName>Martin Agge</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiothoracic Surgery, Aalborg University Hospital, Hobrovej 18-22 9000 Aalborg, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Iran</Country>
<MedlineTA>J Cardiovasc Thorac Res</MedlineTA>
<NlmUniqueID>101528712</NlmUniqueID>
<ISSNLinking>2008-5117</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4685279</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Acute Renal Injury</Keyword>
<Keyword MajorTopicYN="N">Analgesia</Keyword>
<Keyword MajorTopicYN="N">Cardiac Surgery</Keyword>
<Keyword MajorTopicYN="N">Non-steroidal Anti-inflamatory Drugs</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702343</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">2008-5117</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Journal of cardiovascular and thoracic research</Title>
<ISOAbbreviation>J Cardiovasc Thorac Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Influence of Two Various Durations of Resistance Exercise on Oxidative Stress in the Male Rat's Hearts.</ArticleTitle>
<Pagination>
<MedlinePgn>149-53</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.15171/jcvtr.2015.32</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The previous studies have suggested that alteration in oxidative stress and antioxidant defense depends on various factors, such as mode, intensity, frequency and duration of exercise. In this study, we compared the effects of two various durations of resistance exercise (1 month and 4 month) on oxidative stress and antioxidant status in cardiac tissue.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Thirty Wistar male rats divided into 3 groups: control (sedentary), exercise-1 (regular exercise for 1 month) and exercise-2 group (regular exercise for 4 months). After the final to the experiment, the rats were anesthetized, and then blood and heart samples were obtained and used to determine glutathione peroxidase (GPX), superoxide dismutase (SOD), malondialdehyde (MDA) and biochemical estimation.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">MDA levels between control and exercise-2 groups showed no significant difference, hence, MDA level in exercise-1 group was higher compared to control group (P &lt; .01). The heart GPX activity increased significantly in exercise-2 group regarding other groups (P &lt; .01). The SOD activities of groups were similar. Creatine kinase (CK) and lactate dehydrogenase (LDH) concentrations increased in the exercise-1 compared to the other groups (P &lt; .01).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results indicate that in heart, the adaptation and alteration in oxidative stress and cell injury level depend on duration of exercise.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ghiasi</LastName>
<ForeName>Rafigheh</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mohammadi</LastName>
<ForeName>Mustafa</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ashrafi Helan</LastName>
<ForeName>Javad</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathobiology, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jafari Jozani</LastName>
<ForeName>Seied Raziallah</ForeName>
<Initials>SR</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathobiology, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mohammadi</LastName>
<ForeName>Shima</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Student of Pharmacy, Pharmacy School, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ghiasi</LastName>
<ForeName>Akbar</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Faculty of Management, Zabol University of Medical Sciences, Zabol, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Naderi</LastName>
<ForeName>Roya</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Physiology, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Iran</Country>
<MedlineTA>J Cardiovasc Thorac Res</MedlineTA>
<NlmUniqueID>101528712</NlmUniqueID>
<ISSNLinking>2008-5117</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4685280</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Duration of Exercise</Keyword>
<Keyword MajorTopicYN="N">Oxidative Stress</Keyword>
<Keyword MajorTopicYN="N">Rat</Keyword>
<Keyword MajorTopicYN="N">Resistance Exercise</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702344</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">2008-5117</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Journal of cardiovascular and thoracic research</Title>
<ISOAbbreviation>J Cardiovasc Thorac Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Evaluation of the P Wave Axis in Patients With Systemic Lupus Erythematosus.</ArticleTitle>
<Pagination>
<MedlinePgn>154-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.15171/jcvtr.2015.33</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">P wave axis is one of the most practical clinical tool for evaluation of cardiovascular disease. The aim of our study was to evaluate the P wave axis in electrocardiogram (ECG), left atrial function and association between the disease activity score in patients with systemic lupus erythematosus (SLE).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Standard 12-lead surface ECGs were recorded by at a paper speed of 25 m/s and an amplifier gain of 10 mm/mV. The heart rate (HR), the duration of PR, QRS, QTd (dispersion), the axis of P wave were measured by ECG machine automatically.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The P wave axis was significantly increased in patients with SLE (49 ± 20 vs. 40 ± 18, P = 0.037) and the disease activity score was found positively correlated with P wave axis (r: 0.382, P = 0.011). The LA volume and the peak systolic strain of the left atrium (LA) were statistically different between the groups (P = 0.024 and P = 0.000). The parameters of the diastolic function; E/A and E/e' were better in the control group than the patients with SLE (1.1 ± 0.3 vs. 1.3 ± 0.3, P = 0.041 and 6.6 ± 2.8 vs. 5.4 ± 1.4, P = 0.036, respectively).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">P wave axis was found significantly increased in patients with SLE and positively correlated with SELENA-SLEDAI score. As the risk score increases in patients with SLE, P wave axis changes which may predict the risk of all-cause and cardiovascular mortality.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Acar</LastName>
<ForeName>Rezzan Deniz</ForeName>
<Initials>RD</Initials>
<AffiliationInfo>
<Affiliation>Kartal Kosuyolu Education and Research Hospital, Department of Cardiology, Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bulut</LastName>
<ForeName>Mustafa</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Kartal Kosuyolu Education and Research Hospital, Department of Cardiology, Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Acar</LastName>
<ForeName>Şencan</ForeName>
<Initials>Ş</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, Bilim University, Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Izci</LastName>
<ForeName>Servet</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Kartal Kosuyolu Education and Research Hospital, Department of Cardiology, Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fidan</LastName>
<ForeName>Serdar</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Kartal Kosuyolu Education and Research Hospital, Department of Cardiology, Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yesin</LastName>
<ForeName>Mahmut</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Kartal Kosuyolu Education and Research Hospital, Department of Cardiology, Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Efe</LastName>
<ForeName>Suleyman Cagan</ForeName>
<Initials>SC</Initials>
<AffiliationInfo>
<Affiliation>Kartal Kosuyolu Education and Research Hospital, Department of Cardiology, Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Iran</Country>
<MedlineTA>J Cardiovasc Thorac Res</MedlineTA>
<NlmUniqueID>101528712</NlmUniqueID>
<ISSNLinking>2008-5117</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4685281</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Left Atrial Strain</Keyword>
<Keyword MajorTopicYN="N">Left Atrial Volume</Keyword>
<Keyword MajorTopicYN="N">P Wave Axis</Keyword>
<Keyword MajorTopicYN="N">Systemic Lupus Erythematosus</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702345</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">2008-5117</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Journal of cardiovascular and thoracic research</Title>
<ISOAbbreviation>J Cardiovasc Thorac Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Prevalence of Metabolic Syndrome in Elementary School Children in East of Iran.</ArticleTitle>
<Pagination>
<MedlinePgn>158-63</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.15171/jcvtr.2015.34</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Metabolic Syndrome (MS) in children and adolescents is becoming a global public health concern. MS tracks into adulthood increasing the risk for type 2 diabetes mellitus and cardiovascular diseases. This study was designed to verify the rate of MS in elementary school students of Birjand, as a representative sample of Iranian children to verify the best preventive measures in this age group.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">This descriptive-analytical, cross-sectional study was performed on 1425 elementary school children through multiple-cluster sampling in 2013. Height, weight, waist circumference and blood pressure of children were measured by standard methods. Blood glucose, triglycerides, cholesterol, High-density lipoprotein-cholesterol (HDL-C) and low-density lipoprotein-cholesterol (LDL-C) levels were also measured after 12 hours fasting. MS was defined according to the Adult Treatment Panel III (ATP-III) based on the National Cholesterol Education Program. Data were analyzed by SPSS using t test and chi-square test. Significance level was set at P &lt; 0.05.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The prevalence of MS was 5.3% which increased with age. 43.5% of the studied cases had one or more components of the MS. The most common components were hypertension, abdominal obesity, hypertriglyceridemia, low HDL-cholesterol and impaired fasting glucose, respectively. MS prevalence was 0.9% in normal weight, 11.3% in overweight and 36.2% in obese children.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Regarding the high prevalence of MS in elementary school children in our region, screening for obesity is recommended to prevent adulthood complications. Therapeutic lifestyle changes and maintenance of regular physical activity are the most important strategies for preventing childhood obesity.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zardast</LastName>
<ForeName>Mahmoud</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Birjand Atherosclerosis and Coronary Artery Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Namakin</LastName>
<ForeName>Kokab</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Birjand Atherosclerosis and Coronary Artery Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chahkandi</LastName>
<ForeName>Tayeb</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Birjand Atherosclerosis and Coronary Artery Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Taheri</LastName>
<ForeName>Fatemeh</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Birjand Atherosclerosis and Coronary Artery Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kazemi</LastName>
<ForeName>Toba</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Birjand Atherosclerosis and Coronary Artery Diseases Research Center, Department of Cardiology, Birjand University of Medical Sciences, Birjand, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bijari</LastName>
<ForeName>Bita</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Birjand Atherosclerosis and Coronary Artery Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Iran</Country>
<MedlineTA>J Cardiovasc Thorac Res</MedlineTA>
<NlmUniqueID>101528712</NlmUniqueID>
<ISSNLinking>2008-5117</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4685282</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Childhood Obesity</Keyword>
<Keyword MajorTopicYN="N">Elementary School Children</Keyword>
<Keyword MajorTopicYN="N">Metabolic Syndrome</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702346</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">2008-5117</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Journal of cardiovascular and thoracic research</Title>
<ISOAbbreviation>J Cardiovasc Thorac Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Variations in Ischemic Heart Disease Research by Country, Income, Development and Burden of Disease: A Scientometric Approach.</ArticleTitle>
<Pagination>
<MedlinePgn>164-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.15171/jcvtr.2015.35</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Ischemic heart diseases (IHDs) are the leading cause of mortality worldwide. However the global burden of IHD has been concentrated on developing countries, where limited research efforts have been made to address these needs. This study aimed to understand the global distribution of IHD research activities by looking at the countries' burden of disease, income and development data.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">As a scientometric study, Scopus database was searched for research publications indexed under the medical subject heading (MeSH) 'myocardial ischemia' including the following terms: coronary artery disease, coronary heart disease, and ischemic heart disease. The number of research publications in Scopus database was recorded for each individual year 2000-2012, and for each country. Data for estimated IHD disability-adjusted life-year's (DALY's), gross domestic product (GDP) per capita and human development index were also included for the analysis.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">IHD research publications were most likely produced by European and Western pacific countries. High-income countries produced the greatest share of about 81% of the global IHD research. However, no significant association observed between the countries' GDP and number of research publications worldwide (OR = 0.98, P = 0.939). Global IHD research found to be strongly associated with the burden of disease (P &lt; 0.0001) and the countries' HDI values worldwide (OR = 16.8, P = 0.016).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our study suggested that global research on IHD were geographically distributed and highly concentrated among the world's richest countries. Estimated DALYs and HDI were found as important predictors of IHD research and the key drivers of health research disparities across the world.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Okhovati</LastName>
<ForeName>Maryam</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zare</LastName>
<ForeName>Morteza</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bazrafshan</LastName>
<ForeName>Azam</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Iran</Country>
<MedlineTA>J Cardiovasc Thorac Res</MedlineTA>
<NlmUniqueID>101528712</NlmUniqueID>
<ISSNLinking>2008-5117</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4685283</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Burden of Disease</Keyword>
<Keyword MajorTopicYN="N">Ischemic Heart Disease</Keyword>
<Keyword MajorTopicYN="N">Mortality</Keyword>
<Keyword MajorTopicYN="N">National Income</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702347</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">2008-5117</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Journal of cardiovascular and thoracic research</Title>
<ISOAbbreviation>J Cardiovasc Thorac Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Children With Tetralogy of Fallot in an Urban Centre in Africa.</ArticleTitle>
<Pagination>
<MedlinePgn>168-71</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.15171/jcvtr.2015.36</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">There is a dearth of literature on tetralogy of fallot (TOF) in children in Sub-Saharan Africa. This study up aims to describe the prevalence, clinical profile and associated cardiac anomaly of children diagnosed with TOF documented over an eight year period in a tertiary hospital in South Western Nigeria.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A prospective review of all consecutive cases of TOF diagnosed with echocardiography at the Lagos State University Teaching Hospital (LASUTH) between January 2007 and December 2014. Data were analyzed using SPSS version 20. Tables and charts were used to depict those variables. Descriptive statistic are presented as percentages or means and standard deviation. Means of normally distributed variables were compared using the student t test and proportions using chi-square test. Skewed distribution were analyzed using appropriate non-parametric tests. Level of significance set at P &lt; 0.05.</AbstractText>
<AbstractText Label="RESULT" NlmCategory="RESULTS">The prevalence of TOF among children presenting at LASUTH at the study period was 4.9 per 10 000 while its prevalence among those with congenital heart disease was 16.9%. There was a male predominance and most children presented within 1-5 years of age. Chromosomal abnormalities such as Down syndrome, Turners syndrome and CATCH 22 syndrome were documented in some subjects. Some of the subjects had atypical presentation.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">TOF is as common in Nigeria as other parts of the world, there is a need to established cardiac centers to salvage these children. Collaboration from developed countries will be helpful in this resource limited region.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Animasahun</LastName>
<ForeName>Barakat Adeola</ForeName>
<Initials>BA</Initials>
<AffiliationInfo>
<Affiliation>Department of Paediatrics and Child Health, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Madise-Wobo</LastName>
<ForeName>Akpoembele Deborah</ForeName>
<Initials>AD</Initials>
<AffiliationInfo>
<Affiliation>Department of Paediatrics, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Omokhodion</LastName>
<ForeName>Samuel I</ForeName>
<Initials>SI</Initials>
<AffiliationInfo>
<Affiliation>Department of Paediatrics and Child Health, University College Hospital, badan, Oyo State, Nigeria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Njokanma</LastName>
<ForeName>Olisamedua Fidelis</ForeName>
<Initials>OF</Initials>
<AffiliationInfo>
<Affiliation>Department of Paediatrics and Child Health, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Iran</Country>
<MedlineTA>J Cardiovasc Thorac Res</MedlineTA>
<NlmUniqueID>101528712</NlmUniqueID>
<ISSNLinking>2008-5117</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4685284</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Africa</Keyword>
<Keyword MajorTopicYN="N">Fallot</Keyword>
<Keyword MajorTopicYN="N">Nigeria</Keyword>
<Keyword MajorTopicYN="N">Profile</Keyword>
<Keyword MajorTopicYN="N">Tetralogy</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702348</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">2008-5117</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Journal of cardiovascular and thoracic research</Title>
<ISOAbbreviation>J Cardiovasc Thorac Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Persistent Atrial Septum Defect Despite Placement of Two Amplatzer Septal Occluders.</ArticleTitle>
<Pagination>
<MedlinePgn>172-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.15171/jcvtr.2015.37</ELocationID>
<Abstract>
<AbstractText>Herein, we are presenting a case of persistent interatrial septal defect diagnosed during coronary artery bypass grafting (CABG). Twice, attempts had been made to close this shunt using amplatzer septal occlude. However, percutaneous technique had failed in both occasions. The patient presented with chest pain 4 years after the second attempt and required urgent CABG. Persistent shunt was repaired during surgery. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Leissner</LastName>
<ForeName>Kay B</ForeName>
<Initials>KB</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Harvard Medical School, Boston, MA, USA ; Department of Anesthesiology, Boston University School of Medicine, Boston, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Porhomayon</LastName>
<ForeName>Jahan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology and Critical Care Medicine, University at Buffalo, Buffalo, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nader</LastName>
<ForeName>Nader D</ForeName>
<Initials>ND</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology and Critical Care Medicine, University at Buffalo, Buffalo, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Iran</Country>
<MedlineTA>J Cardiovasc Thorac Res</MedlineTA>
<NlmUniqueID>101528712</NlmUniqueID>
<ISSNLinking>2008-5117</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4685285</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Amplatzer</Keyword>
<Keyword MajorTopicYN="N">Atrial Septal Defect</Keyword>
<Keyword MajorTopicYN="N">Percutaneous Occluders</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702349</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">2008-5117</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Journal of cardiovascular and thoracic research</Title>
<ISOAbbreviation>J Cardiovasc Thorac Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Redo-EVAR After Surgical Repair in Ruptured Abdominal Aortic Aneurysm.</ArticleTitle>
<Pagination>
<MedlinePgn>175-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.15171/jcvtr.2015.38</ELocationID>
<Abstract>
<AbstractText>Endovascular aneurysm repair (EVAR) is an adequate means for treating infrarenal abdominal aortic aneurysms (AAA). However, secondary interventions are required in approximately 15% to 20% of patients. The aim of this paper was to report our knowledge with stent grafts in secondary interventions after EVAR in a 73-year-old patient. One of the exceptional complications of EVAR are endoleaks which may lead to expansion of aneurysm and rupture if not repaired. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bozok</LastName>
<ForeName>Şahin</ForeName>
<Initials>Ş</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Surgery, Recep Tayyip Erdogan University Faculty of Medicine, Rize, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ozan Karakişi</LastName>
<ForeName>Sedat</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Surgery, Recep Tayyip Erdogan University Faculty of Medicine, Rize, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ergene</LastName>
<ForeName>Şaban</ForeName>
<Initials>Ş</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Surgery, Recep Tayyip Erdogan University Faculty of Medicine, Rize, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tufekçi</LastName>
<ForeName>Nebiye</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Surgery, Recep Tayyip Erdogan University Faculty of Medicine, Rize, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ilhan</LastName>
<ForeName>Gökhan</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Surgery, Recep Tayyip Erdogan University Faculty of Medicine, Rize, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Karamustafa</LastName>
<ForeName>Hakan</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Surgery, Recep Tayyip Erdogan University Faculty of Medicine, Rize, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Iran</Country>
<MedlineTA>J Cardiovasc Thorac Res</MedlineTA>
<NlmUniqueID>101528712</NlmUniqueID>
<ISSNLinking>2008-5117</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4685286</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Abdominal Aorta</Keyword>
<Keyword MajorTopicYN="N">Aneurysm</Keyword>
<Keyword MajorTopicYN="N">EVAR</Keyword>
<Keyword MajorTopicYN="N">Endovascular Aneurysm</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702350</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">2008-5117</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Journal of cardiovascular and thoracic research</Title>
<ISOAbbreviation>J Cardiovasc Thorac Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Is Two Better Than One? Anticipation of a Favorable Hemodynamic Profile by Combining the Hypnotic Drugs for Induction of Anesthesia.</ArticleTitle>
<Pagination>
<MedlinePgn>178-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.15171/jcvtr.2015.39</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nader</LastName>
<ForeName>Nader D</ForeName>
<Initials>ND</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, University at Buffalo, Buffalo, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Iran</Country>
<MedlineTA>J Cardiovasc Thorac Res</MedlineTA>
<NlmUniqueID>101528712</NlmUniqueID>
<ISSNLinking>2008-5117</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4685287</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26701098</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1746-4269</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>11</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Journal of ethnobiology and ethnomedicine</Title>
<ISOAbbreviation>J Ethnobiol Ethnomed</ISOAbbreviation>
</Journal>
<ArticleTitle>Ethnobotanical survey of plants used in Afyonkarahisar-Turkey.</ArticleTitle>
<Pagination>
<MedlinePgn>84</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13002-015-0067-6</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The traditional knowledge about plants and their uses in Turkey is disappearing in recent years because the new generations of villagers migrate to big cities for a better life. Afyonkarahisar located at the intersection of roads and phytogeographical regions (Mediterranean, Iran-Turan, and Euro-Siberian) has more than 2500 plant species. This richness of plant diversity promotes the indigenous commuity for the traditional use of wild plants. The aim of the study is to show wild plants' ethnobotanical usages associated with medicinal, food, fodder, and household goods in 31 settlements within the boundaries of Afyonkarahisar province.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The ethnobotanical data were collected from 46 informants by means of semi-structured interviews from 2012 to 2014. Ethnobotanical uses of plants of the study area were conducted in the vicinity of Afyonkarahisar (5 districts, 8 towns, 15 villages, and 3 neighborhood centers).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred and thirty plant taxa belonging to 39 families were recorded and collected. Hundred and seventy-eight different uses of these plants were documented and used generally for medicinal (84), food (68), fodder (16), household goods (3), dyes (3), handicrafts (3) and religious (1).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study provides interesting uses of plants in the local community of Afyonkarahisar and its surrounding area, in what purpose they make use of plants, how they make use of them and obtained results will contribute to economy of villagers. Since the local people, especially in villages, are poor and do not have health care, they use the plants to treat illnesses, food, fodder, household goods and other uses (evil eye). Also this study will light the way for posterity for next generations.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Arı</LastName>
<ForeName>Süleyman</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Biology and Genetics, Science &amp; Arts Faculty, Afyon Kocatepe University, 03200, Afyonkarahisar, Turkey. slymanari@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Temel</LastName>
<ForeName>Mehmet</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Biology and Genetics, Science &amp; Arts Faculty, Afyon Kocatepe University, 03200, Afyonkarahisar, Turkey. mtemel@aku.edu.tr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kargıoğlu</LastName>
<ForeName>Mustafa</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Biology and Genetics, Science &amp; Arts Faculty, Afyon Kocatepe University, 03200, Afyonkarahisar, Turkey. kargi@aku.edu.tr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Konuk</LastName>
<ForeName>Muhsin</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Üsküdar University, 34662, Istanbul, Turkey. mkonuk@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Ethnobiol Ethnomed</MedlineTA>
<NlmUniqueID>101245794</NlmUniqueID>
<ISSNLinking>1746-4269</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">PMC4690277</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26701261</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1746-4269</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>11</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Journal of ethnobiology and ethnomedicine</Title>
<ISOAbbreviation>J Ethnobiol Ethnomed</ISOAbbreviation>
</Journal>
<ArticleTitle>Scented grasses in Norway-identity and uses.</ArticleTitle>
<Pagination>
<MedlinePgn>83</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13002-015-0070-y</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Some grass species are richer in coumarin and thus more sweetly scented than others. These have been eagerly sought after in parts of Norway, but the tradition has been weakly documented, both in terms of the species collected, their vernacular names, and uses.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Based on literature data and a substantial body of information collected during my own ethnobotanical field work, artefacts and voucher specimens, the grass species are identified, and their uses clarified.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In Norwegian literature, the tradition of collecting and using scented grasses has received little attention, and past authors largely refer it to Anthoxanthum spp. The tradition's concentration to the Sámi strongholds of northernmost Norway, and most authors' lacking knowledge of the Sámi language, have contributed to the weak and misleading coverage in previous publications. Coumarin-rich grass species are well known in folk tradition in northernmost Norway, as luktegress (Norwegian, "scent grass"), háissasuoidni (North Sámi, "scent grass"), hajuheinä (Finnish, "scent grass"), or similar terms. They have been (and still are) frequently collected, and used as perfume, for storing with clothes, and a number of other purposes. Despite literature records identifying the species used as Anthoxanthum odoratum coll. (including A. nipponicum), the main source utilized in North Norway is Hierochloë odorata, both ssp. arctica and ssp. odorata. Anthoxanthum nipponicum and Milium effusum are alternative, but infrequently used sources of material, depending on local tradition and availability.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">By far the most important grass species hiding behind the "scented grass" tradition in Norway is Hierochloë odorata. Anthoxanthum nipponicum is also used, but much less frequently, and only a single record confirms the use of Milium effusum. Only the foliage of Hierochloë provides suitable material for making traditional braids. The three major ethnic groups in Norway have all utilized scented grasses as perfume and for storing with clothes, but the tradition's geographical concentration to the far north of Norway (Finnmark and NE Troms), suggests that it has originally mainly been a Sámi tradition, adopted by their neighbours.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Alm</LastName>
<ForeName>Torbjørn</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Tromsø museum, University of Tromsø, PO Box 6050, Langnes, N-9037, Tromsø, Norway. torbjorn.alm@uit.no.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Ethnobiol Ethnomed</MedlineTA>
<NlmUniqueID>101245794</NlmUniqueID>
<ISSNLinking>1746-4269</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">PMC4690224</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26698000</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-3390</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>15</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>The journal of evidence-based dental practice</Title>
<ISOAbbreviation>J Evid Based Dent Pract</ISOAbbreviation>
</Journal>
<ArticleTitle>Toward Implementing Primary Care at Chairside: Developing a Clinical Decision Support System for Dental Hygienists.</ArticleTitle>
<Pagination>
<MedlinePgn>145-51</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jebdp.2015.08.003</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1532-3382(15)00131-1</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The goal of this project was to use the Consolidated Framework for Implementation Research (CFIR) as the theoretical foundation for developing a web-based clinical decision support system (CDSS) for primary care screening and care coordination by dental hygienists at chairside.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">First, we appraised New York State education and scope of practice requirements for dental hygienists with input from health experts who constituted a Senior Advisory Board for the project, and reviewed current professional guidelines and best practices for tobacco use, hypertension and diabetes screening, and nutrition counseling at chairside. Second, we created algorithms for these four health issues (tobacco, hypertension, diabetes, and nutrition) using evidence-based guidelines endorsed by authoritative professional bodies. Third, an information technology specialist incorporated the algorithms into a tool using an iterative process to refine the CDSS, with input from dental hygienists, dentists, Senior Advisory Board members and research staff.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">An evidence-based CDSS for use by dental hygienists at chairside for tobacco use, hypertension and diabetes screening, and nutrition counseling was developed with the active participation of the individuals involved in the implementation process.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CDSS technology may potentially be leveraged to enhance primary care screening and coordination by dental hygienists at chairside, leading to improved patient care. Using the CFIR as a pragmatic structure for implementing this intervention across multiple settings, the developed CDSS is available for downloading and adaptation to diverse dental settings and other primary care sensitive conditions.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Russell</LastName>
<ForeName>Stefanie L</ForeName>
<Initials>SL</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology &amp; Health Promotion, New York University College of Dentistry, 433 First Avenue, 7th Floor, New York, NY 10010, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Greenblatt</LastName>
<ForeName>Ariel Port</ForeName>
<Initials>AP</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology &amp; Health Promotion, New York University College of Dentistry, 433 First Avenue, 7th Floor, New York, NY 10010, USA. Electronic address: ap140@nyu.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gomes</LastName>
<ForeName>Danni</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Dental Hygiene Program, New York University College of Dentistry, 421 First Avenue, New York, NY 10010, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Birenz</LastName>
<ForeName>Shirley</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology &amp; Health Promotion, New York University College of Dentistry, 433 First Avenue, 7th Floor, New York, NY 10010, USA; Dental Hygiene Program, New York University College of Dentistry, 421 First Avenue, New York, NY 10010, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Golembeski</LastName>
<ForeName>Cynthia A</ForeName>
<Initials>CA</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology &amp; Health Promotion, New York University College of Dentistry, 433 First Avenue, 7th Floor, New York, NY 10010, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shelley</LastName>
<ForeName>Donna</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Population Health, New York University School of Medicine, 227 East 30th Street, New York, NY 10016, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McGuirk</LastName>
<ForeName>Matthew</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Technology and Informatics Services, New York University College of Dentistry, 421 First Avenue, New York, NY 10010, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eisenberg</LastName>
<ForeName>Elise</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Technology and Informatics Services, New York University College of Dentistry, 421 First Avenue, New York, NY 10010, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Northridge</LastName>
<ForeName>Mary E</ForeName>
<Initials>ME</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology &amp; Health Promotion, New York University College of Dentistry, 433 First Avenue, 7th Floor, New York, NY 10010, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 DE023072</GrantID>
<Acronym>DE</Acronym>
<Agency>NIDCR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1 TR000038</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Evid Based Dent Pract</MedlineTA>
<NlmUniqueID>101083101</NlmUniqueID>
<ISSNLinking>1532-3382</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Care coordination</Keyword>
<Keyword MajorTopicYN="N">Clinical decision support system</Keyword>
<Keyword MajorTopicYN="N">Dental hygienist</Keyword>
<Keyword MajorTopicYN="N">Health screening</Keyword>
<Keyword MajorTopicYN="N">Implementation science</Keyword>
<Keyword MajorTopicYN="N">Primary care</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702359</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2052-0492</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>3</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Journal of intensive care</Title>
<ISOAbbreviation>J Intensive Care</ISOAbbreviation>
</Journal>
<ArticleTitle>Measurement of the vascular pedicle width predicts fluid repletion: a cross-sectional comparison with inferior vena cava ultrasound and lung comets.</ArticleTitle>
<Pagination>
<MedlinePgn>55</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40560-015-0121-4</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Determination of a patient's volume status remains challenging. Ultrasound assessments of the inferior vena cava and lung parenchyma have been shown to reflect fluid status when compared to the more traditional static and dynamic methods. Yet, resource-limited intensive care units (ICUs) may still not have access to bedside ultrasound. The vascular pedicle width (VPW) measured on chest radiographs remains underutilized for fluid assessment. In this study, we aimed to determine the correlation between ultrasound assessment and vascular pedicle width and to identify a discriminant value that predicted a fluid replete state.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Eighty-four data points of simultaneous VPW and inferior vena cava measurements were collected on mechanically ventilated patients. VPW measurements were compared with lung comet scores, fluid balance, and a composite variable of inferior vena cava diameter greater than or equal to 2 cm and variability less than 15 %.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A VPW of 64 mm accurately predicted fluid repletion with a positive predictive value equal to 88.5 % and an area under the curve (AUC) of 0.843, 95 % CI 0.75-0.93, p &lt; 0.001. VPW closely correlated with inferior vena cava diameter (Pearson's r = 0.64, p = &lt;0.001). Poor correlations were observed between VPW and lung comet score, Pearson's r = 0.12, p = 0.26, fluid balance, Pearson's r = 0.3, p = 0.058, and beta natriuretic peptide, Pearson's r = 0.12, p = 0.26.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study shows a high predictive ability of the VPW for fluid repletion, as compared to an accepted method of volume assessment. Given the relationship of fluid overload and mortality, these results may assist fluid resuscitation in resource-limited intensive care units.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Salahuddin</LastName>
<ForeName>Nawal</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Adult Critical Care Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hussain</LastName>
<ForeName>Iqbal</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Adult Critical Care Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alsaidi</LastName>
<ForeName>Hakam</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Adult Critical Care Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shaikh</LastName>
<ForeName>Quratulain</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>Adult Critical Care Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Joseph</LastName>
<ForeName>Mini</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Nursing, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hawa</LastName>
<ForeName>Hassan</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Adult Critical Care Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maghrabi</LastName>
<ForeName>Khalid</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Adult Critical Care Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Intensive Care</MedlineTA>
<NlmUniqueID>101627304</NlmUniqueID>
<ISSNLinking>2052-0492</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688935</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Fluid assessment</Keyword>
<Keyword MajorTopicYN="N">Inferior vena cava</Keyword>
<Keyword MajorTopicYN="N">Ultrasound</Keyword>
<Keyword MajorTopicYN="N">Vascular pedicle width</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702406</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">2329-4302</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>2</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Journal of medical imaging (Bellingham, Wash.)</Title>
<ISOAbbreviation>J Med Imaging (Bellingham)</ISOAbbreviation>
</Journal>
<ArticleTitle>Rank-ordered filter for edge enhancement of cellular images using interval type II fuzzy set.</ArticleTitle>
<Pagination>
<MedlinePgn>044005</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1117/1.JMI.2.4.044005</ELocationID>
<Abstract>
<AbstractText>An edge-enhancement technique using an interval type II fuzzy set that uses rank-ordered filter to enhance the edges of cellular images is proposed. When cellular images from any laboratory are digitized, scanned, and stored, some kind of degradation occurs, and directly using a rank-ordered filter may not produce clear edges. These images contain uncertainties, present in edges or boundaries of the image. Fuzzy sets that take into account these uncertainties may be a good tool to process these images. However, a fuzzy set sometimes does not produce better results. We used an interval type II fuzzy set, which considers the uncertainty in a different way. It considers the membership function in the fuzzy set as "fuzzy," so the membership values lie within an interval range. A type II fuzzy set has upper and lower membership levels, and with the two levels, a new membership function is computed using Hamacher t-conorm. A new fuzzy image is formed. A rank-ordered filter is applied to the image to obtain an edge-enhanced image. The proposed method is compared with the existing methods visually and quantitatively using entropic method. Entropy of the proposed method is higher (0.4418) than the morphology method (0.2275), crisp method (0.3599), and Sobel method (0.2669), implying that the proposed method is better. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chaira</LastName>
<ForeName>Tamalika</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Indian Institute of Technology Delhi Campus , 31 North Avenue, Hauz Khas, New Delhi 110016, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Med Imaging (Bellingham)</MedlineTA>
<NlmUniqueID>101643461</NlmUniqueID>
<ISSNLinking>2329-4302</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4684597 [Available on 12/21/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Hamacher t-conorm</Keyword>
<Keyword MajorTopicYN="N">edge image</Keyword>
<Keyword MajorTopicYN="N">membership function</Keyword>
<Keyword MajorTopicYN="N">type II fuzzy set</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702407</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">2329-4302</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>2</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Journal of medical imaging (Bellingham, Wash.)</Title>
<ISOAbbreviation>J Med Imaging (Bellingham)</ISOAbbreviation>
</Journal>
<ArticleTitle>Correlations between quantitative fat-water magnetic resonance imaging and computed tomography in human subcutaneous white adipose tissue.</ArticleTitle>
<Pagination>
<MedlinePgn>046001</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1117/1.JMI.2.4.046001</ELocationID>
<Abstract>
<AbstractText>Beyond estimation of depot volumes, quantitative analysis of adipose tissue properties could improve understanding of how adipose tissue correlates with metabolic risk factors. We investigated whether the fat signal fraction (FSF) derived from quantitative fat-water magnetic resonance imaging (MRI) scans at 3.0 T correlates to CT Hounsfield units (HU) of the same tissue. These measures were acquired in the subcutaneous white adipose tissue (WAT) at the umbilical level of 21 healthy adult subjects. A moderate correlation exists between MRI- and CT-derived WAT values for all subjects, [Formula: see text], [Formula: see text], with a slope of [Formula: see text], (95% CI [Formula: see text]), indicating that a decrease of 1 HU equals a mean increase of 0.38% FSF. We demonstrate that FSF estimates obtained using quantitative fat-water MRI techniques correlate with CT HU values in subcutaneous WAT, and therefore, MRI-based FSF could be used as an alternative to CT HU for assessing metabolic risk factors. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gifford</LastName>
<ForeName>Aliya</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Vanderbilt University , Institute of Imaging Science, 1161 21st Avenue South, Medical Center North, AA-1105, Nashville, Tennessee 37235, United States ; Vanderbilt University , Chemical and Physical Biology Program, 1161 21st Avenue South, Medical Center North, AA 3105, Nashville, Tennessee 37235, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Walker</LastName>
<ForeName>Ronald C</ForeName>
<Initials>RC</Initials>
<AffiliationInfo>
<Affiliation>Tennessee Valley VA Healthcare , Department of Medical Imaging, 1161 21st Avenue South, Medical Center North, CCC-1121, Nashville, Tennessee 37235, United States ; Vanderbilt University , School of Medicine, Department of Radiology and Radiological Sciences, 1161 21st Avenue South, Medical Center North, CCC-1121, Nashville, Tennessee 37235, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Towse</LastName>
<ForeName>Theodore F</ForeName>
<Initials>TF</Initials>
<AffiliationInfo>
<Affiliation>Vanderbilt University , Institute of Imaging Science, 1161 21st Avenue South, Medical Center North, AA-1105, Nashville, Tennessee 37235, United States ; Vanderbilt University , School of Medicine, Department of Physical Medicine and Rehabilitation, 2201 Children's Way #1014, Nashville, Tennessee 37235, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brian Welch</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Vanderbilt University , Institute of Imaging Science, 1161 21st Avenue South, Medical Center North, AA-1105, Nashville, Tennessee 37235, United States ; Vanderbilt University , School of Medicine, Department of Radiology and Radiological Sciences, 1161 21st Avenue South, Medical Center North, CCC-1121, Nashville, Tennessee 37235, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Med Imaging (Bellingham)</MedlineTA>
<NlmUniqueID>101643461</NlmUniqueID>
<ISSNLinking>2329-4302</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4684077 [Available on 12/18/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Hounsfield units</Keyword>
<Keyword MajorTopicYN="N">fat quantification</Keyword>
<Keyword MajorTopicYN="N">fat signal fraction</Keyword>
<Keyword MajorTopicYN="N">obesity</Keyword>
<Keyword MajorTopicYN="N">quantitative biomarker</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702408</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">2329-4302</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>3</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Journal of medical imaging (Bellingham, Wash.)</Title>
<ISOAbbreviation>J Med Imaging (Bellingham)</ISOAbbreviation>
</Journal>
<ArticleTitle>Use of the Hotelling observer to optimize image reconstruction in digital breast tomosynthesis.</ArticleTitle>
<Pagination>
<MedlinePgn>011008</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1117/1.JMI.3.1.011008</ELocationID>
<Abstract>
<AbstractText>We propose an implementation of the Hotelling observer that can be applied to the optimization of linear image reconstruction algorithms in digital breast tomosynthesis. The method is based on considering information within a specific region of interest, and it is applied to the optimization of algorithms for detectability of microcalcifications. Several linear algorithms are considered: simple back-projection, filtered back-projection, back-projection filtration, and [Formula: see text]-tomography. The optimized algorithms are then evaluated through the reconstruction of phantom data. The method appears robust across algorithms and parameters and leads to the generation of algorithm implementations which subjectively appear optimized for the task of interest. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sánchez</LastName>
<ForeName>Adrian A</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>University of Chicago , Department of Radiology, 5841 South Maryland Avenue, Chicago 60615, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sidky</LastName>
<ForeName>Emil Y</ForeName>
<Initials>EY</Initials>
<AffiliationInfo>
<Affiliation>University of Chicago , Department of Radiology, 5841 South Maryland Avenue, Chicago 60615, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pan</LastName>
<ForeName>Xiaochuan</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>University of Chicago , Department of Radiology, 5841 South Maryland Avenue, Chicago 60615, United States ; University of Chicago , Department of Radiation and Cellular Oncology, 5758 South Maryland Avenue, Chicago 60615, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Med Imaging (Bellingham)</MedlineTA>
<NlmUniqueID>101643461</NlmUniqueID>
<ISSNLinking>2329-4302</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4686589 [Available on 12/22/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Hotelling observer</Keyword>
<Keyword MajorTopicYN="N">digital breast tomosynthesis</Keyword>
<Keyword MajorTopicYN="N">image quality</Keyword>
<Keyword MajorTopicYN="N">image reconstruction</Keyword>
<Keyword MajorTopicYN="N">objective assessment</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702272</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>Early and long-term outcomes of pericardiotomy in the treatment of primary cardiac tamponade.</ArticleTitle>
<Pagination>
<MedlinePgn>191-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54451</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Cardiac tamponade is a life-threatening clinical entity that requires emergent treatment. A variety of therapeutic methods have been applied. The purpose of this retrospective analysis was to study the efficacy of emergent surgical pericardiotomy in both the relief of cardiac tamponade and in the prevention of recurrence of pericardial effusion.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">This study involved 90 consecutive patients (58 males and 32 females) with a mean age of 57.4 ± 14.1 years, who underwent emergent pericardiotomy in the years 2006 to 2011 due to symptomatic primary cardiac tamponade. At the end of the follow-up period all living subjects had control echocardiographic examination. Survival analysis was performed with the use of the Kaplan-Meier method.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean duration time of surgery was 14.2 ± 4.5 minutes. All patients survived surgery but one died during in-hospital stay. During the post-discharge follow-up period (median 49 months) 32 patients died for any reason. One-year and four-year probability of survival was 0.68 ± 0.05 and 0.64 ± 0.05, respectively. Malignancy diagnosis was associated with significant negative impact on survival. One-year and four-year probability of survival was 0.56 ± 0.06 and 0.53 ± 0.06 for cancer patients while it was 0.93 ± 0.05 and 0.89 ± 0.06 for the others, respectively. In two cases, only cancer patients, re-intervention due to effusion recurrence was necessary.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Pericardiotomy, although invasive, is a safe method to relieve cardiac tamponade. It is also very efficient in the prevention of recurrence of pericardial effusion, even in cancer patients.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Perek</LastName>
<ForeName>Bartłomiej</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery and Transplantology, Poznan University of Medical Science, Poznan, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tomaszewska</LastName>
<ForeName>Iga</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>I Department of Cardiology, Poznan University of Medical Science, Poznan, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stefaniak</LastName>
<ForeName>Sebastian</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery and Transplantology, Poznan University of Medical Science, Poznan, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bartczak</LastName>
<ForeName>Agnieszka</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>I Department of Cardiology, Poznan University of Medical Science, Poznan, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jemielity</LastName>
<ForeName>Marek</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery and Transplantology, Poznan University of Medical Science, Poznan, Poland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631908</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">cardiac tamponade</Keyword>
<Keyword MajorTopicYN="N">effusion recurrence</Keyword>
<Keyword MajorTopicYN="N">pericardiotomy</Keyword>
<Keyword MajorTopicYN="N">survival</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702273</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>Multi-factor analysis of failure of renal replacement therapy in acute renal failure developed after cardiac surgery.</ArticleTitle>
<Pagination>
<MedlinePgn>195-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54454</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Acute renal failure (ARF) is a rare (2-15%), but severe complication of cardiac surgery with overall mortality reaching 40-80%. In order to save patients' lives they are treated with renal replacement therapy (RRT). The aim of our study was to assess the impact of different perioperative factors on mortality among patients treated with RRT because of acute renal failure, which occurred as a complication of a heart surgery.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Retrospective analysis included 45 patients, operated in the years 2009-2013, who underwent renal replacement therapy in order to treat postoperative ARF. The perioperative factors were analysed in two groups: group 1 - patients who died before discharge; and group 2 - those who survived until hospital discharge.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Forty-five of 3509 cardiac surgical patients (1.25%) required RRT after the surgery. A total of 23 (51.11%) died before discharge (group 1). Patients in group 1 were characterised by older age (70.21 vs. 67 years), higher mean EuroSCORE value (9.28 vs. 7.15) (p &lt; 0.05), higher percentage of concomitant surgery (63.63% vs. 28.57%) (p &lt; 0.05) and of admission of catecholamines in the postoperative period (100% vs. 68.42%) (p &lt; 0.005), and higher mean urea blood level prior to RRT initiation (156.65 vs. 102.54 mg/dl) (p &lt; 0.05).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The statistically relevant death predictors proved to be: high EuroSCORE, concomitant surgery, and high urea level at RRT initiation and admission of catecholamines in the postoperative period. After conformation in further studies, those factors may prove useful in stratification of death risk among surgical patients requiring RRT.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nawrocki</LastName>
<ForeName>Pawel</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery, Wroclaw Medical University, Wroclaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Szwedo</LastName>
<ForeName>Ireneusz</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Lower Silesian Centre for Heart Diseases MEDINET, Wroclaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tyc</LastName>
<ForeName>Joanna</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Students' Scientific Association at the Lower Silesian Centre for Heart Diseases MEDINET, Wroclaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hawrysz</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Students' Scientific Association at the Lower Silesian Centre for Heart Diseases MEDINET, Wroclaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Janiak</LastName>
<ForeName>Kamila</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Students' Scientific Association at the Lower Silesian Centre for Heart Diseases MEDINET, Wroclaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cichoń</LastName>
<ForeName>Romuald</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery of Chair and Department of Cardiology, Faculty of Medicine, Medical University of Warsaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631910</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">acute renal failure</Keyword>
<Keyword MajorTopicYN="N">renal replacement therapy</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702274</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>Artificial aortic valve dysfunction due to pannus and thrombus - different methods of cardiac surgical management.</ArticleTitle>
<Pagination>
<MedlinePgn>199-203</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54453</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Approximately 60 000 prosthetic valves are implanted annually in the USA. The risk of prosthesis dysfunction ranges from 0.1% to 4% per year. Prosthesis valve dysfunction is usually caused by a thrombus obstructing the prosthetic discs. However, 10% of prosthetic valves are dysfunctional due to pannus formation, and 12% of prostheses are damaged by both fibrinous and thrombotic components. The authors present two patients with dysfunctional aortic prostheses who were referred for cardiac surgery. Different surgical solutions were used in the treatment of each case.</AbstractText>
<AbstractText Label="CASE STUDY 1" NlmCategory="UNASSIGNED">The first patient was a 71-year-old woman whose medical history included arterial hypertension, stable coronary artery disease, diabetes mellitus, chronic obstructive pulmonary disease (COPD), and hypercholesterolemia; she had previously undergone left-sided mastectomy and radiotherapy. The patient was admitted to the Cardiac Surgery Department due to aortic prosthesis dysfunction. Transthoracic echocardiography revealed complete obstruction of one disc and a severe reduction in the mobility of the second. The mean transvalvular gradient was very high. During the operation, pannus covering the discs' surface was found. A biological aortic prosthesis was reimplanted without complications.</AbstractText>
<AbstractText Label="CASE STUDY 2" NlmCategory="UNASSIGNED">The second patient was an 87-year-old woman with arterial hypertension, persistent atrial fibrillation, and COPD, whose past medical history included gastric ulcer disease and ischemic stroke. As in the case of the first patient, she was admitted due to valvular prosthesis dysfunction. Preoperative transthoracic echocardiography revealed an obstruction of the posterior prosthetic disc and significant aortic regurgitation. Transesophageal echocardiography and fluoroscopy confirmed the prosthetic dysfunction. During the operation, a thrombus growing around a minor pannus was found. The thrombus and pannus were removed, and normal functionality of the prosthetic valve was restored.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Precise and modern diagnostic methods facilitated selection of the treatment method. However, the intraoperative view also seems to be crucial in individualizing the surgical approach.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ostrowski</LastName>
<ForeName>Stanisław</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery, Medical University of Lodz, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marcinkiewicz</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery, Medical University of Lodz, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kośmider</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery, Medical University of Lodz, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Walczak</LastName>
<ForeName>Andrzej</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery, Medical University of Lodz, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zwoliński</LastName>
<ForeName>Radosław</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery, Medical University of Lodz, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jaszewski</LastName>
<ForeName>Ryszard</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery, Medical University of Lodz, Poland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631909</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">artificial valve</Keyword>
<Keyword MajorTopicYN="N">echocardiography</Keyword>
<Keyword MajorTopicYN="N">pannus</Keyword>
<Keyword MajorTopicYN="N">thrombus</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702275</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>The impact of environmental factors on the occurrence of congenital heart disease in the form of hypoplastic left heart syndrome.</ArticleTitle>
<Pagination>
<MedlinePgn>204-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54455</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Congenital heart defects are the most common abnormalities in neonatal age. Congenital heart defects occur with a frequency of 3-12/1000 births. A special group is constituted by children with hypoplastic left heart syndrome because their treatment is extremely complex, requiring three-stage surgery and the involvement of various specialists.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">We analysed 100 infants with congenital heart defects in the form of hypoplastic left heart syndrome (HLHS). They were compared with a control group of 100 newborns without structural heart defects. The children's parents were asked to fill out a questionnaire consisting of 10 simple questions. It had been constructed in consultation with a psychologist in order not to offend the feelings of the parents affected by the illness of their offspring.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Congenital heart defects were present in the family medical histories of 16 HLHS children and 11 healthy children (p = 0.4). Genetic disorders were present in the family medical histories of 13 HLHS children and 15 healthy children (p = 0.73). In the HLHS group, the mothers smoked cigarettes or were exposed to tobacco smoke in 32% of cases; in the control group, this proportion amounted to 23% (p = 0.76).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The study found no relationship between the occurrence of hypoplastic left heart syndrome in children and the parents' age, the presence of genetic disorders, or heart defects in the family medical histories.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gładki</LastName>
<ForeName>Marcin Michał</ForeName>
<Initials>MM</Initials>
<AffiliationInfo>
<Affiliation>Paediatric Cardiac Surgery Clinic, USD, Krakow, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Składzień</LastName>
<ForeName>Tomasz</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Anaesthesiology and Intensive Care Clinic, University Hospital, Krakow, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Skalski</LastName>
<ForeName>Janusz Hieronim</ForeName>
<Initials>JH</Initials>
<AffiliationInfo>
<Affiliation>Paediatric Cardiac Surgery Clinic, USD, Krakow, Poland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631911</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">HLHS</Keyword>
<Keyword MajorTopicYN="N">congenital heart disease</Keyword>
<Keyword MajorTopicYN="N">environmental factors</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702276</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>Solitary fibrous tumor of the pleura - analysis of 18 cases.</ArticleTitle>
<Pagination>
<MedlinePgn>208-15</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54456</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Solitary fibrous tumors of the pleura (SFTP) are primary tumors arising from mesenchymal cells. Immunohistochemical studies have demonstrated that the origin of these tumors is mesenchymal rather than mesothelial. The aim of this study is to present our experience with diagnosing and treating patients with SFTP.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">We analyzed 18 patients treated at the Department of Thoracic Surgery of the Medical University of Lodz. The patients' medical histories and the results of postoperative histopathological investigation of the tumors were analyzed. Postoperative histopathological samples were evaluated with regard to the current criteria of malignancy.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In 17 patients, the tumors were surgically removed. Benign and small lesions (less than 3 cm in size) were removed by video-assisted thoracoscopic surgery (VATS). In 5 cases, malignant tumors were found in the postoperative material.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Solitary fibrous tumors of the pleura is a tumor with frequently asymptomatic clinical course. Treatment consists in resection which includes the adjacent structures, especially if the tumor is malignant.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cieślik-Wolski</LastName>
<ForeName>Bartosz</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Thoracic Surgery and Respiratory Rehabilitation, Medical University of Lodz, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pryt</LastName>
<ForeName>Łukasz</ForeName>
<Initials>Ł</Initials>
<AffiliationInfo>
<Affiliation>Department of Thoracic Surgery and Respiratory Rehabilitation, Medical University of Lodz, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Szlachcińska</LastName>
<ForeName>Aleksandra</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Thoracic Surgery and Respiratory Rehabilitation, Medical University of Lodz, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Walczak-Pasz</LastName>
<ForeName>Grażyna</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Copernicus Memorial Hospital in Lodz, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jesionek-Kupnicka</LastName>
<ForeName>Dorota</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Copernicus Memorial Hospital in Lodz, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kozak</LastName>
<ForeName>Józef</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Thoracic Surgery and Respiratory Rehabilitation, Medical University of Lodz, Poland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631912</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">VATS</Keyword>
<Keyword MajorTopicYN="N">pleural tumors</Keyword>
<Keyword MajorTopicYN="N">solitary fibrous tumor</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702277</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>Clinical and laboratory determinants of low serum level of 25-hydroxyvitamin D during escalation of pharmacotherapy in heart failure patients.</ArticleTitle>
<Pagination>
<MedlinePgn>216-27</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54457</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The activation of the renin-angiotensin-aldosterone (RAA) system is a main element of the pathophysiology of chronic heart failure (CHF), determining its symptoms and prognosis. Vitamin D is an RAA inhibitor, and its deficiency frequently accompanies CHF. The factors determining the concentration of 25-hydroxyvitamin D [25(OH)D] in CHF are not well understood, although an association has been suggested between the deficiency and the advancement of CHF. Also unknown is the influence of therapeutic escalation using recommended agents on the serum level of 25(OH)D. The aim of this study was to examine the incidence of abnormal 25(OH)D concentrations in CHF patients and to establish the clinical and laboratory determinants of low activity of this metabolite.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">The retrospective analysis included the data of 412 CHF patients not receiving optimal pharmacological treatment who were initially in NYHA (New York Heart Association) class III or IV. Over the period of 3 months the therapy was escalated until reaching maximum tolerated doses or those recommended by the current guidelines. After optimizing the therapy, the incidence of 25(OH)D deficiency (&lt; 30 ng/ml) and insufficiency (&lt; 20 ng/ml) was established, and clinical and laboratory determinants for these abnormal concentrations were analyzed.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Normal serum level, insufficiency, and deficiency of 25(OH)D were observed in, respectively, 41.5%, 26.0% and 32.5% of patients. The NYHA class improved by at least 1 class in 63.6% of patients, remained unchanged in 32.8% of patients, and deteriorated in 3.6% of patients. In multivariables analysis, low availability of natural ultraviolet B (UVB) radiation, loss of body mass during the CHF, higher concentrations of phosphates and albumins, and the presence of diabetes increased the risk of 25(OH)D deficiency, while higher concentrations of uric acid reduced this risk. In patients with a positive response to therapy, the concentration of 25(OH)D was borderline significantly higher (p = 0.055), while insufficiency and deficiency were less frequent (p = 0.02) than in patients without a treatment response, but this pertained only to patients with higher exposure to UVB. These differences were not observed in patients with low UVB exposure.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The concentration of 25(OH)D in CHF patients is not associated with the advancement of the disease, but is strongly determined by the potential availability of UVB radiation. A positive response to therapy increases the concentration of 25(OH)D only in the case of high UVB exposure; other determinants of 25(OH)D level include the patient's metabolic profile and the presence of diabetes.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Myrda</LastName>
<ForeName>Krzysztof</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>3 Department of Cardiology, SMDZ in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease, Zabrze, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rozentryt</LastName>
<ForeName>Piotr</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>3 Department of Cardiology, SMDZ in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease, Zabrze, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Niedziela</LastName>
<ForeName>Jacek T</ForeName>
<Initials>JT</Initials>
<AffiliationInfo>
<Affiliation>3 Department of Cardiology, SMDZ in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease, Zabrze, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ociessa</LastName>
<ForeName>Aneta</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>3 Department of Cardiology, SMDZ in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease, Zabrze, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kasperova</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>3 Department of Cardiology, SMDZ in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease, Zabrze, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hudzik</LastName>
<ForeName>Bartosz</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>3 Department of Cardiology, SMDZ in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease, Zabrze, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nowak</LastName>
<ForeName>Jolanta U</ForeName>
<Initials>JU</Initials>
<AffiliationInfo>
<Affiliation>3 Department of Cardiology, SMDZ in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease, Zabrze, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gąsior</LastName>
<ForeName>Mariusz</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>3 Department of Cardiology, SMDZ in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease, Zabrze, Poland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631913</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">chronic heart failure</Keyword>
<Keyword MajorTopicYN="N">vitamin D deficiency</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702278</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>Pulsatile-flow mechanical circulatory support (MCS) as a bridge to transplantation or recovery. Single-centre experience with the POLCAS system in 2014.</ArticleTitle>
<Pagination>
<MedlinePgn>228-32</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54458</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Mechanical circulatory support (MCS) is a recognised method of treatment for patients with end-stage chronic or acute heart failure. The POLCAS pulsatile-flow system has been used in our institution for 15 years. Currently, it is being widely replaced by continuous-flow mechanical circulatory support equipment of the second and third generations (HeartMateII, HeartWare). The MCS presented in this study is associated with a significant risk of complications and its use is increasingly considered controversial. The aim of the study was an evaluation of the results of treatment utilising the POLCAS MCS system at our institution in 2014.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">The POLCAS system was implanted in 12 patients aged 16-63 years (42 ± 17 years) during a period of 12 months (from January to December, 2014). Full-blown cardiogenic shock was observed in all patients before MCS implantation. Four of the analysed patients (33%) required prior circulatory support with other devices: IABP (n = 2) or ECMO (n = 2). Episodes of cardiac arrest were reported in three patients; three other patients experienced serious arrhythmias, which accelerated the decision to implant MCS. The presented data was retrospectively obtained from the CliniNET system of the Institute of Cardiology. OpenOffice Calc spreadsheet was used for data analysis.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Average MCS time was 41 days ± 25 (from 15 to 91 days). Survival until transplantation or explantation was 91.67%. The most frequent complications following the therapy were: cardiac tamponade or bleeding requiring an intervention - 25% (n = 3), renal failure requiring dialysis - 25% (n = 3), ischaemic stroke associated with the MCS - 16.6% (n = 2), bacteraemia - 16.6% (n = 2), and wound infection - 8% (n = 1). No malfunctions of the MCS system were reported. Early survival in patients who completed the MCS therapy, defined as discharge, amounted to 63.6% (n = 7).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The POLCAS heart assist system is an effective method of treatment as a bridge to transplantation or recovery in patients with end-stage heart failure. Early survival after the treatment remains at a satisfactory level. The main problem is the large number of complications related to the therapy.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kuśmierczyk</LastName>
<ForeName>Mariusz</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery and Transplantation, Institute of Cardiology, Warsaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kuć</LastName>
<ForeName>Mateusz</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery and Transplantation, Institute of Cardiology, Warsaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Szymański</LastName>
<ForeName>Jarosław</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery and Transplantation, Institute of Cardiology, Warsaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Juraszek</LastName>
<ForeName>Andrzej</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery and Transplantation, Institute of Cardiology, Warsaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kołsut</LastName>
<ForeName>Piotr</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery and Transplantation, Institute of Cardiology, Warsaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kuśmierski</LastName>
<ForeName>Krzysztof</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery and Transplantation, Institute of Cardiology, Warsaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zieliński</LastName>
<ForeName>Tomasz</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Heart Failure and Transplantation, Institute of Cardiology, Warsaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sobieszczańska-Małek</LastName>
<ForeName>Małgorzata</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Heart Failure and Transplantation, Institute of Cardiology, Warsaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sitkowska-Rysiak</LastName>
<ForeName>Ewa</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Institute of Cardiology, Warsaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631914</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">MCS</Keyword>
<Keyword MajorTopicYN="N">POLCAS</Keyword>
<Keyword MajorTopicYN="N">mechanical circulatory support</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702279</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>Von Willebrand factor in patients on mechanical circulatory support - a double-edged sword between bleeding and thrombosis.</ArticleTitle>
<Pagination>
<MedlinePgn>233-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54459</ELocationID>
<Abstract>
<AbstractText>Mechanical circulatory support (MCS) is an umbrella term describing the various technologies used in both short- and long-term management of patients with either end-stage chronic heart failure (HF) or acute HF. Most often, MCS has emerged as a bridge to transplantation, but more recently it is also used as a destination therapy. Mechanical circulatory support includes left ventricular assist device (LVAD) or bi-ventricular assist device (Bi-VAD). Currently, 2- to 3-year survival in carefully selected patients is much better than with medical therapy. However, MCS therapy is hampered by sometimes life-threatening complications including bleeding and device thrombosis. Von Willebrand factor (vWF) has two major functions in haemostasis. First, it plays a crucial role in platelet-subendothelium adhesion and platelet-platelet interactions (aggregation). Second, it is the carrier of factor VIII (FVIII) in plasma. Von Willebrand factor prolongs FVIII half-time by protecting it from proteolytic degradation. It delivers FVIII to the site of vascular injury thus enhancing haemostatic process. On one hand, high plasma levels of vWF have been associated with an increased risk of thrombosis. On the other, defects or deficiencies of vWF underlie the inherited von Willebrand disease or acquired von Willebrand syndrome. Here we review the pathophysiology of thrombosis and bleeding associated with vWF. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hudzik</LastName>
<ForeName>Bartosz</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>3 Department of Cardiology, SMDZ in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease, Zabrze, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kaczmarski</LastName>
<ForeName>Jacek</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Haemostasis Laboratory, Silesian Centre for Heart Disease, Zabrze, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pacholewicz</LastName>
<ForeName>Jerzy</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery and Transplantology, SMDZ in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease, Zabrze, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zakliczynski</LastName>
<ForeName>Michal</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery and Transplantology, SMDZ in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease, Zabrze, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gasior</LastName>
<ForeName>Mariusz</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>3 Department of Cardiology, SMDZ in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease, Zabrze, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zembala</LastName>
<ForeName>Marian</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Surgery and Transplantology, SMDZ in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease, Zabrze, Poland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631915</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">bleeding</Keyword>
<Keyword MajorTopicYN="N">mechanical circulatory support</Keyword>
<Keyword MajorTopicYN="N">thrombosis</Keyword>
<Keyword MajorTopicYN="N">von Willebrand factor</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702280</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>Intramural hematoma or aortic dissection - a diagnostic and therapeutic problem. A case report.</ArticleTitle>
<Pagination>
<MedlinePgn>238-41</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54460</ELocationID>
<Abstract>
<AbstractText>The authors present a case report of a 60-year-old patient with an ascending aortic aneurysm along with the associated diagnostic and therapeutic problems. The choice of therapy in patients with aortic intramural hematoma is difficult and should be based on comprehensive evaluation of the patient's status as well as on the experience of the radiologist and surgeon. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Suder</LastName>
<ForeName>Bogdan</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Surgery and Transplantation, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wasilewski</LastName>
<ForeName>Grzegorz</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Surgery and Transplantation, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bartuś</LastName>
<ForeName>Krzysztof</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Surgery and Transplantation, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sadowski</LastName>
<ForeName>Jerzy</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Surgery and Transplantation, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kapelak</LastName>
<ForeName>Bogusław</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Surgery and Transplantation, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631916</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">aortic aneurysm</Keyword>
<Keyword MajorTopicYN="N">ascending aortic dissection</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702281</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>Surgical removal of entrapped guidewire fragment following direct circumflex artery angioplasty and stenting.</ArticleTitle>
<Pagination>
<MedlinePgn>242-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54461</ELocationID>
<Abstract>
<AbstractText>We present a case of a 64-year-old man with coronary artery disease, who underwent a percutaneous coronary intervention of the circumflex artery. As the guidewire was being withdrawn from the target vessel, it became entrapped by the structure of the previously implanted stent. Attempts to retrieve the foreign body were unsuccessful. Changes in electrocardiogram were observed during the procedure, and the level of cardiac biomarkers increased within the next 24-hours. The patient was admitted to the Cardiac Surgery Department. Remnants of the foreign body were removed under visual control using extracorporeal circulation, and coronary artery bypass grafting was performed. Treatment options and outcomes are discussed. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Domaradzki</LastName>
<ForeName>Wojciech</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Cardiac Surgery, American Heart of Poland, Bielsko-Biała, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sanetra</LastName>
<ForeName>Krzysztof</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Cardiac Surgery, American Heart of Poland, Bielsko-Biała, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Skwarna</LastName>
<ForeName>Bartosz</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Cardiology and Angiology, American Heart of Poland, Ustroń, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Król</LastName>
<ForeName>Marek</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Cardiology and Angiology, American Heart of Poland, Ustroń, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kuczera</LastName>
<ForeName>Małgorzata</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology and Intensive Care, American Heart of Poland, Bielsko-Biała, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cisowski</LastName>
<ForeName>Marek</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Cardiac Surgery, American Heart of Poland, Bielsko-Biała, Poland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631917</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">CABG</Keyword>
<Keyword MajorTopicYN="N">PCI</Keyword>
<Keyword MajorTopicYN="N">guidewire</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702282</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>Novel variant of dual left anterior descending artery arising from single right coronary artery anomaly presenting with angina inversa.</ArticleTitle>
<Pagination>
<MedlinePgn>246-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54462</ELocationID>
<Abstract>
<AbstractText>A 55-year-old female without a history of coronary artery disease, hypertensive for the past 17 years, was admitted with resting chest pain. Electrocardiography revealed a negative T-wave in anterior chest leads. Coronary angiography visualised anomalous coronary anatomy, with a common origin of the right coronary artery and the left main coronary artery in the right sinus of Valsalva serving as a common coronary trunk. It should be emphasised that T-wave abnormalities and chest angina may be related to this congenital coronary anomaly. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cingoz</LastName>
<ForeName>Faruk</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Surgery, Gulhane Military Medical Academy, Etlik, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arslan</LastName>
<ForeName>Gokhan</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Surgery, Gulhane Military Medical Academy, Etlik, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Iyisoy</LastName>
<ForeName>Atilla</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Gulhane Military Medical Academy, Etlik, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bingol</LastName>
<ForeName>Hakan</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Surgery, Baskent University, Konya, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631918</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">coronary anomaly</Keyword>
<Keyword MajorTopicYN="N">ischaemic heart disease</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702283</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>Mitral valve regurgitation due to annular dilatation caused by a huge and floating left atrial myxoma.</ArticleTitle>
<Pagination>
<MedlinePgn>248-50</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54463</ELocationID>
<Abstract>
<AbstractText>We describe a case of mitral valve annular dilatation caused by a huge left atrial myxoma obstructing the mitral valve orifice. A 50-year-old man presenting with palpitation was found to have a huge left atrial myxoma protruding into the left ventricle during diastole, causing severe mitral regurgitation. The diagnosis was made with echocardiogram. Transoesophageal echocardiography revealed a solid mass of 75 × 55 mm. During operation, the myxoma was completely removed from its attachment in the atrium. We preferred to place a mechanical heart valve after an annuloplasty ring because of severely dilated mitral annulus and chordae elongation. The patient had an uneventful recovery. Our case suggests that immediate surgery, careful evaluation of mitral valve annulus preoperatively is recommended. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kaya</LastName>
<ForeName>Mehmet</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Mehmet Akif Ersoy Thoracic and Cardiovascular Training and Research Hospital, Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ersoy</LastName>
<ForeName>Burak</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Mehmet Akif Ersoy Thoracic and Cardiovascular Training and Research Hospital, Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yeniterzi</LastName>
<ForeName>Mehmet</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Mehmet Akif Ersoy Thoracic and Cardiovascular Training and Research Hospital, Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631919</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">annular dilatation</Keyword>
<Keyword MajorTopicYN="N">huge atrial myxoma</Keyword>
<Keyword MajorTopicYN="N">mitral regurgitation</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702284</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>Cardiac tumors: leiomyosarcoma - a case report.</ArticleTitle>
<Pagination>
<MedlinePgn>251-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54464</ELocationID>
<Abstract>
<AbstractText>We present a case report of a 60-year-old woman with a long history of leiomyosarcoma in different locations. She was admitted to the clinic due to a left ventricular tumor diagnosed in ECHO examination. The patient was qualified for radical tumor resection. The early postoperative period was complicated due to low cardiac output syndrome and bradyarrhythmia requiring temporary cardiac pacing. Optimized pharmacological therapy resulted in a gradual reduction of symptoms and a clinical improvement of congestive heart failure (NYHA III - NYHA II). Due to the radical nature of the surgery, the patient was not referred for supplementary treatment. The follow-up currently exceeds 12 months - no new metastases have been found. This case provides an example of how to diagnose and treat heart tumors. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gierlak</LastName>
<ForeName>Włodzimierz</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Hypertension, and Internal Diseases, Second Faculty of Medicine, Medical University of Warsaw, Bródnowski Masovian Hospital, Warsaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Syska-Sumińska</LastName>
<ForeName>Joanna</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Hypertension, and Internal Diseases, Second Faculty of Medicine, Medical University of Warsaw, Bródnowski Masovian Hospital, Warsaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zieliński</LastName>
<ForeName>Piotr</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Hypertension, and Internal Diseases, Second Faculty of Medicine, Medical University of Warsaw, Bródnowski Masovian Hospital, Warsaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dłużniewski</LastName>
<ForeName>Mirosław</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Hypertension, and Internal Diseases, Second Faculty of Medicine, Medical University of Warsaw, Bródnowski Masovian Hospital, Warsaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sadowski</LastName>
<ForeName>Jerzy</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Surgery and Transplantation, Institute of Cardiology, Collegium Medicum of the Jagiellonian University, Pope John Paul II Hospital in Krakow, Poland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631920</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">cardiac tumor</Keyword>
<Keyword MajorTopicYN="N">leiomyosarcoma</Keyword>
<Keyword MajorTopicYN="N">surgery</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702285</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>Multistage resection of esophageal squamous cell cancer of the cardia - successful despite complications.</ArticleTitle>
<Pagination>
<MedlinePgn>255-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54465</ELocationID>
<Abstract>
<AbstractText>Surgery is the treatment of choice for squamous cell esophageal cancer. Complete resection of the esophagus with reconstruction of the digestive tract is performed for tumors located in the chest or cardia. The aim of the report is to present the case of a complete esophageal and gastric resection complicated by colon graft necrosis. The patient was a 45-year-old woman diagnosed with cancer of the cardia infiltrating the distal section of the esophagus and the body and fundus of the stomach. The initial surgical procedure included the opening of three body cavities followed by resection of the thoracic esophagus, stomach, and a portion of the left hepatic lobe. Right colon interposition was performed to restore digestive tract continuity. On the 8th day, a leak was observed in the esophagointestinal anastomosis. Management consisted in two surgical procedures, one of which ended in the removal of the colon patch. The fourth and final procedure was conducted after 10 months. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zieliński</LastName>
<ForeName>Jacek</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgical Oncology, Medical University of Gdańsk, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ptach</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Hospital Emergency Ward, St. Vincent a Paulo Hospital in Gdynia, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sadowski</LastName>
<ForeName>Andrzej</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of General Surgery, Tczew Hospitals JSC, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chruścicka</LastName>
<ForeName>Iwona</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgical Oncology, Medical University of Gdańsk, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pęksa</LastName>
<ForeName>Rafał</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Medical University of Gdańsk, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rak</LastName>
<ForeName>Piotr</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgical Oncology, Medical University of Gdańsk, Poland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631921</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">complications</Keyword>
<Keyword MajorTopicYN="N">esophageal cancer</Keyword>
<Keyword MajorTopicYN="N">esophageal resection</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702286</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>Combined Clagett procedure, negative pressure therapy, and thoracomyoplasty for treatment of late-onset postpneumonectomy empyema necessitatis.</ArticleTitle>
<Pagination>
<MedlinePgn>259-61</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54466</ELocationID>
<Abstract>
<AbstractText>Late-onset post-pneumonectomy empyema necessitatis can occur many years after the surgery and is a life-threatening condition. A 58-year-old male presented with empyema necessitatis 18 years after undergoing pneumonectomy. He was successfully treated with a modified two-stage Clagett procedure and ambulatory negative pressure as the bridge between the stages. The 72-month follow-up was uneventful. The complete obliteration of the rigid and wide residual postpneumonectomy cavity was necessary to avoid re-recurrence of the infection. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Schreiner</LastName>
<ForeName>Waldemar</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Thoracic Surgery, University Hospital of Erlangen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dudek</LastName>
<ForeName>Wojciech</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Thoracic Surgery, University Hospital of Erlangen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sirbu</LastName>
<ForeName>Horia</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Thoracic Surgery, University Hospital of Erlangen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631922</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">late-onset empyema</Keyword>
<Keyword MajorTopicYN="N">negative pressure therapy</Keyword>
<Keyword MajorTopicYN="N">postpneumonectomy empyema necessitatis</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702287</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>A rare case of duodenal ulcer perforation accompanied by Boerhaave syndrome.</ArticleTitle>
<Pagination>
<MedlinePgn>262-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54467</ELocationID>
<Abstract>
<AbstractText>Esophageal perforation is the fastest progressing and the most life-threatening disruption of gastrointestinal tract continuity. It must be regarded as an emergency condition that requires early diagnosis as well as very aggressive and rapid implementation of treatment in order to avoid serious complications and death. Methods of treatment for spontaneous esophageal perforation continue to be a matter of controversy. However, all authors emphasize that ultimate success depends largely on the time taken to establish the diagnosis. The authors of this study describe a rare case of duodenal ulcer perforation accompanied by Boerhaave syndrome. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dżeljilji</LastName>
<ForeName>Agata</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Thoracic Surgery, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rokicki</LastName>
<ForeName>Wojciech</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Thoracic Surgery, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rokicki</LastName>
<ForeName>Marek</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Thoracic Surgery, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Poland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631923</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Boerhaave syndrome</Keyword>
<Keyword MajorTopicYN="N">duodenal ulcer perforation</Keyword>
<Keyword MajorTopicYN="N">esophageal perforation</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702288</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>Primary cardiac lymphoma (PCL) - diagnostic difficulties.</ArticleTitle>
<Pagination>
<MedlinePgn>266-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54468</ELocationID>
<Abstract>
<AbstractText>Primary cardiac lymphoma (PCL) is the very rare disease that is associated with a high mortality rate. A prompt and proper diagnosis may affect the prognosis, and proper treatment may improve life expectancy. This report documents the case of a 74-year-old female with primary cardiac lymphoma. Unfortunately, the patient died from heart failure on her 23(rd) day in hospital. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Skalec</LastName>
<ForeName>Karolina</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, 4 Military Teaching Hospital, Wroclaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Litwin</LastName>
<ForeName>Linda</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, 4 Military Teaching Hospital, Wroclaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Drozdz</LastName>
<ForeName>Katarzyna</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, 4 Military Teaching Hospital, Wroclaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gac</LastName>
<ForeName>Pawel</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology and Diagnostic Imaging, 4 Military Teaching Hospital, Wroclaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jazwiec</LastName>
<ForeName>Przemyslaw</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology and Diagnostic Imaging, 4 Military Teaching Hospital, Wroclaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chabowski</LastName>
<ForeName>Mariusz</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, 4 Military Teaching Hospital, Wroclaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zymlinski</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, 4 Military Teaching Hospital, Wroclaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Molenda</LastName>
<ForeName>Wlodzimierz</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, 4 Military Teaching Hospital, Wroclaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Szuba</LastName>
<ForeName>Andrzej</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Faculty of Health Science, Wroclaw Medical University, Wroclaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Janczak</LastName>
<ForeName>Dariusz</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Faculty of Health Science, Wroclaw Medical University, Wroclaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631924</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">echocardiography</Keyword>
<Keyword MajorTopicYN="N">heart tumour</Keyword>
<Keyword MajorTopicYN="N">primary cardiac lymphoma</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702289</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>Extracutaneous glomus tumour of the trachea.</ArticleTitle>
<Pagination>
<MedlinePgn>269-71</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54469</ELocationID>
<Abstract>
<AbstractText>A 38-year-old man presenting expiratory stridor and high-grade dyspnoea was admitted to hospital in Lodz in February 2013. Chest radiographs and computed tomography scans showed a solid lesion in the upper part of the trachea occluding 85% of the airway lumen. A segmental resection of the trachea with a subsequent end-to-end anastomosis was performed. Histopathology showed an extracutaneous glomus tumour. There were no postoperative complications. Tracheal resection is the primary curative method in cases of this rare tumour. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Brzeziński</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Medical University of Lodz, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Łochowski</LastName>
<ForeName>Mariusz Piotr</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Thoracic Surgery Clinic, Provincial Specialist Hospital, Lodz, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jesionek-Kupnicka</LastName>
<ForeName>Dorota</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Thoracic Surgery Clinic, Provincial Specialist Hospital, Lodz, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kozak</LastName>
<ForeName>Józef</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Thoracic Surgery Clinic, Provincial Specialist Hospital, Lodz, Poland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631925</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">bronchoscopy</Keyword>
<Keyword MajorTopicYN="N">glomus tumour</Keyword>
<Keyword MajorTopicYN="N">trachea</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702290</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>Oesophageal duplication cyst mimicking hydatid cyst in endemic areas.</ArticleTitle>
<Pagination>
<MedlinePgn>272-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54470</ELocationID>
<Abstract>
<AbstractText>The cystic appearance of both oesophageal duplications and pulmonary hydatid cysts can cause a misdiagnosis very easily due to rarity of cystic oesophageal duplications beside the higher incidence of hydatid cyst, especially in endemic areas. Here we report a 7-year-old girl with an oesophageal duplication cyst on the left side misdiagnosed as a hydatid cyst. The aim of the study is to report rare oesophageal duplications in the differential diagnosis of intrathoracic cysts. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Akin</LastName>
<ForeName>Melih</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Paediatric Surgery, Sisli Etfal Education and Research Hospital, Istambul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Erginel</LastName>
<ForeName>Basak</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Paediatric Surgery, Sisli Etfal Education and Research Hospital, Istambul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yildiz</LastName>
<ForeName>Abdullah</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Paediatric Surgery, Sisli Etfal Education and Research Hospital, Istambul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Karadag</LastName>
<ForeName>Cetin Ali</ForeName>
<Initials>CA</Initials>
<AffiliationInfo>
<Affiliation>Department of Paediatric Surgery, Sisli Etfal Education and Research Hospital, Istambul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sever</LastName>
<ForeName>Nihat</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Paediatric Surgery, Sisli Etfal Education and Research Hospital, Istambul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dokucu</LastName>
<ForeName>Ali Ihsan</ForeName>
<Initials>AI</Initials>
<AffiliationInfo>
<Affiliation>Department of Paediatric Surgery, Sisli Etfal Education and Research Hospital, Istambul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631926</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">hydatid cyst</Keyword>
<Keyword MajorTopicYN="N">oesophageal duplication</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702291</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>The application of walking training in the rehabilitation of patients after coronary artery bypass grafting.</ArticleTitle>
<Pagination>
<MedlinePgn>275-87</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54471</ELocationID>
<Abstract>
<AbstractText>Walking is regarded as one of the most common and utilitarian activities of everyday life. Rehabilitation programs developed on the basis of this form of activity often constitute the primary method of rehabilitating patients after coronary artery bypass grafting. This paper provides a review of literature concerning various forms of walking training, discussing their impact on the parameters of exercise capacity and verifying the training methods with regard to the current guidelines. Attention is drawn to the diversity of the exercise protocols applied during the early and late stages of rehabilitation and pre-rehabilitation programs including: treadmill walking, walking down the corridor, treadmill walking enriched with virtual reality, and walking as an element of training sessions consisting of many different forms of activities. Exercise protocols were also analyzed in terms of their safety, especially in the case of high-intensity interval training. Despite the variety of the available rehabilitation programs, the training methodology requires constant improvement, particularly in terms of load dosage and the supervision of training sessions. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sobczak</LastName>
<ForeName>Dorota</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Rehabilitation, University School of Physical Education in Poznan, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dylewicz</LastName>
<ForeName>Piotr</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiac Rehabilitation, University School of Physical Education in Poznan, Poland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631927</OtherID>
<OtherAbstract Language="pol" Type="Publisher">
<AbstractText>Abstract available from the publisher.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">coronary artery bypass grafting</Keyword>
<Keyword MajorTopicYN="N">rehabilitation</Keyword>
<Keyword MajorTopicYN="N">walking training</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702292</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1731-5530</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery</Title>
<ISOAbbreviation>Kardiochir Torakochirurgia Pol</ISOAbbreviation>
</Journal>
<ArticleTitle>Main cardiac surgery procedures performed in Poland in 2014 (according to the National Registry of Cardiac Surgery Procedures - KROK, Warsaw, Poland 2015).</ArticleTitle>
<Pagination>
<MedlinePgn>288-91</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5114/kitp.2015.54626</ELocationID>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Kardiochir Torakochirurgia Pol</MedlineTA>
<NlmUniqueID>101279148</NlmUniqueID>
<ISSNLinking>1731-5530</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4631928</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702399</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2214-5400</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<PubDate>
<Year>2016</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Meta gene</Title>
<ISOAbbreviation>Meta Gene</ISOAbbreviation>
</Journal>
<ArticleTitle>De novo assembly and characterization of tissue-specific transcriptome in the endangered golden mahseer, Tor putitora.</ArticleTitle>
<Pagination>
<MedlinePgn>28-33</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mgene.2015.11.001</ELocationID>
<Abstract>
<AbstractText>The golden mahseer (Tor putitora) graces most of the Himalayan Rivers of India and neighboring South Asian countries. Despite its several importance as a research model, as food, and in sport fishing, knowledge on transcriptome database is nil. Therefore, it was targeted to develop reference transcriptome databases of the species using next-generation sequencing. In the present study, 100,540,130 high-quality paired-end reads were obtained from six cDNA libraries of spleen, liver, gill, kidney, muscle, and brain with 28.4 GB data using Illumina paired-end sequencing technology. Tissue-specific transcriptomes as well as complete transcriptome assembly were analyzed for concise representation of the study. In brief, the de novo assembly of individual tissue resulted in an average of 31,829 (18,512-46,348) contigs per sample, while combined transcriptome comprised 77,907 unique transcript fragments (unigenes) assembled from reads of six tissues. Approximately 75,407 (96.8%) unigenes could be annotated according to their homology matches in the nr, SwisseProt, GO, or KEGG databases. Comparative analysis showed that 84% of the unigenes have significant similarity to zebra fish RefSeq proteins. Tissue-specific-dominated genes were also identified to hypothesize their localization and expression in individual tissue. In addition, 2485 simple sequence repeats (SSRs) were detected from 77,907 transcripts in the combined transcriptome of the golden mahseer. This study has generated organ-specific transcriptome profiles, which will be helpful to understand the local adaptation, genome evolution, and also future functional studies on immune system of the golden mahseer. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Barat</LastName>
<ForeName>Ashoktaru</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>ICAR-Directorate of Coldwater Fisheries Research, Bhimtal, Nainital 263136, Uttarakhand, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>Rohit</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>ICAR-Directorate of Coldwater Fisheries Research, Bhimtal, Nainital 263136, Uttarakhand, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Goel</LastName>
<ForeName>Chirag</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>ICAR-Directorate of Coldwater Fisheries Research, Bhimtal, Nainital 263136, Uttarakhand, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Atul Kumar</ForeName>
<Initials>AK</Initials>
<AffiliationInfo>
<Affiliation>ICAR-Directorate of Coldwater Fisheries Research, Bhimtal, Nainital 263136, Uttarakhand, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sahoo</LastName>
<ForeName>Prabhati Kumari</ForeName>
<Initials>PK</Initials>
<AffiliationInfo>
<Affiliation>ICAR-Directorate of Coldwater Fisheries Research, Bhimtal, Nainital 263136, Uttarakhand, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Meta Gene</MedlineTA>
<NlmUniqueID>101627670</NlmUniqueID>
<ISSNLinking>2214-5400</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669534</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Endangered</Keyword>
<Keyword MajorTopicYN="N">Golden mahseer</Keyword>
<Keyword MajorTopicYN="N">Organ-specific transcriptome</Keyword>
<Keyword MajorTopicYN="N">SSR markers</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702398</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2214-5400</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<PubDate>
<Year>2016</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Meta gene</Title>
<ISOAbbreviation>Meta Gene</ISOAbbreviation>
</Journal>
<ArticleTitle>Single nucleotide polymorphisms of APOA1 gene and their relationship with serum apolipoprotein A-I concentrations in the native population of Assam.</ArticleTitle>
<Pagination>
<MedlinePgn>20-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mgene.2015.10.005</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There is a growing interest in the role of allelic variants of the APOA1 gene in relation to a number of disorders. We described two common polymorphisms of the APOA1 gene, G-75A and C+83T and investigated their potential influence on the serum apolipoprotein A-I (apo A-I) levels in the native population of Assam - a region that is ethnically distinct and from where no information is hitherto available.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Blood samples were collected from 150 healthy volunteers. Apo A-I levels were estimated by immunoturbidometry. Genotyping was done by a PCR-RFLP method that involved DNA extraction from whole blood, followed by polymerase chain reaction and digestion of the PCR product by MspI restriction enzyme, and analysis of fragment sizes in 12% polyacrylamide gel.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The GG variant at G-75A locus and CC variant at C+83T locus were the most prevalent. GG/CC was the most common combination. Homozygous TT genotype was not detected in any of the subjects. The rare allele frequencies for the G-75A and C+83T sites were found to be 0.22 and 0.06 respectively, which significantly differed from those reported in some other populations in neighbouring regions. Serum apo A-I concentrations did not vary significantly across the detected genotypes. These findings were consistent in both sexes.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We described the distribution of the G-75A and C+83T polymorphisms of the APOA1 gene in the population of Assam for the first time. These polymorphisms were not found to directly influence apo A-I concentrations in this population either individually or synergistically.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bora</LastName>
<ForeName>Kaustubh</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Gauhati Medical College and Hospital, Department of Biochemistry, Guwahati 781032, Assam, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pathak</LastName>
<ForeName>Mauchumi Saikia</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>Gauhati Medical College and Hospital, Department of Biochemistry, Guwahati 781032, Assam, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Borah</LastName>
<ForeName>Probodh</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>State Biotech Hub, College of Veterinary Science, Guwahati 781022, Assam, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hussain</LastName>
<ForeName>Md Iftikar</ForeName>
<Initials>MI</Initials>
<AffiliationInfo>
<Affiliation>State Biotech Hub, College of Veterinary Science, Guwahati 781022, Assam, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Das</LastName>
<ForeName>Dulmoni</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Army Institute of Nursing, Guwahati 781029, Assam, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Meta Gene</MedlineTA>
<NlmUniqueID>101627670</NlmUniqueID>
<ISSNLinking>2214-5400</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669535</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">APOA1</Keyword>
<Keyword MajorTopicYN="N">Assam</Keyword>
<Keyword MajorTopicYN="N">C+83T</Keyword>
<Keyword MajorTopicYN="N">G-75A</Keyword>
<Keyword MajorTopicYN="N">PCR-RFLP</Keyword>
<Keyword MajorTopicYN="N">Polymorphism</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26699453</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1347-4405</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>30</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Microbes and environments / JSME</Title>
<ISOAbbreviation>Microbes Environ.</ISOAbbreviation>
</Journal>
<ArticleTitle>Keys to Cultivating Uncultured Microbes: Elaborate Enrichment Strategies and Resuscitation of Dormant Cells.</ArticleTitle>
<Pagination>
<MedlinePgn>289-90</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1264/jsme2.ME3004rh</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kamagata</LastName>
<ForeName>Yoichi</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Bioproduction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST).</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>Microbes Environ</MedlineTA>
<NlmUniqueID>9710937</NlmUniqueID>
<ISSNLinking>1342-6311</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">PMC4676551</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702361</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Print">2095-7467</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>2</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Military Medical Research</Title>
<ISOAbbreviation>Mil Med Res</ISOAbbreviation>
</Journal>
<ArticleTitle>The effectiveness of the department of defense's field manual 3-11 in detecting, deterring and degrading the breach of a combat base by a human-borne with bioagent (HBBA): perceptions of security personnel.</ArticleTitle>
<Pagination>
<MedlinePgn>36</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40779-015-0065-y</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The department of defense's FM 3-11 is among the military's field manuals for preparing for, reacting to and recovering from chemical, biological, radiological and nuclear attacks. Since post 9-11, U.S. military service members have been deployed in the global war on terrorism. This study attempted to determine the effectiveness of the FM 3-11 in detecting, deterring or preventing a human-borne with bioagent (HBBA) terrorist breach at an entry control point (ECP).</AbstractText>
<AbstractText Label="METHOD" NlmCategory="METHODS">This time-specific, cross-sectional study disseminated a validated survey tool with Cronbach's α &gt; 0.82 to respondents who have had antiterrorism training and combat ECP experience. The return rate was greater than 75.0 %; however, many of the respondents failed to meet the inclusion criteria. Consequently, only 26 questionnaires were included in the sample.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The results revealed that while over 60.0 % of the respondents either strongly agreed or agreed that biointelligence, the deployment of biodetectors and the use of biowarning systems could be effective in preventing an ECP breach by a terrorist with a bioagent, the use of protective equipment and immunization to decontaminate service members or other TTPs would never prevent a breach. A large percentage of respondents claimed that soldiers at the ECP lacked the devices or the knowledge to detect an HBBA at an ECP, and 72.0 % suggested modifying current ECP TTPs to include education, training and equipment for security personnel at military base ECPs.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">If obtained from appropriate sources and communicated to the personnel at the ECP in an effective or timely manner, the possible effectiveness of certain TTPs in the FM 3-11, specifically FM 3-11.86 (intelligence), might increase.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Alakpa</LastName>
<ForeName>George Edafese</ForeName>
<Initials>GE</Initials>
<Identifier Source="ORCID">0000-0002-9797-3401</Identifier>
<AffiliationInfo>
<Affiliation>Department of Professional Security Studies, New Jersey City University, Jersey City, NJ USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Collins</LastName>
<ForeName>John W</ForeName>
<Initials>JW</Initials>
<Suffix>Jr</Suffix>
<AffiliationInfo>
<Affiliation>Department of Professional Security Studies, New Jersey City University, Jersey City, NJ USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Mil Med Res</MedlineTA>
<NlmUniqueID>101643181</NlmUniqueID>
<ISSNLinking>2054-9369</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688945</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bioterrorism</Keyword>
<Keyword MajorTopicYN="N">Breach of Combat ECP</Keyword>
<Keyword MajorTopicYN="N">DoD FM 3-11</Keyword>
<Keyword MajorTopicYN="N">HBBA terrorist</Keyword>
<Keyword MajorTopicYN="N">Perception</Keyword>
<Keyword MajorTopicYN="N">Security personnel</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702351</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2040-2392</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>6</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Molecular autism</Title>
<ISOAbbreviation>Mol Autism</ISOAbbreviation>
</Journal>
<ArticleTitle>Is impaired joint attention present in non-clinical individuals with high autistic traits?</ArticleTitle>
<Pagination>
<MedlinePgn>67</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13229-015-0059-3</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Joint attention skills are impaired in individuals with autism spectrum disorder (ASD). Recently, varying degrees of autistic social attention deficit have been detected in the general population. We investigated gaze-triggered attention in individuals with high and low levels of autistic traits under visual-auditory cross-modal conditions, which are more sensitive to social attention deficits than unimodal paradigms.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Sixty-six typically developing adults were divided into low- and high-autistic-trait groups according to scores on the autism-spectrum quotient (AQ) questionnaire. We examined gaze-triggered attention under visual-auditory cross-modal conditions. Two sounds (a social voice and a non-social tone) were manipulated as targets to infer the relationship between the cue and the target. Two types of stimulus onset asynchrony (SOA) conditions (a shorter 200-ms SOA and a longer 800-ms SOA) were used to directly test the effect of gaze cues on the detection of a sound target across different temporal intervals.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Individuals with high autistic traits (high-AQ group) did not differ from those with low autistic traits (low-AQ group) with respect to gaze-triggered attention when voices or tones were used as targets under the shorter SOA condition. In contrast, under the longer SOA condition, gaze-triggered attention was not observed in response to tonal targets among individuals in the high-AQ group, whereas it was observed among individuals in the low-AQ group. The results demonstrated that cross-modal gaze-triggered attention is short-lived in individuals with high autistic traits.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This finding provides insight into the cross-modal joint attention function among individuals along the autism spectrum from low autistic traits to ASD and may further our understanding of social behaviours among individuals at different places along the autistic trait continuum.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zhao</LastName>
<ForeName>Shuo</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Faculty of Human Health Science, Graduate School of Medicine, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507 Japan ; International Research Fellow of the Japan Society for the Promotion of Science, Tokyo, Japan ; Organization for Promoting Developmental Disorder Research, Kyoto, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Uono</LastName>
<ForeName>Shota</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurodevelopmental Psychiatry, Habilitation and Rehabilitation, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yoshimura</LastName>
<ForeName>Sayaka</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurodevelopmental Psychiatry, Habilitation and Rehabilitation, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Toichi</LastName>
<ForeName>Motomi</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Faculty of Human Health Science, Graduate School of Medicine, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507 Japan ; International Research Fellow of the Japan Society for the Promotion of Science, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Mol Autism</MedlineTA>
<NlmUniqueID>101534222</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688927</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Autism-spectrum quotient (AQ)</Keyword>
<Keyword MajorTopicYN="N">Cross-modal</Keyword>
<Keyword MajorTopicYN="N">High autistic traits</Keyword>
<Keyword MajorTopicYN="N">Joint attention</Keyword>
<Keyword MajorTopicYN="N">Low autistic traits</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702301</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1754-9493</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>9</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Patient safety in surgery</Title>
<ISOAbbreviation>Patient Saf Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Arthroscopically guided navigation for repair of acromioclavicular joint dislocations: a safe technique with reduced intraoperative radiation exposure.</ArticleTitle>
<Pagination>
<MedlinePgn>41</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13037-015-0087-0</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Accuracy evaluation of navigated image free placement of double cortical fixation buttons for coracoclavicular tunnel position in comparison to conventional drill guide based placement.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Twenty-six patients with acute acromioclavicular joint instability were included in this non-randomized cohort study. All patients were treated with a Double- TightRope technique. In 13 cases the conventional drill guide based placement was used (group 1). In 13 patients surgery was performed as a navigated procedure with a fluoro-free optoelectronic system (group 2). The number of coracoclavicular drillings per patient (First pass accuracy; FPA (%)) was documented, the subcoracoidal position of the fixation buttons has been evaluated and graded as "intended position achieved (IPA)" or "intended position not achieved (IPnA)".</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In group 1 drilling had to be repeated in four patients (30.8 %) to achieve proper placement of the subcoracoidal fixation buttons. 100 % first pass accuracy was observed in group 2 (p = 0.03). In group 1, the intended position of the subcoracoid buttons was not achieved (IPnA) in six patients (46.2 %). In group 2 all intended positions were achieved (p = 0.005).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Arthroscopic controlled fluoro-free navigated coracoclavicular drilling for the repair of acromioclavicular joint dislocation has higher first pass accuracy in comparison to conventional drill guide based placement. Therefore the navigation enables a precise position of the drill holes, may reduce the risk of an iatrogenic coracoid fracture and migration of fixation devices.</AbstractText>
<AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">Local institutional review board No. 061-14-10032014.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Theopold</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedics, Trauma and Plastic Surgery, University of Leipzig, Liebigstr. 20, 04103 Leipzig, Germany ; Devision of Arthroscopy, Joint Surgery and Sport Injuries, University of Leipzig, Liebigstr. 20, 04103 Leipzig, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marquass</LastName>
<ForeName>Bastian</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedics, Trauma and Plastic Surgery, University of Leipzig, Liebigstr. 20, 04103 Leipzig, Germany ; Devision of Arthroscopy, Joint Surgery and Sport Injuries, University of Leipzig, Liebigstr. 20, 04103 Leipzig, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>von Dercks</LastName>
<ForeName>Nikolaus</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedics, Trauma and Plastic Surgery, University of Leipzig, Liebigstr. 20, 04103 Leipzig, Germany ; Devision of Arthroscopy, Joint Surgery and Sport Injuries, University of Leipzig, Liebigstr. 20, 04103 Leipzig, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mütze</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedics, Trauma and Plastic Surgery, University of Leipzig, Liebigstr. 20, 04103 Leipzig, Germany ; Devision of Arthroscopy, Joint Surgery and Sport Injuries, University of Leipzig, Liebigstr. 20, 04103 Leipzig, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Henkelmann</LastName>
<ForeName>Ralf</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedics, Trauma and Plastic Surgery, University of Leipzig, Liebigstr. 20, 04103 Leipzig, Germany ; Devision of Arthroscopy, Joint Surgery and Sport Injuries, University of Leipzig, Liebigstr. 20, 04103 Leipzig, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Josten</LastName>
<ForeName>Christoph</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedics, Trauma and Plastic Surgery, University of Leipzig, Liebigstr. 20, 04103 Leipzig, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hepp</LastName>
<ForeName>Pierre</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedics, Trauma and Plastic Surgery, University of Leipzig, Liebigstr. 20, 04103 Leipzig, Germany ; Devision of Arthroscopy, Joint Surgery and Sport Injuries, University of Leipzig, Liebigstr. 20, 04103 Leipzig, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Patient Saf Surg</MedlineTA>
<NlmUniqueID>101319176</NlmUniqueID>
<ISSNLinking>1754-9493</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4689049</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">AC joint dislocation</Keyword>
<Keyword MajorTopicYN="N">AC joint injuries</Keyword>
<Keyword MajorTopicYN="N">AC joint reconstruction</Keyword>
<Keyword MajorTopicYN="N">Coracoclavicular</Keyword>
<Keyword MajorTopicYN="N">Navigation</Keyword>
<Keyword MajorTopicYN="N">Shoulder</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702253</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1319-0164</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>23</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</Title>
<ISOAbbreviation>Saudi Pharm J</ISOAbbreviation>
</Journal>
<ArticleTitle>Systemic delivery of β-blockers via transdermal route for hypertension.</ArticleTitle>
<Pagination>
<MedlinePgn>587-602</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsps.2013.12.019</ELocationID>
<Abstract>
<AbstractText>Hypertension is the most common cardiovascular disease worldwide. Moreover, management of hypertension requires long-term treatment that may result in poor patient compliance with conventional dosage forms due to greater frequency of drug administration. Although there is availability of a plethora of therapeutically effective antihypertensive molecules, inadequate patient welfare is observed; this arguably presents an opportunity to deliver antihypertensive agents through a different route. Ever since the transdermal drug delivery came into existence, it has offered great advantages including non-invasiveness, prolonged therapeutic effect, reduced side effects, improved bioavailability, better patient compliance and easy termination of drug therapy. Attempts were made to develop the transdermal therapeutic system for various antihypertensive agents, including β-blockers, an important antihypertensive class. β-blockers are potent, highly effective in the management of hypertension and other heart ailments by blocking the effects of normal amounts of adrenaline in the heart and blood vessels. The shortcomings associated with β-blockers such as more frequent dose administration, extensive first pass metabolism and variable bioavailability, make them an ideal candidate for transdermal therapeutic systems. The present article gives a brief view of different β-blockers formulated as transdermal therapeutic system in detail to enhance the bioavailability as well as to improve patient compliance. Constant improvement in this field holds promise for the long-term success in technologically advanced transdermal dosage forms being commercialized sooner rather than later. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ahad</LastName>
<ForeName>Abdul</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Al-Jenoobi</LastName>
<ForeName>Fahad I</ForeName>
<Initials>FI</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Al-Mohizea</LastName>
<ForeName>Abdullah M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Akhtar</LastName>
<ForeName>Naseem</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics, College of Pharmacy, Buraydah Private Colleges, P.O. Box 31, 717, Buraydah, Al-Qassim, Saudi Arabia ; Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard (Hamdard University), M. B. Road, New Delhi 110062, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Raish</LastName>
<ForeName>Mohammad</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aqil</LastName>
<ForeName>Mohd</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard (Hamdard University), M. B. Road, New Delhi 110062, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>01</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Saudi Arabia</Country>
<MedlineTA>Saudi Pharm J</MedlineTA>
<NlmUniqueID>9705695</NlmUniqueID>
<ISSNLinking>1319-0164</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669430</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Antihypertensive agent</Keyword>
<Keyword MajorTopicYN="N">Transdermal delivery</Keyword>
<Keyword MajorTopicYN="N">Transdermal therapeutic system</Keyword>
<Keyword MajorTopicYN="N">β-Blockers</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702254</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1319-0164</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>23</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</Title>
<ISOAbbreviation>Saudi Pharm J</ISOAbbreviation>
</Journal>
<ArticleTitle>Systematic review and meta-analysis of efficacy and safety of combinational therapy with metformin and dipeptidyl peptidase-4 inhibitors.</ArticleTitle>
<Pagination>
<MedlinePgn>603-13</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsps.2013.12.018</ELocationID>
<Abstract>
<AbstractText>Combinational therapies are often required in the management of type 2 diabetes mellitus (T2DM). Among the important candidates, dipeptidyl peptidase-4 inhibitors (DPPIs) and metformin combination (DPPI-MET) have shown promising endeavors. In order to examine the efficacy and safety of such a combination therapy in T2DM patients finding inadequate control with metformin, this systematic review and meta-analysis has been conducted. Literature search was made in multiple electronic databases. Inclusion criteria included; RCTs examining the efficacy and safety of DPPI-MET against placebo-MET or MET-only groups of T2DM patients by observing changes in disease endpoints including HbA1c and FPG, and the length of trial be at least 12 weeks. Mean differences based meta-analyses were performed and heterogeneity assessment was carried out. Nineteen studies were selected and included in the meta-analyses. DPPI-MET significantly improved all disease endpoints and the difference could be noticed up to 2 years in the majority of outcome measures. In comparison with PBO-MET, the DPPI-MET combinational therapy resulted in the percent HbA1c changes from baseline with a mean difference [95% CI] of -0.77 [-0.86, -0.69] in 3-month (P &lt; 0.00001), -0.67 [-0.76, -0.59] in 6-month (P &lt; 0.00001), -0.67 [-0.88, -0.47] in 1-year (P &lt; 0.00001) and -0.36 [-0.53, -0.20] in 2-year trials (P &lt; 0.0003). Reduction in body weight and safety profile in the treated and control groups were not different. A combinational therapy with DPPI and metformin significantly improves diabetes clinical indicators and this effect has been observed for up to 2 years herein. Safety and tolerability of DPPI-MET combination have been found well-manageable with a very similar adverse event profile in both treated and control groups. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Alanazi</LastName>
<ForeName>Abdulrahman S</ForeName>
<Initials>AS</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Pharmacy, Unaizah College of Pharmacy, Qassim University, P.O. Box 1627, Hail 81441, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>01</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Saudi Arabia</Country>
<MedlineTA>Saudi Pharm J</MedlineTA>
<NlmUniqueID>9705695</NlmUniqueID>
<ISSNLinking>1319-0164</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669429</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Combinational therapy</Keyword>
<Keyword MajorTopicYN="N">DPPIs</Keyword>
<Keyword MajorTopicYN="N">Diabetes mellitus</Keyword>
<Keyword MajorTopicYN="N">Dipeptidyl peptidase-4 inhibitors</Keyword>
<Keyword MajorTopicYN="N">Metformin</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702255</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1319-0164</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>23</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</Title>
<ISOAbbreviation>Saudi Pharm J</ISOAbbreviation>
</Journal>
<ArticleTitle>Safety of pregabalin among hemodialysis patients suffering from uremic pruritus.</ArticleTitle>
<Pagination>
<MedlinePgn>614-20</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsps.2014.10.004</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of this study was to assess the safety and probability of adverse events associated with the use of 75 mg pregabalin post hemodialysis (pHD) among patients with UP.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A cross-sectional study done among the hemodialysis patients suffering from uremic pruritus (UP) Aljaber Kidney Center (AJKC), Al-Ahsa, Eastern Province, Saudi Arabia. Assessment for the safety profile of pregabalin was done using Naranjo's algorithm. A predictive model was developed using binary multiple logistic regression to explore association of patients' demographics and risk factors with the occurrence of AEs. Throughout statistical significance level was considered significant at 0.05.</AbstractText>
<AbstractText Label="KEY FINDINGS" NlmCategory="RESULTS">Assessment of safety of pregabalin revealed that somnolence and dizziness were the two frequent adverse events followed by constipation, weight gain and edema. However, it was noticed that female patients aged less than 50 years were found to be at a higher risk in comparison with men. Moreover, those patients having one comorbid complication (i.e. hypertension or diabetes mellitus alone) were at a higher risk of somnolence, weight gain and dry mouth.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Naranjo's quantification for the possibility and probability of adverse events reflect that all the events were probable. Age, gender and comorbid medical conditions are some of the factors that might have clinical association with the occurrence of the AEs.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Khan</LastName>
<ForeName>Tahir Mehmood</ForeName>
<Initials>TM</Initials>
<AffiliationInfo>
<Affiliation>School of Pharmacy, Monash University, Bundar Sunway, 45700 Selangor, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alhafez</LastName>
<ForeName>Abdul Aziz</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>Director, Aljaber Kidney Center, Eastern Province, Alahsa, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Syed Sulaiman</LastName>
<ForeName>Syed Azhar</ForeName>
<Initials>SA</Initials>
<AffiliationInfo>
<Affiliation>School of Pharmaceutical Sciences, University Sains Malaysia 11800, Pulau Pinang, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bin Chia</LastName>
<ForeName>David Wu</ForeName>
<Initials>DW</Initials>
<AffiliationInfo>
<Affiliation>School of Pharmacy, Monash University, Bundar Sunway, 45700 Selangor, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>01</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Saudi Arabia</Country>
<MedlineTA>Saudi Pharm J</MedlineTA>
<NlmUniqueID>9705695</NlmUniqueID>
<ISSNLinking>1319-0164</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669418</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Adverse events</Keyword>
<Keyword MajorTopicYN="N">Post hemodialysis</Keyword>
<Keyword MajorTopicYN="N">Pregabalin</Keyword>
<Keyword MajorTopicYN="N">Uremic pruritus</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702256</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1319-0164</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>23</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</Title>
<ISOAbbreviation>Saudi Pharm J</ISOAbbreviation>
</Journal>
<ArticleTitle>Preparation, validation and user-testing of pictogram-based patient information leaflets for hemodialysis patients.</ArticleTitle>
<Pagination>
<MedlinePgn>621-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsps.2015.01.022</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patient information leaflets are universally-accepted resources to educate the patients/users about their medications, disease and lifestyle modification.</AbstractText>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The objective of the study was to prepare, validate and perform user-testing of pictogram-based patient information leaflets (P-PILs) among hemodialysis (HD) patients.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The P-PILs are prepared by referring to the primary, secondary and tertiary resources. The content and pictograms of the leaflet have been validated by an expert committee consisting of three nephrologists and two academic pharmacists. The Baker Able Leaflet Design has been applied to develop the layout and design of the P-PILs.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Quasi-experimental pre- and post-test design without control group was conducted on 81 HD patients for user-testing of P-PILs. The mean Baker Able Leaflet Design assessment score for English version of the leaflet was 28, and 26 for Kannada version. The overall user-testing knowledge assessment mean scores were observed to have significantly improved from 44.25 to 69.62 with p value &lt;0.001.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The overall user opinion of content and legibility of the leaflets was good. Pictogram-based patient information leaflets can be considered an effective educational tool for HD patients.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mateti</LastName>
<ForeName>Uday Venkat</ForeName>
<Initials>UV</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacy Management, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal 576104, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nagappa</LastName>
<ForeName>Anantha Naik</ForeName>
<Initials>AN</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacy Management, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal 576104, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Attur</LastName>
<ForeName>Ravindra Prabhu</ForeName>
<Initials>RP</Initials>
<AffiliationInfo>
<Affiliation>Departments of Nephrology, Kasturba Medical College, Kasturba Hospital, Manipal University, Manipal 576104, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bairy</LastName>
<ForeName>Manohar</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Departments of Nephrology, Kasturba Medical College, Kasturba Hospital, Manipal University, Manipal 576104, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nagaraju</LastName>
<ForeName>Shankar Prasad</ForeName>
<Initials>SP</Initials>
<AffiliationInfo>
<Affiliation>Departments of Nephrology, Kasturba Medical College, Kasturba Hospital, Manipal University, Manipal 576104, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mallayasamy</LastName>
<ForeName>Surulivelrajan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal 576104, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vilakkathala</LastName>
<ForeName>Rajesh</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal 576104, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guddattu</LastName>
<ForeName>Vasudev</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Department of Statistics, Manipal University, Manipal 576104, Karnataka, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Balkrishnan</LastName>
<ForeName>Rajesh</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Health Management and Policy, Center for Global Health and College of Pharmacy, University of Michigan, MI, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>02</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Saudi Arabia</Country>
<MedlineTA>Saudi Pharm J</MedlineTA>
<NlmUniqueID>9705695</NlmUniqueID>
<ISSNLinking>1319-0164</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669423</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Hemodialysis</Keyword>
<Keyword MajorTopicYN="N">Leaflets</Keyword>
<Keyword MajorTopicYN="N">Patient education</Keyword>
<Keyword MajorTopicYN="N">User testing</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702257</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1319-0164</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>23</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</Title>
<ISOAbbreviation>Saudi Pharm J</ISOAbbreviation>
</Journal>
<ArticleTitle>Cost-minimization analysis of imipenem/cilastatin versus meropenem in moderate to severe infections at a tertiary care hospital in Saudi Arabia.</ArticleTitle>
<Pagination>
<MedlinePgn>626-34</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsps.2015.02.016</ELocationID>
<Abstract>
<AbstractText Label="AIM" NlmCategory="OBJECTIVE">The aim of this study was to compare the costs of management of moderate to severe infections in patients treated with imipenem/cilastatin (IC) and meropenem (MEM). Pharmacoeconomic studies in Saudi Arabia are scarce. The current hospital formulary contains 2 carbapenems: IC and MEM. These antibiotics share a similar spectrum of activity. There are conflicting reviews with regard to the relative cost-effectiveness of these two agents.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective, single-centre cohort study of 88 patients of IC versus MEM in moderate to severe infections was performed, applying cost-minimization analysis (CMA) methods. In accordance with CMA methods, the assumption of equivalent efficacy was first demonstrated by literature retrieved and appraised. Adult patients (⩾18 years old) diagnosed with moderate to severe infections, including skin and skin structure infections (SSIs), sepsis, intra-abdominal infections (IAIs), respiratory tract infections, urinary tract infections (UTIs) and hospital-acquired infections (HAIs), who were prescribed IC 500 mg every six hours intravenously (2 g per day) or MEM 1 g every eight hours (3 g per day), were included in the study. Only direct costs related to the management of the infections were included, in accordance with a payer perspective.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall there was no difference in the mean total daily costs between IC (SAR 4784.46, 95% CI 4140.68, 5428.24) and MEM (4390.14, 95% CI 3785.82, 4994.45; p = 0.37). A significantly lower medicine acquisition cost per vial of IC was observed when compared to MEM, however there was a significantly higher cost attached to administration sets used in the IC group than the MEM group. Consultation, nursing and physician costs were not significantly different between the groups. No differences were observed in costs associated with adverse drug events (ADEs).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study has shown that while acquisition costs of IC at a dose of 500 mg q6 h may be lower than for MEM 1 g q8 h, mean total costs per day were not significantly different between IC and MEM, indicating that medicine costs are only a small element of the overall costs of managing moderate to severe infections.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Joosub</LastName>
<ForeName>Imraan</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutical Care, PO Box 40740, Prince Muhammed bin Abdulaziz Hospital, Ministry of National Guard Health Affairs, Al-Madina Al-Monowarrah, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gray</LastName>
<ForeName>Andy</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Pharmacology, Discipline of Pharmaceutical Sciences, University of KwaZulu-Natal, Durban, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Crisostomo</LastName>
<ForeName>Analyn</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutical Care, PO Box 2477, Al-Hasa, 31982, King Abdulaziz Hospital, Al-Ahsa, Ministry of National Guard Health Affairs, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Salam</LastName>
<ForeName>Abdul</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>King Abdullah International Medical Research Center-Eastern Region (KAIMRC-ER), Ministry of National Guard Health Affairs, PO Box 2477, Al-Hasa 31982, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>02</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Saudi Arabia</Country>
<MedlineTA>Saudi Pharm J</MedlineTA>
<NlmUniqueID>9705695</NlmUniqueID>
<ISSNLinking>1319-0164</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669425</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Antibiotics</Keyword>
<Keyword MajorTopicYN="N">Antimicrobial therapy</Keyword>
<Keyword MajorTopicYN="N">Carbapenems</Keyword>
<Keyword MajorTopicYN="N">Cost-minimization analysis</Keyword>
<Keyword MajorTopicYN="N">Imipenem</Keyword>
<Keyword MajorTopicYN="N">Meropenem</Keyword>
<Keyword MajorTopicYN="N">Moderate to severe infections</Keyword>
<Keyword MajorTopicYN="N">Pharmacoeconomics</Keyword>
<Keyword MajorTopicYN="N">Saudi Arabia</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702258</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1319-0164</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>23</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</Title>
<ISOAbbreviation>Saudi Pharm J</ISOAbbreviation>
</Journal>
<ArticleTitle>Public's perception and satisfaction on the roles and services provided by pharmacists - Cross sectional survey in Sultanate of Oman.</ArticleTitle>
<Pagination>
<MedlinePgn>635-41</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsps.2015.02.003</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">An important factor that will help in advancement of the pharmacy services in any country would be to understand the public needs, expectation and satisfaction. There are limited published studies conducted in Sultanate of Oman regarding the perception and satisfaction of public on the role and services provided by pharmacists. The present study was conducted to assess the perception and satisfaction of general public in Sultanate of Oman on the roles, and services received from the pharmacists.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The survey was conducted among public in the Governorates of A'Dahera and Muscat in Oman during 2013. The questionnaire had items to assess two aspects: perception on the roles and responsibilities of pharmacists and satisfaction on the services provided. The responses to the questions marked in a five point Likert scale were assessed using a scoring scheme. Accordingly, the median perception, and satisfaction score and median total score for the participants were estimated. The median scores of the participants were related with the demographics of the participants and frequency of visit to pharmacy.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 390 completed questionnaires were obtained. The median total score of the participants based on all the questions was 79 (Inter Quartile Range (IQR), 12) which represents a moderate score. The median perception and satisfaction scores were 44 (IQR 5) and 34 (IQR 7) which represent a good and moderate score, respectively. Perception of the participants differed based on employment status, frequency of visit to pharmacy and governorate represented by participants while satisfaction was influenced by educational qualification and frequency of visit to pharmacy.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Public had a good perception regarding the roles of the pharmacists while they were only moderately satisfied with the services provided. Steps have to be taken to improve the services and relationship of pharmacists, and thereby improve the satisfaction of the customers. An extended study in a broader population involving more governorates will provide an enhanced representation regarding this important aspect.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jose</LastName>
<ForeName>Jimmy</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>School of Pharmacy, College of Pharmacy and Nursing, University of Nizwa, P.B. No. 33, PO 616, Birkat Al Mouz, Nizwa, Oman.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Al Shukili</LastName>
<ForeName>Marwa Nasser</ForeName>
<Initials>MN</Initials>
<AffiliationInfo>
<Affiliation>School of Pharmacy, College of Pharmacy and Nursing, University of Nizwa, P.B. No. 33, PO 616, Birkat Al Mouz, Nizwa, Oman.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jimmy</LastName>
<ForeName>Beena</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>School of Pharmacy, College of Pharmacy and Nursing, University of Nizwa, P.B. No. 33, PO 616, Birkat Al Mouz, Nizwa, Oman.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>02</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Saudi Arabia</Country>
<MedlineTA>Saudi Pharm J</MedlineTA>
<NlmUniqueID>9705695</NlmUniqueID>
<ISSNLinking>1319-0164</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669416</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cross sectional survey</Keyword>
<Keyword MajorTopicYN="N">Omani public</Keyword>
<Keyword MajorTopicYN="N">Perception</Keyword>
<Keyword MajorTopicYN="N">Pharmacists</Keyword>
<Keyword MajorTopicYN="N">Satisfaction</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702259</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1319-0164</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>23</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</Title>
<ISOAbbreviation>Saudi Pharm J</ISOAbbreviation>
</Journal>
<ArticleTitle>Factors influencing warfarin response in hospitalized patients.</ArticleTitle>
<Pagination>
<MedlinePgn>642-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsps.2015.02.004</ELocationID>
<Abstract>
<AbstractText>The objective of this study was to investigate the influence of simultaneous factors that potentially keep patients far from achieving target INR range at discharge in hospitalized patients. Prospective cross-sectional observational study conducted at the Cardiology Department and Intensive Care Unit (ICU) of the Assiut University Hospitals. One-hundred and twenty patients were enrolled in the study from July 2013 to January 2014. Outcome measures were discharge INRs, bleeding and thromboembolic episodes. Bivariate analysis and multinomial logistic regression were conducted to determine independent risk factors that can keep patients outside target INR range. Patients who were newly initiated warfarin on hospital admission were given low initiation dose (2.8 mg ± 0.9). They were more likely to have INR values below 1.5 during hospital stay, 13 (27.7%) patients compared with 9 (12.3%) previously treated patients, respectively (p = .034). We found that the best predictors of achieving below target INR range relative to within target INR range were; shorter hospital stay periods (OR, 0.82 for every day increase [95% CI, 0.72-0.94]), being a male patient (OR, 2.86 [95% CI, 1.05-7.69]), concurrent infection (OR, 0.21 [95% CI, 0.07-0.59]) and new initiation of warfarin therapy on hospital admission (OR, 3.73 [95% CI, 1.28-10.9]). Gender, new initiation of warfarin therapy on hospital admission, shorter hospital stay periods and concurrent infection can have a significant effect on discharge INRs. Initiation of warfarin without giving loading doses increases the risk of having INRs below 1.5 during hospital stay and increases the likelihood of a patient to be discharged with INR below target range. Following warfarin dosing nomograms and careful monitoring of the effect of various factors on warfarin response should be greatly considered. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Abdel-Aziz</LastName>
<ForeName>Mahmoud I</ForeName>
<Initials>MI</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Pharmacy, Faculty of Pharmacy, Assiut University, Assiut, Egypt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ali</LastName>
<ForeName>Mostafa A Sayed</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Pharmacy, Faculty of Pharmacy, Assiut University, Assiut, Egypt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hassan</LastName>
<ForeName>Ayman K M</ForeName>
<Initials>AK</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiovascular Medicine, Assiut University, Assiut, Egypt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Elfaham</LastName>
<ForeName>Tahani H</ForeName>
<Initials>TH</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, Egypt.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>02</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Saudi Arabia</Country>
<MedlineTA>Saudi Pharm J</MedlineTA>
<NlmUniqueID>9705695</NlmUniqueID>
<ISSNLinking>1319-0164</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669420</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Anticoagulation therapy</Keyword>
<Keyword MajorTopicYN="N">Hospitalized patients</Keyword>
<Keyword MajorTopicYN="N">INR</Keyword>
<Keyword MajorTopicYN="N">Warfarin</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702260</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1319-0164</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>23</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</Title>
<ISOAbbreviation>Saudi Pharm J</ISOAbbreviation>
</Journal>
<ArticleTitle>Enhancement of dissolution rate of class II drugs (Hydrochlorothiazide); a comparative study of the two novel approaches; solid dispersion and liqui-solid techniques.</ArticleTitle>
<Pagination>
<MedlinePgn>650-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsps.2015.01.025</ELocationID>
<Abstract>
<AbstractText>Liqui-solid technique and solid dispersion formation are two novel approaches for enhancement of dissolution rate of BCS class II drugs. Liqui-solid compact converts a liquid drug or drug solution into a free flowing powder with enhanced dissolution rate. In case of solid dispersion drug is molecularly dispersed in a hydrophilic polymer in solid state. In the present study, Liqui-solid and solid dispersion techniques were applied to enhance the dissolution of the Hydrochlorothiazide. Three formulations of Hydrochlorothiazide were prepared by liqui-solid technique using micro crystalline cellulose as carrier material and colloidal silicon dioxide as coating material. Water, poly ethylene glycol-400 and Tween-60 were used as solvent system. Solid dispersions of Hydrochlorothiazide were prepared by solvent fusion method using PEG-4000 as carrier polymer. Tablets were subjected to evaluation of various physical and chemical characteristics. Dissolution profiles of tablets prepared by the novel techniques were compared with marketed conventional tablets. Model independent techniques including similarity factor, dissimilarity factor and dissolution efficiency were applied for comparison of dissolution profiles. The results obtained indicated that liqui-solid compact formulations were more effective in enhancing the dissolution rate compared with solid dispersion technique. The liqui-solid compacts improved the dissolution rate up to 95% while the solid dispersion increased it to 88%. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Khan</LastName>
<ForeName>Amjad</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacy, University of Peshawar, Peshawar 25120, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Iqbal</LastName>
<ForeName>Zafar</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacy, University of Peshawar, Peshawar 25120, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shah</LastName>
<ForeName>Yasar</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacy, University of Peshawar, Peshawar 25120, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ahmad</LastName>
<ForeName>Lateef</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacy, University of Peshawar, Peshawar 25120, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ismail</LastName>
<AffiliationInfo>
<Affiliation>Department of Pharmacy, University of Peshawar, Peshawar 25120, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ullah</LastName>
<ForeName>Zia</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacy, University of Peshawar, Peshawar 25120, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ullah</LastName>
<ForeName>Aman</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacy, University of Peshawar, Peshawar 25120, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>02</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Saudi Arabia</Country>
<MedlineTA>Saudi Pharm J</MedlineTA>
<NlmUniqueID>9705695</NlmUniqueID>
<ISSNLinking>1319-0164</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669426</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Dissolution efficiency</Keyword>
<Keyword MajorTopicYN="N">Hydrochlorothiazide</Keyword>
<Keyword MajorTopicYN="N">Liqui-solid compacts</Keyword>
<Keyword MajorTopicYN="N">PEG-4000</Keyword>
<Keyword MajorTopicYN="N">Similarity factor</Keyword>
<Keyword MajorTopicYN="N">Solid dispersion</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702261</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1319-0164</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>23</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</Title>
<ISOAbbreviation>Saudi Pharm J</ISOAbbreviation>
</Journal>
<ArticleTitle>Influence of different types of low substituted hydroxypropyl cellulose on tableting, disintegration, and floating behaviour of floating drug delivery systems.</ArticleTitle>
<Pagination>
<MedlinePgn>658-66</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsps.2014.09.001</ELocationID>
<Abstract>
<AbstractText>The object of the present study is to evaluate the effect of application of low-substituted hydroxypropyl cellulose (L-HPC) 11 and B1 as excipients promoting floating in gastroretentive tablets. Directly compressed tablets were formed based on experimental design. Face-centred central composite design was applied with two factors and 3 levels, where amount of sodium alginate (X 1) and L-HPC (X2 ) were the numerical factors. Applied types of L-HPCs and their 1:1 mixture were included in a categorical factor (X 3). Studied parameters were floating lag time, floating time, floating force, swelling behaviour of tablets and dissolution of paracetamol, which was used as a model active substance. Due to their physical character, L-HPCs had different water uptake and flowability. Lower flowability and lower water uptake was observed after 60 min at L-HPC 11 compared to L-HPC B1. Shorter floating times were detected at L-HPC 11 and L-HPC mixtures with 0.5% content of sodium alginate, whereas alginate was the only significant factor. Evaluating results of drug release and swelling studies on floating tablets revealed correlation, which can serve to help to understand the mechanism of action of L-HPCs in the field development of gastroretentive dosage forms. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Diós</LastName>
<ForeName>Péter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Institute of Pharmaceutical Technology and Biopharmacy, University of Pécs, Rókus u. 2., H-7624 Pécs, Hungary.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pernecker</LastName>
<ForeName>Tivadar</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Institute of Pharmaceutical Technology and Biopharmacy, University of Pécs, Rókus u. 2., H-7624 Pécs, Hungary.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nagy</LastName>
<ForeName>Sándor</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Institute of Pharmaceutical Technology and Biopharmacy, University of Pécs, Rókus u. 2., H-7624 Pécs, Hungary.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pál</LastName>
<ForeName>Szilárd</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Institute of Pharmaceutical Technology and Biopharmacy, University of Pécs, Rókus u. 2., H-7624 Pécs, Hungary.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dévay</LastName>
<ForeName>Attila</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Institute of Pharmaceutical Technology and Biopharmacy, University of Pécs, Rókus u. 2., H-7624 Pécs, Hungary.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>10</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Saudi Arabia</Country>
<MedlineTA>Saudi Pharm J</MedlineTA>
<NlmUniqueID>9705695</NlmUniqueID>
<ISSNLinking>1319-0164</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669424</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Disintegration</Keyword>
<Keyword MajorTopicYN="N">Floating force</Keyword>
<Keyword MajorTopicYN="N">Floating tablets</Keyword>
<Keyword MajorTopicYN="N">Gastroretentive</Keyword>
<Keyword MajorTopicYN="N">Low substituted hydroxypropyl cellulose</Keyword>
<Keyword MajorTopicYN="N">Sodium alginate</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702262</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1319-0164</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>23</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</Title>
<ISOAbbreviation>Saudi Pharm J</ISOAbbreviation>
</Journal>
<ArticleTitle>Fabrication and in vivo evaluation of Nelfinavir loaded PLGA nanoparticles for enhancing oral bioavailability and therapeutic effect.</ArticleTitle>
<Pagination>
<MedlinePgn>667-74</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsps.2015.02.021</ELocationID>
<Abstract>
<AbstractText>Nelfinavir mesylate (NFV) is an anti-viral drug, used in the treatment of Acquired Immunodeficiency Syndrome (AIDS). Poor oral bioavailability and shorter half-life (3.5-5 h) remain a major clinical limitation of NFV leading to unpredictable drug bioavailability and frequent dosing. In this context, the objective of the present study was to formulate NFV loaded poly (lactic-co-glycolic acid) (PLGA) nanoparticles (NPs), which can increase the solubility and oral bioavailability along with sustained release of the drug. NFV loaded PLGA-NPs were prepared by nanoprecipitation method using PLGA and Poloxomer 407. The prepared NPs were evaluated for particle size, zeta potential, morphology, drug content, entrapment efficiency (EE) and in vitro dissolution studies. Oral bioavailability studies were carried out in New Zealand rabbits by administering developed NFV PLGA-NPs and pure drug suspension. PLGA-NPs prepared by using 1:4 ratio of drug and PLGA, with a stirring rate of 1500 rpm for 4 h. The prepared NPs were in the size of 185 ± 0.83 nm with a zeta potential of 28.7 ± 0.09 mV. The developed NPs were found to be spherical with uniform size distribution. The drug content and EE of the optimized formulation were found to be 36 ± 0.19% and 72 ± 0.47% respectively. After oral administration of NFV PLGA-NPs, the relative bioavailability was enhanced about 4.94 fold compared to NFV suspension as a control. The results describe an effective strategy for oral delivery of NFV loaded PLGA NPs that helps in enhancing bioavailability and reduce the frequency of dosing. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Venkatesh</LastName>
<ForeName>D Nagasamy</ForeName>
<Initials>DN</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund, JSS University, Mysore 643001, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baskaran</LastName>
<ForeName>Mahendran</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund, JSS University, Mysore 643001, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Karri</LastName>
<ForeName>Veera Venkata Satyanarayana Reddy</ForeName>
<Initials>VV</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund, JSS University, Mysore 643001, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mannemala</LastName>
<ForeName>Sai Sandeep</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutical Analysis, JSS College of Pharmacy, Ootacamund, JSS University, Mysore, India ; Department of Pharmacy, Annamalai University, Annamalai Nagar, Tamil Nadu, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Radhakrishna</LastName>
<ForeName>Kollipara</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund, JSS University, Mysore 643001, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Goti</LastName>
<ForeName>Sandip</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutical Analysis, JSS College of Pharmacy, Ootacamund, JSS University, Mysore, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>03</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Saudi Arabia</Country>
<MedlineTA>Saudi Pharm J</MedlineTA>
<NlmUniqueID>9705695</NlmUniqueID>
<ISSNLinking>1319-0164</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669422</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bioavailability</Keyword>
<Keyword MajorTopicYN="N">Nanoparticles</Keyword>
<Keyword MajorTopicYN="N">Nelfinavir mesylate</Keyword>
<Keyword MajorTopicYN="N">PLGA</Keyword>
<Keyword MajorTopicYN="N">Sustained release</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702263</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1319-0164</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>23</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</Title>
<ISOAbbreviation>Saudi Pharm J</ISOAbbreviation>
</Journal>
<ArticleTitle>In-vitro and in-vivo evaluation of repaglinide loaded floating microspheres prepared from different viscosity grades of HPMC polymer.</ArticleTitle>
<Pagination>
<MedlinePgn>675-82</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsps.2015.02.013</ELocationID>
<Abstract>
<AbstractText>During the study repaglinide encapsulated floating microspheres were formulated and characterized for enhancing residence time of drug in git and thereby increasing its bioavailability. Floating microspheres of ethylcellulose (EC) and hydroxypropyl methyl cellulose (HPMC) (5 and 100 cps) were prepared by emulsion solvent diffusion technique. During process optimization various parameters were studied such as: drug: polymer ratio, polymer ratio, concentration of emulsifier and stirring speed. Selected optimized formulations were studied for SEM, entrapment, floating behavior, drug release and kinetics. In-vivo floating ability (X-ray) study and in-vivo antidiabetic activity were performed on alloxan induced diabetic rats. Microspheres prepared with different viscosity grade HPMC were spherical shaped with smooth surface. Size of microspheres was in the range of 181.1-248 μm. Good entrapment and buoyancy were observed for 12 h. X-ray image showed that optimized formulation remained buoyant for more than 6 h. Optimized formulation treated group shows significant (p &lt; 0.01) reduction in blood glucose level as compared to pure drug treated group. Repaglinide loaded floating microspheres expected to give new choice for safe, economical and increased bioavailable formulation for effective management of NIDDM. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sharma</LastName>
<ForeName>Megha</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Shri Ram Institute of Technology (Pharmacy), Near ITI, Madhotal, Jabalpur, M.P., India ; SPS, Shiksha 'O' Anusandhan University, Bhubaneswar, Orissa, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kohli</LastName>
<ForeName>Seema</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacy, K.N. Polytechnic College, Jabalpur, M.P., India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dinda</LastName>
<ForeName>Agnimitra</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>SPS, Shiksha 'O' Anusandhan University, Bhubaneswar, Orissa, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>02</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Saudi Arabia</Country>
<MedlineTA>Saudi Pharm J</MedlineTA>
<NlmUniqueID>9705695</NlmUniqueID>
<ISSNLinking>1319-0164</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669415</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">ATP, adenosine tri phosphate</Keyword>
<Keyword MajorTopicYN="N">Alloxan</Keyword>
<Keyword MajorTopicYN="N">Antidiabetic</Keyword>
<Keyword MajorTopicYN="N">EC, ethylcellulose</Keyword>
<Keyword MajorTopicYN="N">GRT, gastric residence time</Keyword>
<Keyword MajorTopicYN="N">HPMC, hydroxypropyl methylcellulose</Keyword>
<Keyword MajorTopicYN="N">PEG, polyethylene glycerol</Keyword>
<Keyword MajorTopicYN="N">PVA, polyvinyl alcohol</Keyword>
<Keyword MajorTopicYN="N">Repaglinide</Keyword>
<Keyword MajorTopicYN="N">SEM, scanning electron microscopy</Keyword>
<Keyword MajorTopicYN="N">Significant</Keyword>
<Keyword MajorTopicYN="N">UV, uv–visible</Keyword>
<Keyword MajorTopicYN="N">Viscosity</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702264</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1319-0164</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>23</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</Title>
<ISOAbbreviation>Saudi Pharm J</ISOAbbreviation>
</Journal>
<ArticleTitle>In vitro and in vivo targeting effect of folate decorated paclitaxel loaded PLA-TPGS nanoparticles.</ArticleTitle>
<Pagination>
<MedlinePgn>683-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsps.2015.02.002</ELocationID>
<Abstract>
<AbstractText>Paclitaxel is one of the most effective chemotherapeutic agents for treating various types of cancer. However, the clinical application of paclitaxel in cancer treatment is considerably limited due to its poor water solubility and low therapeutic index. Thus, it requires an urgent solution to improve therapeutic efficacy of paclitaxel. In this study, folate decorated paclitaxel loaded PLA-TPGS nanoparticles were prepared by a modified emulsification/solvent evaporation method. The obtained nanoparticles were characterized by Field Emission Scanning Electron Microscopy (FESEM), Fourier Transform Infrared (FTIR) and Dynamic Light Scattering (DLS) method. The spherical nanoparticles were around 50 nm in size with a narrow size distribution. Targeting effect of nanoparticles was investigated in vitro on cancer cell line and in vivo on tumor bearing nude mouse. The results indicated the effective targeting of folate decorated paclitaxel loaded copolymer nanoparticles on cancer cells both in vitro and in vivo. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Thu</LastName>
<ForeName>Ha Phuong</ForeName>
<Initials>HP</Initials>
<AffiliationInfo>
<Affiliation>Institute of Materials Science, Vietnam Academy of Science and Technology, 18, Hoang Quoc Viet, Ha Noi, Viet Nam.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nam</LastName>
<ForeName>Nguyen Hoai</ForeName>
<Initials>NH</Initials>
<AffiliationInfo>
<Affiliation>Institute of Materials Science, Vietnam Academy of Science and Technology, 18, Hoang Quoc Viet, Ha Noi, Viet Nam.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Quang</LastName>
<ForeName>Bui Thuc</ForeName>
<Initials>BT</Initials>
<AffiliationInfo>
<Affiliation>Central Transport Hospital, Ha Noi, Viet Nam.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Son</LastName>
<ForeName>Ho Anh</ForeName>
<Initials>HA</Initials>
<AffiliationInfo>
<Affiliation>Vietnam Academy of Military Medicine, Ha Dong, Ha Noi, Viet Nam.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Toan</LastName>
<ForeName>Nguyen Linh</ForeName>
<Initials>NL</Initials>
<AffiliationInfo>
<Affiliation>Vietnam Academy of Military Medicine, Ha Dong, Ha Noi, Viet Nam.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Quang</LastName>
<ForeName>Duong Tuan</ForeName>
<Initials>DT</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, Hue University, Hue, Viet Nam.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>03</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Saudi Arabia</Country>
<MedlineTA>Saudi Pharm J</MedlineTA>
<NlmUniqueID>9705695</NlmUniqueID>
<ISSNLinking>1319-0164</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669427</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Copolymeric micelle</Keyword>
<Keyword MajorTopicYN="N">Fol/PTX/PLA–TPGS NPs</Keyword>
<Keyword MajorTopicYN="N">PLA–TPGS</Keyword>
<Keyword MajorTopicYN="N">Paclitaxel (PTX)</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702265</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1319-0164</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>23</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</Title>
<ISOAbbreviation>Saudi Pharm J</ISOAbbreviation>
</Journal>
<ArticleTitle>Comparison of different serum sample extraction methods and their suitability for mass spectrometry analysis.</ArticleTitle>
<Pagination>
<MedlinePgn>689-97</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsps.2015.01.023</ELocationID>
<Abstract>
<AbstractText>Mass spectrometry has been widely used, particularly in pharmacokinetic investigations and for therapeutic drug monitoring purposes. Like any other analytical method some difficulties exist in employing mass spectrometry, mainly when it is used to test biological samples, such as to detect drug candidates in mammalian serum, which is rich in proteins, lipids and other contents that may interfere with the investigational drug. The complexity of the serum proteome presents challenges for efficient sample preparation and adequate sensitivity for mass spectrometry analysis of drugs. Enrichment procedures prior to the drug analysis are often needed and as a result, the study of serum or plasma components usually demands either methods of purification or depletion of one or more. Selection of the best combination of sample introduction method is a crucial determinant of the sensitivity and accuracy of mass spectrometry. The aim of this study was to determine the highest serum protein precipitation activity of five commonly used sample preparation methods and test their suitability for mass spectrometry. We spiked three small molecules into rabbit serum and applied different protein precipitation methods to determine their precipitation activity and applicability as a mass spectrometry introductory tool. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Alshammari</LastName>
<ForeName>Thamir M</ForeName>
<Initials>TM</Initials>
<AffiliationInfo>
<Affiliation>Pharmacy College Hail University, Hail, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Al-Hassan</LastName>
<ForeName>Ahmed Ali</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>College of Agriculture and Vet Medicine, Qassim University, Buraidah, Qassim 51432, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hadda</LastName>
<ForeName>Taibi B</ForeName>
<Initials>TB</Initials>
<AffiliationInfo>
<Affiliation>Laboratoire Chimie Matériaux, FSO, Université Mohammed 1er, Oujda 60000, Morocco.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aljofan</LastName>
<ForeName>Mohamad</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Pharmacy College Hail University, Hail, Saudi Arabia ; Department of Microbiology, School of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC 3800, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>02</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Saudi Arabia</Country>
<MedlineTA>Saudi Pharm J</MedlineTA>
<NlmUniqueID>9705695</NlmUniqueID>
<ISSNLinking>1319-0164</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669428</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">In-gel alkylation</Keyword>
<Keyword MajorTopicYN="N">LC, liquid chromatography</Keyword>
<Keyword MajorTopicYN="N">MS, mass spectrometry</Keyword>
<Keyword MajorTopicYN="N">Mass spectrometry</Keyword>
<Keyword MajorTopicYN="N">PP, protein precipitation</Keyword>
<Keyword MajorTopicYN="N">Protein extraction method</Keyword>
<Keyword MajorTopicYN="N">Serum sample</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702266</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1319-0164</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>23</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</Title>
<ISOAbbreviation>Saudi Pharm J</ISOAbbreviation>
</Journal>
<ArticleTitle>Synthesis and evaluation of the structural and physicochemical properties of carboxymethyl pregelatinized starch as a pharmaceutical excipient.</ArticleTitle>
<Pagination>
<MedlinePgn>698-711</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsps.2015.01.021</ELocationID>
<Abstract>
<AbstractText>A pregelatinized starch (PGS) was derivatized with sodium chloroacetate (SCA) in alcoholic medium under alkaline condition to produce carboxymethyl pregelatinized starch (CMPGS) with various degrees of substitution (DS). Influence of the molar ratio of SCA to the glucopyranose units (SCA/GU), reaction time, temperature and the amount of sodium hydroxide on the degree of substitution (DS) and the reaction efficiency (RE) was studied. An optimal concentration of 30% of NaOH, for a reaction time of 1 h at 50 °C and molar ratio (SCA/GU) equal to 1.0, yielded an optimal DS of 0.55 and a RE of 55%. SEM micrographs revealed that the carboxymethylation assigned the structural arrangement of CMPGS and caused the granular disintegration. Wide angle diffraction X-ray (XRD) showed that the crystallinity of starch was obviously varied after carboxymethylation. New bands in FTIR spectra at 1417 and 1603 cm(-1) indicated the presence of carboxymethyl groups. The solubility and viscosity of CMPGS increased with an increase in the degree of modification. In order to investigate the influence of DS on physical and drug release properties, CMPGS obtained with DS in the range of 0.12-0.55 was evaluated as tablet excipient for sustained drug release. Dissolution tests performed in phosphate buffer (pH 6.8), with Ibuprofen as drug model (25% loading) showed that CMPGS seems suitable to be used as sustained release excipient since the drug release was driven over a period up to 8 h. The in vitro release kinetics studies revealed that all formulations fit well with Korsmeyer-Peppas model and the mechanism of drug release is non-Fickian diffusion. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lefnaoui</LastName>
<ForeName>Sonia</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Materials and Environmental Laboratory, Faculty of Sciences and Technology, University of Medea, Ain D'Heb, 2001 Medea, Algeria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moulai-Mostefa</LastName>
<ForeName>Nadji</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Materials and Environmental Laboratory, Faculty of Sciences and Technology, University of Medea, Ain D'Heb, 2001 Medea, Algeria.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>02</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Saudi Arabia</Country>
<MedlineTA>Saudi Pharm J</MedlineTA>
<NlmUniqueID>9705695</NlmUniqueID>
<ISSNLinking>1319-0164</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669421</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Carboxymethylation</Keyword>
<Keyword MajorTopicYN="N">Degree of substitution</Keyword>
<Keyword MajorTopicYN="N">Monolithic tablet</Keyword>
<Keyword MajorTopicYN="N">Powder characterization</Keyword>
<Keyword MajorTopicYN="N">Pregelatinized starch</Keyword>
<Keyword MajorTopicYN="N">Sustained release</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702267</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1319-0164</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>23</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</Title>
<ISOAbbreviation>Saudi Pharm J</ISOAbbreviation>
</Journal>
<ArticleTitle>The beneficial roles of Lupineus luteus and lifestyle changes in management of metabolic syndrome: A case study.</ArticleTitle>
<Pagination>
<MedlinePgn>712-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsps.2015.02.006</ELocationID>
<Abstract>
<AbstractText>Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors including obesity, hypertension, dyslipidemia and hyperuricemia. Here, we report a 43-year-old man with obesity, hypertension, hypercholesterolemia, hyperuricemia and mild liver dysfunctions. Lupid (Lupineus luteus) and therapeutic lifestyle change (TLC) were suggested as therapeutic intervention for the present case for 6 months. The body weight, body mass index (BMI), blood pressure, total cholesterol (TC), low density lipoprotein-cholesterol (LDL-C), triacylglycerol (TAG), uric acid (UA) and alanine transaminase (ALT) were markedly decreased by 26.85%, 26.95%, 13%, 53.84%, 57.84%, 36.14%, 47.58% and 61.62% respectively, compared to those at baselines. However, high density lipoprotein cholesterol (HDL-C) value was markedly increased by 30.77%. The present results concluded that administration of lupin with TLC is good intervention for prevention and treatment of MetS. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Harisa</LastName>
<ForeName>Gamaleldin I</ForeName>
<Initials>GI</Initials>
<AffiliationInfo>
<Affiliation>Kayyali Chair for Pharmaceutical Industry, Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia ; Department of Biochemistry, College of Pharmacy, Al-Azhar University (Boys), Nasr City, Cairo, Egypt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alanazi</LastName>
<ForeName>Fars K</ForeName>
<Initials>FK</Initials>
<AffiliationInfo>
<Affiliation>Kayyali Chair for Pharmaceutical Industry, Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>02</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Saudi Arabia</Country>
<MedlineTA>Saudi Pharm J</MedlineTA>
<NlmUniqueID>9705695</NlmUniqueID>
<ISSNLinking>1319-0164</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669417</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Lupin</Keyword>
<Keyword MajorTopicYN="N">Metabolic syndrome</Keyword>
<Keyword MajorTopicYN="N">Satiety value</Keyword>
<Keyword MajorTopicYN="N">Therapeutic lifestyle change</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702268</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1319-0164</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>23</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</Title>
<ISOAbbreviation>Saudi Pharm J</ISOAbbreviation>
</Journal>
<ArticleTitle>Neonatal outcomes after oral administration of antenatal corticosteroid: A case report.</ArticleTitle>
<Pagination>
<MedlinePgn>716-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsps.2015.02.009</ELocationID>
<Abstract>
<AbstractText>The use of antenatal corticosteroids is associated with reduction in morbidity and mortality rates in preterm delivery. A 34 year-old pregnant woman, gravida 2 para1, was planned for elective cesarean section at 36 weeks of gestation as ultrasound study showed intrauterine growth retardation. She has idiopathic thrombocytopenia and anemia, with suspected hypoplastic anemia. Due to mother's low platelet count, antenatal intramuscular corticosteroids injection was avoided. Instead, oral dexamethasone was given for fetal lung maturity. Baby's Apgar score at 1-min and 5-min was 9 and 10, respectively. The baby girl did not develop respiratory distress syndrome. She had mild transient tachypnea of newborn that needed only mild respiratory support with nasal cannula in room air. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>AlSaad</LastName>
<ForeName>Doua</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacy, Women's Hospital, Hamad Medical Corporation, Qatar.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abdulrouf</LastName>
<ForeName>Palli Valapila</ForeName>
<Initials>PV</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacy, Women's Hospital, Hamad Medical Corporation, Qatar.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Parappil</LastName>
<ForeName>Hussain</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of NICU, Women's Hospital, Hamad Medical Corporation, Qatar ; Department of Pediatrics, Weill Cornell Medical College, Qatar.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tarannum</LastName>
<ForeName>Asma</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Women's Hospital, Hamad Medical Corporation, Qatar.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thomas</LastName>
<ForeName>Binny</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacy, Women's Hospital, Hamad Medical Corporation, Qatar.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>02</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Saudi Arabia</Country>
<MedlineTA>Saudi Pharm J</MedlineTA>
<NlmUniqueID>9705695</NlmUniqueID>
<ISSNLinking>1319-0164</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669477</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Antenatal corticosteroids</Keyword>
<Keyword MajorTopicYN="N">Fetal lung maturity</Keyword>
<Keyword MajorTopicYN="N">Oral dexamethasone</Keyword>
<Keyword MajorTopicYN="N">Pregnancy</Keyword>
<Keyword MajorTopicYN="N">Preterm delivery</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702269</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1319-0164</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>23</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</Title>
<ISOAbbreviation>Saudi Pharm J</ISOAbbreviation>
</Journal>
<ArticleTitle>Levetiracetam induced psoriasiform drug eruption: a rare case report.</ArticleTitle>
<Pagination>
<MedlinePgn>720-2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsps.2015.02.010</ELocationID>
<Abstract>
<AbstractText>Levetiracetam (LEV) is an established second generation anti-epileptic drug and LEV associated severe cutaneous reactions are rare. Here we report the case of psoriasiform drug eruption in a patient with newly diagnosed epilepsy who had been treated with levetiracetam. To our knowledge this is the first report of a patient with a psoriasiform eruption that appeared after the administration of LEV. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gencler</LastName>
<ForeName>Onur Serdar</ForeName>
<Initials>OS</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Faculty of Medicine, Turgut Ozal University, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gencler</LastName>
<ForeName>Bilgen</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Dermatology, Koru Hospital, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Altunel</LastName>
<ForeName>Cemile Tugba</ForeName>
<Initials>CT</Initials>
<AffiliationInfo>
<Affiliation>Department of Dermatology, Veni Vidi Hospital, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arslan</LastName>
<ForeName>Nur</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Faculty of Medicine, Turgut Ozal University, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>02</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Saudi Arabia</Country>
<MedlineTA>Saudi Pharm J</MedlineTA>
<NlmUniqueID>9705695</NlmUniqueID>
<ISSNLinking>1319-0164</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4669462</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Epilepsy</Keyword>
<Keyword MajorTopicYN="N">Levetiracetam</Keyword>
<Keyword MajorTopicYN="N">Psoriasiform drug eruption</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702429</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Climate change and glacier retreat drive shifts in an Antarctic benthic ecosystem.</ArticleTitle>
<Pagination>
<MedlinePgn>e1500050</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1500050</ELocationID>
<Abstract>
<AbstractText>The Antarctic Peninsula (AP) is one of the three places on Earth that registered the most intense warming in the last 50 years, almost five times the global mean. This warming has strongly affected the cryosphere, causing the largest ice-shelf collapses ever observed and the retreat of 87% of glaciers. Ecosystem responses, although increasingly predicted, have been mainly reported for pelagic systems. However, and despite most Antarctic species being benthic, responses in the Antarctic benthos have been detected in only a few species, and major effects at assemblage level are unknown. This is probably due to the scarcity of baselines against which to assess change. We performed repeat surveys of coastal benthos in 1994, 1998, and 2010, analyzing community structure and environmental variables at King George Island, Antarctica. We report a marked shift in an Antarctic benthic community that can be linked to ongoing climate change. However, rather than temperature as the primary factor, we highlight the resulting increased sediment runoff, triggered by glacier retreat, as the potential causal factor. The sudden shift from a "filter feeders-ascidian domination" to a "mixed assemblage" suggests that thresholds (for example, of tolerable sedimentation) and alternative equilibrium states, depending on the reversibility of the changes, could be possible traits of this ecosystem. Sedimentation processes will be increasing under the current scenario of glacier retreat, and attention needs to be paid to its effects along the AP. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sahade</LastName>
<ForeName>Ricardo</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Diversidad y Ecología Animal [Consejo Nacional de Investigaciones Científicas y Técnicas-Universidad Nacional de Córdoba (CONICET-UNC)], Facultad de Ciencias Exactas, Físicas y Naturales, UNC, Avenida Vélez Sarsfield 299, 5000 Córdoba, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lagger</LastName>
<ForeName>Cristian</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Diversidad y Ecología Animal [Consejo Nacional de Investigaciones Científicas y Técnicas-Universidad Nacional de Córdoba (CONICET-UNC)], Facultad de Ciencias Exactas, Físicas y Naturales, UNC, Avenida Vélez Sarsfield 299, 5000 Córdoba, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Torre</LastName>
<ForeName>Luciana</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Diversidad y Ecología Animal [Consejo Nacional de Investigaciones Científicas y Técnicas-Universidad Nacional de Córdoba (CONICET-UNC)], Facultad de Ciencias Exactas, Físicas y Naturales, UNC, Avenida Vélez Sarsfield 299, 5000 Córdoba, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Momo</LastName>
<ForeName>Fernando</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Ciencias, Universidad Nacional de General Sarmiento, Juan M. Gutiérrez 1150, B1613GSX Los Polvorines, Argentina. ; Instituto de Ecología y Desarrollo Sustentable, Universidad Nacional de Luján, Luján 6700, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Monien</LastName>
<ForeName>Patrick</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Institute for Chemistry and Biology of the Marine Environment, Carl-von-Ossietzky Straße 9-11, 26129 Oldenburg, Germany. ; Department of Geosciences, University of Bremen, Klagenfurter Straße (GEO), 28359 Bremen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schloss</LastName>
<ForeName>Irene</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Instituto Antártico Argentino, Balcarce 290, Ciudad Autónoma de Buenos Aires C1064AAF, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barnes</LastName>
<ForeName>David K A</ForeName>
<Initials>DK</Initials>
<AffiliationInfo>
<Affiliation>British Antarctic Survey, Natural Environment Research Council, Madingley, Road, Cambridge CB3 0ET, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Servetto</LastName>
<ForeName>Natalia</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Diversidad y Ecología Animal [Consejo Nacional de Investigaciones Científicas y Técnicas-Universidad Nacional de Córdoba (CONICET-UNC)], Facultad de Ciencias Exactas, Físicas y Naturales, UNC, Avenida Vélez Sarsfield 299, 5000 Córdoba, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tarantelli</LastName>
<ForeName>Soledad</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Diversidad y Ecología Animal [Consejo Nacional de Investigaciones Científicas y Técnicas-Universidad Nacional de Córdoba (CONICET-UNC)], Facultad de Ciencias Exactas, Físicas y Naturales, UNC, Avenida Vélez Sarsfield 299, 5000 Córdoba, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tatián</LastName>
<ForeName>Marcos</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Diversidad y Ecología Animal [Consejo Nacional de Investigaciones Científicas y Técnicas-Universidad Nacional de Córdoba (CONICET-UNC)], Facultad de Ciencias Exactas, Físicas y Naturales, UNC, Avenida Vélez Sarsfield 299, 5000 Córdoba, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zamboni</LastName>
<ForeName>Nadia</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Diversidad y Ecología Animal [Consejo Nacional de Investigaciones Científicas y Técnicas-Universidad Nacional de Córdoba (CONICET-UNC)], Facultad de Ciencias Exactas, Físicas y Naturales, UNC, Avenida Vélez Sarsfield 299, 5000 Córdoba, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abele</LastName>
<ForeName>Doris</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Alfred Wegener Institut for Polar and Marine Research, Columbusstraße, 27568 Bremerhaven, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681327</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Antactic fjords</Keyword>
<Keyword MajorTopicYN="N">Antarctica</Keyword>
<Keyword MajorTopicYN="N">Ascidians</Keyword>
<Keyword MajorTopicYN="N">Benthic ecosystems</Keyword>
<Keyword MajorTopicYN="N">Filter feeders</Keyword>
<Keyword MajorTopicYN="N">Glacier retreat</Keyword>
<Keyword MajorTopicYN="N">Sedimentation</Keyword>
<Keyword MajorTopicYN="N">Sudden changes</Keyword>
<Keyword MajorTopicYN="N">Thresholds</Keyword>
<Keyword MajorTopicYN="N">climate change</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702430</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Three-dimensional graphene/Pt nanoparticle composites as freestanding anode for enhancing performance of microbial fuel cells.</ArticleTitle>
<Pagination>
<MedlinePgn>e1500372</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1500372</ELocationID>
<Abstract>
<AbstractText>Microbial fuel cells (MFCs) are able to directly convert about 50 to 90% of energy from oxidation of organic matters in waste to electricity and have great potential application in broad fields such as wastewater treatment. Unfortunately, the power density of the MFCs at present is significantly lower than the theoretical value because of technical limitations including low bacteria loading capacity and difficult electron transfer between the bacteria and the electrode. We reported a three-dimensional (3D) graphene aerogel (GA) decorated with platinum nanoparticles (Pt NPs) as an efficient freestanding anode for MFCs. The 3D GA/Pt-based anode has a continuous 3D macroporous structure that is favorable for microorganism immobilization and efficient electrolyte transport. Moreover, GA scaffold is homogenously decorated with Pt NPs to further enhance extracellular charge transfer between the bacteria and the anode. The MFCs constructed with 3D GA/Pt-based anode generate a remarkable maximum power density of 1460 mW/m(2), 5.3 times higher than that based on carbon cloth (273 mW/m(2)). It deserves to be stressed that 1460 mW/m(2) obtained from the GA/Pt anode shows the superior performance among all the reported MFCs inoculated with Shewanella oneidensis MR-1. Moreover, as a demonstration of the real application, the MFC equipped with the freestanding GA/Pt anode has been successfully applied in driving timer for the first time, which opens the avenue toward the real application of the MFCs. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zhao</LastName>
<ForeName>Shenlong</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>State Key Laboratory of Urban Water Resource and Environment (Harbin Institute of Technology), Harbin 150080, China. ; School of Materials Science and Engineering, Harbin Institute of Technology, Harbin 150080, China. ; CAS Key Laboratory of Nanosystem and Hierarchical Fabrication, National Center for Nanoscience and Technology, Beijing 100190, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Yuchen</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>State Key Laboratory of Urban Water Resource and Environment (Harbin Institute of Technology), Harbin 150080, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yin</LastName>
<ForeName>Huajie</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>CAS Key Laboratory of Nanosystem and Hierarchical Fabrication, National Center for Nanoscience and Technology, Beijing 100190, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Zhouzhou</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>State Key Laboratory of Urban Water Resource and Environment (Harbin Institute of Technology), Harbin 150080, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Luan</LastName>
<ForeName>Enxiao</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>State Key Laboratory of Urban Water Resource and Environment (Harbin Institute of Technology), Harbin 150080, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhao</LastName>
<ForeName>Feng</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Key Laboratory of Urban Pollutant Conversion, Institute of Urban Environment, Chinese Academy of Sciences, Xiamen 361021, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tang</LastName>
<ForeName>Zhiyong</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>CAS Key Laboratory of Nanosystem and Hierarchical Fabrication, National Center for Nanoscience and Technology, Beijing 100190, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Shaoqin</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>State Key Laboratory of Urban Water Resource and Environment (Harbin Institute of Technology), Harbin 150080, China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681333</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Extracellular electron transfer</Keyword>
<Keyword MajorTopicYN="N">Graphene</Keyword>
<Keyword MajorTopicYN="N">Microbial fuel cell</Keyword>
<Keyword MajorTopicYN="N">Porous structure</Keyword>
<Keyword MajorTopicYN="N">Three-dimensional electrode</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702431</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Systemic trade risk of critical resources.</ArticleTitle>
<Pagination>
<MedlinePgn>e1500522</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1500522</ELocationID>
<Abstract>
<AbstractText>In the wake of the 2008 financial crisis, the role of strongly interconnected markets in causing systemic instability has been increasingly acknowledged. Trade networks of commodities are susceptible to cascades of supply shocks that increase systemic trade risks and pose a threat to geopolitical stability. We show that supply risk, scarcity, and price volatility of nonfuel mineral resources are intricately connected with the structure of the worldwide trade networks spanned by these resources. At the global level, we demonstrate that the scarcity of a resource is closely related to the susceptibility of the trade network with respect to cascading shocks. At the regional level, we find that, to some extent, region-specific price volatility and supply risk can be understood by centrality measures that capture systemic trade risk. The resources associated with the highest systemic trade risk indicators are often those that are produced as by-products of major metals. We identify significant strategic shortcomings in the management of systemic trade risk, in particular in the European Union. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Klimek</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Section for Science of Complex Systems, Medical University of Vienna, Spitalgasse 23, Vienna A-1090, Austria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Obersteiner</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<Identifier Source="ORCID">0000-0001-6981-2769</Identifier>
<AffiliationInfo>
<Affiliation>International Institute for Applied Systems Analysis, Schlossplatz 1, Laxenburg A 2361, Austria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thurner</LastName>
<ForeName>Stefan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Section for Science of Complex Systems, Medical University of Vienna, Spitalgasse 23, Vienna A-1090, Austria. ; International Institute for Applied Systems Analysis, Schlossplatz 1, Laxenburg A 2361, Austria. ; Santa Fe Institute, 1399 Hyde Park Road, Santa Fe, NM 87501, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681334</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">critical resources</Keyword>
<Keyword MajorTopicYN="N">network effects</Keyword>
<Keyword MajorTopicYN="N">non-fuel mineral resources</Keyword>
<Keyword MajorTopicYN="N">systemic risk</Keyword>
<Keyword MajorTopicYN="N">trade risk</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702432</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Does the mismatch negativity operate on a consciously accessible memory trace?</ArticleTitle>
<Pagination>
<MedlinePgn>e1500677</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1500677</ELocationID>
<Abstract>
<AbstractText>The extent to which the contents of short-term memory are consciously accessible is a fundamental question of cognitive science. In audition, short-term memory is often studied via the mismatch negativity (MMN), a change-related component of the auditory evoked response that is elicited by violations of otherwise regular stimulus sequences. The prevailing functional view of the MMN is that it operates on preattentive and even preconscious stimulus representations. We directly examined the preconscious notion of the MMN using informational masking and magnetoencephalography. Spectrally isolated and otherwise suprathreshold auditory oddball sequences were occasionally random rendered inaudible by embedding them in random multitone masker "clouds." Despite identical stimulation/task contexts and a clear representation of all stimuli in auditory cortex, MMN was only observed when the preceding regularity (that is, the standard stream) was consciously perceived. The results call into question the preconscious interpretation of MMN and raise the possibility that it might index partial awareness in the absence of overt behavior. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dykstra</LastName>
<ForeName>Andrew R</ForeName>
<Initials>AR</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Ruprecht-Karls-Universität Heidelberg, 69120 Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gutschalk</LastName>
<ForeName>Alexander</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Ruprecht-Karls-Universität Heidelberg, 69120 Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681331</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">ERF</Keyword>
<Keyword MajorTopicYN="N">ERP</Keyword>
<Keyword MajorTopicYN="N">Perception</Keyword>
<Keyword MajorTopicYN="N">auditory cortex</Keyword>
<Keyword MajorTopicYN="N">awareness</Keyword>
<Keyword MajorTopicYN="N">consciousness</Keyword>
<Keyword MajorTopicYN="N">magnetoencephalography</Keyword>
<Keyword MajorTopicYN="N">mismatch negativity</Keyword>
<Keyword MajorTopicYN="N">short-term memory</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702435</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance.</ArticleTitle>
<Pagination>
<MedlinePgn>e1500723</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1500723</ELocationID>
<Abstract>
<AbstractText>Mammalian SWI/SNF [also called Brg/Brahma-associated factors (BAFs)] are evolutionarily conserved chromatin-remodeling complexes regulating gene transcription programs during development and stem cell differentiation. BAF complexes contain an ATP (adenosine 5'-triphosphate)-driven remodeling enzyme (either BRG1 or BRM) and multiple protein interaction domains including bromodomains, an evolutionary conserved acetyl lysine-dependent protein interaction motif that recruits transcriptional regulators to acetylated chromatin. We report a potent and cell active protein interaction inhibitor, PFI-3, that selectively binds to essential BAF bromodomains. The high specificity of PFI-3 was achieved on the basis of a novel binding mode of a salicylic acid head group that led to the replacement of water molecules typically maintained in other bromodomain inhibitor complexes. We show that exposure of embryonic stem cells to PFI-3 led to deprivation of stemness and deregulated lineage specification. Furthermore, differentiation of trophoblast stem cells in the presence of PFI-3 was markedly enhanced. The data present a key function of BAF bromodomains in stem cell maintenance and differentiation, introducing a novel versatile chemical probe for studies on acetylation-dependent cellular processes controlled by BAF remodeling complexes. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Fedorov</LastName>
<ForeName>Oleg</ForeName>
<Initials>O</Initials>
<Identifier Source="ORCID">0000-0002-8662-7300</Identifier>
<AffiliationInfo>
<Affiliation>Target Discovery Institute, University of Oxford, NDM Research Building, Roosevelt Drive, Oxford OX3 7FZ, UK. ; Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Castex</LastName>
<ForeName>Josefina</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Urologische Klinik und Zentrale Klinische Forschung, Klinikum der Universität Freiburg, Breisacher Strasse 66, 79106 Freiburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tallant</LastName>
<ForeName>Cynthia</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Target Discovery Institute, University of Oxford, NDM Research Building, Roosevelt Drive, Oxford OX3 7FZ, UK. ; Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Owen</LastName>
<ForeName>Dafydd R</ForeName>
<Initials>DR</Initials>
<AffiliationInfo>
<Affiliation>Pfizer Worldwide Medicinal Chemistry, 610 Main Street, Cambridge, MA 02139, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Martin</LastName>
<ForeName>Sarah</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Target Discovery Institute, University of Oxford, NDM Research Building, Roosevelt Drive, Oxford OX3 7FZ, UK. ; Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aldeghi</LastName>
<ForeName>Matteo</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Target Discovery Institute, University of Oxford, NDM Research Building, Roosevelt Drive, Oxford OX3 7FZ, UK. ; Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Monteiro</LastName>
<ForeName>Octovia</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Target Discovery Institute, University of Oxford, NDM Research Building, Roosevelt Drive, Oxford OX3 7FZ, UK. ; Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Filippakopoulos</LastName>
<ForeName>Panagis</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK. ; Ludwig Institute for Cancer Research, University of Oxford, Oxford OX3 7DQ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Picaud</LastName>
<ForeName>Sarah</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Trzupek</LastName>
<ForeName>John D</ForeName>
<Initials>JD</Initials>
<Identifier Source="ORCID">0000-0002-9156-0374</Identifier>
<AffiliationInfo>
<Affiliation>Pfizer Worldwide Medicinal Chemistry, 610 Main Street, Cambridge, MA 02139, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gerstenberger</LastName>
<ForeName>Brian S</ForeName>
<Initials>BS</Initials>
<AffiliationInfo>
<Affiliation>Pfizer Worldwide Medicinal Chemistry, 610 Main Street, Cambridge, MA 02139, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bountra</LastName>
<ForeName>Chas</ForeName>
<Initials>C</Initials>
<Identifier Source="ORCID">0000-0001-6596-153X</Identifier>
<AffiliationInfo>
<Affiliation>Target Discovery Institute, University of Oxford, NDM Research Building, Roosevelt Drive, Oxford OX3 7FZ, UK. ; Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Willmann</LastName>
<ForeName>Dominica</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Urologische Klinik und Zentrale Klinische Forschung, Klinikum der Universität Freiburg, Breisacher Strasse 66, 79106 Freiburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wells</LastName>
<ForeName>Christopher</ForeName>
<Initials>C</Initials>
<Identifier Source="ORCID">0000-0001-9985-9816</Identifier>
<AffiliationInfo>
<Affiliation>Target Discovery Institute, University of Oxford, NDM Research Building, Roosevelt Drive, Oxford OX3 7FZ, UK. ; Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Philpott</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Target Discovery Institute, University of Oxford, NDM Research Building, Roosevelt Drive, Oxford OX3 7FZ, UK. ; Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rogers</LastName>
<ForeName>Catherine</ForeName>
<Initials>C</Initials>
<Identifier Source="ORCID">0000-0001-7005-4459</Identifier>
<AffiliationInfo>
<Affiliation>Target Discovery Institute, University of Oxford, NDM Research Building, Roosevelt Drive, Oxford OX3 7FZ, UK. ; Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Biggin</LastName>
<ForeName>Philip C</ForeName>
<Initials>PC</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brennan</LastName>
<ForeName>Paul E</ForeName>
<Initials>PE</Initials>
<Identifier Source="ORCID">0000-0002-8950-7646</Identifier>
<AffiliationInfo>
<Affiliation>Target Discovery Institute, University of Oxford, NDM Research Building, Roosevelt Drive, Oxford OX3 7FZ, UK. ; Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bunnage</LastName>
<ForeName>Mark E</ForeName>
<Initials>ME</Initials>
<AffiliationInfo>
<Affiliation>Pfizer Worldwide Medicinal Chemistry, 610 Main Street, Cambridge, MA 02139, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schüle</LastName>
<ForeName>Roland</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Urologische Klinik und Zentrale Klinische Forschung, Klinikum der Universität Freiburg, Breisacher Strasse 66, 79106 Freiburg, Germany. ; Deutsches Konsortium für Translationale Krebsforschung, Standort Freiburg, 79106 Freiburg, Germany. ; Institute for Pharmaceutical Chemistry and Buchmann Institute for Molecular Life Sciences, Johann Wolfgang Goethe-University, Max-von-Laue-Str. 9, D-60438 Frankfurt am Main, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Günther</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Urologische Klinik und Zentrale Klinische Forschung, Klinikum der Universität Freiburg, Breisacher Strasse 66, 79106 Freiburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Knapp</LastName>
<ForeName>Stefan</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">0000-0002-0604-9185</Identifier>
<AffiliationInfo>
<Affiliation>Target Discovery Institute, University of Oxford, NDM Research Building, Roosevelt Drive, Oxford OX3 7FZ, UK. ; Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK. ; Institute for Pharmaceutical Chemistry and Buchmann Institute for Molecular Life Sciences, Johann Wolfgang Goethe-University, Max-von-Laue-Str. 9, D-60438 Frankfurt am Main, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Müller</LastName>
<ForeName>Susanne</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">0000-0003-2402-4157</Identifier>
<AffiliationInfo>
<Affiliation>Target Discovery Institute, University of Oxford, NDM Research Building, Roosevelt Drive, Oxford OX3 7FZ, UK. ; Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681344</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">BAF complex</Keyword>
<Keyword MajorTopicYN="N">BRG</Keyword>
<Keyword MajorTopicYN="N">BRM</Keyword>
<Keyword MajorTopicYN="N">PB1</Keyword>
<Keyword MajorTopicYN="N">chemical probe</Keyword>
<Keyword MajorTopicYN="N">chromatin remodelling,embryonic stem cells</Keyword>
<Keyword MajorTopicYN="N">epigenetics</Keyword>
<Keyword MajorTopicYN="N">trophoblast stem cells</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702441</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Multiferroicity and skyrmions carrying electric polarization in GaV4S8.</ArticleTitle>
<Pagination>
<MedlinePgn>e1500916</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1500916</ELocationID>
<Abstract>
<AbstractText>Skyrmions are whirl-like topological spin objects with high potential for future magnetic data storage. A fundamental question that is relevant to both basic research and application is whether ferroelectric (FE) polarization can be associated with skyrmions' magnetic texture and whether these objects can be manipulated by electric fields. We study the interplay between magnetism and electric polarization in the lacunar spinel GaV4S8, which undergoes a structural transition associated with orbital ordering at 44 K and reveals a complex magnetic phase diagram below 13 K, including ferromagnetic, cycloidal, and Néel-type skyrmion lattice (SkL) phases. We found that the orbitally ordered phase of GaV4S8 is FE with a sizable polarization of ~1 μC/cm(2). Moreover, we observed spin-driven excess polarizations in all magnetic phases; hence, GaV4S8 hosts three different multiferroic phases with coexisting polar and magnetic order. These include the SkL phase, where we predict a strong spatial modulation of FE polarization close to the skyrmion cores. By taking into account the crystal symmetry and spin patterns of the magnetically ordered phases, we identify exchange striction as the main microscopic mechanism behind the spin-driven FE polarization in each multiferroic phase. Because GaV4S8 is unique among known SkL host materials owing to its polar crystal structure and the observed strong magnetoelectric effect, this study is an important step toward the nondissipative electric field control of skyrmions. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ruff</LastName>
<ForeName>Eugen</ForeName>
<Initials>E</Initials>
<Identifier Source="ORCID">0000-0002-2208-0721</Identifier>
<AffiliationInfo>
<Affiliation>Experimental Physics V, Center for Electronic Correlations and Magnetism, University of Augsburg, Augsburg 86135, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Widmann</LastName>
<ForeName>Sebastian</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Experimental Physics V, Center for Electronic Correlations and Magnetism, University of Augsburg, Augsburg 86135, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lunkenheimer</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<Identifier Source="ORCID">0000-0002-4525-1394</Identifier>
<AffiliationInfo>
<Affiliation>Experimental Physics V, Center for Electronic Correlations and Magnetism, University of Augsburg, Augsburg 86135, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tsurkan</LastName>
<ForeName>Vladimir</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Experimental Physics V, Center for Electronic Correlations and Magnetism, University of Augsburg, Augsburg 86135, Germany. ; Institute of Applied Physics, Academy of Sciences of Moldova, Chisinau MD-2028, Republic of Moldova.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bordács</LastName>
<ForeName>Sandor</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Physics, Budapest University of Technology and Economics and MTA-BME Lendület Magneto-Optical Spectroscopy Research Group, Budapest 1111, Hungary.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kézsmárki</LastName>
<ForeName>Istvan</ForeName>
<Initials>I</Initials>
<Identifier Source="ORCID">0000-0003-4706-3247</Identifier>
<AffiliationInfo>
<Affiliation>Experimental Physics V, Center for Electronic Correlations and Magnetism, University of Augsburg, Augsburg 86135, Germany. ; Department of Physics, Budapest University of Technology and Economics and MTA-BME Lendület Magneto-Optical Spectroscopy Research Group, Budapest 1111, Hungary.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Loidl</LastName>
<ForeName>Alois</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Experimental Physics V, Center for Electronic Correlations and Magnetism, University of Augsburg, Augsburg 86135, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681337</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Orbital order</Keyword>
<Keyword MajorTopicYN="N">dielectric spectroscopy</Keyword>
<Keyword MajorTopicYN="N">ferroelectricity</Keyword>
<Keyword MajorTopicYN="N">lacunar spinel</Keyword>
<Keyword MajorTopicYN="N">multiferroic</Keyword>
<Keyword MajorTopicYN="N">skyrmions</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702446</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Experimental discovery of a topological Weyl semimetal state in TaP.</ArticleTitle>
<Pagination>
<MedlinePgn>e1501092</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1501092</ELocationID>
<Abstract>
<AbstractText>Weyl semimetals are expected to open up new horizons in physics and materials science because they provide the first realization of Weyl fermions and exhibit protected Fermi arc surface states. However, they had been found to be extremely rare in nature. Recently, a family of compounds, consisting of tantalum arsenide, tantalum phosphide (TaP), niobium arsenide, and niobium phosphide, was predicted as a Weyl semimetal candidates. We experimentally realize a Weyl semimetal state in TaP. Using photoemission spectroscopy, we directly observe the Weyl fermion cones and nodes in the bulk, and the Fermi arcs on the surface. Moreover, we find that the surface states show an unexpectedly rich structure, including both topological Fermi arcs and several topologically trivial closed contours in the vicinity of the Weyl points, which provides a promising platform to study the interplay between topological and trivial surface states on a Weyl semimetal's surface. We directly demonstrate the bulk-boundary correspondence and establish the topologically nontrivial nature of the Weyl semimetal state in TaP, by resolving the net number of chiral edge modes on a closed path that encloses the Weyl node. This also provides, for the first time, an experimentally practical approach to demonstrating a bulk Weyl fermion from a surface state dispersion measured in photoemission. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Xu</LastName>
<ForeName>Su-Yang</ForeName>
<Initials>SY</Initials>
<AffiliationInfo>
<Affiliation>Laboratory for Topological Quantum Matter and Spectroscopy (B7), Department of Physics, Princeton University, Princeton, NJ 08544, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Belopolski</LastName>
<ForeName>Ilya</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Laboratory for Topological Quantum Matter and Spectroscopy (B7), Department of Physics, Princeton University, Princeton, NJ 08544, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sanchez</LastName>
<ForeName>Daniel S</ForeName>
<Initials>DS</Initials>
<AffiliationInfo>
<Affiliation>Laboratory for Topological Quantum Matter and Spectroscopy (B7), Department of Physics, Princeton University, Princeton, NJ 08544, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Chenglong</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>International Center for Quantum Materials, School of Physics, Peking University, Beijing 100871, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chang</LastName>
<ForeName>Guoqing</ForeName>
<Initials>G</Initials>
<Identifier Source="ORCID">0000-0003-1180-3127</Identifier>
<AffiliationInfo>
<Affiliation>Centre for Advanced 2D Materials and Graphene Research Centre, National University of Singapore, 6 Science Drive 2, Singapore 117546, Singapore. ; Department of Physics, National University of Singapore, 2 Science Drive 3, Singapore 117542, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guo</LastName>
<ForeName>Cheng</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>International Center for Quantum Materials, School of Physics, Peking University, Beijing 100871, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bian</LastName>
<ForeName>Guang</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Laboratory for Topological Quantum Matter and Spectroscopy (B7), Department of Physics, Princeton University, Princeton, NJ 08544, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yuan</LastName>
<ForeName>Zhujun</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>International Center for Quantum Materials, School of Physics, Peking University, Beijing 100871, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lu</LastName>
<ForeName>Hong</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>International Center for Quantum Materials, School of Physics, Peking University, Beijing 100871, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chang</LastName>
<ForeName>Tay-Rong</ForeName>
<Initials>TR</Initials>
<Identifier Source="ORCID">0000-0003-1222-2527</Identifier>
<AffiliationInfo>
<Affiliation>Department of Physics, National Tsing Hua University, Hsinchu 30013, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shibayev</LastName>
<ForeName>Pavel P</ForeName>
<Initials>PP</Initials>
<Identifier Source="ORCID">0000-0002-7214-5706</Identifier>
<AffiliationInfo>
<Affiliation>Laboratory for Topological Quantum Matter and Spectroscopy (B7), Department of Physics, Princeton University, Princeton, NJ 08544, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Prokopovych</LastName>
<ForeName>Mykhailo L</ForeName>
<Initials>ML</Initials>
<AffiliationInfo>
<Affiliation>Swiss Light Source, Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alidoust</LastName>
<ForeName>Nasser</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Laboratory for Topological Quantum Matter and Spectroscopy (B7), Department of Physics, Princeton University, Princeton, NJ 08544, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zheng</LastName>
<ForeName>Hao</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Laboratory for Topological Quantum Matter and Spectroscopy (B7), Department of Physics, Princeton University, Princeton, NJ 08544, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Chi-Cheng</ForeName>
<Initials>CC</Initials>
<AffiliationInfo>
<Affiliation>Centre for Advanced 2D Materials and Graphene Research Centre, National University of Singapore, 6 Science Drive 2, Singapore 117546, Singapore. ; Department of Physics, National University of Singapore, 2 Science Drive 3, Singapore 117542, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Shin-Ming</ForeName>
<Initials>SM</Initials>
<Identifier Source="ORCID">0000-0003-4273-9682</Identifier>
<AffiliationInfo>
<Affiliation>Centre for Advanced 2D Materials and Graphene Research Centre, National University of Singapore, 6 Science Drive 2, Singapore 117546, Singapore. ; Department of Physics, National University of Singapore, 2 Science Drive 3, Singapore 117542, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sankar</LastName>
<ForeName>Raman</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Center for Condensed Matter Sciences, National Taiwan University, Taipei 10617, Taiwan. ; Institute of Physics, Academia Sinica, Nankang, Taipei 11529, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chou</LastName>
<ForeName>Fangcheng</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Center for Condensed Matter Sciences, National Taiwan University, Taipei 10617, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hsu</LastName>
<ForeName>Chuang-Han</ForeName>
<Initials>CH</Initials>
<Identifier Source="ORCID">0000-0002-2394-8537</Identifier>
<AffiliationInfo>
<Affiliation>Centre for Advanced 2D Materials and Graphene Research Centre, National University of Singapore, 6 Science Drive 2, Singapore 117546, Singapore. ; Department of Physics, National University of Singapore, 2 Science Drive 3, Singapore 117542, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jeng</LastName>
<ForeName>Horng-Tay</ForeName>
<Initials>HT</Initials>
<AffiliationInfo>
<Affiliation>Department of Physics, National Tsing Hua University, Hsinchu 30013, Taiwan. ; Institute of Physics, Academia Sinica, Nankang, Taipei 11529, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bansil</LastName>
<ForeName>Arun</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Physics, Northeastern University, Boston, MA 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Neupert</LastName>
<ForeName>Titus</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Princeton Center for Theoretical Science, Princeton University, Princeton, NJ 08544, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Strocov</LastName>
<ForeName>Vladimir N</ForeName>
<Initials>VN</Initials>
<AffiliationInfo>
<Affiliation>Swiss Light Source, Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lin</LastName>
<ForeName>Hsin</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Centre for Advanced 2D Materials and Graphene Research Centre, National University of Singapore, 6 Science Drive 2, Singapore 117546, Singapore. ; Department of Physics, National University of Singapore, 2 Science Drive 3, Singapore 117542, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jia</LastName>
<ForeName>Shuang</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>International Center for Quantum Materials, School of Physics, Peking University, Beijing 100871, China. ; Collaborative Innovation Center of Quantum Matter, Beijing 100871, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hasan</LastName>
<ForeName>M Zahid</ForeName>
<Initials>MZ</Initials>
<AffiliationInfo>
<Affiliation>Laboratory for Topological Quantum Matter and Spectroscopy (B7), Department of Physics, Princeton University, Princeton, NJ 08544, USA. ; Princeton Center for Complex Materials, Princeton Institute for the Science and Technology of Materials, Princeton University, Princeton, NJ 08544, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681326</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Fermi arc</Keyword>
<Keyword MajorTopicYN="N">Topological insulator</Keyword>
<Keyword MajorTopicYN="N">Topological physics</Keyword>
<Keyword MajorTopicYN="N">Weyl Fermion</Keyword>
<Keyword MajorTopicYN="N">Weyl semimetal</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702437</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Structural-functional connectivity deficits of neocortical circuits in the Fmr1 (-/y) mouse model of autism.</ArticleTitle>
<Pagination>
<MedlinePgn>e1500775</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1500775</ELocationID>
<Abstract>
<AbstractText>Fragile X syndrome (FXS), the most common inherited form of intellectual disability disorder and a frequent cause of autism spectrum disorder (ASD), is characterized by a high prevalence of sensory symptoms. Perturbations in the anatomical connectivity of neocortical circuits resulting in their functional defects have been hypothesized to contribute to the underlying etiology of these disorders. We tested this idea by probing alterations in the functional and structural connectivity of both local and long-ranging neocortical circuits in the Fmr1 (-/y) mouse model of FXS. To achieve this, we combined in vivo ultrahigh-field diffusion tensor magnetic resonance imaging (MRI), functional MRI, and viral tracing approaches in adult mice. Our results show an anatomical hyperconnectivity phenotype for the primary visual cortex (V1), but a disproportional low connectivity of V1 with other neocortical regions. These structural data are supported by defects in the structural integrity of the subcortical white matter in the anterior and posterior forebrain. These anatomical alterations might contribute to the observed functional decoupling across neocortical regions. We therefore identify FXS as a "connectopathy," providing a translational model for understanding sensory processing defects and functional decoupling of neocortical areas in FXS and ASD. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Haberl</LastName>
<ForeName>Matthias G</ForeName>
<Initials>MG</Initials>
<Identifier Source="ORCID">0000-0002-4961-7832</Identifier>
<AffiliationInfo>
<Affiliation>INSERM, Neurocentre Magendie, Physiopathologie de la plasticité neuronale, U862, 33077 Bordeaux, France. ; University of Bordeaux, Neurocentre Magendie, Physiopathologie de la plasticité neuronale, U862, 33076 Bordeaux, France. ; Institute of NeuroInformatics, University of Zurich, 8057 Zurich, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zerbi</LastName>
<ForeName>Valerio</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Biomedical MR Research Group, Department of Radiology and Nuclear Medicine, Radboud University Medical Center, 6500 Nijmegen, Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Veltien</LastName>
<ForeName>Andor</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Biomedical MR Research Group, Department of Radiology and Nuclear Medicine, Radboud University Medical Center, 6500 Nijmegen, Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ginger</LastName>
<ForeName>Melanie</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>INSERM, Neurocentre Magendie, Physiopathologie de la plasticité neuronale, U862, 33077 Bordeaux, France. ; University of Bordeaux, Neurocentre Magendie, Physiopathologie de la plasticité neuronale, U862, 33076 Bordeaux, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Heerschap</LastName>
<ForeName>Arend</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">0000-0001-9930-4562</Identifier>
<AffiliationInfo>
<Affiliation>Biomedical MR Research Group, Department of Radiology and Nuclear Medicine, Radboud University Medical Center, 6500 Nijmegen, Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Frick</LastName>
<ForeName>Andreas</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>INSERM, Neurocentre Magendie, Physiopathologie de la plasticité neuronale, U862, 33077 Bordeaux, France. ; University of Bordeaux, Neurocentre Magendie, Physiopathologie de la plasticité neuronale, U862, 33076 Bordeaux, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681325</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Autism</Keyword>
<Keyword MajorTopicYN="N">DTI</Keyword>
<Keyword MajorTopicYN="N">Fragile X Syndrome</Keyword>
<Keyword MajorTopicYN="N">biomarker</Keyword>
<Keyword MajorTopicYN="N">connectopathy</Keyword>
<Keyword MajorTopicYN="N">fMRI</Keyword>
<Keyword MajorTopicYN="N">functional connectivity</Keyword>
<Keyword MajorTopicYN="N">neocortex</Keyword>
<Keyword MajorTopicYN="N">retrograde tracing</Keyword>
<Keyword MajorTopicYN="N">structural connectivity</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702438</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Transient episodes of mild environmental oxygenation and oxidative continental weathering during the late Archean.</ArticleTitle>
<Pagination>
<MedlinePgn>e1500777</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1500777</ELocationID>
<Abstract>
<AbstractText>It is not known whether environmental O2 levels increased in a linear fashion or fluctuated dynamically between the evolution of oxygenic photosynthesis and the later Great Oxidation Event. New rhenium-osmium isotope data from the late Archean Mount McRae Shale, Western Australia, reveal a transient episode of oxidative continental weathering more than 50 million years before the onset of the Great Oxidation Event. A depositional age of 2495 ± 14 million years and an initial (187)Os/(188)Os of 0.34 ± 0.19 were obtained for rhenium- and molybdenum-rich black shales. The initial (187)Os/(188)Os is higher than the mantle/extraterrestrial value of 0.11, pointing to mild environmental oxygenation and oxidative mobilization of rhenium, molybdenum, and radiogenic osmium from the upper continental crust and to contemporaneous transport of these metals to seawater. By contrast, stratigraphically overlying black shales are rhenium- and molybdenum-poor and have a mantle-like initial (187)Os/(188)Os of 0.06 ± 0.09, indicating a reduced continental flux of rhenium, molybdenum, and osmium to seawater because of a drop in environmental O2 levels. Transient oxygenation events, like the one captured by the Mount McRae Shale, probably separated intervals of less oxygenated conditions during the late Archean. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kendall</LastName>
<ForeName>Brian</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Earth and Environmental Sciences, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Creaser</LastName>
<ForeName>Robert A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>Department of Earth and Atmospheric Sciences, University of Alberta, Edmonton, Alberta T6G 2E3, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Reinhard</LastName>
<ForeName>Christopher T</ForeName>
<Initials>CT</Initials>
<AffiliationInfo>
<Affiliation>School of Earth and Atmospheric Sciences, Georgia Institute of Technology, Atlanta, GA 30332, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lyons</LastName>
<ForeName>Timothy W</ForeName>
<Initials>TW</Initials>
<AffiliationInfo>
<Affiliation>Department of Earth Sciences, University of California, Riverside, Riverside, CA 92521, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Anbar</LastName>
<ForeName>Ariel D</ForeName>
<Initials>AD</Initials>
<AffiliationInfo>
<Affiliation>School of Earth and Space Exploration, Arizona State University, Tempe, AZ 85287, USA. ; Department of Chemistry and Biochemistry, Arizona State University, Tempe, AZ 85287, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681338</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Archean</Keyword>
<Keyword MajorTopicYN="N">Earth sciences</Keyword>
<Keyword MajorTopicYN="N">Geochronology</Keyword>
<Keyword MajorTopicYN="N">Hamersley Basin</Keyword>
<Keyword MajorTopicYN="N">Mount McRae Shale</Keyword>
<Keyword MajorTopicYN="N">atmospheric oxygen</Keyword>
<Keyword MajorTopicYN="N">molybdenum</Keyword>
<Keyword MajorTopicYN="N">osmium</Keyword>
<Keyword MajorTopicYN="N">oxidative continental weathering</Keyword>
<Keyword MajorTopicYN="N">rhenium</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702442</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Estimating the global conservation status of more than 15,000 Amazonian tree species.</ArticleTitle>
<Pagination>
<MedlinePgn>e1500936</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1500936</ELocationID>
<Abstract>
<AbstractText>Estimates of extinction risk for Amazonian plant and animal species are rare and not often incorporated into land-use policy and conservation planning. We overlay spatial distribution models with historical and projected deforestation to show that at least 36% and up to 57% of all Amazonian tree species are likely to qualify as globally threatened under International Union for Conservation of Nature (IUCN) Red List criteria. If confirmed, these results would increase the number of threatened plant species on Earth by 22%. We show that the trends observed in Amazonia apply to trees throughout the tropics, and we predict that most of the world's &gt;40,000 tropical tree species now qualify as globally threatened. A gap analysis suggests that existing Amazonian protected areas and indigenous territories will protect viable populations of most threatened species if these areas suffer no further degradation, highlighting the key roles that protected areas, indigenous peoples, and improved governance can play in preventing large-scale extinctions in the tropics in this century. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ter Steege</LastName>
<ForeName>Hans</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Biodiversity Dynamics, Naturalis Biodiversity Center, Darwin building, Darwinweg 4, Leiden 2300 AA, The Netherlands. ; Ecology and Biodiversity Group, Utrecht University, Padualaan 8, Utrecht, Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pitman</LastName>
<ForeName>Nigel C A</ForeName>
<Initials>NC</Initials>
<AffiliationInfo>
<Affiliation>Science and Education, The Field Museum, 1400 S. Lake Shore Drive, Chicago, IL 60605-2496, USA. ; Center for Tropical Conservation, Duke University, Nicholas School of the Environment, Durham, NC 27708, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Killeen</LastName>
<ForeName>Timothy J</ForeName>
<Initials>TJ</Initials>
<Identifier Source="ORCID">0000-0002-2711-1646</Identifier>
<AffiliationInfo>
<Affiliation>Agteca-Amazonica, Santa Cruz, Bolivia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Laurance</LastName>
<ForeName>William F</ForeName>
<Initials>WF</Initials>
<AffiliationInfo>
<Affiliation>Centre for Tropical Environmental and Sustainability Science, College of Marine and Environmental Sciences, James Cook University, Cairns, Queensland 4870, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peres</LastName>
<ForeName>Carlos A</ForeName>
<Initials>CA</Initials>
<AffiliationInfo>
<Affiliation>School of Environmental Sciences, University of East Anglia, Norwich NR4 7TJ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guevara</LastName>
<ForeName>Juan Ernesto</ForeName>
<Initials>JE</Initials>
<AffiliationInfo>
<Affiliation>Department of Integrative Biology, University of California, Berkeley, CA 94720-3140, USA. ; Museo Ecuatoriano de Ciencias Naturales, Av. Río Coca E6-115 e Isla Floreana, Quito, Ecuador.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Salomão</LastName>
<ForeName>Rafael P</ForeName>
<Initials>RP</Initials>
<Identifier Source="ORCID">0000-0003-0947-0132</Identifier>
<AffiliationInfo>
<Affiliation>Coordenação de Botânica, Museu Paraense Emilio Goeldi, Av. Magalhaes Barata 376, C.P. 399, Belém, PA 66040-170, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Castilho</LastName>
<ForeName>Carolina V</ForeName>
<Initials>CV</Initials>
<Identifier Source="ORCID">0000-0002-1064-2758</Identifier>
<AffiliationInfo>
<Affiliation>EMBRAPA - Centro de Pesquisa Agroflorestal de Roraima, BR 174, km 8 - Distrito Industrial, Boa Vista, RR 69301-970, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Amaral</LastName>
<ForeName>Iêda Leão</ForeName>
<Initials>IL</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Biodiversidade, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Almeida Matos</LastName>
<ForeName>Francisca Dionízia</ForeName>
<Initials>FD</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Biodiversidade, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Souza Coelho</LastName>
<ForeName>Luiz</ForeName>
<Initials>L</Initials>
<Identifier Source="ORCID">0000-0001-6710-7660</Identifier>
<AffiliationInfo>
<Affiliation>Coordenação de Biodiversidade, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Magnusson</LastName>
<ForeName>William E</ForeName>
<Initials>WE</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Pesquisas em Ecologia, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Phillips</LastName>
<ForeName>Oliver L</ForeName>
<Initials>OL</Initials>
<Identifier Source="ORCID">0000-0002-8993-6168</Identifier>
<AffiliationInfo>
<Affiliation>School of Geography, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Andrade Lima Filho</LastName>
<ForeName>Diogenes</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Biodiversidade, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Jesus Veiga Carim</LastName>
<ForeName>Marcelo</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Pesquisas Científicas e Tecnológicas do Amapá - IEPA, Av. Feliciano Coelho, 1509. Trem, Macapá, Amapá 68901-025, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Irume</LastName>
<ForeName>Mariana Victória</ForeName>
<Initials>MV</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Biodiversidade, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Martins</LastName>
<ForeName>Maria Pires</ForeName>
<Initials>MP</Initials>
<Identifier Source="ORCID">0000-0001-8094-1879</Identifier>
<AffiliationInfo>
<Affiliation>Coordenação de Biodiversidade, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Molino</LastName>
<ForeName>Jean-François</ForeName>
<Initials>JF</Initials>
<AffiliationInfo>
<Affiliation>UMR AMAP, Institut de Recherche pour le Développement (IRD), TA 40/PS2, Boulevard de la Lironde, Montpellier Cedex 5 34398, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sabatier</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
<Identifier Source="ORCID">0000-0003-0883-1530</Identifier>
<AffiliationInfo>
<Affiliation>UMR AMAP, Institut de Recherche pour le Développement (IRD), TA 40/PS2, Boulevard de la Lironde, Montpellier Cedex 5 34398, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wittmann</LastName>
<ForeName>Florian</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Biogeochemistry, Max Planck Institute for Chemistry, Hahn-Meitner Weg 1, Mainz 55128, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>López</LastName>
<ForeName>Dairon Cárdenas</ForeName>
<Initials>DC</Initials>
<AffiliationInfo>
<Affiliation>Herbario Amazónico Colombiano, Instituto SINCHI, Calle 20 No 5, Bogotá, DF 44, Colombia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>da Silva Guimarães</LastName>
<ForeName>José Renan</ForeName>
<Initials>JR</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Pesquisas Científicas e Tecnológicas do Amapá - IEPA, Av. Feliciano Coelho, 1509. Trem, Macapá, Amapá 68901-025, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mendoza</LastName>
<ForeName>Abel Monteagudo</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Jardín Botánico de Missouri, Oxapampa, Pasco, Peru.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vargas</LastName>
<ForeName>Percy Núñez</ForeName>
<Initials>PN</Initials>
<AffiliationInfo>
<Affiliation>Herbario Vargas, Universidad Nacional de San Antonio Abad del Cusco, Avenida de la Cultura, Nro 733, Cusco, Cuzco, Peru.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Manzatto</LastName>
<ForeName>Angelo Gilberto</ForeName>
<Initials>AG</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Biologia, Universidade Federal de Rondônia, Rodovia BR 364 s/n Km 9,5 - Sentido Acre, Unir, Porto Velho, Rondônia 76.824-027, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Reis</LastName>
<ForeName>Neidiane Farias Costa</ForeName>
<Initials>NF</Initials>
<Identifier Source="ORCID">0000-0003-2833-7126</Identifier>
<AffiliationInfo>
<Affiliation>Programa de Pós-Graduação em Desenvolvimento Regional e Meio Ambiente PGDRA, Universidade Federal de Rondônia, Rodovia BR 364 s/n Km 9,5 - Sentido Acre, Unir, Porto Velho, Rondônia 76.824-028, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Terborgh</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
<Identifier Source="ORCID">0000-0002-8238-4583</Identifier>
<AffiliationInfo>
<Affiliation>Center for Tropical Conservation, Duke University, Nicholas School of the Environment, Durham, NC 27708, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Casula</LastName>
<ForeName>Katia Regina</ForeName>
<Initials>KR</Initials>
<AffiliationInfo>
<Affiliation>Programa de Pós-Graduação em Desenvolvimento Regional e Meio Ambiente PGDRA, Universidade Federal de Rondônia, Rodovia BR 364 s/n Km 9,5 - Sentido Acre, Unir, Porto Velho, Rondônia 76.824-028, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Montero</LastName>
<ForeName>Juan Carlos</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Biodiversidade, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil. ; Instituto Boliviano de Investigacion Forestal, Universidad Autónoma Gabriel René Moreno, Km 9 Carretera al Norte, El Vallecito, FCA-UAGRM, Santa Cruz, Bolivia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Feldpausch</LastName>
<ForeName>Ted R</ForeName>
<Initials>TR</Initials>
<Identifier Source="ORCID">0000-0002-6631-7962</Identifier>
<AffiliationInfo>
<Affiliation>School of Geography, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, UK. ; College of Life and Environmental Sciences, University of Exeter, Exeter EX4 4RJ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Honorio Coronado</LastName>
<ForeName>Euridice N</ForeName>
<Initials>EN</Initials>
<Identifier Source="ORCID">0000-0003-2314-590X</Identifier>
<AffiliationInfo>
<Affiliation>School of Geography, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, UK. ; Instituto de Investigaciones de la Amazonía Peruana, Av. José A. Quiñones km. 2.5, Iquitos, Loreto, Peru.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Montoya</LastName>
<ForeName>Alvaro Javier Duque</ForeName>
<Initials>AJ</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Ciencias Forestales, Universidad Nacional de Colombia, Calle 64 x Cra 65, Medellín, Antioquia 1027, Colombia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zartman</LastName>
<ForeName>Charles Eugene</ForeName>
<Initials>CE</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Biodiversidade, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mostacedo</LastName>
<ForeName>Bonifacio</ForeName>
<Initials>B</Initials>
<Identifier Source="ORCID">0000-0001-8292-9611</Identifier>
<AffiliationInfo>
<Affiliation>Facultad de Ciencias Agrícolas, Universidad Autónoma Gabriel René Moreno, Santa Cruz, Bolivia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vasquez</LastName>
<ForeName>Rodolfo</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Jardín Botánico de Missouri, Oxapampa, Pasco, Peru.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Assis</LastName>
<ForeName>Rafael L</ForeName>
<Initials>RL</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Dinâmica Ambiental, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Medeiros</LastName>
<ForeName>Marcelo Brilhante</ForeName>
<Initials>MB</Initials>
<AffiliationInfo>
<Affiliation>Prédio da Botânica e Ecologia, Embrapa Recursos Genéticos e Biotecnologia, Parque Estaccao Biologica, Av. W5 Norte, Brasilia, DF 70770-917, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Simon</LastName>
<ForeName>Marcelo Fragomeni</ForeName>
<Initials>MF</Initials>
<AffiliationInfo>
<Affiliation>Prédio da Botânica e Ecologia, Embrapa Recursos Genéticos e Biotecnologia, Parque Estaccao Biologica, Av. W5 Norte, Brasilia, DF 70770-917, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Andrade</LastName>
<ForeName>Ana</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Projeto Dinâmica Biológica de Fragmentos Florestais, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Camargo</LastName>
<ForeName>José Luís</ForeName>
<Initials>JL</Initials>
<Identifier Source="ORCID">0000-0003-0370-9878</Identifier>
<AffiliationInfo>
<Affiliation>Projeto Dinâmica Biológica de Fragmentos Florestais, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Laurance</LastName>
<ForeName>Susan G W</ForeName>
<Initials>SG</Initials>
<AffiliationInfo>
<Affiliation>Centre for Tropical Environmental and Sustainability Science, College of Marine and Environmental Sciences, James Cook University, Cairns, Queensland 4870, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nascimento</LastName>
<ForeName>Henrique Eduardo Mendonça</ForeName>
<Initials>HE</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Biodiversidade, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marimon</LastName>
<ForeName>Beatriz S</ForeName>
<Initials>BS</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Ciências Biológicas, Universidade do Estado de Mato Grosso, Nova Xavantina, MT, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marimon</LastName>
<ForeName>Ben-Hur</ForeName>
<Initials>BH</Initials>
<Suffix>Jr</Suffix>
<AffiliationInfo>
<Affiliation>Departamento de Ciências Biológicas, Universidade do Estado de Mato Grosso, Nova Xavantina, MT, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Costa</LastName>
<ForeName>Flávia</ForeName>
<Initials>F</Initials>
<Identifier Source="ORCID">0000-0002-9600-4625</Identifier>
<AffiliationInfo>
<Affiliation>Coordenação de Pesquisas em Ecologia, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Targhetta</LastName>
<ForeName>Natalia</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Dinâmica Ambiental, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vieira</LastName>
<ForeName>Ima Célia Guimarães</ForeName>
<Initials>IC</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Botânica, Museu Paraense Emilio Goeldi, Av. Magalhaes Barata 376, C.P. 399, Belém, PA 66040-170, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brienen</LastName>
<ForeName>Roel</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>School of Geography, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Castellanos</LastName>
<ForeName>Hernán</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Universidad Nacional Experimental de Guayana, Calle Chile, urbaniz Chilemex, Puerto Ordaz, Bolivar, Venezuela.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Duivenvoorden</LastName>
<ForeName>Joost F</ForeName>
<Initials>JF</Initials>
<AffiliationInfo>
<Affiliation>Institute of Biodiversity and Ecosystem Dynamics, University of Amsterdam, Sciencepark 904, Amsterdam, Noord Holland 1098 XH, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mogollón</LastName>
<ForeName>Hugo F</ForeName>
<Initials>HF</Initials>
<Identifier Source="ORCID">0000-0002-4516-9462</Identifier>
<AffiliationInfo>
<Affiliation>Endangered Species Coalition, 8530 Geren Rd., Silver Spring, MD 20901, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Piedade</LastName>
<ForeName>Maria Teresa Fernandez</ForeName>
<Initials>MT</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Dinâmica Ambiental, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aymard C</LastName>
<ForeName>Gerardo A</ForeName>
<Initials>GA</Initials>
<AffiliationInfo>
<Affiliation>Programa de Ciencias del Agro y el Mar, Herbario Universitario (PORT), UNELLEZ-Guanare, Guanare, Portuguesa 3350, Venezuela.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Comiskey</LastName>
<ForeName>James A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>Inventory and Monitoring Program, National Park Service, 120 Chatham Lane, Fredericksburg, VA 22405, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Damasco</LastName>
<ForeName>Gabriel</ForeName>
<Initials>G</Initials>
<Identifier Source="ORCID">0000-0001-9768-520X</Identifier>
<AffiliationInfo>
<Affiliation>Department of Integrative Biology, University of California, Berkeley, CA 94720-3140, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dávila</LastName>
<ForeName>Nállarett</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Biologia Vegetal, Universidade Estadual de Campinas, Caixa Postal 6109, Campinas, SP 13.083-970, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>García-Villacorta</LastName>
<ForeName>Roosevelt</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Institute of Molecular Plant Sciences, University of Edinburgh, Mayfield Rd, Edinburgh EH3 5LR, UK. ; Royal Botanic Garden of Edinburgh, 20a Inverleith Row, Edinburgh EH3 5LR, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Diaz</LastName>
<ForeName>Pablo Roberto Stevenson</ForeName>
<Initials>PR</Initials>
<Identifier Source="ORCID">0000-0003-2394-447X</Identifier>
<AffiliationInfo>
<Affiliation>Laboratorio de Ecología de Bosques Tropicales y Primatología, Universidad de los Andes, Bogotá, DF, Colombia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vincentini</LastName>
<ForeName>Alberto</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Pesquisas em Ecologia, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Emilio</LastName>
<ForeName>Thaise</ForeName>
<Initials>T</Initials>
<Identifier Source="ORCID">0000-0001-5415-1822</Identifier>
<AffiliationInfo>
<Affiliation>Coordenação de Pesquisas em Ecologia, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil. ; Comparative Plant and Fungal Biology, Royal Botanic Gardens, Kew, Richmond, Surrey TW9 3AB, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Levis</LastName>
<ForeName>Carolina</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Pesquisas em Ecologia, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil. ; Forest Ecology and Forest Management Group, University of Wageningen, Lumen, building no.100, Droevendaalsesteeg 3, Wageningen 6708 PB, Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schietti</LastName>
<ForeName>Juliana</ForeName>
<Initials>J</Initials>
<Identifier Source="ORCID">0000-0002-1687-4373</Identifier>
<AffiliationInfo>
<Affiliation>Coordenação de Pesquisas em Ecologia, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Souza</LastName>
<ForeName>Priscila</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Pesquisas em Ecologia, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alonso</LastName>
<ForeName>Alfonso</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Center for Conservation Education and Sustainability, Smithsonian Conservation Biology Institute, National Zoological Park, MRC 0705, Washington, DC 20013-7012, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dallmeier</LastName>
<ForeName>Francisco</ForeName>
<Initials>F</Initials>
<Identifier Source="ORCID">0000-0001-8240-1315</Identifier>
<AffiliationInfo>
<Affiliation>Center for Conservation Education and Sustainability, Smithsonian Conservation Biology Institute, National Zoological Park, MRC 0705, Washington, DC 20013-7012, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ferreira</LastName>
<ForeName>Leandro Valle</ForeName>
<Initials>LV</Initials>
<Identifier Source="ORCID">0000-0001-9674-0238</Identifier>
<AffiliationInfo>
<Affiliation>Coordenação de Botânica, Museu Paraense Emilio Goeldi, Av. Magalhaes Barata 376, C.P. 399, Belém, PA 66040-170, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Neill</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Ecosistemas, Biodiversidad y Conservación de Especies, Universidad Estatal Amazónica, Km. 2 1/2 vía a Tena (Paso Lateral), Puyo, Pastaza, Ecuador.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Araujo-Murakami</LastName>
<ForeName>Alejandro</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Museo de Historia Natural Noel Kempff Mercado, Universidad Autónoma Gabriel Rene Moreno, Avenida Irala 565 Casilla Post al 2489, Santa Cruz, Bolivia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arroyo</LastName>
<ForeName>Luzmila</ForeName>
<Initials>L</Initials>
<Identifier Source="ORCID">0000-0003-2203-2882</Identifier>
<AffiliationInfo>
<Affiliation>Museo de Historia Natural Noel Kempff Mercado, Universidad Autónoma Gabriel Rene Moreno, Avenida Irala 565 Casilla Post al 2489, Santa Cruz, Bolivia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Carvalho</LastName>
<ForeName>Fernanda Antunes</ForeName>
<Initials>FA</Initials>
<Identifier Source="ORCID">0000-0002-3485-0797</Identifier>
<AffiliationInfo>
<Affiliation>Coordenação de Pesquisas em Ecologia, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Souza</LastName>
<ForeName>Fernanda Coelho</ForeName>
<Initials>FC</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Pesquisas em Ecologia, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>do Amaral</LastName>
<ForeName>Dário Dantas</ForeName>
<Initials>DD</Initials>
<Identifier Source="ORCID">0000-0002-3546-5719</Identifier>
<AffiliationInfo>
<Affiliation>Coordenação de Botânica, Museu Paraense Emilio Goeldi, Av. Magalhaes Barata 376, C.P. 399, Belém, PA 66040-170, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gribel</LastName>
<ForeName>Rogerio</ForeName>
<Initials>R</Initials>
<Identifier Source="ORCID">0000-0002-0850-5578</Identifier>
<AffiliationInfo>
<Affiliation>Diretoria de Pesquisas Científicas, Instituto de Pesquisas Jardim Botânico do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Luize</LastName>
<ForeName>Bruno Garcia</ForeName>
<Initials>BG</Initials>
<Identifier Source="ORCID">0000-0002-8384-8386</Identifier>
<AffiliationInfo>
<Affiliation>Coordenação de Tecnologia e Inovação, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pansonato</LastName>
<ForeName>Marcelo Petrati</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Pesquisas em Ecologia, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Venticinque</LastName>
<ForeName>Eduardo</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Centro de Biociências, Departamento de Ecologia, Universidade Federal do Rio Grande do Norte - UFRN, Campus Universitário - Lagoa Nova, Natal, RN 59072-970, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fine</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Integrative Biology, University of California, Berkeley, CA 94720-3140, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Toledo</LastName>
<ForeName>Marisol</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Instituto Boliviano de Investigacion Forestal, Universidad Autónoma Gabriel René Moreno, Km 9 Carretera al Norte, El Vallecito, FCA-UAGRM, Santa Cruz, Bolivia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baraloto</LastName>
<ForeName>Chris</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>UMR Ecologie des Forêts de Guyane, Institut National de la Recherche Agronomique (INRA), Campus agronomique, Kourou Cedex 97379, French Guiana. ; International Center for Tropical Botany (ICTB), Florida International University, 11200 SW 8th Street, OE 167, Miami, FL 33199, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cerón</LastName>
<ForeName>Carlos</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Escuela de Biología Herbario Alfredo Paredes, Universidad Central, Ap. Postal 17.01.2177, Quito, Pichincha, Ecuador.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Engel</LastName>
<ForeName>Julien</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>UMR Ecologie des Forêts de Guyane, CNRS, Kourou Cedex, French Guiana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Henkel</LastName>
<ForeName>Terry W</ForeName>
<Initials>TW</Initials>
<AffiliationInfo>
<Affiliation>Department of Biological Sciences, Humboldt State University, 1 Harpst Street, Arcata, CA 95521, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jimenez</LastName>
<ForeName>Eliana M</ForeName>
<Initials>EM</Initials>
<Identifier Source="ORCID">0000-0002-8610-1771</Identifier>
<AffiliationInfo>
<Affiliation>Grupo de Ecología de Ecosistemas Terrestres Tropicales, Universidad Nacional de Colombia Sede Amazonía, Leticia, Amazonas, Colombia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maas</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Taxonomy and Systematics, Naturalis Biodiversity Center, Darwin building, Darwinweg 4, Leiden 2300 AA, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mora</LastName>
<ForeName>Maria Cristina Peñuela</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>Universidad Regional Amazónica IKIAM, Km 7 via Muyuna, Tena, Napo, Ecuador.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Petronelli</LastName>
<ForeName>Pascal</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>UMR Ecologie des Forêts de Guyane, Institut National de la Recherche Agronomique (INRA), Campus agronomique, Kourou Cedex 97379, French Guiana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Revilla</LastName>
<ForeName>Juan David Cardenas</ForeName>
<Initials>JD</Initials>
<Identifier Source="ORCID">0000-0002-8277-5023</Identifier>
<AffiliationInfo>
<Affiliation>Coordenação de Biodiversidade, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Silveira</LastName>
<ForeName>Marcos</ForeName>
<Initials>M</Initials>
<Identifier Source="ORCID">0000-0003-0485-7872</Identifier>
<AffiliationInfo>
<Affiliation>Museu Universitário, Universidade Federal do Acre, Rio Branco, AC 69915-559, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stropp</LastName>
<ForeName>Juliana</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Land Resource and Management Unit, Joint Research Centre of the European Commission, Via Enrico Fermi 2749, TP 440, Ispra, VA I-21027, Italy. ; Institute of Biological and Health Sciences, Federal University of Alagoas, Av. Lourival Melo Mota, s/n, Tabuleiro do Martins, Maceio, AL 57072-970, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thomas-Caesar</LastName>
<ForeName>Raquel</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Iwokrama International Programme for Rainforest Conservation, Georgetown, Guyana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baker</LastName>
<ForeName>Tim R</ForeName>
<Initials>TR</Initials>
<AffiliationInfo>
<Affiliation>School of Geography, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Daly</LastName>
<ForeName>Doug</ForeName>
<Initials>D</Initials>
<Identifier Source="ORCID">0000-0003-1205-9491</Identifier>
<AffiliationInfo>
<Affiliation>New York Botanical Garden, 2900 Southern Blvd, Bronx, New York, NY 10458-5126, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Paredes</LastName>
<ForeName>Marcos Ríos</ForeName>
<Initials>MR</Initials>
<AffiliationInfo>
<Affiliation>Servicios de Biodiversidad EIRL, Iquitos, Loreto, Peru.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>da Silva</LastName>
<ForeName>Naara Ferreira</ForeName>
<Initials>NF</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Dinâmica Ambiental, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fuentes</LastName>
<ForeName>Alfredo</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Herbario Nacional de Bolivia, Universitario UMSA, Casilla 10077 Correo Central, La Paz, Bolivia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jørgensen</LastName>
<ForeName>Peter Møller</ForeName>
<Initials>PM</Initials>
<Identifier Source="ORCID">0000-0002-8891-4493</Identifier>
<AffiliationInfo>
<Affiliation>Missouri Botanical Garden, P.O. Box 299, St. Louis, MO 63166-0299, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schöngart</LastName>
<ForeName>Jochen</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Biogeochemistry, Max Planck Institute for Chemistry, Hahn-Meitner Weg 1, Mainz 55128, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Silman</LastName>
<ForeName>Miles R</ForeName>
<Initials>MR</Initials>
<Identifier Source="ORCID">0000-0003-4152-2844</Identifier>
<AffiliationInfo>
<Affiliation>Biology Department and Center for Energy, Environment and Sustainability, Wake Forest University, 1834 Wake Forest Rd, Winston Salem, NC 27106, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arboleda</LastName>
<ForeName>Nicolás Castaño</ForeName>
<Initials>NC</Initials>
<Identifier Source="ORCID">0000-0003-2892-1074</Identifier>
<AffiliationInfo>
<Affiliation>Herbario Amazónico Colombiano, Instituto SINCHI, Calle 20 No 5, Bogotá, DF 44, Colombia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cintra</LastName>
<ForeName>Bruno Barçante Ladvocat</ForeName>
<Initials>BB</Initials>
<Identifier Source="ORCID">0000-0002-5116-2654</Identifier>
<AffiliationInfo>
<Affiliation>Coordenação de Dinâmica Ambiental, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Valverde</LastName>
<ForeName>Fernando Cornejo</ForeName>
<Initials>FC</Initials>
<AffiliationInfo>
<Affiliation>Andes to Amazon Biodiversity Program, Madre de Dios, Madre de Dios, Peru.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Di Fiore</LastName>
<ForeName>Anthony</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">0000-0001-8893-9052</Identifier>
<AffiliationInfo>
<Affiliation>Department of Anthropology, University of Texas at Austin, SAC 5.150, 2201 Speedway Stop C3200, Austin, TX 78712, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Phillips</LastName>
<ForeName>Juan Fernando</ForeName>
<Initials>JF</Initials>
<AffiliationInfo>
<Affiliation>Fundación Puerto Rastrojo, Cra 10 No. 24-76 Oficina 1201, Bogotá, DF, Colombia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van Andel</LastName>
<ForeName>Tinde R</ForeName>
<Initials>TR</Initials>
<Identifier Source="ORCID">0000-0002-4951-1894</Identifier>
<AffiliationInfo>
<Affiliation>Biodiversity Dynamics, Naturalis Biodiversity Center, Darwin building, Darwinweg 4, Leiden 2300 AA, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>von Hildebrand</LastName>
<ForeName>Patricio</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Fundación Estación de Biología, Cra 10 No. 24-76 Oficina 1201, Bogotá, DF, Colombia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barbosa</LastName>
<ForeName>Edelcilio Marques</ForeName>
<Initials>EM</Initials>
<Identifier Source="ORCID">0000-0003-1331-8563</Identifier>
<AffiliationInfo>
<Affiliation>Coordenação de Biodiversidade, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Matos Bonates</LastName>
<ForeName>Luiz Carlos</ForeName>
<Initials>LC</Initials>
<Identifier Source="ORCID">0000-0002-9421-6624</Identifier>
<AffiliationInfo>
<Affiliation>Coordenação de Biodiversidade, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Castro</LastName>
<ForeName>Deborah</ForeName>
<Initials>D</Initials>
<Identifier Source="ORCID">0000-0001-5234-2174</Identifier>
<AffiliationInfo>
<Affiliation>Coordenação de Dinâmica Ambiental, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Sousa Farias</LastName>
<ForeName>Emanuelle</ForeName>
<Initials>E</Initials>
<Identifier Source="ORCID">0000-0001-5949-877X</Identifier>
<AffiliationInfo>
<Affiliation>Laboratório de Ecologia de Doenças Transmissíveis da Amazônia (EDTA), Instituto Leônidas e Maria Deane, Fiocruz, Rua Terezina, 476, Adrianópolis, Manaus, AM 69057-070, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gonzales</LastName>
<ForeName>Therany</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>ACEER Foundation, Jirón Cusco N° 370, Puerto Maldonado, Madre de Dios, Peru.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guillaumet</LastName>
<ForeName>Jean-Louis</ForeName>
<Initials>JL</Initials>
<Identifier Source="ORCID">0000-0002-6297-7939</Identifier>
<AffiliationInfo>
<Affiliation>Departement EV, Muséum national d'histoire naturelle de Paris, 16 rue Buffon, Paris 75005, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hoffman</LastName>
<ForeName>Bruce</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Amazon Conservation Team, Doekhieweg Oost #24, Paramaribo, Suriname.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Malhi</LastName>
<ForeName>Yadvinder</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Environmental Change Institute, Oxford University Centre for the Environment, Dyson Perrins Building, South Parks Road, Oxford, England OX1 3QY, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Andrade Miranda</LastName>
<ForeName>Ires Paula</ForeName>
<Initials>IP</Initials>
<Identifier Source="ORCID">0000-0002-0414-2183</Identifier>
<AffiliationInfo>
<Affiliation>Coordenação de Biodiversidade, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Prieto</LastName>
<ForeName>Adriana</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">0000-0002-7140-6599</Identifier>
<AffiliationInfo>
<Affiliation>Instituto de Ciencias Naturales, UNAL, Universidad Nacional de Colombia, Apartado 7945, Bogotá, DF, Colombia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rudas</LastName>
<ForeName>Agustín</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Ciencias Naturales, UNAL, Universidad Nacional de Colombia, Apartado 7945, Bogotá, DF, Colombia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ruschell</LastName>
<ForeName>Ademir R</ForeName>
<Initials>AR</Initials>
<Identifier Source="ORCID">0000-0002-0352-5238</Identifier>
<AffiliationInfo>
<Affiliation>Embrapa Amazonia Oriental, Trav. Dr. Enéas Pinheiro s/n , Belém, PA, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Silva</LastName>
<ForeName>Natalino</ForeName>
<Initials>N</Initials>
<Identifier Source="ORCID">0000-0003-4068-2432</Identifier>
<AffiliationInfo>
<Affiliation>Universidade Federal Rural da Amazônia, Belém, PA, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vela</LastName>
<ForeName>César I A</ForeName>
<Initials>CI</Initials>
<Identifier Source="ORCID">0000-0001-7177-8352</Identifier>
<AffiliationInfo>
<Affiliation>Facultad de Ciencias Forestales y Medio Ambiente, Universidad Nacional de San Antonio Abad del Cusco, San Martín 451, Puerto Maldonado, Madre de Dios, Peru.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vos</LastName>
<ForeName>Vincent A</ForeName>
<Initials>VA</Initials>
<Identifier Source="ORCID">0000-0002-0388-8530</Identifier>
<AffiliationInfo>
<Affiliation>Universidad Autónoma del Beni, Riberalta, Beni, Bolivia. ; Regional Norte Amazónico, Centro de Investigación y Promoción del Campesinado, Riberalta, Beni, Bolivia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zent</LastName>
<ForeName>Eglée L</ForeName>
<Initials>EL</Initials>
<Identifier Source="ORCID">0000-0002-7475-7335</Identifier>
<AffiliationInfo>
<Affiliation>Laboratory of Human Ecology, Instituto Venezolano de Investigaciones Científicas - IVIC, Ado 20632, Caracas 1020A, Venezuela.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zent</LastName>
<ForeName>Stanford</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">0000-0002-5197-1638</Identifier>
<AffiliationInfo>
<Affiliation>Laboratory of Human Ecology, Instituto Venezolano de Investigaciones Científicas - IVIC, Ado 20632, Caracas 1020A, Venezuela.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cano</LastName>
<ForeName>Angela</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Laboratorio de Ecología de Bosques Tropicales y Primatología, Universidad de los Andes, Bogotá, DF, Colombia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nascimento</LastName>
<ForeName>Marcelo Trindade</ForeName>
<Initials>MT</Initials>
<Identifier Source="ORCID">0000-0003-4492-3344</Identifier>
<AffiliationInfo>
<Affiliation>Laboratório de Ciências Ambientais, Universidade Estadual do Norte Fluminense, Av. Alberto Lamego 2000, Campos dos Goyatacazes, RJ 28013-620, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Oliveira</LastName>
<ForeName>Alexandre A</ForeName>
<Initials>AA</Initials>
<Identifier Source="ORCID">0000-0001-5526-8109</Identifier>
<AffiliationInfo>
<Affiliation>Instituto de Biociências - Dept. Ecologia, Universidade de Sao Paulo - USP, Rua do Matão, Trav. 14, no. 321, Cidade Universitária, São Paulo, SP 05508-090, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ramirez-Angulo</LastName>
<ForeName>Hirma</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Investigaciones para el Desarrollo Forestal (INDEFOR), Universidad de los Andes, Conjunto Forestal, C.P. 5101, Mérida, Mérida, Venezuela.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ramos</LastName>
<ForeName>José Ferreira</ForeName>
<Initials>JF</Initials>
<Identifier Source="ORCID">0000-0002-1580-3370</Identifier>
<AffiliationInfo>
<Affiliation>Coordenação de Biodiversidade, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sierra</LastName>
<ForeName>Rodrigo</ForeName>
<Initials>R</Initials>
<Identifier Source="ORCID">0000-0002-4587-0566</Identifier>
<AffiliationInfo>
<Affiliation>GeoIS, El Día 369 y El Telégrafo, 3° Piso, Quito, Pichincha, Ecuador.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tirado</LastName>
<ForeName>Milton</ForeName>
<Initials>M</Initials>
<Identifier Source="ORCID">0000-0002-8189-8654</Identifier>
<AffiliationInfo>
<Affiliation>GeoIS, El Día 369 y El Telégrafo, 3° Piso, Quito, Pichincha, Ecuador.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Medina</LastName>
<ForeName>Maria Natalia Umaña</ForeName>
<Initials>MN</Initials>
<AffiliationInfo>
<Affiliation>Department of Biology, University of Maryland, College Park, MD 20742, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van der Heijden</LastName>
<ForeName>Geertje</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Biological Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI 53202, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Torre</LastName>
<ForeName>Emilio Vilanova</ForeName>
<Initials>EV</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Investigaciones para el Desarrollo Forestal (INDEFOR), Universidad de los Andes, Conjunto Forestal, C.P. 5101, Mérida, Mérida, Venezuela.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vriesendorp</LastName>
<ForeName>Corine</ForeName>
<Initials>C</Initials>
<Identifier Source="ORCID">0000-0003-2119-6797</Identifier>
<AffiliationInfo>
<Affiliation>Science and Education, The Field Museum, 1400 S. Lake Shore Drive, Chicago, IL 60605-2496, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Ophelia</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Environmental Science and Policy, Northern Arizona University, Flagstaff, AZ 86011, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Young</LastName>
<ForeName>Kenneth R</ForeName>
<Initials>KR</Initials>
<AffiliationInfo>
<Affiliation>Geography and the Environment, University of Texas at Austin, 305 E. 23rd Street, CLA building, Austin, TX 78712, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baider</LastName>
<ForeName>Claudia</ForeName>
<Initials>C</Initials>
<Identifier Source="ORCID">0000-0002-2203-2076</Identifier>
<AffiliationInfo>
<Affiliation>Instituto de Biociências - Dept. Ecologia, Universidade de Sao Paulo - USP, Rua do Matão, Trav. 14, no. 321, Cidade Universitária, São Paulo, SP 05508-090, Brazil. ; Agricultural Services, Ministry of Agro-Industry and Food Security, The Mauritius Herbarium, Reduit, Mauritius.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Balslev</LastName>
<ForeName>Henrik</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Bioscience, Aarhus University, Building 1540 Ny Munkegade, Aarhus C, Aarhus DK-8000, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Castro</LastName>
<ForeName>Natalia</ForeName>
<Initials>N</Initials>
<Identifier Source="ORCID">0000-0002-4789-2814</Identifier>
<AffiliationInfo>
<Affiliation>Coordenação de Dinâmica Ambiental, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Farfan-Rios</LastName>
<ForeName>William</ForeName>
<Initials>W</Initials>
<Identifier Source="ORCID">0000-0002-3196-0317</Identifier>
<AffiliationInfo>
<Affiliation>Biology Department and Center for Energy, Environment and Sustainability, Wake Forest University, 1834 Wake Forest Rd, Winston Salem, NC 27106, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ferreira</LastName>
<ForeName>Cid</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Coordenação de Biodiversidade, Instituto Nacional de Pesquisas da Amazônia - INPA, Av. André Araújo, 2936, Petrópolis, Manaus, AM 69060-001, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mendoza</LastName>
<ForeName>Casimiro</ForeName>
<Initials>C</Initials>
<Identifier Source="ORCID">2708-1975-2001-2009</Identifier>
<AffiliationInfo>
<Affiliation>FOMABO, Manejo Forestal en las Tierras Tropicales de Bolivia, Sacta, Cochabamba, Bolivia. ; Escuela de Ciencias Forestales (ESFOR), Universidad Mayor de San Simon (UMSS), Sacta, Cochabamba, Bolivia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mesones</LastName>
<ForeName>Italo</ForeName>
<Initials>I</Initials>
<Identifier Source="ORCID">0000-0001-7665-7015</Identifier>
<AffiliationInfo>
<Affiliation>Department of Integrative Biology, University of California, Berkeley, CA 94720-3140, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Torres-Lezama</LastName>
<ForeName>Armando</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Investigaciones para el Desarrollo Forestal (INDEFOR), Universidad de los Andes, Conjunto Forestal, C.P. 5101, Mérida, Mérida, Venezuela.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Giraldo</LastName>
<ForeName>Ligia Estela Urrego</ForeName>
<Initials>LE</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Ciencias Forestales, Universidad Nacional de Colombia, Calle 64 x Cra 65, Medellín, Antioquia 1027, Colombia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Villarroel</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Museo de Historia Natural Noel Kempff Mercado, Universidad Autónoma Gabriel Rene Moreno, Avenida Irala 565 Casilla Post al 2489, Santa Cruz, Bolivia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zagt</LastName>
<ForeName>Roderick</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Tropenbos International, Lawickse Allee 11 PO Box 232, Wageningen 6700 AE, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alexiades</LastName>
<ForeName>Miguel N</ForeName>
<Initials>MN</Initials>
<AffiliationInfo>
<Affiliation>School of Anthropology and Conservation, University of Kent, Marlowe Building, Canterbury, Kent CT2 7NR, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Garcia-Cabrera</LastName>
<ForeName>Karina</ForeName>
<Initials>K</Initials>
<Identifier Source="ORCID">0000-0001-8535-5086</Identifier>
<AffiliationInfo>
<Affiliation>Biology Department and Center for Energy, Environment and Sustainability, Wake Forest University, 1834 Wake Forest Rd, Winston Salem, NC 27106, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hernandez</LastName>
<ForeName>Lionel</ForeName>
<Initials>L</Initials>
<Identifier Source="ORCID">0000-0002-7279-1003</Identifier>
<AffiliationInfo>
<Affiliation>Centro de Investigaciones Ecológicas de Guayana, Universidad Nacional Experimental de Guayana, Calle Chile urbaniz Chilemex, Puerto Ordaz, Bolivar, Venezuela.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huamantupa-Chuquimaco</LastName>
<ForeName>Isau</ForeName>
<Initials>I</Initials>
<Identifier Source="ORCID">0000-0002-4153-5875</Identifier>
<AffiliationInfo>
<Affiliation>Herbario Vargas, Universidad Nacional de San Antonio Abad del Cusco, Avenida de la Cultura, Nro 733, Cusco, Cuzco, Peru.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Milliken</LastName>
<ForeName>William</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Comparative Plant and Fungal Biology, Royal Botanic Gardens, Kew, Richmond, Surrey TW9 3AE, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cuenca</LastName>
<ForeName>Walter Palacios</ForeName>
<Initials>WP</Initials>
<AffiliationInfo>
<Affiliation>Herbario Nacional del Ecuador, Universidad Técnica del Norte, Quito, Pichincha, Ecuador.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pansini</LastName>
<ForeName>Susamar</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Programa de Pós-Graduação em Desenvolvimento Regional e Meio Ambiente PGDRA, Universidade Federal de Rondônia, Rodovia BR 364 s/n Km 9,5 - Sentido Acre, Unir, Porto Velho, Rondônia 76.824-029, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pauletto</LastName>
<ForeName>Daniela</ForeName>
<Initials>D</Initials>
<Identifier Source="ORCID">0000-0003-1855-6077</Identifier>
<AffiliationInfo>
<Affiliation>Instituto de Biodiversidade e Floresta, Universidade Federal do Oeste do Pará, Rua Vera Paz, Campus Tapajós, Santarém, PA 68015-110, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arevalo</LastName>
<ForeName>Freddy Ramirez</ForeName>
<Initials>FR</Initials>
<Identifier Source="ORCID">0000-0003-2441-9984</Identifier>
<AffiliationInfo>
<Affiliation>Facultad de Biologia, Universidad Nacional de la Amazonia Peruana, Pevas 5ta cdra, Iquitos, Peru.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sampaio</LastName>
<ForeName>Adeilza Felipe</ForeName>
<Initials>AF</Initials>
<Identifier Source="ORCID">0000-0002-9907-4741</Identifier>
<AffiliationInfo>
<Affiliation>Programa de Pós-Graduação em Desenvolvimento Regional e Meio Ambiente PGDRA, Universidade Federal de Rondônia, Rodovia BR 364 s/n Km 9,5 - Sentido Acre, Unir, Porto Velho, Rondônia 76.824-029, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Valderrama Sandoval</LastName>
<ForeName>Elvis H</ForeName>
<Initials>EH</Initials>
<Identifier Source="ORCID">0000-0001-7587-1941</Identifier>
<AffiliationInfo>
<Affiliation>Facultad de Biologia, Universidad Nacional de la Amazonia Peruana, Pevas 5ta cdra, Iquitos, Peru. ; Department of Biology, University of Missouri, St. Louis, MO 63121, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gamarra</LastName>
<ForeName>Luis Valenzuela</ForeName>
<Initials>LV</Initials>
<Identifier Source="ORCID">0000-0003-1447-8753</Identifier>
<AffiliationInfo>
<Affiliation>Jardín Botánico de Missouri, Oxapampa, Pasco, Peru.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681336</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Amazonia</Keyword>
<Keyword MajorTopicYN="N">Conservation</Keyword>
<Keyword MajorTopicYN="N">Deforestation</Keyword>
<Keyword MajorTopicYN="N">Indigenous areas</Keyword>
<Keyword MajorTopicYN="N">Protected areas</Keyword>
<Keyword MajorTopicYN="N">Tree species</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702443</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Mechanism of strength reduction along the graphenization pathway.</ArticleTitle>
<Pagination>
<MedlinePgn>e1501009</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1501009</ELocationID>
<Abstract>
<AbstractText>Even though polycrystalline graphene has shown a surprisingly high tensile strength, the influence of inherent grain boundaries on such property remains unclear. We study the fracture properties of a series of polycrystalline graphene models of increasing thermodynamic stability, as obtained from a long molecular dynamics simulation at an elevated temperature. All of the models show the typical and well-documented brittle fracture behavior of polycrystalline graphene; however, a clear decrease in all fracture properties is observed with increasing annealing time. The remarkably high fracture properties obtained for the most disordered (less annealed) structures arise from the formation of many nonpropagating prefracture cracks, significantly retarding failure. The stability of these reversible cracks is due to the nonlocal character of load transfer after a bond rupture in very disordered systems. It results in an insufficient strain level on neighboring bonds to promote fracture propagation. Although polycrystallinity seems to be an unavoidable feature of chemically synthesized graphenes, these results suggest that targeting highly disordered states might be a convenient way to obtain improved mechanical properties. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gamboa</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Laboratoire des Composites ThermoStructuraux, Université de Bordeaux, CNRS, Commissariat à l'énergie atomique et aux énergies alternatives, Herakles, Pessac 33600, France. ; Institut des Sciences Moléculaires, Université de Bordeaux, CNRS, Talence 33400, France. ; Centro de Investigaciones Químicas, Universidad Autónoma del Estado de Morelos, Cuernavaca, Mor 62209, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Farbos</LastName>
<ForeName>Baptiste</ForeName>
<Initials>B</Initials>
<Identifier Source="ORCID">0000-0001-5797-0946</Identifier>
<AffiliationInfo>
<Affiliation>Laboratoire des Composites ThermoStructuraux, Université de Bordeaux, CNRS, Commissariat à l'énergie atomique et aux énergies alternatives, Herakles, Pessac 33600, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aurel</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Institut des Sciences Moléculaires, Université de Bordeaux, CNRS, Talence 33400, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vignoles</LastName>
<ForeName>Gérard L</ForeName>
<Initials>GL</Initials>
<Identifier Source="ORCID">0000-0003-1606-6867</Identifier>
<AffiliationInfo>
<Affiliation>Laboratoire des Composites ThermoStructuraux, Université de Bordeaux, CNRS, Commissariat à l'énergie atomique et aux énergies alternatives, Herakles, Pessac 33600, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Leyssale</LastName>
<ForeName>Jean-Marc</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Laboratoire des Composites ThermoStructuraux, Université de Bordeaux, CNRS, Commissariat à l'énergie atomique et aux énergies alternatives, Herakles, Pessac 33600, France. ; MultiScale Material Science for Energy and Environment, Massachusetts Institute of Technology-CNRS, Cambridge, MA 02139, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681329</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">fracture</Keyword>
<Keyword MajorTopicYN="N">grain boundaries</Keyword>
<Keyword MajorTopicYN="N">molecular dynamics</Keyword>
<Keyword MajorTopicYN="N">polycrystalline graphene</Keyword>
<Keyword MajorTopicYN="N">strength</Keyword>
<Keyword MajorTopicYN="N">thermal annealing</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702444</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Quantum entanglement at ambient conditions in a macroscopic solid-state spin ensemble.</ArticleTitle>
<Pagination>
<MedlinePgn>e1501015</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1501015</ELocationID>
<Abstract>
<AbstractText>Entanglement is a key resource for quantum computers, quantum-communication networks, and high-precision sensors. Macroscopic spin ensembles have been historically important in the development of quantum algorithms for these prospective technologies and remain strong candidates for implementing them today. This strength derives from their long-lived quantum coherence, strong signal, and ability to couple collectively to external degrees of freedom. Nonetheless, preparing ensembles of genuinely entangled spin states has required high magnetic fields and cryogenic temperatures or photochemical reactions. We demonstrate that entanglement can be realized in solid-state spin ensembles at ambient conditions. We use hybrid registers comprising of electron-nuclear spin pairs that are localized at color-center defects in a commercial SiC wafer. We optically initialize 10(3) identical registers in a 40-μm(3) volume (with [Formula: see text] fidelity) and deterministically prepare them into the maximally entangled Bell states (with 0.88 ± 0.07 fidelity). To verify entanglement, we develop a register-specific quantum-state tomography protocol. The entanglement of a macroscopic solid-state spin ensemble at ambient conditions represents an important step toward practical quantum technology. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Klimov</LastName>
<ForeName>Paul V</ForeName>
<Initials>PV</Initials>
<AffiliationInfo>
<Affiliation>Institute for Molecular Engineering, University of Chicago, Chicago, IL 60637, USA. ; Department of Physics, University of California, Santa Barbara, CA 93106, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Falk</LastName>
<ForeName>Abram L</ForeName>
<Initials>AL</Initials>
<Identifier Source="ORCID">0000-0002-5531-2891</Identifier>
<AffiliationInfo>
<Affiliation>Institute for Molecular Engineering, University of Chicago, Chicago, IL 60637, USA. ; IBM T. J. Watson Research Center, 1101 Kitchawan Road, Yorktown Heights, NY 10598, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Christle</LastName>
<ForeName>David J</ForeName>
<Initials>DJ</Initials>
<Identifier Source="ORCID">0000-0001-9338-3335</Identifier>
<AffiliationInfo>
<Affiliation>Institute for Molecular Engineering, University of Chicago, Chicago, IL 60637, USA. ; Department of Physics, University of California, Santa Barbara, CA 93106, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dobrovitski</LastName>
<ForeName>Viatcheslav V</ForeName>
<Initials>VV</Initials>
<AffiliationInfo>
<Affiliation>Ames Laboratory and Iowa State University, Ames, IA 50011, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Awschalom</LastName>
<ForeName>David D</ForeName>
<Initials>DD</Initials>
<AffiliationInfo>
<Affiliation>Institute for Molecular Engineering, University of Chicago, Chicago, IL 60637, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681335</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">hybrid quantum systems</Keyword>
<Keyword MajorTopicYN="N">macroscopic quantum phenomena</Keyword>
<Keyword MajorTopicYN="N">nuclear spintronics</Keyword>
<Keyword MajorTopicYN="N">optically detected magnetic resonance</Keyword>
<Keyword MajorTopicYN="N">quantum entanglement</Keyword>
<Keyword MajorTopicYN="N">quantum information processing</Keyword>
<Keyword MajorTopicYN="N">quantum sensing</Keyword>
<Keyword MajorTopicYN="N">room-temperature quantum phenomena</Keyword>
<Keyword MajorTopicYN="N">spintronics</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702445</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Early genome duplications in conifers and other seed plants.</ArticleTitle>
<Pagination>
<MedlinePgn>e1501084</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1501084</ELocationID>
<Abstract>
<AbstractText>Polyploidy is a common mode of speciation and evolution in angiosperms (flowering plants). In contrast, there is little evidence to date that whole genome duplication (WGD) has played a significant role in the evolution of their putative extant sister lineage, the gymnosperms. Recent analyses of the spruce genome, the first published conifer genome, failed to detect evidence of WGDs in gene age distributions and attributed many aspects of conifer biology to a lack of WGDs. We present evidence for three ancient genome duplications during the evolution of gymnosperms, based on phylogenomic analyses of transcriptomes from 24 gymnosperms and 3 outgroups. We use a new algorithm to place these WGD events in phylogenetic context: two in the ancestry of major conifer clades (Pinaceae and cupressophyte conifers) and one in Welwitschia (Gnetales). We also confirm that a WGD hypothesized to be restricted to seed plants is indeed not shared with ferns and relatives (monilophytes), a result that was unclear in earlier studies. Contrary to previous genomic research that reported an absence of polyploidy in the ancestry of contemporary gymnosperms, our analyses indicate that polyploidy has contributed to the evolution of conifers and other gymnosperms. As in the flowering plants, the evolution of the large genome sizes of gymnosperms involved both polyploidy and repetitive element activity. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Zheng</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Department of Ecology and Evolutionary Biology, University of Arizona, Tucson, AZ 85721, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baniaga</LastName>
<ForeName>Anthony E</ForeName>
<Initials>AE</Initials>
<AffiliationInfo>
<Affiliation>Department of Ecology and Evolutionary Biology, University of Arizona, Tucson, AZ 85721, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sessa</LastName>
<ForeName>Emily B</ForeName>
<Initials>EB</Initials>
<AffiliationInfo>
<Affiliation>Department of Biology, University of Florida, Gainesville, FL 32611, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Scascitelli</LastName>
<ForeName>Moira</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Botany, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Graham</LastName>
<ForeName>Sean W</ForeName>
<Initials>SW</Initials>
<Identifier Source="ORCID">0000-0001-8209-5231</Identifier>
<AffiliationInfo>
<Affiliation>Department of Botany, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rieseberg</LastName>
<ForeName>Loren H</ForeName>
<Initials>LH</Initials>
<AffiliationInfo>
<Affiliation>Department of Botany, University of British Columbia, Vancouver, BC V6T 1Z4, Canada. ; Department of Biology, Indiana University, Bloomington, IN 47405, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barker</LastName>
<ForeName>Michael S</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>Department of Ecology and Evolutionary Biology, University of Arizona, Tucson, AZ 85721, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681332</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Phylogenomics</Keyword>
<Keyword MajorTopicYN="N">conifers</Keyword>
<Keyword MajorTopicYN="N">genome duplication</Keyword>
<Keyword MajorTopicYN="N">genome evolution</Keyword>
<Keyword MajorTopicYN="N">gymnosperms</Keyword>
<Keyword MajorTopicYN="N">plant evolution</Keyword>
<Keyword MajorTopicYN="N">polyploidy</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702448</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Electronic plants.</ArticleTitle>
<Pagination>
<MedlinePgn>e1501136</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1501136</ELocationID>
<Abstract>
<AbstractText>The roots, stems, leaves, and vascular circuitry of higher plants are responsible for conveying the chemical signals that regulate growth and functions. From a certain perspective, these features are analogous to the contacts, interconnections, devices, and wires of discrete and integrated electronic circuits. Although many attempts have been made to augment plant function with electroactive materials, plants' "circuitry" has never been directly merged with electronics. We report analog and digital organic electronic circuits and devices manufactured in living plants. The four key components of a circuit have been achieved using the xylem, leaves, veins, and signals of the plant as the template and integral part of the circuit elements and functions. With integrated and distributed electronics in plants, one can envisage a range of applications including precision recording and regulation of physiology, energy harvesting from photosynthesis, and alternatives to genetic modification for plant optimization. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Stavrinidou</LastName>
<ForeName>Eleni</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Organic Electronics, Department of Science and Technology, Linköping University, SE-601 74 Norrköping, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gabrielsson</LastName>
<ForeName>Roger</ForeName>
<Initials>R</Initials>
<Identifier Source="ORCID">0000-0002-9049-0829</Identifier>
<AffiliationInfo>
<Affiliation>Laboratory of Organic Electronics, Department of Science and Technology, Linköping University, SE-601 74 Norrköping, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gomez</LastName>
<ForeName>Eliot</ForeName>
<Initials>E</Initials>
<Identifier Source="ORCID">0000-0003-3341-7139</Identifier>
<AffiliationInfo>
<Affiliation>Laboratory of Organic Electronics, Department of Science and Technology, Linköping University, SE-601 74 Norrköping, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Crispin</LastName>
<ForeName>Xavier</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Organic Electronics, Department of Science and Technology, Linköping University, SE-601 74 Norrköping, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nilsson</LastName>
<ForeName>Ove</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Department of Forest Genetics and Plant Physiology, Swedish University of Agricultural Sciences, SE-901 87 Umeå, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Simon</LastName>
<ForeName>Daniel T</ForeName>
<Initials>DT</Initials>
<Identifier Source="ORCID">0000-0002-2799-3490</Identifier>
<AffiliationInfo>
<Affiliation>Laboratory of Organic Electronics, Department of Science and Technology, Linköping University, SE-601 74 Norrköping, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Berggren</LastName>
<ForeName>Magnus</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Organic Electronics, Department of Science and Technology, Linköping University, SE-601 74 Norrköping, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681328</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">conducting polymers</Keyword>
<Keyword MajorTopicYN="N">organic bioelectronics</Keyword>
<Keyword MajorTopicYN="N">plants</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702433</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Blue reflectance in tarantulas is evolutionarily conserved despite nanostructural diversity.</ArticleTitle>
<Pagination>
<MedlinePgn>e1500709</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1500709</ELocationID>
<Abstract>
<AbstractText>Slight shifts in arrangement within biological photonic nanostructures can produce large color differences, and sexual selection often leads to high color diversity in clades with structural colors. We use phylogenetic reconstruction, electron microscopy, spectrophotometry, and optical modeling to show an opposing pattern of nanostructural diversification accompanied by unusual conservation of blue color in tarantulas (Araneae: Theraphosidae). In contrast to other clades, blue coloration in phylogenetically distant tarantulas peaks within a narrow 20-nm region around 450 nm. Both quasi-ordered and multilayer nanostructures found in different tarantulas produce this blue color. Thus, even within monophyletic lineages, tarantulas have evolved strikingly similar blue coloration through divergent mechanisms. The poor color perception and lack of conspicuous display during courtship of tarantulas argue that these colors are not sexually selected. Therefore, our data contrast with sexual selection that typically produces a diverse array of colors with a single structural mechanism by showing that natural selection on structural color in tarantulas resulted in convergence on similar color through diverse structural mechanisms. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hsiung</LastName>
<ForeName>Bor-Kai</ForeName>
<Initials>BK</Initials>
<Identifier Source="ORCID">0000-0001-9657-3484</Identifier>
<AffiliationInfo>
<Affiliation>Department of Biology and Integrated Bioscience Program, The University of Akron, Akron, OH 44325-3908, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Deheyn</LastName>
<ForeName>Dimitri D</ForeName>
<Initials>DD</Initials>
<Identifier Source="ORCID">0000-0002-6496-9297</Identifier>
<AffiliationInfo>
<Affiliation>Scripps Institution of Oceanography, University of California, San Diego, La Jolla, CA 92093, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shawkey</LastName>
<ForeName>Matthew D</ForeName>
<Initials>MD</Initials>
<AffiliationInfo>
<Affiliation>Department of Biology and Integrated Bioscience Program, The University of Akron, Akron, OH 44325-3908, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Blackledge</LastName>
<ForeName>Todd A</ForeName>
<Initials>TA</Initials>
<AffiliationInfo>
<Affiliation>Department of Biology and Integrated Bioscience Program, The University of Akron, Akron, OH 44325-3908, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681340</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Natural selection</Keyword>
<Keyword MajorTopicYN="N">Sexual selection</Keyword>
<Keyword MajorTopicYN="N">Structural color</Keyword>
<Keyword MajorTopicYN="N">multilayer</Keyword>
<Keyword MajorTopicYN="N">non-iridescence</Keyword>
<Keyword MajorTopicYN="N">quasi-order</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702434</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Frost for the trees: Did climate increase erosion in unglaciated landscapes during the late Pleistocene?</ArticleTitle>
<Pagination>
<MedlinePgn>e1500715</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1500715</ELocationID>
<Abstract>
<AbstractText>Understanding climatic influences on the rates and mechanisms of landscape erosion is an unresolved problem in Earth science that is important for quantifying soil formation rates, sediment and solute fluxes to oceans, and atmospheric CO2 regulation by silicate weathering. Glaciated landscapes record the erosional legacy of glacial intervals through moraine deposits and U-shaped valleys, whereas more widespread unglaciated hillslopes and rivers lack obvious climate signatures, hampering mechanistic theory for how climate sets fluxes and form. Today, periglacial processes in high-elevation settings promote vigorous bedrock-to-regolith conversion and regolith transport, but the extent to which frost processes shaped vast swaths of low- to moderate-elevation terrain during past climate regimes is not well established. By combining a mechanistic frost weathering model with a regional Last Glacial Maximum (LGM) climate reconstruction derived from a paleo-Earth System Model, paleovegetation data, and a paleoerosion archive, we propose that frost-driven sediment production was pervasive during the LGM in our unglaciated Pacific Northwest study site, coincident with a 2.5 times increase in erosion relative to modern rates. Our findings provide a novel framework to quantify how climate modulates sediment production over glacial-interglacial cycles in mid-latitude unglaciated terrain. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Marshall</LastName>
<ForeName>Jill A</ForeName>
<Initials>JA</Initials>
<Identifier Source="ORCID">0000-0002-2388-2072</Identifier>
<AffiliationInfo>
<Affiliation>Department of Geological Sciences, University of Oregon, Eugene, OR 97403, USA. ; Department of Earth and Planetary Science, University of California, Berkeley, Berkeley, CA 94720, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Roering</LastName>
<ForeName>Joshua J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Geological Sciences, University of Oregon, Eugene, OR 97403, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bartlein</LastName>
<ForeName>Patrick J</ForeName>
<Initials>PJ</Initials>
<Identifier Source="ORCID">0000-0001-7657-5685</Identifier>
<AffiliationInfo>
<Affiliation>Department of Geography, University of Oregon, Eugene, OR 97403, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gavin</LastName>
<ForeName>Daniel G</ForeName>
<Initials>DG</Initials>
<Identifier Source="ORCID">0000-0001-8743-3949</Identifier>
<AffiliationInfo>
<Affiliation>Department of Geography, University of Oregon, Eugene, OR 97403, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Granger</LastName>
<ForeName>Darryl E</ForeName>
<Initials>DE</Initials>
<AffiliationInfo>
<Affiliation>Department of Earth, Atmospheric, and Planetary Sciences, Purdue University, West Lafayette, IN 47907, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rempel</LastName>
<ForeName>Alan W</ForeName>
<Initials>AW</Initials>
<Identifier Source="ORCID">0000-0001-6538-180X</Identifier>
<AffiliationInfo>
<Affiliation>Department of Geological Sciences, University of Oregon, Eugene, OR 97403, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Praskievicz</LastName>
<ForeName>Sarah J</ForeName>
<Initials>SJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Geography, University of Alabama, Tuscaloosa, AL 35487, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hales</LastName>
<ForeName>Tristram C</ForeName>
<Initials>TC</Initials>
<AffiliationInfo>
<Affiliation>School of Earth and Ocean Sciences, Cardiff University, Cardiff CF10 3AT, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681330</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Climate</Keyword>
<Keyword MajorTopicYN="N">LGM</Keyword>
<Keyword MajorTopicYN="N">Paleoclimate</Keyword>
<Keyword MajorTopicYN="N">erosion</Keyword>
<Keyword MajorTopicYN="N">frost processes</Keyword>
<Keyword MajorTopicYN="N">frost-cracking</Keyword>
<Keyword MajorTopicYN="N">geomorphology</Keyword>
<Keyword MajorTopicYN="N">soil production</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702436</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>The burrowing origin of modern snakes.</ArticleTitle>
<Pagination>
<MedlinePgn>e1500743</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1500743</ELocationID>
<Abstract>
<AbstractText>Modern snakes probably originated as habitat specialists, but it controversial unclear whether they were ancestrally terrestrial burrowers or marine swimmers. We used x-ray virtual models of the inner ear to predict the habit of Dinilysia patagonica, a stem snake closely related to the origin of modern snakes. Previous work has shown that modern snakes perceive substrate vibrations via their inner ear. Our data show that D. patagonica and modern burrowing squamates share a unique spherical vestibule in the inner ear, as compared with swimmers and habitat generalists. We built predictive models for snake habit based on their vestibular shape, which estimated D. patagonica and the hypothetical ancestor of crown snakes as burrowers with high probabilities. This study provides an extensive comparative data set to test fossoriality quantitatively in stem snakes, and it shows that burrowing was predominant in the lineages leading to modern crown snakes. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yi</LastName>
<ForeName>Hongyu</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>School of Geosciences, University of Edinburgh, James Hutton Road, Edinburgh EH9 3FE, UK. ; Division of Paleontology, American Museum of Natural History, Central Park West and 79th Street, New York, NY 10024, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Norell</LastName>
<ForeName>Mark A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Division of Paleontology, American Museum of Natural History, Central Park West and 79th Street, New York, NY 10024, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681343</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">HRCT</Keyword>
<Keyword MajorTopicYN="N">ancestral state reconstructions</Keyword>
<Keyword MajorTopicYN="N">bony labyrinth</Keyword>
<Keyword MajorTopicYN="N">crown snake origin</Keyword>
<Keyword MajorTopicYN="N">functional morphology</Keyword>
<Keyword MajorTopicYN="N">geometric morphometrics</Keyword>
<Keyword MajorTopicYN="N">inner ear</Keyword>
<Keyword MajorTopicYN="N">virtual model building</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702439</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Suspension feeding in the enigmatic Ediacaran organism Tribrachidium demonstrates complexity of Neoproterozoic ecosystems.</ArticleTitle>
<Pagination>
<MedlinePgn>e1500800</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1500800</ELocationID>
<Abstract>
<AbstractText>The first diverse and morphologically complex macroscopic communities appear in the late Ediacaran period, 575 to 541 million years ago (Ma). The enigmatic organisms that make up these communities are thought to have formed simple ecosystems characterized by a narrow range of feeding modes, with most restricted to the passive absorption of organic particles (osmotrophy). We test between competing feeding models for the iconic Ediacaran organism Tribrachidium heraldicum using computational fluid dynamics. We show that the external morphology of Tribrachidium passively directs water flow toward the apex of the organism and generates low-velocity eddies above apical "pits." These patterns of fluid flow are inconsistent with osmotrophy and instead support the interpretation of Tribrachidium as a passive suspension feeder. This finding provides the oldest empirical evidence for suspension feeding at 555 to 550 Ma, ~10 million years before the Cambrian explosion, and demonstrates that Ediacaran organisms formed more complex ecosystems in the latest Precambrian, involving a larger number of ecological guilds, than currently appreciated. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rahman</LastName>
<ForeName>Imran A</ForeName>
<Initials>IA</Initials>
<AffiliationInfo>
<Affiliation>School of Earth Sciences, University of Bristol, Life Sciences Building, 24 Tyndall Avenue, Bristol BS8 1TQ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Darroch</LastName>
<ForeName>Simon A F</ForeName>
<Initials>SA</Initials>
<AffiliationInfo>
<Affiliation>Smithsonian Institution, P. O. Box 37012, MRC 121, Washington, DC 20013-7012, USA. ; Department of Earth and Environmental Sciences, Vanderbilt University, 2301 Vanderbilt Place, Nashville, TN 37235-1805, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Racicot</LastName>
<ForeName>Rachel A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>Smithsonian Institution, P. O. Box 37012, MRC 121, Washington, DC 20013-7012, USA. ; The Dinosaur Institute, Natural History Museum of Los Angeles County, Los Angeles, CA 90007, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Laflamme</LastName>
<ForeName>Marc</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemical and Physical Sciences, University of Toronto Mississauga, 3359 Mississauga Road, Mississauga, Ontario L5L 1C6, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681345</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Ecology</Keyword>
<Keyword MajorTopicYN="N">Ediacara</Keyword>
<Keyword MajorTopicYN="N">computational fluid dynamics</Keyword>
<Keyword MajorTopicYN="N">ecosystem engineers</Keyword>
<Keyword MajorTopicYN="N">suspension feeding</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702440</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>High-energy density nonaqueous all redox flow lithium battery enabled with a polymeric membrane.</ArticleTitle>
<Pagination>
<MedlinePgn>e1500886</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1500886</ELocationID>
<Abstract>
<AbstractText>Redox flow batteries (RFBs) are considered one of the most promising large-scale energy storage technologies. However, conventional RFBs suffer from low energy density due to the low solubility of the active materials in electrolyte. On the basis of the redox targeting reactions of battery materials, the redox flow lithium battery (RFLB) demonstrated in this report presents a disruptive approach to drastically enhancing the energy density of flow batteries. With LiFePO4 and TiO2 as the cathodic and anodic Li storage materials, respectively, the tank energy density of RFLB could reach ~500 watt-hours per liter (50% porosity), which is 10 times higher than that of a vanadium redox flow battery. The cell exhibits good electrochemical performance under a prolonged cycling test. Our prototype RFLB full cell paves the way toward the development of a new generation of flow batteries for large-scale energy storage. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jia</LastName>
<ForeName>Chuankun</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Materials Science and Engineering, Faculty of Engineering, National University of Singapore, Singapore 117576, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pan</LastName>
<ForeName>Feng</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Materials Science and Engineering, Faculty of Engineering, National University of Singapore, Singapore 117576, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhu</LastName>
<ForeName>Yun Guang</ForeName>
<Initials>YG</Initials>
<AffiliationInfo>
<Affiliation>Department of Materials Science and Engineering, Faculty of Engineering, National University of Singapore, Singapore 117576, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Qizhao</ForeName>
<Initials>Q</Initials>
<Identifier Source="ORCID">0000-0002-3709-865X</Identifier>
<AffiliationInfo>
<Affiliation>Department of Materials Science and Engineering, Faculty of Engineering, National University of Singapore, Singapore 117576, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lu</LastName>
<ForeName>Li</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Mechanical Engineering, Faculty of Engineering, National University of Singapore, Singapore 117576, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Qing</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>Department of Materials Science and Engineering, Faculty of Engineering, National University of Singapore, Singapore 117576, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681342</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">lithium battery</Keyword>
<Keyword MajorTopicYN="N">membrane</Keyword>
<Keyword MajorTopicYN="N">non-aqueous flow battery</Keyword>
<Keyword MajorTopicYN="N">redox flow lithium battery</Keyword>
<Keyword MajorTopicYN="N">vanadium redox flow battery</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702447</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Energy-level alignment at organic heterointerfaces.</ArticleTitle>
<Pagination>
<MedlinePgn>e1501127</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1501127</ELocationID>
<Abstract>
<AbstractText>Today's champion organic (opto-)electronic devices comprise an ever-increasing number of different organic-semiconductor layers. The functionality of these complex heterostructures largely derives from the relative alignment of the frontier molecular-orbital energies in each layer with respect to those in all others. Despite the technological relevance of the energy-level alignment at organic heterointerfaces, and despite continued scientific interest, a reliable model that can quantitatively predict the full range of phenomena observed at such interfaces is notably absent. We identify the limitations of previous attempts to formulate such a model and highlight inconsistencies in the interpretation of the experimental data they were based on. We then develop a theoretical framework, which we demonstrate to accurately reproduce experiment. Applying this theory, a comprehensive overview of all possible energy-level alignment scenarios that can be encountered at organic heterojunctions is finally given. These results will help focus future efforts on developing functional organic interfaces for superior device performance. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Oehzelt</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Helmholtz-Zentrum Berlin für Materialien und Energie GmbH, Bereich Solarenergieforschung, Albert-Einstein-Straße 15, 12489 Berlin, Germany. ; Institut für Physik, Humboldt-Universität zu Berlin, Newtonstraße 15, 12489 Berlin, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Akaike</LastName>
<ForeName>Kouki</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Institut für Physik, Humboldt-Universität zu Berlin, Newtonstraße 15, 12489 Berlin, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Koch</LastName>
<ForeName>Norbert</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Helmholtz-Zentrum Berlin für Materialien und Energie GmbH, Bereich Solarenergieforschung, Albert-Einstein-Straße 15, 12489 Berlin, Germany. ; Institut für Physik, Humboldt-Universität zu Berlin, Newtonstraße 15, 12489 Berlin, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Heimel</LastName>
<ForeName>Georg</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Institut für Physik, Humboldt-Universität zu Berlin, Newtonstraße 15, 12489 Berlin, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681341</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">energy-level alignment</Keyword>
<Keyword MajorTopicYN="N">organic electronics</Keyword>
<Keyword MajorTopicYN="N">organic heterointerfaces</Keyword>
<Keyword MajorTopicYN="N">semi-clasical modeling</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702449</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Recurrent DNA virus domestication leading to different parasite virulence strategies.</ArticleTitle>
<Pagination>
<MedlinePgn>e1501150</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1501150</ELocationID>
<Abstract>
<AbstractText>Relics of ancient infections are abundant in eukaryote genomes, but little is known about how they evolve when they confer a functional benefit on their host. We show here, for the first time, that the virus-like particles shown to protect Venturia canescens eggs against host immunity are derived from a nudivirus genome incorporated by the parasitic wasp into its own genetic material. Nudivirus hijacking was also at the origin of protective particles from braconid wasps. However, we show here that the viral genes produce "liposomes" that wrap and deliver V. canescens virulence proteins, whereas the particles are used as gene transfer agents in braconid wasps. Our findings indicate that virus domestication has occurred repeatedly during parasitic wasp evolution but with different evolutionary trajectories after endogenization, resulting in different virulence molecule delivery strategies. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pichon</LastName>
<ForeName>Apolline</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Microorganism and Insect Diversity, Genomes, and Interactions (DGIMI) Laboratory, UMR 1333 INRA, Université de Montpellier, Place Eugène Bataillon, CC101, Montpellier Cedex 34095, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bézier</LastName>
<ForeName>Annie</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Institut de Recherche sur la Biologie de l'Insecte (IRBI), UMR 7261, CNRS-Université François Rabelais de Tours, Parc de Grandmont, Tours 37200, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Urbach</LastName>
<ForeName>Serge</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Functional Proteomics Platform, BioCampus Montpellier, UMS CNRS 3426, INSERM US009, Institut de Génomique Fonctionnelle, UMR CNRS 5203, INSERM U661, Université de Montpellier, Montpellier 34094, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aury</LastName>
<ForeName>Jean-Marc</ForeName>
<Initials>JM</Initials>
<Identifier Source="ORCID">0000-0003-1718-3010</Identifier>
<AffiliationInfo>
<Affiliation>Commissariat à l'Energie Atomique (CEA), Institut de Génomique (IG), Genoscope, 2 rue Gaston Crémieux, BP5706, Evry 91057, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jouan</LastName>
<ForeName>Véronique</ForeName>
<Initials>V</Initials>
<Identifier Source="ORCID">0000-0002-8146-2367</Identifier>
<AffiliationInfo>
<Affiliation>Microorganism and Insect Diversity, Genomes, and Interactions (DGIMI) Laboratory, UMR 1333 INRA, Université de Montpellier, Place Eugène Bataillon, CC101, Montpellier Cedex 34095, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ravallec</LastName>
<ForeName>Marc</ForeName>
<Initials>M</Initials>
<Identifier Source="ORCID">0000-0001-5782-8448</Identifier>
<AffiliationInfo>
<Affiliation>Microorganism and Insect Diversity, Genomes, and Interactions (DGIMI) Laboratory, UMR 1333 INRA, Université de Montpellier, Place Eugène Bataillon, CC101, Montpellier Cedex 34095, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guy</LastName>
<ForeName>Julie</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Commissariat à l'Energie Atomique (CEA), Institut de Génomique (IG), Genoscope, 2 rue Gaston Crémieux, BP5706, Evry 91057, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cousserans</LastName>
<ForeName>François</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Microorganism and Insect Diversity, Genomes, and Interactions (DGIMI) Laboratory, UMR 1333 INRA, Université de Montpellier, Place Eugène Bataillon, CC101, Montpellier Cedex 34095, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thézé</LastName>
<ForeName>Julien</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Institut de Recherche sur la Biologie de l'Insecte (IRBI), UMR 7261, CNRS-Université François Rabelais de Tours, Parc de Grandmont, Tours 37200, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gauthier</LastName>
<ForeName>Jérémy</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Institut de Recherche sur la Biologie de l'Insecte (IRBI), UMR 7261, CNRS-Université François Rabelais de Tours, Parc de Grandmont, Tours 37200, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Demettre</LastName>
<ForeName>Edith</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Functional Proteomics Platform, BioCampus Montpellier, UMS CNRS 3426, INSERM US009, Institut de Génomique Fonctionnelle, UMR CNRS 5203, INSERM U661, Université de Montpellier, Montpellier 34094, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schmieder</LastName>
<ForeName>Sandra</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">0000-0002-9723-4131</Identifier>
<AffiliationInfo>
<Affiliation>Institut Sophia Agrobiotech (ISA), UMR INRA 1355, CNRS 7254, Université Nice Sophia Antipolis, 400 route des Chappes, Sophia Antipolis 06903, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wurmser</LastName>
<ForeName>François</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>PPF Analyse des systèmes biologiques, Université François Rabelais de Tours, 3 Boulevard Tonnellé, Tours 37000, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sibut</LastName>
<ForeName>Vonick</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Institut de Recherche sur la Biologie de l'Insecte (IRBI), UMR 7261, CNRS-Université François Rabelais de Tours, Parc de Grandmont, Tours 37200, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Poirié</LastName>
<ForeName>Marylène</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institut Sophia Agrobiotech (ISA), UMR INRA 1355, CNRS 7254, Université Nice Sophia Antipolis, 400 route des Chappes, Sophia Antipolis 06903, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Colinet</LastName>
<ForeName>Dominique</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Institut Sophia Agrobiotech (ISA), UMR INRA 1355, CNRS 7254, Université Nice Sophia Antipolis, 400 route des Chappes, Sophia Antipolis 06903, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>da Silva</LastName>
<ForeName>Corinne</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Commissariat à l'Energie Atomique (CEA), Institut de Génomique (IG), Genoscope, 2 rue Gaston Crémieux, BP5706, Evry 91057, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Couloux</LastName>
<ForeName>Arnaud</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Commissariat à l'Energie Atomique (CEA), Institut de Génomique (IG), Genoscope, 2 rue Gaston Crémieux, BP5706, Evry 91057, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barbe</LastName>
<ForeName>Valérie</ForeName>
<Initials>V</Initials>
<Identifier Source="ORCID">0000-0002-8162-3343</Identifier>
<AffiliationInfo>
<Affiliation>Commissariat à l'Energie Atomique (CEA), Institut de Génomique (IG), Genoscope, 2 rue Gaston Crémieux, BP5706, Evry 91057, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Drezen</LastName>
<ForeName>Jean-Michel</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Institut de Recherche sur la Biologie de l'Insecte (IRBI), UMR 7261, CNRS-Université François Rabelais de Tours, Parc de Grandmont, Tours 37200, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Volkoff</LastName>
<ForeName>Anne-Nathalie</ForeName>
<Initials>AN</Initials>
<AffiliationInfo>
<Affiliation>Microorganism and Insect Diversity, Genomes, and Interactions (DGIMI) Laboratory, UMR 1333 INRA, Université de Montpellier, Place Eugène Bataillon, CC101, Montpellier Cedex 34095, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681339</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Microbiology</Keyword>
<Keyword MajorTopicYN="N">genomes</Keyword>
<Keyword MajorTopicYN="N">virus domestication</Keyword>
<Keyword MajorTopicYN="N">wasps</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702450</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2375-2548</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>1</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Science advances</Title>
<ISOAbbreviation>Sci Adv</ISOAbbreviation>
</Journal>
<ArticleTitle>Cellular defense against latent colonization foiled by human cytomegalovirus UL138 protein.</ArticleTitle>
<Pagination>
<MedlinePgn>e1501164</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.1501164</ELocationID>
<Abstract>
<AbstractText>Intrinsic immune defenses mediated by restriction factors inhibit productive viral infections. Select viruses rapidly establish latent infections and, with gene expression profiles that imply cell-autonomous intrinsic defenses, may be the most effective immune control measure against latent reservoirs. We illustrate that lysine-specific demethylases (KDMs) are restriction factors that prevent human cytomegalovirus from establishing latency by removing repressive epigenetic modifications from histones associated with the viral major immediate early promoter (MIEP), stimulating the expression of a viral lytic phase target of cell-mediated adaptive immunity. The viral UL138 protein negates this defense by preventing KDM association with the MIEP. The presence of an intrinsic defense against latency and the emergence of a cognate neutralizing viral factor indicate that "arms races" between hosts and viruses over lifelong colonization exist at the cellular level. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Song Hee</ForeName>
<Initials>SH</Initials>
<AffiliationInfo>
<Affiliation>Institute for Molecular Virology and McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53706, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Albright</LastName>
<ForeName>Emily R</ForeName>
<Initials>ER</Initials>
<AffiliationInfo>
<Affiliation>Institute for Molecular Virology and McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53706, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Jeong-Hee</ForeName>
<Initials>JH</Initials>
<AffiliationInfo>
<Affiliation>Institute for Molecular Virology and McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53706, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jacobs</LastName>
<ForeName>Derek</ForeName>
<Initials>D</Initials>
<Identifier Source="ORCID">0000-0003-0676-8064</Identifier>
<AffiliationInfo>
<Affiliation>Institute for Molecular Virology and McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53706, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kalejta</LastName>
<ForeName>Robert F</ForeName>
<Initials>RF</Initials>
<AffiliationInfo>
<Affiliation>Institute for Molecular Virology and McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53706, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Sci Adv</MedlineTA>
<NlmUniqueID>101653440</NlmUniqueID>
<ISSNLinking>2375-2548</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4681346</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Epigenetics</Keyword>
<Keyword MajorTopicYN="N">cytomegalovirus</Keyword>
<Keyword MajorTopicYN="N">herpes</Keyword>
<Keyword MajorTopicYN="N">restriction</Keyword>
<Keyword MajorTopicYN="N">transcription</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26702157</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0037-5675</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>56</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Singapore medical journal</Title>
<ISOAbbreviation>Singapore Med J</ISOAbbreviation>
</Journal>
<ArticleTitle>Importance of mental capacity: time for greater attention and action.</ArticleTitle>
<Pagination>
<MedlinePgn>646-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.11622/smedj.2015182</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ng</LastName>
<ForeName>Peng Soon</ForeName>
<Initials>PS</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, National Neuroscience Institute, Tan Tock Seng Campus, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ang</LastName>
<ForeName>Lye Poh Aaron</ForeName>
<Initials>LP</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychological Medicine, Tan Tock Seng Hospital, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kandiah</LastName>
<ForeName>Nagaendran</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, National Neuroscience Institute, Tan Tock Seng Campus, Singapore ; Duke-NUS Graduate Medical School, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Singapore</Country>
<MedlineTA>Singapore Med J</MedlineTA>
<NlmUniqueID>0404516</NlmUniqueID>
<ISSNLinking>0037-5675</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">PMC4678401</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26702158</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0037-5675</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>56</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Singapore medical journal</Title>
<ISOAbbreviation>Singapore Med J</ISOAbbreviation>
</Journal>
<ArticleTitle>Kisspeptin signalling and its roles in humans.</ArticleTitle>
<Pagination>
<MedlinePgn>649-56</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.11622/smedj.2015183</ELocationID>
<Abstract>
<AbstractText>Kisspeptins are a group of peptide fragments encoded by the KISS1 gene in humans. They bind to kisspeptin receptors with equal efficacy. Kisspeptins and their receptors are expressed by neurons in the arcuate and anteroventral periventricular nuclei of the hypothalamus. Oestrogen mediates negative feedback of gonadotrophin-releasing hormone secretion via the arcuate nucleus. Conversely, it exerts positive feedback via the anteroventral periventricular nucleus. The sexual dimorphism of these nuclei accounts for the differential behaviour of the hypothalamic-pituitary-gonadal axis between genders. Kisspeptins are essential for reproductive function. Puberty is regulated by the maturation of kisspeptin neurons and by interactions between kisspeptins and leptin. Hence, kisspeptins have potential diagnostic and therapeutic applications. Kisspeptin agonists may be used to localise lesions in cases of hypothalamic-pituitary-gonadal axis dysfunction and evaluate the gonadotrophic potential of subfertile individuals. Kisspeptin antagonists may be useful as contraceptives in women, through the prevention of premature luteinisation during in vitro fertilisation, and in the treatment of sex steroid-dependent diseases and metastatic cancers. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tng</LastName>
<ForeName>Eng Loon</ForeName>
<Initials>EL</Initials>
<AffiliationInfo>
<Affiliation>Associate Consultant, Department of Medicine, Ng Teng Fong General Hospital, 1 Jurong East Street 21, Singapore 609606.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Singapore</Country>
<MedlineTA>Singapore Med J</MedlineTA>
<NlmUniqueID>0404516</NlmUniqueID>
<ISSNLinking>0037-5675</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">PMC4678402</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">hypothalamic-pituitary-gonadal axis</Keyword>
<Keyword MajorTopicYN="N">kisspeptins</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26702159</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0037-5675</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>56</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Singapore medical journal</Title>
<ISOAbbreviation>Singapore Med J</ISOAbbreviation>
</Journal>
<ArticleTitle>Novel oral anticoagulants for atrial fibrillation.</ArticleTitle>
<Pagination>
<MedlinePgn>657-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.11622/smedj.2015184</ELocationID>
<Abstract>
<AbstractText>Anticoagulation therapy is effective in preventing primary and secondary thromboembolic events due to atrial fibrillation. Warfarin, which was approved by the United States in 1954, was the only long-term oral anticoagulation therapy till the approval of dabigatran in 2010, and of rivaroxaban and other direct factor Xa inhibitors from 2011, forming a group known as novel oral anticoagulants (NOAC). NOAC have fewer food and drug interactions compared to warfarin; hence, the patient will require fewer clinic visits. However, the short half-life of NOAC means that twice-a-day dosing is needed and there is higher risk of a prothrombotic state when doses are missed. Other disadvantages are the lack of long-term data on NOAC, their high cost and the current lack of locally available antidotes. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>How</LastName>
<ForeName>Choon How</ForeName>
<Initials>CH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Singapore</Country>
<MedlineTA>Singapore Med J</MedlineTA>
<NlmUniqueID>0404516</NlmUniqueID>
<ISSNLinking>0037-5675</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">PMC4678403</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">NOAC</Keyword>
<Keyword MajorTopicYN="N">anticoagulation</Keyword>
<Keyword MajorTopicYN="N">atrial fibrillation</Keyword>
<Keyword MajorTopicYN="N">non-VKA oral anticoagulants</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26702160</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0037-5675</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>56</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Singapore medical journal</Title>
<ISOAbbreviation>Singapore Med J</ISOAbbreviation>
</Journal>
<ArticleTitle>The clinical presentation and diagnosis of ketamine-associated urinary tract dysfunction in Singapore.</ArticleTitle>
<Pagination>
<MedlinePgn>660-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.11622/smedj.2015185</ELocationID>
<Abstract>
<AbstractText>Ketamine is a short-acting anaesthetic agent that has gained popularity as a 'club drug' due to its hallucinogenic effects. Substance abuse should be considered in young adult patients who present with severe debilitating symptoms such as lower urinary tract symptoms, even though the use of controlled substances is rare in Singapore. Although the natural history of disease varies from person to person, a relationship between symptom severity and frequency/dosage of abuse has been established. It is important to be aware of this condition and have a high degree of clinical suspicion to enable early diagnosis and immediate initiation of multidisciplinary and holistic treatment. A delayed diagnosis can lead to irreversible pathological changes and increased morbidity among ketamine abusers. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yek</LastName>
<ForeName>Jacklyn</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Urology, Singapore General Hospital, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sundaram</LastName>
<ForeName>Palaniappan</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Urology, Singapore General Hospital, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aydin</LastName>
<ForeName>Hakan</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Singapore General Hospital, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kuo</LastName>
<ForeName>Tricia</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Urology, Singapore General Hospital, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ng</LastName>
<ForeName>Lay Guat</ForeName>
<Initials>LG</Initials>
<AffiliationInfo>
<Affiliation>Department of Urology, Singapore General Hospital, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Singapore</Country>
<MedlineTA>Singapore Med J</MedlineTA>
<NlmUniqueID>0404516</NlmUniqueID>
<ISSNLinking>0037-5675</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">PMC4678404</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">bladder dysfunction</Keyword>
<Keyword MajorTopicYN="N">ketamin</Keyword>
<Keyword MajorTopicYN="N">lower urinary tract dysfunction</Keyword>
<Keyword MajorTopicYN="N">ulcerative cystitis</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26702161</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0037-5675</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>56</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Singapore medical journal</Title>
<ISOAbbreviation>Singapore Med J</ISOAbbreviation>
</Journal>
<ArticleTitle>Melatonin premedication versus placebo in wisdom teeth extraction: a randomised controlled trial.</ArticleTitle>
<Pagination>
<MedlinePgn>666-71</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.11622/smedj.2015186</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Pain after wisdom teeth surgery can be moderate in severity and is compounded by preoperative anxiety in young patients. We studied the effect of melatonin premedication on postoperative pain and preoperative anxiety in patients undergoing wisdom teeth extractions.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">This randomised controlled trial recruited 76 patients at Khoo Teck Puat Hospital who were American Society of Anesthesiologists physical status I and II, aged 21 to 65 and scheduled to undergo elective extraction of all four wisdom teeth under general anaesthesia. Patients with a history of long-term use or allergy to melatonin were excluded. The patients received either 6 mg melatonin or a placebo 90 minutes before surgery. Visual analogue scale (VAS) scores at multiple time intervals for postoperative pain and preoperative anxiety, patient satisfaction and first-night sleep quality scores were obtained. Mixed-effects regression models were used for longitudinal analysis of VAS pain, anxiety and satisfaction scores.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Maximum VAS scores for pain and anxiety were 18.6 ± 19.1 mm at 60 minutes postoperatively and 26.2 ± 23.4 mm at 90 minutes preoperatively, respectively. After adjusting for gender, female patients who received melatonin had a faster rate of reduction of VAS pain (p = 0.020) and anxiety scores (p = 0.003) over time compared to the placebo group. No such effect was demonstrated in male patients. There was no significant difference in sleep quality or satisfaction scores.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Melatonin use did not consistently contribute to pain and anxiety amelioration in all patients. Our study demonstrated a positive effect in female patients, suggestive of sexual dimorphism.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Seet</LastName>
<ForeName>Edwin</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia, Khoo Teck Puat Hospital, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liaw</LastName>
<ForeName>Chen Mei</ForeName>
<Initials>CM</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia, Khoo Teck Puat Hospital, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tay</LastName>
<ForeName>Sylvia</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Dental Surgery, Khoo Teck Puat Hospital, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Su</LastName>
<ForeName>Chang</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Clinical Research Unit, Khoo Teck Puat Hospital, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Singapore</Country>
<MedlineTA>Singapore Med J</MedlineTA>
<NlmUniqueID>0404516</NlmUniqueID>
<ISSNLinking>0037-5675</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">PMC4678405</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">anxiety</Keyword>
<Keyword MajorTopicYN="N">melatonin</Keyword>
<Keyword MajorTopicYN="N">pain</Keyword>
<Keyword MajorTopicYN="N">wisdom teeth extraction</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26702162</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0037-5675</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>56</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Singapore medical journal</Title>
<ISOAbbreviation>Singapore Med J</ISOAbbreviation>
</Journal>
<ArticleTitle>Improvement in left ventricular function assessed by tissue Doppler imaging after aortic valve replacement for severe aortic stenosis.</ArticleTitle>
<Pagination>
<MedlinePgn>672-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.11622/smedj.2015187</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The effects of reduction of left ventricular (LV) systemic afterload following aortic valve replacement (AVR) for severe aortic valve stenosis (AS) were investigated, using echocardiography and tissue Doppler imaging (TDI).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We compared the preoperative and postoperative echocardiographic assessments of 23 patients with severe AS who had undergone isolated AVR (n = 13) or concomitant AVR with coronary artery bypass grafting (CABG) (n = 10). Conventional echocardiographic evaluations and TDI at the lateral mitral annulus were performed.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Echocardiography was performed at a median of 120 (interquartile range: 66-141) days after AVR. There was significant reduction in aortic transvalvular mean pressure gradient after AVR. Although LV dimensions, mass and ejection fraction remained unchanged, LV diastolic and systolic functions improved (as observed on TDI). Early diastolic (E'), late diastolic (A') and systolic (S') mitral annular velocities increased significantly (p &lt; 0.05). There was significant improvement in TDI-derived parameters among the patients who had isolated AVR, while among the patients who had concomitant AVR with CABG, only S' had significant improvement (p = 0.028).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">TDI was able to detect improvements in LV systolic and diastolic function after AVR for severe AS. There was less improvement in the TDI-derived diastolic parameters among patients who underwent concomitant AVR with CABG than among patients who underwent isolated AVR.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nieh</LastName>
<ForeName>Chih-Chiang</ForeName>
<Initials>CC</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, National University Heart Centre Singapore, National University Health System, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Teo</LastName>
<ForeName>Alvin Yeng-Hok</ForeName>
<Initials>AY</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, National University Heart Centre Singapore, National University Health System, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Soo</LastName>
<ForeName>Wern Miin</ForeName>
<Initials>WM</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, National University Heart Centre Singapore, National University Health System, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Glenn K</ForeName>
<Initials>GK</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, National University Heart Centre Singapore, National University Health System, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Devinder</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, National University Heart Centre Singapore, National University Health System, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Poh</LastName>
<ForeName>Kian-Keong</ForeName>
<Initials>KK</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, National University Heart Centre Singapore, National University Health System, Singapore ; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Singapore</Country>
<MedlineTA>Singapore Med J</MedlineTA>
<NlmUniqueID>0404516</NlmUniqueID>
<ISSNLinking>0037-5675</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">PMC4678406</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">aortic valve replacement</Keyword>
<Keyword MajorTopicYN="N">aortic valve stenosis</Keyword>
<Keyword MajorTopicYN="N">coronary artery bypass grafting</Keyword>
<Keyword MajorTopicYN="N">left ventricular function</Keyword>
<Keyword MajorTopicYN="N">tissue Doppler imaging</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26702163</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0037-5675</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>56</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Singapore medical journal</Title>
<ISOAbbreviation>Singapore Med J</ISOAbbreviation>
</Journal>
<ArticleTitle>The Little India riot: experience of an emergency department in Singapore.</ArticleTitle>
<Pagination>
<MedlinePgn>677-80</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.11622/smedj.2015188</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Singapore experienced its second riot in 40 years on 8 December 2013, in the area known as Little India. A retrospective review of 36 casualties treated at the emergency department was conducted to evaluate injury patterns.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Characteristics including the rate of arrival, injury severity, type and location, and disposition of the casualties were analysed.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The injuries were predominantly mild (97.2%), with the most common injuries involving the head (50.0%) and limbs (38.9%). 97.2% of the casualties were managed as outpatient cases.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The majority of the injuries in this incident were mild and could be managed as outpatient cases. Important lessons were learnt from the incident about the utilisation of manpower and safety of staff in the emergency department.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Wei Feng</ForeName>
<Initials>WF</Initials>
<AffiliationInfo>
<Affiliation>Department of Emergency Medicine, Tan Tock Seng Hospital, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ooi</LastName>
<ForeName>Chee Kheong</ForeName>
<Initials>CK</Initials>
<AffiliationInfo>
<Affiliation>Department of Emergency Medicine, Tan Tock Seng Hospital, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Phua</LastName>
<ForeName>Dong Haur</ForeName>
<Initials>DH</Initials>
<AffiliationInfo>
<Affiliation>Department of Emergency Medicine, Tan Tock Seng Hospital, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wong</LastName>
<ForeName>Ming Hai Eric</ForeName>
<Initials>MH</Initials>
<AffiliationInfo>
<Affiliation>Department of Emergency Medicine, Tan Tock Seng Hospital, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chan</LastName>
<ForeName>Wui Ling</ForeName>
<Initials>WL</Initials>
<AffiliationInfo>
<Affiliation>Department of Emergency Medicine, Tan Tock Seng Hospital, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ng</LastName>
<ForeName>Yih Yng</ForeName>
<Initials>YY</Initials>
<AffiliationInfo>
<Affiliation>Singapore Civil Defence Force, Ministry of Home Affairs, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Singapore</Country>
<MedlineTA>Singapore Med J</MedlineTA>
<NlmUniqueID>0404516</NlmUniqueID>
<ISSNLinking>0037-5675</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">PMC4678407</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">injury pattern</Keyword>
<Keyword MajorTopicYN="N">mass casualty</Keyword>
<Keyword MajorTopicYN="N">riot</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26702164</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0037-5675</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>56</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Singapore medical journal</Title>
<ISOAbbreviation>Singapore Med J</ISOAbbreviation>
</Journal>
<ArticleTitle>The prevalence of albuminuria among diabetic patients in a primary care setting in Singapore.</ArticleTitle>
<Pagination>
<MedlinePgn>681-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.11622/smedj.2015189</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Microalbuminuria is an early sign of kidney damage. The prevalence of microalbuminuria in Singapore has been reported to be 36.0%-48.5%. However, the prevalence of microalbuminuria reported in these studies was determined with one urine sample using a qualitative urine test. The aim of this study was to determine the prevalence of micro- and macroalbuminuria using a more stringent criterion of two positive quantitative urine albumin-creatinine ratio (ACR) tests.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a cross-sectional study of patients with type 2 diabetes mellitus (T2DM) who were followed up at a primary care clinic in Singapore. Patients were diagnosed to have albuminuria if they had two positive ACR tests within a seven-month period.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 786 patients with T2DM met the study's inclusion criteria. 55.7% were already on an angiotensin-converting enzyme inhibitor (ACEI) and/or angiotensin receptor blocker (ARB). The prevalence rates of micro- and macroalbuminuria were 14.2% and 5.7%, respectively. Patients with albuminuria were more likely to have hypertension (odds ratio [OR] 3.47, 95% confidence interval [CI] 1.55-7.80). Diabetics with poorer diabetic control (OR 1.88, 95% CI 1.26-2.79), and higher systolic (OR 1.69, 95% CI 1.14-2.49) and diastolic (OR 1.96, 95% CI, 1.20 to 3.22) blood pressures were more likely to have albuminuria.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In the present study, the prevalence of microalbuminuria is significantly lower than that previously reported in Singapore. The presence of hypertension, poor diabetic control and suboptimal blood pressure control are possible risk factors for albuminuria in patients with T2DM.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Eng Sing</ForeName>
<Initials>ES</Initials>
<AffiliationInfo>
<Affiliation>Clinical Research Unit, Family Medicine Development Division, National Healthcare Group Polyclinics, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tang</LastName>
<ForeName>Wern Ee</ForeName>
<Initials>WE</Initials>
<AffiliationInfo>
<Affiliation>Clinical Research Unit, Family Medicine Development Division, National Healthcare Group Polyclinics, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Singapore</Country>
<MedlineTA>Singapore Med J</MedlineTA>
<NlmUniqueID>0404516</NlmUniqueID>
<ISSNLinking>0037-5675</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">PMC4678408</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">albuminuria</Keyword>
<Keyword MajorTopicYN="N">macroalbuminuria</Keyword>
<Keyword MajorTopicYN="N">microalbuminuria</Keyword>
<Keyword MajorTopicYN="N">prevalence</Keyword>
<Keyword MajorTopicYN="N">type 2 diabetes mellitus</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26702165</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0037-5675</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>56</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Singapore medical journal</Title>
<ISOAbbreviation>Singapore Med J</ISOAbbreviation>
</Journal>
<ArticleTitle>Development and validation of a food frequency questionnaire for dietary intake assessment among multi-ethnic primary school-aged children.</ArticleTitle>
<Pagination>
<MedlinePgn>687-94</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.11622/smedj.2015190</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">This study aimed to develop and validate a food frequency questionnaire (FFQ) to assess habitual diets of multi-ethnic Malaysian children aged 7-12 years.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A total of 236 primary school children participated in the development of the FFQ and 209 subjects participated in the validation study, with a subsample of 30 subjects participating in the reproducibility study. The FFQ, consisting of 94 food items from 12 food groups, was compared with a three-day dietary record (3DR) as the reference method. The reproducibility of the FFQ was assessed through repeat administration (FFQ2), seven days after the first administration (FFQ1).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The results of the validation study demonstrated good acceptance of the FFQ. Mean intake of macronutrients in FFQ1 and 3DR correlated well, although the FFQ intake data tended to be higher. Cross-classification of nutrient intake between the two methods showed that &lt; 7% of subjects were grossly misclassified. Moderate correlations noted between the two methods ranged from r = 0.310 (p &lt; 0.001) for fat to r = 0.497 (p &lt; 0.001) for energy. The reproducibility of the FFQ, as assessed by Cronbach's alpha, ranged from 0.61 (protein) to 0.70 (energy, carbohydrates and fat). Spearman's correlations between FFQ1 and FFQ2 ranged from rho = 0.333 (p = 0.072) for protein to rho = 0.479 (p &lt; 0.01) for fat.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These findings indicate that the FFQ is valid and reliable for measuring the average intake of energy and macronutrients in a population of multi-ethnic children aged 7-12 years in Malaysia.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Fatihah</LastName>
<ForeName>Fadil</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Nutritional Sciences Programme, School of Healthcare Sciences, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ng</LastName>
<ForeName>Boon Koon</ForeName>
<Initials>BK</Initials>
<AffiliationInfo>
<Affiliation>Nutritional Sciences Programme, School of Healthcare Sciences, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hazwanie</LastName>
<ForeName>Husin</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Nutritional Sciences Programme, School of Healthcare Sciences, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Norimah</LastName>
<ForeName>A Karim</ForeName>
<Initials>AK</Initials>
<AffiliationInfo>
<Affiliation>Nutritional Sciences Programme, School of Healthcare Sciences, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shanita</LastName>
<ForeName>Safii Nik</ForeName>
<Initials>SN</Initials>
<AffiliationInfo>
<Affiliation>Nutritional Sciences Programme, School of Healthcare Sciences, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ruzita</LastName>
<ForeName>Abd Talib</ForeName>
<Initials>AT</Initials>
<AffiliationInfo>
<Affiliation>Nutritional Sciences Programme, School of Healthcare Sciences, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Poh</LastName>
<ForeName>Bee Koon</ForeName>
<Initials>BK</Initials>
<AffiliationInfo>
<Affiliation>Nutritional Sciences Programme, School of Healthcare Sciences, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Singapore</Country>
<MedlineTA>Singapore Med J</MedlineTA>
<NlmUniqueID>0404516</NlmUniqueID>
<ISSNLinking>0037-5675</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">PMC4678409</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">FFQ</Keyword>
<Keyword MajorTopicYN="N">children</Keyword>
<Keyword MajorTopicYN="N">dietary assessment method</Keyword>
<Keyword MajorTopicYN="N">reproducibility</Keyword>
<Keyword MajorTopicYN="N">validation</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26702166</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0037-5675</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>56</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Singapore medical journal</Title>
<ISOAbbreviation>Singapore Med J</ISOAbbreviation>
</Journal>
<ArticleTitle>A handy way to handle hemoclips(®) in surgeries.</ArticleTitle>
<Pagination>
<MedlinePgn>695</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.11622/smedj.2015191</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chua</LastName>
<ForeName>Shunjie</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Ng Teng Fong General Hospital, Singapore ; Dermatology Outcomes Collaboration, University of Chicago, Chicago, IL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pitts</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Dermatology Outcomes Collaboration, University of Chicago, Chicago, IL, USA ; Pritzker School of Medicine, University of Chicago, Chicago, IL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lemark</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Dermatology Outcomes Collaboration, University of Chicago, Chicago, IL, USA ; Booth School of Business, University of Chicago, Chicago, IL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Le</LastName>
<ForeName>Min</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Dermatology Outcomes Collaboration, University of Chicago, Chicago, IL, USA ; Department of Medicine, Nanjing Drum Tower Hospital, Nanjing, China ; Nanjing University School of Medicine, Nanjing, China. newtaraday@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Singapore</Country>
<MedlineTA>Singapore Med J</MedlineTA>
<NlmUniqueID>0404516</NlmUniqueID>
<ISSNLinking>0037-5675</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">PMC4678410</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702369</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Effective recovery of highly purified CD326(+) tumor cells from lavage fluid of patients treated with a novel cell-free and concentrated ascites reinfusion therapy (KM-CART).</ArticleTitle>
<Pagination>
<MedlinePgn>780</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1508-3</ELocationID>
<Abstract>
<AbstractText>For the production of tumor-specific vaccines, including dendritic cell (DC) vaccines, the tumor cells themselves are an ideal source. Floating tumor cells in the ascites fluid from patients with malignant ascites are a good candidate source, but it is not easy to obtain pure tumor cells from ascites because of various types of cell contamination as well as protein aggregates. We here report an effective method to recover pure tumor cells from malignant ascites. We used lavage fluid from 13 patients with malignant ascites who were treated with modified cell-free and concentrated ascites reinfusion therapy (KM-CART). Cellular components were separated from the lavage fluid by centrifugation, enzymatic digestion and hemolysis. Tumor cells were purified by depleting CD45(+) leukocytes with antibody-conjugated magnetic beads. The tumor cell lysate was extracted by freeze-and-thaw cycles. The mean obtained total cell number was 7.50 × 10(7) cells (range 4.40 × 10(6)-2.48 × 10(8) cells). From this fraction, 6.39 × 10(6) (range 3.23 × 10(5)-2.53 × 10(7)) CD45(-) cells were collected, and the tumor cell purity was over 80 % defined as CD45(-)CD326(+). A sufficient amount of tumor lysate, average  = 2416 μg (range 25-8743 μg), was extracted from CD45(-)CD326(+) tumor cells. We here established an effective method to produce highly purified tumor cells from KM-CART lavage fluid. The clinical feasibility of this simple preparation method for generating tumor lysate should be examined in clinical studies of DC vaccines. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kimura</LastName>
<ForeName>Yukino</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>R&amp;D Laboratory for Innovative Biotherapeutics, Graduate School of Pharmaceutical Sciences, Kyushu University, 6 floor, Collaborative Research Station I, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582 Japan ; Tella, Inc., Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Harada</LastName>
<ForeName>Yui</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>R&amp;D Laboratory for Innovative Biotherapeutics, Graduate School of Pharmaceutical Sciences, Kyushu University, 6 floor, Collaborative Research Station I, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yasuda</LastName>
<ForeName>Noriko</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>R&amp;D Laboratory for Innovative Biotherapeutics, Graduate School of Pharmaceutical Sciences, Kyushu University, 6 floor, Collaborative Research Station I, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ishidao</LastName>
<ForeName>Takefumi</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>AllGene, Inc., Kanagawa, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yusa</LastName>
<ForeName>Seiichi</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Tella, Inc., Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Matsusaki</LastName>
<ForeName>Keisuke</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Ascites Treatment Center, Kanamecho Hospital, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yonemitsu</LastName>
<ForeName>Yoshikazu</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>R&amp;D Laboratory for Innovative Biotherapeutics, Graduate School of Pharmaceutical Sciences, Kyushu University, 6 floor, Collaborative Research Station I, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582 Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4683161</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Ascites</Keyword>
<Keyword MajorTopicYN="N">CART</Keyword>
<Keyword MajorTopicYN="N">Tumor lysate</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702370</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Application of ionomics to plant and soil in fields under long-term fertilizer trials.</ArticleTitle>
<Pagination>
<MedlinePgn>781</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1562-x</ELocationID>
<Abstract>
<AbstractText>Ionomics is the study of elemental accumulation in living organisms using high-throughput elemental profiling. In the present study, we examined the ionomic responses to nutrient deficiency in maize grown in the field in long-term fertilizer trials. Furthermore, the available elements in the field soils were analyzed to investigate their changes under long-term fertilizer treatment and the ionomic relationships between plant and soil. Maize was cultivated in a field with the following five long-term fertilizer treatments: complete fertilization, fertilization without nitrogen, without phosphorus, without potassium, and no fertilization. Concentrations of 22 elements in leaves at an early flowering stage and in soils after harvest were determined. The fertilizer treatments changed the availabilities of many elements in soils. For example, available cesium was decreased by 39 % and increased by 126 % by fertilizations without nitrogen and potassium, respectively. Effects of treatments on the ionome in leaves were evaluated using the translocation ratio (the concentration in leaves relative to the available concentration in soils) for each element. Nitrogen deficiency specifically increased the uptake ability of molybdenum, which might induce the enhancement of nitrogen assimilation and/or endophytic nitrogen fixation in plant. Potassium deficiency drastically enhanced the uptake ability of various cationic elements. These elements might act as alternatives to K in osmoregulation and counterion of organic/inorganic anions. Two major groups of elements were detected by multivariate analyses of plant ionome. Elements in the same group may be linked more or less in uptake and/or translocation systems. No significant correlation between plant and soil was found in concentrations of many elements, even though various soil extraction methods were applied, implying that the interactions between the target and other elements in soil must be considered when analyzing mineral dynamics between plant and soil. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Watanabe</LastName>
<ForeName>Toshihiro</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Research Faculty of Agriculture, Hokkaido University, Kita-9, Nishi-9, Kitaku, Sapporo, 0608589 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Urayama</LastName>
<ForeName>Masaru</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Research Faculty of Agriculture, Hokkaido University, Kita-9, Nishi-9, Kitaku, Sapporo, 0608589 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shinano</LastName>
<ForeName>Takuro</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Agricultural Radiation Research Center, NARO Tohoku Agricultural Research Center, 50 Aza Harajyukuminami, Arai, Fukushima, 9602156 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Okada</LastName>
<ForeName>Ryosuke</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Research Faculty of Agriculture, Hokkaido University, Kita-9, Nishi-9, Kitaku, Sapporo, 0608589 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Osaki</LastName>
<ForeName>Mitsuru</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Research Faculty of Agriculture, Hokkaido University, Kita-9, Nishi-9, Kitaku, Sapporo, 0608589 Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4684559</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Ionomics</Keyword>
<Keyword MajorTopicYN="N">Long-term fertilizer experiment field</Keyword>
<Keyword MajorTopicYN="N">Nitrogen</Keyword>
<Keyword MajorTopicYN="N">Phosphorus</Keyword>
<Keyword MajorTopicYN="N">Potassium</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702371</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Meta-heuristic algorithms for parallel identical machines scheduling problem with weighted late work criterion and common due date.</ArticleTitle>
<Pagination>
<MedlinePgn>782</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1559-5</ELocationID>
<Abstract>
<AbstractText>To our knowledge, this paper investigates the first application of meta-heuristic algorithms to tackle the parallel machines scheduling problem with weighted late work criterion and common due date ([Formula: see text]). Late work criterion is one of the performance measures of scheduling problems which considers the length of late parts of particular jobs when evaluating the quality of scheduling. Since this problem is known to be NP-hard, three meta-heuristic algorithms, namely ant colony system, genetic algorithm, and simulated annealing are designed and implemented, respectively. We also propose a novel algorithm named LDF (largest density first) which is improved from LPT (longest processing time first). The computational experiments compared these meta-heuristic algorithms with LDF, LPT and LS (list scheduling), and the experimental results show that SA performs the best in most cases. However, LDF is better than SA in some conditions, moreover, the running time of LDF is much shorter than SA. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Xu</LastName>
<ForeName>Zhenzhen</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>School of Software, Dalian University of Technology, Dalian, 116620 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zou</LastName>
<ForeName>Yongxing</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>School of Software, Dalian University of Technology, Dalian, 116620 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kong</LastName>
<ForeName>Xiangjie</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>School of Software, Dalian University of Technology, Dalian, 116620 China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4684564</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Common due date</Keyword>
<Keyword MajorTopicYN="N">Meta-heuristic algorithms</Keyword>
<Keyword MajorTopicYN="N">Parallel identical machines</Keyword>
<Keyword MajorTopicYN="N">Scheduling</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702372</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Improved automatic steam distillation combined with oscillation-type densimetry for determining alcoholic strength in spirits and liqueurs.</ArticleTitle>
<Pagination>
<MedlinePgn>783</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1574-6</ELocationID>
<Abstract>
<AbstractText>The determination of the alcoholic strength in spirits and liqueurs is required to control the labelling of alcoholic beverages. The reference methodology prescribes a distillation step followed by densimetric measurement. The classic distillation using a Vigreux rectifying column and a West condenser is time consuming and error-prone, especially for liqueurs that may have problems with entrainment and charring. For this reason, this methodology suggests the use of an automated steam distillation device as alternative. The novel instrument comprises an increased steam power, a redesigned geometry of the condenser and a larger cooling coil with controllable flow, compared to previously available devices. Method optimization applying D-optimal and central composite designs showed significant influence of sample volume, distillation time and coolant flow, while other investigated parameters such as steam power, receiver volume, or the use of pipettes or flasks for sample measurement did not significantly influence the results. The method validation was conducted using the following settings: steam power 70 %, sample volume 25 mL transferred using pipettes, receiver volume 50 mL, coolant flow 7 L/min, and distillation time as long as possible just below the calibration mark. For four different liqueurs covering the typical range of these products between 15 and 35 % vol, the method showed an adequate precision, with relative standard deviations below 0.4 % (intraday) and below 0.6 % (interday). The absolute standard deviations were between 0.06 % vol and 0.08 % vol (intraday) and between 0.07 % vol and 0.10 % vol (interday). The improved automatic steam distillation devices offer an excellent alternative for sample cleanup of volatiles from complex matrices. A major advantage are the low costs for consumables per analysis (only distilled water is needed). For alcoholic strength determination, the method has become more rugged than before, and there are only few influences that would lead to incomplete distillation. Our validation parameters have shown that the performance of the method corresponds to the data presented for the reference method and we believe that automated steam distillation, can be used for the purpose of labelling control of alcoholic beverages. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lachenmeier</LastName>
<ForeName>Dirk W</ForeName>
<Initials>DW</Initials>
<Identifier Source="ORCID">0000-0002-3115-864X</Identifier>
<AffiliationInfo>
<Affiliation>Chemisches und Veterinäruntersuchungsamt (CVUA) Karlsruhe, Weissenburger Strasse 3, 76187 Karlsruhe, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Plato</LastName>
<ForeName>Leander</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Chemisches und Veterinäruntersuchungsamt (CVUA) Karlsruhe, Weissenburger Strasse 3, 76187 Karlsruhe, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Suessmann</LastName>
<ForeName>Manuela</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Chemisches und Veterinäruntersuchungsamt (CVUA) Karlsruhe, Weissenburger Strasse 3, 76187 Karlsruhe, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Di Carmine</LastName>
<ForeName>Matthew</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Lab Synergy, 374 Pulaski Highway, Goshen, NY 10924 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Krueger</LastName>
<ForeName>Bjoern</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>C. Gerhardt GmbH &amp; Co. KG, Cäsariusstraße 97, 53639 Königswinter, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kukuck</LastName>
<ForeName>Armin</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>C. Gerhardt GmbH &amp; Co. KG, Cäsariusstraße 97, 53639 Königswinter, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kranz</LastName>
<ForeName>Markus</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>C. Gerhardt GmbH &amp; Co. KG, Cäsariusstraße 97, 53639 Königswinter, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4684557</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Alcoholic strength</Keyword>
<Keyword MajorTopicYN="N">Ethanol</Keyword>
<Keyword MajorTopicYN="N">Experimental design</Keyword>
<Keyword MajorTopicYN="N">Optimisation</Keyword>
<Keyword MajorTopicYN="N">Oscillation-type densimetry</Keyword>
<Keyword MajorTopicYN="N">Steam distillation</Keyword>
<Keyword MajorTopicYN="N">Validation</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702373</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of Mn, Fe and Co on the compression strength and ductility of in situ nano-sized TiB2/TiAl composites.</ArticleTitle>
<Pagination>
<MedlinePgn>784</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1575-5</ELocationID>
<Abstract>
<AbstractText>The element of Fe can enhance the strength of TiB2/TiAl composite, but it is detrimental to the ductility of the composite due to the existence of large bulk TiB2 phase at grain boundary. The element of Mn is beneficial to the ductility of TiB2/TiAl composite, of which the fracture strain increases from 15.9 to 17.9 % with the addition of 2 at.% Mn. The element of Co can improve the strength and ductility of TiB2/TiAl composite simultaneously. With the addition of 2 at.% Co, the ultimate compression strength of TiB2/TiAl composite increases from 1829 to 1906 MPa and the fracture strain increases from 15.9 to 17.2 %. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shu</LastName>
<ForeName>Shili</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Key Laboratory of Automobile Materials, Ministry of Education, and Department of Materials Science and Engineering, Jilin University, No. 5988 Renmin Street, Changchun, 130025 People's Republic of China ; State Key Laboratory of Luminescence and Applications, Changchun Institute of Optics, Fine Mechanics and Physics, Chinese Academy of Sciences, Changchun, 130012 People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tong</LastName>
<ForeName>Cunzhu</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>State Key Laboratory of Luminescence and Applications, Changchun Institute of Optics, Fine Mechanics and Physics, Chinese Academy of Sciences, Changchun, 130012 People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Qiu</LastName>
<ForeName>Feng</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Key Laboratory of Automobile Materials, Ministry of Education, and Department of Materials Science and Engineering, Jilin University, No. 5988 Renmin Street, Changchun, 130025 People's Republic of China ; Department of Mechanical Engineering, Oakland University, Rochester, MI 48309 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jiang</LastName>
<ForeName>Qichuan</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>Key Laboratory of Automobile Materials, Ministry of Education, and Department of Materials Science and Engineering, Jilin University, No. 5988 Renmin Street, Changchun, 130025 People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4684556</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Alloying element</Keyword>
<Keyword MajorTopicYN="N">Composite</Keyword>
<Keyword MajorTopicYN="N">Compression properties</Keyword>
<Keyword MajorTopicYN="N">TiAl</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702374</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Ethnic and adoption attitudes among Guatemalan University students.</ArticleTitle>
<Pagination>
<MedlinePgn>785</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1578-2</ELocationID>
<Abstract>
<AbstractText>Intercountry adoptions from Guatemala were highly controversial, because of the large numbers of children being adopted to the USA, along with evidence of corruption and child theft. Since the implementation of the Hague Convention on Intercountry Adoption in 2008, Guatemala's central authority for adoption has prioritized domestic placements for children over intercountry adoption. A possible attitudinal barrier to domestic adoption in Guatemala-negative attitudes and prejudice against Indigenous people-was investigated through questionnaires measuring attitudes toward adoption and attitudes toward and social distance from the two major ethnic groups (Ladino and Indigenous). Guatemalan university students (N = 177, 61 % men) were recruited from basic required courses at a private university. Results showed that attitudes toward adoption in general were more favorable than toward interethnic adoption, with the most negative attitudes toward adoption of Ladino children by Indigenous parents. Multiple regression and analysis of covariance models revealed that female gender, experience with adoption and more positive attitudes about Indigenous persons were associated with more positive attitudes toward adoption. The findings imply that negative attitudes toward Indigenous persons are associated with negative attitudes toward adoption, and serve as barriers to promoting domestic adoption in Guatemala. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gibbons</LastName>
<ForeName>Judith L</ForeName>
<Initials>JL</Initials>
<Identifier Source="ORCID">0000-0002-9263-3096</Identifier>
<AffiliationInfo>
<Affiliation>Department of Psychology, Saint Louis University, Morrissey Hall 2826, 3700 Lindell Blvd., St. Louis, MO 63108 USA ; Antigua, Guatemala, Central America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>González-Oliva</LastName>
<ForeName>Ana Gabriela</ForeName>
<Initials>AG</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychology, Universidad del Valle de Guatemala, 18 ave. 11-95 zona 15 Vista Hermosa III Oficina G203, Guatemala, Guatemala.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mylonas</LastName>
<ForeName>Kostas</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Psychology Faculty, National and Kapodistrian University of Athens, Panepistimiopolis, ILISIA, 15784 Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4684562</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Adoption</Keyword>
<Keyword MajorTopicYN="N">Ethic attitudes</Keyword>
<Keyword MajorTopicYN="N">Guatemala</Keyword>
<Keyword MajorTopicYN="N">Interethnic adoption</Keyword>
<Keyword MajorTopicYN="N">Subsidiarity clause of the Hague Convention</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702375</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Hearing impairment and nightmares: a theoretical insight.</ArticleTitle>
<Pagination>
<MedlinePgn>786</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1579-1</ELocationID>
<Abstract>
<AbstractText>The aim of this article is to address the issue of nightmares in the deaf population, given that there are no documented studies on this matter to the best of our knowledge. The study of nightmares in the deaf population is of high relevance given their specific characteristics (impossibility of verbalisation) and the lack of studies with this population. Nightmares are dreams of negative content that trigger an awakening associated with a rapid return to a full state of alert and a persistent feeling of anxiety and fear, which may cause significant distress. Various studies show that the deaf population has dreams with more negative imagery and emotions, are more exposed to interpersonal traumas and have higher rates of dissociation, than hearing people. These concepts seem to be connected given that, in the presence of traumatic events, dissociation may act as a defence mechanism and nightmares may operate as an adaptive coping strategy. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rego</LastName>
<ForeName>Maria Francisca</ForeName>
<Initials>MF</Initials>
<AffiliationInfo>
<Affiliation>Department of Social Sciences and Health, Faculty of Medicine, University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Duarte</LastName>
<ForeName>Ivone</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Department of Social Sciences and Health, Faculty of Medicine, University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nunes</LastName>
<ForeName>Rui</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Social Sciences and Health, Faculty of Medicine, University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4684558</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Deafness</Keyword>
<Keyword MajorTopicYN="N">Dissociation</Keyword>
<Keyword MajorTopicYN="N">Nightmares</Keyword>
<Keyword MajorTopicYN="N">Trauma</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702376</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Insulin-like growth factor-1 and insulin-like growth factor binding protein 3 and risk of postoperative cognitive dysfunction.</ArticleTitle>
<Pagination>
<MedlinePgn>787</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1586-2</ELocationID>
<Abstract>
<AbstractText>Insulin-like growth factor (IGF)-1 is implicated in learning and memory. Experimental studies have suggested that the IGF-1 system is beneficial in cognition, especially in Alzheimer's disease (AD), by opposing Aβ amyloid processing and hyperphosphorylated tau toxicity. Low IGF-I and insulin-like growth factor binding protein (IGFBP)-3 serum levels are significantly associated with AD. To assess the relationship between circulating IGF-I and IGFBP3 levels and change of postoperative cognition. The study was performed in patients scheduled for elective head and neck carcinoma surgery under general anesthesia. On the day before the operation and postoperative days 1, 3 and 7, mini-mental state examination (MMSE) was performed by the same doctor, and blood samples were collected at 08:00 h after overnight fasting. The circulating levels of IGF-1 and IGFBP3 were measured by enzyme-linked immunosorbent assay. One hundred and two patients completed all four MMSE tests and forty-four of them completed all the four blood samples collection. Postoperative circulating IGF-1 level, ratio of IGF-1/IGFBP3 and MMSE score significantly decreased, whereas IGFBP3 level significantly increased compared with preoperative values in total patients. The change trends of circulating IGF-1 level and MMSE score were similar. Preoperative circulating IGF-1 level, ratio and MMSE score were significantly lower in POCD group compared to non-POCD group. There was no significant difference in preoperative level of circulating IGFBP3 between the two groups. Preoperative circulating IGF-1 level was negatively correlated with age and positively with MMSE. Logistic regression analysis revealed that lower preoperative IGF-1 level and elderly patients increased the odds of POCD. Down-regulation of circulating IGF-1 level may be involved in the mechanism of postoperative cognitive dysfunction. Older patients had lower circulating IGF-1 levels and were more susceptible to POCD. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jiang</LastName>
<ForeName>Jue</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Zhizaoju Road 639, Shanghai, 200011 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Zhifeng</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Zhizaoju Road 639, Shanghai, 200011 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liang</LastName>
<ForeName>Bing</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Zhizaoju Road 639, Shanghai, 200011 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yan</LastName>
<ForeName>Jia</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Zhizaoju Road 639, Shanghai, 200011 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Ying</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Zhizaoju Road 639, Shanghai, 200011 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jiang</LastName>
<ForeName>Hong</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Zhizaoju Road 639, Shanghai, 200011 China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4684561</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">General anesthesia</Keyword>
<Keyword MajorTopicYN="N">Insulin-like growth factor binding protein3</Keyword>
<Keyword MajorTopicYN="N">Insulin-like growth factor-1</Keyword>
<Keyword MajorTopicYN="N">Postoperative cognition dysfunction</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702377</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Histogram analysis with automated extraction of brain-tissue region from whole-brain CT images.</ArticleTitle>
<Pagination>
<MedlinePgn>788</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1587-1</ELocationID>
<Abstract>
<AbstractText>To determine whether an automated extraction of the brain-tissue region from CT images is useful for the histogram analysis of the brain-tissue region was studied. We used the CT images of 11 patients. We developed an automatic brain-tissue extraction algorithm. We evaluated the similarity index of this automated extraction method relative to manual extraction, and we compared the mean CT number of all extracted pixels and the kurtosis and skewness of the distribution of CT numbers of all extracted pixels from the automated and manual extractions. The similarity index was 0.93. The mean CT number and the kurtosis and skewness from the automated extraction were 35.0 Hounsfield units, 0.63, and 0.51, respectively, and were equivalent to those from the manual extraction (35.4 Hounsfield units, 0.59, and 0.46, respectively). The automated extraction of the brain-tissue region from whole-brain CT images was useful for histogram analysis of the brain-tissue region. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kondo</LastName>
<ForeName>Masatoshi</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Technology, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582 Japan ; Graduate School of Health Sciences, Kumamoto University, 4-24-1 Kuhonji, Kumamoto, 862-0976 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yamashita</LastName>
<ForeName>Koji</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yoshiura</LastName>
<ForeName>Takashi</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582 Japan ; Department of Radiology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8544 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hiwatash</LastName>
<ForeName>Akio</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shirasaka</LastName>
<ForeName>Takashi</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Technology, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582 Japan ; Department of Radiological Technology, Kumamoto University Hospital, 1-1-1 Honjyo, Kumamoto, 860-8556 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arimura</LastName>
<ForeName>Hisao</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Technology, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nakamura</LastName>
<ForeName>Yasuhiko</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Technology, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582 Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Honda</LastName>
<ForeName>Hiroshi</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582 Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4684555</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Automated extraction</Keyword>
<Keyword MajorTopicYN="N">Brain-tissue region</Keyword>
<Keyword MajorTopicYN="N">Histogram analysis</Keyword>
<Keyword MajorTopicYN="N">Whole-brain CT</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702378</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Tumor staging using 3.0 T multiparametric MRI in prostate cancer: impact on treatment decisions for radical radiotherapy.</ArticleTitle>
<Pagination>
<MedlinePgn>789</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1596-0</ELocationID>
<Abstract>
<AbstractText>To assess and validate the incorporation of the multiparametric magnetic resonance imaging (mpMRI) tumour category (mT-category) to the conventional clinical tumour category (cT-category), in order to guide the radiotherapy (RT) treatment decisions in prostate cancer. In addition, to identify the clinical factors associated to the technique reliability. mpMRI was performed in 274 prostate cancer patients in order to refine the treatment decisions according to PSA, Gleason Score (GS) and cT-category. Comparisons between the cT and mT-category were performed, as well as the impact on the RT treatment [target volume, doses and hormonal therapy (HT)] independently if it was finally performed. Changes in HT indication for intermediate risk were also analyzed. mpMRI validation was performed with pathological staging (n = 90 patients finally decided to join surgery). The mpMRI upstaging range was 86-94 % for any PSA value or GS. Following mpMRI, 32.8 % of the patients (90/274) were assigned to a different risk group. Compared to cT-category, mpMRI identified more intermediate-risk (46.4 vs. 59.5 %) and high-risk (19.0 vs. 28.8 %) prostate cancer patients. This resulted in a higher indication (p &lt; 0.05) of seminal vesicle irradiation (63.5 vs. 70.0 %), inclusion of any extracapsular disease (T3-T4) within the target volume (1.8 vs. 18.2 %), higher doses (65.3 vs. 88.3 %) and HT associated to RT (45.6 vs. 62.4 %). Global accuracy for mpMRI was higher compared to DRE/TRUS (8.9 vs. 71.1 %, p &lt; 0.05). mpMRI reliability was independent of PSA or GS. mpMRI tumor staging significantly modified the RT treatment decisions in all prostate cancer risk groups. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Couñago</LastName>
<ForeName>Felipe</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Hospital Universitario Quiron Madrid, Calle Diego de Velazquez, 1, Pozuelo de Alarcón, 28223 Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Del Cerro</LastName>
<ForeName>Elia</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Hospital Universitario Quiron Madrid, Calle Diego de Velazquez, 1, Pozuelo de Alarcón, 28223 Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Díaz-Gavela</LastName>
<ForeName>Ana Aurora</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Hospital Universitario Quiron Madrid, Calle Diego de Velazquez, 1, Pozuelo de Alarcón, 28223 Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marcos</LastName>
<ForeName>Francisco José</ForeName>
<Initials>FJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Hospital Universitario Quiron Madrid, Calle Diego de Velazquez, 1, Pozuelo de Alarcón, 28223 Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Recio</LastName>
<ForeName>Manuel</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Hospital Universitario Quiron, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sanz-Rosa</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Clinical Department, School of Biomedical Sciences, Universidad Europea, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thuissard</LastName>
<ForeName>Israel</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>School of Doctoral Studies and Research, Universidad Europea, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Olaciregui</LastName>
<ForeName>Karmele</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>School of Biomedical Sciences, Universidad Europea, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mateo</LastName>
<ForeName>María</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Hospital Universitario Quiron, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cerezo</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Departament of Radiation Oncology, Hospital Universitario La Princesa, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4684563</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Multiparametric MRI</Keyword>
<Keyword MajorTopicYN="N">Prostate cancer</Keyword>
<Keyword MajorTopicYN="N">Radiotherapy</Keyword>
<Keyword MajorTopicYN="N">Staging</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702379</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Examination of fluctuations in atmospheric pressure related to migraine.</ArticleTitle>
<Pagination>
<MedlinePgn>790</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1592-4</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Japan has four seasons and many chances of low atmospheric pressure or approaches of typhoon, therefore it has been empirically known that the fluctuation of weather induces migraine in people. Generally, its mechanism has been interpreted as follows: physical loading, attributed by atmospheric pressure to human bodies, compresses or dilates human blood vessels, which leads to abnormality in blood flow and induces migraine. We report our examination of the stage in which migraine tends to be induced focusing on the variation of atmospheric pressure.</AbstractText>
<AbstractText Label="FINDINGS" NlmCategory="RESULTS">Subjects were 34 patients with migraine, who were treated in our hospital. The patients included 31 females and three males, whose mean age was 32 ± 6.7. 22 patients had migraine with aura and 12 patients had migraine without aura. All of patients with migraine maintained a headache diary to record atmospheric pressures when they developed a migraine. The standard atmospheric pressure was defined as 1013 hPa, and with this value as the criterion, we investigated slight fluctuations in the atmospheric pressure when they developed a migraine. It was found that the atmospheric pressure when the patients developed a migraine was within 1003-1007 hPa in the approach of low atmospheric pressure and that the patients developed a migraine when the atmospheric pressure decreased by 6-10 hPa, slightly less than the standard atmospheric pressure.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Small decreases of 6-10 hPa relative to the standard atmospheric pressure of 1013 hPa induced migraine attacks most frequently in patients with migraine.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Okuma</LastName>
<ForeName>Hirohisa</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Tokai University School of Medicine, Isehara, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Okuma</LastName>
<ForeName>Yumiko</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Green Heights Clinic, Kawasaki, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kitagawa</LastName>
<ForeName>Yasuhisa</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Tokai University Hachioji Hospital, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4684554</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702380</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Method developments to extract proteins from oil palm chromoplast for proteomic analysis.</ArticleTitle>
<Pagination>
<MedlinePgn>791</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1576-4</ELocationID>
<Abstract>
<AbstractText>Proteins from the plant chromoplast are essential for many physiological processes such as fatty acid biosynthesis. Different protein extraction methods were tested to find the most robust method to obtain oil palm chromoplast proteins for mass spectrometry analysis. Initially, two different solvents were employed to reduce the fruit lipids. Then, two plant cell wall digestive enzymes were used to acquire the protoplasts to increase the protein extraction effectiveness. A two-stage centrifugation-based fractionation approach enhanced the number of identified proteins, particularly the fatty acid biosynthetic enzymes. The effectiveness of each extraction method was assessed using protein yields and 2DE gel profiles. The ideal method was successfully used to establish the 2DE chromoplast proteome maps of low and high oleic acid mesocarps of oil palm. Further nanoLC-MS/MS analysis of the extracted chromoplast proteins led to the identification of 162 proteins, including some of the main enzymes involved in the fatty acid biosynthesis. The established procedures would provide a solid foundation for further functional studies, including fatty acid biosynthetic expression profiling and evaluation of regulatory function. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lau</LastName>
<ForeName>Benjamin Yii Chung</ForeName>
<Initials>BY</Initials>
<Identifier Source="ORCID">0000-0001-7211-8284</Identifier>
<AffiliationInfo>
<Affiliation>Advanced Biotechnology and Breeding Centre, Malaysian Palm Oil Board, No. 6, Persiaran Institusi, Bandar Baru Bangi, 43000 Kajang, Selangor Malaysia ; AgResearch Lincoln Research Centre, Christchurch, New Zealand ; Department of Wine, Food and Molecular Biosciences, Lincoln University, Christchurch, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Deb-Choudhury</LastName>
<ForeName>Santanu</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>AgResearch Lincoln Research Centre, Christchurch, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Morton</LastName>
<ForeName>James D</ForeName>
<Initials>JD</Initials>
<AffiliationInfo>
<Affiliation>Department of Wine, Food and Molecular Biosciences, Lincoln University, Christchurch, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Clerens</LastName>
<ForeName>Stefan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>AgResearch Lincoln Research Centre, Christchurch, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dyer</LastName>
<ForeName>Jolon M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>AgResearch Lincoln Research Centre, Christchurch, New Zealand ; Department of Wine, Food and Molecular Biosciences, Lincoln University, Christchurch, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ramli</LastName>
<ForeName>Umi Salamah</ForeName>
<Initials>US</Initials>
<AffiliationInfo>
<Affiliation>Advanced Biotechnology and Breeding Centre, Malaysian Palm Oil Board, No. 6, Persiaran Institusi, Bandar Baru Bangi, 43000 Kajang, Selangor Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688294</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Chromoplast</Keyword>
<Keyword MajorTopicYN="N">Elaeis guineensis</Keyword>
<Keyword MajorTopicYN="N">Fatty acid biosynthesis</Keyword>
<Keyword MajorTopicYN="N">Gel electrophoresis</Keyword>
<Keyword MajorTopicYN="N">Protein extraction</Keyword>
<Keyword MajorTopicYN="N">Proteomics</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702381</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Optimization of orthogonal adaptive waveform design in presence of compound Gaussian clutter for MIMO radar.</ArticleTitle>
<Pagination>
<MedlinePgn>792</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1501-x</ELocationID>
<Abstract>
<AbstractText>In this paper, an adaptive algorithm is proposed to develop an orthogonally optimized waveforms with good correlation properties that are suitable for the detection of target in the presence of strong clutter. The joint optimization both at the transmitter and receiver is adapted based on the secondary data and clutter to maximize signal to interference noise ratio (SINR) with target and clutter knowledge. The result shows good correlation properties and better SINR and signal to clutter ratio (SCR) compared to the existing iterative algorithm. The proposed algorithm also shows improved detection even for lower SCR when implemented with GLRT. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Reddy</LastName>
<ForeName>B Roja</ForeName>
<Initials>BR</Initials>
<AffiliationInfo>
<Affiliation>R V C E, Bangalore, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Uttarakumari</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>R V C E, Bangalore, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688293</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Adaptive filter</Keyword>
<Keyword MajorTopicYN="N">Generalized likelihood ratio test (GLRT)</Keyword>
<Keyword MajorTopicYN="N">Orthogonal optimal waveform</Keyword>
<Keyword MajorTopicYN="N">Secondary data</Keyword>
<Keyword MajorTopicYN="N">Signal to interference noise ratio (SINR)</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702382</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Results of 20 consecutive patients treated with the Repiphysis expandable prosthesis for primary malignant bone.</ArticleTitle>
<Pagination>
<MedlinePgn>793</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1582-6</ELocationID>
<Abstract>
<AbstractText>Limb-salvage for primary malignant bone tumors in pediatric patients presents a unique challenge when resection includes an active physis. Early expandable prostheses required open surgical procedures to achieve lengthening. Newer prostheses are capable of achieving expansion without open procedures through the use of an electromagnetic field. This study reports our results with 90 consecutive expansion procedures using the Repiphysis(®) prosthesis. We retrospectively reviewed the records of 20 patients (22 limbs) who underwent limb-salvage using the Repiphysis(®) prosthesis from 2003 to 2015. There were 9 males and 11 females with a mean age of 9 years and 9 months (6-16 years). Reconstruction included the distal femur in 11 cases, total femur in four, proximal tibia in three, proximal humerus in three, and total humerus in one. Complications were reviewed and functional scores were recorded using the MSTS/ISOLS system. Five patients had a second prosthesis implanted during the course of the study for a total of 27 prostheses. The mean follow-up was 57 (6-148) months. Four patients have not been expanded: three due to death prior to lengthening, and one patient who has not yet developed a leg length discrepancy. Ninety consecutive expansion procedures were performed in 18 limbs in 16 patients. A mean of 9 (5-20) mm was gained per expansion and 4.8 cm per patient who has undergone expansion to date. Seven patients have reached skeletal maturity and have been converted to an adult endoprosthesis. These patients averaged 8 expansions per patient and a mean of 7.4 (1.8-12.9) cm in length gained. There were 15 complications in 11 patients including one dislocation, one contracture, four cases of aseptic loosening, five structural failures (three expansion mechanism failures and two tibial fractures), three deep infections, and one case of local recurrence. The mean MSTS score was 80 % (37-97 %) and the limb retention rate was 95 %. The results of this study are comparable to previous studies involving non-invasive prostheses. This study hopefully provides additional data for clinicians to consider when faced with limb threatening sarcomas in the immature skeleton. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Benevenia</LastName>
<ForeName>Joseph</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, Rutgers New Jersey Medical School, 140 Bergen Street, ACC Building, Suite D-1610, Newark, NJ 07103 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Patterson</LastName>
<ForeName>Francis</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, Rutgers New Jersey Medical School, 140 Bergen Street, ACC Building, Suite D-1610, Newark, NJ 07103 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Beebe</LastName>
<ForeName>Kathleen</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, Rutgers New Jersey Medical School, 140 Bergen Street, ACC Building, Suite D-1610, Newark, NJ 07103 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tucker</LastName>
<ForeName>Kimberly</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, Rutgers New Jersey Medical School, 140 Bergen Street, ACC Building, Suite D-1610, Newark, NJ 07103 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moore</LastName>
<ForeName>Jeffrey</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, Rutgers New Jersey Medical School, 140 Bergen Street, ACC Building, Suite D-1610, Newark, NJ 07103 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ippolito</LastName>
<ForeName>Joseph</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, Rutgers New Jersey Medical School, 140 Bergen Street, ACC Building, Suite D-1610, Newark, NJ 07103 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rivero</LastName>
<ForeName>Steven</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, Rutgers New Jersey Medical School, 140 Bergen Street, ACC Building, Suite D-1610, Newark, NJ 07103 USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688289</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Expandable endoprosthesis</Keyword>
<Keyword MajorTopicYN="N">Musculoskeletal oncology</Keyword>
<Keyword MajorTopicYN="N">Orthopaedic surgery</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702383</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Modelling of fire count data: fire disaster risk in Ghana.</ArticleTitle>
<Pagination>
<MedlinePgn>794</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1585-3</ELocationID>
<Abstract>
<AbstractText>Stochastic dynamics involved in ecological count data require distribution fitting procedures to model and make informed judgments. The study provides empirical research, focused on the provision of an early warning system and a spatial graph that can detect societal fire risks. It offers an opportunity for communities, organizations, risk managers, actuaries and governments to be aware of, and understand fire risks, so that they will increase the direct tackling of the threats posed by fire. Statistical distribution fitting method that best helps identify the stochastic dynamics of fire count data is used. The aim is to provide a fire-prediction model and fire spatial graph for observed fire count data. An empirical probability distribution model is fitted to the fire count data and compared to the theoretical probability distribution of the stochastic process of fire count data. The distribution fitted to the fire frequency count data helps identify the class of models that are exhibited by the fire and provides time leading decisions. The research suggests that fire frequency and loss (fire fatalities) count data in Ghana are best modelled with a Negative Binomial Distribution. The spatial map of observed fire frequency and fatality measured over 5 years (2007-2011) offers in this study a first regional assessment of fire frequency and fire fatality in Ghana. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Boadi</LastName>
<ForeName>Caleb</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Finance, University of Ghana Business School, Accra, Ghana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Harvey</LastName>
<ForeName>Simon K</ForeName>
<Initials>SK</Initials>
<AffiliationInfo>
<Affiliation>Department of Finance, University of Ghana Business School, Accra, Ghana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gyeke-Dako</LastName>
<ForeName>Agyapomaa</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Finance, University of Ghana Business School, Accra, Ghana.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688283</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Distribution fitting</Keyword>
<Keyword MajorTopicYN="N">Ecological data</Keyword>
<Keyword MajorTopicYN="N">Fatalities</Keyword>
<Keyword MajorTopicYN="N">Fire frequency</Keyword>
<Keyword MajorTopicYN="N">Negative binomial</Keyword>
<Keyword MajorTopicYN="N">Poisson</Keyword>
<Keyword MajorTopicYN="N">Statistical distribution</Keyword>
<Keyword MajorTopicYN="N">Stochastic</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702384</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>STOP-BANG questionnaire as a screening tool for diagnosis of obstructive sleep apnea by unattended portable monitoring sleep study.</ArticleTitle>
<Pagination>
<MedlinePgn>795</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1588-0</ELocationID>
<Abstract>
<AbstractText>The Snoring, Tiredness, Observed apnea, high blood Pressure (STOP)-Body mass index (BMI), Age, Neck circumference, and Gender (BANG) questionnaire is a well validated screening tool for diagnosis of Obstructive sleep apnea (OSA) by an in- lab sleep study. However, performance of STOP-BANG as a screening tool for diagnosis of OSA in patients undergoing portable monitoring (PM) sleep study has not been well validated. We conducted a retrospective chart review of patients older than 18 years who had unattended portable monitoring sleep study done at a VA medical center between June 2012 and October 2014. STOP-BANG questionnaire and Epworth sleepiness scale (ESS) were routinely done prior to study. Sensitivity, specificity, and positive predictive value (PPV) various STOP-BANG score thresholds were calculated for diagnosis of OSA defined by Apnea Hypopnea Index (AHI) ≥5. Out of 502 unattended portable monitoring sleep studies, there were 465 males and 37 females. STOP-BANG thresholds of ≥2 and 3 have high sensitivity of 99.8 and 98.9 %, respectively, but very low specificity. Higher score thresholds of ≥7 and 8 have high specificity of 95 and 98.3 %, and PPV of 98.1 and 98.5 %, respectively, but very low sensitivity. A threshold of ≥7 in patients with BMI ≥30 was 100 % specific. The false negative rate for unattended portable monitoring sleep study compared to in-lab study was 80 %. STOP-BANG score thresholds of ≥7 and 8 are highly specific and have high PPV and therefore can potentially reduce need of diagnostic sleep studies in selected patients. Score thresholds of ≤2 or 3 are highly sensitive for AHI ≥5 by unattended portable monitoring sleep study but have high false negative rates. Therefore, in-lab sleep study should be performed to rule out OSA. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Doshi</LastName>
<ForeName>Viral</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Division of Pulmonary, Critical Care and Sleep Medicine, University of Oklahoma Health Science Center and Oklahoma City VA Medical Center, Oklahoma City, OK USA ; 920 Stanton L Young Blvd, WP 1310, Oklahoma City, OK 73104 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Walia</LastName>
<ForeName>Reuben</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Division of Pulmonary, Critical Care and Sleep Medicine, University of Oklahoma Health Science Center and Oklahoma City VA Medical Center, Oklahoma City, OK USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jones</LastName>
<ForeName>Kellie</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Pulmonary, Critical Care and Sleep Medicine, University of Oklahoma Health Science Center and Oklahoma City VA Medical Center, Oklahoma City, OK USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aston</LastName>
<ForeName>Christopher E</ForeName>
<Initials>CE</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Awab</LastName>
<ForeName>Ahmed</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Pulmonary, Critical Care and Sleep Medicine, University of Oklahoma Health Science Center and Oklahoma City VA Medical Center, Oklahoma City, OK USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688291</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">AHI</Keyword>
<Keyword MajorTopicYN="N">Home sleep study</Keyword>
<Keyword MajorTopicYN="N">STOP-BANG</Keyword>
<Keyword MajorTopicYN="N">Unattended portable monitoring</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702385</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Health in Adapted Youth Sports Study (HAYS): health effects of sports participation in children and adolescents with a chronic disease or physical disability.</ArticleTitle>
<Pagination>
<MedlinePgn>796</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1589-z</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In typically developing children, participation in sports has been proven to be positively correlated to both physical and psychosocial health outcomes. In children and adolescents with a physical disability or chronic disease participation in both recreational and competitive sports is often reduced, while for this population an active lifestyle may be even more important in reaching optimal levels of physical and psychosocial health. Therefore, the aim of the Health in Adapted Youth Sports (HAYS) Study is to determine both negative and positive effects of sports on children and adolescents with a chronic disease or physical disability.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">In this cross-sectional study differences will be compared in regards to physical and psychosocial health, cognitive functioning, school performance, daily physical activity and injuries between children and adolescents with a chronic disease or physical disability who participate in sports and those who do not. Children and adolescents, both ambulatory and wheelchair dependent, in the age of 10-19 years with a physical disability or chronic disease will be included. "Sports" is defined as participation in an organized sport at least two times a week for a duration of 3 months or more prior to the assessment. Parametric and non-parametric statistics will be used to determine the differences between the two groups.</AbstractText>
<AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">This study provides insight in the effects of sports participation in relation to health, psychosocial functioning, physical activity and school performance in children and adolescents (10-19 years) with a chronic disease or physical disability. Results will guide healthcare professionals working with these children to better guide this population in reaching optimal levels of health and physical activity levels.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lankhorst</LastName>
<ForeName>Kristel</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Research Group Lifestyle and Health, Institute of Human Movement Studies, University of Applied Sciences, Utrecht, The Netherlands ; Partner of Shared Utrecht Pediatric Exercise Research (SUPER) Lab, Utrecht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van der Ende-Kastelijn</LastName>
<ForeName>Karin</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Research Group Lifestyle and Health, Institute of Human Movement Studies, University of Applied Sciences, Utrecht, The Netherlands ; Partner of Shared Utrecht Pediatric Exercise Research (SUPER) Lab, Utrecht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Groot</LastName>
<ForeName>Janke</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Research Group Lifestyle and Health, Institute of Human Movement Studies, University of Applied Sciences, Utrecht, The Netherlands ; Partner of Shared Utrecht Pediatric Exercise Research (SUPER) Lab, Utrecht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zwinkels</LastName>
<ForeName>Maremka</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Partner of Shared Utrecht Pediatric Exercise Research (SUPER) Lab, Utrecht, The Netherlands ; Brain Center Rudolf Magnus and Center of Excellence for Rehabilitation Medicine, University of Medical Center Utrecht and De Hoogstraat Rehabilitation, Utrecht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Verschuren</LastName>
<ForeName>Olaf</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Partner of Shared Utrecht Pediatric Exercise Research (SUPER) Lab, Utrecht, The Netherlands ; Brain Center Rudolf Magnus and Center of Excellence for Rehabilitation Medicine, University of Medical Center Utrecht and De Hoogstraat Rehabilitation, Utrecht, The Netherlands ; Department of Rehabilitation, Nursing Science and Sports, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Backx</LastName>
<ForeName>Frank</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Rehabilitation, Nursing Science and Sports, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Visser-Meily</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Brain Center Rudolf Magnus and Center of Excellence for Rehabilitation Medicine, University of Medical Center Utrecht and De Hoogstraat Rehabilitation, Utrecht, The Netherlands ; Department of Rehabilitation, Nursing Science and Sports, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Takken</LastName>
<ForeName>Tim</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Partner of Shared Utrecht Pediatric Exercise Research (SUPER) Lab, Utrecht, The Netherlands ; Child Development and Exercise Center, Wilhelmina Children's Hospital, University Medical Center Utrecht, P.O. Box 85090, 3508AB Utrecht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>HAYS study group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688297</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Children</Keyword>
<Keyword MajorTopicYN="N">Chronic disease</Keyword>
<Keyword MajorTopicYN="N">Health</Keyword>
<Keyword MajorTopicYN="N">Physical disability</Keyword>
<Keyword MajorTopicYN="N">Physical fitness</Keyword>
<Keyword MajorTopicYN="N">Sports participation</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702386</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Short selling and intraday volatility: evidence from the Chinese market.</ArticleTitle>
<Pagination>
<MedlinePgn>797</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1591-5</ELocationID>
<Abstract>
<AbstractText>The implementation of margin trading and securities lending mechanism offers us a unique circumstance to analyze the impact of short selling regulations in China. We define the addition events as the stocks are included to the designated securities list and therefore can be sold short. By focusing on the 30 trading days around the addition events, the results document statistically significant post-event increase in volatility relative to the overall market and absolute value of trading volume. Specifically, small-cap stocks experience the sharpest increase. The robustness is also performed to validate the results. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Yongjie</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>College of Management and Economics, Tianjin University, 300072 Tianjin, People's Republic of China ; China Center for Social Computing and Analytics, Tianjin University, 300072 Tianjin, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Keming</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>College of Management and Economics, Tianjin University, 300072 Tianjin, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shen</LastName>
<ForeName>Dehua</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>College of Management and Economics, Tianjin University, 300072 Tianjin, People's Republic of China ; China Center for Social Computing and Analytics, Tianjin University, 300072 Tianjin, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Wei</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>College of Management and Economics, Tianjin University, 300072 Tianjin, People's Republic of China ; China Center for Social Computing and Analytics, Tianjin University, 300072 Tianjin, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688298</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Chinese stock market</Keyword>
<Keyword MajorTopicYN="N">Intraday volatility</Keyword>
<Keyword MajorTopicYN="N">Relative ranking</Keyword>
<Keyword MajorTopicYN="N">Short selling</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702387</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Change in energy expenditure and physical activity in response to aerobic and resistance exercise programs.</ArticleTitle>
<Pagination>
<MedlinePgn>798</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1594-2</ELocationID>
<Abstract>
<AbstractText>Exercise is considered an important component of a healthy lifestyle but there remains controversy on effects of exercise on non-exercise physical activity (PA). The present study examined the prospective association of aerobic and resistance exercise with total daily energy expenditure and PA in previously sedentary, young men. Nine men (27.0 ± 3.3 years) completed two 16-week exercise programs (3 exercise sessions per week) of aerobic and resistance exercise separated by a minimum of 6 weeks in random order. Energy expenditure and PA were measured with the SenseWear Mini Armband prior to each intervention as well as during week 1, week 8 and week 16 of the aerobic and resistance exercise program. Body composition was measured via dual x-ray absorptiometry. Body composition did not change in response to either exercise intervention. Total daily energy expenditure on exercise days increased by 443 ± 126 kcal/d and 239 ± 152 kcal/d for aerobic and resistance exercise, respectively (p &lt; 0.01). Non-exercise moderate-to-vigorous PA, however, decreased on aerobic exercise days (-148 ± 161 kcal/d; p = 0.03). There was no change in total daily energy expenditure and PA on non-exercise days with aerobic exercise while resistance exercise was associated with an increase in moderate-to-vigorous PA during non-exercise days (216 ± 178 kcal/d, p = 0.01). Results of the present study suggest a compensatory reduction in PA in response to aerobic exercise. Resistance exercise, on the other hand, appears to facilitate non-exercise PA, particularly on non-exercise days, which may lead to more sustainable adaptations in response to an exercise program. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Drenowatz</LastName>
<ForeName>Clemens</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Exercise Science, University of South Carolina, Columbia, SC 29208 USA ; Arnold School of Public Health, Department of Exercise Science, University of South Carolina, 921 Assembly Str., Public Health Research Center, Columbia, SC 29208 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Grieve</LastName>
<ForeName>George L</ForeName>
<Initials>GL</Initials>
<AffiliationInfo>
<Affiliation>Department of Exercise Science, University of South Carolina, Columbia, SC 29208 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>DeMello</LastName>
<ForeName>Madison M</ForeName>
<Initials>MM</Initials>
<AffiliationInfo>
<Affiliation>Department of Exercise Science, University of South Carolina, Columbia, SC 29208 USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688292</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Aerobic training</Keyword>
<Keyword MajorTopicYN="N">Energy balance</Keyword>
<Keyword MajorTopicYN="N">Moderate-to-vigorous physical activity</Keyword>
<Keyword MajorTopicYN="N">Resistance training</Keyword>
<Keyword MajorTopicYN="N">Total daily energy expenditure</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702388</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Survival in water of Campylobacter jejuni strains isolated from the slaughterhouse.</ArticleTitle>
<Pagination>
<MedlinePgn>799</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1595-1</ELocationID>
<Abstract>
<AbstractText>Campylobacter jejuni cause gastroenteritis in humans. The main transmission vector is the consumption or handling of contaminated chicken meat, since chicken can be colonized asymptomatically by C. jejuni. However, water has been implicated as the transmission vector in a few outbreaks. One possibility is the contamination of water effluent by C. jejuni originating from chicken farm. The ability of C. jejuni to be transmitted by water would be closely associated to its ability to survive in water. Therefore, in this study, we have evaluated the ability of reference strains and chicken-isolated strains to survive in water. Defined water media were used, since the composition of tap water is variable. We showed that some isolates survive better than others in defined freshwater (Fraquil) and that the survival was affected by temperature and the concentration of NaCl. By comparing the ability of C. jejuni to survive in water with other phenotypic properties previously tested, we showed that the ability to survive in water was negatively correlated with autoagglutination. Our data showed that not all chicken isolates have the same ability to survive in water, which is probably due to difference in genetic content. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Trigui</LastName>
<ForeName>Hana</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Natural Resource Sciences, Faculty of Agricultural and Environmental Sciences, McGill University, 21,111 Lakeshore Road, Ste-Anne-de-Bellevue, Montreal, QC H9X 3V9 Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thibodeau</LastName>
<ForeName>Alexandre</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology and Microbiology, University of Montreeal, Saint-Hyacinthe, QC Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fravalo</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology and Microbiology, University of Montreeal, Saint-Hyacinthe, QC Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Letellier</LastName>
<ForeName>Ann</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology and Microbiology, University of Montreeal, Saint-Hyacinthe, QC Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>P Faucher</LastName>
<ForeName>Sebastien</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Natural Resource Sciences, Faculty of Agricultural and Environmental Sciences, McGill University, 21,111 Lakeshore Road, Ste-Anne-de-Bellevue, Montreal, QC H9X 3V9 Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688295</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702389</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>The role of spleen in the treatment of experimental lipopolysaccharide-induced sepsis with dexmedetomidine.</ArticleTitle>
<Pagination>
<MedlinePgn>800</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1598-y</ELocationID>
<Abstract>
<AbstractText>Dexmedetomidine (Dex), a highly selective α2-adrenergic receptor agonist, has been shown to attenuate systemic inflammatory response induced by lipopolysaccharide (LPS). The protective effects of Dex may reportedly be due to the activation of the α7 nicotinic acetylcholine receptor (α7nAChR)-dependent cholinergic anti-inflammatory pathway. Spleen has been shown to play a pivotal role in the neural cholinergic anti-inflammatory pathway. However, little is known about the specific function of spleen in the protective effects of Dex against sepsis. To investigate the role of spleen in the treatment of Dex against sepsis, we studied the effects of preemptive administration of Dex to septic mice on the NF-κB p65 activation and downstream pro-inflammatory cytokine expression in the spleen. Our results provided evidence that Dex treatment attenuated LPS-activated NF-κB p65 activation, as well as the production of tumor necrosis factor-α, interleukin-6, and interleukin-1β at the level of both mRNA and protein in spleen. Consequently, serum concentrations of these cytokines decreased. Conversely, preemptive injection of α-bungarotoxin, a selective α7nAChR antagonist, reversed these effects of Dex. Our findings indicated that spleen played a critical role in the protective effects of Dex against sepsis and provided further insight into the anti-inflammatory mechanisms of Dex. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Zhaoguo</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Binzhou Medical University Hospital, Binzhou, 256603 Shandong People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Yaoqi</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Binzhou Medical University Hospital, Binzhou, 256603 Shandong People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ning</LastName>
<ForeName>Qiaoqing</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Binzhou Medical University Hospital, Binzhou, 256603 Shandong People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gong</LastName>
<ForeName>Chunzhi</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Binzhou Medical University Hospital, Binzhou, 256603 Shandong People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Yong</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Binzhou Medical University Hospital, Binzhou, 256603 Shandong People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Li</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Binzhou Medical University Hospital, Binzhou, 256603 Shandong People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bu</LastName>
<ForeName>Xiangmei</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Binzhou Medical University Hospital, Binzhou, 256603 Shandong People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jing</LastName>
<ForeName>Guangjian</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Binzhou Medical University Hospital, Binzhou, 256603 Shandong People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688290</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cholinergic anti-inflammatory pathway</Keyword>
<Keyword MajorTopicYN="N">Dexmedetomidine</Keyword>
<Keyword MajorTopicYN="N">Lipopolysaccharides</Keyword>
<Keyword MajorTopicYN="N">Sepsis</Keyword>
<Keyword MajorTopicYN="N">Spleen</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702390</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Coping strategies among adolescents with chronic headache and mental health problems: a cross-sectional population-based study.</ArticleTitle>
<Pagination>
<MedlinePgn>801</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1599-x</ELocationID>
<Abstract>
<AbstractText>To examine prevalence of mental health problems among adolescents with chronic headache and compare internal and external coping strategies in young people with chronic headaches with and without mental health problems. This study is based on a cross-sectional survey undertaken in Akershus County in Norway. A total of 19,985 adolescents were included in the study, covering lower secondary and upper secondary students, aged 13-19 years. Chronic headache was measured with a single item question based on headache frequency. Mental health was assessed by using the strengths and difficulties questionnaire (SDQ). Internal and external coping strategies were assessed through seven options for answering the question: What do you do/what happens when you are burdened by painful thoughts and feelings? Adolescents with chronic headaches showed more frequent mental health problems overall (23 %) compared to those without chronic headache (6 %). Logistic regression analyses showed that those adolescents having both chronic headaches and comorbid mental health problems more frequently used internal coping strategies, such as keeping feelings inside (OR 2.05), using abusive substances (OR 1.79) and talking oneself out of problems (OR 1.55), compared to those without mental health problems. Groups with mental health problems, especially with chronic headache, less frequently used the external strategy of talking to others about their problem than controls (OR 0.7-0.8). Factor analyses revealed significant differences in profiles of coping strategies between groups. We suggest that attention should be paid towards the high risk group that has both chronic headaches and mental health problems and their tendency to use destructive internal coping strategies. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hartberg</LastName>
<ForeName>Silje</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Landscape Architecture and Spatial Planning, Norwegian University of Life Sciences, Aas, Norway ; Health Services Research Centre, Akershus University Hospital, Lørenskog, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Clench-Aas</LastName>
<ForeName>Jocelyne</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Division of Mental Health, Department of Health Surveillance and Prevention, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Raanaas</LastName>
<ForeName>Ruth Kjærsti</ForeName>
<Initials>RK</Initials>
<AffiliationInfo>
<Affiliation>Department of Landscape Architecture and Spatial Planning, Norwegian University of Life Sciences, Aas, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lundqvist</LastName>
<ForeName>Christofer</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Health Services Research Centre, Akershus University Hospital, Lørenskog, Norway ; Department of Neurology, Akershus University Hospital, Lørenskog, Norway ; Institute of Clinical Medicine, Campus Akershus University Hospital, University of Oslo, Nordbyhagen, Norway.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688278</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Mastery</Keyword>
<Keyword MajorTopicYN="N">Migraine</Keyword>
<Keyword MajorTopicYN="N">Strengths and difficulties questionnaire</Keyword>
<Keyword MajorTopicYN="N">Tension type headache</Keyword>
<Keyword MajorTopicYN="N">Young adults/students</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702391</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Causes, clinical features and outcomes of drug-induced liver injury in hospitalized patients in a Chinese tertiary care hospital.</ArticleTitle>
<Pagination>
<MedlinePgn>802</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1600-8</ELocationID>
<Abstract>
<AbstractText>Drug-induced liver injury (DILI) is an important liver disease in China, owing to the country's huge population and the availability of a multitude of drugs. Consequently, DILI is becoming an increasingly serious health problem. However, there is not enough relevant epidemiological data, and the clinical features of these patients are not clear. We conducted this study to report the causes and clinical features of DILI in hospitalized patients, and identify the mortality and predictive factors. We retrospectively collected and analyzed the data of all hospitalized patients whose discharge diagnosis was DILI at the Second Xiangya Hospital between January 2011 and December 2014. The data analyses were performed using SAS version 9.2. Among the 469 patients who were diagnosed with DILI at discharge, 361 met the criteria for DILI on re-evaluation. The crude annual incidence rate of DILI was 92.95 cases per 100,000 patients. Chinese herbal medicine was identified as the primary cause of DILI in 36.01 % of the patients. The overall mortality was 8.59 %. Alcohol consumption, use of antituberculosis drugs, serum total bilirubin, direct bilirubin, total protein, albumin, thrombinogen time, international normalized ratio, and the model for end-stage liver disease (MELD) score were significantly correlated with DILI-associated mortality. Among them, the MELD score and albumin were found to be independent predictors of outcome in patients with DILI. Chinese herbal medicine was the primary cause of DILI in the identified patients. The MELD score and albumin were independent predictors of outcome in patients with DILI. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ou</LastName>
<ForeName>Pengcheng</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Liver Diseases Center, The Second Xiangya Hospital of Central South University, Changsha, 410011 Hunan China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Yi</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Normin Health Changsha Representative Office, Changsha, 410011 Hunan China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Baozhen</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Liver Diseases Center, The Second Xiangya Hospital of Central South University, Changsha, 410011 Hunan China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Min</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Liver Diseases Center, The Second Xiangya Hospital of Central South University, Changsha, 410011 Hunan China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Xingyu</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Liver Diseases Center, The Second Xiangya Hospital of Central South University, Changsha, 410011 Hunan China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Fangfang</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Liver Diseases Center, The Second Xiangya Hospital of Central South University, Changsha, 410011 Hunan China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Yi</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Liver Diseases Center, The Second Xiangya Hospital of Central South University, Changsha, 410011 Hunan China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Chengwei</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Shanghai Liver Disease Research Center of Nanjing Military Area, Shanghai, 200235 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mao</LastName>
<ForeName>Yimin</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Division of Gastroenterology and Hepatology, Renji Hospital, School of Medicine, Shanghai Institute of Digestive Disease, Shanghai Jiao Tong University, Shanghai, 200127 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Jun</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Liver Diseases Center, The Second Xiangya Hospital of Central South University, Changsha, 410011 Hunan China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688287</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Chinese herbal medicine</Keyword>
<Keyword MajorTopicYN="N">Drug-induced liver injury</Keyword>
<Keyword MajorTopicYN="N">Incidence</Keyword>
<Keyword MajorTopicYN="N">Prognosis</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702392</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>A phase I dose-escalation study of a biosimilar trastuzumab in Chinese metastasis breast cancer patients.</ArticleTitle>
<Pagination>
<MedlinePgn>803</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1603-5</ELocationID>
<Abstract>
<AbstractText>Trastuzumab has been widely used among the breast cancer patients with human epidermal growth factor receptor 2 (HER2) overexpression. The genetically engineered trastuzumab traded as Cipterbin® was developed in China since 2003. We have disclosed the phase I clinical trial data of safety, pharmacokinetic profile (PK) in patients with metastasis breast cancer. Subjects identified as HER2 strong positive received single intravenously doses of 100, 250 or 500 mg Cipterbin® in dose-escalation manner. The safety evaluations were recorded and plasma concentration profiles for the drug were analyzed. 27 Chinese metastatic breast cancer patients were enrolled in this study. Patients in each group of different dosage were well-tolerated. The most frequently drug-related adverse events were fever (59.3 %), transaminase increased (22.2 %), chills (18.5 %) and arrhythmia (18.5 %). Only one patient with severe adverse event was observed in 250 mg group revealing brachycardia. PK profile analysis showed that sera steady concentration could be reached in dose-proportional manner, except volume of distribution (Vd) and clearance (CL), which reached peak values at 250 mg administration cohort. This genetically engineered HER2-target antibody had demonstrated the accepted safety with well-tolerated. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zhou</LastName>
<ForeName>Xinna</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Cancer Hospital &amp; Institute, Peking University School of Oncology, 52 Fucheng Rd, Beijing, 100142 China ; Department of Medical Oncology, Beijing Key Lab for Therapeutic Cancer Vaccines, Beijing Shijitan Hospital, Capital Medical University, 10 Tieyi Rd, Beijing, 100038 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yu</LastName>
<ForeName>Jing</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Cancer Hospital &amp; Institute, Peking University School of Oncology, 52 Fucheng Rd, Beijing, 100142 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Wenmiao</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Phase I Clinical Center, Beijing Shijitan Hospital, Capital Medical University, 10 Tieyi Rd, Beijing, 100038 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Song</LastName>
<ForeName>Guohong</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Cancer Hospital &amp; Institute, Peking University School of Oncology, 52 Fucheng Rd, Beijing, 100142 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Xiaoli</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Cancer Hospital &amp; Institute, Peking University School of Oncology, 52 Fucheng Rd, Beijing, 100142 China ; Department of Medical Oncology, Beijing Key Lab for Therapeutic Cancer Vaccines, Beijing Shijitan Hospital, Capital Medical University, 10 Tieyi Rd, Beijing, 100038 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ren</LastName>
<ForeName>Jun</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Cancer Hospital &amp; Institute, Peking University School of Oncology, 52 Fucheng Rd, Beijing, 100142 China ; Department of Medical Oncology, Beijing Key Lab for Therapeutic Cancer Vaccines, Beijing Shijitan Hospital, Capital Medical University, 10 Tieyi Rd, Beijing, 100038 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Di</LastName>
<ForeName>Lijun</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Cancer Hospital &amp; Institute, Peking University School of Oncology, 52 Fucheng Rd, Beijing, 100142 China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Xinghe</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Phase I Clinical Center, Beijing Shijitan Hospital, Capital Medical University, 10 Tieyi Rd, Beijing, 100038 China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688281</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Breast cancer</Keyword>
<Keyword MajorTopicYN="N">HER2 overexpressed</Keyword>
<Keyword MajorTopicYN="N">Pharmacokinetics</Keyword>
<Keyword MajorTopicYN="N">Trastuzumab</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702393</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">2193-1801</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>SpringerPlus</Title>
<ISOAbbreviation>Springerplus</ISOAbbreviation>
</Journal>
<ArticleTitle>Preferential epithelial expression of type-1 cannabinoid receptor (CB1R) in the developing canine embryo.</ArticleTitle>
<Pagination>
<MedlinePgn>804</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1616-0</ELocationID>
<Abstract>
<AbstractText>The use of cannabinoid receptor agonists is gaining a strong interest both in human and veterinary medicine. The potential use of cannabimimetic compounds in companion animals was reviewed in 2007 for their role in tissue inflammation and pain. A better knowledge of type-1 cannabinoid receptor (CB1R) expression on the target population may help in risk management in order to prevent unwanted side effects. We used 30-days old canine embryos to describe the distribution of CB1R by means of immunohistochemistry with a commercially available antibody.CB1R immunoreactivity was mainly epithelial and included most structures of central and peripheral nervous system, inner ear, olfactory epithelium and related structures, eye and thyroid. Further investigative research on the role of the endocannabinoid system in the developmental biology field is needed, however, we show that in the canine species we must consider pregnancy as risk condition for developmental abnormalities that may arise upon the use of CB1R receptor agonists. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pirone</LastName>
<ForeName>Andrea</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Veterinary Sciences, University of Pisa, Viale Delle Piagge 2, 56124 Pisa, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lenzi</LastName>
<ForeName>Carla</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Veterinary Sciences, University of Pisa, Viale Delle Piagge 2, 56124 Pisa, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Coli</LastName>
<ForeName>Alessandra</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Veterinary Sciences, University of Pisa, Viale Delle Piagge 2, 56124 Pisa, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Giannessi</LastName>
<ForeName>Elisabetta</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Veterinary Sciences, University of Pisa, Viale Delle Piagge 2, 56124 Pisa, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stornelli</LastName>
<ForeName>Maria Rita</ForeName>
<Initials>MR</Initials>
<AffiliationInfo>
<Affiliation>Department of Veterinary Sciences, University of Pisa, Viale Delle Piagge 2, 56124 Pisa, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Miragliotta</LastName>
<ForeName>Vincenzo</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Department of Veterinary Sciences, University of Pisa, Viale Delle Piagge 2, 56124 Pisa, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Springerplus</MedlineTA>
<NlmUniqueID>101597967</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688286</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cannabinoid receptor 1</Keyword>
<Keyword MajorTopicYN="N">Dog</Keyword>
<Keyword MajorTopicYN="N">Embryo</Keyword>
<Keyword MajorTopicYN="N">Immunohistochemistry</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702302</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1872-5325</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>9</Volume>
<Issue>Suppl 1</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Systems and synthetic biology</Title>
<ISOAbbreviation>Syst Synth Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>Recent advances and versatility of MAGE towards industrial applications.</ArticleTitle>
<Pagination>
<MedlinePgn>1-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11693-015-9184-8</ELocationID>
<Abstract>
<AbstractText>The genome engineering toolkit has expanded significantly in recent years, allowing us to study the functions of genes in cellular networks and assist in over-production of proteins, drugs, chemicals and biofuels. Multiplex automated genome engineering (MAGE) has been recently developed and gained more scientific interest towards strain engineering. MAGE is a simple, rapid and efficient tool for manipulating genes simultaneously in multiple loci, assigning genetic codes and integrating non-natural amino acids. MAGE can be further expanded towards the engineering of fast, robust and over-producing strains for chemicals, drugs and biofuels at industrial scales. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Vijai</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Institute of Systems and Synthetic Biology, Université d'Évry Val d'Essonne, Genopole Campus 1, Batiment Genavenir 6, 5 rue Henri Desbruères, 91030 Évry, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Braddick</LastName>
<ForeName>Darren</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Institute of Systems and Synthetic Biology, Université d'Évry Val d'Essonne, Genopole Campus 1, Batiment Genavenir 6, 5 rue Henri Desbruères, 91030 Évry, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Syst Synth Biol</MedlineTA>
<NlmUniqueID>101300404</NlmUniqueID>
<ISSNLinking>1872-5325</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688408 [Available on 12/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Biofuels</Keyword>
<Keyword MajorTopicYN="N">Chemicals</Keyword>
<Keyword MajorTopicYN="N">Drugs</Keyword>
<Keyword MajorTopicYN="N">Genome</Keyword>
<Keyword MajorTopicYN="N">Multiplex automated genome engineering</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702303</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1872-5325</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>9</Volume>
<Issue>Suppl 1</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Systems and synthetic biology</Title>
<ISOAbbreviation>Syst Synth Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>In silico characterization of Plasmodium falciparum purinergic receptor: a novel chemotherapeutic target.</ArticleTitle>
<Pagination>
<MedlinePgn>11-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11693-015-9165-y</ELocationID>
<Abstract>
<AbstractText>Serpentine receptors with G-protein coupled receptor like seven transmembrane (7 TM) topology are identified in Plasmodium. A class of 7 TM receptors known as purinergic receptors binds to purines such as ADP, ATP and UTP and mediates important physiological functions including regulation of calcium signaling. Here we performed in silico analysis of Plasmodium falciparum serpentine receptors and found that one of the P. falciparum serpentine receptors, PfSR12 possess nucleotide binding consensus P-loop sequence in addition to seven transmembrane domains. The presence of conserved seven transmembrane domains and a consensus nucleotide binding sequence (P-loop) suggest that PfSR12 is a putative purinergic receptor. On further analysis using docking programmes we found four active binding residues Asn149, Lys150, Asn151 and Gly152 in P-loop of PfSR12, interact with ATP. This work gives insights into the interactions between putative purinergic receptor PfSR12 and its ligand ATP which can be explored in structure based drug designing against malaria. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gupta</LastName>
<ForeName>Sonal</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Deepak</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Shiv Nadar University, Gautam Budh Nagar, 203207 UP India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Shailja</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Shiv Nadar University, Gautam Budh Nagar, 203207 UP India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>04</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Syst Synth Biol</MedlineTA>
<NlmUniqueID>101300404</NlmUniqueID>
<ISSNLinking>1872-5325</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688407 [Available on 12/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">ATP</Keyword>
<Keyword MajorTopicYN="N">Malaria</Keyword>
<Keyword MajorTopicYN="N">Plasmodium falciparum</Keyword>
<Keyword MajorTopicYN="N">Purinergic receptor</Keyword>
<Keyword MajorTopicYN="N">Serpentine receptor</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702304</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1872-5325</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>9</Volume>
<Issue>Suppl 1</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Systems and synthetic biology</Title>
<ISOAbbreviation>Syst Synth Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>In silico analysis of calcium binding pocket of perforin like protein 1: insights into the regulation of pore formation.</ArticleTitle>
<Pagination>
<MedlinePgn>17-21</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11693-015-9166-x</ELocationID>
<Abstract>
<AbstractText>Plasmodium falciparum perforin like proteins (PfPLPs) are an important arsenal for the entry and exit of malaria parasites. These proteins bind and oligomerize on the membrane in calcium dependent manner and form an open pore. The calcium dependent pore forming activity of PLPs is usually conferred by their C2 like C-terminal domain. Here, we have tried to elucidate the calcium binding residues in the C-terminal domain of PfPLP1, a member of P. falciparum PLPs, playing a crucial role in calcium dependent egress of blood stage parasites. Through our in silico study, we have found that the C-terminal domain of all PfPLPs is rich in β-pleated sheets and is structurally similar to C2 domain of human perforin. Furthermore, homology search based on 3-D structure of PfPLP1 confirmed that it is structurally homologous to the calcium binding C2 domain of many proteins. On further elucidation of the calcium-binding pocket of the C2 like domain of PfPLP1 showed that it binds to two calcium molecules. The calcium-binding pocket could be a target of novel chemotherapeutics for studying functional role of PfPLPs in parasite biology as well as for limiting blood stage growth of malaria parasite. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Garg</LastName>
<ForeName>Swati</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sharma</LastName>
<ForeName>Vijeta</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Shiv Nadar University, Gautam Budha Nagar, 201314 UP India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ramu</LastName>
<ForeName>Dandugudumula</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Shiv Nadar University, Gautam Budha Nagar, 201314 UP India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Shailja</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Shiv Nadar University, Gautam Budha Nagar, 201314 UP India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>04</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Syst Synth Biol</MedlineTA>
<NlmUniqueID>101300404</NlmUniqueID>
<ISSNLinking>1872-5325</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688409 [Available on 12/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">C2 domain</Keyword>
<Keyword MajorTopicYN="N">Calcium</Keyword>
<Keyword MajorTopicYN="N">Malaria</Keyword>
<Keyword MajorTopicYN="N">Perforin</Keyword>
<Keyword MajorTopicYN="N">Perforin like protein (PLP)</Keyword>
<Keyword MajorTopicYN="N">Plasmodium</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702305</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1872-5325</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>9</Volume>
<Issue>Suppl 1</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Systems and synthetic biology</Title>
<ISOAbbreviation>Syst Synth Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>Visualization and quantification of Plasmodium falciparum intraerythrocytic merozoites.</ArticleTitle>
<Pagination>
<MedlinePgn>23-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11693-015-9167-9</ELocationID>
<Abstract>
<AbstractText>Malaria, a leading parasitic killer, is caused by Plasmodium spp. The pathology of the disease starts when Plasmodium merozoites infect erythrocytes to form rings, that matures through a large trophozoite form and develop into schizonts containing multiple merozoites. The number of intra-erythrocytic merozoites is a key-determining factor for multiplication rate of the parasite. Counting of intraerythrocytic merozoites by classical 2-D microscopy method is error prone due to insufficient representation of merozoite in one optical plane of a schizont. Here, we report an alternative 3-D microscopy based automated method for counting of intraerythrocytic merozoites in entire volume of schizont. This method offers a considerable amount of advantages in terms of both, ease and accuracy. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Garg</LastName>
<ForeName>Swati</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, 110067 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Agarwal</LastName>
<ForeName>Shalini</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, 110067 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dabral</LastName>
<ForeName>Surbhi</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, 110067 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>Naveen</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Life Sciences, Shiv Nadar University, Gautam Budha Nagar, 203207 UP India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sehrawat</LastName>
<ForeName>Seema</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Life Sciences, Shiv Nadar University, Gautam Budha Nagar, 203207 UP India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Shailja</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Life Sciences, Shiv Nadar University, Gautam Budha Nagar, 203207 UP India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>04</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Syst Synth Biol</MedlineTA>
<NlmUniqueID>101300404</NlmUniqueID>
<ISSNLinking>1872-5325</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688406 [Available on 12/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">2-D microscopy</Keyword>
<Keyword MajorTopicYN="N">3-D microscopy</Keyword>
<Keyword MajorTopicYN="N">Imaris</Keyword>
<Keyword MajorTopicYN="N">Malaria</Keyword>
<Keyword MajorTopicYN="N">Merozoites</Keyword>
<Keyword MajorTopicYN="N">Plasmodium</Keyword>
<Keyword MajorTopicYN="N">Schizonts</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702306</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1872-5325</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>9</Volume>
<Issue>Suppl 1</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Systems and synthetic biology</Title>
<ISOAbbreviation>Syst Synth Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>Structural insights into a key carotenogenesis related enzyme phytoene synthase of P. falciparum: a novel drug target for malaria.</ArticleTitle>
<Pagination>
<MedlinePgn>27-37</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11693-015-9168-8</ELocationID>
<Abstract>
<AbstractText>Carotenoids represent a diverse group of pigments derived from the common isoprenoid precursors and fulfill a variety of critical functions in plants and animals. Phytoene synthase (PSY), a transferase enzyme that catalyzes the first specific step in carotenoid biosynthesis plays a central role in the regulation of a number of essential functions mediated via carotenoids. PSYs have been deeply investigated in plants, bacteria and algae however in apicomplexans it is poorly studied. In an effort to characterize PSY in apicomplexans especially the malaria parasite Plasmodium falciparum (P. falciparum), a detailed bioinformatics analysis is undertaken. We have analysed the Phylogenetic relationship of PSY also referred to as octaprenyl pyrophosphate synthase (OPPS) in P. falciparum with other taxonomic groups. Further, we in silico characterized the secondary and tertiary structures of P. falciparum PSY/OPPS and compared the tertiary structures with crystal structure of Thermotoga maritima (T. maritima) OPPS. Our results evidenced the resemblance of P. falciparum PSY with the active site of T. maritima OPPS. Interestingly, the comparative structural analysis revealed an unconserved unique loop in P. falciparum OPPS/PSY. Such structural insights might contribute novel accessory functions to the protein thus, offering potential drug targets. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Agarwal</LastName>
<ForeName>Shalini</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067 India ; Department of Biotechnology, Jamia Hamdard, Hamdard Nagar, New Delhi, 110062 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sharma</LastName>
<ForeName>Vijeta</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Shiv Nadar University, Gautam Buddha Nagar, 201314 UP India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Phulera</LastName>
<ForeName>Swastik</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>National Centre for Cell Science, NCCS Complex, Pune, 411007 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abdin</LastName>
<ForeName>M Z</ForeName>
<Initials>MZ</Initials>
<AffiliationInfo>
<Affiliation>Department of Biotechnology, Jamia Hamdard, Hamdard Nagar, New Delhi, 110062 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ayana</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Shiv Nadar University, Gautam Buddha Nagar, 201314 UP India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Shailja</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Shiv Nadar University, Gautam Buddha Nagar, 201314 UP India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>04</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Syst Synth Biol</MedlineTA>
<NlmUniqueID>101300404</NlmUniqueID>
<ISSNLinking>1872-5325</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688404 [Available on 12/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Apicomplexa</Keyword>
<Keyword MajorTopicYN="N">Carotenoid biosynthesis</Keyword>
<Keyword MajorTopicYN="N">Isoprenoid</Keyword>
<Keyword MajorTopicYN="N">OPPS</Keyword>
<Keyword MajorTopicYN="N">PSY</Keyword>
<Keyword MajorTopicYN="N">Phytoene</Keyword>
<Keyword MajorTopicYN="N">Plasmodium falciparum</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702307</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1872-5325</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>9</Volume>
<Issue>Suppl 1</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Systems and synthetic biology</Title>
<ISOAbbreviation>Syst Synth Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>Innovative techniques to discover novel antimalarials.</ArticleTitle>
<Pagination>
<MedlinePgn>39-42</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11693-015-9170-1</ELocationID>
<Abstract>
<AbstractText>Malaria a global pandemic has engulfed nearly 0.63 million people globally. It is high time that a cure for malaria is required to stop its ever increasing menace. Our commentary discusses the advent and contribution of genetic algorithm (GA) in the drug discovery efforts towards developing cure for malaria. GAs are computational models of Darwinian evolution, ideally capture and mimic the principles of genetic variation and natural selection to evolve good solutions through multiple iterations on the space of all possible candidate solutions, called the search space, to a given optimization problem. Herein we will discuss the applications, advantages, disadvantages and future directions of GA with respect to malaria. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hati</LastName>
<ForeName>Santanu</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, School of Natural Science, Shiv Nadar University, Tehsil Dadri, Chithera, Gautam Budhnagar, 201314 UP India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bhattacharya</LastName>
<ForeName>Sudeepto</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Mathematics, School of Natural Science, Shiv Nadar University, Tehsil Dadri, Village Chithera, Gautam Budhnagar, 201314 UP India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sen</LastName>
<ForeName>Subhabrata</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, School of Natural Science, Shiv Nadar University, Tehsil Dadri, Chithera, Gautam Budhnagar, 201314 UP India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>04</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Syst Synth Biol</MedlineTA>
<NlmUniqueID>101300404</NlmUniqueID>
<ISSNLinking>1872-5325</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688411 [Available on 12/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Genetic algorithm</Keyword>
<Keyword MajorTopicYN="N">Malaria</Keyword>
<Keyword MajorTopicYN="N">Metaheuristics</Keyword>
<Keyword MajorTopicYN="N">P. Falciparum</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702308</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1872-5325</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>9</Volume>
<Issue>Suppl 1</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Systems and synthetic biology</Title>
<ISOAbbreviation>Syst Synth Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>Implementation of a genetic logic circuit: bio-register.</ArticleTitle>
<Pagination>
<MedlinePgn>43-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11693-015-9186-6</ELocationID>
<Abstract>
<AbstractText>We introduce an idea of synthesizing a class of genetic registers based on the existing sequential biological circuits, which are composed of fundamental biological gates. In the renowned literature, biological gates and genetic oscillator have been unveiled and experimentally realized in recent years. These biological circuits have formed a basis for realizing a primitive biocomputer. In the traditional computer architecture, there is an intermediate load-store section, i.e. a register, which serves as a part of the digital processor. With which, the processor can load data from a larger memory into it and proceed to conduct necessary arithmetic or logic operations. Then, manipulated data are stored back to the memory by instruction via the register. We propose here a class of bio-registers for the biocomputer. Four types of register structures are presented. In silicon experiments illustrate results of the proposed design. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lin</LastName>
<ForeName>Chun-Liang</ForeName>
<Initials>CL</Initials>
<Identifier Source="ORCID">0000-0002-8520-3450</Identifier>
<AffiliationInfo>
<Affiliation>Department of Electrical Engineering, National Chung Hsing University, Taichung 402, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kuo</LastName>
<ForeName>Ting-Yu</ForeName>
<Initials>TY</Initials>
<AffiliationInfo>
<Affiliation>Department of Electrical Engineering, National Chung Hsing University, Taichung 402, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Yang-Yi</ForeName>
<Initials>YY</Initials>
<AffiliationInfo>
<Affiliation>Department of Electrical Engineering, National Chung Hsing University, Taichung 402, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Syst Synth Biol</MedlineTA>
<NlmUniqueID>101300404</NlmUniqueID>
<ISSNLinking>1872-5325</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688412 [Available on 12/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bio-computer</Keyword>
<Keyword MajorTopicYN="N">Bio-register</Keyword>
<Keyword MajorTopicYN="N">Genetic logic gate</Keyword>
<Keyword MajorTopicYN="N">Synthetic biology</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702309</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1872-5325</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>9</Volume>
<Issue>Suppl 1</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Systems and synthetic biology</Title>
<ISOAbbreviation>Syst Synth Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>Diversity oriented synthesis for novel anti-malarials.</ArticleTitle>
<Pagination>
<MedlinePgn>49-53</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11693-015-9171-0</ELocationID>
<Abstract>
<AbstractText>Malaria a global pandemic has engulfed nearly 0.63 million people globally. It is high time that a cure for malaria is required to stop its ever increasing menace. Our commentary discusses the advent and contribution of diversity oriented synthesis (DOS) in the drug discovery efforts towards developing cure for malaria. DOS based on chemical genetics focusses on design and synthesis of molecular libraries which covers large tracts of biologically relevant chemical space. Herein we will discuss the applications, advantages, disadvantages and future directions of DOS with respect to malaria. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bathula</LastName>
<ForeName>Chandramohan</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, School of Natural Science, Shiv Nadar University, Village Chithera, Tehsil Dadri, District Gautam Buddha Nagar, 201314 UP India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Shailja</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Life Science, School of Natural Science, Shiv Nadar University, Village Chithera, Tehsil Dadri, District Gautam Buddha Nagar, 201314 UP India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sen</LastName>
<ForeName>Subhabrata</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, School of Natural Science, Shiv Nadar University, Village Chithera, Tehsil Dadri, District Gautam Buddha Nagar, 201314 UP India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Syst Synth Biol</MedlineTA>
<NlmUniqueID>101300404</NlmUniqueID>
<ISSNLinking>1872-5325</ISSNLinking>
</MedlineJournalInfo>
<CommentsCorrectionsList>
<CommentsCorrections RefType="ErratumIn">
<RefSource>Syst Synth Biol. 2015 Dec;9(Suppl 1):55</RefSource>
<PMID Version="1">26705261</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">PMC4688405 [Available on 12/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Chemical genetics</Keyword>
<Keyword MajorTopicYN="N">Diversity oriented synthesis</Keyword>
<Keyword MajorTopicYN="N">Michael addition</Keyword>
<Keyword MajorTopicYN="N">Phenotypic screening</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702310</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1872-5325</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>9</Volume>
<Issue>Suppl 1</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Systems and synthetic biology</Title>
<ISOAbbreviation>Syst Synth Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>On genome annotation of Brucellaphage Gadvasu (BpG): discovery of ORFans for integrated systems biology approaches.</ArticleTitle>
<Pagination>
<MedlinePgn>57-62</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11693-015-9185-7</ELocationID>
<Abstract>
<AbstractText>Brucellaphage Gadvasu (BpG) is a lytic phage infecting Brucella spp. Brucellaphages contain dsDNA as genetic material and are short-tailed particles with host-specificity. Here, we report the challenges on annotation in the complete genome sequence of BpG when compared with that of a recent broad host-range brucellaphage Pr, an original reference genome. The extracted DNA was subjected to genome sequencing with Illumina technology and assembled using SSAKE/Velvet. A significant number of genes were found to be similar between the phages with sequence analysis revealing conserved open reading frames that correspond to 33 gene ontology classifiers, transcriptional terminators and a few putative transcriptional promoters. The analyses revealed that the genome constitutes 1269 contigs and 275 genes encoding 260 proteins. The sequence comparison from the reference data indicated that the genome shares an approximately 70 % nucleotide similarity and differs mainly in the region encoding proteins. We bring this commentary providing an overview of how this exemplar genome can allow us to understand these known unknown regions in brucellaphages. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chachra</LastName>
<ForeName>Deepti</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Veterinary Microbiology, College of Veterinary Science, GADVASU, Ludhiana, Punjab 141004 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kaur</LastName>
<ForeName>Pushpinder</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Veterinary Microbiology, College of Veterinary Science, GADVASU, Ludhiana, Punjab 141004 India ; Food and Agricultural Products Center, Oklahoma State University, Stillwater, OK 74078-6055 USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Siddavatam</LastName>
<ForeName>Prasad</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Bioclues.org, Kukatpally, Hyderabad, 500 072 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Suravajhala</LastName>
<ForeName>Prashanth</ForeName>
<Initials>P</Initials>
<Identifier Source="ORCID">0000-0002-8535-278X</Identifier>
<AffiliationInfo>
<Affiliation>Bioclues.org, Kukatpally, Hyderabad, 500 072 India ; Bioinformatics Organization, 28 Pope St, Hudson, MA 01749 USA ; Center for Quantitative Genetics and Genomics, Department of Molecular Biology and Genetics, Aarhus University, 8830 Tjele, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Saxena</LastName>
<ForeName>Hari Mohan</ForeName>
<Initials>HM</Initials>
<AffiliationInfo>
<Affiliation>Department of Veterinary Microbiology, College of Veterinary Science, GADVASU, Ludhiana, Punjab 141004 India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Syst Synth Biol</MedlineTA>
<NlmUniqueID>101300404</NlmUniqueID>
<ISSNLinking>1872-5325</ISSNLinking>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4688410 [Available on 12/01/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Annotation</Keyword>
<Keyword MajorTopicYN="N">Brucellaphage</Keyword>
<Keyword MajorTopicYN="N">De novo assembly</Keyword>
<Keyword MajorTopicYN="N">Genome mapping</Keyword>
<Keyword MajorTopicYN="N">Next generation sequencing</Keyword>
<Keyword MajorTopicYN="N">Whole genome sequence</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26702328</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1920-8642</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>6</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>World journal of emergency medicine</Title>
<ISOAbbreviation>World J Emerg Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Expert consensus on the perioperative management of patients with sepsis.</ArticleTitle>
<Pagination>
<MedlinePgn>245-60</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5847/wjem.j.1920-8642.2015.04.001</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Jun-Ping</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Ningbo Number 2 Hospital, Ningbo, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fang</LastName>
<ForeName>Xiang-Ming</ForeName>
<Initials>XM</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jin</LastName>
<ForeName>Xiao-Ju</ForeName>
<Initials>XJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology and Critical Care Medicine, Yijishan Hospital, Wannan Medical College, Wuhu, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kang</LastName>
<ForeName>Rong-Tian</ForeName>
<Initials>RT</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Second Hospital of Hebei Medical University, Shijiazhuang, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Ke-Xuan</ForeName>
<Initials>KX</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Jin-Bao</ForeName>
<Initials>JB</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology and Intensive Care Medicine, Changhai Hospital, Second Military Medical University, Shanghai, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Luo</LastName>
<ForeName>Yan</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lu</LastName>
<ForeName>Zhi-Jie</ForeName>
<Initials>ZJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology and Intensive Care Medicine, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Miao</LastName>
<ForeName>Chang-Hong</ForeName>
<Initials>CH</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ma</LastName>
<ForeName>Han-Xiang</ForeName>
<Initials>HX</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, General Hospital of Ningxia Medical University, Yinchuan, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mei</LastName>
<ForeName>Wei</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ou</LastName>
<ForeName>Yang-Wen</ForeName>
<Initials>YW</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Qi</LastName>
<ForeName>Si-Hua</ForeName>
<Initials>SH</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Fourth Affiliated Hospital, Harbin Medical University, Harbin, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Qin</LastName>
<ForeName>Zai-Sheng</ForeName>
<Initials>ZS</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tian</LastName>
<ForeName>Guo-Gang</ForeName>
<Initials>GG</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, People's Hospital of Sanya, Sanya, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>An-Shi</ForeName>
<Initials>AS</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Dong-Xin</ForeName>
<Initials>DX</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology and Surgical Intensive Care, Peking University First Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yu</LastName>
<ForeName>Tian</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Affiliated Hospital of Zunyi Medical College, Zunyi, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yu</LastName>
<ForeName>Yong-Hao</ForeName>
<Initials>YH</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Tianjin Medical University General Hospital, and Tianjin Research Institute of Anesthesiology, Tianjin, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhao</LastName>
<ForeName>Jing</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zuo</LastName>
<ForeName>Ming-Zhang</ForeName>
<Initials>MZ</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Beijing Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Shi-Hai</ForeName>
<Initials>SH</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>China</Country>
<MedlineTA>World J Emerg Med</MedlineTA>
<NlmUniqueID>101549691</NlmUniqueID>
</MedlineJournalInfo>
<OtherID Source="NLM">PMC4677066</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26702831</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>25</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1878-1551</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>35</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
<Day>21</Day>
</PubDate>
</JournalIssue>
<Title>Developmental cell</Title>
<ISOAbbreviation>Dev. Cell</ISOAbbreviation>
</Journal>
<ArticleTitle>Oligomerization but Not Membrane Bending Underlies the Function of Certain F-BAR Proteins in Cell Motility and Cytokinesis.</ArticleTitle>
<Pagination>
<MedlinePgn>725-36</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.devcel.2015.11.023</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1534-5807(15)00758-3</ELocationID>
<Abstract>
<AbstractText>F-BAR proteins function in diverse cellular processes by linking membranes to the actin cytoskeleton. Through oligomerization, multiple F-BAR domains can bend membranes into tubules, though the physiological importance of F-BAR-to-F-BAR assemblies is not yet known. Here, we investigate the F-BAR domain of the essential cytokinetic scaffold, Schizosaccharomyces pombe Cdc15, during cytokinesis. Challenging a widely held view that membrane deformation is a fundamental property of F-BARs, we report that the Cdc15 F-BAR binds, but does not deform, membranes in vivo or in vitro, and six human F-BAR domains-including those from Fer and RhoGAP4-share this property. Nevertheless, tip-to-tip interactions between F-BAR dimers are critical for Cdc15 oligomerization and high-avidity membrane binding, stabilization of contractile ring components at the medial cortex, and the fidelity of cytokinesis. F-BAR oligomerization is also critical for Fer and RhoGAP4 physiological function, demonstrating its broad importance to F-BAR proteins that function without membrane bending. </AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>McDonald</LastName>
<ForeName>Nathan A</ForeName>
<Initials>NA</Initials>
<AffiliationInfo>
<Affiliation>Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vander Kooi</LastName>
<ForeName>Craig W</ForeName>
<Initials>CW</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40535, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ohi</LastName>
<ForeName>Melanie D</ForeName>
<Initials>MD</Initials>
<AffiliationInfo>
<Affiliation>Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gould</LastName>
<ForeName>Kathleen L</ForeName>
<Initials>KL</Initials>
<AffiliationInfo>
<Affiliation>Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. Electronic address: kathy.gould@vanderbilt.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 GM101035</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Dev Cell</MedlineTA>
<NlmUniqueID>101120028</NlmUniqueID>
<ISSNLinking>1534-5807</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26702833</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>25</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1878-1551</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>35</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
<Day>21</Day>
</PubDate>
</JournalIssue>
<Title>Developmental cell</Title>
<ISOAbbreviation>Dev. Cell</ISOAbbreviation>
</Journal>
<ArticleTitle>Genetic and Epigenetic Variation, but Not Diet, Shape the Sperm Methylome.</ArticleTitle>
<Pagination>
<MedlinePgn>750-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.devcel.2015.11.024</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1534-5807(15)00759-5</ELocationID>
<Abstract>
<AbstractText>Paternal diet can impact metabolic phenotypes in offspring, but mechanisms underlying such intergenerational information transfer remain obscure. Here, we interrogate cytosine methylation patterns in sperm obtained from mice consuming one of three diets, generating whole genome methylation maps for four pools of sperm samples and for 12 individual sperm samples, as well as 61 genome-scale methylation maps. We find that "epivariation," either stochastic or due to unknown demographic or environmental factors, was a far stronger contributor to the sperm methylome than was the diet consumed. Variation in cytosine methylation was particularly dramatic over tandem repeat families, including ribosomal DNA (rDNA) repeats, but rDNA methylation was strongly correlated with genetic variation in rDNA copy number and was not influenced by paternal diet. These results identify loci of genetic and epigenetic lability in the mammalian genome but argue against a direct role for sperm cytosine methylation in dietary reprogramming of offspring metabolism. </AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shea</LastName>
<ForeName>Jeremy M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Serra</LastName>
<ForeName>Ryan W</ForeName>
<Initials>RW</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Carone</LastName>
<ForeName>Benjamin R</ForeName>
<Initials>BR</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shulha</LastName>
<ForeName>Hennady P</ForeName>
<Initials>HP</Initials>
<AffiliationInfo>
<Affiliation>Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA; Bioinformatics Core, University of Massachusetts Medical School, Worcester, MA 01605, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kucukural</LastName>
<ForeName>Alper</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA; Bioinformatics Core, University of Massachusetts Medical School, Worcester, MA 01605, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ziller</LastName>
<ForeName>Michael J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vallaster</LastName>
<ForeName>Markus P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gu</LastName>
<ForeName>Hongcang</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tapper</LastName>
<ForeName>Andrew R</ForeName>
<Initials>AR</Initials>
<AffiliationInfo>
<Affiliation>Brudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of Massachusetts Medical School, Worcester, MA 01604, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gardner</LastName>
<ForeName>Paul D</ForeName>
<Initials>PD</Initials>
<AffiliationInfo>
<Affiliation>Brudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of Massachusetts Medical School, Worcester, MA 01604, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Meissner</LastName>
<ForeName>Alexander</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Garber</LastName>
<ForeName>Manuel</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA; Bioinformatics Core, University of Massachusetts Medical School, Worcester, MA 01605, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rando</LastName>
<ForeName>Oliver J</ForeName>
<Initials>OJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA. Electronic address: oliver.rando@umassmed.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 DA033664</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HD080224</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Dev Cell</MedlineTA>
<NlmUniqueID>101120028</NlmUniqueID>
<ISSNLinking>1534-5807</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26702835</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>25</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1878-1551</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>35</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
<Day>21</Day>
</PubDate>
</JournalIssue>
<Title>Developmental cell</Title>
<ISOAbbreviation>Dev. Cell</ISOAbbreviation>
</Journal>
<ArticleTitle>Progressive Differentiation and Instructive Capacities of Amniotic Fluid and Cerebrospinal Fluid Proteomes following Neural Tube Closure.</ArticleTitle>
<Pagination>
<MedlinePgn>789-802</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.devcel.2015.11.015</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1534-5807(15)00750-9</ELocationID>
<Abstract>
<AbstractText>After neural tube closure, amniotic fluid (AF) captured inside the neural tube forms the nascent cerebrospinal fluid (CSF). Neuroepithelial stem cells contact CSF-filled ventricles, proliferate, and differentiate to form the mammalian brain, while neurogenic placodes, which generate cranial sensory neurons, remain in contact with the AF. Using in vivo ultrasound imaging, we quantified the expansion of the embryonic ventricular-CSF space from its inception. We developed tools to obtain pure AF and nascent CSF, before and after neural tube closure, and to define how the AF and CSF proteomes diverge during mouse development. Using embryonic neural explants, we demonstrate that age-matched fluids promote Sox2-positive neurogenic identity in developing forebrain and olfactory epithelia. Nascent CSF also stimulates SOX2-positive self-renewal of forebrain progenitor cells, some of which is attributable to LIFR signaling. Our Resource should facilitate the investigation of fluid-tissue interactions during this highly vulnerable stage of early brain development. </AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chau</LastName>
<ForeName>Kevin F</ForeName>
<Initials>KF</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Boston Children's Hospital, Boston, MA 02115, USA; Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, MA 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Springel</LastName>
<ForeName>Mark W</ForeName>
<Initials>MW</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Boston Children's Hospital, Boston, MA 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Broadbelt</LastName>
<ForeName>Kevin G</ForeName>
<Initials>KG</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Boston Children's Hospital, Boston, MA 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Park</LastName>
<ForeName>Hye-Yeon</ForeName>
<Initials>HY</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Boston Children's Hospital, Boston, MA 02115, USA; Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Topal</LastName>
<ForeName>Salih</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Boston Children's Hospital, Boston, MA 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lun</LastName>
<ForeName>Melody P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA 02118, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mullan</LastName>
<ForeName>Hillary</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Boston Children's Hospital, Boston, MA 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maynard</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology and Physiology, Institute for Neuroscience, The George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Steen</LastName>
<ForeName>Hanno</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Boston Children's Hospital, Boston, MA 02115, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>LaMantia</LastName>
<ForeName>Anthony S</ForeName>
<Initials>AS</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology and Physiology, Institute for Neuroscience, The George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lehtinen</LastName>
<ForeName>Maria K</ForeName>
<Initials>MK</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Boston Children's Hospital, Boston, MA 02115, USA; Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, MA 02115, USA; Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA. Electronic address: maria.lehtinen@childrens.harvard.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R00 NS072192</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 NS088566</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Dev Cell</MedlineTA>
<NlmUniqueID>101120028</NlmUniqueID>
<ISSNLinking>1534-5807</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26704963</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>25</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">2211-8179</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>10</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Global heart</Title>
<ISOAbbreviation>Glob Heart</ISOAbbreviation>
</Journal>
<ArticleTitle>Engaging the Entire Care Cascade in Western Kenya: A Model to Achieve the Cardiovascular Disease Secondary Prevention Roadmap Goals.</ArticleTitle>
<Pagination>
<MedlinePgn>313-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.gheart.2015.09.003</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S2211-8160(15)00255-0</ELocationID>
<Abstract>
<AbstractText>Cardiovascular disease (CVD) is the leading cause of death in the world, with a substantial health and economic burden confronted by low- and middle-income countries. In low-income countries such as Kenya, there exists a double burden of communicable and noncommunicable diseases, and the CVD profile includes many nonatherosclerotic entities. Socio-politico-economic realities present challenges to CVD prevention in Kenya, including poverty, low national spending on health, significant out-of-pocket health expenditures, and limited outpatient health insurance. In addition, the health infrastructure is characterized by insufficient human resources for health, medication stock-outs, and lack of facilities and equipment. Within this socio-politico-economic reality, contextually appropriate programs for CVD prevention need to be developed. We describe our experience from western Kenya, where we have engaged the entire care cascade across all levels of the health system, in order to improve access to high-quality, comprehensive, coordinated, and sustainable care for CVD and CVD risk factors. We report on several initiatives: 1) population-wide screening for hypertension and diabetes; 2) engagement of community resources and governance structures; 3) geographic decentralization of care services; 4) task redistribution to more efficiently use of available human resources for health; 5) ensuring a consistent supply of essential medicines; 6) improving physical infrastructure of rural health facilities; 7) developing an integrated health record; and 8) mobile health (mHealth) initiatives to provide clinical decision support and record-keeping functions. Although several challenges remain, there currently exists a critical window of opportunity to establish systems of care and prevention that can alter the trajectory of CVD in low-resource settings. </AbstractText>
<CopyrightInformation>Copyright © 2015 World Heart Federation (Geneva). Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vedanthan</LastName>
<ForeName>Rajesh</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: rajesh.vedanthan@mssm.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kamano</LastName>
<ForeName>Jemima H</ForeName>
<Initials>JH</Initials>
<AffiliationInfo>
<Affiliation>Moi University College of Health Sciences, Eldoret, Kenya; Academic Model Providing Access to Healthcare, Eldoret, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bloomfield</LastName>
<ForeName>Gerald S</ForeName>
<Initials>GS</Initials>
<AffiliationInfo>
<Affiliation>Duke Global Health Institute, Duke Clinical Research Institute, and Duke University School of Medicine, Durham, NC, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Manji</LastName>
<ForeName>Imran</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Academic Model Providing Access to Healthcare, Eldoret, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pastakia</LastName>
<ForeName>Sonak</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Moi University College of Health Sciences, Eldoret, Kenya; Academic Model Providing Access to Healthcare, Eldoret, Kenya; Department of Pharmacy Practice, Purdue University College of Pharmacy, Indianapolis, IN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kimaiyo</LastName>
<ForeName>Sylvester N</ForeName>
<Initials>SN</Initials>
<AffiliationInfo>
<Affiliation>Moi University College of Health Sciences, Eldoret, Kenya; Academic Model Providing Access to Healthcare, Eldoret, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K01 TW009218</GrantID>
<Acronym>TW</Acronym>
<Agency>FIC NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Glob Heart</MedlineTA>
<NlmUniqueID>101584391</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26702503</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>25</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1527-3288</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>45</Volume>
<Issue>1</Issue>
<PubDate>
<MedlineDate>2016 Jan-Feb</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Heart &amp; lung : the journal of critical care</Title>
<ISOAbbreviation>Heart Lung</ISOAbbreviation>
</Journal>
<ArticleTitle>Changes in clinical conversations when providers are informed of asthma patients' beliefs about medication use and integrative medical therapies.</ArticleTitle>
<Pagination>
<MedlinePgn>70-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrtlng.2015.11.002</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0147-9563(15)00321-0</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To explore whether patient's personal beliefs about inhaled corticosteroid (ICS) and integrative medicine (IM) are discussed at routine primary care visits for asthma.</AbstractText>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Negative medication beliefs and preferences for IM can be salient barriers to effective asthma self-management.</AbstractText>
<AbstractText Label="METHOD" NlmCategory="METHODS">A qualitative analysis of transcripts from 33 audio-recorded primary care visits using conventional content analysis techniques.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Four themes emerged when providers had knowledge of patient's beliefs: negative ICS beliefs, IM use for asthma, decision-making and healthy lifestyles. Two themes were identified when providers did not have this knowledge: asthma self-management and healthy lifestyles.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">When providers had knowledge of their patient's IM endorsement or negative ICS beliefs, they initiated conversations about these modifiable beliefs. Without training in IM and in effective communication techniques, it is unlikely that providers will be able to effectively engage in shared decision-making aimed at improving asthma self-management.</AbstractText>
<CopyrightInformation>Copyright © 2016 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>George</LastName>
<ForeName>Maureen</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Columbia University School of Nursing, USA. Electronic address: mg3656@cumc.columbia.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abboud</LastName>
<ForeName>Sarah</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>University of Pennsylvania School of Nursing, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pantalon</LastName>
<ForeName>Michael V</ForeName>
<Initials>MV</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, School of Medicine, Yale University, USA; Department of Emergency Medicine, School of Medicine, Yale University, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sommers</LastName>
<ForeName>Marilyn Lynn S</ForeName>
<Initials>ML</Initials>
<AffiliationInfo>
<Affiliation>University of Pennsylvania School of Nursing, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mao</LastName>
<ForeName>Jun</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>University of Pennsylvania, Perelman School of Medicine, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rand</LastName>
<ForeName>Cynthia</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Johns Hopkins University School of Medicine, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K23 AT003907</GrantID>
<Acronym>AT</Acronym>
<Agency>NCCIH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Heart Lung</MedlineTA>
<NlmUniqueID>0330057</NlmUniqueID>
<ISSNLinking>0147-9563</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Asthma</Keyword>
<Keyword MajorTopicYN="N">Decision-making</Keyword>
<Keyword MajorTopicYN="N">Health beliefs</Keyword>
<Keyword MajorTopicYN="N">Integrative medicine</Keyword>
<Keyword MajorTopicYN="N">Patient-provider communication</Keyword>
<Keyword MajorTopicYN="N">Primary care</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26703906</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>25</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1527-5418</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>55</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Journal of the American Academy of Child and Adolescent Psychiatry</Title>
<ISOAbbreviation>J Am Acad Child Adolesc Psychiatry</ISOAbbreviation>
</Journal>
<ArticleTitle>Developmental Timing of Trauma Exposure Relative to Puberty and the Nature of Psychopathology Among Adolescent Girls.</ArticleTitle>
<Pagination>
<MedlinePgn>25-32.e1</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaac.2015.10.004</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0890-8567(15)00686-3</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Increased neuroplasticity and neural development during puberty provide a context for which stress and trauma can have dramatic and long-lasting effects on psychological systems; therefore, this study was designed to determine whether exposure to potentially traumatic events during puberty uniquely predicts adolescent girls' psychopathology. Because neural substrates associated with different forms of psychopathology seemingly develop at different rates, the possibility that the developmental timing of trauma relative to puberty predicts the nature of psychopathology (posttraumatic stress disorder [PTSD], depressive, and anxiety disorders) was examined.</AbstractText>
<AbstractText Label="METHOD" NlmCategory="METHODS">A subset of 2,899 adolescent girls from the National Comorbidity Survey Replication-Adolescent Supplement who completed the study 2+ years postmenarche was selected. Past-year psychiatric disorders and reports of age of trauma exposure were assessed using the Composite International Diagnostic Interview. Developmental stages were defined as the 2 years after the year of menarche ("postpuberty"), 3 years before and year of menarche ("puberty"), 2 to 6 years before the puberty period ("grade school"), and 4 to 5 years after birth ("infancy-preschool").</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared to other developmental periods, trauma during puberty conferred significantly more risk (50.47% of model R(2)) for girls' past-year anxiety disorder diagnoses (primarily social phobia), whereas trauma during the grade school period conferred significantly more risk (47.24% of model R(2)) for past-year depressive disorder diagnoses. Recency of trauma best predicted past-year PTSD diagnoses.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Supporting rodent models, puberty may be a sensitive period for the impact of trauma on girls' development of an anxiety disorder. Trauma prepuberty or postpuberty distinctly predicts depression or PTSD, suggesting differential etiological processes.</AbstractText>
<CopyrightInformation>Copyright © 2016 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Marshall</LastName>
<ForeName>Amy D</ForeName>
<Initials>AD</Initials>
<AffiliationInfo>
<Affiliation>Pennsylvania State University, University Park. Electronic address: AmyMarshall@psu.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K12 HD055882</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>10</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Am Acad Child Adolesc Psychiatry</MedlineTA>
<NlmUniqueID>8704565</NlmUniqueID>
<ISSNLinking>0890-8567</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">abuse</Keyword>
<Keyword MajorTopicYN="N">anxiety</Keyword>
<Keyword MajorTopicYN="N">depression</Keyword>
<Keyword MajorTopicYN="N">posttraumatic stress disorder</Keyword>
<Keyword MajorTopicYN="N">sensitive period</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26703908</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>25</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1527-5418</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>55</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Journal of the American Academy of Child and Adolescent Psychiatry</Title>
<ISOAbbreviation>J Am Acad Child Adolesc Psychiatry</ISOAbbreviation>
</Journal>
<ArticleTitle>School Achievement and Risk of Eating Disorders in a Swedish National Cohort.</ArticleTitle>
<Pagination>
<MedlinePgn>41-46.e1</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaac.2015.09.021</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0890-8567(15)00652-8</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">High achievement in school has been associated with increased risk of eating disorders, including anorexia nervosa (AN) and bulimia nervosa (BN), but causality of these relationships is unclear. We sought to examine the association between school achievement and AN or BN in a national cohort and to determine the possible contribution of familial confounding using a co-relative design.</AbstractText>
<AbstractText Label="METHOD" NlmCategory="METHODS">This national cohort study involved 1,800,643 persons born in Sweden during 1972 to 1990 who were still living in Sweden at age 16 years and were followed up for AN and BN identified from inpatient and outpatient diagnoses through 2012. We used Cox regression to examine the association between school achievement and subsequent risk of AN or BN, and stratified Cox models to examine the gradient in this association across different strata of co-relative pairs (first cousins, half siblings, full siblings).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">School achievement was positively associated with risk of AN among females and males (hazard ratio [HR] per additional 1 standard deviation, females: HR = 1.29; 95% CI = 1.25-1.33; males: HR = 1.29; 95% CI = 1.10-1.52), and risk of BN among females but not males (females: HR = 1.16; 95% CI = 1.11-1.20; males: HR = 1.05; 95% CI = 0.84-1.31). In co-relative analyses, as the degree of shared genetic and environmental factors increased (e.g., from first-cousin to full-sibling pairs), the association between school achievement and AN or BN substantially decreased.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this large national cohort study, high achievement in school was associated with increased risk of AN and BN, but this appeared to be explained by unmeasured familial (genetic and environmental) factors.</AbstractText>
<CopyrightInformation>Copyright © 2016 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sundquist</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Lund University, Center for Primary Health Care Research, Malmö, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ohlsson</LastName>
<ForeName>Henrik</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Lund University, Center for Primary Health Care Research, Malmö, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Winkleby</LastName>
<ForeName>Marilyn A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Stanford University, Stanford Prevention Research Center, Stanford, CA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sundquist</LastName>
<ForeName>Kristina</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Lund University, Center for Primary Health Care Research, Malmö, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Crump</LastName>
<ForeName>Casey</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Stanford University. Electronic address: kccrump@stanford.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 DA030005</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>10</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Am Acad Child Adolesc Psychiatry</MedlineTA>
<NlmUniqueID>8704565</NlmUniqueID>
<ISSNLinking>0890-8567</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">achievement</Keyword>
<Keyword MajorTopicYN="N">anorexia nervosa</Keyword>
<Keyword MajorTopicYN="N">bulimia nervosa</Keyword>
<Keyword MajorTopicYN="N">eating disorders</Keyword>
<Keyword MajorTopicYN="N">schools</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26419732</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1545-7214</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>23</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</Title>
<ISOAbbreviation>Am J Geriatr Psychiatry</ISOAbbreviation>
</Journal>
<ArticleTitle>Anticholinergic Exposure During Rehabilitation: Cognitive and Physical Function Outcomes in Patients with Delirium Superimposed on Dementia.</ArticleTitle>
<Pagination>
<MedlinePgn>1250-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jagp.2015.07.004</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1064-7481(15)00208-0</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We examined the association between anticholinergic medication exposure and subsequent cognitive and physical function in patients with delirium superimposed on dementia during rehabilitation. We also examined length of stay and discharge disposition by anticholinergic medication exposure.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">In this secondary analysis we used control group data from an ongoing randomized clinical trial.</AbstractText>
<AbstractText Label="SETTING/PARTICIPANTS" NlmCategory="METHODS">Participants with delirium and dementia were enrolled at admission to post-acute care. These 99 participants had a mean age of 86.11 (±6.83) years; 67.6% were women; 98% were Caucasian; and 33% were positive for at least one APOE e4 allele.</AbstractText>
<AbstractText Label="MEASURES" NlmCategory="METHODS">We obtained daily measures of cognitive and physical function using: Digit Span; memory, orientation and attention items from the Montreal Cognitive Assessment; CLOX; the Confusion Assessment Method; and the Barthel Index. Anticholinergic medication exposure was measured weekly using the Anticholinergic Cognitive Burden Scale.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Using multilevel models for time we found that greater use of clinically relevant anticholinergic medications in the previous week reduced cognitive and physical function, as measured by Digit Span Backwards and the Barthel index, in the current week. There was no effect of anticholinergic medication use on delirium severity, and APOE status did not moderate any outcomes. Greater use of clinically relevant anticholinergic medications was related to longer length of stay but not discharge disposition.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">For vulnerable older adults, anticholinergic exposure represents a potentially modifiable risk factor for poor attention, working memory, physical function, and greater length of stay during rehabilitation.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kolanowski</LastName>
<ForeName>Ann</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>College of Nursing, Penn State, University Park, PA, USA. Electronic address: amk20@psu.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mogle</LastName>
<ForeName>Jacqueline</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>College of Nursing, Penn State, University Park, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fick</LastName>
<ForeName>Donna M</ForeName>
<Initials>DM</Initials>
<AffiliationInfo>
<Affiliation>College of Nursing, Penn State, University Park, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Campbell</LastName>
<ForeName>Noll</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacy Practice, Purdue University College of Pharmacy, West Lafayette, IN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hill</LastName>
<ForeName>Nikki</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>College of Nursing, Penn State, University Park, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mulhall</LastName>
<ForeName>Paula</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>College of Nursing, Penn State, University Park, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Behrens</LastName>
<ForeName>Liza</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>College of Nursing, Penn State, University Park, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Colancecco</LastName>
<ForeName>Elise</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>College of Nursing, Penn State, University Park, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Boustani</LastName>
<ForeName>Malaz</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Regenstrief Institute, Indianapolis, IN, USA; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Clare</LastName>
<ForeName>Linda</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>REACH: The Centre for Research in Ageing and Cognitive Health, College of Life and Environmental Sciences, Department of Psychology, Washington Singer Laboratories, Exeter, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 NR012242</GrantID>
<Acronym>NR</Acronym>
<Agency>NINR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>31</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Am J Geriatr Psychiatry</MedlineTA>
<NlmUniqueID>9309609</NlmUniqueID>
<ISSNLinking>1064-7481</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Anticholinergic exposure</Keyword>
<Keyword MajorTopicYN="N">cognition</Keyword>
<Keyword MajorTopicYN="N">dementia</Keyword>
<Keyword MajorTopicYN="N">physical function</Keyword>
<Keyword MajorTopicYN="N">post-acute care</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26525993</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1545-7214</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>23</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</Title>
<ISOAbbreviation>Am J Geriatr Psychiatry</ISOAbbreviation>
</Journal>
<ArticleTitle>Physical and Cognitive Activities as Deterrents of Cognitive Decline in a Biracial Population Sample.</ArticleTitle>
<Pagination>
<MedlinePgn>1225-33</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jagp.2015.07.008</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1064-7481(15)00222-5</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Physical and cognitive activities are associated with slower cognitive decline. Few studies have examined racial differences in these associations, however. The aim of this study was to examine the association of physical and cognitive activities with level and change in cognitive function among black and white participants. A secondary aim was to explore observed differences between black and white participants using post hoc analyses based on education and cognitive function levels.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Data came from a longitudinal study of 7,742 (63% black and 61% female) participants assessed three times over an average of 9.5 years. At baseline, each participant reported number of hours of leisure time physical activity (categorized using quartiles) and rated frequency of participation in cognitively stimulating activities (range: 0-4). A standardized measure of cognition was derived from tests of memory, perceptual speed, and orientation.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 7,742 participants, 2,322 (30%) reported no physical activity. Cognitive decline was slower by about 20% (95% CI: 13%-27%) among whites with physical activity above 1.25 hours compared with those with no physical activity, but showed no significant decrease in cognitive decline relative to those with no physical activity among blacks. Further post hoc analysis revealed cognitive decline to be slower by about 29% (95% CI: 20%-38%) among blacks and whites with higher education and above average baseline cognition. A 1-point increase in cognitive activity frequency decreased cognitive decline by 8% (95% CI: 3%-14%) among blacks and by 14% (95% CI: 7%-20%) among whites.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The benefits of higher physical activity on cognitive decline was observed among whites, and among blacks with higher education and above average baseline cognitive function. Nevertheless, the protective effect of cognitive activity seems to be independent of education and baseline cognitive function among both blacks and whites.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rajan</LastName>
<ForeName>Kumar B</ForeName>
<Initials>KB</Initials>
<AffiliationInfo>
<Affiliation>Rush Institute for Healthy Aging, Department of Internal Medicine, Rush University Medical Center, Chicago, IL. Electronic address: kumar_rajan@rush.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barnes</LastName>
<ForeName>Lisa L</ForeName>
<Initials>LL</Initials>
<AffiliationInfo>
<Affiliation>Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL; Department of Behavioral Sciences, Rush University Medical Center, Chicago, IL.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Skarupski</LastName>
<ForeName>Kimberly A</ForeName>
<Initials>KA</Initials>
<AffiliationInfo>
<Affiliation>Center on Aging and Health, Department of Medicine, Johns Hopkins University, Baltimore, MD.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mendes de Leon</LastName>
<ForeName>Carlos F</ForeName>
<Initials>CF</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, University of Michigan, Ann Arbor, MI.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wilson</LastName>
<ForeName>Robert S</ForeName>
<Initials>RS</Initials>
<AffiliationInfo>
<Affiliation>Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL; Department of Behavioral Sciences, Rush University Medical Center, Chicago, IL.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Evans</LastName>
<ForeName>Denis A</ForeName>
<Initials>DA</Initials>
<AffiliationInfo>
<Affiliation>Rush Institute for Healthy Aging, Department of Internal Medicine, Rush University Medical Center, Chicago, IL.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 AG011101</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Am J Geriatr Psychiatry</MedlineTA>
<NlmUniqueID>9309609</NlmUniqueID>
<ISSNLinking>1064-7481</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Physical activity</Keyword>
<Keyword MajorTopicYN="N">cognitive activity</Keyword>
<Keyword MajorTopicYN="N">cognitive decline</Keyword>
<Keyword MajorTopicYN="N">minority health</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26525994</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1545-7214</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>23</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</Title>
<ISOAbbreviation>Am J Geriatr Psychiatry</ISOAbbreviation>
</Journal>
<ArticleTitle>Proactive Semantic Interference is Associated with Total and Regional Abnormal Amyloid Load in Non-Demented Community-Dwelling Elders: A Preliminary Study.</ArticleTitle>
<Pagination>
<MedlinePgn>1276-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jagp.2015.07.009</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1064-7481(15)00223-7</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the relationship between susceptibility to proactive semantic interference (PSI) and retroactive semantic interference (RSI) and brain amyloid load in non-demented elders.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">27 participants (11 cognitively normal [CN] with subjective memory complaints, 8 CN without memory complaints, and 8 with mild cognitive impairment [MCI]) underwent complete neurological and neuropsychological evaluations. Participants also received the Semantic Interference Test (SIT) and AV-45 amyloid PET imaging.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">High levels of association were present between total amyloid load, regional amyloid levels, and the PSI measure (in the entire sample and a subsample excluding MCI subjects). RSI and other memory measures showed much weaker associations or no associations with total and regional amyloid load. No associations between amyloid levels and non-memory performance were observed.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In non-demented individuals, vulnerability to PSI was highly associated with total and regional beta-amyloid load and may be an early cognitive marker of brain pathology.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Loewenstein</LastName>
<ForeName>David A</ForeName>
<Initials>DA</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami and Center on Aging, Miami, FL; Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, FL. Electronic address: DLoewenstein@med.miami.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Greig</LastName>
<ForeName>Maria T</ForeName>
<Initials>MT</Initials>
<AffiliationInfo>
<Affiliation>Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, FL.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Curiel</LastName>
<ForeName>Rosie</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami and Center on Aging, Miami, FL.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rodriguez</LastName>
<ForeName>Rosemarie</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, FL.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wicklund</LastName>
<ForeName>Meredith</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, University of Florida, Gainesville, FL.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barker</LastName>
<ForeName>Warren W</ForeName>
<Initials>WW</Initials>
<AffiliationInfo>
<Affiliation>Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, FL.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hidalgo</LastName>
<ForeName>Jacqueline</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, FL.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rosado</LastName>
<ForeName>Marian</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami and Center on Aging, Miami, FL.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Duara</LastName>
<ForeName>Ranjan</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, FL; Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL; Department of Neurology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 AG047649</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Am J Geriatr Psychiatry</MedlineTA>
<NlmUniqueID>9309609</NlmUniqueID>
<ISSNLinking>1064-7481</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Amyloid</Keyword>
<Keyword MajorTopicYN="N">MCI</Keyword>
<Keyword MajorTopicYN="N">proactive interference</Keyword>
<Keyword MajorTopicYN="N">semantic interference</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26560509</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1545-7214</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>23</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</Title>
<ISOAbbreviation>Am J Geriatr Psychiatry</ISOAbbreviation>
</Journal>
<ArticleTitle>Examining the Pathways Between Self-Awareness and Well-Being in Mild to Moderate Alzheimer Disease.</ArticleTitle>
<Pagination>
<MedlinePgn>1297-306</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jagp.2015.05.005</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1064-7481(15)00163-3</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the relationship between awareness of memory loss and psychological well-being in a nonclinically depressed sample of participants with mild to moderate Alzheimer disease (AD).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Study participants (N = 104) enrolled through Columbia University Medical Center and the University of Pennsylvania completed clinical and cognitive assessments. Participants were rated with regard to their degree of awareness of memory deficits and completed questionnaires relating to their psychological well-being, including mood and quality of life (QOL). Mediating models were used to establish the relationship between awareness, depression, and QOL and to examine potential mediators of awareness and depression, including psychological distress, objective memory deficits, and negative self-ratings.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">There was a direct association between awareness of memory deficits and depressed mood but not awareness and QOL. However, there was an indirect association between awareness and QOL through depression. Neither psychological distress, memory deficits, nor negative self-ratings mediated the relationship between awareness and depression.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Awareness is associated with depressed mood in nonclinically depressed participants with mild to moderate AD. However, depressed mood does not appear to reflect the direct psychological reaction to awareness of memory loss. Moreover, awareness has only an indirect association with QOL via depressed mood. These results suggest that preserved awareness does not have a direct negative impact on overall psychological well-being in AD.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cines</LastName>
<ForeName>Sarah</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Cognitive Neuroscience Division, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Farrell</LastName>
<ForeName>Meagan</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Cognitive Neuroscience Division, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Steffener</LastName>
<ForeName>Jason</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Cognitive Neuroscience Division, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sullo</LastName>
<ForeName>Liz</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>The G.H. Sergievsky Center, Columbia University Medical Center, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huey</LastName>
<ForeName>Edward</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Cognitive Neuroscience Division, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, NY; Department of Neurology, Columbia University Medical Center, New York, NY; Department of Psychiatry, Columbia University Medical Center, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Karlawish</LastName>
<ForeName>Jason</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Departments of Medicine and Medical Ethics, Alzheimer's Disease Center, Institute on Aging, and Center for Health Incentives, The University of Pennsylvania, Philadelphia, PA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cosentino</LastName>
<ForeName>Stephanie</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Cognitive Neuroscience Division, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, NY; The G.H. Sergievsky Center, Columbia University Medical Center, New York, NY; Department of Neurology, Columbia University Medical Center, New York, NY. Electronic address: sc2460@cumc.columbia.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K01 AG035061</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K23 AG032899</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 AG000261</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Am J Geriatr Psychiatry</MedlineTA>
<NlmUniqueID>9309609</NlmUniqueID>
<ISSNLinking>1064-7481</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">NIHMS701361 [Available on 11/19/16]</OtherID>
<OtherID Source="NLM">PMC4653086 [Available on 11/19/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Awareness</Keyword>
<Keyword MajorTopicYN="N">depression</Keyword>
<Keyword MajorTopicYN="N">quality of life</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26560512</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1545-7214</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>23</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</Title>
<ISOAbbreviation>Am J Geriatr Psychiatry</ISOAbbreviation>
</Journal>
<ArticleTitle>Relationship Between Cerebrovascular Risk, Cognition, and Treatment Outcome in Late-Life Psychotic Depression.</ArticleTitle>
<Pagination>
<MedlinePgn>1270-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jagp.2015.08.002</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1064-7481(15)00231-6</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine whether cerebrovascular risk, executive function, and processing speed are associated with acute treatment outcome of psychotic depression in older adults.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The authors analyzed data from 142 persons aged 60 years or older with major depression with psychotic features who participated in a 12-week randomized controlled trial (RCT) comparing olanzapine plus sertraline with olanzapine plus placebo. The independent variables were baseline cerebrovascular risk (Framingham Stroke Risk Score), baseline executive function (Stroop interference score and the initiation/perseveration subscale of the Mattis Dementia Rating Scale), and baseline processing speed (color and word reading components of the Stroop). The outcome variable was change in severity of depression, measured by the 17-item Hamilton Depression Rating Scale total score, during the course of the RCT.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Greater baseline cerebrovascular risk was significantly associated with less improvement in depression severity over time, after controlling for pertinent covariates. Neither executive function nor processing speed predicted outcome.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study suggests an association of cerebrovascular risk, but not executive function or processing speed, with treatment outcome of major depression with psychotic features in older adults.</AbstractText>
<CopyrightInformation>Copyright © 2015 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bingham</LastName>
<ForeName>Kathleen S</ForeName>
<Initials>KS</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Whyte</LastName>
<ForeName>Ellen M</ForeName>
<Initials>EM</Initials>
<AffiliationInfo>
<Affiliation>Western Psychiatric Institute and Clinic, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Meyers</LastName>
<ForeName>Barnett S</ForeName>
<Initials>BS</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Weill Medical College of Cornell University and New York Presbyterian Hospital, Westchester Division, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mulsant</LastName>
<ForeName>Benoit H</ForeName>
<Initials>BH</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rothschild</LastName>
<ForeName>Anthony J</ForeName>
<Initials>AJ</Initials>
<AffiliationInfo>
<Affiliation>University of Massachusetts Medical School and UMass Memorial Health Care, Worcester, MA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Banerjee</LastName>
<ForeName>Samprit</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Healthcare Policy and Research, Weill Cornell Medical College, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Flint</LastName>
<ForeName>Alastair J</ForeName>
<Initials>AJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, University Health Network, Toronto, Ontario, Canada; Toronto General and Toronto Rehab Research Institutes, Toronto, Ontario, Canada. Electronic address: alastair.flint@uhn.ca.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>STOP-PD Study Group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>U01 MH062446</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 MH062518</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 MH062565</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 MH062624</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Am J Geriatr Psychiatry</MedlineTA>
<NlmUniqueID>9309609</NlmUniqueID>
<ISSNLinking>1064-7481</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Vascular risk</Keyword>
<Keyword MajorTopicYN="N">executive function</Keyword>
<Keyword MajorTopicYN="N">major depressive disorder</Keyword>
<Keyword MajorTopicYN="N">processing speed</Keyword>
<Keyword MajorTopicYN="N">psychotic depression</Keyword>
<Keyword MajorTopicYN="N">treatment outcome</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26163168</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-2607</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>50</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>American journal of preventive medicine</Title>
<ISOAbbreviation>Am J Prev Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Calorie Changes in Large Chain Restaurants: Declines in New Menu Items but Room for Improvement.</ArticleTitle>
<Pagination>
<MedlinePgn>e1-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amepre.2015.05.007</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0749-3797(15)00230-5</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Large chain restaurants reduced the number of calories in newly introduced menu items in 2013 by about 60 calories (or 12%) relative to 2012. This paper describes trends in calories available in large U.S. chain restaurants to understand whether previously documented patterns persist.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Data (a census of items for included restaurants) were obtained from the MenuStat project. This analysis included 66 of the 100 largest U.S. restaurants that are available in all three of the data years (2012-2014; N=23,066 items). Generalized linear models were used to examine: (1) per-item calorie changes from 2012 to 2014 among items on the menu in all years; and (2) mean calories in new items in 2013 and 2014 compared with items on the menu in 2012 only. Data were analyzed in 2014.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, calories in newly introduced menu items declined by 71 (or 15%) from 2012 to 2013 (p=0.001) and by 69 (or 14%) from 2012 to 2014 (p=0.03). These declines were concentrated mainly in new main course items (85 fewer calories in 2013 and 55 fewer calories in 2014; p=0.01). Although average calories in newly introduced menu items are declining, they are higher than items common to the menu in all 3 years. No differences in mean calories among items on menus in 2012, 2013, or 2014 were found.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The previously observed declines in newly introduced menu items among large restaurant chains have been maintained, which suggests the beginning of a trend toward reducing calories.</AbstractText>
<CopyrightInformation>Copyright © 2016 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bleich</LastName>
<ForeName>Sara N</ForeName>
<Initials>SN</Initials>
<AffiliationInfo>
<Affiliation>Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. Electronic address: sbleich@jhsph.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wolfson</LastName>
<ForeName>Julia A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jarlenski</LastName>
<ForeName>Marian P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K01 HL096409</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Am J Prev Med</MedlineTA>
<NlmUniqueID>8704773</NlmUniqueID>
<ISSNLinking>0749-3797</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26321012</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-2607</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>50</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>American journal of preventive medicine</Title>
<ISOAbbreviation>Am J Prev Med</ISOAbbreviation>
</Journal>
<ArticleTitle>A Dietary Intervention in Urban African Americans: Results of the "Five Plus Nuts and Beans" Randomized Trial.</ArticleTitle>
<Pagination>
<MedlinePgn>87-95</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amepre.2015.06.010</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0749-3797(15)00315-3</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Unhealthy diets, often low in potassium, likely contribute to racial disparities in blood pressure. We tested the effectiveness of providing weekly dietary advice, assistance with selection of higher potassium grocery items, and a $30 per week food allowance on blood pressure and other outcomes in African American adults with hypertension.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">We conducted an 8-week RCT with two parallel arms between May 2012 and November 2013.</AbstractText>
<AbstractText Label="SETTING/PARTICIPANTS" NlmCategory="METHODS">We randomized 123 African Americans with controlled hypertension from an urban primary care clinic in Baltimore, Maryland, and implemented the trial in partnership with a community supermarket and the Baltimore City Health Department. Mean (SD) age was 58.6 (9.5) years; 71% were female; blood pressure was 131.3 (14.7)/77.2 (10.5) mmHg; BMI was 34.5 (8.2); and 28% had diabetes.</AbstractText>
<AbstractText Label="INTERVENTION" NlmCategory="METHODS">Participants randomized to the active intervention group (Dietary Approaches to Stop Hypertension [DASH]-Plus) received coach-directed dietary advice and assistance with weekly online ordering and purchasing of high-potassium foods ($30/week) delivered by a community supermarket to a neighborhood library. Participants in the control group received a printed DASH diet brochure along with a debit account of equivalent value to that of the DASH-Plus group.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">The primary outcome was blood pressure change. Analyses were conducted in January to October 2014.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared with the control group, the DASH-Plus group increased self-reported consumption of fruits and vegetables (mean=1.4, 95% CI=0.7, 2.1 servings/day); estimated intake of potassium (mean=0.4, 95% CI=0.1, 0.7 grams/day); and urine potassium excretion (mean=19%, 95% CI=1%, 38%). There was no significant effect on blood pressure.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A program providing dietary advice, assistance with grocery ordering, and $30/week of high-potassium foods in African American patients with controlled hypertension in a community-based clinic did not reduce BP. However, the intervention increased consumption of fruits, vegetables, and urinary excretion of potassium.</AbstractText>
<CopyrightInformation>Copyright © 2016 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Miller</LastName>
<ForeName>Edgar R</ForeName>
<Initials>ER</Initials>
<Suffix>3rd</Suffix>
<AffiliationInfo>
<Affiliation>Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland; Johns Hopkins Center to Eliminate Cardiovascular Health Disparities, Johns Hopkins School of Medicine, Baltimore, Maryland; The Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland. Electronic address: ermiller@jhmi.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cooper</LastName>
<ForeName>Lisa A</ForeName>
<Initials>LA</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland; Johns Hopkins Center to Eliminate Cardiovascular Health Disparities, Johns Hopkins School of Medicine, Baltimore, Maryland; The Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Carson</LastName>
<ForeName>Kathryn A</ForeName>
<Initials>KA</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland; Johns Hopkins Center to Eliminate Cardiovascular Health Disparities, Johns Hopkins School of Medicine, Baltimore, Maryland; The Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland; Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Nae-Yuh</ForeName>
<Initials>NY</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland; Johns Hopkins Center to Eliminate Cardiovascular Health Disparities, Johns Hopkins School of Medicine, Baltimore, Maryland; The Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Appel</LastName>
<ForeName>Lawrence J</ForeName>
<Initials>LJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland; Johns Hopkins Center to Eliminate Cardiovascular Health Disparities, Johns Hopkins School of Medicine, Baltimore, Maryland; The Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gayles</LastName>
<ForeName>Debra</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland; Johns Hopkins Center to Eliminate Cardiovascular Health Disparities, Johns Hopkins School of Medicine, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Charleston</LastName>
<ForeName>Jeanne</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland; Johns Hopkins Center to Eliminate Cardiovascular Health Disparities, Johns Hopkins School of Medicine, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>White</LastName>
<ForeName>Karen</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>You</LastName>
<ForeName>Na</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>School of Mathematics and Computational Science, Sun Yat-sen University, Guangzhou, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Weng</LastName>
<ForeName>Yingjie</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Martin-Daniels</LastName>
<ForeName>Michelle</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland; Johns Hopkins Center to Eliminate Cardiovascular Health Disparities, Johns Hopkins School of Medicine, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bates-Hopkins</LastName>
<ForeName>Barbara</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland; Johns Hopkins Center to Eliminate Cardiovascular Health Disparities, Johns Hopkins School of Medicine, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Robb</LastName>
<ForeName>Inez</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Johns Hopkins Center to Eliminate Cardiovascular Health Disparities, Johns Hopkins School of Medicine, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Franz</LastName>
<ForeName>Whitney K</ForeName>
<Initials>WK</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brown</LastName>
<ForeName>Emily L</ForeName>
<Initials>EL</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Halbert</LastName>
<ForeName>Jennifer P</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland; Johns Hopkins Center to Eliminate Cardiovascular Health Disparities, Johns Hopkins School of Medicine, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Albert</LastName>
<ForeName>Michael C</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland; Johns Hopkins Community Physicians, Johns Hopkins Medical Institutions, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dalcin</LastName>
<ForeName>Arlene T</ForeName>
<Initials>AT</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland; The Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yeh</LastName>
<ForeName>Hsin-Chieh</ForeName>
<Initials>HC</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland; Johns Hopkins Center to Eliminate Cardiovascular Health Disparities, Johns Hopkins School of Medicine, Baltimore, Maryland; The Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland; Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P50 HL105187</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Am J Prev Med</MedlineTA>
<NlmUniqueID>8704773</NlmUniqueID>
<ISSNLinking>0749-3797</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26340864</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-2607</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>50</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>American journal of preventive medicine</Title>
<ISOAbbreviation>Am J Prev Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of Community Volunteering on Physical Activity: A Randomized Controlled Trial.</ArticleTitle>
<Pagination>
<MedlinePgn>106-10</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amepre.2015.06.015</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0749-3797(15)00323-2</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Older adults with a high number of chronic conditions and who live in environments that do not promote physical activity have great difficulty initiating and adhering to exercise programs. Novel lifestyle activity interventions that can effectively increase physical activity may address disparities in health in these populations. This study evaluates the effects of the Baltimore Experience Corps program, a community-based volunteer program, on walking activity in older adults.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The Baltimore Experience Corps Trial is a sex-stratified RCT that recruited participants from 2006 to 2009. Older adult participants aged ≥60 years (n=123) were from a nested objective physical activity trial within the larger Baltimore Experience Corps Trial. Participants randomized to the intervention group were placed as volunteers within the Baltimore public school system for 2 years. The primary study outcome was objectively measured total amount of walking activity measured in steps/day. Differences between intervention and control groups were measured at 12 and 24 months using linear mixed effects models. Data were analyzed in 2014.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">At 24 months, women, but not men, in the intervention group showed an increased amount of walking activity, averaging 1,500.3 (95% CI=77.6, 2,922.9) greater steps/day compared with the control group. Women in the control group showed a decline of 1,191.6 (95% CI=-2243.7, -139.5) steps/day at 24 months compared to baseline.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A community-based volunteer intervention increased walking activity among older women, who were at elevated risk for both inactivity and adverse health outcomes.</AbstractText>
<AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">This study is registered at www.clinicaltrials.gov NCT00380562.</AbstractText>
<CopyrightInformation>Copyright © 2016 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Varma</LastName>
<ForeName>Vijay R</ForeName>
<Initials>VR</Initials>
<AffiliationInfo>
<Affiliation>Johns Hopkins Center on Aging and Health, Baltimore, Maryland; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. Electronic address: vvarma1@jhu.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tan</LastName>
<ForeName>Erwin J</ForeName>
<Initials>EJ</Initials>
<AffiliationInfo>
<Affiliation>The Corporation for National and Community Service, Washington, District of Columbia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gross</LastName>
<ForeName>Alden L</ForeName>
<Initials>AL</Initials>
<AffiliationInfo>
<Affiliation>Johns Hopkins Center on Aging and Health, Baltimore, Maryland; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Harris</LastName>
<ForeName>Greg</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Johns Hopkins Center on Aging and Health, Baltimore, Maryland; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Romani</LastName>
<ForeName>William</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>AARP, Inc., Washington, District of Columbia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fried</LastName>
<ForeName>Linda P</ForeName>
<Initials>LP</Initials>
<AffiliationInfo>
<Affiliation>Mailman School of Public Health, Columbia University, New York, New York.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rebok</LastName>
<ForeName>George W</ForeName>
<Initials>GW</Initials>
<AffiliationInfo>
<Affiliation>Johns Hopkins Center on Aging and Health, Baltimore, Maryland; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Carlson</LastName>
<ForeName>Michelle C</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>Johns Hopkins Center on Aging and Health, Baltimore, Maryland; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P01 AG027735</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 AG021334</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R37 AG019905</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 AG000247</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 AG027668</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Am J Prev Med</MedlineTA>
<NlmUniqueID>8704773</NlmUniqueID>
<ISSNLinking>0749-3797</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26470805</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-2607</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>50</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>American journal of preventive medicine</Title>
<ISOAbbreviation>Am J Prev Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Enrolling Minority and Underserved Populations in Cancer Clinical Research.</ArticleTitle>
<Pagination>
<MedlinePgn>111-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amepre.2015.07.036</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0749-3797(15)00446-8</ELocationID>
<Abstract>
<AbstractText>Research suggests that community involvement is integral to solving public health problems, including involvement in clinical trials-a gold standard. Significant racial/ethnic disparities exist in the accrual of participants for clinical trials. Location and cultural aspects of clinical trials influence recruitment and accrual to clinical trials. It is increasingly necessary to be aware of defining characteristics, such as location and culture of the populations from which research participants are enrolled. Little research has examined the effect of location and cultural competency in adapting clinical trial research for minority and underserved communities on accrual for clinical trials. Utilizing embedded community academic sites, the authors applied cultural competency frameworks to adapt clinical trial research in order to increase minority participation in nontherapeutic cancer clinical trials. This strategy resulted in successful accrual of participants to new clinical research trials, specifically targeting participation from minority and underserved communities in metropolitan Washington, DC. From 2012 to 2014, a total of 559 participants enrolled across six nontherapeutic clinical trials, representing a 62% increase in the enrollment of blacks in clinical research. Embedding cancer prevention programs and research in the community was shown to be yet another important strategy in the arsenal of approaches that can potentially enhance clinical research enrollment and capacity. The analyses showed that the capacity to acquire cultural knowledge about patients-their physical locales, cultural values, and environments in which they live-is essential to recruiting culturally and ethnically diverse population samples. </AbstractText>
<CopyrightInformation>Copyright © 2016 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wallington</LastName>
<ForeName>Sherrie F</ForeName>
<Initials>SF</Initials>
<AffiliationInfo>
<Affiliation>Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia. Electronic address: slw49@georgetown.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dash</LastName>
<ForeName>Chiranjeev</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sheppard</LastName>
<ForeName>Vanessa B</ForeName>
<Initials>VB</Initials>
<AffiliationInfo>
<Affiliation>Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Goode</LastName>
<ForeName>Tawara D</ForeName>
<Initials>TD</Initials>
<AffiliationInfo>
<Affiliation>National Center for Cultural Competence, Department of Pediatrics, Georgetown University Medical Center, Washington, District of Columbia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Oppong</LastName>
<ForeName>Bridget A</ForeName>
<Initials>BA</Initials>
<AffiliationInfo>
<Affiliation>Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia; Georgetown University Medical Center, Department of Surgery, Washington, District of Columbia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dodson</LastName>
<ForeName>Everett E</ForeName>
<Initials>EE</Initials>
<AffiliationInfo>
<Affiliation>Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hamilton</LastName>
<ForeName>Rhonda N</ForeName>
<Initials>RN</Initials>
<AffiliationInfo>
<Affiliation>Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Adams-Campbell</LastName>
<ForeName>Lucile L</ForeName>
<Initials>LL</Initials>
<AffiliationInfo>
<Affiliation>Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K01 CA155417</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>10</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Am J Prev Med</MedlineTA>
<NlmUniqueID>8704773</NlmUniqueID>
<ISSNLinking>0749-3797</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">25855685</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1440-1614</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>50</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>The Australian and New Zealand journal of psychiatry</Title>
<ISOAbbreviation>Aust N Z J Psychiatry</ISOAbbreviation>
</Journal>
<ArticleTitle>Toward understanding the heterogeneity in obsessive-compulsive disorder: Evidence from narratives in adult patients.</ArticleTitle>
<Pagination>
<MedlinePgn>74-81</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1177/0004867415579919</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Current attempts at understanding the heterogeneity in obsessive-compulsive disorder have relied on quantitative methods. The results of such work point toward a dimensional structure for obsessive-compulsive disorder. Existing qualitative work in obsessive-compulsive disorder has focused on understanding specific aspects of the obsessive-compulsive disorder experience in greater depth. However, qualitative methods are also of potential value in furthering our understanding of obsessive-compulsive disorder heterogeneity by allowing for open-ended exploration of the obsessive-compulsive disorder experience and correlating identified subtypes with patient narratives.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We explored variations in patients' experience prior to, during and immediately after performing their compulsions.</AbstractText>
<AbstractText Label="METHOD" NlmCategory="METHODS">Semi-structured interviews were conducted with 20 adults with obsessive-compulsive disorder, followed by inductive thematic analysis. Participant responses were not analyzed within the context of an existing theoretical framework, and themes were labeled descriptively.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The previous dichotomy of 'anxiety' vs 'incompleteness' emerged organically during narrative analysis. In addition, we found that some individuals with obsessive-compulsive disorder utilized their behaviors as a way to cope with stress and anxiety more generally. Other participants did not share this experience and denied finding any comfort in their obsessive-compulsive behaviors. The consequences of attentional difficulties were highlighted, with some participants describing how difficulty focusing on a task could influence the need for it to be repeated multiple times.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The extent to which patients use obsessive-compulsive disorder as a coping mechanism is a relevant distinction with potential implications for treatment engagement. Patients may experience ambivalence about suppressing behaviors that they have come to rely upon for management of stress and anxiety, even if these behaviors represent symptoms of a psychiatric illness.</AbstractText>
<CopyrightInformation>© The Royal Australian and New Zealand College of Psychiatrists 2015.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Van Schalkwyk</LastName>
<ForeName>Gerrit I</ForeName>
<Initials>GI</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Yale University, New Haven, CT, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bhalla</LastName>
<ForeName>Ish P</ForeName>
<Initials>IP</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Yale University, New Haven, CT, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Griepp</LastName>
<ForeName>Matthew</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Yale University, New Haven, CT, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kelmendi</LastName>
<ForeName>Benjamin</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Yale University, New Haven, CT, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Davidson</LastName>
<ForeName>Larry</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Yale University, New Haven, CT, USA Yale Program for Recovery and Community Health, Yale University, New Haven, CT, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pittenger</LastName>
<ForeName>Christopher</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Yale University, New Haven, CT, USA Department of Psychology, Yale University, New Haven, CT, USA Child Study Center, Yale University, New Haven, CT, USA Interdepartmental Neuroscience Program, Yale University, New Haven, CT, USA Christopher.pittenger@yale.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 MH095790</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>04</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Aust N Z J Psychiatry</MedlineTA>
<NlmUniqueID>0111052</NlmUniqueID>
<ISSNLinking>0004-8674</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">NIHMS690536 [Available on 10/08/16]</OtherID>
<OtherID Source="NLM">PMC4598276 [Available on 10/08/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Obsessive-compulsive disorder</Keyword>
<Keyword MajorTopicYN="N">anxiety</Keyword>
<Keyword MajorTopicYN="N">attention</Keyword>
<Keyword MajorTopicYN="N">phenomenology</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">25991764</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1440-1614</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>50</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>The Australian and New Zealand journal of psychiatry</Title>
<ISOAbbreviation>Aust N Z J Psychiatry</ISOAbbreviation>
</Journal>
<ArticleTitle>Violence risk assessment in psychiatric patients in China: A systematic review.</ArticleTitle>
<Pagination>
<MedlinePgn>33-45</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1177/0004867415585580</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of this study was to undertake a systematic review on violence risk assessment instruments used for psychiatric patients in China.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A systematic search was conducted from 1980 until 2014 to identify studies that used psychometric tools or structured instruments to assess aggression and violence risk. Information from primary studies was extracted, including demographic characteristics of the samples used, study design characteristics, and reliability and validity estimates.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 30 primary studies were identified that investigated aggression or violence; 6 reported on tools assessing aggression while an additional 24 studies reported on structured instruments designed to predict violence. Although measures of reliability were typically good, estimates of predictive validity were mostly in the range of poor to moderate, with only 1 study finding good validity. These estimates were typically lower than that found in previous work for Western samples.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">There is currently little evidence to support the use of current violence risk assessment instruments in psychiatric patients in China. Developing more accurate and scalable approaches are research priorities.</AbstractText>
<CopyrightInformation>© The Royal Australian and New Zealand College of Psychiatrists 2015.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zhou</LastName>
<ForeName>Jiansong</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Mental Health Institute of The Second Xiangya Hospital, Hunan Province Technology Institute of Psychiatry, Key Laboratory of Psychiatry and Mental Health of Hunan Province, Central South University, Changsha, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Witt</LastName>
<ForeName>Katrina</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Xiang</LastName>
<ForeName>Yutao</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Unit of Psychiatry, Faculty of Health Sciences, University of Macau, Macau, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhu</LastName>
<ForeName>Xiaomin</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Mental Health Institute of The Second Xiangya Hospital, Hunan Province Technology Institute of Psychiatry, Key Laboratory of Psychiatry and Mental Health of Hunan Province, Central South University, Changsha, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Xiaoping</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Mental Health Institute of The Second Xiangya Hospital, Hunan Province Technology Institute of Psychiatry, Key Laboratory of Psychiatry and Mental Health of Hunan Province, Central South University, Changsha, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fazel</LastName>
<ForeName>Seena</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK seena.fazel@psych.ox.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>095806</GrantID>
<Agency>Wellcome Trust</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Aust N Z J Psychiatry</MedlineTA>
<NlmUniqueID>0111052</NlmUniqueID>
<ISSNLinking>0004-8674</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">China</Keyword>
<Keyword MajorTopicYN="N">Violence</Keyword>
<Keyword MajorTopicYN="N">prediction</Keyword>
<Keyword MajorTopicYN="N">risk assessment</Keyword>
<Keyword MajorTopicYN="N">systematic review</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26673326</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">2211-1247</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>13</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
<Day>22</Day>
</PubDate>
</JournalIssue>
<Title>Cell reports</Title>
<ISOAbbreviation>Cell Rep</ISOAbbreviation>
</Journal>
<ArticleTitle>Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells.</ArticleTitle>
<Pagination>
<MedlinePgn>2425-39</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.celrep.2015.11.021</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S2211-1247(15)01321-2</ELocationID>
<Abstract>
<AbstractText>To identify therapeutic targets for glioblastoma (GBM), we performed genome-wide CRISPR-Cas9 knockout (KO) screens in patient-derived GBM stem-like cells (GSCs) and human neural stem/progenitors (NSCs), non-neoplastic stem cell controls, for genes required for their in vitro growth. Surprisingly, the vast majority GSC-lethal hits were found outside of molecular networks commonly altered in GBM and GSCs (e.g., oncogenic drivers). In vitro and in vivo validation of GSC-specific targets revealed several strong hits, including the wee1-like kinase, PKMYT1/Myt1. Mechanistic studies demonstrated that PKMYT1 acts redundantly with WEE1 to inhibit cyclin B-CDK1 activity via CDK1-Y15 phosphorylation and to promote timely completion of mitosis in NSCs. However, in GSCs, this redundancy is lost, most likely as a result of oncogenic signaling, causing GBM-specific lethality. </AbstractText>
<CopyrightInformation>Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Toledo</LastName>
<ForeName>Chad M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo>
<Affiliation>Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Molecular and Cellular Biology Program, University of Washington, Seattle, WA 98195, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ding</LastName>
<ForeName>Yu</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hoellerbauer</LastName>
<ForeName>Pia</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Molecular and Cellular Biology Program, University of Washington, Seattle, WA 98195, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Davis</LastName>
<ForeName>Ryan J</ForeName>
<Initials>RJ</Initials>
<AffiliationInfo>
<Affiliation>Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Molecular and Cellular Biology Program, University of Washington, Seattle, WA 98195, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Basom</LastName>
<ForeName>Ryan</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Genomics and Bioinformatics Shared Resources, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Girard</LastName>
<ForeName>Emily J</ForeName>
<Initials>EJ</Initials>
<AffiliationInfo>
<Affiliation>Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Eunjee</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Corrin</LastName>
<ForeName>Philip</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hart</LastName>
<ForeName>Traver</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Genetics, University of Toronto and Donnelly Centre, Toronto, ON M5S3E1, Canada; Canadian Institute for Advanced Research, Toronto, ON M5G1Z8, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bolouri</LastName>
<ForeName>Hamid</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Davison</LastName>
<ForeName>Jerry</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Genomics and Bioinformatics Shared Resources, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Qing</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>Genomics and Bioinformatics Shared Resources, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hardcastle</LastName>
<ForeName>Justin</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aronow</LastName>
<ForeName>Bruce J</ForeName>
<Initials>BJ</Initials>
<AffiliationInfo>
<Affiliation>Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Plaisier</LastName>
<ForeName>Christopher L</ForeName>
<Initials>CL</Initials>
<AffiliationInfo>
<Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baliga</LastName>
<ForeName>Nitin S</ForeName>
<Initials>NS</Initials>
<AffiliationInfo>
<Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moffat</LastName>
<ForeName>Jason</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Genetics, University of Toronto and Donnelly Centre, Toronto, ON M5S3E1, Canada; Canadian Institute for Advanced Research, Toronto, ON M5G1Z8, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lin</LastName>
<ForeName>Qi</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>Brain Tumor Program, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Xiao-Nan</ForeName>
<Initials>XN</Initials>
<AffiliationInfo>
<Affiliation>Brain Tumor Program, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nam</LastName>
<ForeName>Do-Hyun</ForeName>
<Initials>DH</Initials>
<AffiliationInfo>
<Affiliation>Institute for Refractory Cancer Research, Samsung Medical Center, Seoul 135-710, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Jeongwu</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44192, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pollard</LastName>
<ForeName>Steven M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Edinburgh CRUK Cancer Research Centre and MRC Centre for Regenerative Medicine, The University of Edinburgh, Edinburgh EH16 4UU, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhu</LastName>
<ForeName>Jun</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Delrow</LastName>
<ForeName>Jeffery J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>Genomics and Bioinformatics Shared Resources, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Clurman</LastName>
<ForeName>Bruce E</ForeName>
<Initials>BE</Initials>
<AffiliationInfo>
<Affiliation>Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Olson</LastName>
<ForeName>James M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. Electronic address: jolson@fredhutch.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Paddison</LastName>
<ForeName>Patrick J</ForeName>
<Initials>PJ</Initials>
<AffiliationInfo>
<Affiliation>Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Molecular and Cellular Biology Program, University of Washington, Seattle, WA 98195, USA. Electronic address: paddison@fredhutch.org.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 DK056465</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA084069</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA114567</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA155360</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA190957</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21 CA170722</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Cell Rep</MedlineTA>
<NlmUniqueID>101573691</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">CRISPR-Cas9</Keyword>
<Keyword MajorTopicYN="N">Glioblastoma</Keyword>
<Keyword MajorTopicYN="N">Myt1</Keyword>
<Keyword MajorTopicYN="N">PKMYT1</Keyword>
<Keyword MajorTopicYN="N">WEE1</Keyword>
<Keyword MajorTopicYN="N">cancer therapeutics</Keyword>
<Keyword MajorTopicYN="N">functional genomics</Keyword>
<Keyword MajorTopicYN="N">gene editing</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26686630</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">2211-1247</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>13</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
<Day>22</Day>
</PubDate>
</JournalIssue>
<Title>Cell reports</Title>
<ISOAbbreviation>Cell Rep</ISOAbbreviation>
</Journal>
<ArticleTitle>Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis.</ArticleTitle>
<Pagination>
<MedlinePgn>2395-402</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.celrep.2015.11.047</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S2211-1247(15)01362-5</ELocationID>
<Abstract>
<AbstractText>Long noncoding RNAs (lncRNAs) significantly influence the development and regulation of genome expression in cells. Here, we demonstrate the role of lncRNA ceruloplasmin (NRCP) in cancer metabolism and elucidate functional effects leading to increased tumor progression. NRCP was highly upregulated in ovarian tumors, and knockdown of NRCP resulted in significantly increased apoptosis, decreased cell proliferation, and decreased glycolysis compared with control cancer cells. In an orthotopic mouse model of ovarian cancer, siNRCP delivered via a liposomal carrier significantly reduced tumor growth compared with control treatment. We identified NRCP as an intermediate binding partner between STAT1 and RNA polymerase II, leading to increased expression of downstream target genes such as glucose-6-phosphate isomerase. Collectively, we report a previously unrecognized role of the lncRNA NRCP in modulating cancer metabolism. As demonstrated, DOPC nanoparticle-incorporated siRNA-mediated silencing of this lncRNA in vivo provides therapeutic avenue toward modulating lncRNAs in cancer. </AbstractText>
<CopyrightInformation>Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rupaimoole</LastName>
<ForeName>Rajesha</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Jaehyuk</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Haemmerle</LastName>
<ForeName>Monika</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ling</LastName>
<ForeName>Hui</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Previs</LastName>
<ForeName>Rebecca A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pradeep</LastName>
<ForeName>Sunila</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Sherry Y</ForeName>
<Initials>SY</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ivan</LastName>
<ForeName>Cristina</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ferracin</LastName>
<ForeName>Manuela</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Experimental and Diagnostic Medicine and Interdepartment Center for Cancer Research, University of Ferrara, Ferrara 44100, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dennison</LastName>
<ForeName>Jennifer B</ForeName>
<Initials>JB</Initials>
<AffiliationInfo>
<Affiliation>Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Millward</LastName>
<ForeName>Niki M Zacharias</ForeName>
<Initials>NM</Initials>
<AffiliationInfo>
<Affiliation>Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nagaraja</LastName>
<ForeName>Archana S</ForeName>
<Initials>AS</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gharpure</LastName>
<ForeName>Kshipra M</ForeName>
<Initials>KM</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McGuire</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sam</LastName>
<ForeName>Nidhin</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Armaiz-Pena</LastName>
<ForeName>Guillermo N</ForeName>
<Initials>GN</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sadaoui</LastName>
<ForeName>Nouara C</ForeName>
<Initials>NC</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rodriguez-Aguayo</LastName>
<ForeName>Cristian</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Calin</LastName>
<ForeName>George A</ForeName>
<Initials>GA</Initials>
<AffiliationInfo>
<Affiliation>Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Drapkin</LastName>
<ForeName>Ronny I</ForeName>
<Initials>RI</Initials>
<AffiliationInfo>
<Affiliation>Obstetrics, Gynecology and Pathology, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kovacs</LastName>
<ForeName>Jeffery</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Institute of Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mills</LastName>
<ForeName>Gordon B</ForeName>
<Initials>GB</Initials>
<AffiliationInfo>
<Affiliation>Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Wei</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lopez-Berestein</LastName>
<ForeName>Gabriel</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bhattacharya</LastName>
<ForeName>Pratip K</ForeName>
<Initials>PK</Initials>
<AffiliationInfo>
<Affiliation>Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sood</LastName>
<ForeName>Anil K</ForeName>
<Initials>AK</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: asood@mdanderson.org.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 CA016672</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Cell Rep</MedlineTA>
<NlmUniqueID>101573691</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26643801</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-3441</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>98</Volume>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V</Title>
<ISOAbbreviation>Eur J Pharm Biopharm</ISOAbbreviation>
</Journal>
<ArticleTitle>A novel floating controlled release drug delivery system prepared by hot-melt extrusion.</ArticleTitle>
<Pagination>
<MedlinePgn>108-21</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejpb.2015.11.015</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0939-6411(15)00487-7</ELocationID>
<Abstract>
<AbstractText>Floating dosage forms are an important formulation strategy for drugs with a narrow absorption window and low intestinal solubility, and for localized gastric treatment. Novel floating pellets were prepared using the hot-melt extrusion (HME) technology. Uniformly foamed strands were created by liquid injection pumping and screw configuration modification. The ammonio methacrylate copolymer (Eudragit® RSPO) foaming structure was formed by a liquid-vapor phase transition inside the strand upon die exiting resulting from the sudden decrease in external pressure, vaporizing the liquid ethanol and vacating the extruded material. This generated uniform vacuous regions in the extrudate. The pellets' internal structure was investigated using scanning electron microscopy (SEM). The formulation constituents' and processing parameters' effects on the drug release profiles, floating force, and the pellets' micromeritic properties were evaluated by design of experiments: all formulations showed zero lag time and excellent floating strength, indicating immediate-floating pellet formation. The pellets' drug release profiles were controlled by multiple independent variables at different time points (⩽24h). Drug loading significantly affected drug release within the first hour, the hydroxypropyl methylcellulose (HPMC) content thereafter. Understanding the variables' effects on the formulations allows for the tailoring of this delivery system to obtain various drug release profiles. </AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vo</LastName>
<ForeName>Anh Q</ForeName>
<Initials>AQ</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, MS 38677, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Feng</LastName>
<ForeName>Xin</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, MS 38677, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Morott</LastName>
<ForeName>Joseph T</ForeName>
<Initials>JT</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, MS 38677, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pimparade</LastName>
<ForeName>Manjeet B</ForeName>
<Initials>MB</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, MS 38677, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tiwari</LastName>
<ForeName>Roshan V</ForeName>
<Initials>RV</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, MS 38677, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Feng</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Repka</LastName>
<ForeName>Michael A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, MS 38677, USA; Pii Center for Pharmaceutical Technology, The University of Mississippi, University, MS 38677, USA. Electronic address: marepka@olemiss.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P20 GM104932</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Eur J Pharm Biopharm</MedlineTA>
<NlmUniqueID>9109778</NlmUniqueID>
<ISSNLinking>0939-6411</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Chemical imaging</Keyword>
<Keyword MajorTopicYN="N">Controlled release</Keyword>
<Keyword MajorTopicYN="N">Eudragit® RSPO</Keyword>
<Keyword MajorTopicYN="N">Floating drug delivery system</Keyword>
<Keyword MajorTopicYN="N">Foamed extrudate</Keyword>
<Keyword MajorTopicYN="N">Hot-melt extrusion</Keyword>
<Keyword MajorTopicYN="N">Theophylline</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">25913389</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-7560</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>69</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>European urology</Title>
<ISOAbbreviation>Eur. Urol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Adverse Pathologic Features at Radical Prostatectomy: Effect of Preoperative Risk on Oncologic Outcomes.</ArticleTitle>
<Pagination>
<MedlinePgn>143-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eururo.2015.03.044</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0302-2838(15)00275-4</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Up to 30% of patients with low-risk prostate cancer (PCa) are found to have features of aggressive disease at radical prostatectomy (RP). Several predictive nomograms and novel genomic markers have been developed to estimate the risk of adverse pathology in men eligible for active surveillance (AS). However, oncologic risk associated with these findings remains unknown.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine if the presence of adverse pathologic features at RP in patients eligible for AS is prognostic of poor oncologic outcome independent of pretreatment risk status.</AbstractText>
<AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="METHODS">A total of 2660 patients underwent immediate RP at our institution between 1998 and 2008. Patients were stratified as low, intermediate, or high risk according to the D'Amico clinical risk criteria.</AbstractText>
<AbstractText Label="OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS" NlmCategory="METHODS">The rates of adverse pathology were reported, and the 5-yr risk of biochemical recurrence (BCR) was calculated in the presence of aggressive disease.</AbstractText>
<AbstractText Label="RESULTS AND LIMITATIONS" NlmCategory="CONCLUSIONS">The 5-yr risk of BCR in patients with extracapsular extension (n=937) was 43% (95% confidence interval [CI], 40-46) overall but only 15% (95% CI, 11-22) for those who met the criteria for low risk (n=181). For the 473 patients with pathologic Gleason score 4+3, the risk of recurrence at 5 yr was 41% (95% CI, 37-46) overall, 13% (95% CI, 5-27) for low-risk men (n=41), 41% (95% CI, 35-47) for intermediate-risk men (n=287), and 51% (95% CI, 43-60) for high-risk men (n=145). Limitations include use of BCR as the study end point and surrogate for oncologic outcome in men who received curative treatment.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The presence of pathologically unfavorable disease in patients eligible for AS is not informative as to the safety of this treatment modality. We question the relevance of adverse pathology as the end point for predictive tools designed to guide treatment decisions in low-risk PCa.</AbstractText>
<AbstractText Label="PATIENT SUMMARY" NlmCategory="RESULTS">The risk of biochemical recurrence associated with adverse pathologic findings at prostatectomy is reduced by approximately 50% in men with clinically low-risk prostate cancer.</AbstractText>
<CopyrightInformation>Copyright © 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Imnadze</LastName>
<ForeName>Mariam</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Urology Service, Department of Surgery, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, NY, USA. Electronic address: imnadzem@mskcc.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sjoberg</LastName>
<ForeName>Daniel D</ForeName>
<Initials>DD</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vickers</LastName>
<ForeName>Andrew J</ForeName>
<Initials>AJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P50 CA092629</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 CA082088</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>04</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Eur Urol</MedlineTA>
<NlmUniqueID>7512719</NlmUniqueID>
<ISSNLinking>0302-2838</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">NIHMS684530 [Available on 10/23/16]</OtherID>
<OtherID Source="NLM">PMC4618775 [Available on 10/23/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Biochemical risk</Keyword>
<Keyword MajorTopicYN="N">Oncologic outcome</Keyword>
<Keyword MajorTopicYN="N">Positive surgical margin</Keyword>
<Keyword MajorTopicYN="N">Prediction</Keyword>
<Keyword MajorTopicYN="N">Prostatic neoplasm</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26051441</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-7560</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>69</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>European urology</Title>
<ISOAbbreviation>Eur. Urol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Genital Human Papillomavirus Infection Progression to External Genital Lesions: The HIM Study.</ArticleTitle>
<Pagination>
<MedlinePgn>166-73</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eururo.2015.05.032</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0302-2838(15)00434-0</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Human papillomavirus (HPV) causes two types of external genital lesions (EGLs) in men: genital warts (condyloma) and penile intraepithelial neoplasia (PeIN).</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The purpose of this study was to describe genital HPV progression to a histopathologically confirmed HPV-related EGL.</AbstractText>
<AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="METHODS">A prospective analysis nested within the HPV Infection in Men (HIM) study was conducted among 3033 men. At each visit, visually distinct EGLs were biopsied; the biopsy specimens were subjected to pathologic evaluation and categorized by pathologic diagnoses. Genital swabs and biopsies were used to identify HPV types using the Linear Array genotyping method for swabs and INNO-LiPA for biopsy specimens.</AbstractText>
<AbstractText Label="OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS" NlmCategory="METHODS">EGL incidence was determined among 1788 HPV-positive men, and cumulative incidence rates at 6, 12, and 24 mo were estimated. The proportion of HPV infections that progressed to EGL was also calculated, along with median time to EGL development.</AbstractText>
<AbstractText Label="RESULTS AND LIMITATIONS" NlmCategory="CONCLUSIONS">Among 1788 HPV-positive men, 92 developed an incident EGL during follow-up (9 PeIN and 86 condyloma). During the first 12 mo of follow-up, 16% of men with a genital HPV 6 infection developed an HPV 6-positive condyloma, and 22% of genital HPV 11 infections progressed to an HPV 11-positive condyloma. During the first 12 mo of follow-up, 0.5% of men with a genital HPV 16 infection developed an HPV 16-positive PeIN. Although we expected PeIN to be a rare event, the sample size for PeIN (n=10) limited the types of analyses that could be performed.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Most EGLs develop following infection with HPV 6, 11, or 16, all of which could be prevented with the 4-valent HPV vaccine.</AbstractText>
<AbstractText Label="PATIENT SUMMARY" NlmCategory="RESULTS">In this study, we looked at genital human papillomavirus (HPV) infections that can cause lesions in men. The HPV that we detected within the lesions could be prevented by a vaccine.</AbstractText>
<CopyrightInformation>Copyright © 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sudenga</LastName>
<ForeName>Staci L</ForeName>
<Initials>SL</Initials>
<AffiliationInfo>
<Affiliation>Moffitt Cancer Center &amp; Research Institute, Tampa, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ingles</LastName>
<ForeName>Donna J</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo>
<Affiliation>Moffitt Cancer Center &amp; Research Institute, Tampa, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pierce Campbell</LastName>
<ForeName>Christine M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo>
<Affiliation>Moffitt Cancer Center &amp; Research Institute, Tampa, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lin</LastName>
<ForeName>Hui-Yi</ForeName>
<Initials>HY</Initials>
<AffiliationInfo>
<Affiliation>Moffitt Cancer Center &amp; Research Institute, Tampa, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fulp</LastName>
<ForeName>William J</ForeName>
<Initials>WJ</Initials>
<AffiliationInfo>
<Affiliation>Moffitt Cancer Center &amp; Research Institute, Tampa, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Messina</LastName>
<ForeName>Jane L</ForeName>
<Initials>JL</Initials>
<AffiliationInfo>
<Affiliation>Moffitt Cancer Center &amp; Research Institute, Tampa, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stoler</LastName>
<ForeName>Mark H</ForeName>
<Initials>MH</Initials>
<AffiliationInfo>
<Affiliation>University of Virginia Health System, Charlottesville, VA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abrahamsen</LastName>
<ForeName>Martha</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Moffitt Cancer Center &amp; Research Institute, Tampa, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Villa</LastName>
<ForeName>Luisa L</ForeName>
<Initials>LL</Initials>
<AffiliationInfo>
<Affiliation>School of Medicine, University of São Paulo and Santa Casa de São Paulo, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lazcano-Ponce</LastName>
<ForeName>Eduardo</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Instituto Nacional de Salud Pública, Cuernavaca, México.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Giuliano</LastName>
<ForeName>Anna R</ForeName>
<Initials>AR</Initials>
<AffiliationInfo>
<Affiliation>Moffitt Cancer Center &amp; Research Institute, Tampa, FL, USA. Electronic address: Anna.Giuliano@Moffitt.org.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 CA076292</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA098803</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R25 CA147832</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R25 CA174664</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Eur Urol</MedlineTA>
<NlmUniqueID>7512719</NlmUniqueID>
<ISSNLinking>0302-2838</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">NIHMS708392 [Available on 12/06/16]</OtherID>
<OtherID Source="NLM">PMC4670812 [Available on 12/06/16]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Condyloma</Keyword>
<Keyword MajorTopicYN="N">External genital lesion</Keyword>
<Keyword MajorTopicYN="N">HIM study</Keyword>
<Keyword MajorTopicYN="N">HPV</Keyword>
<Keyword MajorTopicYN="N">Human papillomavirus</Keyword>
<Keyword MajorTopicYN="N">PeIN</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26376348</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1528-0012</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Gastroenterology</Title>
<ISOAbbreviation>Gastroenterology</ISOAbbreviation>
</Journal>
<ArticleTitle>Physiological Mechanisms of Weight Gain-Induced Steatosis in People With Obesity.</ArticleTitle>
<Pagination>
<MedlinePgn>79-81.e2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1053/j.gastro.2015.09.003</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0016-5085(15)01309-8</ELocationID>
<Abstract>
<AbstractText>Weight gain is associated with an increase in intrahepatic triglycerides (IHTGs), and is the primary cause of nonalcoholic fatty liver disease in obese individuals. We combined imaging and stable isotope tracer techniques to evaluate the physiologic mechanisms of weight gain-induced steatosis in 27 obese people. Weight gain appeared to increase IHTG content by generating an imbalance between hepatic fatty acid availability and disposal, and resulted in increased hepatic de novo lipogenesis, decreased intrahepatic fatty acid oxidation, and inadequate increases in IHTG export via very low-density lipoprotein secretion. ClinicalTrials.gov ID NCT01184170. </AbstractText>
<CopyrightInformation>Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Fabbrini</LastName>
<ForeName>Elisa</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Center for Human Nutrition and Atkins Center of Excellence in Obesity Medicine, Washington University School of Medicine, St Louis, Missouri.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tiemann Luecking</LastName>
<ForeName>Courtney</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Center for Human Nutrition and Atkins Center of Excellence in Obesity Medicine, Washington University School of Medicine, St Louis, Missouri.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Love-Gregory</LastName>
<ForeName>Latisha</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Center for Human Nutrition and Atkins Center of Excellence in Obesity Medicine, Washington University School of Medicine, St Louis, Missouri.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Okunade</LastName>
<ForeName>Adewole L</ForeName>
<Initials>AL</Initials>
<AffiliationInfo>
<Affiliation>Center for Human Nutrition and Atkins Center of Excellence in Obesity Medicine, Washington University School of Medicine, St Louis, Missouri.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yoshino</LastName>
<ForeName>Mihoko</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Center for Human Nutrition and Atkins Center of Excellence in Obesity Medicine, Washington University School of Medicine, St Louis, Missouri.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fraterrigo</LastName>
<ForeName>Gemma</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Center for Human Nutrition and Atkins Center of Excellence in Obesity Medicine, Washington University School of Medicine, St Louis, Missouri.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Patterson</LastName>
<ForeName>Bruce W</ForeName>
<Initials>BW</Initials>
<AffiliationInfo>
<Affiliation>Center for Human Nutrition and Atkins Center of Excellence in Obesity Medicine, Washington University School of Medicine, St Louis, Missouri.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Klein</LastName>
<ForeName>Samuel</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Center for Human Nutrition and Atkins Center of Excellence in Obesity Medicine, Washington University School of Medicine, St Louis, Missouri. Electronic address: sklein@dom.wustl.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 DK020579</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 DK056341</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DK037948</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1 RR024992</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1 TR000448</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Gastroenterology</MedlineTA>
<NlmUniqueID>0374630</NlmUniqueID>
<ISSNLinking>0016-5085</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Fatty Acid Oxidation</Keyword>
<Keyword MajorTopicYN="N">Overweight</Keyword>
<Keyword MajorTopicYN="N">VLDL</Keyword>
<Keyword MajorTopicYN="N">apoB100</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26385073</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1528-0012</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>150</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Gastroenterology</Title>
<ISOAbbreviation>Gastroenterology</ISOAbbreviation>
</Journal>
<ArticleTitle>Pathobiology of Helicobacter pylori-Induced Gastric Cancer.</ArticleTitle>
<Pagination>
<MedlinePgn>64-78</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1053/j.gastro.2015.09.004</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0016-5085(15)01312-8</ELocationID>
<Abstract>
<AbstractText>Colonization of the human stomach by Helicobacter pylori and its role in causing gastric cancer is one of the richest examples of a complex relationship among human cells, microbes, and their environment. It is also a puzzle of enormous medical importance given the incidence and lethality of gastric cancer worldwide. We review recent findings that have changed how we view these relationships and affected the direction of gastric cancer research. For example, recent data have indicated that subtle mismatches between host and microbe genetic traits greatly affect the risk of gastric cancer. The ability of H pylori and its oncoprotein CagA to reprogram epithelial cells and activate properties of stemness show the sophisticated relationship between H pylori and progenitor cells in the gastric mucosa. The observation that cell-associated H pylori can colonize the gastric glands and directly affect precursor and stem cells supports these observations. The ability to mimic these interactions in human gastric organoid cultures as well as animal models will allow investigators to more fully unravel the extent of H pylori control on the renewing gastric epithelium. Finally, our realization that external environmental factors, such as dietary components and essential micronutrients, as well as the gastrointestinal microbiota, can change the balance between H pylori's activity as a commensal or a pathogen has provided direction to studies aimed at defining the full carcinogenic potential of this organism. </AbstractText>
<CopyrightInformation>Copyright © 2016. Published by Elsevier Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Amieva</LastName>
<ForeName>Manuel</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Immunology, Stanford University, Palo Alto, California; Department of Pediatrics, Stanford University, Palo Alto, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peek</LastName>
<ForeName>Richard M</ForeName>
<Initials>RM</Initials>
<Suffix>Jr</Suffix>
<AffiliationInfo>
<Affiliation>Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University, Nashville, Tennessee; Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. Electronic address: richard.peek@vanderbilt.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P01 CA116087</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 DK058404</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA077955</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DK058587</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U19 AI116484</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Gastroenterology</MedlineTA>
<NlmUniqueID>0374630</NlmUniqueID>
<ISSNLinking>0016-5085</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Gastric Cancer</Keyword>
<Keyword MajorTopicYN="N">H pylori</Keyword>
<Keyword MajorTopicYN="N">Microbiota</Keyword>
<Keyword MajorTopicYN="N">Stem Cells</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26142556</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1097-6779</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>83</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Gastrointestinal endoscopy</Title>
<ISOAbbreviation>Gastrointest. Endosc.</ISOAbbreviation>
</Journal>
<ArticleTitle>The esophageal biopsy "pull" sign: a highly specific and treatment-responsive endoscopic finding in eosinophilic esophagitis (with video).</ArticleTitle>
<Pagination>
<MedlinePgn>92-100</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.gie.2015.05.046</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0016-5107(15)02500-6</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Esophageal biopsy specimens from patients with eosinophilic esophagitis (EoE) can feel firm, with resistance felt when pulling the forceps to obtain the tissue sample. We aimed to assess the diagnostic utility of the esophageal biopsy "pull" sign and determine its histologic associations and response to treatment.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">This was a prospective cohort study of adults undergoing outpatient upper endoscopy. Cases of EoE were diagnosed per consensus guidelines, and patients were subsequently treated with either topical steroids or dietary elimination. Control subjects were individuals who did not have EoE. The frequency of the esophageal biopsy "pull" sign was assessed in EoE patients and controls, and diagnostic metrics were calculated. The "pull" sign was also reassessed in patients after therapy.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 83 EoE patients and 121 control subjects were included. Sixty-three EoE patients (76%) were "pull" sign positive compared with just 2 control subjects (2%; P &lt; .001), corresponding to a sensitivity and specificity of 76% and 98%, positive and negative predictive values of 97% and 86%, and positive and negative likelihood ratios of 45.9 and 0.245, respectively. The "pull" sign was the strongest endoscopic predictor of EoE case status at baseline and was less frequent after successful treatment (20% vs 79%; P &lt; .001).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The "pull" sign is highly specific for EoE and is rarely seen in non-EoE control subjects. In patients with EoE who respond to treatment, the "pull" sign often resolves. The "pull" sign may be a simple and easily obtained measure of esophageal remodeling.</AbstractText>
<CopyrightInformation>Copyright © 2016 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dellon</LastName>
<ForeName>Evan S</ForeName>
<Initials>ES</Initials>
<AffiliationInfo>
<Affiliation>Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA; Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gebhart</LastName>
<ForeName>Jessica H</ForeName>
<Initials>JH</Initials>
<AffiliationInfo>
<Affiliation>Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Higgins</LastName>
<ForeName>Leana L</ForeName>
<Initials>LL</Initials>
<AffiliationInfo>
<Affiliation>Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hathorn</LastName>
<ForeName>Kelly E</ForeName>
<Initials>KE</Initials>
<AffiliationInfo>
<Affiliation>Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Woosley</LastName>
<ForeName>John T</ForeName>
<Initials>JT</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shaheen</LastName>
<ForeName>Nicholas J</ForeName>
<Initials>NJ</Initials>
<AffiliationInfo>
<Affiliation>Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA; Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K23 DK090073</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K24 DK100548</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 DK034987</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Gastrointest Endosc</MedlineTA>
<NlmUniqueID>0010505</NlmUniqueID>
<ISSNLinking>0016-5107</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26253018</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1097-6779</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>83</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Gastrointestinal endoscopy</Title>
<ISOAbbreviation>Gastrointest. Endosc.</ISOAbbreviation>
</Journal>
<ArticleTitle>Quantitative analysis of high-resolution microendoscopic images for diagnosis of neoplasia in patients with Barrett's esophagus.</ArticleTitle>
<Pagination>
<MedlinePgn>107-14</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.gie.2015.06.045</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0016-5107(15)02617-6</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Previous studies show that microendoscopic images can be interpreted visually to identify the presence of neoplasia in patients with Barrett's esophagus (BE), but this approach is subjective and requires clinical expertise. This study describes an approach for quantitative image analysis of microendoscopic images to identify neoplastic lesions in patients with BE.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Images were acquired from 230 sites from 58 patients by using a fiberoptic high-resolution microendoscope during standard endoscopic procedures. Images were analyzed by a fully automated image processing algorithm, which automatically selected a region of interest and calculated quantitative image features. Image features were used to develop an algorithm to identify the presence of neoplasia; results were compared with a histopathology diagnosis.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A sequential classification algorithm that used image features related to glandular and cellular morphology resulted in a sensitivity of 84% and a specificity of 85%. Applying the algorithm to an independent validation set resulted in a sensitivity of 88% and a specificity of 85%.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This pilot study demonstrates that automated analysis of microendoscopic images can provide an objective, quantitative framework to assist clinicians in evaluating esophageal lesions from patients with BE. (</AbstractText>
<AbstractText Label="CLINICAL TRIAL REGISTRATION NUMBER" NlmCategory="BACKGROUND">NCT01384227 and NCT02018367.).</AbstractText>
<CopyrightInformation>Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shin</LastName>
<ForeName>Dongsuk</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Bioengineering, Rice University, Houston, Texas, USA; Department of Neurosurgery, The University of Texas Medical School at Houston, Houston, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Michelle H</ForeName>
<Initials>MH</Initials>
<AffiliationInfo>
<Affiliation>Division of Gastroenterology, The Mount Sinai Medical Center, New York, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Polydorides</LastName>
<ForeName>Alexandros D</ForeName>
<Initials>AD</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, The Mount Sinai Medical Center, New York, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pierce</LastName>
<ForeName>Mark C</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Engineering, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vila</LastName>
<ForeName>Peter M</ForeName>
<Initials>PM</Initials>
<AffiliationInfo>
<Affiliation>Division of Gastroenterology, The Mount Sinai Medical Center, New York, New York, USA; Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Parikh</LastName>
<ForeName>Neil D</ForeName>
<Initials>ND</Initials>
<AffiliationInfo>
<Affiliation>Division of Gastroenterology, The Mount Sinai Medical Center, New York, New York, USA; Division of Digestive Diseases, Yale-New Haven Hospital, New Haven, Connecticut, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rosen</LastName>
<ForeName>Daniel G</ForeName>
<Initials>DG</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Baylor College of Medicine, Houston, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Anandasabapathy</LastName>
<ForeName>Sharmila</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Division of Gastroenterology, The Mount Sinai Medical Center, New York, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Richards-Kortum</LastName>
<ForeName>Rebecca R</ForeName>
<Initials>RR</Initials>
<AffiliationInfo>
<Affiliation>Department of Bioengineering, Rice University, Houston, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 CA140257</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 EB007594</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Gastrointest Endosc</MedlineTA>
<NlmUniqueID>0010505</NlmUniqueID>
<ISSNLinking>0016-5107</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26271184</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1097-6779</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>83</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Gastrointestinal endoscopy</Title>
<ISOAbbreviation>Gastrointest. Endosc.</ISOAbbreviation>
</Journal>
<ArticleTitle>Gastrointestinal traits: individualizing therapy for obesity with drugs and devices.</ArticleTitle>
<Pagination>
<MedlinePgn>48-56</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.gie.2015.08.007</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0016-5107(15)02741-8</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">The aims of this article were to review the discrepancy between numbers of people requiring weight loss treatment and results and to assess the potential effects of pharmacologic treatments (recently approved for obesity) and endoscopically deployed devices on quantitative GI traits in development for obesity treatment.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a review of relevant literature to achieve our objectives.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The 2013 guidelines increased the number of adults recommended for weight loss treatment by 20.9% (116.0 million to 140.2 million). There is an imbalance between efficacy and costs of commercial weight loss programs and drug therapy (average weight loss about 5 kg). The number of bariatric procedures performed in the United States has doubled in the past decade. The efficacy of bariatric surgery is attributed to reduction in the volume of the stomach, nutrient malabsorption with some types of surgery, increased postprandial incretin responses, and activation of farnesoid X receptor mechanisms. These GI and behavioral traits identify sub-phenotypes of obesity, based on recent research.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The mechanisms or traits targeted by drug and device treatments include centrally mediated alterations of appetite or satiation, diversion of nutrients, and alteration of stomach capacity, gastric emptying, or incretin hormones. Future treatment may be individualized based on quantitative GI and behavioral traits measured in obese patients.</AbstractText>
<CopyrightInformation>Copyright © 2016 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Camilleri</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Mayo Clinic College of Medicine, Rochester, Minnesota, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Acosta</LastName>
<ForeName>Andres</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Mayo Clinic College of Medicine, Rochester, Minnesota, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 DK067071</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Gastrointest Endosc</MedlineTA>
<NlmUniqueID>0010505</NlmUniqueID>
<ISSNLinking>0016-5107</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">NIHMS715303 [Available on 02/10/17]</OtherID>
<OtherID Source="NLM">PMC4548831 [Available on 02/10/17]</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26278652</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1097-6779</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>83</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Gastrointestinal endoscopy</Title>
<ISOAbbreviation>Gastrointest. Endosc.</ISOAbbreviation>
</Journal>
<ArticleTitle>Direct endoscopic necrosectomy in retroflexion when using a lumen-apposing transmural covered metal stent.</ArticleTitle>
<Pagination>
<MedlinePgn>255</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.gie.2015.08.013</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0016-5107(15)02747-9</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Alexander</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thompson</LastName>
<ForeName>Christopher C</ForeName>
<Initials>CC</Initials>
<AffiliationInfo>
<Affiliation>Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>T32 DK007533</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Gastrointest Endosc</MedlineTA>
<NlmUniqueID>0010505</NlmUniqueID>
<ISSNLinking>0016-5107</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26318834</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1097-6779</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>83</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Gastrointestinal endoscopy</Title>
<ISOAbbreviation>Gastrointest. Endosc.</ISOAbbreviation>
</Journal>
<ArticleTitle>Doppler endoscopic probe as a guide to risk stratification and definitive hemostasis of peptic ulcer bleeding.</ArticleTitle>
<Pagination>
<MedlinePgn>129-36</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.gie.2015.07.012</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0016-5107(15)02658-9</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">For more than 4 decades endoscopists have relied on ulcer stigmata for risk stratification and as a guide to hemostasis. None used arterial blood flow underneath stigmata to predict outcomes. For patients with severe peptic ulcer bleeding (PUB), we used a Doppler endoscopic probe (DEP) for (1) detection of blood flow underlying stigmata of recent hemorrhage (SRH), (2) quantitating rates of residual arterial blood flow under SRH after visually directed standard endoscopic treatment, and (3) comparing risks of rebleeding and actual 30-day rebleed rates for spurting arterial bleeding (Forrest [F] IA) and oozing bleeding (F IB).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Prospective cohort study of 163 consecutive patients with severe PUB and different SRH.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">All blood flow detected by the DEP was arterial. Detection rates were 87.4% in major SRH-spurting arterial bleeding (F IA), non-bleeding visible vessel (F IIA), clot (F IIB)-and were significantly lower at 42.3% (P &lt; .0001) for an intermediate group of oozing bleeding (F IB) or flat spot (F IIC). For spurting bleeding (F IA) versus oozing (F IB), baseline DEP arterial flow was 100% versus 46.7%, residual blood flow detected after endoscopic hemostasis was 35.7% versus 0%, and 30-day rebleed rates were 28.6% versus 0% (all P &lt; .05).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">(1) For major SRH versus oozing or spot, the arterial blood flow detection rate by the DEP was significantly higher, indicating a higher rebleed risk. (2) Before and after endoscopic treatment, spurting (F IA) PUB had significantly higher rates of blood flow detection than oozing (F IB) PUB and a significantly higher 30-day rebleed rate. (3) The DEP is recommended as a new endoscopic guide with SRH to improve risk stratification and potentially definitive hemostasis for PUB.</AbstractText>
<CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jensen</LastName>
<ForeName>Dennis M</ForeName>
<Initials>DM</Initials>
<AffiliationInfo>
<Affiliation>CURE Hemostasis Research Group of the CURE Digestive Diseases Research Center, Divisions of Digestive Diseases and Departments of Medicine, Ronald Reagan University of California at Los Angeles Medical Center, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, Calif, USA; West Los Angeles Veterans Administration Medical Center, Los Angeles, Calif, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ohning</LastName>
<ForeName>Gordon V</ForeName>
<Initials>GV</Initials>
<AffiliationInfo>
<Affiliation>CURE Hemostasis Research Group of the CURE Digestive Diseases Research Center, Divisions of Digestive Diseases and Departments of Medicine, Ronald Reagan University of California at Los Angeles Medical Center, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, Calif, USA; West Los Angeles Veterans Administration Medical Center, Los Angeles, Calif, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kovacs</LastName>
<ForeName>Thomas O G</ForeName>
<Initials>TO</Initials>
<AffiliationInfo>
<Affiliation>CURE Hemostasis Research Group of the CURE Digestive Diseases Research Center, Divisions of Digestive Diseases and Departments of Medicine, Ronald Reagan University of California at Los Angeles Medical Center, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, Calif, USA; West Los Angeles Veterans Administration Medical Center, Los Angeles, Calif, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ghassemi</LastName>
<ForeName>Kevin A</ForeName>
<Initials>KA</Initials>
<AffiliationInfo>
<Affiliation>CURE Hemostasis Research Group of the CURE Digestive Diseases Research Center, Divisions of Digestive Diseases and Departments of Medicine, Ronald Reagan University of California at Los Angeles Medical Center, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, Calif, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jutabha</LastName>
<ForeName>Rome</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>CURE Hemostasis Research Group of the CURE Digestive Diseases Research Center, Divisions of Digestive Diseases and Departments of Medicine, Ronald Reagan University of California at Los Angeles Medical Center, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, Calif, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dulai</LastName>
<ForeName>Gareth S</ForeName>
<Initials>GS</Initials>
<AffiliationInfo>
<Affiliation>CURE Hemostasis Research Group of the CURE Digestive Diseases Research Center, Divisions of Digestive Diseases and Departments of Medicine, Ronald Reagan University of California at Los Angeles Medical Center, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, Calif, USA; West Los Angeles Veterans Administration Medical Center, Los Angeles, Calif, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Machicado</LastName>
<ForeName>Gustavo A</ForeName>
<Initials>GA</Initials>
<AffiliationInfo>
<Affiliation>CURE Hemostasis Research Group of the CURE Digestive Diseases Research Center, Divisions of Digestive Diseases and Departments of Medicine, Ronald Reagan University of California at Los Angeles Medical Center, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, Calif, USA; West Los Angeles Veterans Administration Medical Center, Los Angeles, Calif, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 DK041301</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Gastrointest Endosc</MedlineTA>
<NlmUniqueID>0010505</NlmUniqueID>
<ISSNLinking>0016-5107</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26611529</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1879-0038</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>577</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Feb</Month>
<Day>10</Day>
</PubDate>
</JournalIssue>
<Title>Gene</Title>
<ISOAbbreviation>Gene</ISOAbbreviation>
</Journal>
<ArticleTitle>The cytoplasmic peptide:N-glycanase (NGLY1) - Structure, expression and cellular functions.</ArticleTitle>
<Pagination>
<MedlinePgn>1-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.gene.2015.11.021</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0378-1119(15)01430-4</ELocationID>
<Abstract>
<AbstractText>NGLY1/Ngly1 is a cytosolic peptide:N-glycanase, i.e. de-N-glycosylating enzyme acting on N-glycoproteins in mammals, generating free, unconjugated N-glycans and deglycosylated peptides in which the N-glycosylated asparagine residues are converted to aspartates. This enzyme is known to be involved in the quality control system for the newly synthesized glycoproteins in the endoplasmic reticulum (ER). In this system, misfolded (glyco)proteins are retrotranslocated to the cytosol, where the 26S proteasomes play a central role in degrading the proteins: a process referred to as ER-associated degradation or ERAD in short. PNGase-mediated deglycosylation is believed to facilitate the efficient degradation of some misfolded glycoproteins. Human patients harboring mutations of NGLY1 gene (NGLY1-deficiency) have recently been discovered, clearly indicating the functional importance of this enzyme. This review summarizes the current state of our knowledge on NGLY1 and its gene product in mammalian cells. </AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Suzuki</LastName>
<ForeName>Tadashi</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Glycometabolome Team, Systems Glycobiology Research Group, RIKEN-Max Planck Joint Research Center, Global Research Cluster, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan. Electronic address: tsuzuki_gm@riken.jp.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Chengcheng</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Glycometabolome Team, Systems Glycobiology Research Group, RIKEN-Max Planck Joint Research Center, Global Research Cluster, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fujihira</LastName>
<ForeName>Haruhiko</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Glycometabolome Team, Systems Glycobiology Research Group, RIKEN-Max Planck Joint Research Center, Global Research Cluster, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 GM089820</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Gene</MedlineTA>
<NlmUniqueID>7706761</NlmUniqueID>
<ISSNLinking>0378-1119</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cytosol</Keyword>
<Keyword MajorTopicYN="N">ER associated degradation</Keyword>
<Keyword MajorTopicYN="N">Endo-beta-N-acetylglucosaminidase</Keyword>
<Keyword MajorTopicYN="N">Mammalian cells</Keyword>
<Keyword MajorTopicYN="N">NGLY1</Keyword>
<Keyword MajorTopicYN="N">Peptide:N-glycanase</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26518062</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1878-3511</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</Title>
<ISOAbbreviation>Int. J. Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Time trend analysis of cervical high-risk human papillomavirus (HPV) in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil: the rise of non-16/18 HPV.</ArticleTitle>
<Pagination>
<MedlinePgn>17-20</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijid.2015.10.017</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1201-9712(15)00251-9</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">HIV-infected women are at increased risk of human papillomavirus (HPV) infection. Time trends in annual prevalences of cervical high-risk human papillomavirus (HR-HPV) genotypes among a non-vaccinated, HIV-infected female cohort in urban Brazil were assessed for the period 2006-2012.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Cervical specimens were collected for HPV genotyping yearly between January 2006 and December 2012 in a cross-sectional analysis of participants aged ≥18 years enrolled in the Women's HIV Cohort at Fiocruz in Rio de Janeiro, Brazil. Age-adjusted generalized estimating equation models with an exchangeable matrix were used to estimate odds ratios (OR) and 95% confidence intervals (CI) for annual HPV positivity (reference year: 2006).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 590 participants, the median age across all study years ranged from 35.5 to 40.0 years. The prevalence of any HR-HPV was ≥53% every year; prevalences of HR-HPV 16, 58, 59, and 68 were ≥24% in at least 1 year. The odds of HPV 16 and 68 decreased in 2012. HPV 58 prevalence followed a U-shape, beginning and ending at &gt;20%. HPV 59 prevalence followed a linear trend, with increased odds in 2012 (OR 16.0, 95% CI 3.8-67.3; Bonferroni-adjusted p-value &lt;0.01).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The prevalences of HR-HPV 58, 59, and 68 were high in this cohort. Given current HR-HPV vaccine coverage and availability, further investigations are needed to optimize vaccine recommendations for this population.</AbstractText>
<CopyrightInformation>Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cambou</LastName>
<ForeName>Mary C</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Infectious Diseases, Program in Global Health, UCLA David Geffen School of Medicine, 10833 Le Conte Avenue, CHS 37-121, Los Angeles, CA 90095, USA; Department of Internal Medicine, Montefiore University Hospital of Albert Einstein College of Medicine, Bronx, New York, USA. Electronic address: mcambou@montefiore.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Levi</LastName>
<ForeName>José Eduardo</ForeName>
<Initials>JE</Initials>
<AffiliationInfo>
<Affiliation>Virology Laboratory, Instituto de Medicina Tropical, Universidade de São Paulo, São Paulo, SP, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lake</LastName>
<ForeName>Jordan E</ForeName>
<Initials>JE</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Infectious Diseases, Program in Global Health, UCLA David Geffen School of Medicine, 10833 Le Conte Avenue, CHS 37-121, Los Angeles, CA 90095, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Andrade</LastName>
<ForeName>Angela</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Instituto Nacional de Infectologia Evandro Chagas (IPEC), Fundação Oswaldo Cruz, Fiocruz, Rio de Janeiro, RJ, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jalil</LastName>
<ForeName>Emilia M</ForeName>
<Initials>EM</Initials>
<AffiliationInfo>
<Affiliation>Instituto Nacional de Infectologia Evandro Chagas (IPEC), Fundação Oswaldo Cruz, Fiocruz, Rio de Janeiro, RJ, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Russomano</LastName>
<ForeName>Fabio</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Instituto Fernandes Figueira, Fiocruz, Rio de Janeiro, RJ, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Derrico</LastName>
<ForeName>Mônica</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Instituto Nacional de Infectologia Evandro Chagas (IPEC), Fundação Oswaldo Cruz, Fiocruz, Rio de Janeiro, RJ, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Veloso</LastName>
<ForeName>Valdilea G</ForeName>
<Initials>VG</Initials>
<AffiliationInfo>
<Affiliation>Instituto Nacional de Infectologia Evandro Chagas (IPEC), Fundação Oswaldo Cruz, Fiocruz, Rio de Janeiro, RJ, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Friedman</LastName>
<ForeName>Ruth K</ForeName>
<Initials>RK</Initials>
<AffiliationInfo>
<Affiliation>Instituto Nacional de Infectologia Evandro Chagas (IPEC), Fundação Oswaldo Cruz, Fiocruz, Rio de Janeiro, RJ, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Luz</LastName>
<ForeName>Paula M</ForeName>
<Initials>PM</Initials>
<AffiliationInfo>
<Affiliation>Instituto Nacional de Infectologia Evandro Chagas (IPEC), Fundação Oswaldo Cruz, Fiocruz, Rio de Janeiro, RJ, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Grinsztejn</LastName>
<ForeName>Beatriz</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Instituto Nacional de Infectologia Evandro Chagas (IPEC), Fundação Oswaldo Cruz, Fiocruz, Rio de Janeiro, RJ, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K23 AI110532</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R25 MH087222</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>10</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Canada</Country>
<MedlineTA>Int J Infect Dis</MedlineTA>
<NlmUniqueID>9610933</NlmUniqueID>
<ISSNLinking>1201-9712</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cervical HPV</Keyword>
<Keyword MajorTopicYN="N">Epidemiology</Keyword>
<Keyword MajorTopicYN="N">HIV</Keyword>
<Keyword MajorTopicYN="N">HPV vaccine</Keyword>
<Keyword MajorTopicYN="N">High-risk HPV</Keyword>
<Keyword MajorTopicYN="N">Women</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26518066</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1878-3511</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</Title>
<ISOAbbreviation>Int. J. Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Molecular epidemiology and characterization of multiple drug-resistant (MDR) clinical isolates of Acinetobacter baumannii.</ArticleTitle>
<Pagination>
<MedlinePgn>42-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijid.2015.10.016</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1201-9712(15)00250-7</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of this study was to identify the genetic relatedness of multiple drug-resistant (MDR) Acinetobacter baumannii clinical isolates recovered from a hospital in Los Angeles.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Twenty-one MDR A. baumannii isolates were collected and their antibiotic susceptibilities determined according to Clinical and Laboratory Standards Institute guidelines. Genes coding for antibiotic resistance were identified by PCR, and their identities were confirmed by DNA sequencing. Clonal relationships were studied by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">MDR consistently correlated with the presence of oxacillinases, mostly in the form of the plasmid-mediated OXA-23 enzyme, which was detected in 12 (57.1%) isolates. GES-type carbapenemases were found in 20 (95.2%) strains, AAC in all 21 (100%) strains, and PER in seven (33.3%) strains, and ISAba1 was detected in 16 (76.2%) isolates. The association between ISAba1 and resistance genes confirms insertion elements as a source of β-lactamase production. Of the 21 clinical isolates, five were found to be related to sequence type 1 (ST1) and 16 to ST2, as analyzed by MLST. PFGE demonstrated that the majority of clinical isolates were highly related (&gt;85%).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study supports a more complete understanding of genotyping of antibiotic resistance for better assessment of MDR strain transmission.</AbstractText>
<CopyrightInformation>Copyright © 2015. Published by Elsevier Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>El-Shazly</LastName>
<ForeName>Sherief</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Health Sciences Center, Kuwait University, Kuwait; Division of Adult Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-University of California Los Angeles (UCLA) Medical Center, 1124 West Carson St., St. John's Cardiovascular Research Center, Torrance, CA 90502, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dashti</LastName>
<ForeName>Ali</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Health Sciences Center, Kuwait University, Kuwait.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vali</LastName>
<ForeName>Leila</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Health Sciences Center, Kuwait University, Kuwait.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bolaris</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Division of Pediatric Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-University of California Los Angeles (UCLA) Medical Center, Torrance, California, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ibrahim</LastName>
<ForeName>Ashraf S</ForeName>
<Initials>AS</Initials>
<AffiliationInfo>
<Affiliation>Division of Adult Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-University of California Los Angeles (UCLA) Medical Center, 1124 West Carson St., St. John's Cardiovascular Research Center, Torrance, CA 90502, USA; David Geffen School of Medicine at UCLA, Los Angeles, California, USA. Electronic address: ibrahim@labiomed.org.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>M01 RR000425</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21 AI119339</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>10</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Canada</Country>
<MedlineTA>Int J Infect Dis</MedlineTA>
<NlmUniqueID>9610933</NlmUniqueID>
<ISSNLinking>1201-9712</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Acinetobacter baumannii</Keyword>
<Keyword MajorTopicYN="N">MLST</Keyword>
<Keyword MajorTopicYN="N">PFGE</Keyword>
<Keyword MajorTopicYN="N">β-lactamase</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26487716</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>290</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Defining the Apoptotic Trigger: THE INTERACTION OF CYTOCHROME c AND CARDIOLIPIN.</ArticleTitle>
<Pagination>
<MedlinePgn>30879-87</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M115.689406</ELocationID>
<Abstract>
<AbstractText>The interaction between cytochrome c and the anionic lipid cardiolipin has been proposed as a primary event in the apoptotic signaling cascade. Numerous studies that have examined the interaction of cytochrome c with cardiolipin embedded in a variety of model phospholipid membranes have suggested that partial unfolding of the protein is a precursor to the apoptotic response. However, these studies lacked site resolution and used model systems with negligible or a positive membrane curvature, which is distinct from the large negative curvature of the invaginations of the inner mitochondrial membrane where cytochrome c resides. We have used reverse micelle encapsulation to mimic the potential effects of confinement on the interaction of cytochrome c with cardiolipin. Encapsulation of oxidized horse cytochrome c in 1-decanoyl-rac-glycerol/lauryldimethylamine-N-oxide/hexanol reverse micelles prepared in pentane yields NMR spectra essentially identical to the protein in free aqueous solution. The structure of encapsulated ferricytochrome c was determined to high precision (&lt;r.m.s. deviation&gt;bb ∼ 0.23 Å) using NMR-based methods and is closely similar to the cryogenic crystal structure (&lt;r.m.s. deviation&gt;bb ∼ 1.2 Å). Incorporation of cardiolipin into the reverse micelle surfactant shell causes localized chemical shift perturbations of the encapsulated protein, providing the first view of the cardiolipin/cytochrome c interaction interface at atomic resolution. Three distinct sites of interaction are detected: the so-called A- and L-sites, plus a previously undocumented interaction centered on residues Phe-36, Gly-37, Thr-58, Trp-59, and Lys-60. Importantly, in distinct contrast to earlier studies of this interaction, the protein is not significantly disturbed by the binding of cardiolipin in the context of the reverse micelle. </AbstractText>
<CopyrightInformation>© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>O'Brien</LastName>
<ForeName>Evan S</ForeName>
<Initials>ES</Initials>
<AffiliationInfo>
<Affiliation>From the Johnson Research Foundation and Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6059.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nucci</LastName>
<ForeName>Nathaniel V</ForeName>
<Initials>NV</Initials>
<AffiliationInfo>
<Affiliation>From the Johnson Research Foundation and Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6059.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fuglestad</LastName>
<ForeName>Brian</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>From the Johnson Research Foundation and Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6059.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tommos</LastName>
<ForeName>Cecilia</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the Johnson Research Foundation and Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6059.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wand</LastName>
<ForeName>A Joshua</ForeName>
<Initials>AJ</Initials>
<AffiliationInfo>
<Affiliation>From the Johnson Research Foundation and Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6059 wand@upenn.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>PDB</DataBankName>
<AccessionNumberList>
<AccessionNumber>1AKK</AccessionNumber>
<AccessionNumber>1CRC</AccessionNumber>
<AccessionNumber>1HRC</AccessionNumber>
<AccessionNumber>1KYO</AccessionNumber>
<AccessionNumber>2N3B</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>T32 GM008275</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>10</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">apoptosis</Keyword>
<Keyword MajorTopicYN="N">cardiolipin</Keyword>
<Keyword MajorTopicYN="N">confined space</Keyword>
<Keyword MajorTopicYN="N">cytochrome c</Keyword>
<Keyword MajorTopicYN="N">lipid-protein interaction</Keyword>
<Keyword MajorTopicYN="N">nuclear magnetic resonance (NMR)</Keyword>
<Keyword MajorTopicYN="N">protein folding</Keyword>
<Keyword MajorTopicYN="N">protein hydration</Keyword>
<Keyword MajorTopicYN="N">protein stability</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26534959</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>290</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase.</ArticleTitle>
<Pagination>
<MedlinePgn>30931-46</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M115.675751</ELocationID>
<Abstract>
<AbstractText>The HIV-1 transactivator protein Tat is implicated in the neuronal damage that contributes to neurocognitive impairment affecting people living with HIV/AIDS. Aberrant splicing of TAU exon 10 results in tauopathies characterized by alterations in the proportion of TAU isoforms containing three (3R) or four (4R) microtubule-binding repeats. The splicing factor SC35/SRSF2 binds to nuclear RNA and facilitates the incorporation of exon 10 in the TAU molecule. Here, we utilized clinical samples, an animal model, and neuronal cell cultures and found that Tat promotes TAU 3R up-regulation through increased levels of phosphorylated SC35, which is retained in nuclear speckles. This mechanism involved Tat-mediated increased expression of DYRK1A and was prevented by DYRK1A silencing. In addition, we found that Tat associates with TAU RNA, further demonstrating that Tat interferes with host RNA metabolism in the absence of viral infection. Altogether, our data unravel a novel mechanism of Tat-mediated neuronal toxicity through dysregulation of the SC35-dependent alternative splicing of TAU exon 10. Furthermore, the increased immunostaining of DYRK1A in HIV+ brains without pathology points at dysregulation of DYRK1A as an early event in the neuronal complications of HIV infection. </AbstractText>
<CopyrightInformation>© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kadri</LastName>
<ForeName>Ferdous</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Stanley S. Scott Cancer Center, and Department of Microbiology, Immunology and Parasitology, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pacifici</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Stanley S. Scott Cancer Center, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wilk</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Stanley S. Scott Cancer Center, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Parker-Struckhoff</LastName>
<ForeName>Amanda</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Stanley S. Scott Cancer Center, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Del Valle</LastName>
<ForeName>Luis</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Stanley S. Scott Cancer Center, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hauser</LastName>
<ForeName>Kurt F</ForeName>
<Initials>KF</Initials>
<AffiliationInfo>
<Affiliation>the Departments of Pharmacology and Toxicology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Knapp</LastName>
<ForeName>Pamela E</ForeName>
<Initials>PE</Initials>
<AffiliationInfo>
<Affiliation>Anatomy and Neurobiology, Virginia Commonwealth University, Richmond, Virginia 23284.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Parsons</LastName>
<ForeName>Christopher</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Stanley S. Scott Cancer Center, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jeansonne</LastName>
<ForeName>Duane</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Stanley S. Scott Cancer Center, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lassak</LastName>
<ForeName>Adam</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Stanley S. Scott Cancer Center, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peruzzi</LastName>
<ForeName>Francesca</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Stanley S. Scott Cancer Center, and fperuz@lsuhsc.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K02 DA027374</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DA034231</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">DYRK1A</Keyword>
<Keyword MajorTopicYN="N">RNA splicing</Keyword>
<Keyword MajorTopicYN="N">Tau protein (Tau)</Keyword>
<Keyword MajorTopicYN="N">human immunodeficiency virus (HIV)</Keyword>
<Keyword MajorTopicYN="N">phosphorylation</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26534965</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>290</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Elucidating the Specificity Determinants of the AtxE2 Lasso Peptide Isopeptidase.</ArticleTitle>
<Pagination>
<MedlinePgn>30806-12</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M115.694083</ELocationID>
<Abstract>
<AbstractText>Lasso peptide isopeptidase is an enzyme that specifically hydrolyzes the isopeptide bond of lasso peptides, rendering these peptides linear. To carry out a detailed structure-activity analysis of the lasso peptide isopeptidase AtxE2 from Asticcacaulis excentricus, we solved NMR structures of its substrates astexin-2 and astexin-3. Using in vitro enzyme assays, we show that the C-terminal tail portion of these peptides is dispensable with regards to isopeptidase activity. A collection of astexin-2 and astexin-3 variants with alanine substitutions at each position within the ring and the loop was constructed, and we showed that all of these peptides except for one were cleaved by the isopeptidase. Thus, much like the lasso peptide biosynthetic enzymes, lasso peptide isopeptidase has broad substrate specificity. Quantitative analysis of the cleavage reactions indicated that alanine substitutions in loop positions of these peptides led to reduced cleavage, suggesting that the loop is serving as a recognition element for the isopeptidase. </AbstractText>
<CopyrightInformation>© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Maksimov</LastName>
<ForeName>Mikhail O</ForeName>
<Initials>MO</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Chemical and Biological Engineering.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Koos</LastName>
<ForeName>Joseph D</ForeName>
<Initials>JD</Initials>
<AffiliationInfo>
<Affiliation>Molecular Biology, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zong</LastName>
<ForeName>Chuhan</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Chemistry, Princeton University, Princeton, New Jersey 08544.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lisko</LastName>
<ForeName>Bozhena</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Chemical and Biological Engineering.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Link</LastName>
<ForeName>A James</ForeName>
<Initials>AJ</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-5066-9691</Identifier>
<AffiliationInfo>
<Affiliation>From the Departments of Chemical and Biological Engineering, Molecular Biology, and ajlink@princeton.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>PDB</DataBankName>
<AccessionNumberList>
<AccessionNumber>2N68</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>T32 GM007388</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">enzyme processing</Keyword>
<Keyword MajorTopicYN="N">natural product biosynthesis</Keyword>
<Keyword MajorTopicYN="N">nuclear magnetic resonance (NMR)</Keyword>
<Keyword MajorTopicYN="N">peptidase</Keyword>
<Keyword MajorTopicYN="N">serine protease</Keyword>
<Keyword MajorTopicYN="N">structure-function</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26555260</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>290</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Chronic Hyperinsulinemia Causes Selective Insulin Resistance and Down-regulates Uncoupling Protein 3 (UCP3) through the Activation of Sterol Regulatory Element-binding Protein (SREBP)-1 Transcription Factor in the Mouse Heart.</ArticleTitle>
<Pagination>
<MedlinePgn>30947-61</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M115.673988</ELocationID>
<Abstract>
<AbstractText>The risk for heart failure and death after myocardial infarction is abnormally high in diabetic subjects. We and others have shown previously that mitochondrial uncoupling protein 3 (UCP3) improves functional recovery of the rodent heart during reperfusion. Here, we demonstrate that pharmacological induction of hyperinsulinemia in mice down-regulates myocardial UCP3. Decreased UCP3 expression was linked to the development of selective insulin resistance in the heart, characterized by decreased basal activity of Akt but preserved activity of the p44/42 mitogen-activated protein kinase, and overactivation of the sterol regulatory element-binding protein (SREBP)-1-mediated lipogenic program. In cultured myocytes, insulin treatment and SREBP-1 overexpression decreased, whereas SREBP-1 interference increased, peroxisome proliferator-activated receptor-stimulated expression of UCP3. Promoter deletion and site-directed mutagenesis identified three functional sterol regulatory elements in the vicinity of a known complex intronic enhancer. Increased binding of SREBP-1 to this DNA region was confirmed in the heart of hyperinsulinemic mice. In conclusion, we describe a hitherto unknown regulatory mechanism by which insulin inhibits cardiac UCP3 expression through activation of the lipogenic factor SREBP-1. Sustained down-regulation of cardiac UCP3 by hyperinsulinemia may partly explain the poor prognosis of type 2 diabetic patients after myocardial infarction. </AbstractText>
<CopyrightInformation>© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Harmancey</LastName>
<ForeName>Romain</ForeName>
<Initials>R</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-5040-4500</Identifier>
<AffiliationInfo>
<Affiliation>From the Department of Internal Medicine, Division of Cardiology, University of Texas Medical School, University of Texas Health Science Center, Houston, Texas 77030 and the Department of Physiology and Biophysics, Mississippi Center for Obesity Research and Cardiovascular-Renal Research Center, University of Mississippi Medical Center, Jackson, Mississippi 39216-4505 rharmancey@umc.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Haight</LastName>
<ForeName>Derek L</ForeName>
<Initials>DL</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Internal Medicine, Division of Cardiology, University of Texas Medical School, University of Texas Health Science Center, Houston, Texas 77030 and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Watts</LastName>
<ForeName>Kayla A</ForeName>
<Initials>KA</Initials>
<AffiliationInfo>
<Affiliation>the Department of Physiology and Biophysics, Mississippi Center for Obesity Research and Cardiovascular-Renal Research Center, University of Mississippi Medical Center, Jackson, Mississippi 39216-4505.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Taegtmeyer</LastName>
<ForeName>Heinrich</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Internal Medicine, Division of Cardiology, University of Texas Medical School, University of Texas Health Science Center, Houston, Texas 77030 and.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K99 HL112952</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 DK079638</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R00 HL112952</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL061483</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">gene regulation</Keyword>
<Keyword MajorTopicYN="N">heart</Keyword>
<Keyword MajorTopicYN="N">insulin resistance</Keyword>
<Keyword MajorTopicYN="N">lipogenesis</Keyword>
<Keyword MajorTopicYN="N">uncoupling protein</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26092286</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1878-5921</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>69</Volume>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Journal of clinical epidemiology</Title>
<ISOAbbreviation>J Clin Epidemiol</ISOAbbreviation>
</Journal>
<ArticleTitle>ROBIS: A new tool to assess risk of bias in systematic reviews was developed.</ArticleTitle>
<Pagination>
<MedlinePgn>225-34</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinepi.2015.06.005</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0895-4356(15)00308-X</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To develop ROBIS, a new tool for assessing the risk of bias in systematic reviews (rather than in primary studies).</AbstractText>
<AbstractText Label="STUDY DESIGN AND SETTING" NlmCategory="METHODS">We used four-stage approach to develop ROBIS: define the scope, review the evidence base, hold a face-to-face meeting, and refine the tool through piloting.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">ROBIS is currently aimed at four broad categories of reviews mainly within health care settings: interventions, diagnosis, prognosis, and etiology. The target audience of ROBIS is primarily guideline developers, authors of overviews of systematic reviews ("reviews of reviews"), and review authors who might want to assess or avoid risk of bias in their reviews. The tool is completed in three phases: (1) assess relevance (optional), (2) identify concerns with the review process, and (3) judge risk of bias. Phase 2 covers four domains through which bias may be introduced into a systematic review: study eligibility criteria; identification and selection of studies; data collection and study appraisal; and synthesis and findings. Phase 3 assesses the overall risk of bias in the interpretation of review findings and whether this considered limitations identified in any of the phase 2 domains. Signaling questions are included to help judge concerns with the review process (phase 2) and the overall risk of bias in the review (phase 3); these questions flag aspects of review design related to the potential for bias and aim to help assessors judge risk of bias in the review process, results, and conclusions.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">ROBIS is the first rigorously developed tool designed specifically to assess the risk of bias in systematic reviews.</AbstractText>
<CopyrightInformation>Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Whiting</LastName>
<ForeName>Penny</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK; The National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West at University Hospitals Bristol NHS Foundation Trust, 9th Floor, Whitefriars, Lewins Mead, Bristol BS1 2NT; Kleijnen Systematic Reviews Ltd, Unit 6, Escrick Business Park, Riccall Road, Escrick, York YO19 6FD, UK. Electronic address: penny.whiting@bristol.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Savović</LastName>
<ForeName>Jelena</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK; The National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West at University Hospitals Bristol NHS Foundation Trust, 9th Floor, Whitefriars, Lewins Mead, Bristol BS1 2NT.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Higgins</LastName>
<ForeName>Julian P T</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK; Centre for Reviews and Dissemination, University of York, York YO10 5DD, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Caldwell</LastName>
<ForeName>Deborah M</ForeName>
<Initials>DM</Initials>
<AffiliationInfo>
<Affiliation>School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Reeves</LastName>
<ForeName>Barnaby C</ForeName>
<Initials>BC</Initials>
<AffiliationInfo>
<Affiliation>School of Clinical Sciences, University of Bristol, Bristol Royal Infirmary, Level Queen's Building, 69 St Michael's Hill, Bristol BS2 8DZ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shea</LastName>
<ForeName>Beverley</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Community Information and Epidemiological Technologies Institute of Population Health, 1 Stewart Street, Room 319, Ottawa, Ontario, K1N 6N5, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Davies</LastName>
<ForeName>Philippa</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK; The National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West at University Hospitals Bristol NHS Foundation Trust, 9th Floor, Whitefriars, Lewins Mead, Bristol BS1 2NT.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kleijnen</LastName>
<ForeName>Jos</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Kleijnen Systematic Reviews Ltd, Unit 6, Escrick Business Park, Riccall Road, Escrick, York YO19 6FD, UK; School for Public Health and Primary Care (CAPHRI), Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Churchill</LastName>
<ForeName>Rachel</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>ROBIS group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>MR/K01465X/1</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Clin Epidemiol</MedlineTA>
<NlmUniqueID>8801383</NlmUniqueID>
<ISSNLinking>0895-4356</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Evidence</Keyword>
<Keyword MajorTopicYN="N">Meta-analysis</Keyword>
<Keyword MajorTopicYN="N">Quality</Keyword>
<Keyword MajorTopicYN="N">Risk of bias</Keyword>
<Keyword MajorTopicYN="N">Systematic review</Keyword>
<Keyword MajorTopicYN="N">Tool</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26484787</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1872-678X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>258</Volume>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>Journal of neuroscience methods</Title>
<ISOAbbreviation>J. Neurosci. Methods</ISOAbbreviation>
</Journal>
<ArticleTitle>An automated task for the training and assessment of distal forelimb function in a mouse model of ischemic stroke.</ArticleTitle>
<Pagination>
<MedlinePgn>16-23</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jneumeth.2015.10.004</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0165-0270(15)00376-3</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Behavioral models relevant to stroke research seek to capture important aspects of motor skills typically impaired in human patients, such as coordination of distal musculature. Such models may focus on mice since many genetic tools are available for use only in that species and since the training and behavioral demands of mice can differ from rats even for superficially similar behavioral readouts. However, current mouse assays are time consuming to train and score, especially in a manner producing continuous quantification. An automated assay of mouse forelimb function may provide advantages for quantification and speed, and may be useful for many applications including stroke research.</AbstractText>
<AbstractText Label="NEW METHOD" NlmCategory="METHODS">We present an automated assay of distal forelimb function. In this task, mice reach forward, grip and pull an isometric handle with a prescribed force. The apparatus partially automates the training process so that mice can be trained quickly and simultaneously.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Using this apparatus, it is possible to measure long-lasting impairment in success rate, force pulled, latency to pull, and latency to success up to 22 weeks following photothrombotic cortical strokes in mice.</AbstractText>
<AbstractText Label="COMPARISON WITH EXISTING METHOD(S)" NlmCategory="CONCLUSIONS">This assessment measures forelimb function as do pellet reach tasks, but it utilizes a different motion and provides automatic measures that can ease and augment the research process.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This high-throughput behavioral assay can detect long-lasting motor impairments, eliminates the need for subjective scoring, and produces a rich, continuous data set from which many aspects of the reach and grasp motion can be automatically extracted.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Becker</LastName>
<ForeName>April M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>University of Texas Southwestern Medical Center, Department of Neurology and Neurotherapeutics, Dallas, TX, United States; University of Texas Southwestern Medical Center, Neuroscience PhD Program, Dallas, TX, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Meyers</LastName>
<ForeName>Eric</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>University of Texas at Dallas, Erik Jonsson School of Engineering and Computer Science, Dallas, TX, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sloan</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>University of Texas at Dallas, Erik Jonsson School of Engineering and Computer Science, Dallas, TX, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rennaker</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>University of Texas at Dallas, Erik Jonsson School of Engineering and Computer Science, Dallas, TX, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kilgard</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>University of Texas at Dallas, School of Behavioral and Brain Sciences, Dallas, TX, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Goldberg</LastName>
<ForeName>Mark P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>University of Texas Southwestern Medical Center, Department of Neurology and Neurotherapeutics, Dallas, TX, United States; University of Texas Southwestern Medical Center, Neuroscience PhD Program, Dallas, TX, United States. Electronic address: mark.goldberg@UTSouthwestern.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 NS085167</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R44 DC010084</GrantID>
<Acronym>DC</Acronym>
<Agency>NIDCD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 NS069562</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>10</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>J Neurosci Methods</MedlineTA>
<NlmUniqueID>7905558</NlmUniqueID>
<ISSNLinking>0165-0270</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Behavior</Keyword>
<Keyword MajorTopicYN="N">Forelimb</Keyword>
<Keyword MajorTopicYN="N">Ischemic stroke</Keyword>
<Keyword MajorTopicYN="N">Mouse</Keyword>
<Keyword MajorTopicYN="N">Stroke</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26526459</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1872-678X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>258</Volume>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>Journal of neuroscience methods</Title>
<ISOAbbreviation>J. Neurosci. Methods</ISOAbbreviation>
</Journal>
<ArticleTitle>Two-photon imaging of chronically implanted neural electrodes: Sealing methods and new insights.</ArticleTitle>
<Pagination>
<MedlinePgn>46-55</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jneumeth.2015.10.007</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0165-0270(15)00379-9</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Two-photon microscopy has enabled the visualization of dynamic tissue changes to injury and disease in vivo. While this technique has provided powerful new information, in vivo two-photon chronic imaging around tethered cortical implants, such as microelectrodes or neural probes, present unique challenges.</AbstractText>
<AbstractText Label="NEW METHOD" NlmCategory="METHODS">A number of strategies are described to prepare a cranial window to longitudinally observe the impact of neural probes on brain tissue and vasculature for up to 3 months.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">It was found that silastic sealants limit cell infiltration into the craniotomy, thereby limiting light scattering and preserving window clarity over time. In contrast, low concentration hydrogel sealants failed to prevent cell infiltration and their use at high concentration displaced brain tissue and disrupted probe performance.</AbstractText>
<AbstractText Label="COMPARISON WITH EXISTING METHOD(S)" NlmCategory="CONCLUSIONS">The use of silastic sealants allows for a suitable imaging window for long term chronic experiments and revealed new insights regarding the dynamic leukocyte response around implants and the nature of chronic BBB leakage in the sub-dural space.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The presented method provides a valuable tool for evaluating the chronic inflammatory response and the performance of emerging implantable neural technologies.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kozai</LastName>
<ForeName>Takashi D Y</ForeName>
<Initials>TD</Initials>
<AffiliationInfo>
<Affiliation>Bioengineering, University of Pittsburgh, USA; Center for the Neural Basis of Cognition, University of Pittsburgh, USA; McGowan Institute for Regenerative Medicine, University of Pittsburgh, USA; NeuroTech Center of the University of Pittsburgh Brain Institute, USA. Electronic address: tdk18@pitt.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eles</LastName>
<ForeName>James R</ForeName>
<Initials>JR</Initials>
<AffiliationInfo>
<Affiliation>Bioengineering, University of Pittsburgh, USA; Center for the Neural Basis of Cognition, University of Pittsburgh, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vazquez</LastName>
<ForeName>Alberto L</ForeName>
<Initials>AL</Initials>
<AffiliationInfo>
<Affiliation>Bioengineering, University of Pittsburgh, USA; Center for the Neural Basis of Cognition, University of Pittsburgh, USA; Radiology, University of Pittsburgh, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cui</LastName>
<ForeName>X Tracy</ForeName>
<Initials>XT</Initials>
<AffiliationInfo>
<Affiliation>Bioengineering, University of Pittsburgh, USA; Center for the Neural Basis of Cognition, University of Pittsburgh, USA; McGowan Institute for Regenerative Medicine, University of Pittsburgh, USA. Electronic address: xic11@pitt.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K01 NS066131</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 NS062019</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 NS089688</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 NS094396</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>10</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>J Neurosci Methods</MedlineTA>
<NlmUniqueID>7905558</NlmUniqueID>
<ISSNLinking>0165-0270</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Encapsulation</Keyword>
<Keyword MajorTopicYN="N">Foreign Body</Keyword>
<Keyword MajorTopicYN="N">Giant Cell</Keyword>
<Keyword MajorTopicYN="N">Intracortical microelectrode</Keyword>
<Keyword MajorTopicYN="N">Intravital imaging</Keyword>
<Keyword MajorTopicYN="N">Multiphoton</Keyword>
<Keyword MajorTopicYN="N">Reactive tissue response</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26545443</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1872-678X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>258</Volume>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>Journal of neuroscience methods</Title>
<ISOAbbreviation>J. Neurosci. Methods</ISOAbbreviation>
</Journal>
<ArticleTitle>Vicarious social defeat stress: Bridging the gap between physical and emotional stress.</ArticleTitle>
<Pagination>
<MedlinePgn>94-103</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jneumeth.2015.10.012</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0165-0270(15)00392-1</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Animal models capable of differentiating the neurobiological intricacies between physical and emotional stress are scarce. Current models rely primarily on physical stressors (e.g., chronic unpredictable or mild stress, social defeat, learned helplessness), and neglect the impact of psychological stress alone. This is surprising given extensive evidence that a traumatic event needs not be directly experienced to produce enduring perturbations on an individual's health and psychological well-being. Post-traumatic stress disorder (PTSD), a highly debilitating neuropsychiatric disorder characterized by intense fear of trauma-related stimuli, often occurs in individuals that have only witnessed a traumatic event.</AbstractText>
<AbstractText Label="NEW METHOD" NlmCategory="METHODS">By modifying the chronic social defeat stress (CSDS) paradigm to include a witness component (witnessing the social defeat of another mouse), we demonstrate a novel behavioral paradigm capable of inducing a robust behavioral syndrome reminiscent of PTSD in emotionally stressed adult mice.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">We describe the vicarious social defeat stress (VSDS) model that is capable of inducing a host of behavioral deficits that include social avoidance and other depressive- and anxiety-like phenotypes in adult male mice. VSDS exposure induces weight loss and spike in serum corticosterone (CORT) levels. A month after stress, these mice retain the social avoidant phenotype and have an increased CORT response when exposed to subsequent stress.</AbstractText>
<AbstractText Label="COMPARISON WITH EXISTING METHOD(S)" NlmCategory="CONCLUSIONS">The VSDS is a novel paradigm capable of inducing emotional stress by isolating physical stress/confrontation in mice.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The VSDS model can be used to study the short- and long-term neurobiological consequences of exposure to emotional stress in mice.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sial</LastName>
<ForeName>Omar K</ForeName>
<Initials>OK</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychology and Program in Neuroscience, Florida State University, Tallahassee, FL 32306-4301, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Warren</LastName>
<ForeName>Brandon L</ForeName>
<Initials>BL</Initials>
<AffiliationInfo>
<Affiliation>National Institute on Drug Abuse, Behavioral Neuroscience Research Branch, Baltimore, MD, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alcantara</LastName>
<ForeName>Lyonna F</ForeName>
<Initials>LF</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychology and Program in Neuroscience, Florida State University, Tallahassee, FL 32306-4301, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Parise</LastName>
<ForeName>Eric M</ForeName>
<Initials>EM</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychology and Program in Neuroscience, Florida State University, Tallahassee, FL 32306-4301, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bolaños-Guzmán</LastName>
<ForeName>Carlos A</ForeName>
<Initials>CA</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychology and Program in Neuroscience, Florida State University, Tallahassee, FL 32306-4301, United States. Electronic address: bolanos@psy.fsu.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 DA026854</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21 DA022351</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>J Neurosci Methods</MedlineTA>
<NlmUniqueID>7905558</NlmUniqueID>
<ISSNLinking>0165-0270</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Depression</Keyword>
<Keyword MajorTopicYN="N">Emotional stress</Keyword>
<Keyword MajorTopicYN="N">PTSD</Keyword>
<Keyword MajorTopicYN="N">Social defeat</Keyword>
<Keyword MajorTopicYN="N">Witness stress</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26589380</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1879-0593</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>52</Volume>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Oral oncology</Title>
<ISOAbbreviation>Oral Oncol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Understanding the impact of survival and human papillomavirus tumor status on timing of recurrence in oropharyngeal squamous cell carcinoma.</ArticleTitle>
<Pagination>
<MedlinePgn>97-103</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.oraloncology.2015.10.016</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1368-8375(15)00360-7</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Human papillomavirus (HPV)-positive tumor status is associated with improved prognosis after disease recurrence in oropharyngeal squamous cell carcinoma (OPSCC). In this study the potential role of survival bias in the relationship between HPV tumor status and the timing of recurrence was evaluated, given conflicting evidence in the literature.</AbstractText>
<AbstractText Label="MATERIALS &amp; METHODS" NlmCategory="METHODS">A secondary analysis was performed on a previously published retrospective two institution study of recurrent OPSCC with known HPV tumor status. Patients were categorized as "early" (surviving &lt;24months) or "late" survivors (⩾24months). Timing of first recurrence and overall survival were analyzed using Kaplan-Meier and cox proportional hazard methods. Two-sided p-values &lt;0.05 were considered significant.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In total 101 patients met criteria including 81 late and 20 early survivors. HPV-positive tumor status was associated with longer time to recurrence in late survivors (median 21.8 vs. 13.8months, p=0.028). Late survivors had later recurrences in HPV-positive (p&lt;0.001) and HPV-negative patients (p=0.0096), as well as in both locoregional (p&lt;0.0001) and distant metastatic recurrence (p&lt;0.0001). In multivariate analysis, both HPV-positive tumor status (adjusted HR [aHR] 0.48, p=0.006) and survival beyond 24months (aHR 0.21, p&lt;0.001) were associated with later recurrence. When stratified, HPV tumor status was only associated with later recurrence in late survivors (aHR 0.47, p=0.015).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Late survivorship was associated with late recurrence for both HPV-positive and HPV-negative patients. Stratification by survival illustrates how survival bias links late survivorship with late recurrences and contributes to our understanding of the impact of HPV tumor status on the timing of recurrence.</AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Guo</LastName>
<ForeName>Theresa</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rettig</LastName>
<ForeName>Eleni</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fakhry</LastName>
<ForeName>Carole</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA; Milton J. Dance Jr. Head and Neck Center, Baltimore, MD 21204, USA; Bloomberg School of Public Health, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA. Electronic address: cfakhry@jhmi.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P50 DE019032</GrantID>
<Acronym>DE</Acronym>
<Agency>NIDCR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 DC000027</GrantID>
<Acronym>DC</Acronym>
<Agency>NIDCD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Oral Oncol</MedlineTA>
<NlmUniqueID>9709118</NlmUniqueID>
<ISSNLinking>1368-8375</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Human papillomavirus</Keyword>
<Keyword MajorTopicYN="N">Metastasis</Keyword>
<Keyword MajorTopicYN="N">Oropharynx cancer</Keyword>
<Keyword MajorTopicYN="N">Recurrence</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26498039</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-5150</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>54</Volume>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Pediatric neurology</Title>
<ISOAbbreviation>Pediatr. Neurol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Clinical Electroencephalographic Biomarker for Impending Epilepsy in Asymptomatic Tuberous Sclerosis Complex Infants.</ArticleTitle>
<Pagination>
<MedlinePgn>29-34</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pediatrneurol.2015.09.013</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0887-8994(15)30076-X</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We assessed the clinical utility of routine electroencephalography (EEG) in the prediction of epilepsy onset in asymptomatic infants with tuberous sclerosis complex.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">This multicenter prospective observational study recruited infants younger than 7 months, seizure-free and on no antiepileptic drugs at enrollment, who all underwent serial physical examinations and video EEGs throughout the study. Parental education on seizure recognition was completed at the time of initial enrollment. Once seizure onset occurred, standard of care was applied, and subjects were followed up until 24 months.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Forty patients were enrolled, 28 older than 12 months with completed EEG evaluation at the time of this interim analysis. Of those, 19 (67.8%) developed seizures. Epileptic spasms occurred in 10 (52.6%), focal seizures in five (26.3%), generalized tonic-clonic seizure in one (5.3%), and a combination of epileptic spasms and focal seizures in three (15.7%). Fourteen infants (73.6%) had the first emergence of epileptiform abnormalities on EEG at an average age 4.2 months, preceding seizure onset by a median of 1.9 months. Hypsarrhythmia or modified hypsarrhythmia was not found in any infant before onset of epileptic spasms. All children with epileptiform discharges subsequently developed epilepsy (100% positive predictive value), and the negative predictive value for not developing epilepsy after a normal EEG was 64%.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Serial routine EEGs in infants with tuberous sclerosis complex is a feasible strategy to identify individuals at high risk for epilepsy. The most frequent clinical presentation was epileptic spasms followed by focal seizures, and then a combination of both seizure types.</AbstractText>
<CopyrightInformation>Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Joyce Y</ForeName>
<Initials>JY</Initials>
<AffiliationInfo>
<Affiliation>Division of Pediatric Neurology, Mattel Children's Hospital at UCLA, Los Angeles, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peters</LastName>
<ForeName>Jurriaan M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Boston Children's Hospital, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Goyal</LastName>
<ForeName>Monisha</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, University of Alabama Birmingham, Birmingham, Alabama.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Krueger</LastName>
<ForeName>Darcy</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Cincinnati Children's Hospital, Cincinnati, Ohio.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sahin</LastName>
<ForeName>Mustafa</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Boston Children's Hospital, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Northrup</LastName>
<ForeName>Hope</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>University of Texas Houston, Houston, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Au</LastName>
<ForeName>Kit Sing</ForeName>
<Initials>KS</Initials>
<AffiliationInfo>
<Affiliation>University of Texas Houston, Houston, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cutter</LastName>
<ForeName>Gary</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, University of Alabama Birmingham, Birmingham, Alabama.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bebin</LastName>
<ForeName>E Martina</ForeName>
<Initials>EM</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, University of Alabama Birmingham, Birmingham, Alabama. Electronic address: ebebin@uab.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P20 NS080199</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 NS082320</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Pediatr Neurol</MedlineTA>
<NlmUniqueID>8508183</NlmUniqueID>
<ISSNLinking>0887-8994</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">EEG</Keyword>
<Keyword MajorTopicYN="N">epileptic spasms</Keyword>
<Keyword MajorTopicYN="N">partial seizures</Keyword>
<Keyword MajorTopicYN="N">video EEG use in epilepsy</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26524655</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1096-0333</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>290</Volume>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>Toxicology and applied pharmacology</Title>
<ISOAbbreviation>Toxicol. Appl. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Prenatal nicotinic exposure upregulates pulmonary C-fiber NK1R expression to prolong pulmonary C-fiber-mediated apneic response.</ArticleTitle>
<Pagination>
<MedlinePgn>107-15</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.taap.2015.10.023</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0041-008X(15)30126-5</ELocationID>
<Abstract>
<AbstractText>Prenatal nicotinic exposure (PNE) prolongs bronchopulmonary C-fiber (PCF)-mediated apneic response to intra-atrial bolus injection of capsaicin in rat pups. The relevant mechanisms remain unclear. Pulmonary substance P and adenosine and their receptors (neurokinin-A receptor, NK1R and ADA1 receptor, ADA1R) and transient receptor potential cation channel subfamily V member 1 (TRPV1) expressed on PCFs are critical for PCF sensitization and/or activation. Here, we compared substance P and adenosine in BALF and NK1R, ADA1R, and TRPV1 expression in the nodose/jugular (N/J) ganglia (vagal pulmonary C-neurons retrogradely labeled) between Ctrl and PNE pups. We found that PNE failed to change BALF substance P and adenosine content, but significantly upregulated both mRNA and protein TRPV1 and NK1R in the N/J ganglia and only NK1R mRNA in pulmonary C-neurons. To define the role of NK1R in the PNE-induced PCF sensitization, the apneic response to capsaicin (i.v.) without or with pretreatment of SR140333 (a peripheral and selective NK1R antagonist) was compared and the prolonged apnea by PNE significantly shortened by SR140333. To clarify if the PNE-evoked responses depended on action of nicotinic acetylcholine receptors (nAChRs), particularly α7nAChR, mecamylamine or methyllycaconitine (a general nAChR or a selective α7nAChR antagonist) was administrated via another mini-pump over the PNE period. Mecamylamine or methyllycaconitine eliminated the PNE-evoked mRNA and protein responses. Our data suggest that PNE is able to elevate PCF NK1R expression via activation of nAChRs, especially α7nAChR, which likely contributes to sensitize PCFs and prolong the PCF-mediated apneic response to capsaicin. </AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zhao</LastName>
<ForeName>Lei</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Pathophysiology Program, Lovelace Respiratory Research Institute, Albuquerque, NM, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhuang</LastName>
<ForeName>Jianguo</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Pathophysiology Program, Lovelace Respiratory Research Institute, Albuquerque, NM, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zang</LastName>
<ForeName>Na</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Pathophysiology Program, Lovelace Respiratory Research Institute, Albuquerque, NM, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lin</LastName>
<ForeName>Yong</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Pathophysiology Program, Lovelace Respiratory Research Institute, Albuquerque, NM, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Lu-Yuan</ForeName>
<Initials>LY</Initials>
<AffiliationInfo>
<Affiliation>Department of Physiology, University of Kentucky, Lexington, KY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Xu</LastName>
<ForeName>Fadi</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Pathophysiology Program, Lovelace Respiratory Research Institute, Albuquerque, NM, USA; Department of Physiology, University of Kentucky, Lexington, KY, USA. Electronic address: fxu@lrri.org.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 HL107462</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL119683</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>10</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Toxicol Appl Pharmacol</MedlineTA>
<NlmUniqueID>0416575</NlmUniqueID>
<ISSNLinking>0041-008X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Adenosine</Keyword>
<Keyword MajorTopicYN="N">NK1R</Keyword>
<Keyword MajorTopicYN="N">Nodose/jugular ganglion</Keyword>
<Keyword MajorTopicYN="N">SIDS</Keyword>
<Keyword MajorTopicYN="N">TRPV1</Keyword>
<Keyword MajorTopicYN="N">nAChRs</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26631581</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1096-0333</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>290</Volume>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>Toxicology and applied pharmacology</Title>
<ISOAbbreviation>Toxicol. Appl. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Experimental models of hepatotoxicity related to acute liver failure.</ArticleTitle>
<Pagination>
<MedlinePgn>86-97</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.taap.2015.11.016</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0041-008X(15)30143-5</ELocationID>
<Abstract>
<AbstractText>Acute liver failure can be the consequence of various etiologies, with most cases arising from drug-induced hepatotoxicity in Western countries. Despite advances in this field, the management of acute liver failure continues to be one of the most challenging problems in clinical medicine. The availability of adequate experimental models is of crucial importance to provide a better understanding of this condition and to allow identification of novel drug targets, testing the efficacy of new therapeutic interventions and acting as models for assessing mechanisms of toxicity. Experimental models of hepatotoxicity related to acute liver failure rely on surgical procedures, chemical exposure or viral infection. Each of these models has a number of strengths and weaknesses. This paper specifically reviews commonly used chemical in vivo and in vitro models of hepatotoxicity associated with acute liver failure. </AbstractText>
<CopyrightInformation>Copyright © 2015 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Maes</LastName>
<ForeName>Michaël</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Brussels, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vinken</LastName>
<ForeName>Mathieu</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Brussels, Belgium. Electronic address: mvinken@vub.ac.be.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jaeschke</LastName>
<ForeName>Hartmut</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P20 GM103549</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P20 RR021940</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AA012916</GrantID>
<Acronym>AA</Acronym>
<Agency>NIAAA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DK070195</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DK102142</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Toxicol Appl Pharmacol</MedlineTA>
<NlmUniqueID>0416575</NlmUniqueID>
<ISSNLinking>0041-008X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Acetaminophen</Keyword>
<Keyword MajorTopicYN="N">Acute liver failure</Keyword>
<Keyword MajorTopicYN="N">Concanavalin A</Keyword>
<Keyword MajorTopicYN="N">D-galactosamine</Keyword>
<Keyword MajorTopicYN="N">Fas ligand</Keyword>
<Keyword MajorTopicYN="N">Hepatotoxicity</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="In-Data-Review">
<PMID Version="1">26109528</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>12</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1939-0041</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>8</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology</Title>
<ISOAbbreviation>Wiley Interdiscip Rev Nanomed Nanobiotechnol</ISOAbbreviation>
</Journal>
<ArticleTitle>Nanoparticle-motivated gene delivery for ophthalmic application.</ArticleTitle>
<Pagination>
<MedlinePgn>160-74</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/wnan.1356</ELocationID>
<Abstract>
<AbstractText>Ophthalmic gene therapy is an intellectual and intentional manipulation of desired gene expression into the specific cells of an eye for the treatment of ophthalmic (ocular) genetic dystrophies and pathological conditions. Exogenous nucleic acids such as DNA, small interfering RNA, micro RNA, and so on, are used for the purpose of managing expression of the desired therapeutic proteins in ocular tissues. The delivery of unprotected nucleic acids into the cells is limited because of exogenous and endogenous degradation modalities. Nanotechnology, a promising and sophisticated cutting edge tool, works as a protective shelter for these therapeutic nucleic acids. They can be safely delivered to the required cells in order to modulate anticipated protein expression. To this end, nanotechnology is seen as a potential and promising strategy in the field of ocular gene delivery. This review focused on current nanotechnology modalities and other promising nonviral strategies being used to deliver therapeutic genes in order to treat various devastating ocular diseases. WIREs Nanomed Nanobiotechnol 2015, 8:160-174. doi: 10.1002/wnan.1356 For further resources related to this article, please visit the WIREs website. </AbstractText>
<CopyrightInformation>© 2015 Wiley Periodicals, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mitra</LastName>
<ForeName>Rajendra Narayan</ForeName>
<Initials>RN</Initials>
<AffiliationInfo>
<Affiliation>Department of Ophthalmology, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zheng</LastName>
<ForeName>Min</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Ophthalmology, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Han</LastName>
<ForeName>Zongchao</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Department of Ophthalmology, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Carolina Institute for NanoMedicine, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Division of Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R21 EY024059</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Wiley Interdiscip Rev Nanomed Nanobiotechnol</MedlineTA>
<NlmUniqueID>101508311</NlmUniqueID>
<ISSNLinking>1939-0041</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherID Source="NLM">NIHMS703885 [Available on 12/22/16]</OtherID>
<OtherID Source="NLM">PMC4688250 [Available on 12/22/16]</OtherID>
</MedlineCitation>
<DeleteCitation>
<PMID Version="1">26432306</PMID>
</DeleteCitation>
</MedlineCitationSet>